PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Currie, IS; Henderson, LK				Currie, Ian S.; Henderson, Lorna K.			ABO-incompatible renal transplantation	LANCET			English	Editorial Material							KIDNEY-TRANSPLANTATION; BENEFIT		[Currie, Ian S.; Henderson, Lorna K.] Royal Infirm Edinburgh NHS Trust, Edinburgh Transplant Ctr, Edinburgh EH16 4SA, Midlothian, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh	Currie, IS (corresponding author), Royal Infirm Edinburgh NHS Trust, Edinburgh Transplant Ctr, Edinburgh EH16 4SA, Midlothian, Scotland.	ian.currie@ed.ac.uk			Medical Research Council [MC_PC_12014] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Held PJ, 2016, AM J TRANSPLANT, V16, P877, DOI 10.1111/ajt.13490; Malho A, 2012, TRANSPL P, V44, P2344, DOI 10.1016/j.transproceed.2012.07.030; Montgomery JR, 2012, TRANSPLANTATION, V93, P603, DOI 10.1097/TP.0b013e318245b2af; Orandi BJ, 2016, NEW ENGL J MED, V374, P940, DOI 10.1056/NEJMoa1508380; Scurt FG, 2019, LANCET, V393, P2059, DOI 10.1016/S0140-6736(18)32091-9; Statistics and Clinical Studies NHS Blood and Transplant, 2018, ANN REP KIDN TRANSPL; Takahashi K, 2004, AM J TRANSPLANT, V4, P1089, DOI 10.1111/j.1600-6143.2004.00464.x; Won D, 2014, J CLIN APHERESIS, V29, P243, DOI 10.1002/jca.21312	8	2	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 18	2019	393	10185					2014	2016		10.1016/S0140-6736(19)30296-X	http://dx.doi.org/10.1016/S0140-6736(19)30296-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HY4QC	31006576				2022-12-28	WOS:000468112000007
J	Zhao, Y; Chen, SS; Swensen, AC; Qian, WJ; Gouaux, E				Zhao, Yan; Chen, Shanshuang; Swensen, Adam C.; Qian, Wei-Jun; Gouaux, Eric			Architecture and subunit arrangement of native AMPA receptors elucidated by cryo-EM	SCIENCE			English	Article							SYNAPTIC AMPA; GLUTAMATE RECEPTORS; TERMINAL DOMAIN; PHOSPHORYLATION; DESENSITIZATION; PLASTICITY; PROTEINS; DETERMINANT; VALIDATION; MODULATION	Glutamate-gated AMPA receptors mediate the fast component of excitatory signal transduction at chemical synapses throughout all regions of the mammalian brain. AMPA receptors are tetrameric assemblies composed of four subunits, GluA1-GluA4. Despite decades of study, the subunit composition, subunit arrangement, and molecular structure of native AMPA receptors remain unknown. Here we elucidate the structures of 10 distinct native AMPA receptor complexes by single-particle cryo-electron microscopy (cryo-EM). We find that receptor subunits are arranged nonstochastically, with the GluA2 subunit preferentially occupying the B and D positions of the tetramer and with triheteromeric assemblies comprising a major population of native AMPA receptors. Cryo-EM maps define the structure for S2-M4 linkers between the ligand-binding and transmembrane domains, suggesting how neurotransmitter binding is coupled to ion channel gating.	[Zhao, Yan; Chen, Shanshuang; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Swensen, Adam C.; Qian, Wei-Jun] Pacific Northwest Natl Lab, Integrat Omics, Div Biol Sci, Richland, WA 99352 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA	Oregon Health & Science University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.; Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Howard Hughes Med Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu	QIAN, Wei-Jun/AAC-1907-2021; Gouaux, Eric/Y-4370-2019; Qian, Wei-Jun/C-6167-2011	QIAN, Wei-Jun/0000-0002-5393-2827; Gouaux, Eric/0000-0002-8549-2360; Swensen, Adam/0000-0001-8135-1766	NIH [P41 GM103493]; DOE Environmental Molecular Sciences Laboratory at Pacific Northwest National Laboratory [DE-AC05-76RL0 1830]; NINDS grant of the National Institutes of Health [R01NS038631]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038631] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE Environmental Molecular Sciences Laboratory at Pacific Northwest National Laboratory; NINDS grant of the National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Mass spectrometry experiments were supported by NIH grant P41 GM103493 and performed in the DOE Environmental Molecular Sciences Laboratory at Pacific Northwest National Laboratory, operated by Battelle Memorial Institute under contract DE-AC05-76RL0 1830. This work was supported by a NINDS grant of the National Institutes of Health under award no. R01NS038631 to E.G., who is also an investigator of the Howard Hughes Medical Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551; Alt A, 2006, BIOCHEM PHARMACOL, V71, P1273, DOI 10.1016/j.bcp.2005.12.022; Baucum AJ, 2015, ACS CHEM NEUROSCI, V6, P615, DOI 10.1021/cn500337u; Baucum AJ, 2010, MOL CELL PROTEOMICS, V9, P1243, DOI 10.1074/mcp.M900387-MCP200; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chen SS, 2017, CELL, V170, P1234, DOI 10.1016/j.cell.2017.07.045; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Coleman JA, 2016, NATURE, V532, P334, DOI 10.1038/nature17629; Diaz-Alonso J, 2017, P NATL ACAD SCI USA, V114, P7136, DOI 10.1073/pnas.1707472114; Diering GH, 2018, NEURON, V100, P314, DOI 10.1016/j.neuron.2018.10.018; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Francis PT, 2003, INT J GERIATR PSYCH, V18, pS15, DOI 10.1002/gps.934; Giannone G, 2010, BIOPHYS J, V99, P1303, DOI 10.1016/j.bpj.2010.06.005; Gill MB, 2012, EUR J NEUROSCI, V35, P182, DOI 10.1111/j.1460-9568.2011.07948.x; Greger IH, 2017, NEURON, V94, P713, DOI 10.1016/j.neuron.2017.04.009; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Henley JM, 2016, NAT REV NEUROSCI, V17, P337, DOI 10.1038/nrn.2016.37; Herguedas B, 2016, SCIENCE, V352, DOI 10.1126/science.aad3873; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kazi R, 2014, NAT NEUROSCI, V17, P914, DOI 10.1038/nn.3724; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee SH, 2017, ELIFE, V6, DOI 10.7554/eLife.27744; Liu HQ, 2015, J STRUCT BIOL, V192, P14, DOI 10.1016/j.jsb.2015.09.001; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MOSBACHER J, 1994, SCIENCE, V266, P1059, DOI 10.1126/science.7973663; Moykkynen T, 2014, J BIOL CHEM, V289, P13197, DOI 10.1074/jbc.M113.526301; O'Neill MJ, 2007, CURR DRUG TARGETS, V8, P603, DOI 10.2174/138945007780618517; Partin KM, 1996, J NEUROSCI, V16, P6634, DOI 10.1523/jneurosci.16-21-06634.1996; Pelkey KA, 2015, NEURON, V85, P1257, DOI 10.1016/j.neuron.2015.02.020; Penn AC, 2017, NATURE, V549, P384, DOI 10.1038/nature23658; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pickard L, 2000, J NEUROSCI, V20, P7922; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Saab AS, 2012, SCIENCE, V337, P749, DOI 10.1126/science.1221140; Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Schwenk J, 2014, NEURON, V84, P41, DOI 10.1016/j.neuron.2014.08.044; Seeburg PH, 1996, J NEUROCHEM, V66, P1; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Sukumaran M, 2011, EMBO J, V30, P972, DOI 10.1038/emboj.2011.17; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Turetsky D, 2005, J NEUROSCI, V25, P7438, DOI 10.1523/JNEUROSCI.1108-05.2005; Turski L, 1998, P NATL ACAD SCI USA, V95, P10960, DOI 10.1073/pnas.95.18.10960; Twomey EC, 2016, SCIENCE, V353, P83, DOI 10.1126/science.aaf8411; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Yao GR, 2011, BIOCHEM J, V438, P255, DOI 10.1042/BJ20110801; Yi L, 2018, ANAL CHEM, V90, P5256, DOI 10.1021/acs.analchem.8b00071; Zhao Y, 2016, NATURE, V536, P108, DOI 10.1038/nature18961; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	61	84	85	3	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 26	2019	364	6438					355	+		10.1126/science.aaw8250	http://dx.doi.org/10.1126/science.aaw8250			43	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HU9VW	30975770	Green Accepted			2022-12-28	WOS:000465643400040
J	Reddy, A; Fihn, SD; Liao, JM				Reddy, Ashok; Fihn, Stephan D.; Liao, Joshua M.			The VA MISSION Act - Creating a Center for Innovation within the VA	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Reddy, Ashok] Univ Washington, Sch Med, VA Puget Sound Healthcare Syst, Seattle, WA 98195 USA; [Reddy, Ashok] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Liao, Joshua M.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA	University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; University of Pennsylvania	Reddy, A (corresponding author), Univ Washington, Sch Med, VA Puget Sound Healthcare Syst, Seattle, WA 98195 USA.; Reddy, A (corresponding author), Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA.		Fihn, Stephan/ABA-1040-2020					[Anonymous], 2018, WHAT IS CMMI 11 OTH; Fihn SD, 2018, J GEN INTERN MED, V33, P1589, DOI 10.1007/s11606-018-4508-5; Fortney JC, 2015, JAMA PSYCHIAT, V72, P58, DOI 10.1001/jamapsychiatry.2014.1575; Hebert PL, 2018, HEALTH SERV RES, V53, P5159, DOI 10.1111/1475-6773.13033	4	8	8	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 25	2019	380	17					1592	1594		10.1056/NEJMp1815209	http://dx.doi.org/10.1056/NEJMp1815209			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU9FC	31018067				2022-12-28	WOS:000465598600005
J	Zielinska-Dabkowska, KM; Xavia, K				Zielinska-Dabkowska, Karolina M.; Xavia, Kyra			Protect our right to light	NATURE			English	Editorial Material							PREVALENCE; MYOPIA		[Zielinska-Dabkowska, Karolina M.] GUT, Fac Architecture, Gdansk, Poland; [Zielinska-Dabkowska, Karolina M.] GUT, Lightlab, Gdansk, Poland; [Xavia, Kyra] LLRC, Troy, NY USA; [Xavia, Kyra] Int Dark Sky Assoc, Tucson, AZ USA	Fahrenheit Universities; Gdansk University of Technology; Fahrenheit Universities; Gdansk University of Technology	Zielinska-Dabkowska, KM (corresponding author), GUT, Fac Architecture, Gdansk, Poland.; Zielinska-Dabkowska, KM (corresponding author), GUT, Lightlab, Gdansk, Poland.	k.zielinska-dabkowska@pg.edu.pl	Zielinska-Dabkowska, Karolina/B-4607-2018	Zielinska-Dabkowska, Karolina/0000-0003-1414-6978				Al-Kodmany K, 2018, BUILDINGS-BASEL, V8, DOI 10.3390/buildings8120175; Boubekri M., 2004, J HUMAN ENV SYSTEM, V7, P51; Duhl L, 1999, HLTH CITIES CITY PLA; Galasiu AD, 2007, LEUKOS, V4, P7, DOI 10.1582/LEUKOS.2007.04.01.001; KJELGREN RK, 1992, INT J BIOMETEOROL, V36, P165, DOI 10.1007/BF01224821; Lagreze WA, 2017, DTSCH ARZTEBL INT, V114, P575, DOI 10.3238/arztebl.2017.0575; Lam CSY, 2012, OPHTHAL PHYSL OPT, V32, P17, DOI 10.1111/j.1475-1313.2011.00886.x; Naeem Z, 2010, INT J HLTH SCI QASSI, V4, pV; Rose KA, 2008, OPHTHALMOLOGY, V115, P1279, DOI 10.1016/j.ophtha.2007.12.019; Wai KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135562; Walch JM, 2005, PSYCHOSOM MED, V67, P156, DOI 10.1097/01.psy.0000149258.42508.70; Zielinska-Dabkowska KM, 2018, NATURE, V553, P274, DOI 10.1038/d41586-018-00568-7	12	14	14	2	13	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 25	2019	568	7753					451	453						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HU9DR	31015695	Bronze			2022-12-28	WOS:000465594200023
J	Horton, R				Horton, Richard			Offline: The case for compromise	LANCET			English	Editorial Material												richard.horton@lancet.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 20	2019	393	10181					1582	1582		10.1016/S0140-6736(19)30890-6	http://dx.doi.org/10.1016/S0140-6736(19)30890-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU0DL	31007187	Bronze			2022-12-28	WOS:000464941500011
J	Binnewies, M; Mujal, AM; Pollack, JL; Combes, AJ; Hardison, EA; Barry, KC; Tsui, J; Ruhland, MK; Kersten, K; Abushawish, MA; Spasic, M; Giurintano, JP; Chan, V; Daud, AI; Ha, P; Ye, CJ; Roberts, EW; Krummel, MF				Binnewies, Mikhail; Mujal, Adriana M.; Pollack, Joshua L.; Combes, Alexis J.; Hardison, Emily A.; Barry, Kevin C.; Tsui, Jessica; Ruhland, Megan K.; Kersten, Kelly; Abushawish, Marwan A.; Spasic, Marko; Giurintano, Jonathan P.; Chan, Vincent; Daud, Adil, I; Ha, Patrick; Ye, Chun J.; Roberts, Edward W.; Krummel, Matthew F.			Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4(+) T Cell Immunity	CELL			English	Article							GENE-EXPRESSION; INFLUENZA-VIRUS; RESPONSES; BLOCKADE; CANCER; PROGENITORS; DYSFUNCTION; ANTI-CTLA-4; UNDERLIE; ZBTB46	Differentiation of proinflammatory CD4(+) conventional T cells (T-conv) is critical for productive antitumor responses yet their elicitation remains poorly understood. We comprehensively characterized myeloid cells in tumor draining lymph nodes (tdLN) of mice and identified two subsets of conventional type-2 dendritic cells (cDC2) that traffic from tumor to tdLN and present tumor-derived antigens to CD4(+) T-conv, but then fail to support antitumor CD4(+) T-conv differentiation. Regulatory T cell (T-reg) depletion enhanced their capacity to elicit strong CD4(+) T-conv responses and ensuing antitumor protection. Analogous cDC2 populations were identified in patients, and as in mice, their abundance relative to T-reg predicts protective ICOS+ PD-1(lo) CD4(+) T-conv phenotypes and survival. Further, in melanoma patients with low T-reg abundance, intratumoral cDC2 density alone correlates with abundant CD4(+) T-conv and with responsiveness to anti-PD-1 therapy. Together, this highlights a pathway that restrains cDC2 and whose reversal enhances CD4(+) T-conv abundance and controls tumor growth.	[Binnewies, Mikhail; Mujal, Adriana M.; Combes, Alexis J.; Hardison, Emily A.; Barry, Kevin C.; Tsui, Jessica; Ruhland, Megan K.; Kersten, Kelly; Chan, Vincent; Roberts, Edward W.; Krummel, Matthew F.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Combes, Alexis J.; Barry, Kevin C.; Tsui, Jessica; Chan, Vincent; Krummel, Matthew F.] Univ Calif San Francisco, UCSF Immunoprofiler Initiat, San Francisco, CA 94143 USA; [Spasic, Marko; Daud, Adil, I] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Giurintano, Jonathan P.; Ha, Patrick] Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, San Francisco, CA 94143 USA; [Ye, Chun J.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Binnewies, Mikhail; Pollack, Joshua L.; Abushawish, Marwan A.] Pionyr Immunotherapeut, San Francisco, CA 94080 USA; [Mujal, Adriana M.] Mem Sloan Kettering Canc Ctr, Immunol Program, New York, NY 10065 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Memorial Sloan Kettering Cancer Center	Krummel, MF (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA.; Krummel, MF (corresponding author), Univ Calif San Francisco, UCSF Immunoprofiler Initiat, San Francisco, CA 94143 USA.	matthew.krummel@ucsf.edu	Ye, Chun/AAK-4868-2021	Ye, Chun/0000-0001-6560-3783; Abushawish, Marwan/0000-0001-9273-2871; Roberts, Edward/0000-0002-8229-1715; Combes, Alexis/0000-0002-9110-6542; Daud, Adil/0000-0002-6617-8421	AbbVie; Bristol-Myers Squibb; Pfizer; NSF Graduate Research Fellowship Program; NIH [U54 CA163123, R21CA191428, R01 CA197363]; Amgen; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007470] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA197363, U01CA217864, R21CA191428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI114787] Funding Source: NIH RePORTER	AbbVie(AbbVie); Bristol-Myers Squibb(Bristol-Myers Squibb); Pfizer(Pfizer); NSF Graduate Research Fellowship Program(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amgen(Amgen); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank E. Wan in the Institute for Human Genetics at UCSF for helping prepare samples for scRNA-seq. We would also like to thank the UCSF Parnassus Flow Cytometry Core for maintenance of flow cytometers and sorters, J.J. Engelhardt and Bristol-Myers-Squibb for Fc-modified anti-CTLA-4 antibodies, S.M. Kaech, M. Conti, and M.D. Rosenblum for mouse strains, L. Rodda for advice related to scRNA-seq, and A. Boissonnas, M.L. Broz, and M.B. Headley for guidance, advice, and critical reading of the manuscript. Acquisition and analysis of certain human samples described in this study was partially funded by contributions from AbbVie, Amgen, Bristol-Myers Squibb, and Pfizer. This work was supported in part by the NSF Graduate Research Fellowship Program awarded to M.B and NIH (U54 CA163123, R21CA191428, and R01 CA197363).	Alferink J, 2003, J EXP MED, V197, P585, DOI 10.1084/jem.20021859; Allison KA, 2016, ELIFE, V5, DOI 10.7554/eLife.10134; [Anonymous], JAN 6, V6, P620, DOI [10.3389/fimmu.2015.00620, DOI 10.3389/FIMMU.2015.00620, DOI 10.3389/FIMMU.2015.00363]; Baratin M, 2017, IMMUNITY, V47, P349, DOI 10.1016/j.immuni.2017.07.019; Barry KC, 2018, NAT MED, V24, P1178, DOI 10.1038/s41591-018-0085-8; Bauer CA, 2014, J CLIN INVEST, V124, P2425, DOI 10.1172/JCI66375; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Behrens G, 2004, IMMUNOL CELL BIOL, V82, P84, DOI 10.1111/j.1440-1711.2004.01211.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binnewies M, 2018, NAT MED, V24, P541, DOI 10.1038/s41591-018-0014-x; Bos PD, 2013, J EXP MED, V210, P2435, DOI 10.1084/jem.20130762; Broz ML, 2014, CANCER CELL, V26, P638, DOI 10.1016/j.ccell.2014.09.007; Chiba K, 1998, J IMMUNOL, V160, P5037; Corthay A, 2005, IMMUNITY, V22, P371, DOI 10.1016/j.immuni.2005.02.003; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; Fan XZ, 2014, J EXP MED, V211, P715, DOI 10.1084/jem.20130590; Gao Y, 2013, IMMUNITY, V39, P722, DOI 10.1016/j.immuni.2013.08.028; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365; Headley MB, 2016, NATURE, V531, P513, DOI 10.1038/nature16985; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hodi FS, 2008, P NATL ACAD SCI USA, V105, P3005, DOI 10.1073/pnas.0712237105; Johnson DB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10582; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kowalczyk MS, 2015, GENOME RES, V25, P1860, DOI 10.1101/gr.192237.115; Krishnaswamy JK, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam9169; Kumamoto Y, 2013, IMMUNITY, V39, P733, DOI 10.1016/j.immuni.2013.08.029; Laoui D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13720; Lavin Y, 2017, CELL, V169, P750, DOI 10.1016/j.cell.2017.04.014; Liang J, 2016, CELL REP, V17, P1330, DOI 10.1016/j.celrep.2016.09.091; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Mandal R, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.89829; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Nirschl CJ, 2017, CELL, V170, P127, DOI 10.1016/j.cell.2017.06.016; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roberts EW, 2016, CANCER CELL, V30, P324, DOI 10.1016/j.ccell.2016.06.003; Salmon H, 2016, IMMUNITY, V44, P924, DOI 10.1016/j.immuni.2016.03.012; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Schietinger A, 2016, IMMUNITY, V45, P389, DOI 10.1016/j.immuni.2016.07.011; Selby MJ, 2013, CANCER IMMUNOL RES, V1, P32, DOI 10.1158/2326-6066.CIR-13-0013; Shang B, 2015, SCI REP-UK, V5, DOI 10.1038/srep15179; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Thomas PG, 2006, P NATL ACAD SCI USA, V103, P2764, DOI 10.1073/pnas.0511185103; Topalian SL, 2014, J CLIN ONCOL, V32, P1020, DOI 10.1200/JCO.2013.53.0105; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Wei SC, 2017, CELL, V170, P1120, DOI 10.1016/j.cell.2017.07.024; Zappasodi R, 2018, CANCER CELL, V33, P1017, DOI 10.1016/j.ccell.2018.05.009	54	234	238	10	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2019	177	3					556	+		10.1016/j.cell.2019.02.005	http://dx.doi.org/10.1016/j.cell.2019.02.005			32	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HU0FV	30955881	Green Accepted, Bronze			2022-12-28	WOS:000464947700012
J	Canzio, D; Nwakeze, CL; Horta, A; Rajkumar, SM; Coffey, EL; Duffy, EE; Duffie, R; Monahan, K; O'Keeffe, S; Simon, MD; Lomvardas, S; Maniatis, T				Canzio, Daniele; Nwakeze, Chiamaka L.; Horta, Adan; Rajkumar, Sandy M.; Coffey, Eliot L.; Duffy, Erin E.; Duffie, Rachel; Monahan, Kevin; O'Keeffe, Sean; Simon, Matthew D.; Lomvardas, Stavros; Maniatis, Tom			Antisense lncRNA Transcription Mediates DNA Demethylation to Drive Stochastic Protocadherin alpha Promoter Choice	CELL			English	Article							GENE-EXPRESSION; REGULATORY ELEMENTS; GENOME TOPOLOGY; CTCF; METHYLATION; ACTIVATION; DIVERSITY; SIGNATURE; EFFICIENT; SELECTION	Stochastic activation of clustered Protocadherin (Pcdh) alpha, beta, and gamma genes generates a cell-surface identity code in individual neurons that functions in neural circuit assembly. Here, we show that Pcdh alpha gene choice involves the activation of an antisense promoter located in the first exon of each Pcdh alpha alternate gene. Transcription of an antisense long noncoding RNA (lncRNA) from this antisense promoter extends through the sense promoter, leading to DNA demethylation of the CTCF binding sites proximal to each promoter. Demethylation-dependent CTCF binding to both promoters facilitates cohesin-mediated DNA looping with a distal enhancer (HS5-1), locking in the transcriptional state of the chosen Pcdh alpha gene. Uncoupling DNA demethylation from antisense transcription by Tet3 overexpression in mouse olfactory neurons promotes CTCF binding to all Pcdh alpha promoters, resulting in proximity-biased DNA looping of the HS5-1 enhancer. Thus, antisense transcription-mediated promoter demethylation functions as a mechanism for distance-independent enhancer/promoter DNA looping to ensure stochastic Pcdh alpha promoter choice.	[Canzio, Daniele; Nwakeze, Chiamaka L.; Horta, Adan; Rajkumar, Sandy M.; Duffie, Rachel; Monahan, Kevin; O'Keeffe, Sean; Lomvardas, Stavros; Maniatis, Tom] Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA; [Canzio, Daniele; Nwakeze, Chiamaka L.; Horta, Adan; Rajkumar, Sandy M.; Duffie, Rachel; Monahan, Kevin; Lomvardas, Stavros; Maniatis, Tom] Columbia Univ, Mortimer B Zuckerman Mind Brain & Behav Inst, New York, NY 10027 USA; [Coffey, Eliot L.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Duffy, Erin E.; Simon, Matthew D.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06516 USA; [Maniatis, Tom] New York Genome Ctr, New York, NY 10013 USA; [Canzio, Daniele] Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA 94158 USA; [O'Keeffe, Sean] Celmatix, New York, NY 10005 USA	Columbia University; Columbia University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Yale University; University of California System; University of California San Francisco	Maniatis, T (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.; Maniatis, T (corresponding author), Columbia Univ, Mortimer B Zuckerman Mind Brain & Behav Inst, New York, NY 10027 USA.; Maniatis, T (corresponding author), New York Genome Ctr, New York, NY 10013 USA.	tm2472@cumc.columbia.edu	Simon, Matthew/ABF-9127-2020	Duffie, Rachel/0000-0001-8529-1377; Rajkumar, Sandy/0000-0001-9351-7399; Simon, Matthew/0000-0001-7423-5265; Duffy Lacy, Erin/0000-0002-7519-5098; Lomvardas, Stavros/0000-0002-7668-3026	Helen Hay Whitney Postdoctoral Fellowship; NIH: National Institutes of Health, United States; F32 Postdoctoral Fellowship [GM108474]; NIH F31 Predoctoral Fellowship [DC016785]; NIH Path to Independence Award [K99/R00 K99GM121815]; NIH [DP2 HD083992-01, 1R01MH108579, 5R01NS088476, R01DC013560]; HHMI: Howard Hughes Medical Institute: USA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM121815, K99GM121815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH108579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC013560, F31DC016785] Funding Source: NIH RePORTER	Helen Hay Whitney Postdoctoral Fellowship; NIH: National Institutes of Health, United States; F32 Postdoctoral Fellowship; NIH F31 Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Path to Independence Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI: Howard Hughes Medical Institute: USA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Drs. Richard Axel, Charles Zuker, Max Gottesman, David Hirsh, Germano Cecere, George Mountoufaris, and Enrico Cannavo and members of the Maniatis, Lomvardas, and Simon labs for critical discussions and suggestions on the manuscript. D.C. and T.M. would like to thank Dr. Karen Adelman for advice with the Start-Seq experiment, Dr. Ye Zhang and Dr. Ben Barres for the generous gift of human brain neurons, Dr. Victor Lobanenkov and Dr. Elena Pugacheva for the CTCF monoclonal antibody, and Ira Schieren for assistance with flow cytometry. This work was supported by a Helen Hay Whitney Postdoctoral Fellowship (D.C. and R.D.), an NIH: National Institutes of Health, United States, F32 Postdoctoral Fellowship GM108474 (K.M.), an NIH F31 Predoctoral Fellowship DC016785 (A.H.), an NIH Path to Independence Award K99/R00 K99GM121815 (D.C.), NIH New Innovator Award DP2 HD083992-01 (M.D.S.), NIH grants 1R01MH108579 and 5R01NS088476 (T.M.), and NIH grant R01DC013560 and HHMI: Howard Hughes Medical Institute: USA Faculty Scholar (S.L.).	Arab K, 2019, NAT GENET, V51, P217, DOI 10.1038/s41588-018-0306-6; Arab K, 2014, MOL CELL, V55, P604, DOI 10.1016/j.molcel.2014.06.031; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Brown T, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20178007; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/NMETH.3312, 10.1038/nmeth.3312]; Colquitt BM, 2013, P NATL ACAD SCI USA, V110, P14682, DOI 10.1073/pnas.1302759110; Duffy EE, 2015, MOL CELL, V59, P858, DOI 10.1016/j.molcel.2015.07.023; Esumi S, 2005, NAT GENET, V37, P171, DOI 10.1038/ng1500; Fuchs G, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-5-r69; Fudenberg G, 2016, CELL REP, V15, P2038, DOI 10.1016/j.celrep.2016.04.085; Ghirlando R, 2016, GENE DEV, V30, P881, DOI 10.1101/gad.277863.116; Guo Y, 2015, CELL, V162, P900, DOI 10.1016/j.cell.2015.07.038; Guo Y, 2012, P NATL ACAD SCI USA, V109, P21081, DOI 10.1073/pnas.1219280110; Hasegawa S, 2008, MOL CELL NEUROSCI, V38, P66, DOI 10.1016/j.mcn.2008.01.016; Hirayama T, 2012, CELL REP, V2, P345, DOI 10.1016/j.celrep.2012.06.014; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Jain S, 2018, CELL, V174, P102, DOI 10.1016/j.cell.2018.04.035; Kawaguchi M, 2008, J BIOL CHEM, V283, P12064, DOI 10.1074/jbc.M709648200; Kehayova P, 2011, P NATL ACAD SCI USA, V108, P17195, DOI 10.1073/pnas.1114357108; Lefebvre JL, 2015, ANNU REV CELL DEV BI, V31, P741, DOI 10.1146/annurev-cellbio-100913-013020; Li X, 2016, P NATL ACAD SCI USA, V113, pE8267, DOI 10.1073/pnas.1617802113; Lipovich L, 2006, J MOL EVOL, V62, P73, DOI 10.1007/s00239-005-0041-3; Magklara A, 2011, CELL, V145, P555, DOI 10.1016/j.cell.2011.03.040; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Marina RJ, 2016, CELL CYCLE, V15, P1397, DOI 10.1080/15384101.2016.1171650; Markenscoff-Papadimitriou E, 2014, CELL, V159, P543, DOI 10.1016/j.cell.2014.09.033; Monahan K, 2019, NATURE, V565, P448, DOI 10.1038/s41586-018-0845-0; Monahan K, 2012, P NATL ACAD SCI USA, V109, P9125, DOI 10.1073/pnas.1205074109; Mountoufaris G, 2018, ANNU REV CELL DEV BI, V34, P471, DOI 10.1146/annurev-cellbio-100616-060701; Mountoufaris G, 2017, SCIENCE, V356, P411, DOI 10.1126/science.aai8801; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Noonan JP, 2003, AM J HUM GENET, V72, P621, DOI 10.1086/368060; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Pugacheva EM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0736-8; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Ribich S, 2006, P NATL ACAD SCI USA, V103, P19719, DOI 10.1073/pnas.0609445104; Seitan VC, 2011, NATURE, V476, P467, DOI 10.1038/nature10312; Tasic B, 2002, MOL CELL, V10, P21, DOI 10.1016/S1097-2765(02)00578-6; Tasic B, 2018, NATURE, V563, P72, DOI 10.1038/s41586-018-0654-5; Toyoda S, 2014, NEURON, V82, P94, DOI 10.1016/j.neuron.2014.02.005; Vian L, 2018, CELL, V173, P1165, DOI 10.1016/j.cell.2018.03.072; Wang H, 2012, GENOME RES, V22, P1680, DOI 10.1101/gr.136101.111; Wang XZ, 2002, GENE DEV, V16, P1890, DOI 10.1101/gad.1004802; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Wu XJ, 2017, NAT REV GENET, V18, P517, DOI 10.1038/nrg.2017.33; Zhu ZR, 2014, METHOD ENZYMOL, V546, P215, DOI 10.1016/B978-0-12-801185-0.00011-8; Zipursky SL, 2013, ANNU REV NEUROSCI, V36, P547, DOI 10.1146/annurev-neuro-062111-150414; Zipursky SL, 2010, CELL, V143, P343, DOI 10.1016/j.cell.2010.10.009	48	77	78	3	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2019	177	3					639	+		10.1016/j.cell.2019.03.008	http://dx.doi.org/10.1016/j.cell.2019.03.008			30	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HU0FV	30955885	Green Accepted, Bronze			2022-12-28	WOS:000464947700018
J	Qaseem, A; Lin, JS; Mustafa, RA; Horwitch, CA; Wilt, TJ; Appley, C; Curley, L; Eleey, J; Haeme, R; Pantelas, J; Smith, MC; Vernon, L				Qaseem, Amir; Lin, Jennifer S.; Mustafa, Reem A.; Horwitch, Carrie A.; Wilt, Timothy J.; Appley, Cynthia; Curley, Larry; Eleey, Jane; Haeme, Ray; Pantelas, James; Smith, Missy Carson; Vernon, Lelis		Clinical Guidelines Comm Amer	Screening for Breast Cancer in Average-Risk Women: A Guidance Statement From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							UPDATE; HARMS; RECOMMENDATIONS; FRAMEWORK; BENEFITS	Description: The purpose of this guidance statement is to provide advice to clinicians on breast cancer screening in average-risk women based on a review of existing guidelines and the evidence they include. Methods: This guidance statement is derived from an appraisal of selected guidelines from around the world that address breast cancer screening, as well as their included evidence. All national guidelines published in English between 1 January 2013 and 15 November 2017 in the National Guideline Clearinghouse or Guidelines International Network library were included. In addition, the authors selected other guidelines commonly used in clinical practice. Web sites associated with all selected guidelines were checked for updates on 10 December 2018. The AGREE II (Appraisal of Guidelines for Research and Evaluation II) instrument was used to evaluate the quality of guidelines. Target Audience and Patient Population: The target audience is all clinicians, and the target patient population is all asymptomatic women with average risk for breast cancer. Guidance Statement 1: In average-risk women aged 40 to 49 years, clinicians should discuss whether to screen for breast cancer with mammography before age 50 years. Discussion should include the potential benefits and harms and a woman's preferences. The potential harms outweigh the benefits in most women aged 40 to 49 years. Guidance Statement 2: In average-risk women aged 50 to 74 years, clinicians should offer screening for breast cancer with biennial mammography. Guidance Statement 3: In average-risk women aged 75 years or older or in women with a life expectancy of 10 years or less, clinicians should discontinue screening for breast cancer. Guidance Statement 4: In average-risk women of all ages, clinicians should not use clinical breast examination to screen for breast cancer.	[Qaseem, Amir] 190 N Independence Mall West, Philadelphia, PA 19106 USA; [Lin, Jennifer S.] 3800 North Interstate Ave, Portland, OR 97227 USA; [Mustafa, Reem A.] 3901 Rainbow Blvd,MS3002, Kansas City, KS 66160 USA; [Horwitch, Carrie A.] 1100 Ninth Ave,C8-GIM, Seattle, WA 98101 USA; [Wilt, Timothy J.] VA Med Ctr 111-0, Minneapolis, MN 55417 USA		Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	aqaseem@acponline.org			ACP operating budget	ACP operating budget	Financial support for the development of this guidance statement comes exclusively from the ACP operating budget.	Barbeau P, 2017, BREAST CANC SCREEN A; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Cho H, 2013, ANN INTERN MED, V159, P667, DOI 10.7326/0003-4819-159-10-201311190-00005; Eckstrom E, 2013, J GEN INTERN MED, V28, P292, DOI 10.1007/s11606-012-2227-x; Expert Panel on Breast Imaging:, 2017, J Am Coll Radiol, V14, pS383, DOI 10.1016/j.jacr.2017.08.044; Fuller MS, 2015, MED CLIN N AM, V99, P451, DOI 10.1016/j.mcna.2015.01.002; Klarenbach S, 2018, CAN MED ASSOC J, V190, pE1441, DOI 10.1503/cmaj.180463; Lee SJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8441; Mandelblatt JS, 2016, ANN INTERN MED, V164, P215, DOI 10.7326/M15-1536; Melnikow J, 2016, ANN INTERN MED, V164, P268, DOI 10.7326/M15-1789; Miglioretti DL, 2016, ANN INTERN MED, V164, P205, DOI 10.7326/M15-1241; Myers ER, 2015, JAMA-J AM MED ASSOC, V314, P1615, DOI 10.1001/jama.2015.13183; National Cancer Institute, 2018, CANC STAT FACTS FEM; National Comprehensive Cancer Network (NCCN), 2018, NCCN CLIN PRACT GUID; Nelson HD, 2016, ANN INTERN MED, V164, P256, DOI 10.7326/M15-0970; Nelson HD, 2016, ANN INTERN MED, V164, P244, DOI 10.7326/M15-0969; Oeffinger KC, 2015, JAMA-J AM MED ASSOC, V314, P1599, DOI 10.1001/jama.2015.12783; Oxman A, 2013, GRADE HDB; Practice Bulletin No, 2017, OBSTET GYNECOL, V130, P241, DOI DOI 10.1097/AOG.0000000000002151; Provencher L, 2016, CURR ONCOL, V23, pE332, DOI 10.3747/co.23.2881; Rector T., 2016, LIFE EXPECTANCY CALC; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2750, DOI 10.1001/jama.285.21.2750; World Health Organization, 2014, WHO POS PAP MAMM SCR; 2016, ANN INTERN MED, V164, P279, DOI DOI 10.7326/M15-2886; 2015, ANN INTERN MED, V162, P718, DOI DOI 10.7326/M14-2326; 2015, ANN INTERN MED, V162, P712, DOI DOI 10.7326/M14-2327	27	89	95	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2019	170	8					547	+		10.7326/M18-2147	http://dx.doi.org/10.7326/M18-2147			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU7YQ	30959525				2022-12-28	WOS:000465499900018
J	Sharfstein, JM; Olsen, Y				Sharfstein, Joshua M.; Olsen, Yngvild			Making Amends for the Opioid Epidemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Sharfstein, Joshua M.] Johns Hopkins Bloomberg, Sch Publ Hlth, Publ Hlth Practice & Community Engagement, Baltimore, MD 21205 USA; [Olsen, Yngvild] Inst Behav Resources Inc, Addict Treatment Program, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Sharfstein, JM (corresponding author), Johns Hopkins Bloomberg, Sch Publ Hlth, Publ Hlth Practice & Community Engagement, Baltimore, MD 21205 USA.	joshua.sharfstein@jhu.edu							0	13	13	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 16	2019	321	15					1446	1447		10.1001/jama.2019.3505	http://dx.doi.org/10.1001/jama.2019.3505			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HT7SY	30990541	Bronze			2022-12-28	WOS:000464765900004
J	Liu, YJ; Aguzzi, A				Liu, Yingjun; Aguzzi, Adriano			Immunotherapy for neurodegeneration?	SCIENCE			English	Editorial Material							IMMUNE-CHECKPOINT BLOCKADE; AMYLOID-BETA; PATHOLOGY; NLRP3		[Liu, Yingjun; Aguzzi, Adriano] Univ Zurich, Inst Neuropathol, CH-8091 Zurich, Switzerland	University of Zurich	Liu, YJ (corresponding author), Univ Zurich, Inst Neuropathol, CH-8091 Zurich, Switzerland.	yingjun.liu@usz.ch; adriano.aguzzi@usz.ch	Liu, Yingjun/AAW-5353-2020	Liu, Yingjun/0000-0003-1543-1965; Aguzzi, Adriano/0000-0002-0344-6708	European Research Council; Swiss National Research Foundation; Nomis Foundation	European Research Council(European Research Council (ERC)European Commission); Swiss National Research Foundation(Swiss National Science Foundation (SNSF)); Nomis Foundation	A.A. is supported by the European Research Council, the Swiss National Research Foundation, and the Nomis Foundation.	Baruch K, 2016, NAT MED, V22, P135, DOI 10.1038/nm.4022; Boulanger LM, 2009, NEURON, V64, P93, DOI 10.1016/j.neuron.2009.09.001; Daniels MJD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12504; Gordon R, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aah4066; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Johann S, 2015, GLIA, V63, P2260, DOI 10.1002/glia.22891; Klein MA, 1997, NATURE, V390, P687, DOI 10.1038/37789; Latta-Mahieu M, 2018, GLIA, V66, P492, DOI 10.1002/glia.23260; Liu YJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32712-8; Mao XB, 2016, SCIENCE, V353, DOI 10.1126/science.aah3374; McGinnis GJ, 2017, ONCOTARGET, V8, P9155, DOI 10.18632/oncotarget.13551; Obst J, 2018, BRAIN BEHAV IMMUN, V73, P708, DOI 10.1016/j.bbi.2018.08.006; Schwartz M, 2017, SCIENCE, V357, P254, DOI 10.1126/science.aai8231; Sims R, 2017, NAT GENET, V49, P1373, DOI 10.1038/ng.3916; Venegas C, 2017, NATURE, V552, P355, DOI 10.1038/nature25158	15	12	13	2	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2019	364	6436					130	131		10.1126/science.aaw0685	http://dx.doi.org/10.1126/science.aaw0685			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HT5RC	30975878	Green Published			2022-12-28	WOS:000464620000024
J	Dyer, O				Dyer, Owen			Memorial Sloan Kettering Cancer Center tightens conflict of interest rules after scandals	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Dyer O, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3868; Kettering Memorial Sloan, 2019, NEW ENH CONFL INT PR; Ornstein C, 2018, NEW YORK TIMES	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 11	2019	365								l1762	10.1136/bmj.l1762	http://dx.doi.org/10.1136/bmj.l1762			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU0ER	30975743				2022-12-28	WOS:000464944700011
J	[Anonymous]				[Anonymous]			Endovascular treatment versus medical care alone for ischaemic stroke: systematic review and meta-analysis (vol 353, i1754, 2016)	BMJ-BRITISH MEDICAL JOURNAL			English	Correction													Neves, Joana B/I-8705-2019	Neves, Joana B/0000-0002-8578-9893				Rodrigues FB, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1754	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 11	2019	365								l1658	10.1136/bmj.l1658	http://dx.doi.org/10.1136/bmj.l1658			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU0ER	30975661	Bronze, Green Published			2022-12-28	WOS:000464944700007
J	Piper, RJ; Pike, M; Harrington, R; Magdum, SA				Piper, Rory J.; Pike, Michael; Harrington, Richard; Magdum, Shailendra A.			Chiari malformations: principles of diagnosis and management	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							I MALFORMATION; SPINA-BIFIDA; ADULTS		[Piper, Rory J.; Magdum, Shailendra A.] Oxford Univ Hosp NHS Fdn Trust, John Radcliffe Hosp, Dept Paediat Neurosurg, Oxford OX3 9DU, England; [Pike, Michael] Oxford Univ Hosp NHS Fdn Trust, John Radcliffe Hosp, Dept Paediat Neurol, Oxford, England; [Harrington, Richard] Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England	Oxford University Hospitals NHS Foundation Trust; University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Oxford	Piper, RJ (corresponding author), Oxford Univ Hosp NHS Fdn Trust, John Radcliffe Hosp, Dept Paediat Neurosurg, Oxford OX3 9DU, England.	rorypiper@doctors.org.uk	Piper, Rory/AAN-6122-2021	Piper, Rory/0000-0002-6422-5853				Adzick NS, 2011, NEW ENGL J MED, V364, P993, DOI 10.1056/NEJMoa1014379; Aiken AH, 2012, AM J NEURORADIOL, V33, P1901, DOI 10.3174/ajnr.A3068; Aitken LA, 2009, PEDIATR NEUROL, V40, P449, DOI 10.1016/j.pediatrneurol.2009.01.003; Atkinson JLD, 1998, J NEUROSURG, V88, P237, DOI 10.3171/jns.1998.88.2.0237; Fernandez AA, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-S1-S1; Bahlmann F, 2015, PRENATAL DIAG, V35, P228, DOI 10.1002/pd.4524; Boulet SL, 2008, BIRTH DEFECTS RES A, V82, P527, DOI 10.1002/bdra.20468; Chaoui R, 2009, ULTRASOUND OBST GYN, V34, P249, DOI 10.1002/uog.7329; Cinalli G, 2005, CHILD NERV SYST, V21, P889, DOI 10.1007/s00381-004-1115-z; Dicianno BE, 2009, AM J PHYS MED REHAB, V88, P533, DOI 10.1097/PHM.0b013e3181aa41d4; Dosa N, 2018, BMJ BEST PRACT; ELSTER AD, 1992, RADIOLOGY, V183, P347, DOI 10.1148/radiology.183.2.1561334; Engelborghs Sebastiaan, 2017, Alzheimers Dement (Amst), V8, P111, DOI 10.1016/j.dadm.2017.04.007; Flint G., 2014, SYRINGOMYELIA, P279, DOI [10.1007/978-3-642-13706-8_18, DOI 10.1007/978-3-642-13706-8_18]; Greenberg JK, 2015, NEUROSURGERY, V77, P261, DOI 10.1227/NEU.0000000000000777; Kelly MP, 2015, NEUROSURG CLIN N AM, V26, P579, DOI 10.1016/j.nec.2015.06.005; Kim I, 2018, J NEUROSURG-PEDIATR, V22, P652, DOI 10.3171/2018.5.PEDS18160; Ladner TR, 2016, J NEUROSURG-PEDIATR, V17, P76, DOI 10.3171/2015.5.PEDS1513; Lary J M, 1996, MMWR CDC Surveill Summ, V45, P15; Lennon CA, 1999, OBSTET GYNECOL, V94, P562, DOI 10.1016/S0029-7844(99)00399-3; McDowell MM, 2018, J NEUROSURG-PEDIATR, V21, P587, DOI 10.3171/2018.1.PEDS17496; Meadows J, 2000, J NEUROSURG, V92, P920, DOI 10.3171/jns.2000.92.6.0920; MIKULIS DJ, 1992, RADIOLOGY, V183, P725, DOI 10.1148/radiology.183.3.1584927; Milhorat TH, 1999, NEUROSURGERY, V44, P1005, DOI 10.1097/00006123-199905000-00042; Milhorat TH, 2007, J NEUROSURG-SPINE, V7, P601, DOI 10.3171/SPI-07/12/601; Mollan SP, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k3252; Morris Z, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3016; PAYNER TD, 1994, NEUROSURGERY, V34, P429, DOI 10.1227/00006123-199403000-00007; SATHI S, 1993, NEUROSURGERY, V32, P306, DOI 10.1227/00006123-199302000-00023; Schijman E, 2004, CHILD NERV SYST, V20, P341, DOI 10.1007/s00381-003-0882-2; Speer M C, 2000, Neurosurg Focus, V8, pE12; Stevenson Kevin L, 2004, Neurosurg Focus, V16, pE5; Tubbs RS, 2011, J NEUROSURG-PEDIATR, V7, P248, DOI 10.3171/2010.12.PEDS10379; Tully PA, 2018, CHILD NERV SYST, V34, P2173, DOI 10.1007/s00381-018-3878-7; Warf BC, 2008, J NEUROSURG-PEDIATR, V2, P310, DOI 10.3171/PED.2008.2.11.310; Whitson WJ, 2015, J NEUROSURG-PEDIATR, V16, P159, DOI 10.3171/2014.12.PEDS14301	36	16	17	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 8	2019	365								l1159	10.1136/bmj.l1159	http://dx.doi.org/10.1136/bmj.l1159			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU0EE	30962183				2022-12-28	WOS:000464943400003
J	Veidis, EM; Myers, SS; Almada, AA; Golden, CD				Veidis, Erika M.; Myers, Samuel S.; Almada, Amalia A.; Golden, Christopher D.		Clinicians Planetary Hlth Working	A call for clinicians to act on planetary health	LANCET			English	Editorial Material									[Veidis, Erika M.; Myers, Samuel S.; Almada, Amalia A.; Golden, Christopher D.] Planetary Hlth Alliance, Boston, MA 02115 USA; [Myers, Samuel S.; Golden, Christopher D.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health	Veidis, EM (corresponding author), Planetary Hlth Alliance, Boston, MA 02115 USA.	erikaveidis@g.harvard.edu		Almada, Amalia/0000-0003-2908-4394	Planetary Health Alliance; World Organization of Family Doctors (WONCA); Health Care Without Harm; World Federation of Public Health Associations; International Federation of Medical Students' Associations; American College of Lifestyle Medicine; American Public Health Association; Alliance of Nurses for Healthy Environments; Canadian Medical Association; Canadian Association of Physicians for the Environment; Caribbean College of Family Physicians; Brazilian Society of Family and Community Medicine; Brazilian College of Lifestyle Medicine (CBMEV); Brazilian Ministry of Health Oswaldo Cruz Foundation (Fiocruz); Uruguayan Society of Family and Community Medicine (SUMEFAC); UK Health Alliance on Climate Change; Royal College of General Practitioners; Centre for Sustainable Healthcare, Irish Doctors for the Environment; Association of Public Health Registrars of Ireland; Brookfield Centre for Lifestyle Medicine of Nigeria; Society of Lifestyle Medicine of Nigeria; African Lifestyle Medicine Association; Philippine Academy of Family Physicians, Doctors for the Environment Australia; Public Health Association of Australia, Health Professionals for a Healthy Climate; University of Minnesota School of Nursing & MHealth/Fairview Nursing Collaboratory, Climate for Health, Health In Harmony; True Health Initiative; Consortium of Universities for Global Health	Planetary Health Alliance; World Organization of Family Doctors (WONCA); Health Care Without Harm; World Federation of Public Health Associations; International Federation of Medical Students' Associations; American College of Lifestyle Medicine; American Public Health Association; Alliance of Nurses for Healthy Environments; Canadian Medical Association; Canadian Association of Physicians for the Environment; Caribbean College of Family Physicians; Brazilian Society of Family and Community Medicine; Brazilian College of Lifestyle Medicine (CBMEV); Brazilian Ministry of Health Oswaldo Cruz Foundation (Fiocruz); Uruguayan Society of Family and Community Medicine (SUMEFAC); UK Health Alliance on Climate Change; Royal College of General Practitioners; Centre for Sustainable Healthcare, Irish Doctors for the Environment; Association of Public Health Registrars of Ireland; Brookfield Centre for Lifestyle Medicine of Nigeria; Society of Lifestyle Medicine of Nigeria; African Lifestyle Medicine Association; Philippine Academy of Family Physicians, Doctors for the Environment Australia; Public Health Association of Australia, Health Professionals for a Healthy Climate; University of Minnesota School of Nursing & MHealth/Fairview Nursing Collaboratory, Climate for Health, Health In Harmony; True Health Initiative; Consortium of Universities for Global Health	We declare no competing interests. This global call to action is supported by the Planetary Health Alliance, the World Organization of Family Doctors (WONCA), Health Care Without Harm, the World Federation of Public Health Associations, the International Federation of Medical Students' Associations, the American College of Lifestyle Medicine, the American Public Health Association, the Alliance of Nurses for Healthy Environments, the Canadian Medical Association, the Canadian Association of Physicians for the Environment, the Caribbean College of Family Physicians, the Brazilian Society of Family and Community Medicine, the Brazilian College of Lifestyle Medicine (CBMEV), the Brazilian Ministry of Health Oswaldo Cruz Foundation (Fiocruz), the Uruguayan Society of Family and Community Medicine (SUMEFAC), the UK Health Alliance on Climate Change, the Royal College of General Practitioners, the Centre for Sustainable Healthcare, Irish Doctors for the Environment, the Association of Public Health Registrars of Ireland, the Brookfield Centre for Lifestyle Medicine of Nigeria, the Society of Lifestyle Medicine of Nigeria, the African Lifestyle Medicine Association, the Philippine Academy of Family Physicians, Doctors for the Environment Australia, the Public Health Association of Australia, Health Professionals for a Healthy Climate, the University of Minnesota School of Nursing & MHealth/Fairview Nursing Collaboratory, Climate for Health, Health In Harmony, the True Health Initiative, and the Consortium of Universities for Global Health.	[Anonymous], 2019, DECL CALL CLIN WORLD; Myers SS, 2017, LANCET, V390, P2860, DOI 10.1016/S0140-6736(17)32846-5; Steffen W, 2015, ANTHROPOCENE REV, V2, P81, DOI 10.1177/2053019614564785; Whitmee S, 2015, LANCET, V386, P1973, DOI 10.1016/S0140-6736(15)60901-1	4	21	21	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 18	2019	393	10185					2021	2021		10.1016/S0140-6736(19)30846-3	http://dx.doi.org/10.1016/S0140-6736(19)30846-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HY4QC	31010594				2022-12-28	WOS:000468112000010
J	Heerspink, HJL; Parving, HH; Andress, DL; Bakris, G; Correa-Rotter, R; Hou, FF; Kitzman, DW; Kohan, D; Makino, H; McMurray, JJV; Melnick, JZ; Miller, MG; Pergola, PE; Perkovic, V; Tobe, S; Yi, TT; Wigderson, M; de Zeeuw, D				Heerspink, Hiddo J. L.; Parving, Hans-Henrik; Andress, Dennis L.; Bakris, George; Correa-Rotter, Ricardo; Hou, Fan-Fan; Kitzman, Dalane W.; Kohan, Donald; Makino, Hirofumi; McMurray, John J. V.; Melnick, Joel Z.; Miller, Michael G.; Pergola, Pablo E.; Perkovic, Vlado; Tobe, Sheldon; Yi, Tingting; Wigderson, Melissa; de Zeeuw, Dick		SONAR Comm Investigators	Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial	LANCET			English	Article							ENDOTHELIN; ALBUMINURIA; NEPHROPATHY; INHIBITION	Background Short-term treatment for people with type 2 diabetes using a low dose of the selective endothelin A receptor antagonist atrasentan reduces albuminuria without causing significant sodium retention. We report the long-term effects of treatment with atrasentan on major renal outcomes. Methods We did this double-blind, randomised, placebo-controlled trial at 689 sites in 41 countries. We enrolled adults aged 18-85 years with type 2 diabetes, estimated glomerular filtration rate (eGFR) 25-75 mL/min per 1.73 m(2) of body surface area, and a urine albumin-to-creatinine ratio (UACR) of 300-5000 mg/g who had received maximum labelled or tolerated renin-angiotensin system inhibition for at least 4 weeks. Participants were given atrasentan 0.75 mg orally daily during an enrichment period before random group assignment. Those with a UACR decrease of at least 30% with no substantial fluid retention during the enrichment period (responders) were included in the double-blind treatment period. Responders were randomly assigned to receive either atrasentan 0.75 mg orally daily or placebo. All patients and investigators were masked to treatment assignment. The primary endpoint was a composite of doubling of serum creatinine (sustained for >= 30 days) or end-stage kidney disease (eGFR < 15 mL/min per 1.73 m(2) sustained for >= 90 days, chronic dialysis for >= 90 days, kidney transplantation, or death from kidney failure) in the intention-to-treat population of all responders. Safety was assessed in all patients who received at least one dose of their assigned study treatment. The study is registered with ClinicalTrials. gov, number NCT01858532. Findings Between May 17, 2013, and July 13, 2017, 11 087 patients were screened; 5117 entered the enrichment period, and 4711 completed the enrichment period. Of these, 2648 patients were responders and were randomly assigned to the atrasentan group (n=1325) or placebo group (n=1323). Median follow-up was 2.2 years (IQR 1.4-2.9). 79 (6.0%) of 1325 patients in the atrasentan group and 105 (7.9%) of 1323 in the placebo group had a primary composite renal endpoint event (hazard ratio [HR] 0.65 [95% CI 0.49-0.88]; p=0.0047). Fluid retention and anaemia adverse events, which have been previously attributed to endothelin receptor antagonists, were more frequent in the atrasentan group than in the placebo group. Hospital admission for heart failure occurred in 47 (3.5%) of 1325 patients in the atrasentan group and 34 (2.6%) of 1323 patients in the placebo group (HR 1.33 [95% CI 0.85-2.07]; p=0.208). 58 (4.4%) patients in the atrasentan group and 52 (3.9%) in the placebo group died (HR 1.09 [95% CI 0.75-1.59]; p=0.65). Interpretation Atrasentan reduced the risk of renal events in patients with diabetes and chronic kidney disease who were selected to optimise efficacy and safety. These data support a potential role for selective endothelin receptor antagonists in protecting renal function in patients with type 2 diabetes at high risk of developing end-stage kidney disease. Copyright (C) 2019 Elsevier Ltd. All rights reserved.	[Heerspink, Hiddo J. L.; de Zeeuw, Dick] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, NL-9700 RB Groningen, Netherlands; [Parving, Hans-Henrik] Univ Copenhagen, Rigshosp, Dept Med Endocrinol, Copenhagen, Denmark; [Parving, Hans-Henrik] Aarhus Univ, Fac Hlth Sci, Aarhus, Denmark; [Andress, Dennis L.; Melnick, Joel Z.; Miller, Michael G.; Yi, Tingting; Wigderson, Melissa] AbbVie, Pharmaceut Dev, N Chicago, IL USA; [Bakris, George] Univ Chicago Med & Biol Sci, Amer Soc Hypertens, Comprehens Hypertens Ctr, Chicago, IL USA; [Correa-Rotter, Ricardo] Natl Med Sci & Nutr Inst Salvador Zubiran, Mexico City, DF, Mexico; [Hou, Fan-Fan] Southern Med Univ, Natl Clin Res Ctr Kidney Dis, Nanfang Hosp, Div Nephrol, Guangzhou, Guangdong, Peoples R China; [Kitzman, Dalane W.] Wake Forest Sch Med, Winston Salem, NC USA; [Kohan, Donald] Univ Utah, Hlth Sci Ctr, Div Nephrol, Salt Lake City, UT USA; [Makino, Hirofumi] Okayama Univ, Okayama, Japan; [McMurray, John J. V.] Univ Glasgow, British Heart Fdn, Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Pergola, Pablo E.] Renal Associates PA, San Antonio, TX USA; [Perkovic, Vlado] George Inst Global Hlth, Sydney, NSW, Australia; [Perkovic, Vlado] Univ New South Wales, Sydney, NSW, Australia; [Tobe, Sheldon] Univ Toronto, Sunnybrook Hlth Sci Ctr, Div Nephrol, Toronto, ON, Canada; [Tobe, Sheldon] Northern Ontario Sch Med, Toronto, ON, Canada	University of Groningen; Rigshospitalet; University of Copenhagen; Aarhus University; AbbVie; Southern Medical University - China; Wake Forest University; Utah System of Higher Education; University of Utah; Okayama University; University of Glasgow; George Institute for Global Health; University of Sydney; University of New South Wales Sydney; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Northern Ontario School of Medicine	Heerspink, HJL (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, NL-9700 RB Groningen, Netherlands.	h.j.lambers.heerspink@umcg.nl	Saifutdinov, Rustam/ABC-3695-2020; Montero, Nuria/AAE-7077-2022; de Zeeuw, Dick/E-9080-2014; Tuta, Liliana Ana/AAE-9635-2021; Pavlova, Maria/AAK-6507-2021; Martynyuk, Liliya/AAE-5475-2019; Mark, Patrick/N-5536-2014; Shvarts, Yury Григорьевич/AAB-4929-2022; Budde, Klemens/AAD-2170-2020; Perkovic, Vlado/AAY-1933-2021; Panina, Svitlana/W-2900-2019; Villevalde, Svetlana V/R-8672-2016; mcmurray, John/B-2467-2013; Tesar, Vladimir/O-2312-2017; Vogt, Liffert/C-3168-2018; Gillard, Pieter/GPX-1490-2022; esposito, ciro/AAC-8023-2020; Heerspink, Hiddo J Lambers/K-3358-2014; Gillard, Pieter/AAY-1483-2020; Park, Kyong Soo/C-2265-2008; Navarro-Gonzalez, Juan F./M-7375-2014; rampino, teresa/AAF-3988-2022; De Cosmo, Salvatore/J-7420-2016; Tang, Sydney Chi Wai/C-4411-2009	Saifutdinov, Rustam/0000-0001-6504-8900; Montero, Nuria/0000-0002-5123-4603; de Zeeuw, Dick/0000-0003-3434-7777; Mark, Patrick/0000-0003-3387-2123; Shvarts, Yury Григорьевич/0000-0002-5205-7311; Budde, Klemens/0000-0002-7929-5942; Panina, Svitlana/0000-0003-1080-7185; Villevalde, Svetlana V/0000-0001-7652-2962; mcmurray, John/0000-0002-6317-3975; Tesar, Vladimir/0000-0001-6982-0689; Vogt, Liffert/0000-0002-4585-7505; Gillard, Pieter/0000-0001-9111-4561; esposito, ciro/0000-0002-7906-1097; Heerspink, Hiddo J Lambers/0000-0002-3126-3730; Gillard, Pieter/0000-0001-9111-4561; Schmidt, Alice/0000-0002-5275-0044; Wong, Hin-Seng/0000-0002-4807-7053; Tkac, Ivan/0000-0002-3171-8803; Gonzalez-Gonzalez, Jose Gerardo/0000-0002-6609-9483; Park, Kyong Soo/0000-0003-3597-342X; Zhao, Jiajun/0000-0003-3267-9292; Zanella, Maria Teresa/0000-0002-8451-8522; forti, adriana/0000-0002-5456-2303; Lahtela, Jorma/0000-0003-0752-8089; Bhorat, Qasim Ebrahim/0000-0002-4102-8750; Navarro-Gonzalez, Juan F./0000-0002-5015-7474; Bhorat, Asad/0000-0002-8764-7020; ESSAIAN, ASHOT/0000-0002-7202-3151; Samoilova, Iuliia/0000-0002-2667-4842; rampino, teresa/0000-0002-5311-9174; Zolotaikina, Viktoriia/0000-0002-5265-4861; gnudi, luigi/0000-0002-6353-630X; Stefanidis, Ioannis/0000-0002-5515-8089; De Cosmo, Salvatore/0000-0001-8787-8286; Golestaneh, Ladan/0000-0003-1848-582X; Liakopoulos, Vassilios/0000-0002-7564-2724; Martynyuk, Liliya/0000-0003-0870-2720; Tang, Sydney Chi Wai/0000-0002-6862-1941; Ahn, Kyu Jeung/0000-0002-4648-3605; Santamaria, Rafael/0000-0002-2627-1445; Dixon, Bradley/0000-0002-2534-3259; rossing, peter/0000-0002-1531-4294; GOH, BAK LEONG/0000-0002-4644-7743; Smolyarchuk, Elena/0000-0002-2615-7167; YILDIZ, ALAATTIN/0000-0002-4066-929X; Gallagher, Martin/0000-0001-9187-6187; Woo, Jeong-Taek/0000-0001-9201-0713; Kim, Sin Gon/0000-0002-7430-3675; Jang, Hak Chul/0000-0002-4188-6536; Maxwell, Alexander P./0000-0002-6110-7253	AbbVie; Veterans Affairs [I01BX003391] Funding Source: NIH RePORTER	AbbVie(AbbVie); Veterans Affairs(US Department of Veterans Affairs)	AbbVie.	Benigni A, 1998, DIABETES, V47, P450, DOI 10.2337/diabetes.47.3.450; Boels MGS, 2016, DIABETES, V65, P2429, DOI 10.2337/db15-1413; de Zeeuw D, 2016, LANCET DIABETES ENDO, V4, P638, DOI 10.1016/S2213-8587(16)30045-6; de Zeeuw D, 2014, J AM SOC NEPHROL, V25, P1083, DOI 10.1681/ASN.2013080830; Fried LF, 2013, NEW ENGL J MED, V369, P1892, DOI 10.1056/NEJMoa1303154; Heerspink HJL, 2016, DIABETES OBES METAB, V18, P169, DOI 10.1111/dom.12600; Heerspink HJL, 2018, DIABETES OBES METAB, V20, P1829, DOI 10.1111/dom.13315; Heerspink HJL, 2018, DIABETES OBES METAB, V20, P1369, DOI 10.1111/dom.13245; Keane WF, 2003, KIDNEY INT, V63, P1499, DOI 10.1046/j.1523-1755.2003.00885.x; Kohan DE, 2014, KIDNEY INT, V86, P896, DOI 10.1038/ki.2014.143; Kohan DE, 2011, J AM SOC NEPHROL, V22, P763, DOI 10.1681/ASN.2010080869; Mann JFE, 2010, J AM SOC NEPHROL, V21, P527, DOI 10.1681/ASN.2009060593; Parving HH, 2012, NEW ENGL J MED, V367, P2204, DOI 10.1056/NEJMoa1208799; Perkovic V, 2016, KIDNEY INT, V90, P1175, DOI 10.1016/j.kint.2016.09.010; Sasser JM, 2007, J AM SOC NEPHROL, V18, P143, DOI 10.1681/ASN.2006030208; United States Renal Data System, 2013, 2013 USRDS ANN DAT R, V2; Wenzel RR, 2009, J AM SOC NEPHROL, V20, P655, DOI 10.1681/ASN.2008050482; 2007, NEPHROL DIAL TRANSPL, V22, P3228, DOI DOI 10.1093/NDT/GFM364; 2019, LANCET DIABETES ENDO, V7, P128, DOI DOI 10.1016/S2213-8587(18)30314-0; 2018, KIDNEY INT, V93, P270, DOI DOI 10.1016/J.KINT.2017.10.009; 2010, DIABETOLOGIA, V53, P192, DOI DOI 10.1007/S00125-009-1540-3; 2004, KIDNEY INT, V65, P2309; 2017, DIABETES OBES METAB, V19, P749, DOI DOI 10.1111/DOM.12864; 2019, LANCET DIABETES ENDO, V7, P115, DOI DOI 10.1016/S2213-8587(18)30313-9	24	269	278	4	84	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 11	2019	393	10184					1937	1947		10.1016/S0140-6736(19)30772-X	http://dx.doi.org/10.1016/S0140-6736(19)30772-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HX9AE	30995972	Green Published			2022-12-28	WOS:000467698100029
J	Mosser, JF; Gagne-Maynard, W; Rao, PC; Osgood-Zimmerman, A; Fullman, N; Graetz, N; Burstein, R; Updike, RL; Liu, PY; Ray, SE; Earl, L; Deshpande, A; Casey, DC; Dwyer-Lindgren, L; Cromwell, EA; Pigott, DM; Shearer, FM; Larson, HJ; Weiss, DJ; Bhatt, S; Gething, PW; Murray, CJL; Lim, SS; Reiner, RC; Hay, SI				Mosser, Jonathan F.; Gagne-Maynard, William; Rao, Puja C.; Osgood-Zimmerman, Aaron; Fullman, Nancy; Graetz, Nicholas; Burstein, Roy; Updike, Rachel L.; Liu, Patrick Y.; Ray, Sarah E.; Earl, Lucas; Deshpande, Aniruddha; Casey, Daniel C.; Dwyer-Lindgren, Laura; Cromwell, Elizabeth A.; Pigott, David M.; Shearer, Freya M.; Larson, Heidi Jane; Weiss, Daniel J.; Bhatt, Samir; Gething, Peter W.; Murray, Christopher J. L.; Lim, Stephen S.; Reiner, Robert C., Jr.; Hay, Simon I.			Mapping diphtheria-pertussis-tetanus vaccine coverage in Africa, 2000-2016: a spatial and temporal modelling study	LANCET			English	Article							MIDDLE-INCOME COUNTRIES; PLASMODIUM-FALCIPARUM; ASSISTANCE; MORTALITY	Background Routine childhood vaccination is among the most cost-effective, successful public health interventions available. Amid substantial investments to expand vaccine delivery throughout Africa and strengthen administrative reporting systems, most countries still require robust measures of local routine vaccine coverage and changes in geographical inequalities over time. Methods This analysis drew from 183 surveys done between 2000 and 2016, including data from 881 268 children in 49 African countries. We used a Bayesian geostatistical model calibrated to results from the Global Burden of Diseases, Injuries, and Risk Factors Study 2017, to produce annual estimates with high-spatial resolution (5 x 5 km) of diphtheria-pertussis-tetanus (DPT) vaccine coverage and dropout for children aged 12-23 months in 52 African countries from 2000 to 2016. Findings Estimated third-dose (DPT3) coverage increased in 72.3% (95% uncertainty interval [UI] 64.6-80.3) of second-level administrative units in Africa from 2000 to 2016, but substantial geographical inequalities in DPT coverage remained across and within African countries. In 2016, DPT3 coverage at the second administrative (ie, district) level varied by more than 25% in 29 of 52 countries, with only two (Morocco and Rwanda) of 52 countries meeting the Global Vaccine Action Plan target of 80% DPT3 coverage or higher in all second-level administrative units with high confidence (posterior probability >= 95%). Large areas of low DPT3 coverage (<= 50%) were identified in the Sahel, Somalia, eastern Ethiopia, and in Angola. Low first-dose (DPT1) coverage (<= 50%) and high relative dropout (>= 30%) together drove low DPT3 coverage across the Sahel, Somalia, eastern Ethiopia, Guinea, and Angola. Interpretation Despite substantial progress in Africa, marked national and subnational inequalities in DPT coverage persist throughout the continent. These results can help identify areas of low coverage and vaccine delivery system vulnerabilities and can ultimately support more precise targeting of resources to improve vaccine coverage and health outcomes for African children. Copyright (C) 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.	[Mosser, Jonathan F.; Gagne-Maynard, William; Rao, Puja C.; Osgood-Zimmerman, Aaron; Fullman, Nancy; Graetz, Nicholas; Burstein, Roy; Updike, Rachel L.; Ray, Sarah E.; Earl, Lucas; Deshpande, Aniruddha; Casey, Daniel C.; Dwyer-Lindgren, Laura; Cromwell, Elizabeth A.; Pigott, David M.; Larson, Heidi Jane; Murray, Christopher J. L.; Lim, Stephen S.; Reiner, Robert C., Jr.; Hay, Simon I.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [Cromwell, Elizabeth A.; Pigott, David M.; Murray, Christopher J. L.; Lim, Stephen S.; Reiner, Robert C., Jr.; Hay, Simon I.] Univ Washington, Dept Hlth Metr Sci, Seattle, WA 98195 USA; [Liu, Patrick Y.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Shearer, Freya M.; Weiss, Daniel J.; Gething, Peter W.] Univ Oxford, Big Data Inst, Oxford, England; [Larson, Heidi Jane] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Bhatt, Samir] Imperial Coll London, Dept Infect Dis Epidemiol, Sch Publ Hlth, London, England	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; Imperial College London	Lim, SS; Hay, SI (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA.	stevelim@uw.edu; sihay@uw.edu	Gething, Peter/GQR-1884-2022; Gething, Peter/ABD-2110-2020; Bhatt, Samir/ABE-7938-2020; Hay, Simon Iain/F-8967-2015; Larson, Heidi J./N-1018-2017	Gething, Peter/0000-0001-6759-5449; Hay, Simon Iain/0000-0002-0611-7272; Larson, Heidi J./0000-0002-8477-7583; Shearer, Freya/0000-0001-9600-3473; Bhatt, Samir/0000-0002-0891-4611; Ray, Sarah/0000-0002-5775-8344; Mosser, Jonathan/0000-0001-9093-3186; /0000-0002-6175-5648	Bill & Melinda Gates Foundation [OPP1119467, OPP1106023]; MRC [MR/R015600/1] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007242] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Bill & Melinda Gates Foundation.; This work was primarily supported by grants from the Bill & Melinda Gates Foundation (OPP1182474, OPP11093011, and OPP1132415). SIH is also funded by additional grants from the Bill & Melinda Gates Foundation (OPP1119467 and OPP1106023).	Berkley S, 2017, NATURE, V551, P273, DOI 10.1038/d41586-017-05923-8; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Bhatt S, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0520; BID Initiative, 2016, EMP COUNTR ENH IMM O; Burton A, 2009, B WORLD HEALTH ORGAN, V87, P535, DOI 10.2471/BLT.08.053819; de Figueiredo A, 2016, LANCET GLOB HEALTH, V4, pE726, DOI 10.1016/S2214-109X(16)30167-X; Dowell SF, 2016, NATURE, V540, P189, DOI 10.1038/540189a; Fullman N, 2017, LANCET, V390, P1423, DOI 10.1016/S0140-6736(17)32336-X; Gavi, 2018, GAV BOARD M 28 29 NO; Gavi, 2016, CROSS COUNTR FIND 20; GavI, 2018, SUCC TRANS NIG GAV S; Gavi, 2016, 2016 2020 STRAT IND; Gavi, HLTH SYST IMM STRENG; Gething PW, 2016, NEW ENGL J MED, V375, P2435, DOI 10.1056/NEJMoa1606701; Golding N, 2017, LANCET, V390, P2171, DOI 10.1016/S0140-6736(17)31758-0; Graetz N, 2018, NATURE, V555, P48, DOI 10.1038/nature25761; Haakenstad A, 2016, HEALTH AFFAIR, V35, P242, DOI 10.1377/hlthaff.2015.1080; Hosmer DW, 2013, WILEY SERIES PROBABI; ICF International, SPAT DAT REP DEM HLT; Kallenberg J, 2016, HEALTH AFFAIR, V35, P250, DOI 10.1377/hlthaff.2015.1079; Lindgren F, 2011, J R STAT SOC B, V73, P423, DOI 10.1111/j.1467-9868.2011.00777.x; Martins TG, 2013, COMPUT STAT DATA AN, V67, P68, DOI 10.1016/j.csda.2013.04.014; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; Ozawa S, 2017, B WORLD HEALTH ORGAN, V95, P629, DOI 10.2471/BLT.16.178475; Ozawa S, 2012, VACCINE, V31, P96, DOI 10.1016/j.vaccine.2012.10.103; Rainey JJ, 2011, VACCINE, V29, P8215, DOI 10.1016/j.vaccine.2011.08.096; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; SAGE, 2016, 2016 MIDT REV GLOB; Tatem AJ, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.4; United Nations, 2018, WORK STAT COMM PERTA; Utazi CE, 2018, VACCINE, V36, P1583, DOI 10.1016/j.vaccine.2018.02.020; Vandelaer J., 2008, B WORLD HEALTH ORGAN, V86, P240; Wang H., 2016, ETHIOPIA HLTH EXTENS; Wang HD, 2017, LANCET, V390, P1084, DOI 10.1016/S0140-6736(17)31833-0; WHO, 2018, LIM REL GLOB REP IMM; WHO, 2017, SUBNATIONAL IMMUNIZA; WHO, 2018, THE RED STRAT; World Health Organization, 2013, GLOB VACC ACT PLAN M; World Health Organization (WHO), 2005, IMM DAT QUAL SELF AS; 2018, NATURE, V555, P41	40	58	59	2	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 4	2019	393	10183					1843	1855		10.1016/S0140-6736(19)30226-0	http://dx.doi.org/10.1016/S0140-6736(19)30226-0			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HW7GR	30961907	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000466858700034
J	Vandaele, AC; Korablev, O; Daerden, F; Aoki, S; Thomas, IR; Altieri, F; Lopez-Valverde, M; Villanueva, G; Liuzzi, G; Smith, MD; Erwin, JT; Trompet, L; Fedorova, AA; Montmessin, F; Trokhimovskiy, A; Belyaev, DA; Ignatiev, NI; Luginin, M; Olsen, KS; Baggio, L; Alday, J; Bertaux, JL; Betsis, D; Bolsee, D; Clancy, RT; Cloutis, E; Depiesse, C; Funke, B; Garcia-Comas, M; Gerard, JC; Giuranna, M; Gonzalez-Galindo, F; Grigoriev, AV; Ivanov, YS; Kaminski, J; Karatekin, O; Lefevre, F; Lewis, S; Lopez-Puertas, M; Mahieux, A; Maslov, I; Mason, J; Mumma, MJ; Neary, L; Neefs, E; Patrakeev, A; Patsaev, D; Ristic, B; Robert, S; Schmidt, F; Shakun, A; Teanby, NA; Viscardy, S; Willame, Y; Whiteway, J; Wilquet, V; Wolff, MJ; Bellucci, G; Patel, MR; Lopez-Moreno, JJ; Forget, F; Wilson, CF; Svedhem, H; Vago, JL; Rodionov, D; Alonso-Rodrigo, G; Bauduin, S; Carrozzo, G; Crismani, M; Da Pieve, F; D'Aversa, E; Etiope, G; Fussen, D; Geminale, A; Gkouvelis, L; Holmes, J; Hubert, B; Kasaba, Y; Kass, D; Kleinbohl, A; Lanciano, O; Nakagawa, H; Novak, RE; Oliva, F; Piccialli, A; Renotte, E; Ritter, B; Schneider, N; Sindoni, G; Thiemann, E; Vander Auwera, J; Wolkenberg, P; Yelle, R; Anufreychik, K; Arnold, G; Duxbury, N; Fouchet, T; Grassi, D; Guerlet, S; Hartogh, P; Khatuntsev, I; Kokonkov, N; Krasnopolsky, V; Kuzmin, R; Lacombe, G; Lellouch, E; Maattanen, A; Marcq, E; Martin-Torres, J; Medvedev, A; Millour, E; Moshkin, B; Quantin-Nataf, C; Rodin, A; Shematovich, V; Thomas, N; Vazquez, L; Vincendon, M; Young, R; Zasova, L; Zelenyi, L; Zorzano, MP				Vandaele, Ann Carine; Korablev, Oleg; Daerden, Frank; Aoki, Shohei; Thomas, Ian R.; Altieri, Francesca; Lopez-Valverde, Miguel; Villanueva, Geronimo; Liuzzi, Giuliano; Smith, Michael D.; Erwin, Justin T.; Trompet, Loic; Fedorova, Anna A.; Montmessin, Franck; Trokhimovskiy, Alexander; Belyaev, Denis A.; Ignatiev, Nikolay I.; Luginin, Mikhail; Olsen, Kevin S.; Baggio, Lucio; Alday, Juan; Bertaux, Jean-Loup; Betsis, Daria; Bolsee, David; Clancy, R. Todd; Cloutis, Edward; Depiesse, Cedric; Funke, Bernd; Garcia-Comas, Maia; Gerard, Jean-Claude; Giuranna, Marco; Gonzalez-Galindo, Francisco; Grigoriev, Alexey V.; Ivanov, Yuriy S.; Kaminski, Jacek; Karatekin, Ozgur; Lefevre, Franck; Lewis, Stephen; Lopez-Puertas, Manuel; Mahieux, Arnaud; Maslov, Igor; Mason, Jon; Mumma, Michael J.; Neary, Lori; Neefs, Eddy; Patrakeev, Andrey; Patsaev, Dmitry; Ristic, Bojan; Robert, Severine; Schmidt, Frederic; Shakun, Alexey; Teanby, Nicholas A.; Viscardy, Sebastien; Willame, Yannick; Whiteway, James; Wilquet, Valerie; Wolff, Michael J.; Bellucci, Giancarlo; Patel, Manish R.; Lopez-Moreno, Jose-Juan; Forget, Francois; Wilson, Colin F.; Svedhem, Hakan; Vago, Jorge L.; Rodionov, Daniel; Alonso-Rodrigo, Gustavo; Bauduin, Sophie; Carrozzo, Giacomo; Crismani, Matteo; Da Pieve, Fabiana; D'Aversa, Emiliano; Etiope, Giuseppe; Fussen, Didier; Geminale, Anna; Gkouvelis, Leo; Holmes, James; Hubert, Benoit; Kasaba, Yasumasa; Kass, David; Kleinbohl, Armin; Lanciano, Orietta; Nakagawa, Hiromu; Novak, Robert E.; Oliva, Fabrizio; Piccialli, Arianna; Renotte, Etienne; Ritter, Birgit; Schneider, Nick; Sindoni, Giuseppe; Thiemann, Ed; Vander Auwera, Jean; Wolkenberg, Paulina; Yelle, Roger; Anufreychik, Konstantin; Arnold, Gabriele; Duxbury, Natalia; Fouchet, Thierry; Grassi, Davide; Guerlet, Sandrine; Hartogh, Paul; Khatuntsev, Igor; Kokonkov, Nikita; Krasnopolsky, Vladimir; Kuzmin, Ruslan; Lacombe, Gaetan; Lellouch, Emmanuel; Maattanen, Anni; Marcq, Emmanuel; Martin-Torres, Javier; Medvedev, Alexander; Millour, Ehouarn; Moshkin, Boris; Quantin-Nataf, Cathy; Rodin, Alexander; Shematovich, Valery; Thomas, Nicolas; Vazquez, Luis; Vincendon, Matthieu; Young, Roland; Zasova, Ludmila; Zelenyi, Lev; Zorzano, Maria Paz		NOMAD Sci Team; ACS Sci Team	Martian dust storm impact on atmospheric H2O and D/H observed by ExoMars Trace Gas Orbiter	NATURE			English	Article							WATER-VAPOR; VERTICAL-DISTRIBUTION; NOMAD SPECTROMETER; LINE PARAMETERS; MARS; CLIMATOLOGY; CO2; EXPRESS; LAYERS; ALGORITHM	Global dust storms on Mars are rare(1,2) but can affect the Martian atmosphere for several months. They can cause changes in atmospheric dynamics and inflation of the atmosphere(3), primarily owing to solar heating of the dust(3). In turn, changes in atmospheric dynamics can affect the distribution of atmospheric water vapour, with potential implications for the atmospheric photochemistry and climate on Mars(4). Recent observations of the water vapour abundance in the Martian atmosphere during dust storm conditions revealed a high-altitude increase in atmospheric water vapour that was more pronounced at high northern latitudes(5,6), as well as a decrease in the water column at low latitudes(7,8). Here we present concurrent, high-resolution measurements of dust, water and semiheavy water (HDO) at the onset of a global dust storm, obtained by the NOMAD and ACS instruments onboard the ExoMars Trace Gas Orbiter. We report the vertical distribution of the HDO/H2O ratio (D/H) from the planetary boundary layer up to an altitude of 80 kilometres. Our findings suggest that before the onset of the dust storm, HDO abundances were reduced to levels below detectability at altitudes above 40 kilometres. This decrease in HDO coincided with the presence of water-ice clouds. During the storm, an increase in the abundance of H2O and HDO was observed at altitudes between 40 and 80 kilometres. We propose that these increased abundances may be the result of warmer temperatures during the dust storm causing stronger atmospheric circulation and preventing ice cloud formation, which may confine water vapour to lower altitudes through gravitational fall and subsequent sublimation of ice crystals(3). The observed changes in H2O and HDO abundance occurred within a few days during the development of the dust storm, suggesting a fast impact of dust storms on the Martian atmosphere.	[Vandaele, Ann Carine; Daerden, Frank; Aoki, Shohei; Thomas, Ian R.; Erwin, Justin T.; Trompet, Loic; Bolsee, David; Depiesse, Cedric; Mahieux, Arnaud; Neary, Lori; Neefs, Eddy; Ristic, Bojan; Robert, Severine; Viscardy, Sebastien; Willame, Yannick; Wilquet, Valerie; Da Pieve, Fabiana; Fussen, Didier; Piccialli, Arianna] Royal Belgian Inst Space Aeron IASB BIRA, Brussels, Belgium; [Korablev, Oleg; Fedorova, Anna A.; Trokhimovskiy, Alexander; Belyaev, Denis A.; Ignatiev, Nikolay I.; Luginin, Mikhail; Bertaux, Jean-Loup; Betsis, Daria; Grigoriev, Alexey V.; Maslov, Igor; Patrakeev, Andrey; Patsaev, Dmitry; Shakun, Alexey; Rodionov, Daniel; Anufreychik, Konstantin; Khatuntsev, Igor; Kuzmin, Ruslan; Moshkin, Boris; Zelenyi, Lev] Russian Acad Sci, Space Res Inst IKI, Moscow, Russia; [Altieri, Francesca; Giuranna, Marco; Bellucci, Giancarlo; Carrozzo, Giacomo; D'Aversa, Emiliano; Etiope, Giuseppe; Geminale, Anna; Oliva, Fabrizio; Wolkenberg, Paulina; Grassi, Davide] Ist Astrofis & Planetol Spaziali IAPS INAF, Rome, Italy; [Lopez-Valverde, Miguel; Funke, Bernd; Garcia-Comas, Maia; Lopez-Puertas, Manuel; Lopez-Moreno, Jose-Juan] Inst Astrofis Andalucia IAA, Consejo Super Investigaciones Cient CSIC, Granada, Spain; [Villanueva, Geronimo; Liuzzi, Giuliano; Smith, Michael D.; Mumma, Michael J.; Novak, Robert E.] NASA, Goddard Space Flight Ctr, Greenbelt, MD USA; [Montmessin, Franck; Olsen, Kevin S.; Baggio, Lucio; Bertaux, Jean-Loup; Lefevre, Franck; Lacombe, Gaetan; Maattanen, Anni; Marcq, Emmanuel] Sorbonne Univ, CNRS, UVSQ Univ Paris Saclay, LATMOS, Paris, France; [Alday, Juan; Wilson, Colin F.] Univ Oxford, Dept Phys, Oxford, England; [Clancy, R. Todd; Wolff, Michael J.] Space Sci Inst, Boulder, CO USA; [Cloutis, Edward; Crismani, Matteo] Univ Winnipeg, Dept Geog, Winnipeg, MB R3B 2E9, Canada; [Gerard, Jean-Claude] Univ Liege, Lab Planetary & Atmospher Phys LPAP, Liege, Belgium; [Ivanov, Yuriy S.] Natl Acad Sci Ukraine, MAO, Kiev, Ukraine; [Kaminski, Jacek] Polish Acad Sci, Inst Geog, Warsaw, Poland; [Karatekin, Ozgur; Ritter, Birgit] Royal Observ Belgium, Brussels, Belgium; [Lewis, Stephen; Mason, Jon; Patel, Manish R.; Holmes, James] Open Univ, Sch Phys Sci, Milton Keynes, Bucks, England; [Schmidt, Frederic] Univ Paris Sud, Geosci Paris Sud GEOPS, Orsay, France; [Teanby, Nicholas A.] Univ Bristol, Sch Earth Sci, Bristol, Avon, England; [Whiteway, James] York Univ, Ctr Res Earth & Space Sci, Toronto, ON, Canada; [Forget, Francois; Guerlet, Sandrine; Millour, Ehouarn; Young, Roland] CNRS Jussieu, LMD, Paris, France; [Svedhem, Hakan; Vago, Jorge L.] ESA, European Space Res & Technol Ctr ESTEC, Noordwijk, Netherlands; [Alonso-Rodrigo, Gustavo] Univ Politecn Madrid IDR UPM, Inst Univ Microgravedad, Madrid, Spain; [Bauduin, Sophie; Vander Auwera, Jean] Univ Libre Bruxelles, Brussels, Belgium; [Etiope, Giuseppe] Ist Nazl Geofis Vulcanologia, Rome, Italy; [Etiope, Giuseppe] Univ Babes Bolyai, Fac Environm Sci & Engn, Cluj Napoca, Romania; [Kasaba, Yasumasa; Nakagawa, Hiromu] Tohoku Univ, Sendai, Miyagi, Japan; [Kass, David; Kleinbohl, Armin] CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA USA; [Lanciano, Orietta; Sindoni, Giuseppe] Agenzia Spaziale Italiana ASI, Rome, Italy; [Renotte, Etienne] Adv Mech & Optic Syst AMOS, Liege, Belgium; [Schneider, Nick; Thiemann, Ed] Lab Atmospher & Space Phys LASP, Boulder, CO USA; [Yelle, Roger] Univ Arizona, Lunar & Planetary Lab LPL, Tucson, AZ USA; [Arnold, Gabriele] Inst Planetary Res, Deutsch Zentrum Luft & Raumfahrt DLR, Berlin, Germany; [Duxbury, Natalia] Moscow MV Lomonosov State Univ, Moscow, Russia; [Fouchet, Thierry; Lellouch, Emmanuel] Observatoire Paris Meudon, Lab Etudes Spati & Instrumentat Astrophys LESIA, Paris, France; [Hartogh, Paul; Medvedev, Alexander] Max Planck Inst, Gottingen, Germany; [Krasnopolsky, Vladimir] Cathol Univ Amer, Washington, DC USA; [Krasnopolsky, Vladimir; Rodin, Alexander] Moscow Inst Phys & Technol MIPT, Sch Fundamental & Appl Phys, Moscow, Russia; [Kuzmin, Ruslan] RAS, Vernadsky Inst, Moscow, Russia; [Martin-Torres, Javier] Lulea Univ Technol, Lulea, Sweden; [Martin-Torres, Javier] Univ Granada, Inst Andaluz Ciencias Tierra, Granada, Spain; [Quantin-Nataf, Cathy] Univ Claude Bernard, Lab Geol Lyon, Lyon, France; [Shematovich, Valery] Russian Acad Sci, Astron Inst, Moscow, Russia; [Thomas, Nicolas] Univ Bern, Bern, Switzerland; [Vazquez, Luis] Univ Complutense Madrid, Madrid, Spain; [Vincendon, Matthieu] Univ Paris Sud, Inst Astrophys Spatiale, Orsay, France; [Zorzano, Maria Paz] Inst Nacl Tecn Aeroespacial CSIC INTA, Ctr Astrobiol, Madrid, Spain	Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; Istituto Nazionale Astrofisica (INAF); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; University of Oxford; University of Winnipeg; University of Liege; National Academy of Sciences Ukraine; Main Astronomical Observatory of NASU; Polish Academy of Sciences; Open University - UK; UDICE-French Research Universities; Universite Paris Saclay; University of Bristol; York University - Canada; Centre National de la Recherche Scientifique (CNRS); Ecole des Ponts ParisTech; UDICE-French Research Universities; Sorbonne Universite; European Space Agency; Universidad Politecnica de Madrid; Universite Libre de Bruxelles; Istituto Nazionale Geofisica e Vulcanologia (INGV); Babes Bolyai University from Cluj; Tohoku University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Agenzia Spaziale Italiana (ASI); University of Arizona; Helmholtz Association; German Aerospace Centre (DLR); Lomonosov Moscow State University; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Universite Paris Cite; Max Planck Society; Catholic University of America; Moscow Institute of Physics & Technology; Russian Academy of Sciences; Vernadsky Institute of Geochemistry & Analytical Chemistry; Lulea University of Technology; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Andaluz de Ciencias de la Tierra (IACT); University of Granada; Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Russian Academy of Sciences; University of Bern; Complutense University of Madrid; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA)	Vandaele, AC (corresponding author), Royal Belgian Inst Space Aeron IASB BIRA, Brussels, Belgium.	a-c.vandaele@aeronomie.be	Garcia-Comas, Maya/E-4050-2014; Fouchet, Thierry/C-6374-2017; Krasnopolsky, Vladimir/L-5085-2013; Grassi, Davide/B-7916-2018; Belyaev, Denis/A-5404-2015; Etiope, Giuseppe/H-3343-2011; Määttänen, Anni E/F-2943-2012; Martin-Torres, Javier/G-6329-2015; Martin-Torres, Javier/M-3779-2019; Liuzzi, Giuliano/P-5238-2019; Bellucci, Giancarlo/ABA-9201-2020; karatekin, ozgur/AAS-8419-2020; Korablev, Oleg/L-5083-2013; GIURANNA, Marco/S-9378-2017; Zorzano, María-Paz/F-2184-2015; Malova, Helmi/ABE-6236-2021; Trokhimovskiy, Alexander/GQY-6914-2022; Wilson, Colin/AAI-3307-2020; Kasaba, Yasumasa/ABB-4167-2020; Aoki, Shohei/AAU-8029-2020; Patsaev, Dmitry/AAS-5776-2021; Fedorova, Anna A/L-5116-2013; Funke, Bernd/C-2162-2008; Shematovich, Valery/AAA-8925-2021; Robert, Séverine/AAF-7296-2021; Mahieux, Arnaud/R-2991-2017; Rodin, Alexander V./L-1904-2013; Rodrigo, Gustavo Alonso/G-2986-2015; Kasaba, Yasumasa/AAA-9373-2020; Liuzzi, Giuliano/GQO-7495-2022; Moreno, Jose Juan Lopez/M-5537-2019; Neary, Lori L/S-9299-2017; Guerlet, Sandrine/ABE-1516-2020; Khatuntsev, Igor V./B-4248-2015; Alday, Juan/AAK-8984-2020; Medvedev, Alexander S./AAC-3242-2019; Thomas, Nicolas/G-4693-2015; Vandaele, Ann Carine/D-7167-2016; Lopez-Puertas, Manuel/M-8219-2013; Daerden, Frank/S-8759-2017	Garcia-Comas, Maya/0000-0003-2323-4486; Fouchet, Thierry/0000-0001-9040-8285; Grassi, Davide/0000-0003-1653-3066; Belyaev, Denis/0000-0003-1123-5983; Etiope, Giuseppe/0000-0001-8614-4221; Määttänen, Anni E/0000-0002-7326-8492; Martin-Torres, Javier/0000-0001-6479-2236; Bellucci, Giancarlo/0000-0003-0867-8679; Korablev, Oleg/0000-0003-1115-0656; GIURANNA, Marco/0000-0001-8967-9184; Zorzano, María-Paz/0000-0002-4492-9650; Malova, Helmi/0000-0001-6511-2335; Trokhimovskiy, Alexander/0000-0003-4041-4972; Wilson, Colin/0000-0001-5355-1533; Kasaba, Yasumasa/0000-0002-8160-3553; Aoki, Shohei/0000-0001-6727-125X; Funke, Bernd/0000-0003-0462-4702; Shematovich, Valery/0000-0002-1062-1287; Robert, Séverine/0000-0001-7445-3027; Mahieux, Arnaud/0000-0001-5359-7179; Rodin, Alexander V./0000-0002-3601-7790; Rodrigo, Gustavo Alonso/0000-0002-1220-5586; Liuzzi, Giuliano/0000-0003-3638-5750; Moreno, Jose Juan Lopez/0000-0002-7946-2624; Neary, Lori L/0000-0001-6773-324X; Guerlet, Sandrine/0000-0001-5019-899X; Khatuntsev, Igor V./0000-0002-3256-122X; Alday, Juan/0000-0003-1459-3444; Medvedev, Alexander S./0000-0003-2713-8977; Young, Roland/0000-0002-7241-8954; Thomas, Nicolas/0000-0002-0146-0071; GERARD, Jean-Claude/0000-0002-8565-8746; Thomas, Ian/0000-0003-3887-6668; Altieri, Francesca/0000-0002-6338-8300; Fedorova, Anna/0000-0002-4176-2955; Nakagawa, Hiromu/0000-0001-8166-0171; Mason, Jonathon/0000-0002-4603-4009; D'Aversa, Emiliano/0000-0002-5842-5867; Da Pieve, Fabiana/0000-0001-6985-9145; Vandaele, Ann Carine/0000-0001-8940-9301; Luginin, Mikhail/0000-0002-4434-0213; Kaminski, Jacek/0000-0002-9702-5356; Lopez-Puertas, Manuel/0000-0003-2941-7734; Daerden, Frank/0000-0001-7433-1839; Sindoni, Giuseppe/0000-0002-3348-7930; Montmessin, Franck/0000-0002-4187-1457; Olsen, Kevin/0000-0002-2173-9889; Viscardy, Sebastien/0000-0002-5608-7438; Vago, Jorge Luis/0000-0003-1938-6639; Marcq, Emmanuel/0000-0002-1924-641X; Carrozzo, Filippo Giacomo/0000-0002-0391-6407; Lewis, Stephen/0000-0001-7237-6494	Belgian Science Policy Office (BELSPO); ESA Prodex Office [PEA 4000103401, 4000121493]; Spanish MICINN through its Plan Nacional; UK Space Agency [ST/R005761/1, ST/P001262/1, ST/R001405/1, ST/S00145X/1, ST/R001367/1, ST/P001572/1, ST/R001502/1]; Italian Space Agency [2018-2-HH.0]; State Agency for Research of the Spanish MCIU through the 'Center of Excellence Severo Ochoa' award [SEV-2017-0709]; Belgian Fonds de la Recherche Scientifique - FNRS [30442502]; Roscosmos; CNES; ESA; Russian government [14.W03.31.0017, 0120.0 602993 (0028-2014-0004)];  [ESP2015-65064-C2-1-P];  [ESP2017-87143-R]; STFC [1935849] Funding Source: UKRI; UK Space Agency [ST/M00306X/1] Funding Source: researchfish	Belgian Science Policy Office (BELSPO)(Belgian Federal Science Policy Office); ESA Prodex Office; Spanish MICINN through its Plan Nacional; UK Space Agency; Italian Space Agency(Agenzia Spaziale Italiana (ASI)); State Agency for Research of the Spanish MCIU through the 'Center of Excellence Severo Ochoa' award; Belgian Fonds de la Recherche Scientifique - FNRS(Fonds de la Recherche Scientifique - FNRS); Roscosmos; CNES(Centre National D'etudes Spatiales); ESA(European Space Agency); Russian government; ; ; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UK Space Agency	ExoMars is a space mission of the European Space Agency (ESA) and Roscosmos. The NOMAD experiment is led by the Royal Belgian Institute for Space Aeronomy (IASB-BIRA), assisted by Co-Principal Investigator teams from Spain (IAA-CSIC), Italy (INAF-IAPS) and the UK (Open University). This project acknowledges funding by the Belgian Science Policy Office (BELSPO), with financial and contractual coordination by the ESA Prodex Office (PEA 4000103401, 4000121493); by the Spanish MICINN through its Plan Nacional and by European funds under grants ESP2015-65064-C2-1-P and ESP2017-87143-R (MINECO/FEDER); by the UK Space Agency through grants ST/R005761/1, ST/P001262/1, ST/R001405/1, ST/S00145X/1, ST/R001367/1, ST/P001572/1 and ST/R001502/1; and the Italian Space Agency through grant 2018-2-HH.0. The IAA/CSIC team acknowledges financial support from the State Agency for Research of the Spanish MCIU through the 'Center of Excellence Severo Ochoa' award for the Instituto de Astrofisica de Andalucia (SEV-2017-0709). This work was supported by the Belgian Fonds de la Recherche Scientifique - FNRS under grant number 30442502 (ET_HOME). The ACS experiment is led by IKI, Space Research Institute in Moscow, assisted by LATMOS in France. The project acknowledges funding by Roscosmos and CNES. The science operations of ACS are funded by Roscosmos and ESA. IKI affiliates acknowledge funding under grant number 14.W03.31.0017 and contract number 0120.0 602993 (0028-2014-0004) of the Russian government. We are grateful to all ESA ESOC, ESAC and IKI Science Operations Center personnel, whose efforts made the success of TGO possible.	Aoki S, 2015, ICARUS, V260, P7, DOI 10.1016/j.icarus.2015.06.021; Chaffin MS, 2017, NAT GEOSCI, V10, P174, DOI [10.1038/ngeo2887, 10.1038/NGEO2887]; Clancy RT, 2010, ICARUS, V207, P98, DOI 10.1016/j.icarus.2009.10.011; Daerden F, 2019, ICARUS, V326, P197, DOI 10.1016/j.icarus.2019.02.030; Daerden F, 2015, GEOPHYS RES LETT, V42, P7319, DOI 10.1002/2015GL064892; Devi VM, 2017, J QUANT SPECTROSC RA, V203, P158, DOI 10.1016/j.jqsrt.2017.02.020; Devi VM, 2017, J QUANT SPECTROSC RA, V203, P133, DOI 10.1016/j.jqsrt.2017.01.032; Encrenaz T, 2018, ASTRON ASTROPHYS, V612, DOI 10.1051/0004-6361/201732367; Fedorova AA, 2014, ICARUS, V231, P239, DOI 10.1016/j.icarus.2013.12.015; Fedorova AA, 2009, ICARUS, V200, P96, DOI 10.1016/j.icarus.2008.11.006; Fedorova A, 2018, ICARUS, V300, P440, DOI 10.1016/j.icarus.2017.09.025; Forget F, 1999, J GEOPHYS RES-PLANET, V104, P24155, DOI 10.1029/1999JE001025; Formisano V, 2005, PLANET SPACE SCI, V53, P963, DOI 10.1016/j.pss.2004.12.006; Gordon IE, 2017, J QUANT SPECTROSC RA, V203, P3, DOI 10.1016/j.jqsrt.2017.06.038; Guzewich SD, 2013, J GEOPHYS RES-PLANET, V118, P1177, DOI 10.1002/jgre.20076; Haberle RM, 2017, CAMB PLANET, P1, DOI 10.1017/ 9781139060172; HANSEN JE, 1974, SPACE SCI REV, V16, P527, DOI 10.1007/BF00168069; Heavens NG, 2018, NAT ASTRON, V2, P126, DOI 10.1038/s41550-017-0353-4; Heavens NG, 2014, J GEOPHYS RES-PLANET, V119, P1748, DOI 10.1002/2014JE004619; Korablev O, 2018, SPACE SCI REV, V214, DOI 10.1007/s11214-017-0437-6; Korablev O, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2006JE002696; Lammer H, 2013, SPACE SCI REV, V174, P113, DOI 10.1007/s11214-012-9943-8; Lemoine FG, 2001, J GEOPHYS RES-PLANET, V106, P23359, DOI 10.1029/2000JE001426; Levenberg K., 1944, Q APPL MATH, V2, P164, DOI 10.1090/qam/10666; Lewis SR, 2016, ICARUS, V264, P456, DOI 10.1016/j.icarus.2015.08.039; Liuzzi G, 2019, ICARUS, V321, P671, DOI 10.1016/j.icarus.2018.09.021; Maattanen A, 2013, ICARUS, V223, P892, DOI 10.1016/j.icarus.2012.12.001; Maltagliati L, 2013, ICARUS, V223, P942, DOI 10.1016/j.icarus.2012.12.012; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; McCleese DJ, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2010JE003677; Millour E., 2015, EUR PLAN SCI C; Montabone L, 2015, ICARUS, V251, P65, DOI 10.1016/j.icarus.2014.12.034; Montmessin F, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002357; Neary L, 2018, ICARUS, V300, P458, DOI 10.1016/j.icarus.2017.09.028; Neefs E, 2015, APPL OPTICS, V54, P8494, DOI 10.1364/AO.54.008494; Nevejans D, 2006, APPL OPTICS, V45, P5191, DOI 10.1364/AO.45.005191; Patel MR, 2017, APPL OPTICS, V56, P2771, DOI 10.1364/AO.56.002771; Rafkin SCR, 2012, PLANET SPACE SCI, V60, P147, DOI 10.1016/j.pss.2011.07.015; Rodgers C. D, 2000, INVERSE METHODS ATMO; Sanchez- Lavega A., 2018, AGU FALL M; Schofield J., 2018, 42 COSPAR SCI M; Sefton-Nash E, 2013, ICARUS, V222, P342, DOI 10.1016/j.icarus.2012.11.012; Shirley JH, 2019, ICARUS, V317, P197, DOI 10.1016/j.icarus.2018.07.024; Smith M. D., 2018, AGU FALL M; Smith MD, 2018, ICARUS, V301, P117, DOI 10.1016/j.icarus.2017.09.027; Spiga A, 2013, J GEOPHYS RES-PLANET, V118, P746, DOI 10.1002/jgre.20046; Steele LJ, 2014, ICARUS, V237, P97, DOI 10.1016/j.icarus.2014.04.017; Svedhem H., SPACE SCI REV; Titov DV, 2006, COSMIC RES+, V44, P334, DOI 10.1134/S0010952506040071; Trokhimovskiy A, 2015, ICARUS, V251, P50, DOI 10.1016/j.icarus.2014.10.007; Trompet L, 2016, APPL OPTICS, V55, P9275, DOI 10.1364/AO.55.009275; Vandaele AC, 2018, SPACE SCI REV, V214, DOI 10.1007/s11214-018-0517-2; Vasavada A., 2018, 42 COSPAR SCI M; Villanueva GL, 2018, J QUANT SPECTROSC RA, V217, P86, DOI 10.1016/j.jqsrt.2018.05.023; Villanueva GL, 2015, SCIENCE, V348, P218, DOI 10.1126/science.aaa3630; Wang C, 2018, J GEOPHYS RES-PLANET, V123, P982, DOI 10.1002/2017JE005255; Warren SG, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009744; Webster CR, 2013, SCIENCE, V341, P260, DOI 10.1126/science.1237961; Wolff MJ, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2009JE003350	59	79	79	7	52	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 25	2019	568	7753					521	+		10.1038/s41586-019-1097-3	http://dx.doi.org/10.1038/s41586-019-1097-3			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HU9DR	30971830	Green Accepted, Green Submitted			2022-12-28	WOS:000465594200045
J	Kim, M				Kim, Minjee			The Right to Grieve	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DOCTORS; PATIENT		[Kim, Minjee] Northwestern Univ, Dept Neurol, Div Stroke & Neurocrit Care, Chicago, IL USA	Northwestern University	Kim, M (corresponding author), 625 N Michigan Ave,Ste 1150, Chicago, IL 60611 USA.	minjee.kim@northwestern.edu	Kim, Minjee/T-5030-2019	Kim, Minjee/0000-0002-2720-1940				Baldwin PJ, 1997, SOC SCI MED, V45, P41, DOI 10.1016/S0277-9536(96)00307-3; Doka K.J., 1989, DISENFRANCHISED GRIE; Redinbaugh EM, 2003, BMJ-BRIT MED J, V327, P185, DOI 10.1136/bmj.327.7408.185; Rhodes-Kropf J, 2005, ACAD MED, V80, P634, DOI 10.1097/00001888-200507000-00005; 2005, J EMERGENCY MED, V28, P1, DOI DOI 10.1016/J.JEMERMED.2004.05.00900307-3; 2014, STROKE, V45, P1887, DOI DOI 10.1161/STR.0000000000000015; 2017, SUPPORT CARE CANCER, V25, P1607, DOI DOI 10.1007/S00520-016-3562-Y	7	3	3	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2019	321	16					1569	1570		10.1001/jama.2019.4265	http://dx.doi.org/10.1001/jama.2019.4265			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HV7BZ	31012938				2022-12-28	WOS:000466137800010
J	Slomski, A				Slomski, Anita			Acupuncture May Reduce Menopausal Symptoms	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	3	3	2	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2019	321	16					1558	1558		10.1001/jama.2019.4593	http://dx.doi.org/10.1001/jama.2019.4593			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HV7BZ	31012931				2022-12-28	WOS:000466137800039
J	Hlinka, J				Hlinka, Jiri			Doubling up piezoelectric performance	SCIENCE			English	Editorial Material									[Hlinka, Jiri] Akad Ved Ceske Republ, Fyzikalni Ustav, Prague, Czech Republic	Czech Academy of Sciences	Hlinka, J (corresponding author), Akad Ved Ceske Republ, Fyzikalni Ustav, Prague, Czech Republic.	hlinka@fzu.cz	Hlinka, Jiri/G-5985-2014	Hlinka, Jiri/0000-0002-9293-4462	SOLID21 project of the Czech Ministry of Education [CZ.02.1.01/0.0/0.0/16_019/0000760]	SOLID21 project of the Czech Ministry of Education	Supported by the SOLID21 project of the Czech Ministry of Education (CZ.02.1.01/0.0/0.0/16_019/0000760).	Damjanovic D, 2006, J MATER SCI, V41, P65, DOI 10.1007/s10853-005-5925-5; Fu HX, 2000, NATURE, V403, P281, DOI 10.1038/35002022; Gabor U, 2018, J EUR CERAM SOC, V38, P4453, DOI 10.1016/j.jeurceramsoc.2018.06.013; Krogstad MJ, 2018, NAT MATER, V17, P718, DOI 10.1038/s41563-018-0112-7; Li F, 2019, SCIENCE, V364, P264, DOI 10.1126/science.aaw2781; Li F, 2018, NAT MATER, V17, P349, DOI 10.1038/s41563-018-0034-4; Park SE, 1997, J APPL PHYS, V82, P1804, DOI 10.1063/1.365983; Zhang SJ, 2018, J KOREAN CERAM SOC, V55, P419, DOI 10.4191/kcers.2018.55.5.12; Zhang SJ, 2015, PROG MATER SCI, V68, P1, DOI 10.1016/j.pmatsci.2014.10.002	9	2	2	5	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2019	364	6437					228	229		10.1126/science.aax0693	http://dx.doi.org/10.1126/science.aax0693			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HU0JG	31000647				2022-12-28	WOS:000464956600023
J	Yao, WT; Maitra, A				Yao, Wantong; Maitra, Anirban			Hear Pancreatic Cancer Stem Cells ROR	CELL			English	Editorial Material							THERAPY	In this issue of Cell, Lytle et al. (2019) integrate functional genomic approaches to identify molecular dependencies of pancreatic cancer stem cells that may be exploited therapeutically. The comprehensive analysis reveals an unexpected role for retinoic acid receptor-related orphan receptor gamma (ROR gamma), a T-cell-associated transcription factor, in defining the stemness and the aggressive behavior of pancreatic cancer.	[Yao, Wantong; Maitra, Anirban] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [Yao, Wantong; Maitra, Anirban] Univ Texas MD Anderson Canc Ctr, Sheikh Ahmed Ctr Pancreat Canc Res, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Yao, WT (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA.; Yao, WT (corresponding author), Univ Texas MD Anderson Canc Ctr, Sheikh Ahmed Ctr Pancreat Canc Res, Houston, TX 77030 USA.	wyao22@mdanderson.org						Bailey JM, 2014, GASTROENTEROLOGY, V146, P245, DOI 10.1053/j.gastro.2013.09.050; Candido JB, 2018, CELL REP, V23, P1448, DOI 10.1016/j.celrep.2018.03.131; Fox RG, 2016, NATURE, V534, P407, DOI 10.1038/nature17988; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Lytle NK, 2019, CELL, V177, P572, DOI 10.1016/j.cell.2019.03.010; Mazur PK, 2015, NAT MED, V21, P1163, DOI 10.1038/nm.3952; McAllister F, 2014, CANCER CELL, V25, P621, DOI 10.1016/j.ccr.2014.03.014; Viale A, 2016, RECENT RESULTS CANC, V207, P135, DOI 10.1007/978-3-319-42118-6_6; Westphalen CB, 2016, CELL STEM CELL, V18, P441, DOI 10.1016/j.stem.2016.03.016; Zhang Y, 2018, GASTROENTEROLOGY, V155, P210, DOI 10.1053/j.gastro.2018.03.041	10	3	3	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2019	177	3					516	518		10.1016/j.cell.2019.04.002	http://dx.doi.org/10.1016/j.cell.2019.04.002			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HU0FV	31002791	Bronze			2022-12-28	WOS:000464947700007
J	Punthakee, Z				Punthakee, Zubin			In type 2 diabetes with periodontitis, intensive periodontitis treatment improved glycemic control at 1 year	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Punthakee, Zubin] McMaster Univ, Hamilton, ON, Canada	McMaster University	Punthakee, Z (corresponding author), McMaster Univ, Hamilton, ON, Canada.							IDF Clinical Guidelines Task Force, 2009, IDF GUID OR HLTH PEO; Simpson TC, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004714.pub3	2	2	2	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2019	170	8					JC40	JC40		10.7326/ACPJ201904160-040	http://dx.doi.org/10.7326/ACPJ201904160-040			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU7YQ	30986830				2022-12-28	WOS:000465499900006
J	Torjesen, I				Torjesen, Ingrid			Psychotherapists warn against describing the needs of children with mental health problems as "low level"	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Thornton J, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1732	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 12	2019	365								l1780	10.1136/bmj.l1780	http://dx.doi.org/10.1136/bmj.l1780			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU0EX	30979716				2022-12-28	WOS:000464945300007
J	Xue, YQ; Zheng, XC; Li, Y; Brandt, WN; Zhang, B; Luo, B; Zhang, BB; Bauer, FE; Sun, H; Lehmer, BD; Wu, XF; Yang, G; Kong, X; Li, JY; Sun, MY; Wang, JX; Vito, F				Xue, Y. Q.; Zheng, X. C.; Li, Y.; Brandt, W. N.; Zhang, B.; Luo, B.; Zhang, B. -B.; Bauer, F. E.; Sun, H.; Lehmer, B. D.; Wu, X. -F.; Yang, G.; Kong, X.; Li, J. Y.; Sun, M. Y.; Wang, J. -X.; Vito, F.			A magnetar-powered X-ray transient as the aftermath of a binary neutron-star merger	NATURE			English	Article							EXTENDED EMISSION; TIDAL DISRUPTION; ENERGY INJECTION; EVOLUTION; AFTERGLOW; BURSTS; FLARES; MODEL; BIRTH	Mergers of neutron stars are known to be associated with short gamma-ray bursts(1-4). If the neutron-star equation of state is sufficiently stiff (that is, the pressure increases sharply as the density increases), at least some such mergers will leave behind a supramassive or even a stable neutron star that spins rapidly with a strong magnetic field(5-8) (that is, a magnetar). Such a magnetar signature may have been observed in the form of the X-ray plateau that follows up to half of observed short gamma-ray bursts(9,10). However, it has been expected that some X-ray transients powered by binary neutron-star mergers may not be associated with a short gamma-ray burst(11,12). A fast X-ray transient (CDF-S XT1) was recently found to be associated with a faint host galaxy, the redshift of which is unknown(13). Its X-ray and host-galaxy properties allow several possible explanations including a short gamma-ray burst seen off-axis, a low-luminosity gamma-ray burst at high redshift, or a tidal disruption event involving an intermediate-mass black hole and a white dwarf(13). Here we report a second X-ray transient, CDF-S XT2, that is associated with a galaxy at redshift z = 0.738 (ref.(14)). The measured light curve is fully consistent with the X-ray transient being powered by a millisecond magnetar. More intriguingly, CDF-S XT2 lies in the outskirts of its star-forming host galaxy with a moderate offset from the galaxy centre, as short gamma-ray bursts often do(15,16). The estimated event-rate density of similar X-ray transients, when corrected to the local value, is consistent with the event-rate density of binary neutron-star mergers that is robustly inferred from the detection of the gravitational-wave event GW170817.	[Xue, Y. Q.; Zheng, X. C.; Kong, X.; Li, J. Y.; Sun, M. Y.; Wang, J. -X.] Univ Sci & Technol China, Dept Astron, CAS Key Lab Res Galaxies & Cosmol, Hefei, Anhui, Peoples R China; [Xue, Y. Q.; Zheng, X. C.; Wu, X. -F.; Kong, X.; Li, J. Y.; Sun, M. Y.; Wang, J. -X.] Univ Sci & Technol China, Sch Astron & Space Sci, Hefei, Anhui, Peoples R China; [Zheng, X. C.] Leiden Univ, Leiden Observ, Leiden, Netherlands; [Li, Y.] Peking Univ, Kavli Inst Astron & Astrophys, Beijing, Peoples R China; [Brandt, W. N.; Yang, G.] Penn State Univ, Dept Astron & Astrophys, 525 Davey Lab, University Pk, PA 16802 USA; [Brandt, W. N.; Yang, G.] Penn State Univ, Inst Gravitat & Cosmos, University Pk, PA 16802 USA; [Brandt, W. N.] Penn State Univ, Dept Phys, 104 Davey Lab, University Pk, PA 16802 USA; [Zhang, B.] Univ Nevada, Dept Phys & Astron, Las Vegas, NV 89154 USA; [Zhang, B.; Sun, H.] Chinese Acad Sci, Natl Astron Observ, Beijing, Peoples R China; [Zhang, B.] Peking Univ, Sch Phys, Dept Astron, Beijing, Peoples R China; [Luo, B.; Zhang, B. -B.] Nanjing Univ, Sch Astron & Space Sci, Nanjing, Jiangsu, Peoples R China; [Luo, B.; Zhang, B. -B.] Nanjing Univ, Key Lab Modern Astron & Astrophys, Nanjing, Jiangsu, Peoples R China; [Luo, B.; Zhang, B. -B.] Collaborat Innovat Ctr Modern Astron & Space Expl, Nanjing, Jiangsu, Peoples R China; [Bauer, F. E.; Vito, F.] Pontificia Univ Catolica Chile, Fac Fis, Inst Astrofis, Santiago, Chile; [Bauer, F. E.; Vito, F.] Pontificia Univ Catolica Chile, Fac Fis, Ctr Astroingn, Santiago, Chile; [Bauer, F. E.] Millennium Inst Astrophys MAS, Santiago, Chile; [Bauer, F. E.] Space Sci Inst, Boulder, CO USA; [Lehmer, B. D.] Univ Arkansas, Dept Phys, Fayetteville, AR 72701 USA; [Wu, X. -F.] Chinese Acad Sci, Purple Mt Observ, Nanjing, Jiangsu, Peoples R China; [Vito, F.] Chinese Acad Sci, Natl Astron Observ, CAS South Amer Ctr Astron, Beijing, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Leiden University; Leiden University - Excl LUMC; Peking University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Chinese Academy of Sciences; National Astronomical Observatory, CAS; Peking University; Nanjing University; Nanjing University; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; University of Arkansas System; University of Arkansas Fayetteville; Chinese Academy of Sciences; Nanjing Institute of Astronomical Optics & Technology, NAOC, CAS; Purple Mountain Observatory, CAS; Chinese Academy of Sciences; National Astronomical Observatory, CAS	Xue, YQ; Zheng, XC (corresponding author), Univ Sci & Technol China, Dept Astron, CAS Key Lab Res Galaxies & Cosmol, Hefei, Anhui, Peoples R China.; Xue, YQ; Zheng, XC (corresponding author), Univ Sci & Technol China, Sch Astron & Space Sci, Hefei, Anhui, Peoples R China.; Zheng, XC (corresponding author), Leiden Univ, Leiden Observ, Leiden, Netherlands.; Zhang, B (corresponding author), Univ Nevada, Dept Phys & Astron, Las Vegas, NV 89154 USA.; Zhang, B (corresponding author), Chinese Acad Sci, Natl Astron Observ, Beijing, Peoples R China.; Zhang, B (corresponding author), Peking Univ, Sch Phys, Dept Astron, Beijing, Peoples R China.	xuey@ustc.edu.cn; zheng@strw.leidenuniv.nl; zhang@physics.unlv.edu	Zhang, Bing/AAG-2824-2019; Vito, Fabio/AAO-8064-2020; Brandt, William N/N-2844-2015; Xue, Yongquan/F-6700-2014	Vito, Fabio/0000-0003-0680-9305; Brandt, William N/0000-0002-0167-2453; Xue, Yongquan/0000-0002-1935-8104; Li, Junyao/0000-0002-1605-915X; Zheng, Xuechen/0000-0002-1564-0436; Bauer, Franz Erik/0000-0002-8686-8737; Zhang, Binbin/0000-0003-4111-5958; Zhang, Bing/0000-0002-9725-2524	973 Program [2015CB857004]; National Natural Science Foundation of China [NSFC-11473026, NSFC-11890693, NSFC-11421303]; CAS Frontier Science Key Research Program [QYZDJ-SSW-SLH006]; China Scholarship Council (CSC)-Leiden University Joint Scholarship Program; China Postdoctoral Science Foundation [2016M600485]; K. C. Wong Education Foundation; KIAA-CAS Fellowship - Peking University; KIAA-CAS Fellowship - Chinese Academy of Sciences; Chandra X-ray Center [AR8-19016X]; NASA grant [NNX17AF07G]; NASA ADP grant [80NSSC18K0878]; V.M. Willaman Endowment; National Key RAMP;D Program of China [2016YFA0400702, NSFC-11673010]; National Thousand Young Talents programme of China; National Key Research and Development Program of China [2018YFA0404204, NSFC-11833003]; CONICyT-Chile [Basal AFB-170002, FONDECyT Regular 1141218, FONDO ALMA 31160033]; Ministry of Economy, Development, and Tourism's Millennium Science Initiative [IC120009]; CONICyT; CASSACA through CAS-CONICyT fund	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS Frontier Science Key Research Program; China Scholarship Council (CSC)-Leiden University Joint Scholarship Program(China Scholarship Council); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); K. C. Wong Education Foundation; KIAA-CAS Fellowship - Peking University; KIAA-CAS Fellowship - Chinese Academy of Sciences(Chinese Academy of Sciences); Chandra X-ray Center; NASA grant(National Aeronautics & Space Administration (NASA)); NASA ADP grant; V.M. Willaman Endowment; National Key RAMP;D Program of China; National Thousand Young Talents programme of China; National Key Research and Development Program of China; CONICyT-Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Ministry of Economy, Development, and Tourism's Millennium Science Initiative; CONICyT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); CASSACA through CAS-CONICyT fund	We thank A. Lien, K. Hurley and D. Svinkin for examining the relevant Swift/BAT, IPN3, and Wind/KNOUS data, respectively, for us. Y.Q.X., X.C.Z., J.Y.L. and M.Y.S. acknowledge support from the 973 Program (2015CB857004), the National Natural Science Foundation of China (grant numbers NSFC-11473026, NSFC-11890693 and NSFC-11421303), the CAS Frontier Science Key Research Program (QYZDJ-SSW-SLH006), the China Scholarship Council (CSC)-Leiden University Joint Scholarship Program, the China Postdoctoral Science Foundation (2016M600485), and the K. C. Wong Education Foundation. Y.L. acknowledges support by the KIAA-CAS Fellowship, which is jointly supported by Peking University and the Chinese Academy of Sciences. W.N.B. and G.Y. acknowledge support from Chandra X-ray Center grant AR8-19016X, NASA grant NNX17AF07G, NASA ADP grant 80NSSC18K0878 and the V.M. Willaman Endowment. B.L. acknowledges support from the National Key R&D Program of China (2016YFA0400702) and NSFC-11673010. B.-B.Z. acknowledges support from the National Thousand Young Talents programme of China and the National Key Research and Development Program of China (2018YFA0404204) and NSFC-11833003. F.E.B. acknowledges support from CONICyT-Chile (Basal AFB-170002, FONDECyT Regular 1141218, FONDO ALMA 31160033) and the Ministry of Economy, Development, and Tourism's Millennium Science Initiative through grant IC120009, awarded to The Millennium Institute of Astrophysics (MAS). F.V. acknowledges financial support from CONICyT and CASSACA through the fourth call for tenders of the CAS-CONICyT fund.	Abbott BP, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.161101; Abbott BP, 2017, ASTROPHYS J LETT, V848, DOI 10.3847/2041-8213/aa920c; Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321591; Ai S, 2018, ALLOWED PARAMETER SP; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Arnaud KA, 1996, ASTR SOC P, V101, P17; Bauer FE, 2017, MON NOT R ASTRON SOC, V467, P4841, DOI 10.1093/mnras/stx417; Berger E, 2014, ANNU REV ASTRON ASTR, V52, P43, DOI 10.1146/annurev-astro-081913-035926; Blanchard PK, 2016, ASTROPHYS J, V817, DOI 10.3847/0004-637X/817/2/144; Broos PS, 2010, ASTROPHYS J, V714, P1582, DOI 10.1088/0004-637X/714/2/1582; Bruzual G, 2003, MON NOT R ASTRON SOC, V344, P1000, DOI 10.1046/j.1365-8711.2003.06897.x; Bucciantini N, 2012, MON NOT R ASTRON SOC, V419, P1537, DOI 10.1111/j.1365-2966.2011.19810.x; Burns E, 2016, ASTROPHYS J, V818, DOI 10.3847/0004-637X/818/2/110; Burrows DN, 2011, NATURE, V476, P421, DOI 10.1038/nature10374; Campana S, 2006, NATURE, V442, P1008, DOI 10.1038/natureO4892; Dai ZG, 1998, ASTRON ASTROPHYS, V333, pL87; Dai ZG, 2006, SCIENCE, V311, P1127, DOI 10.1126/science.1123606; Fong W, 2010, ASTROPHYS J, V708, P9, DOI 10.1088/0004-637X/708/1/9; Foreman-Mackey D, 2013, PUBL ASTRON SOC PAC, V125, P306, DOI 10.1086/670067; Gao H, 2016, PHYS REV D, V93, DOI 10.1103/PhysRevD.93.044065; Gao WH, 2006, CHINESE J ASTRON AST, V6, P513, DOI 10.1088/1009-9271/6/5/01; Goldstein A, 2017, ASTROPHYS J LETT, V848, DOI 10.3847/2041-8213/aa8f41; Granot J, 2002, ASTROPHYS J, V570, pL61, DOI 10.1086/340991; Guo YC, 2013, ASTROPHYS J SUPPL S, V207, DOI 10.1088/0067-0049/207/2/24; Hsieh BC, 2012, ASTROPHYS J SUPPL S, V203, DOI 10.1088/0067-0049/203/2/23; Huertas-Company M, 2015, ASTROPHYS J SUPPL S, V221, DOI 10.1088/0067-0049/221/1/8; Komossa S, 2015, J HIGH ENERGY ASTROP, V7, P148, DOI 10.1016/j.jheap.2015.04.006; KRAFT RP, 1991, ASTROPHYS J, V374, P344, DOI 10.1086/170124; Lasky PD, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.047302; Li A, 2016, PHYS REV D, V94, DOI 10.1103/PhysRevD.94.083010; Li SW, 2018, INT J CHEM REACT ENG, V16, DOI 10.1515/ijcre-2017-0055; Li Y, 2016, ASTROPHYS J SUPPL S, V227, DOI 10.3847/0067-0049/227/1/7; Lu HJ, 2015, ASTROPHYS J, V805, DOI 10.1088/0004-637X/805/2/89; Luo B, 2017, ASTROPHYS J SUPPL S, V228, DOI 10.3847/1538-4365/228/1/2; Margalit B, 2017, ASTROPHYS J LETT, V850, DOI 10.3847/2041-8213/aa991c; Metzger BD, 2008, MON NOT R ASTRON SOC, V385, P1455, DOI [10.1111/j.1365-2966.2008.12923.x, 10.1111/J.1365-2966.2008.12923.X]; Park T, 2006, ASTROPHYS J, V652, P610, DOI 10.1086/507406; Piro L, 2019, MON NOT R ASTRON SOC, V483, P1912, DOI 10.1093/mnras/sty3047; Pooley D, 2018, ASTROPHYS J LETT, V859, DOI 10.3847/2041-8213/aac3d6; Rezzolla L, 2018, ASTROPHYS J LETT, V852, DOI 10.3847/2041-8213/aaa401; Rowlinson A, 2013, MON NOT R ASTRON SOC, V430, P1061, DOI 10.1093/mnras/sts683; Ruiz M, 2018, PHYS REV D, V97, DOI 10.1103/PhysRevD.97.021501; Santini P, 2015, ASTROPHYS J, V801, DOI 10.1088/0004-637X/801/2/97; Silverman JD, 2010, ASTROPHYS J SUPPL S, V191, P124, DOI 10.1088/0067-0049/191/1/124; Soderberg AM, 2008, NATURE, V453, P469, DOI 10.1038/nature06997; Speagle JS, 2014, ASTROPHYS J SUPPL S, V214, DOI 10.1088/0067-0049/214/2/15; STARK AA, 1992, ASTROPHYS J SUPPL S, V79, P77, DOI 10.1086/191645; Sun H, 2017, ASTROPHYS J, V835, DOI 10.3847/1538-4357/835/1/7; Sun H, 2015, ASTROPHYS J, V812, DOI 10.1088/0004-637X/812/1/33; Wiersema K, 2007, ASTRON ASTROPHYS, V464, P529, DOI 10.1051/0004-6361:20066273; Xue YQ, 2017, NEW ASTRON REV, V79, P59, DOI 10.1016/j.newar.2017.09.002; Xue YQ, 2011, ASTROPHYS J SUPPL S, V195, DOI 10.1088/0067-0049/195/1/10; Yu Y.-W, 2017, LONG LIVED REMNANT N; Zhang B, 2001, ASTROPHYS J, V552, pL35, DOI 10.1086/320255; Zhang BB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02847-3; Zhang B, 2013, ASTROPHYS J LETT, V763, DOI 10.1088/2041-8205/763/1/L22; Zheng XC, 2017, ASTROPHYS J, V849, DOI 10.3847/1538-4357/aa9378	57	61	64	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2019	568	7751					198	+		10.1038/s41586-019-1079-5	http://dx.doi.org/10.1038/s41586-019-1079-5			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HT2SH	30971846	Green Submitted			2022-12-28	WOS:000464412700041
J	Tanne, JH				Tanne, Janice Hopkins			New York City mayor declares measles public health emergency	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Brum R, 2019, ROCKLAND WESTCH 0409; Centers for Disease Control and Prevention, 2019, MEASL CAS OUTBR; TANNE JH, 2019, BMJ-BRIT MED J, V364, P12640, DOI DOI 10.1136/BMJ.L1481	3	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 10	2019	365								l1724	10.1136/bmj.l1724	http://dx.doi.org/10.1136/bmj.l1724			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU0EL	30971409				2022-12-28	WOS:000464944100012
J	Sugrue, LP; Desikan, RS				Sugrue, Leo P.; Desikan, Rahul S.			What Are Polygenic Scores and Why Are They Important?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Sugrue, Leo P.; Desikan, Rahul S.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, 505 Parnassus Ave,L352, San Francisco, CA 94143 USA; [Desikan, Rahul S.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Sugrue, LP (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, 505 Parnassus Ave,L352, San Francisco, CA 94143 USA.	leo.sugrue@ucsf.edu						Knowles JW, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002546; Maas P, 2016, JAMA ONCOL, V2, P1295, DOI 10.1001/jamaoncol.2016.1025; SEIBERT TM, 2018, BMJ-BRIT MED J, V360, DOI DOI 10.1136/BMJ.J5757; Torkamani A, 2018, NAT REV GENET, V19, P581, DOI 10.1038/s41576-018-0018-x; US Preventive Services Task Force, 2018, JAMA, V319, P1901, DOI 10.1001/jama.2018.3710; 2018, ACTA NEUROPATHOL, V135, P85, DOI DOI 10.1007/S00401-017-1789-4	6	70	72	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2019	321	18					1820	1821		10.1001/jama.2019.3893	http://dx.doi.org/10.1001/jama.2019.3893			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HY7ME	30958510				2022-12-28	WOS:000468319100018
J	Stern, RA; Adler, CH; Chen, KW; Navitsky, M; Luo, J; Dodick, DW; Alosco, ML; Tripodis, Y; Goradia, DD; Martin, B; Mastroeni, D; Fritts, NG; Jarnagin, J; Devous, MD; Mintun, MA; Pontecorvo, MJ; Shenton, ME; Reiman, EM				Stern, Robert A.; Adler, Charles H.; Chen, Kewei; Navitsky, Michael; Luo, Ji; Dodick, David W.; Alosco, Michael L.; Tripodis, Yorghos; Goradia, Dhruman D.; Martin, Brett; Mastroeni, Diego; Fritts, Nathan G.; Jarnagin, Johnny; Devous, Michael D., Sr.; Mintun, Mark A.; Pontecorvo, Michael J.; Shenton, Martha E.; Reiman, Eric M.			Tau Positron-Emission Tomography in Former National Football League Players	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; ALZHEIMER-DISEASE; BETA	BACKGROUND Chronic traumatic encephalopathy (CTE) is a neurodegenerative disease that has been associated with a history of repetitive head impacts. The neuropathological diagnosis is based on a specific pattern of tau deposition with minimal amyloid-beta deposition that differs from other disorders, including Alzheimer's disease. The feasibility of detecting tau and amyloid deposition in the brains of living persons at risk for CTE has not been well studied. METHODS We used flortaucipir positron-emission tomography (PET) and florbetapir PET to measure deposition of tau and amyloid-beta, respectively, in the brains of former National Football League (NFL) players with cognitive and neuropsychiatric symptoms and in asymptomatic men with no history of traumatic brain injury. Automated image-analysis algorithms were used to compare the regional tau standardized uptake value ratio (SUVR, the ratio of radioactivity in a cerebral region to that in the cerebellum as a reference) between the two groups and to explore the associations of SUVR with symptom severity and with years of football play in the former-player group. RESULTS A total of 26 former players and 31 controls were included in the analysis. The mean flortaucipir SUVR was higher among former players than among controls in three regions of the brain: bilateral superior frontal (1.09 vs. 0.98; adjusted mean difference, 0.13; 95% confidence interval [CI], 0.06 to 0.20; P<0.001), bilateral medial temporal (1.23 vs. 1.12; adjusted mean difference, 0.13; 95% CI, 0.05 to 0.21; P<0.001), and left parietal (1.12 vs. 1.01; adjusted mean difference, 0.12; 95% CI, 0.05 to 0.20; P = 0.002). In exploratory analyses, the correlation coefficients in these three regions between the SUVRs and years of play were 0.58 (95% CI, 0.25 to 0.79), 0.45 (95% CI, 0.07 to 0.71), and 0.50 (95% CI, 0.14 to 0.74), respectively. There was no association between tau deposition and scores on cognitive and neuropsychiatric tests. Only one former player had levels of amyloid-beta deposition similar to those in persons with Alzheimer's disease. CONCLUSIONS A group of living former NFL players with cognitive and neuropsychiatric symptoms had higher tau levels measured by PET than controls in brain regions that are affected by CTE and did not have elevated amyloid-beta levels. Further studies are needed to determine whether elevated CTE-associated tau can be detected in individual persons.	[Stern, Robert A.; Alosco, Michael L.; Fritts, Nathan G.; Jarnagin, Johnny] Boston Univ, Sch Med, Boston, MA 02118 USA; [Tripodis, Yorghos; Martin, Brett] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Shenton, Martha E.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Shenton, Martha E.] Harvard Med Sch, Boston, MA 02115 USA; [Shenton, Martha E.] Vet Affairs Boston Healthcare Syst, Boston, MA USA; [Adler, Charles H.; Dodick, David W.] Mayo Clin Arizona, Scottsdale, AZ USA; [Chen, Kewei; Luo, Ji; Goradia, Dhruman D.; Reiman, Eric M.] Banner Alzheimers Inst, Phoenix, AZ USA; [Mastroeni, Diego] Arizona State Univ, Tempe, AZ USA; [Navitsky, Michael; Devous, Michael D., Sr.; Mintun, Mark A.; Pontecorvo, Michael J.] Avid Radio Pharmaceut, Philadelphia, PA USA	Boston University; Boston University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Mayo Clinic; Mayo Clinic Phoenix; Banner Research; Banner Health; Banner Alzheimer's Institute; Arizona State University; Arizona State University-Tempe	Stern, RA (corresponding author), Boston Univ, Sch Med, Alzheimers Dis Ctr, 72 E Concord St,B-7800, Boston, MA 02118 USA.	bobstern@bu.edu	Adler, Charles/ABD-5276-2021; , Bob/ABA-8507-2020; Tripodis, Yorghos/GRY-0583-2022; Shenton, Martha/V-8780-2019	Tripodis, Yorghos/0000-0003-2190-7608	Avid Radiopharmaceuticals; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS093334, K23NS102399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG019610, P30AG013846, U19AG024904] Funding Source: NIH RePORTER	Avid Radiopharmaceuticals; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funded by Avid Radiopharmaceuticals and others.	Alosco ML, 2018, ALZHEIMERS DEMENT, V14, P1159, DOI 10.1016/j.jalz.2018.05.004; Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Alosco ML, 2017, J NEUROTRAUM, V34, P772, DOI 10.1089/neu.2016.4536; Alosco ML, 2016, ALZHEIMERS DEMENT, V7, P33; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Congdon EE, 2018, NAT REV NEUROL, V14, P399, DOI 10.1038/s41582-018-0013-z; Dickstein DL, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.175; Falcon B, 2019, NATURE; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Lee CM, 2018, J ALZHEIMERS DIS, V62, P1691, DOI 10.3233/JAD-170840; Lyoo CH, 2018, J MOV DISORD, V11, P1, DOI 10.14802/jmd.17071; Marquie M, 2017, ANN NEUROL, V81, P117, DOI 10.1002/ana.24844; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Ossenkoppele R, 2018, JAMA-J AM MED ASSOC, V320, P1151, DOI 10.1001/jama.2018.12917; Phillips JS, 2018, HUM BRAIN MAPP, V39, P691, DOI 10.1002/hbm.23874; Pontecorvo MJ, 2017, BRAIN, V140, P748, DOI 10.1093/brain/aww334; Schonhaut DR, 2017, ANN NEUROL, V82, P622, DOI 10.1002/ana.25060; Smith R, 2018, JAMA NEUROL; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Villemagne VL, 2018, NAT REV NEUROL, V14, P225, DOI 10.1038/nrneurol.2018.9; 2012, LANCET NEUROL, V11, P669, DOI DOI 10.1016/S1474-4422(12)70142-4; 2017, ACTA NEUROPATHOL, V133, P337, DOI DOI 10.1007/S00401-017-1680-3	28	99	102	4	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 2	2019	380	18					1716	1725		10.1056/NEJMoa1900757	http://dx.doi.org/10.1056/NEJMoa1900757			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HX9ZK	30969506	Green Accepted, Bronze			2022-12-28	WOS:000467767800007
J	Veglia, F; Tyurin, VA; Blasi, M; De Leo, A; Kossenkov, AV; Donthireddy, L; To, TKJ; Schug, Z; Basu, S; Wang, F; Ricciotti, E; DiRusso, C; Murphy, ME; Vonderheide, RH; Lieberman, PM; Mulligan, C; Nam, B; Hockstein, N; Masters, G; Guarino, M; Lin, C; Nefedova, Y; Black, P; Kagan, VE; Gabrilovich, DI				Veglia, Filippo; Tyurin, Vladimir A.; Blasi, Maria; De Leo, Alessandra; Kossenkov, Andrew V.; Donthireddy, Laxminarasimha; To, Tsun Ki Jerrick; Schug, Zach; Basu, Subhasree; Wang, Fang; Ricciotti, Emanuela; DiRusso, Concetta; Murphy, Maureen E.; Vonderheide, Robert H.; Lieberman, Paul M.; Mulligan, Charles; Nam, Brian; Hockstein, Neil; Masters, Gregory; Guarino, Michael; Lin, Cindy; Nefedova, Yulia; Black, Paul; Kagan, Valerian E.; Gabrilovich, Dmitry I.			Fatty acid transport protein 2 reprograms neutrophils in cancer	NATURE			English	Article							SUPPRESSOR-CELLS; DENDRITIC CELL; PMN-MDSC; DIFFERENTIATION; INHIBITION; METABOLISM; LIPIDS; COX-2	Polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) are pathologically activated neutrophils that are crucial for the regulation of immune responses in cancer. These cells contribute to the failure of cancer therapies and are associated with poor clinical outcomes. Despite recent advances in the understanding of PMN-MDSC biology, the mechanisms responsible for the pathological activation of neutrophils are not well defined, and this limits the selective targeting of these cells. Here we report that mouse and human PMN-MDSCs exclusively upregulate fatty acid transport protein 2 (FATP2). Overexpression of FATP2 in PMN-MDSCs was controlled by granulocyte-macrophage colony-stimulating factor, through the activation of the STAT5 transcription factor. Deletion of FATP2 abrogated the suppressive activity of PMN-MDSCs. The main mechanism of FATP2-mediated suppressive activity involved the uptake of arachidonic acid and the synthesis of prostaglandin E-2. The selective pharmacological inhibition of FATP2 abrogated the activity of PMN-MDSCs and substantially delayed tumour progression. In combination with checkpoint inhibitors, FATP2 inhibition blocked tumour progression in mice. Thus, FATP2 mediates the acquisition of immunosuppressive activity by PMN-MDSCs and represents a target to inhibit the functions of PMN-MDSCs selectively and to improve the efficiency of cancer therapy.	[Veglia, Filippo; Kossenkov, Andrew V.; Donthireddy, Laxminarasimha; Wang, Fang; Lin, Cindy; Nefedova, Yulia; Gabrilovich, Dmitry I.] Wistar Inst Anat & Biol, Immunol Microenvironm & Metastasis Program, 3601 Spruce St, Philadelphia, PA 19104 USA; [Tyurin, Vladimir A.; Kagan, Valerian E.] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA USA; [Blasi, Maria] Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC USA; [De Leo, Alessandra; Lieberman, Paul M.] Wistar Inst Anat & Biol, Gene Express & Regulat Program, 3601 Spruce St, Philadelphia, PA 19104 USA; [To, Tsun Ki Jerrick; Ricciotti, Emanuela; Vonderheide, Robert H.; Masters, Gregory] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Schug, Zach; Basu, Subhasree; Murphy, Maureen E.] Wistar Inst Anat & Biol, Program Mol & Cellular Oncogenesis, 3601 Spruce St, Philadelphia, PA 19104 USA; [DiRusso, Concetta; Black, Paul] Univ Nebraska Lincoln, Dept Biochem, Lincoln, NE USA; [Mulligan, Charles; Nam, Brian; Hockstein, Neil; Masters, Gregory; Guarino, Michael] Christiana Care Hlth Syst, Helen F Graham Canc Ctr, Wilmington, DE USA; [Kagan, Valerian E.] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; [Kagan, Valerian E.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Kagan, Valerian E.] Univ Pittsburgh, Dept Radiat Oncol, Pittsburgh, PA USA; [Kagan, Valerian E.] IM Sechenov Moscow State Med Univ, Lab Nav Redox Lipid, Moscow, Russia	The Wistar Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Duke University; The Wistar Institute; University of Pennsylvania; The Wistar Institute; University of Nebraska System; University of Nebraska Lincoln; Christiana Care Health System; Helen F. Graham Cancer Center & Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Sechenov First Moscow State Medical University	Gabrilovich, DI (corresponding author), Wistar Inst Anat & Biol, Immunol Microenvironm & Metastasis Program, 3601 Spruce St, Philadelphia, PA 19104 USA.	dgabrilovich@wistar.org	Ricciotti, Emanuela/AAH-2729-2019; Lin, Cindy/P-7043-2015; Blasi, Maria/AAX-2293-2021; Donthireddy, Laxminarasimha Reddy/AAC-6008-2020; Gabrilovich, Dmitry/ABE-7122-2020	Lin, Cindy/0000-0002-9930-0411; Kagan, Valerian E./0000-0002-7245-1885; Schug, Zachary/0000-0003-4197-8227; Donthireddy, Laxminarasimha/0000-0003-0457-8486; Veglia, Filippo/0000-0001-6710-1584; Blasi, Maria/0000-0002-7091-0312; Tyurin, Vladimir/0000-0002-3474-1697; Nefedova, Yulia/0000-0002-5121-9294	NIH [AI110485, CA R01CA165065]; NATIONAL CANCER INSTITUTE [P30CA010815, R50CA221838, R01CA100062, R01CA139319, R50CA211199, R01CA165065] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI110485] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD023658, S10OD023586] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant CA R01CA165065 to D.I.G. and V.E.K., NIH grant AI110485 to M.B., and by animal, genomics and flow cytometry core facilities of the Wistar Institute. We thank R. Schreiber for providing us with F244 cells; L. Joannas and J. Henao-Meja for generating Slc27a2fl/fl mice; W. Stremmel for providing Slc27a4<SUP>fl/fl</SUP> mice; and D. Weiner for providing tetramers.	Ahowesso C, 2015, BIOCHEM PHARMACOL, V98, P167, DOI 10.1016/j.bcp.2015.09.004; Al-Khami AA, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1344804; Black PN, 2007, BBA-MOL CELL BIOL L, V1771, P286, DOI 10.1016/j.bbalip.2006.05.003; Black PN, 2016, MEDCHEMCOMM, V7, P612, DOI 10.1039/c6md00043f; Cao W, 2014, J IMMUNOL, V192, P2920, DOI 10.4049/jimmunol.1302801; Casbon AJ, 2015, P NATL ACAD SCI USA, V112, pE566, DOI 10.1073/pnas.1424927112; Chen HS, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006100; Condamine T, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaf8943; Cubillos-Ruiz JR, 2015, CELL, V161, P1527, DOI 10.1016/j.cell.2015.05.025; den Brok MH, 2018, TRENDS IMMUNOL, V39, P380, DOI 10.1016/j.it.2018.01.012; Fujita M, 2011, CANCER RES, V71, P2664, DOI 10.1158/0008-5472.CAN-10-3055; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; He YM, 2018, NAT MED, V24, P224, DOI 10.1038/nm.4467; Henao-Mejia J., 2016, COLD SPRING HARB PRO, V2016; Herber DL, 2010, NAT MED, V16, P880, DOI 10.1038/nm.2172; Hubler MJ, 2016, J NUTR BIOCHEM, V34, P1, DOI 10.1016/j.jnutbio.2015.11.002; Kumar V, 2017, CANCER CELL, V32, P654, DOI 10.1016/j.ccell.2017.10.005; Kumar V, 2016, TRENDS IMMUNOL, V37, P208, DOI 10.1016/j.it.2016.01.004; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li Y, 2014, J IMMUNOL, V193, P2127, DOI 10.4049/jimmunol.1400857; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Melton EM, 2013, BIOCHEM BIOPH RES CO, V440, P743, DOI 10.1016/j.bbrc.2013.09.137; Michelini Z, 2009, VACCINE, V27, P4622, DOI 10.1016/j.vaccine.2009.05.070; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Negri D, 2016, MOL THER, V24, P2021, DOI 10.1038/mt.2016.123; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; Obermajer N, 2011, BLOOD, V118, P5498, DOI 10.1182/blood-2011-07-365825; Rodriguez PC, 2005, J EXP MED, V202, P931, DOI 10.1084/jem.20050715; Sinha P, 2007, CANCER RES, V67, P4507, DOI 10.1158/0008-5472.CAN-06-4174; Veglia F, 2018, NAT IMMUNOL, V19, P108, DOI 10.1038/s41590-017-0022-x; Veglia F, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02186-9; Veltman JD, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-464; Youn JI, 2012, J LEUKOCYTE BIOL, V91, P167, DOI 10.1189/jlb.0311177; Zelenay S, 2015, CELL, V162, P1257, DOI 10.1016/j.cell.2015.08.015; Zhou J, 2018, SEMIN IMMUNOL, V35, P19, DOI 10.1016/j.smim.2017.12.004	36	258	266	6	174	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 2	2019	569	7754					73	+		10.1038/s41586-019-1118-2	http://dx.doi.org/10.1038/s41586-019-1118-2			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HW2NX	30996346	Green Accepted			2022-12-28	WOS:000466523700035
J	Proano, C; Kimball, GP				Proano, Cinthia; Kimball, Glenn P.			Hydroxychloroquine Retinal Toxicity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 57-year-old woman receiving long-term hydroxychloroquine treatment presented for ophthalmic evaluation. Achromatic perimetry revealed paracentral scotomas in each eye, and optical coherence tomography revealed a loss of the retinal inner and outer segments.	[Proano, Cinthia] Watts Eye Associates, Newburyport, MA 01950 USA		Proano, C (corresponding author), Watts Eye Associates, Newburyport, MA 01950 USA.	ceproano@verizon.net							0	5	5	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 25	2019	380	17							e27	10.1056/NEJMicm1304542	http://dx.doi.org/10.1056/NEJMicm1304542			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU9FC	31018072				2022-12-28	WOS:000465598600003
J	Kuehn, B				Kuehn, Bridget			Traumatic Brain Injuries Among Youth	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2019	321	16					1559	1559		10.1001/jama.2019.3877	http://dx.doi.org/10.1001/jama.2019.3877			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HV7BZ	31012944				2022-12-28	WOS:000466137800041
J	Dyer, O				Dyer, Owen			Transvaginal mesh: FDA orders remaining products off US market	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 18	2019	365								l1839	10.1136/bmj.l1839	http://dx.doi.org/10.1136/bmj.l1839			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU8PD	31000503				2022-12-28	WOS:000465550700012
J	Mahase, E				Mahase, Elisabeth			Half of patients prescribed statins fail to hit target reduction in LDL cholesterol	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Akyea RK, 2019, HEART, DOI [10.1136/heartjnl-2018-314253.30988003, DOI 10.1136/HEARTJNL-2018-314253.30988003]; Bittencourt MS, 2019, HEART, DOI [10.1136/heartjnl-2019-314723.30988002, DOI 10.1136/HEARTJNL-2019-314723.30988002]; NICE, 2014, CARD DIS RISK ASS RE, V1, P1	3	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 18	2019	365								l1838	10.1136/bmj.l1838	http://dx.doi.org/10.1136/bmj.l1838			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU8PD	31000633				2022-12-28	WOS:000465550700011
J	Kivimaki, M; Singh-Manoux, A; Pentti, J; Sabia, S; Nyberg, ST; Alfredsson, L; Goldberg, M; Knutsson, A; Koskenvuo, M; Koskinen, A; Kouvonen, A; Nordin, M; Oksanen, T; Strandberg, T; Suominen, SB; Theorell, T; Vahtera, J; Vaananen, A; Virtanen, M; Westerholm, P; Westerlund, H; Zins, M; Seshadri, S; Batty, GD; Sipila, PN; Shipley, MJ; Lindbohm, JV; Ferrie, JE; Jokela, M				Kivimaki, Mika; Singh-Manoux, Archana; Pentti, Jaana; Sabia, Severine; Nyberg, Solja T.; Alfredsson, Lars; Goldberg, Marcel; Knutsson, Anders; Koskenvuo, Markku; Koskinen, Aki; Kouvonen, Anne; Nordin, Maria; Oksanen, Tuula; Strandberg, Timo; Suominen, Sakari B.; Theorell, Tores; Vahtera, Jussi; Vaananen, Ari; Virtanen, Marianna; Westerholm, Peter; Westerlund, Hugo; Zins, Marie; Seshadri, Sudha; Batty, G. David; Sipila, Pyry N.; Shipley, Martin J.; Lindbohm, Joni V.; Ferrie, Jane E.; Jokela, Markus		IPD-Work Consortium	Physical inactivity, cardiometabolic disease, and risk of dementia: an individual-participant meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							JOB STRAIN; PROPORTIONAL-HAZARDS; HEART-DISEASE; LIFE-STYLE; FOLLOW-UP; COHORT; TIME; MEN; ASSOCIATION; MORTALITY	OBJECTIVE To examine whether physical inactivity is a risk factor for dementia, with attention to the role of cardiometabolic disease in this association and reverse causation bias that arises from changes in physical activity in the preclinical (prodromal) phase of dementia. DESIGN Meta-analysis of 19 prospective observational cohort studies. DATA SOURCES The Individual-Participant-Data Meta-analysis in Working Populations Consortium, the Inter-University Consortium for Political and Social Research, and the UK Data Service, including a total of 19 of a potential 9741 studies. REVIEW METHOD The search strategy was designed to retrieve individual-participant data from prospective cohort studies. Exposure was physical inactivity; primary outcomes were incident all-cause dementia and Alzheimer's disease; and the secondary outcome was incident cardiometabolic disease (that is, diabetes, coronary heart disease, and stroke). Summary estimates were obtained using random effects meta-analysis. RESULTS Study population included 404 840 people (mean age 45.5 years, 57.7% women) who were initially free of dementia, had a measurement of physical inactivity at study entry, and were linked to electronic health records. In 6.0 million person-years at risk, we recorded 2044 incident cases of all-cause dementia. In studies with data on dementia subtype, the number of incident cases of Alzheimer's disease was 1602 in 5.2 million person-years. When measured < 10 years before dementia diagnosis (that is, the preclinical stage of dementia), physical inactivity was associated with increased incidence of all-cause dementia (hazard ratio 1.40, 95% confidence interval 1.23 to 1.71) and Alzheimer's disease (1.36, 1.12 to 1.65). When reverse causation was minimised by assessing physical activity >= 10 years before dementia onset, no difference in dementia risk between physically active and inactive participants was observed (hazard ratios 1.01 (0.89 to 1.14) and 0.96 (0.85 to 1.08) for the two outcomes). Physical inactivity was consistently associated with increased risk of incident diabetes (hazard ratio 1.42, 1.25 to 1.61), coronary heart disease (1.24, 1.13 to 1.36), and stroke (1.16, 1.05 to 1.27). Among people in whom cardiometabolic disease preceded dementia, physical inactivity was non-significantly associated with dementia (hazard ratio for physical activity assessed > 10 before dementia onset 1.30, 0.79 to 2.14). CONCLUSIONS In analyses that addressed bias due to reverse causation, physical inactivity was not associated with all-cause dementia or Alzheimer's disease, although an indication of excess dementia risk was observed in a subgroup of physically inactive individuals who developed cardiometabolic disease.	[Kivimaki, Mika; Singh-Manoux, Archana; Sabia, Severine; Batty, G. David; Shipley, Martin J.; Ferrie, Jane E.] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Kivimaki, Mika; Pentti, Jaana; Nyberg, Solja T.; Koskenvuo, Markku; Strandberg, Timo; Lindbohm, Joni V.] Univ Helsinki, Clinicum, Fac Med, FI-00014 Helsinki, Finland; [Kivimaki, Mika] Univ Helsinki, Helsinki Inst Life Sci, Helsinki, Finland; [Singh-Manoux, Archana; Sabia, Severine] INSERM, U1153, Epidemiol Ageing & Neurodegenerat Dis, Paris, France; [Pentti, Jaana; Suominen, Sakari B.; Vahtera, Jussi] Univ Turku, Dept Publ Hlth, Turku, Finland; [Alfredsson, Lars] Karolinska Inst, Inst Environm Med, Stockholm, Sweden; [Goldberg, Marcel; Zins, Marie] INSERM, UMS 011, Populat Based Epidemiol Cohorts Unit, Villejuif, France; [Knutsson, Anders] Mid Sweden Univ, Dept Hlth Sci, Sundsvall, Sweden; [Koskinen, Aki; Oksanen, Tuula; Vaananen, Ari] Finnish Inst Occupat Hlth, Helsinki, Finland; [Kouvonen, Anne] Univ Helsinki, Fac Social Sci, Helsinki, Finland; [Kouvonen, Anne] SWPS Univ Social Sci & Humanities Wroclaw, Wroclaw, Poland; [Kouvonen, Anne] Queens Univ Belfast, Ctr Publ Hlth, Adm Data Res Ctr Northern Ireland, Belfast, Antrim, North Ireland; [Nordin, Maria; Theorell, Tores; Westerlund, Hugo] Stockholm Univ, Stress Res Inst, Stockholm, Sweden; [Nordin, Maria] Umea Univ, Dept Psychol, Umea, Sweden; [Strandberg, Timo] Helsinki Univ Hosp, Helsinki, Finland; [Strandberg, Timo] Univ Oulu, Ctr Life Course Hlth Res, Oulu, Finland; [Suominen, Sakari B.] Univ Skovde, Skovde, Sweden; [Vahtera, Jussi] Turku Univ Hosp, Turku, Finland; [Virtanen, Marianna] Univ Eastern Finland, Sch Educ Sci & Psychol, Joensuu, Finland; [Westerholm, Peter] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Seshadri, Sudha] Univ Texas Hlth Sci Ctr San Antonio, Glenn Biggs Inst Alzheimers & Neurodegenerat Dis, San Antonio, TX 78229 USA; [Seshadri, Sudha] Framingham Heart Dis Epidemiol Study, Framingham, MA USA; [Sipila, Pyry N.; Ferrie, Jane E.] Univ Bristol, Bristol Med Sch, Populat Hlth Sci, Bristol, Avon, England; [Jokela, Markus] Univ Helsinki, Biomedicum, Fac Med, Helsinki, Finland	University of London; University College London; University of Helsinki; University of Helsinki; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Turku; Karolinska Institutet; Institut National de la Sante et de la Recherche Medicale (Inserm); Mid-Sweden University; Finnish Institute of Occupational Health; University of Helsinki; SWPS University of Social Sciences & Humanities; Queens University Belfast; Stockholm University; Umea University; University of Helsinki; Helsinki University Central Hospital; University of Oulu; University of Skovde; University of Turku; University of Eastern Finland; Uppsala University; University of Texas System; University of Texas Health San Antonio; Framingham Heart Study; University of Bristol; University of Helsinki	Kivimaki, M (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England.; Kivimaki, M (corresponding author), Univ Helsinki, Clinicum, Fac Med, FI-00014 Helsinki, Finland.; Kivimaki, M (corresponding author), Univ Helsinki, Helsinki Inst Life Sci, Helsinki, Finland.	m.kivimaki@ucl.ac.uk	Westerlund, Hugo/A-3049-2012; Sabia, Séverine/G-2966-2017; Singh-Manoux, Archana/F-6804-2013; Batty, GD/Y-4401-2018; Zins, Marie/AAX-6551-2021; Ferrie, Jane/AAZ-2009-2020; Oksanen, Tuula/AAK-5599-2021; Alfredsson, Lars/AAC-9007-2019; Kivimaki, Mika/B-3607-2012; Sipilä, Pyry N/ABA-7862-2020; Jokela, Markus/A-4669-2009	Westerlund, Hugo/0000-0002-8806-5698; Sabia, Séverine/0000-0003-3109-9720; Singh-Manoux, Archana/0000-0002-1244-5037; Batty, GD/0000-0003-1822-5753; Alfredsson, Lars/0000-0003-1688-6697; Kivimaki, Mika/0000-0002-4699-5627; Sipilä, Pyry N/0000-0003-4886-8151; Suominen, Sakari B./0000-0001-6648-603X; Seshadri, Sudha/0000-0001-6135-2622; Jokela, Markus/0000-0003-0117-0012; Vahtera, Jussi/0000-0002-6036-061X	NordForsk [70521]; UK Medical Research Council [MRC S011676]; Academy of Finland [311492, 311578]; Helsinki Institute of Life Science [H970]; US National Institutes on Ageing [NIA R01AG056477]; MRC [S011676, P023444/1]; NIA [1R01AG052519-01A1]; British Heart Foundation [32334]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG059421, U01AG052409, R01AG052519, R01AG056477] Funding Source: NIH RePORTER; MRC [MR/S011676/1, MR/R024227/1] Funding Source: UKRI	NordForsk; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Finland(Academy of Finland); Helsinki Institute of Life Science; US National Institutes on Ageing; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The IPD-Work Consortium (PI, MKi) has received funding from NordForsk (70521, the Nordic Research Programme on Health and Welfare), the UK Medical Research Council (MRC S011676), the Academy of Finland (311492), and Helsinki Institute of Life Science (H970). MKi and AS-M were also supported by the US National Institutes on Ageing (NIA R01AG056477). JP and STN were supported by NordForsk. SSa was supported by the MRC (S011676). GDB was supported by the MRC (P023444/1) and NIA (1R01AG052519-01A1). JVL was supported by the Academy of Finland (311492). MJS was supported by the British Heart Foundation (32334). PNS was supported by Helsinki Institute of Life Science (H970). MJ was supported by the Academy of Finland (311578). The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of this manuscript.	Akaike H., 1973, SELECTED PAPERS HIRO, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Allison P. D., 1995, SURVIVAL ANAL USING; Andel R, 2008, J GERONTOL A-BIOL, V63, P62, DOI 10.1093/gerona/63.1.62; Bennett DA, 2017, JAMA CARDIOL, V2, P1349, DOI 10.1001/jamacardio.2017.4069; Binder N, 2017, EUR J EPIDEMIOL, V32, P627, DOI 10.1007/s10654-017-0252-0; Brasure M, 2018, ANN INTERN MED, V168, P30, DOI 10.7326/M17-1528; Chatterjee S, 2016, DIABETES CARE, V39, P300, DOI 10.2337/dc15-1588; Cornell JE, 2014, ANN INTERN MED, V160, P267, DOI 10.7326/M13-2886; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fransson EI, 2012, AM J EPIDEMIOL, V176, P1078, DOI 10.1093/aje/kws336; Fransson EI, 2015, STROKE, V46, P557, DOI 10.1161/STROKEAHA.114.008019; Frost C, 2000, J R STAT SOC A STAT, V163, P173, DOI 10.1111/1467-985X.00164; Gelber RP, 2012, J AM GERIATR SOC, V60, P118, DOI 10.1111/j.1532-5415.2011.03768.x; Hamer M, 2009, PSYCHOL MED, V39, P3, DOI 10.1017/S0033291708003681; Heikkila K, 2013, AM J PUBLIC HEALTH, V103, P2090, DOI 10.2105/AJPH.2012.301090; Heran BS, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001800.pub2, 10.1002/14651858.CD001800.pub3]; Iso-Markku P, 2015, ANN MED, V47, P81, DOI 10.3109/07853890.2014.994675; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Kishimoto H, 2016, EUR J EPIDEMIOL, V31, P267, DOI 10.1007/s10654-016-0125-y; Kivimaki M, 2012, LANCET, V380, P1491, DOI 10.1016/S0140-6736(12)60994-5; Kivimaki M, 2018, ALZHEIMERS DEMENT, V14, P601, DOI 10.1016/j.jalz.2017.09.016; Kivimaki M, 2017, LANCET PUBLIC HEALTH, V2, pE277, DOI 10.1016/S2468-2667(17)30074-9; Kuzma E, 2018, ALZHEIMERS DEMENT, V14, P1416, DOI 10.1016/j.jalz.2018.06.3061; Kyu HH, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3857; Laaksonen DE, 2005, DIABETES, V54, P158, DOI 10.2337/diabetes.54.1.158; Lear SA, 2017, LANCET, V390, P2643, DOI 10.1016/S0140-6736(17)31634-3; Morgan GS, 2012, J ALZHEIMERS DIS, V31, P569, DOI 10.3233/JAD-2012-112171; NHS England, 2015, DEM DIAGN MAN BRIEF; NHS London Clinical Networks, 2016, GUID GPS IMPR DEM CO; Rovio S, 2005, LANCET NEUROL, V4, P705, DOI 10.1016/S1474-4422(05)70198-8; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Rucker G, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-79; Sabia S, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2709; Santos-Lozano A, 2016, MAYO CLIN PROC, V91, P999, DOI 10.1016/j.mayocp.2016.04.024; Smith AD, 2016, DIABETOLOGIA, V59, P2527, DOI 10.1007/s00125-016-4079-0; Sommerlad A, 2018, ALZHEIMERS DEMENT, V14, P933, DOI 10.1016/j.jalz.2018.02.012; Stewart RAH, 2017, J AM COLL CARDIOL, V70, P1689, DOI 10.1016/j.jacc.2017.08.017; Ueki K, 2017, LANCET DIABETES ENDO, V5, P951, DOI 10.1016/S2213-8587(17)30327-3; Vaillant GE, 2014, INT J GERIATR PSYCH, V29, P1278, DOI 10.1002/gps.4108; Wolters FJ, 2018, ALZHEIMERS DEMENT, V14, P1493, DOI 10.1016/j.jalz.2018.01.007; Xie J, 2008, BMJ-BRIT MED J, V336, P258, DOI 10.1136/bmj.39433.616678.25; 2001, STAT MED, V20, P3875, DOI DOI 10.1002/SIM.1009	42	100	101	2	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2019	365								l1495	10.1136/bmj.l1495	http://dx.doi.org/10.1136/bmj.l1495			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU8OY	30995986	hybrid, Green Published			2022-12-28	WOS:000465550000004
J	Evangelista, L; Steinhubl, SR; Topol, EJ				Evangelista, Lorraine; Steinhubl, Steven R.; Topol, Eric J.			Digital health care for older adults	LANCET			English	Editorial Material									[Evangelista, Lorraine] Univ Calif Irvine, Irvine, CA 92697 USA; [Evangelista, Lorraine; Steinhubl, Steven R.; Topol, Eric J.] Scripps Res Translat Inst, La Jolla, CA 92037 USA	University of California System; University of California Irvine	Evangelista, L (corresponding author), Univ Calif Irvine, Irvine, CA 92697 USA.; Evangelista, L (corresponding author), Scripps Res Translat Inst, La Jolla, CA 92037 USA.	levangelista@scripps.edu		Topol, Eric/0000-0002-1478-4729	NCATS NIH HHS [UL1 TR001114] Funding Source: Medline; NIA NIH HHS [R21 AG053162] Funding Source: Medline	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))			0	18	19	1	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 13	2019	393	10180					1493	1493		10.1016/S0140-6736(19)30800-1	http://dx.doi.org/10.1016/S0140-6736(19)30800-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU0DA	30983579	Green Accepted			2022-12-28	WOS:000464940400013
J	Pan, D; Arkell, P; Stone, NRH; Parkinson, B; Tinwell, B; Cosgrove, CA				Pan, Daniel; Arkell, Paul; Stone, Neil R. H.; Parkinson, Belinda; Tinwell, Brendan; Cosgrove, Catherine A.			Delayed Strongyloides stercoralis hyperinfection syndrome in a renal transplant patient with Pneumocystis jirovecii pneumonia receiving high-dose corticosteroids	LANCET			English	Editorial Material									[Pan, Daniel; Arkell, Paul; Stone, Neil R. H.; Cosgrove, Catherine A.] St George Hosp, Clin Infect Unit, London SW17 0QT, England; [Parkinson, Belinda; Tinwell, Brendan] St George Hosp, London Southwest Pathol, London, England	St Georges University London; St Georges University London	Pan, D (corresponding author), St George Hosp, Clin Infect Unit, London SW17 0QT, England.	daniel.pan@nhs.net	Cosgrove, Catherine/AGF-2877-2022	Pan, Daniel/0000-0002-1268-2243					0	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 13	2019	393	10180					1536	1536		10.1016/S0140-6736(19)30708-1	http://dx.doi.org/10.1016/S0140-6736(19)30708-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU0DA	30983588				2022-12-28	WOS:000464940400029
J	Garrett-Bakelman, FE; Darshi, M; Green, SJ; Gur, RC; Lin, L; Macias, BR; McKenna, MJ; Meydan, C; Mishra, T; Nasrini, J; Piening, BD; Rizzardi, LF; Sharma, K; Siamwala, JH; Taylor, L; Vitaterna, MH; Afkarian, M; Afshinnekoo, E; Ahadi, S; Ambati, A; Arya, M; Bezdan, D; Callahan, CM; Chen, SJ; Choi, AMK; Chlipala, GE; Contrepois, K; Covington, M; Crucian, BE; De Vivo, I; Dinges, DF; Ebert, DJ; Feinberg, JI; Gandara, JA; George, KA; Goutsias, J; Grills, GS; Hargens, AR; Heer, M; Hillary, RP; Hoofnagle, AN; Hook, VYH; Jenkinson, G; Jiang, P; Keshavarzian, A; Laurie, SS; Lee-McMullen, B; Lumpkins, SB; MacKay, M; Maienschein-Cline, MG; Melnick, AM; Moore, TM; Nakahira, K; Patel, HH; Pietrzyk, R; Rao, V; Saito, R; Salins, DN; Schilling, JM; Sears, DD; Sheridan, CK; Stenger, MB; Tryggvadottir, R; Urban, AE; Vaisar, T; Van Espen, B; Zhang, J; Ziegler, MG; Zwart, SR; Charles, JB; Kundrot, CE; Scott, GBI; Bailey, SM; Basner, M; Feinberg, AP; Lee, SMC; Mason, CE; Mignot, E; Rana, BK; Smith, SM; Snyder, MP; Turek, FW				Garrett-Bakelman, Francine E.; Darshi, Manjula; Green, Stefan J.; Gur, Ruben C.; Lin, Ling; Macias, Brandon R.; McKenna, Miles J.; Meydan, Cem; Mishra, Tejaswini; Nasrini, Jad; Piening, Brian D.; Rizzardi, Lindsay F.; Sharma, Kumar; Siamwala, Jamila H.; Taylor, Lynn; Vitaterna, Martha Hotz; Afkarian, Maryam; Afshinnekoo, Ebrahim; Ahadi, Sara; Ambati, Aditya; Arya, Maneesh; Bezdan, Daniela; Callahan, Colin M.; Chen, Songjie; Choi, Augustine M. K.; Chlipala, George E.; Contrepois, Kevin; Covington, Marisa; Crucian, Brian E.; De Vivo, Immaculata; Dinges, David F.; Ebert, Douglas J.; Feinberg, Jason I.; Gandara, Jorge A.; George, Kerry A.; Goutsias, John; Grills, George S.; Hargens, Alan R.; Heer, Martina; Hillary, Ryan P.; Hoofnagle, Andrew N.; Hook, Vivian Y. H.; Jenkinson, Garrett; Jiang, Peng; Keshavarzian, Ali; Laurie, Steven S.; Lee-McMullen, Brittany; Lumpkins, Sarah B.; MacKay, Matthew; Maienschein-Cline, Mark G.; Melnick, Ari M.; Moore, Tyler M.; Nakahira, Kiichi; Patel, Hemal H.; Pietrzyk, Robert; Rao, Varsha; Saito, Rintaro; Salins, Denis N.; Schilling, Jan M.; Sears, Dorothy D.; Sheridan, Caroline K.; Stenger, Michael B.; Tryggvadottir, Rakel; Urban, Alexander E.; Vaisar, Tomas; Van Espen, Benjamin; Zhang, Jing; Ziegler, Michael G.; Zwart, Sara R.; Charles, John B.; Kundrot, Craig E.; Scott, Graham B. I.; Bailey, Susan M.; Basner, Mathias; Feinberg, Andrew P.; Lee, Stuart M. C.; Mason, Christopher E.; Mignot, Emmanuel; Rana, Brinda K.; Smith, Scott M.; Snyder, Michael P.; Turek, Fred W.			The NASA Twins Study: A multidimensional analysis of a year-long human spaceflight	SCIENCE			English	Article							DIRECTIONAL GENOMIC HYBRIDIZATION; DIFFERENTIAL EXPRESSION ANALYSIS; SHORT-DURATION SPACEFLIGHT; RENIN-ANGIOTENSIN SYSTEM; INTIMA-MEDIA THICKNESS; COGNITION TEST BATTERY; OPTIC DISC EDEMA; TELOMERE LENGTH; RNA-SEQ; CARDIOVASCULAR-DISEASE	To understand the health impact of long-duration spaceflight, one identical twin astronaut was monitored before, during, and after a 1-year mission onboard the International Space Station; his twin served as a genetically matched ground control. Longitudinal assessments identified spaceflight-specific changes, including decreased body mass, telomere elongation, genome instability, carotid artery distension and increased intima-media thickness, altered ocular structure, transcriptional and metabolic changes, DNA methylation changes in immune and oxidative stress-related pathways, gastrointestinal microbiota alterations, and some cognitive decline postflight. Although average telomere length, global gene expression, and microbiome changes returned to near preflight levels within 6 months after return to Earth, increased numbers of short telomeres were observed and expression of some genes was still disrupted. These multiomic, molecular, physiological, and behavioral datasets provide a valuable roadmap of the putative health risks for future human spaceflight.	[Garrett-Bakelman, Francine E.; Meydan, Cem; Afshinnekoo, Ebrahim; Bezdan, Daniela; Choi, Augustine M. K.; Gandara, Jorge A.; Grills, George S.; MacKay, Matthew; Melnick, Ari M.; Nakahira, Kiichi; Sheridan, Caroline K.; Mason, Christopher E.] Weill Cornell Med, New York, NY 10021 USA; [Garrett-Bakelman, Francine E.] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA; [Darshi, Manjula; Sharma, Kumar] Univ Texas Hlth, Ctr Renal Precis Med, San Antonio, TX USA; [Green, Stefan J.; Chlipala, George E.; Maienschein-Cline, Mark G.] Univ Illinois, Chicago, IL USA; [Gur, Ruben C.; Nasrini, Jad; Dinges, David F.; Moore, Tyler M.; Basner, Mathias] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Lin, Ling; Mishra, Tejaswini; Piening, Brian D.; Ahadi, Sara; Ambati, Aditya; Chen, Songjie; Contrepois, Kevin; Hillary, Ryan P.; Lee-McMullen, Brittany; Rao, Varsha; Salins, Denis N.; Urban, Alexander E.; Zhang, Jing; Mignot, Emmanuel; Snyder, Michael P.] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA; [Macias, Brandon R.; Arya, Maneesh; Ebert, Douglas J.; George, Kerry A.; Laurie, Steven S.; Pietrzyk, Robert; Lee, Stuart M. C.] KBRwyle, Houston, TX 77058 USA; [McKenna, Miles J.; Taylor, Lynn; Bailey, Susan M.] Colorado State Univ, Ft Collins, CO 80523 USA; [Meydan, Cem; Afshinnekoo, Ebrahim; Bezdan, Daniela; Mason, Christopher E.] Bin Talal Bin Abdulaziz Alsaud Inst Computat Biom, New York, NY 10065 USA; [Rizzardi, Lindsay F.; Callahan, Colin M.; Feinberg, Jason I.; Goutsias, John; Jenkinson, Garrett; Tryggvadottir, Rakel; Feinberg, Andrew P.] Johns Hopkins Univ, Baltimore, MD 21218 USA; [Siamwala, Jamila H.; Hargens, Alan R.; Hook, Vivian Y. H.; Patel, Hemal H.; Saito, Rintaro; Schilling, Jan M.; Sears, Dorothy D.; Van Espen, Benjamin; Ziegler, Michael G.; Rana, Brinda K.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Vitaterna, Martha Hotz; Jiang, Peng; Turek, Fred W.] Northwestern Univ, Evanston, IL 60208 USA; [Afkarian, Maryam] Univ Calif Davis, Davis, CA 95616 USA; [Covington, Marisa; Crucian, Brian E.; Stenger, Michael B.; Charles, John B.; Smith, Scott M.] NASA, Houston, TX 77058 USA; [De Vivo, Immaculata] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Heer, Martina] Univ Bonn, Bonn, Germany; [Hoofnagle, Andrew N.; Vaisar, Tomas] Univ Washington, Seattle, WA 98195 USA; [Keshavarzian, Ali] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Lumpkins, Sarah B.] MEI Technol, Houston, TX USA; [Zwart, Sara R.] Univ Texas Med Branch, Galveston, TX 77555 USA; [Kundrot, Craig E.] NASA Headquarters, Space Life & Phys Sci Div, Washington, DC 20546 USA; [Scott, Graham B. I.] Baylor Coll Med, Natl Space Biomed Res Inst, Houston, TX 77030 USA; [Mason, Christopher E.] Feil Family Brain & Mind Res Inst, New York, NY 10065 USA; [Mason, Christopher E.] WorldQuant Initiat Quantitat Predict, New York, NY 10065 USA; [Piening, Brian D.] Providence Portland Med Ctr, Portland, OR 10065 USA; [Rizzardi, Lindsay F.] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Siamwala, Jamila H.] Brown Univ, Providence, RI 02912 USA; [Grills, George S.] Augusta Univ, Augusta, GA USA; [Heer, Martina] IUBH Int Univ Appl Sci, Bad Reichenhall, Germany; [Jenkinson, Garrett] Mayo Clin, Rochester, MN USA; [Nakahira, Kiichi] Nara Med Univ, Nara, Japan; [Saito, Rintaro] Keio Univ, Inst Adv Biosci, Tokyo, Japan	Cornell University; University of Virginia; University of Texas System; University of Texas Health San Antonio; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Pennsylvania; Pennsylvania Medicine; Stanford University; Colorado State University; Johns Hopkins University; University of California System; University of California San Diego; Northwestern University; University of California System; University of California Davis; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Harvard University; Harvard T.H. Chan School of Public Health; University of Bonn; University of Washington; University of Washington Seattle; Rush University; University of Texas System; University of Texas Medical Branch Galveston; National Aeronautics & Space Administration (NASA); Baylor College of Medicine; Providence Portland Medical Center; HudsonAlpha Institute for Biotechnology; Brown University; University System of Georgia; Augusta University; International University of Applied Sciences - Germany; Mayo Clinic; Nara Medical University; Keio University	Mason, CE (corresponding author), Weill Cornell Med, New York, NY 10021 USA.; Basner, M (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.; Mignot, E; Snyder, MP (corresponding author), Stanford Univ, Sch Med, Palo Alto, CA 94304 USA.; Lee, SMC (corresponding author), KBRwyle, Houston, TX 77058 USA.; Bailey, SM (corresponding author), Colorado State Univ, Ft Collins, CO 80523 USA.; Mason, CE (corresponding author), Bin Talal Bin Abdulaziz Alsaud Inst Computat Biom, New York, NY 10065 USA.; Feinberg, AP (corresponding author), Johns Hopkins Univ, Baltimore, MD 21218 USA.; Rana, BK (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.; Turek, FW (corresponding author), Northwestern Univ, Evanston, IL 60208 USA.; Charles, JB; Smith, SM (corresponding author), NASA, Houston, TX 77058 USA.; Kundrot, CE (corresponding author), NASA Headquarters, Space Life & Phys Sci Div, Washington, DC 20546 USA.; Scott, GBI (corresponding author), Baylor Coll Med, Natl Space Biomed Res Inst, Houston, TX 77030 USA.; Mason, CE (corresponding author), Feil Family Brain & Mind Res Inst, New York, NY 10065 USA.; Mason, CE (corresponding author), WorldQuant Initiat Quantitat Predict, New York, NY 10065 USA.	jbcharle@gmail.com; craig.e.kundrot@nasa.gov; graham_b_scott@yahoo.com; susan.bailey@colostate.edu; basner@pennmedicine.upenn.edu; afeinberg@jhu.edu; stuart.lee-1@nasa.gov; chm2042@med.cornell.edu; mignot@stanford.edu; bkrana@ucsd.edu; scott.m.smith@nasa.gov; mpsnyder@stanford.edu; fturek@northwestern.edu	Feinberg, Andrew/AAY-7666-2020; BEZDAN, DANIELA/H-2259-2015; Sears, Dorothy D/B-6979-2019; Mishra, Tejaswini/D-3528-2018; Melnick, Ari/AAA-5763-2020; Sears, Dorothy D/AHE-5524-2022; Ambati, Aditya/K-4095-2019; Siamwala, Jamila/AGN-8667-2022; Mason, Christopher/HCH-3977-2022; Dinges, David/P-7183-2019	BEZDAN, DANIELA/0000-0002-1203-8239; Sears, Dorothy D/0000-0002-9260-3540; Mishra, Tejaswini/0000-0001-9931-1260; Sears, Dorothy D/0000-0002-9260-3540; Ambati, Aditya/0000-0001-8462-3552; Chlipala, George/0000-0003-0203-3191; Snyder, Michael/0000-0003-0784-7987; Meydan, Cem/0000-0002-0663-6216; Green, Stefan/0000-0003-2781-359X; De Vivo, Immaculata/0000-0002-7185-7402; Nasrini, Jad/0000-0003-3769-1186; Moore, Tyler/0000-0002-1384-0151; Macias, Brandon/0000-0003-2527-5089; Siamwala, Jamila/0000-0001-9482-9183; Vaisar, Tomas/0000-0002-7406-6606	NASA [NNX14AH51G, NNX14AB02G, NNX14AH27G/NCC 9-58, NN13AJ12G, NNX14AN75G, NNX17AB26G, TRISH: NNX16AO69A: 0107, NNX16AO69A: 0061, NNX14AH52G, NNX14AH26G]; NIH [AG035031]; NIH/NIDDK [P30 DK017047, P30 DK035816]; NSF [CCF-1656201]; DLR space program grant [50WB1535]; Bert L. and N. Kuggie Vallee Foundation; WorldQuant Foundation; Pershing Square Sohn Cancer Research Alliance; Bill and Melinda Gates Foundation [OPP1151054]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL098049, K12HL120001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047, P30DK035816] Funding Source: NIH RePORTER	NASA(National Aeronautics & Space Administration (NASA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NSF(National Science Foundation (NSF)); DLR space program grant; Bert L. and N. Kuggie Vallee Foundation; WorldQuant Foundation; Pershing Square Sohn Cancer Research Alliance(Pershing Square Sohn Cancer Research Alliance); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was supported by NASA: NNX14AH51G [all Twins Study principal investigators (PIs)]; NNX14AB02G (S.M.B.); NNX14AH27G/NCC 9-58 (M.B.); NN13AJ12G (A.R.H.); NNX14AN75G (S.M.C.L.); NNX17AB26G, NNX17AB26G, and TRISH: NNX16AO69A: 0107 and NNX16AO69A: 0061 (C.E.M.); NNX14AH52G (M.P.S.); and NNX14AH26G (F.W.T.). Additional support was provided by NIH grants AG035031, NIH/NIDDK P30 DK017047, and P30 DK035816 (K.S.); NSF grant CCF-1656201 (J.G.); and DLR space program grant 50WB1535 (M.H.), as well as the Bert L. and N. Kuggie Vallee Foundation, the WorldQuant Foundation, The Pershing Square Sohn Cancer Research Alliance, and the Bill and Melinda Gates Foundation (OPP1151054) for funding (C.E.M.).	Ade CJ, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005564; Akima H, 2000, MED SCI SPORT EXER, V32, P1743, DOI 10.1097/00005768-200010000-00013; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Andrews S., 2010, FASTQC QUALITY CONTR; Arbeille P, 2016, AEROSP MED HUM PERF, V87, P449, DOI 10.3357/AMHP.4493.2016; Arbeille P, 2015, EUR J APPL PHYSIOL, V115, P2099, DOI 10.1007/s00421-015-3189-6; Arsenis NC, 2017, ONCOTARGET, V8, P45008, DOI 10.18632/oncotarget.16726; Aurelie NDC, 2011, PEPTIDES, V32, P2141, DOI 10.1016/j.peptides.2011.09.010; Barger LK, 2014, LANCET NEUROL, V13, P904, DOI 10.1016/S1474-4422(14)70122-X; Barratt M.R., 2008, PRINCIPLES CLIN MED; Basner M, 2018, SLEEP, V41, DOI 10.1093/sleep/zsx187; Basner M, 2015, AEROSP MED HUM PERF, V86, P942, DOI 10.3357/AMHP.4343.2015; Basner M, 2011, ACTA ASTRONAUT, V69, P949, DOI 10.1016/j.actaastro.2011.07.015; Beheshti A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22613-1; Behjati S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12605; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benn M, 2007, ARTERIOSCL THROM VAS, V27, P661, DOI 10.1161/01.ATV.0000255580.73689.8e; BENTON AL, 1978, ARCH NEUROL-CHICAGO, V35, P364, DOI 10.1001/archneur.1978.00500300038006; Berardinelli F, 2013, ENVIRON MOL MUTAGEN, V54, P172, DOI 10.1002/em.21761; Boccardi V, 2016, AGING-US, V8, P12, DOI 10.18632/aging.100886; Borresen EC, 2016, NUTR CANCER, V68, P1269, DOI 10.1080/01635581.2016.1224370; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Calder PC, 2009, BIOCHIMIE, V91, P791, DOI 10.1016/j.biochi.2009.01.008; Carminati MV, 2011, AVIAT SPACE ENVIR MD, V82, P144, DOI 10.3357/ASEM.2846.2011; Carulli L, 2016, MOL GENET METAB, V118, P138, DOI 10.1016/j.ymgme.2016.04.003; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Cherkas LF, 2008, ARCH INTERN MED, V168, P154, DOI 10.1001/archinternmed.2007.39; Cold Spring Harbor Laboratory, 2014, COLD SPRING HARB PRO, V2014, ppdb.r, DOI [10.1101/pdb.rec083295, DOI 10.1101/PDB.REC083295]; Contrepois K, 2015, MOL CELL PROTEOMICS, V14, P1684, DOI 10.1074/mcp.M114.046508; Convertino V. A., 2011, HDB PHYSL, P815; Cornforth MN, 2018, MUTAT RES-GEN TOX EN, V836, P28, DOI 10.1016/j.mrgentox.2018.05.002; Crucian BE, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01437; Crucian BE, 2014, J INTERF CYTOK RES, V34, P778, DOI 10.1089/jir.2013.0129; Cucinotta FA, 2016, LIFE SCI SPACE RES, V10, P53, DOI 10.1016/j.lssr.2016.08.002; Cucinotta FA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096099; de Batlle J, 2012, J NUTR BIOCHEM, V23, P817, DOI 10.1016/j.jnutbio.2011.04.005; Dinges DF, 1995, J SLEEP RES, V4, P4, DOI 10.1111/j.1365-2869.1995.tb00220.x; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Ewels P, 2016, BIOINFORMATICS, V32, P3047, DOI 10.1093/bioinformatics/btw354; Florvall G, 2006, J GERONTOL A-BIOL, V61, P1262, DOI 10.1093/gerona/61.12.1262; Futschik Matthias E., 2005, Journal of Bioinformatics and Computational Biology, V3, P965, DOI 10.1142/S0219720005001375; Gardiner CM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00367; George K, 2013, MUTAT RES-GEN TOX EN, V756, P165, DOI 10.1016/j.mrgentox.2013.04.007; George K, 2010, MUTAT RES-GEN TOX EN, V701, P75, DOI 10.1016/j.mrgentox.2010.02.007; Glahn DC, 2000, BIOL PSYCHIAT, V47, P34, DOI 10.1016/S0006-3223(99)00187-0; Glahn DC, 1997, NEUROPSYCHOLOGY, V11, P602, DOI 10.1037/0894-4105.11.4.602; Gopalakrishnan R, 2010, AVIAT SPACE ENVIR MD, V81, P91, DOI 10.3357/ASEM.2583.2010; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Gur RC, 2001, NEUROPSYCHOPHARMACOL, V25, P766, DOI 10.1016/S0893-133X(01)00278-0; Gur RC, 2012, NEUROPSYCHOLOGY, V26, P251, DOI 10.1037/a0026712; Gur RC, 2010, J NEUROSCI METH, V187, P254, DOI 10.1016/j.jneumeth.2009.11.017; Hansen KD, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r83, 10.1186/gb-2012-13-10-R83]; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hayes J. C., 2013, BIOMEDICAL RESULTS S, P289; Honig LS, 2015, NEUROBIOL AGING, V36, P2785, DOI 10.1016/j.neurobiolaging.2015.06.017; Hou M, 2001, CLIN CHEM, V47, P519; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Hughson RL, 2016, AM J PHYSIOL-HEART C, V310, pH628, DOI 10.1152/ajpheart.00802.2015; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jenkinson G, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2086-5; Jenkinson G, 2017, NAT GENET, V49, P719, DOI 10.1038/ng.3811; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kamburov A, 2011, BIOINFORMATICS, V27, P2917, DOI 10.1093/bioinformatics/btr499; Koyanagi A, 2012, BIOCHEM BIOPH RES CO, V418, P799, DOI 10.1016/j.bbrc.2012.01.106; Krueger F, 2016, TRIM GALORE; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Laimer M, 2016, INT J OBESITY, V40, P773, DOI 10.1038/ijo.2015.238; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Laurie SS, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13302; Leach CS, 1996, J APPL PHYSIOL, V81, P105, DOI 10.1152/jappl.1996.81.1.105; Lee SMC, 2015, AEROSP MED HUM PERF, V86, pA54, DOI 10.3357/AMHP.EC08.2015; Leek J. T., 2016, SVA SURROGATE VARIAB; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75; Li S, 2014, NAT BIOTECHNOL, V32, P915, DOI 10.1038/nbt.2972; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lim JL, 2008, ANN NY ACAD SCI, V1129, P305, DOI 10.1196/annals.1417.002; Lin J, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/5371050; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Mader TH, 2013, J NEURO-OPHTHALMOL, V33, P249, DOI 10.1097/WNO.0b013e31829b41a6; Mader TH, 2011, OPHTHALMOLOGY, V118, P2058, DOI 10.1016/j.ophtha.2011.06.021; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Mardanov AV, 2013, ACTA NATURAE, V5, P116, DOI 10.32607/20758251-2013-5-3-116-125; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Meck JV, 2001, PSYCHOSOM MED, V63, P865, DOI 10.1097/00006842-200111000-00003; Michel FS, 2014, HYPERTENSION, V64, P149, DOI 10.1161/HYPERTENSIONAHA.114.03336; Mienaltowski MJ, 2014, ADV EXP MED BIOL, V802, P5, DOI 10.1007/978-94-007-7893-1_2; MOORE TP, 1987, AVIAT SPACE ENVIR MD, V58, pA91; Moore TM, 2017, AEROSP MED HUM PERF, V88, P937, DOI 10.3357/AMHP.4801.2017; Moore TM, 2015, NEUROPSYCHOLOGY, V29, P235, DOI 10.1037/neu0000093; Mulavara AP, 2018, MED SCI SPORT EXER, V50, P1961, DOI 10.1249/MSS.0000000000001615; Nakahira K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001577; Nakaya M, 2014, IMMUNITY, V40, P692, DOI 10.1016/j.immuni.2014.04.007; Norsk P, 2015, J PHYSIOL-LONDON, V593, P573, DOI 10.1113/jphysiol.2014.284869; Nygaard V, 2016, BIOSTATISTICS, V17, P29, DOI 10.1093/biostatistics/kxv027; Pendergrass WR, 2001, EXP EYE RES, V73, P221, DOI 10.1006/exer.2001.1033; Perfetti B, 2009, HUM BRAIN MAPP, V30, P497, DOI 10.1002/hbm.20519; Perhonen MA, 2001, J APPL PHYSIOL, V91, P645, DOI 10.1152/jappl.2001.91.2.645; Piening BD, 2018, CELL SYST, V6, P157, DOI 10.1016/j.cels.2017.12.013; Ragland JD, 2002, NEUROPSYCHOLOGY, V16, P370, DOI 10.1037//0894-4105.16.3.370; Raven J. C., 1965, ADV PROGR MATRICES S; Ray FA, 2014, RADIAT ENVIRON BIOPH, V53, P255, DOI 10.1007/s00411-014-0513-1; Ray FA, 2013, CHROMOSOME RES, V21, P165, DOI 10.1007/s10577-013-9345-0; Reynolds RJ, 2010, AVIAT SPACE ENVIR MD, V81, P1024, DOI 10.3357/ASEM.2847.2010; Roalf DR, 2014, NEUROPSYCHOLOGY, V28, P161, DOI 10.1037/neu0000011; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sasaki S, 2012, MOL ASPECTS MED, V33, P535, DOI 10.1016/j.mam.2012.03.004; Searle BC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07454-w; Sergushichev A., 2016, BIORXIV, DOI [10.1101/060012, DOI 10.1101/060012]; Shammas MA, 2011, CURR OPIN CLIN NUTR, V14, P28, DOI 10.1097/MCO.0b013e32834121b1; Silva GGZ, 2016, BIOINFORMATICS, V32, P354, DOI 10.1093/bioinformatics/btv584; Sishc BJ, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00257; Smith CL, 2018, NUCLEIC ACIDS RES, V46, pD836, DOI 10.1093/nar/gkx1006; Smith SM, 2014, ANNU REV NUTR, V34, P377, DOI 10.1146/annurev-nutr-071813-105440; Smith SM, 2015, BONE, V81, P712, DOI 10.1016/j.bone.2015.10.002; Smith SM, 2012, J BONE MINER RES, V27, P1896, DOI 10.1002/jbmr.1647; Smith SM, 2012, J CLIN ENDOCR METAB, V97, P270, DOI 10.1210/jc.2011-2233; Smith SM, 2001, J NUTR, V131, P2053, DOI 10.1093/jn/131.7.2053; Soller BR, 2002, NUTRITION, V18, P930, DOI 10.1016/S0899-9007(02)00897-3; Stenger M. B., 2018, EVIDENCE REPORT RISK; Stone RC, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006144; Su ZQ, 2014, NAT BIOTECHNOL, V32, P903, DOI 10.1038/nbt.2957; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Teo GS, 2015, J PROTEOMICS, V129, P108, DOI 10.1016/j.jprot.2015.09.013; Thaventhiran JED, 2013, CURR OPIN IMMUNOL, V25, P321, DOI 10.1016/j.coi.2013.05.010; THORNTON WE, 1987, AVIAT SPACE ENVIR MD, V58, pA86; Ting YS, 2017, NAT METHODS, V14, P903, DOI [10.1038/NMETH.4390, 10.1038/nmeth.4390]; Trappe S, 2009, J APPL PHYSIOL, V106, P1159, DOI 10.1152/japplphysiol.91578.2008; Turroni S, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0256-8; Usui N, 2009, NEUROSCI LETT, V463, P1, DOI 10.1016/j.neulet.2009.07.048; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Walldius G, 2006, J INTERN MED, V259, P493, DOI 10.1111/j.1365-2796.2006.01643.x; Wang CL, 2010, P NATL ACAD SCI USA, V107, P1518, DOI 10.1073/pnas.0913939107; Wang XM, 2013, NATURE, V499, P306, DOI 10.1038/nature12345; Williams ES, 2011, METHODS MOL BIOL, V735, P113, DOI 10.1007/978-1-61779-092-8_11; Wong HP, 2004, CYTOGENET GENOME RES, V105, P464, DOI 10.1159/000078220; Yamada H, 1997, BIOCHEM BIOPH RES CO, V231, P835, DOI 10.1006/bbrc.1997.6198; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; Zhang JW, 2016, AGEING RES REV, V25, P55, DOI 10.1016/j.arr.2015.11.006; Zhang LF, 2018, PHYSIOL REV, V98, P59, DOI 10.1152/physrev.00017.2016; Zhao Y, 2006, MUTAT RES-FUND MOL M, V601, P19, DOI 10.1016/j.mrfmmm.2006.05.001; Zwart SR, 2017, FASEB J, V31, P3746, DOI 10.1096/fj.201700294; Zwart SR, 2016, FASEB J, V30, P141, DOI 10.1096/fj.15-278457; Zwart SR, 2014, AVIAT SPACE ENVIR MD, V85, P897, DOI 10.3357/ASEM.3979.2014; Zwart SR, 2012, J NUTR, V142, P427, DOI 10.3945/jn.111.154245	156	342	363	32	209	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2019	364	6436					144	+	eaau8650	10.1126/science.aau8650	http://dx.doi.org/10.1126/science.aau8650			106	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HT5RC	30975860	Green Accepted			2022-12-28	WOS:000464620000031
J	Kelso, MV; Mahenderkar, NK; Chen, QZ; Tubbesing, JZ; Switzer, JA				Kelso, Meagan V.; Mahenderkar, Naveen K.; Chen, Qingzhi; Tubbesing, John Z.; Switzer, Jay A.			Spin coating epitaxial films	SCIENCE			English	Article							SINGLE-CRYSTAL GOLD; CHEMICAL EPITAXY; THIN-FILMS; ELECTRODEPOSITION; ZNO	Spin-coated films, such as photoresists for lithography or perovskite films for solar cells, are either amorphous or polycrystalline. We show that epitaxial films of inorganic materials such as cesium lead bromide (CsPbBr3), lead(II) iodide (PbI2), zinc oxide (ZnO), and sodium chloride (NaCl) can be deposited onto a variety of single-crystal and single-crystal-like substrates by simply spin coating either solutions of the material or precursors to the material. The out-of-plane and in-plane orientations of the spin-coated films are determined by the substrate. The thin stagnant layer of supersaturated solution produced during spin coating promotes heterogeneous nucleation of the material onto the single-crystal substrate over homogeneous nucleation in the bulk solution, and ordered anion adlayers may lower the activation energy for nucleation on the surface. The method can be used to produce functional materials such as inorganic semiconductors or to deposit water-soluble materials such as NaCl that can serve as growth templates.	[Kelso, Meagan V.; Mahenderkar, Naveen K.] Missouri Univ Sci & Technol, Dept Mat Sci & Engn, Rolla, MO 65409 USA; [Kelso, Meagan V.; Mahenderkar, Naveen K.; Chen, Qingzhi; Tubbesing, John Z.; Switzer, Jay A.] Missouri Univ Sci & Technol, Grad Ctr Mat Res, Rolla, MO 65409 USA; [Chen, Qingzhi; Tubbesing, John Z.; Switzer, Jay A.] Missouri Univ Sci & Technol, Dept Chem, Rolla, MO 65409 USA; [Mahenderkar, Naveen K.] Lam Res Corp, 4650 Cushing Pkwy, Fremont, CA 94538 USA	University of Missouri System; Missouri University of Science & Technology; University of Missouri System; Missouri University of Science & Technology; University of Missouri System; Missouri University of Science & Technology; Lam Research Corporation	Switzer, JA (corresponding author), Missouri Univ Sci & Technol, Grad Ctr Mat Res, Rolla, MO 65409 USA.; Switzer, JA (corresponding author), Missouri Univ Sci & Technol, Dept Chem, Rolla, MO 65409 USA.	jswitzer@mst.edu		Tubbesing, John/0000-0003-2598-2517	U.S. Department of Energy, Office of Basic Sciences, Division of Materials Sciences and Engineering [DE-FG02-08ER46518]	U.S. Department of Energy, Office of Basic Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE))	The material is based on work supported by the U.S. Department of Energy, Office of Basic Sciences, Division of Materials Sciences and Engineering, under grant DE-FG02-08ER46518.	Andeen D, 2003, J CRYST GROWTH, V259, P103, DOI 10.1016/S0022-0248(03)01589-6; Bard A. J., 2001, ELECTROCHEMICAL METH; BAUER EG, 1990, J MATER RES, V5, P852, DOI 10.1557/JMR.1990.0852; Burschka J, 2013, NATURE, V499, P316, DOI 10.1038/nature12340; FLACK WW, 1984, J APPL PHYS, V56, P1199, DOI 10.1063/1.334049; Frankenheim M., 1836, ANN PHYS, V113, P516; Friedman O, 2017, CRYSTENGCOMM, V19, P5381, DOI 10.1039/c7ce01137g; FROMENT M, 1995, J ELECTROCHEM SOC, V142, P2642, DOI 10.1149/1.2050067; Heo JH, 2014, ADV MATER, V26, P8179, DOI 10.1002/adma.201403140; Hull CM, 2018, ACS APPL MATER INTER, V10, P38596, DOI 10.1021/acsami.8b13188; Janotti A, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/12/126501; Jeon NJ, 2014, NAT MATER, V13, P897, DOI [10.1038/NMAT4014, 10.1038/nmat4014]; Ji L, 2018, NANO LETT, V18, P994, DOI 10.1021/acs.nanolett.7b04445; JOHNSON GW, 1950, J APPL PHYS, V21, P1057, DOI 10.1063/1.1699442; Kokubun Y, 2016, THIN SOLID FILMS, V601, P76, DOI 10.1016/j.tsf.2015.09.058; LAWRENCE CJ, 1988, PHYS FLUIDS, V31, P2786, DOI 10.1063/1.866986; Lee DK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09603-5; Li JQ, 2016, J PHYS CHEM LETT, V7, P4059, DOI 10.1021/acs.jpclett.6b01942; Liu C, 2018, J AM CHEM SOC, V140, P3825, DOI 10.1021/jacs.7b13229; Liu R, 2003, CHEM MATER, V15, P4882, DOI 10.1021/cm034807c; Liu R, 2001, CHEM MATER, V13, P508, DOI 10.1021/cm0007631; Magnussen OM, 2002, CHEM REV, V102, P679, DOI 10.1021/cr000069p; Mahenderkar NK, 2017, SCIENCE, V355, P1203, DOI 10.1126/science.aam5830; Nie WY, 2015, SCIENCE, V347, P522, DOI 10.1126/science.aaa0472; Park SY, 2014, RSC ADV, V4, P11295, DOI 10.1039/c3ra47437b; Prod'homme P, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3006064; Rivadulla F, 2013, CHEM MATER, V25, P55, DOI 10.1021/cm3031472; SEIFERT A, 1995, J MATER RES, V10, P680, DOI 10.1557/JMR.1995.0680; Sengupta S, 2016, J MATER CHEM C, V4, P1996, DOI 10.1039/c5tc04147c; STRINGFELLOW GB, 1982, REP PROG PHYS, V45, P469, DOI 10.1088/0034-4885/45/5/001; Switzer JA, 2016, ACS APPL MATER INTER, V8, P15828, DOI 10.1021/acsami.6b04552; Yuan YB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4005; Zhang FJ, 2013, ADV MATER, V25, P1401, DOI 10.1002/adma.201204075	33	91	91	39	475	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2019	364	6436					166	+		10.1126/science.aaw6184	http://dx.doi.org/10.1126/science.aaw6184			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HT5RC	30975885				2022-12-28	WOS:000464620000039
J	Moda-Sava, RN; Murdock, MH; Parekh, PK; Fetcho, RN; Huang, BS; Huynh, TN; Witztum, J; Shaver, DC; Rosenthal, DL; Alway, EJ; Lopez, K; Meng, Y; Nellissen, L; Grosenick, L; Milner, TA; Deisseroth, K; Bito, H; Kasai, H; Liston, C				Moda-Sava, R. N.; Murdock, M. H.; Parekh, P. K.; Fetcho, R. N.; Huang, B. S.; Huynh, T. N.; Witztum, J.; Shaver, D. C.; Rosenthal, D. L.; Alway, E. J.; Lopez, K.; Meng, Y.; Nellissen, L.; Grosenick, L.; Milner, T. A.; Deisseroth, K.; Bito, H.; Kasai, H.; Liston, C.			Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation	SCIENCE			English	Article							DEPENDENT SYNAPSE FORMATION; CHRONIC CORTICOSTERONE; CHRONIC STRESS; DENDRITIC MORPHOLOGY; MEMORY PERFORMANCE; LATERAL HABENULA; SOCIAL DEFEAT; PLASTICITY; BRAIN; MODEL	The neurobiological mechanisms underlying the induction and remission of depressive episodes over time are not well understood. Through repeated longitudinal imaging of medial prefrontal microcircuits in the living brain, we found that prefrontal spinogenesis plays a critical role in sustaining specific antidepressant behavioral effects and maintaining long-term behavioral remission. Depression-related behavior was associated with targeted, branch-specific elimination of postsynaptic dendritic spines on prefrontal projection neurons. Antidepressant-dose ketamine reversed these effects by selectively rescuing eliminated spines and restoring coordinated activity in multicellular ensembles that predict motivated escape behavior. Prefrontal spinogenesis was required for the long-term maintenance of antidepressant effects on motivated escape behavior but not for their initial induction.	[Moda-Sava, R. N.; Murdock, M. H.; Parekh, P. K.; Fetcho, R. N.; Huang, B. S.; Huynh, T. N.; Witztum, J.; Shaver, D. C.; Rosenthal, D. L.; Alway, E. J.; Lopez, K.; Meng, Y.; Nellissen, L.; Grosenick, L.; Milner, T. A.; Liston, C.] Weill Cornell Med, Dept Psychiat, Brain & Mind Res Inst, New York, NY 10021 USA; [Moda-Sava, R. N.; Murdock, M. H.; Parekh, P. K.; Fetcho, R. N.; Huang, B. S.; Huynh, T. N.; Witztum, J.; Shaver, D. C.; Rosenthal, D. L.; Alway, E. J.; Lopez, K.; Meng, Y.; Nellissen, L.; Grosenick, L.; Milner, T. A.; Liston, C.] Weill Cornell Med, Sackler Inst Dev Psychobiol, New York, NY 10021 USA; [Grosenick, L.; Deisseroth, K.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Grosenick, L.; Deisseroth, K.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Bito, H.] Univ Tokyo, Grad Sch Med, Dept Neurochem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan; [Kasai, H.] Univ Tokyo, Ctr Dis Biol & Integrat Med, Lab Struct Physiol, Fac Med,Bunkyo Ku, Tokyo 1130033, Japan; [Kasai, H.] Univ Tokyo, UTIAS, Int Res Ctr Neurointelligence WPI IRCN, Bunkyo Ku, Tokyo 1130033, Japan	Cornell University; Cornell University; Stanford University; Stanford University; University of Tokyo; University of Tokyo; University of Tokyo	Liston, C (corresponding author), Weill Cornell Med, Dept Psychiat, Brain & Mind Res Inst, New York, NY 10021 USA.; Liston, C (corresponding author), Weill Cornell Med, Sackler Inst Dev Psychobiol, New York, NY 10021 USA.	col2004@med.cornell.edu	, Conor Liston/GQH-8931-2022; Huang, Ben S./AAH-8370-2019; Bito, Haruhiko/A-8635-2008; Huynh, Thu/I-5864-2014	Huang, Ben S./0000-0003-2838-6315; Rosenthal, David/0000-0002-8020-6206; Parekh, Puja/0000-0002-4158-2305; Murdock, Mitchell/0000-0001-8625-624X; Lopez, Katherine/0000-0002-7549-8849; Alway, Emily/0000-0003-2524-7539; Huynh, Thu/0000-0002-7625-5101; Fetcho, Robert/0000-0002-4557-4177; Bito, Haruhiko/0000-0001-6315-9594; Witztum, Jonathan/0000-0003-0092-2366	Whitehall Foundation; Hartwell Foundation; One Mind Institute; Rita Allen Foundation; National Institute of Mental Health [R00 MH097822, R01 MH109685, R01 MH118451]; Klingenstein-Simons Fellowship in Brain Science; NSF; KAKENHI [17H06312]; CREST from JST [JPMJCR1652]; SRPBS from AMED [17dm0107120h002]; MEXT of Japan [26221001]; WPI from MEXT of Japan; Medical Scientist Training Program grant from the National Institute of General Medical Sciences of the National Institutes of Health [T32GM007739]; NIH [F30 MH115622, R01 DA08259, HL136520]; Simons Foundation [429965]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL136520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH109685, F30MH115622, R01MH118451, R00MH097822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA008259] Funding Source: NIH RePORTER	Whitehall Foundation; Hartwell Foundation; One Mind Institute; Rita Allen Foundation; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Klingenstein-Simons Fellowship in Brain Science; NSF(National Science Foundation (NSF)); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); CREST from JST(Core Research for Evolutional Science and Technology (CREST)); SRPBS from AMED; MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); WPI from MEXT of Japan; Medical Scientist Training Program grant from the National Institute of General Medical Sciences of the National Institutes of Health; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by funds from the Whitehall Foundation, Hartwell Foundation, One Mind Institute, Rita Allen Foundation, and National Institute of Mental Health (R00 MH097822, R01 MH109685, and R01 MH118451) and by a Klingenstein-Simons Fellowship in Brain Science. R.N.M.-S. was supported by a fellowship from the NSF. H.B. was supported by KAKENHI grant 17H06312. H.K. was supported by CREST (JPMJCR1652) from JST, SRPBS (17dm0107120h002) from AMED, and a grant-in-aid (26221001) and WPI from MEXT of Japan. D.C.S. and R.N.F. were supported by a Medical Scientist Training Program grant from the National Institute of General Medical Sciences of the National Institutes of Health under award T32GM007739 to the Weill Cornell/Rockefeller/Sloan Kettering Tri-Institutional MD-PhD Program. R.N.F. was supported by a fellowship from the NIH (F30 MH115622). L.G. was supported by Simons Foundation award 429965. T.A.M. was supported by NIH grants R01 DA08259 and HL136520.	Andermann ML, 2013, NEURON, V80, P900, DOI 10.1016/j.neuron.2013.07.052; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; Bagot RC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8062; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Birnbaum SG, 2004, SCIENCE, V306, P882, DOI 10.1126/science.1100021; BODNOFF SR, 1995, J NEUROSCI, V15, P61; Carrillo-Reid L, 2016, SCIENCE, V353, P691, DOI 10.1126/science.aaf7560; Castren E, 2013, TRENDS NEUROSCI, V36, P259, DOI 10.1016/j.tins.2012.12.010; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chen YC, 2010, P NATL ACAD SCI USA, V107, P13123, DOI 10.1073/pnas.1003825107; Chia TH, 2009, J NEUROPHYSIOL, V102, P1310, DOI 10.1152/jn.91208.2008; Cook SC, 2004, J NEUROBIOL, V60, P236, DOI 10.1002/neu.20025; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Cui GH, 2013, NATURE, V494, P238, DOI 10.1038/nature11846; Dias-Ferreira E, 2009, SCIENCE, V325, P621, DOI 10.1126/science.1171203; Druckmann S, 2014, NEURON, V81, P629, DOI 10.1016/j.neuron.2013.11.026; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Duman RS, 2016, NAT MED, V22, P238, DOI 10.1038/nm.4050; Duman RS, 2012, SCIENCE, V338, P68, DOI 10.1126/science.1222939; Duman RS, 1999, BIOL PSYCHIAT, V46, P1181, DOI 10.1016/S0006-3223(99)00177-8; Friedman A, 2014, SCIENCE, V346, DOI 10.1126/science.1260781; Gokce O, 2016, ELIFE, V5, DOI 10.7554/eLife.09222; Gourley SL, 2008, BIOL PSYCHIAT, V63, P353, DOI 10.1016/j.biopsych.2007.07.016; Gourley SL, 2013, J NEUROSCI, V33, P3107, DOI 10.1523/JNEUROSCI.2138-12.2013; Gourley Shannon L, 2009, Curr Protoc Neurosci, VChapter 9, DOI 10.1002/0471142301.ns0932s49; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; Hamm JP, 2017, NEURON, V94, P153, DOI 10.1016/j.neuron.2017.03.019; Hayashi-Takagi A, 2015, NATURE, V525, P333, DOI 10.1038/nature15257; Hedrick NG, 2016, NATURE, V538, P104, DOI 10.1038/nature19784; Hikosaka O, 2010, NAT REV NEUROSCI, V11, P503, DOI 10.1038/nrn2866; Hodes GE, 2015, NAT NEUROSCI, V18, P1386, DOI 10.1038/nn.4113; Hodes GE, 2014, P NATL ACAD SCI USA, V111, P16136, DOI 10.1073/pnas.1415191111; Hultman R, 2018, CELL, V173, P166, DOI 10.1016/j.cell.2018.02.012; Ibrahim L, 2012, NEUROPSYCHOPHARMACOL, V37, P1526, DOI 10.1038/npp.2011.338; Joels M, 2009, NAT REV NEUROSCI, V10, P459, DOI 10.1038/nrn2632; Karatsoreos IN, 2011, P NATL ACAD SCI USA, V108, P1657, DOI 10.1073/pnas.1018375108; Karatsoreos IN, 2010, ENDOCRINOLOGY, V151, P2117, DOI 10.1210/en.2009-1436; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kavalaii ET, 2012, AM J PSYCHIAT, V169, P1150, DOI 10.1176/appi.ajp.2012.12040531; Kleindienst T, 2011, NEURON, V72, P1012, DOI 10.1016/j.neuron.2011.10.015; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; LaPlant Q, 2010, NAT NEUROSCI, V13, P1137, DOI 10.1038/nn.2619; LeGates TA, 2018, NATURE, V564, P258, DOI 10.1038/s41586-018-0740-8; Li B, 2011, NATURE, V470, P535, DOI 10.1038/nature09742; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Lim BK, 2012, NATURE, V487, P183, DOI 10.1038/nature11160; Liston C, 2006, J NEUROSCI, V26, P7870, DOI 10.1523/JNEUROSCI.1184-06.2006; Liston C, 2013, NAT NEUROSCI, V16, P698, DOI 10.1038/nn.3387; Liston C, 2011, P NATL ACAD SCI USA, V108, P16074, DOI 10.1073/pnas.1110444108; Lohmann C, 2008, NEURON, V59, P253, DOI 10.1016/j.neuron.2008.05.025; Low RJ, 2014, P NATL ACAD SCI USA, V111, P18739, DOI 10.1073/pnas.1421753111; LUINE VN, 1993, BRAIN RES, V616, P65, DOI 10.1016/0006-8993(93)90193-Q; Ma XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077926; Makino H, 2011, NEURON, V72, P1001, DOI 10.1016/j.neuron.2011.09.036; McBride TJ, 2008, J NEUROSCI, V28, P6960, DOI 10.1523/JNEUROSCI.1352-08.2008; McGirr A, 2017, BRAIN, V140, P2210, DOI 10.1093/brain/awx142; McLay RN, 1998, PHYSIOL BEHAV, V63, P933, DOI 10.1016/S0031-9384(97)00529-5; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Miller JEK, 2014, P NATL ACAD SCI USA, V111, pE4053, DOI 10.1073/pnas.1406077111; Mitra R, 2005, P NATL ACAD SCI USA, V102, P9371, DOI 10.1073/pnas.0504011102; Mitra R, 2008, P NATL ACAD SCI USA, V105, P5573, DOI 10.1073/pnas.0705615105; Ota KT, 2014, NAT MED, V20, P535, DOI 10.1038/nm.3513; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Pattwell SS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11475; Phoumthipphavong V, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0133-15.2016; Popoli M, 2012, NAT REV NEUROSCI, V13, P22, DOI 10.1038/nrn3138; Proulx CD, 2014, NAT NEUROSCI, V17, P1146, DOI 10.1038/nn.3779; Radley J, 2015, NEUROSCI BIOBEHAV R, V58, P79, DOI 10.1016/j.neubiorev.2015.06.018; Radley JJ, 2006, CEREB CORTEX, V16, P313, DOI 10.1093/cercor/bhi104; Rah JC, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00177; Russo SJ, 2013, NAT REV NEUROSCI, V14, P609, DOI 10.1038/nrn3381; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Shansky RM, 2009, CEREB CORTEX, V19, P2479, DOI 10.1093/cercor/bhp003; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Strekalova T, 2004, NEUROPSYCHOPHARMACOL, V29, P2007, DOI 10.1038/sj.npp.1300532; Takahashi N, 2012, SCIENCE, V335, P353, DOI 10.1126/science.1210362; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Wang F, 2011, SCIENCE, V334, P693, DOI 10.1126/science.1209951; Warden MR, 2012, NATURE, V492, P428, DOI 10.1038/nature11617; Wohleb ES, 2016, NAT REV NEUROSCI, V17, P497, DOI 10.1038/nrn.2016.69; Yang C, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.136; Yang Y, 2018, NATURE, V554, P317, DOI 10.1038/nature25509; Yuen EY, 2012, NEURON, V73, P962, DOI 10.1016/j.neuron.2011.12.033; Yuen EY, 2009, P NATL ACAD SCI USA, V106, P14075, DOI 10.1073/pnas.0906791106; Zanos P, 2016, NATURE, V533, P481, DOI 10.1038/nature17998; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856; Zhao Y, 2008, EUR J PHARMACOL, V581, P113, DOI 10.1016/j.ejphar.2007.12.005; Zhou TT, 2017, SCIENCE, V357, P162, DOI 10.1126/science.aak9726	95	239	244	7	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2019	364	6436					147	+	eaat8078	10.1126/science.aat8078	http://dx.doi.org/10.1126/science.aat8078			44	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HT5RC	30975859	Green Accepted			2022-12-28	WOS:000464620000034
J	Schwartz, AL; Basilico, MF; Friedman, JL				Schwartz, Aaron L.; Basilico, Matthew F.; Friedman, Jennifer L.			Lactates and Local Knowledge - A Parable of Teamwork	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Our patient looked bad, and his labs looked worse. We'd never seen such a high lactate level. What was going on? The diagnosis would soon emerge, along with a lesson: the different perspectives and types of expertise within our team were crucial to solving the case.	[Schwartz, Aaron L.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Friedman, Jennifer L.] Brigham & Womens Hosp, Dept Nursing, 75 Francis St, Boston, MA 02115 USA; [Schwartz, Aaron L.; Basilico, Matthew F.] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Schwartz, AL (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.; Schwartz, AL (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.							Geertz C., 2000, LOCAL KNOWLEDGE FURT; Kleinman A, 2010, LANCET, V375, P1518, DOI 10.1016/S0140-6736(10)60646-0	2	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 11	2019	380	15					1392	1393		10.1056/NEJMp1815228	http://dx.doi.org/10.1056/NEJMp1815228			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HT5NG	30970185				2022-12-28	WOS:000464610000005
J	Ferenchick, EK; Ramanuj, P; Pincus, HA				Ferenchick, Erin K.; Ramanuj, Parashar; Pincus, Harold Alan			Depression in primary care: part 1-screening and diagnosis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MAJOR DEPRESSION; MENTAL-DISORDERS; SUBSTANCE USE; ANXIETY DISORDERS; BIPOLAR DISORDER; GENERAL-PRACTICE; SUICIDE-RISK; LIFE EVENTS; HEALTH; PREVALENCE	Depression is a common and heterogeneous condition with a chronic and recurrent natural course that is frequently seen in the primary care setting. Primary care providers play a central role in managing depression and concurrent physical comorbidities, and they face challenges in diagnosing and treating the condition. In this two part series, we review the evidence available to help to guide primary care providers and practices to recognize and manage depression. In this first of two reviews, we outline an approach to screening and diagnosing depression in primary care that evaluates current evidence based guidelines and applies the recommendations to clinical practice. The second review presents an evidence based approach to the treatment of depression in primary care, detailing the recommended lifestyle, drug, and psychological interventions at the individual level. It also highlights strategies that are being adopted at an organizational level to manage depression more effectively in primary care.	[Ferenchick, Erin K.] Columbia Univ, Med Ctr, Ctr Family & Community Med, New York, NY 10027 USA; [Ramanuj, Parashar] Royal Natl Orthopaed Hosp, Stanmore, Middx, England; [Ramanuj, Parashar] RAND Europe, Cambridge, England; [Pincus, Harold Alan] Columbia Univ, Dept Psychiat, New York State Psychiat Inst, New York, NY USA; [Pincus, Harold Alan] Columbia Univ, Irving Inst Clin & Translat Res, New York, NY USA; [Pincus, Harold Alan] RAND Corp, Pittsburgh, PA USA	Columbia University; University of London; University College London; Royal National Orthopaedic Hospital NHS Trust; RAND Corporation; RAND Europe; Columbia University; New York State Psychiatry Institute; Columbia University; RAND Corporation	Ferenchick, EK (corresponding author), Columbia Univ, Med Ctr, Ctr Family & Community Med, New York, NY 10027 USA.	ef2015@columbia.edu	Ramanuj, Parashar/AAP-4189-2020	Ramanuj, Parashar/0000-0002-0488-7070				Agerwala SM, 2012, J PSYCHOACTIVE DRUGS, V44, P307, DOI 10.1080/02791072.2012.720169; Arroll B, 2005, BRIT MED J, V331, P884, DOI 10.1136/bmj.38607.464537.7C; Arroll B, 2003, BMJ-BRIT MED J, V327, P1144, DOI 10.1136/bmj.327.7424.1144; Arroll B, 2010, ANN FAM MED, V8, P348, DOI 10.1370/afm.1139; Baas KD, 2009, BRIT J PSYCHIAT, V194, P399, DOI 10.1192/bjp.bp.107.046052; Bienvenu OJ, 2011, PSYCHOL MED, V41, P33, DOI 10.1017/S003329171000084X; Bishop TF, 2016, HEALTH AFFAIR, V35, P394, DOI 10.1377/hlthaff.2015.1068; Bostwick JM, 2000, AM J PSYCHIAT, V157, P1925, DOI 10.1176/appi.ajp.157.12.1925; Brown C, 1996, ANXIETY, V2, P210; Brown C, 1996, AM J PSYCHIAT, V153, P1293; Brugha T, 2009, ADULT PSYCHIAT MORBI; Carter G, 2017, BRIT J PSYCHIAT, V210, P387, DOI 10.1192/bjp.bp.116.182717; Centers for Disease Control, AM CAR US PHYS OFF; Central London NHS. (Westminster) CCG, 2017, COMM VAL MENT HLTH D; Cerimele JM, 2013, PSYCHOSOMATICS, V54, P515, DOI 10.1016/j.psym.2013.05.009; Conner KR, 2009, J SUBST ABUSE TREAT, V37, P127, DOI 10.1016/j.jsat.2008.11.007; Davis L, 2008, CURR OPIN PSYCHIATR, V21, P14, DOI 10.1097/YCO.0b013e3282f32408; Davis LL, 2006, AM J ADDICTION, V15, P278, DOI 10.1080/10550490600754317; Dumais A, 2005, AM J PSYCHIAT, V162, P2116, DOI 10.1176/appi.ajp.162.11.2116; Egede LE, 2007, GEN HOSP PSYCHIAT, V29, P409, DOI 10.1016/j.genhosppsych.2007.06.002; El-Den S, 2018, J AFFECT DISORDERS, V225, P503, DOI 10.1016/j.jad.2017.08.060; Elderon L, 2011, CIRC-CARDIOVASC QUAL, V4, P533, DOI 10.1161/CIRCOUTCOMES.110.960302; Fava M, 2008, AM J PSYCHIAT, V165, P342, DOI 10.1176/appi.ajp.2007.06111868; Fiske A, 2009, ANNU REV CLIN PSYCHO, V5, P363, DOI 10.1146/annurev.clinpsy.032408.153621; Freudenreich O, 2010, PSYCHIAT TIMES, V27, P56; Gavin AR, 2010, PSYCHOL MED, V40, P51, DOI 10.1017/S0033291709006023; Gilbody S, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002792.pub2; Gilbody S, 2007, J GEN INTERN MED, V22, P1596, DOI 10.1007/s11606-007-0333-y; Greenberg PE, 2015, J CLIN PSYCHIAT, V76, P155, DOI 10.4088/JCP.14m09298; Hammar A, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.026.2009; Herran A, 1999, BRIT MED J, V318, P1558, DOI 10.1136/bmj.318.7197.1558; Hirschfeld RMA, 2003, J CLIN PSYCHIAT, V64, P161, DOI 10.4088/JCP.v64n0209; Hirschfeld Robert M. A., 2001, Prim Care Companion J Clin Psychiatry, V3, P244; Insel TR, 2017, JAMA-J AM MED ASSOC, V318, P1215, DOI 10.1001/jama.2017.11295; Jablensky A, 2002, PSYCHIAT DIAGNOSIS C, DOI DOI 10.1002/047084647X.CH1; Jackson JL, 1998, PSYCHOSOMATICS, V39, P431, DOI 10.1016/S0033-3182(98)71302-7; Joffres M, 2013, CAN MED ASSOC J, V185, P775, DOI 10.1503/cmaj.130403; Johnson JA, 2014, DIABETES CARE, V37, P3220, DOI 10.2337/dc14-1308; Kalibatseva Zornitsa, 2011, Depress Res Treat, V2011, P320902, DOI 10.1155/2011/320902; Katon W, 2002, J PSYCHOSOM RES, V53, P859, DOI 10.1016/S0022-3999(02)00313-6; Keshavan MS, 2013, WORLD PSYCHIATRY, V12, P4, DOI 10.1002/wps.20001; Kessler RC, 1998, ARCH GEN PSYCHIAT, V55, P801, DOI 10.1001/archpsyc.55.9.801; Kessler RC, 2013, ANNU REV PUBL HEALTH, V34, P119, DOI 10.1146/annurev-publhealth-031912-114409; Kilbourne AM, 2005, PSYCHIAT SERV, V56, P1549, DOI 10.1176/appi.ps.56.12.1549; King M, 2008, BRIT J PSYCHIAT, V192, P362, DOI 10.1192/bjp.bp.107.039966; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Kuehner C, 2003, ACTA PSYCHIAT SCAND, V108, P163, DOI 10.1034/j.1600-0447.2003.00204.x; Lee KS, 2017, AM J CRIT CARE, V26, P240, DOI 10.4037/ajcc2017325; LISH JD, 1994, J AFFECT DISORDERS, V31, P281, DOI 10.1016/0165-0327(94)90104-X; Lombardo P, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-114; Luoma JB, 2002, AM J PSYCHIAT, V159, P909, DOI 10.1176/appi.ajp.159.6.909; McDowell AK, 2011, MAYO CLIN PROC, V86, P792, DOI 10.4065/mcp.2011.0076; McInerney Shane J, 2014, Prim Care Companion CNS Disord, V16, DOI 10.4088/PCC.14r01653; McKee Jerry, 2016, Ment Health Clin, V6, P289, DOI 10.9740/mhc.2016.11.289; Mitchell AJ, 2007, BRIT J GEN PRACT, V57, P144; Mitchell J., 2013, ADULT DEPRESSION PRI; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Nathanson AM, 2012, PARTN ABUSE, V3, P59, DOI 10.1891/1946-6560.3.1.59; National Institute for Health and Care Excellence, 2018, DEPRESSION ADULTS TR; National Institute of Mental Health, 2018, DEPRESSION; National Institute of Mental Health, 2017, MAJ DEPR; Nordt C, 2015, LANCET PSYCHIAT, V2, P239, DOI 10.1016/S2215-0366(14)00118-7; Oxford Centre for Evidence-Based Medicine, 2009, LEVELS EVIDENCE; PAYKEL ES, 1994, ACTA PSYCHIAT SCAND, V89, P50, DOI 10.1111/j.1600-0447.1994.tb05803.x; Qato DM, 2018, JAMA-J AM MED ASSOC, V319, P2289, DOI 10.1001/jama.2018.6741; Ramanuj P, 2019, BMJ-BRIT MED J, V365, pl835; Rao U, 2012, ASIAN J PSYCHIATR, V5, P28, DOI 10.1016/j.ajp.2012.01.006; Regier DA, 2013, WORLD PSYCHIATRY, V12, P92, DOI 10.1002/wps.20050; Rickards H, 2005, J NEUROL NEUROSUR PS, V76, pI48, DOI 10.1136/jnnp.2004.060426; Romera I, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-83; Roy-Byrne PP, 2000, BRIT J PSYCHIAT, V176, P229, DOI 10.1192/bjp.176.3.229; Runeson B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180292; Saito M, 2010, INT J METH PSYCH RES, V19, P211, DOI 10.1002/mpr.320; Schmitz N, 2007, PSYCHOSOM MED, V69, P332, DOI 10.1097/PSY.0b013e31804259e0; Smith KM, 2013, COMPR PSYCHIAT, V54, P1, DOI 10.1016/j.comppsych.2012.06.006; SPITZER RL, 1995, JAMA-J AM MED ASSOC, V274, P1511, DOI 10.1001/jama.274.19.1511; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Tennant C, 2002, AUST NZ J PSYCHIAT, V36, P173, DOI 10.1046/j.1440-1614.2002.01007.x; The Columbia Lighthouse Project/ Center for Suicide Risk Assessment, 2018, COL SUIC SEV RAT SCA; Thomas CM, 2003, BRIT J PSYCHIAT, V183, P514, DOI 10.1192/bjp.183.6.514; Thombs BD, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0903-8; TYLEE A, 1995, BRIT J GEN PRACT, V45, P575; US Preventive Services Task Force, 2013, FIN REC STAT DEPR AD; Viguera AC, 2018, PSYCHOSOMATICS, V59, P369, DOI 10.1016/j.psym.2017.12.003; Von Korff M, 2001, J Fam Pract, V50, pE1; Wells K, 2001, AM J PSYCHIAT, V158, P2027, DOI 10.1176/appi.ajp.158.12.2027; WHO, 2017, DEPR OTH COMM MENT D; Williams JW, 2002, GEN HOSP PSYCHIAT, V24, P225, DOI 10.1016/S0163-8343(02)00195-0; Zheng DY, 1997, ANN EPIDEMIOL, V7, P213, DOI 10.1016/S1047-2797(97)00014-8	90	47	47	2	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 8	2019	365								l794	10.1136/bmj.l794	http://dx.doi.org/10.1136/bmj.l794			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU0EE	30962184				2022-12-28	WOS:000464943400001
J	Hammitt, LL; Etyang, AO; Morpeth, SC; Ojal, J; Mutuku, A; Mturi, N; Moisi, JC; Adetifa, IM; Karani, A; Akech, DO; Otiende, M; Bwanaali, T; Wafula, J; Mataza, C; Mumbo, E; Tabu, C; Knoll, MD; Bauni, E; Marsh, K; Williams, TN; Kamau, T; Sharif, SK; Levine, OS; Scott, JAG				Hammitt, Laura L.; Etyang, Anthony O.; Morpeth, Susan C.; Ojal, John; Mutuku, Alex; Mturi, Neema; Moisi, Jennifer C.; Adetifa, Ifedayo M.; Karani, Angela; Akech, Donald O.; Otiende, Mark; Bwanaali, Tahreni; Wafula, Jackline; Mataza, Christine; Mumbo, Edward; Tabu, Collins; Knoll, Maria Deloria; Bauni, Evasius; Marsh, Kevin; Williams, Thomas N.; Kamau, Tatu; Sharif, Shahnaaz K.; Levine, Orin S.; Scott, J. Anthony G.			Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study	LANCET			English	Article							NONTYPABLE HAEMOPHILUS-INFLUENZAE; STREPTOCOCCUS-PNEUMONIAE; CHILDREN; IMPACT; SEROTYPES; ENGLAND; KILIFI; ADULTS; BRAZIL; WALES	Background Ten-valent pneumococcal conjugate vaccine (PCV10), delivered at 6, 10, and 14 weeks of age was introduced in Kenya in January, 2011, accompanied by a catch-up campaign in Kilifi County for children aged younger than 5 years. Coverage with at least two PCV10 doses in children aged 2-11 months was 80% in 2011 and 84% in 2016; coverage with at least one dose in children aged 12-59 months was 66% in 2011 and 87% in 2016. We aimed to assess PCV10 effect against nasopharyngeal carriage and invasive pneumococcal disease (IPD) in children and adults in Kilifi County. Methods This study was done at the KEMRI-Wellcome Trust Research Programme among residents of the Kilifi Health and Demographic Surveillance System, a rural community on the Kenyan coast covering an area of 891 km(2). We linked clinical and microbiological surveillance for IPD among admissions of all ages at Kilifi County Hospital, Kenya, which serves the community, to the Kilifi Health and Demographic Surveillance System from 1999 to 2016. We calculated the incidence rate ratio (IRR) comparing the prevaccine (Jan 1, 1999-Dec 31, 2010) and postvaccine (Jan 1, 2012-Dec 31, 2016) eras, adjusted for confounding, and reported percentage reduction in IPD as 1 minus IRR. Annual cross-sectional surveys of nasopharyngeal carriage were done from 2009 to 2016. Findings Surveillance identified 667 cases of IPD in 3 211 403 person-years of observation. Yearly IPD incidence in children younger than 5 years reduced sharply in 2011 following vaccine introduction and remained low (PCV10-type IPD: 60 . 8 cases per 100 000 in the prevaccine era vs 3 . 2 per 100 000 in the postvaccine era [ adjusted IRR 0 . 08, 95% CI 0 . 03-0 . 22]; IPD caused by any serotype: 81 . 6 per 100 000 vs 15 . 3 per 100 000 [ 0 . 32, 0 . 17-0 . 60]). PCV10-type IPD also declined in the post-vaccination era in unvaccinated age groups (< 2 months [ no cases in the postvaccine era], 5-14 years [ adjusted IRR 0 . 26, 95% CI 0 . 11-0 . 59], and = 15 years [ 0 . 19, 0 . 07-0 . 51]). Incidence of non-PCV10-type IPD did not differ between eras. In children younger than 5 years, PCV10-type carriage declined between eras (age-standardised adjusted prevalence ratio 0 . 26, 95% CI 0 . 19-0 . 35) and non-PCV10-type carriage increased (1 . 71, 1 . 47-1 . 99). Interpretation Introduction of PCV10 in Kenya, accompanied by a catch-up campaign, resulted in a substantial reduction in PCV10-type IPD in children and adults without significant replacement disease. Although the catch-up campaign is likely to have brought forward the benefits by several years, the study suggests that routine infant PCV10 immunisation programmes will provide substantial direct and indirect protection in low-income settings in tropical Africa. Funding Gavi, The Vaccine Alliance and The Wellcome Trust of Great Britain. Copyright (c) 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.	[Hammitt, Laura L.; Etyang, Anthony O.; Morpeth, Susan C.; Ojal, John; Mutuku, Alex; Mturi, Neema; Moisi, Jennifer C.; Adetifa, Ifedayo M.; Karani, Angela; Akech, Donald O.; Otiende, Mark; Bwanaali, Tahreni; Wafula, Jackline; Bauni, Evasius; Marsh, Kevin; Williams, Thomas N.; Scott, J. Anthony G.] Ctr Geog Med Coast, KEMRI Wellcome Trust Res Programme, Epidemiol & Demog Dept, Kilifi, Kenya; [Hammitt, Laura L.; Morpeth, Susan C.; Moisi, Jennifer C.; Bwanaali, Tahreni; Marsh, Kevin; Scott, J. Anthony G.] Univ Oxford, Nuffield Dept Clin Med, Oxford, England; [Hammitt, Laura L.; Knoll, Maria Deloria; Levine, Orin S.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21231 USA; [Etyang, Anthony O.; Morpeth, Susan C.; Ojal, John; Adetifa, Ifedayo M.; Scott, J. Anthony G.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Moisi, Jennifer C.] Pfizer Vaccines, Paris, France; [Mataza, Christine; Mumbo, Edward] Cty Hlth Dept, Kilifi, Kilifi County, Kenya; [Tabu, Collins; Kamau, Tatu; Sharif, Shahnaaz K.] Minist Hlth, Natl Vaccines & Immunizat Programme, Nairobi, Kenya; [Williams, Thomas N.] Imperial Coll, London, England; [Williams, Thomas N.; Scott, J. Anthony G.] INDEPTH Network, Accra, Ghana; [Levine, Orin S.] Bill & Melinda Gates Fdn, Seattle, WA USA	University of Oxford; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of London; London School of Hygiene & Tropical Medicine; Pfizer; Imperial College London; INDEPTH Network; Bill & Melinda Gates Foundation	Hammitt, LL (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21231 USA.	lhammitt@jhu.edu	Etyang, Anthony/AAJ-2704-2020	Etyang, Anthony/0000-0003-1267-6422; Ojal, John/0000-0002-3010-1158; Tabu, Collins/0000-0002-0537-1172; Deloria Knoll, Maria/0000-0001-9041-2671; Otiende, Mark/0000-0002-1389-1813	Gavi; Vaccine Alliance; Wellcome Trust of Great Britain	Gavi; Vaccine Alliance; Wellcome Trust of Great Britain(Wellcome Trust)	Gavi, The Vaccine Alliance and The Wellcome Trust of Great Britain.	Adetifa IMO, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyw202; Andrade AL, 2016, HUM VACC IMMUNOTHER, V12, P285, DOI 10.1080/21645515.2015.1117713; [Anonymous], 2009, CLNIC MAN REF GUID; Australian Technical Advisory Group on Immunisation, 2017, B 64 M 12 13 OCT 201; Ben-Shimol S, 2018, VACCINE, V36, P5477, DOI 10.1016/j.vaccine.2017.05.059; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Berkley JA, 2001, LANCET, V357, P1753, DOI 10.1016/S0140-6736(00)04897-2; Bruce MG, 2015, VACCINE, V33, P4813, DOI 10.1016/j.vaccine.2015.07.080; Cowgill KD, 2006, JAMA-J AM MED ASSOC, V296, P671, DOI 10.1001/jama.296.6.671; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Dagan R, 2009, PEDIATR INFECT DIS J, V28, pS63, DOI 10.1097/INF.0b013e318199f5f2; de Oliveira LH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166736; Desai AP, 2015, PEDIATR INFECT DIS J, V34, P1168, DOI 10.1097/INF.0000000000000849; Domingues CMAS, 2014, LANCET RESP MED, V2, P464, DOI 10.1016/S2213-2600(14)70060-8; Dunais B, 2015, PEDIATR INFECT DIS J, V34, P286, DOI 10.1097/INF.0000000000000559; Etyang AO, 2014, LANCET GLOB HEALTH, V2, pE216, DOI 10.1016/S2214-109X(14)70023-3; Flasche S, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0882-9; Grant LR, 2016, PEDIATR INFECT DIS J, V35, P907, DOI 10.1097/INF.0000000000001207; Hammitt LL, 2014, LANCET GLOB HEALTH, V2, pE397, DOI 10.1016/S2214-109X(14)70224-4; Hsu HE, 2009, NEW ENGL J MED, V360, P244, DOI 10.1056/NEJMoa0800836; Jayasinghe S, 2018, CLIN INFECT DIS, V67, P367, DOI 10.1093/cid/ciy129; Johnson HL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000348; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Ladhani SN, 2018, LANCET INFECT DIS, V18, P441, DOI 10.1016/S1473-3099(18)30052-5; Mackenzie GA, 2016, LANCET INFECT DIS, V16, P703, DOI 10.1016/S1473-3099(16)00054-2; Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3; National AIDS and STI Control Programme (NASCOP), 2014, KEN AIDS IND SURV 20; Nhantumbo AA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177746; Nzenze SA, 2013, PEDIATR INFECT DIS J, V32, P1270, DOI 10.1097/01.inf.0000435805.25366.64; Otiti MI, 2018, 11 INT S PNEUM PNEUM; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Rinta-Kokko H, 2018, VACCINE, V36, P1934, DOI 10.1016/j.vaccine.2018.03.001; Roca A, 2014, 9 INT S PNEUM PNEUM; Scott JAG, 2012, INT J EPIDEMIOL, V41, P650, DOI 10.1093/ije/dys062; Silaba M, 2019, LANCET GLOB HEALTH, V7, pe288; Tsaban G, 2017, VACCINE, V35, P2882, DOI 10.1016/j.vaccine.2017.04.032; van Hoek AJ, 2014, VACCINE, V32, P4349, DOI 10.1016/j.vaccine.2014.03.017; Verani JR, 2018, 11 INT S PNEUM PNEUM; von Gottberg A, 2014, NEW ENGL J MED, V371, P1889, DOI 10.1056/NEJMoa1401914; Wahl B, 2018, LANCET GLOB HEALTH, V6, pE744, DOI 10.1016/S2214-109X(18)30247-X; Waight PA, 2015, LANCET INFECT DIS, V15, P535, DOI 10.1016/S1473-3099(15)70044-7; Walter ND, 2009, NEW ENGL J MED, V361, P2584, DOI 10.1056/NEJMc0904844; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; World Health Organization, 2005, POCK BOOK HOSP CAR C, P72	44	62	62	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 25	2019	393	10186					2146	2154		10.1016/S0140-6736(18)33005-8	http://dx.doi.org/10.1016/S0140-6736(18)33005-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HZ5KS	31000194	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000468891400031
J	[Anonymous]				[Anonymous]			Long-Term Weight Loss With Metformin or Lifestyle Intervention	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																		Apolzan JW, 2019, ANN INTERN MED, V170, P682, DOI 10.7326/M18-1605	1	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 21	2019	170	10					I24	I24		10.7326/P19-0006	http://dx.doi.org/10.7326/P19-0006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HY7RL	31009938				2022-12-28	WOS:000468333600013
J	Tweed, EJ; Aldridge, RW; Capewell, S; Davies, L; Luchenski, S; Lyons, R; McKee, M; Mair, F; Melendez-Torres, GJ; Rutter, H; Tweed, EJ; van Schalkwyk, M; Vrinten, C; Wilson, C; Wulaningsih, W				Tweed, Emily J.; Aldridge, Robert W.; Capewell, Simon; Davies, Llion; Luchenski, Serena; Lyons, Ronan; McKee, Martin; Mair, Frances; Melendez-Torres, G. J.; Rutter, Harry; Tweed, Emily J.; van Schalkwyk, May; Vrinten, Charlotte; Wilson, Claire; Wulaningsih, Wahyu		Public Hlth Sci Conference Grp	UK Public Health Science 2019: a call for abstracts	LANCET			English	Editorial Material									[Tweed, Emily J.] Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Glasgow G2 3AX, Lanark, Scotland; [Aldridge, Robert W.] UCL, Inst Hlth Informat, London, England; [Capewell, Simon] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool, Merseyside, England; [Davies, Llion] Publ Hlth Wales, Swansea, W Glam, Wales; [Luchenski, Serena] UCL, UCL Collaborat Ctr Inclus Hlth, London, England; [Lyons, Ronan] Univ Swansea, Natl Ctr Populat Hlth & Wellbeing Res, Swansea, W Glam, Wales; [McKee, Martin] London Sch Hyg & Trop Med, Ctr Global Chron Condit, London, England; [Mair, Frances] Univ Glasgow, Dept Gen Practice & Primary Care, Glasgow, Lanark, Scotland; [Melendez-Torres, G. J.] Univ Exeter, Coll Med & Hlth, Exeter, Devon, England; [Rutter, Harry] Univ Bath, Dept Social & Policy Sci, Bath, Avon, England; [van Schalkwyk, May] Imperial Coll London, Dept Primary Care & Publ Hlth, London, England; [Vrinten, Charlotte] Imperial Coll London, Ctr Hlth Econ & Policy Innovat, London, England; [Wilson, Claire] Kings Coll London, Inst Psychiat Psychol & Neurosci, Sect Womens Mental Hlth, London, England; [Wulaningsih, Wahyu] UCL, MRC Unit Lifelong Hlth & Ageing, London, England	MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow; University of London; University College London; University of Liverpool; University of London; University College London; Swansea University; University of London; London School of Hygiene & Tropical Medicine; University of Glasgow; University of Exeter; University of Bath; Imperial College London; Imperial College London; University of London; King's College London; University of London; University College London	Tweed, EJ (corresponding author), Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Glasgow G2 3AX, Lanark, Scotland.	emily.tweed@glasgow.ac.uk	Rutter, Harry/HCI-8765-2022; Wulaningsih, Wahyu/AAW-4307-2020	Aldridge, Robert/0000-0003-0542-0816					0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 11	2019	393	10184					1920	1921		10.1016/S0140-6736(19)30895-5	http://dx.doi.org/10.1016/S0140-6736(19)30895-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HX9AE	31005384				2022-12-28	WOS:000467698100008
J	Nakanishi, M; Mitchell, RR; Benoit, YD; Orlando, L; Reid, JC; Shimada, K; Davidson, KC; Shapovalova, Z; Collins, TJ; Nagy, A; Bhatia, M				Nakanishi, Mio; Mitchell, Ryan R.; Benoit, Yannick D.; Orlando, Luca; Reid, Jennifer C.; Shimada, Kenichi; Davidson, Kathryn C.; Shapovalova, Zoya; Collins, Tony J.; Nagy, Andras; Bhatia, Mickie			Human Pluripotency Is Initiated and Preserved by a Unique Subset of Founder Cells	CELL			English	Article							PRIMITIVE ENDODERM; STEM-CELLS; TRANSCRIPTION FACTOR; SELF-ORGANIZATION; SOMATIC-CELLS; DIFFERENTIATION; HETEROGENEITY; REVEALS; WNT; SPECIFICATION	The assembly of organized colonies is the earliest manifestation in the derivation or induction of pluripotency in vitro. However, the necessity and origin of this assemblance is unknown. Here, we identify human pluripotent founder cells (hPFCs) that initiate, as well as preserve and establish, pluripotent stem cell (PSC) cultures. PFCs are marked by N-cadherin expression (NCAD(+)) and reside exclusively at the colony boundary of primate PSCs. As demonstrated by functional analysis, hPFCs harbor the clonogenic capacity of PSC cultures and emerge prior to commitment events or phenotypes associated with pluripotent reprogramming. Comparative single-cell analysis with pre- and post-implantation primate embryos revealed hPFCs share hallmark properties with primitive endoderm (PrE) and can be regulated by non-canonical Wnt signaling. Uniquely informed by primate embryo organization in vivo, our study defines a subset of founder cells critical to the establishment pluripotent state.	[Nakanishi, Mio; Mitchell, Ryan R.; Benoit, Yannick D.; Orlando, Luca; Reid, Jennifer C.; Shapovalova, Zoya; Collins, Tony J.; Bhatia, Mickie] McMaster Univ, Stem Cell & Canc Res Inst, Hamilton, ON L8S 4L8, Canada; [Reid, Jennifer C.; Bhatia, Mickie] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4L8, Canada; [Shimada, Kenichi] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Davidson, Kathryn C.; Nagy, Andras] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic 3800, Australia; [Nagy, Andras] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada	McMaster University; McMaster University; Harvard University; Harvard Medical School; Australian Regenerative Medicine Institute; Monash University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Bhatia, M (corresponding author), McMaster Univ, Stem Cell & Canc Res Inst, Hamilton, ON L8S 4L8, Canada.; Bhatia, M (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4L8, Canada.	mbhatia@mcmaster.ca	Orlando, Luca/AAA-1714-2019; Nagy, Andras/G-6465-2013; Shimada, Kenichi/AAD-7996-2021	Orlando, Luca/0000-0002-6182-018X; Nagy, Andras/0000-0003-4311-0413; Shimada, Kenichi/0000-0001-8540-9785; Reid, Jennifer/0000-0002-7046-5271; Benoit, Yannick/0000-0002-6677-4020	Natural Sciences and Engineering Research Council of Canada [NSERC 06416]; Canadian Institutes of Health Research (CIHR); CIHR; Fonds de Recherche en Sante du Quebec (FRSQ); Cancer Research Institute (CRS); JSPS Overseas Research Fellowships; Australian Department of Education and Training	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Cancer Research Institute (CRS); JSPS Overseas Research Fellowships; Australian Department of Education and Training(Australian GovernmentDepartment of Industry, Innovation and Science)	We thank Aline Fiebig-Comyn, Monica Graham, Makondo Kennedy, Sarah Laronde, Jong-Hee Lee, Linda May, Nicole McFarlane, Jamie D. McNicol, Steven Moreira, Jennifer Russell, Minomi K. Subapanditha, and Princess Margaret Genomics Centre for their technical assistance, as well as the Timothy J. Mitchison at Harvard for his collegiality in facilitating K.S. participation in this study and Morag Stewart and Sean Bendall for the hPSC niche prophecy that initiated the path to this work. This work was supported by grants to M.B. from Natural Sciences and Engineering Research Council of Canada (NSERC 06416) and the Canadian Institutes of Health Research (CIHR). Y.D.B. is supported by the CIHR, the Fonds de Recherche en Sante du Quebec (FRSQ), and the Cancer Research Institute (CRS). K.S. was supported by JSPS Overseas Research Fellowships. K.C.D. was supported by an Endeavour Fellowship from the Australian Department of Education and Training.	Allison TF, 2018, STEM CELL REP, V10, P1895, DOI 10.1016/j.stemcr.2018.04.015; Ariasi AM, 2011, CURR OPIN CELL BIOL, V23, P650, DOI 10.1016/j.ceb.2011.09.007; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Buganim Y, 2013, NAT REV GENET, V14, P427, DOI 10.1038/nrg3473; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Dahmann C, 2011, NAT REV GENET, V12, P43, DOI 10.1038/nrg2902; Deglincerti A, 2016, NATURE, V533, P251, DOI 10.1038/nature17948; Dormeyer W, 2008, J PROTEOME RES, V7, P2936, DOI 10.1021/pr800056j; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Drukker M, 2012, NAT BIOTECHNOL, V30, P531, DOI 10.1038/nbt.2239; Fogarty NME, 2017, NATURE, V550, P67, DOI 10.1038/nature24033; Fossat N, 2015, DEVELOPMENT, V142, P2069, DOI 10.1242/dev.120907; Gifford CA, 2013, CELL, V153, P1149, DOI 10.1016/j.cell.2013.04.037; Grabarek JB, 2012, DEVELOPMENT, V139, P129, DOI 10.1242/dev.067702; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Hough SR, 2014, STEM CELL REP, V2, P881, DOI 10.1016/j.stemcr.2014.04.014; Hussein SMI, 2014, NATURE, V516, P198, DOI 10.1038/nature14046; Irvine KD, 2001, ANNU REV CELL DEV BI, V17, P189, DOI 10.1146/annurev.cellbio.17.1.189; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Koutsourakis M, 1999, DEVELOPMENT, V126, P723; Kumar RM, 2014, NATURE, V516, P56, DOI 10.1038/nature13920; Lee JH, 2017, CELL REP, V19, P20, DOI 10.1016/j.celrep.2017.03.036; Lee JH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6605; Lo Nigro A, 2017, STEM CELL REP, V8, P318, DOI 10.1016/j.stemcr.2016.12.010; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Martyn I, 2018, NATURE, V558, P132, DOI 10.1038/s41586-018-0150-y; Mohseni P, 2011, J NEUROSCI, V31, P11547, DOI 10.1523/JNEUROSCI.4396-10.2011; Moore R, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-39; Nakamura T, 2016, NATURE, V537, P57, DOI 10.1038/nature19096; Nazareth EJP, 2013, NAT METHODS, V10, P1225, DOI [10.1038/nmeth.2684, 10.1038/NMETH.2684]; Niakan KK, 2013, DEV BIOL, V375, P54, DOI 10.1016/j.ydbio.2012.12.008; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; O'Leary T, 2012, NAT BIOTECHNOL, V30, P278, DOI 10.1038/nbt.2135; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Petropoulos S, 2016, CELL, V167, P285, DOI [10.1016/j.cell.2016.08.009, 10.1016/j.cell.2016.03.023]; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Salati S, 2008, STEM CELLS, V26, P950, DOI 10.1634/stemcells.2007-0597; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Shahbazi MN, 2016, NAT CELL BIOL, V18, P700, DOI 10.1038/ncb3347; Stewart MH, 2006, NAT METHODS, V3, P807, DOI 10.1038/nmeth939; Sugimura R, 2012, CELL, V150, P351, DOI 10.1016/j.cell.2012.05.041; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4678; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Warmflash A, 2014, NAT METHODS, V11, P847, DOI [10.1038/NMETH.3016, 10.1038/nmeth.3016]; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Werbowetski-Ogilvie TE, 2009, NAT BIOTECHNOL, V27, P91, DOI 10.1038/nbt.1516; Winklbauer R, 2001, NATURE, V413, P856, DOI 10.1038/35101621; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yang DH, 2002, DEV BIOL, V251, P27, DOI 10.1006/dbio.2002.0810; Zhao Y, 2015, CELL, V163, P1678, DOI 10.1016/j.cell.2015.11.017; 2009, STEM CELL RES AMST, V2, P113, DOI DOI 10.1016/J.SCR.2008.08.001	55	22	22	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 2	2019	177	4					910	+		10.1016/j.cell.2019.03.013	http://dx.doi.org/10.1016/j.cell.2019.03.013			37	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HW7AU	30982595	Bronze			2022-12-28	WOS:000466843000012
J	Tomas-Loba, A; Manieri, E; Gonzalez-Teran, B; Mora, A; Leiva-Vega, L; Santamans, AM; Romero-Becerra, R; Rodriguez, E; Pintor-Chocano, A; Feixas, F; Lopez, JA; Caballero, B; Trakala, M; Blanco, O; Torres, JL; Hernandez-Cosido, L; Montalvo-Romeral, V; Matesanz, N; Roche-Molina, M; Bernal, JA; Mischo, H; Leon, M; Caballero, A; Miranda-Saavedra, D; Ruiz-Cabello, J; Nevzorova, YA; Cubero, FJ; Bravo, J; Vazquez, J; Malumbres, M; Marcos, M; Osuna, S; Sabio, G				Tomas-Loba, Antonia; Manieri, Elisa; Gonzalez-Teran, Barbara; Mora, Alfonso; Leiva-Vega, Luis; Santamans, Ayelen M.; Romero-Becerra, Rafael; Rodriguez, Elena; Pintor-Chocano, Aranzazu; Feixas, Ferran; Antonio Lopez, Juan; Caballero, Beatriz; Trakala, Marianna; Blanco, Oscar; Torres, Jorge L.; Hernandez-Cosido, Lourdes; Montalvo-Romeral, Valle; Matesanz, Nuria; Roche-Molina, Marta; Antonio Bernal, Juan; Mischo, Hannah; Leon, Marta; Caballero, Ainoa; Miranda-Saavedra, Diego; Ruiz-Cabello, Jesus; Nevzorova, Yulia A.; Javier Cubero, Francisco; Bravo, Jeronimo; Vazquez, Jesus; Malumbres, Marcos; Marcos, Miguel; Osuna, Silvia; Sabio, Guadalupe			p38 gamma is essential for cell cycle progression and liver tumorigenesis	NATURE			English	Article							PROTEIN; PHOSPHORYLATION; CANCER; PROLIFERATION; INACTIVATION; REPLICATION; METABOLISM; DYNAMICS; REGION; CDKS	The cell cycle is a tightly regulated process that is controlled by the conserved cyclin-dependent kinase (CDK)-cyclin protein complex(1). However, control of the G0-to-G1 transition is not completely understood. Here we demonstrate that p38 MAPK gamma (p38 gamma) acts as a CDK-like kinase and thus cooperates with CDKs, regulating entry into the cell cycle. p38 gamma shares high sequence homology, inhibition sensitivity and substrate specificity with CDK family members. In mouse hepatocytes, p38 gamma induces proliferation after partial hepatectomy by promoting the phosphorylation of retinoblastoma tumour suppressor protein at known CDK target residues. Lack of p38 gamma or treatment with the p38 gamma inhibitor pirfenidone protects against the chemically induced formation of liver tumours. Furthermore, biopsies of human hepatocellular carcinoma show high expression of p38 gamma, suggesting that p38 gamma could be a therapeutic target in the treatment of this disease.	[Tomas-Loba, Antonia; Manieri, Elisa; Gonzalez-Teran, Barbara; Mora, Alfonso; Leiva-Vega, Luis; Santamans, Ayelen M.; Romero-Becerra, Rafael; Rodriguez, Elena; Pintor-Chocano, Aranzazu; Antonio Lopez, Juan; Caballero, Beatriz; Montalvo-Romeral, Valle; Matesanz, Nuria; Roche-Molina, Marta; Antonio Bernal, Juan; Leon, Marta; Caballero, Ainoa; Ruiz-Cabello, Jesus; Vazquez, Jesus; Sabio, Guadalupe] CNIC, Madrid, Spain; [Manieri, Elisa] CSIC, Ctr Nacl Biotecnol, Madrid, Spain; [Feixas, Ferran; Osuna, Silvia] Univ Girona, Dept Quim, Girona, Spain; [Feixas, Ferran; Osuna, Silvia] Univ Girona, Inst Quim Computac & Catalisi, Girona, Spain; [Trakala, Marianna; Malumbres, Marcos] CNIO, Madrid, Spain; [Blanco, Oscar; Torres, Jorge L.; Hernandez-Cosido, Lourdes; Marcos, Miguel] Univ Salamanca, Univ Hosp Salamanca, IBSAL, Salamanca, Spain; [Mischo, Hannah] Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England; [Miranda-Saavedra, Diego] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Miranda-Saavedra, Diego] Univ Oxford, Wolfson Bldg, Oxford, England; [Ruiz-Cabello, Jesus] CIC BiomaGUNE, Donostia San Sebastian 2014, Spain; [Ruiz-Cabello, Jesus] Ikerbasque, Basque Fdn Sci, Bilbao, Spain; [Ruiz-Cabello, Jesus] Ciber Enfermedades Resp CIBERES, Madrid, Spain; [Nevzorova, Yulia A.] Univ Hosp RWTH Aachen, Aachen, Germany; [Ruiz-Cabello, Jesus; Nevzorova, Yulia A.] Univ Complutense Madrid, Fac Biol, Madrid, Spain; [Javier Cubero, Francisco] Univ Complutense Madrid, Sch Med, Madrid, Spain; [Javier Cubero, Francisco] 12 Octubre Hlth Res Inst imas12, Madrid, Spain; [Bravo, Jeronimo] CSIC, IBV, Valencia, Spain; [Vazquez, Jesus] CIBER Enfermedades Cardiovasc CIBERCV, Madrid, Spain; [Osuna, Silvia] ICREA, Barcelona, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Universitat de Girona; Universitat de Girona; Centro Nacional de Investigaciones Oncologicas (CNIO); University of Salamanca; University of Oxford; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); University of Oxford; CIC biomaGUNE; Basque Foundation for Science; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; RWTH Aachen University; RWTH Aachen University Hospital; Complutense University of Madrid; Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; ICREA	Sabio, G (corresponding author), CNIC, Madrid, Spain.	gsabio@cnic.es	Bernal, Juan A/N-4544-2014; Loba, Antonia Tomas/AAB-6814-2019; Manieri, Elisa/AAM-4706-2021; Marcos, Miguel/B-3550-2008; Feixas, Ferran/K-5597-2014; Sabio, Guadalupe/H-9733-2015; Ruiz-Cabello, Jesus/A-9570-2012; BLANCO, OSCAR/AAB-6306-2019; Triana, Jorge Luis Torres/AAA-7819-2019; Lopez, Juan Antonio/G-7750-2015; Roche-Molina, Marta/G-2731-2016; Osuna, Sílvia/B-6191-2009; Romeral, Valle Montalvo/ABC-2292-2020; Feixas, Ferran/B-6192-2009; Bravo, Jeronimo/K-9103-2014; Vazquez, Jesus/B-7697-2015; Malumbres, Marcos/E-8834-2011	Bernal, Juan A/0000-0002-9933-5550; Manieri, Elisa/0000-0002-7525-019X; Marcos, Miguel/0000-0003-1269-4487; Feixas, Ferran/0000-0001-5147-0000; Sabio, Guadalupe/0000-0002-2822-0625; Ruiz-Cabello, Jesus/0000-0001-8681-5056; BLANCO, OSCAR/0000-0002-2667-0489; Triana, Jorge Luis Torres/0000-0001-6853-9115; Lopez, Juan Antonio/0000-0002-9097-6060; Osuna, Sílvia/0000-0003-3657-6469; Romeral, Valle Montalvo/0000-0001-7183-3710; Bravo, Jeronimo/0000-0001-6695-2846; Vazquez, Jesus/0000-0003-1461-5092; Malumbres, Marcos/0000-0002-0829-6315; Cubero, Francisco Javier/0000-0003-1499-650X; Hernandez Cosido, Lourdes/0000-0003-1359-7478; Mora, Alfonso/0000-0002-6397-4836; Matesanz, Nuria/0000-0002-5756-3424; Nevzorova, Yulia A/0000-0003-1390-8002; Romero-Becerra, Rafael/0000-0003-3935-2647; Trakala, Marianna/0000-0001-8749-731X; Roche-Molina, Marta/0000-0002-9487-6980; Pintor Chocano, Aranzazu/0000-0002-5755-4181	La Caixa fellowships; FPI Severo Ochoa CNIC program [SVP-2013-067639]; European Regional Development Fund: the European Union's Seventh Framework Programme (FP7/2007-2013) ERC [260464]; EFSD/Lilly European Diabetes Research Programme Dr Sabio; 2017 Leonardo Grant for Researchers and Cultural Creators; BBVA Foundation [IN[17]_BBM_BAS_0066]; MINECO-FEDER [SAF2016-79126-R]; Comunidad de Madrid [IMMUNOTHERCAN-CM S2010/BMD-2326, B2017/BMD-3733]; Juan de la Cierva; MINECO [SAF2014-61233-JIN, SAF2016-78711, SAF2015-67077-R, SAF2017-89901-R, BIO2015-67580-P]; European Community [MSCA-IF-2014-EF-661160-MetAccembly]; Spanish MINECO [CTQ2014-59212-P]; European Research Council (ERC) under the European Union's Horizon 2020 [ERC-2015-StG-679001-NetMoDEzyme]; German Research Foundation [SFB/TRR57/P04, DFG NE 2128/2-1]; COST Action [CA17112]; AMMF Cholangiocarcinoma Charity [2018/117]; MINECO - ERDF-EU [SAF2015-69920-R]; Consolider-Ingenio 2010 Programme [SAF2014-57791-REDC]; Excellence Network CellSYS [BFU2014-52125-REDT]; iLUNG Programme from the Comunidad de Madrid [B2017/BMD-3884]; Carlos III Institute of Health-Fondo de Investigacion Sanitaria [ProteoRed PRB3, IPT17/0019]; Fundacion La Marato; 'La Caixa' Banking Foundation [HR17-00247]; ISCIII; FEDER [PI16/01548]; Junta de Castilla y Leon [GRS 1362/A/16, INT/M/17/17, GRS 1356/A/16, GRS 1587/A/17]; MCNU [SAF2017-84494-C2-1-R]; Ministerio de Ciencia, Innovacion y Universidades (MCNU); Pro CNIC Foundation; Severo Ochoa Center of Excellence [SEV-2015-0505];  [RYC-2009-04972];  [RYC-2014-15242];  [RYC-2015-17438];  [EXOHEP-CM S2017/BMD-3727]	La Caixa fellowships; FPI Severo Ochoa CNIC program; European Regional Development Fund: the European Union's Seventh Framework Programme (FP7/2007-2013) ERC; EFSD/Lilly European Diabetes Research Programme Dr Sabio; 2017 Leonardo Grant for Researchers and Cultural Creators; BBVA Foundation(BBVA Foundation); MINECO-FEDER(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); Juan de la Cierva(Instituto de Salud Carlos III); MINECO(Spanish Government); European Community(European Commission); Spanish MINECO(Spanish Government); European Research Council (ERC) under the European Union's Horizon 2020(European Research Council (ERC)); German Research Foundation(German Research Foundation (DFG)); COST Action(European Cooperation in Science and Technology (COST)); AMMF Cholangiocarcinoma Charity; MINECO - ERDF-EU; Consolider-Ingenio 2010 Programme(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Excellence Network CellSYS; iLUNG Programme from the Comunidad de Madrid; Carlos III Institute of Health-Fondo de Investigacion Sanitaria; Fundacion La Marato; 'La Caixa' Banking Foundation(La Caixa Foundation); ISCIII(Instituto de Salud Carlos III); FEDER(European Commission); Junta de Castilla y Leon(Junta de Castilla y Leon); MCNU; Ministerio de Ciencia, Innovacion y Universidades (MCNU)(Spanish Government); Pro CNIC Foundation; Severo Ochoa Center of Excellence(Spanish Government); ; ; ; 	We thank S. Bartlett for English editing, D. Engelberg for the constitutively active mutants, the Division of Signal Transduction Therapy for recombinant proteins, and CNIC Advanced Imaging and Vector Units for technical support. G.S. (RYC-2009-04972), F.J.C. (RYC-2014-15242), and Y.A.N. (RYC-2015-17438) are investigators of the Ramon y Cajal Program. E.M. and M.T. were awarded La Caixa fellowships and R.R.-B. was a fellow of the Fundacion Ramon Areces-UAM and FPU. B.G.-T. is a fellow of the FPI Severo Ochoa CNIC program (SVP-2013-067639). F.J.C. is a Gilead Liver Research Scholar. This work was funded by grants supported in part by funds from the European Regional Development Fund: the European Union's Seventh Framework Programme (FP7/2007-2013) ERC 260464, EFSD/Lilly European Diabetes Research Programme Dr Sabio, 2017 Leonardo Grant for Researchers and Cultural Creators, BBVA Foundation (Investigadores-BBVA-2017) IN[17]_BBM_BAS_0066, MINECO-FEDER SAF2016-79126-R, and Comunidad de Madrid IMMUNOTHERCAN-CM S2010/BMD-2326 and B2017/BMD-3733 to G.S.; Juan de la Cierva and MINECO SAF2014-61233-JIN to A.T.-L.; the European Community for MSCA-IF-2014-EF-661160-MetAccembly grant to F.F.; Spanish MINECO CTQ2014-59212-P, European Community for CIG project (PCIG14-GA-2013-630978), and European Research Council (ERC) under the European Union's Horizon 2020 (ERC-2015-StG-679001-NetMoDEzyme) to S.O.; the German Research Foundation (SFB/TRR57/P04 and DFG NE 2128/2-1) and MINECO SAF2017-87919R to Y.A.N.; EXOHEP-CM S2017/BMD-3727 and the COST Action CA17112, MINECO SAF2016-78711, and the AMMF Cholangiocarcinoma Charity 2018/117 to F.J.C.; MINECO (SAF2015-69920-R co-funded by ERDF-EU), the Consolider-Ingenio 2010 Programme (SAF2014-57791-REDC), Excellence Network CellSYS (BFU2014-52125-REDT), and the iLUNG Programme (B2017/BMD-3884) from the Comunidad de Madrid to M. Malumbres; MINECO SAF2015-67077-R and SAF2017-89901-R to J.B.; MINECO (BIO2015-67580-P), Carlos III Institute of Health-Fondo de Investigacion Sanitaria (ProteoRed PRB3, IPT17/0019 - ISCIII-SGEFI/ERDF), Fundacion La Marato and 'La Caixa' Banking Foundation (HR17-00247) to J.V.; ISCIII and FEDER PI16/01548 and Junta de Castilla y Leon GRS 1362/A/16 and INT/M/17/17 to M. Marcos; Junta de Castilla y Leon GRS 1356/A/16 and GRS 1587/A/17 to J. L.-T.; and MCNU (SAF2017-84494-C2-1-R) to J.R.-C. The CNIC is supported by the Ministerio de Ciencia, Innovacion y Universidades (MCNU) and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (SEV-2015-0505).	Askari N, 2007, J BIOL CHEM, V282, P91, DOI 10.1074/jbc.M608012200; Canhoto AJ, 2000, ONCOGENE, V19, P5116, DOI 10.1038/sj.onc.1203893; Cubero FJ, 2015, J HEPATOL, V62, P140, DOI 10.1016/j.jhep.2014.08.029; Dalvi V., 2017, MUMBAI MIRROR 0930, P16; Diril MK, 2012, P NATL ACAD SCI USA, V109, P3826, DOI 10.1073/pnas.1115201109; Diskin R, 2004, J BIOL CHEM, V279, P47040, DOI 10.1074/jbc.M404595200; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Gonzalez-Teran B, 2016, EMBO J, V35, P536, DOI 10.15252/embj.201591857; Gonzalez-Teran B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10477; Gonzalez-Teran B, 2013, J CLIN INVEST, V123, P164, DOI 10.1172/JCI65124; Gubern A, 2016, MOL CELL, V64, P25, DOI 10.1016/j.molcel.2016.08.015; Hamelberg D, 2004, J CHEM PHYS, V120, P11919, DOI 10.1063/1.1755656; Hamelberg D, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2789432; Hu W, 2014, HEPATOLOGY, V59, P651, DOI 10.1002/hep.26584; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; Malumbres M, 2014, GENOME BIOL, V15, DOI 10.1186/gb4184; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Manieri E, 2015, J MOL ENDOCRINOL, V55, pR11, DOI 10.1530/JME-15-0146; Matesanz N, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2004455; Mayhew CN, 2005, CANCER RES, V65, P4568, DOI 10.1158/0008-5472.CAN-04-4221; Miao CH, 2000, MOL THER, V1, P522, DOI 10.1006/mthe.2000.0075; Narasimha AM, 2014, ELIFE, V3, DOI 10.7554/eLife.02872; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Sabio G, 2005, EMBO J, V24, P1134, DOI 10.1038/sj.emboj.7600578; Trakala M, 2015, DEV CELL, V32, P155, DOI 10.1016/j.devcel.2014.12.015; Varjosalo M, 2013, CELL REP, V3, P1306, DOI 10.1016/j.celrep.2013.03.027; Repetto MV, 2018, MOL CELL, V69, P938, DOI 10.1016/j.molcel.2018.02.018; Zheng K, 2017, GENES-BASEL, V8, DOI 10.3390/genes8040123	29	52	55	3	67	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 25	2019	568	7753					557	+		10.1038/s41586-019-1112-8	http://dx.doi.org/10.1038/s41586-019-1112-8			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HU9DR	30971822	Green Accepted, Green Submitted			2022-12-28	WOS:000465594200052
J	Torkamani, A; Topol, E				Torkamani, Ali; Topol, Eric			Polygenic Risk Scores Expand to Obesity	CELL			English	Editorial Material								Obesity is one of the most serious health challenges of our time. In this issue of Cell, Khera and co-authors demonstrate the striking ability of genetics, in the form of a polygenic risk score, to identify those individuals at high risk for obesity. This genetic risk expresses itself early as childhood obesity, reinforcing the notion that early prevention is essential to combatting the obesity epidemic.	[Torkamani, Ali; Topol, Eric] Scripps Res Translat Inst, La Jolla, CA 92037 USA; [Torkamani, Ali] Scripps Res, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Topol, Eric] Scripps Res, Dept Mol Med, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Topol, E (corresponding author), Scripps Res Translat Inst, La Jolla, CA 92037 USA.; Topol, E (corresponding author), Scripps Res, Dept Mol Med, La Jolla, CA 92037 USA.	etopol@scripps.edu		Topol, Eric/0000-0002-1478-4729				Butler EM, 2018, HORM RES PAEDIAT, V90, P358, DOI 10.1159/000496563; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Khera AV, 2019, CELL, V177, P587, DOI 10.1016/j.cell.2019.03.028; Khera AV, 2018, NAT GENET, V50, P1219, DOI 10.1038/s41588-018-0183-z; Lotta LA, 2019, CELL, V177, P597, DOI 10.1016/j.cell.2019.03.044; Mega JL, 2015, LANCET, V385, P2264, DOI 10.1016/S0140-6736(14)61730-X; Torkamani A, 2018, NAT REV GENET, V19, P581, DOI 10.1038/s41576-018-0018-x; Turcot V, 2018, NAT GENET, V50, P26, DOI 10.1038/s41588-017-0011-x	8	23	23	3	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2019	177	3					518	520		10.1016/j.cell.2019.03.051	http://dx.doi.org/10.1016/j.cell.2019.03.051			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HU0FV	31002792	Bronze			2022-12-28	WOS:000464947700008
J	Cantor, AG; Hendrickson, R; Blazina, I; Griffin, J; Grusing, S; McDonagh, MS				Cantor, Amy G.; Hendrickson, Rob; Blazina, Ian; Griffin, Jessica; Grusing, Sara; McDonagh, Marian S.			Screening for Elevated Blood Lead Levels in Childhood and Pregnancy Updated Evidence Report and Systematic Review for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CALCIUM SUPPLEMENTATION; CHELATION-THERAPY; RISK-ASSESSMENT; CHILDREN; QUESTIONNAIRE; CAPILLARY; EXPOSURE; POPULATION; ACCURACY; EFFICACY	IMPORTANCE Elevated blood lead level is associated with serious, often irreversible, health consequences. OBJECTIVE To synthesize evidence on the effects of screening, testing, and treatment for elevated blood lead level in pregnant women and children aged 5 years and younger in the primary care setting to inform the US Preventive Services Task Force. DATA SOURCES Cochrane CENTRAL and Cochrane Database of Systematic Reviews (through June 2018) and Ovid MEDLINE (1946 to June 2018); surveillance through December 5, 2018. STUDY SELECTION English-language trials and observational studies of screening for and treating elevated lead levels in asymptomatic children and pregnant women. DATA EXTRACTION AND SYNTHESIS Independent critical appraisal and data abstraction by 2 reviewers using predefined criteria. MAIN OUTCOMES AND MEASURES Elevated blood lead level, morbidity, mortality, clinical prediction tools, test accuracy, adverse events. RESULTS A total of 24 studies (N = 11 433) were included in this review. No studies evaluated the benefits or harms of screening vs no screening in children. More than 1 positive answer on the 5-item 1991 Centers for Disease Control and Prevention (CDC) screening questionnaire was associated with a pooled sensitivity of 48%(95% CI, 31.4% to 65.6%) and specificity of 58%(95% CI, 39.9% to 74.0%) for identifying children with a venous blood lead level greater than 10 mu g/dL (5 studies [n = 2265]). Adapted versions of the CDC questionnaire did not demonstrate improved accuracy. Capillary blood lead testing demonstrated sensitivity of 87% to 91% and specificity greater than 90%, compared with venous measurement (4 studies [n = 1431]). Counseling and nutritional interventions or residential lead hazard control techniques did not reduce blood lead concentrations in asymptomatic children, but studies were few and had methodological limitations (7 studies [n = 1419]). One trial (n = 780) of dimercaptosuccinic acid (DMSA) chelation therapy found reduced blood lead levels in children at 1 week to 1 year but not at 4.5 to 6 years, while another trial (n = 39) found no effect at 1 and 6 months. Seven-year follow-up assessments showed no effect on neuropsychological development, a small deficit in linear growth (height difference, 1.17 cm [95% CI, 0.41 to 1.93]), and poorer cognitive outcomes reported as the Attention and Executive Functions subscore of the Developmental Neuropsychological Assessment (unadjusted difference, -1.8 [95% CI, -4.5 to 1.0]; adjusted P = .045) in children treated with DMSA chelation. Evidence was too limited to determine the accuracy of screening questionnaires or benefits and harms of treatment in pregnant women. CONCLUSIONS AND RELEVANCE Screening questionnaires were not accurate for identifying children with elevated blood lead levels. Chelating agents in children were not significantly associated with sustained effects on blood level levels but were associated with harms.	[Cantor, Amy G.] Oregon Hlth & Sci Univ, Pacific Northwest Evidence Based Practice Ctr, Dept Med Informat & Clin Epidemiol, 3181 SW Sam Jackson Pk Rd,Mail Code BICC, Portland, OR 97239 USA; [Cantor, Amy G.] Oregon Hlth & Sci Univ, Pacific Northwest Evidence Based Practice Ctr, Dept Family Med, Portland, OR 97201 USA; [Cantor, Amy G.] Oregon Hlth & Sci Univ, Pacific Northwest Evidence Based Practice Ctr, Dept Obstet & Gynecol, Portland, OR 97201 USA; [Hendrickson, Rob] Oregon Hlth & Sci Univ, Dept Emergency Med, Portland, OR 97201 USA; [Blazina, Ian; Griffin, Jessica; Grusing, Sara; McDonagh, Marian S.] Pacific Northwest Evidence Based Practice Ctr, Portland, OR USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Cantor, AG (corresponding author), Oregon Hlth & Sci Univ, Pacific Northwest Evidence Based Practice Ctr, Dept Med Informat & Clin Epidemiol, 3181 SW Sam Jackson Pk Rd,Mail Code BICC, Portland, OR 97239 USA.	cantor@ohsu.edu		Blazina, Ian/0000-0003-0164-6674; Hendrickson, Robert/0000-0002-5998-3908; Cantor, Amy/0000-0002-4467-8484	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services [HHSA290201500009I, 7]	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services	This studywas funded under contract HHSA290201500009I, Task Order No. 7, from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services, under a contract to support the USPSTF.	Advisory Committee on Childhood Lead Poisoning Prevention of the Centers for Disease Control and Prevention, 2012, LOW LEV LEAD EXP HAR; Boreland F, 2009, SCI TOTAL ENVIRON, V408, P202, DOI 10.1016/j.scitotenv.2009.10.013; Bornschein RL, 2000, PEDIATR RES, V48, P593; Brown MJ, 2006, PEDIATRICS, V117, P147, DOI 10.1542/peds.2004-2880; Cantor A, 2019, AHRQ PUBLICATION, V18-05245-EF-1; CASEY R, 1994, CLIN PEDIATR, V33, P480, DOI 10.1177/000992289403300806; Centers for Disease Control and Prevention, STAND SURV DEF CLASS; Centers for Disease Control and Prevention, 2010, GUIDELINES IDENTIFIC; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P1041; Centers for Disease Control and Prevention (CDC), SCREEN YOUNG CHILDR; Centers for Disease Control (CDC), 1983, MMWR Morb Mortal Wkly Rep, V32, P554; Dalton MA, 1996, ARCH PEDIAT ADOL MED, V150, P197, DOI 10.1001/archpedi.1996.02170270079012; Dietrich KN, 2004, PEDIATRICS, V114, P19, DOI 10.1542/peds.114.1.19; Ettinger AS, 2009, ENVIRON HEALTH PERSP, V117, P26, DOI [10.1289/ehp.11868, 10.1289/ehp.1171c26]; Flora Gagan, 2012, Interdiscip Toxicol, V5, P47, DOI 10.2478/v10102-012-0009-2; France EK, 1996, ARCH PEDIAT ADOL MED, V150, P958, DOI 10.1001/archpedi.1996.02170340072014; Holmes SE, 1997, J TOXICOL-CLIN TOXIC, V35, P181, DOI 10.3109/15563659709001190; Holtrop TG, 1998, ARCH PEDIAT ADOL MED, V152, P455; Kazal LA, 1997, J FAM PRACTICE, V45, P515; Lanphear BP, 1996, AM J PUBLIC HEALTH, V86, P1460, DOI 10.2105/AJPH.86.10.1460; Liu XC, 2002, PEDIATRICS, V110, P787, DOI 10.1542/peds.110.4.787; Liu Z, 2013, BRIT J CANCER, V108, P2299, DOI 10.1038/bjc.2013.185; Markowitz ME, 2004, PEDIATRICS, V113, pE34, DOI 10.1542/peds.113.1.e34; MOSES LE, 1993, STAT MED, V12, P1293, DOI 10.1002/sim.4780121203; Muniz MA, 2003, J RURAL HEALTH, V19, P15, DOI 10.1111/j.1748-0361.2003.tb00536.x; Nicholson JS, 2018, CHILD HEALTH CARE, V47, P379, DOI 10.1080/02739615.2017.1370673; O'Connor ME, 1999, CLIN PEDIATR, V38, P325, DOI 10.1177/000992289903800602; Ossiander EM, 2013, J PUBLIC HEALTH MAN, V19, pE21, DOI 10.1097/PHH.0b013e3182249523; Parsons PJ, 1993, EVALUATION IMPROVEME; Raymond Jaime, 2014, MMWR Suppl, V63, P36; Rischitelli G, 2006, SCREENING ELEVATED L; Robin LF, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.4.e9; Rogan WJ, 2001, NEW ENGL J MED, V344, P1421, DOI 10.1056/NEJM200105103441902; Roper W.L., 1991, PREVENTING LEAD POIS; SARGENT JD, 1995, AM J PUBLIC HEALTH, V85, P528, DOI 10.2105/AJPH.85.4.528; Sargent JD, 1996, ARCH PEDIAT ADOL MED, V150, P1084, DOI 10.1001/archpedi.1996.02170350086015; Schaffer SJ, 1996, PEDIATRICS, V97, P84; SCHLENKER TL, 1994, JAMA-J AM MED ASSOC, V271, P1346, DOI 10.1001/jama.271.17.1346; SHANNON M, 1988, J PEDIATR-US, V112, P799, DOI 10.1016/S0022-3476(88)83212-8; SNYDER DC, 1995, PEDIATRICS, V96, P643; Sowers M, 2002, ARCH ENVIRON HEALTH, V57, P489, DOI 10.1080/00039890209601442; Stefanak MA, 1996, OBSTET GYNECOL, V87, P209, DOI 10.1016/0029-7844(95)00397-5; TEJEDA DM, 1994, PEDIATRICS, V93, P192; Toft N, 2009, PREV VET MED, V92, P249, DOI 10.1016/j.prevetmed.2009.08.019; Tong S, 2000, B WORLD HEALTH ORGAN, V78, P1068; U. S. Preventive Services Task Force (USPSTF), 2006, LEAD LEV CHILDH PREG; United Nations Development Programme (UNDP), 2017, GLOB HUM DEV IND COU; US Preventive Services Task Force (USPSTF), 2018, PROC MAN; Wolf AW, 2003, J PEDIATR-US, V143, P789, DOI 10.1067/S0022-3476(03)00540-7	49	12	12	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 16	2019	321	15					1510	1526		10.1001/jama.2019.1004	http://dx.doi.org/10.1001/jama.2019.1004			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HT7SY	30990555	Bronze			2022-12-28	WOS:000464765900018
J	Friedrich, MJ				Friedrich, M. J.			Cancer Goes Undiagnosed in Almost Half the World's Children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 16	2019	321	15					1448	1448		10.1001/jama.2019.3827	http://dx.doi.org/10.1001/jama.2019.3827			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HT7SY	30990558				2022-12-28	WOS:000464765900029
J	Kang, YK; Cho, H				Kang, Yoon-Koo; Cho, Hyungwoo			Perioperative FLOT: new standard for gastric cancer?	LANCET			English	Editorial Material							PHASE-III; CHEMOTHERAPY; SURGERY		[Kang, Yoon-Koo; Cho, Hyungwoo] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul 05505, South Korea	University of Ulsan	Kang, YK (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul 05505, South Korea.	ykkang@amc.seoul.kr						Al-Batran SE, 2019, LANCET, V393, P1948, DOI 10.1016/S0140-6736(18)32557-1; Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; Cats A, 2018, LANCET ONCOL, V19, P616, DOI 10.1016/S1470-2045(18)30132-3; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; IWASAKI Y, 2018, J CLIN ONCOL S15, V36; Kang YK, 2018, ANN ONCOL, V29; Kang YK, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.15_suppl.tps4136; Leong T, 2017, ANN SURG ONCOL, V24, P2252, DOI 10.1245/s10434-017-5830-6; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Smyth EC, 2017, JAMA ONCOL, V3, P1197, DOI 10.1001/jamaoncol.2016.6762; Van Cutsem E, 2006, J CLIN ONCOL, V24, P4991, DOI 10.1200/JCO.2006.06.8429	12	10	10	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 11	2019	393	10184					1914	1916		10.1016/S0140-6736(18)33189-1	http://dx.doi.org/10.1016/S0140-6736(18)33189-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HX9AE	30982685				2022-12-28	WOS:000467698100005
J	Barisic, D; Stadler, MB; Iurlaro, M; Schubeler, D				Barisic, Darko; Stadler, Michael B.; Iurlaro, Mario; Schuebeler, Dirk			Mammalian ISWI and SWI/SNF selectively mediate binding of distinct transcription factors	NATURE			English	Article							CHROMATIN REMODELING COMPLEX; GENOME; ORGANIZATION; EXPANSION; ENZYMES; PROTEIN; COHESIN; ESBAF; CTCF	Chromatin remodelling complexes evict, slide, insert or replace nucleosomes, which represent an intrinsic barrier for access to DNA. These remodellers function in most aspects of genome utilization including transcription-factor binding, DNA replication and repair(1,2). Although they are frequently mutated in cancer(3), it remains largely unclear how the four mammalian remodeller families (SWI/SNF, ISWI, CHD and INO80) orchestrate the global organization of nucleosomes. Here we generated viable embryonic stem cells that lack SNF2H, the ATPase of ISWI complexes, enabling study of SNF2H cellular function, and contrast it to BRG1, the ATPase of SWI/SNF. Loss of SNF2H decreases nucleosomal phasing and increases linker lengths, providing in vivo evidence for an ISWI function in ruling nucleosomal spacing in mammals. Systematic analysis of transcription-factor binding reveals that these remodelling activities have specific effects on binding of different transcription factors. One group critically depends on BRG1 and contains the transcriptional repressor REST, whereas a non-overlapping set of transcription factors, including the insulator protein CTCF, relies on SNF2H. This selectivity readily explains why chromosomal folding and insulation of topologically associated domains requires SNF2H, but not BRG1. Collectively, this study shows that mammalian ISWI is critical for nucleosomal periodicity and nuclear organization and that transcription factors rely on specific remodelling pathways for correct genomic binding.	[Barisic, Darko; Stadler, Michael B.; Iurlaro, Mario; Schuebeler, Dirk] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Barisic, Darko; Schuebeler, Dirk] Univ Basel, Fac Sci, Basel, Switzerland; [Stadler, Michael B.] Swiss Inst Bioinformat, Basel, Switzerland; [Barisic, Darko] Weill Cornell Med, New York, NY USA	Friedrich Miescher Institute for Biomedical Research; University of Basel; Swiss Institute of Bioinformatics; Cornell University	Schubeler, D (corresponding author), Friedrich Miescher Inst Biomed Res, Basel, Switzerland.; Schubeler, D (corresponding author), Univ Basel, Fac Sci, Basel, Switzerland.	dirk@fmi.ch	Iurlaro, Mario/ABB-4283-2020	Iurlaro, Mario/0000-0003-3919-9689	Novartis Research Foundation; European Research Council (ERC) under the European Union's Horizon research and innovation program [667951]; Swiss National Sciences Foundation; EMBO long-term postdoctoral fellowship; Boehringer Ingelheim Fonds PhD fellowship	Novartis Research Foundation; European Research Council (ERC) under the European Union's Horizon research and innovation program(European Research Council (ERC)); Swiss National Sciences Foundation(Swiss National Science Foundation (SNSF)); EMBO long-term postdoctoral fellowship(European Molecular Biology Organization (EMBO)); Boehringer Ingelheim Fonds PhD fellowship(Boehringer Ingelheim)	We thank L. Giorgetti and L. Burger for suggestions and feedback, C. Wirbelauer for technical assistance, S. Smallwood for next-generation sequencing support and members of the Schubeler group for feedback on the project and manuscript. Brg1<SUP>fl/fl</SUP> embryonic stem cells were provided by G. Crabtree. Research in the laboratory of D.S. is supported by the Novartis Research Foundation, the European Research Council (ERC) under the European Union's Horizon research and innovation program (grant agreement no. 667951) and the Swiss National Sciences Foundation. D.B. was funded by a Boehringer Ingelheim Fonds PhD fellowship. M.I. is funded by an EMBO long-term postdoctoral fellowship.	Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Corona DFV, 2004, BBA-GENE STRUCT EXPR, V1677, P113, DOI 10.1016/j.bbaexp.2003.09.018; Crane E, 2015, NATURE, V523, P240, DOI 10.1038/nature14450; Dekker J, 2016, CELL, V164, P1110, DOI 10.1016/j.cell.2016.02.007; Deuring R, 2000, MOL CELL, V5, P355, DOI 10.1016/S1097-2765(00)80430-X; Fry CJ, 2001, CURR BIOL, V11, pR185, DOI 10.1016/S0960-9822(01)00090-2; Fyodorov DV, 2004, GENE DEV, V18, P170, DOI 10.1101/gad.1139604; Gkikopoulos T, 2011, SCIENCE, V333, P1758, DOI 10.1126/science.1206097; Hakimi MA, 2002, NATURE, V418, P994, DOI 10.1038/nature01024; Ho L, 2011, NAT CELL BIOL, V13, P903, DOI 10.1038/ncb2285; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Kadoch C, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500447; Kelly TK, 2012, GENOME RES, V22, P2497, DOI 10.1101/gr.143008.112; King HW, 2017, ELIFE, V6, DOI 10.7554/eLife.22631; Lambert SA, 2018, CELL, V172, P650, DOI 10.1016/j.cell.2018.01.029; Langst G, 2001, J CELL SCI, V114, P2561; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; Merkenschlager M, 2016, ANNU REV GENOM HUM G, V17, P17, DOI 10.1146/annurev-genom-083115-022339; Miller EL, 2017, NAT STRUCT MOL BIOL, V24, P344, DOI 10.1038/nsmb.3384; Mumbach MR, 2016, NAT METHODS, V13, P919, DOI 10.1038/nmeth.3999; Nora EP, 2017, CELL, V169, P930, DOI 10.1016/j.cell.2017.05.004; Ocampo J, 2016, NUCLEIC ACIDS RES, V44, P4625, DOI 10.1093/nar/gkw068; Oppikofer M, 2017, EMBO REP, V18, P1697, DOI 10.15252/embr.201744011; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Stopka T, 2003, P NATL ACAD SCI USA, V100, P14097, DOI 10.1073/pnas.2336105100; Teif VB, 2012, NAT STRUCT MOL BIOL, V19, P1185, DOI 10.1038/nsmb.2419; Valouev A, 2011, NATURE, V474, P516, DOI 10.1038/nature10002; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Wiechens N, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005940; Yamada K, 2011, NATURE, V472, P448, DOI 10.1038/nature09947; Yen KY, 2012, CELL, V149, P1461, DOI 10.1016/j.cell.2012.04.036	35	86	86	3	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 2	2019	569	7754					136	+		10.1038/s41586-019-1115-5	http://dx.doi.org/10.1038/s41586-019-1115-5			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HW2NX	30996347	Green Accepted			2022-12-28	WOS:000466523700048
J	DeMartino, ES; Sperry, BP; Doyle, CK; Chor, J; Kramer, DB; Dudzinski, DM; Mueller, PS				DeMartino, Erin S.; Sperry, Beau P.; Doyle, Cavan K.; Chor, Julie; Kramer, Daniel B.; Dudzinski, David M.; Mueller, Paul S.			US State Regulation of Decisions for Pregnant Women Without Decisional Capacity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[DeMartino, Erin S.] Mayo Clin, Div Pulm & Crit Care Med, 200 First St SW, Rochester, MN 55905 USA; [Sperry, Beau P.] Mayo Clin, Biomed Eth Res Program, Rochester, MN USA; [Doyle, Cavan K.] Loyola Univ Chicago, Stritch Sch Med, Neiswanger Inst Bioeth, Maywood, IL USA; [Chor, Julie] Univ Chicago, Dept Obstet & Gynecol, Chicago, IL 60637 USA; [Kramer, Daniel B.] Beth Israel Deaconess Med Ctr, Richard A & Susan F Smith Ctr Outcomes Res Cardio, Boston, MA 02215 USA; [Dudzinski, David M.] Massachusetts Gen Hosp, Dept Cardiol, Boston, MA 02114 USA; [Mueller, Paul S.] Mayo Clin Hlth Syst, Gen Internal Med, La Crosse, WI USA	Mayo Clinic; Mayo Clinic; Loyola University Chicago; University of Chicago; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital	DeMartino, ES (corresponding author), Mayo Clin, Div Pulm & Crit Care Med, 200 First St SW, Rochester, MN 55905 USA.	demartino.erin@mayo.edu		Sperry, Beau/0000-0002-1776-191X				Beauchamp T, 2013, PRINCIPLES BIOMEDICA; DeMartino ES, 2017, NEW ENGL J MED, V376, P1478, DOI 10.1056/NEJMms1611497; Manninen BA, 2016, KENNEDY INST ETHIC J, V26, P399, DOI 10.1353/ken.2016.0036; Sabatino CP, 2010, MILBANK Q, V88, P211, DOI 10.1111/j.1468-0009.2010.00596.x; Sabatino CP, 2003, PUBLIC POLICY AGING, V13, P1, DOI 10.1093/ppar/13.1.1	5	8	8	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2019	321	16					1628	1631		10.1001/jama.2019.2587	http://dx.doi.org/10.1001/jama.2019.2587			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HV7BZ	31012920	Green Published, Bronze			2022-12-28	WOS:000466137800023
J	Dyer, O				Dyer, Owen			US officials charge 31 doctors over opioid prescribing	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 23	2019	365								l1854	10.1136/bmj.l1854	http://dx.doi.org/10.1136/bmj.l1854			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HW1MM	31015219				2022-12-28	WOS:000466447000004
J	Burki, T				Burki, Talha			Concerns raised about NHS gender identity service	LANCET			English	Editorial Material																			0	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 20	2019	393	10181					E38	E38		10.1016/S0140-6736(19)30894-3	http://dx.doi.org/10.1016/S0140-6736(19)30894-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU0DL	31007205				2022-12-28	WOS:000464941500001
J	Zhou, M; Higaki, T; Hu, GX; Sfeir, MY; Chen, YX; Jiang, DE; Jin, RC				Zhou, Meng; Higaki, Tatsuya; Hu, Guoxiang; Sfeir, Matthew Y.; Chen, Yuxiang; Jiang, De-en; Jin, Rongchao			Three-orders-of-magnitude variation of carrier lifetimes with crystal phase of gold nanoclusters	SCIENCE			English	Article							ULTRAFAST RELAXATION DYNAMICS; EXCITON RELAXATION; LIGAND; CLUSTER; SIZE; NANOPARTICLES; STATE	We report a three-orders-of-magnitude variation of carrier lifetimes in exotic crystalline phases of gold nanoclusters (NCs) in addition to the well-known face-centered cubic structure, including hexagonal close-packed (hcp) Au-30 and body-centered cubic (bcc) Au-38 NCs protected by the same type of capping ligand. The bcc Au-38 NC had an exceptionally long carrier lifetime (4.7 microseconds) comparable to that of bulk silicon, whereas the hcp Au-30 NC had a very short lifetime (1 nanosecond). Although the presence of ligands may, in general, affect carrier lifetimes, experimental and theoretical results showed that the drastically different recombination lifetimes originate in the different overlaps of wave functions between the tetrahedral Au-4 building blocks in the hierarchical structures of these NCs.	[Zhou, Meng; Higaki, Tatsuya; Chen, Yuxiang; Jin, Rongchao] Carnegie Mellon Univ, Dept Chem, 4400 5th Ave, Pittsburgh, PA 15213 USA; [Hu, Guoxiang; Jiang, De-en] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA; [Sfeir, Matthew Y.] Brookhaven Natl Lab, Ctr Funct Nanomat, Upton, NY 11973 USA; [Sfeir, Matthew Y.] CUNY, Photon Initiat, Adv Sci Res Ctr, New York, NY 10031 USA; [Sfeir, Matthew Y.] CUNY, Grad Ctr, Dept Phys, New York, NY 10016 USA	Carnegie Mellon University; University of California System; University of California Riverside; United States Department of Energy (DOE); Brookhaven National Laboratory; City University of New York (CUNY) System; City University of New York (CUNY) System	Jin, RC (corresponding author), Carnegie Mellon Univ, Dept Chem, 4400 5th Ave, Pittsburgh, PA 15213 USA.; Jiang, DE (corresponding author), Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA.	djiang@ucr.edu; rongchao@andrew.cmu.edu	Zhou, Meng/AAK-2930-2020; Sfeir, Matthew/AAE-7390-2019; Jiang, De-en/D-9529-2011; Higaki, Tatsuya/H-3090-2016; Hu, Guoxiang/N-6137-2018	Zhou, Meng/0000-0001-5187-9084; Sfeir, Matthew/0000-0001-5619-5722; Jiang, De-en/0000-0001-5167-0731; Higaki, Tatsuya/0000-0002-6759-9009; Hu, Guoxiang/0000-0003-2942-8564	National Science Foundation [DMR-1808675]; Air Force Office of Scientific Research; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, Chemical Sciences, Geosciences, and Biosciences Division; U.S. DOE Office of Science Facility at Brookhaven National Laboratory [DR-SC0012704]	National Science Foundation(National Science Foundation (NSF)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, Chemical Sciences, Geosciences, and Biosciences Division(United States Department of Energy (DOE)); U.S. DOE Office of Science Facility at Brookhaven National Laboratory(United States Department of Energy (DOE))	R.J. acknowledges financial support from the National Science Foundation (DMR-1808675) and the Air Force Office of Scientific Research. D.J. was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, Chemical Sciences, Geosciences, and Biosciences Division. This work used resources of the Center of Functional Nanomaterials, which is a U.S. DOE Office of Science Facility at Brookhaven National Laboratory under contract no. DR-SC0012704.	Abbas MA, 2016, J AM CHEM SOC, V138, P390, DOI 10.1021/jacs.5b11174; AHLRICHS R, 1989, CHEM PHYS LETT, V162, P165, DOI 10.1016/0009-2614(89)85118-8; ANDRAE D, 1990, THEOR CHIM ACTA, V77, P123, DOI 10.1007/BF01114537; Chen YX, 2016, J AM CHEM SOC, V138, P1482, DOI 10.1021/jacs.5b12094; Das A, 2013, J AM CHEM SOC, V135, P18264, DOI 10.1021/ja409177s; Du BJ, 2017, NAT NANOTECHNOL, V12, P1096, DOI [10.1038/nnano.2017.170, 10.1038/NNANO.2017.170]; Guido CA, 2013, J CHEM THEORY COMPUT, V9, P3118, DOI 10.1021/ct400337e; Hartland GV, 2011, CHEM REV, V111, P3858, DOI 10.1021/cr1002547; Higaki T, 2017, J AM CHEM SOC, V139, P9994, DOI 10.1021/jacs.7b04678; Higaki T, 2016, ANGEW CHEM INT EDIT, V55, P6694, DOI 10.1002/anie.201601947; Jin RC, 2016, CHEM REV, V116, P10346, DOI 10.1021/acs.chemrev.5b00703; Jones TC, 2018, J PHYS CHEM C, V122, P17726, DOI 10.1021/acs.jpcc.8b01106; Klimov VI, 2000, SCIENCE, V287, P1011, DOI 10.1126/science.287.5455.1011; Kwak K, 2017, J PHYS CHEM LETT, V8, P4898, DOI 10.1021/acs.jpclett.7b01892; Liu C, 2015, ANGEW CHEM INT EDIT, V54, P9826, DOI 10.1002/anie.201502667; Lu T, 2012, J COMPUT CHEM, V33, P580, DOI 10.1002/jcc.22885; Mirkovic T, 2017, CHEM REV, V117, P249, DOI 10.1021/acs.chemrev.6b00002; Mustalahti S, 2015, ACS NANO, V9, P2328, DOI 10.1021/nn506711a; Negishi Y, 2010, CHEM COMMUN, V46, P4713, DOI 10.1039/c0cc01021a; Pei Y, 2013, J AM CHEM SOC, V135, P19060, DOI 10.1021/ja409788k; Peterson MD, 2014, ANNU REV PHYS CHEM, V65, P317, DOI 10.1146/annurev-physchem-040513-103649; Pietryga JM, 2016, CHEM REV, V116, P10513, DOI 10.1021/acs.chemrev.6b00169; Pyo K, 2015, J AM CHEM SOC, V137, P8244, DOI 10.1021/jacs.5b04210; Qian HF, 2010, J PHYS CHEM C, V114, P19935, DOI 10.1021/jp107915x; Scholes GD, 2011, NAT CHEM, V3, P763, DOI [10.1038/NCHEM.1145, 10.1038/nchem.1145]; Sfeir MY, 2011, J PHYS CHEM C, V115, P6200, DOI 10.1021/jp110703e; Stamplecoskie KG, 2014, J AM CHEM SOC, V136, P11093, DOI 10.1021/ja505361n; Tang Q, 2015, NANOSCALE, V7, P2225, DOI 10.1039/c4nr05826g; Tao JM, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.146401; Varnavski O, 2010, ACS NANO, V4, P3406, DOI 10.1021/nn1003524; Voisin C, 2000, PHYS REV LETT, V85, P2200, DOI 10.1103/PhysRevLett.85.2200; Wan XK, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701823; Yang J, 2012, ACS NANO, V6, P8120, DOI 10.1021/nn302739e; Yi CY, 2017, J PHYS CHEM C, V121, P24894, DOI 10.1021/acs.jpcc.7b09347; Zeng CJ, 2016, SCIENCE, V354, P1580, DOI 10.1126/science.aak9750; Zeng CJ, 2016, J AM CHEM SOC, V138, P3950, DOI 10.1021/jacs.5b12747; Zeng CJ, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500425; Zhou M, 2018, J PHYS CHEM C, V122, P13435, DOI 10.1021/acs.jpcc.7b11057; Zhou M, 2017, ANGEW CHEM INT EDIT, V56, P16257, DOI 10.1002/anie.201709095; Zhou M, 2017, J PHYS CHEM LETT, V8, P4023, DOI 10.1021/acs.jpclett.7b01597; Zhou M, 2017, P NATL ACAD SCI USA, V114, pE4697, DOI 10.1073/pnas.1704699114; Zhou M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13240; Zhu M, 2008, J AM CHEM SOC, V130, P5883, DOI 10.1021/ja801173r	43	130	130	23	259	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2019	364	6437					279	+		10.1126/science.aaw8007	http://dx.doi.org/10.1126/science.aaw8007			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HU0JG	31000661				2022-12-28	WOS:000464956600049
J	Mayor, S				Mayor, Susan			Guided self led or group therapy as effective as individual CBT for acute depression, finds review	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Cuijpers P, 2019, JAMA PSYCHIAT, V76, P700, DOI 10.1001/jamapsychiatry.2019.0268; Swartz HA, 2019, JAMA PSYCHIAT, V76, P678, DOI 10.1001/jamapsychiatry.2019.0243	2	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2019	365								l1833	10.1136/bmj.l1833	http://dx.doi.org/10.1136/bmj.l1833			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU8OY	30995977				2022-12-28	WOS:000465550000011
J	Oliver, D				Oliver, David			David Oliver: Are we seeing value based rationing clearly?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Anand JK, 2017, BMJ; Campbell D., 2019, GUARDIAN; Edwards N, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l1343; Harwood RH, 2005, BRIT J OPHTHALMOL, V89, P53, DOI 10.1136/bjo.2004.049478; MacLeod A., 2019, NHS HOSP CONTINUE RE; NHS England, 2019 20 NAT TAR PAYM; NHS Inform, 2018, REAL MED; NICE, 2017, NICE GUID NG77; Peninsula NHS Treatment Centre, NICE GUID CAT BAS IT; Prudent Healthcare, 2016, SEC HLTH WELL BEING; Royal College of Ophthalmologists, 2017, 66 CLIN LEADS SURV R; Royal College of Ophthalmologists, 2017, GETT IT RIGHT 1 TIM; Royal College of Ophthalmologists, 2017, WAY FORW CAT; Smyth C., 2019, TIMES	14	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2019	365								l1734	10.1136/bmj.l1734	http://dx.doi.org/10.1136/bmj.l1734			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU8OY	30996025	Bronze			2022-12-28	WOS:000465550000007
J	Curry, SJ; Krist, AH; Owens, DK; Barry, MJ; Cabana, M; Caughey, AB; Doubeni, CA; Epling, JW; Kemper, AR; Kubik, M; Landefeld, CS; Mangione, CM; Pbert, L; Silverstein, M; Simon, MA; Tseng, CW; Wong, JB				Curry, Susan J.; Krist, Alex H.; Owens, Douglas K.; Barry, Michael J.; Cabana, Michael; Caughey, Aaron B.; Doubeni, Chyke A.; Epling, John W.; Kemper, Alex R.; Kubik, Martha; Landefeld, C. Seth; Mangione, Carol M.; Pbert, Lori; Silverstein, Michael; Simon, Melissa A.; Tseng, Chien-Wen; Wong, John B.		US Preventive Serv Task Force	Screening for Elevated Blood Lead Levels in Children and Pregnant Women US Preventive Services Task Force Recommendation Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CALCIUM SUPPLEMENTATION; CHELATION; THERAPY; TRIAL	IMPORTANCE Elevated blood lead levels in children are associated with neurologic effects such as behavioral and learning problems, lower IQ, hyperactivity, hearing problems, and impaired growth. In pregnant women, lead exposure can impair organ systems such as the hematopoietic, hepatic, renal, and nervous systems, and increase the risk of preeclampsia and adverse perinatal outcomes. Many of the adverse health effects of lead exposure are irreversible. OBJECTIVE To update the 2006 US Preventive Services Task Force (USPSTF) recommendation on screening for elevated blood lead levels in children and pregnant women. EVIDENCE REVIEW The USPSTF reviewed the evidence on the benefits and harms of screening for and treatment of elevated blood lead levels. In this update, an elevated blood lead level was defined according to the Centers for Disease Control and Prevention reference level of 5 mu g/dL. FINDINGS The USPSTF found adequate evidence that questionnaires and other clinical prediction tools to identify asymptomatic children with elevated blood lead levels are inaccurate. The USPSTF found adequate evidence that capillary blood testing accurately identifies children with elevated blood lead levels. The USPSTF found inadequate evidence on the effectiveness of treatment of elevated blood lead levels in asymptomatic children 5 years and younger and in pregnant women. The USPSTF found inadequate evidence regarding the accuracy of questionnaires and other clinical prediction tools to identify asymptomatic pregnant women with elevated blood lead levels. The USPSTF found inadequate evidence on the harms of screening for or treatment of elevated blood lead levels in asymptomatic children and pregnant women. The USPSTF concluded that the current evidence is insufficient, and that the balance of benefits and harms of screening for elevated blood lead levels in asymptomatic children 5 years and younger and in pregnant women cannot be determined. CONCLUSIONS AND RECOMMENDATION The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for elevated blood lead levels in asymptomatic children. (I statement) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for elevated blood lead levels in asymptomatic pregnant persons. (I statement)	[Curry, Susan J.] Univ Iowa, Iowa City, IA 52242 USA; [Krist, Alex H.] Fairfax Family Practice Residency, Fairfax, VA USA; [Krist, Alex H.] Virginia Commonwealth Univ, Richmond, VA USA; [Owens, Douglas K.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Owens, Douglas K.] Stanford Univ, Stanford, CA 94305 USA; [Barry, Michael J.] Harvard Med Sch, Boston, MA 02115 USA; [Cabana, Michael] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Caughey, Aaron B.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Doubeni, Chyke A.] Univ Penn, Philadelphia, PA 19104 USA; [Epling, John W.] Virginia Tech, Caril Sch Med, Roanoke, VA USA; [Kemper, Alex R.] Nationwide Childrens Hosp, Columbus, OH USA; [Kubik, Martha] Temple Univ, Philadelphia, PA 19122 USA; [Landefeld, C. Seth] Univ Alabama Birmingham, Birmingham, AL USA; [Mangione, Carol M.] Univ Calif Los Angeles, Los Angeles, CA USA; [Pbert, Lori] Univ Massachusetts, Med Sch, Worcester, MA 01605 USA; [Silverstein, Michael] Boston Univ, Boston, MA 02215 USA; [Simon, Melissa A.] Northwestern Univ, Evanston, IL USA; [Tseng, Chien-Wen] Univ Hawaii, Honolulu, HI 96822 USA; [Tseng, Chien-Wen] Pacif Hlth Res & Educ Inst, Honolulu, HI USA; [Wong, John B.] Tufts Univ, Medford, MA 02155 USA	University of Iowa; Virginia Commonwealth University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Harvard University; Harvard Medical School; University of California System; University of California San Francisco; Oregon Health & Science University; University of Pennsylvania; Virginia Polytechnic Institute & State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Los Angeles; University of Massachusetts System; University of Massachusetts Worcester; Boston University; Northwestern University; University of Hawaii System; Tufts University	Curry, SJ (corresponding author), Univ Iowa, Iowa City, IA 52242 USA.	chair@uspstf.net	Epling, John W/J-1097-2019	Epling, John W/0000-0001-9445-8669; Wong, John/0000-0003-4203-9010; Kemper, Alex/0000-0001-5491-3997				Advisory Committee on Childhood Lead Poisoning Prevention of the Centers for Disease Control and Prevention, 2012, LOW LEV LEAD EXP HAR; American Academy of Family Physicians (AAFP), 2006, CLIN PREV SERV REC L; Boreland F, 2009, SCI TOTAL ENVIRON, V408, P202, DOI 10.1016/j.scitotenv.2009.10.013; Bornschein RL, 2000, PEDIATR RES, V48, P593; Brown MJ, 2006, PEDIATRICS, V117, P147, DOI 10.1542/peds.2004-2880; Cantor A, 2019, AHRQ PUBLICATION, V18-05245-EF-1; Cantor AG, 2019, JAMA-J AM MED ASSOC, V321, P1510, DOI 10.1001/jama.2019.1004; *CDCP, 1997, SCREEN YOUNG CHILDR; Centers for Disease Control and Prevention, 2016, STAND SURV DEF CLASS; Centers for Disease Control and Prevention, 2010, GUIDELINES IDENTIFIC; Committee on Obstetric Practice, 2012, Obstet Gynecol, V120, P416, DOI 10.1097/AOG.0b013e31826804e8; Ettinger AS, 2009, ENVIRON HEALTH PERSP, V117, P26, DOI [10.1289/ehp.11868, 10.1289/ehp.1171c26]; Flora Gagan, 2012, Interdiscip Toxicol, V5, P47, DOI 10.2478/v10102-012-0009-2; Hagen JF., 2017, BRIGHT FUTURES GUIDE; Lane WG, 2001, AM J PREV MED, V20, P78, DOI 10.1016/S0749-3797(00)00257-9; Lanphear BP, 1996, AM J PUBLIC HEALTH, V86, P1460, DOI 10.2105/AJPH.86.10.1460; Lowry JA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-1493; Markowitz ME, 2004, PEDIATRICS, V113, pE34, DOI 10.1542/peds.113.1.e34; Nicholson JS, 2018, CHILD HEALTH CARE, V47, P379, DOI 10.1080/02739615.2017.1370673; O'Connor ME, 1999, CLIN PEDIATR, V38, P325, DOI 10.1177/000992289903800602; Rogan WJ, 2001, NEW ENGL J MED, V344, P1421, DOI 10.1056/NEJM200105103441902; SHANNON M, 1988, J PEDIATR-US, V112, P799, DOI 10.1016/S0022-3476(88)83212-8; Tchounwou P.B., 2012, EXPERIENTIA SUPPL, V101, P133, DOI [10.1007/978-3-7643-8340-4_6, DOI 10.1007/978-3-7643-8340-4_6, 10.1007/978-3-7643-8340-4]; US Preventive Services Task Force, 2006, SCREEN EL BLOOD LEAD; Wolf AW, 2003, J PEDIATR-US, V143, P789, DOI 10.1067/S0022-3476(03)00540-7	25	20	20	3	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 16	2019	321	15					1502	1509		10.1001/jama.2019.3326	http://dx.doi.org/10.1001/jama.2019.3326			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HT7SY	30990556	Bronze			2022-12-28	WOS:000464765900017
J	Sancar, F				Sancar, Feyza			Agreement to Regulate Cell-Based Meat Products	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	2	2	1	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 16	2019	321	15					1449	1449		10.1001/jama.2019.3831	http://dx.doi.org/10.1001/jama.2019.3831			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HT7SY	30990538				2022-12-28	WOS:000464765900032
J	Wise, J				Wise, Jacqui			BMJ Awards 2019: Clinical Leadership Team of the Year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 15	2019	365								l1659	10.1136/bmj.l1659	http://dx.doi.org/10.1136/bmj.l1659			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU8OI	30987965				2022-12-28	WOS:000465548300001
J	Hollmann, MW; Rathmell, JP; Lirk, P				Hollmann, Markus W.; Rathmell, James P.; Lirk, Philipp			Optimal postoperative pain management: redefining the role for opioids	LANCET			English	Editorial Material							ANESTHESIA; SURGERY		[Hollmann, Markus W.] Univ Med Ctr Amsterdam, Dept Anaesthesiol, NL-1105 AZ Amsterdam, Netherlands; [Rathmell, James P.; Lirk, Philipp] Harvard Med Sch, Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA USA	University of Amsterdam; Academic Medical Center Amsterdam; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Hollmann, MW (corresponding author), Univ Med Ctr Amsterdam, Dept Anaesthesiol, NL-1105 AZ Amsterdam, Netherlands.	m.w.hollmann@amc.uva.nl	Rathmell, James/GQZ-1503-2022	Hollmann, Markus/0000-0001-8248-0244				Abdallah FW, 2015, ANESTH ANALG, V120, P1114, DOI 10.1213/ANE.0000000000000688; Bonnie RJ, 2017, JAMA-J AM MED ASSOC, V318, P423, DOI 10.1001/jama.2017.10046; Brandal D, 2017, ANESTH ANALG, V125, P1784, DOI 10.1213/ANE.0000000000002510; Chaparro LE, PHARMACOTHERAPY PREV; Clarke H, 2018, CAN J PAIN, V2, P236, DOI 10.1080/24740527.2018.1501669; Colvin LA, 2019, LANCET, V393, P1558, DOI 10.1016/S0140-6736(19)30430-1; Gerbershagen HJ, 2013, ANESTHESIOLOGY, V118, P934, DOI 10.1097/ALN.0b013e31828866b3; Glare P, 2019, LANCET, V393, P1537, DOI 10.1016/S0140-6736(19)30352-6; Joshi GP, 2014, BEST PRACT RES-CLIN, V28, P191, DOI 10.1016/j.bpa.2014.03.005; Katz J, 2015, J PAIN RES, V8, P695, DOI 10.2147/JPR.S91924; Kumar K, 2017, ANESTH ANALG, V125, P1749, DOI 10.1213/ANE.0000000000002497; Ladha KS, 2016, ANESTHESIOLOGY, V124, P837, DOI 10.1097/ALN.0000000000001034; Levene JL, 2019, J CLIN ANESTH, V55, P116, DOI 10.1016/j.jclinane.2018.12.043; Lirk P, 2019, EUR J ANAESTH, V36, P250, DOI 10.1097/EJA.0000000000000965; Neuman MD, 2019, LANCET, V393, P1547, DOI 10.1016/S0140-6736(19)30428-3; Schreiber KL, 2013, PAIN, V154, P660, DOI 10.1016/j.pain.2012.11.015; Schuchat A, 2017, JAMA-J AM MED ASSOC, V318, P425, DOI 10.1001/jama.2017.8913; Shafer A, 1996, ANESTH ANALG, V83, P1285, DOI 10.1097/00000539-199612000-00027	18	29	30	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 13	2019	393	10180					1483	1485		10.1016/S0140-6736(19)30854-2	http://dx.doi.org/10.1016/S0140-6736(19)30854-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU0DA	30983573				2022-12-28	WOS:000464940400007
J	Lucas, A				Lucas, Andrew			An exotic quantum fluid in graphene	SCIENCE			English	Editorial Material							RESISTANCE		[Lucas, Andrew] Stanford Univ, Dept Phys, Stanford, CA 94305 USA	Stanford University	Lucas, A (corresponding author), Stanford Univ, Dept Phys, Stanford, CA 94305 USA.	ajlucas@stanford.edu			Gordon and Betty Moore Foundation [GBMF4302]	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	I am supported by the Gordon and Betty Moore Foundation through grant GBMF4302.	Avron JE, 1998, J STAT PHYS, V92, P543, DOI 10.1023/A:1023084404080; Bandurin DA, 2016, SCIENCE, V351, P1055, DOI 10.1126/science.aad0201; Berdyugin AI, 2019, SCIENCE, V364, P163, DOI 10.1126/science.aau0685; Bruin JAN, 2013, SCIENCE, V339, P804, DOI 10.1126/science.1227612; Crossno J, 2016, SCIENCE, V351, P1058, DOI 10.1126/science.aad0343; DEJONG MJM, 1995, PHYS REV B, V51, P13389, DOI 10.1103/PhysRevB.51.13389; DYAKONOV M, 1993, PHYS REV LETT, V71, P2465, DOI 10.1103/PhysRevLett.71.2465; Gallagher P, 2019, SCIENCE, V364, P158, DOI 10.1126/science.aat8687; GURZHI RN, 1963, SOV PHYS JETP-USSR, V17, P521; Hartnoll SA, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.144502; Kumar RK, 2017, NAT PHYS, V13, P1182, DOI 10.1038/NPHYS4240; Pellegrino FMD, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.155414	12	3	3	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2019	364	6436					125	125		10.1126/science.aaw9869	http://dx.doi.org/10.1126/science.aaw9869			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HT5RC	30975874				2022-12-28	WOS:000464620000020
J	Allen, MA				Allen, Mary A.			Train students to navigate ethical swamps	NATURE			English	Editorial Material									[Allen, Mary A.] Univ Colorado, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Allen, MA (corresponding author), Univ Colorado, Boulder, CO 80309 USA.	mary.a.allen@colorado.edu	Allen, Mary/AAQ-2364-2021	Allen, Mary/0000-0001-7490-0165					0	0	0	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2019	568	7751					145	145		10.1038/d41586-019-01046-4	http://dx.doi.org/10.1038/d41586-019-01046-4			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HT2SH	30971841	Bronze			2022-12-28	WOS:000464412700058
J	Mayor, S				Mayor, Susan			Being a junior clinical director: five minutes with . . . Lauren Carter	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 8	2019	365								l1647	10.1136/bmj.l1647	http://dx.doi.org/10.1136/bmj.l1647			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU0EE	30962258				2022-12-28	WOS:000464943400010
J	Rubin, R				Rubin, Rita			Screening Preteens in the Emergency Department for Suicide Risk	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item													Rubin, Rita/AAD-1259-2020						0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2019	321	16					1557	1557		10.1001/jama.2019.4588	http://dx.doi.org/10.1001/jama.2019.4588			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HV7BZ	31012916				2022-12-28	WOS:000466137800036
J	Gerhart, J; Pederson, T				Gerhart, John; Pederson, Thoru			Arthur B. Pardee (1921-2019)	SCIENCE			English	Biographical-Item									[Gerhart, John] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Pederson, Thoru] Univ Massachusetts, Med Sch, Worcester, MA USA	University of California System; University of California Berkeley; University of Massachusetts System; University of Massachusetts Worcester	Gerhart, J (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.	jgerhart@berkeley.edu; thoru.pederson@umassmed.edu						PARDEE AB, PUBLICATION LIST	1	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2019	364	6437					238	238		10.1126/science.aax4995	http://dx.doi.org/10.1126/science.aax4995			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HU0JG	31000653				2022-12-28	WOS:000464956600029
J	Kurien, M; Sanders, DS; Ashton, JJ; Beattie, RM				Kurien, Matthew; Sanders, David S.; Ashton, James J.; Beattie, R. Mark			Should I publish in an open access journal?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kurien, Matthew; Sanders, David S.] Univ Sheffield, Med Sch, Acad Unit Gastroenterol, Dept Infect, Sheffield, S Yorkshire, England; [Kurien, Matthew; Sanders, David S.] Univ Sheffield, Med Sch, Acad Unit Gastroenterol, Dept Immun & Cardiovasc Sci, Sheffield, S Yorkshire, England; [Kurien, Matthew; Sanders, David S.] Royal Hallamshire Hosp, Dept Gastroenterol, Sheffield, S Yorkshire, England; [Ashton, James J.; Beattie, R. Mark] Southampton Childrens Hosp, Dept Paediat Gastroenterol, Southampton, Hants, England; [Ashton, James J.] Univ Southampton, Dept Human Genet & Genom Med, Southampton, Hants, England	University of Sheffield; University of Sheffield; University of Sheffield; University of Southampton	Kurien, M (corresponding author), Univ Sheffield, Med Sch, Acad Unit Gastroenterol, Dept Infect, Sheffield, S Yorkshire, England.; Kurien, M (corresponding author), Univ Sheffield, Med Sch, Acad Unit Gastroenterol, Dept Immun & Cardiovasc Sci, Sheffield, S Yorkshire, England.; Kurien, M (corresponding author), Royal Hallamshire Hosp, Dept Gastroenterol, Sheffield, S Yorkshire, England.; Beattie, RM (corresponding author), Southampton Childrens Hosp, Dept Paediat Gastroenterol, Southampton, Hants, England.	m.kurien@sheffield.ac.uk; mark.beattie@uhs.nhs.uk		Ashton, James/0000-0003-0348-8198				Angell M, 2008, JAMA-J AM MED ASSOC, V300, P1069, DOI 10.1001/jama.300.9.1069; Bohannon J, 2013, SCIENCE, V342, P60, DOI 10.1126/science.342.6154.60; Carpenter CR, 2014, ACAD EMERG MED, V21, P1160, DOI 10.1111/acem.12482; Else H, 2018, NATURE, DOI 10.1038/d41586-018-06945-6; Eysenbach G, 2006, PLOS BIOL, V4, P692, DOI 10.1371/journal.pbio.0040157; Jakobsen AK, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2243; Laakso M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020961; Logan Corina J, 2017, F1000Res, V6, P518, DOI 10.12688/f1000research.11415.2; McCartney M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i355; Parker M, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-16; Rej A, 2019, FRONTLINE GASTROENTE, P1; Schiltz M, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002663; Smith E, 2017, HEALTH RES POLICY SY, V15, DOI 10.1186/s12961-017-0235-3; Tennant Jonathan P, 2016, F1000Res, V5, P632; Van Noorden R, 2013, NATURE, V495, P426, DOI 10.1038/495426a; Warren M, 2019, NATURE, DOI [10.1038/d41586-019-00610-2, DOI 10.1038/D41586-019-00610-2]; 2015, SCIENTOMETRICS, V103, P555, DOI DOI 10.1007/S11192-015-1547-0	17	6	6	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 18	2019	365								l1544	10.1136/bmj.l1544	http://dx.doi.org/10.1136/bmj.l1544			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU8PD	31000528				2022-12-28	WOS:000465550700002
J	Htay, T; Aung, K				Htay, Thwe; Aung, Koko			Review: Some ED triage systems better predict ED mortality than in-hospital mortality or hospitalization	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Htay, Thwe; Aung, Koko] Paul L Foster Sch Med, El Paso, TX 79905 USA		Htay, T (corresponding author), Paul L Foster Sch Med, El Paso, TX 79905 USA.		Aung, KoKo/I-1236-2019	Aung, KoKo/0000-0002-3152-0610				Bullard MJ, 2017, CAN J EMERG MED, V19, pS28, DOI 10.1017/cem.2017.363; Nakao H, 2017, ACUTE MED SURG, V4, P379, DOI 10.1002/ams2.293	2	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2019	170	8					JC47	JC47		10.7326/ACPJ201904160-047	http://dx.doi.org/10.7326/ACPJ201904160-047			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU7YQ	30986837				2022-12-28	WOS:000465499900013
J	Uchino, K				Uchino, Ken			Guideline: Starting dual antiplatelet therapy <= 24 h after high-risk TIA or minor ischemic stroke is recommended	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Uchino, Ken] Cleveland Clin, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Uchino, K (corresponding author), Cleveland Clin, Cleveland, OH 44106 USA.		Uchino, Ken/ABC-1611-2021	Uchino, Ken/0000-0001-9468-4172				Liu LP, 2015, NEUROLOGY, V85, P1154, DOI 10.1212/WNL.0000000000001972; Lovett JK, 2004, NEUROLOGY, V62, P569, DOI 10.1212/01.WNL.0000110311.09970.83; Pan YS, 2017, NEUROLOGY, V88, P1906, DOI 10.1212/WNL.0000000000003941	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2019	170	8					JC38	JC38		10.7326/ACPJ201904160-038	http://dx.doi.org/10.7326/ACPJ201904160-038			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU7YQ	30986828				2022-12-28	WOS:000465499900004
J	Andersen, TI; Dwyer, BL; Sanchez-Yamagishi, JD; Rodriguez-Nieva, JF; Agarwal, K; Watanabe, K; Taniguchi, T; Demler, EA; Kim, P; Park, H; Lukin, MD				Andersen, Trond I.; Dwyer, Bo L.; Sanchez-Yamagishi, Javier D.; Rodriguez-Nieva, Joaquin F.; Agarwal, Kartiek; Watanabe, Kenji; Taniguchi, Takashi; Demler, Eugene A.; Kim, Philip; Park, Hongkun; Lukin, Mikhail D.			Electron-phonon instability in graphene revealed by global and local noise probes	SCIENCE			English	Article							AMPLIFICATION; SPIN; SATURATION; TRANSISTOR; GENERATION	Understanding and controlling nonequilibrium electronic phenomena is an outstanding challenge in science and engineering. By electrically driving ultraclean graphene devices out of equilibrium, we observe an instability that is manifested as substantially enhanced current fluctuations and suppressed conductivity at microwave frequencies. Spatial mapping of the nonequilibrium current fluctuations using nanoscale magnetic field sensors reveals that the fluctuations grow exponentially along the direction of carrier flow. Our observations, including the dependence on density and temperature, are consistently explained by the emergence of an electron-phonon Cerenkov instability at supersonic drift velocities. These results offer the opportunity for tunable terahertz generation and active phononic devices based on two-dimensional materials.	[Andersen, Trond I.; Dwyer, Bo L.; Rodriguez-Nieva, Joaquin F.; Demler, Eugene A.; Kim, Philip; Park, Hongkun; Lukin, Mikhail D.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Sanchez-Yamagishi, Javier D.] Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA; [Agarwal, Kartiek] McGill Univ, Dept Phys, Montreal, PQ H3A 2T8, Canada; [Watanabe, Kenji; Taniguchi, Takashi] Natl Inst Mat Sci, Namiki 1-1, Tsukuba, Ibaraki 3050044, Japan; [Kim, Philip] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Park, Hongkun] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University; University of California System; University of California Irvine; McGill University; National Institute for Materials Science; Harvard University; Harvard University	Lukin, MD (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	lukin@physics.harvard.edu	Demler, Eugene/ABG-1933-2021; Park, Hongkun/R-9842-2019; Kim, Philip/N-1886-2013; Watanabe, Kenji/H-2825-2011	Demler, Eugene/0000-0002-2499-632X; Park, Hongkun/0000-0001-9576-8829; Kim, Philip/0000-0002-8255-0086; Watanabe, Kenji/0000-0003-3701-8119; Sanchez-Yamagishi, Javier/0000-0001-9703-6525; Rodriguez Nieva, Joaquin/0000-0002-3023-396X	Center for Ultracold Atoms; National Science Foundation (NSF); Department of Defense Vannevar Bush Faculty Fellowship; Gordon and Betty Moore Foundation; National Science Foundation [1541959]; UK Foundation; Elemental Strategy Initiative; CREST, JST [JPMJCR15F3]; ARO [W911NF-17-1-0574]	Center for Ultracold Atoms; National Science Foundation (NSF)(National Science Foundation (NSF)); Department of Defense Vannevar Bush Faculty Fellowship(United States Department of Defense); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Science Foundation(National Science Foundation (NSF)); UK Foundation; Elemental Strategy Initiative; CREST, JST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); ARO	T.I.A., B.L.D., J.D.S.-Y., and M.D.L. acknowledge financial support from the Center for Ultracold Atoms, the National Science Foundation (NSF), the Department of Defense Vannevar Bush Faculty Fellowship, and the Gordon and Betty Moore Foundation. All fabrication was performed at the Center for Nanoscale Systems (CNS), a member of the National Nanotechnology Coordinated Infrastructure Network (NNCI), which is supported by the National Science Foundation under NSF award 1541959. CNS is part of Harvard University. K.A. acknowledges support from the UK Foundation. K.W. and T.T. acknowledge support from the Elemental Strategy Initiative conducted by the MEXT, Japan and the CREST (JPMJCR15F3), JST. P.K. acknowledges support from ARO (W911NF-17-1-0574).	Agarwal K, 2017, PHYS REV B, V95, DOI 10.1103/PhysRevB.95.155107; Aslam N, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/1/013064; Awan SA, 2016, 2D MATER, V3, DOI 10.1088/2053-1583/3/1/015010; Balandin AA, 2013, NAT NANOTECHNOL, V8, P549, DOI [10.1038/NNANO.2013.144, 10.1038/nnano.2013.144]; Balandin AA, 2011, NAT MATER, V10, P569, DOI [10.1038/nmat3064, 10.1038/NMAT3064]; Betz AC, 2013, NAT PHYS, V9, P109, DOI 10.1038/nphys2494; Brunel D, 2015, J PHYS-CONDENS MAT, V27, DOI 10.1088/0953-8984/27/16/164208; Casola F, 2018, NAT REV MATER, V3, DOI 10.1038/natrevmats.2017.88; Crossno J, 2016, SCIENCE, V351, P1058, DOI 10.1126/science.aad0343; DaSilva AM, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.236601; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; DYAKONOV M, 1993, PHYS REV LETT, V71, P2465, DOI 10.1103/PhysRevLett.71.2465; EIZENBERG M, 1978, J APPL PHYS, V49, P5260, DOI 10.1063/1.324425; Freitag M, 2010, NAT NANOTECHNOL, V5, P497, DOI [10.1038/NNANO.2010.90, 10.1038/nnano.2010.90]; Fu KMC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.256404; Gabbana A., 2018, ARXIV180707117CONDMA; Grosse KL, 2011, NAT NANOTECHNOL, V6, P287, DOI [10.1038/NNANO.2011.39, 10.1038/nnano.2011.39]; Harrison J, 2006, DIAM RELAT MATER, V15, P586, DOI 10.1016/j.diamond.2005.12.027; Hartnagel H., 2001, MICROWAVE NOISE SEMI; Henkel C, 2003, APPL PHYS B-LASERS O, V76, P173, DOI 10.1007/s00340-003-1112-z; Horng J, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.165113; HUTSON AR, 1961, PHYS REV LETT, V7, P237, DOI 10.1103/PhysRevLett.7.237; Hwang EH, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.115449; Kaasbjerg K, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.165440; Kaminer I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11880; Kim RH, 2011, NANO LETT, V11, P3881, DOI 10.1021/nl202000u; Kim YD, 2018, NANO LETT, V18, P934, DOI 10.1021/acs.nanolett.7b04324; KLEMENS PG, 1994, CARBON, V32, P735, DOI 10.1016/0008-6223(94)90096-5; Kolkowitz S, 2015, SCIENCE, V347, P1129, DOI 10.1126/science.aaa4298; Komirenko SM, 2000, PHYS REV B, V62, P7459, DOI 10.1103/PhysRevB.62.7459; Kumar RK, 2017, NAT PHYS, V13, P1182, DOI 10.1038/NPHYS4240; Lin YM, 2010, SCIENCE, V327, P662, DOI 10.1126/science.1184289; Lundeberg MB, 2017, SCIENCE, V357, P187, DOI 10.1126/science.aan2735; Mariani E, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.195403; Maze JR, 2008, NATURE, V455, P644, DOI 10.1038/nature07279; Mendoza M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.156601; Meric I, 2008, NAT NANOTECHNOL, V3, P654, DOI 10.1038/nnano.2008.268; Mikhailov SA, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.115405; Nika DL, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.155413; Norambuena A, 2018, PHYS REV B, V97, DOI 10.1103/PhysRevB.97.094304; Novoselov KS, 2016, SCIENCE, V353, DOI 10.1126/science.aac9439; Perebeinos V, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.195442; PIPPARD AB, 1963, PHILOS MAG, V8, P161, DOI 10.1080/14786436308212497; POMERANTZ M, 1964, PHYS REV LETT, V13, P308, DOI 10.1103/PhysRevLett.13.308; Purdie D., 2018, ARXIV180300912CONDMA; Saito R, 2018, PHYS REV APPL, V9, DOI 10.1103/PhysRevApplied.9.024017; Sangtawesin S., 2018, ARXIV181100144CONDMA; Shields BJ, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.136402; Shinokita K, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.075504; Song JCW, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.106602; SPECTOR HN, 1962, PHYS REV, V127, P1084, DOI 10.1103/PhysRev.127.1084; Stauber T, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.205423; Tetienne JP, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602429; Tomadin A, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.205426; Wang L, 2013, SCIENCE, V342, P614, DOI 10.1126/science.1244358; Yamoah MK, 2017, ACS NANO, V11, P9914, DOI 10.1021/acsnano.7b03878; Yang W, 2018, NAT NANOTECHNOL, V13, P47, DOI 10.1038/s41565-017-0007-9; Zhao CX, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4808392	59	32	33	6	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2019	364	6436					154	+		10.1126/science.aaw2104	http://dx.doi.org/10.1126/science.aaw2104			45	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HT5RC	30975884				2022-12-28	WOS:000464620000036
J	Kutschera, A; Dawid, C; Gisch, N; Schmid, C; Raasch, L; Gerster, T; Schaffer, M; Smakowska-Luzan, E; Belkhadir, Y; Vlot, AC; Chandler, CE; Schellenberger, R; Schwudke, D; Ernst, RK; Dorey, S; Huckelhoven, R; Hofmann, T; Ranf, S				Kutschera, Alexander; Dawid, Corinna; Gisch, Nicolas; Schmid, Christian; Raasch, Lars; Gerster, Tim; Schaeffer, Milena; Smakowska-Luzan, Elwira; Belkhadir, Youssef; Vlot, A. Corina; Chandler, Courtney E.; Schellenberger, Romain; Schwudke, Dominik; Ernst, Robert K.; Dorey, Stephan; Hueckelhoven, Ralph; Hofmann, Thomas; Ranf, Stefanie			Bacterial medium-chain 3-hydroxy fatty acid metabolites trigger immunity in Arabidopsis plants	SCIENCE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; O-SPECIFIC POLYSACCHARIDE; LIPID-A COMPONENT; PSEUDOMONAS-AERUGINOSA; MOLECULAR-PATTERNS; SOMATIC ANTIGENS; LIPOPOLYSACCHARIDE; RECEPTOR; IDENTIFICATION; RHAMNOLIPIDS	In plants, cell-surface immune receptors sense molecular non-self-signatures. Lipid A of Gram-negative bacterial lipopolysaccharide is considered such a non-self-signature. The receptor kinase LIPOOLIGOSACCHARIDE-SPECIFIC REDUCED ELICITATION (LORE) mediates plant immune responses to Pseudomonas and Xanthomonas but not enterobacterial lipid A or lipopolysaccharide preparations. Here, we demonstrate that synthetic and bacterial lipopolysaccharide-copurified medium-chain 3-hydroxy fatty acid (mc-3-OH-FA) metabolites elicit LORE-dependent immunity. The mc-3-OH-FAs are sensed in a chain length- and hydroxylation-specific manner, with free (R)-3-hydroxydecanoic acid [(R)-3-OH-C10:0] representing the strongest immune elicitor. By contrast, bacterial compounds comprising mc-3-OH-acyl building blocks but devoid of free mc-3-OH-FAs-including lipid A or lipopolysaccharide, rhamnolipids, lipopeptides, and acyl-homoserine-lactones-do not trigger LORE-dependent responses. Hence, plants sense low-complexity bacterial metabolites to trigger immune responses.	[Kutschera, Alexander; Raasch, Lars; Gerster, Tim; Schaeffer, Milena; Hueckelhoven, Ralph; Ranf, Stefanie] Tech Univ Munich, Chair Phytopathol, TUM Sch Life Sci Weihenstephan, D-85354 Freising Weihenstephan, Germany; [Dawid, Corinna; Schmid, Christian; Hofmann, Thomas] Tech Univ Munich, Chair Food Chem & Mol Sensory Sci, TUM Sch Life Sci Weihenstephan, D-85354 Freising Weihenstephan, Germany; [Gisch, Nicolas; Schwudke, Dominik] Leibniz Lung Ctr, Div Bioanalyt Chem, Prior Area Infect, Res Ctr Borstel, Pk Allee 1-40, D-23845 Borstel, Germany; [Smakowska-Luzan, Elwira; Belkhadir, Youssef] Austrian Acad Sci, Gregor Mendel Inst, Vienna Bioctr, A-1030 Vienna, Austria; [Vlot, A. Corina] Helmholtz Zentrum Muenchen, Dept Environm Sci, Inst Biochem Plant Pathol, D-85764 Neuherberg, Germany; [Chandler, Courtney E.; Ernst, Robert K.] Univ Maryland, Sch Dent, Dept Microbial Pathogenesis, Baltimore, MD 21201 USA; [Schellenberger, Romain; Dorey, Stephan] Univ Reims, RIBP EA 4707, SFR Condorcet FR CNRS 3417, F-51100 Reims, France	Technical University of Munich; Technical University of Munich; Forschungszentrum Borstel; Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University System of Maryland; University of Maryland Baltimore; Universite de Reims Champagne-Ardenne	Ranf, S (corresponding author), Tech Univ Munich, Chair Phytopathol, TUM Sch Life Sci Weihenstephan, D-85354 Freising Weihenstephan, Germany.	ranf@wzw.tum.de	dorey, stephan/GLV-3991-2022; Huckelhoven, Ralph/H-6676-2013; Ranf, Stefanie/J-2474-2016; Schwudke, Dominik/B-3478-2013; Belkhadir, Youssef/GXM-6743-2022; Vlot, Corina/M-7351-2014	Huckelhoven, Ralph/0000-0001-5632-5451; Ranf, Stefanie/0000-0003-2262-2938; Schwudke, Dominik/0000-0002-1379-9451; Gisch, Nicolas/0000-0003-3260-5269; Schmid, Christian/0000-0003-2129-1807; dorey, stephan/0000-0002-9583-2824; Ernst, Robert/0000-0001-5016-8694; Gerster, Tim/0000-0003-3493-4023; Kutschera, Alexander/0000-0003-3218-1371; Belkhadir, Youssef/0000-0001-7149-7139; Vlot, Corina/0000-0002-8146-6018	German Research Foundation [SFB924/TP-B10, TP-B06, RA2541/1]; grant Rhamnoprot; Region Grand-Est; FEDER; Vienna Science and Technology Fund (WWTF) project [LS17-047]; Austrian Academy of Science through the Gregor Mendel Institute; Hertha Firnberg Programme postdoctoral fellowship from the FWF Austrian Science Fund [T-947]	German Research Foundation(German Research Foundation (DFG)); grant Rhamnoprot; Region Grand-Est(Region Grand-Est); FEDER(European Commission); Vienna Science and Technology Fund (WWTF) project; Austrian Academy of Science through the Gregor Mendel Institute; Hertha Firnberg Programme postdoctoral fellowship from the FWF Austrian Science Fund	This work was supported by the German Research Foundation (SFB924/TP-B10 to S.R. and TP-B06 to A.C.V. and Emmy Noether program RA2541/1 to S.R.); grant Rhamnoprot, Region Grand-Est and FEDER (R.S.); Vienna Science and Technology Fund (WWTF) project LS17-047 and grants from the Austrian Academy of Science through the Gregor Mendel Institute (Y.B.). E.S.-L is supported by a Hertha Firnberg Programme postdoctoral fellowship (T-947) from the FWF Austrian Science Fund.	Abdel-Mawgoud AM, 2010, APPL MICROBIOL BIOT, V86, P1323, DOI 10.1007/s00253-010-2498-2; Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; Bitter W, 2007, J BACTERIOL, V189, P2967, DOI 10.1128/JB.01583-06; Blad CC, 2012, NAT REV DRUG DISCOV, V11, P603, DOI 10.1038/nrd3777; Boudsocq M, 2010, NATURE, V464, P418, DOI 10.1038/nature08794; Boutrot F, 2017, ANNU REV PHYTOPATHOL, V55, P257, DOI 10.1146/annurev-phyto-080614-120106; Braunsdorf C, 2016, CELL MICROBIOL, V18, P1188, DOI 10.1111/cmi.12610; Breitenbach HH, 2014, PLANT PHYSIOL, V165, P791, DOI 10.1104/pp.114.239665; Bystrova OV, 2002, EUR J BIOCHEM, V269, P2194, DOI 10.1046/j.1432-1033.2002.02875.x; Carballo PMS, 1999, EUR J BIOCHEM, V261, P500, DOI 10.1046/j.1432-1327.1999.00299.x; Cheng SY, 2013, MOLECULES, V18, P13003, DOI 10.3390/molecules181013003; de Souza JT, 2003, APPL ENVIRON MICROB, V69, P7161, DOI 10.1128/AEM.69.12.7161-7172.2003; De Soyza A, 2008, INNATE IMMUN-LONDON, V14, P127, DOI 10.1177/1753425908093984; Dietz C, 2016, TETRAHEDRON, V72, P7557, DOI 10.1016/j.tet.2016.10.010; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Ernst RK, 2006, J BACTERIOL, V188, P191, DOI 10.1128/JB.188.1.191-201.2006; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Frank O, 2014, J AGR FOOD CHEM, V62, P2506, DOI 10.1021/jf405529b; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; Geurtsen J, 2005, J BIOL CHEM, V280, P8248, DOI 10.1074/jbc.M414235200; GOLENBOCK DT, 1991, J BIOL CHEM, V266, P19490; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; Greger V, 2007, J AGR FOOD CHEM, V55, P5221, DOI 10.1021/jf0705015; Hanlon CD, 2015, J CELL SCI, V128, P3533, DOI 10.1242/jcs.175158; HASE S, 1977, EUR J BIOCHEM, V75, P23, DOI 10.1111/j.1432-1033.1977.tb11500.x; He P, 2006, CELL, V125, P563, DOI 10.1016/j.cell.2006.02.047; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hittle LE, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv053; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Hon YS, 2007, SYNTHETIC COMMUN, V37, P1635, DOI 10.1080/00397910701263767; Isshiki Y, 1998, CARBOHYD RES, V313, P21, DOI 10.1016/S0008-6215(98)00179-7; Jimenez-Barbero J, 2002, EUR J ORG CHEM, V2002, P1770, DOI 10.1002/1099-0690(200206)2002:11<1770::AID-EJOC1770>3.0.CO;2-5; Katsir L, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006306; KAWAHARA K, 1992, FEMS MICROBIOL LETT, V96, P129; Kieser KJ, 2017, NAT REV IMMUNOL, V17, P376, DOI 10.1038/nri.2017.25; KNIGHT MR, 1991, NATURE, V352, P524, DOI 10.1038/352524a0; Knirel YA, 1996, CARBOHYD RES, V291, P217; KNIREL YA, 1985, EUR J BIOCHEM, V150, P541, DOI 10.1111/j.1432-1033.1985.tb09055.x; Knirel YA, 2006, J ENDOTOXIN RES, V12, P324, DOI 10.1179/096805106X118906; Kondakov A, 2005, EUR J MASS SPECTROM, V11, P535, DOI 10.1255/ejms.721; Kooistra O, 2003, CARBOHYD RES, V338, P2667, DOI 10.1016/j.carres.2003.07.004; Kumar V, 2016, TETRAHEDRON, V72, P5369, DOI 10.1016/j.tet.2016.07.022; Kvitko BH, 2011, METHODS MOL BIOL, V712, P109, DOI 10.1007/978-1-61737-998-7_10; Lasierra P, 2018, METHODS MOL BIOL, V1794, P311, DOI 10.1007/978-1-4939-7871-7_22; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mamat U, 2009, J BIOL CHEM, V284, P22248, DOI 10.1074/jbc.M109.033308; MASOUD H, 1990, SYST APPL MICROBIOL, V13, P227, DOI 10.1016/S0723-2020(11)80190-6; MASOUD H, 1994, BIOCHEMISTRY-US, V33, P10568, DOI 10.1021/bi00201a002; Mishina TE, 2007, PLANT J, V50, P500, DOI 10.1111/j.1365-313X.2007.03067.x; Miyamoto Y, 2011, BIOORGAN MED CHEM, V19, P172, DOI 10.1016/j.bmc.2010.11.038; Mizoi K, 2016, BIOORG MED CHEM LETT, V26, P921, DOI 10.1016/j.bmcl.2015.12.069; Mott GA, 2018, MOL PLANT MICROBE IN, V31, P499, DOI [10.1094/MPMI-11-17-0279-TA, 10.1094/mpmi-11-17-0279-ta]; Nishizawa M, 2007, J ORG CHEM, V72, P1627, DOI 10.1021/jo062018j; PETERSON AA, 1985, J BACTERIOL, V162, P738, DOI 10.1128/JB.162.2.738-745.1985; Raaijmakers JM, 2006, MOL PLANT MICROBE IN, V19, P699, DOI 10.1094/MPMI-19-0699; Raaijmakers JM, 2010, FEMS MICROBIOL REV, V34, P1037, DOI 10.1111/j.1574-6976.2010.00221.x; Radivojevic J, 2016, APPL MICROBIOL BIOT, V100, P161, DOI 10.1007/s00253-015-6984-4; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ramu R, 2011, TETRAHEDRON LETT, V52, P2950, DOI 10.1016/j.tetlet.2011.03.101; Ranf S, 2017, CURR OPIN PLANT BIOL, V38, P68, DOI [10.1016/j.pbi.2017.04.011, 10.1016/j.p]; Ranf S, 2016, MOL PLANT PATHOL, V17, P1165, DOI 10.1111/mpp.12452; Ranf S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005596; Ranf S, 2015, NAT IMMUNOL, V16, P426, DOI 10.1038/ni.3124; Ranf S, 2012, MOL PLANT, V5, P115, DOI 10.1093/mp/ssr064; RIETSCHEL ET, 1976, EUR J BIOCHEM, V64, P423, DOI 10.1111/j.1432-1033.1976.tb10318.x; Sanchez L, 2012, PLANT PHYSIOL, V160, P1630, DOI 10.1104/pp.112.201913; Schelhaas M, 1999, CHEM-EUR J, V5, P1239, DOI 10.1002/(SICI)1521-3765(19990401)5:4<1239::AID-CHEM1239>3.0.CO;2-N; SCHILDKNECHT H, 1971, ANGEW CHEM INT EDIT, V10, P124, DOI 10.1002/anie.197101241; Senchenkova SN, 2002, CARBOHYD RES, V337, P1723, DOI 10.1016/S0008-6215(02)00268-9; Senchenkova SN, 1999, CARBOHYD RES, V319, P148, DOI 10.1016/S0008-6215(99)00125-1; Seydel U, 2000, EUR J BIOCHEM, V267, P3032; Shang-Guan K, 2018, PLANT PHYSIOL, V176, P2543, DOI 10.1104/pp.17.01637; Silipo A, 2008, CHEMBIOCHEM, V9, P896, DOI 10.1002/cbic.200700693; Sjogren J, 2003, APPL ENVIRON MICROB, V69, P7554, DOI 10.1128/AEM.69.12.7554-7557.2003; Suzuki M, 2013, J BIOL CHEM, V288, P10684, DOI 10.1074/jbc.M112.420042; Tanaka Y, 2008, J AM CHEM SOC, V130, P3278, DOI 10.1021/ja7109772; Tirsoaga A, 2007, APPL ENVIRON MICROB, V73, P1803, DOI 10.1128/AEM.02452-06; Varnier AL, 2009, PLANT CELL ENVIRON, V32, P178, DOI 10.1111/j.1365-3040.2008.01911.x; Verlinden RAJ, 2007, J APPL MICROBIOL, V102, P1437, DOI 10.1111/j.1365-2672.2007.03335.x; Vlot AC, 2008, PLANT J, V56, P445, DOI 10.1111/j.1365-313X.2008.03618.x; WEAVER N, 1968, LIPIDS, V3, P535, DOI 10.1007/BF02530898; Weis C, 2013, J EXP BOT, V64, P3855, DOI 10.1093/jxb/ert217; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030; Williams DR, 2011, TETRAHEDRON, V67, P5083, DOI 10.1016/j.tet.2011.05.020; Wise AA, 2006, METH MOL B, V343, P3; WOLLENWEBER HW, 1985, ARCH MICROBIOL, V142, P6, DOI 10.1007/BF00409228; WOLLENWEBER HW, 1984, EUR J BIOCHEM, V145, P265, DOI 10.1111/j.1432-1033.1984.tb08547.x; ZAHRINGER U, 1994, ADV CARBOHYD CHEM BI, V50, P211, DOI 10.1016/S0065-2318(08)60152-3; Zheng Z, 2004, APPL ENVIRON MICROB, V70, P3807, DOI 10.1128/AEM.70.7.3807-3813.2004	89	87	88	11	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2019	364	6436					178	+		10.1126/science.aau1279	http://dx.doi.org/10.1126/science.aau1279			87	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HT5RC	30975887				2022-12-28	WOS:000464620000042
J	Hondebrink, L; Opstelten, W				Hondebrink, Lieke; Opstelten, Wim			SPOT DIAGNOSIS A woman with an itchy hyperpigmentation on her back	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NOTALGIA PARESTHETICA		[Hondebrink, Lieke; Opstelten, Wim] Hlth Ctr Vondelpl, Amersfoort, Netherlands		Opstelten, W (corresponding author), Hlth Ctr Vondelpl, Amersfoort, Netherlands.	w.opstelten@umcutrecht.nl						Pagliarello C, 2017, INT J DERMATOL, V56, P932, DOI 10.1111/ijd.13666; Raison-Peyron N, 1999, J EUR ACAD DERMATOL, V12, P215, DOI 10.1111/j.1468-3083.1999.tb01031.x; WALLENGREN J, 1995, J AM ACAD DERMATOL, V32, P287, DOI 10.1016/0190-9622(95)90152-3; WEBER PJ, 1988, J AM ACAD DERMATOL, V18, P25, DOI 10.1016/S0190-9622(88)70003-1; Maciel AAW, 2014, AN BRAS DERMATOL, V89, P570, DOI 10.1590/abd1806-4841.20142777	5	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 11	2019	365								l1332	10.1136/bmj.l1332	http://dx.doi.org/10.1136/bmj.l1332			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU0ER	30975720				2022-12-28	WOS:000464944700002
J	Margetts, H; Dorobantu, C				Margetts, Helen; Dorobantu, Cosmina			Rethink government with AI	NATURE			English	Editorial Material									[Margetts, Helen; Dorobantu, Cosmina] Alan Turing Inst, Publ Policy, London, England; [Margetts, Helen] Univ Oxford, Oxford Internet Inst, Soc & Internet, Oxford, England; [Dorobantu, Cosmina] Univ Oxford, Oxford Internet Inst, Oxford, England	University of Oxford; University of Oxford	Margetts, H (corresponding author), Alan Turing Inst, Publ Policy, London, England.; Margetts, H (corresponding author), Univ Oxford, Oxford Internet Inst, Soc & Internet, Oxford, England.	hmargetts@turing.ac.uk		Dorobantu, Cosmina/0000-0001-7903-4796				Axtell R, 2018, HANDB COMPUT ECON, V4, P157, DOI 10.1016/bs.hescom.2018.05.001; Bright J., 2019, DATA SCI LOCAL GOVT; Castaneda G, 2018, J ECON BEHAV ORGAN, V154, P335, DOI 10.1016/j.jebo.2018.07.017; Cuccaro-Alamin S, 2017, CHILD YOUTH SERV REV, V79, P291, DOI 10.1016/j.childyouth.2017.06.027; GULLAND A, 2017, BMJ-BRIT MED J, V356, DOI DOI 10.1136/BMJ.J911; Margetts Helen, 1999, INFORM TECHNOLOGY GO; Sadilek A, 2017, AI MAG, V38, P37, DOI 10.1609/aimag.v38i1.2711; Shapiro A, 2017, NATURE, V541, P458, DOI 10.1038/541458a; SPOHN C, 1982, LAW SOC REV, V16, P71; Spohn C., 2000, CRIMINAL JUSTICE, V3, P427	10	34	36	8	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2019	568	7751					163	165		10.1038/d41586-019-01099-5	http://dx.doi.org/10.1038/d41586-019-01099-5			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HT2SH	30967667	Bronze			2022-12-28	WOS:000464412700024
J	Kuehn, B				Kuehn, Bridget			Measles Vaccine Exemptions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 9	2019	321	14					1344	1344		10.1001/jama.2019.3063	http://dx.doi.org/10.1001/jama.2019.3063			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HT5PG	30964534				2022-12-28	WOS:000464615200006
J	Wang, SSY; Solomon, M				Wang, Samuel S. Y.; Solomon, Michael			Watching and waiting in chronic hip pain	LANCET			English	Editorial Material									[Wang, Samuel S. Y.; Solomon, Michael] Univ New South Wales, Prince Wales Hosp, Dept Orthopaed, Prince Wales Clin Sch, Sydney, NSW, Australia; [Solomon, Michael] Prince Wales Private Hosp, Dept Orthopaed, Sydney, NSW, Australia	University of New South Wales Sydney	Wang, SSY (corresponding author), Prince Wales Private, Sydney, NSW 2030, Australia.	samuel0707@gmail.com							0	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 6	2019	393	10179					E36	E36		10.1016/S0140-6736(19)30655-5	http://dx.doi.org/10.1016/S0140-6736(19)30655-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HS0OU	30967219				2022-12-28	WOS:000463561000001
J	Dyer, O				Dyer, Owen			US consumer agency wins $50m order against predatory publisher OMICS	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		DYER O, 2016, BMJ-BRIT MED J, V354, DOI DOI 10.1136/BMJ.I4917	1	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 5	2019	365								l1639	10.1136/bmj.l1639	http://dx.doi.org/10.1136/bmj.l1639			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HS6UC	30952626				2022-12-28	WOS:000464005800007
J	Gostin, LO; Ratzan, SC; Bloom, BR				Gostin, Lawrence O.; Ratzan, Scott C.; Bloom, Barry R.			Safe Vaccinations for a Healthy Nation Increasing US Vaccine Coverage Through Law, Science, and Communication	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.] Georgetown Univ, Law Ctr, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA; [Ratzan, Scott C.] Harvard Kennedy Sch, Mossavar Rahmani Ctr Business & Govt, Cambridge, MA USA; [Ratzan, Scott C.] Journal Hlth Commun Int Perspect, Washington, DC USA; [Bloom, Barry R.] Harvard TH Chan Sch Publ, Dept Immunol & Infect Dis, Boston, MA USA; [Bloom, Barry R.] Harvard TH Chan Sch Publ, Dept Global Hlth & Populat, Boston, MA USA	Georgetown University; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Gostin, LO (corresponding author), Georgetown Univ, Law Ctr, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				Centers for Disease Control and Prevention, FASTSTATS IMM; Chou WYS, 2018, JAMA-J AM MED ASSOC, V320, P2417, DOI 10.1001/jama.2018.16865; Lin II R-G, 2017, L A TIMES; Merchant RM, 2018, JAMA-J AM MED ASSOC, V320, P2415, DOI 10.1001/jama.2018.18416; National Conference of State Legislatures, STAT REL PHIL EX SCH; Sundaram ME, 2019, JAMA-J AM MED ASSOC, V321, P1155, DOI 10.1001/jama.2019.1506; Tauren D., 2019, SOCIAL MEDIA PLATFOR; The National Academy of Medicine; Institute of Medicine, 2004, IMM SAF REV VACC AUT; World Health Organization, MEASL	9	15	15	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 28	2019	321	20					1969	1970		10.1001/jama.2019.4270	http://dx.doi.org/10.1001/jama.2019.4270			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IA1CQ	31002339				2022-12-28	WOS:000469297300013
J	Wagner, J; Rapsomaniki, MA; Chevrier, S; Anzeneder, T; Langwieder, C; Dykgers, A; Rees, M; Ramaswamy, A; Muenst, S; Soysa, SD; Jacobs, A; Windhager, J; Silina, K; van den Broek, M; Dedes, KJ; Martinez, MR; Weber, WP; Bodenmiller, B				Wagner, Johanna; Rapsomaniki, Maria Anna; Chevrier, Stephane; Anzeneder, Tobias; Langwieder, Claus; Dykgers, August; Rees, Martin; Ramaswamy, Annette; Muenst, Simone; Soysa, Savas Deniz; Jacobs, Andrea; Windhager, Jonas; Silina, Karina; van den Broek, Manes; Dedes, Konstantin Johannes; Martinez, Maria Rodriguez; Weber, Walter Paul; Bodenmiller, Bernd			A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer	CELL			English	Article							MASS CYTOMETRY; HETEROGENEITY; MANAGEMENT; RESISTANCE; THERAPY; REVEALS; IMPACT; HER2	Breast cancer is a heterogeneous disease. Tumor cells and associated healthy cells form ecosystems that determine disease progression and response to therapy. To characterize features of breast cancer ecosystems and their associations with clinical data, we analyzed 144 human breast tumor and 50 non-tumor tissue samples using mass cytometry. The expression of 73 proteins in 26 million cells was evaluated using tumor and immune cell-centric antibody panels. Tumors displayed individuality in tumor cell composition, including phenotypic abnormalities and phenotype dominance. Relationship analyses between tumor and immune cells revealed characteristics of ecosystems related to immunosuppression and poor prognosis. High frequencies of PD-L1(+) tumor-associated macrophages and exhausted T cells were found in high-grade ER+ and ER- tumors. This largo-scale, single-cell atlas deepens our understanding breast tumor ecosystems and suggests that ecosystem-based patient classification will facilitate identification of individuals for precision medicine approaches targeting the tumor and its immunoenvironment.	[Wagner, Johanna; Chevrier, Stephane; Jacobs, Andrea; Windhager, Jonas; Bodenmiller, Bernd] Univ Zurich, Inst Mol Life Sci, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Wagner, Johanna] Swiss Fed Inst Technol, Life Sci Zurich Grad Sch, Mol Life Sci PhD Program, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Wagner, Johanna; Windhager, Jonas] Univ Zurich, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Rapsomaniki, Maria Anna; Martinez, Maria Rodriguez] IBM Res Zurich, Saeumerstr 4, CH-8803 Ruschlikon, Switzerland; [Anzeneder, Tobias] Patients Tumor Bank Hope PATH Biobank, PO 750729, D-81337 Munich, Germany; [Langwieder, Claus; Dykgers, August; Rees, Martin] Inst Pathol Josefshaus, Amalienstr 21, D-44137 Dortmund, Germany; [Ramaswamy, Annette] Univ Hosp Giessen & Marburg, Inst Pathol, Baldingerstr, D-35043 Marburg, Germany; [Muenst, Simone] Univ Hosp Basel, Inst Pathol, Schoenbeinstr 40, CH-4031 Basel, Switzerland; [Muenst, Simone] Univ Basel, Schoenbeinstr 40, CH-4031 Basel, Switzerland; [Soysa, Savas Deniz] Univ Hosp Basel, Clarunis, Spitalstr 21, CH-4031 Basel, Switzerland; [Soysa, Savas Deniz; Weber, Walter Paul] Univ Basel, Spitalstr 21, CH-4031 Basel, Switzerland; [Soysa, Savas Deniz; Weber, Walter Paul] Univ Hosp Basel, Breast Canc Ctr, Spitalstr 21, CH-4031 Basel, Switzerland; [Windhager, Jonas] Swiss Fed Inst Technol, Life Sci Zurich Grad Sch, Syst Biol PhD Program, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Silina, Karina; van den Broek, Manes] Univ Zurich, Inst Expt Immunol, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Dedes, Konstantin Johannes] Univ Hosp Zurich, Breast Canc Ctr, Frauenklinikstr 10, CH-8091 Zurich, Switzerland; [Weber, Walter Paul] Univ Hosp Basel, Dept Surg, Spitalstr 21, CH-4031 Basel, Switzerland; [Wagner, Johanna; Chevrier, Stephane; Jacobs, Andrea; Windhager, Jonas; Bodenmiller, Bernd] Univ Zurich, Dept Quantitat Biomed, Winterthurerstr 190, CH-8057 Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; International Business Machines (IBM); University Hospital of Giessen & Marburg; University of Basel; University of Basel; University of Basel; University of Basel; University of Basel; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Zurich; University Zurich Hospital; University of Basel; University of Zurich	Bodenmiller, B (corresponding author), Univ Zurich, Inst Mol Life Sci, Winterthurerstr 190, CH-8057 Zurich, Switzerland.; Bodenmiller, B (corresponding author), Univ Zurich, Dept Quantitat Biomed, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	bernd.bodenmiller@imls.uzh.ch	Windhager, Jonas/AAS-4701-2020; Martinez, Maria Rodriguez/M-4624-2019; Dedes, Konstantin/AAK-1281-2021; van den Broek, Maries/G-4128-2016	Windhager, Jonas/0000-0002-2111-5291; Martinez, Maria Rodriguez/0000-0003-3766-4233; Wagner, Johanna/0000-0002-5087-3657; Soysal, Savas/0000-0002-0761-449X; Muenst, Simone/0000-0001-7973-1401; Rapsomaniki, Maria Anna/0000-0003-3883-4871; Silina, Karina/0000-0003-3947-2710; van den Broek, Maries/0000-0002-9489-3692	SNSF R'Equip grant; SNSF assistant professorship grant; SystemsX Transfer Project "Friends and Foes"; SystemsX MetastasiX grant; SystemsX PhosphoNetX grant; European Research Council (ERC) under the European Union Seventh Framework Program (FP/2007-2013)/ERC [336921]; Roche postdoctoral fellowship	SNSF R'Equip grant; SNSF assistant professorship grant; SystemsX Transfer Project "Friends and Foes"; SystemsX MetastasiX grant; SystemsX PhosphoNetX grant; European Research Council (ERC) under the European Union Seventh Framework Program (FP/2007-2013)/ERC(European Research Council (ERC)); Roche postdoctoral fellowship	We are grateful for the generous donation of tissue samples by patients undergoing surgery, facilitated by sample acquisition through the PATH foundation. We thank the Bodenmiller lab for fruitful discussions, Vito R.T. Zanotelli for advice regarding data visualization, and Stefanie Engler for excellent technical support. We thank the Systems Biology group at IBM Rueschlikon and especially Matteo Manica for excellent discussions. B.B.' s research is funded by an SNSF R'Equip grant, an SNSF assistant professorship grant, the SystemsX Transfer Project "Friends and Foes,'' SystemsX MetastasiX and PhosphoNetX grants, and by the European Research Council (ERC) under the European Union Seventh Framework Program (FP/2007-2013)/ERC grant agreement 336921. S.C. was funded by a Roche postdoctoral fellowship. B.B., M.A.R., S.M.S., S.D.S., W.P.W., and M.R.M. were supported by a SystemsX MetastasiX grant.	Amin MB, 2017, AJCC CANC STAGING MA, V8th; Angelo M, 2014, NAT MED, V20, P436, DOI 10.1038/nm.3488; Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Bandura DR, 2009, ANAL CHEM, V81, P6813, DOI 10.1021/ac901049w; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Buisseret L, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2016.1257452; Cassetta L, 2018, NAT REV DRUG DISCOV, V17, P887, DOI 10.1038/nrd.2018.169; Catena R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1006-0; Chamberlin T, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0921-7; Chevrier S, 2018, CELL SYST, V6, P612, DOI 10.1016/j.cels.2018.02.010; Chevrier S, 2017, CELL, V169, P736, DOI 10.1016/j.cell.2017.04.016; Chung W, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15081; Costa A, 2018, CANCER CELL, V33, P463, DOI 10.1016/j.ccell.2018.01.011; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Daud AI, 2016, J CLIN INVEST, V126, P3447, DOI 10.1172/JCI87324; Dieci MV, 2016, CANCER TREAT REV, V46, P9, DOI 10.1016/j.ctrv.2016.03.011; Egelston CA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06653-9; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Fortier AM, 2010, FEBS LETT, V584, P984, DOI 10.1016/j.febslet.2010.01.045; Giesen C, 2014, NAT METHODS, V11, P417, DOI [10.1038/NMETH.2869, 10.1038/nmeth.2869]; Goodfellow I., 2016, DEEP LEARNING, V738; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Hsu JL, 2016, CANCER METAST REV, V35, P575, DOI 10.1007/s10555-016-9649-6; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Karakasheva TA, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97022; Keren L, 2018, CELL, V174, P1373, DOI 10.1016/j.cell.2018.08.039; Kingma D.P., 2014, ARXIV, DOI DOI 10.48550/ARXIV.1412.6980; Kotecha Nikesh, 2010, Curr Protoc Cytom, VChapter 10, DOI 10.1002/0471142956.cy1017s53; Lavin Y, 2017, CELL, V169, P750, DOI 10.1016/j.cell.2017.04.014; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Li HJ, 2019, CELL, V176, P775, DOI 10.1016/j.cell.2018.11.043; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; McAllister SS, 2010, J CLIN ONCOL, V28, P4022, DOI 10.1200/JCO.2010.28.4257; MOLLER MF, 1993, NEURAL NETWORKS, V6, P525, DOI 10.1016/S0893-6080(05)80056-5; Murphy CG, 2016, ENDOCR-RELAT CANCER, V23, pR337, DOI 10.1530/ERC-16-0121; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Park IA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182786; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; R Development Core Team, 2009, R LANG ENV STAT COMP; Rakha EA, 2014, HISTOPATHOLOGY, V64, P609, DOI 10.1111/his.12357; Ramos P, 2015, ONCOGENE, V34, P3617, DOI 10.1038/onc.2014.314; Rapsomaniki MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03005-5; Reinert T, 2015, THER ADV MED ONCOL, V7, P304, DOI 10.1177/1758834015608993; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Santagata S, 2014, J CLIN INVEST, V124, P859, DOI 10.1172/JCI70941; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shih K, 2014, DRUGS, V74, P1993, DOI 10.1007/s40265-014-0305-6; Sternlicht MD, 1997, MED HYPOTHESES, V48, P37, DOI 10.1016/S0306-9877(97)90022-0; Stingl J, 2001, BREAST CANCER RES TR, V67, P93, DOI 10.1023/A:1010615124301; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; The MathWorks Inc, 2018, MATLAB STAT TOOLB RE; Torre LA, 2017, CANCER EPIDEM BIOMAR, V26, P444, DOI 10.1158/1055-9965.EPI-16-0858; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vargas F. A., 2018, CANC CELL; Visvader JE, 2014, GENE DEV, V28, P1143, DOI 10.1101/gad.242511.114; Weber LM, 2016, CYTOM PART A, V89A, P1084, DOI 10.1002/cyto.a.23030; Wein L, 2018, BRIT J CANCER, V119, P4, DOI 10.1038/s41416-018-0126-6; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Zunder ER, 2015, NAT PROTOC, V10, P316, DOI 10.1038/nprot.2015.020; 2016, HUM PATHOL, V47, P52, DOI DOI 10.1016/J.HUMPATH.2015.09.003; 2015, ANN ONCOL, V26, P1533, DOI DOI 10.1093/ANNONC/MDV221	68	316	325	21	121	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 16	2019	177	5					1330	+		10.1016/j.cell.2019.03.005	http://dx.doi.org/10.1016/j.cell.2019.03.005			34	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HY4NB	30982598	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000468103800023
J	Yeung, SLA; Lam, TH				Yeung, Shiu Lun Au; Lam, Tai Hing			Unite for a Framework Convention for Alcohol Control	LANCET			English	Editorial Material									[Yeung, Shiu Lun Au; Lam, Tai Hing] Univ Hong Kong, Sch Publ Hlth, Li Ka Shing Fac Med, Hong Kong, Peoples R China	University of Hong Kong	Lam, TH (corresponding author), Univ Hong Kong, Sch Publ Hlth, Li Ka Shing Fac Med, Hong Kong, Peoples R China.	hrmrlth@hkucc.hku.hk	SL, Au Yeung/ABD-3938-2021; Lam, Tai Hing/C-4317-2009	SL, Au Yeung/0000-0001-6136-1836; Lam, Tai Hing/0000-0002-2033-9971				Braillon A, 2018, J AM COLL CARDIOL, V71, P582, DOI 10.1016/j.jacc.2017.10.096; Casswell S, 2009, LANCET, V373, P2247, DOI 10.1016/S0140-6736(09)60745-5; Griswold MG, 2018, LANCET, V392, P1015, DOI [10.1016/S0140-6736(18)31310-2, 10.1016/s0140-6736(18)31310-2, 10.1136/bmj.l94]; Holmes MV, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4164; Lawlor DA, 2016, INT J EPIDEMIOL, V45, P1866, DOI 10.1093/ije/dyw314; Millwood IY, 2019, LANCET, V393, P1831, DOI 10.1016/S0140-6736(18)31772-0; Xi B, 2017, J AM COLL CARDIOL, V70, P913, DOI 10.1016/j.jacc.2017.06.054; Xu L, 2018, J DIABETES, V10, P564, DOI 10.1111/1753-0407.12647; Yeung SLA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068054; Yoon S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-630; 2017, INT J EPIDEMIOL, V46, P547, DOI DOI 10.1093/IJE/DYW309; 2018, LANCET, V391, P1513, DOI DOI 10.1016/S0140-6736(18)30134-X	12	9	9	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 4	2019	393	10183					1778	1779		10.1016/S0140-6736(18)32214-1	http://dx.doi.org/10.1016/S0140-6736(18)32214-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HW7GR	30955974	hybrid			2022-12-28	WOS:000466858700006
J	Sacks, CA; Modi, YS; Singh, RP				Sacks, Chana A.; Modi, Yasha S.; Singh, Rishi P.			Bull's-Eye Maculopathy Associated with Hydroxychloroquine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Modi, Yasha S.; Singh, Rishi P.] Cole Eye Inst, Cleveland, OH 44106 USA		Modi, YS (corresponding author), Cole Eye Inst, Cleveland, OH 44106 USA.	yasha.modi@gmail.com							0	7	7	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 25	2019	380	17					1656	1656		10.1056/NEJMicm1412167	http://dx.doi.org/10.1056/NEJMicm1412167			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU9FC	31018071				2022-12-28	WOS:000465598600012
J	[Anonymous]				[Anonymous]			Medicolegal Conditions Warranting Requirement of Vaccination [Reprinted from vol 72, pg 1247-1248, 1919)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		REILING J, 1919, JAMA-J AM MED ASSOC, V72, P1247	1	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2019	321	16					1638	1638		10.1001/jama.2018.15308	http://dx.doi.org/10.1001/jama.2018.15308			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HV7BZ	31012919				2022-12-28	WOS:000466137800035
J	Rueda, A; Sedlmeir, F; Kumari, M; Leuchs, G; Schwefel, HGL				Rueda, Alfredo; Sedlmeir, Florian; Kumari, Madhuri; Leuchs, Gerd; Schwefel, Harald G. L.			Resonant electro-optic frequency comb	NATURE			English	Article							CONVERSION; MICROWAVE	High-speed optical telecommunication is enabled by wavelength-division multiplexing, whereby hundreds of individually stabilized lasers encode information within a single-mode optical fibre. Higher bandwidths require higher total optical power, but the power sent into the fibre is limited by optical nonlinearities within the fibre, and energy consumption by the light sources starts to become a substantial cost factor(1). Optical frequency combs have been suggested to remedy this problem by generating numerous discrete, equidistant laser lines within a monolithic device; however, at present their stability and coherence allow them to operate only within small parameter ranges(2-4). Here we show that a broadband frequency comb realized through the electro-optic effect within a high-quality whispering-gallery-mode resonator can operate at low microwave and optical powers. Unlike the usual third-order Kerr nonlinear optical frequency combs, our combs rely on the second-order nonlinear effect, which is much more efficient. Our result uses a fixed microwave signal that is mixed with an optical-pump signal to generate a coherent frequency comb with a precisely determined carrier separation. The resonant enhancement enables us to work with microwave powers that are three orders of magnitude lower than those in commercially available devices. We emphasize the practical relevance of our results to high rates of data communication. To circumvent the limitations imposed by nonlinear effects in optical communication fibres, one has to solve two problems: to provide a compact and fully integrated, yet high-quality and coherent, frequency comb generator; and to calculate nonlinear signal propagation in real time5. We report a solution to the first problem.	[Rueda, Alfredo; Sedlmeir, Florian; Leuchs, Gerd] Max Planck Inst Sci Light, Erlangen, Germany; [Rueda, Alfredo; Sedlmeir, Florian; Leuchs, Gerd] Univ Erlangen Nuernberg, Inst Opt Informat & Photon, Erlangen, Germany; [Rueda, Alfredo] SAOT, Erlangen, Germany; [Rueda, Alfredo] IST Austria, Klosterneuburg, Austria; [Rueda, Alfredo; Kumari, Madhuri; Leuchs, Gerd; Schwefel, Harald G. L.] Dodd Walls Ctr Photon & Quantum Technol, Dunedin, New Zealand; [Rueda, Alfredo; Kumari, Madhuri; Leuchs, Gerd; Schwefel, Harald G. L.] Univ Otago, Dept Phys, Dunedin, New Zealand; [Leuchs, Gerd] Russian Acad Sci, Inst Appl Phys, Nizhnii Novgorod, Russia	Max Planck Society; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Institute of Science & Technology - Austria; University of Otago; Russian Academy of Sciences; Institute of Applied Physics of the Russian Academy of Sciences	Schwefel, HGL (corresponding author), Dodd Walls Ctr Photon & Quantum Technol, Dunedin, New Zealand.; Schwefel, HGL (corresponding author), Univ Otago, Dept Phys, Dunedin, New Zealand.	harald.schwefel@otago.ac.nz	Schwefel, Harald G L/D-2710-2009; Leuchs, Gerd/G-6178-2012	Schwefel, Harald G L/0000-0002-4304-6469; Leuchs, Gerd/0000-0003-1967-2766; Rueda, Alfredo/0000-0001-6249-5860	Marsden Fund Council; Julius von Haast Fellowship; Max Planck Institute for the Science of Light, Erlangen, Germany	Marsden Fund Council(Royal Society of New ZealandMarsden Fund (NZ)); Julius von Haast Fellowship; Max Planck Institute for the Science of Light, Erlangen, Germany	This work was supported by the Marsden Fund Council and Julius von Haast Fellowship from government funding, managed by Royal Society Te Aparangi of New Zealand, and the Max Planck Institute for the Science of Light, Erlangen, Germany.	Ataie V, 2015, J LIGHTWAVE TECHNOL, V33, P694, DOI 10.1109/JLT.2015.2388579; Beha K, 2017, OPTICA, V4, P406, DOI 10.1364/OPTICA.4.000406; Breunig I, 2016, LASER PHOTONICS REV, V10, P569, DOI 10.1002/lpor.201600038; Herr SJ, 2018, OPT LETT, V43, P5745, DOI 10.1364/OL.43.005745; Hobbs P.C., 2011, BUILDING ELECTROOPTI; Holzwarth R, 2000, PHYS REV LETT, V85, P2264, DOI 10.1103/PhysRevLett.85.2264; Ilchenko VS, 2003, J OPT SOC AM B, V20, P333, DOI 10.1364/JOSAB.20.000333; Imran M, 2018, IEEE COMMUN SURV TUT, V20, P211, DOI 10.1109/COMST.2017.2775039; Kahn JM, 2017, NAT PHOTONICS, V11, P5, DOI 10.1038/nphoton.2016.256; Kippenberg TJ, 2011, SCIENCE, V332, P555, DOI 10.1126/science.1193968; KOUROGI M, 1993, IEEE J QUANTUM ELECT, V29, P2693, DOI 10.1109/3.250392; Kovacich RP, 2000, APPL OPTICS, V39, P4372, DOI 10.1364/AO.39.004372; LAW CK, 1994, PHYS REV A, V49, P433, DOI 10.1103/PhysRevA.49.433; Leo F, 2016, PHYS REV A, V93, DOI 10.1103/PhysRevA.93.043831; Li J, 2012, OPT EXPRESS, V20, P26337, DOI 10.1364/OE.20.026337; Liang W, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8957; Luo LW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4069; Mandel L, 1995, OPTICAL COHERENCE QU; Marin-Palomo P, 2017, NATURE, V546, P274, DOI 10.1038/nature22387; Mitchell G, 2017, FIBER INTEGRATED OPT, V36, P101, DOI 10.1080/01468030.2017.1326254; Pfeifle J, 2014, NAT PHOTONICS, V8, P375, DOI 10.1038/nphoton.2014.57; Pozar D, 2011, MICROWAVE ENG, V4th; Rueda A, 2016, OPTICA, V3, P597, DOI 10.1364/OPTICA.3.000597; Botello GS, 2018, OPTICA, V5, P1210, DOI 10.1364/OPTICA.5.001210; Stefszky M, 2018, PHYS REV A, V98, DOI 10.1103/PhysRevA.98.053850; Strekalov DV, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.033810; Strekalov DV, 2016, J OPTICS-UK, V18, DOI 10.1088/2040-8978/18/12/123002; Suh MG, 2018, OPTICA, V5, P65, DOI 10.1364/OPTICA.5.000065; Temprana E, 2015, SCIENCE, V348, P1445, DOI 10.1126/science.aab1781; Torres-Company V, 2014, LASER PHOTONICS REV, V8, P368, DOI 10.1002/lpor.201300126; Tsang M, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.063837; Zelmon DE, 1997, J OPT SOC AM B, V14, P3319, DOI 10.1364/JOSAB.14.003319	32	67	69	9	134	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 18	2019	568	7752					378	+		10.1038/s41586-019-1110-x	http://dx.doi.org/10.1038/s41586-019-1110-x			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HU0GZ	30996319	Green Submitted			2022-12-28	WOS:000464950700053
J	Shivkumar, K				Shivkumar, Kalyanam			Catheter Ablation of Ventricular Arrhythmias	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							STRUCTURAL HEART-DISEASE; INFARCTED HUMAN HEART; NONISCHEMIC CARDIOMYOPATHY; TACHYCARDIA ABLATION; RADIOFREQUENCY ABLATION; EXPERT CONSENSUS; OUTCOMES; SCAR; COMPLICATIONS; SUBSTRATE	Catheter ablation of ventricular tachycardia involves identifying the mechanism (a focus with abnormal impulse formation or a reentrant circuit), mapping the VT, and using radiofrequency current to ablate the tissue involved.	[Shivkumar, Kalyanam] Univ Calif Los Angeles, Cardiac Arrhythmia Ctr, 100 UCLA Med Plaza,Suite 660, Los Angeles, CA 90095 USA; [Shivkumar, Kalyanam] Univ Calif Los Angeles, David Geffen Sch Med, Electrophysiol Programs, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Shivkumar, K (corresponding author), Univ Calif Los Angeles, Cardiac Arrhythmia Ctr, 100 UCLA Med Plaza,Suite 660, Los Angeles, CA 90095 USA.	kshivkumar@mednet.ucla.edu	Shivkumar, Kalyanam/AAI-1085-2019	Shivkumar, Kalyanam/0000-0002-4121-1766				Al-Khatib Sana M, 2018, J Am Coll Cardiol, V72, pe91, DOI 10.1016/j.jacc.2017.10.054; Aliot EM, 2009, HEART RHYTHM, V6, P886, DOI 10.1016/j.hrthm.2009.04.030; [Anonymous], 2017, CIRC-ARRHYTHMIA ELEC, V10, ps1; Blanc JJ, 2008, EUROPACE, V10, P513, DOI 10.1093/europace/eun104; Bogun F, 2007, HEART RHYTHM, V4, P863, DOI 10.1016/j.hrthm.2007.03.003; Bogun FM, 2009, J AM COLL CARDIOL, V53, P1138, DOI 10.1016/j.jacc.2008.11.052; Bohnen M, 2011, HEART RHYTHM, V8, P1661, DOI 10.1016/j.hrthm.2011.05.017; Boyle NG, 2012, CIRCULATION, V126, P1752, DOI 10.1161/CIRCULATIONAHA.111.060327; Carbucicchio C, 2008, CIRCULATION, V117, P462, DOI 10.1161/CIRCULATIONAHA.106.686534; Cesario DA, 2006, HEART RHYTHM, V3, P1, DOI 10.1016/j.hrthm.2005.10.015; ClinicalTrials. gov, 2018, VENTR TACH; Cuculich PS, 2017, NEW ENGL J MED, V377, P2325, DOI 10.1056/NEJMoa1613773; Das MK, 2010, HEART RHYTHM, V7, P305, DOI 10.1016/j.hrthm.2009.11.006; DEBAKKER JMT, 1991, J AM COLL CARDIOL, V18, P1005, DOI 10.1016/0735-1097(91)90760-7; DEBAKKER JMT, 1993, CIRCULATION, V88, P915, DOI 10.1161/01.CIR.88.3.915; DELUNA AB, 1989, AM HEART J, V117, P151, DOI 10.1016/0002-8703(89)90670-4; Dinov B, 2014, CIRCULATION, V129, P728, DOI 10.1161/CIRCULATIONAHA.113.003063; Greener ID, 2012, J AM COLL CARDIOL, V60, P1103, DOI 10.1016/j.jacc.2012.04.042; Haqqani HM, 2011, HEART RHYTHM, V8, P1169, DOI 10.1016/j.hrthm.2011.03.008; HARTZLER GO, 1983, J AM COLL CARDIOL, V2, P1107, DOI 10.1016/S0735-1097(83)80337-4; Hsia HH, 2003, CIRCULATION, V108, P704, DOI 10.1161/01.CIR.0000083725.72693.EA; Jais P, 2012, CIRCULATION, V125, P2184, DOI 10.1161/CIRCULATIONAHA.111.043216; Knecht S, 2009, J AM COLL CARDIOL, V54, P522, DOI 10.1016/j.jacc.2009.03.065; Koplan BA, 2006, HEART RHYTHM, V3, P924, DOI 10.1016/j.hrthm.2006.03.031; Koruth JS, 2011, CIRC-ARRHYTHMIA ELEC, V4, P882, DOI 10.1161/CIRCEP.111.965731; Kuck KH, 2010, LANCET, V375, P31, DOI 10.1016/S0140-6736(09)61755-4; Lakkireddy D, 2012, J AM COLL CARDIOL, V60, P1531, DOI 10.1016/j.jacc.2012.06.035; Latchamsetty Rakesh, 2017, Card Electrophysiol Clin, V9, P133, DOI 10.1016/j.ccep.2016.10.010; Lopera G, 2004, J CARDIOVASC ELECTR, V15, P52, DOI 10.1046/j.1540-8167.2004.03189.x; Marrouche NF, 2004, J AM COLL CARDIOL, V43, P1715, DOI 10.1016/j.jacc.2004.03.004; Mathuria N, 2017, J INTERV CARD ELECTR, V48, P27, DOI 10.1007/s10840-016-0168-8; Michowitz Y, 2010, HEART RHYTHM, V7, P1635, DOI 10.1016/j.hrthm.2010.07.009; MILLER JM, 1985, AM J CARDIOL, V55, P980, DOI 10.1016/0002-9149(85)90730-1; Miller John M, 2017, Card Electrophysiol Clin, V9, P1, DOI 10.1016/j.ccep.2016.10.001; Morady F, 1999, NEW ENGL J MED, V340, P534, DOI 10.1056/NEJM199902183400707; Nakahara S, 2010, HEART RHYTHM, V7, P1817, DOI 10.1016/j.hrthm.2010.07.032; Nakahara S, 2010, J AM COLL CARDIOL, V55, P2355, DOI 10.1016/j.jacc.2010.01.041; Palaniswamy C, 2014, HEART RHYTHM, V11, P2056, DOI 10.1016/j.hrthm.2014.07.012; Pedersen CT, 2014, HEART RHYTHM, V11, pE166, DOI 10.1016/j.hrthm.2014.07.024; Pokorney SD, 2016, HEART RHYTHM, V13, P1748, DOI 10.1016/j.hrthm.2016.04.001; Reddy VY, 2007, NEW ENGL J MED, V357, P2657, DOI 10.1056/NEJMoa065457; Reddy YM, 2014, CIRC-ARRHYTHMIA ELEC, V7, P244, DOI 10.1161/CIRCEP.113.000548; Roberts-Thomson KC, 2011, NAT REV CARDIOL, V8, P311, DOI 10.1038/nrcardio.2011.15; Rutherford SL, 2012, CIRC RES, V111, P301, DOI 10.1161/CIRCRESAHA.111.260943; Sacher F, 2010, J AM COLL CARDIOL, V55, P2366, DOI 10.1016/j.jacc.2009.10.084; Santangeli P, 2015, CIRC-ARRHYTHMIA ELEC, V8, P1413, DOI 10.1161/CIRCEP.115.003562; Sapp JL, 2016, NEW ENGL J MED, V375, P111, DOI 10.1056/NEJMoa1513614; Sapp JL, 2013, CIRCULATION, V128, P2289, DOI 10.1161/CIRCULATIONAHA.113.003423; Shivkumar K, 2016, J PHYSIOL-LONDON, V594, P3911, DOI 10.1113/JP271870; Sosa E, 1999, PACE, V22, P128, DOI 10.1111/j.1540-8159.1999.tb00311.x; Stevenson WG, 2007, CIRCULATION, V115, P2750, DOI 10.1161/CIRCULATIONAHA.106.655720; Stevenson WG, 2013, HEART RHYTHM, V10, P1919, DOI 10.1016/j.hrthm.2013.10.019; Stevenson WG, 2008, CIRCULATION, V118, P2773, DOI 10.1161/CIRCULATIONAHA.108.788604; Tholakanahalli VN, 2013, HEART RHYTHM, V10, P292, DOI 10.1016/j.hrthm.2012.10.031; Tung R, 2015, HEART RHYTHM, V12, P2488, DOI 10.1016/j.hrthm.2015.08.014; Tung R, 2015, HEART RHYTHM, V12, P1997, DOI 10.1016/j.hrthm.2015.05.036; Tung R, 2013, HEART RHYTHM, V10, P490, DOI 10.1016/j.hrthm.2012.12.013; Tung R, 2012, CIRC-ARRHYTHMIA ELEC, V5, P264, DOI 10.1161/CIRCEP.111.967976; Vaseghi M, 2008, PROG CARDIOVASC DIS, V50, P404, DOI 10.1016/j.pcad.2008.01.003; Vaseghi M, 2017, J AM COLL CARDIOL, V69, P3070, DOI 10.1016/j.jacc.2017.04.035; Yagishita D, 2013, CIRC-ARRHYTHMIA ELEC, V6, P776, DOI 10.1161/CIRCEP.113.000448; Yu R, 2015, HEART RHYTHM, V12, P86, DOI 10.1016/j.hrthm.2014.10.004	62	33	33	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 18	2019	380	16					1555	1564		10.1056/NEJMra1615244	http://dx.doi.org/10.1056/NEJMra1615244			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU3AO	30995375				2022-12-28	WOS:000465144100016
J	Brand, A; Gao, LD; Hamann, A; Crayen, C; Brand, H; Squier, SM; Stangl, K; Kendel, F; Stangl, V				Brand, Anna; Gao, Linde; Hamann, Alexandra; Crayen, Claudia; Brand, Hannah; Squier, Susan M.; Stangl, Karl; Kendel, Friederike; Stangl, Verena			Medical Graphic Narratives to Improve Patient Comprehension and Periprocedural Anxiety Before Coronary Angiography and Percutaneous Coronary Intervention: A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Letter							INFORMED-CONSENT		[Brand, Anna; Gao, Linde; Brand, Hannah; Stangl, Karl; Kendel, Friederike; Stangl, Verena] Charite Univ Med Berlin, Berlin, Germany; [Brand, Anna; Stangl, Karl; Stangl, Verena] DZHK German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany; [Hamann, Alexandra] Mintwissen, Berlin, Germany; [Crayen, Claudia] Free Univ Berlin, Berlin, Germany; [Squier, Susan M.] Penn State Univ, University Pk, PA 16802 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Centre for Cardiovascular Research; Free University of Berlin; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Brand, A (corresponding author), Charite Univ Med Berlin, Berlin, Germany.; Brand, A (corresponding author), DZHK German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany.	anna.brand@charite.de		Kendel, Friederike/0000-0002-3726-0338	Friede Springer Herz Stiftung, Berlin	Friede Springer Herz Stiftung, Berlin	We thank Sophia Martineck for illustrations, and the Friede Springer Herz Stiftung, Berlin, for funding.	Chandrasekharan DP, 2011, EUR J CARDIO-THORAC, V39, P912, DOI 10.1016/j.ejcts.2010.08.033; Houts PS, 2006, PATIENT EDUC COUNS, V61, P173, DOI 10.1016/j.pec.2005.05.004; Lattuca B, 2018, AM HEART J, V200, P67, DOI 10.1016/j.ahj.2018.03.006; MAYER RE, 1994, J EDUC PSYCHOL, V86, P389, DOI 10.1037/0022-0663.86.3.389; Neumann FJ, 2019, EUR HEART J, V40, P87, DOI 10.1093/eurheartj/ehy394	5	15	15	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2019	170	8					579	+		10.7326/M18-2976	http://dx.doi.org/10.7326/M18-2976			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU7YQ	30959523				2022-12-28	WOS:000465499900026
J	Agren, J				Agren, Jon			Pollinators, herbivores, and the evolution of floral traits	SCIENCE			English	Editorial Material							ARTIFICIAL SELECTION		[Agren, Jon] Uppsala Univ, Dept Ecol & Genet, EBC, Uppsala, Sweden	Uppsala University	Agren, J (corresponding author), Uppsala Univ, Dept Ecol & Genet, EBC, Uppsala, Sweden.		Ågren, Jon/E-6093-2011	Ågren, Jon/0000-0001-9573-2463	Swedish Research Council; Formas	Swedish Research Council(Swedish Research CouncilEuropean Commission); Formas(Swedish Research Council Formas)	This work was financially supported by the Swedish Research Council and Formas.	Agren J, 2013, P NATL ACAD SCI USA, V110, P18202, DOI 10.1073/pnas.1301421110; Franks SJ, 2018, INT J PLANT SCI, V179, P175, DOI 10.1086/696220; Guimaraes PR, 2017, NATURE, V550, P511, DOI 10.1038/nature24273; Johnson MTJ, 2015, ANNU REV ECOL EVOL S, V46, P191, DOI 10.1146/annurev-ecolsys-112414-054215; Ramos SE, 2019, SCIENCE, V364, P193, DOI 10.1126/science.aav6962; Santangelo JS, 2019, J EVOLUTION BIOL, V32, P4, DOI 10.1111/jeb.13392; Sletvold N, 2015, ECOLOGY, V96, P214, DOI 10.1890/14-0119.1; Strauss S.Y., 2006, ECOLOGY EVOLUTION FL, P120; Thomann M, 2018, ECOLOGY, V99, P2167, DOI 10.1002/ecy.2470; WILLIAMS PH, 1986, SCIENCE, V232, P1385, DOI 10.1126/science.232.4756.1385; Zu PJ, 2016, NEW PHYTOL, V209, P1208, DOI 10.1111/nph.13652	11	4	5	7	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2019	364	6436					122	123		10.1126/science.aax1656	http://dx.doi.org/10.1126/science.aax1656			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HT5RC	30975872				2022-12-28	WOS:000464620000018
J	Dyer, O				Dyer, Owen			US authorities seek $3bn penalty in criminal charges against UK opioid maker	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 11	2019	365								l1777	10.1136/bmj.l1777	http://dx.doi.org/10.1136/bmj.l1777			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU0ER	30975660				2022-12-28	WOS:000464944700016
J	Sneyd, JR				Sneyd, J. Robert			ESSAY Capital punishment, my sixth great grandfather, and me-an essay by J Robert Sneyd	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sneyd, J. Robert] Univ Plymouth, Fac Med & Dent, Plymouth, Devon, England	University of Plymouth	Sneyd, JR (corresponding author), Univ Plymouth, Fac Med & Dent, Plymouth, Devon, England.	robert.sneyd@pms.ac.uk	Sneyd, John/AFV-7886-2022; Sneyd, John Robert/B-2957-2012; Sneyd, John/AFV-7887-2022	Sneyd, John/0000-0003-3546-9856; Sneyd, John Robert/0000-0003-3546-9856; Sneyd, John/0000-0003-3546-9856				Caplan L., 2016, NEW YORKER; Dyer C, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1085; Dyer O., 2019, BMJ-BRIT MED J, V365, pI620; Fielding S., 2008, EXECUTIONERS BIBLE S; Lind D., 2015, VOX              JUN; Pilkington Ed, 2017, GUARDIAN; Segura L., 2019, THE INTERCEPT	7	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 11	2019	365								l1512	10.1136/bmj.l1512	http://dx.doi.org/10.1136/bmj.l1512			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU0ER	30975662	Green Submitted			2022-12-28	WOS:000464944700004
J	[Anonymous]				[Anonymous]			Green Foods and Vitamins (Reprinted from JAMA, vol 72, pg 1077-1078, 1919)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		[Anonymous], 1918, JAMA-J AM MED ASSOC, V71; [Anonymous], 1914, JAMA-J AM MED ASSOC, V63; [Anonymous], 1918, JAMA-J AM MED ASSOC, V71; [Anonymous], 1916, JAMA-J AM MED ASSOC, V76; [Anonymous], 1918, JAMA-J AM MED ASSOC, V71; [Anonymous], 1918, JAMA-J AM MED ASSOC, V71; [Anonymous], 1916, JAMA-J AM MED ASSOC, V66; [Anonymous], 1916, JAMA-J AM MED ASSOC, V67; Osborne T. B., 1918, P SOC EXP BIOL MED, V16; Osborne TB, 1919, J BIOL CHEM, V37, P187; VOEGTLIN Carl, 1918, Public Health Reports, V33, P647, DOI 10.2307/4574788; 1919, JAMA, V72, P1077	12	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 9	2019	321	14					1414	1414		10.1001/jama.2018.15286	http://dx.doi.org/10.1001/jama.2018.15286			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HT5PG	30964518				2022-12-28	WOS:000464615200031
J	Remuzzi, G; Ricciardi, W				Remuzzi, Giuseppe; Ricciardi, Walter			Why and how did Leonardo happen: the Renaissance context	LANCET			English	Editorial Material									[Remuzzi, Giuseppe] Ctr Anna Maria Astori, IRCCS, Ist Ric Farmacol Mario Negri, Sci & Technol Pk Kilometro Rosso, I-24126 Bergamo, Italy; [Remuzzi, Giuseppe] Univ Milan, L Sacco Dept Biomed & Clin Sci, Milan, Italy; [Ricciardi, Walter] Univ Cattolica Sacro Cuore, Rome, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Milan; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Remuzzi, G (corresponding author), Ctr Anna Maria Astori, IRCCS, Ist Ric Farmacol Mario Negri, Sci & Technol Pk Kilometro Rosso, I-24126 Bergamo, Italy.; Remuzzi, G (corresponding author), Univ Milan, L Sacco Dept Biomed & Clin Sci, Milan, Italy.	giuseppe.remuzzi@marionegri.it	Ricciardi, Walter/AAB-2056-2019	Ricciardi, Walter/0000-0002-5655-688X				Barbagallo C., 1964, STORIA UNIVERSALE 1, V4, P102; BELL J, 1993, J WARBURG COURTAULD, V56, P100, DOI 10.2307/751367; BRAMLY S, 1991, LEONARDO DISCOVERING; Cognasso F., 1965, SOCIETA COSTUME PANO, V5, p[307, 723, 833]; da Vinci L., CODEX ATLANTICUS; Fornasari L, 2001, VERROCCHIO LATELIER; Johnson P., 2000, RENAISSANCE; Plumb J.H., 2001, ITALIAN RENAISSANCE; Porter R., 1997, GREATEST BENEFIT MAN	9	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 6	2019	393	10179					1396	1397		10.1016/S0140-6736(19)30548-3	http://dx.doi.org/10.1016/S0140-6736(19)30548-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HS0OU	30967202				2022-12-28	WOS:000463561000010
J	Newman, M				Newman, Melanie			EXCLUSIVE Most men on top BMA committee don't think lack of diversity is a problem	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Newman M, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1614	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 5	2019	365								l1638	10.1136/bmj.l1638	http://dx.doi.org/10.1136/bmj.l1638			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HS6UC	30952649				2022-12-28	WOS:000464005800006
J	Dyer, C				Dyer, Clare			Gynaecologist is suspended for insensitive remarks in front of colleagues	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2019	364								l1390	10.1136/bmj.l1390	http://dx.doi.org/10.1136/bmj.l1390			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HR5VS	30957773				2022-12-28	WOS:000463215700011
J	Ross, ZE; Trugman, DT; Hauksson, E; Shearer, PM				Ross, Zachary E.; Trugman, Daniel T.; Hauksson, Egill; Shearer, Peter M.			Searching for hidden earthquakes in Southern California	SCIENCE			English	Article							MAYOR-CUCAPAH EARTHQUAKE; AFTERSHOCKS DRIVEN; FAULT STRUCTURE; UNITED-STATES; MAGNITUDE; SEISMICITY; LANDERS; VALLEY; SWARM	Earthquakes follow a well-known power-law size relation, with smaller events occurring much more often than larger events. Earthquake catalogs are thus dominated by small earthquakes yet are still missing a much larger number of even smaller events because of signal fidelity issues. To overcome these limitations, we applied a template-matching detection technique to the entire waveform archive of the regional seismic network in Southern California. This effort resulted in a catalog with 1.81 million earthquakes, a 10-fold increase, which provides important insights into the geometry of fault zones at depth, foreshock behavior and nucleation processes, and earthquake-triggering mechanisms. The rich detail resolved in this type of catalog will facilitate the next generation of analyses of earthquakes and faults.	[Ross, Zachary E.; Hauksson, Egill] CALTECH, Seismol Lab, Pasadena, CA 91125 USA; [Trugman, Daniel T.] Los Alamos Natl Lab, Geophys Grp, Earth & Environm Sci Div, Los Alamos, NM 87545 USA; [Shearer, Peter M.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	California Institute of Technology; United States Department of Energy (DOE); Los Alamos National Laboratory; University of California System; University of California San Diego; Scripps Institution of Oceanography	Ross, ZE (corresponding author), CALTECH, Seismol Lab, Pasadena, CA 91125 USA.	zross@gps.caltech.edu	; Shearer, Peter/K-5247-2012	Ross, Zachary/0000-0002-6343-8400; Shearer, Peter/0000-0002-2992-7630; Trugman, Daniel/0000-0002-9296-4223; Hauksson, Egill/0000-0002-6834-5051	USGS/NEHRP grant [G18AP00028]; NSF [EAR-1550704, EAR-1818582, EAR-1033462]; Southern California Earthquake Center; Los Alamos National Laboratory LDRD program; USGS [G12AC20038]	USGS/NEHRP grant; NSF(National Science Foundation (NSF)); Southern California Earthquake Center; Los Alamos National Laboratory LDRD program(United States Department of Energy (DOE)Los Alamos National Laboratory); USGS(United States Geological Survey)	This research was supported by USGS/NEHRP grant G18AP00028; NSF awards EAR-1550704 and EAR-1818582; the Southern California Earthquake Center, which is funded by NSF Cooperative Agreement EAR-1033462 and USGS Cooperative Agreement G12AC20038; and by the Los Alamos National Laboratory LDRD program.	BENDER B, 1983, B SEISMOL SOC AM, V73, P831; Cochran ES, 2004, SCIENCE, V306, P1164, DOI 10.1126/science.1103961; DIETERICH J, 1994, J GEOPHYS RES-SOL EA, V99, P2601, DOI 10.1029/93JB02581; Ellsworth WL, 2018, NAT GEOSCI, V11, P531, DOI 10.1038/s41561-018-0145-1; Felzer KR, 2006, NATURE, V441, P735, DOI 10.1038/nature04799; Fukuyama E, 2003, B SEISMOL SOC AM, V93, P1468, DOI 10.1785/0120020123; Gibbons SJ, 2006, GEOPHYS J INT, V165, P149, DOI 10.1111/j.1365-246X.2006.02865.x; Gomberg J, 2001, NATURE, V411, P462, DOI 10.1038/35078053; Gutenberg B., 1944, B SEISMOL SOC AM, V34, P185, DOI [DOI 10.1785/BSSA0340040185, 10.1785/BSSA0340040185]; Hauksson E, 2000, J GEOPHYS RES-SOL EA, V105, P13875, DOI 10.1029/2000JB900016; Hauksson E, 2013, SEISMOL RES LETT, V84, P177, DOI 10.1785/0220120169; Hauksson E, 2012, B SEISMOL SOC AM, V102, P2239, DOI 10.1785/0120120010; HILL DP, 1993, SCIENCE, V260, P1617, DOI 10.1126/science.260.5114.1617; Huang MH, 2017, J GEOPHYS RES-SOL EA, V122, P607, DOI 10.1002/2016JB012858; Kato A, 2016, GEOPHYS RES LETT, V43, P8945, DOI 10.1002/2016GL070079; Kilb D, 2000, NATURE, V408, P570, DOI 10.1038/35046046; Lohman RB, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004596; Meng XF, 2014, GEOPHYS J INT, V197, P1750, DOI 10.1093/gji/ggu085; Mignan A, COMMUNITY ONLINE RES, DOI [10.5078/corssa-00180805, DOI 10.5078/CORSSA-00180805]; Miller SA, 2004, NATURE, V427, P724, DOI 10.1038/nature02251; Omori F, 1894, J COLL SCI IMP U TOK, V7, P111; Peng ZG, 2009, NAT GEOSCI, V2, P877, DOI 10.1038/ngeo697; Prejean SG, 2004, B SEISMOL SOC AM, V94, pS348, DOI 10.1785/0120040610; Richter C. F., 1935, B SEISMOL SOC AM, V25, P1; Ross ZE, 2018, B SEISMOL SOC AM, V108, P2894, DOI 10.1785/0120180080; Ross ZE, 2017, GEOPHYS RES LETT, V44, P8260, DOI 10.1002/2017GL074634; Ross ZE, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601946; Shearer PM, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015302; Shelly DR, 2007, NATURE, V446, P305, DOI 10.1038/nature05666; Shelly DR, 2016, J GEOPHYS RES-SOL EA, V121, P1776, DOI 10.1002/2015JB012719; Stein RS, 1999, NATURE, V402, P605, DOI 10.1038/45144; Tarantola A, 2005, INVERSE PROBLEM THEO; Toda S., 2011, 20111060 US GEOL SUR; Trugman DT, 2017, SEISMOL RES LETT, V88, P379, DOI 10.1785/0220160188; Wei SJ, 2015, EARTH PLANET SC LETT, V422, P115, DOI 10.1016/j.epsl.2015.03.054; Wei SJ, 2011, NAT GEOSCI, V4, P615, DOI 10.1038/ngeo1213; Wiemer S, 2000, B SEISMOL SOC AM, V90, P859, DOI 10.1785/0119990114; Zhu WQ, 2019, GEOPHYS J INT, V216, P261, DOI 10.1093/gji/ggy423	39	147	154	5	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 24	2019	364	6442					767	+		10.1126/science.aaw6888	http://dx.doi.org/10.1126/science.aaw6888			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1CD	31000593				2022-12-28	WOS:000469296000041
J	Loo, BW; Diehn, M				Loo, Billy W., Jr.; Diehn, Maximilian			SABR-COMET: harbinger of a new cancer treatment paradigm	LANCET			English	Editorial Material							CELL LUNG-CANCER; LOCAL CONSOLIDATIVE THERAPY; BODY RADIATION-THERAPY; MULTICENTER; TRIAL		[Loo, Billy W., Jr.; Diehn, Maximilian] Stanford Univ, Dept Radiat Oncol, Sch Med, Stanford, CA 94305 USA; [Loo, Billy W., Jr.; Diehn, Maximilian] Stanford Univ, Stanford Canc Inst, Sch Med, Stanford, CA 94305 USA; [Diehn, Maximilian] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA	Stanford University; Stanford Cancer Institute; Stanford University; Stanford University	Loo, BW (corresponding author), Stanford Univ, Dept Radiat Oncol, Sch Med, Stanford, CA 94305 USA.; Loo, BW (corresponding author), Stanford Univ, Stanford Canc Inst, Sch Med, Stanford, CA 94305 USA.	bwloo@stanford.edu						Ashworth AB, 2014, CLIN LUNG CANCER, V15, P346, DOI 10.1016/j.cllc.2014.04.003; Chang JY, 2015, LANCET ONCOL, V16, P630, DOI 10.1016/S1470-2045(15)70168-3; Chaudhuri AA, 2017, CANCER DISCOV, V7, P1394, DOI 10.1158/2159-8290.CD-17-0716; Favaudon V, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008973; Gomez DR, 2018, INT J RADIAT ONCOL, V102, P1604, DOI 10.1016/j.ijrobp.2018.08.050; Gomez DR, 2016, LANCET ONCOL, V17, P1672, DOI 10.1016/S1470-2045(16)30532-0; HELLMAN S, 1995, J CLIN ONCOL, V13, P8, DOI 10.1200/JCO.1995.13.1.8; Iyengar P, 2018, JAMA ONCOL, V4, P8; Nagata Y, 2018, INT J RADIAT ONCOL, V102, pS9, DOI 10.1016/j.ijrobp.2018.06.115; Nagata Y, 2015, INT J RADIAT ONCOL, V93, P989, DOI 10.1016/j.ijrobp.2015.07.2278; Nordlinger B, 1996, CANCER, V77, P1254, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1254::AID-CNCR5>3.3.CO;2-R; Palma DA, 2018, INT J RADIAT ONCOL, V102, pS3, DOI 10.1016/j.ijrobp.2018.06.105; Palma DA, 2019, LANCET, V393, P2051, DOI 10.1016/S0140-6736(18)32487-5; Pastorino U, 1997, J THORAC CARDIOV SUR, V113, P37, DOI 10.1016/S0022-5223(97)70397-0; Taniguchi CM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008523; Timmerman RD, 2018, JAMA ONCOL, V4, P1263, DOI 10.1001/jamaoncol.2018.1251	16	11	11	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 18	2019	393	10185					2013	2014		10.1016/S0140-6736(19)30278-8	http://dx.doi.org/10.1016/S0140-6736(19)30278-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HY4QC	30982688				2022-12-28	WOS:000468112000006
J	Cortese, I; Muranski, P; Enose-Akahata, Y; Ha, SK; Smith, B; Monaco, M; Ryschkewitsch, C; Major, EO; Ohayon, J; Schindler, MK; Beck, E; Reoma, LB; Jacobson, S; Reich, DS; Nath, A				Cortese, Irene; Muranski, Pawel; Enose-Akahata, Yoshimi; Ha, Seung-Kwon; Smith, Bryan; Monaco, MariaChiara; Ryschkewitsch, Caroline; Major, Eugene O.; Ohayon, Joan; Schindler, Matthew K.; Beck, Erin; Reoma, Lauren B.; Jacobson, Steve; Reich, Daniel S.; Nath, Avindra			Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CIDOFOVIR; JC	Background Progressive multifocal leukoencephalopathy (PML) is an opportunistic brain infection that is caused by the JC virus and is typically fatal unless immune function can be restored. Programmed cell death protein 1 (PD-1) is a negative regulator of the immune response that may contribute to impaired viral clearance. Whether PD-1 blockade with pembrolizumab could reinvigorate anti-JC virus immune activity in patients with PML was unknown. Methods We administered pembrolizumab at a dose of 2 mg per kilogram of body weight every 4 to 6 weeks to eight adults with PML, each with a different underlying predisposing condition. Each patient received at least one dose but no more than three doses. Results Pembrolizumab induced down-regulation of PD-1 expression on lymphocytes in peripheral blood and in cerebrospinal fluid (CSF) in all eight patients. Five patients had clinical improvement or stabilization of PML accompanied by a reduction in the JC viral load in the CSF and an increase in in vitro CD4+ and CD8+ anti-JC virus activity. In the other three patients, no meaningful change was observed in the viral load or in the magnitude of antiviral cellular immune response, and there was no clinical improvement. Conclusions Our findings are consistent with the hypothesis that in some patients with PML, pembrolizumab reduces JC viral load and increases CD4+ and CD8+ activity against the JC virus; clinical improvement or stabilization occurred in five of the eight patients who received pembrolizumab. Further study of immune checkpoint inhibitors in the treatment of PML is warranted. (Funded by the National Institutes of Health.)	[Cortese, Irene; Ohayon, Joan] NIH, Neuroimmunol Clin, Bldg 10, Bethesda, MD 20892 USA; [Enose-Akahata, Yoshimi; Jacobson, Steve] NIH, Viral Immunol Sect, Bldg 10, Bethesda, MD 20892 USA; [Smith, Bryan; Reoma, Lauren B.; Nath, Avindra] NIH, Sect Infect Nervous Syst, Bldg 10, Bethesda, MD 20892 USA; [Monaco, MariaChiara; Ryschkewitsch, Caroline; Major, Eugene O.] NIH, Lab Mol Med & Neurosci, Bldg 10, Bethesda, MD 20892 USA; [Ha, Seung-Kwon; Schindler, Matthew K.; Beck, Erin; Reich, Daniel S.] NIH, Translat Neuroradiol Sect, Bldg 10, Bethesda, MD 20892 USA; [Muranski, Pawel] NIH, NINDS, Bldg 10, Bethesda, MD 20892 USA; [Muranski, Pawel] NIH, Hematol Branch, NHLBI, Bldg 10, Bethesda, MD 20892 USA; [Muranski, Pawel] Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, New York, NY USA	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Columbia University	Cortese, I (corresponding author), Neuroimmunol Clin, 10 Ctr Dr.,5C103, Bethesda, MD 20892 USA.	corteseir@ninds.nih.gov	Reich, Daniel S./E-5701-2010; Schindler, Matthew/ABG-6790-2020; Beck, Erin/AAA-8399-2022; Enose-Akahata, Yoshimi/AAY-2327-2021	Reich, Daniel S./0000-0002-2628-4334; Schindler, Matthew/0000-0003-0157-5669; Reoma, Lauren/0000-0001-6305-7723	National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003119] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by the National Institutes of Health.	Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Clifford DB, 2013, J NEUROVIROL, V19, P351, DOI 10.1007/s13365-013-0173-y; Darvin P, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0191-1; Enose-Akahata Y, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007042; Gasnault J, 2001, J NEUROVIROL, V7, P375; Hall CD, 1998, NEW ENGL J MED, V338, P1345, DOI 10.1056/NEJM199805073381903; Jamilloux Y, 2016, CLIN DRUG INVEST, V36, P783, DOI 10.1007/s40261-016-0433-8; Major EO, 2018, LANCET NEUROL, V17, P578, DOI 10.1016/S1474-4422(18)30040-1; Marra CM, 2002, AIDS, V16, P1791, DOI 10.1097/00002030-200209060-00012; Ryschkewitsch C, 2004, J VIROL METHODS, V121, P217, DOI 10.1016/j.jviromet.2004.06.021; Ryschkewitsch CF, 2013, J CLIN VIROL, V57, P243, DOI 10.1016/j.jcv.2013.03.009; Tan CS, 2012, JAIDS-J ACQ IMM DEF, V60, P244, DOI 10.1097/QAI.0b013e31825a313c	12	176	178	1	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 25	2019	380	17					1597	1605		10.1056/NEJMoa1815039	http://dx.doi.org/10.1056/NEJMoa1815039			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU9FC	30969503	Bronze			2022-12-28	WOS:000465598600007
J	Slomski, A				Slomski, Anita			Flexible Duty Hours, Sleep, and Patient Outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2019	321	16					1558	1558		10.1001/jama.2019.4594	http://dx.doi.org/10.1001/jama.2019.4594			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HV7BZ	31012932				2022-12-28	WOS:000466137800040
J	Bhandari, S; Kumar, R				Bhandari, Shruti; Kumar, Rohit			A Thrombotic Thrombocytopenic Purpura	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bhandari, Shruti; Kumar, Rohit] Univ Louisville, Louisville, KY 40292 USA	University of Louisville	Bhandari, S (corresponding author), Univ Louisville, Louisville, KY 40292 USA.	s0bhan04@louisville.edu	Bhandari, Shruti/W-2143-2019; Kumar, Rohit/Q-1356-2019	Bhandari, Shruti/0000-0002-7576-8896; Kumar, Rohit/0000-0002-5815-0541					0	6	7	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 18	2019	380	16							e23	10.1056/NEJMicm1813768	http://dx.doi.org/10.1056/NEJMicm1813768			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU3AO	30995377				2022-12-28	WOS:000465144100001
J	Lu, ML; Ma, XC; Castillo-Menendez, LR; Gorman, J; Alsahafi, N; Ermel, U; Terry, DS; Chambers, M; Peng, DJ; Zhang, BS; Zhou, TQ; Reichard, N; Wang, K; Grover, JR; Carman, BP; Gardner, MR; Nikic-Spiegel, I; Sugawara, A; Arthos, J; Lemke, EA; Smith, AB; Farzan, M; Abrams, C; Munro, JB; McDermott, AB; Finzi, A; Kwong, PD; Blanchard, SC; Sodroski, JG; Mothes, W				Lu, Maolin; Ma, Xiaochu; Castillo-Menendez, Luis R.; Gorman, Jason; Alsahafi, Nirmin; Ermel, Utz; Terry, Daniel S.; Chambers, Michael; Peng, Dongjun; Zhang, Baoshan; Zhou, Tongqing; Reichard, Nick; Wang, Kevin; Grover, Jonathan R.; Carman, Brennan P.; Gardner, Matthew R.; Nikic-Spiegel, Ivana; Sugawara, Akihiro; Arthos, James; Lemke, Edward A.; Smith, Amos B., III; Farzan, Michael; Abrams, Cameron; Munro, James B.; McDermott, Adrian B.; Finzi, Andres; Kwong, Peter D.; Blanchard, Scott C.; Sodroski, Joseph G.; Mothes, Walther			Associating HIV-1 envelope glycoprotein structures with states on the virus observed by smFRET	NATURE			English	Article							CRYO-EM STRUCTURE; CRYSTAL-STRUCTURE; RECOGNITION; TRIMERS; REVEALS; VACCINE; VIREMIA; SURFACE	The HIV-1 envelope glycoprotein (Env) trimer mediates cell entry and is conformationally dynamic(1-8.) Imaging by single-molecule fluorescence resonance energy transfer (smFRET) has revealed that, on the surface of intact virions, mature pre-fusion Env transitions from a pre-triggered conformation (state 1) through a default intermediate conformation (state 2) to a conformation in which it is bound to three CD4 receptor molecules (state 3)(8-10). It is currently unclear how these states relate to known structures. Breakthroughs in the structural characterization of the HIV-1 Env trimer have previously been achieved by generating soluble and proteolytically cleaved trimers of gp140 Env that are stabilized by a disulfide bond, an isoleucine-to-proline substitution at residue 559 and a truncation at residue 664 (SOSIP. 664 trimers)(5,11-18). Cryo-electron microscopy studies have been performed with C-terminally truncated Env of the HIV-1(JR-FL) strain in complex with the antibody PGT151(19). Both approaches have revealed similar structures for Env. Although these structures have been presumed to represent the pre-triggered state 1 of HIV-1 Env, this hypothesis has never directly been tested. Here we use smFRET to compare the conformational states of Env trimers used for structural studies with native Env on intact virus. We find that the constructs upon which extant high-resolution structures are based predominantly occupy downstream conformations that represent states 2 and 3. Therefore, the structure of the pretriggered state-1 conformation of viral Env that has been identified by smFRET and that is preferentially stabilized by many broadly neutralizing antibodies-and thus of interest for the design of immunogens-remains unknown.	[Lu, Maolin; Ma, Xiaochu; Ermel, Utz; Reichard, Nick; Wang, Kevin; Grover, Jonathan R.; Carman, Brennan P.; Mothes, Walther] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06520 USA; [Castillo-Menendez, Luis R.; Sodroski, Joseph G.] Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02115 USA; [Castillo-Menendez, Luis R.; Sodroski, Joseph G.] Harvard Med Sch, Dept Microbiol, Boston, MA 02115 USA; [Gorman, Jason; Chambers, Michael; Peng, Dongjun; Zhang, Baoshan; Zhou, Tongqing; McDermott, Adrian B.; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Alsahafi, Nirmin; Finzi, Andres] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Alsahafi, Nirmin; Finzi, Andres] Univ Montreal, Dept Microbiol Infectiol & Immunol, CRCHUM, Montreal, PQ, Canada; [Terry, Daniel S.; Blanchard, Scott C.] Weill Cornell Med, Dept Physiol & Biophys, New York, NY 10065 USA; [Gardner, Matthew R.; Farzan, Michael] Scripps Res Inst, Dept Immunol & Microbiol, Jupiter, FL USA; [Nikic-Spiegel, Ivana] Univ Tubingen, Werner Reichardt Ctr Integrat Neurosci, Tubingen, Germany; [Sugawara, Akihiro; Smith, Amos B., III] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Arthos, James] NIAID, Lab Immunoregulat, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Lemke, Edward A.] Johannes Gutenberg Univ Mainz, Dept Biol, Mainz, Germany; [Lemke, Edward A.] Johannes Gutenberg Univ Mainz, Dept Chem Pharm & Geosci, Mainz, Germany; [Lemke, Edward A.] Johannes Gutenberg Univ Mainz, IMB, Mainz, Germany; [Lemke, Edward A.] EMBL, Struct & Computat Biol Unit, Heidelberg, Germany; [Lemke, Edward A.] EMBL, Cell Biol & Biophys Unit, Heidelberg, Germany; [Abrams, Cameron] Drexel Univ, Dept Chem & Biol Engn, Philadelphia, PA 19104 USA; [Munro, James B.] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA	Yale University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); McGill University; Universite de Montreal; Cornell University; Scripps Research Institute; Eberhard Karls University of Tubingen; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Institute of Molecular Biology (IMB); Johannes Gutenberg University of Mainz; European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Drexel University; Tufts University	Mothes, W (corresponding author), Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06520 USA.; Sodroski, JG (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02115 USA.; Sodroski, JG (corresponding author), Harvard Med Sch, Dept Microbiol, Boston, MA 02115 USA.; Blanchard, SC (corresponding author), Weill Cornell Med, Dept Physiol & Biophys, New York, NY 10065 USA.	scb2005@med.cornell.edu; Joseph_Sodroski@dfci.harvard.edu; walther.mothes@yale.edu	McDermott, Adrian B/E-7306-2011; Zhou, Tongqing/A-6880-2010; Sugawara, Akihiro/G-6120-2017; Blanchard, Scott C./A-5804-2009; Gorman, Jason/AGG-9417-2022; Lu, Maolin/U-7778-2017; Lemke, Edward/J-3337-2015	Zhou, Tongqing/0000-0002-3935-4637; Sugawara, Akihiro/0000-0003-1266-7497; Blanchard, Scott C./0000-0003-2717-9365; Gorman, Jason/0000-0002-3775-6560; Reichard, Nick/0000-0002-1366-2287; McDermott, Adrian/0000-0003-0616-9117; Lu, Maolin/0000-0002-8099-6447; Nikic, Ivana/0000-0002-6666-3486; Lemke, Edward/0000-0002-0634-0503; Gardner, Matthew/0000-0003-2872-7597; Farzan, Michael/0000-0002-2990-5319; Wang, Kevin/0000-0002-4911-4848	NIH [RO1 GM116654, UM1 AI100645, RO1 GM098859, RO1 AI124982, RO1 AI100645, K22 AI116262]; CRC [RCHS0235]; CIHR foundation [352417, PO1 GM056550]; Brown Coxe Fellowship; China Scholarship Council; International AIDS Vaccine Initiative's (IAVI's) Neutralizing Antibody Consortium; Intramural Research Program of the Vaccine Research Center (NIAID, NIH); Emmy-Noether programme of the German Research Foundation [317530061];  [SFB1129]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100645, R01AI145547, K22AI116262, ZIAAI005143, ZICAI005114, ZIAAI000883, ZIAAI005023, R01AI124982] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM056550, R01GM116654] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); CIHR foundation(Canadian Institutes of Health Research (CIHR)); Brown Coxe Fellowship; China Scholarship Council(China Scholarship Council); International AIDS Vaccine Initiative's (IAVI's) Neutralizing Antibody Consortium; Intramural Research Program of the Vaccine Research Center (NIAID, NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Emmy-Noether programme of the German Research Foundation(German Research Foundation (DFG)); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. B. Ward, R. W. Sanders and P. J. Bjorkman for discussions, R. Blakemore for assistance with molecular modelling, D. Burton and M. Feinberg for reagents including PGT121, PGT122, PGT145, PGT151 and NC-Cow1, NC-Cow8, NC-Cow9 and NC-Cow10 antibodies, and the AIDS Research and the Reference Reagent Program (Division of AIDS, NIAID, NIH) for the antibodies 3BNC117, 10-1074, PG9 and PG16. This work was supported by NIH grants RO1 GM116654 and UM1 AI100645 to W. M., RO1 GM098859 to S.C.B., RO1 AI124982 and RO1 AI100645 to J.G.S., K22 AI116262 to J. B. M., CRC Tier 2 RCHS0235 and a CIHR foundation grant 352417 to A.F., PO1 GM056550 to W. M., J.G.S., S.C.B, A.B.S. and C.A., by a Brown Coxe Fellowship to M.L., a fellowship from the China Scholarship Council-Yale World Scholars to X.M., by the International AIDS Vaccine Initiative's (IAVI's) Neutralizing Antibody Consortium to P.D.K. and by the Intramural Research Program of the Vaccine Research Center (NIAID, NIH) to P.D.K. and A. B. M., and by the SFB1129 and the Emmy-Noether programme (project number 317530061) of the German Research Foundation to E.A.L. and I.N.-S., respectively.	Aitken CE, 2008, BIOPHYS J, V94, P1826, DOI 10.1529/biophysj.107.117689; Alsahafi N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129405; Alsahafi N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122111; Bartesaghi A, 2013, NAT STRUCT MOL BIOL, V20, P1352, DOI 10.1038/nsmb.2711; Caskey M, 2017, NAT MED, V23, P185, DOI 10.1038/nm.4268; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Castillo-Menendez LR, 2019, J VIROL, V93, DOI 10.1128/JVI.01709-18; Chuang GY, 2017, J VIROL, V91, DOI 10.1128/JVI.02268-16; Dave R, 2009, BIOPHYS J, V96, P2371, DOI 10.1016/j.bpj.2008.11.061; Do Kwon Y, 2015, NAT STRUCT MOL BIOL, V22, P522, DOI 10.1038/nsmb.3051; Gardner MR, 2015, NATURE, V519, P87, DOI 10.1038/nature14264; Gristick HB, 2016, NAT STRUCT MOL BIOL, V23, P906, DOI 10.1038/nsmb.3291; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Haynes BF, 2017, SCIENCE, V355, P1129, DOI 10.1126/science.aan0662; Herschhorn A, 2016, MBIO, V7, DOI 10.1128/mBio.01598-16; Juette MF, 2016, NAT METHODS, V13, P341, DOI [10.1038/NMETH.3769, 10.1038/nmeth.3769]; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lee JH, 2016, SCIENCE, V351, P1043, DOI 10.1126/science.aad2450; Lin CW, 2006, J AM CHEM SOC, V128, P4542, DOI 10.1021/ja0604111; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Ma X, 2018, ELIFE, V7, P1; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; Munro JB, 2014, SCIENCE, V346, P759, DOI 10.1126/science.1254426; Nishimura Y, 2017, NATURE, V543, P559, DOI 10.1038/nature21435; Ozorowski G, 2017, NATURE, V547, P360, DOI 10.1038/nature23010; Pancera M, 2017, NAT CHEM BIOL, V13, P1115, DOI [10.1038/NCHEMBIO.2460, 10.1038/nchembio.2460]; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Poss M, 1999, J VIROL, V73, P5255, DOI 10.1128/JVI.73.7.5255-5264.1999; Sakin V, 2017, CELL CHEM BIOL, V24, P635, DOI 10.1016/j.chembiol.2017.04.007; Sanders RW, 2017, IMMUNOL REV, V275, P161, DOI 10.1111/imr.12481; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sen J, 2008, BIOCHEMISTRY-US, V47, P7788, DOI 10.1021/bi800227z; Sok D, 2017, NATURE, V548, P108, DOI 10.1038/nature23301; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Wang HQ, 2016, P NATL ACAD SCI USA, V113, pE7151, DOI 10.1073/pnas.1615939113; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yin J, 2006, NAT PROTOC, V1, P280, DOI 10.1038/nprot.2006.43; Zhong P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053138	40	97	99	6	93	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 18	2019	568	7752					415	+		10.1038/s41586-019-1101-y	http://dx.doi.org/10.1038/s41586-019-1101-y			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HU0GZ	30971821	Green Accepted			2022-12-28	WOS:000464950700061
J	Chou, R				Chou, Roger			Review: Opioids improve chronic noncancer pain, but difference may not be clinically meaningful in most patients	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Chou, Roger] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Oregon Health & Science University	Chou, R (corresponding author), Oregon Hlth & Sci Univ, Portland, OR 97201 USA.			Chou, Roger/0000-0001-9889-8610				Krebs EE, 2018, JAMA-J AM MED ASSOC, V319, P872, DOI 10.1001/jama.2018.0899; Moore RA, 2014, PAIN PRACT, V14, P378, DOI 10.1111/papr.12100; Olsen MF, 2018, J CLIN EPIDEMIOL, V101, P87, DOI 10.1016/j.jclinepi.2018.05.007	3	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2019	170	8					JC41	JC41		10.7326/ACPJ201904160-041	http://dx.doi.org/10.7326/ACPJ201904160-041			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU7YQ	30986831				2022-12-28	WOS:000465499900007
J	Marchiano, S; Murry, CE				Marchiano, Silvia; Murry, Charles E.			Lost in the fire	SCIENCE			English	Editorial Material									[Marchiano, Silvia; Murry, Charles E.] Univ Washington, Dept Pathol, 850 Republican St, Seattle, WA 98109 USA; [Marchiano, Silvia; Murry, Charles E.] Univ Washington, Ctr Cardiovasc Biol, 850 Republican St,Brotman Bldg, Seattle, WA 98109 USA; [Marchiano, Silvia; Murry, Charles E.] Univ Washington, Inst Stem Cell & Regenerat Med, 850 Republican St, Seattle, WA 98109 USA; [Murry, Charles E.] Univ Washington, Dept Med & Cardiol, 1959 NE Pacific St, Seattle, WA 98195 USA; [Murry, Charles E.] Univ Washington, Dept Bioengn, 3720 15th Ave NE, Seattle, WA 98105 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Murry, CE (corresponding author), Univ Washington, Dept Pathol, 850 Republican St, Seattle, WA 98109 USA.; Murry, CE (corresponding author), Univ Washington, Ctr Cardiovasc Biol, 850 Republican St,Brotman Bldg, Seattle, WA 98109 USA.; Murry, CE (corresponding author), Univ Washington, Inst Stem Cell & Regenerat Med, 850 Republican St, Seattle, WA 98109 USA.; Murry, CE (corresponding author), Univ Washington, Dept Med & Cardiol, 1959 NE Pacific St, Seattle, WA 98195 USA.; Murry, CE (corresponding author), Univ Washington, Dept Bioengn, 3720 15th Ave NE, Seattle, WA 98105 USA.	murry@uw.edu		Marchiano, Silvia/0000-0001-6198-518X	NIH [R01HL084642, R01HL128362, R01 HL128368, R01 HL141570, U01HL100405]; Fondation Leducq Transatlantic Networks of Excellence; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128368, R01HL128362, R01HL141570] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Leducq Transatlantic Networks of Excellence; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	C.E.M. is supported by NIH grants R01HL084642, R01HL128362, R01 HL128368, R01 HL141570, and U01HL100405 and a grant from the Fondation Leducq Transatlantic Networks of Excellence. C.E.M. is a scientific founder and equity holder in Cytocardia.	Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Asakura H., 2005, J NIPPON MED SCH, V6, P360; Bely AE, 2010, TRENDS ECOL EVOL, V25, P161, DOI 10.1016/j.tree.2009.08.005; Broeders EPM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145049; Chien KR, 2019, NAT BIOTECHNOL, V37, P232, DOI 10.1038/s41587-019-0042-1; Gonzalez-Rosa JM, 2018, DEV CELL, V44, P433, DOI 10.1016/j.devcel.2018.01.021; Hirose K, 2019, SCIENCE, V364, P184, DOI 10.1126/science.aar2038; Janssen R, 2017, EUR THYROID J, V6, P130, DOI 10.1159/000469708; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Olivetti G, 1996, J MOL CELL CARDIOL, V28, P1463, DOI 10.1006/jmcc.1996.0137; Patterson M, 2017, NAT GENET, V49, P1346, DOI 10.1038/ng.3929; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Vale C, 2019, CARDIOVASC DRUG THER, V33, P179, DOI 10.1007/s10557-019-06870-4; Yang XL, 2014, J MOL CELL CARDIOL, V72, P296, DOI 10.1016/j.yjmcc.2014.04.005; Yun MH, 2015, INT J MOL SCI, V16, P25392, DOI 10.3390/ijms161025392	15	0	0	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2019	364	6436					123	124		10.1126/science.aax1006	http://dx.doi.org/10.1126/science.aax1006			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HT5RC	30975873				2022-12-28	WOS:000464620000019
J	Watts, MC; Picco, L; Russell-Pavier, FS; Cullen, PL; Miller, TS; Bartus, SP; Payton, OD; Skipper, NT; Tileli, V; Howard, CA				Watts, Mitchell C.; Picco, Loren; Russell-Pavier, Freddie S.; Cullen, Patrick L.; Miller, Thomas S.; Bartus, Szymon P.; Payton, Oliver D.; Skipper, Neal T.; Tileli, Vasiliki; Howard, Christopher A.			Production of phosphorene nanoribbons	NATURE			English	Article							LAYER BLACK PHOSPHORUS; SODIUM; LITHIUM; 1ST-PRINCIPLES; MECHANISM; ANODE; INTERCALATION; DEGRADATION; TEMPERATURE; NANOTUBES	Phosphorene is a mono-elemental, two-dimensional (2D) substance with outstanding, highly directional properties and a bandgap that depends on the number of layers of the material(1-8). Nanoribbons, meanwhile, combine the flexibility and unidirectional properties of one-dimensional nanomaterials, the high surface area of 2D nanomaterials and the electron-confinement and edge effects of both. The structures of nanoribbons can thus lead to exceptional control over electronic band structure, the emergence of novel phenomena and unique architectures for applications(5,6,9-24). Phosphorene's intrinsically anisotropic structure has motivated numerous theoretical calculations of phosphorene nanoribbons (PNRs), predicting extraordinary properties(5,6,12-24). So far, however, discrete PNRs have not been produced. Here we present a method for creating quantities of high-quality, individual PNRs by ionic scissoring of macroscopic black phosphorus crystals. This top-down process results in stable liquid dispersions of PNRs with typical widths of 4-50 nm, predominantly single-layer thickness, measured lengths of up to 75 mu m and aspect ratios of up to 1,000. The nanoribbons are atomically flat single crystals, aligned exclusively in the zigzag crystallographic orientation. The ribbons have remarkably uniform widths along their entire lengths, and are extremely flexible. These properties-together with the ease of downstream manipulation via liquid-phase methods-should enable the search for predicted exotic states(6,12-14,17-19,21), and an array of applications in which PNRs have been predicted to offer transformative advantages. These applications range from thermoelectric devices to high-capacity fast-charging batteries and integrated high-speed electronic circuits(6,14-16,20,23,24).	[Watts, Mitchell C.; Cullen, Patrick L.; Bartus, Szymon P.; Skipper, Neal T.; Howard, Christopher A.] UCL, Dept Phys & Astron, London, England; [Picco, Loren; Russell-Pavier, Freddie S.; Payton, Oliver D.] Univ Bristol, HH Wills Phys Lab, Interface Anal Ctr, Bristol, Avon, England; [Picco, Loren] Virginia Commonwealth Univ, Dept Phys, Richmond, VA 23284 USA; [Cullen, Patrick L.; Miller, Thomas S.] UCL, Dept Chem Engn, Electrochem Innovat Lab, London, England; [Tileli, Vasiliki] Ecole Polytech Fed Lausanne, Inst Mat, Lausanne, Switzerland	University of London; University College London; University of Bristol; Virginia Commonwealth University; University of London; University College London; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Howard, CA (corresponding author), UCL, Dept Phys & Astron, London, England.	c.howard@ucl.ac.uk	Miller, Thomas/AAT-1108-2021	Miller, Thomas/0000-0002-2224-5768; Tileli, Vasiliki/0000-0002-0520-6900; Russell-Pavier, Freddie/0000-0002-2150-6989	Engineering and Physical Sciences Research Council (EPSRC); Royal Academy of Engineering; EPSRC [EP/P023851/1, EP/S001298/1]	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Academy of Engineering(Royal Academy of Engineering - UK); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This publication was funded, in part, by the Engineering and Physical Sciences Research Council (EPSRC). L.P. and O.D.P. thank the Royal Academy of Engineering for funding their time and for support, and also O. Ward for help with analysing the HS-AFM data. T.S.M. thanks the EPSRC for support via fellowship EP/P023851/1. P.L.C. thanks the EPSRC for support via fellowship EP/S001298/1. The HS-AFM data were collected using the University of Bristol's Low Noise Labs. We thank M. Wood for early experiments, and A. Sella and A. Pakpour-Tabrizi for enlightening discussions.	Abate Y, 2018, ADV MATER, V30, DOI 10.1002/adma.201704749; Abellan G, 2017, ANGEW CHEM INT EDIT, V56, P15267, DOI 10.1002/anie.201707462; Abellan G, 2017, J AM CHEM SOC, V139, P10432, DOI 10.1021/jacs.7b04971; Basma NS, 2018, J PHYS CHEM B, V122, P8963, DOI 10.1021/acs.jpcb.8b08020; Brent JR, 2016, RSC ADV, V6, P86955, DOI 10.1039/c6ra21296d; Cai JM, 2010, NATURE, V466, P470, DOI 10.1038/nature09211; Canet-Ferrer J, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/39/395703; Carvalho A, 2014, EPL-EUROPHYS LETT, V108, DOI 10.1209/0295-5075/108/47005; Cheng YC, 2017, CHEM MATER, V29, P1350, DOI 10.1021/acs.chemmater.6b05052; Clancy AJ, 2018, CHEM REV, V118, P7363, DOI 10.1021/acs.chemrev.8b00128; Cullen PL, 2017, NAT CHEM, V9, P244, DOI [10.1038/NCHEM.2650, 10.1038/nchem.2650]; Das PM, 2016, ACS NANO, V10, P5687, DOI 10.1021/acsnano.6b02435; Edmonds MT, 2015, ACS APPL MATER INTER, V7, P14557, DOI 10.1021/acsami.5b01297; EVERS EC, 1951, J AM CHEM SOC, V73, P2038, DOI 10.1021/ja01149a040; Favron A, 2015, NAT MATER, V14, P826, DOI [10.1038/NMAT4299, 10.1038/nmat4299]; Feng XW, 2018, ADV FUNCT MATER, V28, DOI 10.1002/adfm.201801524; Hanlon D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9563; Hembram KPSS, 2016, PHYS CHEM CHEM PHYS, V18, P21391, DOI 10.1039/c6cp02049f; Hembrarn KPSS, 2015, J PHYS CHEM C, V119, P15041, DOI 10.1021/acs.jpcc.5b05482; Hu W, 2017, J AM CHEM SOC, V139, P15429, DOI 10.1021/jacs.7b08474; KNEISL P, 1987, J CHEM ENG DATA, V32, P11, DOI 10.1021/je00047a003; Kosynkin DV, 2009, NATURE, V458, P872, DOI 10.1038/nature07872; Lee S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9573; Lewis EA, 2017, CHEM COMMUN, V53, P1445, DOI 10.1039/c6cc09658a; Li LK, 2014, NAT NANOTECHNOL, V9, P372, DOI [10.1038/NNANO.2014.35, 10.1038/nnano.2014.35]; Li WF, 2015, NANO LETT, V15, P1691, DOI 10.1021/nl504336h; Liu H, 2014, ACS NANO, V8, P4033, DOI 10.1021/nn501226z; Lui CH, 2009, NATURE, V462, P339, DOI 10.1038/nature08569; Mao NN, 2018, SMALL METHODS, V2, DOI 10.1002/smtd.201700409; Mayo M, 2016, CHEM MATER, V28, P2011, DOI 10.1021/acs.chemmater.5b04208; Mikheikin A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01891-9; Miller TS, 2017, NANO LETT, V17, P5891, DOI 10.1021/acs.nanolett.7b01353; Nourbakhsh Z, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.035437; Peng XH, 2014, MATER RES EXPRESS, V1, DOI 10.1088/2053-1591/1/4/045041; Penicaud A, 2005, J AM CHEM SOC, V127, P8, DOI 10.1021/ja0443373; Penicaud A, 2013, ACCOUNTS CHEM RES, V46, P129, DOI 10.1021/ar300141s; Phaneuf-L'Heureux AL, 2016, NANO LETT, V16, P7761, DOI 10.1021/acs.nanolett.6b03907; Picco LM, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/4/044030; Poljak M, 2016, NANO RES, V9, P1723, DOI 10.1007/s12274-016-1066-1; Qiao JS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5475; Reinhold R, 2018, ACS APPL MATER INTER, V10, P7096, DOI 10.1021/acsami.7b18697; Ribeiro HB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12191; Ribeiro HB, 2018, J RAMAN SPECTROSC, V49, P76, DOI 10.1002/jrs.5238; Scheer M, 2010, CHEM REV, V110, P4236, DOI 10.1021/cr100010e; Shin C, 2016, SPR SER ADV MICROELE, V56, P1, DOI 10.1007/978-94-017-7597-7; Sisakht ET, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.085417; Sorkin V, 2017, CRIT REV SOLID STATE, V42, P1, DOI 10.1080/10408436.2016.1182469; Sun J, 2015, NAT NANOTECHNOL, V10, P980, DOI [10.1038/nnano.2015.194, 10.1038/NNANO.2015.194]; Wang XM, 2015, NAT NANOTECHNOL, V10, P517, DOI [10.1038/nnano.2015.71, 10.1038/NNANO.2015.71]; Wood JD, 2014, NANO LETT, V14, P6964, DOI 10.1021/nl5032293; Woomer AH, 2015, ACS NANO, V9, P8869, DOI 10.1021/acsnano.5b02599; Wu QY, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.035436; Wu RJ, 2015, J VAC SCI TECHNOL A, V33, DOI 10.1116/1.4926753; Wu XH, 2016, AIP ADV, V6, DOI 10.1063/1.4948537; Xia FN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5458; Yagmurcukardes M, 2016, APPL PHYS REV, V3, DOI 10.1063/1.4966963; Yang G., 2016, PHYS REV B, V94, DOI DOI 10.1103/PHYSREVB.94.075106; Yang YR, 2016, RSC ADV, V6, P44019, DOI 10.1039/c6ra04069a; Yao QS, 2015, J PHYS CHEM C, V119, P6923, DOI 10.1021/acs.jpcc.5b02130; Yu XF, 2014, CHEM LETT, V43, P1940, DOI 10.1246/cl.140741; Zhang J, 2014, SCI REP-UK, V4, DOI 10.1038/srep06452; Zhang R, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15036; Zhang TM, 2018, J AM CHEM SOC, V140, P7561, DOI 10.1021/jacs.8b02156; Zhou QH, 2016, ANGEW CHEM INT EDIT, V55, P11437, DOI 10.1002/anie.201605168	65	146	147	33	418	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2019	568	7751					216	+		10.1038/s41586-019-1074-x	http://dx.doi.org/10.1038/s41586-019-1074-x			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HT2SH	30971839	Green Submitted			2022-12-28	WOS:000464412700045
J	Salisbury, H				Salisbury, Helen			PRIMARY COLOUR Helen Salisbury: Should I go private, doctor?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												helen.salisbury@phc.ox.ac.uk						Department of Health and Social Care Public Health England, 2019, HDB NHS CONST ENGL 1; Health Foundation, 2018, HLTH FDN RESP GOV AN; IACOBUCCI G, 2018, BMJ-BRIT MED J, V361, DOI DOI 10.1136/BMJ.K1606; NHS England, CONS LED REF TREATM	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2019	364								l873	10.1136/bmj.l873	http://dx.doi.org/10.1136/bmj.l873			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HR5VS	30957780	Bronze			2022-12-28	WOS:000463215700003
J	Lee, PV; Berwick, D; Sinsky, CA				Lee, Peter V.; Berwick, Donald; Sinsky, Christine A.			Building Trust Between the Government and Clinicians Person to Person and Organization to Organization	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE; HEALTH		[Lee, Peter V.] Covered Calif, 1601 Exposition Blvd, Sacramento, CA 95815 USA; [Berwick, Donald] Inst Healthcare Improvement, Boston, MA USA; [Sinsky, Christine A.] Amer Med Assoc, 515 N State St, Chicago, IL 60610 USA	Institute for Healthcare Improvement; American Medical Association	Lee, PV (corresponding author), Covered Calif, 1601 Exposition Blvd, Sacramento, CA 95815 USA.	peter.lee@covered.ca.gov						ABIM Foundation, PHYS CHART; Bock RW, 2016, NEW ENGL J MED, V374, P1201, DOI 10.1056/NEJMp1600068; Dzau VJ, 2018, NEW ENGL J MED, V378, P312, DOI 10.1056/NEJMp1715127; Dzau VJ, 2017, JAMA-J AM MED ASSOC, V317, P1461, DOI 10.1001/jama.2017.1964; Papanicolas I, 2018, JAMA-J AM MED ASSOC, V319, P1024, DOI 10.1001/jama.2018.1150; Sinsky C, 2016, ANN INTERN MED, V165, P753, DOI 10.7326/M16-0961; 2017, ANN FAM MED, V15, P419; 2016, MAYO CLIN P, V91, P836	8	7	7	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2019	321	18					1763	1764		10.1001/jama.2019.4499	http://dx.doi.org/10.1001/jama.2019.4499			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HY7ME	30969328				2022-12-28	WOS:000468319100007
J	Bashor, CJ; Patel, N; Choubey, S; Beyzavi, A; Kondev, J; Collins, JJ; Khalil, AS				Bashor, Caleb J.; Patel, Nikit; Choubey, Sandeep; Beyzavi, Ali; Kondev, Jane; Collins, James J.; Khalil, Ahmad S.			Complex signal processing in synthetic gene circuits using cooperative regulatory assemblies	SCIENCE			English	Article							TRANSCRIPTIONAL REGULATION; BINDING; COMBINATORIAL; BIOLOGY; INFORMATION; SPECIFICITY; EXPRESSION; PRINCIPLES; AFFINITY; NUMBERS	Eukaryotic genes are regulated by multivalent transcription factor complexes. Through cooperative self-assembly, these complexes perform nonlinear regulatory operations involved in cellular decision-making and signal processing. In this study, we apply this design principle to synthetic networks, testing whether engineered cooperative assemblies can program nonlinear gene circuit behavior in yeast. Using a model-guided approach, we show that specifying the strength and number of assembly subunits enables predictive tuning between linear and nonlinear regulatory responses for single- and multi-input circuits. We demonstrate that assemblies can be adjusted to control circuit dynamics. We harness this capability to engineer circuits that perform dynamic filtering, enabling frequency-dependent decoding in cell populations. Programmable cooperative assembly provides a versatile way to tune the nonlinearity of network connections, markedly expanding the engineerable behaviors available to synthetic circuits.	[Bashor, Caleb J.] Rice Univ, Dept Bioengn, Houston, TX 77030 USA; [Patel, Nikit; Khalil, Ahmad S.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Patel, Nikit; Khalil, Ahmad S.] Boston Univ, Biol Design Ctr, Boston, MA 02215 USA; [Choubey, Sandeep; Kondev, Jane] Brandeis Univ, Dept Phys, Waltham, MA 02453 USA; [Beyzavi, Ali] Boston Univ, Dept Mech Engn, Boston, MA 02215 USA; [Collins, James J.] MIT, Inst Med Engn & Sci, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Collins, James J.] MIT, Synthet Biol Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Collins, James J.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Collins, James J.; Khalil, Ahmad S.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA	Rice University; Boston University; Boston University; Brandeis University; Boston University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Khalil, AS (corresponding author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.; Khalil, AS (corresponding author), Boston Univ, Biol Design Ctr, Boston, MA 02215 USA.; Khalil, AS (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.	khalil@bu.edu		Choubey, Sandeep/0000-0002-7387-6148; Patel, Nikit/0000-0002-5033-8072; Bashor, Caleb/0000-0003-1354-2098	NSF Expeditions in Computing grant [CCF-1522074]; DARPA [W911NF-11-2-0056, D16AP00142]; NSF CAREER award [MCB-1350949]; NIH [1DP2AI131083-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [DP2AI131083] Funding Source: NIH RePORTER	NSF Expeditions in Computing grant(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSF CAREER award(National Science Foundation (NSF)NSF - Office of the Director (OD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NSF Expeditions in Computing grant CCF-1522074 (A.S.K.) and DARPA grant W911NF-11-2-0056 (J.J.C. and A.S.K.). A.S.K. also acknowledges funding from the NIH director's New Innovator award (1DP2AI131083-01), an NSF CAREER award (MCB-1350949), and a DARPA Young Faculty award (D16AP00142).	Antebi YE, 2017, CELL, V170, P1184, DOI 10.1016/j.cell.2017.08.015; Aymoz D, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20178024; Baker CR, 2012, CELL, V151, P80, DOI 10.1016/j.cell.2012.08.018; Bashor CJ, 2010, ANNU REV BIOPHYS, V39, P515, DOI 10.1146/annurev.biophys.050708.133652; Bennett MR, 2008, NATURE, V454, P1119, DOI 10.1038/nature07211; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; Bintu L, 2005, CURR OPIN GENET DEV, V15, P125, DOI 10.1016/j.gde.2005.02.006; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Brophy JAN, 2014, NAT METHODS, V11, P508, DOI [10.1038/NMETH.2926, 10.1038/nmeth.2926]; Buchler NE, 2003, P NATL ACAD SCI USA, V100, P5136, DOI 10.1073/pnas.0930314100; Buchler NE, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.30; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; Cookson S, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100032; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; Estrada J, 2016, CELL, V166, P234, DOI 10.1016/j.cell.2016.06.012; Ferrell JE, 2014, TRENDS BIOCHEM SCI, V39, P612, DOI 10.1016/j.tibs.2014.10.002; Garcia HG, 2011, METHOD ENZYMOL, V492, P27, DOI 10.1016/B978-0-12-381268-1.00014-8; Gertz J, 2009, NATURE, V457, P215, DOI 10.1038/nature07521; GUARENTE L, 1984, CELL, V36, P503, DOI 10.1016/0092-8674(84)90243-5; Hansen AS, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.56; Harris BZ, 2001, BIOCHEMISTRY-US, V40, P5921, DOI 10.1021/bi010142l; Hill A.V., 1910, J PHYSIOL-LONDON, V40, piv; Hnisz D, 2017, CELL, V169, P13, DOI 10.1016/j.cell.2017.02.007; Jantz D, 2010, BIOPHYS J, V98, P852, DOI 10.1016/j.bpj.2009.11.021; Kang JS, 2007, BIOCHEM J, V403, P177, DOI 10.1042/BJ20061644; Keung AJ, 2014, CELL, V158, P110, DOI 10.1016/j.cell.2014.04.047; Khalil AS, 2012, CELL, V150, P647, DOI 10.1016/j.cell.2012.05.045; Levine JH, 2013, SCIENCE, V342, P1193, DOI 10.1126/science.1239999; Levine M, 2010, CURR BIOL, V20, pR754, DOI 10.1016/j.cub.2010.06.070; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mao CH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.83; McIsaac RS, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1313; Mirny LA, 2010, P NATL ACAD SCI USA, V107, P22534, DOI 10.1073/pnas.0913805107; Mitchell A, 2015, SCIENCE, V350, P1379, DOI 10.1126/science.aab0892; Nevozhay D, 2009, P NATL ACAD SCI USA, V106, P5123, DOI 10.1073/pnas.0809901106; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; STRUHL K, 1991, NEURON, V7, P177, DOI 10.1016/0896-6273(91)90256-Y; Tuch BB, 2008, SCIENCE, V319, P1797, DOI 10.1126/science.1152398; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Vega NM, 2012, NAT CHEM BIOL, V8, P431, DOI [10.1038/NCHEMBIO.915, 10.1038/nchembio.915]; Veitia RA, 2003, BIOL REV, V78, P149, DOI 10.1017/S1464793102006036; Wang QL, 2010, CYTOM PART A, V77A, P101, DOI 10.1002/cyto.a.20812; Whitty A, 2008, NAT CHEM BIOL, V4, P435, DOI 10.1038/nchembio0808-435; Wiedemann U, 2004, J MOL BIOL, V343, P703, DOI 10.1016/j.jmb.2004.08.064; Williamson JR, 2008, NAT CHEM BIOL, V4, P458, DOI 10.1038/nchembio.102; Zhang Q, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130031; Zhu JW, 2016, NAT REV NEUROSCI, V17, P209, DOI 10.1038/nrn.2016.18; 2003, BIOL REV CAMBRIDGE P, V78, P149, DOI DOI 10.1017/S1464793102006036; 2002, CURR OPIN CELL BIOL, V14, P140, DOI DOI 10.1016/S0955-0674(02)00314-9	55	59	60	3	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2019	364	6440					593	+		10.1126/science.aau8287	http://dx.doi.org/10.1126/science.aau8287			78	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HX8BW	31000590	Green Published, Green Accepted			2022-12-28	WOS:000467631800044
J	de Boer, J; Stapleton, HM				de Boer, Jacob; Stapleton, Heather M.			Toward fire safety without chemical risk	SCIENCE			English	Editorial Material							FLAME RETARDANTS		[de Boer, Jacob] Vrije Univ, Dept Environm & Hlth, Amsterdam, Netherlands; [Stapleton, Heather M.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA	Vrije Universiteit Amsterdam; Duke University	de Boer, J (corresponding author), Vrije Univ, Dept Environm & Hlth, Amsterdam, Netherlands.	jacob.de.boer@vu.nl	de Boer, Jacob/L-5094-2013; Stapleton, Heather/AAE-7232-2019	de Boer, Jacob/0000-0001-6949-4828; Stapleton, Heather/0000-0002-9995-6517				[Anonymous], 2019, UNEPEA421; Babrauskas V., 2011, FIRE SAF SCI P INT S, V10, P265, DOI DOI 10.3801/IAFSS.FSS.10-265; Beard A., 2018, FIR RET PLAST 2018 P; de Boer J, 1998, NATURE, V394, P28, DOI 10.1038/27798; de Wit CA, 2002, CHEMOSPHERE, V46, P583, DOI 10.1016/S0045-6535(01)00225-9; GOLD MD, 1978, SCIENCE, V200, P785, DOI 10.1126/science.347576; Jayakody C, 2000, J FIRE SCI, V18, P430, DOI 10.1106/4EGW-LH1C-XFBJ-AFWL; Jonkers N, 2016, INT J LIFE CYCLE ASS, V21, P146, DOI 10.1007/s11367-015-0999-z; Kierkegaard A, 2004, ENVIRON SCI TECHNOL, V38, P3247, DOI 10.1021/es049867d; Kortenkamp A, 2018, SCIENCE, V361, P224, DOI 10.1126/science.aat9219; Lavoie ET, 2010, ENVIRON SCI TECHNOL, V44, P9244, DOI 10.1021/es1015789; Lucattini L, 2018, CHEMOSPHERE, V201, P466, DOI 10.1016/j.chemosphere.2018.02.161; Noren K, 2000, CHEMOSPHERE, V40, P1111, DOI 10.1016/S0045-6535(99)00360-4; Posner S., 2008, NORWEGIAN GUIDANCE R; Stapleton HM, 2012, ENVIRON SCI TECHNOL, V46, P13432, DOI 10.1021/es303471d	15	38	39	11	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2019	364	6437					231	232		10.1126/science.aax2054	http://dx.doi.org/10.1126/science.aax2054			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HU0JG	31000649	Green Published			2022-12-28	WOS:000464956600025
J	Gonzalez, JELY				Liquet y Gonzalez, Jose E.			We regret to inform you	SCIENCE			English	Editorial Material									[Liquet y Gonzalez, Jose E.] Univ Tennessee, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	Gonzalez, JELY (corresponding author), Univ Tennessee, Knoxville, TN 37996 USA.	SciCareerEditor@aaas.org							0	0	0	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2019	364	6437					302	302		10.1126/science.364.6437.302	http://dx.doi.org/10.1126/science.364.6437.302			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HU0JG	31000664				2022-12-28	WOS:000464956600054
J	Das, S; Tang, YL; Hong, Z; Goncalves, MAP; McCarter, MR; Klewe, C; Nguyen, KX; Gomez-Ortiz, F; Shafer, P; Arenholz, E; Stoica, VA; Hsu, SL; Wang, B; Ophus, C; Liu, JF; Nelson, CT; Saremi, S; Prasad, B; Mei, AB; Schlom, DG; Iniguez, J; Garcia-Fernandez, P; Muller, DA; Chen, LQ; Junquera, J; Martin, LW; Ramesh, R				Das, S.; Tang, Y. L.; Hong, Z.; Goncalves, M. A. P.; McCarter, M. R.; Klewe, C.; Nguyen, K. X.; Gomez-Ortiz, F.; Shafer, P.; Arenholz, E.; Stoica, V. A.; Hsu, S. -L.; Wang, B.; Ophus, C.; Liu, J. F.; Nelson, C. T.; Saremi, S.; Prasad, B.; Mei, A. B.; Schlom, D. G.; Iniguez, J.; Garcia-Fernandez, P.; Muller, D. A.; Chen, L. Q.; Junquera, J.; Martin, L. W.; Ramesh, R.			Observation of room-temperature polar skyrmions	NATURE			English	Article							FERROELECTRIC DOMAIN-STRUCTURES; LATTICE; VORTICES; STABILITY; STATES	Complex topological configurations are fertile ground for exploring emergent phenomena and exotic phases in condensed-matter physics. For example, the recent discovery of polarization vortices and their associated complex-phase coexistence and response under applied electric fields in superlattices of (PbTiO3)(n)/(SrTiO3)(n) suggests the presence of a complex, multi-dimensional system capable of interesting physical responses, such as chirality, negative capacitance and large piezo-electric responses(1-3). Here, by varying epitaxial constraints, we discover room-temperature polar-skyrmion bubbles in a lead titanate layer confined by strontium titanate layers, which are imaged by atomic-resolution scanning transmission electron microscopy. Phase-field modelling and second-principles calculations reveal that the polar-skyrmion bubbles have a skyrmion number of +1, and resonant soft-X-ray diffraction experiments show circular dichroism, confirming chirality. Such nanometre-scale polar-skyrmion bubbles are the electric analogues of magnetic skyrmions, and could contribute to the advancement of ferroelectrics towards functionalities incorporating emergent chirality and electrically controllable negative capacitance.	[Das, S.; Tang, Y. L.; Hsu, S. -L.; Saremi, S.; Prasad, B.; Martin, L. W.; Ramesh, R.] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA; [Tang, Y. L.; Martin, L. W.; Ramesh, R.] Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Hong, Z.; Wang, B.; Chen, L. Q.] Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA; [Goncalves, M. A. P.; Iniguez, J.] LIST, Mat Res & Technol Dept, Esch Sur Alzette, Luxembourg; [McCarter, M. R.; Ramesh, R.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Klewe, C.; Shafer, P.; Arenholz, E.] Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA USA; [Nguyen, K. X.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY USA; [Gomez-Ortiz, F.; Garcia-Fernandez, P.; Junquera, J.] Univ Cantabria, Dept Ciencias Tierra & Fis Mat Condensada, Santander, Spain; [Stoica, V. A.] Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA; [Hsu, S. -L.; Ophus, C.] Lawrence Berkeley Natl Lab, Mol Foundry, Natl Ctr Electron Microscopy, Berkeley, CA USA; [Liu, J. F.] Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA USA; [Nelson, C. T.] Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN USA; [Mei, A. B.; Schlom, D. G.] Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA; [Schlom, D. G.; Muller, D. A.] Cornell Nanoscale Sci, Kavli Inst, Ithaca, NY USA; [Iniguez, J.] Univ Luxembourg, Phys & Mat Sci Res Unit, Belvaux, Luxembourg; [Muller, D. A.] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Luxembourg Institute of Science & Technology; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Cornell University; Universidad de Cantabria; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; Center for Nanophase Materials Sciences; Cornell University; University of Luxembourg; Cornell University	Das, S; Ramesh, R (corresponding author), Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA.; Ramesh, R (corresponding author), Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA.; Ramesh, R (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	sujitdas@berkeley.edu; rramesh@berkeley.edu	Íñiguez, Jorge/B-6856-2009; Martin, Lane W./H-2409-2011; Muller, David/A-7745-2010; Ophus, Colin/P-5390-2019; Pereira Gonçalves, Mauro António/CAG-0909-2022; Chen, LongQing/I-7536-2012; Ramesh, Ramamoorthy/ABI-4883-2020; Íñiguez, Jorge/K-3828-2019; Schlom, Darrell G/J-2412-2013	Íñiguez, Jorge/0000-0001-6435-3604; Martin, Lane W./0000-0003-1889-2513; Muller, David/0000-0003-4129-0473; Ophus, Colin/0000-0003-2348-8558; Pereira Gonçalves, Mauro António/0000-0002-2951-8394; Chen, LongQing/0000-0003-3359-3781; Íñiguez, Jorge/0000-0001-6435-3604; Schlom, Darrell G/0000-0003-2493-6113; Gomez-Ortiz, Fernando/0000-0002-7203-8476; Liu, Jianfang/0000-0001-6786-8873; Prasad, Bhagwati/0000-0002-2348-6993	Gordon and Betty Moore Foundation's EPiQS Initiative [GBMF5307]; Army Research Office [W911NF-16-1-0315]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division [DE-AC02-05-CH11231, KC2202]; National Science Foundation Graduate Research Fellowship [DGE-1106400]; Luxembourg National Research Fund through the CORE programme [FNR/C15/MS/10458889 NEWALLS]; National Science Foundation [DMR-1210588]; Spanish Ministry of Economy and Competitiveness [FIS2015-64886-C5-2-P]; Ramon y Cajal grant [RyC-2013-12515]; US DOE, Office of Basic Energy Sciences [FG02-07ER46417]; US DOE, Office of Science, Office of Basic Energy Sciences [DE-SC-0012375]; US DOE, Office of Science, Office of Basic Energy Science [DE-AC02-06CH11357]; DOE Office of Science User Facility [DE-AC02-05CH11231]; Office of Science, Office of Basic Energy Sciences, US DOE [DE-AC02-05CH11231]; US DOE, Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division; US DOE [DE-SC0002334]; Cornell Center for Materials Research through the National Science Foundation MRSEC programme [DMR DMR-1719875]	Gordon and Betty Moore Foundation's EPiQS Initiative; Army Research Office; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division(United States Department of Energy (DOE)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Luxembourg National Research Fund through the CORE programme; National Science Foundation(National Science Foundation (NSF)); Spanish Ministry of Economy and Competitiveness(Spanish Government); Ramon y Cajal grant(Spanish Government); US DOE, Office of Basic Energy Sciences(United States Department of Energy (DOE)); US DOE, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); US DOE, Office of Science, Office of Basic Energy Science(United States Department of Energy (DOE)); DOE Office of Science User Facility(United States Department of Energy (DOE)); Office of Science, Office of Basic Energy Sciences, US DOE(United States Department of Energy (DOE)); US DOE, Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division(United States Department of Energy (DOE)); US DOE(United States Department of Energy (DOE)); Cornell Center for Materials Research through the National Science Foundation MRSEC programme	S.D. acknowledges support from the Gordon and Betty Moore Foundation's EPiQS Initiative, under grant GBMF5307. Funding for the synthesis and characterization work (to A.B.M., D.G.S. and R.R.) was also provided by the Army Research Office under grant W911NF-16-1-0315. Y.L.T. and R.R. acknowledge support by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division, under contract number DE-AC02-05-CH11231 (Quantum Materials program KC2202) for detailed polarization vector analysis. M.R.M. acknowledges support from the National Science Foundation Graduate Research Fellowship under grant number DGE-1106400. M.A.P.G. and J.I. are funded by the Luxembourg National Research Fund through the CORE programme (grant FNR/C15/MS/10458889 NEWALLS). Z.H. acknowledges support from the National Science Foundation (DMR-1210588). F.G.-O., P.G.-F. and J.J. acknowledge financial support from the Spanish Ministry of Economy and Competitiveness through grant number FIS2015-64886-C5-2-P, and P.G.-F. acknowledges support from Ramon y Cajal grant number RyC-2013-12515. L.Q.C. is supported by the US DOE, Office of Basic Energy Sciences under award FG02-07ER46417. V.A.S. acknowledges support from the US DOE, Office of Science, Office of Basic Energy Sciences, under award number DE-SC-0012375. M.R.M. and S.D. acknowledges use of the Advanced Photon Source, which was supported by the US DOE, Office of Science, Office of Basic Energy Science (DE-AC02-06CH11357), for the synchrotron-based reciprocal space map studies of samples at the Sector 33-BM-C and 7-ID-C beamline. This research used resources of the Advanced Light Source, which is a DOE Office of Science User Facility, under contract number DE-AC02-05CH11231. L.W.M. acknowledges support from the US DOE, Office of Science, Office of Basic Energy Sciences, under award number DE-SC-0012375 for the development of novel ferroic heterostructures. Electron microscopy of superlattice structures was performed at the Molecular Foundry, LBNL, supported by the Office of Science, Office of Basic Energy Sciences, US DOE (DE-AC02-05CH11231). STEM and phase-field analysis and visualization performed by C.T.N. was supported by the US DOE, Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division. EMPAD-STEM polar mapping at the Cornell Center for Materials Research was funded by the US DOE, grant DE-SC0002334. The Cornell EM Facility is supported by the Cornell Center for Materials Research through the National Science Foundation MRSEC programme, award #DMR DMR-1719875.	BERG B, 1981, NUCL PHYS B, V190, P412, DOI 10.1016/0550-3213(81)90568-X; Bogatyrev AB, 2018, J MAGN MAGN MATER, V465, P743, DOI 10.1016/j.jmmm.2018.06.058; Chen LQ, 2008, J AM CERAM SOC, V91, P1835, DOI 10.1111/j.1551-2916.2008.02413.x; Chen LQ, 1998, COMPUT PHYS COMMUN, V108, P147, DOI 10.1016/S0010-4655(97)00115-X; Cherifi-Hertel S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15768; Damodaran AR, 2017, NAT MATER, V16, P1003, DOI [10.1038/nmat4951, 10.1038/NMAT4951]; Durr HA, 1999, SCIENCE, V284, P2166, DOI 10.1126/science.284.5423.2166; Eto M, 2014, PROG THEOR EXP PHYS, V2014, DOI 10.1093/ptep/ptt095; Fert A, 2013, NAT NANOTECHNOL, V8, P152, DOI 10.1038/nnano.2013.29; Garcia-Fernandez P, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.195137; Gregg JM, 2012, FERROELECTRICS, V433, P74, DOI 10.1080/00150193.2012.678131; HAUN MJ, 1987, J APPL PHYS, V62, P3331, DOI 10.1063/1.339293; Hong JW, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.172101; Hong ZJ, 2017, NANO LETT, V17, P2246, DOI 10.1021/acs.nanolett.6b04875; Jiang WJ, 2017, PHYS REP, V704, P1, DOI 10.1016/j.physrep.2017.08.001; Kezsmarki I, 2015, NAT MATER, V14, P1116, DOI [10.1038/NMAT4402, 10.1038/nmat4402]; Kirkland EJ, 2016, ACTA CRYSTALLOGR A, V72, P1, DOI 10.1107/S205327331501757X; Lai BK, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.137602; Lee D, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.060102; Lee W, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao3820; Li YL, 2002, APPL PHYS LETT, V81, P427, DOI 10.1063/1.1492025; Li YL, 2002, ACTA MATER, V50, P395, DOI 10.1016/S1359-6454(01)00360-3; Lim LK, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.016401; Lovesey SW, 2018, PHYS REV B, V98, DOI 10.1103/PhysRevB.98.155410; MERMIN ND, 1979, REV MOD PHYS, V51, P591, DOI 10.1103/RevModPhys.51.591; Muhlbauer S, 2009, SCIENCE, V323, P915, DOI 10.1126/science.1166767; Nahas Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9542; Nelson CT, 2011, NANO LETT, V11, P828, DOI 10.1021/nl1041808; Parkin SSP, 2008, SCIENCE, V320, P190, DOI 10.1126/science.1145799; Rayfield G. W., 1965, PHYS REV, V137, pAB4; Rossler UK, 2006, NATURE, V442, P797, DOI 10.1038/nature05056; Ruostekoski J, 2001, PHYS REV LETT, V86, P3934, DOI 10.1103/PhysRevLett.86.3934; Rybakov FN, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.094424; Shafer P, 2018, P NATL ACAD SCI USA, V115, P915, DOI 10.1073/pnas.1711652115; Sheng G, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3442915; Tate MW, 2016, MICROSC MICROANAL, V22, P237, DOI 10.1017/S1431927615015664; Thorner G, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.220103; Tomasello R, 2014, SCI REP-UK, V4, DOI 10.1038/srep06784; Wojdel JC, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.247603; Wojdel JC, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/30/305401; Woo S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15573; Yadav AK, 2016, NATURE, V534, P138, DOI 10.1038/nature17420; Yadav AK, 2016, NATURE, V530, P198, DOI 10.1038/nature16463; Yadav AK, 2019, NATURE, V565, P468, DOI 10.1038/s41586-018-0855-y; Yu XZ, 2010, NATURE, V465, P901, DOI 10.1038/nature09124; Zhang Q, 2017, ADV MATER, V29, DOI 10.1002/adma.201702375; Zuo J. M., 1993, ELECT MICRODIFFRACTI	48	257	262	50	557	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 18	2019	568	7752					368	+		10.1038/s41586-019-1092-8	http://dx.doi.org/10.1038/s41586-019-1092-8			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HU0GZ	30996320	Green Submitted			2022-12-28	WOS:000464950700051
J	Mahase, E				Mahase, Elisabeth			Gene therapy can cure "bubble boy" disease in babies, researchers find	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Kohn DB, 2003, NAT REV CANCER, V3, P477, DOI 10.1038/nrc1122; Mamcarz E, 2019, NEW ENGL J MED, V380, P1525, DOI 10.1056/NEJMoa1815408; Sorrentino B, 2014, PRECLINICAL SAFETY E	3	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 18	2019	365								l1848	10.1136/bmj.l1848	http://dx.doi.org/10.1136/bmj.l1848			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU8PD	31000579				2022-12-28	WOS:000465550700014
J	Mahase, E				Mahase, Elisabeth			Campaigners criticise Home Office's use of child's medical records to reject family's asylum request	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		IACOBUCCI G, 2018, BMJ-BRIT MED J, V360, P28117, DOI DOI 10.1136/BMJ.K512; Pogrund G, 2019, SUNDAY TIMES	2	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2019	365								l1811	10.1136/bmj.l1811	http://dx.doi.org/10.1136/bmj.l1811			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU8OP	30992320				2022-12-28	WOS:000465549000012
J	Song, ZR; Baicker, K				Song, Zirui; Baicker, Katherine			Effect of a Workplace Wellness Program on Employee Health and Economic Outcomes A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROMOTION	IMPORTANCE Employers have increasingly invested in workplace wellness programs to improve employee health and decrease health care costs. However, there is little experimental evidence on the effects of these programs. OBJECTIVE To evaluate a multicomponent workplace wellness program resembling programs offered by US employers. DESIGN, SETTING, AND PARTICIPANTS This clustered randomized trial was implemented at 160 worksites from January 2015 through June 2016. Administrative claims and employment data were gathered continuously through June 30, 2016; data from surveys and biometrics were collected from July 1, 2016, through August 31, 2016. INTERVENTIONS There were 20 randomly selected treatment worksites (4037 employees) and 140 randomly selected control worksites (28 937 employees, including 20 primary control worksites [4106 employees]). Control worksites received no wellness programming. The program comprised 8 modules focused on nutrition, physical activity, stress reduction, and related topics implemented by registered dietitians at the treatment worksites. MAIN OUTCOMES AND MEASURES Four outcome domains were assessed. Self-reported health and behaviors via surveys (29 outcomes) and clinical measures of health via screenings (10 outcomes) were compared among 20 intervention and 20 primary control sites; health care spending and utilization (38 outcomes) and employment outcomes (3 outcomes) from administrative data were compared among 20 intervention and 140 control sites. RESULTS Among 32 974 employees (mean [SD] age, 38.6 [15.2] years; 15 272 [45.9%] women), the mean participation rate in surveys and screenings at intervention sites was 36.2% to 44.6%(n = 4037 employees) and at primary control sites was 34.4% to 43.0% (n = 4106 employees) (mean of 1.3 program modules completed). After 18 months, the rates for 2 self-reported outcomes were higher in the intervention group than in the control group: for engaging in regular exercise (69.8% vs 61.9%; adjusted difference, 8.3 percentage points [95% CI, 3.9-12.8]; adjusted P = .03) and for actively managing weight (69.2% vs 54.7%; adjusted difference, 13.6 percentage points [95% CI, 7.1-20.2]; adjusted P = .02). The program had no significant effects on other prespecified outcomes: 27 self-reported health outcomes and behaviors (including self-reported health, sleep quality, and food choices), 10 clinical markers of health (including cholesterol, blood pressure, and body mass index), 38 medical and pharmaceutical spending and utilization measures, and 3 employment outcomes (absenteeism, job tenure, and job performance). CONCLUSIONS AND RELEVANCE Among employees of a large US warehouse retail company, a workplace wellness program resulted in significantly greater rates of some positive self-reported health behaviors among those exposed compared with employees who were not exposed, but there were no significant differences in clinical measures of health, health care spending and utilization, and employment outcomes after 18 months. Although limited by incomplete data on some outcomes, these findings may temper expectations about the financial return on investment that wellness programs can deliver in the short term.	[Song, Zirui] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Baicker, Katherine] Univ Chicago, Harris Sch Publ Policy, Chicago, IL 60637 USA; [Baicker, Katherine] NBER, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Chicago; National Bureau of Economic Research	Song, ZR (corresponding author), Harvard Med Sch, Dept Hlth Care Policy, 180A Longwood Ave, Boston, MA 02115 USA.	song@hcp.med.harvard.edu			National Institute on Aging (National Bureau of Economic Research) [R01 AG050329, P30 AG012810]; RobertWood Johnson Foundation [72611]; Abdul Latif Jameel Poverty Action Lab North America; NATIONAL INSTITUTE ON AGING [P30AG012810, R01AG050329] Funding Source: NIH RePORTER	National Institute on Aging (National Bureau of Economic Research); RobertWood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Abdul Latif Jameel Poverty Action Lab North America; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute on Aging (R01 AG050329; P30 AG012810 through the National Bureau of Economic Research), RobertWood Johnson Foundation (grant 72611), and Abdul Latif Jameel Poverty Action Lab North America. BJ's Wholesale Club provided in-kind logistical and personnel support for the fielding of the wellness program.	[Anonymous], 2005, American Journal of Health Promotion, V20, P1; Baicker K, 2010, HEALTH AFFAIR, V29, DOI 10.1377/hlthaff.2009.0626; BLY JL, 1986, JAMA-J AM MED ASSOC, V256, P3235, DOI 10.1001/jama.256.23.3235; Cahill K, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004307.pub5; DeMets DL, 2019, JAMA-J AM MED ASSOC, V321, P145, DOI 10.1001/jama.2018.19192; Fries J F, 1994, Am J Health Promot, V8, P216; Goetzel RZ, 2008, ANNU REV PUBL HEALTH, V29, P303, DOI 10.1146/annurev.publhealth.29.020907.090930; Goetzel RZ, 2014, J OCCUP ENVIRON MED, V56, P927, DOI 10.1097/JOM.0000000000000276; Halpern SD, 2015, NEW ENGL J MED, V372, P2108, DOI 10.1056/NEJMoa1414293; Hirshberg DA, 2017, EPIDEMIOLOGY, V28, P812, DOI 10.1097/EDE.0000000000000735; Jones D, 2018, NBER WORKING PAPER S, P24229; Kaiser Family Foundation, 2018, 2018 EMPL HLTH BEN S; LEIGH JP, 1992, ARCH INTERN MED, V152, P1201, DOI 10.1001/archinte.152.6.1201; Mattke S., 2012, REV US WORKPLACE WEL; Mello MM, 2008, NEW ENGL J MED, V359, P192, DOI 10.1056/NEJMhle0801929; Ozminkowski RJ, 1999, AM J HEALTH PROMOT, V14, P31, DOI 10.4278/0890-1171-14.1.31; Pelletier KR, 2011, J OCCUP ENVIRON MED, V53, P1310, DOI 10.1097/JOM.0b013e3182337748; Pollitz K., 2016, WORKPLACE WELLNESS P; Volpp KG, 2009, NEW ENGL J MED, V360, P699, DOI 10.1056/NEJMsa0806819; Volpp KG, 2008, JAMA-J AM MED ASSOC, V300, P2631, DOI 10.1001/jama.2008.804; Wang X, 2017, BIOMETRIKA, V103, P1, DOI [10.1093/biomet/asxO11, DOI 10.1093/BIOMET/ASX011]; Ware JE., 2001, SCORE INTERPRET SING, V15, P5; Westfall P.H., 1993, RESAMPLING BASED MUL; Zubizarreta JR, 2015, J AM STAT ASSOC, V110, P910, DOI 10.1080/01621459.2015.1023805	24	120	124	7	55	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 16	2019	321	15					1491	1501		10.1001/jama.2019.3307	http://dx.doi.org/10.1001/jama.2019.3307			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HT7SY	30990549	Bronze, Green Published			2022-12-28	WOS:000464765900016
J	Zhao, LH; Ma, SS; Sutkeviciute, I; Shen, DD; Zhou, XE; de Waal, PW; Li, CY; Kang, YY; Clark, LJ; Jean-Alphonse, FG; White, AD; Yang, DH; Dai, AT; Cai, XQ; Chen, J; Li, C; Jiang, Y; Watanabe, T; Gardella, TJ; Melcher, K; Wang, MW; Vilardaga, JP; Xu, HE; Zhang, Y				Zhao, Li-Hua; Ma, Shanshan; Sutkeviciute, Ieva; Shen, Dan-Dan; Zhou, X. Edward; de Waal, Parker W.; Li, Chen-Yao; Kang, Yanyong; Clark, Lisa J.; Jean-Alphonse, Frederic G.; White, Alex D.; Yang, Dehua; Dai, Antao; Cai, Xiaoqing; Chen, Jian; Li, Cong; Jiang, Yi; Watanabe, Tomoyuki; Gardella, Thomas J.; Melcher, Karsten; Wang, Ming-Wei; Vilardaga, Jean-Pierre; Xu, H. Eric; Zhang, Yan			Structure and dynamics of the active human parathyroid hormone receptor-1	SCIENCE			English	Article							CRYO-EM STRUCTURE; GLP-1 RECEPTOR; PTHRP RECEPTOR; BINDING; ACTIVATION; RECOGNITION; VALIDATION; MECHANISM; RESPONSES; DOMAINS	The parathyroid hormone receptor-1 (PTH1R) is a class B G protein-coupled receptor central to calcium homeostasis and a therapeutic target for osteoporosis and hypoparathyroidism. Here we report the cryo-electron microscopy structure of human PTH1R bound to a long-acting PTH analog and the stimulatory G protein. The bound peptide adopts an extended helix with its amino terminus inserted deeply into the receptor transmembrane domain (TMD), which leads to partial unwinding of the carboxyl terminus of transmembrane helix 6 and induces a sharp kink at the middle of this helix to allow the receptor to couple with G protein. In contrast to a single TMD structure state, the extracellular domain adopts multiple conformations. These results provide insights into the structural basis and dynamics of PTH binding and receptor activation.	[Zhao, Li-Hua; Ma, Shanshan; Li, Chen-Yao; Kang, Yanyong; Yang, Dehua; Dai, Antao; Cai, Xiaoqing; Jiang, Yi; Wang, Ming-Wei; Xu, H. Eric] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China; [Ma, Shanshan; Li, Chen-Yao] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Sutkeviciute, Ieva; Clark, Lisa J.; Jean-Alphonse, Frederic G.; White, Alex D.; Vilardaga, Jean-Pierre] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Lab GPCR Biol, Pittsburgh, PA 15261 USA; [Shen, Dan-Dan; Zhang, Yan] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Pathol, Hangzhou 310058, Zhejiang, Peoples R China; [Shen, Dan-Dan; Zhang, Yan] Zhejiang Univ, Sch Med, Dept Biophys, Hangzhou 310058, Zhejiang, Peoples R China; [Zhou, X. Edward; de Waal, Parker W.; Melcher, Karsten; Xu, H. Eric] Van Andel Res Inst, Innovat & Integrat Program, Ctr Canc & Cell Biol, Grand Rapids, MI 49503 USA; [Clark, Lisa J.] Univ Pittsburgh, Sch Med, Grad Program Mol Biophys & Struct Biol, Pittsburgh, PA 15261 USA; [White, Alex D.] Univ Pittsburgh, Sch Med, Grad Program Mol Pharmacol, Pittsburgh, PA 15261 USA; [Chen, Jian; Li, Cong; Wang, Ming-Wei] Fudan Univ, Sch Pharm, Shanghai 201203, Peoples R China; [Watanabe, Tomoyuki; Gardella, Thomas J.] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Watanabe, Tomoyuki; Gardella, Thomas J.] Harvard Med Sch, Boston, MA 02114 USA; [Watanabe, Tomoyuki] Chugai Pharmaceut Co Ltd, Tokyo 1038324, Japan	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Zhejiang University; Zhejiang University; Van Andel Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Fudan University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Chugai Pharmaceutical Co., Ltd.; Roche Holding	Wang, MW; Xu, HE (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China.; Vilardaga, JP (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Lab GPCR Biol, Pittsburgh, PA 15261 USA.; Zhang, Y (corresponding author), Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Pathol, Hangzhou 310058, Zhejiang, Peoples R China.; Zhang, Y (corresponding author), Zhejiang Univ, Sch Med, Dept Biophys, Hangzhou 310058, Zhejiang, Peoples R China.; Xu, HE (corresponding author), Van Andel Res Inst, Innovat & Integrat Program, Ctr Canc & Cell Biol, Grand Rapids, MI 49503 USA.; Wang, MW (corresponding author), Fudan Univ, Sch Pharm, Shanghai 201203, Peoples R China.	mwwang@simm.ac.cn; jpv@pitt.edu; eric.xu@vai.org; zhang_yan@zju.edu.cn	Zhang, Yan/V-8007-2019; Yang, Dehua/M-5789-2019; Xu, H. Eric/ABD-7487-2021; Melcher, Karsten/AAZ-3861-2020; de Waal, Parker/M-1138-2017	Zhang, Yan/0000-0003-2189-0244; Melcher, Karsten/0000-0002-9125-4027; Xu, H. Eric/0000-0002-6829-8144; JEAN-ALPHONSE, Frederic/0000-0002-7380-5825; Zhao, Li-Hua/0000-0002-7175-5174; Clark, Lisa/0000-0003-0484-4596; Vilardaga, Jean-Pierre/0000-0002-1217-1435; Sutkeviciute, Ieva/0000-0002-2168-3344; de Waal, Parker/0000-0001-6922-9768	National Key Basic Research Program of China [2018YFC1003600]; Zhejiang Province Science Fund for Distinguished Young Scholars [LR19H310001]; Shanghai Science and Technology Development Fund [18ZR1447800, 16ZR1407100]; Young Innovator Association of CAS [2018325]; SA-SIBS Scholarship Program; Fudan-SIMM Joint Research Fund [FU-SIMM-20174003]; National Key R&D Program of China [2018YFA0507000]; National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program," China [2018ZX09711002-002-005, 2018ZX09735-001]; National Natural Science Foundation of China [31300245, 81573479, 81773792]; Ministry of Science and Technology (China) [2012ZX09301001, 2012CB910403, 2013CB910600, XDB08020303, 2013ZX09507001]; Novo Nordisk-CAS Research Fund [NNCAS-2017-1-CC]; Jay and Betty Van Andel Foundation; National Institutes of Health [GM127710, R01-DK102495, R01-DK111427, R01-DK116780, DK11794, T32-GM008424]; Cotswold Foundation Fellowship Awards; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F31AR074843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102495, P01DK011794, R01DK116780, R01DK111427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008424, R01GM127710] Funding Source: NIH RePORTER	National Key Basic Research Program of China(National Basic Research Program of China); Zhejiang Province Science Fund for Distinguished Young Scholars; Shanghai Science and Technology Development Fund; Young Innovator Association of CAS; SA-SIBS Scholarship Program; Fudan-SIMM Joint Research Fund; National Key R&D Program of China; National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program," China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology (China)(Ministry of Science and Technology, China); Novo Nordisk-CAS Research Fund; Jay and Betty Van Andel Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cotswold Foundation Fellowship Awards; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially supported by National Key Basic Research Program of China (2018YFC1003600 to Y.Z.); Zhejiang Province Science Fund for Distinguished Young Scholars (LR19H310001 to Y.Z.); Shanghai Science and Technology Development Fund (18ZR1447800 to L.-H.Z. and 16ZR1407100 to A.D.); the Young Innovator Association of CAS (2018325 to L.-H.Z.); SA-SIBS Scholarship Program (L.-H.Z. and D.Y.); the Fudan-SIMM Joint Research Fund (FU-SIMM-20174003 to L.-H.Z. and M.-W.W.); National Key R&D Program of China grant (2018YFA0507000 to M.-W.W.); National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program," China (2018ZX09711002-002-005 to D.Y. and 2018ZX09735-001 to M.-W.W.); the National Natural Science Foundation of China (31300245 to L.-H.Z.;81573479 and 81773792 to D.Y.); Ministry of Science and Technology (China) grants 2012ZX09301001, 2012CB910403, 2013CB910600, XDB08020303, and 2013ZX09507001 (to H.E.X.); Novo Nordisk-CAS Research Fund (NNCAS-2017-1-CC to D.Y.); the Jay and Betty Van Andel Foundation (H.E.X.); National Institutes of Health grants (GM127710 to H.E.X.; R01-DK102495, R01-DK111427, and R01-DK116780 to J.-P.V.; DK11794 to T.J.G.; and T32-GM008424 to A.D.W.); and the Cotswold Foundation Fellowship Awards (to F.G. J.-A. and A.D.W.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Behar V, 1999, ENDOCRINOLOGY, V140, P4251, DOI 10.1210/en.140.9.4251; Bergwitz C, 1996, J BIOL CHEM, V271, P26469, DOI 10.1074/jbc.271.43.26469; Case D. A., 2016, AMBER 2016; Castro M, 2005, P NATL ACAD SCI USA, V102, P16084, DOI 10.1073/pnas.0503942102; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dean T, 2006, J BIOL CHEM, V281, P32485, DOI 10.1074/JBC.M606179200; Draper-Joyce CJ, 2018, NATURE, V558, P559, DOI 10.1038/s41586-018-0236-6; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; Ehrenmann J, 2018, NAT STRUCT MOL BIOL, V25, P1086, DOI 10.1038/s41594-018-0151-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; Garcia-Nafria J, 2018, NATURE, V558, P620, DOI 10.1038/s41586-018-0241-9; Gardella TJ, 2015, PHARMACOL REV, V67, P310, DOI 10.1124/pr.114.009464; GARDELLA TJ, 1995, J BIOL CHEM, V270, P6584, DOI 10.1074/jbc.270.12.6584; Glukhova A, 2018, ACS PHARMACOL TRANSL, V1, P73, DOI 10.1021/acsptsci.8b00026; Gourlet P, 1996, EUR J BIOCHEM, V239, P349, DOI 10.1111/j.1432-1033.1996.0349u.x; Hattersley G, 2016, ENDOCRINOLOGY, V157, P141, DOI 10.1210/en.2015-1726; Heymann JB, 2018, PROTEIN SCI, V27, P159, DOI 10.1002/pro.3293; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iiri T, 1999, P NATL ACAD SCI USA, V96, P499, DOI 10.1073/pnas.96.2.499; Kang YY, 2018, NATURE, V558, P553, DOI 10.1038/s41586-018-0215-y; Kir S, 2014, NATURE, V513, P100, DOI 10.1038/nature13528; Koehl A, 2018, NATURE, V558, P547, DOI 10.1038/s41586-018-0219-7; Kohlhoff KJ, 2014, NAT CHEM, V6, P15, DOI [10.1038/NCHEM.1821, 10.1038/nchem.1821]; Liang YL, 2018, NATURE, V561, P492, DOI 10.1038/s41586-018-0535-y; Liang YL, 2018, NATURE, V555, P121, DOI 10.1038/nature25773; Liang YL, 2017, NATURE, V546, P118, DOI 10.1038/nature22327; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Luck MD, 1999, MOL ENDOCRINOL, V13, P670, DOI 10.1210/me.13.5.670; Maeda A, 2013, P NATL ACAD SCI USA, V110, P5864, DOI 10.1073/pnas.1301674110; McGibbon RT, 2015, BIOPHYS J, V109, P1528, DOI 10.1016/j.bpj.2015.08.015; Mitternacht Simon, 2016, F1000Res, V5, P189, DOI 10.12688/f1000research.7931.1; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Pal K, 2012, ACTA PHARMACOL SIN, V33, P300, DOI 10.1038/aps.2011.170; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Pioszak AA, 2009, J BIOL CHEM, V284, P28382, DOI 10.1074/jbc.M109.022905; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; SCHIPANI E, 1995, SCIENCE, V268, P98, DOI 10.1126/science.7701349; Shimizu M, 2016, J BONE MINER RES, V31, P1405, DOI 10.1002/jbmr.2811; Shimizu N, 2001, J BIOL CHEM, V276, P49003, DOI 10.1074/jbc.M106827200; Vilardaga JP, 2014, NAT CHEM BIOL, V10, P700, DOI [10.1038/NCHEMBIO.1611, 10.1038/nchembio.1611]; Vilardaga JP, 2011, METHODS MOL BIOL, V756, P133, DOI 10.1007/978-1-61779-160-4_6; Vilardaga JP, 2001, MOL ENDOCRINOL, V15, P1186, DOI 10.1210/me.15.7.1186; Wootten D, 2013, P NATL ACAD SCI USA, V110, P5211, DOI 10.1073/pnas.1221585110; Yin YT, 2017, J BIOL CHEM, V292, P9865, DOI 10.1074/jbc.M117.782987; Yin YT, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.42; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang Y, 2017, NATURE, V546, P248, DOI 10.1038/nature22394; Zhao LH, 2016, J BIOL CHEM, V291, P15119, DOI 10.1074/jbc.M116.726620; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhou XE, 2019, PROTEIN SCI, V28, P487, DOI 10.1002/pro.3526	58	95	95	5	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2019	364	6436					148	+		10.1126/science.aav7942	http://dx.doi.org/10.1126/science.aav7942			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HT5RC	30975883	Green Accepted			2022-12-28	WOS:000464620000035
J	Barry, E; Finnikin, S				Barry, Eleanor; Finnikin, Samuel			10-MINUTE CONSULTATION A borderline HbA(1c) result	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RISK; PROGRESSION		[Barry, Eleanor] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Finnikin, Samuel] Univ Birmingham, Birmingham, W Midlands, England	University of Oxford; University of Birmingham	Finnikin, S (corresponding author), Univ Birmingham, Birmingham, W Midlands, England.	S.J.Finnikin@bham.ac.uk			NIHR Doctoral Research Fellowship [DRF-2017-10-024]; Clinical Research Network West Midlands grant	NIHR Doctoral Research Fellowship; Clinical Research Network West Midlands grant	The BMJ has judged that there are no disqualifying financial ties to commercial companies. The authors declare the following other interests: Eleanor Barry is supported by an NIHR Doctoral Research Fellowship (DRF-2017-10-024) and Samuel Finnikin is in receipt of a Clinical Research Network West Midlands grant.	Ashra N. B., 2015, SYSTEMATIC REV META; Barry E, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6538; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Bray GA, 1999, DIABETES CARE, V22, P623; DeJesus RS, 2017, POPUL HEALTH MANAG, V20, P216, DOI 10.1089/pop.2016.0067; Diabetes UK, PREV TYP 2 DIAB; Ford ES, 2010, J AM COLL CARDIOL, V55, P1310, DOI 10.1016/j.jacc.2009.10.060; Gerstein HC, 2007, DIABETES RES CLIN PR, V78, P305, DOI 10.1016/j.diabres.2007.05.004; Greenhalgh T, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0360-1; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V338, pb880, DOI DOI 10.1136/bmj.b880; Hippisley-Cox J, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5019; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Morris DH, 2013, DIABETOLOGIA, V56, P1489, DOI 10.1007/s00125-013-2902-4; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; National Institute for Health and Care Excellence, 2012, TYP 2 DIAB PREV PEOP; National Institute for Health and Care Excellence, 2015, DIAB PREGN MAN PREC; NHS, FOOD KEEP ACT; Public Health England, HLTH MATT EV NEXT ST; Rubak S, 2005, BRIT J GEN PRACT, V55, P305; YUDKIN JS, 2014, BMJ-BRIT MED J, V349, pNIL11, DOI [10.1136/bmj.g4485, DOI 10.1136/BMJ.G4485]	20	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 11	2019	365								l1361	10.1136/bmj.l1361	http://dx.doi.org/10.1136/bmj.l1361			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU0ER	30975710				2022-12-28	WOS:000464944700003
J	Egan, MF; Kost, J; Voss, T; Mukai, Y; Aisen, PS; Cummings, JL; Tariot, PN; Vellas, B; van Dyck, CH; Boada, M; Zhang, Y; Li, W; Furtek, C; Mahoney, E; Mozley, LH; Mo, Y; Sur, C; Michelson, D				Egan, Michael F.; Kost, James; Voss, Tiffini; Mukai, Yuki; Aisen, Paul S.; Cummings, Jeffrey L.; Tariot, Pierre N.; Vellas, Bruno; van Dyck, Christopher H.; Boada, Merce; Zhang, Ying; Li, Wen; Furtek, Christine; Mahoney, Erin; Mozley, Lyn Harper; Mo, Yi; Sur, Cyrille; Michelson, David			Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLINICAL-TRIALS; BACE1; INVENTORY; SCALE	Background Prodromal Alzheimer's disease offers an opportunity to test the effect of drugs that modify the deposition of amyloid in the brain before the onset of dementia. Verubecestat is an orally administered beta-site amyloid precursor protein-cleaving enzyme 1 (BACE-1) inhibitor that blocks production of amyloid-beta (A beta). The drug did not prevent clinical progression in a trial involving patients with mild-to-moderate dementia due to Alzheimer's disease. Methods We conducted a randomized, double-blind, placebo-controlled, 104-week trial to evaluate verubecestat at doses of 12 mg and 40 mg per day, as compared with placebo, in patients who had memory impairment and elevated brain amyloid levels but whose condition did not meet the case definition of dementia. The primary outcome was the change from baseline to week 104 in the score on the Clinical Dementia Rating Scale-Sum of Boxes (CDR-SB; scores range from 0 to 18, with higher scores indicating worse cognition and daily function). Secondary outcomes included other assessments of cognition and daily function. Results The trial was terminated for futility after 1454 patients had been enrolled; 485 had been assigned to receive verubecestat at a dose of 12 mg per day (the 12-mg group), 484 to receive verubecestat at a dose of 40 mg per day (the 40-mg group), and 485 to receive placebo. A total of 234 patients, 231 patients, and 239 patients per group, respectively, completed 104 weeks of the trial regimen. The estimated mean change from baseline to week 104 in the CDR-SB score was 1.65 in the 12-mg group, 2.02 in the 40-mg group, and 1.58 in the placebo group (P=0.67 for the comparison between the 12-mg group and the placebo group and P=0.01 for the comparison between the 40-mg group and the placebo group), suggesting a worse outcome in the higher-dose group than in the placebo group. The estimated rate of progression to dementia due to Alzheimer's disease was 24.5, 25.5, and 19.3 events per 100 patient-years in the 12-mg group, the 40-mg group, and the placebo group, respectively (hazard ratio for 40 mg vs. placebo, 1.38; 97.51% confidence interval, 1.07 to 1.79, not adjusted for multiple comparisons), favoring placebo. Adverse events were more common in the verubecestat groups than in the placebo group. Conclusions Verubecestat did not improve clinical ratings of dementia among patients with prodromal Alzheimer's disease, and some measures suggested that cognition and daily function were worse among patients who received verubecestat than among those who received placebo. (Funded by Merck Sharp & Dohme; ClinicalTrials.gov number, .) In a randomized trial, patients with brain amyloid deposition but no dementia who received a beta-site amyloid precursor protein-cleaving enzyme 1 inhibitor had no benefit with respect to clinical outcomes and worsening on some measures of cognition and daily function.	[Egan, Michael F.; Kost, James; Voss, Tiffini; Mukai, Yuki; Zhang, Ying; Li, Wen; Furtek, Christine; Mahoney, Erin; Mozley, Lyn Harper; Mo, Yi; Sur, Cyrille; Michelson, David] Merck, Kenilworth, NJ USA; [Aisen, Paul S.] Univ Southern Calif, San Diego, CA USA; [Cummings, Jeffrey L.] Cleveland Clin, Lou Ruvo Ctr Brain Hlth, Las Vegas, NV USA; [Tariot, Pierre N.] Banner Alzheimers Inst, Phoenix, AZ USA; [Vellas, Bruno] Toulouse Univ Hosp, Alzheimers Dis Res & Clin Ctr, Gerontopole, INSERM Unite 1027, Toulouse, France; [van Dyck, Christopher H.] Yale Univ, Sch Med, New Haven, CT USA; [Boada, Merce] Univ Int Catalunya, Inst Catala Neurociences Aplicades, Fundacio Alzheimer Ctr Educ, Res Ctr, Barcelona, Spain; [Boada, Merce] Univ Int Catalunya, Inst Catala Neurociences Aplicades, Fundacio Alzheimer Ctr Educ, Mem Clin, Barcelona, Spain; [Boada, Merce] Inst Salud Carlos III, Network Ctr Biomed Res Neurodegenerat Dis CIBERNE, Madrid, Spain	Merck & Company; University of Southern California; Cleveland Clinic Foundation; Banner Research; Banner Health; Banner Alzheimer's Institute; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Yale University; Universitat Internacional de Catalunya (UIC); Universitat Internacional de Catalunya (UIC); Instituto de Salud Carlos III	Egan, MF (corresponding author), Merck, UG 4C-06,POB 1000, N Wales, PA 19454 USA.	michael.egan@merck.com	Cummings, Jeffrey/AAC-5947-2019; Sur, Cyrille/G-1154-2010	Cummings, Jeffrey/0000-0001-8944-4158; 	Merck Sharp Dohme; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109025] Funding Source: NIH RePORTER	Merck Sharp Dohme(Merck & Company); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by Merck Sharp & Dohme; ClinicalTrials.gov number, NCT01953601.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Barao S, 2016, TRENDS NEUROSCI, V39, P158, DOI 10.1016/j.tins.2016.01.003; Blume T, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00229; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; Dubois B, 2010, LANCET NEUROL, V9, P1118, DOI 10.1016/S1474-4422(10)70223-4; Egan MF, 2018, NEW ENGL J MED, V378, P1691, DOI 10.1056/NEJMoa1706441; Filser S, 2015, BIOL PSYCHIAT, V77, P729, DOI 10.1016/j.biopsych.2014.10.013; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galasko D, 1997, ALZ DIS ASSOC DIS, V11, pS33; Holler CJ, 2012, AM J PATHOL, V180, P337, DOI 10.1016/j.ajpath.2011.09.034; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Kennedy ME, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad9704; Landau SM, 2015, J NUCL MED, V56, P567, DOI 10.2967/jnumed.114.148981; Liu FC, 2018, MOL PSYCHIATR, V23, P1542, DOI 10.1038/s41380-018-0060-2; Masters CL, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.56; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mo Yi, 2017, Alzheimers Dement (Amst), V6, P201, DOI 10.1016/j.dadm.2017.02.004; Mohs RC, 1997, ALZ DIS ASSOC DIS, V11, pS13; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Posner K, 2011, AM J PSYCHIAT, V168, P1266, DOI 10.1176/appi.ajp.2011.10111704; RANDOLPH C, 1998, RBANS REPEATABLE BAT; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Scott JD, 2016, J MED CHEM, V59, P10435, DOI 10.1021/acs.jmedchem.6b00307; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323; Sperling R, 2014, NEURON, V84, P608, DOI 10.1016/j.neuron.2014.10.038; Vassar R, 2014, J NEUROCHEM, V130, P4, DOI 10.1111/jnc.12715; Yan RQ, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00097; Yan RQ, 2014, LANCET NEUROL, V13, P319, DOI 10.1016/S1474-4422(13)70276-X; Zhu KC, 2018, BIOL PSYCHIAT, V84, P478, DOI 10.1016/j.biopsych.2018.04.022	31	279	286	3	37	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 11	2019	380	15					1408	1420		10.1056/NEJMoa1812840	http://dx.doi.org/10.1056/NEJMoa1812840			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HT5NG	30970186	Bronze, Green Accepted			2022-12-28	WOS:000464610000008
J	Levis, B; Benedetti, A; Thombs, BD; Akena, DH; Arroll, B; Ayalon, L; Azar, M; Baradaran, HR; Baron, M; Bombardier, CH; Boruff, J; Butterworth, P; Carter, G; Chagas, MH; Chan, JCN; Chiovitti, MJ; Clover, K; Conwell, Y; Cuijpers, P; de Man-van Ginkel, JM; Delgadillo, J; Fann, JR; Fischer, FH; Fung, D; Gelaye, B; Gilbody, S; Goodyear-Smith, F; Greeno, CG; Hall, BJ; Hambridge, J; Harrison, PA; Harter, M; Hegerl, U; Hides, L; Hobfoll, SE; Hudson, M; Inagaki, M; Ioannidis, JPA; Ismail, K; Jette, N; Khamseh, ME; Kiely, KM; Kloda, LA; Kwan, YX; Levis, AW; Liu, SI; Lotrakul, M; Loureiro, SR; Lowe, B; Marsh, L; McGuire, A; McMillan, D; Sidik, SM; Munhoz, TN; Muramatsu, K; Osorio, FL; Patel, V; Patten, SB; Pence, BW; Persoons, P; Picardi, A; Rice, DB; Riehm, KE; Reuter, K; Rooney, AG; Saadat, N; Sanchez, TA; Santos, IS; Shaaban, J; Sidebottom, A; Simning, A; Shrier, I; Stafford, L; Sung, SC; Tan, PLL; Turner, A; van der Feltz-Cornelis, CM; van Weert, HC; Vohringer, PA; White, J; Whooley, MA; Winkley, K; Yamada, M; Ziegelstein, RC; Zhang, YY				Levis, Brooke; Benedetti, Andrea; Thombs, Brett D.; Akena, Dickens H.; Arroll, Bruce; Ayalon, Liat; Azar, Marleine; Baradaran, Hamid R.; Baron, Murray; Bombardier, Charles H.; Boruff, Jill; Butterworth, Peter; Carter, Gregory; Chagas, Marcos H.; Chan, Juliana C. N.; Chiovitti, Matthew J.; Clover, Kerrie; Conwell, Yeates; Cuijpers, Pim; de Man-van Ginkel, Janneke M.; Delgadillo, Jaime; Fann, Jesse R.; Fischer, Felix H.; Fung, Daniel; Gelaye, Bizu; Gilbody, Simon; Goodyear-Smith, Felicity; Greeno, Catherine G.; Hall, Brian J.; Hambridge, John; Harrison, Patricia A.; Harter, Martin; Hegerl, Ulrich; Hides, Leanne; Hobfoll, Stevan E.; Hudson, Marie; Inagaki, Masatoshi; Ioannidis, John P. A.; Ismail, Khalida; Jette, Nathalie; Khamseh, Mohammad E.; Kiely, Kim M.; Kloda, Lorie A.; Kwan, Yunxin; Levis, Alexander W.; Liu, Shen-Ing; Lotrakul, Manote; Loureiro, Sonia R.; Lowe, Bernd; Marsh, Laura; McGuire, Anthony; McMillan, Dean; Sidik, Sherina Mohd; Munhoz, Tiago N.; Muramatsu, Kumiko; Osorio, Flavia L.; Patel, Vikram; Patten, Scott B.; Pence, Brian W.; Persoons, Philippe; Picardi, Angelo; Rice, Danielle B.; Riehm, Kira E.; Reuter, Katrin; Rooney, Alasdair G.; Saadat, Nazanin; Sanchez, Tatiana A.; Santos, Ina S.; Shaaban, Juwita; Sidebottom, Abbey; Simning, Adam; Shrier, Ian; Stafford, Lesley; Sung, Sharon C.; Tan, Pei Lin Lynnette; Turner, Alyna; van der Feltz-Cornelis, Christina M.; van Weert, Henk C.; Vohringer, Paul A.; White, Jennifer; Whooley, Mary A.; Winkley, Kirsty; Yamada, Mitsuhiko; Ziegelstein, Roy C.; Zhang, Yuying		DEPRESsion Screening Data DEPRESSD	Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INTERNATIONAL DIAGNOSTIC INTERVIEW; PRIMARY-CARE; VALIDITY; RECOMMENDATIONS; RELIABILITY; DISORDER; UTILITY; CIDI; MINI	OBJECTIVE To determine the accuracy of the Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression. DESIGN Individual participant data meta-analysis. DATA SOURCES Medline, Medline In-Process and Other Non-Indexed Citations, PsycINFO, and Web of Science (January 2000-February 2015). INCLUSION CRITERIA Eligible studies compared PHQ-9 scores with major depression diagnoses from validated diagnostic interviews. Primary study data and study level data extracted from primary reports were synthesized. For PHQ-9 cut-off scores 5-15, bivariate random effects meta-analysis was used to estimate pooled sensitivity and specificity, separately, among studies that used semistructured diagnostic interviews, which are designed for administration by clinicians; fully structured interviews, which are designed for lay administration; and the Mini International Neuropsychiatric (MINI) diagnostic interviews, a brief fully structured interview. Sensitivity and specificity were examined among participant subgroups and, separately, using meta-regression, considering all subgroup variables in a single model. RESULTS Data were obtained for 58 of 72 eligible studies (total n=17 357; major depression cases n=2312). Combined sensitivity and specificity was maximized at a cut-off score of 10 or above among studies using a semistructured interview (29 studies, 6725 participants; sensitivity 0.88, 95% confidence interval 0.83 to 0.92; specificity 0.85, 0.82 to 0.88). Across cut-off scores 5-15, sensitivity with semistructured interviews was 5-22% higher than for fully structured interviews (MINI excluded; 14 studies, 7680 participants) and 2-15% higher than for the MINI (15 studies, 2952 participants). Specificity was similar across diagnostic interviews. The PHQ-9 seems to be similarly sensitive but may be less specific for younger patients than for older patients; a cut-off score of 10 or above can be used regardless of age.. CONCLUSIONS PHQ-9 sensitivity compared with semistructured diagnostic interviews was greater than in previous conventional meta-analyses that combined reference standards. A cut-off score of 10 or above maximized combined sensitivity and specificity overall and for subgroups.	[Levis, Brooke; Thombs, Brett D.] Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ, Canada; [Benedetti, Andrea] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada	Lady Davis Institute; McGill University; McGill University	Thombs, BD (corresponding author), Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ, Canada.	brett.thombs@mcgill.ca	Rice, Danielle B/AAS-3681-2020; Butterworth, Peter/AFK-2636-2022; Lotrakul, Manote/AAA-1323-2020; Fischer, Felix/AAF-2612-2020; Baradaran, Hamid R/N-2577-2019; Munhoz, Tiago Neuenfeld/ABF-6742-2020; Gilbody, Simon/AAY-3720-2021; fischer, felix/AAW-6634-2021; Patten, Scott/B-4434-2011; Boruff, Jill T./K-4940-2015; Bombardier, Charles H./AAZ-3260-2021; Hall, Brian J./B-7694-2016; Ioannidis, John P. A./G-9836-2011; Baradaran, Hamid Reza/C-1556-2017; Conwell, Yeates/C-9347-2011; Fung, Daniel/AAF-4775-2020; Winkley, Kirsty/AAH-9458-2020; Yamada, Mitsuhiko/AAO-1107-2020; Munhoz, Tiago N/F-9061-2013; Sheng, Daniel Fung Shuen/AAN-9385-2021; Shrier, Ian/AAI-6502-2020; Osório, Flávia L./H-6079-2012; Löwe, Bernd/AAG-4038-2020; Jette, Nathalie/HCH-4827-2022; Baron, Murray/AAF-9486-2019; Simning, Adam/K-9477-2019; Chan, Juliana/B-7918-2016; Fung, Daniel S S/W-6915-2019	Lotrakul, Manote/0000-0002-1220-7610; Baradaran, Hamid R/0000-0002-5070-5864; Munhoz, Tiago Neuenfeld/0000-0003-1281-9542; Gilbody, Simon/0000-0002-8236-6983; fischer, felix/0000-0002-9693-6676; Patten, Scott/0000-0001-9871-4041; Boruff, Jill T./0000-0002-0338-7322; Bombardier, Charles H./0000-0003-4758-6283; Hall, Brian J./0000-0001-9358-2377; Baradaran, Hamid Reza/0000-0002-5070-5864; Conwell, Yeates/0000-0001-8517-2132; Winkley, Kirsty/0000-0002-1725-6040; Yamada, Mitsuhiko/0000-0002-5649-2310; Munhoz, Tiago N/0000-0003-1281-9542; Sheng, Daniel Fung Shuen/0000-0003-0718-9363; Shrier, Ian/0000-0001-9914-3498; Jette, Nathalie/0000-0003-1351-5866; Chan, Juliana/0000-0003-1325-1194; Sung, Sharon/0000-0003-3293-2112; Thombs, Brett D./0000-0002-5644-8432; Ismail, Khalida/0000-0001-6084-449X; Carter, Gregory/0000-0001-8180-1798; Delgadillo, Jaime/0000-0001-5349-230X	Canadian Institutes of Health Research (CIHR) [KRS-134297]; CIHR Frederick Banting and Charles Best Canada Graduate Scholarship doctoral award; Fonds de recherche du Quebec - Sante (FRQS); CIHR Frederick Banting and Charles Best Canada Graduate Scholarship master's awards; FRQS Masters Training Awards; Vanier Canada Graduate Scholarship; Health Research Council of New Zealand; Lundbeck International; Tehran University of Medical Sciences [M-288]; Department of Education, National Institute on Disability and Rehabilitation Research, Spinal Cord Injury Model Systems: University of Washington [H133N060033]; Department of Education, National Institute on Disability and Rehabilitation Research, Spinal Cord Injury Model Systems: Baylor College of Medicine [H133N060003]; Department of Education, National Institute on Disability and Rehabilitation Research, Spinal Cord Injury Model Systems: University of Michigan [H133N060032]; Australian Research Council Future Fellowship [FT130101444]; European Foundation for Study of Diabetes; Chinese Diabetes Society; Lilly Foundation; Liao Wun Yuk Diabetes Memorial Fund; NIMH [RO1-MH069666, R24MH071604, R34 MH072925, K02 MH65919, P30 DK50456, R24 MH56858, R01 MH073687, R34 MH084673]; Centers for Disease Control and Prevention [R49 CE002093]; St Anne's Community Services, Leeds, UK; US National Center for Medical Rehabilitation Research [RO1 HD39415]; University of Calgary Faculty of Medicine; German Federal Ministry of Education and Research [01GY1150]; NIH [T32 GM07356, T37 MD001449]; Ohio Board of Regents; Research and Development Administration Office, University of Macau [MYRG2015-00109-FSS]; Federal Ministry of Education and Research [01 GD 9802/4, 01 GD 0101]; Federation of German Pension Insurance Institute; Jack Brockhoff Foundation; Grosvenor Settlement; Danks Trust; CIHR [FRN 83518]; Scleroderma Society of Canada; Cure Scleroderma Foundation; FRQS; Canadian Arthritis Network; Lady Davis Institute of Medical Research of the Jewish General Hospital, Montreal, QC; FRQS Senior Investigator Award; European Union; Greek Ministry of Education, Lifelong Learning and Religious Affairs (ARISTEIA-ABREVIATE) [1259]; Ministry of Health, Labour and Welfare, Japan; Canada Research Chair in Neurological Health Services Research; National Health and Medical Research Council [1002160]; Safe Work Australia; Australian National Health and Medical Research Council fellowship [1088313]; Netherlands Organisation for Health Research and Development [945-03-047]; National Health Research Institute, Republic of China [NHRI-EX97-9706PI]; Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand [49086]; Pfizer, Germany; medical faculty of the University of Heidelberg, Germany [121/2000]; Research University Grant Scheme from Universiti Putra Malaysia, Malaysia; Postgraduate Research Student Support Accounts of the University of Auckland, New Zealand; Pfizer US Pharmaceutical Inc.; Reitoria de Pesquisa da Universidade de Sao Paulo [09.1.01689.17.7]; Banco Santander [10.1.01232.17.9]; Italian Ministry of Health; Belgian Ministry of Public Health and Social Affairs; Pfizer Belgium; Universiti Sains Malaysia; United States Department of Health and Human Services, Health Resources and Services Administration [R40MC07840]; Agency for Healthcare Research and Quality [R36 HS018246]; National Center for Research Resources [TL1 RR024135]; University of Melbourne; Innovatiefonds Zorgverzekeraars; Fund for Innovation and Competitiveness of the Chilean Ministry of Economy, Development and Tourism, through the Millennium Scientific Initiative [IS130005]; Department of Veterans Epidemiology Merit Review Program; Department of Veterans Affairs Health Services Research and Development service; National Heart Lung and Blood Institute [R01 HL079235]; American Federation for Ageing Research; Robert Wood Johnson Foundation; UK National Institute for Health Research under its Programme Grants for Applied Research Programme [RP-PG-0606-1142]; Netherlands Organization for Health Research and Development (ZonMw) Mental Health Program [100.003.005, 100.002.021]; Academic Medical Center/University of Amsterdam; Asia Diabetes Foundation; Alberta Health Services; Hotchkiss Brain Institute; Perpetual Trustees; Flora and Frank Leith Charitable Trust; Sunshine Foundation; German Ministry of Research and Education; Scleroderma Society of Ontario; Scleroderma Society of Saskatchewan; Sclerodermie Quebec; Inova Diagnostics Inc; Euroimmun; National Strategic Reference Framework; National Program for Centers of Excellence (PRONEX/FAPERGS/CNPq, Brazil); PQ-CNPq-2 [301321/2016-7]; UK National Health Service Lothian Neuro-Oncology Endowment Fund; Hunter Medical Research Institute; Ischemia Research and Education Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007356] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [T37MD001449] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Frederick Banting and Charles Best Canada Graduate Scholarship doctoral award(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du Quebec - Sante (FRQS)(Fonds de la Recherche en Sante du Quebec); CIHR Frederick Banting and Charles Best Canada Graduate Scholarship master's awards(Canadian Institutes of Health Research (CIHR)); FRQS Masters Training Awards; Vanier Canada Graduate Scholarship; Health Research Council of New Zealand(Health Research Council of New Zealand); Lundbeck International; Tehran University of Medical Sciences(Tehran University of Medical Sciences); Department of Education, National Institute on Disability and Rehabilitation Research, Spinal Cord Injury Model Systems: University of Washington; Department of Education, National Institute on Disability and Rehabilitation Research, Spinal Cord Injury Model Systems: Baylor College of Medicine; Department of Education, National Institute on Disability and Rehabilitation Research, Spinal Cord Injury Model Systems: University of Michigan; Australian Research Council Future Fellowship(Australian Research Council); European Foundation for Study of Diabetes; Chinese Diabetes Society; Lilly Foundation; Liao Wun Yuk Diabetes Memorial Fund; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); St Anne's Community Services, Leeds, UK; US National Center for Medical Rehabilitation Research; University of Calgary Faculty of Medicine; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio Board of Regents; Research and Development Administration Office, University of Macau; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Federation of German Pension Insurance Institute; Jack Brockhoff Foundation; Grosvenor Settlement; Danks Trust; CIHR(Canadian Institutes of Health Research (CIHR)); Scleroderma Society of Canada; Cure Scleroderma Foundation; FRQS; Canadian Arthritis Network; Lady Davis Institute of Medical Research of the Jewish General Hospital, Montreal, QC; FRQS Senior Investigator Award; European Union(European Commission); Greek Ministry of Education, Lifelong Learning and Religious Affairs (ARISTEIA-ABREVIATE); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Canada Research Chair in Neurological Health Services Research; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Safe Work Australia; Australian National Health and Medical Research Council fellowship(National Health and Medical Research Council (NHMRC) of Australia); Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); National Health Research Institute, Republic of China(National Health Research Institutes - Taiwan); Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; Pfizer, Germany(Pfizer); medical faculty of the University of Heidelberg, Germany; Research University Grant Scheme from Universiti Putra Malaysia, Malaysia; Postgraduate Research Student Support Accounts of the University of Auckland, New Zealand; Pfizer US Pharmaceutical Inc.; Reitoria de Pesquisa da Universidade de Sao Paulo; Banco Santander; Italian Ministry of Health(Ministry of Health, Italy); Belgian Ministry of Public Health and Social Affairs; Pfizer Belgium(Pfizer); Universiti Sains Malaysia(Universiti Sains Malaysia); United States Department of Health and Human Services, Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of Melbourne(University of Melbourne); Innovatiefonds Zorgverzekeraars; Fund for Innovation and Competitiveness of the Chilean Ministry of Economy, Development and Tourism, through the Millennium Scientific Initiative; Department of Veterans Epidemiology Merit Review Program(US Department of Veterans Affairs); Department of Veterans Affairs Health Services Research and Development service(US Department of Veterans Affairs); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Federation for Ageing Research; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); UK National Institute for Health Research under its Programme Grants for Applied Research Programme; Netherlands Organization for Health Research and Development (ZonMw) Mental Health Program; Academic Medical Center/University of Amsterdam; Asia Diabetes Foundation; Alberta Health Services; Hotchkiss Brain Institute; Perpetual Trustees; Flora and Frank Leith Charitable Trust; Sunshine Foundation; German Ministry of Research and Education(Federal Ministry of Education & Research (BMBF)); Scleroderma Society of Ontario; Scleroderma Society of Saskatchewan; Sclerodermie Quebec; Inova Diagnostics Inc; Euroimmun; National Strategic Reference Framework; National Program for Centers of Excellence (PRONEX/FAPERGS/CNPq, Brazil); PQ-CNPq-2; UK National Health Service Lothian Neuro-Oncology Endowment Fund; Hunter Medical Research Institute; Ischemia Research and Education Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was funded by the Canadian Institutes of Health Research (CIHR; KRS-134297). BLevis was supported by a CIHR Frederick Banting and Charles Best Canada Graduate Scholarship doctoral award. AB and BDT were supported by Fonds de recherche du Quebec -Sante (FRQS) researcher salary awards. KER and NS were supported by CIHR Frederick Banting and Charles Best Canada Graduate Scholarship master's awards. AWL and MA were supported by FRQS Masters Training Awards. DBR was supported by a Vanier Canada Graduate Scholarship. Collection of data for the study by Arroll et al was supported by a project grant from the Health Research Council of New Zealand. Data collection for the study by Ayalon et al was supported from a grant from Lundbeck International. The primary study by Khamseh et al was supported by a grant (M-288) from Tehran University of Medical Sciences. The primary study by Bombardier et al was supported by the Department of Education, National Institute on Disability and Rehabilitation Research, Spinal Cord Injury Model Systems: University of Washington (grant No H133N060033), Baylor College of Medicine (grant No H133N060003), and University of Michigan (grant No H133N060032). PB was supported by Australian Research Council Future Fellowship FT130101444. Collection of data for the primary study by Zhang et al was supported by the European Foundation for Study of Diabetes, the Chinese Diabetes Society, Lilly Foundation, Asia Diabetes Foundation, and Liao Wun Yuk Diabetes Memorial Fund. YC received support from NIMH (R24MH071604) and the Centers for Disease Control and Prevention (R49 CE002093). Collection of data for the primary study by Delgadillo et al was supported by grant from St Anne's Community Services, Leeds, UK. Collection of data for the primary study by Fann et al was supported by grant RO1 HD39415 from the US National Center for Medical Rehabilitation Research. The primary studies by Amoozegar and by Fiest et al were funded by the Alberta Health Services, the University of Calgary Faculty of Medicine, and the Hotchkiss Brain Institute. The primary study by Fischer et al was funded by the German Federal Ministry of Education and Research (01GY1150). Data for the primary study by Gelaye et al was supported by grant from the NIH (T37 MD001449). Collection of data for the primary study by Gjerdingen et al was supported by grants from the NIMH (R34 MH072925, K02 MH65919, P30 DK50456). The primary study by Eack et al was funded by the NIMH (R24 MH56858). Collection of data for the primary study by Hobfoll et al was made possible in part by grants from NIMH (RO1 MH073687) and the Ohio Board of Regents. BJH received support from a grant awarded by the Research and Development Administration Office, University of Macau (MYRG2015-00109-FSS). Collection of data provided by MHarter and KR was supported by the Federal Ministry of Education and Research (grants No 01 GD 9802/4 and 01 GD 0101) and by the Federation of German Pension Insurance Institute. The primary study by Hides et al was funded by the Perpetual Trustees, Flora and Frank Leith Charitable Trust, Jack Brockhoff Foundation, Grosvenor Settlement, Sunshine Foundation, and Danks Trust. The primary study by Henkel et al was funded by the German Ministry of Research and Education.; Data for the study by Razykov et al was collected by the Canadian Scleroderma Research Group, which was funded by the CIHR (FRN 83518), the Scleroderma Society of Canada, the Scleroderma Society of Ontario, the Scleroderma Society of Saskatchewan, Sclerodermie Quebec, the Cure Scleroderma Foundation, Inova Diagnostics Inc, Euroimmun, FRQS, the Canadian Arthritis Network, and the Lady Davis Institute of Medical Research of the Jewish General Hospital, Montreal, QC. MHudson was supported by a FRQS Senior Investigator Award. Collection of data for the primary study by Hyphantis et al was supported by grant from the National Strategic Reference Framework, European Union, and the Greek Ministry of Education, Lifelong Learning and Religious Affairs (ARISTEIA-ABREVIATE, 1259). The primary study by Inagaki et al was supported by the Ministry of Health, Labour and Welfare, Japan. NJ was supported by a Canada Research Chair in Neurological Health Services Research. Collection of data for the primary study by Kiely et al was supported by National Health and Medical Research Council (grant No 1002160) and Safe Work Australia. KMK was supported by funding from a Australian National Health and Medical Research Council fellowship (grant No 1088313). The primary study by Lamers et al was funded by the Netherlands Organisation for Health Research and Development (grant No 945-03-047). The primary study by Liu et al was funded by a grant from the National Health Research Institute, Republic of China (NHRI-EX97-9706PI). The primary study by Lotrakul et al was supported by the Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand (grant No 49086). BLowe received research grants from Pfizer, Germany, and from the medical faculty of the University of Heidelberg, Germany (project 121/2000) for the study by Grafe et al. The primary study by Mohd Sidik et al was funded under the Research University Grant Scheme from Universiti Putra Malaysia, Malaysia, and the Postgraduate Research Student Support Accounts of the University of Auckland, New Zealand. The primary study by Santos et al was funded by the National Program for Centers of Excellence (PRONEX/FAPERGS/CNPq, Brazil). The primary study by Muramatsu et al was supported by an educational grant from Pfizer US Pharmaceutical Inc. Collection of primary data for the study by BWP was provided by NIMH (R34MH084673). The primary studies by Osorio et al were funded by Reitoria de Pesquisa da Universidade de Sao Paulo (grant No 09.1.01689.17.7) and Banco Santander (grant No 10.1.01232.17.9). FLO was supported by Productivity Grants (PQ-CNPq-2 number 301321/2016-7). The primary study by Picardi et al was supported by funds for current research from the Italian Ministry of Health. PP was supported by a grant from the Belgian Ministry of Public Health and Social Affairs and a restricted grant from Pfizer Belgium. JS was supported by funding from Universiti Sains Malaysia. The primary study by Rooney et al was funded by the UK National Health Service Lothian Neuro-Oncology Endowment Fund. The primary study by Sidebottom et al was funded by a grant from the United States Department of Health and Human Services, Health Resources and Services Administration (grant No R40MC07840). Simning et al's research was supported in part by grants from the NIH (T32 GM07356), Agency for Healthcare Research and Quality (R36 HS018246), NIMH (R24 MH071604), and the National Center for Research Resources (TL1 RR024135). LS received PhD scholarship funding from the University of Melbourne.; Collection of data for the studies by Turner et al were funded by a bequest from Jennie Thomas through the Hunter Medical Research Institute. The study by van Steenbergen-Weijenburg et al was funded by Innovatiefonds Zorgverzekeraars. PAV was supported by the Fund for Innovation and Competitiveness of the Chilean Ministry of Economy, Development and Tourism, through the Millennium Scientific Initiative (grant No IS130005). Collection of data for the primary study by Williams et al was supported by an NIMH grant to LM (RO1-MH069666). The primary study by Thombs et al was done with data from the Heart and Soul Study (PI Mary Whooley). The Heart and Soul Study was funded by the Department of Veterans Epidemiology Merit Review Program, the Department of Veterans Affairs Health Services Research and Development service, the National Heart Lung and Blood Institute (R01 HL079235), the American Federation for Ageing Research, the Robert Wood Johnson Foundation, and the Ischemia Research and Education Foundation. The primary study by Twist et al was funded by the UK National Institute for Health Research under its Programme Grants for Applied Research Programme (grant reference No RP-PG-0606-1142). The study by Wittkampf et al was funded by the Netherlands Organization for Health Research and Development (ZonMw) Mental Health Program (No 100.003.005 and 100.002.021) and the Academic Medical Center/University of Amsterdam. No other authors reported funding for primary studies or for their work on this study. No funder had any role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Allaby M, 2010, SCREENING DEPRESSION; Brugha TS, 1999, PSYCHOL MED, V29, P1013, DOI 10.1017/S0033291799008880; Brugha TS, 2001, PSYCHOL MED, V31, P1001, DOI 10.1017/S0033291701004184; Ferrante di Ruffano L, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e686; First M.B., 2016, STRUCTURED CLIN INTE; Freedland KE, 2002, PSYCHOSOM MED, V64, P897, DOI 10.1097/01.PSY.0000028826.64279.29; Gilbody S, 2007, J GEN INTERN MED, V22, P1596, DOI 10.1007/s11606-007-0333-y; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Joffres M, 2013, CAN MED ASSOC J, V185, P775, DOI 10.1503/cmaj.130403; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kurdyak PA, 2005, CAN J PSYCHIAT, V50, P851, DOI 10.1177/070674370505001308; Lecrubier Y, 1997, EUR PSYCHIAT, V12, P224, DOI 10.1016/S0924-9338(97)83296-8; Leeden R., 2008, HDB MULTILEVEL ANAL, P401, DOI [10.1007/978-0-387-73186-5_11, DOI 10.1007/978-0-387-73186-5_11]; Levis B, 2018, BRIT J PSYCHIAT, V212, P377, DOI 10.1192/bjp.2018.54; Levis B, 2017, AM J EPIDEMIOL, V185, P954, DOI 10.1093/aje/kww191; LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415; McGowan J., 2016, PRESS PEER REV ELECT; McInnes MDF, 2018, JAMA-J AM MED ASSOC, V319, P388, DOI 10.1001/jama.2017.19163; Mitchell AJ, 2016, BJPSYCH OPEN, V2, P127, DOI 10.1192/bjpo.bp.115.001685; Moriarty AS, 2015, GEN HOSP PSYCHIAT, V37, P567, DOI 10.1016/j.genhosppsych.2015.06.012; National Institute for Health and Care Excellence, 2018, DEPR AD TREATM MAN; Nosen E, 2008, HDB RES METHODS ABNO; Rice DB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150067; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; Riley RD, 2008, STAT MED, V27, P6111, DOI 10.1002/sim.3441; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; ROBINS LN, 1981, ARCH GEN PSYCHIAT, V38, P381; SEMLER G, 1987, EUR ARCH PSY CLIN N, V236, P214, DOI 10.1007/BF00383851; Shankman SA, 2018, INT J METH PSYCH RES, V27, DOI 10.1002/mpr.1590; Sheehan DV, 1997, EUR PSYCHIAT, V12, P232, DOI 10.1016/S0924-9338(97)83297-X; Siu AL, 2016, JAMA-J AM MED ASSOC, V315, P380, DOI 10.1001/jama.2015.18392; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Stewart LA, 2015, JAMA-J AM MED ASSOC, V313, P1657, DOI 10.1001/jama.2015.3656; Thombs BD, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-124; Thombs BD, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1253; Thombs BD, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-13; Thombs BD, 2012, CAN MED ASSOC J, V184, P413, DOI 10.1503/cmaj.111035; Thombs BD, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4825; United Nations, GLOB HUM DEV IND; van der Leeden R, 1997, 9704 PRM LEID U DEP; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Wittkampf KA, 2007, GEN HOSP PSYCHIAT, V29, P388, DOI 10.1016/j.genhosppsych.2007.06.004; World Health Organization (WHO) Division of Mental Health, 1994, SCHED CLIN ASS NEUR	44	434	445	9	45	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2019	365								l1476	10.1136/bmj.l1476	http://dx.doi.org/10.1136/bmj.l1476			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU0EH	30967483	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000464943700002
J	Musso, G; Gambino, R; Cassader, M; Paschetta, E				Musso, Giovanni; Gambino, Roberto; Cassader, Maurizio; Paschetta, Elena			Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							META-ANALYTICAL METHODS; SEVERE HYPOGLYCEMIA; GLYCEMIC VARIABILITY; ADJUNCT THERAPY; MEAN GLUCOSE; INSULIN; COMPLICATIONS; ASSOCIATION; MORTALITY; ADULTS	OBJECTIVE To assess the efficacy and safety of dual sodium glucose cotransporter (SGLT) 1/2 inhibitor sotagliflozin in type 1 diabetes mellitus. DESIGN Meta-analysis of randomised controlled trials. DATA SOURCES Medline; Cochrane Library; Embase; international meeting abstracts; international and national clinical trial registries; and websites of US, European, and Japanese regulatory authorities, up to 10 January 2019. ELIGIBILITY CRITERIA FOR SELECTING STUDIES Randomised controlled trials evaluating the effect of sotagliflozin versus active comparators or placebo on glycaemic and non-glycaemic outcomes and on adverse events in type 1 diabetes in participants older than 18. Three reviewers extracted data for study characteristics, outcomes of interest, and risk of bias and summarised strength of evidence using the grading of recommendations assessment, development, and evaluation approach. Main outcomes were pooled using random effects models. RESULTS Of 739 records identified, six randomised placebo controlled trials (n = 3238, duration 4-52 weeks) were included. Sotagliflozin reduced levels of glycated haemoglobin (HbA1c; weighted mean difference -0.34% (95% confidence interval -0.41% to -0.27%), P<0.001); fasting plasma glucose (-16.98 mg/dL, -22.1 to -11.9; 1 mg/dL=0.0555 mmol/L) and two hour-postprandial plasma glucose (-39.2 mg/dL, -50.4 to -28.1); and daily total, basal, and bolus insulin dose (-8.99%, -10.93% to -7.05%; -8.03%, -10.14% to -5.93%; -9.14%, -12.17% to -6.12%; respectively). Sotagliflozin improved time in range (weighted mean difference 9.73%, 6.66% to 12.81%) and other continuous glucose monitoring parameters, and reduced body weight (-3.54%, -3.98% to -3.09%), systolic blood pressure (-3.85 mm Hg, -4.76 to -2.93), and albuminuria (albumin: creatinine ratio -14.57 mg/g, -26.87 to -2.28). Sotagliflozin reduced hypoglycaemia (weighted mean difference -9.09 events per patient year, -13.82 to -4.36) and severe hypoglycaemia (relative risk 0.69, 0.49 to 0.98). However, the drug increased the risk of ketoacidosis (relative risk 3.93, 1.94 to 7.96), genital tract infections (3.12, 2.14 to 4.54), diarrhoea (1.50, 1.08 to 2.10), and volume depletion events (2.19, 1.10 to 4.36). Initial HbA1c and basal insulin dose adjustment were associated with the risk of diabetic ketoacidosis. A sotagliflozin dose of 400 mg/day was associated with a greater improvement in most glycaemic and non-glycaemic outcomes than the 200 mg/day dose, without increasing the risk of adverse events. The quality of evidence was high to moderate for most outcomes, but low for major adverse cardiovascular events and all cause death. The relatively short duration of trials prevented assessment of long term outcomes. CONCLUSIONS In type 1 diabetes, sotagliflozin improves glycaemic and non-glycaemic outcomes and reduces hypoglycaemia rate and severe hypoglycaemia. The risk of diabetic ketoacidosis could be minimised by appropriate patient selection and down-titration of the basal insulin dose.	[Musso, Giovanni; Paschetta, Elena] Humanitas Univ, Gradenigo Hosp, 8 Corso Regina Margherita, I-10132 Turin, Italy; [Gambino, Roberto; Cassader, Maurizio] Univ Turin, Dept Med Sci, Lab Diabet & Metab Disorders, Turin, Italy	Humanitas Hospital Gradenigo; Humanitas University; University of Turin	Musso, G (corresponding author), Humanitas Univ, Gradenigo Hosp, 8 Corso Regina Margherita, I-10132 Turin, Italy.	giovanni_musso@yahoo.it	GAMBINO, Roberto/AAC-7517-2022; Musso, Giovanni/AAB-7884-2022	GAMBINO, Roberto/0000-0003-1902-3627; Musso, Giovanni/0000-0002-8569-2872				Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS73, DOI 10.2337/dc18-S008; Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS65, DOI 10.2337/dc18-S007; Aslam AA, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012040.pub2; Baghurst PA, 2011, DIABETES TECHNOL THE, V13, P296, DOI 10.1089/dia.2010.0090; Baker C, 2017, DIABETOLOGIA, V60, pS409; Bode B, 2017, DIABETOLOGIA, V60, pS87; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; Cefalu WT, 2015, DIABETES CARE, V38, P968, DOI 10.2337/dc15-0615; Ceriello A, 2008, DIABETES, V57, P1349, DOI 10.2337/db08-0063; Dandona P, 2017, LANCET DIABETES ENDO, V5, P864, DOI 10.1016/S2213-8587(17)30308-X; Danne T, 2018, DIABETES CARE, V41, P1981, DOI 10.2337/dc18-0342; Danne T, 2017, DIABETES CARE, V40, P1631, DOI 10.2337/dc17-1600; Davies MJ, 2018, DIABETOLOGIA, V61, P2461, DOI 10.1007/s00125-018-4729-5; Esposito K, 2004, CIRCULATION, V110, P214, DOI 10.1161/01.CIR.0000134501.57864.66; European Association for the Study of Diabetes, 2017, EASD VIRT M, P186; European Medicines Agency, SEARCH RES SOT; FANELLI CG, 1993, DIABETES, V42, P1683, DOI 10.2337/diabetes.42.11.1683; Fisher DJ, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j573; Garg SK, 2017, NEW ENGL J MED, V377, P2337, DOI 10.1056/NEJMoa1708337; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gotzsche PC, 2006, JAMA-J AM MED ASSOC, V295, P1645, DOI 10.1001/jama.295.14.1645; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Heerspink HJL, 2016, CIRCULATION, V134, P752, DOI 10.1161/CIRCULATIONAHA.116.021887; Henry DA, 2005, MED J AUSTRALIA, V182, P557, DOI 10.5694/j.1326-5377.2005.tb06813.x; Henry RR, 2017, DIABETES OBES METAB, V19, P814, DOI 10.1111/dom.12882; Hong JL, 2018, DIABETES CARE, V41, P1196, DOI 10.2337/dc17-2212; Janssen Research & Development, 2012, CAN ADJ TREATM DIET; Lachin JM, 2016, CLIN TRIALS, V13, P161, DOI 10.1177/1740774515602688; Lee AK, 2018, DIABETES CARE, V41, P104, DOI 10.2337/dc17-1669; Lexchin Joel, 2012, Int J Risk Saf Med, V24, P233, DOI 10.3233/JRS-2012-0574; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lind M, 2014, NEW ENGL J MED, V371, P1972, DOI 10.1056/NEJMoa1408214; Manager R., 2012, MAN R REVMAN VERS 5; Meek TH, 2015, DIABETES, V64, P2376, DOI 10.2337/db14-1562; Miller KM, 2015, DIABETES CARE, V38, P971, DOI 10.2337/dc15-0078; Monnier L, 2017, DIABETES CARE, V40, P832, DOI 10.2337/dc16-1769; Monnier L, 2012, DIABETES RES CLIN PR, V95, P303, DOI 10.1016/j.diabres.2011.10.014; Musso G, 2012, ANN MED, V44, P375, DOI 10.3109/07853890.2011.560181; Nathan DM, 2014, DIABETES CARE, V37, P9, DOI 10.2337/dc13-2112; National Research Council, 2010, PREVENTION TREATMENT; Neuen BL, 2018, CIRCULATION, V138, P1537, DOI 10.1161/CIRCULATIONAHA.118.035901; Neumiller JJ, 2014, DRUGS CONTEXT, V3; NovoNordisk, NN9211; Olsen SE, 2014, DIABETIC MED, V31, P1210, DOI 10.1111/dme.12496; Peters AL, 2015, DIABETES CARE, V38, P1687, DOI 10.2337/dc15-0843; Pieber TR, 2018, DIABETOLOGIA, V61, P58, DOI 10.1007/s00125-017-4422-0; Powell DR, 2014, J PHARMACOL EXP THER, V350, P232, DOI 10.1124/jpet.114.214304; Powell DR, 2013, J PHARMACOL EXP THER, V345, P250, DOI 10.1124/jpet.113.203364; Psaty BM, 2008, JAMA-J AM MED ASSOC, V299, P1813, DOI 10.1001/jama.299.15.1813; Raz I, 2011, DIABETES CARE, V34, P1511, DOI 10.2337/dc10-2375; Rosenstock J, 2015, DIABETES CARE, V38, P1638, DOI 10.2337/dc15-1380; Safer DJ, 2002, J NERV MENT DIS, V190, P583, DOI 10.1097/00005053-200209000-00002; Sands AT, 2015, DIABETES CARE, V38, P1181, DOI 10.2337/dc14-2806; Seaquist ER, 2013, DIABETES CARE, V36, P1384, DOI 10.2337/dc12-2480; Seidelmann SB, 2018, J AM COLL CARDIOL, V72, P1763, DOI 10.1016/j.jacc.2018.07.061; Snell-Bergeon JK, 2010, DIABETIC MED, V27, P1436, DOI 10.1111/j.1464-5491.2010.03127.x; Soupal J, 2014, DIABETES TECHNOL THE, V16, P198, DOI 10.1089/dia.2013.0205; Turner R, 1997, LANCET, V350, P1288, DOI 10.1016/S0140-6736(97)03062-6; US Food and Drug Administration, 2018, FDA APPR 1 CONT GLUC; US Food and Drug Administration, SEARCH RES SOT; Viswanathan M, 2018, J CLIN EPIDEMIOL, V97, P26, DOI 10.1016/j.jclinepi.2017.12.004; Wright LAC, 2017, DIABETES TECHNOL THE, V19, pS16, DOI 10.1089/dia.2017.0029; Yamada T, 2018, DIABETES OBES METAB, V20, P1755, DOI 10.1111/dom.13260; Zinman B, 2018, DIABETOLOGIA, V61, P48, DOI 10.1007/s00125-017-4423-z; Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795	65	60	63	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2019	365								l1328	10.1136/bmj.l1328	http://dx.doi.org/10.1136/bmj.l1328			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU0EH	30967375	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000464943700001
J	Ng, K; Nimeiri, HS; McCleary, NJ; Abrams, TA; Yurgelun, MB; Cleary, JM; Rubinson, DA; Schrag, D; Miksad, R; Bullock, AJ; Allen, J; Zuckerman, D; Chan, E; Chan, JA; Wolpin, BM; Constantine, M; Weckstein, DJ; Faggen, MA; Thomas, CA; Kournioti, C; Yuan, C; Ganser, C; Wilkinson, B; Mackintosh, C; Zheng, H; Hollis, BW; Meyerhardt, JA; Fuchs, CS				Ng, Kimmie; Nimeiri, Halla S.; McCleary, Nadine J.; Abrams, Thomas A.; Yurgelun, Matthew B.; Cleary, James M.; Rubinson, Douglas A.; Schrag, Deborah; Miksad, Rebecca; Bullock, Andrea J.; Allen, Jill; Zuckerman, Dan; Chan, Emily; Chan, Jennifer A.; Wolpin, Brian M.; Constantine, Michael; Weckstein, Douglas J.; Faggen, Meredith A.; Thomas, Christian A.; Kournioti, Chryssanthi; Yuan, Chen; Ganser, Christine; Wilkinson, Brittney; Mackintosh, Christopher; Zheng, Hui; Hollis, Bruce W.; Meyerhardt, Jeffrey A.; Fuchs, Charles S.			Effect of High-Dose vs Standard-Dose Vitamin D-3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer The SUNSHINE Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARCINOMA-CELLS; INHIBITION; EXPRESSION; ANALOGS; D-3; 1,25-DIHYDROXYVITAMIN-D3; MECHANISM; GROWTH; DEATH; RISK	IMPORTANCE In observational studies, higher plasma 25-hydroxyvitamin D (25[OH]D) levels have been associated with improved survival in metastatic colorectal cancer (CRC). OBJECTIVE To determine if high-dose vitamin D3 added to standard chemotherapy improves outcomes in patients with metastatic CRC. DESIGN, SETTING, AND PARTICIPANTS Double-blind phase 2 randomized clinical trial of 139 patients with advanced or metastatic CRC conducted at 11 US academic and community cancer centers from March 2012 through November 2016 (database lock: September 2018). INTERVENTIONS mFOLFOX6 plus bevacizumab chemotherapy every 2 weeks and either high-dose vitamin D-3 (n = 69) or standard-dose vitamin D-3 (n = 70) daily until disease progression, intolerable toxicity, or withdrawal of consent. MAIN OUTCOMES AND MEASURES The primary end point was progression-free survival (PFS) assessed by the log-rank test and a supportive Cox proportional hazards model. Testing was 1-sided. Secondary end points included tumor objective response rate (ORR), overall survival (OS), and change in plasma 25(OH) D level. RESULTS Among 139 patients (mean age, 56 years; 60 [43%] women) who completed or discontinued chemotherapy and vitamin D-3 (median follow-up, 22.9 months), the median PFS for high-dose vitamin D-3 was 13.0 months (95% CI, 10.1 to 14.7; 49 PFS events) vs 11.0 months (95% CI, 9.5 to 14.0; 62 PFS events) for standard-dose vitamin D-3 (log-rank P = .07); multivariable hazard ratio for PFS or death was 0.64 (1-sided 95% CI, 0 to 0.90; P = .02). There were no significant differences between high-dose and standard-dose vitamin D-3 for tumor ORR (58% vs 63%, respectively; difference, -5% [95% CI, -20% to 100%], P = .27) or OS (median, 24.3 months vs 24.3 months; log-rank P = .43). The median 25(OH) D level at baseline for high-dose vitamin D-3 was 16.1 ng/mL vs 18.7 ng/mL for standard-dose vitamin D-3 (difference, -2.6 ng/mL [95% CI, -6.6 to 1.4], P = .30); at first restaging, 32.0 ng/mL vs 18.7 ng/mL (difference, 12.8 ng/mL [95% CI, 9.0 to 16.6], P < .001); at second restaging, 35.2 ng/mL vs 18.5 ng/mL (difference, 16.7 ng/mL [95% CI, 10.9 to 22.5], P < .001); and at treatment discontinuation, 34.8 ng/mL vs 18.7 ng/mL (difference, 16.2 ng/mL [95% CI, 9.9 to 22.4], P < .001). The most common grade 3 and higher adverse events for chemotherapy plus high-dose vs standard-dose vitamin D-3 were neutropenia (n = 24 [35%]vs n = 21 [31%], respectively) and hypertension (n = 9 [13%]vs n = 11 [16%]). CONCLUSIONS AND RELEVANCE Among patients with metastatic CRC, addition of high-dose vitamin D-3, vs standard-dose vitamin D-3, to standard chemotherapy resulted in a difference in median PFS that was not statistically significant, but with a significantly improved supportive hazard ratio. These findings warrant further evaluation in a larger multicenter randomized clinical trial.	[Ng, Kimmie; McCleary, Nadine J.; Abrams, Thomas A.; Yurgelun, Matthew B.; Cleary, James M.; Rubinson, Douglas A.; Schrag, Deborah; Chan, Jennifer A.; Wolpin, Brian M.; Yuan, Chen; Ganser, Christine; Wilkinson, Brittney; Mackintosh, Christopher; Meyerhardt, Jeffrey A.] Dana Farber Canc Inst, 450 Brookline Ave, Boston, MA 02215 USA; [Nimeiri, Halla S.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Miksad, Rebecca; Bullock, Andrea J.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Allen, Jill; Zheng, Hui] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Zuckerman, Dan] St Lukes Mt States Tumor Inst, Boise, ID USA; [Chan, Emily] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Constantine, Michael] Dana Farber Milford Reg Med Ctr, Milford, MA USA; [Weckstein, Douglas J.] New Hampshire Oncol Hematol, Hookset, NH USA; [Faggen, Meredith A.] Dana Farber South Shore Hosp, South Weymouth, MA USA; [Thomas, Christian A.] New England Canc Specialists, Scarborough, ME USA; [Kournioti, Chryssanthi] Newton Wellesley Hosp, Newton, MA USA; [Hollis, Bruce W.] Med Univ South Carolina, Charleston, SC 29425 USA; [Fuchs, Charles S.] Yale Canc Ctr, New Haven, CT USA	Harvard University; Dana-Farber Cancer Institute; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Vanderbilt University; Newton Wellesley Hospital; Medical University of South Carolina; Yale University	Ng, K (corresponding author), Dana Farber Canc Inst, 450 Brookline Ave, Boston, MA 02215 USA.	kimmie_ng@dfci.harvard.edu	Miksad, Rebecca Anne/GPF-9176-2022; Thomas, Christian/AAI-6276-2020	Yuan, Chen/0000-0002-0708-9648	National Institutes of Health, National Cancer Institute [P50CA127003, R01CA205406, R01CA118553]; Gloria Spivak Faculty Advancement Award; Friends of Dana-Farber Cancer Institute Award; Project P Fund; Consano; Genentech; Pharmavite LLC; NATIONAL CANCER INSTITUTE [P50CA127003, R01CA118553, R01CA205406] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Gloria Spivak Faculty Advancement Award; Friends of Dana-Farber Cancer Institute Award; Project P Fund; Consano; Genentech(Roche HoldingGenentech); Pharmavite LLC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grants P50CA127003, R01CA205406, R01CA118553 from the National Institutes of Health, National Cancer Institute. Additional funding was provided by the Gloria Spivak Faculty Advancement Award, Friends of Dana-Farber Cancer Institute Award, Project P Fund, Consano, Pharmavite LLC, and Genentech. Pharmavite provided the vitamin D3 and placebo capsules for the study.	Bises G, 2004, J HISTOCHEM CYTOCHEM, V52, P985, DOI 10.1369/jhc.4B6271.2004; Cicero G, 2018, ONCOTARGETS THER, V11, P3059, DOI 10.2147/OTT.S151276; Diaz GD, 2000, CANCER RES, V60, P2304; EISMAN JA, 1987, CANCER RES, V47, P21; Evans SRT, 2000, INT J ONCOL, V16, P1249; Feldman D, 2014, NAT REV CANCER, V14, P342, DOI 10.1038/nrc3691; Fiscella K, 2011, CANCER-AM CANCER SOC, V117, P1061, DOI 10.1002/cncr.25647; Froicu M, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-5; Hollis BW, 1997, METHOD ENZYMOL, V282, P174; Huerta S, 2002, CANCER RES, V62, P741; Iseki K, 1999, INT J CANCER, V81, P730, DOI 10.1002/(SICI)1097-0215(19990531)81:5&lt;730::AID-IJC11&gt;3.0.CO;2-Q; Jeong Y, 2015, MOL CANCER THER, V14, P1951, DOI 10.1158/1535-7163.MCT-15-0066; Liu GM, 2010, INT J CANCER, V126, P631, DOI 10.1002/ijc.24762; Ma YL, 2011, J CLIN ONCOL, V29, P3775, DOI 10.1200/JCO.2011.35.7566; Manson JE, 2019, NEW ENGL J MED, V380, P33, DOI [10.1056/NEJMoa1809944, 10.1056/nejmoa1809944]; Mathieu C, 2002, TRENDS MOL MED, V8, P174, DOI 10.1016/S1471-4914(02)02294-3; MEGGOUH F, 1991, CANCER RES, V51, P1227; Mezawa H, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-347; Nesby-O'Dell S, 2002, AM J CLIN NUTR, V76, P187, DOI 10.1093/ajcn/76.1.187; Ng K, 2015, ANN M AM SOC CLIN ON; Ng K, 2017, J CLIN ONCOL, V35, p3506A; Ng K, 2008, J CLIN ONCOL, V26, P2984, DOI 10.1200/JCO.2007.15.1027; Ng K, 2011, J CLIN ONCOL, V29, P1599, DOI 10.1200/JCO.2010.31.7255; Qi XM, 2004, J BIOL CHEM, V279, P22138, DOI 10.1074/jbc.M313964200; Scaglione-Sewell BA, 2000, ENDOCRINOLOGY, V141, P3931, DOI 10.1210/en.141.11.3931; SHABAHANG M, 1994, CANCER RES, V54, P4057; Solomon C, 2001, RADIAT RES, V155, P156, DOI 10.1667/0033-7587(2001)155[0156:VDRIRT]2.0.CO;2; Solomon C, 1998, J BIOL CHEM, V273, P17573, DOI 10.1074/jbc.273.28.17573; Wang YJ, 2012, ARCH BIOCHEM BIOPHYS, V523, P123, DOI 10.1016/j.abb.2012.04.001; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Zehnder D, 2001, J CLIN ENDOCR METAB, V86, P888, DOI 10.1210/jc.86.2.888; Zgaga L, 2014, J CLIN ONCOL, V32, P2430, DOI 10.1200/JCO.2013.54.5947; Zhang Z, 2008, AM J PHYSIOL-GASTR L, V294, pG208, DOI 10.1152/ajpgi.00398.2007; Zhao P, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-1	34	92	92	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 9	2019	321	14					1370	1379		10.1001/jama.2019.2402	http://dx.doi.org/10.1001/jama.2019.2402			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HT5PG	30964527	Green Published, Bronze			2022-12-28	WOS:000464615200016
J	Urashima, M; Ohdaira, H; Akutsu, T; Okada, S; Yoshida, M; Kitajima, M; Suzuki, Y				Urashima, Mitsuyoshi; Ohdaira, Hironori; Akutsu, Taisuke; Okada, Shinya; Yoshida, Masashi; Kitajima, Masaki; Suzuki, Yutaka			Effect of Vitamin D Supplementation on Relapse-Free Survival Among Patients With Digestive Tract Cancers The AMATERASU Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							25-HYDROXYVITAMIN D; POLYMORPHISMS; MORTALITY; PREDICTORS; RISK	IMPORTANCE Randomized clinical trials of vitamin D supplementation for secondary prevention in patients with cancer are needed, given positive results of observational studies. OBJECTIVE To determine whether postoperative vitamin D3 supplementation can improve survival of patients with digestive tract cancers overall and in subgroups stratified by 25-hydroxyvitamin D (25[OH]D) levels. DESIGN, SETTING, AND PARTICIPANTS The AMATERASU trial, a randomized, double-blind, placebo-controlled trial conducted at a single university hospital in Japan. Enrollment began in January 2010 and follow-up was completed in February 2018. Patients aged 30 to 90 years with cancers of the digestive tract from the esophagus to the rectum, stages I to III, were recruited. Of 439 eligible patients, 15 declined and 7 were excluded after operation. INTERVENTIONS Patients were randomized to receive oral supplemental capsules of vitamin D (2000 IU/d; n = 251) or placebo (n = 166) from the first postoperative outpatient visit to until the end of the trial. MAIN OUTCOMES AND MEASURES The primary outcomewas relapse-free survival time to relapse or death. The secondary outcomewas overall survival time to death due to any cause. Subgroups analyzed had baseline serum 25 (OH) D levels of 0 to less than 20 ng/mL, 20 to 40 ng/mL, and greater than 40 ng/mL; because of small sample size for the highest-baseline-level group, interactions were tested only between the low-and middle-baseline-level groups. RESULTS All 417 randomized patients (mean age, 66 years; male, 66%; esophageal cancer, 10%; gastric cancer, 42%; colorectal cancer, 48%) were included in the analyses. There was 99.8% follow-up over a median 3.5 (interquartile range, 2.3-5.3) years, with maximal follow-up of 7.6 years. Relapse or death occurred in 50 patients (20%) randomized to vitamin D and 43 patients (26%) randomized to placebo. Death occurred in 37 (15%) in the vitamin D group and 25 (15%) in the placebo group. The 5-year relapse-free survival was 77% with vitamin D vs 69% with placebo (hazard ratio [HR] for relapse or death, 0.76; 95% CI, 0.50-1.14; P = .18). The 5-year overall survival in the vitamin D vs placebo groups was 82% vs 81% (HR for death, 0.95; 95% CI, 0.57-1.57; P = .83). In the subgroup of patients with baseline serum 25 (OH) D levels between 20 and 40 ng/mL, the 5-year relapse-free survival was 85% with vitamin D vs 71% with placebo (HR for relapse or death, 0.46; 95% CI, 0.24-0.86; P = .02; P = .04 for interaction). Fractures occurred in 3 patients (1.3%) in the vitamin D group and 5 (3.4%) in the placebo group. Urinary stones occurred in 2 patients (0.9%) in the vitamin D group and 0 in the placebo group. CONCLUSIONS AND RELEVANCE Among patients with digestive tract cancer, vitamin D supplementation, compared with placebo, did not result in significant improvement in relapse-free survival at 5 years.	[Urashima, Mitsuyoshi; Akutsu, Taisuke] Jikei Univ, Sch Med, Div Mol Epidemiol, Tokyo, Japan; [Ohdaira, Hironori; Yoshida, Masashi; Kitajima, Masaki; Suzuki, Yutaka] Int Univ Hlth & Welfare Hosp, Dept Surg, Otawara, Tochigi, Japan; [Okada, Shinya] Int Univ Hlth & Welfare Hosp, Dept Pathol, Otawara, Tochigi, Japan	Jikei University; International University of Health & Welfare; International University of Health & Welfare	Urashima, M (corresponding author), Jikei Univ, Sch Med, Div Mol Epidemiol, Minato Ku, Nishi Shimbashi 3-25-8, Tokyo 1058461, Japan.	urashima@jikei.ac.jp	Yoshida, Masashi/ABG-7085-2021	Akutsu, Taisuke/0000-0003-3649-4519	Ministry of Education, Culture, Sports, Science, and Technology in the Japan-Supported Program for the Strategic Research Foundation at Private Universities from the International University of Health and Welfare Hospital; Jikei University School of Medicine	Ministry of Education, Culture, Sports, Science, and Technology in the Japan-Supported Program for the Strategic Research Foundation at Private Universities from the International University of Health and Welfare Hospital; Jikei University School of Medicine(Jikei University)	This research was supported by the Ministry of Education, Culture, Sports, Science, and Technology in the Japan-Supported Program for the Strategic Research Foundation at Private Universities, funding from the International University of Health and Welfare Hospital, and Jikei University School of Medicine.	Akiba T, 2018, CLIN CANCER RES, V24, P4089, DOI 10.1158/1078-0432.CCR-18-0483; Avenell A, 2012, J CLIN ENDOCR METAB, V97, P614, DOI 10.1210/jc.2011-1309; Bikle D, 2009, J CLIN ENDOCR METAB, V94, P26, DOI 10.1210/jc.2008-1454; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; GARLAND CF, 1989, LANCET, V2, P1176, DOI 10.1016/s0140-6736(89)91789-3; Giovannucci E, 2006, JNCI-J NATL CANCER I, V98, P451, DOI 10.1093/jnci/djj101; Hama T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029634; Heist RS, 2008, J CLIN ONCOL, V26, P5596, DOI 10.1200/JCO.2008.18.0406; HESS KR, 1995, STAT MED, V14, P1707, DOI 10.1002/sim.4780141510; HOLLIS BW, 1993, CLIN CHEM, V39, P529; Janssens W, 2010, THORAX, V65, P215, DOI 10.1136/thx.2009.120659; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Keum N, 2014, BRIT J CANCER, V111, P976, DOI 10.1038/bjc.2014.294; Lappe JM, 2007, AM J CLIN NUTR, V85, P1586, DOI 10.1093/ajcn/85.6.1586; Manson JE, 2019, NEW ENGL J MED, V380, P33, DOI [10.1056/NEJMoa1809944, 10.1056/nejmoa1809944]; Mezawa H, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-347; Morales-Oyarvide V, 2016, CANCER J, V22, P223, DOI 10.1097/PPO.0000000000000197; Ng K, 2009, BRIT J CANCER, V101, P916, DOI 10.1038/sj.bjc.6605262; Ng K, 2008, J CLIN ONCOL, V26, P2984, DOI 10.1200/JCO.2007.15.1027; SCHOTTKER B, 2014, BMJ-BRIT MED J, V348, DOI DOI 10.1136/BMJ.G3656; Schulz KF, 2005, LANCET, V365, P1657, DOI 10.1016/S0140-6736(05)66516-6; Sinotte M, 2009, AM J CLIN NUTR, V89, P634, DOI 10.3945/ajcn.2008.26445; Skender S, 2017, NUTR CANCER, V69, P229, DOI 10.1080/01635581.2017.1265131; Suzuki M, 2012, MOVEMENT DISORD, V27, P264, DOI 10.1002/mds.24016; Tamez S, 2009, BRIT J CANCER, V101, P1957, DOI 10.1038/sj.bjc.6605414; Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469; Uitterlinden AG, 2004, GENE, V338, P143, DOI 10.1016/j.gene.2004.05.014; Van Blarigan EL, 2018, JAMA ONCOL, V4, P783, DOI 10.1001/jamaoncol.2018.0126; van Harten-Gerritsen AS, 2015, CANCER EPIDEM BIOMAR, V24, P1820, DOI 10.1158/1055-9965.EPI-15-0601; Vaughan-Shaw PG, 2017, BRIT J CANCER, V116, P1092, DOI 10.1038/bjc.2017.44; Wactawski-Wende J, 2006, NEW ENGL J MED, V354, P684, DOI 10.1056/NEJMoa055222; Watanabe T, 2012, INT J CLIN ONCOL, V17, P1, DOI 10.1007/s10147-011-0315-2	32	65	65	1	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 9	2019	321	14					1361	1369		10.1001/jama.2019.2210	http://dx.doi.org/10.1001/jama.2019.2210			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HT5PG	30964526	Bronze, Green Published			2022-12-28	WOS:000464615200015
J	Kemp, M				Kemp, Martin			The art of medicine Leonardo's philosophical anatomies	LANCET			English	Editorial Material									[Kemp, Martin] Univ Oxford, Trinity Coll, Oxford OX1 3BH, England	University of Oxford	Kemp, M (corresponding author), Univ Oxford, Trinity Coll, Oxford OX1 3BH, England.	martin.kemp@trinity.ox.ac.uk							0	1	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 6	2019	393	10179					1404	1408		10.1016/S0140-6736(19)30584-7	http://dx.doi.org/10.1016/S0140-6736(19)30584-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HS0OU	30967206				2022-12-28	WOS:000463561000014
J	Iacobucci, G				Iacobucci, Gareth			Patients "increasingly worried" about drug supplies amid Brexit uncertainty, says royal college	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2019	364								l1397	10.1136/bmj.l1397	http://dx.doi.org/10.1136/bmj.l1397			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HR5VS	30957769				2022-12-28	WOS:000463215700013
J	Klugman, KP; Rodgers, GL				Klugman, Keith P.; Rodgers, Gail L.			pulation versus individual protection by pneumococcal conjugate vaccination	LANCET			English	Editorial Material							DISEASE; CARRIAGE; CHILDREN		[Klugman, Keith P.; Rodgers, Gail L.] Bill & Melinda Gates Fdn, Seattle, WA 98119 USA	Bill & Melinda Gates Foundation	Klugman, KP (corresponding author), Bill & Melinda Gates Fdn, Seattle, WA 98119 USA.	keith.klugman@gatesfoundation.org						Goldblatt D, 2018, LANCET INFECT DIS, V18, P171, DOI 10.1016/S1473-3099(17)30654-0; Hammitt LL, 2019, LANCET, V393, P2146, DOI 10.1016/S0140-6736(18)33005-8; Heinsbroek E, 2018, VACCINE, V36, P7369, DOI 10.1016/j.vaccine.2018.10.021; Loughlin AM, 2014, PEDIATR INFECT DIS J, V33, P504, DOI 10.1097/INF.0000000000000279; Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3; Nzenze SA, 2017, AM J EPIDEMIOL, V186, P435, DOI 10.1093/aje/kwx048; Sigauque B, 2018, PEDIATR INFECT DIS J, V37, P1054, DOI 10.1097/INF.0000000000002134; Southern J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195799; Usuf E, 2019, CLIN INFECT DIS, V68, P1512, DOI 10.1093/cid/ciy726; von Gottberg A, 2014, NEW ENGL J MED, V371, P1889, DOI 10.1056/NEJMoa1401914; Weinberger DM, 2019, AM J EPIDEMIOL, V188, P160, DOI 10.1093/aje/kwy219	11	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 25	2019	393	10186					2102	2104		10.1016/S0140-6736(19)30039-X	http://dx.doi.org/10.1016/S0140-6736(19)30039-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HZ5KS	31000193	hybrid, Green Published			2022-12-28	WOS:000468891400006
J	Grunewald, J; Zhou, RH; Garcia, SP; Iyer, S; Lareau, CA; Aryee, MJ; Joung, JK				Grunewald, Julian; Zhou, Ronghao; Garcia, Sara P.; Iyer, Sowmya; Lareau, Caleb A.; Aryee, Martin J.; Joung, J. Keith			Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors	NATURE			English	Article							B MESSENGER-RNA; ENZYME APOBEC1; GENOMIC DNA; PROTEIN; DEAMINASE; OVEREXPRESSION; MUTAGENESIS; FRAMEWORK; BINDING; MOTIF	CRISPR-Cas base-editor technology enables targeted nucleotide alterations, and is being increasingly used for research and potential therapeutic applications(1,2). The most widely used cytosine base editors (CBEs) induce deamination of DNA cytosines using the rat APOBEC1 enzyme, which is targeted by a linked Cas protein-guide RNA complex(3,4). Previous studies of the specificity of CBEs have identified off-target DNA edits in mammalian cells(5,6). Here we show that a CBE with rat APOBEC1 can cause extensive transcriptome-wide deamination of RNA cytosines in human cells, inducing tens of thousands of C-to-U edits with frequencies ranging from 0.07% to 100% in 38-58% of expressed genes. CBE-induced RNA edits occur in both protein-coding and non-protein-coding sequences and generate missense, nonsense, splice site, and 5' and 3' untranslated region mutations. We engineered two CBE variants bearing mutations in rat APOBEC1 that substantially decreased the number of RNA edits (by more than 390-fold and more than 3,800-fold) in human cells. These variants also showed more precise on-target DNA editing than the wild-type CBE and, for most guide RNAs tested, no substantial reduction in editing efficiency. Finally, we show that an adenine base editor(7) can also induce transcriptome-wide RNA edits. These results have implications for the use of base editors in both research and clinical settings, illustrate the feasibility of engineering improved variants with reduced RNA editing activities, and suggest the need to more fully define and characterize the RNA off-target effects of deaminase enzymes in base editor platforms.	[Grunewald, Julian; Zhou, Ronghao; Garcia, Sara P.; Iyer, Sowmya; Lareau, Caleb A.; Aryee, Martin J.; Joung, J. Keith] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA; [Grunewald, Julian; Zhou, Ronghao; Aryee, Martin J.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; [Grunewald, Julian; Zhou, Ronghao; Aryee, Martin J.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Charlestown, MA 02129 USA; [Grunewald, Julian; Aryee, Martin J.; Joung, J. Keith] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA; [Lareau, Caleb A.; Aryee, Martin J.] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Joung, JK (corresponding author), Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA.; Joung, JK (corresponding author), Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA.; Joung, JK (corresponding author), Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Charlestown, MA 02129 USA.; Joung, JK (corresponding author), Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA.	jjoung@mgh.harvard.edu	Aryee, Martin/AAC-8113-2020; Lareau, Caleb/ABF-9490-2020	Lareau, Caleb/0000-0003-4179-4807; Garcia, Sara/0000-0003-3312-6454; Grunewald, Julian/0000-0001-7537-7505; Zhou, Ronghao/0000-0002-3917-0694	Defense Advanced Research Projects Agency [HR0011-17-2-0042]; National Institutes of Health [RM1 HG009490, R35 GM118158]; Desmond and Ann Heathwood MGH Research Scholar Award; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RM1HG009490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118158] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Desmond and Ann Heathwood MGH Research Scholar Award; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	J.K.J., J.G. and R.Z. are supported by the Defense Advanced Research Projects Agency (HR0011-17-2-0042). Support was also provided by the National Institutes of Health (RM1 HG009490 to J.K.J. and J.G. and R35 GM118158 to J.K.J. and M.J.A.). J.K.J. is additionally supported by the Desmond and Ann Heathwood MGH Research Scholar Award. We thank M. M. Kaminski, B. P. Kleinstiver and K. Petri for discussions; V. Pattanayak for input on the manuscript; Y. E. Tak, G. Boulay, M. K. Clement, A. A. Sousa, R. T. Walton, M. L. Bobbin, M. V. Maus and A. Schmidts for technical advice; and P. K. Cabeceiras and O. R. Cervantes for technical assistance. J.K.J. dedicates this paper to the memory of C. J. Park.	BOSTROM K, 1990, J BIOL CHEM, V265, P22446; CHEN SH, 1987, SCIENCE, V238, P363, DOI 10.1126/science.3659919; Chen ZG, 2010, RNA, V16, P1040, DOI 10.1261/rna.1863010; Clement K, 2019, NAT BIOTECHNOL, V37, P224, DOI 10.1038/s41587-019-0032-3; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Gaudelli NM, 2017, NATURE, V551, P464, DOI 10.1038/nature24644; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim D, 2017, NAT BIOTECHNOL, V35, P475, DOI 10.1038/nbt.3852; Kim J, 2006, BIOCHEMISTRY-US, V45, P6407, DOI 10.1021/bi0522394; Koblan LW, 2018, NAT BIOTECHNOL, V36, P843, DOI 10.1038/nbt.4172; Komor AC, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao4774; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LAU PP, 1990, NUCLEIC ACIDS RES, V18, P5817, DOI 10.1093/nar/18.19.5817; MACGINNITIE AJ, 1995, J BIOL CHEM, V270, P14768, DOI 10.1074/jbc.270.24.14768; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; NAVARATNAM N, 1995, CELL, V81, P187, DOI 10.1016/0092-8674(95)90328-3; Olarerin-George AO, 2015, NUCLEIC ACIDS RES, V43, P2535, DOI 10.1093/nar/gkv136; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; Rees HA, 2018, NAT REV GENET, V19, P770, DOI 10.1038/s41576-018-0059-1; Rohland N, 2012, GENOME RES, V22, P939, DOI 10.1101/gr.128124.111; Rosenberg BR, 2011, NAT STRUCT MOL BIOL, V18, P230, DOI 10.1038/nsmb.1975; Salter JD, 2016, TRENDS BIOCHEM SCI, V41, P578, DOI 10.1016/j.tibs.2016.05.001; Seo H, 2018, NAT MED, V24, P1493, DOI 10.1038/s41591-018-0215-3; Skuse GR, 1996, NUCLEIC ACIDS RES, V24, P478, DOI 10.1093/nar/24.3.478; Sowden M, 1996, J BIOL CHEM, V271, P3011, DOI 10.1074/jbc.271.6.3011; Teng BB, 1999, J LIPID RES, V40, P623; Wolf J, 2002, EMBO J, V21, P3841, DOI 10.1093/emboj/cdf362; Yamanaka S, 1996, J BIOL CHEM, V271, P11506, DOI 10.1074/jbc.271.19.11506; YAMANAKA S, 1994, J BIOL CHEM, V269, P21725; Zuo EW, 2019, SCIENCE, V364, P289, DOI 10.1126/science.aav9973	37	270	284	9	168	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 16	2019	569	7756					433	+		10.1038/s41586-019-1161-z	http://dx.doi.org/10.1038/s41586-019-1161-z			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY4UP	30995674	Green Accepted			2022-12-28	WOS:000468123700044
J	Hainer, SJ; Boskovic, A; McCannell, KN; Rando, OJ; Fazzio, TG				Hainer, Sarah J.; Boskovic, Ana; McCannell, Kurtis N.; Rando, Oliver J.; Fazzio, Thomas G.			Profiling of Pluripotency Factors in Single Cells and Early Embryos	CELL			English	Article							TRANSCRIPTIONAL REGULATORY CIRCUITRY; CHIP-SEQ; CHROMATIN ACCESSIBILITY; ACTIVE PROMOTERS; READ ALIGNMENT; SELF-RENEWAL; STEM-CELLS; NANOG; LANDSCAPE; ENHANCERS	Cell fate decisions are governed by sequence-specific transcription factors (TFs) that act in small populations of cells within developing embryos. To understand their functions in vivo, it is important to identify TF binding sites in these cells. However, current methods cannot profile TFs genome-wide at or near the single-cell level. Here we adapt the cleavage under targets and release using nuclease (CUT&RUN) method to profile TFs in low cell numbers, including single cells and individual pre-implantation embryos. Single-cell experiments suggest that only a fraction of TF binding sites are occupied in most cells, in a manner broadly consistent with measurements of peak intensity from multi-cell studies. We further show that chromatin binding by the pluripotency TF NANOG is highly dependent on the SWI/SNF chromatin remodeling complex in individual blastocysts but not in cultured cells. Ultra-low input CUT&RUN (uliCUT&RUN) therefore enables interrogation of TF binding from rare cell populations of particular importance in development or disease.	[Hainer, Sarah J.; McCannell, Kurtis N.; Fazzio, Thomas G.] Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA 01605 USA; [Hainer, Sarah J.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Boskovic, Ana; Rando, Oliver J.] Univ Massachusetts, Dept Biochem & Mol Pharmacol, Sch Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Massachusetts System; University of Massachusetts Worcester	Hainer, SJ; Fazzio, TG (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA 01605 USA.; Hainer, SJ (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.	sarah.hainer@pitt.edu; thomas.fazzio@umassmed.edu		Hainer, Sarah/0000-0003-0503-1183; McCannell, Kurtis/0000-0002-7217-2202; Boskovic, Ana/0000-0003-1258-4376	NIH [R01HD072122, R01HD080224]; Human Frontier Science Program [LT000857/2015-L]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD080224, R01HD072122] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank S. Henikoff, T. Wu, and C.-H. Chao for providing purified pA-MN protein. We thank the UMMS and University of Pittsburgh Flow Cytometry cores and the Health Sciences Sequencing Core at the University of Pittsburgh Children's Hospital for assistance. Finally, we thank J. Benanti, I. Bach, J. Dekker, and M. Walhout for critical reading of the manuscript. This work was supported by NIH grants R01HD072122 (to T.G.F.) and R01HD080224 (to O.J.R.). A.B. is supported by a fellowship from the Human Frontier Science Program (LT000857/2015-L). S.J.H. is a Special Fellow of the Leukemia and Lymphoma Society. T.G.F. is a Leukemia and Lymphoma Society Scholar.	Baranello L, 2016, CHROMOSOME RES, V24, P175, DOI 10.1007/s10577-015-9509-1; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brind'Amour J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7033; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Bultman SJ, 2006, GENE DEV, V20, P1744, DOI 10.1101/gad.1435106; Cao ZN, 2015, NAT METHODS, V12, P959, DOI [10.1038/NMETH.3488, 10.1038/nmeth.3488]; Carone BR, 2014, DEV CELL, V30, P11, DOI 10.1016/j.devcel.2014.05.024; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen PB, 2013, ELIFE, V2, DOI 10.7554/eLife.01557; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Crawford GE, 2004, P NATL ACAD SCI USA, V101, P992, DOI 10.1073/pnas.0307540100; Cusanovich DA, 2015, SCIENCE, V348, P910, DOI 10.1126/science.aab1601; Dahl JA, 2016, NATURE, V537, P548, DOI 10.1038/nature19360; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; Hainer SJ, 2015, CELL REP, V13, P61, DOI 10.1016/j.celrep.2015.08.071; Hainer SJ, 2015, GENE DEV, V29, P362, DOI 10.1101/gad.253534.114; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Hodges HC, 2018, NAT STRUCT MOL BIOL, V25, P61, DOI 10.1038/s41594-017-0007-3; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Hu GQ, 2011, GENOME RES, V21, P1650, DOI 10.1101/gr.121145.111; Jain D, 2015, NUCLEIC ACIDS RES, V43, P6959, DOI 10.1093/nar/gkv637; Jin WF, 2015, NATURE, V528, P142, DOI 10.1038/nature15740; Kaneko S, 2013, NAT STRUCT MOL BIOL, V20, P1258, DOI 10.1038/nsmb.2700; Kidder BL, 2009, STEM CELLS, V27, P317, DOI 10.1634/stemcells.2008-0710; King HW, 2017, ELIFE, V6, DOI 10.7554/eLife.22631; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leonid TB, 2013, P NATL ACAD SCI USA, V110, P18602, DOI 10.1073/pnas.1316064110; Levasseur DN, 2008, GENE DEV, V22, P575, DOI 10.1101/gad.1606308; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu Q, 2017, CIRC RES, V121, P376, DOI 10.1161/CIRCRESAHA.116.310456; Liu XY, 2016, NATURE, V537, P558, DOI 10.1038/nature19362; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Long HK, 2016, CELL, V167, P1170, DOI 10.1016/j.cell.2016.09.018; Marinov GK, 2014, GENOME RES, V24, P496, DOI 10.1101/gr.161034.113; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Meyer CA, 2014, NAT REV GENET, V15, P709, DOI 10.1038/nrg3788; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Rotem A, 2015, NAT BIOTECHNOL, V33, P1165, DOI 10.1038/nbt.3383; Sabo PJ, 2004, P NATL ACAD SCI USA, V101, P16837, DOI 10.1073/pnas.0407387101; Schmid M, 2004, MOL CELL, V16, P147, DOI 10.1016/j.molcel.2004.09.007; Schmidt C, 2015, NAT METHODS, V12, P963, DOI [10.1038/nmeth.3542, 10.1038/NMETH.3542]; Skene PJ, 2018, NAT PROTOC, V13, P1006, DOI 10.1038/nprot.2018.015; Skene PJ, 2017, ELIFE, V6, DOI 10.7554/eLife.21856; Teif VB, 2012, NAT STRUCT MOL BIOL, V19, P1185, DOI 10.1038/nsmb.2419; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Torres-Padilla ME, 2006, INT J DEV BIOL, V50, P455, DOI 10.1387/ijdb.052073mt; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Yuan GC, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1218-y; Zaret KS, 2016, CURR OPIN GENET DEV, V37, P76, DOI 10.1016/j.gde.2015.12.003; Zwart W, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-232; 2015, MOL CELL BIOL, V35, P4158, DOI DOI 10.1128/MCB.00546-15	57	88	94	3	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 16	2019	177	5					1319	+		10.1016/j.cell.2019.03.014	http://dx.doi.org/10.1016/j.cell.2019.03.014			22	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HY4NB	30955888	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000468103800022
J	Tikhonova, AN; Dolgalev, I; Hu, H; Sivaraj, KK; Hoxha, E; Cuesta-Dominguez, A; Pinho, S; Akhmetzyanova, I; Gao, J; Witkowski, M; Guillamot, M; Gutkin, MC; Zhang, YT; Marier, C; Diefenbach, C; Kousteni, S; Heguy, A; Zhong, H; Fooksman, DR; Butler, JM; Economides, A; Frenette, PS; Adams, RH; Satija, R; Tsirigos, A; Aifantis, I				Tikhonova, Anastasia N.; Dolgalev, Igor; Hu, Hai; Sivaraj, Kishor K.; Hoxha, Edlira; Cuesta-Dominguez, Alvaro; Pinho, Sandra; Akhmetzyanova, Ilseyar; Gao, Jie; Witkowski, Matthew; Guillamot, Maria; Gutkin, Michael C.; Zhang, Yutong; Marier, Christian; Diefenbach, Catherine; Kousteni, Stavroula; Heguy, Adriana; Zhong, Hua; Fooksman, David R.; Butler, Jason M.; Economides, Aris; Frenette, Paul S.; Adams, Ralf H.; Satija, Rahul; Tsirigos, Aristotelis; Aifantis, Iannis			The bone marrow microenvironment at single-cell resolution	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; CRE-RECOMBINASE; DIFFERENTIATION; PROGENITORS; NICHES; LIGAND; FATE; GENE; REGENERATION; COMMITMENT	The bone marrow microenvironment has a key role in regulating haematopoiesis, but its molecular complexity and response to stress are incompletely understood. Here we map the transcriptional landscape of mouse bone marrow vascular, perivascular and osteoblast cell populations at single -cell resolution, both at homeostasis and under conditions of stress-induced haematopoiesis. This analysis revealed previously unappreciated levels of cellular heterogeneity within the bone marrow niche and resolved cellular sources of pro-haematopoietic growth factors, chemokines and membrane-bound ligands. Our studies demonstrate a considerable transcriptional remodelling of niche elements under stress conditions, including an adipocytic skewing of perivascular cells. Among the stress-induced changes, we observed that vascular Notch delta-like ligands (encoded by Dll1 and Dll4) were downregulated. In the absence of vascular Dll4, haematopoietic stem cells prematurely induced a myeloid transcriptional program. These findings refine our understanding of the cellular architecture of the bone marrow niche, reveal a dynamic and heterogeneous molecular landscape that is highly sensitive to stress and illustrate the utility of single-cell transcriptomic data in evaluating the regulation of haematopoiesis by discrete niche populations.	[Tikhonova, Anastasia N.; Dolgalev, Igor; Hu, Hai; Hoxha, Edlira; Witkowski, Matthew; Guillamot, Maria; Diefenbach, Catherine; Heguy, Adriana; Tsirigos, Aristotelis; Aifantis, Iannis] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Tikhonova, Anastasia N.; Dolgalev, Igor; Hu, Hai; Hoxha, Edlira; Witkowski, Matthew; Guillamot, Maria; Diefenbach, Catherine; Heguy, Adriana; Tsirigos, Aristotelis; Aifantis, Iannis] NYU, Sch Med, Laura & Isaac Perlmutter Canc Ctr, New York, NY 10016 USA; [Dolgalev, Igor; Tsirigos, Aristotelis] NYU, Sch Med, Appl Bioinformat Labs, New York, NY 10016 USA; [Sivaraj, Kishor K.; Adams, Ralf H.] Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, Munster, Germany; [Sivaraj, Kishor K.; Adams, Ralf H.] Univ Munster, Fac Med, Munster, Germany; [Cuesta-Dominguez, Alvaro; Kousteni, Stavroula] Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY USA; [Pinho, Sandra; Frenette, Paul S.] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, New York, NY USA; [Akhmetzyanova, Ilseyar; Fooksman, David R.] Albert Einstein Coll Med, Dept Pathol, New York, NY USA; [Gao, Jie; Economides, Aris] Regeneron Genet Ctr, Tarrytown, NY USA; [Gutkin, Michael C.; Butler, Jason M.] Hackensack Univ Med Ctr, Ctr Discovery & Innovat, Nutley, NJ USA; [Zhang, Yutong; Marier, Christian; Heguy, Adriana] NYU, Sch Med, Genome Technol Ctr, Div Adv Res Technol, New York, NY USA; [Zhong, Hua] NYU, Sch Med, Div Biostatist, Dept Populat Hlth, New York, NY USA; [Satija, Rahul] New York Genome Ctr, New York, NY USA	New York University; New York University; New York University; Max Planck Society; University of Munster; Columbia University; Yeshiva University; Yeshiva University; Regeneron; Hackensack University Medical Center; New York University; New York University	Tikhonova, AN; Tsirigos, A; Aifantis, I (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10016 USA.; Tikhonova, AN; Tsirigos, A; Aifantis, I (corresponding author), NYU, Sch Med, Laura & Isaac Perlmutter Canc Ctr, New York, NY 10016 USA.; Tsirigos, A (corresponding author), NYU, Sch Med, Appl Bioinformat Labs, New York, NY 10016 USA.	Anastasia.Tikhonova@nyumc.org; Aristotelis.Tsirigos@nyumc.org; Iannis.Aifantis@nyumc.org	zhong, Judy/ABE-8314-2020; Pinho, Sandra/GWC-8029-2022; Satija, Rahul/AAF-9564-2019; Dolgalev, Igor/AAY-6406-2020; Heguy, Adriana/GPP-3907-2022; Adams, Ralf H/AAE-9274-2019; Sivaraj, Kishor K/AAN-6540-2020	Dolgalev, Igor/0000-0003-4451-126X; Sivaraj, Kishor K/0000-0002-5321-3400; Witkowski, Matthew/0000-0003-1434-4288; Zhong, Judy/0000-0002-2163-8447; Diefenbach, Catherine/0000-0003-1116-3246; Tsirigos, Aristotelis/0000-0002-7512-8477; Pinho, Sandra/0000-0002-5241-7364	US National Institutes of Health [RO1CA202025, RO1CA202027, DK056638, HL069438, DK116312, DK112976]; Leukemia & Lymphoma Society; Alex's Lemonade Stand Foundation for Childhood Cancer; ERC Advanced grant: European Research Council [AdG 339409]; American Cancer Society [RSG-15-189-01-RMC]; St. Baldrick's Foundation [581357]; NATIONAL CANCER INSTITUTE [R01CA202025, R01CA202027, R01CA169784] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130937, R01HL069438] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [DP2HG009623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK112976, R01DK056638, U01DK116312] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Alex's Lemonade Stand Foundation for Childhood Cancer; ERC Advanced grant: European Research Council; American Cancer Society(American Cancer Society); St. Baldrick's Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the NYULMC High Performance Computing, Flow Cytometry, Genome Technology Center, Histopathology Core and the Microscopy Laboratory. This research was supported by the US National Institutes of Health (RO1CA202025, RO1CA202027 (I. Aifantis), DK056638, HL069438, DK116312, DK112976 to P.S.F.), the Leukemia & Lymphoma Society (I. Aifantis and A.N.T), the Alex's Lemonade Stand Foundation for Childhood Cancer (I. Aifantis and A.N.T.), the ERC Advanced grant: European Research Council (AdG 339409, AngioBone) (R.H.A.), the American Cancer Society (RSG-15-189-01-RMC to A.T.) and the St. Baldrick's Foundation (581357 to A.T.). I. Aifantis thanks the late H. von Boehmer for his support.	Acar M, 2015, NATURE, V526, P126, DOI 10.1038/nature15250; Alva JA, 2006, DEV DYNAM, V235, P759, DOI 10.1002/dvdy.20643; Bruns I, 2014, NAT MED, V20, P1315, DOI 10.1038/nm.3707; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Crane GM, 2017, NAT REV IMMUNOL, V17, P573, DOI 10.1038/nri.2017.53; DeFalco J, 2001, SCIENCE, V291, P2608, DOI 10.1126/science.1056602; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Economides AN, 2013, P NATL ACAD SCI USA, V110, pE3179, DOI 10.1073/pnas.1217812110; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Ghazanfari R, 2016, STEM CELLS DEV, V25, P1652, DOI 10.1089/scd.2016.0169; Giladi A, 2018, NAT CELL BIOL, V20, P836, DOI 10.1038/s41556-018-0121-4; Goldman DC, 2009, BLOOD, V114, P4393, DOI 10.1182/blood-2009-02-206433; Gomes AC, 2016, IMMUNITY, V45, P1219, DOI 10.1016/j.immuni.2016.11.004; Herault A, 2017, NATURE, V544, P53, DOI 10.1038/nature21693; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Hozumi K, 2004, NAT IMMUNOL, V5, P638, DOI 10.1038/ni1075; Jacobsen SEW, 2019, NAT CELL BIOL, V21, P2, DOI 10.1038/s41556-018-0227-8; Kim JE, 2004, AM J PATHOL, V165, P1875, DOI 10.1016/S0002-9440(10)63240-3; Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Lehar SM, 2005, BLOOD, V105, P1440, DOI 10.1182/blood-2004-08-3257; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lucas D, 2013, NAT MED, V19, P695, DOI 10.1038/nm.3155; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; MAUCH P, 1995, INT J RADIAT ONCOL, V31, P1319, DOI 10.1016/0360-3016(94)00430-S; Mayer C, 2018, NATURE, V555, P457, DOI 10.1038/nature25999; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mitroulis I, 2017, J CLIN INVEST, V127, P3624, DOI 10.1172/JCI92571; Mizoguchi T, 2014, DEV CELL, V29, P340, DOI 10.1016/j.devcel.2014.03.013; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Mrozek E, 1996, BLOOD, V87, P2632, DOI 10.1182/blood.V87.7.2632.bloodjournal8772632; Nemeth MJ, 2007, P NATL ACAD SCI USA, V104, P15436, DOI 10.1073/pnas.0704747104; Ng SYM, 2009, IMMUNITY, V30, P493, DOI 10.1016/j.immuni.2009.01.014; Nombela-Arrieta C, 2013, NAT CELL BIOL, V15, P533, DOI 10.1038/ncb2730; Olsson A, 2016, NATURE, V537, P698, DOI 10.1038/nature19348; Passaro D, 2015, CANCER CELL, V27, P769, DOI 10.1016/j.ccell.2015.05.003; Pietras EM, 2015, CELL STEM CELL, V17, P35, DOI 10.1016/j.stem.2015.05.003; Pitt LA, 2015, CANCER CELL, V27, P755, DOI 10.1016/j.ccell.2015.05.002; Poulos MG, 2013, CELL REP, V4, P1022, DOI 10.1016/j.celrep.2013.07.048; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Ramasamy SK, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/5046953; Reizis B, 2001, J EXP MED, V194, P979, DOI 10.1084/jem.194.7.979; Rodda LB, 2018, IMMUNITY, V48, P1014, DOI 10.1016/j.immuni.2018.04.006; Schmitt TM, 2004, J EXP MED, V200, P469, DOI 10.1084/jem.20040394; Shi C, 2011, IMMUNITY, V34, P590, DOI 10.1016/j.immuni.2011.02.016; Smith GD, 2000, BMJ-BRIT MED J, V321, P847, DOI 10.1136/bmj.321.7265.847; Song R, 2008, J EXP MED, V205, P2525, DOI 10.1084/jem.20081344; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; VANZANT G, 1984, J EXP MED, V159, P679, DOI 10.1084/jem.159.3.679; Wei QZ, 2018, IMMUNITY, V48, P632, DOI 10.1016/j.immuni.2018.03.024; Winkler IG, 2012, NAT MED, V18, P1651, DOI 10.1038/nm.2969; Xu CL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04726-3; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Yang G, 2014, CELL RES, V24, P1266, DOI 10.1038/cr.2014.111; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yu VWC, 2016, STEM CELL REP, V7, P220, DOI 10.1016/j.stemcr.2016.06.009; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049; Zhou BO, 2017, NAT CELL BIOL, V19, P891, DOI 10.1038/ncb3570; Zhou BO, 2014, CELL STEM CELL, V15, P154, DOI 10.1016/j.stem.2014.06.008; Zhu J, 2007, BLOOD, V109, P3706, DOI 10.1182/blood-2006-08-041384	69	361	370	19	180	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 9	2019	569	7755					222	+		10.1038/s41586-019-1104-8	http://dx.doi.org/10.1038/s41586-019-1104-8			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HX5VX	30971824	Green Accepted			2022-12-28	WOS:000467473600042
J	Deneke, VE; Puliafito, A; Krueger, D; Narla, AV; De Simone, A; Primo, L; Vergassola, M; De Renzis, S; Di Talia, S				Deneke, Victoria E.; Puliafito, Alberto; Krueger, Daniel; Narla, Avaneesh V.; De Simone, Alessandro; Primo, Luca; Vergassola, Massimo; De Renzis, Stefano; Di Talia, Stefano			Self-Organized Nuclear Positioning Synchronizes the Cell Cycle in Drosophila Embryos	CELL			English	Article							MIGRATION; MECHANICS; CYTOPLASM; VISCOSITY; BEHAVIOR; MITOSIS; WAVES; FLOW; EGG	The synchronous cleavage divisions of early embryogenesis require coordination of the cell-cycle oscillator, the dynamics of the cytoskeleton, and the cytoplasm. Yet, it remains unclear how spatially restricted biochemical signals are integrated with physical properties of the embryo to generate collective dynamics. Here, we show that synchronization of the cell cycle in Drosophila embryos requires accurate nuclear positioning, which is regulated by the cell-cycle oscillator through cortical contractility and cytoplasmic flows. We demonstrate that biochemical oscillations are initiated by local Cdkl inactivation and spread through the activity of phosphatase PP1 to generate cortical myosin II gradients. These gradients cause cortical and cytoplasmic flows that control proper nuclear positioning. Perturbations of PP1 activity and optogenctic manipulations of cortical actomyosin disrupt nuclear spreading, resulting in loss of cell-cycle synchrony. We conclude that mitotic synchrony is established by a self-organized mechanism that integrates the cell-cycle oscillator and embryo mechanics.	[Deneke, Victoria E.; De Simone, Alessandro; Di Talia, Stefano] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Puliafito, Alberto; Primo, Luca] Candiolo Canc Inst FPO IRCCS, Lab Cell Migrat, I-10060 Candiolo Torino, Italy; [Puliafito, Alberto; Primo, Luca] Univ Torino, Dept Oncol, I-10060 Turin, Italy; [Krueger, Daniel; De Renzis, Stefano] EMBL Heidelberg, Meyerhofstr 1, D-69117 Heidelberg, Germany; [Narla, Avaneesh V.; Vergassola, Massimo] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA	Duke University; IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin; European Molecular Biology Laboratory (EMBL); University of California System; University of California San Diego	Di Talia, S (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	stefano.ditalia@duke.edu	Narla, Avaneesh/AAC-5473-2022; Puliafito, Alberto/K-2462-2018	Narla, Avaneesh/0000-0002-9328-8271; Deneke, Victoria/0000-0002-4404-8706; De Simone, Alessandro/0000-0002-1165-8014; Vergassola, Massimo/0000-0002-7212-8244; Krueger, Daniel/0000-0003-1139-7755; Puliafito, Alberto/0000-0002-0096-1536; PRIMO, Luca/0000-0002-1294-0441	Schlumberger Faculty for the Future Fellowship; HHMI International Student Research Fellowship; Boehringer Ingelheim Fonds Travel Grant; Swiss National Science Foundation [P2ELP3_172293, P300PA_177838]; Associazione Italiana per la Ricerca sul Cancro [AIRC AIG 18675]; Fondazione Piemontese per la Ricerca sul Cancro, Ministero della Salute (FPRC 5x1000 2014); NIH [R01-GM122936]; Fondazione Umberto Veronesi; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM122936] Funding Source: NIH RePORTER	Schlumberger Faculty for the Future Fellowship(Schlumberger); HHMI International Student Research Fellowship; Boehringer Ingelheim Fonds Travel Grant(Boehringer Ingelheim); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Fondazione Piemontese per la Ricerca sul Cancro, Ministero della Salute (FPRC 5x1000 2014); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondazione Umberto Veronesi(Fondazione Umberto Veronesi); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Bloomington Drosophila Stock Center, the Kyoto Drosophila Stock Center, Dan Kiehart, Thomas Lecuit and Ruth Lehmann for providing stocks. We thank the Drosophila Genomics Resource Center and Sally Korn-bluth for constructs. We thank Anna Chao and Maggie Xing for help with experiments. We acknowledge discussions with Daniel Lew, Jonathon Pines and Eric Wieschaus. We thank Sharyn Endow, Brigid Hogan, Bernard Mathey-Prevot and members of the Di Talia lab for comments on the manuscript. This work was supported by a Schlumberger Faculty for the Future Fellowship, an HHMI International Student Research Fellowship, a Boehringer Ingelheim Fonds Travel Grant (to V.E.D.), a Fondazione Umberto Veronesi postdoctoral fellowship 2017 and 2018 (to A.P.), Early (P2ELP3_172293) and Advanced (P300PA_177838) Postdoc Mobility fellowships from the Swiss National Science Foundation (to A.D.S.), an Associazione Italiana per la Ricerca sul Cancro (AIRC AIG 18675), Fondazione Piemontese per la Ricerca sul Cancro, Ministero della Salute (FPRC 5x1000 2014 to L.P.), and NIH (R01-GM122936 to S.D.T.)	Acheson D J, 1990, ELEMENTARY FLUID DYN; BAKER J, 1993, J CELL BIOL, V122, P113, DOI 10.1083/jcb.122.1.113; Carroll NJ, 2014, LANGMUIR, V30, P4868, DOI 10.1021/la404891g; Chang JB, 2013, NATURE, V500, P603, DOI 10.1038/nature12321; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Deneke VE, 2018, J CELL BIOL, V217, P1193, DOI 10.1083/jcb.201701158; Deneke VE, 2016, DEV CELL, V38, P399, DOI 10.1016/j.devcel.2016.07.023; EDGAR BA, 1994, GENE DEV, V8, P440, DOI 10.1101/gad.8.4.440; Farrell JA, 2014, ANNU REV GENET, V48, P269, DOI 10.1146/annurev-genet-111212-133531; Ferree PL, 2016, SEMIN CELL DEV BIOL, V55, P80, DOI 10.1016/j.semcdb.2016.03.013; Field CM, 2011, J CELL SCI, V124, P2086, DOI 10.1242/jcs.082263; FOE VE, 1983, J CELL SCI, V61, P31; Foe Victoria E., 1993, P149; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; Gilmour D, 2017, NATURE, V541, P311, DOI 10.1038/nature21348; Goldstein RE, 2015, INTERFACE FOCUS, V5, DOI 10.1098/rsfs.2015.0030; Grant M, 2014, CVX MATLAB SOFTWARE; Gross P, 2017, ANNU REV BIOPHYS, V46, P337, DOI 10.1146/annurev-biophys-070816-033602; Guglielmi G, 2015, DEV CELL, V35, P646, DOI 10.1016/j.devcel.2015.10.020; HATANAKA K, 1991, DEVELOPMENT, V111, P909; Heim A, 2017, ADV EXP MED BIOL, V953, P83, DOI 10.1007/978-3-319-46095-6_3; Huang JY, 1999, EMBO J, V18, P2184, DOI 10.1093/emboj/18.8.2184; Izquierdo E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04754-z; Mayer M, 2010, NATURE, V467, P617, DOI 10.1038/nature09376; Mitchison TJ, 2008, SEMIN CELL DEV BIOL, V19, P215, DOI 10.1016/j.semcdb.2008.01.008; Mochida S, 2010, SCIENCE, V330, P1670, DOI 10.1126/science.1195689; Mogilner A, 2018, ANNU REV FLUID MECH, V50, P347, DOI 10.1146/annurev-fluid-010816-060238; Morgan D. O., 2007, CELL CYCLE PRINCIPLE; Munjal A, 2015, NATURE, V524, P351, DOI 10.1038/nature14603; Pozrikidis C., 2011, INTRO THEORETICAL CO; Quinlan ME, 2016, ANNU REV CELL DEV BI, V32, P173, DOI 10.1146/annurev-cellbio-111315-125416; Rabinowitz M, 1941, J MORPHOL, V69, P1, DOI 10.1002/jmor.1050690102; Royou A, 2002, J CELL BIOL, V158, P127, DOI 10.1083/jcb.200203148; Samarage CR, 2015, DEV CELL, V34, P435, DOI 10.1016/j.devcel.2015.07.004; Sibon OCM, 1997, NATURE, V388, P93, DOI 10.1038/40439; Su TT, 1998, GENE DEV, V12, P1495, DOI 10.1101/gad.12.10.1495; Swaminathan R, 1997, BIOPHYS J, V72, P1900, DOI 10.1016/S0006-3495(97)78835-0; Vergassola M, 2018, P NATL ACAD SCI USA, V115, pE2165, DOI 10.1073/pnas.1714873115; VONDASSOW G, 1994, J CELL BIOL, V127, P1637, DOI 10.1083/jcb.127.6.1637; Wu J, 2009, PROCEEDINGS OF THE 3RD INTERNATIONAL CONFERENCE ON ANTI-COUNTERFEITING, SECURITY, AND IDENTIFICATION IN COMMUNICATION, P1, DOI 10.1109/ICASID.2009.5277043; Yohn CB, 2003, GENETICS, V165, P1889; ZALOKAR M, 1976, J MICROSC BIOL CELL, V25, P97; 2007, GENETICS, V176, P273; 2016, NATURE, V536, P344, DOI DOI 10.1038/NATURE18958; 2015, NATURE, V517, P94, DOI DOI 10.1038/NATURE14019	45	48	48	3	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 2	2019	177	4					925	+		10.1016/j.cell.2019.03.007	http://dx.doi.org/10.1016/j.cell.2019.03.007			34	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HW7AU	30982601	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000466843000013
J	Robinson, F				Robinson, Francesca			Breast ironing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		CAME Women and Girls Development Organisation, 2019, SUPP TO WOM; Gender Empowerment and Development, 2011, BREAST IR HARMF PRAC; Haque A, 2019, BBC NEWS; Lazareva I, 2019, GUARDIAN; National FGM Centre, BREAST FLATT	5	0	0	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 23	2019	365								l1790	10.1136/bmj.l1790	http://dx.doi.org/10.1136/bmj.l1790			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HW1MM	31015186				2022-12-28	WOS:000466447000003
J	Raymond, N				Raymond, Nathaniel			Reboot ethical review for the age of big data	NATURE			English	Editorial Material									[Raymond, Nathaniel] Yale Univ, Jackson Inst Global Affairs, New Haven, CT 06520 USA	Yale University	Raymond, N (corresponding author), Yale Univ, Jackson Inst Global Affairs, New Haven, CT 06520 USA.	nathaniel.raymond@yale.edu							0	10	10	0	12	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 18	2019	568	7752					277	277		10.1038/d41586-019-01164-z	http://dx.doi.org/10.1038/d41586-019-01164-z			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HU0GZ	30988466	Bronze			2022-12-28	WOS:000464950700014
J	Amies-Cull, B; Briggs, ADM; Scarborough, P				Amies-Cull, Ben; Briggs, Adam D. M.; Scarborough, Peter			Estimating the potential impact of the UK government's sugar reduction programme on child and adult health: modelling study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SWEETENED BEVERAGES; BODY-WEIGHT; OBESITY; REVIEWS; TRIAL	OBJECTIVE To estimate the impact of the UK government's sugar reduction programme on child and adult obesity, adult disease burden, and healthcare costs. DESIGN Modelling study. SETTING Simulated scenario based on National Diet and Nutrition Survey waves 5 and 6, England. PARTICIPANTS 1508 survey respondents were used to model weight change among the population of England aged 4-80 years. MAIN OUTCOME MEASURES Calorie change, weight change, and body mass index change were estimated for children and adults. Impact on non-communicable disease incidence, quality adjusted life years, and healthcare costs were estimated for adults. Changes to disease burden were modelled with the PRIMEtime-CE Model, based on the 2014 population in England aged 18-80. RESULTS If the sugar reduction programme was achieved in its entirety and resulted in the planned sugar reduction, then the calorie reduction was estimated to be 25 kcal/day (1 kcal= 4.18 kJ= 0.00418 MJ) for 4-10 year olds (95% confidence interval 23 to 26), 25 kcal/day (24 to 28) for 11-18 year olds, and 19 kcal/day (17 to 20) for adults. The reduction in obesity could represent 5.5% of the baseline obese population of 4-10 year olds, 2.2% of obese 11-18 year olds, and 5.5% of obese 19-80 year olds. A modelled 51 729 quality adjusted life years (95% uncertainty interval 45 768 to 57 242) were saved over 10 years, including 154 550 (132 623 to 174 604) cases of diabetes and relating to a net healthcare saving of pound 285.8m ((sic)332.5m, $373.5m; pound 249.7m to pound 319.8m). CONCLUSIONS The UK government's sugar reduction programme could reduce the burden of obesity and obesity related disease, provided that reductions in sugar levels and portion sizes do not prompt unanticipated changes in eating patterns or product formulation.	[Amies-Cull, Ben; Briggs, Adam D. M.; Scarborough, Peter] Univ Oxford, Big Data Inst, Ctr Populat Approaches Noncommunicable Dis Preven, Oxford OX3 7FZ, England; [Amies-Cull, Ben] Univ Manchester, Ctr Primary Care, Manchester, Lancs, England; [Scarborough, Peter] Oxford Univ Hosp NHS Fdn Trust, Natl Inst Hlth Res Oxford Biomed Res Ctr, Oxford, England	University of Oxford; University of Manchester; Oxford University Hospitals NHS Foundation Trust	Amies-Cull, B (corresponding author), Univ Oxford, Big Data Inst, Ctr Populat Approaches Noncommunicable Dis Preven, Oxford OX3 7FZ, England.; Amies-Cull, B (corresponding author), Univ Manchester, Ctr Primary Care, Manchester, Lancs, England.	ben.amies-cull@dph.ox.ac.uk	Scarborough, Peter/ABD-6111-2021	Scarborough, Peter/0000-0002-2378-2944; Briggs, Adam/0000-0002-2314-1039	National Institute of Health Research Biomedical Research Centre at Oxford	National Institute of Health Research Biomedical Research Centre at Oxford	There was no specific funding for this study. In addition to the authors' funders, this study was partly supported by the National Institute of Health Research Biomedical Research Centre at Oxford, but it had no input into the study design, collection, analysis, or interpretation of data; writing of the report; or the decision to submit the article for publication. The views expressed are those of the authors and not necessarily those of the National Health Service, National Institute of Health Research, or Department of Health and Social Care. All authors are independent from funders.	[Anonymous], 2012, INDEPENDENT; Barendregt J J, 1998, Math Popul Stud, V7, P29; Briggs A., 2017, THESIS; Briggs ADM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197257; Briggs ADM, 2017, LANCET PUBLIC HEALTH, V2, pE15, DOI 10.1016/S2468-2667(16)30037-8; Briggs ADM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6189; Capewell S, 2018, J PUBLIC HEALTH-UK, V40, P350, DOI 10.1093/pubmed/fdx055; Christiansen E, 2002, EUR J CLIN INVEST, V32, P826, DOI 10.1046/j.1365-2362.2002.01036.x; Cobiac LJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167859; de Ruyter JC, 2012, NEW ENGL J MED, V367, P1397, DOI 10.1056/NEJMoa1203034; Ebbeling CB, 2012, NEW ENGL J MED, V367, P1407, DOI 10.1056/NEJMoa1203388; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; HM Government, 2016, CHILDH OB PLAN ACT; Hollands GJ, 2015, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009164.pub2, 10.1002/14651858.CD011045.pub2]; Khan TA, 2016, EUR J NUTR, V55, pS25, DOI 10.1007/s00394-016-1345-3; Lennox A, 2014, NATL DIET NUTR SURVE; Public Health England, 2018, SUG RED WID REF PROG; Public Health England, 2015, SUG RED EV ACT; Public Health England, 2017, SUG RED ACH 20 TECHN; Public Health England, 2016, NEW PHE DAT SALT CON; Ross SE, 2016, J SPORT SCI, V34, P1148, DOI 10.1080/02640414.2015.1093650; Scientifc Advisory Committee on Nutrition, 2015, CARB HLTH; Teff KL, 2004, J CLIN ENDOCR METAB, V89, P2963, DOI 10.1210/jc.2003-031855; The Royal College of Paediatrics and Child Health, SCH AG CHARTS RES; UK sugar tax revenue estimate halved, 2018, VERDICT DRINKS; 2014, SCI CAIRO, DOI DOI 10.1155/2014/748750	26	27	28	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2019	365								l1417	10.1136/bmj.l1417	http://dx.doi.org/10.1136/bmj.l1417			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU8OY	30996021	Green Published, hybrid			2022-12-28	WOS:000465550000003
J	Bonnett, LJ; Snell, KIE; Collins, GS; Riley, RD				Bonnett, Laura J.; Snell, Kym I. E.; Collins, Gary S.; Riley, Richard D.			Guide to presenting clinical prediction models for use in clinical settings	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INDIVIDUAL PROGNOSIS; DIAGNOSIS TRIPOD; DISEASE; RISK; NOMOGRAM; DEATH	Clinical prediction models estimate the risk of existing disease or future outcome for an individual, which is conditional on the values of multiple predictors such as age, sex, and biomarkers. In this article, Bonnett and colleagues provide a guide to presenting clinical prediction models so that they can be implemented in practice, if appropriate. They describe how to create four presentation formats and discuss the advantages and disadvantages of each format. A key message is the need for stakeholder engagement to determine the best presentation option in relation to the clinical context of use and the intended users	[Bonnett, Laura J.] Univ Liverpool, Dept Biostat, Liverpool L69 3GL, Merseyside, England; [Snell, Kym I. E.; Riley, Richard D.] Keele Univ, Res Inst Primary Care & Hlth Sci, Ctr Prognosis Res, Keele, Staffs, England; [Collins, Gary S.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Ctr Stat Med, Oxford, England	University of Liverpool; Keele University; University of Oxford	Bonnett, LJ (corresponding author), Univ Liverpool, Dept Biostat, Liverpool L69 3GL, Merseyside, England.	L.J.Bonnett@liverpool.ac.uk	Snell, Kym/L-1918-2015; Riley, Richard David/ABE-5877-2020; Collins, Gary Stephen/A-2258-2014; Bonnett, Laura/A-2159-2015	Snell, Kym/0000-0001-9373-6591; Riley, Richard David/0000-0001-8699-0735; Collins, Gary Stephen/0000-0002-2772-2316; Bonnett, Laura/0000-0002-6981-9212	National Institute for Health Research [PDF-2015-08-044]; NIHR Biomedical Research Centre, Oxford; Evidence Synthesis Working Group - National Institute for Health Research School for Primary Care Research (NIHR SPCR) [390]; NIHR SPCR launching fellowship	National Institute for Health Research(National Institute for Health Research (NIHR)); NIHR Biomedical Research Centre, Oxford(National Institute for Health Research (NIHR)); Evidence Synthesis Working Group - National Institute for Health Research School for Primary Care Research (NIHR SPCR); NIHR SPCR launching fellowship	This article is independent research arising from a postdoctoral fellowship (LJB: PDF-2015-08-044) supported by the National Institute for Health Research (www.nihr.ac.uk/). GSC was supported by the NIHR Biomedical Research Centre, Oxford. RDR and KIES are supported by funding from the Evidence Synthesis Working Group, which is funded by the National Institute for Health Research School for Primary Care Research (NIHR SPCR; project No 390). KIES is also supported by an NIHR SPCR launching fellowship. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research, or the Department of Health.	American College of Cardiology, 2013, ASCVD RISK EST PLUS; [Anonymous], 2017, SWIRE WEB APPS; [Anonymous], 2017, SHINY WEB APPL FRAME; Bouwmeester W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001221; Collins GS, 2015, J CLIN EPIDEMIOL, V68, P112, DOI [10.1016/j.jclinepi.2014.11.010, 10.7326/M14-0697, 10.1136/bmj.g7594, 10.1186/s12916-014-0241-z, 10.1016/j.eururo.2014.11.025, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Fagerlin A, 2005, MED DECIS MAKING, V25, P398, DOI 10.1177/0272989X05278931; Groenwold RHH, 2016, J CLIN EPIDEMIOL, V78, P90, DOI 10.1016/j.jclinepi.2016.03.017; GULLAND A, 2018, BMJ-BRIT MED J, V360, DOI DOI 10.1136/BMJ.K685; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Kattan MW, 2003, STAT MED, V22, P3515, DOI 10.1002/sim.1574; Kattan MW, 1998, JNCI-J NATL CANCER I, V90, P766, DOI 10.1093/jnci/90.10.766; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Krijnen P, 1998, ANN INTERN MED, V129, P705, DOI 10.7326/0003-4819-129-9-199811010-00005; Leening MJG, 2017, EUR HEART J, V38, P1542, DOI 10.1093/eurheartj/ehw287; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; Moons KGM, 2002, J CLIN EPIDEMIOL, V55, P1054, DOI 10.1016/S0895-4356(02)00453-5; Pepe MS, 2003, STAT EVALUATION MED; Perel P, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5166; Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI 10.1093/eurheartj/ehw106; Riley RD, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3140; rms: Regression Modeling Strategies [ program], 2018, RMS REGRESSION MODEL; Spiegelhalter D, 2011, SCIENCE, V333, P1393, DOI 10.1126/science.1191181; Steyerberg EW, 2009, CLIN PREDICTION MODE, DOI 10.1007/978-0-387-77244-8; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; Therneau T. M., 2013, MODELING SURVIVAL DA, DOI 10.1007/978-1-4757-3294-8; Van Belle V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164568; Van Belle V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132614; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Zlotnik A, 2015, STATA J, V15, P537, DOI 10.1177/1536867X1501500212; 1985, GASTROENTEROLOGY, V89, P1084, DOI DOI 10.1016/0016-5085(85)90213-6	34	55	55	1	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2019	365								kl737	10.1136/bmj.l737	http://dx.doi.org/10.1136/bmj.l737			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU8OY	30995987	Green Submitted, Green Accepted			2022-12-28	WOS:000465550000001
J	Thornton, J				Thornton, Jacqui			Children's mental health: getting early support "leaves much to chance," says commissioner	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Children's Commissioner, 2019, EARL ACC MENT HLTH S; House of Commons Health Committee, 2014, CHILDR AD MENT HLTH; IACOBUCCI G, 2019, BMJ-BRIT MED J, V364, P17145, DOI DOI 10.1136/BMJ.L85	3	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 10	2019	365								l1732	10.1136/bmj.l1732	http://dx.doi.org/10.1136/bmj.l1732			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU0EL	30971415				2022-12-28	WOS:000464944100013
J	Sutter, P; Wimer, S; Sutter, E				Sutter, Peter; Wimer, Shawn; Sutter, Eli			Chiral twisted van der Waals nanowires	NATURE			English	Article							LIQUID-SOLID GROWTH; SULFIDE; GRAPHENE; CATHODOLUMINESCENCE; MORPHOLOGY; CRYSTALS; SELENIDE	Van der Waals heterostructures with small misalignment between adjacent layers ('interlayer twist') are of interest because of electronic structure and correlation phenomena (such as superconductivity) that are determined by both the atomic lattice and long-range superlattice potentials arising in interlayer moire patterns(1-7). Previously, such twisted heterostructures have involved a single planar interface between layers isolated by exfoliation and micromechanically stacked in the desired relative orientation(1,8-12). Here we demonstrate a class of materials-van der Waals nanowires of layered crystals-in which a tunable interlayer twist evolves naturally during synthesis. In vapour-liquid-solid growth, nanowires of germanium(ii) sulfide, an anisotropic layered semiconductor, crystallize with layering along the wire axis(13) and have a strong propensity for forming axial screw dislocations. Nanometre-resolved electron diffraction shows that Eshelby twist, induced by a torque on the ends of a cylindrical solid due to the stress field of an axial dislocation(14,15), causes a chiral structure in the van der Waals nanowires. The in-plane germanium sulfide crystal axes progressively rotate along the wire, and germanium sulfide layers in adjacent turns of the helix naturally form a moire pattern because of their interlayer twist. The axial rotation and the twist are tunable by varying the nanowire thickness. Combined electron diffraction and cathodoluminescence spectroscopy show the correlation between the interlayer twist and locally excited light emission that is due to progressive changes in the lattice orientation and in the interlayer moire registry along the nanowires. The findings demonstrate a step towards scalable fabrication of van der Waals structures with defined twist angles, in which interlayer moire patterns are realized along a helical path on a nanowire instead of a planar interface.	[Sutter, Peter; Wimer, Shawn] Univ Nebraska, Dept Elect & Comp Engn, Lincoln, NE 68588 USA; [Sutter, Eli] Univ Nebraska, Dept Mech & Mat Engn, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Sutter, P (corresponding author), Univ Nebraska, Dept Elect & Comp Engn, Lincoln, NE 68588 USA.; Sutter, E (corresponding author), Univ Nebraska, Dept Mech & Mat Engn, Lincoln, NE 68588 USA.	psutter@unl.edu; esutter@unl.edu	Sutter, Peter W/C-5182-2008; Sutter, Eli A./AAD-7878-2019	Sutter, Peter W/0000-0002-3301-309X; 	National Science Foundation, Division of Materials Research, Solid State and Materials Chemistry Program [DMR-1607795]; US Department of Energy, Office of Science, Basic Energy Sciences [DE-SC0016343]	National Science Foundation, Division of Materials Research, Solid State and Materials Chemistry Program; US Department of Energy, Office of Science, Basic Energy Sciences(United States Department of Energy (DOE))	The synthesis of twisted GeS nanowires, analysis of nanobeam diffraction and transport measurements were supported by the National Science Foundation, Division of Materials Research, Solid State and Materials Chemistry Program under grant no. DMR-1607795. The development of nanobeam electron diffraction correlated with locally excited CL spectroscopy measurements and of associated data analysis methods was supported by the US Department of Energy, Office of Science, Basic Energy Sciences, under award no. DE-SC0016343.	Alegria LD, 2014, PHYS STATUS SOLIDI-R, V8, P991, DOI 10.1002/pssr.201409428; Bierman MJ, 2008, SCIENCE, V320, P1060, DOI 10.1126/science.1157131; BISSERT G, 1978, ACTA CRYSTALLOGR B, V34, P1322, DOI 10.1107/S0567740878005439; BLETSKAN DI, 1975, KRISTALLOGRAFIYA+, V20, P1008; BURTON WK, 1951, PHILOS T R SOC S-A, V243, P299, DOI 10.1098/rsta.1951.0006; Cao Y, 2018, NATURE, V556, P80, DOI 10.1038/nature26154; Cao Y, 2018, NATURE, V556, P43, DOI 10.1038/nature26160; Carr S, 2017, PHYS REV B, V95, DOI 10.1103/PhysRevB.95.075420; Dean CR, 2013, NATURE, V497, P598, DOI 10.1038/nature12186; ESHELBY JD, 1953, J APPL PHYS, V24, P176, DOI 10.1063/1.1721234; Frisenda R, 2018, CHEM SOC REV, V47, P53, DOI 10.1039/c7cs00556c; Hentschel M, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602735; Jain A, 2013, APL MATER, V1, DOI 10.1063/1.4812323; Kang K, 2017, NATURE, V550, P229, DOI 10.1038/nature23905; Kim K, 2016, NANO LETT, V16, P1989, DOI 10.1021/acs.nanolett.5b05263; Kociak M, 2017, ULTRAMICROSCOPY, V176, P112, DOI 10.1016/j.ultramic.2017.03.014; Liu KH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5966; Liu S, 2011, ANGEW CHEM INT EDIT, V50, P12050, DOI 10.1002/anie.201105614; Morales AM, 1998, SCIENCE, V279, P208, DOI 10.1126/science.279.5348.208; Peng HL, 2007, NANO LETT, V7, P199, DOI 10.1021/nl062047+; Ponomarenko LA, 2013, NATURE, V497, P594, DOI 10.1038/nature12187; Ribeiro-Palau R, 2018, SCIENCE, V361, P690, DOI 10.1126/science.aat6981; Suryawanshi SR, 2014, ACS APPL MATER INTER, V6, P2018, DOI 10.1021/am405039j; Sutter E, 2018, ACS APPL NANO MATER, V1, P1042, DOI 10.1021/acsanm.7b00053; Sutter EA, 2010, ACS NANO, V4, P4943, DOI 10.1021/nn101366w; Sutter P, 2018, ACS APPL NANO MATER, V1, P3026, DOI 10.1021/acsanm.8b00660; Sutter P, 2018, NANO LETT, V18, P4576, DOI 10.1021/acs.nanolett.8b01840; Tan DZ, 2017, NANO RES, V10, P546, DOI 10.1007/s12274-016-1312-6; WAGNER RS, 1964, APPL PHYS LETT, V4, P89, DOI 10.1063/1.1753975; Wei PC, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.045306; Yang RB, 2009, ADV MATER, V21, P3170, DOI 10.1002/adma.200803436; Yeh PC, 2016, NANO LETT, V16, P953, DOI 10.1021/acs.nanolett.5b03883; Zhai TY, 2010, ACS NANO, V4, P1596, DOI 10.1021/nn9012466	34	75	75	10	211	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 20	2019	570	7761					354	+		10.1038/s41586-019-1147-x	http://dx.doi.org/10.1038/s41586-019-1147-x			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IE1KW	31011183	Green Submitted			2022-12-28	WOS:000472145700061
J	de Figueiredo, A; Were, F				de Figueiredo, Alexandre; Were, Fredrick			Local trends in immunisation coverage across Africa	LANCET			English	Editorial Material									[de Figueiredo, Alexandre] Imperial Coll London, Dept Math, London SW7 2AZ, England; [Were, Fredrick] Univ Nairobi, Sch Med, Nairobi, Kenya	Imperial College London; University of Nairobi	de Figueiredo, A (corresponding author), Imperial Coll London, Dept Math, London SW7 2AZ, England.	ad907@ic.ac.uk		De Figueiredo, Alexandre/0000-0002-7751-0645				Arevshatian L, 2007, B WORLD HEALTH ORGAN, V85, P449, DOI 10.2471/BLT.06.031526; de Figueiredo A, 2016, LANCET GLOB HEALTH, V4, pE726, DOI 10.1016/S2214-109X(16)30167-X; Global Vaccine Action Plan, 2018, GLOB VACC ACT PLAN M; Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8; Metcalf CJE, 2015, EPIDEMIOL INFECT, V143, P1457, DOI 10.1017/S0950268814001988; Mosser JF, 2019, LANCET; Ozawa S, 2017, B WORLD HEALTH ORGAN, V95, P629, DOI 10.2471/BLT.16.178475; Takahashi S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15585; WHO. Data, 2019, DAT STAT GRAPH OFF C; World Health Organization, 2015, REG STRAT PLAN IMM 2	10	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 4	2019	393	10183					1779	1781		10.1016/S0140-6736(19)30702-0	http://dx.doi.org/10.1016/S0140-6736(19)30702-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HW7GR	30961906	hybrid			2022-12-28	WOS:000466858700007
J	Millwood, IY; Walters, RG; Mei, XW; Guo, Y; Yang, L; Bian, Z; Bennett, DA; Chen, YP; Dong, CX; Hu, RY; Zhou, G; Yu, B; Jia, WF; Parish, S; Clarke, R; Smith, GD; Collins, R; Holmes, MV; Li, LM; Peto, R; Chen, ZM				Millwood, Iona Y.; Walters, Robin G.; Mei, Xue W.; Guo, Yu; Yang, Ling; Bian, Zheng; Bennett, Derrick A.; Chen, Yiping; Dong, Caixia; Hu, Ruying; Zhou, Gang; Yu, Bo; Jia, Weifang; Parish, Sarah; Clarke, Robert; Smith, George Davey; Collins, Rory; Holmes, Michael V.; Li, Liming; Peto, Richard; Chen, Zhengming		China Kadoorie Biobank Collaborati	Conventional and genetic evidence on alcohol and vascular disease aetiology: a prospective study of 500 000 men and women in China	LANCET			English	Article							CORONARY-HEART-DISEASE; 0.5 MILLION PEOPLE; BLOOD-PRESSURE; CONSUMPTION; RISK; ASSOCIATION; METAANALYSIS; STROKE; MORTALITY; VARIANTS	Background Moderate alcohol intake has been associated with reduced cardiovascular risk in many studies, in comparison with abstinence or with heavier drinking. Studies in east Asia can help determine whether these associations are causal, since two common genetic variants greatly affect alcohol drinking patterns. We used these two variants to assess the relationships between cardiovascular risk and genotype-predicted mean alcohol intake in men, contrasting the findings in men with those in women (few of whom drink). Methods The prospective China Kadoorie Biobank enrolled 512 715 adults between June 25, 2004, and July 15, 2008, from ten areas of China, recording alcohol use and other characteristics. It followed them for about 10 years (until Jan 1, 2017), monitoring cardiovascular disease (including ischaemic stroke, intracerebral haemorrhage, and myocardial infarction) by linkage with morbidity and mortality registries and electronic hospital records. 161 498 participants were genotyped for two variants that alter alcohol metabolism, ALDH2-rs671 and ADH1B-rs1229984. Adjusted Cox regression was used to obtain the relative risks associating disease incidence with self-reported drinking patterns (conventional epidemiology) or with genotype-predicted mean male alcohol intake (genetic epidemiology-ie, Mendelian randomisation), with stratification by study area to control for variation between areas in disease rates and in genotype-predicted intake. Findings 33% (69 897/210 205) of men reported drinking alcohol in most weeks, mainly as spirits, compared with only 2% (6245/302 510) of women. Among men, conventional epidemiology showed that self-reported alcohol intake had U-shaped associations with the incidence of ischaemic stroke (n=14930), intracerebral haemorrhage (n=3496), and acute myocardial infarction (n=2958); men who reported drinking about 100 g of alcohol per week (one to two drinks per day) had lower risks of all three diseases than non-drinkers or heavier drinkers. In contrast, although genotype-predicted mean male alcohol intake varied widely (from 4 to 256 g per week-ie, near zero to about four drinks per day), it did not have any U-shaped associations with risk. For stroke, genotype-predicted mean alcohol intake had a continuously positive log-linear association with risk, which was stronger for intracerebral haemorrhage (relative risk [RR] per 280 g per week 1.58, 95% CI 1.36-1.84, p<0.0001) than for ischaemic stroke (1.27, 1.13-1.43, p=0.0001). For myocardial infarction, however, genotype-predicted mean alcohol intake was not significantly associated with risk (RR per 280 g per week 0.96, 95% CI 0.78-1.18, p=0.69). Usual alcohol intake in current drinkers and genotype-predicted alcohol intake in all men had similarly strong positive associations with systolic blood pressure (each p<0.0001). Among women, few drank and the studied genotypes did not predict high mean alcohol intake and were not positively associated with blood pressure, stroke, or myocardial infarction. Interpretation Genetic epidemiology shows that the apparently protective effects of moderate alcohol intake against stroke are largely non-causal. Alcohol consumption uniformly increases blood pressure and stroke risk, and appears in this one study to have little net effect on the risk of myocardial infarction. Copyright (C) 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.	[Millwood, Iona Y.; Walters, Robin G.; Mei, Xue W.; Yang, Ling; Chen, Yiping; Parish, Sarah; Holmes, Michael V.] Univ Oxford, Nuffield Dept Populat Hlth, Med Res Council Populat Hlth Res Unit, Oxford, England; [Millwood, Iona Y.; Walters, Robin G.; Mei, Xue W.; Yang, Ling; Bennett, Derrick A.; Chen, Yiping; Parish, Sarah; Clarke, Robert; Collins, Rory; Holmes, Michael V.; Peto, Richard; Chen, Zhengming] Univ Oxford, Clin Trial Serv Unit, Nuffield Dept Populat Hlth, Oxford OX3 7LF, England; [Millwood, Iona Y.; Walters, Robin G.; Mei, Xue W.; Yang, Ling; Bennett, Derrick A.; Chen, Yiping; Parish, Sarah; Clarke, Robert; Collins, Rory; Holmes, Michael V.; Peto, Richard; Chen, Zhengming] Univ Oxford, Epidemiol Studies Unit, Nuffield Dept Populat Hlth, Oxford OX3 7LF, England; [Guo, Yu; Bian, Zheng] Chinese Acad Med Sci, Beijing, Peoples R China; [Dong, Caixia] Gansu Prov Ctr Dis Control & Prevent, Lanzhou, Gansu, Peoples R China; [Hu, Ruying] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Zhou, Gang] Henan Ctr Dis Control & Prevent, Zhengzhou, Henan, Peoples R China; [Yu, Bo] Nangang Ctr Dis Control & Prevent, Harbin, Heilongjiang, Peoples R China; [Jia, Weifang] Liuyang Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China; [Smith, George Davey] Univ Bristol, Med Res Council Integrat Epidemiol Unit, Populat Hlth Sci, Bristol, Avon, England; [Li, Liming] Peking Univ, Dept Epidemiol & Biostat, Hlth Sci Ctr, Beijing 100191, Peoples R China	University of Oxford; University of Oxford; University of Oxford; Chinese Academy of Medical Sciences - Peking Union Medical College; Zhejiang Provincial Center for Disease Control & Prevention; University of Bristol; Peking University	Chen, ZM (corresponding author), Univ Oxford, Clin Trial Serv Unit, Nuffield Dept Populat Hlth, Oxford OX3 7LF, England.; Chen, ZM (corresponding author), Univ Oxford, Epidemiol Studies Unit, Nuffield Dept Populat Hlth, Oxford OX3 7LF, England.; Li, LM (corresponding author), Peking Univ, Dept Epidemiol & Biostat, Hlth Sci Ctr, Beijing 100191, Peoples R China.	lmleeph@vip.163.com; zhengming.chen@ndph.ox.ac.uk	, Bennett/O-7998-2019; Walters, Robin G/E-6069-2010; Davey Smith, George/A-7407-2013; Collins, Rory/ABA-8487-2020; Holmes, Michael/AAA-2208-2021	Walters, Robin G/0000-0002-9179-0321; Davey Smith, George/0000-0002-1407-8314; Bennett, Derrick/0000-0002-9170-8447; Mei, Xue/0000-0002-6279-4884	Chinese Ministry of Science and Technology; Kadoorie Charitable Foundation; National Natural Science Foundation of China; British Heart Foundation; Cancer Research UK; GlaxoSmithKline; Medical Research Council; Wellcome Trust; Hong Kong Kadoorie Charitable Foundation; UK Wellcome Trust [212946/Z/18/Z, 202922/Z/16/Z, 104085/Z/14/Z, 088158/Z/09/Z]; National Natural Science Foundation of China [81390540, 81390541, 81390544]; National Key Research and Development Program of China [2016YFC 0900500, 0900501, 0900504, 1303904]; UK Medical Research Council [MC-PC-13049, MC-PC-14135, MC_UU_00011/1]; British Heart Foundation [FS/18/23/33512]; National Institute for Health Research Oxford Biomedical Research Centre; UK Medical Research Council; MRC [MC_PC_14135, MC_U137686851, MC_UU_00017/1, MC_PC_13049, MC_UU_00011/1, MC_UU_12026/2] Funding Source: UKRI	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Kadoorie Charitable Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); GlaxoSmithKline(GlaxoSmithKline); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Hong Kong Kadoorie Charitable Foundation; UK Wellcome Trust(Wellcome Trust); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); National Institute for Health Research Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Chinese Ministry of Science and Technology, Kadoorie Charitable Foundation, National Natural Science Foundation of China, British Heart Foundation, Cancer Research UK, GlaxoSmithKline, Medical Research Council, and Wellcome Trust.; We thank the participants, project staff, the China National Centre for Disease Control and Prevention and its regional offices. The Chinese National Health Insurance scheme provided electronic linkage to all hospital admission data. The baseline survey and first resurvey were supported by a research grant from the Hong Kong Kadoorie Charitable Foundation. Long-term follow-up was supported by grants from the UK Wellcome Trust (212946/Z/18/Z, 202922/Z/16/Z, 104085/Z/14/Z, 088158/Z/09/Z), National Natural Science Foundation of China (81390540, 81390541, 81390544), and National Key Research and Development Program of China (2016YFC 0900500, 0900501, 0900504, 1303904). DNA extraction and genotyping was supported by grants from GlaxoSmithKline and the UK Medical Research Council (MC-PC-13049, MC-PC-14135). GDS is supported by the UK Medical Research Council (MC_UU_00011/1). MVH is supported by the British Heart Foundation (FS/18/23/33512) and the National Institute for Health Research Oxford Biomedical Research Centre. The British Heart Foundation, UK Medical Research Council, and Cancer Research UK provide core funding to the Clinical Trial Service Unit and Epidemiological Studies Unit, Oxford University (Oxford, UK).	Bell S, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j909; Brien SE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d636; Chen CH, 2014, PHYSIOL REV, V94, P1, DOI 10.1152/physrev.00017.2013; Chen L, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050052; Chen ZM, 2011, INT J EPIDEMIOL, V40, P1652, DOI 10.1093/ije/dyr120; Cho Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep18422; Christensen AL, 2018, J STROKE, V20, P218, DOI 10.5853/jos.2017.01466; Davey Smith G, 2014, HUM MOL GENET, V23, pR89, DOI 10.1093/hmg/ddu328; Edenberg HJ, 2013, NAT REV GASTRO HEPAT, V10, P487, DOI 10.1038/nrgastro.2013.86; Emberson JR, 2006, VASC HEALTH RISK MAN, V2, P239, DOI 10.2147/vhrm.2006.2.3.239; Holmes MV, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4164; HPS3 TIMI55-REVEAl Collaborative, 2017, NEW ENGL J MED, V377, P1217, DOI 10.1056/NEJMoa1706444; Lacey B, 2018, LANCET GLOB HEALTH, V6, pE641, DOI [10.1016/S2214-109X(18)30217-1, 10.1016/s2214-109x(18)30217-1]; Larsson SC, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0721-4; Lu XF, 2017, NAT GENET, V49, P1722, DOI 10.1038/ng.3978; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Millwood IY, 2018, JAMA CARDIOL, V3, P34, DOI 10.1001/jamacardio.2017.4177; Millwood IY, 2013, INT J EPIDEMIOL, V42, P816, DOI 10.1093/ije/dyt078; Plummer M, 2004, STAT MED, V23, P93, DOI 10.1002/sim.1485; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Roerecke M, 2017, LANCET PUBLIC HEALTH, V2, pE108, DOI 10.1016/S2468-2667(17)30003-8; Roerecke M, 2012, ADDICTION, V107, P1246, DOI 10.1111/j.1360-0443.2012.03780.x; Ronksley PE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d671; Takeuchi F, 2012, EUR J HUM GENET, V20, P333, DOI 10.1038/ejhg.2011.184; Taylor AE, 2015, SCI REP-UK, V5, DOI 10.1038/srep14005; Wood AM, 2018, LANCET, V391, P1513, DOI 10.1016/S0140-6736(18)30134-X; Zaridze D, 2014, LANCET, V383, P1465, DOI 10.1016/S0140-6736(13)62247-3; Zhao J, 2017, J STUD ALCOHOL DRUGS, V78, P375, DOI 10.15288/jsad.2017.78.375; 2018, AM J MED GENET B, V177, P113, DOI DOI 10.1002/AJMG.B.32523	29	199	222	18	99	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 4	2019	393	10183					1831	1842		10.1016/S0140-6736(18)31772-0	http://dx.doi.org/10.1016/S0140-6736(18)31772-0			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HW7GR	30955975	Green Published, hybrid			2022-12-28	WOS:000466858700033
J	Kucab, JE; Zou, XQ; Morganella, S; Joel, M; Nanda, AS; Nagy, E; Gomez, C; Degasperi, A; Harris, R; Jackson, SP; Arlt, VM; Phillips, DH; Nik-Zainal, S				Kucab, Jill E.; Zou, Xueqing; Morganella, Sandro; Joel, Madeleine; Nanda, A. Scott; Nagy, Eszter; Gomez, Celine; Degasperi, Andrea; Harris, Rebecca; Jackson, Stephen P.; Arlt, Volker M.; Phillips, David H.; Nik-Zainal, Serena			A Compendium of Mutational Signatures of Environmental Agents	CELL			English	Article							MISMATCH REPAIR; SOMATIC MUTATIONS; TP53 MUTATIONS; DNA-DAMAGE; METABOLIC-ACTIVATION; ENDEMIC NEPHROPATHY; BREAST-CANCER; P53 MUTATIONS; GENOME; CARCINOGENS	Whole-genome-sequencing (WGS) of human tumors has revealed distinct mutation patterns that hint at the causative origins of cancer. We examined mutational signatures in 324 WGS human-induced pluripotent stem cells exposed to 79 known or suspected environmental carcinogens. Forty-one yielded characteristic substitution mutational signatures. Some were similar to signatures found in human tumors. Additionally, six agents produced double-substitution signatures and eight produced indel signatures. Investigating mutation asymmetries across genome topography revealed fully functional mismatch and transcription-coupled repair pathways. DNA damage induced by environmental mutagens can be resolved by disparate repair and/or replicative pathways, resulting in an assortment of signature outcomes even for a single agent. This compendium of experimentally induced mutational signatures permits fur" ration of roles of environmental agents in cancer etiology and underscores how human stem cell DNA is directly vulnerable to environmental agents.	[Kucab, Jill E.; Joel, Madeleine; Nagy, Eszter; Arlt, Volker M.; Phillips, David H.] Kings Coll London, MRC PHE Ctr Environm & Hlth, Dept Analyt Environm & Forens Sci, 150 Stamford St, London SE1 9NH, England; [Zou, Xueqing; Nanda, A. Scott; Degasperi, Andrea; Harris, Rebecca; Nik-Zainal, Serena] Univ Cambridge, Sch Clin Med, Acad Dept Med Genet, Cambridge CB2 9NB, England; [Zou, Xueqing; Degasperi, Andrea; Nik-Zainal, Serena] Univ Cambridge, MRC Canc Unit, Cambridge CB2 0XZ, England; [Zou, Xueqing; Morganella, Sandro; Gomez, Celine; Degasperi, Andrea; Harris, Rebecca; Nik-Zainal, Serena] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Jackson, Stephen P.] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England	University of London; King's College London; University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute; University of Cambridge	Phillips, DH (corresponding author), Kings Coll London, MRC PHE Ctr Environm & Hlth, Dept Analyt Environm & Forens Sci, 150 Stamford St, London SE1 9NH, England.; Nik-Zainal, S (corresponding author), Univ Cambridge, Sch Clin Med, Acad Dept Med Genet, Cambridge CB2 9NB, England.; Nik-Zainal, S (corresponding author), Univ Cambridge, MRC Canc Unit, Cambridge CB2 0XZ, England.; Nik-Zainal, S (corresponding author), Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England.	david.phillips@kcl.ac.uk; snz@mrc-cu.cam.ac.uk	Jackson, Stephen Philip/R-4548-2019; Degasperi, Andrea/AAG-1315-2019; Nik-Zainal, Serena/ABD-4437-2020	Jackson, Stephen Philip/0000-0001-9317-7937; Degasperi, Andrea/0000-0001-6879-0596; Nik-Zainal, Serena/0000-0001-5054-1727; Arlt, Volker Manfred/0000-0003-4314-9318; Nanda, Scott/0000-0001-5014-3104; Zou, Xueqing/0000-0003-1143-1028	Wellcome Trust Strategic Award [101126/B/13/Z]; University of Cambridge; Wellcome Intermediate Clinical Fellowship [WT100183MA]; CRUK Advanced Clinician Scientist Award [C60100/A23916]; King's College London; Wellcome Trust [101126/B/13/Z, WT100183MA, C60100/A23916]; Cancer Research UK [C313/A14329]; CRUK Pioneer Award	Wellcome Trust Strategic Award(Wellcome Trust); University of Cambridge(University of Cambridge); Wellcome Intermediate Clinical Fellowship(Wellcome Trust); CRUK Advanced Clinician Scientist Award; King's College London(General Electric); Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK); CRUK Pioneer Award	We thank Osman Sozeri, Sabine Schnell, and Myriam Lemmens for Western blots, Anthony Young and Karl Lawrence for facilities for SSR exposures, and Mahvash Tavassoli and Hersi Hersi for help with gamma irradiation (all at King's College London). We thank Rohinder Bains, Summik Limbu, Sharad Patel, Emily Mallett, and Rachel Boyd (CGAP team at Sanger Institute) and the Sanger Institute sequencing and IT teams. This work was funded by a Wellcome Trust Strategic Award (101126/B/13/Z) for the COMSIG (Causes of Mutational SIGnatures) consortium (S.P.J., Principal Investigator), the University of Cambridge (S.P.J.), Wellcome Intermediate Clinical Fellowship (WT100183MA to S.N.-Z.), CRUK Advanced Clinician Scientist Award (C60100/A23916 to S.N.-Z.), King's College London (to D.H.P. and V.M.A.), Wellcome Trust (101126/B/13/Z to J.E.K., M.J., and E.N. and WT100183MA and C60100/A23916 to R.H.), Cancer Research UK (C313/A14329 to J.E.K., M.J., and E.N.), Wellcome Trust Strategic Award (101126/B/13/Z to X.Z.), and a CRUK Pioneer Award (to A.D.).	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Arlt VM, 2002, CARCINOGENESIS, V23, P1937, DOI 10.1093/carcin/23.11.1937; Behjati S, 2014, NATURE, V513, P422, DOI 10.1038/nature13448; Berger MF, 2018, NAT REV CLIN ONCOL, V15, P353, DOI 10.1038/s41571-018-0002-6; Boot A, 2018, GENOME RES, V28, P654, DOI 10.1101/gr.230219.117; BROWN J R, 1957, Br J Ind Med, V14, P68; Butlin H T, 1892, Br Med J, V2, P66; DeMarini DM, 2001, CANCER RES, V61, P6679; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; FRESCO JR, 1960, P NATL ACAD SCI USA, V46, P311, DOI 10.1073/pnas.46.3.311; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Giglia-Mari G, 2003, HUM MUTAT, V21, P217, DOI 10.1002/humu.10179; Greene CN, 1997, MOL CELL BIOL, V17, P2844, DOI 10.1128/MCB.17.5.2844; Hainaut P, 2001, CARCINOGENESIS, V22, P367, DOI 10.1093/carcin/22.3.367; Helleday T, 2014, NAT REV GENET, V15, P585, DOI 10.1038/nrg3729; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010, IARC Monogr Eval Carcinog Risks Hum, V92, P1; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Jenkins GJS, 2005, MUTAGENESIS, V20, P389, DOI 10.1093/mutage/gei054; Jones D, 2016, CURR PROTOC BIOINFOR, V56; Krais AM, 2016, ARCH TOXICOL, V90, P839, DOI 10.1007/s00204-015-1531-8; Kucab JE, 2015, MUTAT RES-FUND MOL M, V773, P48, DOI 10.1016/j.mrfmmm.2015.01.013; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Lawrence KP, 2018, BRIT J DERMATOL, V178, P1353, DOI 10.1111/bjd.16125; Mardis ER, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002209; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Morganella S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11383; Nedelko T, 2009, INT J CANCER, V124, P987, DOI 10.1002/ijc.24006; Nik-Zainal S, 2017, CLIN CANCER RES, V23, P2617, DOI 10.1158/1078-0432.CCR-16-2810; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; Nik-Zainal S, 2015, MUTAGENESIS, V30, P763, DOI 10.1093/mutage/gev073; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; NIKZAINAL S, 2012, CELL, V149; Olivier M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04482; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Pfeifer GP, 2000, MUTAT RES-FUND MOL M, V450, P155, DOI 10.1016/S0027-5107(00)00022-1; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803; Pilati C, 2017, J PATHOL, V242, P10, DOI 10.1002/path.4880; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Poon SL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0161-3; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raine K. M., 2015, CURR PROTOC BIOINFOR, V52, P15, DOI [10.1002/0471250953.bi1507s52Medline, DOI 10.1002/0471250953.BI1507S52MEDLINE]; Rouhani FJ, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005932; Stiborova M, 2016, ARCH TOXICOL, V90, P2595, DOI 10.1007/s00204-016-1819-3; Strauss BS, 2002, DNA REPAIR, V1, P125, DOI 10.1016/S1568-7864(01)00014-3; STREISINGER G, 1985, GENETICS, V109, P633; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; Supek F, 2015, NATURE, V521, P81, DOI 10.1038/nature14173; Szikriszt B, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0963-7; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; Thomas NE, 2004, J INVEST DERMATOL, V122, P1245, DOI 10.1111/j.0022-202X.2004.22523.x; Tran HT, 1997, MOL CELL BIOL, V17, P2859, DOI 10.1128/MCB.17.5.2859; Walker B Jr, 1981, Natl Cancer Inst Monogr, P11; Wohak LE, 2016, ARCH TOXICOL, V90, P291, DOI 10.1007/s00204-014-1409-1; Yang M, 2011, J ENVIRON SCI HEAL C, V29, P223, DOI 10.1080/10590501.2011.601848; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zhivagui M, 2017, BASIC CLIN PHARMACOL, V121, P16, DOI 10.1111/bcpt.12690; Zou XQ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04052-8	60	231	231	2	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 2	2019	177	4					821	+		10.1016/j.cell.2019.03.001	http://dx.doi.org/10.1016/j.cell.2019.03.001			32	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HW7AU	30982602	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000466843000006
J	Rennie, D				Rennie, Drummond			A Tribute to Douglas G. Altman, DSc	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Biographical-Item									[Rennie, Drummond] Univ Calif San Francisco, Phillip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Rennie, D (corresponding author), Univ Calif San Francisco, Phillip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA.	drummond.rennie@ucsf.edu						ALTMAN DG, PUBLICATION LIST; JONATHAN JD, 2018, COCHRANE DB SYST REV, V9; Juszczak E, 2019, JAMA-J AM MED ASSOC, V321, P1610, DOI 10.1001/jama.2019.3087	3	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2019	321	16					1621	1621		10.1001/jama.2019.3830	http://dx.doi.org/10.1001/jama.2019.3830			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HV7BZ	31012914	Bronze			2022-12-28	WOS:000466137800019
J	Hancock, ML; Meyer, RC; Mistry, M; Khetani, RS; Wagschal, A; Shin, T; Sui, SJH; Naar, AM; Flanagan, JG				Hancock, Melissa L.; Meyer, Rebecca C.; Mistry, Meeta; Khetani, Radhika S.; Wagschal, Alexandre; Shin, Taehwan; Sui, Shannan J. Ho; Naar, Anders M.; Flanagan, John G.			Insulin Receptor Associates with Promoters Genome-wide and Regulates Gene Expression	CELL			English	Article							NUCLEAR; COMPLEX; PROTEIN; VIRUS; INVOLVEMENT; RESISTANCE; NETWORKS; BINDING; GROWTH; ALPHA	Insulin receptor (IR) signaling is central to normal metabolic control and dysregulated in prevalent chronic diseases. IR binds insulin at the cell surface and transduces rapid signaling via cytoplasmic kinases. However, mechanisms mediating long-term effects of insulin remain unclear. Here, we show that IR associates with RNA polymerase II in the nucleus, with striking enrichment at promoters genome-wide. The target genes were highly enriched for insulin-related functions including lipid metabolism and protein synthesis and diseases including diabetes, neurodegeneration, and cancer. IR chromatin binding was increased by insulin and impaired in an insulin-resistant disease model. Promoter binding by IR was mediated by coregulator host cell factor-1 (HCF-1) and transcription factors, revealing an HCF-1-dependent pathway for gene regulation by insulin. These results show that IR interacts with transcriptional machinery at promoters and identify a pathway regulating genes linked to insulin's effects in physiology and disease.	[Hancock, Melissa L.; Meyer, Rebecca C.; Wagschal, Alexandre; Shin, Taehwan; Naar, Anders M.; Flanagan, John G.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Mistry, Meeta; Khetani, Radhika S.; Sui, Shannan J. Ho] Harvard TH Chan Sch Publ Hlth, Bioinformat Core, Boston, MA 02115 USA; [Wagschal, Alexandre; Naar, Anders M.] Massachusetts Gen Hosp, Canc Ctr, Charlestown, MA 02129 USA; [Flanagan, John G.] Harvard Med Sch, Program Neurosci, Boston, MA 02115 USA; [Hancock, Melissa L.] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Wagschal, Alexandre] Exon Therapeut, Watertown, MA USA; [Naar, Anders M.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA	Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; University of California System; University of California Berkeley	Flanagan, JG (corresponding author), Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA.; Flanagan, JG (corresponding author), Harvard Med Sch, Program Neurosci, Boston, MA 02115 USA.	flanagan@hms.harvard.edu	Flanagan, John/AAM-2995-2020	/0000-0002-6191-4709; Shin, Taehwan/0000-0003-3604-8594; Khetani, Radhika/0000-0003-2430-2970	NIH [R01EY011559, R01NS069913, R01DK084459, R01HL116391, U54HL119145, UL1RR025758, T32CA009361, F32NS073307]; MGH Research Scholar award; Harvard NeuroDiscovery Center; HMS Tools and Technology Committee; NATIONAL EYE INSTITUTE [R01EY011559] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL119145, R01HL116391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069913] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MGH Research Scholar award; Harvard NeuroDiscovery Center; HMS Tools and Technology Committee; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Steve Buratowski, Karen Adelman, Malcolm Whitman, Pere Puigserver, Alex Banks, Steve Gygi, Clary Clish, Shirley Liu, James Kadonaga, Sudha Biddinger, David Van Vactor, Stephen Liberles, and Jeffrey Flier for helpful discussions and Maria Ericsson, Seung-Joo Lee, Hyunsuk Suh, Kfir Sharabi, Jianhua Shi, Bowen Tan, Ross Tomaino, and Caroline Lewis for experimental help and advice. This work was supported by NIH grants (R01EY011559 and R01NS069913 to J.G.F.; R01DK084459, R01HL116391, and U54HL119145 to A.M.N.; UL1RR025758 to S.J.H.S.; T32CA009361 to R.C.M; and F32NS073307 to M.L.H.); an MGH Research Scholar award to A.M.N.; and funds from the Harvard NeuroDiscovery Center and the HMS Tools and Technology Committee to S.J.H.S.	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; Altindis E, 2018, P NATL ACAD SCI USA, V115, P2461, DOI 10.1073/pnas.1721117115; Ambrosini G, 2018, BIOINFORMATICS, V34, P2483, DOI 10.1093/bioinformatics/bty127; Babu M, 2011, METHODS MOL BIOL, V781, P99, DOI 10.1007/978-1-61779-276-2_7; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Boucher J, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a009191; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Cai WK, 2017, NAT COMMUN, V8, DOI [10.1038/s41467-017-00417-7, 10.1038/ncomms14892]; Carpenter G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008979; Cheung E, 2010, ANNU REV PHYSIOL, V72, P191, DOI 10.1146/annurev-physiol-021909-135840; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Czech MP, 2017, NAT MED, V23, P804, DOI 10.1038/nm.4350; de la Monte SM, 2017, DRUGS, V77, P47, DOI 10.1007/s40265-016-0674-0; Dejosez M, 2010, GENE DEV, V24, P1479, DOI 10.1101/gad.1935210; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; GOLDFINE ID, 1976, P NATL ACAD SCI USA, V73, P1427, DOI 10.1073/pnas.73.5.1427; Haqshenas G, 2019, CELL REP, V26, P529, DOI 10.1016/j.celrep.2018.12.068; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Heni M, 2015, NAT REV ENDOCRINOL, V11, P701, DOI 10.1038/nrendo.2015.173; Hermann R, 1996, HISTOCHEM CELL BIOL, V106, P31; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kang S, 2016, TRENDS CELL BIOL, V26, P341, DOI 10.1016/j.tcb.2016.01.002; Kelley JB, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-63; Kennedy AJ, 2010, DIS MODEL MECH, V3, P156, DOI 10.1242/dmm.003467; Kim W, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002519; Kruger M, 2001, MOL CELL BIOL, V21, P8357, DOI 10.1128/MCB.21.24.8357-8364.2001; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mao YTS, 2011, NAT CELL BIOL, V13, P95, DOI 10.1038/ncb2140; MCCLAIN DA, 1987, J BIOL CHEM, V262, P14663; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meikle PJ, 2017, NAT REV ENDOCRINOL, V13, P79, DOI 10.1038/nrendo.2016.169; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Michaud J, 2013, GENOME RES, V23, P907, DOI 10.1101/gr.150078.112; Mikula M, 2016, NUCLEIC ACIDS RES, V44, P10150, DOI 10.1093/nar/gkw763; Miyamoto Y, 2016, J BIOCHEM, V160, P69, DOI 10.1093/jb/mvw036; Nelson JD, 2011, DIABETES, V60, P127, DOI 10.2337/db09-1806; Papadopoulos N, 2018, J CELL BIOL, V217, P1701, DOI 10.1083/jcb.201706118; Parker JB, 2014, CELL REP, V9, P967, DOI 10.1016/j.celrep.2014.09.051; Parker JB, 2012, MOL CELL BIOL, V32, P1654, DOI 10.1128/MCB.06033-11; PODLECKI DA, 1987, J BIOL CHEM, V262, P3362; PURRELLO F, 1983, SCIENCE, V221, P462, DOI 10.1126/science.6346487; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Ruan HB, 2012, CELL METAB, V16, P226, DOI 10.1016/j.cmet.2012.07.006; Shin DJ, 2012, NUCLEIC ACIDS RES, V40, P11499, DOI 10.1093/nar/gks932; Song SM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009001; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sudhof TC, 2012, NEURON, V75, P11, DOI 10.1016/j.neuron.2012.06.012; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tcherkezian J, 2010, CELL, V141, P632, DOI 10.1016/j.cell.2010.04.008; Titchenell PM, 2017, TRENDS ENDOCRIN MET, V28, P497, DOI 10.1016/j.tem.2017.03.003; Vigneri R, 2016, J ENDOCRINOL INVEST, V39, P1365, DOI 10.1007/s40618-016-0508-7; Wang S, 2013, NAT PROTOC, V8, P2502, DOI 10.1038/nprot.2013.150; Wang XW, 2012, NUCLEIC ACIDS RES, V40, pD1144, DOI 10.1093/nar/gkr1013; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; WILSON AC, 1993, CELL, V74, P115, DOI 10.1016/0092-8674(93)90299-6; Winer S, 2012, IMMUNOL CELL BIOL, V90, P755, DOI 10.1038/icb.2011.110; WONG KY, 1988, BIOCHEMISTRY-US, V27, P375, DOI 10.1021/bi00401a056; Wysocka J, 2003, TRENDS BIOCHEM SCI, V28, P294, DOI 10.1016/S0968-0004(03)00088-4; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	65	66	69	0	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2019	177	3					722	+		10.1016/j.cell.2019.02.030	http://dx.doi.org/10.1016/j.cell.2019.02.030			37	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HU0FV	30955890	Bronze, Green Accepted			2022-12-28	WOS:000464947700024
J	Sheldon, T				Sheldon, Tony			Testing of illicit drugs in the Netherlands could be a model for the UK	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												tonysheldon5@cs.com						Brunt T., 2017, DRUG CHECKING HARM R; Bucheli A, 2010, SUCHTMAGAZIN, V5, P41; DIMS, 2018, DIMS 2017 ANN REP; European Monitoring Centre for Drugs and Drug Addiction, 2018, EUR DRUG REP 2018 TR, P88; Evans M., 2017, TELEGRAPH; Measham FC, 2019, INT J DRUG POLICY, V67, P102, DOI 10.1016/j.drugpo.2018.11.001; Release, 2016, QUIET REV DRUG DESCR; Trimbos-Netherlands Institute of Mental Health and Addiction. Scientific Research and Documentation Centre Dutch Ministry of Justice, 2019, NAT DRUG MON JAARB 2	8	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 18	2019	365								l1784	10.1136/bmj.l1784	http://dx.doi.org/10.1136/bmj.l1784			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU8PD	31000531				2022-12-28	WOS:000465550700004
J	Zhu, M; Lu, TS; Jia, YM; Luo, X; Gopal, P; Li, L; Odewole, M; Renteria, V; Singa, AG; Jang, Y; Ge, K; Wang, SC; Sorouri, M; Parekh, JR; MacConmara, MP; Yopp, AC; Wang, T; Zhu, H				Zhu, Min; Lu, Tianshi; Jia, Yuemeng; Luo, Xin; Gopal, Purva; Li, Lin; Odewole, Mobolaji; Renteria, Veronica; Singa, Amit G.; Jang, Younghoon; Ge, Kai; Wang, Sam C.; Sorouri, Mahsa; Parekh, Justin R.; MacConmara, Malcolm P.; Yopp, Adam C.; Wang, Tao; Zhu, Hao			Somatic Mutations Increase Hepatic Clonal Fitness and Regeneration in Chronic Liver Disease	CELL			English	Article							HEPATOCELLULAR-CARCINOMA; GENOME ANALYSIS; MURINE MODEL; IN-VIVO; CANCER; HEPATOCYTES; ANEUPLOIDY; NODULES; PROTEIN; HEMATOPOIESIS	Normal tissues accumulate genetic changes with age, but it is unknown if somatic mutations promote clonal expansion of non-malignant cells in the setting of chronic degenerative diseases. Exome sequencing of diseased liver samples from 82 patients revealed a complex mutational landscape in cirrhosis. Additional ultra-deep sequencing identified recurrent mutations in PKD1, PPARGC1B, KMT2D, and ARID1A. The number and size of mutant clones increased as a function of fibrosis stage and tissue damage. To interrogate the functional impact of mutated genes, a pooled in vivo CRISPR screening approach was established. In agreement with sequencing results, examination of 147 genes again revealed that loss of Pkd1,Kmt2d, and Arid1a promoted clonal expansion. Conditional heterozygous deletion of these genes in mice was also hepatoprotective in injury assays. Pre-malignant somatic alterations are often viewed throught the lens of cancer, but we show that mutatior can promote regeneration, likely independent of carcinogenesis.	[Zhu, Min; Lu, Tianshi; Jia, Yuemeng; Luo, Xin; Li, Lin; Wang, Sam C.; Sorouri, Mahsa; Zhu, Hao] Univ Texas Southwestern Med Ctr Dallas, Childrens Res Inst, Ctr Regenerat Sci & Med, Dept Pediat, Dallas, TX 75390 USA; [Zhu, Min; Lu, Tianshi; Jia, Yuemeng; Luo, Xin; Li, Lin; Wang, Sam C.; Sorouri, Mahsa; Zhu, Hao] Univ Texas Southwestern Med Ctr Dallas, Childrens Res Inst, Ctr Regenerat Sci & Med, Dept Internal Med, Dallas, TX 75390 USA; [Lu, Tianshi; Wang, Tao] Univ Texas Southwestern Med Ctr Dallas, Quantitat Biomed Res Ctr, Dept Populat & Data Sci, Dallas, TX 75390 USA; [Luo, Xin] Univ Texas Southwestern Med Ctr Dallas, Dept Bioinformat, Dallas, TX 75390 USA; [Gopal, Purva] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Odewole, Mobolaji; Renteria, Veronica; Singa, Amit G.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Jang, Younghoon; Ge, Kai] NIDDK, NIH, Bethesda, MD 20892 USA; [Wang, Sam C.; Parekh, Justin R.; MacConmara, Malcolm P.; Yopp, Adam C.] Univ Texas Southwestern Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA; [Wang, Tao] Univ Texas Southwestern Med Ctr Dallas, Kidney Canc Program, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhu, H (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Childrens Res Inst, Ctr Regenerat Sci & Med, Dept Pediat, Dallas, TX 75390 USA.; Zhu, H (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Childrens Res Inst, Ctr Regenerat Sci & Med, Dept Internal Med, Dallas, TX 75390 USA.; Wang, T (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Quantitat Biomed Res Ctr, Dept Populat & Data Sci, Dallas, TX 75390 USA.; Wang, T (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Kidney Canc Program, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA.	Tao.Wang@utsouthwestern.edu; Hao.Zhu@utsouthwestern.edu	Jia, Yuemeng/AAQ-9853-2021; Ge, Kai/H-2810-2019; Zhu, Hao/L-5114-2013	Ge, Kai/0000-0002-7442-5138; Jang, Younghoon/0000-0002-5705-4945; Zhu, Hao/0000-0002-8417-9698; Jia, Yuemeng/0000-0002-8019-1534	CPRIT [RP150596]; Pollack Foundation; NIH/NIDDK R01 grant [DK111588]; Burroughs Wellcome Career Award for Medical Scientists; CPRIT Scholar Award [R1209]; Stand Up To Cancer Innovative Research Grant [SU2C-AACR-IRG 10-16];  [R03ES026397-01]; NATIONAL CANCER INSTITUTE [K08CA222611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075003, R01DK111588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R03ES026397] Funding Source: NIH RePORTER	CPRIT; Pollack Foundation; NIH/NIDDK R01 grant; Burroughs Wellcome Career Award for Medical Scientists(Burroughs Wellcome Fund); CPRIT Scholar Award; Stand Up To Cancer Innovative Research Grant; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We would like to thank Helen Hobbs and Teresa Eversole for contributing human samples; Sean Morrison, Joshua Mendell, Branden Tarlow, and Jian Xu for constructive comments on the manuscript; Cheryl Lewis and John Shelton for histopathology; and the CRI Sequencing Core (Jian Xu, Xin Liu) and Admera Health (Yun Zhao) for genomics. T.W. is supported by a R03ES026397-01. T.W. and X.L. were supported by CPRIT (RP150596). H.Z. was supported by the Pollack Foundation, an NIH/NIDDK R01 grant (DK111588), a Burroughs Wellcome Career Award for Medical Scientists, a CPRIT Scholar Award (R1209), a Stand Up To Cancer Innovative Research Grant (SU2C-AACR-IRG 10-16). Stand Up To Cancer is a program of the Entertainment Industry Foundation, and its research grants are administered by the American Association for Cancer Research, the scientific partner of SU2C.	AIHARA T, 1994, GASTROENTEROLOGY, V107, P1805, DOI 10.1016/0016-5085(94)90824-9; Ally A, 2017, CELL, V169, P1327, DOI 10.1016/j.cell.2017.05.046; Beer S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002493; Chen XY, 2016, BIOINFORMATICS, V32, P1220, DOI 10.1093/bioinformatics/btv710; Chiang C, 2015, NAT METHODS, V12, P966, DOI [10.1038/nmeth.3505, 10.1038/NMETH.3505]; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dow LE, 2015, NAT BIOTECHNOL, V33, P390, DOI 10.1038/nbt.3155; Duncan AW, 2012, J CLIN INVEST, V122, P3307, DOI 10.1172/JCI64026; Duncan AW, 2012, GASTROENTEROLOGY, V142, P25, DOI 10.1053/j.gastro.2011.10.029; Duncan AW, 2010, NATURE, V467, P707, DOI 10.1038/nature09414; Fanti M, 2014, HEPATOLOGY, V59, P2309, DOI 10.1002/hep.26775; Fellous TG, 2009, HEPATOLOGY, V49, P1655, DOI 10.1002/hep.22791; Font-Burgada J, 2015, CELL, V162, P766, DOI 10.1016/j.cell.2015.07.026; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Gong L, 2010, HISTOPATHOLOGY, V56, P589, DOI 10.1111/j.1365-2559.2010.03523.x; GROMPE M, 1995, NAT GENET, V10, P453, DOI 10.1038/ng0895-453; Guido M, 2011, DIGEST LIVER DIS, V43, pS331, DOI 10.1016/S1590-8658(11)60589-6; Hansen NF, 2013, BIOINFORMATICS, V29, P1498, DOI 10.1093/bioinformatics/btt183; Hogan MC, 2015, CLIN GASTROENTEROL H, V13, P155, DOI 10.1016/j.cgh.2014.07.051; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Ikeda A, 2014, GASTROENTEROLOGY, V146, P222, DOI 10.1053/j.gastro.2013.09.025; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Kim DH, 2016, CELL REP, V17, P1671, DOI 10.1016/j.celrep.2016.10.023; Kim DH, 2015, HEPATOLOGY, V61, P1012, DOI 10.1002/hep.27578; Knouse KA, 2014, P NATL ACAD SCI USA, V111, P13409, DOI 10.1073/pnas.1415287111; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kulik L, 2019, GASTROENTEROLOGY, V156, P477, DOI 10.1053/j.gastro.2018.08.065; Lee JE, 2013, ELIFE, V2, DOI 10.7554/eLife.01503; Lee-Six H, 2018, BIORXIV, DOI [10.1101/416800, DOI 10.1101/416800]; Lee-Six H, 2018, NATURE, V561, P473, DOI 10.1038/s41586-018-0497-0; Lefkowitch JH, 2007, ARCH MED RES, V38, P634, DOI 10.1016/j.arcmed.2006.08.005; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lin SD, 2018, NATURE, V556, P244, DOI 10.1038/s41586-018-0004-7; Lin WR, 2010, HEPATOLOGY, V51, P1017, DOI 10.1002/hep.23483; Liu C, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt481; Martincorena I, 2018, SCIENCE, V362, P911, DOI 10.1126/science.aau3879; Martincorena I, 2015, SCIENCE, V348, P880, DOI 10.1126/science.aaa6806; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nault JC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3218; OVERMOYER BA, 1987, ARCH PATHOL LAB MED, V111, P549; Overturf K, 1996, NAT GENET, V12, P266, DOI 10.1038/ng0396-266; Paradis V, 1998, HEPATOLOGY, V28, P953, DOI 10.1002/hep.510280409; Piccinin E, 2018, HEPATOLOGY, V67, P884, DOI 10.1002/hep.29484; Piontek KB, 2004, J AM SOC NEPHROL, V15, P3035, DOI 10.1097/01.ASN.0000144204.01352.86; Qiu W, 2008, HEPATOLOGY, V48, P1799, DOI 10.1002/hep.22565; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Singal AG, 2015, CLIN GASTROENTEROL H, V13, P2140, DOI 10.1016/j.cgh.2015.08.014; Sun XX, 2016, CELL STEM CELL, V18, P456, DOI 10.1016/j.stem.2016.03.001; Tahvanainen E, 2005, ANN MED, V37, P546, DOI 10.1080/07853890500389181; Talevich E, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004873; Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]; Wang B, 2015, NATURE, V524, P180, DOI 10.1038/nature14863; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; White DL, 2012, CLIN GASTROENTEROL H, V10, P1342, DOI 10.1016/j.cgh.2012.10.001; Wilm A, 2012, NUCLEIC ACIDS RES, V40, P11189, DOI 10.1093/nar/gks918; Yokoyama A, 2019, NATURE, V565, P312, DOI 10.1038/s41586-018-0811-x; Zare F, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1705-x; Zhu Y, 2016, ONCOTARGET, V7, P5327, DOI 10.18632/oncotarget.6633	65	111	113	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2019	177	3					608	+		10.1016/j.cell.2019.03.026	http://dx.doi.org/10.1016/j.cell.2019.03.026			26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HU0FV	30955891	Green Accepted, Bronze			2022-12-28	WOS:000464947700016
J	Dahm, P; Wilt, T				Dahm, Philipp; Wilt, Timothy			In early prostate cancer, radical prostatectomy reduced mortality more than watchful waiting at 23 years	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Dahm, Philipp; Wilt, Timothy] Minneapolis VA Hlth Care Syst, Minneapolis, MN 55417 USA; [Dahm, Philipp; Wilt, Timothy] Univ Minnesota, Minneapolis, MN 55455 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities	Dahm, P (corresponding author), Minneapolis VA Hlth Care Syst, Minneapolis, MN 55417 USA.; Dahm, P (corresponding author), Univ Minnesota, Minneapolis, MN 55455 USA.							Hamdy FC, 2016, NEW ENGL J MED, V375, P1415, DOI 10.1056/NEJMoa1606220; Wilt TJ, 2017, NEW ENGL J MED, V377, P132, DOI 10.1056/NEJMoa1615869	2	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2019	170	8					JC44	JC44		10.7326/ACPJ201904160-044	http://dx.doi.org/10.7326/ACPJ201904160-044			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU7YQ	30986834				2022-12-28	WOS:000465499900010
J	Colvin, LA; Bull, F; Hales, TG				Colvin, Lesley A.; Bull, Fiona; Hales, Tim G.			Perioperative opioid analgesia-when is enough too much? A review of opioid-induced tolerance and hyperalgesia	LANCET			English	Review							POSTOPERATIVE PAIN MANAGEMENT; CHRONIC BACK-PAIN; MORPHINE-TOLERANCE; NMDA RECEPTOR; INTRAOPERATIVE REMIFENTANIL; POSTINFUSION HYPERALGESIA; KNEE ARTHROPLASTY; NEUROPATHIC PAIN; SURGERY; SRC	Opioids are a mainstay of acute pain management but can have many adverse effects, contributing to problematic long-term use. Opioid tolerance (increased dose needed for analgesia) and opioid-induced hyperalgesia (paradoxical increase in pain with opioid administration) can contribute to both poorly controlled pain and dose escalation. Hyperalgesia is particularly problematic as further opioid prescribing is largely futile. The mechanisms of opioid tolerance and hyperalgesia are complex, involving mu opioid receptor signalling pathways that offer opportunities for novel analgesic alternatives. The intracellular scaffold protein beta-arrestin-2 is implicated in tolerance, hyperalgesia, and other opioid side-effects. Development of agonists biased against recruitment of beta-arrestin-2 could provide analgesic efficacy with fewer side-effects. Alternative approaches include inhibition of peripheral mu opioid receptors and blockade of downstream signalling mechanisms, such as the non-receptor tyrosine kinase Src or N-methyl-D-aspartate receptors. Furthermore, it is prudent to use multimodal analgesic regimens to reduce reliance on opioids during the perioperative period. In the third paper in this Series we focus on clinical and mechanism-based understanding of tolerance and opioid-induced hyperalgesia, and discuss current and future strategies for pain management.	[Colvin, Lesley A.] Univ Dundee, Div Populat Hlth & Genom, Ninewells Hosp & Med Sch, Dundee DD2 4RB, Scotland; [Bull, Fiona; Hales, Tim G.] Univ Dundee, Inst Acad Anaesthesia, Div Syst Med, Sch Med,Ninewells Hosp, Dundee, Scotland	University of Dundee; University of Dundee	Colvin, LA (corresponding author), Univ Dundee, Div Populat Hlth & Genom, Ninewells Hosp & Med Sch, Dundee DD2 4RB, Scotland.	l.a.colvin@dundee.ac.uk		Colvin, Lesley/0000-0002-1563-8600; Bull, Fiona/0000-0002-7016-0611				Aley KO, 1997, J NEUROSCI, V17, P8018; Araldi D, 2018, J NEUROSCI, V38, P2226, DOI 10.1523/JNEUROSCI.3476-17.2018; Arout CA, 2015, CNS DRUGS, V29, P465, DOI 10.1007/s40263-015-0255-x; Arumugam S, 2016, J PAIN RES, V9, P631, DOI 10.2147/JPR.S112626; Bantel C, 2015, BRIT J ANAESTH, V114, P850, DOI 10.1093/bja/aev083; Belgrade M, 2010, PAIN MED, V11, P1819, DOI 10.1111/j.1526-4637.2010.00973.x; Belkin M, 2017, AM J ADDICTION, V26, P738, DOI 10.1111/ajad.12605; Berterame S, 2016, LANCET, V387, P1644, DOI 10.1016/S0140-6736(16)00161-6; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Brat GA, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.j5790; Bujalska-Zadrozny M, 2017, EUR J PHARM SCI, V99, P113, DOI 10.1016/j.ejps.2016.11.020; Bull FA, 2017, ANESTHESIOLOGY, V127, P878, DOI 10.1097/ALN.0000000000001834; Bull FA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10360-8; Cahill CM, 2017, CURR OPIN BEHAV SCI, V13, P171, DOI 10.1016/j.cobeha.2016.12.003; Cata JP, 2017, MINERVA ANESTESIOL, V83, P315, DOI 10.23736/S0375-9393.16.11698-0; Chaparro LE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008307.pub2; Chou R, 2015, ANN INTERN MED, V162, P276, DOI 10.7326/M14-2559; Clarke Hance, 2014, BMJ, V348, pg1251, DOI 10.1136/bmj.g1251; Comelon M, 2016, BRIT J ANAESTH, V116, P524, DOI 10.1093/bja/aev547; Cooper TE, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011669.pub2; Corder G, 2017, NAT MED, V23, P164, DOI 10.1038/nm.4262; Cunningham JL, 2016, PAIN MED, V17, P1676, DOI 10.1093/pm/pnv079; Dahl JB, 2014, ACTA ANAESTH SCAND, V58, P1165, DOI 10.1111/aas.12382; Dang VC, 2012, MOL PHARMACOL, V82, P473, DOI 10.1124/mol.112.079350; De Felice M, 2016, MOL PAIN, V12, DOI 10.1177/1744806916643725; de Hoogd S, 2018, PAIN PRACT, V18, P443, DOI 10.1111/papr.12615; de Hoogd S, 2016, CLIN J PAIN, V32, P726, DOI 10.1097/AJP.0000000000000317; Dumas EO, 2008, AAPS J, V10, P537, DOI 10.1208/s12248-008-9056-1; Edwards RR, 2016, PAIN MED, V17, P1882, DOI 10.1093/pm/pnw010; Eippert F, 2009, NEURON, V63, P533, DOI 10.1016/j.neuron.2009.07.014; Eisenberg E, 2015, J PAIN SYMPTOM MANAG, V49, P632, DOI 10.1016/j.jpainsymman.2014.07.005; ELS C, 2017, COCHRANE DB SYST REV, V10, DOI DOI 10.1002/14651858.CD012299.PUB2; Fields HL, 2015, TRENDS NEUROSCI, V38, P217, DOI 10.1016/j.tins.2015.01.002; Fine PG, 2009, J PAIN SYMPTOM MANAG, V38, P418, DOI 10.1016/j.jpainsymman.2009.06.002; Finn AK, 2001, NEURON, V32, P829, DOI 10.1016/S0896-6273(01)00517-7; Fischer B, 2014, ADDICTION, V109, P177, DOI 10.1111/add.12224; Fletcher D, 2014, BRIT J ANAESTH, V112, P991, DOI 10.1093/bja/aeu137; Glare P, 2019, LANCET, V393, P1537, DOI 10.1016/S0140-6736(19)30352-6; Guo W, 2002, J NEUROSCI, V22, P6208; Haanpaa M, 2011, PAIN, V152, P14, DOI 10.1016/j.pain.2010.07.031; Hah JM, 2017, ANESTH ANALG, V125, P1733, DOI 10.1213/ANE.0000000000002458; Han SS, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0026-8; Hayhurst CJ, 2016, ANESTHESIOLOGY, V124, P483, DOI 10.1097/ALN.0000000000000963; Heinke B, 2011, J NEUROSCI, V31, P1313, DOI 10.1523/JNEUROSCI.4060-10.2011; Hill R, ETHANOL REVERSAL TOL; Hill R, 2018, BRIT J PHARMACOL, V175, P2653, DOI 10.1111/bph.14224; Hnasko TS, 2005, NATURE, V438, P854, DOI 10.1038/nature04172; Hooten WM, 2015, PAIN, V156, P1145, DOI 10.1097/j.pain.0000000000000170; Imam MZ, 2018, NEUROPHARMACOLOGY, V131, P238, DOI 10.1016/j.neuropharm.2017.12.032; Khan JS, 2016, EUR J ANAESTH, V33, P204, DOI 10.1097/EJA.0000000000000346; Kim SH, 2015, AM J THER, V22, pE62, DOI 10.1097/MJT.0000000000000019; Koehl A, 2018, NATURE, V558, P547, DOI 10.1038/s41586-018-0219-7; Koppert W, 2003, ANESTHESIOLOGY, V99, P152, DOI 10.1097/00000542-200307000-00025; Kranke P, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009642.pub2; Krebs EE, 2018, JAMA-J AM MED ASSOC, V319, P872, DOI 10.1001/jama.2018.0899; Lam H, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-24; Lang E, 1996, ANESTHESIOLOGY, V85, P721, DOI 10.1097/00000542-199610000-00006; Laskowski K, 2011, CAN J ANESTH, V58, P911, DOI 10.1007/s12630-011-9560-0; Leduc-Pessah H, 2017, J NEUROSCI, V37, P10154, DOI 10.1523/JNEUROSCI.0852-17.2017; Lee MC, 2008, J NEUROSCI, V28, P11642, DOI 10.1523/JNEUROSCI.2638-08.2008; Lee MC, 2014, NEUROPHARMACOLOGY, V84, P123, DOI 10.1016/j.neuropharm.2013.06.035; Liu XJ, 2008, NAT MED, V14, P1325, DOI 10.1038/nm.1883; Ljungqvist O, 2017, JAMA SURG, V152, P292, DOI 10.1001/jamasurg.2016.4952; Loftus RW, 2010, ANESTHESIOLOGY, V113, P639, DOI 10.1097/ALN.0b013e3181e90914; Luttrell DK, 2004, ONCOGENE, V23, P7969, DOI 10.1038/sj.onc.1208162; Madariaga-Mazon A, 2017, DRUG DISCOV TODAY, V22, P1719, DOI 10.1016/j.drudis.2017.07.002; Maldonado R, 1997, NATURE, V388, P586, DOI 10.1038/41567; Malik OS, 2017, CURR PAIN HEADACHE R, V21, DOI 10.1007/s11916-017-0602-3; Manglik A, 2016, NATURE, V537, P185, DOI 10.1038/nature19112; Mao JR, 2015, REGION ANESTH PAIN M, V40, P663, DOI 10.1097/AAP.0000000000000317; Martinez V, 2017, BRIT J ANAESTH, V118, P22, DOI 10.1093/bja/aew391; McClendon J, 2010, ANN NY ACAD SCI, V1200, P85, DOI 10.1111/j.1749-6632.2010.05515.x; McDougall JJ, 2011, BBA-MOL BASIS DIS, V1812, P459, DOI 10.1016/j.bbadis.2010.12.011; McNicol ED, 2015, COCHRANE DB SYST REV, V6; Memtsoudis SG, 2018, ANESTHESIOLOGY, V128, P891, DOI 10.1097/ALN.0000000000002132; Mercieri M, 2017, BRIT J ANAESTH, V119, P792, DOI 10.1093/bja/aex174; Mohammad HR, 2018, ACTA ORTHOP, V89, P71, DOI 10.1080/17453674.2017.1391409; Neuman MD, 2019, LANCET, V393, P1547, DOI 10.1016/S0140-6736(19)30428-3; Poelaert J, 2015, CLIN THER, V37, P784, DOI 10.1016/j.clinthera.2015.02.010; Porkka K, 2008, BLOOD, V112, P1005, DOI 10.1182/blood-2008-02-140665; Powell R, 2016, COCHRANE DB SYST REV, V5; Raehal KM, 2011, NEUROPHARMACOLOGY, V60, P58, DOI 10.1016/j.neuropharm.2010.08.003; Raehal KM, 2005, J PHARMACOL EXP THER, V314, P1195, DOI 10.1124/jpet.105.087254; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; Richebe P, 2005, ANESTHESIOLOGY, V103, P845, DOI 10.1097/00000542-200510000-00024; Rivat C, 2013, CURR OPIN ANESTHESIO, V26, P621, DOI 10.1097/01.aco.0000432511.08070.de; Roeckel LA, 2016, NEUROSCIENCE, V338, P160, DOI 10.1016/j.neuroscience.2016.06.029; Rowan MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093688; Ruscheweyh R, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-20; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Samuelsen PJ, 2017, BMC PHARMACOL TOXICO, V18, DOI 10.1186/s40360-017-0149-2; Sanfilippo F, 2016, J CLIN ANESTH, V31, P27, DOI 10.1016/j.jclinane.2015.12.025; Santonocito C, 2018, LOCAL REG ANESTH, V11, DOI 10.2147/LRA.S143618; Schrepf A, 2016, PAIN, V157, P2217, DOI 10.1097/j.pain.0000000000000633; Singler B, 2007, ANESTH ANALG, V104, P1397, DOI 10.1213/01.ane.0000261305.22324.f3; Smith JS, 2016, J BIOL CHEM, V291, P8969, DOI 10.1074/jbc.R115.713313; Sun EC, 2017, ANESTH ANALG, V125, P999, DOI 10.1213/ANE.0000000000001943; Szeverenyi C, 2018, J PAIN, V19, P1231, DOI 10.1016/j.jpain.2018.05.006; Tan M, 2009, J BIOL CHEM, V284, P6270, DOI 10.1074/jbc.M806742200; TERWILLIGER RZ, 1991, BRAIN RES, V548, P100, DOI 10.1016/0006-8993(91)91111-D; Torrance N, 2018, BRIT J ANAESTH, V120, P1345, DOI 10.1016/j.bja.2018.02.022; Trigo JM, 2010, DRUG ALCOHOL DEPEN, V108, P183, DOI 10.1016/j.drugalcdep.2009.10.011; Trujillo KA, 2002, NEUROTOX RES, V4, P373, DOI 10.1080/10298420290023954; Vadivelu Nalini, 2016, J Opioid Manag, V12, P289, DOI 10.5055/jom.2016.0344; van Hecke O, 2013, BRIT J ANAESTH, V111, P13, DOI 10.1093/bja/aet123; Varrassi G, 2018, PAIN THER, V7, P59, DOI 10.1007/s40122-018-0094-9; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31678-6, 10.1016/S0140-6736(16)31012-1]; Walwyn W, 2007, J NEUROSCI, V27, P5092, DOI 10.1523/JNEUROSCI.1157-07.2007; Ward EN, 2018, ANESTH ANALG, V127, P539, DOI 10.1213/ANE.0000000000003477; Wasserman RA, 2015, REGION ANESTH PAIN M, V40, P687, DOI 10.1097/AAP.0000000000000315; Wasserman RA, 2014, REGION ANESTH PAIN M, V39, P13, DOI 10.1097/AAP.0000000000000024; Weber L, 2017, CURR OPIN ANESTHESIO, V30, P458, DOI 10.1097/ACO.0000000000000485; Wesson DR, 2003, J PSYCHOACTIVE DRUGS, V35, P253, DOI 10.1080/02791072.2003.10400007; Williams JT, 2013, PHARMACOL REV, V65, P223, DOI 10.1124/pr.112.005942; Wunsch H, 2016, JAMA-J AM MED ASSOC, V315, P1654, DOI 10.1001/jama.2016.0130; Xu JT, 2014, J CLIN INVEST, V124, P592, DOI 10.1172/JCI70236; Yang CH, 2011, BRIT J ANAESTH, V107, P774, DOI 10.1093/bja/aer291; Yang DZ, 2019, AM J THER, V26, pE397, DOI 10.1097/MJT.0000000000000734; Yaster M, 2017, ANESTH ANALG, V125, P1429, DOI 10.1213/ANE.0000000000002395; Yu EHY, 2016, ANAESTHESIA, V71, P1347, DOI 10.1111/anae.13602; Zhang L, 2017, EMBO MOL MED, V9, P1521, DOI 10.15252/emmm.201607324	121	173	178	16	79	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 13	2019	393	10180					1558	1568		10.1016/S0140-6736(19)30430-1	http://dx.doi.org/10.1016/S0140-6736(19)30430-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU0DA	30983591	Green Published			2022-12-28	WOS:000464940400032
J	Honigsbaum, M				Honigsbaum, Mark			Disease X and other unknowns	LANCET			English	Editorial Material														honigsbaum, mark/0000-0002-1891-8763				Dubos R. J., 1987, MIRAGE HLTH UTOPIAS; Garrett L., 1994, COMING PLAGUE NEWLY; Lederberg J., 1992, I MED US COMMITTEE; Morse Stephen S., 1993, EMERGING VIRUSES	4	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 13	2019	393	10180					1496	1497		10.1016/S0140-6736(19)30803-7	http://dx.doi.org/10.1016/S0140-6736(19)30803-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU0DA	30983581	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000464940400015
J	Gimpel, D; Fisher, R; Khan, Z; McCormack, DJ				Gimpel, Damian; Fisher, Raewyn; Khan, Zahoor; McCormack, David J.			PRACTICE POINTER Primary care management of chest pain after coronary artery bypass surgery	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARDIAC-SURGERY; POSTOPERATIVE PAIN; GRAFT-SURGERY; SOCIETY; PREVENTION; THERAPY		[Gimpel, Damian; McCormack, David J.] Waikato Hosp, Waikato Cardiothorac Unit, Hamilton, New Zealand; [Gimpel, Damian; McCormack, David J.] Univ Auckland, Fac Med & Hlth Sci, Auckland, New Zealand; [Fisher, Raewyn] Waikato Hosp, Dept Cardiol, Hamilton, New Zealand; [Khan, Zahoor] Roodlane Med, Gen Practice, London, England	Waikato Hospital; University of Auckland; Waikato Hospital	McCormack, DJ (corresponding author), Waikato Hosp, Waikato Cardiothorac Unit, Hamilton, New Zealand.; McCormack, DJ (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Auckland, New Zealand.	david.mccormack@waikatodhb.health.nz						Abbate A, 2007, EUR HEART J, V28, P1057, DOI 10.1093/eurheartj/ehl562; Adler Y, 2015, EUR HEART J, V36, P2921, DOI 10.1093/eurheartj/ehv318; Aroney CN, 2016, MED J AUSTRALIA, V205, P91, DOI 10.5694/mja16.00263; Bolotin G, 2007, J THORAC CARDIOV SUR, V133, P949, DOI 10.1016/j.jtcvs.2006.09.065; Boudreau D, 2009, PHARMACOEPIDEM DR S, V18, P1166, DOI 10.1002/pds.1833; Brieger D, 2004, CHEST, V126, P461, DOI 10.1378/chest.126.2.461; British Cardiovascular Intervention Society, 2017, BCIS AUD RET PERS CO; CAVENDER JB, 1992, J AM COLL CARDIOL, V20, P287, DOI 10.1016/0735-1097(92)90092-2; Cayley WE, 2005, AM FAM PHYSICIAN, V72, P2012; Chepla Kyle J, 2011, Semin Plast Surg, V25, P98, DOI 10.1055/s-0031-1275176; Choiniere M, 2014, CAN MED ASSOC J, V186, pE213, DOI 10.1503/cmaj.131012; Chou R, 2016, J PAIN, V17, P131, DOI 10.1016/j.jpain.2015.12.008; Correll Darin, 2017, F1000Res, V6, P1054, DOI 10.12688/f1000research.11101.1; D'Agostino RS, 2018, ANN THORAC SURG, V105, P15, DOI 10.1016/j.athoracsur.2017.10.035; Doering LV, 2016, EUR J CARDIOVASC NUR, V15, P417, DOI 10.1177/1474515115592292; Eitz T, 2003, J CARDIAC SURG, V18, P519, DOI 10.1046/j.0886-0440.2003.02062.x; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Greszta Elzbieta, 2008, Roczniki Pomorskiej Akademii Medycznej w Szczecinie, V54, P157; Guimaraes-Pereira L, 2016, EUR J PAIN, V20, P1433, DOI 10.1002/ejp.866; Kalso E, 2013, BRIT J ANAESTH, V111, P9, DOI 10.1093/bja/aet211; Kwanten LE, 2019, J CARDIOTHOR VASC AN, V33, P808, DOI 10.1053/j.jvca.2018.05.053; Lahtinen P, 2006, ANESTHESIOLOGY, V105, P794, DOI 10.1097/00000542-200610000-00026; Lazar HL, 2016, J THORAC CARDIOV SUR, V152, P962, DOI 10.1016/j.jtcvs.2016.01.060; Mailis A, 2000, ANN THORAC SURG, V69, P1455, DOI 10.1016/S0003-4975(00)01186-3; Royal Australian College of General Practitioners, 2017, PRESCR DRUG DEP GEN; Taha A., 2017, J EGYPTIAN SOC CARDI, V25, P142, DOI DOI 10.1016/J.JESCTS.2017.04.004	26	3	3	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 12	2019	365								l1303	10.1136/bmj.l1303	http://dx.doi.org/10.1136/bmj.l1303			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU0EX	30979696				2022-12-28	WOS:000464945300001
J	Farmer, SR				Farmer, Stephen R.			Boning Up on Irisin	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FAT	A recent study suggests that irisin, a cytokine secreted by muscle during exercise, effects bone resorption and the differentiation of preadipocytes into thermogenic brown fat cells by displacing tethers between the cell and extracellular matrix molecules.	[Farmer, Stephen R.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University	Farmer, SR (corresponding author), Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA.			Farmer, Stephen/0000-0003-2483-2795				Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Jedrychowski MP, 2015, CELL METAB, V22, P734, DOI 10.1016/j.cmet.2015.08.001; Kim H, 2018, CELL, V175, P1756, DOI 10.1016/j.cell.2018.10.025; Morandi EM, 2016, SCI REP-UK, V6, DOI 10.1038/srep28889; Thi MM, 2013, P NATL ACAD SCI USA, V110, P21012, DOI 10.1073/pnas.1321210110	5	14	14	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 11	2019	380	15					1480	1482		10.1056/NEJMcibr1900041	http://dx.doi.org/10.1056/NEJMcibr1900041			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HT5NG	30970196				2022-12-28	WOS:000464610000018
J	Tilghman, JM; Ling, AY; Turner, TN; Sosa, MX; Krumm, N; Chatterjee, S; Kapoor, A; Coe, BP; Nguyen, KDH; Gupta, N; Gabriel, S; Eichler, EE; Berrios, C; Chakravarti, A				Tilghman, Joseph M.; Ling, Albee Y.; Turner, Tychele N.; Sosa, Maria X.; Krumm, Niklas; Chatterjee, Sumantra; Kapoor, Ashish; Coe, Bradley P.; Nguyen, Khanh-Dung H.; Gupta, Namrata; Gabriel, Stacey; Eichler, Evan E.; Berrios, Courtney; Chakravarti, Aravinda			Molecular Genetic Anatomy and Risk Profile of Hirschsprung's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; RET ENHANCER; COMMON; MUTATIONS; EDNRB; NRG1	Background Hirschsprung's disease, or congenital aganglionosis, is a developmental disorder of the enteric nervous system and is the most common cause of intestinal obstruction in neonates and infants. The disease has more than 80% heritability, including significant associations with rare and common sequence variants in genes related to the enteric nervous system, as well as with monogenic and chromosomal syndromes. Methods We genotyped and exome-sequenced samples from 190 patients with Hirschsprung's disease to quantify the genetic burden in patients with this condition. DNA sequence variants, large copy-number variants, and karyotype variants in probands were considered to be pathogenic when they were significantly associated with Hirschsprung's disease or another neurodevelopmental disorder. Novel genes were confirmed by functional studies in the mouse and human embryonic gut and in zebrafish embryos. Results The presence of five or more variants in four noncoding elements defined a widespread risk of Hirschsprung's disease (48.4% of patients and 17.1% of controls; odds ratio, 4.54; 95% confidence interval [CI], 3.19 to 6.46). Rare coding variants in 24 genes that play roles in enteric neural-crest cell fate, 7 of which were novel, were also common (34.7% of patients and 5.0% of controls) and conferred a much greater risk than noncoding variants (odds ratio, 10.02; 95% CI, 6.45 to 15.58). Large copy-number variants, which were present in fewer patients (11.4%, as compared with 0.2% of controls), conferred the highest risk (odds ratio, 63.07; 95% CI, 36.75 to 108.25). At least one identifiable genetic risk factor was found in 72.1% of the patients, and at least 48.4% of patients had a structural or regulatory deficiency in the gene encoding receptor tyrosine kinase (RET). For individual patients, the estimated risk of Hirschsprung's disease ranged from 5.33 cases per 100,000 live births (approximately 1 per 18,800) to 8.38 per 1000 live births (approximately 1 per 120). Conclusions Among the patients in our study, Hirschsprung's disease arose from common noncoding variants, rare coding variants, and copy-number variants affecting genes involved in enteric neural-crest cell fate that exacerbate the widespread genetic susceptibility associated with RET. For individual patients, the genotype-specific odds ratios varied by a factor of approximately 67, which provides a basis for risk stratification and genetic counseling. (Funded by the National Institutes of Health.) Understanding the nature of the genetic risk of complex diseases is becoming easier, thanks to advances in genomic analyses. This study implicates three types of risk variant for Hirschsprung's disease and shows that the genotype-specific incidence of the disease varies by a factor more than 100.	[Tilghman, Joseph M.; Ling, Albee Y.; Turner, Tychele N.; Sosa, Maria X.; Chatterjee, Sumantra; Kapoor, Ashish; Nguyen, Khanh-Dung H.; Berrios, Courtney; Chakravarti, Aravinda] Johns Hopkins Univ, Sch Med, Ctr Complex Dis Genom, Baltimore, MD USA; [Turner, Tychele N.; Krumm, Niklas; Kapoor, Ashish; Coe, Bradley P.; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA USA; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Nguyen, Khanh-Dung H.; Gupta, Namrata; Gabriel, Stacey] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Johns Hopkins University; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Chakravarti, A (corresponding author), NYU, Sch Med, Ctr Human Genet & Genom, 435 E 30th St,Rm 802-3, New York, NY 10016 USA.	aravinda.chakravarti@nyulangone.org		Berrios, Courtney/0000-0001-5170-070X; Chatterjee, Sumantra/0000-0002-5076-1698; Kapoor, Ashish/0000-0003-3977-6140; Coe, Bradley/0000-0001-8471-4016; Turner, Tychele/0000-0001-8246-6477	National Institutes of Health; MRC [MR/R006237/1] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD028088, R37HD028088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101221] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funded by the National Institutes of Health.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; Angrist M, 1996, NAT GENET, V14, P341, DOI 10.1038/ng1196-341; Arnold S, 2009, HUM MUTAT, V30, P771, DOI 10.1002/humu.20944; BADNER JA, 1990, AM J HUM GENET, V46, P568; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; BODIAN M, 1963, ANN HUM GENET, V26, P261, DOI 10.1111/j.1469-1809.1963.tb01983.x; Carrasquillo MM, 2002, NAT GENET, V32, P237, DOI 10.1038/ng998; CARTER CO, 1969, BRIT MED BULL, V25, P52, DOI 10.1093/oxfordjournals.bmb.a070671; CHAKRAVARTI A, 2001, METABOLIC MOL BASES, P6231; Chatterjee S, 2016, CELL, V167, P355, DOI 10.1016/j.cell.2016.09.005; Coe BP, 2014, NAT GENET, V46, P1063, DOI 10.1038/ng.3092; Dasgupta R, 2008, J PEDIATR GASTR NUTR, V46, P13, DOI 10.1097/01.mpg.0000304448.69305.28; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; EDERY P, 1994, NATURE, V367, P378, DOI 10.1038/367378a0; Emison ES, 2010, AM J HUM GENET, V87, P60, DOI 10.1016/j.ajhg.2010.06.007; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; Garcia-Barcelo MM, 2009, P NATL ACAD SCI USA, V106, P2694, DOI 10.1073/pnas.0809630105; Gui HS, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1174-6; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Jiang Q, 2015, AM J HUM GENET, V96, P581, DOI 10.1016/j.ajhg.2015.02.014; Kapoor A, 2015, HUM MOL GENET, V24, P2997, DOI 10.1093/hmg/ddv051; Krumm N, 2012, GENOME RES, V22, P1525, DOI 10.1101/gr.138115.112; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Menezes M, 2006, PEDIATR SURG INT, V22, P987, DOI 10.1007/s00383-006-1783-8; PASSARGE E, 1967, NEW ENGL J MED, V276, P138, DOI 10.1056/NEJM196701192760303; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Stanchina L, 2006, DEV BIOL, V295, P232, DOI 10.1016/j.ydbio.2006.03.031; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	32	74	78	1	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 11	2019	380	15					1421	1432		10.1056/NEJMoa1706594	http://dx.doi.org/10.1056/NEJMoa1706594			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HT5NG	30970187	Bronze, Green Accepted			2022-12-28	WOS:000464610000009
J	Oliver, D				Oliver, David			David Oliver: Why aren't more doctors NHS chief executives?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Bohmer RMJ, 2016, NEW ENGL J MED, V375, P709, DOI 10.1056/NEJMp1606458; Goodall A, 2018, HARVARD BUS REV; Ham C., 2014, REFORMING NHS HIERAR; Kmietowicz Z., 2011, BMJ-BRIT MED J, V343, pd4889, DOI [10.1136/bmj.d4889, DOI 10.1136/BMJ.D4889]; Lees P, 2018, FMLM            0907; Lewis R, 2014, HLTH SERV J; Stoller JK, 2016, HARVARD BUS REV	7	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2019	365								l1627	10.1136/bmj.l1627	http://dx.doi.org/10.1136/bmj.l1627			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU0EH	30967376	Bronze			2022-12-28	WOS:000464943700006
J	Rimmer, A				Rimmer, Abi			Tackling bullying and undermining in the NHS	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		College of Medicine Tucson, 2017, CUP COFF CONV PROM P; General Medical Council, 2019, DOCT REC TRAIN SUPP; Hickson GB, 2007, ACAD MED, V82, P1040, DOI 10.1097/ACM.0b013e31815761ee; Lyubovnikova J, 2015, EUR J WORK ORGAN PSY, V24, P929, DOI 10.1080/1359432X.2014.992421; NHS Improvement, 2018, NAT GUARD OFF ANN RE; Royal College of Surgeons of Edinburgh National Freedom to Speak Up Guardian, 2019, ALL BULL YND HAR NHS	6	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2019	365								l1667	10.1136/bmj.l1667	http://dx.doi.org/10.1136/bmj.l1667			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU0EH	30967365				2022-12-28	WOS:000464943700012
J	Thornton, J				Thornton, Jacqui			WHO report shows that women outlive men worldwide	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	6	6	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 5	2019	365								l1631	10.1136/bmj.l1631	http://dx.doi.org/10.1136/bmj.l1631			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HS6UC	30952650				2022-12-28	WOS:000464005800001
J	Wise, J				Wise, Jacqui			Role model: Thomas Abraham	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												arimmer@bmj.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2019	364								l1080	10.1136/bmj.l1080	http://dx.doi.org/10.1136/bmj.l1080			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HR5VS	30957777	Bronze			2022-12-28	WOS:000463215700005
J	Dowell, D; Haegerich, T; Chou, R				Dowell, Deborah; Haegerich, Tamara; Chou, Roger			No Shortcuts to Safer Opioid Prescribing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								The CDC's 2016 Guideline for Prescribing Opioids for Chronic Pain has largely been embraced by the medical and health policy communities. Unfortunately, some policies and practices purportedly derived from the guideline have been inconsistent with its recommendations.	[Dowell, Deborah; Haegerich, Tamara] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Chou, Roger] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Centers for Disease Control & Prevention - USA; Oregon Health & Science University	Dowell, D (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.			Chou, Roger/0000-0001-9889-8610	Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Bohnert ASB, 2018, ANN INTERN MED, V169, P367, DOI 10.7326/M18-1243; Centers for Medicare and Medicaid Services, 2019, CMCS INF B MED STRAT; Dowell D, 2017, ANN INTERN MED, V167, P208, DOI 10.7326/M17-1402; Dowell D, 2016, MMWR RECOMM REP, V65, P1, DOI [10.15585/mmwr.rr7103a1, 10.1001/jama.2016.1464]; Kroenke K, 2019, PAIN MED, V20, P724, DOI 10.1093/pm/pny307	5	217	217	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 13	2019	380	24					2285	2287		10.1056/NEJMp1904190	http://dx.doi.org/10.1056/NEJMp1904190			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IC9JQ	31018066	Bronze, Green Accepted			2022-12-28	WOS:000471299100004
J	Nowotschin, S; Setty, M; Kuo, YY; Liu, V; Garg, V; Sharma, R; Simon, CS; Saiz, N; Gardner, R; Boutet, SC; Church, DM; Hoodless, PA; Hadjantonakis, AK; Pe'er, D				Nowotschin, Sonja; Setty, Manu; Kuo, Ying-Yi; Liu, Vincent; Garg, Vidur; Sharma, Roshan; Simon, Claire S.; Saiz, Nestor; Gardner, Rui; Boutet, Stephane C.; Church, Deanna M.; Hoodless, Pamela A.; Hadjantonakis, Anna-Katerina; Pe'er, Dana			The emergent landscape of the mouse gut endoderm at single-cell resolution	NATURE			English	Article							PRIMITIVE ENDODERM; VISCERAL ENDODERM; XEN CELLS; DIFFERENTIATION; EXPRESSION; REVEALS; EMBRYO; MORPHOGENESIS; ESTABLISHMENT; EPIBLAST	Here we delineate the ontogeny of the mammalian endoderm by generating 112,217 single-cell transcriptomes, which represent all endoderm populations within the mouse embryo until midgestation. We use graph-based approaches to model differentiating cells, which provides a spatio-temporal characterization of developmental trajectories and defines the transcriptional architecture that accompanies the emergence of the first (primitive or extra-embryonic) endodermal population and its sister pluripotent (embryonic) epiblast lineage. We uncover a relationship between descendants of these two lineages, in which epiblast cells differentiate into endoderm at two distinct time points-before and during gastrulation. Trajectories of endoderm cells were mapped as they acquired embryonic versus extra-embryonic fates and as they spatially converged within the nascent gut endoderm, which revealed these cells to be globally similar but retain aspects of their lineage history. We observed the regionalized identity of cells along the anterior-posterior axis of the emergent gut tube, which reflects their embryonic or extra-embryonic origin, and the coordinated patterning of these cells into organ-specific territories.	[Nowotschin, Sonja; Kuo, Ying-Yi; Garg, Vidur; Simon, Claire S.; Saiz, Nestor; Hadjantonakis, Anna-Katerina] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dev Biol Program, 1275 York Ave, New York, NY 10021 USA; [Setty, Manu; Liu, Vincent; Sharma, Roshan; Pe'er, Dana] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Computat & Syst Biol Program, 1275 York Ave, New York, NY 10021 USA; [Gardner, Rui] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Flow Cytometry Core Facil, 1275 York Ave, New York, NY 10021 USA; [Boutet, Stephane C.; Church, Deanna M.] 10x Genom, Pleasanton, CA USA; [Hoodless, Pamela A.] BC Canc, Terry Fox Lab, Vancouver, BC, Canada	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Hadjantonakis, AK (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dev Biol Program, 1275 York Ave, New York, NY 10021 USA.; Pe'er, D (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Computat & Syst Biol Program, 1275 York Ave, New York, NY 10021 USA.	hadj@mskcc.org; peerd@mskcc.org		Simon, Claire/0000-0001-9614-1403; Garg, Vidur/0000-0001-9443-0359; Pe'er, Dana/0000-0002-9259-8817; Saiz, Nestor/0000-0003-0637-791X; Setty, Manu/0000-0002-0344-2627; Hoodless, Pamela/0000-0003-1371-0725; Liu, Vincent/0000-0002-6790-6603	NIH [R01-DK084391, R01-HD094868, DP1-HD084071, R01-CA164729, P30-CA008748]; MSKCC Society for Special Projects and Functional Genomics Initiative; NSERC [RGPIN-2018-05018]; NYSTEM postdoctoral training award from the Center for Stem Cell Biology MSKCC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD094868, DP1HD084071] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA164729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084391] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSKCC Society for Special Projects and Functional Genomics Initiative; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NYSTEM postdoctoral training award from the Center for Stem Cell Biology MSKCC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank K. Anderson, A. Joyner, A. Martinez-Arias and L. Mazutis for discussions; L. Beccari, D. Duboule, L. Sussel, M. Torres, D. Wellik and M. Wilkinson for plasmids; B. Merill for antibodies; and J. Brickman for embryonic stem cells. This work was supported by grants from the NIH (R01-DK084391 and R01-HD094868 to A.-K.H.; DP1-HD084071 and R01-CA164729 to D.P.; P30-CA008748 to C. Thompson), MSKCC Society for Special Projects and Functional Genomics Initiative (to A.-K.H. and D.P.) and NSERC (RGPIN-2018-05018 to P.A.H.). C.S.S. is supported by a NYSTEM postdoctoral training award from the Center for Stem Cell Biology MSKCC.	Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Artus J, 2012, DEV BIOL, V361, P245, DOI 10.1016/j.ydbio.2011.10.015; Artus J, 2011, DEV BIOL, V350, P393, DOI 10.1016/j.ydbio.2010.12.007; Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Becker MB, 2001, MECH DEVELOP, V106, P155, DOI 10.1016/S0925-4773(01)00412-9; Behringer R, 2014, MANIPULATING MOUSE E, V4; Belo JA, 1997, MECH DEVELOP, V68, P45, DOI 10.1016/S0925-4773(97)00125-1; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Chazaud C, 2016, DEVELOPMENT, V143, P1063, DOI 10.1242/dev.128314; Deschamps J, 2005, DEVELOPMENT, V132, P2931, DOI 10.1242/dev.01897; Di Gregorio A, 2016, DEV CELL, V38, P621, DOI 10.1016/j.devcel.2016.08.012; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; Farrell JA, 2018, SCIENCE, V360, P979, DOI 10.1126/science.aar3131; Haghverdi L, 2016, NAT METHODS, V13, P845, DOI 10.1038/nmeth.3971; Hayashi S, 2002, MECH DEVELOP, V119, pS97, DOI 10.1016/S0925-4773(03)00099-6; Hiramatsu R, 2013, DEV CELL, V27, P131, DOI 10.1016/j.devcel.2013.09.026; Hou J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-92; Ibarra-Soria X, 2018, NAT CELL BIOL, V20, P127, DOI 10.1038/s41556-017-0013-z; Kang MJ, 2017, DEV CELL, V41, P496, DOI 10.1016/j.devcel.2017.05.003; Kang MJ, 2013, DEVELOPMENT, V140, P267, DOI 10.1242/dev.084996; Kruithof-de Julio M, 2011, DEVELOPMENT, V138, P3885, DOI 10.1242/dev.065656; Kwon GS, 2008, DEV CELL, V15, P509, DOI 10.1016/j.devcel.2008.07.017; Kwon GS, 2006, DEV DYNAM, V235, P2549, DOI 10.1002/dvdy.20843; Kwon GS, 2009, GENESIS, V47, P447, DOI 10.1002/dvg.20522; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; McCauley HA, 2017, DEVELOPMENT, V144, P958, DOI 10.1242/dev.140731; Meno C, 1999, MOL CELL, V4, P287, DOI 10.1016/S1097-2765(00)80331-7; Molotkov A, 2017, DEV CELL, V41, P511, DOI 10.1016/j.devcel.2017.05.004; Morgani SM, 2018, DEV BIOL, V441, P104, DOI 10.1016/j.ydbio.2018.06.017; Morgani SM, 2013, CELL REP, V3, P1945, DOI 10.1016/j.celrep.2013.04.034; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nowotschin S, 2010, CURR OPIN GENET DEV, V20, P420, DOI 10.1016/j.gde.2010.05.008; Offield MF, 1996, DEVELOPMENT, V122, P983; Ohnishi Y, 2014, NAT CELL BIOL, V16, P27, DOI 10.1038/ncb2881; Paca A, 2012, DEV BIOL, V361, P90, DOI 10.1016/j.ydbio.2011.10.013; Plusa B, 2008, DEVELOPMENT, V135, P3081, DOI 10.1242/dev.021519; Schrode N, 2014, DEV CELL, V29, P454, DOI 10.1016/j.devcel.2014.04.011; Serra M, 2017, DEVELOPMENT, V144, P3879, DOI 10.1242/dev.150193; Setty M., 2018, PREPRINT; Setty M, 2019, NAT BIOTECHNOL, V37, P451, DOI 10.1038/s41587-019-0068-4; Setty M, 2016, NAT BIOTECHNOL, V34, P637, DOI 10.1038/nbt.3569; Sherwood RI, 2009, DEV DYNAM, V238, P29, DOI 10.1002/dvdy.21810; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Takaoka K, 2011, NAT CELL BIOL, V13, P743, DOI 10.1038/ncb2251; Thomas PQ, 1998, DEVELOPMENT, V125, P85; Tremblay KD, 2010, PROG MOL BIOL TRANSL, V96, P1, DOI 10.1016/S1877-1173(10)96001-8; Tsai YH, 2017, DEVELOPMENT, V144, P1045, DOI 10.1242/dev.138453; van Dijk D, 2018, CELL, V174, P716, DOI 10.1016/j.cell.2018.05.061; Viotti M, 2014, NAT CELL BIOL, V16, P1146, DOI 10.1038/ncb3070; Viotti M, 2011, GENESIS, V49, P124, DOI 10.1002/dvg.20695; Yang Y, 2013, MECH DEVELOP, V130, P602, DOI 10.1016/j.mod.2013.08.002; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	57	126	128	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 16	2019	569	7756					361	+		10.1038/s41586-019-1127-1	http://dx.doi.org/10.1038/s41586-019-1127-1			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HY4UP	30959515	Green Accepted			2022-12-28	WOS:000468123700030
J	Zhang, YH; Cheng, TC; Huang, GR; Lu, QY; Surleac, MD; Mandell, JD; Pontarotti, P; Petrescu, AJ; Xu, AL; Xiong, Y; Schatz, DG				Zhang, Yuhang; Cheng, Tat Cheung; Huang, Guangrui; Lu, Qingyi; Surleac, Marius D.; Mandell, Jeffrey D.; Pontarotti, Pierre; Petrescu, Andrei J.; Xu, Anlong; Xiong, Yong; Schatz, David G.			Transposon molecular domestication and the evolution of the RAG recombinase	NATURE			English	Article							V(D)J RECOMBINATION; MECHANISM; ADAPTATION; VALIDATION; PROTEINS; ELEMENTS; DOMAINS; PATHWAY; ENDS	Domestication of a transposon (a DNA sequence that can change its position in a genome) to give rise to the RAG1-RAG2 recombinase (RAG) and V(D)J recombination, which produces the diverse repertoire of antibodies and T cell receptors, was a pivotal event in the evolution of the adaptive immune system of jawed vertebrates. The evolutionary adaptations that transformed the ancestral RAG transposase into a RAG recombinase with appropriately regulated DNA cleavage and transposition activities are not understood. Here, beginning with cryo-electron microscopy structures of the amphioxus ProtoRAG transposase (an evolutionary relative of RAG), we identify amino acid residues and domains the acquisition or loss of which underpins the propensity of RAG for coupled cleavage, its preference for asymmetric DNA substrates and its inability to perform transposition in cells. In particular, we identify two adaptations specific to jawed-vertebrates-arginine 848 in RAG1 and an acidic region in RAG2-that together suppress RAG-mediated transposition more than 1,000-fold. Our findings reveal a two-tiered mechanism for the suppression of RAG-mediated transposition, illuminate the evolution of V(D)J recombination and provide insight into the principles that govern the molecular domestication of transposons.	[Zhang, Yuhang; Mandell, Jeffrey D.; Schatz, David G.] Yale Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; [Cheng, Tat Cheung; Xiong, Yong] Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA; [Huang, Guangrui; Lu, Qingyi; Xu, Anlong] Beijing Univ Chinese Med, Beijing, Peoples R China; [Surleac, Marius D.; Petrescu, Andrei J.] Romanian Acad, Inst Biochem, Dept Bioinformat & Struct Biochem, Bucharest, Romania; [Pontarotti, Pierre] Aix Marseille Univ, IRD, APHM, MEPHI,IHU Mediterranee Infect, Marseille, France; [Pontarotti, Pierre] CNRS, Marseille, France; [Xu, Anlong] Sun Yat Sen Univ, Higher Educ Mega Ctr, Guangdong Prov Key Lab Pharmaceut Funct Genes, State Key Lab Biocontrol,Dept Biochem,Sch Life Sc, Guangzhou, Guangdong, Peoples R China	Yale University; Yale University; Beijing University of Chinese Medicine; Romanian Academy of Sciences; Institute of Biochemistry, Bucharest; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); Sun Yat Sen University	Schatz, DG (corresponding author), Yale Sch Med, Dept Immunobiol, New Haven, CT 06510 USA.; Xiong, Y (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.; Xu, AL (corresponding author), Beijing Univ Chinese Med, Beijing, Peoples R China.; Xu, AL (corresponding author), Sun Yat Sen Univ, Higher Educ Mega Ctr, Guangdong Prov Key Lab Pharmaceut Funct Genes, State Key Lab Biocontrol,Dept Biochem,Sch Life Sc, Guangzhou, Guangdong, Peoples R China.	xuanlong@bucm.edu.cn; yong.xiong@yale.edu; david.schatz@yale.edu	Petrescu, Andrei-Jose J/G-4576-2016; Surleac, Marius/M-2859-2019; , pontarotti/ABB-1753-2021; Surleac, Marius D/C-6182-2017	Petrescu, Andrei-Jose J/0000-0002-4478-3946; Surleac, Marius/0000-0003-3218-4644; Surleac, Marius D/0000-0003-3218-4644; Schatz, David/0000-0002-5669-1176; Xu, Anlong/0000-0002-1419-3494; Mandell, Jeffrey/0000-0002-3839-2543	Ministry of Science and Technology of China [R01 AI32524, R01 AI137079, R01 AI102778, 2013CB917800]; National Natural Science Foundation of China [91231206]; UEFISCDI grant [PN-III-ID-PCE-2016-0650]; Romanian Academy program 1 of IBAR; Romanian Academy program 3 of IBAR; Centre National de la Recherche Scientifique; Aix-Marseille Universite; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI137079, R01AI102778, R01AI032524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); UEFISCDI grant(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); Romanian Academy program 1 of IBAR; Romanian Academy program 3 of IBAR; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille Universite; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Y. Kong for computational analysis of genome transposition data, W. Eliason for assistance with size-exclusion chromatography-multiple angle light scattering, C. Akey for help with freezing of the grids for BbRAGL-intact 3' TIR, R. Huang and H. Chuan for help with cryo-EM data collection, J. Wang for advice and insight in structural analysis, E. Hendrickson for HCT116 cells, XEGEN for NBD phylogenetic sequence analysis, Z. Chou, X. Liu and H. Zhang for an insertion-site mapping script, M. Ciubotaru for advice and members of the Schatz laboratory for comments on the manuscript. This work was supported in part by R01 AI32524 and R01 AI137079 (D.G.S.), R01 AI102778 (Y.X.), 2013CB917800 from the Ministry of Science and Technology of China and 91231206 from the National Natural Science Foundation of China (A.X.), UEFISCDI grant PN-III-ID-PCE-2016-0650 and Romanian Academy programs 1 & 3 of IBAR (M.D.S. and A.J.P.)and grants from the Centre National de la Recherche Scientifique and Aix-Marseille Universite (P.P.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agrawal A, 1998, NATURE, V394, P744, DOI 10.1038/29457; Carmona LM, 2017, FEBS J, V284, P1590, DOI 10.1111/febs.13990; Chatterji M, 2006, MOL CELL BIOL, V26, P1558, DOI 10.1128/MCB.26.4.1558-1568.2006; Chatterji M, 2004, IMMUNOL REV, V200, P261, DOI 10.1111/j.0105-2896.2004.00167.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Corneo B, 2007, NATURE, V449, P483, DOI 10.1038/nature06168; Coster G, 2012, J BIOL CHEM, V287, P36488, DOI 10.1074/jbc.M112.402487; Coussens MA, 2013, CELL REP, V4, P870, DOI 10.1016/j.celrep.2013.07.041; Curry JD, 2007, J EXP MED, V204, P2293, DOI 10.1084/jem.20070583; DiMaio F, 2015, NAT METHODS, V12, P361, DOI [10.1038/nmeth.3286, 10.1038/NMETH.3286]; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fugmann SD, 2010, SEMIN IMMUNOL, V22, P10, DOI 10.1016/j.smim.2009.11.004; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; Henssen AG, 2015, ELIFE, V4, DOI 10.7554/eLife.10565; Hsu E, 2015, MOL BIOL B CELLS, P133; Hu JZ, 2016, NAT PROTOC, V11, P853, DOI 10.1038/nprot.2016.043; Huang SF, 2016, CELL, V166, P102, DOI 10.1016/j.cell.2016.05.032; Jangam D, 2017, TRENDS GENET, V33, P817, DOI 10.1016/j.tig.2017.07.011; Jones JM, 2004, IMMUNOL REV, V200, P233, DOI 10.1111/j.0105-2896.2004.00168.x; Kapitonov VV, 2005, PLOS BIOL, V3, P998, DOI 10.1371/journal.pbio.0030181; Kim MS, 2018, MOL CELL, V70, P358, DOI 10.1016/j.molcel.2018.03.008; Kim MS, 2015, NATURE, V518, P507, DOI 10.1038/nature14174; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Kozuki T, 2017, NUCLEIC ACIDS RES, V45, P5995, DOI 10.1093/nar/gkx325; Kriatchko AN, 2006, MOL CELL BIOL, V26, P4712, DOI 10.1128/MCB.02487-05; Krupovic M, 2017, CURR OPIN MICROBIOL, V38, P36, DOI 10.1016/j.mib.2017.04.004; Lapkouski M, 2015, J BIOL CHEM, V290, P14618, DOI 10.1074/jbc.M115.641787; Lefranc MP, 2001, T CELL RECEPTOR FACT; Levin HL, 2011, NAT REV GENET, V12, P615, DOI 10.1038/nrg3030; LEWIS SM, 1994, ADV IMMUNOL, V56, P27, DOI 10.1016/S0065-2776(08)60450-2; Little AJ, 2015, MOL BIOL B CELLS, P13; Lu C, 2015, CELL REP, V10, P29, DOI 10.1016/j.celrep.2014.12.001; Majumdar S, 2013, SCIENCE, V339, P446, DOI 10.1126/science.1231789; Messier TL, 2003, EMBO J, V22, P1381, DOI 10.1093/emboj/cdg137; Neiditch MB, 2002, MOL CELL, V9, P871, DOI 10.1016/S1097-2765(02)00494-X; Pawlowski M, 2013, NUCLEIC ACIDS RES, V41, pW389, DOI 10.1093/nar/gkt408; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Reddy YVR, 2006, GENE DEV, V20, P1575, DOI 10.1101/gad.1432706; Ru H, 2018, NAT STRUCT MOL BIOL, V25, P732, DOI 10.1038/s41594-018-0098-5; Ru H, 2015, CELL, V163, P1138, DOI 10.1016/j.cell.2015.10.055; SAKANO H, 1979, NATURE, V280, P288, DOI 10.1038/280288a0; Schatz DG, 2011, ANNU REV GENET, V45, P167, DOI 10.1146/annurev-genet-110410-132552; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Sinzelle L, 2009, CELL MOL LIFE SCI, V66, P1073, DOI 10.1007/s00018-009-8376-3; Slootweg EJ, 2013, PLANT PHYSIOL, V162, P1510, DOI 10.1104/pp.113.218842; THOMPSON CB, 1995, IMMUNITY, V3, P531, DOI 10.1016/1074-7613(95)90124-8; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Ward A, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00159-18; Yin FF, 2009, NAT STRUCT MOL BIOL, V16, P499, DOI 10.1038/nsmb.1593; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang YH, 2015, J BIOL CHEM, V290, P11802, DOI 10.1074/jbc.M115.638627; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; 1998, CELL, V94, P463; 2017, IMMUNOGENETICS, V69, P391, DOI DOI 10.1007/S00251-017-0979-5; 2006, METHOD ENZYMOL, V408, P511, DOI DOI 10.1016/S0076-6879(06)08032-3	58	67	67	6	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 2	2019	569	7754					79	+		10.1038/s41586-019-1093-7	http://dx.doi.org/10.1038/s41586-019-1093-7			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HW2NX	30971819	Green Accepted			2022-12-28	WOS:000466523700036
J	Sanderson, A				Sanderson, Atharine			AUTOMATION: CHEMISTRY SHOOTS FOR THE MOON	NATURE			English	Editorial Material																			0	22	22	2	10	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 25	2019	568	7753					577	579						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HU9DR	31015690	Bronze			2022-12-28	WOS:000465594200057
J	Iacobucci, G				Iacobucci, Gareth			Drive to curb prescribing of over-the-counter drugs saves less money than planned	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2018, NHS ENGLAND FREES MI; NHS England, 2018, COND WHICH COUNT IT	2	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 18	2019	365								l1837	10.1136/bmj.l1837	http://dx.doi.org/10.1136/bmj.l1837			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU8PD	31000532				2022-12-28	WOS:000465550700010
J	Rogers, KK				Rogers, Kaitlyn K.			Diabetes and Disclosure	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A medical student with type 1 diabetes has to develop workarounds for her surgical rotation, choose her specialty carefully horizontal ellipsis and decide whether, when, and how to disclose her condition to her educators and to patients.	[Rogers, Kaitlyn K.] Univ N Carolina, Sch Med, Asheville, NC 28804 USA	University of North Carolina; University of North Carolina - Asheville; University of North Carolina School of Medicine	Rogers, KK (corresponding author), Univ N Carolina, Sch Med, Asheville, NC 28804 USA.								0	4	4	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 18	2019	380	16					1495	1497		10.1056/NEJMp1814423	http://dx.doi.org/10.1056/NEJMp1814423			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU3AO	30995371				2022-12-28	WOS:000465144100010
J	Shaw, WM; Yamauchi, H; Mead, J; Gowers, GOF; Bell, DJ; Oling, D; Larsson, N; Wigglesworth, M; Ladds, G; Ellis, T				Shaw, William M.; Yamauchi, Hitoshi; Mead, Jack; Gowers, Glen-Oliver F.; Bell, David J.; Oling, David; Larsson, Niklas; Wigglesworth, Mark; Ladds, Graham; Ellis, Tom			Engineering a Model Cell for Rational Tuning of GPCR Signaling	CELL			English	Article							PROTEIN-COUPLED-RECEPTOR; PHEROMONE RESPONSE PATHWAY; BETA-GAMMA COMPLEX; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL EXPRESSION; GENE-EXPRESSION; KINASE CASCADE; MATING PATHWAY; ALPHA-SUBUNIT; YEAST	G protein-coupled receptor (GPCR) signaling is the primary method eukaryotes use to respond to specific cues in their environment. However, the relationship between stimulus and response for each GPCR is difficult to predict due to diversity in natural signal transduction architecture and expression. Using genome engineering in yeast, we constructed an insulated, modular GPCR signs transduction system to study how the response to stimuli can be predictably tuned using synthetic tools. We delineated the contributions of a minimal set of key components via computational and experimental refactoring, identifying simple design principles for rationally tuning the dose response. Using five different GPCRs, we demonstrate how this enables cells and consortia to be engineered to respond to desired concentrations of peptides, metabolites, and hormones relevant to human health. This work enables rational tuning of cell sensing while providing a framework to guide reprogramming of GPCR-based signaling in other systems.	[Shaw, William M.; Gowers, Glen-Oliver F.; Ellis, Tom] Imperial Coll London, Dept Bioengn, London SW7 2AZ, England; [Shaw, William M.; Gowers, Glen-Oliver F.; Bell, David J.; Ellis, Tom] Imperial Coll London, Ctr Synthet Biol, London SW7 2AZ, England; [Yamauchi, Hitoshi; Mead, Jack; Ladds, Graham] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Bell, David J.] Imperial Coll London, SynbiCITE Innovat & Knowledge Ctr, London SW7 2AZ, England; [Oling, David; Larsson, Niklas] AstraZeneca R&D, Discovery Biol Discovery Sci Innovat Med & Early, S-43150 Molndal, Sweden; [Wigglesworth, Mark] AstraZeneca, IMED Biotech Unit, Discovery Sci, Hit Discovery, Macclesfield SK10 4TG, Cheshire, England	Imperial College London; Imperial College London; University of Cambridge; Imperial College London; AstraZeneca; AstraZeneca	Ellis, T (corresponding author), Imperial Coll London, Dept Bioengn, London SW7 2AZ, England.; Ellis, T (corresponding author), Imperial Coll London, Ctr Synthet Biol, London SW7 2AZ, England.; Ladds, G (corresponding author), Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England.; Wigglesworth, M (corresponding author), AstraZeneca, IMED Biotech Unit, Discovery Sci, Hit Discovery, Macclesfield SK10 4TG, Cheshire, England.	mark.wigglesworth@astrazeneca.com; grl30@cam.ac.uk; t.ellis@imperial.ac.uk		Ellis, Thomas/0000-0001-5392-976X; Ladds, Graham/0000-0001-7320-9612; Gowers, Glen/0000-0002-8827-4465; Shaw, William/0000-0002-1289-1993	UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/M503381/1]; AstraZeneca [BB/M00015X/2]; BBSRC [BB/M00015X/2] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); AstraZeneca(AstraZeneca); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors wish to thank Simo Baallal Jacobsen, Susanne Germann, and Jochen Forster for providing the melatonin producer strains. We also wish to thank Nili Ostrov and Miguel Jimenez for providing data for the P. brasiliensis fungal sensor. Thanks to Benjamin Blount and Charlie Gilbert for advice and input during this project, Robert Chen for establishing the YTK system in our lab, and John Dueber for early access to the YTK plasmids. We acknowledge the UK Biotechnology and Biological Sciences Research Council (BBSRC) for funding of this work as a CASE PhD award BB/M503381/1 in collaboration with AstraZeneca and grant BB/M00015X/2.	Adeniran A, 2018, ACS SYNTH BIOL, V7, P696, DOI 10.1021/acssynbio.7b00410; Adeniran A, 2015, FEMS YEAST RES, V15, DOI 10.1111/1567-1364.12203; Aldridge BB, 2006, NAT CELL BIOL, V8, P1195, DOI 10.1038/ncb1497; Alvaro CG, 2016, J BIOL CHEM, V291, P7788, DOI 10.1074/jbc.R116.714980; Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Atay O, 2017, J CELL BIOL, V216, P317, DOI 10.1083/jcb.201609124; Bakker RA, 2001, MOL PHARMACOL, V60, P1133, DOI 10.1124/mol.60.5.1133; Baranski TJ, 1999, J BIOL CHEM, V274, P15757, DOI 10.1074/jbc.274.22.15757; Bardwell L, 2004, PEPTIDES, V25, P1465, DOI 10.1016/j.peptides.2003.10.022; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Beukers MW, 2004, MOL PHARMACOL, V65, P702, DOI 10.1124/mol.65.3.702; Billerbeck S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07610-2; Blount BA, 2012, FEBS LETT, V586, P2112, DOI 10.1016/j.febslet.2012.01.053; Brewster RC, 2014, CELL, V156, P1312, DOI 10.1016/j.cell.2014.02.022; Bridge LJ, 2018, J THEOR BIOL, V442, P44, DOI 10.1016/j.jtbi.2018.01.010; Bridge LJ, 2010, MATH BIOSCI, V223, P115, DOI 10.1016/j.mbs.2009.11.005; Brophy JAN, 2014, NAT METHODS, V11, P508, DOI [10.1038/NMETH.2926, 10.1038/nmeth.2926]; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Brown AJ, 2000, YEAST, V16, P11, DOI 10.1002/(SICI)1097-0061(20000115)16:1<11::AID-YEA502>3.0.CO;2-K; Brown AJ, 2011, J PHARMACOL EXP THER, V337, P236, DOI 10.1124/jpet.110.172650; Buchler NE, 2008, J MOL BIOL, V384, P1106, DOI 10.1016/j.jmb.2008.09.079; Burstein ES, 1997, MOL PHARMACOL, V51, P312, DOI 10.1124/mol.51.2.312; Bush A, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20166910; Chambers JK, 2000, J BIOL CHEM, V275, P10767, DOI 10.1074/jbc.275.15.10767; Chan LY, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100025; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; Croft W, 2013, J BIOL CHEM, V288, P27327, DOI 10.1074/jbc.M113.497826; DENOBEL JG, 1991, YEAST, V7, P313, DOI 10.1002/yea.320070402; DOLAN JW, 1990, GENE DEV, V4, P492, DOI 10.1101/gad.4.4.492; Dong SY, 2010, NAT PROTOC, V5, P561, DOI 10.1038/nprot.2009.239; Dueber JE, 2007, NAT BIOTECHNOL, V25, P660, DOI 10.1038/nbt1308; Ehrenworth AM, 2017, BIOCHEMISTRY-US, V56, P5471, DOI 10.1021/acs.biochem.7b00605; Erickson JP, 1998, J BIOL CHEM, V273, P1506, DOI 10.1074/jbc.273.3.1506; Erlenbach I, 2001, J BIOL CHEM, V276, P29382, DOI 10.1074/jbc.M103203200; Erlenbach I, 2001, J NEUROCHEM, V77, P1327, DOI 10.1046/j.1471-4159.2001.00344.x; Evans BJ, 2009, METHOD ENZYMOL, V460, P399, DOI 10.1016/S0076-6879(09)05220-3; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Ferrell JE, 1996, TRENDS BIOCHEM SCI, V21, P460, DOI 10.1016/S0968-0004(96)20026-X; Fowler TJ, 1999, MOL BIOL CELL, V10, P2559, DOI 10.1091/mbc.10.8.2559; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Fukutani Y, 2015, ANAL BIOCHEM, V471, P1, DOI 10.1016/j.ab.2014.10.012; Gaibelet G, 1999, EUR J BIOCHEM, V261, P517, DOI 10.1046/j.1432-1327.1999.00301.x; Galloway KE, 2013, SCIENCE, V341, P1358, DOI 10.1126/science.1235005; Germann SM, 2016, BIOTECHNOL J, V11, P717, DOI 10.1002/biot.201500143; Gietz RD, 2007, NAT PROTOC, V2, P5, DOI 10.1038/nprot.2007.16; Gika HG, 2014, J CHROMATOGR B, V966, P1, DOI 10.1016/j.jchromb.2014.01.054; Gross A, 2011, LETT APPL MICROBIOL, V52, P521, DOI 10.1111/j.1472-765X.2011.03035.x; HAGEN DC, 1991, MOL CELL BIOL, V11, P2952, DOI 10.1128/MCB.11.6.2952; Harrigan P, 2018, CELL, V175, P877, DOI 10.1016/j.cell.2018.09.044; Hauser AS, 2018, CELL, V172, P41, DOI 10.1016/j.cell.2017.11.033; Heng BC, 2014, ANNU REV PHARMACOL, V54, P227, DOI 10.1146/annurev-pharmtox-011613-135921; Hirschman JE, 1997, J BIOL CHEM, V272, P240; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Houser JR, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.18; Huang XP, 2015, NATURE, V527, P477, DOI 10.1038/nature15699; Ingolia NT, 2007, CURR BIOL, V17, P668, DOI 10.1016/j.cub.2007.03.016; Jarque S, 2016, CHEMOSPHERE, V148, P204, DOI 10.1016/j.chemosphere.2016.01.038; Kajkowski EM, 1997, J RECEPT SIGNAL TR R, V17, P293, DOI 10.3109/10799899709036610; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Kenakin T, 2013, BRIT J PHARMACOL, V168, P554, DOI 10.1111/j.1476-5381.2012.02223.x; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; KING K, 1990, SCIENCE, V250, P121, DOI 10.1126/science.2171146; Klein C, 1998, NAT BIOTECHNOL, V16, P1334, DOI 10.1038/4310; Kofahl B, 2004, YEAST, V21, P831, DOI 10.1002/yea.1122; Kokkola T, 1998, BIOCHEM BIOPH RES CO, V249, P531, DOI 10.1006/bbrc.1998.9182; Ladds G, 2005, TRENDS BIOTECHNOL, V23, P367, DOI 10.1016/j.tibtech.2005.05.007; Ladds G, 2005, MOL MICROBIOL, V55, P482, DOI 10.1111/j.1365-2958.2004.04394.x; Larsen MJ, 2013, INT J PARASITOL-DRUG, V3, P1, DOI 10.1016/j.ijpddr.2012.10.002; Lee ME, 2015, ACS SYNTH BIOL, V4, P975, DOI 10.1021/sb500366v; Leplatois P, 2001, EUR J BIOCHEM, V268, P4860, DOI 10.1046/j.0014-2956.2001.02407.x; Liu RF, 2016, EUR J PHARMACOL, V770, P70, DOI 10.1016/j.ejphar.2015.11.052; Liu ZQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02460-2; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; McIsaac RS, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1402; Miret JJ, 2002, J BIOL CHEM, V277, P6881, DOI 10.1074/jbc.M107384200; Motulsky H, 2003, PRACTICAL GUIDE CURV; Mukherjee K, 2015, ACS SYNTH BIOL, V4, P1261, DOI 10.1021/sb500365m; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Olesnicky NS, 1999, EMBO J, V18, P2756, DOI 10.1093/emboj/18.10.2756; Ostrov N, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1603221; Overton HA, 2006, CELL METAB, V3, P167, DOI 10.1016/j.cmet.2006.02.004; Paliwal S, 2007, NATURE, V446, P46, DOI 10.1038/nature05561; Pi HW, 1997, MOL CELL BIOL, V17, P6410, DOI 10.1128/MCB.17.11.6410; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Portiz MA, 2001, YEAST, V18, P1331, DOI 10.1002/yea.777; Prezeau L, 2010, CURR OPIN PHARMACOL, V10, P6, DOI 10.1016/j.coph.2009.10.009; PRICE LA, 1995, MOL CELL BIOL, V15, P6188; Prokic EJ, 2015, NEUROPHARMACOLOGY, V95, P192, DOI 10.1016/j.neuropharm.2015.03.006; Pryciak PM, 1998, GENE DEV, V12, P2684, DOI 10.1101/gad.12.17.2684; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Routledge SJ, 2016, METHODS, V95, P26, DOI 10.1016/j.ymeth.2015.09.027; SANDER P, 1994, FEBS LETT, V344, P41, DOI 10.1016/0014-5793(94)00335-1; Santos R, 2017, NAT REV DRUG DISCOV, V16, P19, DOI 10.1038/nrd.2016.230; Sarramegna V, 2003, CELL MOL LIFE SCI, V60, P1529, DOI 10.1007/s00018-003-3168-7; Scott BM, 2019, GENETICS, V211, P597, DOI 10.1534/genetics.118.301733; Segota I, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.248101; Selbie LA, 1998, TRENDS PHARMACOL SCI, V19, P87, DOI 10.1016/S0165-6147(97)01166-8; Shao DY, 2006, BIOPHYS J, V91, P3986, DOI 10.1529/biophysj.106.081661; Smith B, 2009, CELL SIGNAL, V21, P1151, DOI 10.1016/j.cellsig.2009.03.004; Song JP, 1996, J BIOL CHEM, V271, P20273, DOI 10.1074/jbc.271.34.20273; SPRAGUE GF, 1981, J MOL BIOL, V153, P305, DOI 10.1016/0022-2836(81)90280-1; Su TC, 2010, FEBS J, V277, P3235, DOI 10.1111/j.1742-4658.2010.07728.x; Temme K, 2012, P NATL ACAD SCI USA, V109, P7085, DOI 10.1073/pnas.1120788109; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Urrios A, 2016, ACS SYNTH BIOL, V5, P862, DOI 10.1021/acssynbio.5b00252; Vallee-Belisle A, 2012, J AM CHEM SOC, V134, P2876, DOI 10.1021/ja209850j; Versele M, 2001, EMBO REP, V2, P574, DOI 10.1093/embo-reports/kve132; Ward LD, 2012, NAT BIOTECHNOL, V30, P1095, DOI 10.1038/nbt.2422; Weston C, 2014, BRIT J PHARMACOL, V171, P3651, DOI 10.1111/bph.12716; Weston C, 2015, J BIOL CHEM, V290, P23009, DOI 10.1074/jbc.M114.624601; WHITEWAY M, 1989, CELL, V56, P467, DOI 10.1016/0092-8674(89)90249-3; Yi TM, 2003, P NATL ACAD SCI USA, V100, P10764, DOI 10.1073/pnas.1834247100; Yu RC, 2008, IET SYST BIOL, V2, P222, DOI 10.1049/iet-syb:20080127; Zhang Q, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130031	115	61	62	4	74	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2019	177	3					782	+		10.1016/j.cell.2019.02.023	http://dx.doi.org/10.1016/j.cell.2019.02.023			42	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HU0FV	30955892	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000464947700028
J	Tian, X; Firsanov, D; Zhang, ZH; Cheng, Y; Luo, LF; Tombline, G; Tan, RY; Simon, M; Henderson, S; Steffan, J; Goldfarb, A; Tam, J; Zheng, K; Cornwell, A; Johnson, A; Yang, JN; Mao, ZY; Manta, B; Dang, WW; Zhang, ZD; Vijg, J; Wolfe, A; Moody, K; Kennedy, BK; Bohmann, D; Gladyshev, VN; Seluanov, A; Gorbunova, V				Tian, Xiao; Firsanov, Denis; Zhang, Zhihui; Cheng, Yang; Luo, Lingfeng; Tombline, Gregory; Tan, Ruiyue; Simon, Matthew; Henderson, Steven; Steffan, Janine; Goldfarb, Audrey; Tam, Jonathan; Zheng, Kitty; Cornwell, Adam; Johnson, Adam; Yang, Jiang-Nan; Mao, Zhiyong; Manta, Bruno; Dang, Weiwei; Zhang, Zhengdong; Vijg, Jan; Wolfe, Aaron; Moody, Kelsey; Kennedy, Brian K.; Bohmann, Dirk; Gladyshev, Vadim N.; Seluanov, Andrei; Gorbunova, Vera			SIRT6 Is Responsible for More Efficient DNA Double-Strand Break Repair in Long-Lived Species	CELL			English	Article							LIFE-SPAN; SEASONAL ACTIVITY; CHINCHILLA-LANIGERA; GENOMIC INSTABILITY; EXCISION-REPAIR; CELLS; MOUSE; CHROMATIN; BIOLOGY; DEACETYLASE	DNA repair has been hypothesized to be a longevity determinant, but the evidence for it is based largely on accelerated aging phenotypes of DNA repair mutants. Here, using a panel of 18 rodent species with diverse lifespans, we show that more robust DNA double-strand break (DSB) repair, but not nucleotide excision repair (NER), coevolves with longevity. Evolution of NER, unlike DSB, is shaped primarily by sunlight exposure. We further show that the capacity of the SIRT6 protein to promote DSB repair accounts for a major part of the variation in DSB repair efficacy between short-and long-lived species. We dissected the molecular differences between a weak (mouse) and a strong (beaver) SIRT6 protein and identified five amino acid residues that are fully responsible for their differential activities. Our findings demonstrate that DSB repair and SIRT6 have been optimized during the evolution of longevity, which provides new targets for anti-aging interventions.	[Tian, Xiao; Firsanov, Denis; Zhang, Zhihui; Luo, Lingfeng; Tombline, Gregory; Tan, Ruiyue; Simon, Matthew; Henderson, Steven; Steffan, Janine; Goldfarb, Audrey; Tam, Jonathan; Zheng, Kitty; Cornwell, Adam; Johnson, Adam; Seluanov, Andrei; Gorbunova, Vera] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Cheng, Yang; Bohmann, Dirk] Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA; [Yang, Jiang-Nan] Fritz Lipmann Inst, Leibniz Inst Aging, Beutenbergstr 11, D-07745 Jena, Germany; [Mao, Zhiyong] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Manta, Bruno; Gladyshev, Vadim N.] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Dang, Weiwei] Baylor Coll Med, Huffington Ctr Aging, Dept Mol & Human Genet, Houston, TX 77030 USA; [Zhang, Zhengdong; Vijg, Jan] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Wolfe, Aaron; Moody, Kelsey] Ichor Therapeut, 2521 US-11, La Fayette, NY 13084 USA; [Kennedy, Brian K.] Natl Univ Singapore, Dept Biochem, Singapore, Singapore; [Kennedy, Brian K.] Natl Univ Singapore, Dept Physiol, Singapore, Singapore; [Kennedy, Brian K.] Natl Univ Hlth Syst, Ctr Hlth Aging, Singapore, Singapore	University of Rochester; University of Rochester; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Tongji University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Baylor College of Medicine; Yeshiva University; Albert Einstein College of Medicine; National University of Singapore; National University of Singapore; National University of Singapore	Seluanov, A; Gorbunova, V (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	andrei.seluanov@rochester.edu; vera.gorbunova@rochester.edu	Firsanov, Denis/AAM-9270-2021; zhang, zheng/HCH-9684-2022; Tian, Xiao/E-3998-2017; zhang, zh/GWV-4677-2022	Tian, Xiao/0000-0001-5300-3596; Gladyshev, Vadim/0000-0002-0372-7016; Dang, Weiwei/0000-0002-6931-4636; Cornwell, Adam/0000-0002-0572-3107; , Yang/0000-0001-7667-4704; Wolfe, Aaron/0000-0001-5287-8710; Gorbunova, Vera/0000-0001-8979-0333; Seluanov, Andrei/0000-0003-3400-538X; Mao, Zhiyong/0000-0002-5298-1918	US National Institutes of Health; Life Extension Foundation; NATIONAL INSTITUTE ON AGING [R01AG046320, R01AG027237, R56AG055316, P01AG051449, P01AG047200] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Life Extension Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Dr. Daven Presgraves for suggestions on statistical analysis and Nicholas Macoretta for critically reading the manuscript. This work was supported by the US National Institutes of Health grants to V.G., A.S., V.N.G., Z.Z., and J.V.; and Life Extension Foundation to V.G. and A.S.	Batista LFZ, 2009, MUTAT RES-REV MUTAT, V681, P197, DOI 10.1016/j.mrrev.2008.09.001; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bodgi L, 2016, J THEOR BIOL, V394, P93, DOI 10.1016/j.jtbi.2016.01.018; BOVET J, 1974, J COMP PHYSIOL, V92, P1, DOI 10.1007/BF00696522; BOVET J, 1984, BEHAV ECOL SOCIOBIOL, V16, P81, DOI 10.1007/BF00293107; Busch C, 2000, LIFE UNDERGROUND, P183; CLARKE JA, 1983, BEHAV ECOL SOCIOBIOL, V13, P205, DOI 10.1007/BF00299924; de Magalhaes JP, 2013, EMBO REP, V14, P661, DOI 10.1038/embor.2013.96; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dolle MET, 2000, P NATL ACAD SCI USA, V97, P8403, DOI 10.1073/pnas.97.15.8403; Fabre PH, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-88; Faghri S, 2008, J MED GENET, V45, P609, DOI 10.1136/jmg.2008.058743; Feldman JL, 2013, J BIOL CHEM, V288, P31350, DOI 10.1074/jbc.C113.511261; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; FRANCIS AA, 1981, MECH AGEING DEV, V16, P181, DOI 10.1016/0047-6374(81)90094-4; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; GARLAND T, 1993, SYST BIOL, V42, P265, DOI 10.2307/2992464; Garm C, 2013, AGING CELL, V12, P58, DOI 10.1111/acel.12019; Gattermann R, 2008, BIOL LETTERS, V4, P253, DOI 10.1098/rsbl.2008.0066; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gil R, 2013, NUCLEIC ACIDS RES, V41, P8537, DOI 10.1093/nar/gkt642; Pereyra MLG, 2008, J VET DIAGN INVEST, V20, P853, DOI 10.1177/104063870802000629; Gorbunova V, 2016, MUTAT RES-FUND MOL M, V788, P2, DOI 10.1016/j.mrfmmm.2016.02.004; Gorbunova V, 2014, NAT REV GENET, V15, P531, DOI 10.1038/nrg3728; GRIZZELL ROY A., 1955, AMER MIDLAND NAT, V53, P257, DOI 10.2307/2422068; GRUBE K, 1992, P NATL ACAD SCI USA, V89, P11759, DOI 10.1073/pnas.89.24.11759; Han SK, 2016, ONCOTARGET, V7, P56147, DOI 10.18632/oncotarget.11269; Harper JM, 2007, AGING CELL, V6, P1, DOI 10.1111/j.1474-9726.2006.00255.x; HART RW, 1974, P NATL ACAD SCI USA, V71, P2169, DOI 10.1073/pnas.71.6.2169; Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161; HAYES SR, 1976, J MAMMAL, V57, P291, DOI 10.2307/1379689; HICKS ELLIS A., 1949, ECOL MONOGR, V19, P287, DOI 10.2307/1943272; Jimenez JE, 1996, BIOL CONSERV, V77, P1, DOI 10.1016/0006-3207(95)00116-6; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Kapahi P, 1999, FREE RADICAL BIO MED, V26, P495, DOI 10.1016/S0891-5849(98)00323-2; Karikkineth AC, 2017, AGEING RES REV, V33, P3, DOI 10.1016/j.arr.2016.08.002; KATO H, 1980, JPN J GENET, V55, P99, DOI 10.1266/jjg.55.99; Kugel S, 2015, CELL REP, V13, P479, DOI 10.1016/j.celrep.2015.09.022; Kugel S, 2014, TRENDS BIOCHEM SCI, V39, P72, DOI 10.1016/j.tibs.2013.12.002; Lapytsko A, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0816-5; Latham N, 2004, APPL ANIM BEHAV SCI, V86, P261, DOI 10.1016/j.applanim.2004.02.006; Link A., 2012, MASTOZOOL NEOTROP, V19; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; LORD RD, 1991, STUD NEOTROP FAUNA E, V26, P113, DOI 10.1080/01650529109360840; Lorenzini A, 2009, MECH AGEING DEV, V130, P784, DOI 10.1016/j.mad.2009.10.004; Ma SM, 2016, ELIFE, V5, DOI 10.7554/eLife.19130; MACDONALD DW, 1981, J ZOOL, V194, P371, DOI 10.1111/j.1469-7998.1981.tb04588.x; MacRae SL, 2015, AGING-US, V7, P1171, DOI 10.18632/aging.100866; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Meagher S, 2000, P NATL ACAD SCI USA, V97, P3324, DOI 10.1073/pnas.060284797; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; MORRIS JG, 1981, AM MIDL NAT, V105, P368, DOI 10.2307/2424755; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Oshima J, 2017, AGEING RES REV, V33, P105, DOI 10.1016/j.arr.2016.03.002; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Pan PW, 2011, J BIOL CHEM, V286, P14575, DOI 10.1074/jbc.M111.218990; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PROMISLOW DEL, 1994, J THEOR BIOL, V170, P291, DOI 10.1006/jtbi.1994.1190; RADO R, 1993, CAN J ZOOL, V71, P1733, DOI 10.1139/z93-245; RANDALL JA, 1980, BEHAV ECOL SOCIOBIOL, V7, P267, DOI 10.1007/BF00300666; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Riccio AP, 2000, PHYSIOL BEHAV, V71, P1, DOI 10.1016/S0031-9384(00)00281-X; Rood J., 1972, ANIMAL BEHAV MONOGRA; Schuster S, 2016, SCI REP-UK, V6, DOI 10.1038/srep22643; Seluanov A., 2010, JOVE-J VIS EXP, V43, DOI [DOI 10.3791/2002, 10.3791/2002]; Seluanov A, 2007, AGING CELL, V6, P45, DOI 10.1111/j.1474-9726.2006.00262.x; Seluanov Andrei, 2010, J Vis Exp, DOI 10.3791/2033; Seluanov A, 2008, AGING CELL, V7, P813, DOI 10.1111/j.1474-9726.2008.00431.x; Sen P, 2016, CELL, V166, P822, DOI 10.1016/j.cell.2016.07.050; Shiloh Y, 2017, AGEING RES REV, V33, P76, DOI 10.1016/j.arr.2016.05.002; SNYDER D P, 1982, Mammalian Species, P1, DOI 10.2307/3503819; Steele Michael A., 1998, Mammalian Species, V586, P1; Stuart GR, 2000, GENETICS, V155, P1359; Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002; Tacutu R, 2013, NUCLEIC ACIDS RES, V41, pD1027, DOI 10.1093/nar/gks1155; TAYLOR KD, 1978, J APPL ECOL, V15, P663, DOI 10.2307/2402767; THOMPSON DC, 1977, CAN J ZOOL, V55, P1185, DOI 10.1139/z77-153; Tian X, 2018, PHILOS T R SOC B, V373, DOI [10.1098/rstb.2016.0443, 10.1098/rstb.2018.0319]; Toiber D, 2013, MOL CELL, V51, P454, DOI 10.1016/j.molcel.2013.06.018; Vaidya A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004511; Vermeij WP, 2016, ANNU REV PHARMACOL, V56, P427, DOI 10.1146/annurev-pharmtox-010814-124316; White RR, 2016, MOL CELL, V63, P729, DOI 10.1016/j.molcel.2016.08.004; Woods C. A., 1973, SPECIES, V29, P1; Zhang GJ, 2013, SCIENCE, V339, P456, DOI 10.1126/science.1230835	89	121	125	6	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2019	177	3					622	+		10.1016/j.cell.2019.03.043	http://dx.doi.org/10.1016/j.cell.2019.03.043			39	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HU0FV	31002797	Green Accepted, Bronze			2022-12-28	WOS:000464947700017
J	Youngner, S; Hyun, I				Youngner, Stuart; Hyun, Insoo			Pig brain study could fuel debates around death	NATURE			English	Editorial Material							CIRCULATORY DETERMINATION; UNCONTROLLED DONATION; CARDIAC-ARREST; RESUSCITATION; SUPPORT		[Youngner, Stuart] Case Western Reserve Univ, Sch Med, Bioeth & Psychiat, Cleveland, OH 44106 USA; [Hyun, Insoo] Case Western Reserve Univ, Sch Med, Bioeth & Philosophy, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Youngner, S (corresponding author), Case Western Reserve Univ, Sch Med, Bioeth & Psychiat, Cleveland, OH 44106 USA.	stuart.youngner@case.edu; insoo.hyun@case.edu						Ave ALD, 2016, RESUSCITATION, V108, P87, DOI 10.1016/j.resuscitation.2016.07.003; Bernat JL, 2014, ANN EMERG MED, V63, P384, DOI 10.1016/j.annemergmed.2013.05.018; Bernat JL, 2013, HASTINGS CENT REP, V43, P30, DOI 10.1002/hast.129; Childress JF., 2006, ORGAN DONATION OPPOR; Goldberger ZD, 2012, LANCET, V380, P1473, DOI 10.1016/S0140-6736(12)60862-9; Helft PR, 2000, NEW ENGL J MED, V343, P293, DOI 10.1056/NEJM200007273430411; Ko WJ, 2000, CLIN TRANSPLANT, V14, P152, DOI 10.1034/j.1399-0012.2000.140209.x; Magliocca JF, 2005, J TRAUMA, V58, P1095, DOI 10.1097/01.TA.0000169949.82778.DF; Munjal KG, 2013, HASTINGS CENT REP, V43, P19, DOI 10.1002/hast.113; Ortega-Deballon I, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0985-7; Torke AM, 2015, ANN AM THORAC SOC, V12, P440, DOI 10.1513/AnnalsATS.201412-552PS; Vrselja Z, 2019, NATURE, V568, P336, DOI 10.1038/s41586-019-1099-1	12	14	14	0	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 18	2019	568	7752					302	+		10.1038/d41586-019-01169-8	http://dx.doi.org/10.1038/d41586-019-01169-8			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HU0GZ	30996309	Bronze			2022-12-28	WOS:000464950700023
J	Eaton, L				Eaton, Lynn			UK universities show the way in reporting clinical trial results	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Bruckner T, 2019, WHY BRIT U ARE NOW R; HAWKES N, 2018, BMJ-BRIT MED J, V363, DOI DOI 10.1136/BMJ.K4582	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2019	365								l1834	10.1136/bmj.l1834	http://dx.doi.org/10.1136/bmj.l1834			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU8OY	30995976				2022-12-28	WOS:000465550000012
J	Dyer, C				Dyer, Clare			Forensic examiner who failed to examine two alleged rape victims has suspension extended by12 months	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2019	365								l1804	10.1136/bmj.l1804	http://dx.doi.org/10.1136/bmj.l1804			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU8OP	30992288				2022-12-28	WOS:000465549000009
J	Ensrud, KE; Crandall, CJ				Ensrud, Kristine E.; Crandall, Carolyn J.			In older postmenopausal women with osteopenia, zoledronate reduced fragility fractures at 6 years	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							LOW BONE-DENSITY; OSTEOPOROSIS; RISK		[Ensrud, Kristine E.] Univ Minnesota, Minneapolis, MN 55455 USA; [Ensrud, Kristine E.] Minneapolis Vet Affairs Hlth Care Syst, Minneapolis, MN 55417 USA; [Crandall, Carolyn J.] Univ Calif Los Angeles, Los Angeles, CA USA	University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of California System; University of California Los Angeles	Ensrud, KE (corresponding author), Univ Minnesota, Minneapolis, MN 55455 USA.; Ensrud, KE (corresponding author), Minneapolis Vet Affairs Hlth Care Syst, Minneapolis, MN 55417 USA.			Ensrud, Kristine/0000-0002-9069-3036				BLACK DM, 2007, NEW ENGL J MED, V356, P1809, DOI [DOI 10.1056/NEJMOA067312, 10.1056/NEJMoa067312]; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; Gedmintas L, 2013, J BONE MINER RES, V28, P1729, DOI 10.1002/jbmr.1893; Qaseem A, 2017, ANN INTERN MED, V166, P818, DOI 10.7326/M15-1361; Solomon DH, 2014, J BONE MINER RES, V29, P1929, DOI 10.1002/jbmr.2202; 2018, J BONE MINER RES S1, V33, P2	6	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2019	170	8					JC42	JC42		10.7326/ACPJ201904160-042	http://dx.doi.org/10.7326/ACPJ201904160-042			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU7YQ	30986832				2022-12-28	WOS:000465499900008
J	Pereiro, AC				Cristina Pereiro, Ana			Guidelines for the diagnosis and treatment of Chagas disease	LANCET			English	Editorial Material									[Cristina Pereiro, Ana] Fdn Mundo Sano, C1061ABC, Buenos Aires, DF, Argentina		Pereiro, AC (corresponding author), Fdn Mundo Sano, C1061ABC, Buenos Aires, DF, Argentina.	apereiro@mundosano.org						Castillo-Riquelme M, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000336; Pereiro AC, 2018, REV PANAM SALUD PUBL, V42, DOI [10.26633/rpsp.2018.69, 10.26633/RPSP.2018.69]; Gascon J, 2010, ACTA TROP, V115, P22, DOI 10.1016/j.actatropica.2009.07.019; Hotez P.J., 2008, EMERG INFECT DIS; Hotez PJ, 2013, PLOS NEGLECT TROP D, V7, DOI [10.1371/journal.pntd.0002300, 10.1371/journal.pntd.0002570]; Jackson Y, 2009, EMERG INFECT DIS, V15, P601, DOI 10.3201/eid1504.080438; Lee BY, 2013, LANCET INFECT DIS, V13, P342, DOI 10.1016/S1473-3099(13)70002-1; Lescure FX, 2008, EMERG INFECT DIS, V14, P644, DOI 10.3201/eid1404.070489; Pan American Health Organization, 2019, PAHO ISS NEW GUID DI; Pan American Health Organization, 2019, CHAG DIS; Pan American Health Organization, CHAG DIS GEN INF; Pan-American Health Organization, 2018, GUIA DIAGN TRAT ENF	12	18	20	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 13	2019	393	10180					1486	1487		10.1016/S0140-6736(19)30288-0	http://dx.doi.org/10.1016/S0140-6736(19)30288-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU0DA	30983574				2022-12-28	WOS:000464940400008
J	Neuman, MD; Bateman, BT; Wunsch, H				Neuman, Mark D.; Bateman, Brian T.; Wunsch, Hannah			Inappropriate opioid prescription after surgery	LANCET			English	Article							CHRONIC POSTSURGICAL PAIN; UNITED-STATES; PRESCRIBING PATTERNS; POSTOPERATIVE PAIN; RISK-FACTORS; ARTHROPLASTY EVIDENCE; NONMALIGNANT PAIN; NERVE BLOCKADE; NAIVE PATIENTS; ANALGESICS	Worldwide, the use of prescription opioid analgesics more than doubled between 2001 and 2013, with several countries, including the USA, Canada, and Australia, experiencing epidemics of opioid misuse and abuse over this period. In this context, excessive prescribing of opioids for pain treatment after surgery has been recognised as an important concern for public health and a potential contributor to patterns of opioid misuse and related harm. In the second paper in this Series we review the evolution of prescription opioid use for pain treatment after surgery in the USA, Canada, and other countries. We summarise evidence on the extent of opioid overprescribing after surgery and its potential association with subsequent opioid misuse, diversion, and the development of opioid use disorder. We discuss evidence on patient, physician, and system-level predictors of excessive prescribing after surgery, and summarise recent work on clinical and policy efforts to reduce such prescribing while ensuring adequate pain control.	[Neuman, Mark D.] Univ Penn, Dept Anesthesiol & Crit Care, Perelman Sch Med, Philadelphia, PA 19104 USA; [Neuman, Mark D.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Bateman, Brian T.] Brigham & Womens Hosp, Dept Anesthesia Perioperat & Pain Med, 75 Francis St, Boston, MA 02115 USA; [Bateman, Brian T.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA; [Bateman, Brian T.] Harvard Med Sch, Boston, MA 02115 USA; [Wunsch, Hannah] Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON, Canada; [Wunsch, Hannah] Sunnybrook Res Inst, Toronto, ON, Canada; [Wunsch, Hannah] Univ Toronto, Dept Anesthesia, Toronto, ON, Canada; [Wunsch, Hannah] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto	Bateman, BT (corresponding author), Brigham & Womens Hosp, Boston, MA 02115 USA.	bbateman@bwh.harvard.edu			National Institute on Drug Abuse [R01 DA042299-01A1, R01 DA044293-01A1]; Canadian Institutes of Health Research (CIHR) [365432]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA042299, R01DA044293] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	All authors received support from the National Institute on Drug Abuse (R01 DA042299-01A1 to MDN, BTB, and HW, and R01 DA044293-01A1 to BTB). HW received support from the Canadian Institutes of Health Research (CIHR grant number 365432). The study sponsors had no role in study design; the collection, analysis, and interpretation of data; the writing of the report; or the decision to submit the series for publication. We would like to thank Hance Clarke and Michael Ashburn who provided comments on an early draft of the manuscript. BTB confirms that he had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Alam A, 2012, ARCH INTERN MED, V172, P425, DOI 10.1001/archinternmed.2011.1827; American Psychiatric Association, 2013, OP US DIS DIAGN STAT; Angst MS, 2006, ANESTHESIOLOGY, V104, P570, DOI 10.1097/00000542-200603000-00025; [Anonymous], 2017, FINANCIAL TIMES; [Anonymous], 2017, LANCET ONCOL, V18, P1285; [Anonymous], 2013, CBHSQ DATA REV; Antman KH, 2016, ACAD MED, V91, P1348, DOI 10.1097/ACM.0000000000001347; Ashburn MA, 2012, ANESTHESIOLOGY, V116, P248, DOI 10.1097/ALN.0b013e31823c1030; Azam MA, 2017, CAN J PAIN, V1, P37, DOI 10.1080/24740527.2017.1325317; Baker DW, 2017, JAMA-J AM MED ASSOC, V317, P1117, DOI 10.1001/jama.2017.0935; Baker-White A, 2017, LOOK STATE LEGISLATI; Ballantyne JC, 2015, NEW ENGL J MED, V373, P2098, DOI 10.1056/NEJMp1507136; Bao YH, 2016, HEALTH AFFAIR, V35, P1045, DOI 10.1377/hlthaff.2015.1673; Barnett ML, 2017, NEW ENGL J MED, V376, P663, DOI 10.1056/NEJMsa1610524; Bateman BT, 2017, OBSTET GYNECOL, V130, P29, DOI 10.1097/AOG.0000000000002093; Bateman BT, 2016, JAMA INTERN MED, V176, P583, DOI 10.1001/jamainternmed.2016.0544; Bateman BT, 2016, AM J OBSTET GYNECOL, V215; Bates C, 2011, J UROLOGY, V185, P551, DOI 10.1016/j.juro.2010.09.088; Berterame S, 2016, LANCET, V387, P1644, DOI 10.1016/S0140-6736(16)00161-6; Bicket MC, 2017, JAMA SURG, V152, P1066, DOI 10.1001/jamasurg.2017.0831; Bounes V, 2016, AM J EMERG MED, V34, P1955, DOI 10.1016/j.ajem.2016.06.107; Brandal D, 2017, ANESTH ANALG, V125, P1784, DOI 10.1213/ANE.0000000000002510; Brat GA, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.j5790; Brummett CM, 2017, JAMA SURG, V152, DOI 10.1001/jamasurg.2017.0504; Callinan CE, 2017, J PAIN, V18, P360, DOI 10.1016/j.jpain.2016.11.001; Campbell JN, 1996, PAIN FORUM, V5, P85; Carr D, 2018, PUBLIC HLTH REP, V1; Chang AK, 2017, JAMA-J AM MED ASSOC, V318, P1661, DOI 10.1001/jama.2017.16190; Chen EY, 2018, JAMA SURG, V153, DOI 10.1001/jamasurg.2017.4859; Chiu AS, 2018, JAMA SURG, V153, P1012, DOI 10.1001/jamasurg.2018.2083; Chou R, 2016, J PAIN, V17, P131, DOI 10.1016/j.jpain.2015.12.008; Clarke H, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1251; Davis CS, 2015, DRUG ALCOHOL DEPEN, V157, P112, DOI 10.1016/j.drugalcdep.2015.10.013; Delgado MK, 2018, J GEN INTERN MED, V33, P409, DOI 10.1007/s11606-017-4286-5; Devine CA, 2016, J BONE JOINT SURG AM, V98, DOI 10.2106/JBJS.15.01004; Deyo RA, 2017, J GEN INTERN MED, V32, P21, DOI 10.1007/s11606-016-3810-3; Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464; Dunn KM, 2010, ANN INTERN MED, V152, P85, DOI 10.7326/0003-4819-152-2-201001190-00006; Egan KL, 2018, ADDICT BEHAV, V86, P44, DOI 10.1016/j.addbeh.2018.03.029; Fischer B, 2012, PAIN PHYSICIAN, V15, pES191; Gawande AA, 2017, ANN SURG, V265, P693, DOI 10.1097/SLA.0000000000002133; Gerbershagen HJ, 2014, ANESTHESIOLOGY, V120, P1237, DOI 10.1097/ALN.0000000000000108; Gerbershagen HJ, 2013, ANESTHESIOLOGY, V118, P934, DOI 10.1097/ALN.0b013e31828866b3; Geriatrics and Extended Care Strategic Healthcare Group National Pain Management Coordinating Committee Veterans Health Administration, 2000, PAIN 5 VIT SIGN TOOL; Gomes T, 2011, ARCH INTERN MED, V171, P686, DOI 10.1001/archinternmed.2011.117; Gomes Tara, 2011, Healthc Q, V14, P22; Gray J, 2015, AM J PUBLIC HEALTH, V105, pE89, DOI 10.2105/AJPH.2015.302689; Gray JA, 2012, ARCH INTERN MED, V172, P1186, DOI 10.1001/archinternmed.2012.2374; Guy GP, 2017, MMWR-MORBID MORTAL W, V66, P697, DOI 10.15585/mmwr.mm6626a4; Haddox JD, 1997, CLIN J PAIN, V13, P6; Haffajee RL, 2015, JAMA-J AM MED ASSOC, V313, P891, DOI 10.1001/jama.2014.18514; Hah J, 2018, JAMA SURG, V153, P303, DOI [10.1001/jamasurg.2017.4915, 10.1001/jamasurg.2022.1392]; Han B, 2017, ANN INTERN MED, V167, P293, DOI 10.7326/M17-0865; Hanna MN, 2019, AM J MED QUAL, V1; Harris K, 2013, JAMA DERMATOL; Hasak JM, 2018, J AM COLL SURGEONS, V226, P235, DOI 10.1016/j.jamcollsurg.2017.11.023; Helmerhorst GTT, 2017, BONE JOINT J, V99B, P856, DOI 10.1302/0301-620X.99B7.BJJ-2016-1350.R1; Hill MV, 2018, J AM COLL SURGEONS, V226, P996, DOI 10.1016/j.jamcollsurg.2017.10.012; Hill MV, 2018, ANN SURG, V267, P468, DOI 10.1097/SLA.0000000000002198; Hill MV, 2017, ANN SURG, V265, P709, DOI 10.1097/SLA.0000000000001993; Hooten WM, 2017, MAYO CLIN PROC, V92, P1822, DOI 10.1016/j.mayocp.2017.10.010; Howard R, 2018, JAMA SURG, V153, P285, DOI 10.1001/jamasurg.2017.4436; Howe CQ, 2014, GEN HOSP PSYCHIAT, V36, P99, DOI 10.1016/j.genhosppsych.2013.10.003; Huxtable CA, 2011, ANAESTH INTENS CARE, V39, P804, DOI 10.1177/0310057X1103900505; Inciardi JA, 2007, PAIN MED, V8, P171, DOI 10.1111/j.1526-4637.2006.00255.x; Inciardi James A, 2007, Law Enforc Exec Forum, V7, P127; Katz J, 2015, J PAIN RES, V8, P695, DOI 10.2147/JPR.S91924; Katz NP, 2013, AM J MANAG CARE, V19, P295; KEHLET H, 1994, BRIT J ANAESTH, V72, P375, DOI 10.1093/bja/72.4.375; Kolodny A, 2015, ANNU REV PUBL HEALTH, V36, P559, DOI 10.1146/annurev-publhealth-031914-122957; Krawczyk N, 2018, AM J PUBLIC HEALTH, V108, P666, DOI 10.2105/AJPH.2018.304341; Ladha KS, 2018, JAMA-J AM MED ASSOC, V320, P502, DOI 10.1001/jama.2018.6933; Ladha KS, 2016, ANESTHESIOLOGY, V124, P837, DOI 10.1097/ALN.0000000000001034; Ladha KS, 2016, ANESTHESIOLOGY, V124, P396, DOI 10.1097/ALN.0000000000000952; Larance B, 2018, DRUG ALCOHOL REV, V37, pS203, DOI 10.1111/dar.12617; Lavand'homme P, 2018, CURR OPIN ANESTHESIO, V31, P556, DOI 10.1097/ACO.0000000000000632; Lee JS, 2017, JAMA-J AM MED ASSOC, V317, P2013, DOI 10.1001/jama.2017.2827; Li RJ, 2018, JAMA OTOLARYNGOL, V144, P1060, DOI 10.1001/jamaoto.2018.1787; Liepert A., 2016, B AM COLL SURG, V101, P35; Lin HC, 2018, ADDICT BEHAV, V76, P348, DOI 10.1016/j.addbeh.2017.08.032; Lindenhovious ALC, 2009, J TRAUMA, V67, P160, DOI 10.1097/TA.0b013e31818c12ee; Macrae WA, 2008, BRIT J ANAESTH, V101, P77, DOI 10.1093/bja/aen099; Mars SG, 2014, INT J DRUG POLICY, V25, P257, DOI 10.1016/j.drugpo.2013.10.004; Maughan BC, 2016, DRUG ALCOHOL DEPEN, V168, P328, DOI 10.1016/j.drugalcdep.2016.08.016; MAX MB, 1990, ANN INTERN MED, V113, P885, DOI 10.7326/0003-4819-113-11-885; MAX MB, 1995, JAMA-J AM MED ASSOC, V274, P1874, DOI 10.1001/jama.1995.03530230060032; Michigan Opioid Prescribing Engagement Network, 2018, OP PRESCR REC SURG; Morden NE, 2014, MED CARE, V52, P852, DOI 10.1097/MLR.0000000000000183; Mosher HJ, 2018, J HOSP MED, V13, P243, DOI 10.12788/jhm.2930; Mudumbai SC, 2019, PAIN MED, V20, P1020, DOI 10.1093/pm/pny150; Mueller KG, 2017, ANESTH ANALG, V125, P1014, DOI 10.1213/ANE.0000000000002031; Okie S, 2010, NEW ENGL J MED, V363, P1981, DOI 10.1056/NEJMp1011512; Onishi E, 2017, J AM BOARD FAM MED, V30, P248, DOI 10.3122/jabfm.2017.02.160299; Paulozzi LJ, 2014, J AM BOARD FAM MED, V27, P329, DOI 10.3122/jabfm.2014.03.130290; Perkins FM, 2000, ANESTHESIOLOGY, V93, P1123, DOI 10.1097/00000542-200010000-00038; Pizzi LT, 2012, PHARMACOTHERAPY, V32, P502, DOI 10.1002/j.1875-9114.2012.01101.x; PORTENOY RK, 1986, PAIN, V25, P171, DOI 10.1016/0304-3959(86)90091-6; Portenoy RK, 1996, J LAW MED ETHICS, V24, P296, DOI 10.1111/j.1748-720X.1996.tb01871.x; PORTER J, 1980, NEW ENGL J MED, V302, P123; Prabhu M, 2017, OBSTET GYNECOL, V130, P42, DOI 10.1097/AOG.0000000000002094; Quinones S., 2016, DREAMLAND TRUE TALE; Rodgers J, 2012, J HAND SURG-AM, V37A, P645, DOI 10.1016/j.jhsa.2012.01.035; Rozet I, 2014, ANESTH ANALG, V119, P454, DOI 10.1213/ANE.0000000000000292; Schnell M, 2017, NBER WORKING PAPERS; Schoenfeld AJ, 2017, J BONE JOINT SURG AM, V99, P1247, DOI 10.2106/JBJS.16.01075; Schwenkglenks M, 2014, PAIN, V155, P1401, DOI 10.1016/j.pain.2014.04.021; Scully RE, 2018, JAMA SURG, V153, P37, DOI 10.1001/jamasurg.2017.3132; Sekhri S, 2018, ANN SURG, V268, P271, DOI 10.1097/SLA.0000000000002308; Shah A, 2017, J PAIN; Shah A, 2017, MMWR-MORBID MORTAL W, V66, P265, DOI 10.15585/mmwr.mm6610a1; Simanski CJP, 2014, PAIN MED, V15, P1222, DOI 10.1111/pme.12434; Sommer M, 2010, CLIN J PAIN, V26, P87, DOI 10.1097/AJP.0b013e3181b43d68; Steel Z, 2014, INT J EPIDEMIOL, V43, P476, DOI 10.1093/ije/dyu038; Sun EC, 2017, ANESTH ANALG, V125, P999, DOI 10.1213/ANE.0000000000001943; Sun EC, 2016, JAMA INTERN MED, V176, P1286, DOI 10.1001/jamainternmed.2016.3298; Theunissen M, 2012, CLIN J PAIN, V28, P819, DOI 10.1097/AJP.0b013e31824549d6; Thompson CA, 2017, AM J HEALTH-SYST PH, V74, P1924, DOI 10.2146/news170084; Truth Initiative, 2018, TRUTH OP; US Centers for Disease Control and Prevention National Center, 2017, RX AW; US Centers for Medicare and Medicaid Services, 2018, CMS ROADM ADDR OP EP; US National Institute on Drug Abuse, MIS PRESCR DRUGS; Volkow ND, 2011, JAMA-J AM MED ASSOC, V305, P1346, DOI 10.1001/jama.2011.369; Walley AY, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f174; Ward EN, 2018, ANESTH ANALG, V127, P539, DOI 10.1213/ANE.0000000000003477; Webster PC, 2012, CAN MED ASSOC J, V184, pE345, DOI 10.1503/cmaj.109-4158; Winstock AR, 2014, INT J CLIN PRACT, V68, P1147, DOI 10.1111/ijcp.12429; Winstock A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5599; Wu CL, 2011, LANCET, V377, P2215, DOI 10.1016/S0140-6736(11)60245-6; Wunsch H, 2016, JAMA-J AM MED ASSOC, V315, P1654, DOI 10.1001/jama.2016.0130; Yu SY, 2017, J GLOB ONCOL, V3, P583, DOI 10.1200/JGO.2016.005686; Zivin K, 2019, PAIN MED, V20, P103, DOI 10.1093/pm/pnx304	131	168	169	2	30	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 13	2019	393	10180					1547	1557		10.1016/S0140-6736(19)30428-3	http://dx.doi.org/10.1016/S0140-6736(19)30428-3			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU0DA	30983590	Green Accepted			2022-12-28	WOS:000464940400031
J	Veasey, SC; Rosen, IM				Veasey, Sigrid C.; Rosen, Ilene M.			Obstructive Sleep Apnea in Adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSITIVE AIRWAY PRESSURE; BLOOD-PRESSURE; CARDIOVASCULAR EVENTS; AMERICAN ACADEMY; ORAL APPLIANCE; WEIGHT-LOSS; FOLLOW-UP; RISK; CPAP; ADHERENCE	Obstructive sleep apnea is common and is associated with daytime sleepiness and increased risks of motor vehicle accidents and cardiovascular disease. CPAP is considered first-line therapy for symptomatic or moderate-to-severe obstructive sleep apnea; mandibular-advancement devices and various surgical options are other approaches.	[Veasey, Sigrid C.; Rosen, Ilene M.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Veasey, SC (corresponding author), Univ Penn, Translat Res Lab, Rm 2115,125 S 31st St, Philadelphia, PA 19104 USA.	veasey@pennmedicine.upenn.edu						Andren A, 2013, SLEEP BREATH, V17, P705, DOI 10.1007/s11325-012-0746-7; [Anonymous], 2009, PLOS MED, V6, pS1; Barbe F, 2012, JAMA-J AM MED ASSOC, V307, P2161, DOI 10.1001/jama.2012.4366; BAYLISS DA, 1987, P NATL ACAD SCI USA, V84, P7788, DOI 10.1073/pnas.84.21.7788; Caples SM, 2010, SLEEP, V33, P1396, DOI 10.1093/sleep/33.10.1396; Chirinos JA, 2014, NEW ENGL J MED, V370, P2265, DOI 10.1056/NEJMoa1306187; Dempsey JA, 2010, PHYSIOL REV, V90, P47, DOI 10.1152/physrev.00043.2008; Dixon JB, 2012, JAMA-J AM MED ASSOC, V308, P1142, DOI 10.1001/2012.jama.11580; Drager LF, 2013, J AM COLL CARDIOL, V62, P569, DOI 10.1016/j.jacc.2013.05.045; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Faccenda JF, 2001, AM J RESP CRIT CARE, V163, P344, DOI 10.1164/ajrccm.163.2.2005037; Gami AS, 2013, J AM COLL CARDIOL, V62, P610, DOI 10.1016/j.jacc.2013.04.080; George CFP, 2001, THORAX, V56, P508, DOI 10.1136/thorax.56.7.508; Holmes TH, 2017, SLEEP MED, V37, P130, DOI 10.1016/j.sleep.2017.06.022; Hudgel DW, 2018, AM J RESP CRIT CARE, V198, pE70, DOI [10.1164/rccm.201807-1326ST, 10.1164/rccm.201807-1326st]; Kapur VK, 2017, J CLIN SLEEP MED, V13, P479, DOI 10.5664/jcsm.6506; Kushida CA, 2012, SLEEP, V35, P1593, DOI 10.5665/sleep.2226; Lettieri CJ, 2009, ANN INTERN MED, V151, P696, DOI 10.7326/0003-4819-151-10-200911170-00006; Lin TY, 2017, SLEEP MED, V36, P165, DOI 10.1016/j.sleep.2016.12.029; Liu PY, 2003, J CLIN ENDOCR METAB, V88, P3605, DOI 10.1210/jc.2003-030236; Martinez-Garcia MA, 2013, JAMA-J AM MED ASSOC, V310, P2407, DOI 10.1001/jama.2013.281250; McEvoy RD, 2016, NEW ENGL J MED, V375, P919, DOI 10.1056/NEJMoa1606599; Mehra R, 2006, AM J RESP CRIT CARE, V173, P910, DOI 10.1164/rccm.200509-1442OC; Myhill PC, 2012, J CLIN ENDOCR METAB, V97, P4212, DOI 10.1210/jc.2012-2107; Nadeem R, 2014, J CLIN SLEEP MED, V10, P475, DOI 10.5664/jcsm.3690; Ozcan KM, 2014, EUR ARCH OTO-RHINO-L, V271, P2937, DOI 10.1007/s00405-014-2962-1; Pepin JLD, 2018, J CLIN SLEEP MED, V14, P57, DOI 10.5664/jcsm.6880; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Peromaa-Haavisto P, 2017, SLEEP MED, V35, P85, DOI 10.1016/j.sleep.2016.12.017; Phillips CL, 2013, AM J RESP CRIT CARE, V187, P879, DOI 10.1164/rccm.201212-2223OC; Pliska BT, 2014, J CLIN SLEEP MED, V10, P1285, DOI 10.5664/jcsm.4278; Redline S, 2010, AM J RESP CRIT CARE, V182, P269, DOI 10.1164/rccm.200911-1746OC; Richards D, 2007, SLEEP, V30, P635, DOI 10.1093/sleep/30.5.635; Rosen IM, 2018, J CLIN SLEEP MED, V14, P2075, DOI 10.5664/jcsm.7540; Ruehland WR, 2009, SLEEP, V32, P150, DOI 10.1093/sleep/32.2.150; Sarbjit G, 2018, J AM HEART ASSOC, V7, pe286, DOI 10.1002/WENE.286; Shah N, 2009, CLIN CHEST MED, V30, P455, DOI 10.1016/j.ccm.2009.05.012; Siccoli MM, 2008, SLEEP, V31, P1551, DOI 10.1093/sleep/31.11.1551; Somers V K, 1992, Clin Auton Res, V2, P171, DOI 10.1007/BF01818958; Somers VK, 2008, CIRCULATION, V118, P1080, DOI [10.1161/CIRCULATIONAHA.107.189420, 10.1161/CIRCULATIONAHA.107.189375]; Stone KL, 2016, SLEEP, V39, P531, DOI 10.5665/sleep.5520; Taranto-Montemurro L, 2018, AM J RESPIR CRIT CAR; Tasali Esra, 2008, Proc Am Thorac Soc, V5, P207, DOI 10.1513/pats.200708-139MG; Tomfohr LM, 2011, SLEEP, V34, P121, DOI 10.1093/sleep/34.1.121; Turan O, 2018, CLIN RESPIR J, V12, P1003, DOI 10.1111/crj.12618; Wang LU, 2017, SLEEP MED, V36, P44, DOI 10.1016/j.sleep.2017.04.016; Woodson BT, 2018, OTOLARYNG HEAD NECK, V159, P194, DOI 10.1177/0194599818762383; Xie J, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003162; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; Young T, 2005, J APPL PHYSIOL, V99, P1592, DOI 10.1152/japplphysiol.00587.2005; Young T, 2008, SLEEP, V31, P1071; Young Terry, 2009, WMJ, V108, P246	52	165	175	8	63	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 11	2019	380	15					1442	1449		10.1056/NEJMcp1816152	http://dx.doi.org/10.1056/NEJMcp1816152			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HT5NG	30970189				2022-12-28	WOS:000464610000011
J	Khullar, D; Chokshi, DA				Khullar, Dhruv; Chokshi, Dave A.			Challenges for immigrant health in the USA-the road to crisis	LANCET			English	Article							UNDOCUMENTED IMMIGRANTS; CHILDHOOD ARRIVALS; DEFERRED ACTION; CARE USE; DACA	The USA is home to more immigrants than any other country-about 46 million, just less than a fifth of the world's immigrants. Immigrant health and access to health care in the USA varies widely by ethnicity, citizenship, and legal status. In recent decades, several policy and regulatory changes have worsened health-care quality and access for immigrant populations. These changes include restrictions on access to public health insurance programmes, rhetoric discouraging the use of social services, aggressive immigration enforcement activities, intimidation within health-care settings, decreased caps on the number of admitted refugees, and rescission of protections from deportation. A receding of ethical norms has created an environment favourable for moral and public health crises, as evident in the separation of children from their parents at the southern US border. Given the polarising immigration rhetoric at the national level, individual states rather than the country as a whole might be better positioned to address the barriers to improved health and health care for immigrants in the USA.	[Khullar, Dhruv] Weill Cornell Med Coll, Dept Healthcare Policy & Res, New York, NY USA; [Khullar, Dhruv] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Chokshi, Dave A.] New York City Hlth & Hosp Corp, New York, NY USA; [Chokshi, Dave A.] New York Univ Langone Hlth, Dept Populat Hlth, New York, NY USA; [Chokshi, Dave A.] New York Univ Langone Hlth, Dept Med, New York, NY USA	Cornell University; Cornell University; New York University; New York University	Khullar, D (corresponding author), Weill Cornell Med Coll, New York, NY 10065 USA.	khd9010@med.cornell.edu		Chokshi, Dave/0000-0001-7467-4591				Abubakar I, 2018, LANCET, V392, P2606, DOI 10.1016/S0140-6736(18)32114-7; Adams RJ, 2018, UNDOCUMENTED KIDS GE; Amuedo-Dorantes C, 2016, ECON LETT, V147, P1, DOI 10.1016/j.econlet.2016.08.001; [Anonymous], 2017, INT MIGR REP 2017 HI; Ansell D, 2015, HEALTH AFFAIR, V34, P781, DOI 10.1377/hlthaff.2014.1192; Bailik K, 2018, ICE ARRESTS WENT 201; Castaneda H, 2015, ANNU REV PUBL HEALTH, V36, P375, DOI 10.1146/annurev-publhealth-032013-182419; Cervantes L, 2018, JAMA INTERN MED, V178, P188, DOI 10.1001/jamainternmed.2017.7039; Chilton LA, 2013, PEDIATRICS, V131, pE2028, DOI 10.1542/peds.2013-1099; Connor Phillip, 2016, INT MIGRATION KEY FI; Dickerson C., 2018, NEW YORK TIMES; East CN, 2020, J HUM RESOUR, V55, P387, DOI 10.3368/jhr.55.3.0916-8197R2; Fazel-Zarandi MM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201193; Flavin L, 2018, INT J HEALTH SERV, V48, P601, DOI 10.1177/0020731418791963; Flores G, 2005, ARCH PEDIAT ADOL MED, V159, P295, DOI 10.1001/archpedi.159.3.295; Flores G, 2006, NEW ENGL J MED, V355, P229, DOI 10.1056/NEJMp058316; Gonzalez-Barrera A, 2018, NATURALIZATION RATE; Hainmueller J, 2017, SCIENCE, V357, P1041, DOI 10.1126/science.aan5893; Hanson Devlin., 2014, LOW INCOME IMMIGRANT; Hatzenbuehler ML, 2017, SOC SCI MED, V174, P169, DOI 10.1016/j.socscimed.2016.11.040; Honarvar Ari, 2018, NATION; Kaiser Family Foundation, 2019, HLTH COV IMM; Kelley AT, 2018, NEW ENGL J MED, V378, P1661, DOI 10.1056/NEJMp1801871; Khullar D, 2019, JAMA-J AM MED ASSOC, V321, P928, DOI 10.1001/jama.2019.0839; Kraft C., 2018, COMMUNICATION; Krogstad JM, 2018, NUMBER REFUGEES ADMI; Kuka Elira, 2018, 24315 NAT BUR EC RES; Lind, 2018, VOX             1210; Liptak A, 2016, SUPREME COURT TIE BL; Marcella Alsan, 2018, NATL BUREAU EC RES W, DOI 10.3386/w24731; Mays Jeffery., 2018, NEW YORK TIMES; Mendoza Fernando S, 2009, Pediatrics, V124 Suppl 3, pS187, DOI 10.1542/peds.2009-1100F; Moreno A, 2001, JAMA-J AM MED ASSOC, V285, P1215, DOI 10.1001/jama.285.9.1215; Novak NL, 2017, INT J EPIDEMIOL, V46, P839, DOI 10.1093/ije/dyw346; Office of the United Nations High Commissioner for Human Rights, 2018, UN EXP US REL MIGR C; Okie S, 2007, NEW ENGL J MED, V357, P525, DOI 10.1056/NEJMp078113; Page KR, 2017, NEW ENGL J MED, V376, DOI 10.1056/NEJMp1700829; Parmet WE, 2018, HEALTH AFFAIR; Patterson D.G., 2017, IMMIGRANTS HEALTHCAR; Pedraza FI, 2017, J HEALTH POLIT POLIC, V42, P925, DOI 10.1215/03616878-3940486; Perreira KM, 2018, NEW ENGL J MED, V379, P901, DOI 10.1056/NEJMp1808020; Pompeo MR, 2018, COMMUNICATION   0917; Pope NG, 2016, J PUBLIC ECON, V143, P98, DOI 10.1016/j.jpubeco.2016.08.014; Radford J, 2017, KEY FACTS REFUGEES U; Saadi A, 2017, JAMA-J AM MED ASSOC, V318, P2079, DOI 10.1001/jama.2017.15714; Sacchetti M., 2017, KELLY REVOKES OBAMA; Sanders T, 2018, PROPUBLICA      0802; Sheikh-Hamad D, 2007, TEX MED, V; 103, P53; Venkataramani AS, 2017, LANCET PUBLIC HEALTH, V2, pE175, DOI 10.1016/S2468-2667(17)30047-6; Venkataramani M, 2018, JAMA PEDIATR, V172, P699, DOI 10.1001/jamapediatrics.2018.0775; Viruell-Fuentes EA, 2012, SOC SCI MED, V75, P2099, DOI 10.1016/j.socscimed.2011.12.037; Watson T, 2014, AM ECON J-ECON POLIC, V6, P313, DOI 10.1257/pol.6.3.313; Weinstein DF, 2017, NEW ENGL J MED, V377, P1913, DOI 10.1056/NEJMp1713102; Wong Tom K., 2017, DACA RECIPIENTS EC E; Young MJ, 2014, NEW ENGL J MED, V370, P669, DOI 10.1056/NEJMhle1311198	55	26	26	1	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 25	2019	393	10186					2168	2174		10.1016/S0140-6736(19)30035-2	http://dx.doi.org/10.1016/S0140-6736(19)30035-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HZ5KS	30981536				2022-12-28	WOS:000468891400033
J	Keiser, J; Utzinger, J				Keiser, Jennifer; Utzinger, Jurg			Community-wide soil-transmitted helminth treatment is equity-effective	LANCET			English	Editorial Material									[Keiser, Jennifer; Utzinger, Jurg] Swiss Trop & Publ Hlth Inst, CH-4002 Basel, Switzerland; [Keiser, Jennifer; Utzinger, Jurg] Univ Basel, Basel, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Keiser, J (corresponding author), Swiss Trop & Publ Hlth Inst, CH-4002 Basel, Switzerland.; Keiser, J (corresponding author), Univ Basel, Basel, Switzerland.	jennifer.keiser@swisstph.ch						Anderson R, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0435; Asbjornsdottir KH, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006166; Becker SL, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006606; Clarke NE, 2017, LANCET, V389, P287, DOI 10.1016/S0140-6736(16)32123-7; Coulibaly JT, 2018, TROP MED INFECT DIS, V3, DOI 10.3390/tropicalmed3020069; Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X; Hotez PJ, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P467; Hotez PJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002865; Jourdan PM, 2018, LANCET, V391, P252, DOI 10.1016/S0140-6736(17)31930-X; Medley GF, 2016, ADV PARASIT, V94, P343, DOI 10.1016/bs.apar.2016.08.005; Moser W, 2019, ADV PARASIT, V103, P91, DOI 10.1016/bs.apar.2018.08.002; Moser W, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j4307; Pullan RL, 2019, LANCET, V393, P2039, DOI 10.1016/S0140-6736(18)32591-1; Speich B, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0702-z; World Health Organization, 2002, WHO TRADITIONAL MED, P1	15	9	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 18	2019	393	10185					2011	2012		10.1016/S0140-6736(18)32981-7	http://dx.doi.org/10.1016/S0140-6736(18)32981-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HY4QC	31006574	hybrid, Green Accepted			2022-12-28	WOS:000468112000005
J	Kornacki, MJ; Silversin, J; Chokshi, DA				Kornacki, Mary Jane; Silversin, Jack; Chokshi, Dave A.			From Distrust to Building Trust in Clinician-Organization Relationships	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kornacki, Mary Jane; Silversin, Jack] Amicus Inc, Cambridge, MA USA; [Chokshi, Dave A.] New York City Hlth Hosp, 199 Water St,31st Floor, New York, NY 10038 USA		Chokshi, DA (corresponding author), New York City Hlth Hosp, 199 Water St,31st Floor, New York, NY 10038 USA.	Dave.Chokshi@nychhc.org		Chokshi, Dave/0000-0001-7467-4591				Cerise F., 2018, 2018 AM BOARD INT ME; Covey S.R., 2006, SPEED TRUST ONE THIN; Glenn D., 2018, HOPKINSMEDICINE; Khullar D., 2018, 2018 AM BOARD INT ME; Kornacki MJ, 2015, NEW COMPACT ALIGNING; Lewicki R.J., 1996, TRUST ORG FRONTIERS, V114, P139; Lynch T., 2018, BACKGROUND PAPER; Schein E.H., 2018, HUMBLE LEADERSHIP PO	8	7	7	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2019	321	18					1761	1762		10.1001/jama.2018.22133	http://dx.doi.org/10.1001/jama.2018.22133			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HY7ME	30973574				2022-12-28	WOS:000468319100006
J	Forouhi, NG; Unwin, N				Forouhi, Nita G.; Unwin, Nigel			Global diet and health: old questions, fresh evidence, and new horizons	LANCET			English	Editorial Material							18 COUNTRIES; CONSUMPTION; METAANALYSIS; MORTALITY; RISK		[Forouhi, Nita G.; Unwin, Nigel] Univ Cambridge, Sch Clin Med, Epidemiol Unit, MRC, Cambridge CB2 0QQ, England; [Unwin, Nigel] Univ West Indies, George Alleyne Chron Dis Res Ctr, Bridgetown, Barbados	University of Cambridge; University West Indies Mona Jamaica; University of the West Indies Open Campus	Forouhi, NG (corresponding author), Univ Cambridge, Sch Clin Med, Epidemiol Unit, MRC, Cambridge CB2 0QQ, England.	nita.forouhi@mrc-epid.cam.ac.uk		Unwin, Nigel/0000-0002-1368-1648; Forouhi, Nita/0000-0002-5041-248X	MRC [MC_UU_12015/5] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2016, LANCET, V388, P1447, DOI 10.1016/S0140-6736(16)31790-1; Dehghan M, 2017, LANCET, V390, P2050, DOI [10.1016/s0140-6736(17)32252-3, 10.1016/S0140-6736(17)32252-3]; Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8; GBD 2017 Diet Collaborators, 2019, LANCET; Guo J, 2017, EUR J EPIDEMIOL, V32, P269, DOI 10.1007/s10654-017-0243-1; Miller V, 2016, LANCET GLOB HEALTH, V4, pE695, DOI 10.1016/S2214-109X(16)30186-3; Stanaway JD, 2018, LANCET, V392, P1923, DOI [10.1016/S0140-6736(18)32225-6, 10.1016/s0140-6736(18)32225-6]; Swinburn BA, 2019, LANCET, V393, P791, DOI 10.1016/S0140-6736(18)32822-8; Wallin A, 2012, DIABETES CARE, V35, P918, DOI 10.2337/dc11-1631; Willett W, 2019, LANCET, V393, P447, DOI 10.1016/S0140-6736(18)31788-4; World Cancer Research Fund/American Institute for Cancer Research, CONT UPD PROJ EXP RE; 2016, AM J CLIN NUTR, V103, P1111, DOI DOI 10.3945/AJCN.115.123216	12	30	32	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 11	2019	393	10184					1916	1918		10.1016/S0140-6736(19)30500-8	http://dx.doi.org/10.1016/S0140-6736(19)30500-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HX9AE	30954306	hybrid, Green Submitted			2022-12-28	WOS:000467698100006
J	Beaman, J; Schillinger, D				Beaman, Jessica; Schillinger, Dean			Responding to Evolving Abortion Regulations - The Critical Role of Primary Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Beaman, Jessica] Zuckerberg San Francisco Gen Hosp & Trauma Ctr, Div Gen Internal Med, San Francisco, CA 94110 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Beaman, J (corresponding author), Zuckerberg San Francisco Gen Hosp & Trauma Ctr, Div Gen Internal Med, San Francisco, CA 94110 USA.							Department of Health and Human Services, 2019, FED REGISTER, V84, P7714; Freedman L, 2010, PERSPECT SEX REPRO H, V42, P146, DOI 10.1363/4214610; Grossman D, 2017, JAMA-J AM MED ASSOC, V317, P437, DOI 10.1001/jama.2016.17026; Upadhyay UD, 2015, OBSTET GYNECOL, V125, P175, DOI 10.1097/AOG.0000000000000603; 2017, PERSPECT SEX REPRO H, V49, P17, DOI DOI 10.1363/PSRH.12015	5	7	7	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 2	2019	380	18							E30	10.1056/NEJMp1903572	http://dx.doi.org/10.1056/NEJMp1903572			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HX9ZK	30995367	Bronze			2022-12-28	WOS:000467767800004
J	Jack, SM; Boyle, M; Mckee, C; Ford-Gilboe, M; Wathen, CN; Scribano, P; Davidov, D; McNaughton, D; O'Brien, R; Johnston, C; Gasbarro, M; Tanaka, M; Kimber, M; Coben, J; Olds, DL; MacMillan, HL				Jack, Susan M.; Boyle, Michael; Mckee, Christine; Ford-Gilboe, Marilyn; Wathen, C. Nadine; Scribano, Philip; Davidov, Danielle; McNaughton, Diane; O'Brien, Ruth; Johnston, Carolyn; Gasbarro, Mariarosa; Tanaka, Masako; Kimber, Melissa; Coben, Jeffrey; Olds, David L.; MacMillan, Harriet L.			Effect of Addition of an Intimate Partner Violence Intervention to a Nurse Home Visitation Programon Maternal Quality of Life A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FOLLOW-UP; CHILD-ABUSE; VALIDATION; PREGNANCY; NEGLECT; UTILITY; VERSION; VISITS; WOMEN	IMPORTANCE Intimate partner violence (IPV) is a public health problem with significant adverse consequences for women and children. Past evaluations of a nurse home visitation program for pregnant women and first-time mothers experiencing social and economic disadvantage have not consistently shown reductions in IPV. OBJECTIVE To determine the effect on maternal quality of life of a nurse home visitation program augmented by an IPV intervention, compared with the nurse home visitation program alone. DESIGN, SETTING, AND PARTICIPANTS Cluster-based, single-blind, randomized clinical trial at 15 sites in 8 US states (May 2011-May 2015) enrolling 492 socially disadvantaged pregnant women (>= 16 years) participating in a 2.5-year nurse home visitation program. INTERVENTIONS In augmented program sites (n = 229 participants across 7 sites), nurses received intensive IPV education and delivered an IPV intervention that included a clinical pathway to guide assessment and tailor care focused on safety planning, violence awareness, self-efficacy, and referral to social supports. The standard program (n = 263 participants across 8 sites) included limited questions about violence exposure and information for abused women but no standardized IPV training for nurses. MAIN OUTCOMES AND MEASURES The primary outcome was quality of life (WHOQOL-BREF; range, 0-400; higher score indicates better quality of life) obtained through interviews at baseline and every 6 months until 24 months after delivery. From 17 prespecified secondary outcomes, 7 secondary end points are reported, including scores on the Composite Abuse Scale, SPAN (Startle, Physiological Arousal, Anger, and Numbness), Prime-MD Patient Health Questionnaire, TWEAK (Tolerance/Worry About Drinking/Eye-Opener/Amnesia/C[K]ut Down on Drinking), Drug Abuse Severity Test, and the 12-Item Short-Form Health Survey (physical and mental health), version 2. RESULTS Among 492 participants enrolled (mean age, 20.4 years), 421 (86%) completed the trial. Quality of life improved from baseline to 24 months in both groups (change in WHOQOL-BREF scores from 299.5 [SD, 54.4] to 308.2 [SD, 52.6] in the augmented program group vs from 293.6 [SD, 56.4] to 316.4 [SD, 57.5] in the standard program group). Based on multilevel growth curve analysis, there was no statistically significant difference between groups (modeled score difference, -4.9 [95% CI, -16.5 to 6.7]). There were no statistically significant differences between study groups in any of the secondary participant end points. There were no adverse events recorded in either group. CONCLUSIONS AND RELEVANCE Among pregnant women experiencing social and economic disadvantage and preparing to parent for the first time, augmentation of a nurse home visitation program with a comprehensive IPV intervention, compared with the home visitation program alone, did not significantly improve quality of life at 24 months after delivery. These findings do not support the use of this intervention.	[Jack, Susan M.] McMaster Univ, Sch Nursing, 1280 Main St W,HSC 3H48B, Hamilton, ON L8S 4K1, Canada; [Jack, Susan M.; Boyle, Michael; MacMillan, Harriet L.] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Jack, Susan M.; Boyle, Michael; Mckee, Christine; Tanaka, Masako; Kimber, Melissa; MacMillan, Harriet L.] McMaster Univ, Offord Ctr Child Studies, Hamilton, ON, Canada; [Boyle, Michael; Tanaka, Masako; Kimber, Melissa; MacMillan, Harriet L.] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [Ford-Gilboe, Marilyn; Wathen, C. Nadine] Western Univ, Arthur Labatt Family Sch Nursing, London, ON, Canada; [Wathen, C. Nadine] Western Univ, Fac Informat & Media Studies, London, ON, Canada; [Scribano, Philip] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Scribano, Philip] Univ Penn, Perelman Sch Med, Dept Clin Pediat, Philadelphia, PA 19104 USA; [Davidov, Danielle] West Virginia Univ, Dept Emergency Med, Morgantown, WV 26506 USA; [Davidov, Danielle; Coben, Jeffrey] West Virginia Univ, Sch Publ Hlth, Morgantown, WV 26506 USA; [McNaughton, Diane] Rush Univ, Med Ctr, Dept Commun Syst & Mental Hlth Nursing, Chicago, IL 60612 USA; [O'Brien, Ruth] Univ Colorado Anschutz Med Campus, Coll Nursing, Denver, CO USA; [Johnston, Carolyn] Nurse Family Partnership Natl Serv Off, Denver, CO USA; [Gasbarro, Mariarosa; Olds, David L.] Univ Colorado, Sch Med, Dept Pediat, Denver, CO USA; [MacMillan, Harriet L.] McMaster Univ, Dept Pediat, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University; McMaster University; Western University (University of Western Ontario); Western University (University of Western Ontario); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; West Virginia University; West Virginia University; Rush University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; McMaster University	Jack, SM (corresponding author), McMaster Univ, Sch Nursing, 1280 Main St W,HSC 3H48B, Hamilton, ON L8S 4K1, Canada.	jacksm@mcmaster.ca	MacMillan, Harriet/B-4530-2016; Kimber, Melissa/ABH-5900-2020	MacMillan, Harriet/0000-0002-1223-706X; Kimber, Melissa/0000-0002-1255-8947	National Center for Injury Prevention and Control, CDC [5R49CE001170]; PHAC [4500311097]; Annie E. Casey Foundation; Women's Health Research Chair in Rural Research, Western University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104942] Funding Source: NIH RePORTER	National Center for Injury Prevention and Control, CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); PHAC; Annie E. Casey Foundation; Women's Health Research Chair in Rural Research, Western University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grant 5R49CE001170 from the National Center for Injury Prevention and Control, CDC, to the West Virginia University Injury Control Research Center (2007-2013) and since 2014 by funds (contract 4500311097) from PHAC. This study was also funded in part by the Annie E. Casey Foundation. Dr MacMillan holds the Chedoke Health Chair in Child Psychiatry; Dr Boyle holds a Canada Research Chair in the Social Determinants of Child Health. Dr Ford-Gilboe's research is supported by the Women's Health Research Chair in Rural Research, Western University.	Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; Bonomi AE, 2000, J CLIN EPIDEMIOL, V53, P1, DOI 10.1016/S0895-4356(99)00123-7; Bradley KA, 1998, JAMA-J AM MED ASSOC, V280, P166, DOI 10.1001/jama.280.2.166; BROWNE GB, 1990, MED CARE, V28, P43, DOI 10.1097/00005650-199001000-00006; Campbell JC, 2009, J INTERPERS VIOLENCE, V24, P653, DOI 10.1177/0886260508317180; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Davidson JRT, 1997, PSYCHOL MED, V27, P153, DOI 10.1017/S0033291796004229; Dickson F, 1998, J Nurs Meas, V6, P87; Dienemann J, 2002, PATIENT EDUC COUNS, V46, P221, DOI 10.1016/S0738-3991(01)00216-6; Eckenrode J, 2000, JAMA-J AM MED ASSOC, V284, P1385, DOI 10.1001/jama.284.11.1385; ElBassel N, 1997, RES SOCIAL WORK PRAC, V7, P99, DOI 10.1177/104973159700700106; Goodman L, 2003, VIOLENCE AGAINST WOM, V9, P163, DOI 10.1177/1077801202239004; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Hegarty K, 1999, J FAM VIOLENCE, V14, P399, DOI 10.1023/A:1022834215681; Hegarty Kelsey, 2005, Violence Vict, V20, P529, DOI 10.1891/088667005780927548; Jack SM, 2017, J CLIN NURS, V26, P2215, DOI 10.1111/jocn.13392; Jack SM, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-50; McFarlane J, 2007, ABUSE PREGNANCY PROT; Mejdoubi J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078185; NORTON LB, 1995, OBSTET GYNECOL, V85, P321, DOI 10.1016/0029-7844(94)00429-H; Olds DL, 2007, J CHILD PSYCHOL PSYC, V48, P355, DOI 10.1111/j.1469-7610.2006.01702.x; Olds DL, 2004, PEDIATRICS, V114, P1550, DOI 10.1542/peds.2004-0962; Olds DL, 1997, JAMA-J AM MED ASSOC, V278, P637, DOI 10.1001/jama.278.8.637; Olds DL, 2004, PEDIATRICS, V114, P1560, DOI 10.1542/peds.2004-0961; Prosman GJ, 2015, FAM PRACT, V32, P247, DOI 10.1093/fampra/cmu091; Rasbash J., 2009, USERS GUIDE MLWIN VE; RUSSELL M, 1994, ALCOHOL CLIN EXP RES, V18, P1156, DOI 10.1111/j.1530-0277.1994.tb00097.x; Rutterford C, 2015, INT J EPIDEMIOL, V44, P1051, DOI 10.1093/ije/dyv113; Sharps PW, 2016, J WOMENS HEALTH, V25, P1129, DOI 10.1089/jwh.2015.5547; Skevington SM, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000609; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Walsh CA, 2008, CHILD ABUSE NEGLECT, V32, P1037, DOI 10.1016/j.chiabu.2008.05.003; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003	33	20	21	2	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2019	321	16					1576	1585		10.1001/jama.2019.3211	http://dx.doi.org/10.1001/jama.2019.3211			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HV7BZ	31012933	Bronze, Green Published			2022-12-28	WOS:000466137800013
J	Rubin, R				Rubin, Rita			Free App to Help Patients Ask Appropriate Questions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item													Rubin, Rita/AAD-1259-2020						0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2019	321	16					1557	1557		10.1001/jama.2019.4590	http://dx.doi.org/10.1001/jama.2019.4590			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HV7BZ	31012917				2022-12-28	WOS:000466137800037
J	Zhong, DW; Yi, Y; Lin, CL				Zhong, Dewen; Yi, Yi; Lin, Chaolu			A kidney changes size: first increasing and then decreasing	LANCET			English	Editorial Material									[Zhong, Dewen; Yi, Yi; Lin, Chaolu] Fujian Med Univ, Affiliated Hosp 1, Dept Urol, Longyan, Peoples R China	Fujian Medical University	Yi, Y (corresponding author), Fujian Med Univ, Affiliated Hosp 1, Dept Urol, Longyan, Peoples R China.	shkudo221b@gmail.com	Yi, Yi/GYV-5338-2022	Yi, Yi/0000-0001-6745-7628					0	4	4	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 20	2019	393	10181					1641	1641		10.1016/S0140-6736(19)30771-8	http://dx.doi.org/10.1016/S0140-6736(19)30771-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU0DL	31007204				2022-12-28	WOS:000464941500035
J	Buscaill, P; Chandrasekar, B; Sanguankiattichai, N; Kourelis, J; Kaschani, F; Thomas, EL; Morimoto, K; Kaiser, M; Preston, GM; Ichinose, Y; van der Hoorn, RAL				Buscaill, Pierre; Chandrasekar, Balakumaran; Sanguankiattichai, Nattapong; Kourelis, Jiorgos; Kaschani, Farnusch; Thomas, Emma L.; Morimoto, Kyoko; Kaiser, Markus; Preston, Gail M.; Ichinose, Yuki; van der Hoorn, Renier A. L.			Glycosidase and glycan polymorphism control hydrolytic release of immunogenic flagellin peptides	SCIENCE			English	Article							PV. SYRINGAE B728A; PSEUDOMONAS-SYRINGAE; NICOTIANA-BENTHAMIANA; MOLECULAR-PATTERN; RECEPTOR KINASE; INNATE IMMUNITY; IDENTIFICATION; GLYCOSYLATION; ARABIDOPSIS; PERCEPTION	Plants and animals recognize conserved flagellin fragments as a signature of bacterial invasion. These immunogenic elicitor peptides are embedded in the flagellin polymer and require hydrolytic release before they can activate cell surface receptors. Although much of flagellin signaling is understood, little is known about the release of immunogenic fragments. We discovered that plant-secreted beta-galactosidase 1 (BGAL1) of Nicotiana benthamiana promotes hydrolytic elicitor release and acts in immunity against pathogenic Pseudomonas syringae strains only when they carry a terminal modified viosamine (mVio) in the flagellin O-glycan. In counter defense, P. syringae pathovars evade host immunity by using BGAL1-resistant O-glycans or by producing a BGAL1 inhibitor. Polymorphic glycans on flagella are common to plant and animal pathogenic bacteria and represent an important determinant of host immunity to bacterial pathogens.	[Buscaill, Pierre; Chandrasekar, Balakumaran; Sanguankiattichai, Nattapong; Kourelis, Jiorgos; Thomas, Emma L.; Morimoto, Kyoko; Preston, Gail M.; van der Hoorn, Renier A. L.] Univ Oxford, Dept Plant Sci, Oxford, England; [Kaschani, Farnusch; Kaiser, Markus] Univ Duisburg Essen, ZMB Chem Biol, Fac Biol, Essen, Germany; [Ichinose, Yuki] Okayama Univ, Grad Sch Environm & Life Sci, Okayama, Japan; [Chandrasekar, Balakumaran] Heinrich Heine Univ, Inst Pflanzliche Zellbiol & Biotechnol, Dusseldorf, Germany	University of Oxford; University of Duisburg Essen; Okayama University; Heinrich Heine University Dusseldorf	van der Hoorn, RAL (corresponding author), Univ Oxford, Dept Plant Sci, Oxford, England.	renier.vanderhoorn@plants.ox.ac.uk	van der Hoorn, Renier/AAU-1005-2020	van der Hoorn, Renier/0000-0002-3692-7487; Buscaill, Pierre/0000-0003-4756-1203; Kaschani, Farnusch/0000-0001-6572-3232; Chandrasekar, Balakumaran/0000-0001-5696-6777; Preston, Gail/0000-0003-3882-4438; ICHINOSE, Yuki/0000-0002-7767-7912; Sanguankiattichai, Nattapong/0000-0003-4408-8262; Kourelis, Jiorgos/0000-0002-9007-1333	ERC Consolidator grant [616449]; BBSRC [BB/R017913/1]; Royal Thai Government Scholarship; Clarendon Foundation; Oxford Interdisciplinary Bioscience DTP [BB/M011224/1]; BBSRC [BB/R009236/1] Funding Source: UKRI	ERC Consolidator grant(European Research Council (ERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Thai Government Scholarship; Clarendon Foundation; Oxford Interdisciplinary Bioscience DTP; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by ERC Consolidator grant 616449 "GreenProteases" (to P.B., K.M., R.A.L.v.d.H.), BBSRC grant BB/R017913/1 (to P.B., R.A.L.v.d.H.), a Royal Thai Government Scholarship (to N.S.), the Clarendon Foundation (to J.K.), and the Oxford Interdisciplinary Bioscience DTP (BB/M011224/1 to N.S., E.L.T., G.M.P.).	Arora SK, 2005, INFECT IMMUN, V73, P4395, DOI 10.1128/IAI.73.7.4395-4398.2005; Belhaj K, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-39; Bohm H, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004491; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Bombarely A, 2012, MOL PLANT MICROBE IN, V25, P1523, DOI 10.1094/MPMI-06-12-0148-TA; Bronstein PA, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-209; Brunner F, 2002, EMBO J, V21, P6681, DOI 10.1093/emboj/cdf667; Chandrasekar B, 2017, METHODS MOL BIOL, V1491, P47, DOI 10.1007/978-1-4939-6439-0_4; Chandrasekar B, 2014, MOL CELL PROTEOMICS, V13, P2787, DOI 10.1074/mcp.O114.041616; Chiku K, 2013, CARBOHYD RES, V375, P100, DOI 10.1016/j.carres.2013.04.018; Couto D, 2016, NAT REV IMMUNOL, V16, P537, DOI 10.1038/nri.2016.77; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cui HT, 2009, CELL MICROBIOL, V11, P1453, DOI 10.1111/j.1462-5822.2009.01359.x; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Fliegmann J, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.136, 10.1038/nplants.2016.136]; Gao MH, 2009, CELL HOST MICROBE, V6, P34, DOI 10.1016/j.chom.2009.05.019; Gimenez-Ibanez S, 2009, CURR BIOL, V19, P423, DOI 10.1016/j.cub.2009.01.054; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Grosse-Holz F, 2018, PLANT BIOTECHNOL J, V16, P1797, DOI 10.1111/pbi.12916; Grosse-Holz F, 2018, PLANT BIOTECHNOL J, V16, P1068, DOI 10.1111/pbi.12852; Hann DR, 2007, PLANT J, V49, P607, DOI 10.1111/j.1365-313X.2006.02981.x; Hanuszkiewicz A, 2014, J BIOL CHEM, V289, P19231, DOI 10.1074/jbc.M114.562603; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Hind SR, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.128, 10.1038/nplants.2016.128]; Hirai H, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.29933; Husaini AM, 2018, PLANT PHYSIOL, V177, P24, DOI 10.1104/pp.18.00250; Kallemeijn WW, 2012, ANGEW CHEM INT EDIT, V51, P12529, DOI 10.1002/anie.201207771; Katsuragi Y, 2015, MOL PLANT MICROBE IN, V28, P648, DOI 10.1094/MPMI-11-14-0372-R; Kourelis J., 2018, BIORXIV373506; Kourelis J, 2018, BIORXIV373506, DOI [10.1101/373506, DOI 10.1101/373506]; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Kvitko BH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000388; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lee S, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-65; Lindeberg M, 2012, ANNU REV PHYTOPATHOL, V50, P111, DOI 10.1146/annurev-phyto-081211-173022; Liu DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046451; Liu YL, 2002, PLANT J, V30, P415, DOI 10.1046/j.1365-313X.2002.01297.x; Michalski A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.013698; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Naim F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052717; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Nguyen LC, 2009, MOL GENET GENOMICS, V282, P595, DOI 10.1007/s00438-009-0489-8; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Oome S, 2014, P NATL ACAD SCI USA, V111, P16955, DOI 10.1073/pnas.1410031111; Ottmann C, 2009, P NATL ACAD SCI USA, V106, P10359, DOI 10.1073/pnas.0902362106; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ranf S, 2015, NAT IMMUNOL, V16, P426, DOI 10.1038/ni.3124; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Reiss K, 2011, J BIOL CHEM, V286, P42585, DOI 10.1074/jbc.M111.290544; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Robatzek S, 2007, PLANT MOL BIOL, V64, P539, DOI 10.1007/s11103-007-9173-8; Rossez Y, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004483; Schaffer C, 2017, FEMS MICROBIOL REV, V41, P49, DOI 10.1093/femsre/fuw036; Scott AE, 2011, J BACTERIOL, V193, P3577, DOI 10.1128/JB.01385-10; Segonzac C, 2011, PLANT PHYSIOL, V156, P687, DOI 10.1104/pp.110.171249; Shimizu R, 2003, MOL GENET GENOMICS, V269, P21, DOI 10.1007/s00438-003-0817-3; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smith JM, 2014, PLANT METHODS, V10, DOI 10.1186/1746-4811-10-6; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; Taguchi F, 2003, PLANT CELL PHYSIOL, V44, P342, DOI 10.1093/pcp/pcg042; Taguchi F, 2006, CELL MICROBIOL, V8, P923, DOI 10.1111/j.1462-5822.2005.00674.x; Takai R, 2008, MOL PLANT MICROBE IN, V21, P1635, DOI 10.1094/MPMI-21-12-1635; Takeuchi K, 2007, J BACTERIOL, V189, P6945, DOI 10.1128/JB.00500-07; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Van der Hoorn RAL, 2003, PLANT J, V35, P305, DOI 10.1046/j.1365-313X.2003.01803.x; Vinatzer BA, 2006, MOL MICROBIOL, V62, P26, DOI 10.1111/j.1365-2958.2006.05350.x; Waite C, 2017, MBIO, V8, DOI 10.1128/mBio.02273-16; Wang F, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01075-5; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016765; Wei CF, 2007, PLANT J, V51, P32, DOI 10.1111/j.1365-313X.2007.03126.x; Wei WS, 2000, P NATL ACAD SCI USA, V97, P2247, DOI 10.1073/pnas.040570097; Willmann R, 2011, P NATL ACAD SCI USA, V108, P19824, DOI 10.1073/pnas.1112862108; Yamamoto M, 2011, GENES-BASEL, V2, P788, DOI 10.3390/genes2040788; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	80	52	53	7	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2019	364	6436					145	+	eaav0748	10.1126/science.aav0748	http://dx.doi.org/10.1126/science.aav0748			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HT5RC	30975858	Green Submitted			2022-12-28	WOS:000464620000032
J	Dyer, C				Dyer, Clare			Asbestos disease expert wins right to obtain information held on him by lobbyist	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 12	2019	365								l1783	10.1136/bmj.l1783	http://dx.doi.org/10.1136/bmj.l1783			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU0EX	30981994				2022-12-28	WOS:000464945300009
J	Lobrich, M; Jeggo, PA				Loebrich, Markus; Jeggo, Penny A.			Hazards of human spaceflight	SCIENCE			English	Editorial Material							LYMPHOCYTES; RADIATION		[Loebrich, Markus] Tech Univ Darmstadt, Radiat Biol & DNA Repair, D-64287 Darmstadt, Germany; [Jeggo, Penny A.] Univ Sussex, Genome Damage & Stabil Ctr, Sch Life Sci, Brighton BN1 9RQ, E Sussex, England	Technical University of Darmstadt; University of Sussex	Lobrich, M (corresponding author), Tech Univ Darmstadt, Radiat Biol & DNA Repair, D-64287 Darmstadt, Germany.	lobrich@bio.tu-darmstadt.de; p.a.jeggo@sussex.ac.uk						Arbeille P, 2015, EUR J APPL PHYSIOL, V115, P2099, DOI 10.1007/s00421-015-3189-6; Behjati S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12605; Cucinotta FA, 2006, LANCET ONCOL, V7, P431, DOI 10.1016/S1470-2045(06)70695-7; Debs TA, 1996, AM J PHYS, V64, P384, DOI 10.1119/1.18252; Durante M, 2006, RADIAT RES, V165, P51, DOI 10.1667/RR3489.1; Garrett-Bakelman FE, 2019, SCIENCE, V364, P144, DOI 10.1126/science.aau8650; George K, 2013, MUTAT RES-GEN TOX EN, V756, P165, DOI 10.1016/j.mrgentox.2013.04.007; Hughson RL, 2018, NAT REV CARDIOL, V15, P167, DOI 10.1038/nrcardio.2017.157; Jandial Rahul, 2018, Surg Neurol Int, V9, P9, DOI 10.4103/sni.sni_250_17; Parihar VK, 2018, EXP NEUROL, V305, P44, DOI 10.1016/j.expneurol.2018.03.009; Ray FA, 2014, RADIAT ENVIRON BIOPH, V53, P255, DOI 10.1007/s00411-014-0513-1; Roberts DR, 2017, NEW ENGL J MED, V377, P1746, DOI 10.1056/NEJMoa1705129	12	14	15	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2019	364	6436					127	128		10.1126/science.aaw7086	http://dx.doi.org/10.1126/science.aaw7086			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HT5RC	30975876				2022-12-28	WOS:000464620000022
J	Hsiao, CC; Chen, WL				Hsiao, Chia-Chieh; Chen, Wei-Li			Traumatic Iridodialysis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hsiao, Chia-Chieh; Chen, Wei-Li] Natl Taiwan Univ Hosp, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital	Chen, WL (corresponding author), Natl Taiwan Univ Hosp, Taipei, Taiwan.	chenweili@ntu.edu.tw		CHEN, WEI-LI/0000-0002-1538-2414; Hsiao, Chia-Chieh/0000-0001-5346-6574					0	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 11	2019	380	15					1463	1463		10.1056/NEJMicm1812087	http://dx.doi.org/10.1056/NEJMicm1812087			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HT5NG	30970191				2022-12-28	WOS:000464610000013
J	St Clair, TM; Zwemer, E				St Clair, Tiffany M.; Zwemer, Eric			Diffuse Subcutaneous Emphysema	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 14-year-old boy was admitted with a severe asthma exacerbation. A chest radiograph showed pneumomediastinum with diffuse subcutaneous emphysema. As his respiratory status improved, swelling and palpable crepitus developed in both cheeks and the right eyelid.	[St Clair, Tiffany M.; Zwemer, Eric] UNC Hlth Care Syst, Chapel Hill, NC 27514 USA		St Clair, TM (corresponding author), UNC Hlth Care Syst, Chapel Hill, NC 27514 USA.	tiffany.st.clair@unchealth.unc.edu		Zwemer, Eric/0000-0002-1146-0390					0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 11	2019	380	15					E20	E20		10.1056/NEJMicm1811009	http://dx.doi.org/10.1056/NEJMicm1811009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HT5NG	30970192				2022-12-28	WOS:000464610000003
J	Dyer, C				Dyer, Clare			Surgeon who failed to tell patient that he removed wrong tooth is suspended for eight months	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2019	365								l1669	10.1136/bmj.l1669	http://dx.doi.org/10.1136/bmj.l1669			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU0EH	30967382				2022-12-28	WOS:000464943700013
J	Dyer, C				Dyer, Clare			Woman is jailed after exaggerating injuries from vaginal mesh operation	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		DYER C, 2018, BMJ-BRIT MED J, V361, DOI DOI 10.1136/BMJ.K1913	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2019	365								l1661	10.1136/bmj.l1661	http://dx.doi.org/10.1136/bmj.l1661			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU0EH	30967385				2022-12-28	WOS:000464943700010
J	Green, A				Green, Andrew			DR Congo Ebola virus treatment centres attacked	LANCET			English	Editorial Material																			0	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 16	2019	393	10176					1088	1088		10.1016/S0140-6736(19)30576-8	http://dx.doi.org/10.1016/S0140-6736(19)30576-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HP1HF	30957744	Bronze			2022-12-28	WOS:000461416600013
J	Dalziel, SR; Borland, ML; Furyk, J; Bonisch, M; Neutze, J; Donath, S; Francis, KL; Sharpe, C; Harvey, AS; Davidson, A; Craig, S; Phillips, N; George, S; Rao, A; Cheng, N; Zhang, M; Kochar, A; Brabyn, C; Oakley, E; Babl, FE				Dalziel, Stuart R.; Borland, Meredith L.; Furyk, Jeremy; Bonisch, Megan; Neutze, Jocelyn; Donath, Susan; Francis, Kate L.; Sharpe, Cynthia; Harvey, A. Simon; Davidson, Andrew; Craig, Simon; Phillips, Natalie; George, Shane; Rao, Arjun; Cheng, Nicholas; Zhang, Michael; Kochar, Amit; Brabyn, Christine; Oakley, Ed; Babl, Franz E.		PREDICT Res Network	Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial	LANCET			English	Article							PEDIATRIC STATUS EPILEPTICUS; INTRAVENOUS LEVETIRACETAM; MANAGEMENT; LORAZEPAM; SEIZURES; EPILEPSY	Background Phenytoin is the current standard of care for second-line treatment of paediatric convulsive status epilepticus after failure of first-line benzodiazepines, but is only effective in 60% of cases and is associated with considerable adverse effects. A newer anticonvulsant, levetiracetam, can be given more quickly, is potentially more efficacious, and has a more tolerable adverse effect profile. We aimed to determine whether phenytoin or levetiracetam is the superior second-line treatment for paediatric convulsive status epilepticus. Methods ConSEPT was an open-label, multicentre, randomised controlled trial conducted in 13 emergency departments in Australia and New Zealand. Children aged between 3 months and 16 years, with convulsive status epilepticus that failed first-line benzodiazepine treatment, were randomly assigned (1: 1) using a computer-generated permuted block (block sizes 2 and 4) randomisation sequence, stratified by site and age (= 5 years, > 5 years), to receive 20 mg/kg phenytoin (intravenous or intraosseous infusion over 20 min) or 40 mg/kg levetiracetam (intravenous or intraosseous infusion over 5 min). The primary outcome was clinical cessation of seizure activity 5 min after the completion of infusion of the study drug. Analysis was by intention to treat. This trial is registered with the Australian and New Zealand Clinical Trials Registry, number ACTRN12615000129583. Findings Between March 19, 2015, and Nov 29, 2017, 639 children presented to participating emergency departments with convulsive status epilepticus; 127 were missed, and 278 did not meet eligibility criteria. The parents of one child declined to give consent, leaving 233 children (114 assigned to phenytoin and 119 assigned to levetiracetam) in the intention-to-treat population. Clinical cessation of seizure activity 5 min after completion of infusion of study drug occurred in 68 (60%) patients in the phenytoin group and 60 (50%) patients in the levetiracetam group (risk difference -9 center dot 2% [95% CI -21 center dot 9 to 3 center dot 5]; p= 0 center dot 16). One participant in the phenytoin group died at 27 days because of haemorrhagic encephalitis; this death was not thought to be due to the study drug. There were no other serious adverse events. Interpretation Levetiracetam is not superior to phenytoin for second-line management of paediatric convulsive status epilepticus. Funding Health Research Council of New Zealand, A+ Trust, Emergency Medicine Foundation, Townsville Hospital Private Practice Fund, Eric Ormond Baker Charitable Fund, and Princess Margaret Hospital Foundation. Copyright (c) 2019 Elsevier Ltd. All rights reserved.	[Dalziel, Stuart R.; Bonisch, Megan; Sharpe, Cynthia] Starship Childrens Hosp, Childrens Emergency Dept, Private Bag 92024, Auckland 1142, New Zealand; [Dalziel, Stuart R.] Univ Auckland, Dept Surg, Auckland, New Zealand; [Dalziel, Stuart R.] Univ Auckland, Dept Paediat Child & Youth Hlth, Auckland, New Zealand; [Borland, Meredith L.] Perth Childrens Hosp, Perth, WA, Australia; [Borland, Meredith L.] Univ Western Australia, Sch Med, Div Emergency Med, Perth, WA, Australia; [Borland, Meredith L.] Univ Western Australia, Sch Med, Div Paediat, Perth, WA, Australia; [Furyk, Jeremy] Townsville Hosp, Emergency Dept, Townsville, Qld, Australia; [Furyk, Jeremy] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Townsville, Qld, Australia; [Neutze, Jocelyn] Kith First Hosp, Auckland, New Zealand; [Donath, Susan; Francis, Kate L.; Harvey, A. Simon; Davidson, Andrew; Oakley, Ed; Babl, Franz E.] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Donath, Susan; Harvey, A. Simon; Oakley, Ed; Babl, Franz E.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Harvey, A. Simon; Davidson, Andrew; Oakley, Ed; Babl, Franz E.] Royal Childrens Hosp, Melbourne, Vic, Australia; [Craig, Simon] Monash Med Ctr, Melbourne, Vic, Australia; [Craig, Simon] Monash Univ, Dept Med, Sch Clin Sci, Melbourne, Vic, Australia; [Phillips, Natalie] Queensland Childrens Hosp, Brisbane, Qld, Australia; [Phillips, Natalie; George, Shane] Univ Queensland, Child Hlth Res Ctr, Brisbane, Qld, Australia; [George, Shane] Gold Coast Univ Hosp, Dept Emergency Med, Southport, Qld, Australia; [George, Shane] Griffith Univ, Sch Med, Gold Coast, Qld, Australia; [Rao, Arjun] Sydney Childrens Hosp, Randwick, NSW, Australia; [Rao, Arjun] Univ New South Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia; [Cheng, Nicholas] Childrens Hosp Westmead, Sydney, NSW, Australia; [Zhang, Michael] John Hunter Hosp, Emergency Dept, Newcastle, NSW, Australia; [Kochar, Amit] Womens & Childrens Hosp, Emergency Dept, Adelaide, SA, Australia; [Brabyn, Christine] Waikato Hosp, Emergency Dept, Hamilton, New Zealand	Starship Children's Hospital; University of Auckland; University of Auckland; University of Western Australia; University of Western Australia; James Cook University; Murdoch Children's Research Institute; University of Melbourne; Royal Children's Hospital Melbourne; Monash University; Monash University; University of Queensland; Gold Coast University Hospital; Griffith University; University of New South Wales Sydney; University of Sydney; John Hunter Hospital; Womens & Childrens Hospital Australia; Waikato Hospital	Dalziel, SR (corresponding author), Starship Childrens Hosp, Childrens Emergency Dept, Private Bag 92024, Auckland 1142, New Zealand.	sdalziel@adhb.govt.nz	Craig, Simon/H-9410-2019; George, Shane/E-2019-2015; Francis, Kate/K-2679-2015	George, Shane/0000-0002-8880-1245; Donath, Susan/0000-0003-2489-3977; Francis, Kate/0000-0002-1751-5313	Health Research Council of New Zealand; A+ Trust; Emergency Medicine Foundation; Townsville Hospital Private Practice Fund; Eric Ormond Baker Charitable Fund; Princess Margaret Hospital Foundation	Health Research Council of New Zealand(Health Research Council of New Zealand); A+ Trust; Emergency Medicine Foundation; Townsville Hospital Private Practice Fund; Eric Ormond Baker Charitable Fund; Princess Margaret Hospital Foundation	Health Research Council of New Zealand, A+ Trust, Emergency Medicine Foundation, Townsville Hospital Private Practice Fund, Eric Ormond Baker Charitable Fund, and Princess Margaret Hospital Foundation.	Abend NS, 2008, PEDIATR EMERG CARE, V24, P705, DOI 10.1097/PEC.0b013e318188fcac; Abend NS, 2014, SEMIN PEDIATR NEUROL, V21, P263, DOI 10.1016/j.spen.2014.12.006; Advanced Life Support Group, 2016, ADV PAED LIF SUPP PR, V6th; Babl Franz, 2006, Emerg Med Australas, V18, P143, DOI 10.1111/j.1742-6723.2006.00823.x; Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; Chakravarthi S, 2015, J CLIN NEUROSCI, V22, P959, DOI 10.1016/j.jocn.2014.12.013; Chamberlain JM, 2014, JAMA-J AM MED ASSOC, V311, P1652, DOI 10.1001/jama.2014.2625; Chin RFM, 2006, LANCET, V368, P222, DOI 10.1016/S0140-6736(06)69043-0; Dalziel SR, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0887-8; Dang LT, 2017, PEDIATR CLIN N AM, V64, P1291, DOI 10.1016/j.pcl.2017.08.007; Glauser T, 2016, EPILEPSY CURR, V16, P48, DOI 10.5698/1535-7597-16.1.48; Goraya JS, 2008, PEDIATR NEUROL, V38, P177, DOI 10.1016/j.pediatrneurol.2007.11.003; Gujjar AR, 2017, SEIZURE-EUR J EPILEP, V49, P8, DOI 10.1016/j.seizure.2017.05.001; Gustafson M, REV 400 INTRAVENOUS; Kirmani BF, 2009, PEDIATR NEUROL, V41, P37, DOI 10.1016/j.pediatrneurol.2009.02.016; Knake S, 2008, J NEUROL NEUROSUR PS, V79, P588, DOI 10.1136/jnnp.2007.130260; Lewena S, 2009, PEDIATR EMERG CARE, V25, P83, DOI 10.1097/PEC.0b013e318196ea6e; McTague A, 2018, COCHRANE DB SYST REV, V1; Michaelides C, 2008, EPILEPSY RES, V81, P143, DOI 10.1016/j.eplepsyres.2008.05.004; Mundlamuri RC, 2015, EPILEPSY RES, V114, P52, DOI 10.1016/j.eplepsyres.2015.04.013; National Patient Safety Agency, 2010, NPSA2010RRR018; NICE, 2012, EP DIAGN MAN; Novorol CL, 2007, ARCH DIS CHILD, V92, P948, DOI 10.1136/adc.2006.107516; Raspall-Chaure M, 2006, LANCET NEUROL, V5, P769, DOI 10.1016/S1474-4422(06)70546-4; Fernandez IS, 2014, SEIZURE-EUR J EPILEP, V23, P87, DOI 10.1016/j.seizure.2013.10.004; Schmidt D, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g254; Senthil Kumar CS, 2018, INT J PEDIAT RES, V5, P237, DOI DOI 10.17511/ijpr.2018.i04.13; Treiman DM, 1998, NEW ENGL J MED, V339, P792, DOI 10.1056/NEJM199809173391202; Trinka E, 2015, EPILEPSIA, V56, P1515, DOI 10.1111/epi.13121; Wheless James W, 2007, Neuropsychiatr Dis Treat, V3, P409; Wheless JW, 2009, J CHILD NEUROL, V24, P946, DOI 10.1177/0883073808331351	31	96	99	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 25	2019	393	10186					2135	2145		10.1016/S0140-6736(19)30722-6	http://dx.doi.org/10.1016/S0140-6736(19)30722-6			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HZ5KS	31005386				2022-12-28	WOS:000468891400030
J	Lyttle, MD; Rainford, NEA; Gamble, C; Messahel, S; Humphreys, A; Hickey, H; Woolfall, K; Roper, L; Noblet, J; Lee, ED; Potter, S; Tate, P; Iyer, A; Evans, V; Appleton, RE				Lyttle, Mark D.; Rainford, Naomi E. A.; Gamble, Carrol; Messahel, Shrouk; Humphreys, Amy; Hickey, Helen; Woolfall, Kerry; Roper, Louise; Noblet, Joanne; Lee, Elizabeth D.; Potter, Sarah; Tate, Paul; Iyer, Anand; Evans, Vicki; Appleton, Richard E.		Paediatric Emergency Res United	Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial	LANCET			English	Article							CHILDREN; SEIZURES; MANAGEMENT; CHILDHOOD; VALPROATE; SAFETY	fBackground Phenytoin is the recommended second-line intravenous anticonvulsant for treatment of paediatric convulsive status epilepticus in the UK; however, some evidence suggests that levetiracetam could be an effective and safer alternative. This trial compared the efficacy and safety of phenytoin and levetiracetam for second-line management of paediatric convulsive status epilepticus. Methods This open-label, randomised clinical trial was undertaken at 30 UK emergency departments at secondary and tertiary care centres. Participants aged 6 months to under 18 years, with convulsive status epilepticus requiring second-line treatment, were randomly assigned (1: 1) using a computer-generated randomisation schedule to receive levetiracetam (40 mg/ kg over 5 min) or phenytoin (20 mg/ kg over at least 20 min), stratified by centre. The primary outcome was time from randomisation to cessation of convulsive status epilepticus, analysed in the modified intention-to-treat population (excluding those who did not require second-line treatment after randomisation and those who did not provide consent). This trial is registered with ISRCTN, number ISRCTN22567894. Findings Between July 17, 2015, and April 7, 2018, 1432 patients were assessed for eligibility. After exclusion of ineligible patients, 404 patients were randomly assigned. After exclusion of those who did not require second-line treatment and those who did not consent, 286 randomised participants were treated and had available data: 152 allocated to levetiracetam, and 134 to phenytoin. Convulsive status epilepticus was terminated in 106 (70%) children in the levetiracetam group and in 86 (64%) in the phenytoin group. Median time from randomisation to cessation of convulsive status epilepticus was 35 min (IQR 20 to not assessable) in the levetiracetam group and 45 min (24 to not assessable) in the phenytoin group (hazard ratio 1 center dot 20, 95% CI 0 center dot 91-1 center dot 60; p= 0 center dot 20). One participant who received levetiracetam followed by phenytoin died as a result of catastrophic cerebral oedema unrelated to either treatment. One participant who received phenytoin had serious adverse reactions related to study treatment (hypotension considered to be immediately life-threatening [ a serious adverse reaction] and increased focal seizures and decreased consciousness considered to be medically significant [ a suspected unexpected serious adverse reaction]). Interpretation Although levetiracetam was not significantly superior to phenytoin, the results, together with previously reported safety profiles and comparative ease of administration of levetiracetam, suggest it could be an appropriate alternative to phenytoin as the first-choice, second-line anticonvulsant in the treatment of paediatric convulsive status epilepticus. Funding National Institute for Health Research Health Technology Assessment programme. Copyright (c) 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license.	[Lyttle, Mark D.; Potter, Sarah] Bristol Royal Hosp Children, Emergency Dept, Bristol, Avon, England; [Lyttle, Mark D.] Univ West England, Fac Hlth & Appl Sci, Bristol, Avon, England; [Gamble, Carrol] Univ Liverpool, Dept Biostat, Liverpool, Merseyside, England; [Woolfall, Kerry; Roper, Louise] Univ Liverpool, Inst Populat Hlth Sci, Liverpool, Merseyside, England; [Rainford, Naomi E. A.; Gamble, Carrol; Humphreys, Amy; Hickey, Helen] Univ Liverpool, Clin Trials Res Ctr, Liverpool, Merseyside, England; [Rainford, Naomi E. A.; Gamble, Carrol; Humphreys, Amy; Hickey, Helen; Tate, Paul] Alder Hey Childrens NHS Fdn Trust, Inst Child Hlth, Liverpool, Merseyside, England; [Messahel, Shrouk; Noblet, Joanne; Lee, Elizabeth D.] Alder Hey Childrens NHS Fdn Trust, Emergency Dept, Liverpool, Merseyside, England; [Iyer, Anand; Appleton, Richard E.] Alder Hey Childrens NHS Fdn Trust, Dept Neurol, Liverpool, Merseyside, England	Bristol Royal Hospital For Children; University of West England; University of Liverpool; University of Liverpool; University of Liverpool; Alder Hey Children's NHS Foundation Trust; University of Liverpool; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's NHS Foundation Trust	Appleton, RE (corresponding author), Alder Hey Childrens Hlth Pk, Dept Neurol, Roald Dahl EEG Unit, Liverpool L12 2AP, Merseyside, England.	richardappleton55@hotmail.co.uk	Gamble, Carrol/AAE-9895-2019; Ramlakhan, Shammi/ABD-5794-2020; Skene, Imogen/D-6153-2018; Roland, Damian/D-9553-2018	Gamble, Carrol/0000-0002-3021-1955; Ramlakhan, Shammi/0000-0003-1792-0842; Skene, Imogen/0000-0001-5215-2899; Roper, Louise/0000-0002-2918-7628; Cathie, Katrina/0000-0001-5074-0769; Lyttle, Mark/0000-0002-8634-7210; Roland, Damian/0000-0001-9334-5144; Hartshorn, Stuart/0000-0003-0419-1564	National Institute for Health Research Health Technology Assessment programme	National Institute for Health Research Health Technology Assessment programme(National Institute for Health Research (NIHR))	National Institute for Health Research Health Technology Assessment programme.	[Anonymous], PICANET ANN REP 2010; Appleton RE, 2003, SEIZURE-EUR J EPILEP, V12, P369, DOI 10.1016/S1059-1311(02)00338-2; Brigo F, 2016, EPILEPSY BEHAV, V64, P110, DOI 10.1016/j.yebeh.2016.09.030; Chakravarthi S, 2015, J CLIN NEUROSCI, V22, P959, DOI 10.1016/j.jocn.2014.12.013; Chin RFM, 2006, LANCET, V368, P222, DOI 10.1016/S0140-6736(06)69043-0; Craig S, 2005, NEUROCRIT CARE, V3, P161, DOI 10.1385/NCC:3:2:161; Eriksson K, 2005, NEUROLOGY, V65, P1316, DOI 10.1212/01.wnl.0000180959.31355.92; Frith L., 2015, RES PRIOR CONSENT DE; Fuller KL, 2013, EPILEPSIA, V54, P45, DOI 10.1111/j.1528-1167.2012.03563.x; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Hussain N, 2007, SEIZURE-EUR J EPILEP, V16, P305, DOI 10.1016/j.seizure.2007.01.007; Inwald DP, 2018, ARCH DIS CHILD; Lewena S, 2009, PEDIATR EMERG CARE, V25, P83, DOI 10.1097/PEC.0b013e318196ea6e; Lyttle MD, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2010-8; Lyttle MD, 2014, ARCH DIS CHILD, V99, P602, DOI 10.1136/archdischild-2013-304998; McIntyre J, 2005, LANCET, V366, P205, DOI 10.1016/S0140-6736(05)66909-7; McTague A, 2012, SEIZURE-EUR J EPILEP, V21, P529, DOI 10.1016/j.seizure.2012.05.010; McTague A, 2018, COCHRANE DB SYST REV, V1; Metsaranta P, 2004, DEV MED CHILD NEUROL, V46, P4, DOI 10.1017/S0012162204000027; Misra UK, 2012, J NEUROL, V259, P645, DOI 10.1007/s00415-011-6227-2; Mundlamuri RC, 2015, EPILEPSY RES, V114, P52, DOI 10.1016/j.eplepsyres.2015.04.013; Nakamura K, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007206; National Institute for Health and Care Excellence, 2018, EP DIAGN MAN CLIN GU; Novorol CL, 2007, ARCH DIS CHILD, V92, P948, DOI 10.1136/adc.2006.107516; Singh K, 2018, J PEDIATR NEUROSCI, V13, P158, DOI 10.4103/jpn.JPN_126_17; Trinka Eugen, 2009, Ther Adv Neurol Disord, V2, P79, DOI 10.1177/1756285608100460; WOOLFALL K, 2019, TRIALS, V20; Woolfall K, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005045	28	105	108	1	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 25	2019	393	10186					2125	2134		10.1016/S0140-6736(19)30724-X	http://dx.doi.org/10.1016/S0140-6736(19)30724-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HZ5KS	31005385	Green Published, hybrid			2022-12-28	WOS:000468891400029
J	[Anonymous]				[Anonymous]			Scam Awareness Measure Related to Development of Alzheimer Dementia	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																		Boyle PA, 2019, ANN INTERN MED, V170, P702, DOI 10.7326/M18-2711	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 21	2019	170	10					I26	I26		10.7326/P19-0003	http://dx.doi.org/10.7326/P19-0003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HY7RL	30986827				2022-12-28	WOS:000468333600011
J	Sugiura, D; Maruhashi, T; Okazaki, I; Shimizu, K; Maeda, TK; Takemoto, T; Okazaki, T				Sugiura, Daisuke; Maruhashi, Takumi; Okazaki, Il-mi; Shimizu, Kenji; Maeda, Takeo K.; Takemoto, Tatsuya; Okazaki, Taku			Restriction of PD-1 function by cis-PD-L1/CD80 interactions is required for optimal T cell responses	SCIENCE			English	Article							CRYSTAL-STRUCTURE; ANTI-PD-L1 ANTIBODY; RECEPTOR; SUPPRESSION; ACTIVATION; EXPRESSION; INDUCTION; MPDL3280A; LIGANDS; COMPLEX	Targeted blockade of PD-1 with immune checkpoint inhibitors can activate Tcells to destroy tumors. PD-1 is believed to function mainly at the effector, but not in the activation, phase of Tcell responses, yet how PD-1 function is restricted at the activation stage is currently unknown. Here we demonstrate that CD80 interacts with PD-L1 in cis on antigen-presenting cells (APCs) to disrupt PD-L1/PD-1 binding. Subsequently, PD-L1 cannot engage PD-1 to inhibit Tcell activation when APCs express substantial amounts of CD80. In knock-in mice in which cis-PD-L1/CD80 interactions do not occur, tumor immunity and autoimmune responses were greatly attenuated by PD-1. These findings indicate that CD80 on APCs limits the PD-1 coinhibitory signal, while promoting CD28-mediated costimulation, and highlight critical components for induction of optimal immune responses.	[Sugiura, Daisuke; Maruhashi, Takumi; Okazaki, Il-mi; Shimizu, Kenji; Maeda, Takeo K.; Okazaki, Taku] Tokushima Univ, Inst Adv Med Sci, Div Immune Regulat, 3-18-15 Kuramoto, Tokushima 7708503, Japan; [Takemoto, Tatsuya] Tokushima Univ, Inst Adv Med Sci, Lab Embryol, 3-18-15 Kuramoto, Tokushima 7708503, Japan	Tokushima University; Tokushima University	Okazaki, T (corresponding author), Tokushima Univ, Inst Adv Med Sci, Div Immune Regulat, 3-18-15 Kuramoto, Tokushima 7708503, Japan.	tokazaki@genome.tokushima-u.ac.jp		Shimizu, Kenji/0000-0003-4204-555X; Okazaki, Taku/0000-0003-4790-1925; Sugiura, Daisuke/0000-0002-3865-3889; Maruhashi, Takumi/0000-0003-2944-1611; Okazaki, Il-mi/0000-0001-8644-0100	Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency; Basic Science and Platform Technology Program for Innovative Biological Medicine of the Japan Agency for Medical Research and Development [JP18am0301007]; Japan Society for the Promotion of Science [JP18H05417, JP19H01029]	Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Basic Science and Platform Technology Program for Innovative Biological Medicine of the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by the Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency, Basic Science and Platform Technology Program for Innovative Biological Medicine of the Japan Agency for Medical Research and Development (JP18am0301007), and Grant-in-Aid by the Japan Society for the Promotion of Science (JP18H05417 and JP19H01029).	Ahn E, 2018, P NATL ACAD SCI USA, V115, P4749, DOI 10.1073/pnas.1718217115; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Butte MJ, 2008, MOL IMMUNOL, V45, P3567, DOI 10.1016/j.molimm.2008.05.014; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Chaudhri A, 2018, CANCER IMMUNOL RES, V6, P921, DOI 10.1158/2326-6066.CIR-17-0316; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Cheng XX, 2013, J BIOL CHEM, V288, P11771, DOI 10.1074/jbc.M112.448126; Chikuma S, 2009, J IMMUNOL, V182, P6682, DOI 10.4049/jimmunol.0900080; Collins AV, 2002, IMMUNITY, V17, P201, DOI 10.1016/S1074-7613(02)00362-X; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Evans EJ, 2005, NAT IMMUNOL, V6, P271, DOI 10.1038/ni1170; Fife BT, 2008, IMMUNOL REV, V224, P166, DOI 10.1111/j.1600-065X.2008.00662.x; Haile ST, 2013, J IMMUNOL, V191, P2829, DOI 10.4049/jimmunol.1202777; Haile ST, 2011, J IMMUNOL, V186, P6822, DOI 10.4049/jimmunol.1003682; Hashimoto M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11315; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Ikemizu S, 2000, IMMUNITY, V12, P51, DOI 10.1016/S1074-7613(00)80158-2; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Li KT, 2017, J BIOL CHEM, V292, P6799, DOI 10.1074/jbc.M116.763888; Lin DYW, 2008, P NATL ACAD SCI USA, V105, P3011, DOI 10.1073/pnas.0712278105; LINSLEY PS, 1991, J EXP MED, V174, P561, DOI 10.1084/jem.174.3.561; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Malissen B, 2014, NAT REV IMMUNOL, V14, P417, DOI 10.1038/nri3683; Maruhashi T, 2018, NAT IMMUNOL, V19, P1415, DOI 10.1038/s41590-018-0217-9; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; Okazaki T, 2013, NAT IMMUNOL, V14, P1212, DOI 10.1038/ni.2762; Park JJ, 2010, BLOOD, V116, P1291, DOI 10.1182/blood-2010-01-265975; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Sharpe AH, 2018, NAT REV IMMUNOL, V18, P153, DOI 10.1038/nri.2017.108; Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Sun C, 2018, IMMUNITY, V48, P434, DOI 10.1016/j.immuni.2018.03.014; Terskikh AV, 1997, P NATL ACAD SCI USA, V94, P1663, DOI 10.1073/pnas.94.5.1663; Topalian SL, 2016, NAT REV CANCER, V16, P275, DOI 10.1038/nrc.2016.36; WHITE J, 1989, J IMMUNOL, V143, P1822; Yamazaki T, 2002, J IMMUNOL, V169, P5538, DOI 10.4049/jimmunol.169.10.5538; Zhang XW, 2003, P NATL ACAD SCI USA, V100, P2586, DOI 10.1073/pnas.252771499; 2013, SCIENCE, V339, P823, DOI DOI 10.1126/SCIENCE.1232033	41	162	174	8	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2019	364	6440					558	+		10.1126/science.aav7062	http://dx.doi.org/10.1126/science.aav7062			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HX8BW	31000591				2022-12-28	WOS:000467631800037
J	Chan, EM; Shibue, T; McFarland, JM; Gaeta, B; Ghandi, M; Dumont, N; Gonzalez, A; McPartlan, JS; Li, TX; Zhang, YX; Liu, JB; Lazaro, JB; Gu, PL; Piett, CG; Apffel, A; Ali, SO; Deasy, R; Keskula, P; Ng, RWS; Roberts, EA; Reznichenko, E; Leung, L; Alimova, M; Schenone, M; Islam, M; Maruvka, YE; Liu, Y; Roper, J; Raghavan, S; Giannakis, M; Tseng, YY; Nagel, ZD; D'Andrea, A; Root, DE; Boehm, JS; Getz, G; Chang, S; Golub, TR; Tsherniak, A; Vazquez, F; Bass, AJ				Chan, Edmond M.; Shibue, Tsukasa; McFarland, James M.; Gaeta, Benjamin; Ghandi, Mahmoud; Dumont, Nancy; Gonzalez, Alfredo; McPartlan, Justine S.; Li, Tianxia; Zhang, Yanxi; Liu, Jie Bin; Lazaro, Jean-Bernard; Gu, Peili; Piett, Cortt G.; Apffel, Annie; Ali, Syed O.; Deasy, Rebecca; Keskula, Paula; Ng, Raymond W. S.; Roberts, Emma A.; Reznichenko, Elizaveta; Leung, Lisa; Alimova, Maria; Schenone, Monica; Islam, Mirazul; Maruvka, Yosef E.; Liu, Yang; Roper, Jatin; Raghavan, Srivatsan; Giannakis, Marios; Tseng, Yuen-Yi; Nagel, Zachary D.; D'Andrea, Alan; Root, David E.; Boehm, Jesse S.; Getz, Gad; Chang, Sandy; Golub, Todd R.; Tsherniak, Aviad; Vazquez, Francisca; Bass, Adam J.			WRN helicase is a synthetic lethal target in microsatellite unstable cancers	NATURE			English	Article							INSTABILITY; PROTEIN; LANDSCAPE; HOMOLOG; PACKAGE; BLM	Synthetic lethality-an interaction between two genetic events through which the co-occurrence of these two genetic events leads to cell death, but each event alone does not-can be exploited for cancer therapeutics(1). DNA repair processes represent attractive synthetic lethal targets, because many cancers exhibit an impairment of a DNA repair pathway, which can lead to dependence on specific repair proteins(2). The success of poly(ADP-ribose) polymerase 1 (PARP-1) inhibitors in cancers with deficiencies in homologous recombination highlights the potential of this approach(3). Hypothesizing that other DNA repair defects would give rise to synthetic lethal relationships, we queried dependencies in cancers with microsatellite instability (MSI), which results from deficient DNA mismatch repair. Here we analysed data from large-scale silencing screens using CRISPR-Cas9-mediated knockout and RNA interference, and found that the RecQ DNA helicase WRN was selectively essential in MSI models in vitro and in vivo, yet dispensable in models of cancers that are microsatellite stable. Depletion of WRN induced double-stranded DNA breaks and promoted apoptosis and cell cycle arrest selectively in MSI models. MSI cancer models required the helicase activity of WRN, but not its exonuclease activity. These findings show that WRN is a synthetic lethal vulnerability and promising drug target for MSI cancers.	[Chan, Edmond M.; Shibue, Tsukasa; McFarland, James M.; Gaeta, Benjamin; Ghandi, Mahmoud; Dumont, Nancy; Gonzalez, Alfredo; McPartlan, Justine S.; Apffel, Annie; Ali, Syed O.; Deasy, Rebecca; Keskula, Paula; Ng, Raymond W. S.; Leung, Lisa; Alimova, Maria; Schenone, Monica; Islam, Mirazul; Maruvka, Yosef E.; Liu, Yang; Raghavan, Srivatsan; Giannakis, Marios; Tseng, Yuen-Yi; Root, David E.; Boehm, Jesse S.; Getz, Gad; Golub, Todd R.; Tsherniak, Aviad; Vazquez, Francisca; Bass, Adam J.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Chan, Edmond M.; Li, Tianxia; Zhang, Yanxi; Liu, Jie Bin; Ali, Syed O.; Ng, Raymond W. S.; Islam, Mirazul; Liu, Yang; Raghavan, Srivatsan; Giannakis, Marios; Vazquez, Francisca; Bass, Adam J.] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Lazaro, Jean-Bernard; Roberts, Emma A.; Reznichenko, Elizaveta; D'Andrea, Alan] Harvard Med Sch, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA; [Gu, Peili; Chang, Sandy] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA; [Piett, Cortt G.; Nagel, Zachary D.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Maruvka, Yosef E.; Getz, Gad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Roper, Jatin] Duke Univ, Dept Med, Div Gastroenterol, Durham, NC USA; [Chang, Sandy] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Chang, Sandy] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA; [Golub, Todd R.] Harvard Med Sch, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Golub, Todd R.] Howard Hughes Med Inst, Chevy Chase, MD USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Yale University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Duke University; Yale University; Yale University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute	Vazquez, F; Bass, AJ (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Vazquez, F; Bass, AJ (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	vazquez@broadinstitute.org; adam_bass@dfci.harvard.edu	Giannakis, Marios/Z-4908-2019; Vazquez, Francisca/ABC-4620-2020; Islam, Mirazul/ABI-3514-2020; Vazquez, Francisca/AAA-3751-2020	Vazquez, Francisca/0000-0002-2857-4685; Leung, Lisa/0000-0001-8973-7006; Apffel, Annie/0000-0002-2209-3944; Maruvka, Yosef/0000-0002-8918-9887; Islam, Mirazul/0000-0003-4959-739X; Roberts, Emma/0000-0001-5905-1716; Tsherniak, Aviad/0000-0002-3797-1877; Keskula, Paula/0000-0002-0458-9153; Ng, Raymond/0000-0003-2573-8207; Ghandi, Mahmoud/0000-0003-1897-2265; Chan, Edmond/0000-0002-7460-2560	The Carlos Slim Foundation/Slim Initiative for Genomic Medicine; Broad Institute; Team MG; NIH [2T32CA009172-42A1]; Irving W. Janock Fellowship; NATIONAL CANCER INSTITUTE [T32CA009172, K08CA198002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854] Funding Source: NIH RePORTER	The Carlos Slim Foundation/Slim Initiative for Genomic Medicine; Broad Institute; Team MG; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irving W. Janock Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank C. R. Boland, A. Goel, M. Koi, R. J. Monnat and R. Weissleder for reagents; A. Tang for graphical assistance; and P. Montgomery for the website. This work was funded by The Carlos Slim Foundation/Slim Initiative for Genomic Medicine, Broad Institute, Team MG, NIH (2T32CA009172-42A1 to E.M.C.) and the Irving W. Janock Fellowship (to E.M.C.).	Aggarwal M, 2013, CELL CYCLE, V12, P3329, DOI 10.4161/cc.26320; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Behan FM, 2019, NATURE, V568, P511, DOI 10.1038/s41586-019-1103-9; Bendtsen KM, 2014, EUR BIOPHYS J BIOPHY, V43, P509, DOI 10.1007/s00249-014-0981-x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Billingsley CC, 2015, CANCER-AM CANCER SOC, V121, P386, DOI 10.1002/cncr.29046; Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Brown JS, 2016, BRIT J CANCER, V114, P713, DOI 10.1038/bjc.2016.67; Buehler E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051942; Chan DA, 2011, NAT REV DRUG DISCOV, V10, P351, DOI 10.1038/nrd3374; Dejmek J, 2009, MOL CANCER RES, V7, P581, DOI 10.1158/1541-7786.MCR-08-0049; Giacomelli AO, 2018, NAT GENET, V50, P1381, DOI 10.1038/s41588-018-0204-y; Haugen AC, 2008, CANCER RES, V68, P8465, DOI 10.1158/0008-5472.CAN-08-0002; Iorio F, 2016, CELL, V166, P740, DOI 10.1016/j.cell.2016.06.017; Ivy SP, 2016, TRENDS CANCER, V2, P646, DOI 10.1016/j.trecan.2016.10.014; Kim TM, 2013, CELL, V155, P858, DOI 10.1016/j.cell.2013.10.015; Kunitomi H, 2017, ONCOL LETT, V14, P3297, DOI 10.3892/ol.2017.6640; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Lebel M, 2018, AGEING RES REV, V41, P82, DOI 10.1016/j.arr.2017.11.003; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Loughery J, 2014, NUCLEIC ACIDS RES, V42, P7664, DOI 10.1093/nar/gku501; McDonald ER, 2017, CELL, V170, P577, DOI 10.1016/j.cell.2017.07.005; McFarland JM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06916-5; Meyers RM, 2017, NAT GENET, V49, P1779, DOI 10.1038/ng.3984; Myung K, 2001, NAT GENET, V27, P113, DOI 10.1038/83673; Nagel ZD, 2014, P NATL ACAD SCI USA, V111, pE1823, DOI 10.1073/pnas.1401182111; Nowsheen S., 2012, Experimental Oncology, V34, P243; Opresko PL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004825; Overman MJ, 2018, J CLIN ONCOL, V36, P773, DOI 10.1200/JCO.2017.76.9901; Pal T, 2008, CLIN CANCER RES, V14, P6847, DOI 10.1158/1078-0432.CCR-08-1387; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rossi ML, 2010, DNA REPAIR, V9, P331, DOI 10.1016/j.dnarep.2009.12.011; Sergushichev A., 2016, BIORXIV, DOI [10.1101/060012, DOI 10.1101/060012]; Shibue T, 2012, CANCER DISCOV, V2, P706, DOI 10.1158/2159-8290.CD-11-0239; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Sidorova JM, 2008, DNA REPAIR, V7, P1776, DOI 10.1016/j.dnarep.2008.07.017; Spies M, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a022657; Stransky N, 2015, NATURE, V528, P84, DOI 10.1038/nature15736; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swanson C, 2004, DNA REPAIR, V3, P475, DOI 10.1016/j.dnarep.2004.01.002; Tsherniak A, 2017, CELL, V170, P564, DOI 10.1016/j.cell.2017.06.010	47	154	156	8	92	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 25	2019	568	7753					551	+		10.1038/s41586-019-1102-x	http://dx.doi.org/10.1038/s41586-019-1102-x			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HU9DR	30971823	Green Accepted, Green Submitted			2022-12-28	WOS:000465594200051
J	Brown, CC; Moore, JE; Felix, HC; Stewart, MK; Mac Bird, T; Lowery, CL; Tilford, JM				Brown, Clare C.; Moore, Jennifer E.; Felix, Holly C.; Stewart, M. Kathryn; Mac Bird, T.; Lowery, Curtis L.; Tilford, J. Mick			Association of State Medicaid Expansion Status With Low Birth Weight and Preterm Birth	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTH-INSURANCE COVERAGE; AFFORDABLE CARE ACT; MORTALITY; IMPACT; RATES; WOMEN; DISPARITIES; CHILDREN; BLACK	IMPORTANCE Low birth weight and preterm birth are associated with adverse consequences including increased risk of infant mortality and chronic health conditions. Black infants are more likely than white infants to be born prematurely, which has been associated with disparities in infant mortality and other chronic conditions. OBJECTIVE To evaluate whether Medicaid expansion was associated with changes in rates of low birth weight and preterm birth outcomes, both overall and by race/ethnicity. DESIGN, SETTING, AND PARTICIPANTS Using US population-based data from the National Center for Health Statistics Birth Data Files (2011-2016), difference-in-differences (DID) and difference-in-difference-in-differences (DDD) models were estimated using multivariable linear probability regressions to compare birth outcomes among infants in Medicaid expansion states relative to non-Medicaid expansion states and changes in relative disparities among racial/ethnic minorities for singleton live births to women aged 19 years and older. EXPOSURES State Medicaid expansion status and racial/ethnic category. MAIN OUTCOMES AND MEASURES Preterm birth (<37weeks' gestation), very preterm birth (<32 weeks' gestation), low birth weight (<2500 g), and very low birth weight (<1500 g). RESULTS The final sample of 15 631 174 births (white infants: 8 244 924, black infants: 2 201 658, and Hispanic infants: 3 944 665) came from the District of Columbia and 18 states that expanded Medicaid (n = 8 530 751) and 17 states that did not (n = 7 100 423). In the DID analyses, there were no significant changes in preterm birth in expansion relative to nonexpansion states (preexpansion to postexpansion period, 6.80% to 6.67%[difference: -0.12] vs 7.86% to 7.78%[difference: -0.08]; adjusted DID: 0.00 percentage points [95% CI, -0.14 to 0.15], P = .98), very preterm birth (0.87% to 0.83%[difference: -0.04] vs 1.02% to 1.03%[difference: 0.01]; adjusted DID: -0.02 percentage points [95% CI, -0.05 to 0.02], P = .37), low birth weight (5.41% to 5.36%[difference: -0.05] vs 6.06% to 6.18%[difference: 0.11]; adjusted DID: -0.08 percentage points [95% CI, -0.20 to 0.04], P = .20), or very low birth weight (0.76% to 0.72%[difference: -0.03] vs 0.88% to 0.90% [difference: 0.02]; adjusted DID: -0.03 percentage points [95% CI, -0.06 to 0.01], P = .14). Disparities for black infants relative to white infants in Medicaid expansion states compared with nonexpansion states declined for all 4 outcomes, indicated by a negative DDD coefficient for preterm birth (-0.43 percentage points [95% CI, -0.84 to -0.02], P = .05), very preterm birth (-0.14 percentage points [95% CI, -0.26 to -0.02], P = .03), low birth weight (-0.53 percentage points [95% CI, -0.96 to -0.10], P = .02), and very low birth weight (-0.13 percentage points [95% CI, -0.25 to -0.01], P = .04). There were no changes in relative disparities for Hispanic infants. CONCLUSIONS AND RELEVANCE Based on data from 2011-2016, state Medicaid expansion was not significantly associated with differences in rates of low birth weight or preterm birth outcomes overall, although there were significant improvements in relative disparities for black infants compared with white infants in states that expanded Medicaid vs those that did not.	[Brown, Clare C.; Felix, Holly C.; Stewart, M. Kathryn; Mac Bird, T.; Tilford, J. Mick] Univ Arkansas Med Sci, Dept Hlth Policy & Management, 4301 W Markham,Slot 820-12, Little Rock, AR 72205 USA; [Moore, Jennifer E.] Inst Medicaid Innovat, Washington, DC USA; [Moore, Jennifer E.] Univ Michigan, Dept Obstet & Gynecol, Sch Med, Ann Arbor, MI 48109 USA; [Lowery, Curtis L.] Univ Arkansas Med Sci, Dept Obstet & Gynecol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Michigan System; University of Michigan; University of Arkansas System; University of Arkansas Medical Sciences	Tilford, JM (corresponding author), Univ Arkansas Med Sci, Dept Hlth Policy & Management, 4301 W Markham,Slot 820-12, Little Rock, AR 72205 USA.	tilfordmickj@uams.edu			ARCHD - NIMHD of the NIH [5U54MD002329]; TRI through the NCATS of the NIH [U54TR001629]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [U54TR001629] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD002329] Funding Source: NIH RePORTER	ARCHD - NIMHD of the NIH; TRI through the NCATS of the NIH; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Drs Tilford and Stewart were supported by grants from the ARCHD, which is supported by the NIMHD of the NIH (award ID 5U54MD002329), and from the TRI (award ID U54TR001629) through the NCATS of the NIH.	Antonisse L., 2017, EFFECTS MEDICAID EXP; Armstrong J, 2015, CLIN OBSTET GYNECOL, V58, P323, DOI 10.1097/GRF.0000000000000096; Behrman RE, 2007, PRETERM BIRTH CAUSES; Bhatt CB, 2018, AM J PUBLIC HEALTH, V108, P565, DOI 10.2105/AJPH.2017.304218; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Boudreaux MH, 2018, HEALTH SERV RES, V53, P2406, DOI 10.1111/1475-6773.12779; Braveman Paula, 2009, Pediatrics, V124 Suppl 3, pS163, DOI 10.1542/peds.2009-1100D; Courtemanche C, 2017, J POLICY ANAL MANAG, V36, P178, DOI 10.1002/pam.21961; D'Onofrio BM, 2013, JAMA PSYCHIAT, V70, P1231, DOI 10.1001/jamapsychiatry.2013.2107; Daw JR, 2017, HEALTH AFFAIR, V36, P598, DOI 10.1377/hlthaff.2016.1241; de Kieviet JF, 2009, JAMA-J AM MED ASSOC, V302, P2235, DOI 10.1001/jama.2009.1708; DeFranco EA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-316; Delnord M, 2017, BJOG-INT J OBSTET GY, V124, P785, DOI 10.1111/1471-0528.14273; Gonzales S, 2018, HEALTH SERV RES, V53, P1373, DOI 10.1111/1475-6773.12733; Henry J. Kaiser Family Foundation, 2017, POPULATION DISTRIBUT; Howell EM, 2001, MED CARE RES REV, V58, P3, DOI 10.1177/107755870105800101; Johnson K, 2015, CLIN OBSTET GYNECOL, V58, P336, DOI 10.1097/GRF.0000000000000115; Kaestner R, 2017, J POLICY ANAL MANAG, V36, P608, DOI 10.1002/pam.21993; Kaiser Family Foundation, STAT HLTH FACTS STAT; Karaca-Mandic P, 2012, HEALTH SERV RES, V47, P255, DOI 10.1111/j.1475-6773.2011.01314.x; Lu Michael C, 2010, Ethn Dis, V20, pS2; MacDorman Marian F, 2014, Natl Vital Stat Rep, V63, P1; Martin Joyce A, 2018, Natl Vital Stat Rep, V67, P1; Matthews T J, 2015, Natl Vital Stat Rep, V64, P1; McMorrow S, 2015, HEALTH AFFAIR, V34, P1774, DOI 10.1377/hlthaff.2015.0757; Murphy SL, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-3239; National Center for Health Statistics, NCHS VIT STAT NAT BI; Northam S, 2006, JOGNN-J OBST GYN NEO, V35, P3, DOI 10.1111/J.1552-6909.2006.00016.x; Riddell CA, 2017, JAMA PEDIATR, V171, P911, DOI 10.1001/jamapediatrics.2017.1365; Roohan PJ, 2003, J COMMUN HEALTH, V28, P335, DOI 10.1023/A:1025492512915; Ryan AM, 2015, HEALTH SERV RES, V50, P1211, DOI 10.1111/1475-6773.12270; Shah SI, 2016, J PERINATOL, V36, P586, DOI 10.1038/jp.2016.93; Simon K, 2017, J POLICY ANAL MANAG, V36, P390, DOI 10.1002/pam.21972; Sommers BD, 2017, HEALTH AFFAIR, V36, P1119, DOI 10.1377/hlthaff.2017.0293; Sommers BD, 2016, JAMA INTERN MED, V176, P1501, DOI 10.1001/jamainternmed.2016.4419; Wehby GL, 2018, HEALTH SERV RES, V53, P1248, DOI 10.1111/1475-6773.12711; Xu Jiaquan, 2018, Natl Vital Stat Rep, V67, P1; Yue DH, 2018, HEALTH SERV RES, V53, P3640, DOI 10.1111/1475-6773.12834	38	66	66	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2019	321	16					1598	1609		10.1001/jama.2019.3678	http://dx.doi.org/10.1001/jama.2019.3678			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HV7BZ	31012935	Green Published, Bronze			2022-12-28	WOS:000466137800016
J	Li, F; Cabral, MJ; Xu, B; Cheng, ZX; Dickey, EC; LeBeau, JM; Wang, JL; Luo, J; Taylor, S; Hackenberger, W; Bellaiche, L; Xu, Z; Chen, LQ; Shrout, TR; Zhang, SJ				Li, Fei; Cabral, Matthew J.; Xu, Bin; Cheng, Zhenxiang; Dickey, Elizabeth C.; LeBeau, James M.; Wang, Jianli; Luo, Jun; Taylor, Samuel; Hackenberger, Wesley; Bellaiche, Laurent; Xu, Zhuo; Chen, Long-Qing; Shrout, Thomas R.; Zhang, Shujun			Giant piezoelectricity of Sm-doped Pb(Mg1/3Nb2/3)O-3-PbTiO3 single crystals	SCIENCE			English	Article							ELECTROMECHANICAL RESPONSE; ULTRAHIGH PIEZOELECTRICITY; POLARIZATION; TITANATE; GROWTH; FIELDS	High-performance piezoelectrics benefit transducers and sensors in a variety of electromechanical applications. The materials with the highest piezoelectric charge coefficients (d(33)) are relaxor-PbTiO3 crystals, which were discovered two decades ago. We successfully grew Sm-doped Pb(Mg1/3Nb2/3)O-3-PbTiO3 (Sm-PMN-PT) single crystals with even higher d(33) values ranging from 3400 to 4100 picocoulombs per newton, with variation below 20% over the as-grown crystal boule, exhibiting good property uniformity. We characterized the Sm-PMN-PT on the atomic scale with scanning transmission electron microscopy and made first-principles calculations to determine that the giant piezoelectric properties arise from the enhanced local structural heterogeneity introduced by Sm3+ dopants. Rare-earth doping is thus identified as a general strategy for introducing local structural heterogeneity in order to enhance the piezoelectricity of relaxor ferroelectric crystals.	[Li, Fei; Xu, Zhuo] Xi An Jiao Tong Univ, State Key Lab Mech Behav Mat, Sch Elect & Informat Engn,Key Lab, Elect Mat Res Lab,Int Ctr Dielect Res,Educ Minist, Xian 710049, Shaanxi, Peoples R China; [Li, Fei; Chen, Long-Qing; Shrout, Thomas R.; Zhang, Shujun] Penn State Univ, Dept Mat Sci & Engn, Mat Res Inst, University Pk, PA 16802 USA; [Cabral, Matthew J.; Dickey, Elizabeth C.; LeBeau, James M.] North Carolina State Univ, Dept Mat Sci & Engn, Raleigh, NC 27695 USA; [Xu, Bin] Soochow Univ, Sch Phys Sci & Technol, Suzhou 215006, Peoples R China; [Xu, Bin; Bellaiche, Laurent] Univ Arkansas, Inst Nanosci & Engn, Fayetteville, AR 72701 USA; [Xu, Bin; Bellaiche, Laurent] Univ Arkansas, Dept Phys, Fayetteville, AR 72701 USA; [Cheng, Zhenxiang; Wang, Jianli; Zhang, Shujun] Univ Wollongong, Australian Inst Innovat Mat, ISEM, Wollongong, NSW 2500, Australia; [Luo, Jun; Taylor, Samuel; Hackenberger, Wesley] TRS Technol Inc, 2820 East Coll Ave, State Coll, PA 16801 USA	Xi'an Jiaotong University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of North Carolina; North Carolina State University; Soochow University - China; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville; University of Wollongong; TRS Technologies Inc	Li, F (corresponding author), Xi An Jiao Tong Univ, State Key Lab Mech Behav Mat, Sch Elect & Informat Engn,Key Lab, Elect Mat Res Lab,Int Ctr Dielect Res,Educ Minist, Xian 710049, Shaanxi, Peoples R China.; Li, F; Zhang, SJ (corresponding author), Penn State Univ, Dept Mat Sci & Engn, Mat Res Inst, University Pk, PA 16802 USA.; Zhang, SJ (corresponding author), Univ Wollongong, Australian Inst Innovat Mat, ISEM, Wollongong, NSW 2500, Australia.	ful5@xjtu.edu.cn; shujun@uow.edu.au	Dickey, Elizabeth C/A-3368-2011; Chen, LongQing/I-7536-2012; Wang, Jianli/F-4589-2012; Li, Fei/C-1423-2009; Zhang, Shujun/A-5259-2008; Xu, Bin/I-2158-2014; LeBeau, James/B-6370-2008	Dickey, Elizabeth C/0000-0003-4005-7872; Chen, LongQing/0000-0003-3359-3781; Li, Fei/0000-0002-4572-0322; Zhang, Shujun/0000-0001-6139-6887; Xu, Bin/0000-0002-0107-0727; LeBeau, James/0000-0002-7726-3533	National Natural Science Foundation of China [51572214, 51831010, 51761145024]; Shaanxi Provincial Natural Science Foundation [2018KJXX-081, 2018TD-024]; NSF, as part of NRT-SEAS [DGE-1633587]; Center for Dielectrics and Piezoelectrics under NSF [IIP-1361571, IIP-1361503]; Australian Synchrotron; U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-FG02-07ER46417]; ONR [N00014-17-1-2818]; DARPA under the MATRIX program [HR0011-15-2-0038]; ONRG [N62909-16-12126, N62909-18-12168]; ARC [FT140100698]; State of North Carolina; NSF [ECCS-1542015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shaanxi Provincial Natural Science Foundation; NSF, as part of NRT-SEAS(National Science Foundation (NSF)); Center for Dielectrics and Piezoelectrics under NSF; Australian Synchrotron; U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); ONR(Office of Naval Research); DARPA under the MATRIX program; ONRG; ARC(Australian Research Council); State of North Carolina; NSF(National Science Foundation (NSF))	Supported by ONR (F.L. and T.R.S.); National Natural Science Foundation of China grants 51572214, 51831010, and 51761145024 and Shaanxi Provincial Natural Science Foundation grants 2018KJXX-081 and 2018TD-024 (F.L.); NSF, as part of NRT-SEAS under grant DGE-1633587 (M.J.C.); the Center for Dielectrics and Piezoelectrics under NSF grants IIP-1361571 and IIP-1361503 (J.M.L., E.C.D., and M.J.C.); Australian Synchrotron (J.W. and Z.X.C.); U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering award DE-FG02-07ER46417 (L.-Q.C.); ONR grant N00014-17-1-2818 and DARPA grant HR0011-15-2-0038 under the MATRIX program (B.X. and L.B.); ONRG grants N62909-16-12126 and N62909-18-12168; and ARC grant FT140100698 (S.Z.). The TEM work was performed at the Analytical Instrumentation Facility (AIF) at North Carolina State University, which is supported by the State of North Carolina and NSF grant ECCS-1542015. The AIF is a member of the North Carolina Research Triangle Nanotechnology Network, a site in the National Nanotechnology Coordinated Infrastructure.	Bell AJ, 2001, J APPL PHYS, V89, P3907, DOI 10.1063/1.1352682; Bellaiche L, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.014111; Bellaiche L, 2000, PHYS REV LETT, V84, P5427, DOI 10.1103/PhysRevLett.84.5427; Cabral MJ, 2018, APPL PHYS LETT, V112, DOI 10.1063/1.5016561; Cannata JM, 2006, IEEE T ULTRASON FERR, V53, P224, DOI 10.1109/TUFFC.2006.1588408; Catalan G, 2009, ADV MATER, V21, P2463, DOI 10.1002/adma.200802849; Damjanovic D, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3479479; Damjanovic D, 2009, IEEE T ULTRASON FERR, V56, P1574, DOI 10.1109/TUFFC.2009.1222; Davis M, 2007, J APPL PHYS, V101, DOI 10.1063/1.2653925; Dycus JH, 2015, MICROSC MICROANAL, V21, P946, DOI 10.1017/S1431927615013732; Fu HX, 2000, NATURE, V403, P281, DOI 10.1038/35002022; Gao YK, 2002, J APPL PHYS, V92, P2094, DOI 10.1063/1.1490617; Grinberg I, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.144118; GUNTER P, 1977, J APPL PHYS, V48, P3475, DOI 10.1063/1.324196; Hackenberger W., 2018, U. S. patent, Patent No. [application 62/ 553,511, 62553511]; HAUN MJ, 1989, FERROELECTRICS, V99, P13, DOI 10.1080/00150198908221436; HILTON AD, 1990, J MATER SCI, V25, P3461, DOI 10.1007/BF00575371; Hlinka J, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/10/105709; Hou D, 2017, J APPL PHYS, V122, DOI 10.1063/1.4989393; Huang Y, 2017, IEEE T ULTRASON FERR, V64, P1617, DOI 10.1109/TUFFC.2017.2735800; KIM N, 1989, FERROELECTRICS, V93, P341, DOI 10.1080/00150198908017366; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Krogstad MJ, 2018, NAT MATER, V17, P718, DOI 10.1038/s41563-018-0112-7; Kutnjak Z, 2006, NATURE, V441, P956, DOI 10.1038/nature04854; LeBeau JM, 2010, ULTRAMICROSCOPY, V110, P118, DOI 10.1016/j.ultramic.2009.10.001; Li F, 2018, NAT MATER, V17, P349, DOI 10.1038/s41563-018-0034-4; Li F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13807; Li F, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4802792; Li F, 2010, J APPL PHYS, V108, DOI 10.1063/1.3466978; Liu H, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.055501; Luo J, 2014, CRYSTALS, V4, P306, DOI 10.3390/cryst4030306; Manley ME, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501814; Nakamoto R, 2017, PHYS REV B, V95, DOI 10.1103/PhysRevB.95.024434; Noheda B, 2002, CURR OPIN SOLID ST M, V6, P27, DOI 10.1016/S1359-0286(02)00015-3; Park SE, 1997, J APPL PHYS, V82, P1804, DOI 10.1063/1.365983; Perdew JP, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.136406; Phelan D, 2015, PHASE TRANSIT, V88, P283, DOI 10.1080/01411594.2014.989226; Phelan D, 2014, P NATL ACAD SCI USA, V111, P1754, DOI 10.1073/pnas.1314780111; Prosandeev S, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.180102; Rabe KA, 2007, TOP APPL PHYS, V105, P1; Rafalovskyi I, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.064110; Sang XH, 2014, MICROSC MICROANAL, V20, P1764, DOI 10.1017/S1431927614013506; Service RF, 1997, SCIENCE, V275, P1878, DOI 10.1126/science.275.5308.1878; Shannigrahi SR, 2004, J EUR CERAM SOC, V24, P163, DOI 10.1016/S0955-2219(03)00316-9; Shung KK, 1996, IEEE ENG MED BIOL, V15, P20, DOI 10.1109/51.544509; Sun EW, 2014, PROG MATER SCI, V65, P124, DOI 10.1016/j.pmatsci.2014.03.006; Takenaka H, 2017, NATURE, V546, P391, DOI 10.1038/nature22068; Tan HX, 2018, PHYS REV B, V97, DOI 10.1103/PhysRevB.97.174101; Tian J, 2007, IEEE T ULTRASON FERR, V54, P1895, DOI 10.1109/TUFFC.2007.474; Wang YJ, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.134107; Wu JG, 2015, CHEM REV, V115, P2559, DOI 10.1021/cr5006809; Xu GY, 2008, NAT MATER, V7, P562, DOI 10.1038/nmat2196; Ye ZG, 2009, MRS BULL, V34, P277, DOI 10.1557/mrs2009.79; Zhang R, 2003, APPL PHYS LETT, V82, P787, DOI 10.1063/1.1541937; Zhang S. J., 2012, J APPL PHYS, V111; Zhang SJ, 2015, PROG MATER SCI, V68, P1, DOI 10.1016/j.pmatsci.2014.10.002	56	368	371	100	844	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2019	364	6437					264	+		10.1126/science.aaw2781	http://dx.doi.org/10.1126/science.aaw2781			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HU0JG	31000659				2022-12-28	WOS:000464956600045
J	Wienert, B; Wyman, SK; Richardson, CD; Yeh, CD; Akcakaya, P; Porritt, MJ; Morlock, M; Vu, JT; Kazane, KR; Watry, HL; Judge, LM; Conklin, BR; Maresca, M; Corn, JE				Wienert, Beeke; Wyman, Stacia K.; Richardson, Christopher D.; Yeh, Charles D.; Akcakaya, Pinar; Porritt, Michelle J.; Morlock, Michaela; Vu, Jonathan T.; Kazane, Katelynn R.; Watry, Hannah L.; Judge, Luke M.; Conklin, Bruce R.; Maresca, Marcello; Corn, Jacob E.			Unbiased detection of CRISPR off-targets in vivo using DISCOVER-Seq	SCIENCE			English	Article							GENOME; CAS9; ENDONUCLEASE; DYNAMICS; IMPACT	CRISPR-Cas genome editing induces targeted DNA damage but can also affect off-target sites. Current off-target discovery methods work using purified DNA or specific cellular models but are incapable of direct detection in vivo. We developed DISCOVER-Seq (discovery of in situ Cas off-targets and verification by sequencing), a universally applicable approach for unbiased off-target identification that leverages the recruitment of DNA repair factors in cells and organisms. Tracking the precise recruitment of MRE11 uncovers the molecular nature of Cas activity in cells with single-base resolution. DISCOVER-Seq works with multiple guide RNA formats and types of Cas enzymes, allowing characterization of new editing tools. Off-targets can be identified in cell lines and patient-derived induced pluripotent stem cells and during adenoviral editing of mice, paving the way for in situ off-target discovery within individual patient genotypes during therapeutic genome editing.	[Wienert, Beeke; Wyman, Stacia K.; Richardson, Christopher D.; Yeh, Charles D.; Vu, Jonathan T.; Kazane, Katelynn R.; Watry, Hannah L.; Corn, Jacob E.] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94704 USA; [Wienert, Beeke; Richardson, Christopher D.; Yeh, Charles D.; Kazane, Katelynn R.; Corn, Jacob E.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Wienert, Beeke; Watry, Hannah L.; Judge, Luke M.; Conklin, Bruce R.] Gladstone Inst, San Francisco, CA 94158 USA; [Akcakaya, Pinar; Porritt, Michelle J.; Morlock, Michaela; Maresca, Marcello] AstraZeneca, Discovery Biol, S-43150 Gothenburg, Sweden; [Judge, Luke M.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Conklin, Bruce R.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Conklin, Bruce R.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; [Conklin, Bruce R.] Univ Calif San Francisco, Dept Pharmacol, San Francisco, CA 94143 USA; [Yeh, Charles D.; Corn, Jacob E.] Swiss Fed Inst Technol, Dept Biol, CH-8092 Zurich, Switzerland	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco; The J David Gladstone Institutes; AstraZeneca; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Swiss Federal Institutes of Technology Domain; ETH Zurich	Corn, JE (corresponding author), Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94704 USA.; Corn, JE (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Corn, JE (corresponding author), Swiss Fed Inst Technol, Dept Biol, CH-8092 Zurich, Switzerland.	jacob.corn@biol.ethz.ch		Wyman, Stacia/0000-0002-8937-8397; Vu, Jonathan/0000-0002-4950-7967; Conklin, Bruce/0000-0003-1463-6061; Richardson, Chris/0000-0003-3122-4851; Porritt, Michelle/0000-0003-1700-0085; Wienert, Beeke/0000-0002-9867-0795; Kazane, Katelynn/0000-0003-3782-5666	Li Ka Shing Foundation; Heritage Medical Research Institute; National Heart, Lung, and Blood Institute of the NIH [DP2-HL-141006]; Fanconi Anemia Research Foundation; CIRM [TRAN1-09292]; Sir Keith Murdoch Fellowship from the American Australian Association; NHMRC Early Career Fellowship; NIH Instrumentation grant [S10 OD018174]; NATIONAL EYE INSTITUTE [R01EY028249] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [DP2HL141006, R01HL130533, R01HL135358] Funding Source: NIH RePORTER	Li Ka Shing Foundation; Heritage Medical Research Institute; National Heart, Lung, and Blood Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Fanconi Anemia Research Foundation; CIRM(California Institute for Regenerative Medicine); Sir Keith Murdoch Fellowship from the American Australian Association; NHMRC Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NIH Instrumentation grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	J.E.C., B.W., C.D.R., S.K.W., C.D.Y., and K.R.K. are supported by the Li Ka Shing Foundation and the Heritage Medical Research Institute. J.E.C. is supported by the National Heart, Lung, and Blood Institute of the NIH under DP2-HL-141006. C.D.R. is supported by the Fanconi Anemia Research Foundation. J.T.V. is supported by CIRM TRAN1-09292. B.W. is supported by the Fanconi Anemia Research Foundation, a Sir Keith Murdoch Fellowship from the American Australian Association, and an NHMRC Early Career Fellowship. This work used the Vincent J. Coates Genomics Sequencing Laboratory at UC Berkeley, which is supported by NIH Instrumentation grant S10 OD018174.	Akcakaya P, 2018, NATURE, V561, P416, DOI 10.1038/s41586-018-0500-9; Aleksandrov R, 2018, MOL CELL, V69, P1046, DOI 10.1016/j.molcel.2018.02.016; Cameron P, 2017, NAT METHODS, V14, P600, DOI [10.1038/nmeth.4284, 10.1038/NMETH.4284]; Chen XY, 2016, NUCLEIC ACIDS RES, V44, P6482, DOI 10.1093/nar/gkw524; Clarke R, 2018, MOL CELL, V71, P42, DOI 10.1016/j.molcel.2018.06.005; Connelly JC, 2002, TRENDS BIOCHEM SCI, V27, P410, DOI 10.1016/S0968-0004(02)02144-8; Crosetto N, 2013, NAT METHODS, V10, P361, DOI 10.1038/nmeth.2408; Daer RM, 2017, ACS SYNTH BIOL, V6, P428, DOI 10.1021/acssynbio.5b00299; Dai Wei-Jing, 2016, Mol Ther Nucleic Acids, V5, pe349, DOI 10.1038/mtna.2016.58; DeWitt MA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9336; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Hsiau T, 2018, BIORXIV, DOI [10.1101/251082, DOI 10.1101/251082]; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kallimasioti-Pazi EM, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005595; Kim D, 2018, GENOME RES, V28, P1894, DOI 10.1101/gr.236620.118; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/nmeth.3284, 10.1038/NMETH.3284]; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Knight SC, 2015, SCIENCE, V350, P823, DOI 10.1126/science.aac6572; Kosicki M, 2018, NAT BIOTECHNOL, V36, P765, DOI 10.1038/nbt.4192; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Pinello L, 2016, NAT BIOTECHNOL, V34, P695, DOI 10.1038/nbt.3583; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Shen MW, 2018, NATURE, V563, P646, DOI 10.1038/s41586-018-0686-x; Shou J, 2018, MOL CELL, V71, P498, DOI 10.1016/j.molcel.2018.06.021; Taheri-Ghahfarokhi A, 2018, NUCLEIC ACIDS RES, V46, P8417, DOI 10.1093/nar/gky653; Tsai SQ, 2017, NAT METHODS, V14, P607, DOI [10.1038/NMETH.4278, 10.1038/nmeth.4278]; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Vakulskas CA, 2018, NAT MED, V24, P1216, DOI 10.1038/s41591-018-0137-0; van Overbeek M, 2016, MOL CELL, V63, P633, DOI 10.1016/j.molcel.2016.06.037; Verkuijl SAN, 2019, CURR OPIN BIOTECH, V55, P68, DOI 10.1016/j.copbio.2018.07.005; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Yan WX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15058; Yarrington RM, 2018, P NATL ACAD SCI USA, V115, P9351, DOI 10.1073/pnas.1810062115; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	36	177	183	4	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2019	364	6437					286	+		10.1126/science.aav9023	http://dx.doi.org/10.1126/science.aav9023			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HU0JG	31000663	Green Accepted, Green Submitted			2022-12-28	WOS:000464956600051
J	Gestaut, D; Roh, SH; Ma, BX; Pintilie, G; Joachimiak, LA; Leitner, A; Walzthoeni, T; Aebersold, R; Chiu, W; Frydman, J				Gestaut, Daniel; Roh, Soung Hun; Ma, Boxue; Pintilie, Grigore; Joachimiak, Lukasz A.; Leitner, Alexander; Walzthoeni, Thomas; Aebersold, Ruedi; Chiu, Wah; Frydman, Judith			The Chaperonin TRiC/CCT Associates with Prefoldin through a Conserved Electrostatic Interface Essential for Cellular Proteostasis	CELL			English	Article							IN-VIVO; PROTEINS; RESOLUTION; COMPLEXES; BINDING; ACTIN; PURIFICATION; AGGREGATION; POLYPEPTIDE; REFINEMENT	Maintaining proteostasis in eukaryotic protein folding involves cooperation of distinct chaperone systems. To understand how the essential ring-shaped chaperonin TRiC/CCT cooperates with the chaperone prefoldin/GIMc (PFD), we integrate cryoelectron microscopy (cryo-EM), crosslinking-masss-pectrometry and biochemical and cellular approaches to elucidate the structural and functional interplay between TRiC/CCT and PFD. We find these hetero-oligomeric chaperones associate in a defined architecture, through a conserved interface of electrostatic contacts that serves as a pivot point for a TRiC-PFD conformational cycle. PFD alternates between an open "latched" conformation and a closed "engaged" conformation that aligns the PFD-TRiC substrate binding chambers. PFD can act after TRiC bound its substrates to enhance the rate and yield of the folding reaction, suppressing non-productive reaction cycles. Disrupting the TRiC-PFD interaction in vivo is strongly deleterious, leading to accumulation of amyloid aggregates. The supra-chaperone assembly formed by PFD and TRiC is essential to prevent toxic conformations and ensure effective cellular proteostasis.	[Gestaut, Daniel; Joachimiak, Lukasz A.; Frydman, Judith] Stanford Univ, Dept Biol & Genet, Stanford, CA 94305 USA; [Roh, Soung Hun; Pintilie, Grigore] Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea; [Ma, Boxue] Baylor Coll Med, Houston, TX 77030 USA; [Joachimiak, Lukasz A.] UTSouthwestern, Dept Biochem, North Campus, Dallas, TX 75390 USA; [Leitner, Alexander; Walzthoeni, Thomas; Aebersold, Ruedi] Swiss Fed Inst Technol, Dept Biol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Walzthoeni, Thomas] Univ Zurich, Mol Life Sci, ETH Zurich, CH-8057 Zurich, Switzerland; [Walzthoeni, Thomas] Helmholtz Zentrum Munchen, Inst Computat Biol, D-85764 Neuherberg, Germany; [Aebersold, Ruedi] Univ Zurich, Fac Sci, Zurich, Switzerland; [Chiu, Wah] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Stanford University; Seoul National University (SNU); Baylor College of Medicine; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Zurich; Stanford University	Frydman, J (corresponding author), Stanford Univ, Dept Biol & Genet, Stanford, CA 94305 USA.	jfrydman@stanford.edu	Leitner, Alexander/U-1601-2019	Leitner, Alexander/0000-0003-4126-0725; , judith/0000-0003-2302-6943; Pintilie, Grigore/0000-0002-0848-5335	NIH [R01GM074074, F32GM103124, P41GM103832, R01GM079429, P01NS092525]; ERC (AdvG) [233226, 670821]; NRF [2019R1C1C004598]; Seoul National University Settlement; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074074, P41GM103832, R01GM079429, U24GM129541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS092525] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERC (AdvG); NRF; Seoul National University Settlement; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank P. Aliaga and K. Goncalves for help in yeast strain production; K. Rainbolt and R. Samant for advice on Proteostat staining; E. Sontag for help with fluorescence microscopy; R. Aviner; K. Li, and Al Burlingame for help with mass spectrometry; R. Andino and K. Dalton for discussions and comments on the manuscript; and the Frydman lab for useful advice and discussions. CryoEM data were collected at NCMI and processed at the CIBR at Baylor College of Medicine. This work was supported by NIH (R01GM074074 to J.F., F32GM103124 to D.G., P41GM103832 and R01GM079429 to W.C., and P01NS092525 to W.C. and J.F.), the ERC (AdvG #233226 and AdvG #670821 to R.A.), Seoul National University Settlement, and NRF (2019R1C1C004598 to S.H.R).	Abe A, 2013, J BIOL CHEM, V288, P27764, DOI 10.1074/jbc.M113.476358; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Bai XC, 2015, ELIFE, V4, DOI 10.7554/eLife.11182; Balchin D, 2018, CELL, V174, P1507, DOI 10.1016/j.cell.2018.07.006; Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Bell JM, 2016, METHODS, V100, P25, DOI 10.1016/j.ymeth.2016.02.018; Chakraborty K, 2010, CELL, V142, P112, DOI 10.1016/j.cell.2010.05.027; Comyn SA, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006184; Costanzo M, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1420; Ferreyra RG, 2000, METH MOL B, V140, P153; Frydman J, 1996, SCIENCE, V272, P1497, DOI 10.1126/science.272.5267.1497; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; GAO YJ, 1992, CELL, V69, P1043, DOI 10.1016/0092-8674(92)90622-J; Geissler S, 1998, EMBO J, V17, P952, DOI 10.1093/emboj/17.4.952; Greber BJ, 2014, NATURE, V505, P515, DOI 10.1038/nature12890; Hansen WJ, 1999, J CELL BIOL, V145, P265, DOI 10.1083/jcb.145.2.265; Ilca SL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9843; Joachimiak LA, 2014, CELL, V159, P1042, DOI 10.1016/j.cell.2014.10.042; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leitner A, 2014, NAT PROTOC, V9, P120, DOI 10.1038/nprot.2013.168; Leitner A, 2012, STRUCTURE, V20, P814, DOI 10.1016/j.str.2012.03.007; Li D, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/484528; Lopez T, 2015, J MOL BIOL, V427, P2919, DOI 10.1016/j.jmb.2015.04.013; Lopez V, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-182; Martin-Benito J, 2002, EMBO J, V21, P6377, DOI 10.1093/emboj/cdf640; Melville MW, 2003, MOL CELL BIOL, V23, P3141, DOI 10.1128/MCB.23.9.3141-3151.2003; Meyer AS, 2003, CELL, V113, P369, DOI 10.1016/S0092-8674(03)00307-6; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pintilie G, 2016, BIOPHYS J, V110, P827, DOI 10.1016/j.bpj.2015.11.3522; Reissmann S, 2007, NAT STRUCT MOL BIOL, V14, P432, DOI 10.1038/nsmb1236; Reissmann S, 2012, CELL REP, V2, P866, DOI 10.1016/j.celrep.2012.08.036; Roh SH, 2017, P NATL ACAD SCI USA, V114, P8259, DOI 10.1073/pnas.1704725114; Russmann F, 2012, P NATL ACAD SCI USA, V109, P21208, DOI 10.1073/pnas.1218836109; Ryan Owen W, 2016, Cold Spring Harb Protoc, V2016, DOI 10.1101/pdb.prot086827; Sahlan M, 2010, J MOL BIOL, V399, P628, DOI 10.1016/j.jmb.2010.04.046; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Shen K, 2012, PROTEIN QUALITY CONT; Siegers K, 1999, EMBO J, V18, P75, DOI 10.1093/emboj/18.1.75; Siegert R, 2000, CELL, V103, P621, DOI 10.1016/S0092-8674(00)00165-3; Sot B, 2017, SCI REP-UK, V7, DOI 10.1038/srep40859; Spiess C, 2006, MOL CELL, V24, P25, DOI 10.1016/j.molcel.2006.09.003; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Tan S, 2001, PROTEIN EXPRES PURIF, V21, P224, DOI 10.1006/prep.2000.1363; Tashiro E, 2013, J BIOL CHEM, V288, P19958, DOI 10.1074/jbc.M113.477984; Thulasiraman V, 2000, METH MOL B, V140, P161; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Vainberg IE, 1998, CELL, V93, P863, DOI 10.1016/S0092-8674(00)81446-4; Walzthoeni T, 2012, NAT METHODS, V9, P901, DOI 10.1038/nmeth.2103; Willmund F, 2013, CELL, V152, P196, DOI 10.1016/j.cell.2012.12.001; Xu Y, 2013, FASEB J, V27, P4799, DOI 10.1096/fj.13-235127; Yam AY, 2008, NAT STRUCT MOL BIOL, V15, P1255, DOI 10.1038/nsmb.1515; Zako T, 2006, J MOL BIOL, V364, P110, DOI 10.1016/j.jmb.2006.08.088; Zang YX, 2016, NAT STRUCT MOL BIOL, V23, P1083, DOI 10.1038/nsmb.3309	54	41	41	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2019	177	3					751	+		10.1016/j.cell.2019.03.012	http://dx.doi.org/10.1016/j.cell.2019.03.012			30	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HU0FV	30955883	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000464947700026
J	Horwitz, SB				Horwitz, Susan Band			Reflections on My Life with Taxol	CELL			English	Editorial Material																			0	2	2	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2019	177	3					502	505		10.1016/j.cell.2019.03.031	http://dx.doi.org/10.1016/j.cell.2019.03.031			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HU0FV	30952446	Bronze			2022-12-28	WOS:000464947700003
J	Lytle, NK; Ferguson, LP; Rajbhandari, N; Gilroy, K; Fox, RG; Deshpande, A; Schurch, CM; Hamilton, M; Robertson, N; Noel, P; Wartenberg, M; Zlobec, I; Eichmann, M; Galvan, JA; Karamitopoulou, E; Gilderman, T; Esparza, LA; Shima, Y; Spahn, P; French, R; Lewis, NE; Fisch, KM; Sasik, R; Rosenthal, SB; Kritzik, M; Von Hoff, D; Han, HY; Ideker, T; Deshpande, AJ; Lowy, AM; Adams, PD; Reya, T; Lin, W				Lytle, Nikki K.; Ferguson, L. Paige; Rajbhandari, Nirakar; Gilroy, Kathryn; Fox, Raymond G.; Deshpande, Anagha; Schurch, Christian M.; Hamilton, Michael; Robertson, Neil; Noel, Pawan; Wartenberg, Martin; Zlobec, Inti; Eichmann, Micha; Galvan, Jose A.; Karamitopoulou, Eva; Gilderman, Tami; Esparza, Lourdes Adriana; Shima, Yutaka; Spahn, Philipp; French, Randall; Lewis, Nathan E.; Fisch, Kathleen M.; Sasik, Roman; Rosenthal, Sara Brin; Kritzik, Marcie; Von Hoff, Daniel; Han, Haiyong; Ideker, Trey; Deshpande, Aniruddha J.; Lowy, Andrew M.; Adams, Peter D.; Reya, Tannishtha; Lin, Wei			A Multiscale Map of the Stem Cell State in Pancreatic Adenocarcinoma	CELL			English	Article							SET ENRICHMENT ANALYSIS; LENTIVIRUS VECTOR; SUPER-ENHANCERS; READ ALIGNMENT; CANCER; EXPRESSION; GENE; IDENTIFICATION; POPULATIONS; MICROARRAY	Drug resistance and relapse remain key challenges in pancreatic cancer. Here, we have used RNA sequencing (RNA-seq), chromatin immunoprecipitation (ChIP)-seq, and genome-wide CRISPR analysis to map the molecular dependencies of pancreatic cancer stem cells, highly therapy-resistant cells that preferentially drive tumorigenesis and progression. This integrated genomic approach revealed an unexpected utilization of immuno-regulatory signals by pancreatic cancer epithelial cells. In particular, the nuclear hormone receptor retinoic-acid-receptor-related orphan receptor gamma (ROR gamma), known to drive inflammation and T cell differentiation, was upregulated during pancreatic cancer progression, and its genetic or pharmacologic inhibition led to a striking defect in pancreatic cancer growth and a marked improvement in survival. Further, a large-scale retrospective analysis in patients revealed that ROR gamma expression may predict pancreatic cancer aggressiveness, as it positively correlated with advanced disease and metastasis. Collectively, these data identify an orthogonal co-option of immuno-regulatory signals by pancreatic cancer stem cells, suggesting that autoimmune drugs should be evaluated as novel treatment strategies for pancratic cancer patients.	[Lytle, Nikki K.; Ferguson, L. Paige; Rajbhandari, Nirakar; Fox, Raymond G.; Hamilton, Michael; Gilderman, Tami; Esparza, Lourdes Adriana; Shima, Yutaka; Kritzik, Marcie; Reya, Tannishtha] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; [Lytle, Nikki K.; Ferguson, L. Paige; Rajbhandari, Nirakar; Fox, Raymond G.; Hamilton, Michael; Gilderman, Tami; Esparza, Lourdes Adriana; Shima, Yutaka; Kritzik, Marcie; Reya, Tannishtha] Sanford Consortium Regenerat Med, La Jolla, CA 92037 USA; [Gilroy, Kathryn; Robertson, Neil; Adams, Peter D.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Canc Sci, Glasgow G61 1BD, Lanark, Scotland; [Deshpande, Anagha; Deshpande, Aniruddha J.; Adams, Peter D.] Sanford Burnham Prebys Med Discovery Inst, NCI Designated Canc Ctr, Tumor Initiat & Maintenance Program, La Jolla, CA USA; [Schurch, Christian M.] Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Sch Med, 269 Campus Dr, Stanford, CA 94305 USA; [Noel, Pawan; Von Hoff, Daniel; Han, Haiyong; Lin, Wei] Translat Genom Res Inst, Mol Med Div, Phoenix, AZ USA; [Wartenberg, Martin; Zlobec, Inti; Eichmann, Micha; Galvan, Jose A.; Karamitopoulou, Eva] Univ Bern, Inst Pathol, Murtenstr 31, CH-3008 Bern, Switzerland; [Spahn, Philipp; Lewis, Nathan E.] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; [Spahn, Philipp; Lewis, Nathan E.] Univ Calif San Diego, Sch Med, Novo Nord Fdn Ctr Biosustainabil, La Jolla, CA 92093 USA; [French, Randall; Ideker, Trey; Lowy, Andrew M.; Reya, Tannishtha] Univ Calif San Diego, Sch Med, Moores Canc Ctr, La Jolla, CA 92093 USA; [Fisch, Kathleen M.; Sasik, Roman; Rosenthal, Sara Brin] Univ Calif San Diego, Sch Med, Ctr Computat Biol & Bioinformat, La Jolla, CA 92093 USA; [Ideker, Trey; Reya, Tannishtha] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Lowy, Andrew M.] Univ Calif San Diego, Sch Med, Dept Surg, Div Surg Oncol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of Glasgow; Sanford Burnham Prebys Medical Discovery Institute; Stanford University; Translational Genomics Research Institute; University of Bern; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Reya, T (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA.; Reya, T (corresponding author), Sanford Consortium Regenerat Med, La Jolla, CA 92037 USA.; Reya, T (corresponding author), Univ Calif San Diego, Sch Med, Moores Canc Ctr, La Jolla, CA 92093 USA.; Reya, T (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA.	treya@ucsd.edu	Schürch, Christian/L-6188-2019; Wartenberg, Martin/AAX-1538-2021; Rosenthal, Sara Brin/J-3366-2019; Lin, Wei/AAH-9924-2019; /C-7753-2013	Schürch, Christian/0000-0002-1792-1768; Lin, Wei/0000-0002-7506-3466; Wartenberg, Martin/0000-0002-5378-3825; Karamitopoulou-Diamantis, Eva/0000-0002-4833-1373; /0000-0003-3138-7642; Robertson, Neil/0000-0002-9509-1157; Ideker, Trey/0000-0002-1708-8454; Adams, Peter/0000-0002-0684-1770; Zlobec, Inti/0000-0001-6741-3000; Gilroy, Kathryn/0000-0003-4607-194X; Eichmann, Micha/0000-0001-6283-659X; Rosenthal, Sara Brin/0000-0002-6548-9658; Ferguson, Lesley/0000-0001-7071-1594	T32 GM007752; Ruth L. Kirschstein National Research Service Award [F31 CA206416]; NIH [UL1TR001442]; CRUK [C10652-A16566, CA169281]; National Foundation for Cancer Research [R35 GM119850, NNF10CC1016517, CA155620, R35 CA197699, R01 CA186043]; SU2C-CRUK-Lustgarten Foundation Pancreatic Cancer Dream Team Research Grant [SU2C-AACR-DT-20-16]; SU2C-Lustgarten Foundation pancreatic cancer collective grant [SU2C-AACR-PCC-05-18]; NATIONAL CANCER INSTITUTE [R01CA155620, R35CA197699, R01CA186043, R01CA169281, F31CA206416] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001442] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL086344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752, R35GM119850] Funding Source: NIH RePORTER	T32 GM007752; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CRUK(Cancer Research UK); National Foundation for Cancer Research; SU2C-CRUK-Lustgarten Foundation Pancreatic Cancer Dream Team Research Grant; SU2C-Lustgarten Foundation pancreatic cancer collective grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Olivier Harismendy, Prashant Mali, and Kristen Jepsen for help with the CRISPR screen design; Dan Littman for comments on the manuscript; Michael Karin and Ron Evans for scientific advice; Christopher Wright for providing the Ptf1a-Cre mice; and Armin Ahmadi and Kendall Chambers for technical support. N.K.L. received support from T32 GM007752 and a Ruth L. Kirschstein National Research Service Award F31 CA206416; L.P.F. received support from T32 GM007752. The project was partially supported by the NIH grant UL1TR001442, as well as by CRUK program C10652-A16566 to P.D.A, CA169281 to H.H. and D.V.H., a grant from the National Foundation for Cancer Research to D.V.H., R35 GM119850 and NNF10CC1016517 to N.E.L., CA155620 to A.M.L., R35 CA197699 to T.R., and R01 CA186043 to A.M.L and T.R. This work was also supported by an SU2C-CRUK-Lustgarten Foundation Pancreatic Cancer Dream Team Research Grant (SU2C-AACR-DT-20-16) to D.V.H., H.H., A.M.L., and T.R. and an SU2C-Lustgarten Foundation pancreatic cancer collective grant (SU2C-AACR-PCC-05-18) to A.M.L. and T.R. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bailey JM, 2014, GASTROENTEROLOGY, V146, P245, DOI 10.1053/j.gastro.2013.09.050; Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Cole JJ, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1185-3; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Cook Donald N, 2015, Nucl Receptor Res, V2; Deshpande AJ, 2014, CANCER CELL, V26, P896, DOI 10.1016/j.ccell.2014.10.009; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Dwyer JR, 2012, P NATL ACAD SCI USA, V109, pE2486, DOI 10.1073/pnas.1205221109; Efron B, 2002, GENET EPIDEMIOL, V23, P70, DOI 10.1002/gepi.1124; Fox RG, 2016, NATURE, V534, P407, DOI 10.1038/nature17988; Gege C, 2016, EXPERT OPIN THER PAT, V26, P737, DOI 10.1517/13543776.2016.1153066; Grosse-Wilde A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126522; Guillonneau C, 2017, CELL MOL LIFE SCI, V74, P2569, DOI 10.1007/s00018-017-2482-4; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Huh JR, 2012, EUR J IMMUNOL, V42, P2232, DOI 10.1002/eji.201242740; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Kawamoto M, 2009, HUM PATHOL, V40, P189, DOI 10.1016/j.humpath.2008.02.022; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kopp JL, 2012, CANCER CELL, V22, P737, DOI 10.1016/j.ccr.2012.10.025; Kumar N, 2012, ACS CHEM BIOL, V7, P672, DOI 10.1021/cb200496y; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li CW, 2011, GASTROENTEROLOGY, V141, P2218, DOI 10.1053/j.gastro.2011.08.009; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Lonnstedt I, 2002, STAT SINICA, V12, P31; Lu HQ, 2017, CELL REP, V18, P1946, DOI 10.1016/j.celrep.2017.02.001; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; MORGAN RT, 1980, INT J CANCER, V25, P591, DOI 10.1002/ijc.2910250507; Neph S, 2012, CELL, V150, P1274, DOI 10.1016/j.cell.2012.04.040; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Pimentel H, 2017, NAT METHODS, V14, P687, DOI 10.1038/nmeth.4324; Rasheed ZA, 2010, JNCI-J NATL CANCER I, V102, P340, DOI 10.1093/jnci/djp535; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rosenthal SB, 2018, BIOINFORMATICS, V34, P126, DOI 10.1093/bioinformatics/btx581; Rovira M, 2010, P NATL ACAD SCI USA, V107, P75, DOI 10.1073/pnas.0912589107; Ryu CS, 2011, TOXICOL APPL PHARM, V255, P94, DOI 10.1016/j.taap.2011.06.004; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sankhala KK, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.11078; Sena-Esteves M, 2004, J VIROL METHODS, V122, P131, DOI 10.1016/j.jviromet.2004.08.017; Spahn PN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16193-9; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Van den Broeck A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073968; van Laarhoven T., 2012, PATTERN RECOGNITION; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; Wang J, 2017, NUCLEIC ACIDS RES, V45, pW130, DOI 10.1093/nar/gkx356; Wang JJ, 2016, NAT MED, V22, P488, DOI 10.1038/nm.4070; Wang XT, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a028548; Wartenberg M, 2018, CLIN CANCER RES, V24, P4444, DOI 10.1158/1078-0432.CCR-17-3401; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Xie P., 2018, BIORXIV, DOI [10.1101/416719, DOI 10.1101/416719]; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhao LH, 2015, P NATL ACAD SCI USA, V112, P12962, DOI 10.1073/pnas.1516733112; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237	69	73	74	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2019	177	3					572	+		10.1016/j.cell.2019.03.010	http://dx.doi.org/10.1016/j.cell.2019.03.010			37	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HU0FV	30955884	Green Accepted, Bronze			2022-12-28	WOS:000464947700013
J	Lum, E; Jimenez, G; Huang, ZL; Thai, L; Semwal, M; Boehm, BO; Car, J				Lum, Elaine; Jimenez, Geronimo; Huang, Zhilian; Linh Thai; Semwal, Monika; Boehm, Bernhard O.; Car, Josip			Decision Support and Alerts of Apps for Self-management of Blood Glucose for Type 2 Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Lum, Elaine; Jimenez, Geronimo; Huang, Zhilian; Linh Thai; Semwal, Monika; Car, Josip] Nanyang Technol Univ, Ctr Populat Hlth Sci CePHaS, Singapore, Singapore; [Boehm, Bernhard O.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Car, J (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, CePHaS, 11 Mandalay Rd,Level 18,Clin Sci Bldg, Singapore 308232, Singapore.	josip.car@ntu.edu.sg	Jimenez, Geronimo/J-4131-2019; Car, Josip/H-6755-2015	Jimenez, Geronimo/0000-0002-1304-426X; Car, Josip/0000-0001-8969-371X; Thai, Linh/0000-0002-2230-0712; Lum, Elaine/0000-0002-0853-3018	Nanyang Technological University, Singapore, through the CePHaS; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Ageing Research Institute for Society and Education, Nanyang Technological University, Singapore; Nanyang Technological University	Nanyang Technological University, Singapore, through the CePHaS(Nanyang Technological University); Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore(Nanyang Technological University); Ageing Research Institute for Society and Education, Nanyang Technological University, Singapore(Nanyang Technological University); Nanyang Technological University(Nanyang Technological University)	This study was funded by Nanyang Technological University, Singapore, through the CePHaS, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, and the Ageing Research Institute for Society and Education, Nanyang Technological University, Singapore. Ms Huang received research scholarship support from Nanyang Technological University.	Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS55, DOI 10.2337/dc18-S006; Hou C, 2016, DIABETES CARE, V39, P2089, DOI 10.2337/dc16-0346; Shuren J, 2018, JAMA-J AM MED ASSOC, V320, P337, DOI 10.1001/jama.2018.8832; Veazie S, 2018, J GEN INTERN MED, V33, P1167, DOI 10.1007/s11606-018-4410-1	4	15	17	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 16	2019	321	15					1530	1532		10.1001/jama.2019.1644	http://dx.doi.org/10.1001/jama.2019.1644			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HT7SY	30990543	Bronze, Green Published			2022-12-28	WOS:000464765900020
J	Paules, CI; Marston, HD; Fauci, AS				Paules, Catharine I.; Marston, Hilary D.; Fauci, Anthony S.			Measles in 2019-Going Backward	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Recent increases in measles cases in the United States mirror patterns in other countries that had previously eliminated the virus. This resurgence is all the more frustrating since the disease is entirely preventable through vaccination.	[Paules, Catharine I.] Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Infect Dis, Hershey, PA 17033 USA; [Marston, Hilary D.; Fauci, Anthony S.] NIAID, Off Director, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Paules, CI (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Infect Dis, Hershey, PA 17033 USA.			Paules, Catharine/0000-0002-9064-6678				Dabbagh A, 2018, MMWR-MORBID MORTAL W, V67, P1323, DOI 10.15585/mmwr.mm6747a6; Ge YL, 2017, CHINESE MED J-PEKING, V130, P1320, DOI 10.4103/0366-6999.206358; Moss WJ, 2017, LANCET, V390, P2490, DOI 10.1016/S0140-6736(17)31463-0; Rota PA, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.49; THORNTON J, 2019, BMJ-BRIT MED J, V364, P28117, DOI DOI 10.1136/BMJ.L634	5	80	88	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 6	2019	380	23					2185	2187		10.1056/NEJMp1905099	http://dx.doi.org/10.1056/NEJMp1905099			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IC4KH	30995368	Bronze			2022-12-28	WOS:000470933900002
J	Hendricks-Sturrup, RM; Prince, AER; Lu, CY				Hendricks-Sturrup, Rachele M.; Prince, Anya E. R.; Lu, Christine Y.			Direct-to-Consumer Genetic Testing and Potential Loopholes in Protecting Consumer Privacy and Nondiscrimination	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Hendricks-Sturrup, Rachele M.; Lu, Christine Y.] Harvard Pilgrim Hlth Care Inst, Dept Populat Med, Precis Med Translat Res PROMoTeR Ctr, Boston, MA USA; [Hendricks-Sturrup, Rachele M.; Lu, Christine Y.] Harvard Med Sch, Boston, MA 02115 USA; [Prince, Anya E. R.] Univ Iowa, Coll Law, Iowa City, IA 52242 USA	Harvard University; Harvard Medical School; University of Iowa	Hendricks-Sturrup, RM (corresponding author), Harvard Pilgrim Hlth Care Inst, Dept Populat Med, Landmark Ctr,401 Pk Dr,Ste 401 E, Boston, MA 02115 USA.	rachele_hendricks-sturrup@harvardpilgrim.org			Thomas O. Pyle fellowship award at Harvard Pilgrim Health Care Institute; Harvard Medical School	Thomas O. Pyle fellowship award at Harvard Pilgrim Health Care Institute; Harvard Medical School	Dr Hendricks-Sturrup is supported by a Thomas O. Pyle fellowship award at Harvard Pilgrim Health Care Institute and Harvard Medical School. Dr Lu is supported in part by an Ebert Career Development Award, Harvard Pilgrim Health Care Institute & Harvard Medical School, and reports contract with the Center for Genomic Medicine, Massachusetts General Hospital outside the submitted work. No other disclosures were reported.	[Anonymous], UND DISP ACC GEN MED; [Anonymous], PROT CONS PRIV SEC; Bollinger JM, 2013, GENET TEST MOL BIOMA, V17, P424, DOI 10.1089/gtmb.2012.0453; Guerrini CJ, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006906; Haeusermann Tobias, 2018, AJOB Empir Bioeth, V9, P207, DOI 10.1080/23294515.2018.1550123; Kim J, 2018, CELL, V175, P848, DOI 10.1016/j.cell.2018.09.008; Ram N, 2018, SCIENCE, V360, P1078, DOI 10.1126/science.aau1083	7	17	17	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 21	2019	321	19					1869	1870		10.1001/jama.2019.3384	http://dx.doi.org/10.1001/jama.2019.3384			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HZ1FC	30998825				2022-12-28	WOS:000468591200012
J	Chen, HW; Nwe, PK; Yang, Y; Rosen, CE; Bielecka, AA; Kuchroo, M; Cline, GW; Kruse, AC; Ring, AM; Crawford, JM; Palm, NW				Chen, Haiwei; Nwe, Phu-Khat; Yang, Yi; Rosen, Connor E.; Bielecka, Agata A.; Kuchroo, Manik; Cline, Gary W.; Kruse, Andrew C.; Ring, Aaron M.; Crawford, Jason M.; Palm, Noah W.			A Forward Chemical Genetic Screen Reveals Gut Microbiota Metabolites That Modulate Host Physiology	CELL			English	Article							PROTEIN-COUPLED RECEPTORS; CHAIN FATTY-ACIDS; HISTAMINE-RECEPTORS; NATURAL-PRODUCTS; AMINO-ACIDS; BACTERIA; DOPAMINE; IDENTIFICATION; ACETYLCHOLINE; DISCOVERY	The intestinal microbiota produces tens of thousands of metabolites. Here, we used host sensing of small molecules by G-protein coupled receptors (GPCRs) as a lens to illuminate bioactive microbial metabolites that impact host physiology. We screened 144 human gut bacteria against the non-olfactory GPCRome and identified dozens of bacteria that activated both well-characterized and orphan GPCRs, including strains that converted dietary histidine into histamine and shaped colonic motility; a prolific producer of the essential amino acid L-Phe, which we identified as an agonist for GPR56 and GPR97; and a species that converted L-Phe into the potent psychoactive trace amine phenethylamine, which crosses the blood-brain barrier and triggers lethal phenethylamine poisoning after monoamine oxidase inhibitor administration. These studies establish an orthogonal approach for parsing the microbiota metabolome and uncover multiple biologically relevant host-microbiota metabolome interactions.	[Chen, Haiwei; Yang, Yi; Rosen, Connor E.; Bielecka, Agata A.; Ring, Aaron M.; Palm, Noah W.] Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06510 USA; [Nwe, Phu-Khat; Crawford, Jason M.] Yale Univ, Chem Biol Inst, West Haven, CT USA; [Nwe, Phu-Khat; Crawford, Jason M.] Yale Univ, Dept Chem, West Haven, CT USA; [Nwe, Phu-Khat; Crawford, Jason M.] Yale Univ, Chem Biol Inst, New Haven, CT USA; [Nwe, Phu-Khat; Crawford, Jason M.] Yale Univ, Dept Chem, New Haven, CT USA; [Kuchroo, Manik] Yale Univ, Sch Med, New Haven, CT USA; [Cline, Gary W.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Kruse, Andrew C.] Harvard Med Sch, Blavatnik Inst, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Crawford, Jason M.] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT USA	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Harvard University; Harvard Medical School; Yale University	Palm, NW (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06510 USA.	noah.palm@yale.edu	Yang, Yi/GPX-3687-2022	Yang, Yi/0000-0002-5200-0614; Rosen, Connor/0000-0003-2442-3676; Kuchroo, Manik/0000-0001-7512-9739; Ring, Aaron/0000-0003-3699-2446; Palm, Noah/0000-0001-7262-9455	Yale University School of Medicine; Kingsley Award in Biomedical Research; Leona M. and Harry B. Helmsley Charitable Trust [3083]; Richard and Susan Smith Family Foundation; Rainin Foundation; Global Probiotics Council; National Institutes of Health [K22 AI123477, R21 AI137935, 1DP2-CA186575]; TATA Sons Limited, India [YTP-2016-002]; Juvenile Diabetes Research Foundation [2-SRA-2018-549-B]; Camille and Henry Dreyfus Foundation [TC-17-011]; Damon Runyon Cancer Research Foundation [DRR-39-16]; Burroughs Wellcome Foundation [1016720]; Yale University; NIH Director's Early Independence Award [DP5-OD023088]; Robert T. McCluskey Foundation; Artizan Biosciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI123477, R21AI137935] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD023088] Funding Source: NIH RePORTER	Yale University School of Medicine; Kingsley Award in Biomedical Research; Leona M. and Harry B. Helmsley Charitable Trust; Richard and Susan Smith Family Foundation; Rainin Foundation; Global Probiotics Council; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); TATA Sons Limited, India; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Camille and Henry Dreyfus Foundation; Damon Runyon Cancer Research Foundation; Burroughs Wellcome Foundation(Burroughs Wellcome Fund); Yale University; NIH Director's Early Independence Award; Robert T. McCluskey Foundation; Artizan Biosciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank members of the Palm laboratory for useful discussions and J. Henao-Mejia, A. Wang, and R. Medzhitov for critical reading of the manuscript. The N.W.P. lab acknowledges support from Yale University School of Medicine and the Kingsley Award in Biomedical Research, as well as the Leona M. and Harry B. Helmsley Charitable Trust (#3083); the Richard and Susan Smith Family Foundation; the Rainin Foundation; the Global Probiotics Council; the National Institutes of Health (K22 AI123477; R21 AI137935); TATA Sons Limited, India (YTP-2016-002); the Juvenile Diabetes Research Foundation (2-SRA-2018-549-B); and Artizan Biosciences. The J.M.C. lab acknowledges support from the Camille and Henry Dreyfus Foundation (TC-17-011), the Damon Runyon Cancer Research Foundation (DRR-39-16), the National Institutes of Health (1DP2-CA186575), the Burroughs Wellcome Foundation (1016720), and Yale University. The AMR lab acknowledges support from an NIH Director's Early Independence Award (DP5-OD023088) and the Robert T. McCluskey Foundation.	ADIBI SA, 1973, J CLIN INVEST, V52, P1586, DOI 10.1172/JCI107335; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Amisten S, 2013, PHARMACOL THERAPEUT, V139, P359, DOI 10.1016/j.pharmthera.2013.05.004; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Barcik W, 2016, J ALLERGY CLIN IMMUN, V138, P1491, DOI 10.1016/j.jaci.2016.05.049; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Bhushan R, 2011, J CHROMATOGR B, V879, P3148, DOI 10.1016/j.jchromb.2011.05.058; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Borowsky B, 2001, P NATL ACAD SCI USA, V98, P8966, DOI 10.1073/pnas.151105198; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cohen LJ, 2017, NATURE, V549, P48, DOI 10.1038/nature23874; Cohen LJ, 2015, P NATL ACAD SCI USA, V112, pE4825, DOI 10.1073/pnas.1508737112; Dodd D, 2017, NATURE, V551, P648, DOI 10.1038/nature24661; Donia MS, 2015, SCIENCE, V349, DOI 10.1126/science.1254766; Durocher Y, 2000, ANAL BIOCHEM, V284, P316, DOI 10.1006/abio.2000.4698; Eun CS, 2016, BMC GASTROENTEROL, V16, DOI 10.1186/s12876-016-0437-0; Fiedorowicz Jess G, 2004, J Psychiatr Pract, V10, P239, DOI 10.1097/00131746-200407000-00005; Fischbach MA, 2018, CELL, V174, P785, DOI 10.1016/j.cell.2018.07.038; GLOVER V, 1977, NATURE, V265, P80, DOI 10.1038/265080a0; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; Guo CJ, 2017, CELL, V168, P517, DOI 10.1016/j.cell.2016.12.021; Haiser HJ, 2013, SCIENCE, V341, P295, DOI 10.1126/science.1235872; Husted AS, 2017, CELL METAB, V25, P777, DOI 10.1016/j.cmet.2017.03.008; Irsfeld M., 2013, WEBMEDCENTRAL, V4, P4; Jutel M, 2009, CLIN EXP ALLERGY, V39, P1786, DOI 10.1111/j.1365-2222.2009.03374.x; Kim H, 2011, NEUROGASTROENT MOTIL, V23, P949, DOI 10.1111/j.1365-2982.2011.01760.x; Kim SH, 2000, J FOOD PROTECT, V63, P244, DOI 10.4315/0362-028X-63.2.244; Kroeze WK, 2015, NAT STRUCT MOL BIOL, V22, P362, DOI 10.1038/nsmb.3014; Larsbrink J, 2014, NATURE, V506, P498, DOI 10.1038/nature12907; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; LOVENBERG W, 1962, J BIOL CHEM, V237, P89; LOVITT RW, 1987, J APPL BACTERIOL, V62, P71, DOI 10.1111/j.1365-2672.1987.tb02382.x; Mavromatis P, 2002, J FOOD PROTECT, V65, P546, DOI 10.4315/0362-028X-65.3.546; Milshteyn A, 2018, CELL HOST MICROBE, V23, P725, DOI 10.1016/j.chom.2018.05.013; Nurk S, 2013, J COMPUT BIOL, V20, P714, DOI 10.1089/cmb.2013.0084; OLDENDORF WH, 1971, AM J PHYSIOL, V221, P1629, DOI 10.1152/ajplegacy.1971.221.6.1629; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Pedersen HK, 2016, NATURE, V535, P376, DOI 10.1038/nature18646; Perry RJ, 2016, NATURE, V534, P213, DOI 10.1038/nature18309; Pezeshki A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25145; Proctor LM, 2014, CELL HOST MICROBE, V16, P276, DOI 10.1016/j.chom.2014.08.014; Purcell RH, 2018, ANNU REV PHARMACOL, V58, P429, DOI 10.1146/annurev-pharmtox-010617-052933; Ramachandraih Chaitra T, 2011, Indian J Psychiatry, V53, P180, DOI 10.4103/0019-5545.82567; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Smolinska S, 2014, ALLERGY, V69, P273, DOI 10.1111/all.12330; Sotnikova TD, 2004, J NEUROCHEM, V91, P362, DOI 10.1111/j.1471-4159.2004.02721.x; Tan JK, 2017, ANNU REV IMMUNOL, V35, P371, DOI 10.1146/annurev-immunol-051116-052235; Thurmond RL, 2008, NAT REV DRUG DISCOV, V7, P41, DOI 10.1038/nrd2465; Tyagi P, 2009, J PEDIATR SURG, V44, P2156, DOI 10.1016/j.jpedsurg.2009.04.032; Wacker D, 2017, CELL, V170, P414, DOI 10.1016/j.cell.2017.07.009; Williams Robin A, 2008, Clin Biochem Rev, V29, P31; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047; 2016, J CLIN ENDOCR METAB, V101, P4637, DOI DOI 10.1210/JC.2016-1884; 2001, MOL PHARM, V60, P1181; 2016, J BIOL CHEM, V291, P3385, DOI DOI 10.1074/JBC.M115.689349; 2004, EUR FOOD RES TECHNOL, V219, P465, DOI DOI 10.1007/S00217-004-0988-0	61	141	144	5	85	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 16	2019	177	5					1217	+		10.1016/j.cell.2019.03.036	http://dx.doi.org/10.1016/j.cell.2019.03.036			33	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HY4NB	31006530	Green Accepted, Bronze			2022-12-28	WOS:000468103800014
J	Chen, F; Du, MX; Blumberg, JB; Chui, KKH; Ruan, MY; Rogers, G; Shan, ZL; Zeng, LX; Zhang, FF				Chen, Fan; Du, Mengxi; Blumberg, Jeffrey B.; Chui, Kenneth Kwan Ho; Ruan, Mengyuan; Rogers, Gail; Shan, Zhilei; Zeng, Luxian; Zhang, Fang Fang			Association Among Dietary Supplement Use, Nutrient Intake, and Mortality Among US Adults A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							CANCER; PREVENTION	Background: The health benefits and risks of dietary supplement use are controversial. Objective: To evaluate the association among dietary supplement use, levels of nutrient intake from foods and supplements, and mortality among U.S. adults. Design: Prospective cohort study. Setting: NHANES (National Health and Nutrition Examination Survey) data from 1999 to 2010, linked to National Death Index mortality data. Participants: 30 899 U.S. adults aged 20 years or older who answered questions on dietary supplement use. Measurements: Dietary supplement use in the previous 30 days and nutrient intake from foods and supplements. Outcomes included mortality from all causes, cardiovascular disease (CVD), and cancer. Results: During a median follow-up of 6.1 years, 3613 deaths occurred, including 945 CVD deaths and 805 cancer deaths. Ever-use of dietary supplements was not associated with mortality outcomes. Adequate intake (at or above the Estimated Average Requirement or the Adequate Intake level) of vitamin A, vitamin K, magnesium, zinc, and copper was associated with reduced all-cause or CVD mortality, but the associations were restricted to nutrient intake from foods. Excess intake of calcium was associated with increased risk for cancer death (above vs. at or below the Tolerable Upper Intake Level: multivariable-adjusted rate ratio, 1.62 [95% CI, 1.07 to 2.451; multivariable-adjusted rate difference, 1.7 [CI, -0.1 to 3.51 deaths per >= 1000 person-years), and the association seemed to be related to calcium intake from supplements 000 mg/d vs. no use: multivariable- adjusted rate ratio, 1.53 [CI, 1.04 to 2.25]; multivariable-adjusted rate difference, 1.5 [CI, -0.1 to 3.1] deaths per 1000 person-years) rather than foods. Limitations: Results from observational data may be affected by residual confounding. Reporting of dietary supplement use is subject to recall bias. Conclusion: Use of dietary supplements is not associated with mortality benefits among U.S. adults. Primary Funding Source: National Institutes of Health.	[Chen, Fan; Du, Mengxi; Blumberg, Jeffrey B.; Ruan, Mengyuan; Rogers, Gail; Shan, Zhilei; Zeng, Luxian; Zhang, Fang Fang] Tufts Univ, Friedman Sch Nutr Sci & Policy, 150 Harrison Ave, Boston, MA 02111 USA; [Chen, Fan] Hebrew SeniorLife, Hinda & Arthur Marcus Inst Aging Res, 1200 Ctr St, Boston, MA 02131 USA; [Chui, Kenneth Kwan Ho; Ruan, Mengyuan] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Rogers, Gail] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Shan, Zhilei] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Chui, Kenneth Kwan Ho; Ruan, Mengyuan] Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, 136 Harrison Ave, Boston, MA 02111 USA; [Rogers, Gail] Tufts Univ, Nutr Epidemiol Program, Jean Mayer USDA Human Nutr Res Ctr Aging, 711 Washington St, Boston, MA 02111 USA; [Shan, Zhilei] Harvard TH Chan Sch Publ Hlth, Dept Nutr, 677 Huntington Ave, Boston, MA 02115 USA	Tufts University; Harvard University; Hebrew SeniorLife; Tufts University; Tufts University; United States Department of Agriculture (USDA); Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts Department of Public Health; Tufts University; Tufts University; United States Department of Agriculture (USDA); Harvard University; Harvard T.H. Chan School of Public Health	Zhang, FF (corresponding author), Tufts Univ, Friedman Sch Nutr Sci & Policy, 150 Harrison Ave, Boston, MA 02111 USA.	fang_fang.zhang@tufts.edu	Chui, Kenneth/AFT-2074-2022; Zhang, Fang/HHN-2153-2022; Du, Mengxi/AAE-5930-2021; Blumberg, Jeffrey/ABH-7888-2020; Shan, Zhilei/S-5189-2019	Chui, Kenneth/0000-0002-8063-8631; Du, Mengxi/0000-0002-6406-7250; Chen, Fan/0000-0001-8750-6087	National Institute on Minority Health and Health Disparities, National Institutes of Health [1R01MD011501]; National Institute on Minority Health and Health Disparities [R01MD011501] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities, National Institutes of Health; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	By grant 1R01MD011501 from the National Institute on Minority Health and Health Disparities, National Institutes of Health (Dr. Zhang).	Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; Bailey RL, 2012, J ACAD NUTR DIET, V112, P657, DOI 10.1016/j.jand.2012.01.026; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; Bjelakovic G, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007470.pub3; Blumberg JB, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121325; Bolland Mark J, 2011, BMJ, V342, pd2040, DOI 10.1136/bmj.d2040; Chattopadhyay N, 2006, AM J PHYSIOL-ENDOC M, V290, pE761, DOI 10.1152/ajpendo.00350.2005; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Herrick Kristen A, 2018, Vital Health Stat 2, P1; Ilic D, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008007.pub2; Institute of Medicine, 2006, DIETARY REFERENCE IN, DOI [10.17226/11537, DOI 10.17226/11537]; Kantor ED, 2016, JAMA-J AM MED ASSOC, V316, P1464, DOI 10.1001/jama.2016.14403; Kipnis V, 2009, BIOMETRICS, V65, P1003, DOI 10.1111/j.1541-0420.2009.01223.x; Klein EA, 2011, JAMA-J AM MED ASSOC, V306, P1549, DOI 10.1001/jama.2011.1437; Lappe J, 2017, JAMA-J AM MED ASSOC, V317, P1234, DOI 10.1001/jama.2017.2115; Manson JE, 2019, NEW ENGL J MED, V380, P33, DOI [10.1056/NEJMoa1809944, 10.1056/nejmoa1809944]; National Cancer Institute, 2018, DEV HLTH EAT IND; National Center for Health Statistics, 2011, PUBL US LINK MORT FI; National Center for Health Statistics, NAT HLTH NUTR EX SUR; Office of Disease Prevention and Health Promotion, 2008, PHYS ACT GUID AM; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Rahmati Shoboo, 2018, Asian Pac J Cancer Prev, V19, P1449, DOI 10.22034/APJCP.2018.19.6.1449; Scragg R, 2018, JAMA ONCOL, V4, DOI 10.1001/jamaoncol.2018.2178; U. S. Department of Agriculture Food Surveys Research Group, 2018, FOOD NUTR DATABASE D; Willett W., 2013, NUTR EPIDEMIOLOGY, V3rd, DOI DOI 10.1093/ACPROF:OSO/9780199754038.001.0001; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; World Cancer Research Fund / American Institute for Cancer Research, 2018, DIET NUTR PHYS ACT C; Yetley EA, 2007, AM J CLIN NUTR, V85, p269S, DOI 10.1093/ajcn/85.1.269S; 2017, JAMA CARDIOL, V2, P608, DOI DOI 10.1001/JAMACARDIO.2017.0175; 2011, ARCH INTERN MED, V171, P1625, DOI DOI 10.1001/ARCHINTERNMED.2011.445; 2013, ANN INTERN MED, V159, P824, DOI DOI 10.7326/0003-4819-159-12-201312170-00729; 2012, EUR J NUTR, V51, P407, DOI DOI 10.1007/S00394-011-0224-1; 2006, CANCER EPIDEM BIOMAR, V15, P203, DOI DOI 10.1158/1055-9965.EPI-05-0586; 2016, WORLD J GASTROENTERO, V22, P4594, DOI DOI 10.3748/WJG.V22.I18.4594; 2013, JAMA INTERN MED, V173, P355, DOI DOI 10.1001/JAMAINTERNMED.2013.2299; 2007, AM J CLIN NUTR, V85, P1586; 2010, STAT MED, V29, P2857, DOI DOI 10.1002/SIM.4063; 2017, EUR J NEUROL, V24, P1266, DOI DOI 10.1111/ENE.13358; 2016, ANN INTERN MED, V165, P856, DOI DOI 10.7326/M16-1165; 2006, CIRCULATION, V114, P1388, DOI DOI 10.1161/CIRCULATIONAHA.106.628321; 2017, J CLIN HYPERTENS, V19, P640, DOI DOI 10.1111/JCH.13010; 2005, CANC EPIDEMIOL BIOMA, V14, P586; 2017, ANN INTERN MED, V166, P684, DOI DOI 10.7326/L17-0135; 2016, AM J CLIN NUTR, V103, P886, DOI DOI 10.3945/AJCN.115.117994; 2006, J AM DIET ASSOC, V106, P1640, DOI DOI 10.1016/J.JADA.2006.07.011; 2012, MATURITAS, V72, P269, DOI DOI 10.1016/J.MATURITAS.2012.04.014; 2017, ADV NUTR, V8, P27, DOI DOI 10.3945/AN.116.013516; 2018, J STEROID BIOCHEM, V177, P6, DOI DOI 10.1016/J.JSBMB.2017.06.006; 2004, J NUTR, V134, P1836; 2011, J NUTR, V141, P261, DOI DOI 10.3945/JN.110.133025; 2006, J AM DIET ASSOC, V106, P1575, DOI DOI 10.1016/J.JADA.2006.07.003	51	71	75	2	45	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 7	2019	170	9					604	+		10.7326/M18-2478	http://dx.doi.org/10.7326/M18-2478			23	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HW9KX	30959527	Green Accepted			2022-12-28	WOS:000467010800005
J	Zhou, WK; Lozano-Torres, JL; Blilou, I; Zhang, XY; Zhai, QZ; Smant, G; Li, CY; Scheres, B				Zhou, Wenkun; Lozano-Torres, Jose L.; Blilou, Ikram; Zhang, Xiaoyue; Zhai, Qingzhe; Smant, Geert; Li, Chuanyou; Scheres, Ben			A Jasmonate Signaling Network Activates Root Stem Cells and Promotes Regeneration	CELL			English	Article							MYC TRANSCRIPTION FACTORS; QUIESCENT CENTER; GROWTH; GENES; NICHE; BIOSYNTHESIS; TRANSDUCTION; PERCEPTION; MODULATION; DIVISION	Plants are sessile and have to cope with environmentally induced damage through modification of growth and defense pathways. How tissue regeneration is triggered in such responses and whether this involves stem cell activation is an open question. The stress hormone jasmonate (JA) plays well-established roles in wounding and defense responses. JA also affects growth, which is hitherto interpreted as a trade-off between growth and defense. Here, we describe a molecular network triggered by wound-induced JA that promotes stem cell activation and regeneration. JA regulates organizer cell activity in the root stem cell niche through the RBR-SCR network and stress response protein ERF115. Moreover, JA-induced ERF109 transcription stimulates CYCD6;1 expression, functions upstream of ERF115, and promotes regeneration. Soil penetration and response to nematode herbivory induce and require this JA-mediated regeneration response. Therefore. the JA tissue dam- age response pathway induces stem cell activation and regeneration and activates growth after environmental stress.	[Zhou, Wenkun; Blilou, Ikram; Scheres, Ben] Wageningen Univ & Res, Lab Plant Dev Biol, NL-6708 PB Wageningen, Netherlands; [Zhou, Wenkun; Zhang, Xiaoyue; Zhai, Qingzhe; Li, Chuanyou] Chinese Acad Sci, State Key Lab Plant Genom, Beijing 100101, Peoples R China; [Zhou, Wenkun; Zhang, Xiaoyue; Zhai, Qingzhe; Li, Chuanyou] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res Beijing, Beijing 100101, Peoples R China; [Lozano-Torres, Jose L.; Smant, Geert] Wageningen Univ & Res, Lab Nematol, NL-6708 PB Wageningen, Netherlands; [Blilou, Ikram] KAUST, Thuwall 23955, Saudi Arabia; [Li, Chuanyou] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Scheres, Ben] Rijk Zwaan R&D, NL-4793 RS Fijnaart, Netherlands	Wageningen University & Research; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Wageningen University & Research; King Abdullah University of Science & Technology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Scheres, B (corresponding author), Wageningen Univ & Res, Lab Plant Dev Biol, NL-6708 PB Wageningen, Netherlands.; Scheres, B (corresponding author), Rijk Zwaan R&D, NL-4793 RS Fijnaart, Netherlands.	ben.scheres@wur.nl	Lozano, Jose/M-6392-2014; Li, Chuanyou/ABF-4143-2020	Lozano, Jose/0000-0002-0021-5947; Blilou, Ikram/0000-0001-8003-3782; zhou, wenkun/0000-0002-2480-2644	National Basic Research Program of China [2015CB942900]; EMBO long-term fellowship [ALTF 784-2014]; NWO domain Applied and Engineering Sciences VENI grant [14250]; National Natural Science Foundation of China [31730010]	National Basic Research Program of China(National Basic Research Program of China); EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); NWO domain Applied and Engineering Sciences VENI grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank Lieven de Veylder, Cheng-Bin Xiang, Lin Xu, Philip Benfey, Laurent Laplaze, James A.H. Murray, Roberto Solano, and the Nottingham Arabidopsis Stock Centre for sharing research materials. We thank Casper van Schaik and Axel Kuil for experimental help. We greatly appreciated helpful discussions with Jaap Bakker, Jian Xu, Niko Geldner, and all members from the Scheres lab. This work was supported by the National Basic Research Program of China (2015CB942900 to C.L.), an EMBO long-term fellowship (ALTF 784-2014 to W.Z.), a NWO domain Applied and Engineering Sciences VENI grant (14250 to J.L.L.-T.), and the National Natural Science Foundation of China (31730010 to C.L.).	Asahina M, 2011, P NATL ACAD SCI USA, V108, P16128, DOI 10.1073/pnas.1110443108; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Boter M, 2004, GENE DEV, V18, P1577, DOI 10.1101/gad.297704; Cai XT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6833; Campos ML, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12570; Chen LQ, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2016.1238548; Chen M, 2004, ANNU REV GENET, V38, P87, DOI 10.1146/annurev.genet.38.072902.092259; Chen Q, 2011, PLANT CELL, V23, P3335, DOI 10.1105/tpc.111.089870; Chen R, 2012, PLANT CELL, V24, P2898, DOI 10.1105/tpc.112.098277; Creelman RA, 1997, ANNU REV PLANT PHYS, V48, P355, DOI 10.1146/annurev.arplant.48.1.355; Cruz-Ramirez A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001724; Cruz-Ramirez A, 2012, CELL, V150, P1002, DOI 10.1016/j.cell.2012.07.017; Dick FA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-26; Dombrecht B, 2007, PLANT CELL, V19, P2225, DOI 10.1105/tpc.106.048017; Efroni I, 2016, CELL, V165, P1721, DOI 10.1016/j.cell.2016.04.046; Fernandez-Calvo P, 2011, PLANT CELL, V23, P701, DOI 10.1105/tpc.110.080788; Gehl C, 2009, MOL PLANT, V2, P1051, DOI 10.1093/mp/ssp040; Glauser G, 2009, J BIOL CHEM, V284, P34506, DOI 10.1074/jbc.M109.061432; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Heyman J, 2018, J CELL SCI, V131, DOI 10.1242/jcs.208215; Heyman J, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.165, 10.1038/nplants.2016.165]; Heyman J, 2013, SCIENCE, V342, P860, DOI 10.1126/science.1240667; Hickman R, 2017, PLANT CELL, V29, P2086, DOI 10.1105/tpc.16.00958; Hou XL, 2010, DEV CELL, V19, P884, DOI 10.1016/j.devcel.2010.10.024; Ikeuchi M, 2018, PLANT CELL PHYSIOL, V59, P770, DOI 10.1093/pcp/pcy013; Ikeuchi M, 2017, PLANT PHYSIOL, V175, P1158, DOI 10.1104/pp.17.01035; Jones JT, 2013, MOL PLANT PATHOL, V14, P946, DOI 10.1111/mpp.12057; Karasov TL, 2017, PLANT CELL, V29, P666, DOI 10.1105/tpc.16.00931; Kareem A, 2015, CURR BIOL, V25, P1017, DOI 10.1016/j.cub.2015.02.022; Kehn K, 2005, ONCOGENE, V24, P525, DOI 10.1038/sj.onc.1208105; Kong XP, 2018, CELL REP, V22, P1350, DOI 10.1016/j.celrep.2017.12.105; Larrieu A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7043; Li H, 2017, ENVIRON POLLUT, V2, P2, DOI DOI 10.1103/PhysRevB.96.075107; Melnyk CW, 2018, P NATL ACAD SCI USA, V115, pE2447, DOI 10.1073/pnas.1718263115; Mueller MJ, 1998, CHEM BIOL, V5, pR323, DOI 10.1016/S1074-5521(98)90660-3; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Navarro L, 2008, CURR BIOL, V18, P650, DOI 10.1016/j.cub.2008.03.060; Nemhauser JL, 2006, CELL, V126, P467, DOI 10.1016/j.cell.2006.05.050; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Ortega-Martinez O, 2007, SCIENCE, V317, P507, DOI 10.1126/science.1143409; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; Sena G, 2009, NATURE, V457, P1150, DOI 10.1038/nature07597; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Shimotohno A, 2018, GENE DEV, V32, P1085, DOI 10.1101/gad.314096.118; Sozzani R, 2010, NATURE, V466, P128, DOI 10.1038/nature09143; Sugimoto K, 2010, DEV CELL, V18, P463, DOI 10.1016/j.devcel.2010.02.004; Vilarrasa-Blasi J, 2014, DEV CELL, V30, P36, DOI 10.1016/j.devcel.2014.05.020; Wang Z, 2008, PLANT CELL REP, V27, P125, DOI 10.1007/s00299-007-0410-z; Warmerdam S, 2018, NEW PHYTOL, V218, P724, DOI 10.1111/nph.15034; Wasternack C, 2013, ANN BOT-LONDON, V111, P1021, DOI 10.1093/aob/mct067; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Xu J, 2006, SCIENCE, V311, P385, DOI 10.1126/science.1121790; Xu LH, 2002, PLANT CELL, V14, P1919, DOI 10.1105/tpc.003368; Yan JB, 2009, PLANT CELL, V21, P2220, DOI 10.1105/tpc.109.065730; Yang DL, 2012, P NATL ACAD SCI USA, V109, pE1192, DOI 10.1073/pnas.1201616109; Zhang F, 2015, NATURE, V525, P269, DOI 10.1038/nature14661; Zhang HM, 2010, PLANT J, V64, P764, DOI 10.1111/j.1365-313X.2010.04367.x; Zhang XY, 2018, P NATL ACAD SCI USA, V115, pE5624, DOI 10.1073/pnas.1800592115; Zhang YY, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2340; 2018, MOL CELL, V70, P136	60	133	140	6	174	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 2	2019	177	4					942	+		10.1016/j.cell.2019.03.006	http://dx.doi.org/10.1016/j.cell.2019.03.006			29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HW7AU	30955889	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000466843000014
J	Walker, SP				Walker, Susan P.			The ROC Curve Redefined - Optimizing Sensitivity (and Specificity) to the Lived Reality of Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEALTH-CARE		[Walker, Susan P.] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; [Walker, Susan P.] Mercy Hosp Women, Melbourne, Vic, Australia	University of Melbourne	Walker, SP (corresponding author), Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic, Australia.; Walker, SP (corresponding author), Mercy Hosp Women, Melbourne, Vic, Australia.							Berry LL, 2017, J ONCOL PRACT, V13, P744, DOI 10.1200/JOP.2017.026195; Campling P, 2015, BJPSYCH BULL, V39, P1, DOI 10.1192/pb.bp.114.047449; Carlson LE, 2016, ANN NY ACAD SCI, V1373, P5, DOI 10.1111/nyas.13029; Cormie P, 2018, MED J AUSTRALIA, V209, P184, DOI 10.5694/mja18.00199; Jeffrey D, 2016, J ROY SOC MED, V109, P446, DOI 10.1177/0141076816680120	5	12	14	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 25	2019	380	17					1594	1595		10.1056/NEJMp1814951	http://dx.doi.org/10.1056/NEJMp1814951			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU9FC	31018068				2022-12-28	WOS:000465598600006
J	Cyster, JG; Allen, CDC				Cyster, Jason G.; Allen, Christopher D. C.			B Cell Responses: Cell Interaction Dynamics and Decisions	CELL			English	Review							FOLLICULAR HELPER-CELLS; GERMINAL-CENTER; PLASMA-CELLS; AFFINITY MATURATION; ANTIBODY-RESPONSES; TRANSCRIPTION FACTOR; LYMPHOCYTE EGRESS; HUMORAL IMMUNITY; ANTIGEN; RECEPTOR	B cells and the antibodies they produce have a deeply penetrating influence on human physiology. Here, we review current understanding of how B cell responses are initiated; the different paths to generate short- and long-lived plasma cells, germinal center cells, and memory cells; and how each path impacts antibody diversity, selectivity, and affinity. We discuss how basic research is informing efforts to generate vaccines that induce broadly neutralizing antibodies against viral pathogens, revs .ling the special features associated with allc-gen-reactive IgE recponses and uncovering the antibody-independent mechanisms by which B cells contribute to health and disease.	[Cyster, Jason G.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Cyster, Jason G.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Allen, Christopher D. C.] Univ Calif San Francisco, Cardiovasc Res Inst, Dept Anat, Box 0544, San Francisco, CA 94143 USA; [Allen, Christopher D. C.] Univ Calif San Francisco, Sandler Asthma Basic Res Ctr, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Cyster, JG (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.; Cyster, JG (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.; Allen, CDC (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, Dept Anat, Box 0544, San Francisco, CA 94143 USA.; Allen, CDC (corresponding author), Univ Calif San Francisco, Sandler Asthma Basic Res Ctr, San Francisco, CA 94143 USA.	jason.cyster@ucsf.edu; chris.allen@ucsf.edu		Allen, Christopher/0000-0002-1879-9047	Pew Charitable Trusts; National Institute of Allergy and Infectious Diseases of the NIH [R01AI130470, R01AI40098, R01AI45073]; Cardiovascular Research Institute; Sandler Asthma Basic Research Center at UCSF; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045073, R01AI130470, R01AI040098] Funding Source: NIH RePORTER	Pew Charitable Trusts; National Institute of Allergy and Infectious Diseases of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Cardiovascular Research Institute; Sandler Asthma Basic Research Center at UCSF; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank their lab members for helpful discussions. J.G.C. is a HHMI investigator. C.D.C.A. is a Pew Scholar in the Biomedical Sciences, supported by The Pew Charitable Trusts. Research related to this review was supported in part by the National Institute of Allergy and Infectious Diseases of the NIH (R01AI130470, R01AI40098, and R01AI45073), as well as the Cardiovascular Research Institute and the Sandler Asthma Basic Research Center at UCSF. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.	Aalberse RC, 2004, J ALLERGY CLIN IMMUN, V113, P983, DOI 10.1016/j.jaci.2004.02.046; Abbott RK, 2018, IMMUNITY, V48, P133, DOI 10.1016/j.immuni.2017.11.023; Achatz-Straussberger G, 2008, EUR J IMMUNOL, V38, P3167, DOI 10.1002/eji.200838456; Aleyd E, 2015, IMMUNOL REV, V268, P123, DOI 10.1111/imr.12337; Allen CDC, 2008, SEMIN IMMUNOL, V20, P14, DOI 10.1016/j.smim.2007.12.001; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Allie SR, 2019, NAT IMMUNOL, V20, P97, DOI 10.1038/s41590-018-0260-6; Ammirante M, 2010, NATURE, V464, P302, DOI 10.1038/nature08782; Andrabi R, 2018, CURR OPIN IMMUNOL, V53, P143, DOI 10.1016/j.coi.2018.04.025; Andrade P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08845-3; Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; Ballesteros-Tato A, 2016, IMMUNITY, V44, P259, DOI 10.1016/j.immuni.2015.11.017; Bannard O, 2017, CURR OPIN IMMUNOL, V45, P21, DOI 10.1016/j.coi.2016.12.004; Bannard O, 2016, J EXP MED, V213, P993, DOI 10.1084/jem.20151682; Barr TA, 2012, J EXP MED, V209, P1001, DOI 10.1084/jem.20111675; Basso K, 2015, NAT REV IMMUNOL, V15, P172, DOI 10.1038/nri3814; Batista FD, 2009, NAT REV IMMUNOL, V9, P15, DOI 10.1038/nri2454; Baumgarth N, 2013, IMMUNOL REV, V255, P82, DOI 10.1111/imr.12094; Bonsignori M, 2017, IMMUNOL REV, V275, P145, DOI [10., 10.1111/imr.12509]; Bortnick A, 2018, EUR J IMMUNOL, V48, P815, DOI 10.1002/eji.201747229; Brandtzaeg P, 2005, IMMUNOL REV, V206, P32, DOI 10.1111/j.0105-2896.2005.00283.x; Briney B, 2019, NATURE, V566, P393, DOI 10.1038/s41586-019-0879-y; Browning JL, 2008, IMMUNOL REV, V223, P202, DOI 10.1111/j.1600-065X.2008.00633.x; Burbage M, 2018, ELIFE, V7, DOI 10.7554/eLife.26556; Burnet F. M., 1960, NOBEL LECT; Burnett DL, 2018, SCIENCE, V360, P223, DOI 10.1126/science.aao3859; Cahenzli J, 2013, CELL HOST MICROBE, V14, P559, DOI 10.1016/j.chom.2013.10.004; Cannons JL, 2011, ANNU REV IMMUNOL, V29, P665, DOI 10.1146/annurev-immunol-030409-101302; Carroll MC, 2012, IMMUNITY, V37, P199, DOI 10.1016/j.immuni.2012.08.002; Chen SS, 2017, J EXP MED, V214, P475, DOI 10.1084/jem.20161312; Chen XJ, 2018, SCIENCE, V362, P700, DOI 10.1126/science.aap9310; Cho SH, 2016, NATURE, V537, P234, DOI 10.1038/nature19334; Chou C, 2016, IMMUNITY, V45, P570, DOI 10.1016/j.immuni.2016.07.023; Clingan JM, 2013, J IMMUNOL, V191, P810, DOI 10.4049/jimmunol.1300244; Cremasco V, 2014, NAT IMMUNOL, V15, P973, DOI 10.1038/ni.2965; Croote D, 2018, SCIENCE, V362, P1306, DOI 10.1126/science.aau2599; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Cyster JG, 2014, NAT REV IMMUNOL, V14, P731, DOI 10.1038/nri3755; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Cyster JG, 2010, NAT IMMUNOL, V11, P989, DOI 10.1038/ni.1946; Cyster JG, 2003, IMMUNOL REV, V194, P48, DOI 10.1034/j.1600-065X.2003.00041.x; Dalla-Favera R, 2017, HEMATOL ONCOL, V35, P76, DOI 10.1002/hon.2405; Dosenovic P, 2018, P NATL ACAD SCI USA, V115, P4743, DOI 10.1073/pnas.1803457115; Druzd D, 2017, IMMUNITY, V46, P120, DOI 10.1016/j.immuni.2016.12.011; EHRLICH P, 1908, NOBEL LECT; Ersching J, 2017, IMMUNITY, V46, P1045, DOI 10.1016/j.immuni.2017.06.005; Fabbri G, 2016, NAT REV CANCER, V16, P145, DOI 10.1038/nrc.2016.8; Fereidan-Esfahani M, 2019, METHODS MOL BIOL, V1904, P53, DOI 10.1007/978-1-4939-8958-4_3; Fillatreau S, 2018, CURR OPIN IMMUNOL, V55, P62, DOI 10.1016/j.coi.2018.09.012; Finney J, 2018, IMMUNOL REV, V284, P42, DOI 10.1111/imr.12661; Flemming W., 1885, ARCH MIKROSK ANAT, V24, P50; Gatto D., 2013, TRENDS IMMUNOL, V14, P446; Gitlin AD, 2015, SCIENCE, V349, P643, DOI 10.1126/science.aac4919; Gommerman JL, 2014, GUT MICROBES, V5, P652, DOI 10.4161/19490976.2014.969977; Gonzalez DG, 2018, J IMMUNOL, V201, P3569, DOI 10.4049/jimmunol.1500497; Goodnow CC, 2010, NAT IMMUNOL, V11, P681, DOI 10.1038/ni.1900; Grigorova IL, 2010, P NATL ACAD SCI USA, V107, P20447, DOI 10.1073/pnas.1009968107; Haberland K, 2018, EUR J IMMUNOL, V48, P822, DOI 10.1002/eji.201747227; Hale M, 2018, CURR OPIN IMMUNOL, V55, P81, DOI 10.1016/j.coi.2018.10.008; Haniuda K, 2016, NAT IMMUNOL, V17, P1109, DOI 10.1038/ni.3508; Havenar-Daughton C, 2018, CURR OPIN IMMUNOL, V53, P209, DOI 10.1016/j.coi.2018.08.002; Havenar-Daughton C, 2016, P NATL ACAD SCI USA, V113, P2702, DOI 10.1073/pnas.1520112113; He JS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00723-0; He JS, 2015, CURR TOP MICROBIOL, V388, P1, DOI 10.1007/978-3-319-13725-4_1; Heesters BA, 2014, NAT REV IMMUNOL, V14, P495, DOI 10.1038/nri3689; Hong S, 2018, IMMUNITY, V49, P695, DOI 10.1016/j.immuni.2018.08.012; Hoogeboom R, 2016, CURR TOP MICROBIOL, V393, P45, DOI 10.1007/82_2015_476; Hu JK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156074; Hu JK, 2015, J VIROL, V89, P10383, DOI 10.1128/JVI.01653-15; Huang BN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156072; Huang HY, 2018, P NATL ACAD SCI USA, V115, pE6826, DOI 10.1073/pnas.1712628115; Huet S, 2018, NAT REV CANCER, V18, P224, DOI 10.1038/nrc.2017.127; Hwang JK, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0037-2014; Ise W, 2018, IMMUNITY, V48, P702, DOI 10.1016/j.immuni.2018.03.027; Jelcic I, 2018, CELL, V175, P85, DOI 10.1016/j.cell.2018.08.011; Jellusova J, 2017, NAT IMMUNOL, V18, P303, DOI 10.1038/ni.3664; Jerkeman M, 2017, J INTERN MED, V282, P415, DOI 10.1111/joim.12600; Jimenez-Saiz R, 2017, J ALLERGY CLIN IMMUN, V140, P1604, DOI 10.1016/j.jaci.2017.01.018; Kearney JF, 2015, ANNU REV IMMUNOL, V33, P475, DOI 10.1146/annurev-immunol-032713-120140; Khalil AM, 2012, SCIENCE, V336, P1178, DOI 10.1126/science.1213368; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; Krautler NJ, 2017, J EXP MED, V214, P1259, DOI 10.1084/jem.20161533; Kuraoka M, 2016, IMMUNITY, V44, P542, DOI 10.1016/j.immuni.2016.02.010; Kurosaki T, 2015, NAT REV IMMUNOL, V15, P149, DOI 10.1038/nri3802; Kurosaki T, 2010, ANNU REV IMMUNOL, V28, P21, DOI 10.1146/annurev.immunol.021908.132541; Kwak K, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aau6598; Laffleur B, 2015, CELL REP, V10, P900, DOI 10.1016/j.celrep.2015.01.023; Laidlaw BJ, 2017, J EXP MED, V214, P639, DOI 10.1084/jem.20161461; Lam WY, 2018, TRENDS IMMUNOL, V39, P19, DOI 10.1016/j.it.2017.08.007; Li R, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab4176; Li X, 2018, IMMUNITY, V48, P530, DOI 10.1016/j.immuni.2018.03.006; Lin JX, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028449; Lindell DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003129; Liu D, 2015, NATURE, V517, P214, DOI 10.1038/nature13803; Liu WL, 2016, TRENDS IMMUNOL, V37, P680, DOI 10.1016/j.it.2016.07.007; Lu PW, 2017, SCIENCE, V356, DOI 10.1126/science.aai9264; Luthje K, 2012, NAT IMMUNOL, V13, P491, DOI 10.1038/ni.2261; Luo W, 2018, IMMUNITY, V48, P313, DOI 10.1016/j.immuni.2018.01.008; Lycke NY, 2017, MUCOSAL IMMUNOL, V10, P1361, DOI 10.1038/mi.2017.62; Madan R, 2009, J IMMUNOL, V183, P2312, DOI 10.4049/jimmunol.0900185; Masahata K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4704; Matsuo K, 2018, J IMMUNOL, V200, P800, DOI 10.4049/jimmunol.1700037; Mayer CT, 2017, SCIENCE, V358, DOI 10.1126/science.aao2602; Mesin L, 2016, IMMUNITY, V45, P471, DOI 10.1016/j.immuni.2016.09.001; Moens L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00065; Moran I, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05772-7; Nemazee D, 2017, NAT REV IMMUNOL, V17, P281, DOI 10.1038/nri.2017.19; Nguyen DC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05853-7; Noviski M, 2018, CURR OPIN IMMUNOL, V55, P67, DOI 10.1016/j.coi.2018.09.015; Noviski M, 2018, ELIFE, V7, DOI 10.7554/eLife.35074; Nowosad CR, 2016, NAT IMMUNOL, V17, P870, DOI 10.1038/ni.3458; Nutt SL, 2015, NAT REV IMMUNOL, V15, P160, DOI 10.1038/nri3795; Nydegger UE, 2005, ANN NY ACAD SCI, V1050, P40, DOI 10.1196/annals.1313.006; Ozorowski G, 2018, J VIROL, V92, DOI 10.1128/JVI.00381-18; Papa I, 2017, NATURE, V547, P318, DOI 10.1038/nature23013; Pauthner M, 2017, IMMUNITY, V46, P1073, DOI 10.1016/j.immuni.2017.05.007; Purtha WE, 2011, J EXP MED, V208, P2599, DOI 10.1084/jem.20110740; Qi H, 2014, ANNU REV CELL DEV BI, V30, P141, DOI 10.1146/annurev-cellbio-100913-013254; Ramadani F, 2017, ALLERGY, V72, P66, DOI 10.1111/all.12911; Reed JH, 2016, J EXP MED, V213, P1255, DOI 10.1084/jem.20151978; Reynolds AE, 2015, J IMMUNOL, V194, P231, DOI 10.4049/jimmunol.1401203; Rodda LB, 2018, IMMUNITY, V48, P1014, DOI 10.1016/j.immuni.2018.04.006; Rookhuizen DC, 2014, P NATL ACAD SCI USA, V111, pE3224, DOI 10.1073/pnas.1323985111; Sabouri Z, 2014, P NATL ACAD SCI USA, V111, pE2567, DOI 10.1073/pnas.1406974111; Sage AP, 2019, NAT REV CARDIOL, V16, P180, DOI 10.1038/s41569-018-0106-9; Sage PT, 2015, TRENDS IMMUNOL, V36, P410, DOI 10.1016/j.it.2015.05.005; Sakkas L. I., 2018, SEMIN ARTHRITIS RHEU; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; Schmitz R, 2018, NEW ENGL J MED, V378, P1396, DOI 10.1056/NEJMoa1801445; Schmitz R, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014282; Schulz O, 2016, ANNU REV IMMUNOL, V34, P203, DOI 10.1146/annurev-immunol-041015-055649; Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477; Shalapour S, 2015, NATURE, V521, P94, DOI 10.1038/nature14395; Shen P, 2015, NAT REV IMMUNOL, V15, P441, DOI 10.1038/nri3857; Shen P, 2014, NATURE, V507, P366, DOI 10.1038/nature12979; Shi JW, 2018, IMMUNITY, V49, P264, DOI 10.1016/j.immuni.2018.06.012; Smith MJ, 2017, NAT REV NEPHROL, V13, P712, DOI 10.1038/nrneph.2017.138; Stewart I, 2018, IMMUNITY, V49, P477, DOI 10.1016/j.immuni.2018.08.025; Suan D, 2015, IMMUNITY, V42, P704, DOI 10.1016/j.immuni.2015.03.002; Suthers A. N., 2017, CELLS IMMUNOL, V8, P775, DOI DOI 10.3389/FIMMU.2017.00775; Suzuki K, 2016, J EXP MED, V213, P2567, DOI 10.1084/jem.20160723; Taher TE, 2017, CLIN REV ALLERG IMMU, V53, P237, DOI 10.1007/s12016-017-8609-4; Takatsuka S, 2018, NAT IMMUNOL, V19, P1025, DOI 10.1038/s41590-018-0177-0; Tam HH, 2016, P NATL ACAD SCI USA, V113, pE6639, DOI 10.1073/pnas.1606050113; Tarlinton D, 2008, CURR OPIN IMMUNOL, V20, P162, DOI 10.1016/j.coi.2008.03.016; Tas JMJ, 2016, SCIENCE, V351, P1048, DOI 10.1126/science.aad3439; Tian MJ, 2018, J IMMUNOL, V200, P937, DOI 10.4049/jimmunol.1701067; Toellner KM, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028795; Tonegawa S., 1987, NOBEL LECT; Townsend MJ, 2010, IMMUNOL REV, V237, P264, DOI 10.1111/j.1600-065X.2010.00945.x; Tsubata T, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02276; Turner JS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183877; Turqueti-Neves A, 2014, EUR J IMMUNOL, V44, P2130, DOI 10.1002/eji.201344203; Vanshylla K, 2018, EUR J IMMUNOL, V48, P441, DOI 10.1002/eji.201747196; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Vidarsson G, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00520; Vinuesa CG, 2016, ANNU REV IMMUNOL, V34, P335, DOI 10.1146/annurev-immunol-041015-055605; Vinuesa CG, 2011, IMMUNITY, V35, P671, DOI 10.1016/j.immuni.2011.11.001; Vonberg AD, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99860; Wang YF, 2017, NAT IMMUNOL, V18, P921, DOI 10.1038/ni.3788; Ward ES, 2018, TRENDS PHARMACOL SCI, V39, P892, DOI 10.1016/j.tips.2018.07.007; Weinstein JS, 2016, NAT IMMUNOL, V17, P1197, DOI 10.1038/ni.3554; Weisel F, 2017, ANNU REV IMMUNOL, V35, P255, DOI 10.1146/annurev-immunol-041015-055531; Wienands J, 2016, CURR TOP MICROBIOL, V393, P107, DOI 10.1007/82_2015_480; Wilmore JR, 2017, J IMMUNOL, V199, P839, DOI 10.4049/jimmunol.1700461; Wing JB, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01910; Wollenberg I, 2011, J IMMUNOL, V187, P4553, DOI 10.4049/jimmunol.1101328; Woodruff MC, 2018, CELL REP, V25, P321, DOI 10.1016/j.celrep.2018.09.029; Wouters MCA, 2018, CLIN CANCER RES, V24, P6125, DOI 10.1158/1078-0432.CCR-18-1481; Wu J, 2017, AUTOIMMUN REV, V16, P1270, DOI 10.1016/j.autrev.2017.10.012; Yan H, 2017, CELL REP, V19, P995, DOI 10.1016/j.celrep.2017.04.022; Yang JY, 2016, CURR TOP MICROBIOL, V393, P27, DOI 10.1007/82_2015_482; Yang ZY, 2016, ELIFE, V5, DOI 10.7554/eLife.21238; Yang ZY, 2014, CURR OPIN IMMUNOL, V28, P64, DOI 10.1016/j.coi.2014.02.001; Yeap LS, 2015, CELL, V163, P1124, DOI 10.1016/j.cell.2015.10.042; Yu JB, 2018, J CLIN INVEST, V128, P1820, DOI 10.1172/JCI97280; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zaretsky I, 2017, J EXP MED, V214, P3435, DOI 10.1084/jem.20171129; Zhang TT, 2017, ELIFE, V6, DOI 10.7554/eLife.19552; Zhou JHS, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02053	182	284	288	14	96	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2019	177	3					524	540		10.1016/j.cell.2019.03.016	http://dx.doi.org/10.1016/j.cell.2019.03.016			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HU0FV	31002794	Green Accepted, Bronze			2022-12-28	WOS:000464947700010
J	Lotta, LA; Mokrosinski, J; de Oliveira, EM; Li, C; Sharp, SJ; Luan, JA; Brouwers, B; Ayinampudi, V; Bowker, N; Kerrison, N; Kaimakis, V; Hoult, D; Stewart, ID; Wheeler, E; Day, FR; Perry, JRB; Langenberg, C; Wareham, NJ; Farooqi, IS				Lotta, Luca A.; Mokrosinski, Jacek; de Oliveira, Edson Mendes; Li, Chen; Sharp, Stephen J.; Luan, Jian'an; Brouwers, Bas; Ayinampudi, Vikram; Bowker, Nicholas; Kerrison, Nicola; Kaimakis, Vasileios; Hoult, Diana; Stewart, Isobel D.; Wheeler, Eleanor; Day, Felix R.; Perry, John R. B.; Langenberg, Claudia; Wareham, Nicholas J.; Farooqi, I. Sadaf			Human Gain-of-Function MC4R Variants Show Signaling Bias and Protect against Obesity	CELL			English	Article							BODY-MASS INDEX; FUNCTION MUTATIONS; FRAMESHIFT MUTATION; BLOOD-PRESSURE; LIFE-STYLE; RECEPTOR; ASSOCIATION; AGONIST; GENE; DISEASE	The melanocortin 4 receptor (MC4R) is a G protein-coupled receptor whose disruption causes obesity. We functionally characterized 61 MC4R variants identified in 0.5 million people from UK Biobank and their associations with body mass index (BMI) and obesity-related cardiometabolic diseases. We found that the maximal efficacy of beta-arrestin recruitment to MC4R, rather than canonical G(alpha s)-mediated cyclic adenosine-monophosphate production, explained 88% of the variance in the association of MC4R variants with BMI. While most MC4R variants caused loss of function, a subset caused gain of function; these variants were associated with significantly lower BMI and lower odds of obesity, type 2 diabetes, and coronary artery disease. Protective associations were driven by MC4R variants exhibiting signaling bias toward beta-arrestin recruitment and increased mitogen-activated protein kinase pathway activation. Harnessing beta-arrestinbiased MC4R signaling may represent an effective strategy for weight loss and the treatment of obesity-related cardiometabolic diseases.	[Lotta, Luca A.; Li, Chen; Sharp, Stephen J.; Luan, Jian'an; Bowker, Nicholas; Kerrison, Nicola; Kaimakis, Vasileios; Hoult, Diana; Stewart, Isobel D.; Wheeler, Eleanor; Day, Felix R.; Perry, John R. B.; Langenberg, Claudia; Wareham, Nicholas J.] Univ Cambridge, MRC Epidemiol Unit, Wellcome Trust MRC, Inst Metab Sci,Addenbrookes Hosp, Cambridge CB2 0QQ, England; [Mokrosinski, Jacek; de Oliveira, Edson Mendes; Brouwers, Bas; Ayinampudi, Vikram; Farooqi, I. Sadaf] Univ Cambridge, Metab Res Labs, Wellcome Trust MRC, Inst Metab Sci,Addenbrookes Hosp, Cambridge CB2 0QQ, England; [Mokrosinski, Jacek; de Oliveira, Edson Mendes; Brouwers, Bas; Ayinampudi, Vikram; Farooqi, I. Sadaf] Univ Cambridge, NIHR Cambridge Biomed Res Ctr, Wellcome Trust MRC, Inst Metab Sci,Addenbrookes Hosp, Cambridge CB2 0QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Lotta, LA (corresponding author), Univ Cambridge, MRC Epidemiol Unit, Wellcome Trust MRC, Inst Metab Sci,Addenbrookes Hosp, Cambridge CB2 0QQ, England.; Farooqi, IS (corresponding author), Univ Cambridge, Metab Res Labs, Wellcome Trust MRC, Inst Metab Sci,Addenbrookes Hosp, Cambridge CB2 0QQ, England.; Farooqi, IS (corresponding author), Univ Cambridge, NIHR Cambridge Biomed Res Ctr, Wellcome Trust MRC, Inst Metab Sci,Addenbrookes Hosp, Cambridge CB2 0QQ, England.	luca.lotta@mrc-epid.cam.ac.uk; isf20@cam.ac.uk	Li, Chen/GPX-2756-2022; O'Rahilly, Stephen/ABF-6509-2020; de Oliveira, Edson M/C-9885-2014; Farooqi, Ismaa Sadaf/AAZ-3046-2020	Li, Chen/0000-0002-6423-6325; O'Rahilly, Stephen/0000-0003-2199-4449; de Oliveira, Edson M/0000-0002-7330-7826; Farooqi, Sadaf/0000-0001-7609-3504; Bowker, Nicholas/0000-0002-8794-894X; Brouwers, Bas/0000-0001-6541-4835; Wheeler, Eleanor/0000-0002-8616-6444; Mokrosinski, Jacek/0000-0001-5008-0457; Kerrison, Nicola/0000-0002-1471-953X	United Kingdom's Medical Research Council [MC_UU_12015/1, MC_PC_13046, MC_PC_13048, MR/L00002/1]; Cambridge NIHR Biomedical Research Centre; EU FP6 program [LSHM_CT_2006_037197]; Wellcome Trust [098497/Z/12/Z]; NIHR Cambridge Biomedical Research Centre; Botnar Foundation; Bernard Wolfe Health Neuroscience Endowment; Wellcome Trust Major Award [208363/Z/17/Z]; MRC [1950385, MC_UU_12015/1, MC_UU_00014/1, MC_UU_12015/2] Funding Source: UKRI	United Kingdom's Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cambridge NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); EU FP6 program(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Botnar Foundation; Bernard Wolfe Health Neuroscience Endowment; Wellcome Trust Major Award(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research has been conducted using the UK Biobank resource (application 12885). Access to the UK Biobank genotype and phenotype data are open to all approved health researchers (https://www.ukbiobank.ac.uk/).Data from the EPIC-InterAct study contributed to this study. This study was funded by the United Kingdom's Medical Research Council through grants MC_UU_12015/1, MC_PC_13046, MC_PC_13048, and MR/L00002/1 and by the Cambridge NIHR Biomedical Research Centre. Funding for the EPIC-InterAct project was provided by the EU FP6 program (grant number LSHM_CT_2006_037197). I.S.F. was supported by the Wellcome Trust (098497/Z/12/Z), the NIHR Cambridge Biomedical Research Centre, the Botnar Foundation, and the Bernard Wolfe Health Neuroscience Endowment. The authors gratefully acknowledge the help of the MRC Epidemiology Unit Support Teams and the MRL Imaging Core, supported by a Wellcome Trust Major Award (208363/Z/17/Z). The funding bodies had no role in the design or conduct of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.	Bray GA, 2016, LANCET, V387, P1947, DOI 10.1016/S0140-6736(16)00271-3; Burgess S, 2013, GENET EPIDEMIOL, V37, P658, DOI 10.1002/gepi.21758; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Chen KY, 2015, J CLIN ENDOCR METAB, V100, P1639, DOI 10.1210/jc.2014-4024; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Clement K, 2018, NAT MED, V24, P551, DOI 10.1038/s41591-018-0015-9; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Collet TH, 2017, MOL METAB, V6, P1321, DOI 10.1016/j.molmet.2017.06.015; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Crosby J, 2014, NEW ENGL J MED, V371, P22, DOI 10.1056/NEJMoa1307095; Dewey FE, 2017, NEW ENGL J MED, V377, P211, DOI 10.1056/NEJMoa1612790; Fan T, 2000, ENDOCRINOLOGY, V141, P3072; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Farooqi IS, 2000, J CLIN INVEST, V106, P271, DOI 10.1172/JCI9397; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Ference BA, 2015, J AM COLL CARDIOL, V65, P1552, DOI 10.1016/j.jacc.2015.02.020; Flannick J, 2014, NAT GENET, V46, P357, DOI 10.1038/ng.2915; Friend SH, 2014, SCIENCE, V344, P970, DOI 10.1126/science.1255648; Geller F, 2004, AM J HUM GENET, V74, P572, DOI 10.1086/382490; Goate A, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P341; Govindaraju D, 2015, APPL TRANSL GENOM, V4, P23, DOI 10.1016/j.atg.2015.01.001; Greenfield JR, 2009, NEW ENGL J MED, V360, P44, DOI 10.1056/NEJMoa0803085; Gu W, 1999, DIABETES, V48, P635, DOI 10.2337/diabetes.48.3.635; Gundry J, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00017; Harper AR, 2015, NAT REV GENET, V16, P689, DOI 10.1038/nrg4017; Hauser AS, 2018, CELL, V172, P41, DOI 10.1016/j.cell.2017.11.033; Hauser AS, 2017, NAT REV DRUG DISCOV, V16, P829, DOI 10.1038/nrd.2017.178; Heid IM, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.027011; Heymsfield SB, 2017, NEW ENGL J MED, V376, P254, DOI 10.1056/NEJMra1514009; Hinney A, 2006, J CLIN ENDOCR METAB, V91, P1761, DOI 10.1210/jc.2005-2056; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Jorgensen AB, 2014, NEW ENGL J MED, V371, P32, DOI 10.1056/NEJMoa1308027; Kievit P, 2013, DIABETES, V62, P490, DOI 10.2337/db12-0598; Kishi T, 2003, J COMP NEUROL, V457, P213, DOI 10.1002/cne.10454; Kuhnen P, 2016, NEW ENGL J MED, V375, P240, DOI 10.1056/NEJMoa1512693; Langenberg C, 2011, DIABETOLOGIA, V54, P2272, DOI 10.1007/s00125-011-2182-9; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Lotta LA, 2018, JAMA-J AM MED ASSOC, V320, P2553, DOI 10.1001/jama.2018.19329; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Musunuru K, 2010, NEW ENGL J MED, V363, P2220, DOI 10.1056/NEJMoa1002926; Nelson MR, 2015, NAT GENET, V47, P856, DOI 10.1038/ng.3314; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Plenge RM, 2013, NAT REV DRUG DISCOV, V12, P581, DOI 10.1038/nrd4051; Povsic TJ, 2017, CARDIOVASC DRUG THER, V31, P445, DOI 10.1007/s10557-017-6739-9; Rajagopal S, 2017, CELL SIGNAL, V41, P9, DOI 10.1016/j.cellsig.2017.01.024; Rajagopal S, 2011, MOL PHARMACOL, V80, P367, DOI 10.1124/mol.111.072801; Santos R, 2017, NAT REV DRUG DISCOV, V16, P19, DOI 10.1038/nrd.2016.230; Sayk F, 2010, J CLIN ENDOCR METAB, V95, P1998, DOI 10.1210/jc.2009-2297; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Shinyama H, 2003, ENDOCRINOLOGY, V144, P1301, DOI 10.1210/en.2002-220931; Simonds SE, 2014, CELL, V159, P1404, DOI 10.1016/j.cell.2014.10.058; Smith JS, 2018, NAT REV DRUG DISCOV, V17, P243, DOI 10.1038/nrd.2017.229; Stitziel NO, 2014, NEW ENGL J MED, V371, P2072, DOI 10.1056/NEJMoa1405386; Stutzmann F, 2008, DIABETES, V57, P2511, DOI 10.2337/db08-0153; Stutzmann F, 2007, HUM MOL GENET, V16, P1837, DOI 10.1093/hmg/ddm132; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Tallam LS, 2005, HYPERTENSION, V46, P326, DOI 10.1161/01.HYP.0000175474.99326.bf; Turcot V, 2018, NAT GENET, V50, P26, DOI 10.1038/s41588-017-0011-x; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; Wadman M, 2017, SCIENCE, V358, P847, DOI 10.1126/science.358.6365.847; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Wright CF, 2019, AM J HUM GENET, V104, P275, DOI 10.1016/j.ajhg.2018.12.015; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404; Young EH, 2007, INT J OBESITY, V31, P1437, DOI 10.1038/sj.ijo.0803609	70	108	110	7	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2019	177	3					597	+		10.1016/j.cell.2019.03.044	http://dx.doi.org/10.1016/j.cell.2019.03.044			20	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HU0FV	31002796	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000464947700015
J	Mamcarz, E; Zhou, S; Lockey, T; Abdelsamed, H; Cross, SJ; Kang, G; Ma, ZJ; Condori, J; Dowdy, J; Triplett, B; Li, C; Maron, G; Becerra, JCA; Church, JA; Dokmeci, E; Love, JT; Ain, ACD; van der Watt, H; Tang, X; Janssen, W; Ryu, BY; De Ravin, SS; Weiss, MJ; Youngblood, B; Long-Boyle, JR; Gottschalk, S; Meagher, MM; Malech, HL; Puck, JM; Cowan, MJ; Sorrentino, BP				Mamcarz, Ewelina; Zhou, Sheng; Lockey, Timothy; Abdelsamed, Hossam; Cross, Shane J.; Kang, Guolian; Ma, Zhijun; Condori, Jose; Dowdy, Jola; Triplett, Brandon; Li, Chen; Maron, Gabriela; Aldave Becerra, Juan C.; Church, Joseph A.; Dokmeci, Elif; Love, James T.; da Matta Ain, Ana C.; van der Watt, Hedi; Tang, Xing; Janssen, William; Ryu, Byoung Y.; De Ravin, Suk See; Weiss, Mitchell J.; Youngblood, Benjamin; Long-Boyle, Janel R.; Gottschalk, Stephen; Meagher, Michael M.; Malech, Harry L.; Puck, Jennifer M.; Cowan, Morton J.; Sorrentino, Brian P.			Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; STEM-CELL TRANSPLANTATION; VECTOR; CHEMOTHERAPY; OUTCOMES	Background Allogeneic hematopoietic stem-cell transplantation for X-linked severe combined immunodeficiency (SCID-X1) often fails to reconstitute immunity associated with T cells, B cells, and natural killer (NK) cells when matched sibling donors are unavailable unless high-dose chemotherapy is given. In previous studies, autologous gene therapy with gamma-retroviral vectors failed to reconstitute B-cell and NK-cell immunity and was complicated by vector-related leukemia. Methods We performed a dual-center, phase 1-2 safety and efficacy study of a lentiviral vector to transfer IL2RG complementary DNA to bone marrow stem cells after low-exposure, targeted busulfan conditioning in eight infants with newly diagnosed SCID-X1. Results Eight infants with SCID-X1 were followed for a median of 16.4 months. Bone marrow harvest, busulfan conditioning, and cell infusion had no unexpected side effects. In seven infants, the numbers of CD3+, CD4+, and naive CD4+ T cells and NK cells normalized by 3 to 4 months after infusion and were accompanied by vector marking in T cells, B cells, NK cells, myeloid cells, and bone marrow progenitors. The eighth infant had an insufficient T-cell count initially, but T cells developed in this infant after a boost of gene-corrected cells without busulfan conditioning. Previous infections cleared in all infants, and all continued to grow normally. IgM levels normalized in seven of the eight infants, of whom four discontinued intravenous immune globulin supplementation; three of these four infants had a response to vaccines. Vector insertion-site analysis was performed in seven infants and showed polyclonal patterns without clonal dominance in all seven. Conclusions Lentiviral vector gene therapy combined with low-exposure, targeted busulfan conditioning in infants with newly diagnosed SCID-X1 had low-grade acute toxic effects and resulted in multilineage engraftment of transduced cells, reconstitution of functional T cells and B cells, and normalization of NK-cell counts during a median follow-up of 16 months. (Funded by the American Lebanese Syrian Associated Charities and others; LVXSCID-ND ClinicalTrials.gov number, NCT01512888.)	[Mamcarz, Ewelina; Triplett, Brandon; Janssen, William; Gottschalk, Stephen] St Jude Childrens Res Hosp, Dept Bone Marrow Transplantat & Cellular Therapy, 262 Danny Thomas Pl,Mail Stop 1130, Memphis, TN 38105 USA; [Zhou, Sheng; Ma, Zhijun; Condori, Jose; Dowdy, Jola; Tang, Xing; Ryu, Byoung Y.; Weiss, Mitchell J.; Sorrentino, Brian P.] St Jude Childrens Res Hosp, Dept Hematol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Lockey, Timothy; Meagher, Michael M.] St Jude Childrens Res Hosp, Dept Therapeut Prod & Qual, 332 N Lauderdale St, Memphis, TN 38105 USA; [Abdelsamed, Hossam; Youngblood, Benjamin] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Cross, Shane J.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, 332 N Lauderdale St, Memphis, TN 38105 USA; [Kang, Guolian; Li, Chen] St Jude Childrens Res Hosp, Dept Biostat, 332 N Lauderdale St, Memphis, TN 38105 USA; [Maron, Gabriela] St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA; [Aldave Becerra, Juan C.] Hosp Nacl Edgardo Rebagliati Martins, Allergy & Clin Immunol Div, Lima, Peru; [Church, Joseph A.] Childrens Hosp Los Angeles, Dept Pediat, Div Allergy Immunol, Los Angeles, CA 90027 USA; [Long-Boyle, Janel R.; Puck, Jennifer M.; Cowan, Morton J.] Univ Calif San Francisco, Dept Pediat, Benioff Childrens Hosp, Div Pediat Allergy Immunol Bone Marrow Transplant, San Francisco, CA USA; [Dokmeci, Elif] Univ New Mexico, Dept Pediat Pediat Allergy & Immunol, Albuquerque, NM 87131 USA; [Love, James T.] Univ Oklahoma, Hlth Sci Ctr, Tulsa, OK USA; [da Matta Ain, Ana C.] Univ Taubate, Dept Pediat, Conselho Nacl Med, Sao Paulo, Brazil; [van der Watt, Hedi] Copperfield Childcare, Claremont, South Africa; [De Ravin, Suk See; Malech, Harry L.] NIAID, Genet Immunotherapy Sect, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Seguro Social de Salud del Peru; Children's Hospital Los Angeles; University of California System; University of California San Francisco; University of New Mexico; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma - Tulsa; Universidade de Taubate; Universidade Federal de Sao Paulo (UNIFESP); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Mamcarz, E (corresponding author), St Jude Childrens Res Hosp, Dept Bone Marrow Transplantat & Cellular Therapy, 262 Danny Thomas Pl,Mail Stop 1130, Memphis, TN 38105 USA.	ewelina.mamcarz@stjude.org	Maron, Gabriela M./N-8091-2018; Li, Chen/AAI-7364-2021; Triplett, Brandon M/N-2463-2018; Keerthi, Dinesh/ABH-1420-2020; Youngblood, Benjamin/N-2508-2018; Weiss, Mitchell/W-9814-2018; Gottschalk, Stephen/M-9343-2018	Maron, Gabriela M./0000-0001-5247-5399; Li, Chen/0000-0002-9366-0993; Triplett, Brandon M/0000-0001-8220-9980; Zhou, Sheng/0000-0001-5902-5868; Youngblood, Benjamin/0000-0002-1261-9957; Weiss, Mitchell/0000-0003-2460-3036; Malech, Harry/0000-0001-5874-5775; Gottschalk, Stephen/0000-0003-3991-7468; Aldave, Juan/0000-0003-3548-0385; De Ravin, Suk See/0000-0002-9800-774X	American Lebanese Syrian Associated Charities; California Institute of Regenerative Medicine [CLIN2-09504]; National Heart, Lung, and Blood Institute [P01 HL053749]; National Cancer Institute [CA21765]; National Institute of Allergy and Infectious Diseases (NIAID) [Z01-AI-00988]; NIAID [U54-AI082973]; Assisi Foundation of Memphis; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL053749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000644, ZIAAI000988, U54AI082973, ZIAAI000645, ZIAAI000992] Funding Source: NIH RePORTER	American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Assisi Foundation of Memphis; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the American Lebanese Syrian Associated Charities; by grants from the California Institute of Regenerative Medicine (CLIN2-09504), the National Heart, Lung, and Blood Institute (P01 HL053749), the National Cancer Institute (CA21765), the intramural program of the National Institute of Allergy and Infectious Diseases (NIAID) (Z01-AI-00988, to Drs. De Ravin and Malech), and the NIAID (U54-AI082973, to Drs. Cowan and Puck); and by the Assisi Foundation of Memphis.	Aiuti A, 2013, SCIENCE, V341, P865, DOI 10.1126/science.1233151; [Anonymous], 2015, RES, V4, pA1; [Anonymous], 2006, RUSSICA ROMANA, VXIII, P15; Buckley RH, 1999, NEW ENGL J MED, V340, P508, DOI 10.1056/NEJM199902183400703; Buckley RH, 2004, ANNU REV IMMUNOL, V22, P625, DOI 10.1146/annurev.immunol.22.012703.104614; Cowan MJ, 2017, HEMATOL ONCOL CLIN N, V31, P809, DOI 10.1016/j.hoc.2017.06.003; Cowan MJ, 2008, BIOL BLOOD MARROW TR, V14, P73, DOI 10.1016/j.bbmt.2007.10.017; De Ravin SS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad8856; Dvorak C, 2008, BONE MARROW TRANSPL, V41, P119, DOI 10.1038/sj.bmt.1705890; Dvorak CC, 2014, J ALLERGY CLIN IMMUN, V134, P935, DOI 10.1016/j.jaci.2014.06.021; Fuchs S, 2014, EUR J IMMUNOL, V44, P3129, DOI 10.1002/eji.201444689; Gaspar HB, 2013, BLOOD, V122, P3749, DOI 10.1182/blood-2013-02-380105; Gaspar HB, 2004, LANCET, V364, P2181, DOI 10.1016/S0140-6736(04)17590-9; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616; Hacein-Bey-Abina S, 2014, NEW ENGL J MED, V371, P1407, DOI 10.1056/NEJMoa1404588; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Haddad E, 2018, BLOOD, V132, P1737, DOI 10.1182/blood-2018-03-840702; Horn B, 2013, J ALLERGY CLIN IMMUN, V131, P1306, DOI 10.1016/j.jaci.2013.03.014; Humbert O, 2018, BLOOD ADV, V2, P987, DOI 10.1182/bloodadvances.2018016451; Huston MW, 2011, MOL THER, V19, P1867, DOI 10.1038/mt.2011.127; Long-Boyle JR, 2015, THER DRUG MONIT, V37, P236, DOI 10.1097/FTD.0000000000000131; Myers LA, 2002, BLOOD, V99, P872, DOI 10.1182/blood.V99.3.872; Pai SY, 2014, NEW ENGL J MED, V371, P434, DOI 10.1056/NEJMoa1401177; PUCK JM, 1993, HUM MOL GENET, V2, P1099, DOI 10.1093/hmg/2.8.1099; Railey MD, 2009, J PEDIATR-US, V155, P834, DOI 10.1016/j.jpeds.2009.07.049; Savic RM, 2013, BIOL BLOOD MARROW TR, V19, P1608, DOI 10.1016/j.bbmt.2013.08.014; Thrasher AJ, 2008, IMMUNOL ALLERGY CLIN, V28, P457, DOI 10.1016/j.iac.2008.02.001; Throm RE, 2009, BLOOD, V113, P5104, DOI 10.1182/blood-2008-11-191049; Wahlstrom Justin T, 2015, Curr Pediatr Rep, V3, P1; Zhou S, 2015, HUM GENE THER METHOD, V26, P4, DOI 10.1089/hgtb.2014.122; Zhou S, 2010, BLOOD, V116, P900, DOI 10.1182/blood-2009-10-250209	31	119	125	7	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 18	2019	380	16					1525	1534		10.1056/NEJMoa1815408	http://dx.doi.org/10.1056/NEJMoa1815408			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU3AO	30995372	Bronze, Green Accepted			2022-12-28	WOS:000465144100013
J	Marshall, RS; Hua, ZH; Mali, S; McLoughlin, F; Vierstra, RD				Marshall, Richard S.; Hua, Zhihua; Mali, Sujina; McLoughlin, Fionn; Vierstra, Richard D.			ATG8-Binding UIM Proteins Define a New Class of Autophagy Adaptors and Receptors	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; FUNCTIONAL-CHARACTERIZATION; ARABIDOPSIS; YEAST; GENE; DEGRADATION; SYSTEM; DOMAIN; RECOGNITION; COMPONENTS	During autophagy, vesicle dynamics and cargo recruitment are driven by numerous adaptors and receptors that become tethered to the phagophore through interactions with lipidated ATG8/LC3 decorating the expanding membrane. Most currently described ATG8-binding proteins exploit a welldefined ATG8-interacting motif (AIM, or LC3-interacting region [LIR]) that contacts a hydrophobic patch on ATG8 known as the LIR/AIM docking site (LDS). Here we describe a new class of ATG8 interactors that exploit ubiquitin-interacting motif (UIM)-like sequences for high-affinity binding to an alternative ATG8 interaction site. Assays with candidate UIM-containing proteins together with unbiased screens identified a large collection of UIM-based ATG8 interactors in plants, yeast, and humans. Analysis of a subset also harboring ubic . in regulatory X (UBX) domains revealed a role for UIM-directed autophagy in clearing non-functional CDC48/p97 complexes, including some impaired in human disease. With this new class of adaptors and receptors, we greatly extend the reach of selective autophagy and identify new factors regulating autophagic vesicle dynamics.	[Marshall, Richard S.; Mali, Sujina; McLoughlin, Fionn; Vierstra, Richard D.] Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA; [Hua, Zhihua] Ohio Univ, Dept Environm & Plant Biol, Athens, OH 45701 USA	Washington University (WUSTL); University System of Ohio; Ohio University	Vierstra, RD (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	rdvierstra@wustl.edu	Hua, Zhihua/AAD-1146-2021		National Institutes of Health, National Institute of General Medical Science [R01-GM124452]; National Science Foundation, Plant Genome Research Program [IOS-1339325]; Ohio University [SU-1007172]; National Science Foundation CAREER award [MCB-1750361]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM124452] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation, Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD)); Ohio University; National Science Foundation CAREER award(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We wish to thank Sebastian Y. Bednarek, Pedro Carvalho, Stephen J. Elledge, Jean-Luc Gallois, Daniel J. Klionsky, and Mamie Z. Li for generously sharing reagents, and Robert C. Augustine, E. Sethe Burgie, Ryan Calcutt, Michael Dyer, Faqiang Li, Katrice E. McLoughlin, Samantha K. Powers, and Joseph M. Walker for advice and technical support. Work in the Vierstra lab was supported by grants from the National Institutes of Health, National Institute of General Medical Science (R01-GM124452), and the National Science Foundation, Plant Genome Research Program (IOS-1339325). Work in the Hua lab was supported by an Ohio University start-up grant (SU-1007172) and a National Science Foundation CAREER award (MCB-1750361).	BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Brachmann CB, 1998, YEAST, V14, P115; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; den Besten W, 2012, NAT STRUCT MOL BIOL, V19, P511, DOI 10.1038/nsmb.2269; ELLEDGE SJ, 1991, P NATL ACAD SCI USA, V88, P1731, DOI 10.1073/pnas.88.5.1731; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Gallois JL, 2013, GENE, V526, P299, DOI 10.1016/j.gene.2013.05.056; Gatica D, 2018, NAT CELL BIOL, V20, P233, DOI 10.1038/s41556-018-0037-z; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; HARPER JW, 1993, CELL, V75, P805; Hofius D, 2009, CELL, V137, P773, DOI 10.1016/j.cell.2009.02.036; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kaplun L, 2003, J BIOL CHEM, V278, P48727, DOI 10.1074/jbc.M308671200; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kellner R, 2017, TRENDS PLANT SCI, V22, P204, DOI 10.1016/j.tplants.2016.11.015; Khaminets A, 2016, TRENDS CELL BIOL, V26, P6, DOI 10.1016/j.tcb.2015.08.010; Krick R, 2010, J CELL BIOL, V190, P965, DOI 10.1083/jcb.201002075; Levine B, 2019, CELL, V176, P11, DOI 10.1016/j.cell.2018.09.048; Lin L, 2013, J CELL BIOL, V201, P113, DOI 10.1083/jcb.201209098; Lu KF, 2014, CELL, V158, P549, DOI 10.1016/j.cell.2014.05.048; Marshall RS, 2008, J BIOL CHEM, V283, P15869, DOI 10.1074/jbc.M709316200; Marshall RS, 2018, ANNU REV PLANT BIOL, V69, P173, DOI 10.1146/annurev-arplant-042817-040606; Marshall RS, 2016, CELL REP, V16, P1717, DOI 10.1016/j.celrep.2016.07.015; Marshall RS, 2015, MOL CELL, V58, P1053, DOI 10.1016/j.molcel.2015.04.023; Noda NN, 2010, FEBS LETT, V584, P1379, DOI 10.1016/j.febslet.2010.01.018; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Nolan TM, 2017, DEV CELL, V41, P33, DOI 10.1016/j.devcel.2017.03.013; O'Malley RC, 2015, METHODS MOL BIOL, V1284, P323, DOI 10.1007/978-1-4939-2444-8_16; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Park S, 2008, PLANT PHYSIOL, V148, P246, DOI 10.1104/pp.108.121897; Phillips AR, 2008, GENETICS, V178, P1339, DOI 10.1534/genetics.107.086199; Rancour DM, 2004, J BIOL CHEM, V279, P54264, DOI 10.1074/jbc.M405498200; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Ruggiano A, 2016, EMBO J, V35, P1644, DOI 10.15252/embj.201593106; Stach L, 2017, BIOCHEM J, V474, P2953, DOI 10.1042/BCJ20160783; Suttangkakul A, 2011, PLANT CELL, V23, P3761, DOI 10.1105/tpc.111.090993; Tang WK, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00079; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Thompson AR, 2005, PLANT PHYSIOL, V138, P2097, DOI 10.1104/pp.105.060673; Vidal M, 1996, P NATL ACAD SCI USA, V93, P10315, DOI 10.1073/pnas.93.19.10315; Wendland B, 1999, EMBO J, V18, P4383, DOI 10.1093/emboj/18.16.4383; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yang F, 2019, MOL PLANT, V12, P113, DOI 10.1016/j.molp.2018.11.011; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199	51	152	153	10	85	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2019	177	3					766	+		10.1016/j.cell.2019.02.009	http://dx.doi.org/10.1016/j.cell.2019.02.009			40	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HU0FV	30955882	Bronze, Green Accepted			2022-12-28	WOS:000464947700027
J	Richardson, RSF; Lothe, K; Sturridge, S				Richardson, Ruth S. F.; Lothe, Karen; Sturridge, Seb			Is surgery effective in patients with femoroacetabular impingement syndrome?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PROSPECTIVE COHORT; OSTEOARTHRITIS; HIP		[Richardson, Ruth S. F.; Sturridge, Seb] Frimley Pk Hosp, Camberley, Surrey, England; [Lothe, Karen] Upper Gordon Rd Surg, Camberley, Surrey, England		Richardson, RSF (corresponding author), Frimley Pk Hosp, Camberley, Surrey, England.	rsfrichardson@gmail.com						Agricola R, 2013, OSTEOARTHR CARTILAGE, V21, P1514, DOI 10.1016/j.joca.2013.07.004; [Anonymous], 2017, NONARTHROPLASTY HIP; Ayeni OR, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0500-y; Bardakos NV, 2009, J BONE JOINT SURG BR, V91B, P162, DOI 10.1302/0301-620X.91B2.21137; Beck M, 2005, J BONE JOINT SURG BR, V87B, P1012, DOI 10.1302/0301-620X.87B7.15203; Clohisy JC, 2010, CLIN ORTHOP RELAT R, V468, P555, DOI 10.1007/s11999-009-1138-6; Dick AG, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1086; Fairley J, 2016, OSTEOARTHR CARTILAGE, V24, P1682, DOI 10.1016/j.joca.2016.04.014; Ganz R, 2003, CLIN ORTHOP RELAT R, P112, DOI 10.1097/01.blo.0000096804.78689.c2; Ganz R, 2008, CLIN ORTHOP RELAT R, V466, P264, DOI 10.1007/s11999-007-0060-z; Griffin DR, 2016, BRIT J SPORT MED, V50, P1169, DOI 10.1136/bjsports-2016-096743; Griffin DR, 2018, LANCET, V391, P2225, DOI 10.1016/S0140-6736(18)31202-9; Ito K, 2001, J BONE JOINT SURG BR, V83B, P171, DOI 10.1302/0301-620X.83B2.11092; Jackson KA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007609; Mansell NS, 2018, AM J SPORT MED, V46, P1306, DOI 10.1177/0363546517751912; Minkara AA, 2018, AM J SPORTS MED, DOI [10.1177/0363546517749475.29373805, DOI 10.1177/0363546517749475.29373805]; Murphy NJ, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1767-y; NICE Interventional Procedures Guidance, 2011, ARTHR FEM AC SURG HI; Nwachukwu B, 2015, AM J SPORTS MED, DOI [10.1177/0363546515587719.26059179, DOI 10.1177/0363546515587719.26059179]; Palmer A J R, 2016, BMJ Open Sport Exerc Med, V2, pe000082; Palmer AJR, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l185; Reiman MP, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2014-093821; Risberg MA, 2018, J ORTHOP SPORT PHYS, V48, P325, DOI 10.2519/jospt.2018.7931; Roling MA, 2016, J HIP PRESERV SURG, V3, P203, DOI 10.1093/jhps/hnw009; Wall PDH, 2014, COCHRANE DB SYST REV, V9; Wall PDH, 2013, PM&R, V5, P418, DOI 10.1016/j.pmrj.2013.02.005	26	0	0	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 18	2019	365								l1359	10.1136/bmj.l1359	http://dx.doi.org/10.1136/bmj.l1359			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU8PD	31000520				2022-12-28	WOS:000465550700001
J	Rimmer, A				Rimmer, Abi			Doctors who make single clinical mistake are unlikely to face full GMC investigation under new process	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 18	2019	365								l1829	10.1136/bmj.l1829	http://dx.doi.org/10.1136/bmj.l1829			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU8PD	31000500				2022-12-28	WOS:000465550700007
J	Wise, J				Wise, Jacqui			The BMJ Awards 2019: Innovation in Quality Improvement Team of the Year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 10	2019	365								l1653	10.1136/bmj.l1653	http://dx.doi.org/10.1136/bmj.l1653			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU0EL	30971388				2022-12-28	WOS:000464944100009
J	Wise, J				Wise, Jacqui			BMJ Awards 2019: Stroke and Cardiovascular Team of the Year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2019	364								l1354	10.1136/bmj.l1354	http://dx.doi.org/10.1136/bmj.l1354			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HR5VS	30957781				2022-12-28	WOS:000463215700010
J	Wang, JG; Xu, CC; Liao, FL; Jiang, TL; Krishna, S; Tu, YY				Wang, Jigang; Xu, Chengchao; Liao, Fu Long; Jiang, Tingliang; Krishna, Sanjeev; Tu, Youyou			A Temporizing Solution to "Artemisinin Resistance"	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DRUG-RESISTANCE		[Wang, Jigang; Xu, Chengchao; Liao, Fu Long; Jiang, Tingliang; Tu, Youyou] China Acad Chinese Med Sci, Artemisinin Res Ctr, Beijing, Peoples R China; [Wang, Jigang; Xu, Chengchao; Liao, Fu Long; Jiang, Tingliang; Tu, Youyou] China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing, Peoples R China; [Wang, Jigang; Xu, Chengchao] ShenZhen Peoples Hosp, Shenzhen, Peoples R China; [Wang, Jigang; Xu, Chengchao] Natl Univ Singapore, Dept Pharmacol & Biol Sci, Singapore, Singapore; [Krishna, Sanjeev] St Georges Univ London, Inst Infect & Immun, Ctr Diagnost & Antimicrobial Resistance, London, England; [Krishna, Sanjeev] St Georges Univ Hosp NHS Fdn Trust, London, England; [Krishna, Sanjeev] Univ Klinikum Tubingen, Inst Tropenmed, Tubingen, Germany	China Academy of Chinese Medical Sciences; China Academy of Chinese Medical Sciences; Institute of Chinese Materia Medica, CACMS; Jinan University; National University of Singapore; St Georges University London; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Wang, JG (corresponding author), China Acad Chinese Med Sci, Artemisinin Res Ctr, Beijing, Peoples R China.; Wang, JG (corresponding author), China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing, Peoples R China.; Wang, JG (corresponding author), ShenZhen Peoples Hosp, Shenzhen, Peoples R China.; Wang, JG (corresponding author), Natl Univ Singapore, Dept Pharmacol & Biol Sci, Singapore, Singapore.			Xu, Chengchao/0000-0003-4558-7581; Krishna, Sanjeev/0000-0003-0066-0634				Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Gil JP, 2017, EXPERT REV ANTI-INFE, V15, P527, DOI 10.1080/14787210.2017.1313703; Haldar K, 2018, NAT REV MICROBIOL, V16, P156, DOI 10.1038/nrmicro.2017.161; Krishna S, 2013, TRENDS PARASITOL, V29, P313, DOI 10.1016/j.pt.2013.04.001; Wang J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10111	5	52	57	8	117	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 30	2019	380	22					2087	2089		10.1056/NEJMp1901233	http://dx.doi.org/10.1056/NEJMp1901233			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IC6IF	31018065	Green Accepted, Bronze			2022-12-28	WOS:000471074800004
J	Boyle, PA; Yu, L; Schneider, JA; Wilson, RS; Bennett, DA				Boyle, Patricia A.; Yu, Lei; Schneider, Julie A.; Wilson, Robert S.; Bennett, David A.			Scam Awareness Related to Incident Alzheimer Dementia and Mild Cognitive Impairment A Prospective Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							MORTALITY	Background: Decreased scam awareness may be an early indicator of impending Alzheimer dementia and its precursor, mild cognitive impairment, but prior studies have not systematically examined the associations between scam awareness and adverse cognitive outcomes. Objective: To test the hypothesis that low scam awareness is associated with increased risk for incident Alzheimer dementia, mild cognitive impairment, and Alzheimer disease pathology in the brain. Design: Prospective cohort study of aging. Setting: Community-based study in the greater Chicago metropolitan area. Participants: 935 older persons initially free of dementia. Measurements: Scam awareness was measured via questionnaire, incident Alzheimer dementia and mild cognitive impairment were documented in detailed annual cognitive and clinical evaluations, and Alzheimer disease neuropathology was quantified after death among a subset of persons who died (n = 264). Proportional hazards models examined associations between scam awareness and incident Alzheimer dementia and mild cognitive impairment. Regression models examined associations between scam awareness and Alzheimer disease pathology, particularly beta-amyloid burden and tau tangle density. Results: During a mean of about 6 years (SD, 2.4) of observation, 151 persons (16.1%) developed Alzheimer dementia. Low scam awareness was associated with increased risk for Alzheimer dementia (hazard ratio [HR], 1.56 [95% CI, 1.21 to 2.01]; P < 0.001), such that each 1-unit increase in scam score (indicating lower awareness) was associated with about a 60% increase in dementia risk. Low scam awareness was also associated with increased risk for mild cognitive impairment (HR, 1.47 [CI, 1.20 to 1.81]; P < 0.001). These associations persisted even after adjustment for global cognitive function. Finally, low scam awareness was associated with a higher burden of Alzheimer pathology in the brain, particularly beta-amyloid (estimated increase [+/- SE] in beta-amyloid per 1-unit increase in scam score, 0.22 +/- 0.10 unit; P = 0.029). Limitation: The measure of scam awareness used here is too weak for prediction at the individual level. Conclusion: Low scam awareness among older persons is a harbinger of adverse cognitive outcomes and is associated with Alzheimer disease pathology in the brain. Primary Funding Source: National Institute on Aging.	[Boyle, Patricia A.; Yu, Lei; Schneider, Julie A.; Wilson, Robert S.; Bennett, David A.] Rush Univ, Rush Alzheimers Dis Ctr, Med Ctr, 1750 West Harrison St,Suite 1000, Chicago, IL 60612 USA	Rush University	Boyle, PA (corresponding author), Rush Alzheimers Dis Ctr, 1750 West Harrison St,Suite 1000, Chicago, IL 60612 USA.	Patricia_Boyle@rush.edu	Yu, Lei/AAT-3685-2020		National Institute on Aging (NIA) [R01AG33678, R01AG34374, R01AG17917]; Illinois Department of Public Health	National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Illinois Department of Public Health	By grants R01AG33678, R01AG34374, and R01AG17917 from the National Institute on Aging (NIA) and by the Illinois Department of Public Health.	American Association of Retired Persons, 1996, TEL FRAUD OLD AM AAR; Bennett DA, 2018, J ALZHEIMERS DIS, V64, pS161, DOI 10.3233/JAD-179939; Bonnie R. J., 2003, ELDER MISTREATMENT A; Boyle PA, 2017, BRAIN, V140, P804, DOI 10.1093/brain/aww341; Boyle PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043647; Burnes D, 2017, AM J PUBLIC HEALTH, V107, pE13, DOI [10.2105/AJPH.2017.303821, 10.2105/ajph.2017.303821]; Centers for Disease Control and Prevention, 2018, ELD AB PREV; Cooper C, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b155; Dong XQ, 2009, JAMA-J AM MED ASSOC, V302, P517, DOI 10.1001/jama.2009.1109; Financial Industry Regulatory Authority, 2019, RISK MET; FINRA Investor Education Foundation, 2013, FIN FRAUD FRAUD SUSC; FINRA Investor Education Foundation, 2007, SEN FRAUD RISK SURV; Jack CR., 2018, ALZHEIMERS DEMENT, V14, P535, DOI [10.1016/j.jalz.2018.02.018, DOI 10.1016/J.JALZ.2018.02.018]; Lachs MS, 1998, JAMA-J AM MED ASSOC, V280, P428, DOI 10.1001/jama.280.5.428; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; True Link Financial, 2015, POOL SPEC NEEDS TRUS; 2008, NEUROLOGY, V71, P1474, DOI DOI 10.1212/01.WNL.0000334301.32358.48; 2006, NEUROEPIDEMIOLOGY, V27, P169, DOI DOI 10.1159/000096129; 2012, ARCH GEN PSYCHIAT, V69, P499, DOI DOI 10.1001/ARCHGENPSYCHIATRY.2011.1487; 2014, J ELDER ABUSE NEGL, V26, P107, DOI DOI 10.1080/08946566.2013.821809; 2015, J AM GERIATR SOC, V63, P676, DOI DOI 10.1111/JGS.13346; 2011, ALZHEIMERS DEMENT, V7, P280, DOI DOI 10.1016/J.JALZ.2011.03.003; 2011, ANN NEUROL, V69, P181, DOI DOI 10.1002/ANA.22248; 2009, NEUROLOGY, V73, P928, DOI DOI 10.1212/WNL.0B013E3181B87971; 2016, NEUROPSYCHOLOGY, V30, P135, DOI DOI 10.1037/NEU0000223; 2010, AM J PUBLIC HEALTH, V100, P292, DOI DOI 10.2105/AJPH.2009.163089; 2013, NEUROLOGY, V81, P314, DOI DOI 10.1212/WNL.0B013E31829C5E8A; 2005, CLIN GERIATR MED, V21, P293, DOI DOI 10.1016/J.CGER.2004.10.006; 2019, ARCH CLIN NEUROPSYCH, V34, P152, DOI DOI 10.1093/ARCLIN/ACY030; 2016, BRAIN IMAGING BEHAV, V10, P524, DOI DOI 10.1007/S11682-015-9422-4; 2016, J ELDER ABUSE NEGL, V28, P320, DOI DOI 10.1080/08946566.2016.1237918; 2016, ALZ DIS ASSOC DIS, V30, P27, DOI DOI 10.1097/WAD.0000000000000120; 2002, PSYCHOL AGING, V17, P179, DOI DOI 10.1037//0882-7974.17.2.179; 2016, J ELDER ABUSE NEGL, V28, P59, DOI DOI 10.1080/08946566.2016.1142920; 2016, J ALZHEIMERS DIS, V49, P845, DOI DOI 10.3233/JAD-150442; 2016, NEUROBIOL AGING, V37, P19, DOI DOI 10.1016/J.NEUROBIOLAGING.2015.09.011; 2002, NEUROLOGY, V59, P198	37	31	31	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 21	2019	170	10					702	+		10.7326/M18-2711	http://dx.doi.org/10.7326/M18-2711			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HY7RL	30986826				2022-12-28	WOS:000468333600018
J	Ikuta, D; Hirata, Y; Wakamori, S; Shimada, H; Tomabechi, Y; Kawasaki, Y; Ikeuchi, K; Hagimori, T; Matsumoto, S; Yamada, H				Ikuta, Daiki; Hirata, Yasuaki; Wakamori, Shinnosuke; Shimada, Hiroaki; Tomabechi, Yusuke; Kawasaki, Yuri; Ikeuchi, Kazutada; Hagimori, Takara; Matsumoto, Shintaro; Yamada, Hidetoshi			Conformationally supple glucose monomers enable synthesis of the smallest cyclodextrins	SCIENCE			English	Article							SELECTIVE GLYCOSYLATION; MOLECULAR-STRUCTURE; GLYCOSIDATION; CRYSTAL	Cyclodextrins (CDs) are cyclic oligomers of alpha-1,4-D-glucopyranoside and are known mainly as hexamers to octamers. The central cavities of CDs can retain small molecules, enabling diverse applications. The smallest members, CD3 and CD4, have ring sizes too small to permit the most stable conformations of glucopyranose and have not been accessible synthetically. In this study, we present methods to chemically synthesize both CD3 and CD4. The main factor in the successful synthesis is the creation of a glucopyranose ring conformationally counterbalanced between equatorial-and axial-rich forms. This suppleness is imparted by a bridge between 0-3 and 0-6 of glucose, which enables the generation of desirable, albeit deformed, conformers when synthesizing the cyclic trimer and tetramer.	[Ikuta, Daiki; Hirata, Yasuaki; Wakamori, Shinnosuke; Shimada, Hiroaki; Tomabechi, Yusuke; Kawasaki, Yuri; Ikeuchi, Kazutada; Hagimori, Takara; Matsumoto, Shintaro; Yamada, Hidetoshi] Kwansei Gakuin Univ, Sch Sci & Technol, 2-1 Gakuen, Sanda 6691337, Japan; [Tomabechi, Yusuke] Tokai Univ, Sch Engn, Dept Appl Chem, 4-1-1 Kitakaname, Hiratsuka, Kanagawa 2591292, Japan; [Ikeuchi, Kazutada] Hokkaido Univ, Fac Sci, Dept Chem, North 10 West 8, Sapporo, Hokkaido 0600810, Japan	Kwansei Gakuin University; Tokai University; Hokkaido University	Yamada, H (corresponding author), Kwansei Gakuin Univ, Sch Sci & Technol, 2-1 Gakuen, Sanda 6691337, Japan.	hidetosh@kwansei.ac.jp	Ikeuchi, Kazutada/ABC-3900-2020; Ikeuchi, Kazutada/GQA-3636-2022	Ikeuchi, Kazutada/0000-0001-5343-3502; Ikeuchi, Kazutada/0000-0001-5343-3502; Yamada, Hidetoshi/0000-0003-2272-319X; Wakamori, Shinnosuke/0000-0002-0544-9486	MEXT in Japan through the program for the Strategic Research Foundation at Private Universities [S1311046]; JSPS KAKENHI [JP16H01163, JP16KT0061]; Naohiko Fukuoka Memorial Foundation	MEXT in Japan through the program for the Strategic Research Foundation at Private Universities; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Naohiko Fukuoka Memorial Foundation	The research reported here was supported by the MEXT in Japan through the program for the Strategic Research Foundation at Private Universities (S1311046), JSPS KAKENHI (grants JP16H01163 in Middle Molecular Strategy and JP16KT0061), and the Naohiko Fukuoka Memorial Foundation.	Asakura N, 2011, TETRAHEDRON LETT, V52, P534, DOI 10.1016/j.tetlet.2010.11.113; BERGMANN ED, 1953, J AM CHEM SOC, V75, P4281, DOI 10.1021/ja01113a040; Cao Y, 2009, TETRAHEDRON, V65, P2574, DOI 10.1016/j.tet.2009.01.019; CREMER D, 1975, J AM CHEM SOC, V97, P1354, DOI 10.1021/ja00839a011; Daskhan GC, 2014, CHEM COMMUN, V50, P8554, DOI 10.1039/c3cc48794f; FRENCH D, 1957, ADV CARBOHYD CHEM, V12, P189; Furukawa T, 2012, ORG LETT, V14, P2102, DOI 10.1021/ol300634x; HAASNOOT CAG, 1980, TETRAHEDRON, V36, P2783, DOI 10.1016/0040-4020(80)80155-4; HARATA K, 1987, B CHEM SOC JPN, V60, P2763, DOI 10.1246/bcsj.60.2763; Hashimoto Y, 2016, J AM CHEM SOC, V138, P14840, DOI 10.1021/jacs.6b08874; Heuckendorff M, 2013, J ORG CHEM, V78, P7234, DOI 10.1021/jo4012464; HOUDIER S, 1994, ANGEW CHEM INT EDIT, V33, P354, DOI 10.1002/anie.199403541; IMMEL S, 1995, LIEBIGS ANN, P929; Kobayashi S, 2004, TETRAHEDRON, V60, P6923, DOI 10.1016/j.tet.2004.05.089; LINDNER K, 1982, CARBOHYD RES, V99, P103, DOI 10.1016/S0008-6215(00)81901-1; Maiti K, 2016, J ORG CHEM, V81, P4616, DOI 10.1021/acs.joc.6b00462; MANOR PC, 1974, J AM CHEM SOC, V96, P3630, DOI 10.1021/ja00818a042; MATSUMOTO T, 1988, TETRAHEDRON LETT, V29, P3567, DOI 10.1016/0040-4039(88)85294-8; Motoyama A, 2018, SYNTHESIS-STUTTGART, V50, P4695, DOI 10.1055/s-0037-1610841; Motoyama A, 2018, SYNTHESIS-STUTTGART, V50, P282, DOI 10.1055/s-0036-1590927; Mukaiyama T, 2001, CHEM LETT, P388, DOI 10.1246/cl.2001.388; NAKAGAWA T, 1994, TETRAHEDRON LETT, V35, P1921, DOI 10.1016/S0040-4039(00)73196-0; OGAWA T, 1985, CARBOHYD RES, V138, pC5, DOI 10.1016/0008-6215(85)85239-3; Okada Y, 2007, ORG LETT, V9, P1573, DOI 10.1021/ol070427b; Okada Y, 2012, J AM CHEM SOC, V134, P6940, DOI 10.1021/ja301480g; Paul S, 2009, CARBOHYD RES, V344, P177, DOI 10.1016/j.carres.2008.10.026; SEO S, 1978, J AM CHEM SOC, V100, P3331, DOI 10.1021/ja00479a014; Stoddart J. F., 1971, STEREOCHEMISTRY CARB, P50, DOI DOI 10.1021/JO025887RMEDLINE; SUNDARARAJAN PR, 1970, CARBOHYD RES, V13, P351, DOI 10.1016/S0008-6215(00)80592-3; Szejtli J, 2004, PURE APPL CHEM, V76, P1825, DOI 10.1351/pac200476101825; Szejtli J, 1998, CHEM REV, V98, P1743, DOI 10.1021/cr970022c; Taubken N, 1998, GLYCOCONJUGATE J, V15, P757, DOI 10.1023/A:1006999614526; TOSHIMA K, 1994, J AM CHEM SOC, V116, P9042, DOI 10.1021/ja00099a022; Tsukamoto H, 2007, SYNLETT, P3131, DOI 10.1055/s-2007-992352; Uchino T, 2015, CARBOHYD RES, V402, P118, DOI 10.1016/j.carres.2014.10.004; Ueda H., 2006, CYCLODEXTRINS THEIR, P370; UTAMURA T, 1983, YAKUGAKU ZASSHI, V103, P929, DOI 10.1248/yakushi1947.103.9_929; Wakao M, 2002, J ORG CHEM, V67, P8182, DOI 10.1021/jo025887r; WHO, 2000, WHOCDSRBM2000, P26; WHO, 1995, WORLD HLTH REP 1995, P28; World Health Organization, 2005, WHO REC CLASS PEST H, P16	41	55	55	9	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 17	2019	364	6441					674	+		10.1126/science.aaw3053	http://dx.doi.org/10.1126/science.aaw3053			162	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ0SB	30975766				2022-12-28	WOS:000468551000032
J	Podolsky, SH; Herzberg, D; Greene, JA				Podolsky, Scott H.; Herzberg, David; Greene, Jeremy A.			Preying on Prescribers (and Their Patients) - Pharmaceutical Marketing, Iatrogenic Epidemics, and the Sackler Legacy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Podolsky, Scott H.] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Podolsky, Scott H.] Ctr Hist Med, Countway Med Lib, Boston, MA 02115 USA; [Herzberg, David] SUNY Buffalo, Dept Hist, Buffalo, NY 14260 USA; [Greene, Jeremy A.] Johns Hopkins Univ, Sch Med, Dept Hist Med, Baltimore, MD USA; [Greene, Jeremy A.] Johns Hopkins Univ, Sch Med, Ctr Med Humanities & Social Med, Baltimore, MD USA	Harvard University; Harvard Medical School; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Johns Hopkins University; Johns Hopkins University	Podolsky, SH (corresponding author), Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 USA.; Podolsky, SH (corresponding author), Ctr Hist Med, Countway Med Lib, Boston, MA 02115 USA.							Abraham Y., 2019, BOSTON GLOBE    0202; Greene JA, 2009, B HIST MED, V83, P331, DOI 10.1353/bhm.0.0218; Keefe PR, 2017, NEW YORKER, P34; PODOLSKY SH, 2015, ANT ER REF RES PURS, P1; Schwartz LM, 2019, JAMA-J AM MED ASSOC, V321, P80, DOI 10.1001/jama.2018.19320	5	6	6	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 9	2019	380	19					1785	1787		10.1056/NEJMp1902811	http://dx.doi.org/10.1056/NEJMp1902811			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HX9ZZ	30969504				2022-12-28	WOS:000467769800001
J	Jacobs, GS; Hudjashov, G; Saag, L; Kusuma, P; Darusallam, CC; Lawson, DJ; Mondal, M; Pagani, L; Ricaut, FX; Stoneking, M; Metspalu, M; Sudoyo, H; Lansing, JS; Cox, MP				Jacobs, Guy S.; Hudjashov, Georgi; Saag, Lauri; Kusuma, Pradiptajati; Darusallam, Chelzie C.; Lawson, Daniel J.; Mondal, Mayukh; Pagani, Luca; Ricaut, Francois-Xavier; Stoneking, Mark; Metspalu, Mait; Sudoyo, Herawati; Lansing, J. Stephen; Cox, Murray P.			Multiple Deeply Divergent Denisovan Ancestries in Papuans	CELL			English	Article							MODERN HUMANS; ANCIENT ADMIXTURE; SELECTIVE SWEEPS; GENOME SEQUENCE; GENETIC HISTORY; SOUTHEAST-ASIA; POPULATION; NEANDERTHAL; HOMININ; ROBUST	Genome sequences are known for two archaic hominins-Neanderthals and Denisovans-which interbred with anatomically modern humans as they dispersed out of Africa. We identified high-confidence archaic haplotypes in 161 new genomes spanning 14 island groups in Island Southeast Asia and New Guinea and found large stretches of DNA that are inconsistent with a single introgressing Denisovan origin. Instead, modern Papuans carry hundreds of gene variants from two deeply divergent Denisovan lineages that separated over 350 thousand years ago. Spatial and temporal structure among these lineages suggest that introgression from one of these Denisovan groups predominantly took place east of the Wallace line and continued until near the end of the Pleistocene. A third Denisovan lineage occurs in modern East Asians. This regional mosaic suggests considerable complexity in archaic contact, with modern humans interbreeding with multiple Denisovan groups that were geographically isolated from each other over deep evolutionary time.	[Jacobs, Guy S.; Kusuma, Pradiptajati] Nanyang Technol Univ, Complex Inst, Singapore 637723, Singapore; [Hudjashov, Georgi; Cox, Murray P.] Massey Univ, Sch Fundamental Sci, Stat & Bioinformat Grp, Palmerston North 4410, New Zealand; [Hudjashov, Georgi; Saag, Lauri; Mondal, Mayukh; Pagani, Luca; Metspalu, Mait] Univ Tartu, Inst Genom, EE-51010 Tartu, Tartumaa, Estonia; [Kusuma, Pradiptajati; Darusallam, Chelzie C.; Sudoyo, Herawati] Eijkman Inst Mol Biol, Genome Divers & Dis Lab, Jakarta 10430, Indonesia; [Lawson, Daniel J.] Univ Bristol, Populat Hlth Sci, Integrat Epidemiol Unit, Bristol BS8 2BN, Avon, England; [Pagani, Luca] Univ Padua, Dept Biol, APE Lab, I-35131 Padua, Italy; [Ricaut, Francois-Xavier] Univ Toulouse Midi Pyrenees, Dept Evolut & Biol Divers, CNRS, UMR 5174,IRD,UPS, F-31062 Toulouse, France; [Stoneking, Mark] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany; [Sudoyo, Herawati] Univ Indonesia, Dept Med Biol, Fac Med, Jakarta 10430, Indonesia; [Sudoyo, Herawati] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Lansing, J. Stephen] Nanyang Technol Univ, Asian Sch Environm, Singapore 637723, Singapore; [Lansing, J. Stephen] Santa Fe Inst, Santa Fe, NM 87501 USA; [Lansing, J. Stephen] Kraftriket, Stockholm Resilience Ctr, S-10405 Stockholm, Sweden	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Massey University; University of Tartu; Eijkman Institute; University of Bristol; University of Padua; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Max Planck Society; University of Indonesia; University of Sydney; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; The Santa Fe Institute; Stockholm University	Hudjashov, G; Cox, MP (corresponding author), Massey Univ, Sch Fundamental Sci, Stat & Bioinformat Grp, Palmerston North 4410, New Zealand.; Hudjashov, G (corresponding author), Univ Tartu, Inst Genom, EE-51010 Tartu, Tartumaa, Estonia.	g.hudjashov@massey.ac.nz; m.p.cox@massey.ac.nz	Mondal, Mayukh/M-5476-2015; Lawson, Daniel/A-8550-2011; Pagani, Luca/G-8511-2017	Mondal, Mayukh/0000-0003-0122-0323; Lawson, Daniel/0000-0002-5311-6213; RICAUT, Francois-Xavier/0000-0001-7609-7898; Pagani, Luca/0000-0002-6639-524X; Crenna-Darusallam, Chelzie/0000-0001-6236-9418; Kusuma, Pradiptajati/0000-0002-9722-4048	National Science Foundation [SES 0725470]; Singapore Ministry of Education [MOE2015-T2-1-127]; NTU Presidential Postdoctoral Fellowship; French ANR [ANR-14-CE31-0013-01]; European Union grant through the European Regional Development Fund [2014-2020.4.01.15-0012]; Royal Society of New Zealand [17-MAU-040]; German Alexander von Humboldt Foundation; Microsoft research grant; NTU Complexity Institute Individual Fellowship	National Science Foundation(National Science Foundation (NSF)); Singapore Ministry of Education(Ministry of Education, Singapore); NTU Presidential Postdoctoral Fellowship; French ANR(French National Research Agency (ANR)); European Union grant through the European Regional Development Fund; Royal Society of New Zealand(Royal Society of New Zealand); German Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Microsoft research grant(Microsoft); NTU Complexity Institute Individual Fellowship	We thank Hie Lim Kim (Nanyang Technological University), Matthew Leavesley (University of Papua New Guinea), Irene Gallego Romero (University of Melbourne), Nicolas Brucato (Universitede Toulouse Midi-Pyrenees), Jeff Wall (University of California San Francisco), and Vitor Sousa (University of Bern) for helpful comments. We also thank Anto Aasa (University of Tartu) for help with preparing the geographical map of the D1 distribution, and Jonathan Friedlaender (Temple University) for providing New Britain samples as part of the GenomeAsia 100K project. We especially thank all of our study participants. This study was supported by National Science Foundation Grant SES 0725470 and Singapore Ministry of Education Tier II Grant MOE2015-T2-1-127 to J.S.L., an NTU Presidential Postdoctoral Fellowship to G.S.J., an NTU Complexity Institute Individual Fellowship to P.K., a French ANR grant ANR-14-CE31-0013-01 to F.-X.R., a European Union grant through the European Regional Development Fund (Project No. 2014-2020.4.01.15-0012) to M. Metspalu, and a Royal Society of New Zealand Marsden Grant 17-MAU-040 and a German Alexander von Humboldt Foundation fellowship to M.P.C. Computational resources were provided by a Microsoft research grant for Azure cloud computing and the High Performance Computing Center, University of Tartu, Estonia.	1000 Genomes Project Consortium, 2015, Nature, V526, P68, DOI 10.1038/nature15393; Abi-Rached L, 2011, SCIENCE, V334, P89, DOI 10.1126/science.1209202; Barker G, 2007, J HUM EVOL, V52, P243, DOI 10.1016/j.jhevol.2006.08.011; Bergstrom A, 2017, SCIENCE, V357, P1160, DOI 10.1126/science.aan3842; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Browning SR, 2018, CELL, V173, P53, DOI 10.1016/j.cell.2018.02.031; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Cox MP, 2010, P ROY SOC B-BIOL SCI, V277, P1589, DOI 10.1098/rspb.2009.2041; Delaneau O, 2013, AM J HUM GENET, V93, P687, DOI 10.1016/j.ajhg.2013.09.002; Dias-Alves T, 2018, MOL BIOL EVOL, V35, P2318, DOI 10.1093/molbev/msy126; Ferrer-Admetlla A, 2014, MOL BIOL EVOL, V31, P1275, DOI 10.1093/molbev/msu077; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Friedlaender JS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040019; Fritzius T, 2008, EMBO J, V27, P1399, DOI 10.1038/emboj.2008.67; Gittelman RM, 2016, CURR BIOL, V26, P3375, DOI 10.1016/j.cub.2016.10.041; Gravel S, 2012, GENETICS, V191, P607, DOI 10.1534/genetics.112.139808; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hammer MF, 2011, P NATL ACAD SCI USA, V108, P15123, DOI 10.1073/pnas.1109300108; Hayakawa A, 2006, P NATL ACAD SCI USA, V103, P11928, DOI 10.1073/pnas.0508832103; Henn BM, 2015, NAT REV GENET, V16, P333, DOI 10.1038/nrg3931; Henningsson S, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.70; Higham T, 2014, NATURE, V512, P306, DOI 10.1038/nature13621; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Horton R, 2016, LANCET, V387, P830, DOI 10.1016/S0140-6736(16)00544-4; Hublin JJ, 2017, NATURE, V546, P289, DOI 10.1038/nature22336; Hudjashov G, 2017, MOL BIOL EVOL, V34, P2439, DOI 10.1093/molbev/msx196; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Ilardo MA, 2018, CELL, V173, P569, DOI 10.1016/j.cell.2018.03.054; Ingicco T, 2018, NATURE, V557, P233, DOI 10.1038/s41586-018-0072-8; Jinam TA, 2017, GENOME BIOL EVOL, V9, P2013, DOI 10.1093/gbe/evx118; Kelleher J, 2013, BIOINFORMATICS, V29, P955, DOI 10.1093/bioinformatics/btt067; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H., 2013, ARXIV13033997, DOI DOI 10.48550/ARXIV.1303.3997; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Liang M, 2014, GENETICS, V197, P953, DOI 10.1534/genetics.114.162362; Lipson M, 2018, SCIENCE, V361, P92, DOI 10.1126/science.aat3188; Lipson M, 2017, MOL BIOL EVOL, V34, P889, DOI 10.1093/molbev/msw293; Lu DS, 2016, AM J HUM GENET, V99, P580, DOI 10.1016/j.ajhg.2016.07.002; Malaspinas AS, 2016, NATURE, V538, P207, DOI 10.1038/nature18299; Mallick S, 2016, NATURE, V538, P201, DOI 10.1038/nature18964; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Maples BK, 2013, AM J HUM GENET, V93, P278, DOI 10.1016/j.ajhg.2013.06.020; McColl H, 2018, SCIENCE, V361, P88, DOI 10.1126/science.aat3628; McDougall I, 2005, NATURE, V433, P733, DOI 10.1038/nature03258; McVicker G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000471; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Mondal M, 2016, NAT GENET, V48, P1066, DOI 10.1038/ng.3621; Narasimhan VM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00323-y; O'Connell JF, 2018, P NATL ACAD SCI USA, V115, P8482, DOI 10.1073/pnas.1808385115; O'Connor S., 2010, GLOBAL ORIGINS DEV S, P41; Pagani L, 2016, NATURE, V538, P238, DOI 10.1038/nature19792; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Plagnol V, 2006, PLOS GENET, V2, P972, DOI 10.1371/journal.pgen.0020105; Poplin R., 2017, SCALING ACCURATE GEN, DOI [10.1101/201178, DOI 10.1101/201178]; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000519; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Racimo F, 2017, MOL BIOL EVOL, V34, P509, DOI 10.1093/molbev/msw283; Racimo F, 2014, MOL BIOL EVOL, V31, P3344, DOI 10.1093/molbev/msu255; Reich D, 2011, AM J HUM GENET, V89, P516, DOI 10.1016/j.ajhg.2011.09.005; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Rodriguez I, 2002, CURR BIOL, V12, pR409, DOI 10.1016/S0960-9822(02)00909-0; Sankararaman S, 2016, CURR BIOL, V26, P1241, DOI 10.1016/j.cub.2016.03.037; Seabold S., 2010, 9 PYTH SCI C, P6, DOI DOI 10.25080/MAJORA-92BF1922-011; Seguin-Orlando A, 2014, SCIENCE, V346, P1113, DOI 10.1126/science.aaa0114; Skoglund P, 2018, NAT GENET, V50, P632, DOI 10.1038/s41588-018-0097-9; Skoglund P, 2016, NATURE, V538, P510, DOI 10.1038/nature19844; Skov L, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007641; Slon V, 2018, NATURE, V561, P113, DOI 10.1038/s41586-018-0455-x; STONEKING M, 1990, GENETICS, V124, P717; SWADLING P, 2005, PAPUAN PASTS CULTURA, P289; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; TERHORST J, 2017, NAT GENET, V49, P303, DOI [10.1038/ng.3748, DOI 10.1038/NG.3748]; Tucci S, 2018, SCIENCE, V361, P511, DOI 10.1126/science.aar8486; Vernot B, 2016, SCIENCE, V352, P235, DOI 10.1126/science.aad9416; Wall JD, 2017, AM J HUM GENET, V100, P766, DOI 10.1016/j.ajhg.2017.04.002; Wall JD, 2013, GENETICS, V194, P199, DOI 10.1534/genetics.112.148213; Wall JD, 2009, MOL BIOL EVOL, V26, P1823, DOI 10.1093/molbev/msp096; Walz HA, 2010, J BIOL CHEM, V285, P14101, DOI 10.1074/jbc.M110.110536; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Yasukochi Y, 2017, IMMUNOGENETICS, V69, P63, DOI 10.1007/s00251-016-0952-8; Yokoyama Y, 2008, J HUM EVOL, V55, P274, DOI 10.1016/j.jhevol.2008.01.006; 1994, ANTIQUITY, V68, P604; 2016, NATURE, V532, P366; 2017, SCIENCE, V358, P655	91	98	100	5	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 2	2019	177	4					1010	+		10.1016/j.cell.2019.02.035	http://dx.doi.org/10.1016/j.cell.2019.02.035			44	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology	HW7AU	30981557	Green Submitted, Bronze			2022-12-28	WOS:000466843000019
J	Kato, M; Yang, YS; Sutter, BM; Wang, Y; McKnight, SL; Tu, BP				Kato, Masato; Yang, Yu-San; Sutter, Benjamin M.; Wang, Yun; McKnight, Steven L.; Tu, Benjamin P.			Redox State Controls Phase Separation of the Yeast Ataxin-2 Protein via Reversible Oxidation of Its Methionine-Rich Low-Complexity Domain	CELL			English	Article							CELL-FREE FORMATION; SUPEROXIDE-DISMUTASE; P-BODIES; GENE; EXPRESSION; DROPLETS	Yeast ataxin-2, also known as Pbp1, senses the activity state of mitochondria to regulate TORC1. A domain of Pbp1 required to adapt cells to mitochondria activity is of low sequence complexity. The low-complexity (LC) domain of Pbp1 forms labile, cross-beta polymers that facilitate phase transition of the protein into liquid-like or gel-like states. Phase transition for other LC domains is reliant upon widely distributed aromatic amino acids. In place of tyrosine or phenylalanine residues prototypically used for phase separation, Pbp1 contains 24 similarly disposed methionine residues. Here, we show that the Pbp1 methionine residues are sensitive to hydrogen peroxide (H2O2)-mediated oxidation in vitro and in living cells. Methionine oxidation melts Pbp1 liquid-like droplets in a manner reversed by methionine sulfoxide reductase enzymes. These observations explain how reversible formation of labile polymers by the Pbp1 LC domain enables the protein to function as a sensor of cellular redox state.	[Kato, Masato; Yang, Yu-San; Sutter, Benjamin M.; Wang, Yun; McKnight, Steven L.; Tu, Benjamin P.] UT Southwestern Med Ctr, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	McKnight, SL; Tu, BP (corresponding author), UT Southwestern Med Ctr, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	steven.mcknight@utsouthwestern.edu; benjamin.tu@utsouthwestern.edu			NIH [R01GM094314, U01GM107623]; Welch Foundation [I-1797]; HHMI-Simons Foundation; Packard Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094314, U01GM107623, R35GM130358] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021684] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); HHMI-Simons Foundation; Packard Foundation(The David & Lucile Packard Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was enabled by funding support to B.P.T. from the NIH (R01GM094314), the Welch Foundation (I-1797), HHMI-Simons Foundation, and the Packard Foundation; funding support to S.L.M. from NIH (U01GM107623); and unrestricted support to S.L.M. provided by an anonymous donor. We thank Y. Lin for assistance with some in vitro experiments and N.E. Wood for assistance with some image analysis.	Achilli C, 2015, BIOFACTORS, V41, P135, DOI 10.1002/biof.1214; Bakthavachalu B, 2018, NEURON, V98, P754, DOI 10.1016/j.neuron.2018.04.032; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Chen J, 2017, NAT CHEM BIOL, V13, P1179, DOI [10.1038/NCHEMBIO.2478, 10.1038/nchembio.2478]; Chong PA, 2016, CURR OPIN STRUC BIOL, V41, P180, DOI 10.1016/j.sbi.2016.08.001; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Johansson AS, 2007, NEUROREPORT, V18, P559, DOI 10.1097/WNR.0b013e3280b07c21; Kanki T, 2009, AUTOPHAGY, V5, P1186, DOI 10.4161/auto.5.8.9854; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007; Laxman S, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005948; Lee ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057708; Lin Y, 2017, J BIOL CHEM, V292, P19110, DOI 10.1074/jbc.M117.800466; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Ma XX, 2011, J BIOL CHEM, V286, P13430, DOI 10.1074/jbc.M110.205161; Mangus DA, 1998, MOL CELL BIOL, V18, P7383, DOI 10.1128/MCB.18.12.7383; MCCORD JM, 1988, FREE RADICAL BIO MED, V5, P363, DOI 10.1016/0891-5849(88)90109-8; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Moskovitz J, 1997, P NATL ACAD SCI USA, V94, P9585, DOI 10.1073/pnas.94.18.9585; MOSKOVITZ J, 1995, J BACTERIOL, V177, P502, DOI 10.1128/jb.177.3.502-507.1995; Murray DT, 2017, CELL, V171, P615, DOI 10.1016/j.cell.2017.08.048; Nonhoff U, 2007, MOL BIOL CELL, V18, P1385, DOI 10.1091/mbc.E06-12-1120; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Ralser M, 2005, J MOL BIOL, V346, P203, DOI 10.1016/j.jmb.2004.11.024; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Ross OA, 2011, HUM MOL GENET, V20, P3207, DOI 10.1093/hmg/ddr227; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Tu BP, 2007, P NATL ACAD SCI USA, V104, P16886, DOI 10.1073/pnas.0708365104; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Uversky VN, 2002, FEBS LETT, V517, P239, DOI 10.1016/S0014-5793(02)02638-8; van Dijken JP, 2000, ENZYME MICROB TECH, V26, P706, DOI 10.1016/S0141-0229(00)00162-9; Wang J, 2018, CELL, V174, P688, DOI 10.1016/j.cell.2018.06.006; Wu X, 2011, MOL BIOL CELL, V22, P4124, DOI 10.1091/mbc.E11-06-0525; Xiang SH, 2015, CELL, V163, P829, DOI 10.1016/j.cell.2015.10.040; Yang YS, 2019, CELL, V177, P697, DOI 10.1016/j.cell.2019.02.043	39	74	76	1	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2019	177	3					711	+		10.1016/j.cell.2019.02.044	http://dx.doi.org/10.1016/j.cell.2019.02.044			19	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HU0FV	30982603	Green Accepted, Bronze			2022-12-28	WOS:000464947700023
J	Glare, P; Aubrey, KR; Myles, PS				Glare, Paul; Aubrey, Karin R.; Myles, Paul S.			Postoperative pain management and opioids 1 Transition from acute to chronic pain after surgery	LANCET			English	Article							CHRONIC POSTSURGICAL PAIN; ROSTRAL VENTROMEDIAL MEDULLA; NEUROPATHIC PAIN; PERSISTENT PAIN; NITROUS-OXIDE; MOUSE MODEL; DESCENDING PAIN; CLINICAL-TRIALS; RISK; PREVALENCE	Over the past decade there has been an increasing reliance on strong opioids to treat acute and chronic pain, which has been associated with a rising epidemic of prescription opioid misuse, abuse, and overdose-related deaths. Deaths from prescription opioids have more than quadrupled in the USA since 1999, and this pattern is now occurring globally. Inappropriate opioid prescribing after surgery, particularly after discharge, is a major cause of this problem. Chronic postsurgical pain, occurring in approximately 10% of patients who have surgery, typically begins as acute postoperative pain that is difficult to control, but soon transitions into a persistent pain condition with neuropathic features that are unresponsive to opioids. Research into how and why this transition occurs has led to a stronger appreciation of opioid-induced hyperalgesia, use of more effective and safer opioid-sparing analgesic regimens, and non-pharmacological interventions for pain management. This Series provides an overview of the epidemiology and societal effect, basic science, and current recommendations for managing persistent postsurgical pain. We discuss the advances in the prevention of this transitional pain state, with the aim to promote safer analgesic regimens to better manage patients with acute and chronic pain.	[Glare, Paul; Aubrey, Karin R.] Univ Sydney, Pain Management Res Inst, Sydney, NSW, Australia; [Aubrey, Karin R.] Royal North Shore Hosp, Kolling Inst, St Leonards, NSW, Australia; [Myles, Paul S.] Alfred Hosp, Dept Anaesthesiol & Perioperat Med, Melbourne, Vic 3004, Australia	University of Sydney; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; Florey Institute of Neuroscience & Mental Health	Myles, PS (corresponding author), Alfred Hosp, Dept Anaesthesiol & Perioperat Med, Melbourne, Vic 3004, Australia.	p.myles@alfred.org.au	Myles, Paul/AAU-9524-2020; , Karin/R-3241-2019; Aubrey, Karin/J-6526-2012; Glare, Paul Andrew/AAE-8468-2021	Myles, Paul/0000-0002-3324-5456; , Karin/0000-0002-1808-4041; Aubrey, Karin/0000-0002-1808-4041; Glare, Paul/0000-0001-6850-7025	Australian National Health and Medical Research Council Practitioner Fellowship [GNT1135937]; PMRI Limited Foundation	Australian National Health and Medical Research Council Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia); PMRI Limited Foundation	This paper is supported in part by an Australian National Health and Medical Research Council Practitioner Fellowship (GNT1135937 to PSM), and PMRI Limited Foundation (to KRA).	Aasvang EK, 2010, ANESTHESIOLOGY, V112, P957, DOI 10.1097/ALN.0b013e3181d31ff8; Althaus A, 2014, EUR J PAIN, V18, P513, DOI 10.1002/j.1532-2149.2013.00385.x; Althaus A, 2012, EUR J PAIN, V16, P901, DOI 10.1002/j.1532-2149.2011.00090.x; Atlas SJ, 1996, SPINE, V21, P1777, DOI 10.1097/00007632-199608010-00011; Azevedo LF, 2012, J PAIN, V13, P773, DOI 10.1016/j.jpain.2012.05.012; Baber Z, 2016, J PAIN RES, V9, P979, DOI 10.2147/JPR.S92776; Baker DW, 2017, JAMA-J AM MED ASSOC, V317, P1117, DOI 10.1001/jama.2017.0935; Baliki MN, 2012, NAT NEUROSCI, V15, P1117, DOI 10.1038/nn.3153; Barnes NSA, 2016, BRIT J PHARMACOL, V173, P77, DOI 10.1111/bph.13337; Barragan-Iglesias P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02449-5; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Beswick AD, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000435; Bonin RP, 2013, NEUROSCI LETT, V557, P43, DOI 10.1016/j.neulet.2013.09.047; Bruce J, 2001, Health Technol Assess, V5, P1; Bruce Julie, 2011, Rev Pain, V5, P23, DOI 10.1177/204946371100500306; Burgess SE, 2002, J NEUROSCI, V22, P5129, DOI 10.1523/JNEUROSCI.22-12-05129.2002; Cabanero D, 2009, ANESTHESIOLOGY, V111, P1334, DOI 10.1097/ALN.0b013e3181bfab61; Casey SL, 2017, PAIN, V158, P2452, DOI 10.1097/j.pain.0000000000001051; Chan MTV, 2016, BRIT J ANAESTH, V117, P801, DOI 10.1093/bja/aew338; Chan MTV, 2011, PAIN, V152, P2514, DOI 10.1016/j.pain.2011.07.015; Chaparro LE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008307.pub2; Clarke H, 2012, ANESTH ANALG, V115, P428, DOI 10.1213/ANE.0b013e318249d36e; Clay FJ, 2012, PAIN RES MANAG, V17, P35, DOI 10.1155/2012/935194; Crombie IK, 1998, PAIN, V76, P167, DOI 10.1016/S0304-3959(98)00038-4; De Felice M, 2011, PAIN, V152, P2701, DOI 10.1016/j.pain.2011.06.008; de Gray LC, 2005, ANAESTHESIA, V60, P693, DOI 10.1111/j.1365-2044.2005.03997.x; De Kock M, 2009, ANESTHESIOLOGY, V111, P461, DOI 10.1097/ALN.0b013e3181afde28; Denk F, 2014, NAT NEUROSCI, V17, P192, DOI 10.1038/nn.3628; Descalzi G, 2015, TRENDS NEUROSCI, V38, P237, DOI 10.1016/j.tins.2015.02.001; Dworkin RH, 2013, PAIN, V154, P2249, DOI 10.1016/j.pain.2013.06.004; Elman I, 2016, NEURON, V89, P11, DOI 10.1016/j.neuron.2015.11.027; Emery EC, 2016, EXPERT OPIN THER TAR, V20, P975, DOI 10.1517/14728222.2016.1162295; Finnerup NB, 2015, LANCET NEUROL, V14, P162, DOI 10.1016/S1474-4422(14)70251-0; Fletcher D, 2015, EUR J ANAESTH, V32, P725, DOI 10.1097/EJA.0000000000000319; Flexman AM, 2010, CURR OPIN ANESTHESIO, V23, P551, DOI 10.1097/ACO.0b013e32833e15b9; Forsberg A, 2018, SCAND J CARING SCI, V32, P971, DOI 10.1111/scs.12537; Francois A, 2017, NEURON, V93, P822, DOI 10.1016/j.neuron.2017.01.008; Gan TJ, 2017, J PAIN RES, V10, P2287, DOI 10.2147/JPR.S144066; Gewandter JS, 2015, PAIN, V156, P1184, DOI 10.1097/j.pain.0000000000000191; Gradl G, 2013, ANESTH ANALG, V116, P216, DOI 10.1213/ANE.0b013e31826e0fe0; Guimaraes-Pereira L, 2016, ANESTH PAIN MED, V6; Hauser W, 2018, EUR J PAIN, V22, P455, DOI 10.1002/ejp.1118; Hah JM, 2017, ANESTH ANALG, V125, P1733, DOI 10.1213/ANE.0000000000002458; Haroutiunian S, 2013, PAIN, V154, P95, DOI 10.1016/j.pain.2012.09.010; Hetmann F, 2017, J PAIN RES, V10, P663, DOI 10.2147/JPR.S126639; Higgins ET, 1997, AM PSYCHOL, V52, P1280, DOI 10.1037/0003-066X.52.12.1280; Hobo S, 2011, NEUROSCI LETT, V502, P52, DOI 10.1016/j.neulet.2011.07.023; Hsu E, 2013, J PAIN RES, V6, P121, DOI 10.2147/JPR.S32299; Huang A, 2016, PAIN MANAG, V6, P435, DOI 10.2217/pmt-2016-0004; Humble SR, 2015, EUR J PAIN, V19, P451, DOI 10.1002/ejp.567; Inquimbert P, 2018, CELL REP, V23, P2678, DOI 10.1016/j.celrep.2018.04.107; Institute of Medicine Committee on Quality of Health Care in America, 2001, CROSSING QUALITY CHA; Jin JY, 2016, BMC ANESTHESIOL, V16, DOI 10.1186/s12871-016-0270-6; Johansen A, 2012, PAIN, V153, P1390, DOI 10.1016/j.pain.2012.02.018; Kai YZ, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0152-4; Katz J, 2015, J PAIN RES, V8, P695, DOI 10.2147/JPR.S91924; Kazantzis NP, 2016, BRIT J PHARMACOL, V173, P2521, DOI 10.1111/bph.13534; Kehlet H, 2006, LANCET, V367, P1618, DOI 10.1016/S0140-6736(06)68700-X; King KM, 2017, BRIT J PHARMACOL, V174, P2832, DOI 10.1111/bph.13887; Kumar K, 2017, ANESTH ANALG, V125, P1749, DOI 10.1213/ANE.0000000000002497; Kuner R, 2017, NAT REV NEUROSCI, V18, P20, DOI 10.1038/nrn.2016.162; Lau BK, 2014, CURR OPIN NEUROBIOL, V29, P159, DOI 10.1016/j.conb.2014.07.010; Lau BK, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00028; Lavand'homme P, 2017, PAIN, V158, pS50, DOI 10.1097/j.pain.0000000000000809; Leong ML, 2011, J NEUROSCI, V31, P17028, DOI 10.1523/JNEUROSCI.1268-11.2011; Li MH, 2017, J NEUROSCI, V37, P626, DOI [10.1523/JNEUROSCI.1310-16.2017, 10.1523/JNEUROSCI.1310-16.2016]; LIU B, 2017, MEDICINE, V96, DOI DOI 10.1097/MD.0000000000008031; Luongo L, 2017, PHARMACOL RES, V119, P272, DOI 10.1016/j.phrs.2017.02.019; Macdonald L, 2005, BRIT J CANCER, V92, P225, DOI 10.1038/sj.bjc.6602304; Macrae WA, 2008, BRIT J ANAESTH, V101, P77, DOI 10.1093/bja/aen099; Macrae WA, 2001, BRIT J ANAESTH, V87, P88, DOI 10.1093/bja/87.1.88; Manangi M, 2014, INT SCH RES NOTICES, V2014, DOI DOI 10.1155/2014/83968; Marks DM, 2009, CURR NEUROPHARMACOL, V7, P331, DOI 10.2174/157015909790031201; Matsumura Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep32461; Mauck MC, 2017, CLIN J PAIN, V33, P627, DOI 10.1097/AJP.0000000000000446; Meretoja TJ, 2017, J CLIN ONCOL, V35, P1660, DOI 10.1200/JCO.2016.70.3413; Merlin JS, 2018, JAIDS-J ACQ IMM DEF, V79, P77, DOI [10.1097/QAI.0000000000001741, 10.1097/qai.0000000000001741]; Meyerson J, 2001, ACTA ANAESTH SCAND, V45, P940, DOI 10.1034/j.1399-6576.2001.450804.x; Mitrirattanakul S, 2006, PAIN, V126, P102, DOI 10.1016/j.pain.2006.06.016; Morel V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152741; Mucke M, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012182.pub2; Myles PS, 2007, ANESTHESIOLOGY, V107, P221, DOI 10.1097/01.anes.0000270723.30772.da; Myles PS, 2007, LANCET, V369, P810, DOI 10.1016/S0140-6736(07)60388-2; National Center for Health Statistics, 2017, 2014 NAT HOSP DISCH; National Institute for Health and Care Excellence (Great Britain), 2018, NEUR PAIN AD PHARM M; Nicholls JL, 2018, PATIENT-RELAT OUTCOM, V9, DOI 10.2147/PROM.S121251; Ossipov MH, 2014, CURR OPIN SUPPORT PA, V8, P143, DOI 10.1097/SPC.0000000000000055; Patel R, 2017, BRIT J PHARMACOL, V175, P2173; Peirs C, 2016, SCIENCE, V354, P578, DOI 10.1126/science.aaf8933; Perkins FM, 2000, ANESTHESIOLOGY, V93, P1123, DOI 10.1097/00000542-200010000-00038; Petersen KK, 2018, SCAND J PAIN, V18, P237, DOI 10.1515/sjpain-2018-0027; Petrenko AB, 2003, ANESTH ANALG, V97, P1108, DOI 10.1213/01.ANE.0000081061.12235.55; Pogatzki-Zahn EM, 2017, PAIN REP, V2, DOI 10.1097/PR9.0000000000000588; Prescott SA, 2014, NAT NEUROSCI, V17, P183, DOI 10.1038/nn.3629; Rashiq S, 2014, CAN J ANESTH, V61, P123, DOI 10.1007/s12630-013-0072-y; Rawal Narinder, 2005, Anesthesiol Clin North Am, V23, P211, DOI 10.1016/j.atc.2004.11.012; Renton Tara, 2011, Rev Pain, V5, P8, DOI 10.1177/204946371100500103; Roth RS, 2018, BREAST, V37, P119, DOI 10.1016/j.breast.2017.11.001; Russo EB, 2007, CHEM BIODIVERS, V4, P1729, DOI 10.1002/cbdv.200790150; Salvat E, 2018, MOL PAIN, V14, DOI 10.1177/1744806917749683; Schug SA, 2017, PAIN REP, V2, DOI 10.1097/PR9.0000000000000627; Sieberg CB, 2013, J PAIN, V14, P1694, DOI 10.1016/j.jpain.2013.09.005; Smith CE, 2017, CELL CHEM BIOL, V24, P281, DOI 10.1016/j.chembiol.2017.02.003; The Joint Commission, 2018, PAIN MAN STAND 2018; Theunissen M, 2012, CLIN J PAIN, V28, P819, DOI 10.1097/AJP.0b013e31824549d6; Thomson S, 2013, BRIT J PAIN, V7, P56, DOI 10.1177/2049463713479096; Tiippana E, 2016, SCAND J PAIN, V12, P19, DOI 10.1016/j.sjpain.2016.02.008; Treede RD, 2015, PAIN, V156, P1003, DOI 10.1097/j.pain.0000000000000160; Tsantoulas C, 2014, TRENDS NEUROSCI, V37, P146, DOI 10.1016/j.tins.2013.12.002; Urban Michael K, 2018, HSS J, V14, P41, DOI 10.1007/s11420-017-9584-2; Vachon-Presseau E, 2016, J DENT RES, V95, P605, DOI 10.1177/0022034516638027; Vachon-Presseau E, 2016, BRAIN, V139, P1958, DOI 10.1093/brain/aww100; Vambheim SM, 2017, J PAIN RES, V10, P1831, DOI 10.2147/JPR.S134745; VanDenKerkhof EG, 2013, CLIN J PAIN, V29, P2, DOI 10.1097/AJP.0b013e31824730c2; VanDenKerkhof EG, 2012, CAN J ANESTH, V59, P670, DOI 10.1007/s12630-012-9712-x; Ventzel L, 2018, PAIN MED, V19, P1813, DOI 10.1093/pm/pnx231; Vetter TR, 2017, ANESTH ANALG, V125, P1653, DOI 10.1213/ANE.0000000000002280; Volkow ND, 2017, NEW ENGL J MED, V377, P1798; von Hehn CA, 2012, NEURON, V73, P638, DOI 10.1016/j.neuron.2012.02.008; Wang L, 2016, CAN MED ASSOC J, V188, pE352, DOI 10.1503/cmaj.151276; Wang ZJ, 2001, J NEUROSCI, V21, P1779, DOI 10.1523/JNEUROSCI.21-05-01779.2001; Wei F, 2008, J NEUROSCI, V28, P10482, DOI 10.1523/JNEUROSCI.3593-08.2008; Weinrib AZ, 2017, BRIT J PAIN, V11, P169, DOI 10.1177/2049463717720636; Weir S, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017585; Weiser TG, 2016, B WORLD HEALTH ORGAN, V94, P201, DOI 10.2471/BLT.15.159293; Wermeling DR, 2005, PHARMACOTHERAPY, V25, P1084, DOI 10.1592/phco.2005.25.8.1084; Werner MU, 2014, BRIT J ANAESTH, V113, P1, DOI 10.1093/bja/aeu012; Whalley Katherine, 2017, Nat Rev Neurosci, V18, P195, DOI 10.1038/nrn.2017.28; Williams G, 2017, PAIN REP, V2, DOI 10.1097/PR9.0000000000000616; Williamson OD, 2009, J ORTHOP TRAUMA, V23, P139, DOI 10.1097/BOT.0b013e3181962e29; Wylde V, 2011, PAIN, V152, P566, DOI 10.1016/j.pain.2010.11.023; Yaksh Tony L, 2015, F1000Prime Rep, V7, P56, DOI 10.12703/P7-56; Yuill MB, 2017, MOL PAIN, V13, DOI 10.1177/1744806917728227; Zapata A, 2012, J NEUROSCI, V32, P12431, DOI 10.1523/JNEUROSCI.2730-12.2012; Zhuo M, 2002, J NEUROPHYSIOL, V88, P2928, DOI 10.1152/jn.00005.2002	135	221	236	18	80	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 13	2019	393	10180					1537	1546		10.1016/S0140-6736(19)30352-6	http://dx.doi.org/10.1016/S0140-6736(19)30352-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU0DA	30983589				2022-12-28	WOS:000464940400030
J	Servick, K				Servick, Kelly			THE TRESPASSER	SCIENCE			English	Editorial Material																			0	1	1	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2019	364	6436					118	121		10.1126/science.364.6436.118	http://dx.doi.org/10.1126/science.364.6436.118			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HT5RC	30975871				2022-12-28	WOS:000464620000017
J	Detroit, F; Mijares, AS; Corny, J; Daver, G; Zanolli, C; Dizon, E; Robles, E; Grun, R; Piper, PJ				Detroit, Florent; Salvador Mijares, Armand; Corny, Julien; Daver, Guillaume; Zanolli, Clement; Dizon, Eusebio; Robles, Emil; Grun, Rainer; Piper, Philip J.			A new species of Homo from the Late Pleistocene of the Philippines	NATURE			English	Article							EVOLUTIONARY HISTORY; HADAR FORMATION; SHAPE VARIATION; MORPHOLOGY; BONES; HAND; FLORESIENSIS; REMAINS; JOINT; FOOT	A hominin third metatarsal discovered in 2007 in Callao Cave (Northern Luzon, the Philippines) and dated to 67 thousand years ago provided the earliest direct evidence of a human presence in the Philippines. Analysis of this foot bone suggested that it belonged to the genus Homo, but to which species was unclear. Here we report the discovery of twelve additional hominin elements that represent at least three individuals that were found in the same stratigraphic layer of Callao Cave as the previously discovered metatarsal. These specimens display a combination of primitive and derived morphological features that is different from the combination of features found in other species in the genus Homo (including Homo floresiensis and Homo sapiens) and warrants their attribution to a new species, which we name Homo luzonensis. The presence of another and previously unknown hominin species east of the Wallace Line during the Late Pleistocene epoch underscores the importance of island Southeast Asia in the evolution of the genus Homo.	[Detroit, Florent; Corny, Julien] Museum Natl Hist Nat, CNRS, Dept Homme & Environm, UMR 7194,Musee Homme, Paris, France; [Salvador Mijares, Armand; Robles, Emil] Univ Philippines, Archaeol Studies Program, Quezon City, Philippines; [Salvador Mijares, Armand; Dizon, Eusebio; Piper, Philip J.] Natl Museum Philippines, Manila, Philippines; [Daver, Guillaume] Univ Poitiers, CNRS, UMR 7262, Lab Paleontol Evolut Paleoecosyst Paleoprimatol P, Poitiers, France; [Zanolli, Clement] Univ Bordeaux, CNRS, UMR 5199, Lab PACEA, Bordeaux, France; [Zanolli, Clement] Univ Toulouse III Paul Sabatier, CNRS, UMR 5288, Lab AMIS, Toulouse, France; [Grun, Rainer] Griffith Univ, Environm Futures Res Inst, Australian Res Ctr Human Evolut, Brisbane, Qld, Australia; [Grun, Rainer] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia; [Piper, Philip J.] Australian Natl Univ, Sch Archaeol & Anthropol, Canberra, ACT, Australia	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); University of the Philippines System; University of the Philippines Diliman; National Museum of the Philippines; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Griffith University; Australian National University; Australian National University	Detroit, F (corresponding author), Museum Natl Hist Nat, CNRS, Dept Homme & Environm, UMR 7194,Musee Homme, Paris, France.; Mijares, AS (corresponding author), Univ Philippines, Archaeol Studies Program, Quezon City, Philippines.; Mijares, AS (corresponding author), Natl Museum Philippines, Manila, Philippines.	florent.detroit@mnhn.fr; mandy24_us@yahoo.com	Détroit, Florent/AFU-6586-2022; Détroit, Florent/G-1022-2010	Détroit, Florent/0000-0001-5208-6203; Détroit, Florent/0000-0001-5208-6203; Zanolli, Clement/0000-0002-5617-1613	WennerGren Foundation; Leakey Foundation Research Grant; University of the Philippines Enhanced Creative Work and Research Grant [ECWRG 2015-1016]; Australian Research Council [DP110101415, FT100100527, DP140100384]; Agence Nationale pour la Recherche [ANR ARCHOR12-CULT-0006]; Omo Group Research Expedition; MEAE; Universite de Poitiers; Conseil departemental de la Vienne; SYNTHESYS [NLTAF-1130]; 'IUSS Ferrara 1391' grants; Labex BCDiv 'Biological and Cultural Diversities'; Erasmus Mundus IMQP; IDQP; MQPI (MEAE); PaleoFED	WennerGren Foundation; Leakey Foundation Research Grant; University of the Philippines Enhanced Creative Work and Research Grant; Australian Research Council(Australian Research Council); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Omo Group Research Expedition; MEAE; Universite de Poitiers; Conseil departemental de la Vienne; SYNTHESYS; 'IUSS Ferrara 1391' grants; Labex BCDiv 'Biological and Cultural Diversities'; Erasmus Mundus IMQP; IDQP; MQPI (MEAE); PaleoFED	F.D., J.C., G.D. and C.Z. thank L. Puymerail. We thank T. Sutikna and W. Saptomo (Pusat Penelitian Arkeologi Nasional); X.-J. Wu and W. Liu (IVPP); J. de Vos (Naturalis); N. Giang Hai, N. Kim Thuy, N. Lan Cuong and N. Thi Mai Huong (Institute of Archaeology); N. Viet (Center for Southeast Asian Prehistory); A. Kijngam and R. Thosarat (Thai Fine Arts Department); the National Research Council of Thailand; G. Garcia-Pack, I. Tattersall and E. Delson (American Museum of Natural History); the Field Museum of Natural History; the Ethiopian Authority for Research and Conservation of the Cultural Heritage; the National Museums of Kenya and Government of Kenya; the Ditsong National Museum of Natural History, the Evolutionary Studies Institute, University of the Witwatersrand; the Centre de Valorisation des Collections scientifiques de l'Universite de Poitiers; S. Bahuchet, A. Fort, M. Friess, A. Froment, D. Grimaud-Herve, L. Huet, V. Laborde and P. Mennecier (MNHN); the Nespos Society (https://www.nespos.org); MorphoSource, Duke University (https://www.morphosource.org/); the Senckenberg Research Institute Frankfurt; the ESRF Paleontological Database (paleo.esrf.eu); P. Fernandez, C. Higham, W. Jungers, Y. Kaifu, R. Kono, H. Matsumura, M. Oxenham, N. Tayles and M. Tocheri for granting access to or sharing information and data on recent and fossil hominins; M. Stoneking and Q. Fu (Max Planck Institute for Evolutionary Anthropology); AST-RX and Imagerie 2D/3D MH-SU platforms (MNHN); G. Champion, A. Giral, A. Gossez, A. Van Heteren, J. Surault and J. Tanedo for discussions or technical assistance; the National Museum of the Philippines and its Directorial staff; colleagues and students from the Archaeological Studies Program (University of the Philippines); the 2011 and 2015 IMQP Erasmus Mundus students; and the Cagayan Provincial Government and the Protected Area Management Board-Penablanca for authorizing fieldwork at Callao Cave. Funding was provided by the WennerGren Foundation, the Leakey Foundation Research Grant and the University of the Philippines Enhanced Creative Work and Research Grant (ECWRG 2015-1016). R.G.'s work was partly funded by the Australian Research Council Grant DP110101415. The research of P. J. P. was supported by Australian Research Council grants FT100100527 and DP140100384. The research of G. D. was supported by the Agence Nationale pour la Recherche (ANR ARCHOR12-CULT-0006), the Omo Group Research Expedition (J.-R. Boisserie), the MEAE, the Universite de Poitiers and the Conseil departemental de la Vienne (ACI 2013-2014). The research of J. C. was supported by SYNTHESYS (NLTAF-1130) and 'IUSS Ferrara 1391' grants. Aspects of the research of F. D. were supported by the Labex BCDiv 'Biological and Cultural Diversities', Erasmus Mundus IMQP and IDQP, MQPI (MEAE) and PaleoFED.	[Anonymous], R LANG ENV STAT COMP; Argue D, 2017, J HUM EVOL, V107, P107, DOI 10.1016/j.jhevol.2017.02.006; Bellwood P, 2018, SCIENCE, V361, P31, DOI 10.1126/science.aat8662; Bonhomme V, 2014, J STAT SOFTW, V56, P1; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; BUSH ME, 1982, AM J PHYS ANTHROPOL, V57, P651, DOI 10.1002/ajpa.1330570410; Case DT, 2006, INT J OSTEOARCHAEOL, V16, P338, DOI 10.1002/oa.826; Christensen AM, 2009, FORENSIC SCI INT, V193, P84, DOI 10.1016/j.forsciint.2009.09.012; Claude J, 2008, MORPHOMETRICS R; Corny J, 2017, J HUM EVOL, V112, P41, DOI 10.1016/j.jhevol.2017.08.017; Corny J, 2014, AM J PHYS ANTHROPOL, V153, P314, DOI 10.1002/ajpa.22428; DARROCH JN, 1985, BIOMETRIKA, V72, P241, DOI 10.2307/2336077; DeSilva JM, 2013, SCIENCE, V340, DOI 10.1126/science.1232999; Detroit F, 2013, HUM BIOL, V85, P45, DOI 10.3378/027.085.0303; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; DUNCAN AS, 1994, AM J PHYS ANTHROPOL, V93, P67, DOI 10.1002/ajpa.1330930105; Duval M, 2017, AM J PHYS ANTHROPOL, V163, P205, DOI 10.1002/ajpa.23180; Gomez-Robles A, 2011, J HUM EVOL, V61, P688, DOI 10.1016/j.jhevol.2011.09.004; Griffin NL, 2010, AM J PHYS ANTHROPOL, V141, P116, DOI 10.1002/ajpa.21121; Grine Frederick Edward, 1994, Courier Forschungsinstitut Senckenberg, V171, P75; Grun R, 2014, PALAEOGEOGR PALAEOCL, V416, P150, DOI 10.1016/j.palaeo.2014.07.023; Grun R, 2012, ARCHAEOL ANTHROP SCI, V4, P25, DOI 10.1007/s12520-011-0079-7; Harcourt-Smith WEH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9432; Heaney L. R., 1998, FIELDIANA ZOOL, V88, P1, DOI DOI 10.5962/BHL.TITLE.3419; Heaney LR, 2016, MAMMALS OF LUZON ISLAND: BIOGEOGRAPHY AND NATURAL HISTORY OF A PHILIPPINE FAUNA, P1; Immel A, 2016, SCI REP-UK, V6, DOI 10.1038/srep32969; Ingicco T, 2018, NATURE, V557, P233, DOI 10.1038/s41586-018-0072-8; Irish JD, 2018, J HUM EVOL, V122, P108, DOI 10.1016/j.jhevol.2018.05.007; Jungers WL, 2009, J HUM EVOL, V57, P538, DOI 10.1016/j.jhevol.2008.08.014; Jungers WL, 2009, NATURE, V459, P81, DOI 10.1038/nature07989; Jungers WL, 2013, BLACKW COMPANION ANT, P582; Jungers WL, 1995, YEARB PHYS ANTHROPOL, V38, P137; Kaifu Y, 2005, AM J PHYS ANTHROPOL, V128, P709, DOI 10.1002/ajpa.10425; Kaifu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141614; Kaifu Y, 2015, ANTHROPOL SCI, V123, P129, DOI 10.1537/ase.150501; Kivell TL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9431; Larson SG, 2009, J HUM EVOL, V57, P555, DOI 10.1016/j.jhevol.2008.06.007; LATIMER B, 1987, AM J PHYS ANTHROPOL, V74, P155, DOI 10.1002/ajpa.1330740204; LATIMER BM, 1982, AM J PHYS ANTHROPOL, V57, P701, DOI 10.1002/ajpa.1330570412; Li ZY, 2017, SCIENCE, V355, P969, DOI 10.1126/science.aal2482; Lorenzo C, 1999, J HUM EVOL, V37, P501, DOI 10.1006/jhev.1999.0341; Mitteroecker P, 2011, EVOL BIOL, V38, P100, DOI 10.1007/s11692-011-9109-8; Mittra ES, 2007, AM J PHYS ANTHROPOL, V134, P449, DOI 10.1002/ajpa.20687; Monsarrat P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165329; Moya-Sola S, 2008, FOLIA PRIMATOL, V79, P215, DOI 10.1159/000113458; Musgrave J. H, 1973, HUMAN EVOLUTION, V11, P59; NAPIER J, 1962, NATURE, V196, P409, DOI 10.1038/196409a0; Mijares AS, 2010, J HUM EVOL, V59, P123, DOI 10.1016/j.jhevol.2010.04.008; Sawyer S, 2015, P NATL ACAD SCI USA, V112, P15696, DOI 10.1073/pnas.1519905112; Schlager S., 2017, STAT SHAPE DEFORMATI, P217; Scott G.R., 2018, ANTHR MODERN HUMAN T, V2nd; SPOOR CF, 1993, AM J PHYS ANTHROPOL, V91, P469, DOI 10.1002/ajpa.1330910405; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; SUSMAN RL, 1984, FOLIA PRIMATOL, V43, P113, DOI 10.1159/000156176; SUSMAN RL, 1979, AM J PHYS ANTHROPOL, V50, P215, DOI 10.1002/ajpa.1330500211; Sutikna T, 2016, NATURE, V532, P366, DOI 10.1038/nature17179; Trinkaus, 2014, SHANIDAR NEANDERTALS; Trinkaus E, 2016, CR PALEVOL, V15, P978, DOI 10.1016/j.crpv.2016.07.003; van den Bergh GD, 2016, NATURE, V534, P245, DOI 10.1038/nature17999; Ostende LWV, 2018, CLADISTICS, V34, P708, DOI 10.1111/cla.12238; van der Geer AAE, 2017, J BIOGEOGR, V44, P995, DOI 10.1111/jbi.12857; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Walker A., 1993, NARIOKOTOME HOMO ERE; Ward CV, 2012, J HUM EVOL, V63, P1, DOI 10.1016/j.jhevol.2011.11.012; Westaway KE, 2017, NATURE, V548, P322, DOI 10.1038/nature23452; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wood B., 1991, HOMINID CRANIAL REMA, V4; WOOD BA, 1988, J ANAT, V161, P1; Xing S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20432-y; Xing S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114265; Zanolli C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189773; Zanolli C, 2018, J HUM EVOL, V116, P1, DOI 10.1016/j.jhevol.2017.11.002; Zanolli C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067233	73	92	98	6	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2019	568	7751					181	+		10.1038/s41586-019-1067-9	http://dx.doi.org/10.1038/s41586-019-1067-9			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HT2SH	30971845	Green Submitted			2022-12-28	WOS:000464412700038
J	Wojciechowski, D; Gandhi, RT; Rosales, IA				Wojciechowski, David; Gandhi, Rajesh T.; Rosales, Ivy A.			Case 11-2019: A 49-Year-Old Man with HIV Infection and Chronic Kidney Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PATHOLOGICAL CLASSIFICATION; TRANSPLANTATION; NEPHROPATHY; DIALYSIS; OUTCOMES; TIME; ERA		[Wojciechowski, David; Gandhi, Rajesh T.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Rosales, Ivy A.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Wojciechowski, David; Gandhi, Rajesh T.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Rosales, Ivy A.] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Wojciechowski, D (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; Wojciechowski, D (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.		Rosales, Ivy/AAE-8371-2019	Rosales, Ivy/0000-0003-0621-3202	Harvard University Center for AIDS Research [NIH P30 AI060354]; Centre for the AIDS Programme of Research in South Africa; KwaZulu-Natal Department of Health; University of KwaZulu-Natal; Southern African HIV Clinicians Society	Harvard University Center for AIDS Research; Centre for the AIDS Programme of Research in South Africa; KwaZulu-Natal Department of Health; University of KwaZulu-Natal; Southern African HIV Clinicians Society	This case was presented at the 12th Annual Workshop on Advanced Clinical Care-AIDS in Durban, South Africa, organized by Drs. Henry Sunpath and Mahomed-Yunus S. Moosa (Infectious Diseases Unit, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal) and Dr. Rajesh T. Gandhi (Massachusetts General Hospital and the Ragon Institute) and sponsored by the Harvard University Center for AIDS Research (NIH P30 AI060354), the Centre for the AIDS Programme of Research in South Africa, the University of KwaZulu-Natal, the Southern African HIV Clinicians Society, and the KwaZulu-Natal Department of Health.	Altfeld M, 2002, NATURE, V420, P434, DOI 10.1038/nature01200; Calmy A, 2016, AM J TRANSPLANT, V16, P2473, DOI 10.1111/ajt.13824; D'Agati V, 2003, SEMIN NEPHROL, V23, P117, DOI 10.1053/snep.2003.50012; D'Agati VD, 2004, AM J KIDNEY DIS, V43, P368, DOI 10.1053/j.ajkd.2003.10.024; de Brito-Ashurst I, 2009, J AM SOC NEPHROL, V20, P2075, DOI 10.1681/ASN.2008111205; De Luca A, 2013, J INFECT DIS, V207, P1216, DOI 10.1093/infdis/jit017; Dickersin RG., 2000, DIAGNOSTIC ELECT MIC; Eustace JA, 2000, KIDNEY INT, V58, P1253, DOI 10.1046/j.1523-1755.2000.00280.x; Hathorn E, 2016, NEW ENGL J MED, V375, P1807, DOI 10.1056/NEJMc1603850; Herlitz LC, 2010, KIDNEY INT, V78, P1171, DOI 10.1038/ki.2010.318; Ho YH, 2015, NEW ENGL J MED, V372, P2070, DOI 10.1056/NEJMc1503288; Laradi A, 1998, J AM SOC NEPHROL, V9, P2327; Lescure FX, 2012, NEPHROL DIAL TRANSPL, V27, P2349, DOI 10.1093/ndt/gfr676; Locke JE, 2017, CLIN J AM SOC NEPHRO, V12, P467, DOI 10.2215/CJN.07460716; Markowitz GS, 2010, CLIN J AM SOC NEPHRO, V5, P607, DOI 10.2215/CJN.07311009; Meier-Kriesche HU, 2002, TRANSPLANTATION, V74, P1377, DOI 10.1097/00007890-200211270-00005; Mohan S, 2013, CLIN NEPHROL, V79, P285, DOI 10.5414/CN107774; Muller E, 2015, NEW ENGL J MED, V372, P613, DOI 10.1056/NEJMoa1408896; Muller E, 2010, NEW ENGL J MED, V362, P2336, DOI 10.1056/NEJMc0900837; Peters L, 2012, AIDS, V26, P1917, DOI 10.1097/QAD.0b013e3283574e71; Sawinski D, 2017, AM J TRANSPLANT, V17, P3114, DOI 10.1111/ajt.14419; Stock PG, 2010, NEW ENGL J MED, V363, P2004, DOI 10.1056/NEJMoa1001197; Tricot L, 2009, AM J TRANSPLANT, V9, P1946, DOI 10.1111/j.1600-6143.2009.02684.x; Trullas JC, 2011, JAIDS-J ACQ IMM DEF, V57, P276, DOI 10.1097/QAI.0b013e318221fbda; University of Liverpool, 2019, HIV DRUG INT; Wei A, 2003, KIDNEY INT, V64, P1462, DOI 10.1046/j.1523-1755.2003.00230.x; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Woodward CLN, 2009, HIV MED, V10, P482, DOI 10.1111/j.1468-1293.2009.00716.x	28	1	1	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 11	2019	380	15					1464	1472		10.1056/NEJMcpc1900417	http://dx.doi.org/10.1056/NEJMcpc1900417			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HT5NG	30970193				2022-12-28	WOS:000464610000014
J	Singal, G; Miller, PG; Agarwala, V; Li, G; Kaushik, G; Backenroth, D; Gossai, A; Frampton, GM; Torres, AZ; Lehnert, EM; Bourque, D; O'Connell, C; Bowser, B; Caron, T; Baydur, E; Seidl-Rathkopf, K; Ivanov, I; Alpha-Cobb, G; Guria, A; He, J; Frank, S; Nunnally, AC; Bailey, M; Jaskiw, A; Feuchtbaum, D; Nussbaum, N; Abernethy, AP; Miller, VA				Singal, Gaurav; Miller, Peter G.; Agarwala, Vineeta; Li, Gerald; Kaushik, Gaurav; Backenroth, Daniel; Gossai, Anala; Frampton, Garrett M.; Torres, Aracelis Z.; Lehnert, Erik M.; Bourque, David; O'Connell, Claire; Bowser, Bryan; Caron, Thomas; Baydur, Ezra; Seidl-Rathkopf, Kathi; Ivanov, Ivan; Alpha-Cobb, Garrett; Guria, Ameet; He, Jie; Frank, Shannon; Nunnally, Allen C.; Bailey, Mark; Jaskiw, Ann; Feuchtbaum, Dana; Nussbaum, Nathan; Abernethy, Amy P.; Miller, Vincent A.			Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non-Small Cell Lung Cancer Using a Clinicogenomic Database	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LANDSCAPE; REVEALS	IMPORTANCE Data sets linking comprehensive genomic profiling (CGP) to clinical outcomes may accelerate precision medicine. OBJECTIVE To assess whether a database that combines EHR-derived clinical data with CGP can identify and extend associations in non-small cell lung cancer (NSCLC). DESIGN, SETTING, AND PARTICIPANTS Clinical data from EHRs were linked with CGP results for 28 998 patients from 275 US oncology practices. Among 4064 patients with NSCLC, exploratory associations between tumor genomics and patient characteristics with clinical outcomes were conducted, with data obtained between January 1, 2011, and January 1, 2018. EXPOSURES Tumor CGP, including presence of a driver alteration (a pathogenic or likely pathogenic alteration in a gene shown to drive tumor growth); tumor mutation burden (TMB), defined as the number of mutations per megabase; and clinical characteristics gathered from EHRs. MAIN OUTCOMES AND MEASURES Overall survival (OS), time receiving therapy, maximal therapy response (as documented by the treating physician in the EHR), and clinical benefit rate (fraction of patients with stable disease, partial response, or complete response) to therapy. RESULTS Among 4064 patients with NSCLC (median age, 66.0 years; 51.9% female), 3183 (78.3%) had a history of smoking, 3153 (77.6%) had nonsquamous cancer, and 871 (21.4%) had an alteration in EGFR, ALK, or ROS1 (701 [17.2%] with EGFR, 128 [3.1%] with ALK, and 42 [1.0%] with ROS1 alterations). There were 1946 deaths in 7 years. For patients with a driver alteration, improved OS was observed among those treated with (n = 575) vs not treated with (n = 560) targeted therapies (median, 18.6 months [95% CI, 15.2-21.7] vs 11.4 months [95% CI, 9.7-12.5] from advanced diagnosis; P < .001). TMB (in mutations/Mb) was significantly higher among smokers vs nonsmokers (8.7 [IQR, 4.4-14.8] vs 2.6 [IQR, 1.7-5.2]; P < .001) and significantly lower among patients with vs without an alteration in EGFR (3.5 [IQR, 1.76-6.1] vs 7.8 [IQR, 3.5-13.9]; P < .001), ALK (2.1 [IQR, 0.9-4.0] vs 7.0 [IQR, 3.5-13.0]; P < .001), RET (4.6 [IQR, 1.7-8.7] vs 7.0 [IQR, 2.6-13.0]; P = .004), or ROS1 (4.0 [IQR, 1.2-9.6] vs 7.0 [IQR, 2.6-13.0]; P = .03). In patients treated with anti-PD-1/PD-L1 therapies (n = 1290, 31.7%), TMB of 20 or more was significantly associated with improved OS from therapy initiation (16.8 months [95% CI, 11.6-24.9] vs 8.5 months [95% CI, 7.6-9.7]; P < .001), longer time receiving therapy (7.8 months [95% CI, 5.5-11.1] vs 3.3 months [95% CI, 2.8-3.7]; P < .001), and increased clinical benefit rate (80.7% vs 56.7%; P < .001) vs TMB less than 20. CONCLUSIONS AND RELEVANCE Among patients with NSCLC included in a longitudinal database of clinical data linked to CGP results from routine care, exploratory analyses replicated previously described associations between clinical and genomic characteristics, between driver mutations and response to targeted therapy, and between TMB and response to immunotherapy. These findings demonstrate the feasibility of creating a clinicogenomic database derived from routine clinical experience and provide support for further research and discovery evaluating this approach in oncology.	[Singal, Gaurav; Li, Gerald; Kaushik, Gaurav; Frampton, Garrett M.; Lehnert, Erik M.; Bourque, David; Alpha-Cobb, Garrett; Guria, Ameet; He, Jie; Bailey, Mark; Miller, Vincent A.] Fdn Med Inc, 150 Second St, Cambridge, MA 02140 USA; [Singal, Gaurav] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Miller, Peter G.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Agarwala, Vineeta; Backenroth, Daniel; Gossai, Anala; Torres, Aracelis Z.; O'Connell, Claire; Bowser, Bryan; Caron, Thomas; Baydur, Ezra; Seidl-Rathkopf, Kathi; Ivanov, Ivan; Frank, Shannon; Jaskiw, Ann; Feuchtbaum, Dana; Nussbaum, Nathan; Abernethy, Amy P.] Flatiron Hlth Inc, New York, NY USA; [Agarwala, Vineeta] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Nunnally, Allen C.] Voyager Therapeut, Cambridge, MA USA; [Nussbaum, Nathan] NYU, Sch Med, New York, NY USA; [Abernethy, Amy P.] US FDA, Silver Spring, MD USA	Foundation Medicine; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Stanford University; New York University; US Food & Drug Administration (FDA)	Singal, G (corresponding author), Fdn Med Inc, 150 Second St, Cambridge, MA 02140 USA.	gsingal@foundationmedicine.com		Frampton, Garrett/0000-0002-2361-2750; Li, Gerald/0000-0002-5617-6262; Miller, Peter/0000-0002-6797-9335	Flatiron Health and Foundation Medicine	Flatiron Health and Foundation Medicine	Flatiron Health and Foundation Medicine provided the funding for this work. No external source of funding was obtained.	Agarwala V, 2018, HEALTH AFFAIR, V37, P765, DOI 10.1377/hlthaff.2017.1579; Andre F, 2017, CANCER DISCOV, V7, P818, DOI 10.1158/2159-8290.CD-17-0151; Barlesi F, 2016, LANCET, V387, P1415, DOI 10.1016/S0140-6736(16)00004-0; Carbone DP, 2017, NEW ENGL J MED, V376, P2415, DOI 10.1056/NEJMoa1613493; Chalmers ZR, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0424-2; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Curtis MD, 2018, HEALTH SERV RES, V53, P4460, DOI 10.1111/1475-6773.12872; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Goodman AM, 2017, MOL CANCER THER, V16, P2598, DOI 10.1158/1535-7163.MCT-17-0386; Janne PA, 2015, BRIT J CANCER, V113, P199, DOI 10.1038/bjc.2015.215; Vignot S, 2013, J CLIN ONCOL, V31, P2167, DOI 10.1200/JCO.2012.47.7737; Zehir A, 2017, NAT MED, V23, P703, DOI 10.1038/nm.4333	12	222	232	3	49	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 9	2019	321	14					1391	1399		10.1001/jama.2019.3241	http://dx.doi.org/10.1001/jama.2019.3241			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HT5PG	30964529	Green Published, Bronze			2022-12-28	WOS:000464615200018
J	Torjesen, I				Torjesen, Ingrid			Exclusive: Partnering with alcohol industry on public health is not okay, WHO says	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Gilmore I, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3928; Iacobucci G, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3882; Marten R, 2018, LANCET, V391, P735, DOI 10.1016/S0140-6736(18)30253-8; MOBERLY T, 2018, BMJ-BRIT MED J, V362, P12640, DOI DOI 10.1136/BMJ.K3942	4	7	7	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2019	365								l1666	10.1136/bmj.l1666	http://dx.doi.org/10.1136/bmj.l1666			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU0EH	30967412				2022-12-28	WOS:000464943700011
J	Ramanuj, P; Ferenchick, EK; Pincus, HA				Ramanuj, Parashar; Ferenchick, Erin K.; Pincus, Harold Alan			Depression in primary care: part 2-management	BMJ-BRITISH MEDICAL JOURNAL			English	Review							COGNITIVE-BEHAVIORAL THERAPY; TREATMENT-RESISTANT DEPRESSION; SEROTONIN REUPTAKE INHIBITORS; RANDOMIZED CONTROLLED-TRIAL; MENTAL-HEALTH-CARE; SELF-HELP INTERVENTIONS; LONG-TERM PROGNOSIS; STAR-ASTERISK-D; COMMITMENT THERAPY; ANXIETY DISORDERS	Depression is a common and heterogeneous condition with a chronic and recurrent natural course that is frequently seen in the primary care setting. Primary care providers play a central role in managing depression and concurrent physical comorbidities, and they face challenges in diagnosing and treating the condition. In this two part series, we review the evidence available to help to guide primary care providers and practices to recognize and manage depression. The first review outlined an approach to screening and diagnosing depression in primary care. This second review presents an evidence based approach to the treatment of depression in primary care, detailing the recommended lifestyle, drug, and psychological interventions at the individual level. It also highlights strategies that are being adopted at an organizational level to manage depression more effectively in primary care.	[Ramanuj, Parashar] Columbia Univ, Ctr Family & Community Med, Med Ctr, New York, NY 10027 USA; [Ramanuj, Parashar] Royal Natl Orthopaed Hosp, Stanmore, Middx, England; [Ferenchick, Erin K.] RAND Europe, Cambridge, England; [Pincus, Harold Alan] Columbia Univ, Dept Psychiat, New York State Psychiat Inst, New York, NY USA; [Pincus, Harold Alan] Columbia Univ, Irving Inst Clin & Translat Res, New York, NY USA; [Pincus, Harold Alan] RAND Corp, Pittsburgh, PA USA	Columbia University; University of London; University College London; Royal National Orthopaedic Hospital NHS Trust; RAND Corporation; RAND Europe; Columbia University; New York State Psychiatry Institute; Columbia University; RAND Corporation	Ramanuj, P (corresponding author), Columbia Univ, Ctr Family & Community Med, Med Ctr, New York, NY 10027 USA.; Ramanuj, P (corresponding author), Royal Natl Orthopaed Hosp, Stanmore, Middx, England.		Ramanuj, Parashar/AAP-4189-2020	Ramanuj, Parashar/0000-0002-0488-7070				A-Tjak JGL, 2015, PSYCHOTHER PSYCHOSOM, V84, P30, DOI 10.1159/000365764; Abbass AA, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004687.pub4; American Psychiatric Association, 2010, PRACTICE GUIDELINE T; American Psychiatric Association Academy of Psychosomatic Medicine, 2016, DISS INT CAR AD PRIM; Amick HR, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6019; Anderson HD, 2012, CLIN THER, V34, P113, DOI 10.1016/j.clinthera.2011.11.024; Anglin R, 2014, AM J GASTROENTEROL, V109, P810, DOI 10.1038/ajg.2014.82; Anthony JS, 2010, REHABIL NURS, V35, P113, DOI 10.1002/j.2048-7940.2010.tb00286.x; Archer J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006525.pub2; Ashworth DK, 2015, J COUNS PSYCHOL, V62, P115, DOI 10.1037/cou0000059; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Baldwin DS, 2006, INT CLIN PSYCHOPHARM, V21, P159, DOI 10.1097/01.yic.0000194377.88330.1d; Barkham M, 2017, COUNS PSYCHOTHER RES, V17, P253, DOI 10.1002/capr.12141; Barth J, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001454; Beck AT, 1987, COGNITIVE THERAPY DE; Beltman MW, 2010, BRIT J PSYCHIAT, V197, P11, DOI 10.1192/bjp.bp.109.064675; Bishop TF, 2016, HEALTH AFFAIR, V35, P394, DOI 10.1377/hlthaff.2015.1068; Brown C, 1996, AM J PSYCHIAT, V153, P1293; Caddy C, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011612.pub2; Callahan CM, 2005, J AM GERIATR SOC, V53, P367, DOI 10.1111/j.1532-5415.2005.53151.x; Cape J, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-38; Cattan M, 2005, AGEING SOC, V25, P41, DOI 10.1017/S0144686X04002594; Center for Evidence Based Medicine, 2009, LEVELS EVIDENCE; Chapman E, 2017, PSYCHIAT SERV, V68, P756, DOI 10.1176/appi.ps.201700085; Chung H, 2016, ADV INTEGRATION BEHA; Cipriani A., 2010, COCHRANE DATABASE SY; Cipriani Andrea, 2018, Focus (Am Psychiatr Publ), V16, P420, DOI 10.1176/appi.focus.16407; Cipriani A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006533.pub2; Cipriani A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006534.pub2; Colman I, 2011, CAN MED ASSOC J, V183, P1969, DOI 10.1503/cmaj.110676; Connolly KR, 2012, EXPERT OPIN EMERG DR, V17, P105, DOI 10.1517/14728214.2012.660146; Conway CR, 2017, JAMA PSYCHIAT, V74, P9, DOI 10.1001/jamapsychiatry.2016.2586; Coull G, 2011, PSYCHOL MED, V41, P2239, DOI 10.1017/S0033291711000900; Coupland NJ, 1996, J CLIN PSYCHOPHARM, V16, P356, DOI 10.1097/00004714-199610000-00003; Crawford MJ, 2016, BRIT J PSYCHIAT, V208, P260, DOI 10.1192/bjp.bp.114.162628; Cuijpers P, 2010, PSYCHOL MED, V40, P1943, DOI 10.1017/S0033291710000772; Cuijpers P, 2018, EUR PSYCHIAT, V48, P27, DOI 10.1016/j.eurpsy.2017.11.006; Cuijpers P, 2016, AM J PSYCHIAT, V173, P680, DOI 10.1176/appi.ajp.2015.15091141; Cuijpers P, 2014, WORLD PSYCHIATRY, V13, P56, DOI 10.1002/wps.20089; Cuijpers P, 2013, CAN J PSYCHIAT, V58, P376, DOI 10.1177/070674371305800702; Cuijpers P, 2013, WORLD PSYCHIATRY, V12, P137, DOI 10.1002/wps.20038; Cuijpers P, 2011, NORD J PSYCHIAT, V65, P354, DOI 10.3109/08039488.2011.596570; Cuijpers P, 2008, J CLIN PSYCHIAT, V69, P1675, DOI 10.4088/JCP.v69n1102; Cuijpers P, 2008, J CONSULT CLIN PSYCH, V76, P909, DOI 10.1037/a0013075; Dale E, 2015, BIOCHEM PHARMACOL, V95, P81, DOI 10.1016/j.bcp.2015.03.011; Driessen E, 2015, CLIN PSYCHOL REV, V42, P1, DOI 10.1016/j.cpr.2015.07.004; Ekers D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100100; Farah Wigdan H, 2016, Evid Based Med, V21, P214, DOI 10.1136/ebmed-2016-110522; Fava M, 2006, J CLIN PSYCHIAT, V67, P14; Ferenchik E, 2019, BMJ-BRIT MED J, V265; Fick D, 2012, J AM GERIATR SOC, V60, P616, DOI 10.1111/j.1532-5415.2012.03923.x; Flanagan RJ, 2008, HUM PSYCHOPHARM CLIN, V23, P43, DOI 10.1002/hup.916; Fonagy P, 2015, WORLD PSYCHIATRY, V14, P312, DOI 10.1002/wps.20267; Fond G, 2014, PSYCHOPHARMACOLOGY, V231, P3663, DOI 10.1007/s00213-014-3664-5; Forshall S, 1999, PSYCHIAT B, V23, P370; Furukawa TA, 2008, ACTA PSYCHIAT SCAND, V117, P35, DOI 10.1111/j.1600-0447.2007.01119.x; Galvez V, 2018, J PSYCHOPHARMACOL, V32, P397, DOI 10.1177/0269881118760660; Gebara MA, 2015, AM J GERIAT PSYCHIAT, V23, P1016, DOI 10.1016/j.jagp.2014.11.004; Geddes JR, 2003, LANCET, V361, P653, DOI 10.1016/S0140-6736(03)12599-8; Gelenberg AJ, 2000, J CLIN PSYCHIAT, V61, P356, DOI 10.4088/JCP.v61n0506; Gellatly J, 2007, PSYCHOL MED, V37, P1217, DOI 10.1017/S0033291707000062; Gilbody S, 2003, JAMA-J AM MED ASSOC, V289, P3145, DOI 10.1001/jama.289.23.3145; Gilbody S, 2002, EFFECT HLTH CARE, V7, P1; Gill JM, 2010, J AM BOARD FAM MED, V23, P499, DOI 10.3122/jabfm.2010.04.090299; Glozier N, 2012, PSYCHIAT SERV, V63, P1247, DOI 10.1176/appi.ps.201200017; Glue P, 2010, AUST NZ J PSYCHIAT, V44, P697, DOI 10.3109/00048671003705441; Goldman ML, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0671-8; Goldstein BJ, 1998, J PSYCHOPHARMACOL, V12, pS55, DOI 10.1177/0269881198012003041; Goodrich DE, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0383-2; Goodwin GM, 2009, J CLIN PSYCHIAT, V70, P1128, DOI 10.4088/JCP.08m04548; Grembowski DE, 2002, J GEN INTERN MED, V17, P258, DOI 10.1046/j.1525-1497.2002.10321.x; Guaiana G, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008851.pub2; Harding KJK, 2011, J CLIN PSYCHIAT, V72, P1136, DOI 10.4088/JCP.10r06282whi; Harman JS, 2006, J GEN INTERN MED, V21, P926, DOI 10.1007/BF02743139; Hassan AK, 2016, INT J CLIN PHARM-NET, V38, P429, DOI 10.1007/s11096-016-0272-y; Hayes SC, 2004, BEHAV THER, V35, P639, DOI 10.1016/S0005-7894(04)80013-3; Health Quality Ontario, 2016, Ont Health Technol Assess Ser, V16, P1; Holzel L, 2011, J AFFECT DISORDERS, V129, P1, DOI 10.1016/j.jad.2010.03.025; Hofmann SG, 2012, COGNITIVE THER RES, V36, P427, DOI 10.1007/s10608-012-9476-1; Hoifodt RS, 2011, FAM PRACT, V28, P489, DOI 10.1093/fampra/cmr017; Huguet A, 2018, J AFFECT DISORDERS, V235, P27, DOI 10.1016/j.jad.2018.02.073; Hunot V, 2010, COCHRANE DB SYST REV; Hunot V, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008704.pub2; Huynh Nhu N, 2008, Prim Care Companion J Clin Psychiatry, V10, P91; Institute for Clinical Systems Improvement, 2016, DEPR AD PRIM CAR; Jain R, 2013, INT J NEUROPSYCHOPH, V16, P313, DOI 10.1017/S1461145712000727; Jonsson U, 2016, CLIN CHILD PSYCHOL P, V21, P432, DOI 10.1177/1359104515614072; Judd LL, 2000, AM J PSYCHIAT, V157, P1501, DOI 10.1176/appi.ajp.157.9.1501; Kahl KG, 2012, CURR OPIN PSYCHIATR, V25, P522, DOI 10.1097/YCO.0b013e328358e531; Kamenov K, 2017, PSYCHOL MED, V47, P414, DOI 10.1017/S0033291716002774; Karyotaki E, 2017, JAMA PSYCHIAT, V74, P351, DOI 10.1001/jamapsychiatry.2017.0044; Katon W, 2010, GEN HOSP PSYCHIAT, V32, P456, DOI 10.1016/j.genhosppsych.2010.04.001; Keller MB, 2003, JAMA-J AM MED ASSOC, V289, P3152, DOI 10.1001/jama.289.23.3152; Kendrick T, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b750; Kennedy Noel, 2005, Curr Psychiatry Rep, V7, P441, DOI 10.1007/s11920-005-0065-9; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kilbourne AM, 2004, MILBANK Q, V82, P631, DOI 10.1111/j.0887-378X.2004.00326.x; Kilbourne AM, 2018, WORLD PSYCHIATRY, V17, P30, DOI 10.1002/wps.20482; King M, 2014, PSYCHOL MED, V44, P1835, DOI 10.1017/S0033291713002377; Koesters M, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011520.pub2; Kravitz RL, 2006, J GEN INTERN MED, V21, P584, DOI 10.1111/j.1525-1497.2006.00411.x; Krogh J, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014820; Kuyken W, 2016, JAMA PSYCHIAT, V73, P565, DOI 10.1001/jamapsychiatry.2016.0076; Lambert D, 1999, J RURAL HEALTH, V15, P344, DOI 10.1111/j.1748-0361.1999.tb00756.x; LeBlanc A, 2015, JAMA INTERN MED, V175, P1761, DOI 10.1001/jamainternmed.2015.5214; Lecrubier Y, 2002, ACTA PSYCHIAT SCAND, V106, P7, DOI 10.1034/j.1600-0447.106.s415.2.x; Lee KU, 2010, PSYCHIAT INVEST, V7, P55, DOI 10.4306/pi.2010.7.1.55; Lepine JP, 1997, INT CLIN PSYCHOPHARM, V12, P19, DOI 10.1097/00004850-199701000-00003; Lewinsohn P.M., 1974, ESSENTIAL PAPERS DEP, P150; Lin EHB, 1998, ARCH FAM MED, V7, P443, DOI 10.1001/archfami.7.5.443; Linde K, 2015, ANN FAM MED, V13, P69, DOI 10.1370/afm.1687; Linde K, 2015, ANN FAM MED, V13, P56, DOI 10.1370/afm.1719; Liptzin B, 2009, PSYCHIAT SERV, V60, P108, DOI 10.1176/appi.ps.60.1.108; Magni LR, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004185.pub3; Majd M, 2015, IRAN J PHARM RES, V14, P891; Malhi GS, 2015, AUST NZ J PSYCHIAT, V49, P1087, DOI 10.1177/0004867415617657; Marcum ZA, 2016, ANN PHARMACOTHER, V50, P525, DOI 10.1177/1060028016644466; Mars B, 2017, SOC PSYCH PSYCH EPID, V52, P193, DOI 10.1007/s00127-016-1306-4; Martin DJ, 2000, J CONSULT CLIN PSYCH, V68, P438, DOI 10.1037//0022-006X.68.3.438; Martin JL, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003493; Martin-Merino Elisa, 2010, Prim Care Companion J Clin Psychiatry, V12, DOI 10.4088/PCC.08m00764blu; Martin-Vazquez MJ, 2016, NEUROPSYCHIATRY, V6; Menchetti M, 2009, J PSYCHOSOM RES, V66, P335, DOI 10.1016/j.jpsychores.2008.10.008; Michael L, 2001, PSYCHOTHERAPY, V38; Mitchell AJ, 2009, LANCET, V374, P609, DOI 10.1016/S0140-6736(09)60879-5; Montejo AL, 2001, J CLIN PSYCHIAT, V62, P10; Moore M, 2013, J AFFECT DISORDERS, V145, P120, DOI 10.1016/j.jad.2012.04.042; Moore M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3999; Na KS, 2014, PROG NEURO-PSYCHOPH, V48, P79, DOI 10.1016/j.pnpbp.2013.09.006; National Institute for Health and Care Excellence, 2017, DEPR AD TREATM MAN; Nelson JC, 2009, AM J PSYCHIAT, V166, P980, DOI 10.1176/appi.ajp.2009.09030312; O'Donnell AN, 2013, AM J MANAG CARE, V19, P180; ODriscoll P., 2016, WHAT ARE COUNSELLING; Omori IM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006114.pub2; Ost LG, 2014, BEHAV RES THER, V61, P105, DOI 10.1016/j.brat.2014.07.018; Papakostas GI, 2006, J CLIN PSYCHOPHARM, V26, P56, DOI 10.1097/01.jcp.0000195042.62724.76; Piek E, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-41; Pincus HA, 2017, PSYCHIAT SERV, V68, P1182, DOI 10.1176/appi.ps.201600222; Pincus HA, 2017, INT J QUAL HEALTH C, V29, P557, DOI 10.1093/intqhc/mzx071; Pincus HA, 2015, JAMA-J AM MED ASSOC, V314, P1227, DOI 10.1001/jama.2015.9212; Pintor L, 2004, J AFFECT DISORDERS, V82, P291, DOI 10.1016/j.jad.2003.11.008; Posternak MA, 2011, J CLIN PSYCHIAT, V72, P949, DOI 10.4088/JCP.10m06098; Purgato M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006531.pub2; Pybis J, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1370-7; Quach L, 2013, J GERONTOL A-BIOL, V68, P1575, DOI 10.1093/gerona/glt084; Ramanuj PP, 2018, COMMUNITY MENT HLT J, V54, P1116, DOI 10.1007/s10597-018-0251-y; Richards JB, 2007, ARCH INTERN MED, V167, P188, DOI 10.1001/archinte.167.2.188; Rizvi SJ, 2014, CAN J PSYCHIAT, V59, P349, DOI 10.1177/070674371405900702; Rosen RC, 1999, J CLIN PSYCHOPHARM, V19, P67, DOI 10.1097/00004714-199902000-00013; Rosenbaum JF, 1998, BIOL PSYCHIAT, V44, P77, DOI 10.1016/S0006-3223(98)00126-7; Roth A, 2013, WHAT WORKS WHOM CRIT; Roth T, 2004, INT J NEUROPSYCHOPH, V7, pS34; Rozental A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157503; Rush AJ, 2004, BIOL PSYCHIAT, V56, P46, DOI 10.1016/j.biopsych.2004.04.005; Sarris J, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-107; Schwenk TL, 1996, GEN HOSP PSYCHIAT, V18, P407, DOI 10.1016/S0163-8343(96)00062-X; Shinohara K, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008696.pub2; Sikorski C, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-10; Simon G E, 1995, Arch Fam Med, V4, P99, DOI 10.1001/archfami.4.2.99; Simon GE, 2000, B WORLD HEALTH ORGAN, V78, P439; Sinclair LI, 2009, BRIT J PSYCHIAT, V194, P483, DOI 10.1192/bjp.bp.107.048371; Sinyor M, 2010, CAN J PSYCHIAT, V55, P126, DOI 10.1177/070674371005500303; Sir A, 2005, J CLIN PSYCHIAT, V66, P1312, DOI 10.4088/JCP.v66n1015; So M, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-113; Spigset O, 1999, DRUG SAFETY, V20, P277, DOI 10.2165/00002018-199920030-00007; Stegenga BT, 2012, SOC PSYCH PSYCH EPID, V47, P87, DOI 10.1007/s00127-010-0317-9; Stojanovic J, 2017, EPIDEMIOL BIOSTAT PU, V14, DOI 10.2427/12408; Sudak D, 2007, ACAD PSYCHIATR, V31, P345, DOI 10.1176/appi.ap.31.5.345; Tai-Seale M, 2007, J AM GERIATR SOC, V55, P1903, DOI 10.1111/j.1532-5415.2007.01467.x; Tamburrino Marijo B, 2009, Prim Care Companion J Clin Psychiatry, V11, P205, DOI 10.4088/PCC.08m00694; Taylor DM, 2018, MAUDSLEY PRESCRIBING, P358; Taylor MJ, 2006, ARCH GEN PSYCHIAT, V63, P1217, DOI 10.1001/archpsyc.63.11.1217; Telford R, 2002, FAM PRACT, V19, P45, DOI 10.1093/fampra/19.1.45; Tint A, 2008, J PSYCHOPHARMACOL, V22, P330, DOI [10.1177/0269881107081550, 10.1177/0269881107087488]; Trivedi MH, 2007, DRUG ALCOHOL DEPEN, V88, pS61, DOI 10.1016/j.drugalcdep.2007.01.007; Trivedi MH, 2013, J CLIN PSYCHIAT, V74, P802, DOI [10.4088/JCP.12075tx2c, 10.4088/JCP.13m08360]; Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28; Trivedi MH, 2006, NEW ENGL J MED, V354, P1243, DOI 10.1056/NEJMoa052964; Truax C., 1967, EFFECTIVE COUNSELLIN; Tylee A, 2005, BMJ-BRIT MED J, V330, P800, DOI 10.1136/bmj.330.7495.800; Unutzer J, 2006, PSYCHIAT SERV, V57, P37, DOI 10.1176/appi.ps.57.1.37; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836; Van Beek Ken, 2008, Perm J, V12, P20; van Walraven C, 2001, BMJ-BRIT MED J, V323, P655, DOI 10.1136/bmj.323.7314.655; Vaughan B, 2014, COMPR PSYCHIAT, V55, P849, DOI 10.1016/j.comppsych.2014.01.001; Wang J-D, 2017, INT J PHYS MED REHAB, V5, P389, DOI [10.4172/2329-9096.1000389, DOI 10.4172/2329-9096.1000389]; Wang JL, 2003, PSYCHIAT SERV, V54, P878, DOI 10.1176/appi.ps.54.6.878; Watanabe N, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006528.pub2; Wiles N, 2013, LANCET, V381, P375, DOI 10.1016/S0140-6736(12)61552-9; Woltmann E, 2012, AM J PSYCHIAT, V169, P790, DOI 10.1176/appi.ajp.2012.11111616; Working Group of the Clinical Practice Guideline on the Management of Depression in Adults, 2014, CLIM PRACT GUID MAN; Zimmerman M, 2006, AM J PSYCHIAT, V163, P148, DOI 10.1176/appi.ajp.163.1.148; Zimmerman M, 2007, COMPR PSYCHIAT, V48, P113, DOI 10.1016/j.comppsych.2006.10.005	193	22	23	4	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 8	2019	365								l835	10.1136/bmj.l835	http://dx.doi.org/10.1136/bmj.l835			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU0EE	30962249				2022-12-28	WOS:000464943400002
J	Dyer, C				Dyer, Clare			Paediatrician who downloaded videos of child abuse is given suspended sentence	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 5	2019	365								l1637	10.1136/bmj.l1637	http://dx.doi.org/10.1136/bmj.l1637			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HS6UC	30952647				2022-12-28	WOS:000464005800005
J	Esterhazy, D; Canesso, MCC; Mesin, L; Muller, PA; de Castro, TBR; Lockhart, A; ElJalby, M; Faria, AMC; Mucida, D				Esterhazy, Daria; Canesso, Maria C. C.; Mesin, Luka; Muller, Paul A.; de Castro, Tiago B. R.; Lockhart, Ainsley; ElJalby, Mahmoud; Faria, Ana M. C.; Mucida, Daniel			Compartmentalized gut lymph node drainage dictates adaptive immune responses	NATURE			English	Article							REGULATORY T-CELLS; DENDRITIC CELLS; ORAL TOLERANCE; INDUCTION; INFECTION; SYSTEM	The intestinal immune system has the challenging task of tolerating foreign nutrients and the commensal microbiome, while excluding or eliminating ingested pathogens. Failure of this balance leads to conditions such as inflammatory bowel diseases, food allergies and invasive gastrointestinal infections(1). Multiple immune mechanisms are therefore in place to maintain tissue integrity, including balanced generation of effector T (T-H) cells and FOXP3(+) regulatory T (pT(reg)) cells, which mediate resistance to pathogens and regulate excessive immune activation, respectively(1-4). The gut-draining lymph nodes (gLNs) are key sites for orchestrating adaptive immunity to luminal perturbations(5-7). However, it is unclear how they simultaneously support tolerogenic and inflammatory reactions. Here we show that gLNs are immunologically specific to the functional gut segment that they drain. Stromal and dendritic cell gene signatures and polarization of T cells against the same luminal antigen differ between gLNs, with the proximal small intestine-draining gLNs preferentially giving rise to tolerogenic responses and the distal gLNs to pro-inflammatory T cell responses. This segregation permitted the targeting of distal gLNs for vaccination and the maintenance of duodenal pTreg cell induction during colonic infection. Conversely, the compartmentalized dichotomy was perturbed by surgical removal of select distal gLNs and duodenal infection, with effects on both lymphoid organ and tissue immune responses. Our findings reveal that the conflict between tolerogenic and inflammatory intestinal responses is in part resolved by discrete gLN drainage, and encourage antigen targeting to specific gut segments for therapeutic immune modulation.	[Esterhazy, Daria; Canesso, Maria C. C.; Muller, Paul A.; de Castro, Tiago B. R.; Lockhart, Ainsley; ElJalby, Mahmoud; Mucida, Daniel] Rockefeller Univ, Lab Mucosal Immunol, 1230 York Ave, New York, NY 10021 USA; [Canesso, Maria C. C.; de Castro, Tiago B. R.; Faria, Ana M. C.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Mesin, Luka] Rockefeller Univ, Lab Lymphocyte Dynam, 1230 York Ave, New York, NY 10021 USA; [Esterhazy, Daria] Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA	Rockefeller University; Universidade Federal de Minas Gerais; Rockefeller University; University of Chicago	Esterhazy, D; Mucida, D (corresponding author), Rockefeller Univ, Lab Mucosal Immunol, 1230 York Ave, New York, NY 10021 USA.; Esterhazy, D (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	desterhazy@bsd.uchicago.edu; mucida@rockefeller.edu	Faria, Ana Maria/AAK-8688-2021	Muller, Paul/0000-0002-1957-4763; Faria, Ana Maria/0000-0002-0604-8510	Swiss National Science Foundation; University of Chicago start-up funds; CAPES fellowship; NIH F31 Kirchstein Fellowship; Philip M. Levine Fellowship; Kavli Neural Systems Institute Graduate Fellowship; Leona M. and Harry B. Helmsley Charitable Trust; Crohn's & Colitis Foundation of America Senior Research Award; Burroughs Wellcome Fund PATH Award; National Institute of Health [R21AI31188, R01DK113375, R01DK093674]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI131188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F31DK112601, R01DK113375, R01DK093674] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Chicago start-up funds; CAPES fellowship(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NIH F31 Kirchstein Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philip M. Levine Fellowship; Kavli Neural Systems Institute Graduate Fellowship; Leona M. and Harry B. Helmsley Charitable Trust; Crohn's & Colitis Foundation of America Senior Research Award; Burroughs Wellcome Fund PATH Award(Burroughs Wellcome Fund); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank all members of the Mucida laboratory, past and present, for assistance, discussions and reading of the manuscript; B. Reis for figure preparation; F. Matheis for propagating S. venezuelensis; A. Rogoz and S. Gonzalez for the maintenance of mice; T Rendon and B. Lopez for genotyping; K. Gordon and K. Chosphel for assistance with cell sorting; the Rockefeller University Bio-imaging Research Center for assistance with microscopy and image analysis; the Rockefeller University Genomics Center for RNA sequencing; Rockefeller University employees for assistance; M. Nussenzweig, G. Victora and J. Lafaille and their respective laboratory members for discussions and suggestions; D. Littman and M. Xu (NYU) for 7B8tg mice and faeces from SFB monocolonized mice; and S. Galli and K. Matsushita (Stanford University) for providing S. venezuelensis and guidance on how to maintain it. This work was supported by a Swiss National Science Foundation postdoctoral fellowship and University of Chicago start-up funds (D.E.); a CAPES fellowship (M.C.C.C.); an NIH F31 Kirchstein Fellowship, Philip M. Levine Fellowship, and Kavli Neural Systems Institute Graduate Fellowship (P.A.M.); the Leona M. and Harry B. Helmsley Charitable Trust, the Crohn's & Colitis Foundation of America Senior Research Award, the Burroughs Wellcome Fund PATH Award, and National Institute of Health grants R21AI31188, R01DK113375 and R01DK093674 (D.M.).	Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Balmer ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008618; Bouziat R, 2017, SCIENCE, V356, P44, DOI 10.1126/science.aah5298; CARTER PB, 1974, J EXP MED, V139, P1189, DOI 10.1084/jem.139.5.1189; Cording S, 2014, MUCOSAL IMMUNOL, V7, P359, DOI 10.1038/mi.2013.54; da Fonseca DM, 2015, CELL, V163, P354, DOI 10.1016/j.cell.2015.08.030; Durai V, 2016, IMMUNITY, V45, P719, DOI 10.1016/j.immuni.2016.10.010; Esterhazy D, 2016, NAT IMMUNOL, V17, P545, DOI 10.1038/ni.3408; GAUTREAUX MD, 1994, INFECT IMMUN, V62, P2132, DOI 10.1128/IAI.62.5.2132-2134.1994; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Hammerschmidt SI, 2008, J EXP MED, V205, P2483, DOI 10.1084/jem.20080039; Honda K, 2016, NATURE, V535, P75, DOI 10.1038/nature18848; Houston SA, 2016, MUCOSAL IMMUNOL, V9, P468, DOI 10.1038/mi.2015.77; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; Mukai K, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00053-17; Pezoldt J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06423-7; Randolph GJ, 2017, ANNU REV IMMUNOL, V35, P31, DOI 10.1146/annurev-immunol-041015-055354; Sano T, 2015, CELL, V163, P381, DOI 10.1016/j.cell.2015.08.061; Tussiwand R, 2015, IMMUNITY, V42, P916, DOI 10.1016/j.immuni.2015.04.017; Van den Broeck W, 2006, J IMMUNOL METHODS, V312, P12, DOI 10.1016/j.jim.2006.01.022; Veenbergen S, 2016, MUCOSAL IMMUNOL, V9, P894, DOI 10.1038/mi.2015.118; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016; Xu M, 2018, NATURE, V554, P373, DOI 10.1038/nature25500; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279	25	127	131	2	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 2	2019	569	7754					126	+		10.1038/s41586-019-1125-3	http://dx.doi.org/10.1038/s41586-019-1125-3			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HW2NX	30988509	Green Accepted, Green Submitted			2022-12-28	WOS:000466523700046
J	Kates-Harbeck, J; Svyatkovskiy, A; Tang, W				Kates-Harbeck, Julian; Svyatkovskiy, Alexey; Tang, William			Predicting disruptive instabilities in controlled fusion plasmas through deep learning	NATURE			English	Article							JET; CHALLENGES; MITIGATION	Nuclear fusion power delivered by magnetic-confinement tokamak reactors holds the promise of sustainable and clean energy(1). The avoidance of large-scale plasma instabilities called disruptions within these reactors(2,3) is one of the most pressing challenges(4,5), because disruptions can halt power production and damage key components. Disruptions are particularly harmful for large burning-plasma systems such as the multibillion-dollar International Thermonuclear Experimental Reactor (ITER) project(6) currently under construction, which aims to be the first reactor that produces more power from fusion than is injected to heat the plasma. Here we present a method based on deep learning for forecasting disruptions. Our method extends considerably the capabilities of previous strategies such as first-principles-based(5) and classical machine-learning(7-11) approaches. In particular, it delivers reliable predictions for machines other than the one on which it was trained-a crucial requirement for future large reactors that cannot afford training disruptions. Our approach takes advantage of high-dimensional training data to boost predictive performance while also engaging supercomputing resources at the largest scale to improve accuracy and speed. Trained on experimental data from the largest tokamaks in the United States (DIII-D-12) and the world (Joint European Torus, JET(13)), our method can also be applied to specific tasks such as prediction with long warning times: this opens up the possibility of moving from passive disruption prediction to active reactor control and optimization. These initial results illustrate the potential for deep learning to accelerate progress in fusion-energy science and, more generally, in the understanding and prediction of complex physical systems.	[Kates-Harbeck, Julian] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Kates-Harbeck, Julian] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Kates-Harbeck, Julian; Tang, William] Princeton Plasma Phys Lab, POB 451, Princeton, NJ 08543 USA; [Svyatkovskiy, Alexey; Tang, William] Princeton Univ, Princeton Inst Computat Sci & Engn, Princeton, NJ 08544 USA; [Svyatkovskiy, Alexey] Microsoft, One Microsoft Way, Redmond, WA USA	Harvard University; Harvard University; Princeton University; United States Department of Energy (DOE); Princeton Plasma Physics Laboratory; Princeton University; Microsoft	Kates-Harbeck, J (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.; Kates-Harbeck, J (corresponding author), Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA.; Kates-Harbeck, J (corresponding author), Princeton Plasma Phys Lab, POB 451, Princeton, NJ 08543 USA.	jkatesharbeck@g.harvard.edu	Tang, William/AHA-7918-2022; Kates-Harbeck, Julian/Y-3186-2019	Tang, William/0000-0002-8211-3636; Kates-Harbeck, Julian/0000-0002-6294-909X	DOE Computational Science Graduate Fellowship Program of the Office of Science; National Nuclear Security Administration in the DOE [DE-FG02-97ER25308]; PICSciE; PPPL; Euratom research and training programme 2014-2018 [633053]; US DOE, Office of Science, Office of Fusion Energy Sciences [DE-FC02-04ER54698]; US Government	DOE Computational Science Graduate Fellowship Program of the Office of Science(United States Department of Energy (DOE)); National Nuclear Security Administration in the DOE(National Nuclear Security Administration); PICSciE; PPPL; Euratom research and training programme 2014-2018; US DOE, Office of Science, Office of Fusion Energy Sciences(United States Department of Energy (DOE)); US Government	We are grateful to E. Feibush from the US Department of Energy (DOE) Princeton Plasma Physics Laboratory (PPPL) and the Princeton Institute for Computational Science and Engineering (PICSciE) for assisting with visualization and data collection; to W. Wichser, C. Hillegas, J. Wells, S. Matsuoka, R. Yokota and T. Gibbs for supporting our supercomputing efforts; to T. Donne for facilitating collaborations with JET; to E. Joffrin, R. Buttery and T. Strait for leading the internal reviews of this work at JET and DIII-D; to A. Murari, J. Vega and the associated JET data analysis team for discussions of their classical machine-learning methods; and to M. Maslov for support with the JET data. We also thank R. Nazikian, N. Logan, M. Parsons and M. Churchill of PPPL; K. Felker of Princeton University; R. Granetz and C. Rea of the Massachusetts Institute of Technology (MIT); and P. DeVries of ITER for support and for discussions. We thank the JET contributors<SUP>35</SUP> and management as well as General Atomics (GA) and its DIII-D tokamak project for access to their fusion databases. J. K.-H. was supported by the DOE Computational Science Graduate Fellowship Program of the Office of Science and National Nuclear Security Administration in the DOE under contract DE-FG02-97ER25308. A. S. is supported by PICSciE, and W. T. by PPPL and PICSciE. This work was carried out within the framework of the EUROfusion Consortium, with funding from the Euratom research and training programme 2014-2018 under grant 633053. The views and opinions expressed herein do not necessarily reflect those of the European Commission. This material is based upon work supported by the US DOE, Office of Science, Office of Fusion Energy Sciences, using the DIII-D National Fusion Facility, a DOE Office of Science user facility, under award DE-FC02-04ER54698. Disclaimer: this report was prepared as an account of work sponsored by an agency of the US Government. Neither the US Government nor any agency thereof, nor any of their employees, makes any warranty, express or implied, or assumes any legal liability or responsibility for the accuracy, completeness, or usefulness of any information, apparatus, product, or process disclosed, or represents that its use would not infringe privately owned rights. Reference herein to any specific commercial product, process, or service by trade name, trademark, manufacturer, or otherwise does not necessarily constitute or imply its endorsement, recommendation, or favoring by the US Government or any agency thereof. The views and opinions of authors expressed herein do not necessarily state or reflect those of the US Government or any agency thereof.	Abadi M., 2016, TENSORFLOW LARGE SCA; Alonso JA, 2008, AIP CONF PROC, V988, P185; Aymar R, 2002, PLASMA PHYS CONTR F, V44, P519, DOI 10.1088/0741-3335/44/5/304; Barton JE, 2015, P AMER CONTR CONF, P3316, DOI 10.1109/ACC.2015.7171844; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cannas B, 2004, NUCL FUSION, V44, P68, DOI 10.1088/0029-5515/44/1/008; Carleo G, 2017, SCIENCE, V355, P602, DOI 10.1126/science.aag2302; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Cheng T, 2016, AIDS BEHAV, V20, P377, DOI 10.1007/s10461-015-1101-3; Chetlur, 2014, ARXIV14100759; Chollet F., 2018, DEEP LEARNING PYTHON; Coelho R, 2013, FUSION SCI TECHNOL, V63, P1; Das D., 2016, DISTRIBUTED DEEP LEA; de Vries PC, 2016, FUSION SCI TECHNOL, V69, P471, DOI 10.13182/FST15-176; de Vries PC, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/5/055011; Dean J., 2012, ADV NEURAL INFORM PR, P1223, DOI DOI 10.5555/2999134.2999271; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Ferron JR, 1998, NUCL FUSION, V38, P1055, DOI 10.1088/0029-5515/38/7/308; Freidberg J.P., 2008, PLASMA PHYS FUSION E; Gentile C, 1999, ADV NEUR IN, V11, P225; Goyal P., 2017, ACCURATE LARGE MINIB; Graves Alex, 2013, ARXIV13080850; Kates-Harbeck J., 2017, FRNN CODEBASE; Khomenko V, 2016, PROCEEDINGS OF THE 2016 IEEE FIRST INTERNATIONAL CONFERENCE ON DATA STREAM MINING & PROCESSING (DSMP), P100, DOI 10.1109/DSMP.2016.7583516; Kingma D.P., 2014, ARXIV, DOI DOI 10.48550/ARXIV.1412.6980; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lehnen M, 2015, J NUCL MATER, V463, P39, DOI 10.1016/j.jnucmat.2014.10.075; Litaudon X, 2017, NUCL FUSION, V57, DOI 10.1088/1741-4326/aa5e28; Maas R. E., 2011, PROC 49 ANN M ASS CO, P142; Marcus Mitchell, 1993, COMPUTATIONAL LINGUI, DOI DOI 10.21236/ADA273556; Matthews GF, 2011, PHYS SCRIPTA, VT145, DOI 10.1088/0031-8949/2011/T145/014001; Mnih V, 2015, NATURE, V518, P529, DOI 10.1038/nature14236; Moreno R, 2016, FUSION SCI TECHNOL, V69, P485, DOI 10.13182/FST15-167; Morgan T. P., THE NEXT PLATFORM; Mote CD, 2016, ENGINEERING-PRC, V2, P4, DOI 10.1016/J.ENG.2016.01.025; Murari A, 2008, NUCL FUSION, V48, DOI 10.1088/0029-5515/48/3/035010; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Ratta GA, 2012, FUSION ENG DES, V87, P1670, DOI 10.1016/j.fusengdes.2012.07.002; Ratta GA, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2965020; Ruder S., 2016, ARXIV; Schuller FC, 1995, PLASMA PHYS CONTR F, V37, pA135, DOI 10.1088/0741-3335/37/11A/009; Smith LN, 2017, IEEE WINT CONF APPL, P464, DOI 10.1109/WACV.2017.58; Svyatkovskiy A., 2017, P MACH LEARN HPC ENV, V10; Tang W., 2009, US DEP EN OFF FUS EN; Tang WM, 2005, PLASMA PHYS CONTR F, V47, pR1, DOI 10.1088/0741-3335/47/2/R01; Taylor PL, 1999, PHYS PLASMAS, V6, P1872, DOI 10.1063/1.873445; Tobias B, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3460456; Vega J, 2013, FUSION ENG DES, V88, P1228, DOI 10.1016/j.fusengdes.2013.03.003; Windsor CG, 2005, NUCL FUSION, V45, P337, DOI 10.1088/0029-5515/45/5/004; Wroblewski D, 1997, NUCL FUSION, V37, P725, DOI 10.1088/0029-5515/37/6/I02; Wu R., 2015, DEEP IMAGE SCALING I; Zadrozny B, 2003, THIRD IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P435, DOI 10.1109/icdm.2003.1250950; Zavaryaev V., 2012, PLASMA DIAGNOSTICS, P360	58	129	133	23	131	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 25	2019	568	7753					526	+		10.1038/s41586-019-1116-4	http://dx.doi.org/10.1038/s41586-019-1116-4			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HU9DR	30996348				2022-12-28	WOS:000465594200046
J	Slomski, A				Slomski, Anita			Rapid Blood Pressure Reduction Safe for Ischemic Stroke	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2019	321	16					1558	1558		10.1001/jama.2019.3797	http://dx.doi.org/10.1001/jama.2019.3797			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HV7BZ	31012929				2022-12-28	WOS:000466137800004
J	Navratilova, E; Patwardhan, A; Porreca, F				Navratilova, Edita; Patwardhan, Amol; Porreca, Frank			Opioid analgesics pass the acid test	LANCET			English	Editorial Material							PAIN		[Navratilova, Edita; Patwardhan, Amol; Porreca, Frank] Univ Arizona, Coll Med, Dept Pharmacol, Tucson, AZ 85724 USA; [Patwardhan, Amol] Univ Arizona, Coll Med, Dept Anesthesiol, Tucson, AZ 85724 USA	University of Arizona; University of Arizona	Porreca, F (corresponding author), Univ Arizona, Coll Med, Dept Pharmacol, Tucson, AZ 85724 USA.	frankp@medadmin.arizona.edu						Anissian L, 2012, J HOSP MED, V7, P67, DOI 10.1002/jhm.943; Ballantyne JC, 2017, PAIN, V158, P2290, DOI 10.1097/j.pain.0000000000001043; Ballantyne JC, 2017, ANESTH ANALG, V125, P1769, DOI 10.1213/ANE.0000000000002500; Basbaum A.I., 2010, TRANSLATIONAL PAIN R; Che T, 2018, CELL, V172, P55, DOI 10.1016/j.cell.2017.12.011; Colloca L, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.2; Corder G, 2017, NAT MED, V23, P164, DOI 10.1038/nm.4262; Fields HL, 2011, NEURON, V69, P591, DOI 10.1016/j.neuron.2011.02.001; Imam MZ, 2018, NEUROPHARMACOLOGY, V131, P238, DOI 10.1016/j.neuropharm.2017.12.032; Navratilova E, 2015, J NEUROSCI, V35, P7264, DOI 10.1523/JNEUROSCI.3862-14.2015; Oertel BG, 2008, CLIN PHARMACOL THER, V83, P577, DOI 10.1038/sj.clpt.6100441; Ossipov MH, 2014, CURR OPIN SUPPORT PA, V8, P143, DOI 10.1097/SPC.0000000000000055; Spahn V, 2017, SCIENCE, V356; Spahn V, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27313-4	14	0	0	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 20	2019	393	10181					1579	1581		10.1016/S0140-6736(19)30421-0	http://dx.doi.org/10.1016/S0140-6736(19)30421-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU0DL	31007186				2022-12-28	WOS:000464941500010
J	Boyd, PW; Claustre, H; Levy, M; Siegel, DA; Weber, T				Boyd, Philip W.; Claustre, Herve; Levy, Marina; Siegel, David A.; Weber, Thomas			Multi-faceted particle pumps drive carbon sequestration in the ocean	NATURE			English	Review							PARTICULATE ORGANIC-CARBON; MIXED-LAYER; GRAVITATIONAL SINKING; VERTICAL-DISTRIBUTION; NET COMMUNITY; MARINE SNOW; EXPORT; FLUX; MATTER; ZOOPLANKTON	The ocean's ability to sequester carbon away from the atmosphere exerts an important control on global climate. The biological pump drives carbon storage in the deep ocean and is thought to function via gravitational settling of organic particles from surface waters. However, the settling flux alone is often insufficient to balance mesopelagic carbon budgets or to meet the demands of subsurface biota. Here we review additional biological and physical mechanisms that inject suspended and sinking particles to depth. We propose that these 'particle injection pumps' probably sequester as much carbon as the gravitational pump, helping to close the carbon budget and motivating further investigation into their environmental control.	[Boyd, Philip W.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Claustre, Herve] Sorbonne Univ, Villefranche Sur Mer, France; [Claustre, Herve] CNRS, LOV, Villefranche Sur Mer, France; [Levy, Marina] Sorbonne Univ, LOCEAN IPSL, CNRS IRD MNHN, Paris, France; [Siegel, David A.] Univ Calif Santa Barbara, Dept Geog, Santa Barbara, CA 93106 USA; [Siegel, David A.] Univ Calif Santa Barbara, Earth Res Inst, Santa Barbara, CA 93106 USA; [Weber, Thomas] Univ Rochester, Dept Earth & Environm Sci, Rochester, NY USA	University of Tasmania; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of Rochester	Boyd, PW (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	philip.boyd@utas.edu.au	Levy, Marina/A-1315-2012; CLAUSTRE, Herve/E-6877-2011; Boyd, Philip/J-7624-2014	Levy, Marina/0000-0003-2961-608X; CLAUSTRE, Herve/0000-0001-6243-0258; Boyd, Philip/0000-0001-7850-1911	Australian Research Council [FL160100131]; Australian Research Council's Special Research Initiative for Antarctic Gateway Partnership [SR140300001]; European Research Council (remOcean project) [246777]; Climate Initiative of the BNP Paribas foundation (SOCLIM project); CNES; ANR project SOBUMS [ANR-16-CE01-0014]; National Aeronautics and Space Administration (NASA) [NNX16AR50G]; NASA [80NSSC17K0692]; National Science Foundation [OCE-1635414]	Australian Research Council(Australian Research Council); Australian Research Council's Special Research Initiative for Antarctic Gateway Partnership(Australian Research Council); European Research Council (remOcean project); Climate Initiative of the BNP Paribas foundation (SOCLIM project); CNES(Centre National D'etudes Spatiales); ANR project SOBUMS(French National Research Agency (ANR)); National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); NASA(National Aeronautics & Space Administration (NASA)); National Science Foundation(National Science Foundation (NSF))	P.W.B. was primarily supported by the Australian Research Council through a Laureate (FL160100131), and this research was also supported under the Australian Research Council's Special Research Initiative for Antarctic Gateway Partnership (project ID SR140300001). H.C. acknowledges the support of the European Research Council (remOcean project, grant agreement 246777) and of the Climate Initiative of the BNP Paribas foundation (SOCLIM project). M.L. was supported by CNES, by the ANR project SOBUMS (ANR-16-CE01-0014) and by the National Aeronautics and Space Administration (NASA) grant NNX16AR50G. D.A.S. acknowledges support from NASA as part of the EXport Processes in the global Ocean from RemoTe Sensing (EXPORTS) field campaign, grant 80NSSC17K0692. T.W. was supported by National Science Foundation grant OCE-1635414.	ALLDREDGE AL, 1988, PROG OCEANOGR, V20, P41, DOI 10.1016/0079-6611(88)90053-5; Aumont O, 2018, GLOBAL BIOGEOCHEM CY, V32, P1622, DOI 10.1029/2018GB005886; Aumont O, 2017, BIOGEOSCIENCES, V14, P2321, DOI 10.5194/bg-14-2321-2017; Bernardello R, 2014, J CLIMATE, V27, P2033, DOI 10.1175/JCLI-D-13-00343.1; Bianchi D, 2018, NAT GEOSCI, V11, P263, DOI 10.1038/s41561-018-0081-0; Bianchi D, 2013, GLOBAL BIOGEOCHEM CY, V27, P478, DOI 10.1002/gbc.20031; Bianchi D, 2013, NAT GEOSCI, V6, P545, DOI 10.1038/NGEO1837; BISHOP JKB, 1989, LIFE SCI R, V44, P117; BISHOP JKB, 1986, DEEP-SEA RES, V33, P1813, DOI 10.1016/0198-0149(86)90081-6; Bopp L, 2013, BIOGEOSCIENCES, V10, P6225, DOI 10.5194/bg-10-6225-2013; Boyd PW, 2007, PROG OCEANOGR, V72, P276, DOI 10.1016/j.pocean.2006.10.007; Boyd PW, 2015, LIMNOL OCEANOGR-METH, V13, P494, DOI 10.1002/lom3.10043; Boyd PW, 2005, LIMNOL OCEANOGR, V50, P1872, DOI 10.4319/lo.2005.50.6.1872; Bradford-Grieve JM, 2001, J PLANKTON RES, V23, P963, DOI 10.1093/plankt/23.9.963; Briggs N, 2011, DEEP-SEA RES PT I, V58, P1031, DOI 10.1016/j.dsr.2011.07.007; Buesseler KO, 2007, SCIENCE, V316, P567, DOI 10.1126/science.1137959; Buesseler KO, 2009, LIMNOL OCEANOGR, V54, P1210, DOI 10.4319/lo.2009.54.4.1210; Burd AB, 2010, DEEP-SEA RES PT II, V57, P1557, DOI 10.1016/j.dsr2.2010.02.022; Callies J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7862; Castelvecchi D, 2016, NATURE, V537, P20, DOI [10.1038/nature.2016.20491, 10.1038/538020a]; Cavan EL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14847; CHILDRESS JJ, 1980, MAR BIOL, V61, P27, DOI 10.1007/BF00410339; Cram JA, 2018, GLOBAL BIOGEOCHEM CY, V32, P858, DOI 10.1029/2017GB005710; Cushman-Roisin B., 1987, DYN OC SURF MIX LAYE, P181; D'Asaro EA, 2018, P NATL ACAD SCI USA, V115, P1162, DOI 10.1073/pnas.1718453115; Dall'Olmo G, 2016, NAT GEOSCI, V9, P820, DOI [10.1038/ngeo2818, 10.1038/NGEO2818]; Dall'Olmo G, 2014, GEOPHYS RES LETT, V41, P2921, DOI 10.1002/2014GL059244; DAM HG, 1993, DEEP-SEA RES PT II, V40, P197, DOI 10.1016/0967-0645(93)90013-D; Davison PC, 2013, PROG OCEANOGR, V116, P14, DOI 10.1016/j.pocean.2013.05.013; DeVries T, 2017, GLOBAL BIOGEOCHEM CY, V31, P535, DOI 10.1002/2016GB005551; DeVries T, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051963; Durkin CA, 2015, MAR CHEM, V175, P72, DOI 10.1016/j.marchem.2015.02.011; Emerson S, 2014, GLOBAL BIOGEOCHEM CY, V28, P14, DOI 10.1002/2013GB004680; Estapa ML, 2015, GLOBAL BIOGEOCHEM CY, V29, P1266, DOI 10.1002/2014GB004913; Fu LL, 2014, J ATMOS OCEAN TECH, V31, P560, DOI 10.1175/JTECH-D-13-00109.1; Giering SLC, 2017, GLOBAL BIOGEOCHEM CY, V31, P159, DOI 10.1002/2016GB005424; Giering SLC, 2014, NATURE, V507, P480, DOI 10.1038/nature13123; Hansell DA, 2009, OCEANOGRAPHY, V22, P202, DOI 10.5670/oceanog.2009.109; Harrison CS, 2018, GLOBAL BIOGEOCHEM CY, V32, P680, DOI 10.1002/2017GB005751; Henson SA, 2015, GLOBAL BIOGEOCHEM CY, V29, P33, DOI 10.1002/2014GB004965; Irigoien X, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4271; Iversen MH, 2013, BIOGEOSCIENCES, V10, P4073, DOI 10.5194/bg-10-4073-2013; JACKSON GA, 1990, DEEP-SEA RES, V37, P1197, DOI 10.1016/0198-0149(90)90038-W; Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; Johnson K., 2017, AUTONOMOUS LAGRANGIA; Jonasdottir SH, 2015, P NATL ACAD SCI USA, V112, P12122, DOI 10.1073/pnas.1512110112; Karleskind P, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006446; Karleskind P, 2011, OCEAN MODEL, V39, P47, DOI 10.1016/j.ocemod.2010.12.003; Kiorboe T, 2001, SCI MAR, V65, P57, DOI 10.3989/scimar.2001.65s257; Klevjer TA, 2016, SCI REP-UK, V6, DOI 10.1038/srep19873; Kobari T, 2008, DEEP-SEA RES PT II, V55, P1648, DOI 10.1016/j.dsr2.2008.04.016; Landschutzer P, 2014, GLOBAL BIOGEOCHEM CY, V28, P927, DOI 10.1002/2014GB004853; Landschutzer P, 2013, BIOGEOSCIENCES, V10, P7793, DOI 10.5194/bg-10-7793-2013; Levy M, 2013, GLOBAL BIOGEOCHEM CY, V27, P1001, DOI 10.1002/gbc.20092; Levy M, 2012, OCEAN MODEL, V43-44, P77, DOI 10.1016/j.ocemod.2011.12.003; Levy M, 2001, J MAR RES, V59, P535, DOI 10.1357/002224001762842181; Liu LL, 2012, J CLIMATE, V25, P1096, DOI 10.1175/2011JCLI4228.1; Llort J., 2018, J GEOPHYS RES OCEANS; MaierReimer E, 1996, CLIM DYNAM, V12, P711, DOI 10.1007/s003820050138; Marsay CM, 2015, P NATL ACAD SCI USA, V112, P1089, DOI 10.1073/pnas.1415311112; MARSHALL JC, 1993, J PHYS OCEANOGR, V23, P1315, DOI 10.1175/1520-0485(1993)023<1315:ITSRAP>2.0.CO;2; MARTIN JH, 1987, DEEP-SEA RES, V34, P267, DOI 10.1016/0198-0149(87)90086-0; Martinez-Garcia A, 2014, SCIENCE, V343, P1347, DOI 10.1126/science.1246848; McDonnell AMP, 2015, GLOBAL BIOGEOCHEM CY, V29, P175, DOI 10.1002/2014GB004935; McKinley GA, 2016, NATURE, V530, P469, DOI 10.1038/nature16958; Moore JK, 2018, SCIENCE, V359, P1139, DOI 10.1126/science.aao6379; Nagai T, 2015, J GEOPHYS RES-OCEANS, V120, P5318, DOI 10.1002/2015JC010889; Niewiadomska K, 2008, LIMNOL OCEANOGR, V53, P2210, DOI 10.4319/lo.2008.53.5_part_2.2210; Nurser AJG, 2000, J GEOPHYS RES-OCEANS, V105, P21851, DOI 10.1029/2000JC900018; Ohman MD, 2016, LIMNOL OCEANOGR, V61, P765, DOI 10.1002/lno.10251; Ohman MD, 2012, J PLANKTON RES, V34, P815, DOI 10.1093/plankt/fbs028; Omand MM, 2015, SCIENCE, V348, P222, DOI 10.1126/science.1260062; Picheral M, 2010, LIMNOL OCEANOGR-METH, V8, P462, DOI 10.4319/lom.2010.8.462; POLLARD RT, 1990, NATURE, V348, P227, DOI 10.1038/348227a0; Powell JR, 2012, J PLANKTON RES, V34, P563, DOI 10.1093/plankt/fbs023; Reinthaler T, 2006, LIMNOL OCEANOGR, V51, P1262, DOI 10.4319/lo.2006.51.3.1262; Resplandy L, 2012, DEEP-SEA RES PT I, V68, P24, DOI 10.1016/j.dsr.2012.05.015; Sarmiento J. L., 2006, OCEAN BIOGEOCHEMICAL; Sauzede R, 2016, J GEOPHYS RES-OCEANS, V121, P2552, DOI 10.1002/2015JC011408; Schlitzer R, 2002, DEEP-SEA RES PT II, V49, P1623, DOI 10.1016/S0967-0645(02)00004-8; Siegel DA, 2008, DEEP-SEA RES PT I, V55, P108, DOI 10.1016/j.dsr.2007.10.006; Siegel DA, 2014, GLOBAL BIOGEOCHEM CY, V28, P181, DOI 10.1002/2013GB004743; Siegel DA, 1997, DEEP-SEA RES PT I, V44, P1519, DOI 10.1016/S0967-0637(97)00028-9; Stanley RHR, 2017, DEEP-SEA RES PT I, V130, P1, DOI 10.1016/j.dsr.2017.10.005; Steinberg DK, 2008, LIMNOL OCEANOGR, V53, P1327, DOI 10.4319/lo.2008.53.4.1327; Steinberg DK, 2017, ANNU REV MAR SCI, V9, P413, DOI 10.1146/annurev-marine-010814-015924; Stukel MR, 2018, LIMNOL OCEANOGR, V63, P363, DOI 10.1002/lno.10636; Stukel MR, 2017, P NATL ACAD SCI USA, V114, P1252, DOI 10.1073/pnas.1609435114; Swan BK, 2011, SCIENCE, V333, P1296, DOI 10.1126/science.1203690; Turner JT, 2015, PROG OCEANOGR, V130, P205, DOI 10.1016/j.pocean.2014.08.005; Vinogradov ME, 1997, ADV MAR BIOL, V32, P1; Volk T., 1985, GEOPHYS MONOGR SER, V32, P99, DOI DOI 10.1029/GM032P0099; Weber T, 2016, P NATL ACAD SCI USA, V113, P8606, DOI 10.1073/pnas.1604414113; Werdell PJ, 2018, PROG OCEANOGR, V160, P186, DOI 10.1016/j.pocean.2018.01.001	94	238	242	69	325	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 18	2019	568	7752					327	335		10.1038/s41586-019-1098-2	http://dx.doi.org/10.1038/s41586-019-1098-2			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HU0GZ	30996317	Green Submitted			2022-12-28	WOS:000464950700044
J	Dustin, ML				Dustin, Michael L.			Integrins and Their Role in Immune Cell Adhesion	CELL			English	Editorial Material							BETA-SUBUNIT; DISTINCT; LFA-1; FIBRONECTIN; DOMAINS	One of the 2019 Canada Gairdner International Awards recognizes Timothy Springer's discovery of the first immune system adhesion molecules involved in lymphocyte homing and the translation of those discoveries into therapeutics for autoimmune disease and cancer.	[Dustin, Michael L.] Univ Oxford, NDORMS, Kennedy Inst Rheumatol, Oxford OX3 7FY, Oxon, England	University of Oxford	Dustin, ML (corresponding author), Univ Oxford, NDORMS, Kennedy Inst Rheumatol, Oxford OX3 7FY, Oxon, England.	michael.dustin@kennedy.ox.ac.uk	Dustin, Michael/AAM-4611-2020	Dustin, Michael/0000-0003-4983-6389				CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; DUSTIN ML, 1988, J CELL BIOL, V107, P321, DOI 10.1083/jcb.107.1.321; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; KISHIMOTO TK, 1987, CELL, V48, P681, DOI 10.1016/0092-8674(87)90246-7; KISHIMOTO TK, 1987, CELL, V50, P193, DOI 10.1016/0092-8674(87)90215-7; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; Nordenfelt P, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01848-y; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; SANCHEZMADRID F, 1982, P NATL ACAD SCI-BIOL, V79, P7489, DOI 10.1073/pnas.79.23.7489; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Springer TA, 1997, P NATL ACAD SCI USA, V94, P65, DOI 10.1073/pnas.94.1.65; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; TAMKUN JW, 1986, CELL, V46, P271, DOI 10.1016/0092-8674(86)90744-0; VONANDRIAN UH, 1991, P NATL ACAD SCI USA, V88, P7538, DOI 10.1073/pnas.88.17.7538	15	24	24	2	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2019	177	3					499	501		10.1016/j.cell.2019.03.038	http://dx.doi.org/10.1016/j.cell.2019.03.038			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HU0FV	30952447	Bronze, Green Submitted			2022-12-28	WOS:000464947700002
J	Armitage, A				Armitage, Alex			Just 11 years to avert disaster	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Armitage, Alex] Queen Alexandra Hosp, Paediat Emergency Med, Portsmouth, Hants, England	Portsmouth Hospitals NHS Trust; Queen Alexandra Hospital	Armitage, A (corresponding author), Queen Alexandra Hosp, Paediat Emergency Med, Portsmouth, Hants, England.								0	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2019	365								l1801	10.1136/bmj.l1801	http://dx.doi.org/10.1136/bmj.l1801			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU8OP	30992260				2022-12-28	WOS:000465549000008
J	Navar, AM				Navar, Ann Marie			Some patient interventions increased thiazide prescriptions and improved blood pressure control	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Navar, Ann Marie] Duke Clin Res Inst, Durham, NC 27705 USA	Duke University	Navar, AM (corresponding author), Duke Clin Res Inst, Durham, NC 27705 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL133416] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))			0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2019	170	8					JC46	JC46		10.7326/ACPJ201904160-046	http://dx.doi.org/10.7326/ACPJ201904160-046			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU7YQ	30986836				2022-12-28	WOS:000465499900012
J	Sancar, F				Sancar, Feyza			New Therapy for Treatment-Resistant Depression	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 16	2019	321	15					1449	1449		10.1001/jama.2019.3596	http://dx.doi.org/10.1001/jama.2019.3596			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HT7SY	30990537				2022-12-28	WOS:000464765900031
J	Dyer, O				Dyer, Owen			Dozens of device companies implicated in $1.2bn scam, say US prosecutors	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 15	2019	365								l1785	10.1136/bmj.l1785	http://dx.doi.org/10.1136/bmj.l1785			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU8OI	30987971				2022-12-28	WOS:000465548300005
J	Lim, R; Sugino, T; Nolte, H; Andrade, J; Zimmermann, B; Shi, C; Doddaballapur, A; Ong, YT; Wilhelm, K; Fasse, JWD; Ernst, A; Kaulich, M; Husnjak, K; Boettger, T; Guenther, S; Braun, T; Kruger, M; Benedito, R; Dikic, I; Potente, M				Lim, R.; Sugino, T.; Nolte, H.; Andrade, J.; Zimmermann, B.; Shi, C.; Doddaballapur, A.; Ong, Y. T.; Wilhelm, K.; Fasse, J. W. D.; Ernst, A.; Kaulich, M.; Husnjak, K.; Boettger, T.; Guenther, S.; Braun, T.; Krueger, M.; Benedito, R.; Dikic, I.; Potente, M.			Deubiquitinase USP10 regulates Notch signaling in the endothelium	SCIENCE			English	Article							CELL BEHAVIOR; ACTIVATION; ANGIOGENESIS; PROTEINS; DLL4; EFFICIENT; VEGF	Notch signaling is a core patterning module for vascular morphogenesis that codetermines the sprouting behavior of endothelial cells (ECs). Tight quantitative and temporal control of Notch activity is essential for vascular development, yet the details of Notch regulation in ECs are incompletely understood. We found that ubiquitin-specific peptidase 10 (USP10) interacted with the NOTCH1 intracellular domain (NICD1) to slow the ubiquitin-dependent turnover of this short-lived form of the activated NOTCH1 receptor. Accordingly, inactivation of USP10 reduced NICD1 abundance and stability and diminished Notch-induced target gene expression in ECs. In mice, the loss of endothelial Usp10 increased vessel sprouting and partially restored the patterning defects caused by ectopic expression of NICD1. Thus, USP10 functions as an NICD1 deubiquitinase that fine-tunes endothelial Notch responses during angiogenic sprouting.	[Lim, R.; Sugino, T.; Andrade, J.; Zimmermann, B.; Shi, C.; Doddaballapur, A.; Ong, Y. T.; Wilhelm, K.; Fasse, J. W. D.; Potente, M.] Max Planck Inst Heart & Lung Res, Angiogenesis & Metab Lab, D-61231 Bad Nauheim, Germany; [Nolte, H.; Krueger, M.] Univ Cologne, Inst Genet, D-50931 Cologne, Germany; [Nolte, H.; Krueger, M.] Univ Cologne, Excellence Cluster Cellular Stress Responses Agin, D-50931 Cologne, Germany; [Ernst, A.; Kaulich, M.; Husnjak, K.; Dikic, I.] Goethe Univ, Inst Biochem 2, Fac Med, D-60590 Frankfurt, Germany; [Ernst, A.] Fraunhofer Inst Mol Biol & Appl Ecol IME, Project Grp Translat Med & Pharmacol TMP, D-60590 Frankfurt, Germany; [Boettger, T.; Guenther, S.; Braun, T.] Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodeling, D-61231 Bad Nauheim, Germany; [Benedito, R.] CNIC, Mol Genet Angiogenesis Lab, Madrid 28029, Spain; [Dikic, I.] Goethe Univ, Buchmann Inst Mol Life Sci, D-60438 Frankfurt, Germany; [Potente, M.] Partner Site Frankfurt Rhine Main, DZHK German Ctr Cardiovasc Res, D-13347 Berlin, Germany; [Potente, M.] Int Inst Mol & Cell Biol, PL-02109 Warsaw, Poland	Max Planck Society; University of Cologne; University of Cologne; Goethe University Frankfurt; Fraunhofer Gesellschaft; Max Planck Society; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Goethe University Frankfurt; German Centre for Cardiovascular Research; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej	Potente, M (corresponding author), Max Planck Inst Heart & Lung Res, Angiogenesis & Metab Lab, D-61231 Bad Nauheim, Germany.; Potente, M (corresponding author), Partner Site Frankfurt Rhine Main, DZHK German Ctr Cardiovasc Res, D-13347 Berlin, Germany.; Potente, M (corresponding author), Int Inst Mol & Cell Biol, PL-02109 Warsaw, Poland.	michael.potente@mpi-bn.mpg.de	Benedito, Rui/AAQ-8096-2020; Braun, Thomas/B-2310-2008; Andrade, Jorge/AAD-6324-2021; Wilhelm, Kerstin/AAX-5025-2020; Kaulich, Manuel/U-4523-2017; Dikic, Ivan/O-4650-2015; Boettger, Thomas/E-3406-2012; Husnjak, Koraljka/C-3717-2015; Benedito, Rui/G-8295-2012; Ernst, Andreas/M-3013-2019	Benedito, Rui/0000-0003-2458-3055; Wilhelm, Kerstin/0000-0001-8159-2850; Kaulich, Manuel/0000-0002-9528-8822; Dikic, Ivan/0000-0001-8156-9511; Boettger, Thomas/0000-0003-4280-8449; Husnjak, Koraljka/0000-0003-0573-6239; Benedito, Rui/0000-0003-2458-3055; Lim, Radiance/0000-0002-9865-7064; Ong, Yu Ting/0000-0003-3407-2515; Andrade, Jorge/0000-0002-4577-8620; Braun, Thomas/0000-0002-6165-4804; Potente, Michael/0000-0002-5689-0036	Max Planck Society; European Research Council (ERC) starting grant ANGIOMET [311546]; ERC consolidator grant EMERGE [773047]; Deutsche Forschungsgemeinschaft [SFB 834]; Excellence Cluster Cardiopulmonary System [EXC 147/1]; LOEWE grant Ub-Net; DZHK (German Center for Cardiovascular Research); Stiftung Charite; Cardio-Pulmonary Institute (EXC 2026 project) [390649896]; European Molecular Biology Organization (EMBO) Young Investigator Programme	Max Planck Society(Max Planck Society); European Research Council (ERC) starting grant ANGIOMET; ERC consolidator grant EMERGE; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Cluster Cardiopulmonary System(German Research Foundation (DFG)); LOEWE grant Ub-Net; DZHK (German Center for Cardiovascular Research); Stiftung Charite; Cardio-Pulmonary Institute (EXC 2026 project); European Molecular Biology Organization (EMBO) Young Investigator Programme	This work is supported by the Max Planck Society, European Research Council (ERC) starting grant ANGIOMET (311546), ERC consolidator grant EMERGE (773047), the Deutsche Forschungsgemeinschaft (SFB 834), the Excellence Cluster Cardiopulmonary System (EXC 147/1), LOEWE grant Ub-Net, the DZHK (German Center for Cardiovascular Research), the Stiftung Charite, the Cardio-Pulmonary Institute (EXC 2026 project ID 390649896), and the European Molecular Biology Organization (EMBO) Young Investigator Programme.	Baker RT, 2005, METHOD ENZYMOL, V398, P540, DOI 10.1016/S0076-6879(05)98044-0; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Bray SJ, 2016, NAT REV MOL CELL BIO, V17, P722, DOI 10.1038/nrm.2016.94; Claxton S, 2008, GENESIS, V46, P74, DOI 10.1002/dvg.20367; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Deng M, 2016, MOL CELL, V61, P614, DOI 10.1016/j.molcel.2016.01.010; Emmerich CH, 2013, P NATL ACAD SCI USA, V110, P15247, DOI 10.1073/pnas.1314715110; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Guarani V, 2011, NATURE, V473, P234, DOI 10.1038/nature09917; Harrington LS, 2008, MICROVASC RES, V75, P144, DOI 10.1016/j.mvr.2007.06.006; Hasan SS, 2017, NAT CELL BIOL, V19, P928, DOI 10.1038/ncb3574; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Higuchi M, 2016, STEM CELL REP, V7, P1116, DOI 10.1016/j.stemcr.2016.11.003; Hjerpe R, 2009, EMBO REP, V10, P1250, DOI 10.1038/embor.2009.192; Izumi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041116; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244; Lin ZH, 2013, CELL REP, V5, P1639, DOI 10.1016/j.celrep.2013.11.029; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Nandagopal N, 2018, CELL, V172, P869, DOI 10.1016/j.cell.2018.01.002; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; Pitulescu ME, 2017, NAT CELL BIOL, V19, P915, DOI 10.1038/ncb3555; Pitulescu ME, 2010, NAT PROTOC, V5, P1518, DOI 10.1038/nprot.2010.113; Pontes-Quero S, 2017, CELL, V170, P800, DOI 10.1016/j.cell.2017.07.031; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rocha SF, 2014, CIRC RES, V115, P581, DOI 10.1161/CIRCRESAHA.115.304718; Schulein-Volk C, 2014, CELL REP, V9, P1099, DOI 10.1016/j.celrep.2014.09.057; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Siebel C, 2017, PHYSIOL REV, V97, P1235, DOI 10.1152/physrev.00005.2017; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Su H, 2002, GENESIS, V32, P187, DOI 10.1002/gene.10043; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Tetzlaff MT, 2004, P NATL ACAD SCI USA, V101, P3338, DOI 10.1073/pnas.0307875101; Tsunematsu R, 2004, J BIOL CHEM, V279, P9417, DOI 10.1074/jbc.M312337200; Ubezio B, 2016, ELIFE, V5, DOI 10.7554/eLife.12167; Yatim A, 2012, MOL CELL, V48, P445, DOI 10.1016/j.molcel.2012.08.022; Yuan J, 2010, CELL, V140, P384, DOI 10.1016/j.cell.2009.12.032; Zhang JZ, 2012, G3-GENES GENOM GENET, V2, P1563, DOI 10.1534/g3.112.003780; Zhang T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8140	43	42	42	2	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2019	364	6436					188	+		10.1126/science.aat0778	http://dx.doi.org/10.1126/science.aat0778			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HT5RC	30975888				2022-12-28	WOS:000464620000045
J	Ramos, SE; Schiestl, FP				Ramos, Sergio E.; Schiestl, Florian P.			Rapid plant evolution driven by the interaction of pollination and herbivory	SCIENCE			English	Article							SELECTION; REPRODUCTION; VOLATILES; RESPONSES; DEFENSE	Pollination and herbivory are both key drivers of plant diversity but are traditionally studied in isolation from each other. We investigated real-time evolutionary changes in plant traits over six generations by using fast-cycling Brassica rapa plants and manipulating the presence and absence of bumble bee pollinators and leaf herbivores. We found that plants under selection by bee pollinators evolved increased floral attractiveness, but this process was compromised by the presence of herbivores. Plants under selection from both bee pollinators and herbivores evolved higher degrees of self-compatibility and autonomous selfing, as well as reduced spatial separation of sexual organs (herkogamy). Overall, the evolution of most traits was affected by the interaction of bee pollination and herbivory, emphasizing the importance of the cross-talk between both types of interactions for plant evolution.	[Ramos, Sergio E.; Schiestl, Florian P.] Univ Zurich, Dept Systemat & Evolutionary Bot, Zollikerstr 107, CH-8008 Zurich, Switzerland	University of Zurich	Schiestl, FP (corresponding author), Univ Zurich, Dept Systemat & Evolutionary Bot, Zollikerstr 107, CH-8008 Zurich, Switzerland.	florian.schiestl@systbot.uzh.ch	Ramos, Sergio/W-5482-2019	Ramos, Sergio/0000-0003-4734-839X; Schiestl, Florian/0000-0001-7637-6918	European Union's Seventh Framework Program (FP7/2007-2013) [281093]; Consejo de Ciencia y Tecnologia CONACYT-Mexico [CVU-346745]; European Union's Seventh Framework Program (FP7/2007-2011) [281093]	European Union's Seventh Framework Program (FP7/2007-2013); Consejo de Ciencia y Tecnologia CONACYT-Mexico; European Union's Seventh Framework Program (FP7/2007-2011)	The research was funded by grants to F.P.S. from the European Union's Seventh Framework Program (FP7/2007-2013, FP7/2007-2011) under grant agreement 281093 and by a full graduate fellowship to S.E.R. funded by the Consejo de Ciencia y Tecnologia CONACYT-Mexico (CVU-346745).	Adler LS, 2006, ECOL LETT, V9, P960, DOI 10.1111/j.1461-0248.2006.00944.x; Agrawal AA, 2012, SCIENCE, V338, P113, DOI 10.1126/science.1225977; Barrett SCH, 2002, NAT REV GENET, V3, P274, DOI 10.1038/nrg776; Bruinsma M, 2014, J CHEM ECOL, V40, P39, DOI 10.1007/s10886-013-0369-x; Chretien LTS, 2018, NEW PHYTOL, V217, P1279, DOI 10.1111/nph.14904; Galetti M, 2013, SCIENCE, V340, P1086, DOI 10.1126/science.1233774; Gervasi DDL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14691; Guimaraes PR, 2017, NATURE, V550, P511, DOI 10.1038/nature24273; Hare JD, 2003, EVOLUTION, V57, P793, DOI 10.1111/j.0014-3820.2003.tb00291.x; Herrera CM, 2002, P NATL ACAD SCI USA, V99, P16823, DOI 10.1073/pnas.252362799; Ivey CT, 2005, AM J BOT, V92, P1641, DOI 10.3732/ajb.92.10.1641; Johnson MTJ, 2015, ANNU REV ECOL EVOL S, V46, P191, DOI 10.1146/annurev-ecolsys-112414-054215; Kalisz S, 2004, NATURE, V430, P884, DOI 10.1038/nature02776; Kawecki TJ, 2012, TRENDS ECOL EVOL, V27, P547, DOI 10.1016/j.tree.2012.06.001; Kessler A, 2011, ECOLOGY, V92, P1769, DOI 10.1890/10-1945.1; Knauer AC, 2017, EVOL ECOL, V31, P285, DOI 10.1007/s10682-016-9878-8; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.2307/2408842; LLOYD DG, 1979, NEW ZEAL J BOT, V17, P595, DOI 10.1080/0028825X.1979.10432573; Lucas-Barbosa D, 2016, TRENDS PLANT SCI, V21, P125, DOI 10.1016/j.tplants.2015.10.013; Mery F, 2003, P ROY SOC B-BIOL SCI, V270, P2465, DOI 10.1098/rspb.2003.2548; Roels SAB, 2011, EVOLUTION, V65, P2541, DOI 10.1111/j.1558-5646.2011.01326.x; Schiestl FP, 2018, EVOLUTION, V72, P2653, DOI 10.1111/evo.13611; Schiestl FP, 2014, NEW PHYTOL, V203, P257, DOI 10.1111/nph.12783; Sicard A, 2016, P NATL ACAD SCI USA, V113, P13911, DOI 10.1073/pnas.1613394113; Stinchcombe JR, 2008, EVOLUTION, V62, P2435, DOI 10.1111/j.1558-5646.2008.00449.x; Strauss SY, 1996, AM NAT, V147, P1098, DOI 10.1086/285896; Strauss SY, 2004, J ECOL, V92, P132, DOI 10.1111/j.1365-2745.2004.00843.x; Theis N, 2012, ECOLOGY, V93, P430, DOI 10.1890/11-0825.1; Yuan Z, 2015, CURR OPIN PLANT BIOL, V27, P44, DOI 10.1016/j.pbi.2015.05.024; Zu PJ, 2016, NEW PHYTOL, V209, P1208, DOI 10.1111/nph.13652; Zust T, 2012, SCIENCE, V338, P116, DOI 10.1126/science.1226397; Zuur A. F., 2013, BEGINNERS GUIDE GLM	32	74	75	20	242	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2019	364	6436					193	+		10.1126/science.aav6962	http://dx.doi.org/10.1126/science.aav6962			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HT5RC	30975889				2022-12-28	WOS:000464620000046
J	Sivashanker, K; Rexrode, K; Nour, N; Kachalia, A				Sivashanker, Karthik; Rexrode, Kathryn; Nour, Nawal; Kachalia, Allen			Healthcare portraiture and unconscious bias	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sivashanker, Karthik] Boston Univ, Sch Med, Dept Psychiat, Qual & Patient Safety, Boston, MA 02215 USA; [Rexrode, Kathryn] Harvard Med Sch, Brigham & Womens Hosp, Div Womens Hlth, Boston, MA 02115 USA; [Nour, Nawal] Harvard Med Sch, Brigham & Womens Hosp, Dept Obstet & Gynaecol, Fac Trainees & Students, Boston, MA 02115 USA; [Kachalia, Allen] Johns Hopkins Sch Med, Dept Med, Baltimore, MD 21205 USA; [Kachalia, Allen] Armstrong Inst Patient Safety & Qual, Baltimore, MD 21202 USA	Boston University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Johns Hopkins University; Johns Hopkins Medicine	Kachalia, A (corresponding author), Johns Hopkins Sch Med, Dept Med, Baltimore, MD 21205 USA.; Kachalia, A (corresponding author), Armstrong Inst Patient Safety & Qual, Baltimore, MD 21202 USA.	kachalia@jhu.edu	Rexrode, Kathryn M/I-1177-2018	Rexrode, Kathryn/0000-0003-3387-8429				Hennessy E., 2012, LEADING DEMOGRAPHIC; National Museum of African American History and Culture, 2018, MASC MYTHS MON MEM; Tator Carol, 1998, CHALLENGING RACISM A; Wellbery C, 2018, JAMA-J AM MED ASSOC, V320, P528, DOI 10.1001/jama.2018.11013; Zebrowitz LA, 2008, SOC COGNITION, V26, P259, DOI 10.1521/soco.2008.26.3.259	5	1	1	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 12	2019	365								l1668	10.1136/bmj.l1668	http://dx.doi.org/10.1136/bmj.l1668			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU0EX	30979700				2022-12-28	WOS:000464945300004
J	[Anonymous]				[Anonymous]			Most UK doctors support assisted dying, a new poll shows: the BMA's opposition does not represent members (vol 360, k301, 2018)	BMJ-BRITISH MEDICAL JOURNAL			English	Correction																		Davis J, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k301	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2019	364								l1408	10.1136/bmj.l1408	http://dx.doi.org/10.1136/bmj.l1408			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HR5VS	30957775	Bronze			2022-12-28	WOS:000463215700016
J	Perkovic, V; Jardine, MJ; Neal, B; Bompoint, S; Heerspink, HJL; Charytan, DM; Edwards, R; Agarwal, R; Bakris, G; Bull, S; Cannon, CP; Capuano, G; Chu, PL; De Zeeuw, D; Greene, T; Levin, A; Pollock, C; Wheeler, DC; Yavin, Y; Zhang, H; Zinman, B; Meininger, G; Brenner, BM; Mahaffey, KW; McGuire, DK; Holman, R; Home, P; Scharfstein, D; Parfrey, P; Shahinfar, S; August, P; Chang, T; Sinha, AD; Januzzi, J; Kolansky, D; Amerena, J; Hillis, G; Gorelick, P; Kissela, B; Kasner, S; Lindley, R; Fulcher, G; Ounadjela, S; Hufert, K; von Ingersleben, G; Gaglia, J; Harris, R; Hudson, M; Turchin, A; Cheifetz, A; Sheth, S; Feuerstein, J; Cohen, S; Li, N; Kolesnyk, I; Aizenberg, D; Pecoits, R; Cherney, D; Obrador, G; Chertow, G; Hawley, C; Ji, LN; Wada, T; Jha, V; Lim, SK; Lim-Abrahan, MA; Santos, F; Chae, DW; Hwang, SJ; Vazelov, E; Rychlik, I; Hadjadj, S; Krane, V; Rosivall, L; De Nicola, L; Dreval, A; Nowicki, M; Schiller, A; Distiller, L; Gorriz, JL; Kolesnyk, M; Morren, F; Goykhman, S; David, C; Yost, L; Wang, H; Hettiarachchi, M; Thimmaiah, R; Koppolu, D; George, S; Schmidt, M; Ignjatovic, J; Chapin, L; Travis, K; Destree, M; Sood, V; Coffee, L; De Brouwer, K; Zaviriukha, V; Starzec, A; Koizumi, M; Lin, G; Chen, E; Lin, P; Leia, C; Mascaro, D; Amigo, A; Limos, A; Abrahamsen, I; Jaffer, S; Guerrero, RAA; Aizenberg, D; Albisu, JP; Alvarisqueta, A; Bartolacci, I; Berli, MA; Bordonava, A; Calella, P; Cantero, MC; Cartasegna, LR; Cercos, E; Coloma, GC; Colombo, H; Commendatore, V; Cuadrado, J; Cuneo, CA; Cusumano, AM; Douthat, WG; Dran, RD; Farias, E; Fernandez, MF; Finkelstein, H; Fragale, G; Fretes, JO; Garcia, NH; Gastaldi, A; Gelersztein, E; Glenny, JA; Gonzalez, JP; Colaso, PDG; Goycoa, C; Greloni, GC; Guinsburg, A; Hermida, S; Juncos, LI; Klyver, MI; Kraft, F; Krynski, F; Lanchiotti, PV; de la Fuente, RAL; Marchetta, N; Mele, P; Nicolai, S; Novoa, PA; Orio, SI; Otreras, F; Oviedo, A; Raffaele, P; Resk, JH; Rista, L; Papini, NR; Sala, J; Santos, JC; Schiavi, LB; Sessa, H; Casabella, TS; Ulla, MR; Valdez, M; Vallejos, A; Villarino, A; Visco, VE; Wassermann, A; Zaidman, CJ; Cheung, NW; Droste, C; Fraser, I; Johnson, D; Mah, PM; Nicholls, K; Packham, D; Proietto, J; Roberts, A; Roger, S; Tsang, V; Raduan, RA; da Costa, FAA; Amodeo, C; Turatti, LAA; Bregman, R; Sanches, FCC; Canani, LH; Chacra, AR; Borges, JLC; Vencio, SAC; Franco, RJD; d'Avila, D; Portes, ED; de Souza, P; Deboni, LM; Fraige, F; Neto, BG; Gomes, M; Kohara, SK; Keitel, E; Saraiva, JFK; Lisboa, HRK; Contieri, FLD; Milagres, R; Montenegro, R; de Brito, CM; Hissa, MN; Sabbag, ARN; Noronha, I; Panarotto, D; Pecoits, R; Pereira, MA; Saporito, W; Scotton, AS; Schuch, T; de Almeida, RS; Ramos, CS; Felicio, JS; Thome, F; Hachmann, JCT; Yamada, S; Hayashida, CY; Petry, TBZ; Zanella, MT; Andreeva, V; Angelova, A; Dimitrov, S; Genadieva, V; Genova-Hristova, G; Hristozov, K; Kamenov, Z; Koundurdjiev, A; Lozanov, L; Margaritov, V; Nonchev, B; Rangelov, R; Shinkov, A; Temelkova, M; Velichkova, E; Yakov, A; Aggarwal, N; Aronson, R; Bajaj, H; Cherney, D; Chouinard, G; Conway, J; Cournoyer, S; DaRoza, G; De Serres, S; Dube, F; Goldenberg, R; Gupta, A; Gupta, M; Henein, S; Khandwala, H; Leiter, L; Madore, F; McMahon, A; Muirhead, N; Pichette, V; Rabasa-Lhoret, R; Steele, A; Tangri, N; Torshizi, A; Woo, V; Zalunardo, N; Montenegro, MAF; Jorquera, JGG; Farina, MM; Gajardo, VS; Vejar, M; Chen, N; Chen, QK; Gan, SL; Kong, YZ; Li, DT; Li, WG; Li, XM; Lin, HL; Liu, J; Lu, WP; Mao, H; Ren, Y; Song, WH; Sun, J; Sun, L; Tu, P; Wang, GX; Yang, JK; Yin, AP; Yu, XQ; Zhao, MH; Zheng, HG; Mendoza, JLA; Arcos, E; Avendano, J; Ruiz, JEAD; Ortiz, LHG; Gonzalez, A; Triana, EH; Higuera, JD; Malaver, N; de Salazar, DIM; Rosero, R; Lozano, MAT; Cometa, LV; Valenzuela, A; Alonso, RDV; Villegas, I; Yupanqui, H; Bartaskova, D; Barton, P; Belobradkova, J; Dohnalova, L; Drasnar, T; Ferkl, R; Halciakova, K; Klokocnikova, V; Kovar, R; Lastuvka, J; Lukac, M; Pesickova, S; Peterka, K; Pumprla, J; Rychlik, I; Saudek, F; Tesar, V; Valis, M; Weiner, P; Zemek, S; Alamartine, E; Borot, S; Cariou, B; Dussol, B; Fauvel, JP; Gourdy, P; Klein, A; Le Meur, Y; Penfornis, A; Roussel, R; Saulnier, PJ; Thervet, E; Zaoui, P; Burst, V; Faghih, M; Faulmann, G; Haller, H; Jerwan-Keim, R; Maxeiner, S; Paschen, B; Plassmann, G; Rose, L; Orellana, RAG; Haase, FP; Diaz, JPM; Roca, LAR; Arenales, JAS; Polo, JVS; Juarez, ET; Csecsei, G; Csiky, B; Danos, P; Deak, L; Dudas, M; Harcsa, E; Keltai, K; Keresztesi, S; Kiss, K; Konyves, L; Major, L; Mileder, M; Molnar, M; Mucsi, J; Oroszlan, T; Ory, I; Paragh, G; Peterfai, E; Petro, G; Revesz, K; Takacs, R; Vangel, S; Vasas, S; Zsom, M; Abraham, O; Bhushan, R; Deepak, D; Edwin, FM; Gopalakrishnan, N; Gracious, N; Hansraj, A; Jain, D; Keshavamurthy, CB; Khullar, D; Manisha, S; Peringat, J; Prasad, N; Satyanarayana, RK; Sreedhar, R; Sreelatha, M; Sudhakar, B; Vyasam, RC; Bonadonna, R; Castellino, P; Ceriello, A; Chiovato, L; De Cosmo, S; De Nicola, L; Derosa, G; Di Carlo, A; Di Cianni, G; Frasca, G; Fuiano, G; Gambaro, G; Garibotto, G; Giorda, C; Malberti, F; Mandreoli, M; Mannucci, E; Orsi, E; Piatti, P; Santoro, D; Sasso, FC; Serviddio, G; Stella, A; Trevisan, R; Veronelli, AM; Zanoli, L; Akiyama, H; Aoki, H; Asano, A; Iitsuka, T; Kajiyama, S; Kashine, S; Kawada, T; Kodera, T; Kono, H; Koyama, K; Kumeda, Y; Miyauchi, S; Mizuyama, K; Niiya, T; Oishi, H; Ota, S; Sakakibara, T; Takai, M; Tomonaga, O; Tsujimoto, M; Wada, T; Wakasugi, M; Wakida, Y; Watanabe, T; Yamada, M; Yanagida, K; Yanase, T; Yumita, W; Gaupsiene, E; Kozloviene, D; Navickas, A; Urbanaviciene, E; Ghani, RA; Kadir, KA; Ali, N; Yusof, MDC; Gan, CL; Ismail, M; Kong, WY; Lam, SW; Lee, LY; Lim, SK; Loh, CL; Manocha, AB; Ng, KS; Ahmad, NNFN; Ratnasingam, V; Bin Shudim, SS; Vengadasalam, P; Munoz, LDA; Salazar, MA; Cruz, JB; Soto, MB; Ramos, JC; Wong, AC; Rotter, JRC; Escalante, TD; Sosa, FEE; Lozano, FF; Cervera, LFF; Baron, PF; Ballesteros, CG; Rangel, JDG; Jimenez, LEH; Santana, SSI; Flores, FJ; Molina, HL; Ceballos, RIL; Blanco, BMD; Franco, GM; Loza, OTM; Rocha, CM; Vera, GO; Castellanos, RO; Calcaneo, JP; Rosano, MAR; Pattzi, HR; Guzman, JR; Joerg, IER; Sanchez, SBS; Mijangos, JHS; Sanson, PS; Orozco, JATY; Chavez, ET; Cepeda, AV; Carrillo, LV; Mesa, JV; Escobedo, RZ; Baker, J; Noonan, P; Scott, R; Walker, R; Watson, E; Williams, M; Young, S; Abejuela, Z; Agra, J; Aquitania, G; Caringal, C; Comia, RS; Delos Santos, L; Gomez, O; Jimeno, C; Tan, G; Tolentino, M; Yao, C; Yap, YE; Ygpuara, MDL; Bijata-Bronisz, R; Hotlos, L; Januszewicz, A; Kaczmarek, B; Kaminska, A; Lazuka, L; Madej, A; Mazur, S; Mlodawska-Choluj, D; Orlowska-Kowalik, G; Popenda, G; Rewerska, B; Sowinski, D; Angelescu, LM; Anghel, V; Avram, RI; Busegeanu, MM; Cif, A; Cosma, D; Crisan, C; Demian, LD; Ferariu, IE; Halmagyi, I; Hancu, N; Munteanu, M; Negru, D; Onaca, AG; Petrica, L; Popa, AR; Ranetti, AE; Serafinceanu, C; Toarba, C; Agafyina, A; Barbarash, O; Barysheva, O; Chizhov, D; Dobronravov, V; Glinkina, I; Grineva, E; Khirmanov, V; Kolmakova, E; Koroleva, T; Kvitkova, L; Marasaev, V; Mkrtumyan, A; Morugova, T; Nagibovich, G; Nagibovich, O; Nedogoda, S; Osipova, I; Raskina, T; Samoylova, Y; Sazonova, O; Shamkhalova, M; Shutemova, E; Shwartz, Y; Uriasyev, O; Vorobyev, S; Zateyshchikova, A; Zateyshshikov, D; Zykova, T; Antic, S; Djordjevic, M; Kendereski, A; Lalic, K; Lalic, N; Popovic-Radinovic, V; Babikova, J; Benusova, O; Buganova, I; Culak, J; Dzupina, A; Dzuponova, J; Fulop, P; Ilavska, A; Martinka, E; Ochodnicka, Z; Pella, D; Smatanova, I; Ahmed, F; Badat, A; Breedt, J; Distiller, L; Govender, V; Govender, R; Joshi, M; Jurgens, J; Latiff, G; Lombard, L; Mookadam, M; Ngcakani, N; Nortje, H; Oosthuizen, H; Pillay-Ramaya, L; Prozesky, H; Reddy, J; Rheeder, P; Seeber, M; Cho, YM; Jeong, IK; Kim, SG; Kim, YH; Kwon, HS; Kwon, MJ; Lee, BW; Lee, J; Lee, MK; Nam, MS; Oh, KH; Park, CY; Park, SH; Yoon, KH; Garcia, PA; Mercadal, LA; Barrios, C; Castro, FC; Guldris, SC; Lopez, MD; de los Rios, JE; Fresnedo, GF; Serrano, AG; Garcia, I; Martinez, FJG; Gimeno, JEJ; Mendoza, ML; Marin, TM; Portillo, CM; Vila, MAM; Torres, MM; Iglesias, JN; Perez, JP; Vera, MP; Perez, JMP; Simon, MAQ; Canonge, RS; Gonzalez, AS; Riera, MT; Madueno, FJT; Plaza, MV; Chang, CT; Chuang, LM; Hsia, TL; Hsieh, CH; Lin, CC; Lu, YC; Sheu, WHH; Barna, O; Bilyk, SD; Botsyurko, V; Dudar, I; Fushtey, I; Godlevska, O; Golovchenko, O; Gyrina, O; Kazmirchuk, A; Komisarenko, I; Korzh, O; Kravchun, N; Legun, O; Mankovskyy, B; Martynyuk, L; Mostovoy, Y; Pashkovska, N; Pererva, L; Pertseva, T; Samoylov, O; Smirnov, I; Svyshchenko, Y; Tomashkevych, H; Topchii, I; Tryshchuk, N; Tseluyko, V; Vizir, V; Vlasenko, M; Zlova, T; Zub, L; Abusnana, S; Railey, M; Abouglila, K; Ainsworth, P; Ali, Z; Arutchelvam, V; Barnard, M; Bellary, S; Davies, E; Davies, M; Davies, S; Dawson, A; El Kossi, M; English, P; Fraser, D; Gnudi, L; Gunstone, A; Hall, T; Hanif, W; Jackson, A; Johnson, A; Joseph, F; Krishnan, S; Kumwenda, M; MacDougall, I; Nixon, P; O'Hare, J; Philip, S; Ramtoola, S; Saxena, M; Sennik, D; Simon, G; Singh, B; Stephens, J; Strzelecka, A; Symonds, R; Turner, W; Wahba, M; Wakeling, J; Wheeler, D; Winocour, P; Abdallah, J; Abdullah, R; Abramowitz, M; Acosta, I; Aiello, J; Akright, L; Akyea-Djamson, A; Alappan, R; Alicic, R; Al-Karadsheh, A; Allison, DC; Arauz-Pacheco, C; Arfeen, S; Arif, A; Arvind, M; Atray, N; Awad, A; Barnhill, P; Barranco, E; Barrera, C; Beacom, M; Behara, V; Belo, D; Bentley-Lewis, R				Perkovic, V.; Jardine, M. J.; Neal, B.; Bompoint, S.; Heerspink, H. J. L.; Charytan, D. M.; Edwards, R.; Agarwal, R.; Bakris, G.; Bull, S.; Cannon, C. P.; Capuano, G.; Chu, P. -L.; De Zeeuw, D.; Greene, T.; Levin, A.; Pollock, C.; Wheeler, D. C.; Yavin, Y.; Zhang, H.; Zinman, B.; Meininger, G.; Brenner, B. M.; Mahaffey, K. W.; McGuire, Darren K.; Holman, Rury; Home, Philip; Scharfstein, Dan; Parfrey, Patrick; Shahinfar, Shahnaz; August, Phyllis; Chang, Tara; Sinha, Arjun D.; Januzzi, James; Kolansky, Daniel; Amerena, John; Hillis, Graham; Gorelick, Philip; Kissela, Brett; Kasner, Scott; Lindley, Richard; Fulcher, Greg; Ounadjela, Souhila; Hufert, Karina; von Ingersleben, Gabriele; Gaglia, Jason; Harris, Ronald; Hudson, Margo; Turchin, Alexander; Cheifetz, Adam; Sheth, Sunil; Feuerstein, Joseph; Cohen, Samuel; Li, Nicole; Kolesnyk, Inna; Aizenberg, Diego; Pecoits-Filho, Roberto; Cherney, David; Obrador, Gregorio; Chertow, Glenn; Hawley, Carmel; Ji, Linong; Wada, Takashi; Jha, Vivekanand; Lim, Soo Kun; Lim-Abrahan, Mary Anne; Santos, Florence; Chae, Dong-Wan; Hwang, Shang-Jyh; Vazelov, Evgueniy; Rychlik, Ivan; Hadjadj, Samy; Krane, Vera; Rosivall, Laszlo; De Nicola, Luca; Dreval, Alexander; Nowicki, Michal; Schiller, Adalbert; Distiller, Larry; Gorriz, Jose L.; Kolesnyk, Mykola; Morren, Fran; Goykhman, Svetlana; David, Caryl; Yost, Lori; Wang, Holly; Hettiarachchi, Manthi; Thimmaiah, Ramesh; Koppolu, Deepak; George, Sini; Schmidt, Manuela; Ignjatovic, Jelena; Chapin, Lincoln; Travis, Kim; Destree, Martine; Sood, Vivek; Coffee, Laura; De Brouwer, Kati; Zaviriukha, Viktor; Starzec, Agnieszka; Koizumi, Masahiro; Lin, Grace; Chen, Evaly; Lin, Peggy; Leia, Chen; Mascaro, Debbie; Amigo, Anabella; Limos, Ana; Abrahamsen, Ingrid; Jaffer, Sara; Ahuad Guerrero, Rodolfo Andres; Aizenberg, Diego; Pablo Albisu, Juan; Alvarisqueta, Andres; Bartolacci, Ines; Alberto Berli, Mario; Bordonava, Anselmo; Calella, Pedro; Cecilia Cantero, Maria; Rodolfo Cartasegna, Luis; Cercos, Esteban; Cecilia Coloma, Gabriela; Colombo, Hugo; Commendatore, Victor; Cuadrado, Jesus; Alberto Cuneo, Carlos; Maria Cusumano, Ana; Guillermo Douthat, Walter; Dario Dran, Ricardo; Farias, Eduardo; Florencia Fernandez, Maria; Finkelstein, Hernan; Fragale, Guillermo; Osvaldo Fretes, Jose; Horacio Garcia, Nestor; Gastaldi, Anibal; Gelersztein, Elizabeth; Archibaldo Glenny, Jorge; Pablo Gonzalez, Joaquin; Gonzalez Colaso, Patricia del Carmen; Goycoa, Claudia; Cristian Greloni, Gustavo; Guinsburg, Adrian; Hermida, Sonia; Isaias Juncos, Luis; Isabel Klyver, Maria; Kraft, Florencia; Krynski, Fernando; Virginia Lanchiotti, Paulina; Leon de la Fuente, Ricardo Alfonso; Marchetta, Nora; Mele, Pablo; Nicolai, Silvia; Antonio Novoa, Pablo; Ines Orio, Silvia; Otreras, Fabian; Oviedo, Alejandra; Raffaele, Pablo; Hector Resk, Jorge; Rista, Lucas; Rodriguez Papini, Nelson; Sala, Jorgelina; Carlos Santos, Juan; Beatriz Schiavi, Lilia; Sessa, Horacio; Casabella, Tomas Smith; Ulla, Maria Rosa; Valdez, Maria; Vallejos, Augusto; Villarino, Adriana; Esther Visco, Virginia; Wassermann, Alfredo; Javier Zaidman, Cesar; Cheung, Ngai Wah; Droste, Carolyn; Fraser, Ian; Johnson, David; Mah, Peak Mann; Nicholls, Kathy; Packham, David; Proietto, Joseph; Roberts, Anthony; Roger, Simon; Tsang, Venessa; Raduan, Roberto Abrao; Alves da Costa, Fernando Augusto; Amodeo, Celso; Andreotti Turatti, Luiz Alberto; Bregman, Rachel; Camelo Sanches, Fernanda Cristina; Canani, Luis Henrique; Chacra, Antonio Roberto; Cunha Borges, Joao Lindolfo; Cunha Vencio, Sergio Alberto; da Silva Franco, Roberto Jorge; d'Avila, Domingos; Portes, Evandro de Souza; de Souza, Pedro; Deboni, Luciane Monica; Fraige Filho, Fadlo; Geloneze Neto, Bruno; Gomes, Marcus; Kohara, Suely Keiko; Keitel, Elizete; Kerr Saraiva, Jose Francisco; Kurtz Lisboa, Hugo Roberto; de Carvalho Contieri, Fabiana Loss; Milagres, Rosangela; Montenegro Junior, Renan; de Brito, Claudia Moreira; Hissa, Miguel Nasser; Nazario Sabbag, Angela Regina; Noronha, Irene; Panarotto, Daniel; Pecoits Filho, Roberto; Pereira, Marcio Antonio; Saporito, Wladmir; Scotton, Antonio Scafuto; Schuch, Tiago; de Almeida, Roberto Simoes; Ramos, Cassio Slompo; Felicio, Joao Soares; Thome, Fernando; Tibes Hachmann, Jean Carlo; Yamada, Sergio; Hayashida, Cesar Yoiti; Zanata Petry, Tarissa Beatrice; Zanella, Maria Teresa; Andreeva, Viktoria; Angelova, Angelina; Dimitrov, Stefan; Genadieva, Veselka; Genova-Hristova, Gabriela; Hristozov, Kiril; Kamenov, Zdravko; Koundurdjiev, Atanas; Lozanov, Lachezar; Margaritov, Viktor; Nonchev, Boyan; Rangelov, Rangel; Shinkov, Alexander; Temelkova, Margarita; Velichkova, Ekaterina; Yakov, Andrian; Aggarwal, Naresh; Aronson, Ronnie; Bajaj, Harpreet; Cherney, David; Chouinard, Guy; Conway, James; Cournoyer, Serge; DaRoza, Gerald; De Serres, Sacha; Dube, Francois; Goldenberg, Ronald; Gupta, Anil; Gupta, Milan; Henein, Sam; Khandwala, Hasnain; Leiter, Lawrence; Madore, Francois; McMahon, Alan; Muirhead, Norman; Pichette, Vincent; Rabasa-Lhoret, Remi; Steele, Andrew; Tangri, Navdeep; Torshizi, Ali; Woo, Vincent; Zalunardo, Nadia; Fernandez Montenegro, Maria Alicia; Godoy Jorquera, Juan Gonzalo; Medina Farina, Marcelo; Saavedra Gajardo, Victor; Vejar, Margarita; Chen, Nan; Chen, Qinkai; Gan, Shenglian; Kong, Yaozhong; Li, Detian; Li, Wenge; Li, Xuemei; Lin, Hongli; Liu, Jian; Lu, Weiping; Mao, Hong; Ren, Yan; Song, Weihong; Sun, Jiao; Sun, Lin; Tu, Ping; Wang, Guixia; Yang, Jinkui; Yin, Aiping; Yu, Xueqing; Zhao, Minghui; Zheng, Hongguang; Accini Mendoza, Jose Luis; Arcos, Edgar; Avendano, Jorge; Andres Diaz Ruiz, Jorge Ernesto; Garcia Ortiz, Luis Hernando; Gonzalez, Alexander; Hernandez Triana, Eric; Diego Higuera, Juan; Malaver, Natalia; Molina de Salazar, Dora Ines; Rosero, Ricardo; Terront Lozano, Monica Alexandra; Valderrama Cometa, Luis; Valenzuela, Alex; Vargas Alonso, Ruben Dario; Villegas, Ivan; Yupanqui, Hernan; Bartaskova, Dagmar; Barton, Petr; Belobradkova, Jana; Dohnalova, Lenka; Drasnar, Tomas; Ferkl, Richard; Halciakova, Katarina; Klokocnikova, Vera; Kovar, Richard; Lastuvka, Jiri; Lukac, Martin; Pesickova, Satu; Peterka, Karel; Pumprla, Jiri; Rychlik, Ivan; Saudek, Frantisek; Tesar, Vladimir; Valis, Martin; Weiner, Pavel; Zemek, Stanislav; Alamartine, Eric; Borot, Sophie; Cariou, Bertrand; Dussol, Bertrand; Fauvel, Jean-Pierre; Gourdy, Pierre; Klein, Alexandre; Le Meur, Yannick; Penfornis, Alfred; Roussel, Ronan; Saulnier, Pierre-Jean; Thervet, Eric; Zaoui, Philippe; Burst, Volker; Faghih, Markus; Faulmann, Grit; Haller, Hermann; Jerwan-Keim, Reinhold; Maxeiner, Stephan; Paschen, Bjoern; Plassmann, Georg; Rose, Ludger; Gonzalez Orellana, Ronaldo Arturo; Paul Haase, Franklin; Moreira Diaz, Juan Pablo; Ramirez Roca, Luis Alberto; Sanchez Arenales, Jose Antonio; Sanchez Polo, Jose Vicente; Turcios Juarez, Erick; Csecsei, Gyongyi; Csiky, Botond; Danos, Peter; Deak, Laszlo; Dudas, Mihaly; Harcsa, Eleonora; Keltai, Katalin; Keresztesi, Sandor; Kiss, Krisztian; Konyves, Laszlo; Major, Lajos; Mileder, Margit; Molnar, Marta; Mucsi, Janos; Oroszlan, Tamas; Ory, Ivan; Paragh, Gyorgy; Peterfai, Eva; Petro, Gizella; Revesz, Katalin; Takacs, Robert; Vangel, Sandor; Vasas, Szilard; Zsom, Marianna; Abraham, Oomman; Bhushan, Raju Sree; Deepak, Dewan; Edwin, Fernando M.; Gopalakrishnan, Natarajan; Gracious, Noble; Hansraj, Alva; Jain, Dinesh; Keshavamurthy, C. B.; Khullar, Dinesh; Manisha, Sahay; Peringat, Jayameena; Prasad, Narayan; Satyanarayana, Rao K.; Sreedhar, Reddy; Sreelatha, Melemadathil; Sudhakar, Bhimavarapu; Vyasam, Ramesh Chandra; Bonadonna, Riccardo; Castellino, Pietro; Ceriello, Antonio; Chiovato, Luca; De Cosmo, Salvatore; De Nicola, Luca; Derosa, Giuseppe; Di Carlo, Alberto; Di Cianni, Graziano; Frasca, Giovanni; Fuiano, Giorgio; Gambaro, Giovanni; Garibotto, Giacomo; Giorda, Carlo; Malberti, Fabio; Mandreoli, Marcora; Mannucci, Edoardo; Orsi, Emanuela; Piatti, Piermarco; Santoro, Domenico; Sasso, Ferdinando Carlo; Serviddio, Gaetano; Stella, Andrea; Trevisan, Roberto; Veronelli, Anna Maria; Zanoli, Luca; Akiyama, Hitoshi; Aoki, Hiromi; Asano, Akimichi; Iitsuka, Tadashi; Kajiyama, Shizuo; Kashine, Susumu; Kawada, Toshio; Kodera, Takamoto; Kono, Hiroshi; Koyama, Kazunori; Kumeda, Yasuro; Miyauchi, Shozo; Mizuyama, Kazuyuki; Niiya, Tetsuji; Oishi, Hiroko; Ota, Satoshi; Sakakibara, Terue; Takai, Masahiko; Tomonaga, Osamu; Tsujimoto, Mitsuru; Wada, Takashi; Wakasugi, Masakiyo; Wakida, Yasushi; Watanabe, Takayuki; Yamada, Masayo; Yanagida, Kazuhiro; Yanase, Toshihiko; Yumita, Wataru; Gaupsiene, Egle; Kozloviene, Dalia; Navickas, Antanas; Urbanaviciene, Egle; Ghani, Rohana Abdul; Kadir, Khalid Abdul; Ali, Norsiah; Yusof, Mohd Daud Che; Gan, Chye Lee; Ismail, Mastura; Kong, Wei Yen; Lam, Swee Win; Lee, Li Yuan; Lim, Soo Kun; Loh, Chek Loong; Manocha, Anita Bhajan; Ng, Kee Sing; Ahmad, Nik Nur Fatnoon Nik; Ratnasingam, Vanassa; Bin Shudim, Saiful Shahrizal; Vengadasalam, Paranthaman; Abraira Munoz, Luis David; Alpizar Salazar, Melchor; Baas Cruz, Juan; Burgos Soto, Mario; Chevaile Ramos, Jose; Chew Wong, Alfredo; Correa Rotter, Jose Ricardo; Diaz Escalante, Tonatiu; Enriquez Sosa, Favio Edmundo; Flores Lozano, Fernando; Flota Cervera, Luis Fernando; Frenk Baron, Paul; Garcia Ballesteros, Cecilia; Gomez Rangel, Jose David; Herrera Jimenez, Luis Enrique; Irizar Santana, Sergio Saul; Jimenez Flores, Fernando; Laviada Molina, Hugo; Luna Ceballos, Rosa Isela; del Campo Blanco, Belia Martin; Morales Franco, Guadalupe; Moreno Loza, Oscar Tarsicio; Mustieles Rocha, Cynthia; Obrador Vera, Gregorio; Orozco Castellanos, Ricardo; Peralta Calcaneo, Juan; Reyes Rosano, Miguel Angel; Rodriguez Pattzi, Hiromi; Rosas Guzman, Juan; Rucker Joerg, Isabel Erika; Saavedra Sanchez, Sandra Berenice; Sanchez Mijangos, Jose Hector; Serrano Sanson, Pablo; Tamayo y Orozco, Juan Alfredo; Tellez Chavez, Eloisa; Valdes Cepeda, Alejandro; Venegas Carrillo, Luis; Villagordoa Mesa, Juan; Zamarripa Escobedo, Rolando; Baker, John; Noonan, Paul; Scott, Russell; Walker, Robert; Watson, Edward; Williams, Michael; Young, Simon; Abejuela, Zaynab; Agra, Jeimeen; Aquitania, Grace; Caringal, Clodoaido; Comia, Rhea Severina; Delos Santos, Lalaine; Gomez, Olivert; Jimeno, Cecilia; Tan, Gerry; Tolentino, Marsha; Yao, Christy; Yap, Yvette Ethel; Ygpuara, Maria Dovie Lallaine; Bijata-Bronisz, Renata; Hotlos, Lucyna; Januszewicz, Andrzej; Kaczmarek, Barbara; Kaminska, Anna; Lazuka, Lech; Madej, Andrzej; Mazur, Stanislaw; Mlodawska-Choluj, Dorota; Orlowska-Kowalik, Grazyna; Popenda, Grazyna; Rewerska, Barbara; Sowinski, Dariusz; Angelescu, Liliana Monica; Anghel, Veronica; Avram, Rodica-Ioana; Busegeanu, Mihaela-Magdalena; Cif, Adriana; Cosma, Dana; Crisan, Carmen; Demian, Luiza Despina; Ferariu, Ioana Emilia; Halmagyi, Ildiko; Hancu, Nicolae; Munteanu, Mircea; Negru, Doru; Onaca, Adriana Gabriela; Petrica, Ligia; Popa, Amorin Remus; Ranetti, Aurelian-Emil; Serafinceanu, Cristian; Toarba, Cristina; Agafyina, Alina; Barbarash, Olga; Barysheva, Olga; Chizhov, Daniil; Dobronravov, Vladimir; Glinkina, Irina; Grineva, Elena; Khirmanov, Vladimir; Kolmakova, Elena; Koroleva, Tatiana; Kvitkova, Liudmila; Marasaev, Viacheslav; Mkrtumyan, Ashot; Morugova, Tatiana; Nagibovich, Galina; Nagibovich, Oleg; Nedogoda, Sergei; Osipova, Irina; Raskina, Tatiana; Samoylova, Yulia; Sazonova, Olga; Shamkhalova, Minara; Shutemova, Elena; Shwartz, Yuriy; Uriasyev, Oleg; Vorobyev, Sergey; Zateyshchikova, Anna; Zateyshshikov, Dmitry; Zykova, Tatyana; Antic, Slobodan; Djordjevic, Miodrag; Kendereski, Aleksandra; Lalic, Katarina; Lalic, Nebojsa; Popovic-Radinovic, Vesna; Babikova, Jana; Benusova, Olga; Buganova, Ingrid; Culak, Jan; Dzupina, Andrej; Dzuponova, Jana; Fulop, Peter; Ilavska, Adriana; Martinka, Emil; Ochodnicka, Zuzana; Pella, Daniel; Smatanova, Iveta; Ahmed, Fayzal; Badat, Aysha; Breedt, Johannes; Distiller, Lawrence; Govender, Vimladhevi; Govender, Ravendran; Joshi, Mukesh; Jurgens, Jaco; Latiff, Gulam; Lombard, Landman; Mookadam, Mohamed; Ngcakani, Nomangesi; Nortje, Hendrik; Oosthuizen, Helena; Pillay-Ramaya, Larisha; Prozesky, Hans; Reddy, Jeevren; Rheeder, Paul; Seeber, Mary; Cho, Young Min; Jeong, In-Kyung; Kim, Sin Gon; Kim, Yeong Hoon; Kwon, Hyuk-Sang; Kwon, Min Jeong; Lee, Byung-Wan; Lee, JungEun; Lee, Moon-Kyu; Nam, Moon-Suk; Oh, Kook-Hwan; Park, Cheol-Young; Park, Sun-Hee; Yoon, Kun Ho; Alvarez Garcia, Pere; Asmarats Mercadal, Luis; Barrios, Clara; Cereto Castro, Fernando; Cigarran Guldris, Secundino; Dominguez Lopez, Marta; Egido de los Rios, Jesus; Fernandez Fresnedo, Gema; Galan Serrano, Antonio; Garcia, Isabel; Gonzalez Martinez, Francisco Javier; Jodar Gimeno, Jose Esteban; Lopez Mendoza, Manuel; Malek Marin, Tamara; Morales Portillo, Cristobal; Munar Vila, Maria Antonia; Munoz Torres, Manuel; Nieto Iglesias, Javier; Pantoja Perez, Jonay; Perez Vera, Merce; Portoles Perez, Jose Maria; Quesada Simon, Maria Angustias; Simo Canonge, Rafael; Soto Gonzalez, Alfonso; Terns Riera, Manel; Tinahones Madueno, Francisco Jose; Velo Plaza, Mercedes; Chang, Chwen-Tzuei; Chuang, Lee-Ming; Hsia, Te-Lin; Hsieh, Chang-Hsun; Lin, Chih-Ching; Lu, Yung-Chuan; Sheu, Wayne H-H; Barna, Olga; Bilyk, Svitlana D.; Botsyurko, Volodymyr; Dudar, Iryna; Fushtey, Ivan; Godlevska, Olga; Golovchenko, Oleksandr; Gyrina, Olga; Kazmirchuk, Anatoliy; Komisarenko, Iuliia; Korzh, Oleksii; Kravchun, Nonna; Legun, Oleg; Mankovskyy, Borys; Martynyuk, Liliya; Mostovoy, Yuriy; Pashkovska, Nataliia; Pererva, Larysa; Pertseva, Tetyana; Samoylov, Oleksandr; Smirnov, Ivan; Svyshchenko, Yevgeniya; Tomashkevych, Halyna; Topchii, Ivan; Tryshchuk, Nadiya; Tseluyko, Vira; Vizir, Vadym; Vlasenko, Maryna; Zlova, Tetiana; Zub, Liliia; Abusnana, Salah; Railey, Mohamed; Abouglila, Kamal; Ainsworth, Paul; Ali, Zishan; Arutchelvam, Vijayaraman; Barnard, Maria; Bellary, Srikanth; Davies, Emyr; Davies, Mark; Davies, Simon; Dawson, Alison; El Kossi, Mohsen; English, Patrick; Fraser, Donald; Gnudi, Luigi; Gunstone, Anthony; Hall, Timothy; Hanif, Wasim; Jackson, Alan; Johnson, Andrew; Joseph, Franklin; Krishnan, Singhan; Kumwenda, Mick; MacDougall, Iain; Nixon, Paul; O'Hare, Joseph; Philip, Sam; Ramtoola, Shenaz; Saxena, Manish; Sennik, Davesh; Simon, Godwin; Singh, Baldev; Stephens, Jeffrey; Strzelecka, Anna; Symonds, Rehan; Turner, Wayne; Wahba, Mona; Wakeling, John; Wheeler, David; Winocour, Peter; Abdallah, Joseph; Abdullah, Raied; Abramowitz, Matthew; Acosta, Idalia; Aiello, Joseph; Akright, Laura; Akyea-Djamson, Ayim; Alappan, Rajendran; Alicic, Radica; Al-Karadsheh, Amer; Allison, Dale Crawford; Arauz-Pacheco, Carlos; Arfeen, Shahabul; Arif, Ahmed; Arvind, Moogali; Atray, Naveen; Awad, Ahmed; Barnhill, Peggy; Barranco, Elizabeth; Barrera, Carlos; Beacom, Matthew; Behara, Venkata; Belo, Diogo; Bentley-Lewis, Rhonda		CREDENCE Trial Investigators	Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIOVASCULAR OUTCOMES; KIDNEY-DISEASE; EMPAGLIFLOZIN	Background Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long-term treatments are available. In cardiovascular trials of inhibitors of sodium-glucose cotransporter 2 (SGLT2), exploratory results have suggested that such drugs may improve renal outcomes in patients with type 2 diabetes. Methods In this double-blind, randomized trial, we assigned patients with type 2 diabetes and albuminuric chronic kidney disease to receive canagliflozin, an oral SGLT2 inhibitor, at a dose of 100 mg daily or placebo. All the patients had an estimated glomerular filtration rate (GFR) of 30 to <90 ml per minute per 1.73 m(2) of body-surface area and albuminuria (ratio of albumin [mg] to creatinine [g], >300 to 5000) and were treated with renin-angiotensin system blockade. The primary outcome was a composite of end-stage kidney disease (dialysis, transplantation, or a sustained estimated GFR of <15 ml per minute per 1.73 m(2)), a doubling of the serum creatinine level, or death from renal or cardiovascular causes. Prespecified secondary outcomes were tested hierarchically. Results The trial was stopped early after a planned interim analysis on the recommendation of the data and safety monitoring committee. At that time, 4401 patients had undergone randomization, with a median follow-up of 2.62 years. The relative risk of the primary outcome was 30% lower in the canagliflozin group than in the placebo group, with event rates of 43.2 and 61.2 per 1000 patient-years, respectively (hazard ratio, 0.70; 95% confidence interval [CI], 0.59 to 0.82; P=0.00001). The relative risk of the renal-specific composite of end-stage kidney disease, a doubling of the creatinine level, or death from renal causes was lower by 34% (hazard ratio, 0.66; 95% CI, 0.53 to 0.81; P<0.001), and the relative risk of end-stage kidney disease was lower by 32% (hazard ratio, 0.68; 95% CI, 0.54 to 0.86; P=0.002). The canagliflozin group also had a lower risk of cardiovascular death, myocardial infarction, or stroke (hazard ratio, 0.80; 95% CI, 0.67 to 0.95; P=0.01) and hospitalization for heart failure (hazard ratio, 0.61; 95% CI, 0.47 to 0.80; P<0.001). There were no significant differences in rates of amputation or fracture. Conclusions In patients with type 2 diabetes and kidney disease, the risk of kidney failure and cardiovascular events was lower in the canagliflozin group than in the placebo group at a median follow-up of 2.62 years. (Funded by Janssen Research and Development; CREDENCE ClinicalTrials.gov number, NCT02065791.)	[Perkovic, V.; Jardine, M. J.; Neal, B.; Bompoint, S.] Univ New South Wales Sydney, George Inst Global Hlth, Sydney, NSW, Australia; [Perkovic, V.] Royal North Shore Hosp, Sydney, NSW, Australia; [Jardine, M. J.] Concord Repatriat Gen Hosp, Sydney, NSW, Australia; [Neal, B.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW, Australia; [Cannon, C. P.] Univ Sydney, Royal North Shore Hosp, Sydney Med Sch, Kolling Inst Med Res, St Leonards, NSW, Australia; [Neal, B.] Imperial Coll London, London, England; [Wheeler, D. C.] UCL, Med Sch, Dept Renal Med, London, England; [Heerspink, H. J. L.; De Zeeuw, D.] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands; [Charytan, D. M.] NYU, Sch Med, Nephrol Div, New York, NY USA; [Charytan, D. M.] NYU, Langone Med Ctr, New York, NY USA; [Charytan, D. M.; Cannon, C. P.; Brenner, B. M.] Brigham & Womens Hosp, Baim Inst Clin Res, Boston, MA USA; [Cannon, C. P.] Brigham & Womens Hosp, Cardiovasc Div, 75 Francis St, Boston, MA 02115 USA; [Brenner, B. M.] Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA; [Brenner, B. M.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Brenner, B. M.] Harvard Med Sch, Boston, MA 02115 USA; [Edwards, R.; Bull, S.; Capuano, G.; Chu, P. -L.; Yavin, Y.; Meininger, G.] Janssen Res & Dev, Raritan, NJ USA; [Agarwal, R.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Agarwal, R.] Vet Affairs Med Ctr, Indianapolis, IN USA; [Bakris, G.] Univ Chicago Med, Dept Med, Chicago, IL USA; [Greene, T.] Univ Utah, Div Biostat, Dept Populat Hlth Sci, Salt Lake City, UT USA; [Levin, A.] Univ British Columbia, Div Nephrol, Vancouver, BC, Canada; [Zinman, B.] Univ Toronto, Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Zhang, H.] Peking Univ, Hosp 1, Renal Div, Beijing, Peoples R China; [Mahaffey, K. W.] Stanford Univ, Dept Med, Stanford Ctr Clin Res, Sch Med, Stanford, CA 94305 USA	George Institute for Global Health; University of New South Wales Sydney; University of Sydney; Royal North Shore Hospital; Concord Repatriation General Hospital; University of Sydney; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; Imperial College London; University of London; University College London; University of Groningen; New York University; New York University; NYU Langone Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Johnson & Johnson; Janssen Pharmaceuticals; Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Utah System of Higher Education; University of Utah; University of British Columbia; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Peking University; Stanford University	Perkovic, V (corresponding author), Univ New South Wales Sydney, George Inst Global Hlth, Level 5,1 King St, Newtown, NSW 2042, Australia.	vperkovic@georgeinstitute.org.au	Runova, Gyuzel/AAJ-7814-2021; Geloneze, Bruno/F-4231-2010; serviddio, gaetano/C-7629-2011; Korzh, Oleksii/E-4291-2016; McGuire, Darren K./AAL-4172-2021; chiovato, luca/AAC-9003-2019; Linong, Ji/AAB-6543-2020; Grineva, Ele N./V-8221-2018; DEBONI, LUCIANE MONICA/AAP-3821-2021; Komisarenko, Yulia/ABD-4260-2020; Jimeno, Cecilia Alegado/P-4702-2017; Heerspink, Hiddo J Lambers/K-3358-2014; Tryshchuk, Nadiya/AAB-6103-2020; Garcia, Nestor H/AAP-5410-2020; Zanoli, Luca/L-9309-2016; Lu, Wei/AAE-2921-2022; Goldenberg, Ronald/GRS-5067-2022; Piatti, Piermarco/AAN-3115-2020; Pesickova, Satu Sinikka/AAI-9673-2021; De Nicola, Luca/AAB-7682-2019; castellino, pietro/AAB-8793-2022; Sasso, Ferdinando Carlo/AAA-8423-2020; Thome, Fernando/O-9840-2019; Shinkov, Alexander/F-8140-2013; Prozesky, Hans Walter/ABE-6956-2020; de Zeeuw, Dick/E-9080-2014; Morales, Cristobal/T-5071-2019; Li, Jing/GYU-5036-2022; Shamkhalova, Minara/HHM-4410-2022; Tesar, Vladimir/O-2312-2017; Glinkina, Irina/AAE-9783-2019; Nonchev, Boyan/GZA-9195-2022; Agarwal, Rajiv/H-3454-2019; Sasso, Ferdinando Carlo/AAE-5665-2019; Mannucci, Edoardo/K-6749-2016; Philip, Sam/AAE-3349-2021; Januzzi, James/Y-2436-2019; Leiter, Lawrence/AAG-4059-2020; Turatti, Luiz Alberto Andreotti/AAM-5631-2021; Chiovato, Luca/K-6617-2016; RAMOS, CASSIO SLOMPO/AAV-9778-2020; Martynyuk, Liliya/AAE-5475-2019; Keitel, Elizete/K-8587-2012; Rychlik, Ivan/ABH-1704-2020; Jardine, Meg/AFR-1699-2022; Perkovic, Vlado/AAY-1933-2021; Goldenberg, Ronald Michael/AFU-9722-2022; Pertseva, Tetyana/ABA-9172-2021; Schiller, Adalbert A./AAT-8957-2021; Garibotto, Giacomo/AAB-1190-2019; Chuang, Lee-Ming/AAF-3324-2019; Feuerstein, Joseph David/AAF-5183-2020; Muirhead, Norman/G-3337-2011; Gracious, Noble/AAD-4006-2022; Park, Sun/GSD-9620-2022; Barna, Olga/ABC-6535-2020; Canani, Luis H/G-9686-2012; Nagibovich, Oleg Alexandrovich/J-4049-2013; Serafinceanu, Cristian/AAL-5411-2021; Cannon, Christopher P/AAY-7644-2020; Pashkovska, Nataliia/W-1508-2019; Jeong, In-Kyung/AAI-6488-2020; Bellary, Srikanth/ABA-1977-2020; Lindley, Richard/B-8148-2013; Vlasenko, Maryna V/I-2730-2018; Jardine, Meg/AAS-1864-2020; Barrios, Clara/AAF-6865-2021	Runova, Gyuzel/0000-0003-2144-8595; Geloneze, Bruno/0000-0002-0557-4578; serviddio, gaetano/0000-0002-6424-7841; Korzh, Oleksii/0000-0001-6838-4360; Komisarenko, Yulia/0000-0001-9912-4879; Jimeno, Cecilia Alegado/0000-0002-7658-0123; Heerspink, Hiddo J Lambers/0000-0002-3126-3730; Tryshchuk, Nadiya/0000-0002-6680-2060; Garcia, Nestor H/0000-0002-9057-9030; Zanoli, Luca/0000-0003-1678-3778; Lu, Wei/0000-0002-4150-8674; Goldenberg, Ronald/0000-0002-1788-3255; Shinkov, Alexander/0000-0002-9203-4149; Prozesky, Hans Walter/0000-0001-9715-3449; de Zeeuw, Dick/0000-0003-3434-7777; Morales, Cristobal/0000-0003-0348-826X; Shamkhalova, Minara/0000-0002-3433-0142; Tesar, Vladimir/0000-0001-6982-0689; Agarwal, Rajiv/0000-0001-8355-7100; Sasso, Ferdinando Carlo/0000-0002-9142-7848; Mannucci, Edoardo/0000-0001-9759-9408; Chiovato, Luca/0000-0001-7457-7353; RAMOS, CASSIO SLOMPO/0000-0002-3895-4956; Jardine, Meg/0000-0002-0160-2375; Goldenberg, Ronald Michael/0000-0002-1788-3255; Garibotto, Giacomo/0000-0001-6432-2429; Canani, Luis H/0000-0002-1813-4491; Nagibovich, Oleg Alexandrovich/0000-0002-1520-0860; Cannon, Christopher P/0000-0003-4596-2791; Pashkovska, Nataliia/0000-0002-9896-1744; Jeong, In-Kyung/0000-0001-7857-546X; Bellary, Srikanth/0000-0002-5924-5278; Lindley, Richard/0000-0002-0104-5679; Jardine, Meg/0000-0002-0160-2375; charytan, david/0000-0002-7695-3583; Guinsburg, Adrian/0000-0001-8770-1894; Tinahones, Francisco J/0000-0001-6871-4403; Madej, Andrzej/0000-0002-7626-0840; Kim, Sun/0000-0003-0895-7491; Montenegro Junior, Renan/0000-0001-7287-8726; Greene, Tom/0000-0002-3706-7570; Sahay, Manisha/0000-0001-5534-2516; Cariou, Bertrand/0000-0002-1580-8040; Bompoint, Severine/0000-0001-5226-4321; da Silva Franco, Roberto Jorge/0000-0001-9787-4393; Le Meur, Yannick/0000-0001-8913-415X; Neal, Bruce/0000-0002-0490-7465; Chertow, Glenn/0000-0002-7599-0534; Narayanan, Mohanram/0000-0001-5501-7617	Janssen Research and Development	Janssen Research and Development	Supported by Janssen Research and Development.	Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; BRENNER BM, 1990, PHYSIOL REV, V70, P665, DOI 10.1152/physrev.1990.70.3.665; Chakraborty S, 2018, CELL REP, V25, P677, DOI 10.1016/j.celrep.2018.09.058; Cherney DZI, 2014, CIRCULATION, V129, P587, DOI 10.1161/CIRCULATIONAHA.113.005081; Esterline RL, 2018, EUR J ENDOCRINOL, V178, pR113, DOI 10.1530/EJE-17-0832; Fitchett D, 2016, EUR HEART J, V37, P1526, DOI 10.1093/eurheartj/ehv728; Guyatt GH, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3863; IDF International Diabetes Federation, 2017, DIABETES ATLAS, V8th; Inzucchi SE, 2018, DIABETES CARE, V41, pE4, DOI 10.2337/dc17-1551; Jardine MJ, 2017, AM J NEPHROL, V46, P462, DOI 10.1159/000484633; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Liyanage T, 2015, LANCET, V385, P1975, DOI 10.1016/S0140-6736(14)61601-9; Neal B, 2017, NEW ENGL J MED, V377, P644, DOI 10.1056/NEJMoa1611925; ORTOLA FV, 1987, J CLIN INVEST, V80, P670, DOI 10.1172/JCI113120; Perkovic V, 2018, LANCET DIABETES ENDO, V6, P691, DOI 10.1016/S2213-8587(18)30141-4; Radholm K, 2018, CIRCULATION, V138, P458, DOI 10.1161/CIRCULATIONAHA.118.034222; Schutten JC, 2018, ADV CHRONIC KIDNEY D, V25, P244, DOI 10.1053/j.ackd.2017.12.003; Sternlicht H, 2019, CURR HYPERTENS REP, V21, DOI 10.1007/s11906-019-0920-4; Wanner C, 2016, NEW ENGL J MED, V375, P323, DOI [10.1056/NEJMoa1515920, 10.1056/NEJMc1611290]; Wiviott SD, 2019, NEW ENGL J MED, V380, P347, DOI 10.1056/NEJMoa1812389; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720	21	2187	2264	27	364	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 13	2019	380	24					2295	2306		10.1056/NEJMoa1811744	http://dx.doi.org/10.1056/NEJMoa1811744			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IC9JQ	30990260	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000471299100008
J	Gregg, EW; Hora, I; Benoit, SR				Gregg, Edward W.; Hora, Israel; Benoit, Stephen R.			Resurgence in Diabetes-Related Complications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES; ACHIEVEMENT; GOALS; CARE		[Gregg, Edward W.; Hora, Israel; Benoit, Stephen R.] US Ctr Dis Control & Prevent, Epidemiol & Stat Branch, Div Diabet Translat, Atlanta, GA USA; [Gregg, Edward W.] Imperial Coll London, Sch Publ Hlth, London, England	Centers for Disease Control & Prevention - USA; Imperial College London	Gregg, EW (corresponding author), Imperial Coll London, Sch Publ Hlth, St Marys Hosp, Med Sch Bldg,Norfolk Pl, London W2 1PG, England.	egregg@ic.ac.uk		Gregg, Edward/0000-0003-2381-6822				Ali MK, 2013, NEW ENGL J MED, V368, P1613, DOI 10.1056/NEJMsa1213829; Carls G, 2017, DIABETES THER, V8, P863, DOI 10.1007/s13300-017-0280-5; Geiss LS, 2019, DIABETES CARE, V42, P50, DOI 10.2337/dc18-1380; Gregg EW, 2018, LANCET, V391, P2430, DOI [10.1016/S0140-6736(18)30314-3, 10.1016/s0140-6736(18)30314-3]; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Riddle MC, 2018, DIABETES CARE, V41, P929, DOI 10.2337/dci18-0012; US Centers for Disease Control and Prevention, 2019, US DIAB SURV SYST DI; Wharam JF, 2018, DIABETES CARE, V41, P940, DOI 10.2337/dc17-1183; Woolf SH, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3096; Yang QH, 2017, MMWR-MORBID MORTAL W, V66, P933, DOI 10.15585/mmwr.mm6635e1	10	119	119	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 21	2019	321	19					1867	1868		10.1001/jama.2019.3471	http://dx.doi.org/10.1001/jama.2019.3471			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HZ1FC	30985875	Green Published			2022-12-28	WOS:000468591200011
J	Tong, JH; Song, ZN; Kim, DH; Chen, XH; Chen, C; Palmstrom, AF; Ndione, PF; Reese, MO; Dunfield, SP; Reid, OG; Liu, J; Zhang, F; Harvey, SP; Li, Z; Christensen, ST; Teeter, G; Zhao, DW; Al-Jassim, MM; van Hest, MFAM; Beard, MC; Shaheen, SE; Berry, JJ; Yan, YF; Zhu, K				Tong, Jinhui; Song, Zhaoning; Kim, Dong Hoe; Chen, Xihan; Chen, Cong; Palmstrom, Axel F.; Ndione, Paul F.; Reese, Matthew O.; Dunfield, Sean P.; Reid, Obadiah G.; Liu, Jun; Zhang, Fei; Harvey, Steven P.; Li, Zhen; Christensen, Steven T.; Teeter, Glenn; Zhao, Dewei; Al-Jassim, Mowafak M.; van Hest, Maikel F. A. M.; Beard, Matthew C.; Shaheen, Sean E.; Berry, Joseph J.; Yan, Yanfa; Zhu, Kai			Carrier lifetimes of > 1 mu s in Sn-Pb perovskites enable efficient all-perovskite tandem solar cells	SCIENCE			English	Article							LOW SURFACE RECOMBINATION; DEFECT PASSIVATION; PHOTOVOLTAICS; FABRICATION; VELOCITY	All-perovskite-based polycrystalline thin-film tandem solar cells have the potential to deliver efficiencies of >30%. However, the performance of all-perovskite-based tandem devices has been limited by the lack of high-efficiency, low-band gap tin-lead (Sn-Pb) mixed-perovskite solar cells (PSCs). We found that the addition of guanidinium thiocyanate (GuaSCN) resulted in marked improvements in the structural and optoelectronic properties of Sn-Pb mixed, low-band gap (similar to 1.25 electron volt) perovskite films. The films have defect densities that are lower by a factor of 10, leading to carrier lifetimes of greater than 1 microsecond and diffusion lengths of 2.5 micrometers. These improved properties enable our demonstration of >20% efficient low-band gap PSCs. When combined with wider-band gap PSCs, we achieve 25% efficient four-terminal and 23.1% efficient two-terminal all-perovskite-based polycrystalline thin-film tandem solar cells.	[Tong, Jinhui; Kim, Dong Hoe; Chen, Xihan; Palmstrom, Axel F.; Ndione, Paul F.; Reese, Matthew O.; Dunfield, Sean P.; Reid, Obadiah G.; Liu, Jun; Zhang, Fei; Harvey, Steven P.; Li, Zhen; Christensen, Steven T.; Teeter, Glenn; Al-Jassim, Mowafak M.; van Hest, Maikel F. A. M.; Beard, Matthew C.; Berry, Joseph J.; Zhu, Kai] Natl Renewable Energy Lab, Golden, CO 80401 USA; [Tong, Jinhui; Dunfield, Sean P.; Reid, Obadiah G.; Shaheen, Sean E.] Univ Colorado, Renewable & Sustainable Energy Inst, Boulder, CO 80309 USA; [Song, Zhaoning; Chen, Cong; Zhao, Dewei; Yan, Yanfa] Univ Toledo, Dept Phys & Astron, Toledo, OH 43606 USA; [Song, Zhaoning; Chen, Cong; Zhao, Dewei; Yan, Yanfa] Univ Toledo, Wright Ctr Photovolta Innovat & Commercializat, Toledo, OH 43606 USA; [Dunfield, Sean P.] Univ Colorado, Mat Sci & Engn Program, Boulder, CO 80309 USA; [Shaheen, Sean E.] Univ Colorado, Dept Elect Comp & Energy Engn, Boulder, CO 80309 USA; [Kim, Dong Hoe] Sejong Univ, Dept Nanotechnol & Adv Mat Engn, Seoul 05006, South Korea	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; University of Colorado System; University of Colorado Boulder; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Sejong University	Berry, JJ; Zhu, K (corresponding author), Natl Renewable Energy Lab, Golden, CO 80401 USA.; Yan, YF (corresponding author), Univ Toledo, Dept Phys & Astron, Toledo, OH 43606 USA.; Yan, YF (corresponding author), Univ Toledo, Wright Ctr Photovolta Innovat & Commercializat, Toledo, OH 43606 USA.	joe.berry@nrel.gov; yanfa.yan@utoledo.edu; kai.zhu@nrel.gov	Song, Zhaoning/J-2905-2017; Beard, MATTHEW C/E-4270-2015; Chen, Xihan/M-9210-2016; Zhu, Kai/AAF-1940-2019; Zhu, Kai/G-3647-2010; ZHANG, FEI/L-3977-2019; Zhao, Dewei/F-5928-2010; Li, Zhen/E-9341-2015	Song, Zhaoning/0000-0002-6677-0994; Beard, MATTHEW C/0000-0002-2711-1355; Chen, Xihan/0000-0001-7907-2549; ZHANG, FEI/0000-0002-3774-9520; Zhao, Dewei/0000-0001-7914-6288; Yan, Yanfa/0000-0003-3977-5789; Kim, Dong Hoe/0000-0001-8909-2076; Reese, Matthew/0000-0001-9927-5984; Dunfield, Sean/0000-0002-2855-4457; Palmstrom, Axel/0000-0001-6633-209X; Chen, Cong/0000-0003-2692-1871; Li, Zhen/0000-0003-1177-2818; REID, OBADIAH/0000-0003-0646-3981	U.S. Department of Energy (DOE) [DE-AC36-08GO28308]; Alliance for Sustainable Energy LLC; Air Force Research Laboratory under Space Vehicles Directorate [FA9453-11-C-0253]; DOE SunShot Initiative under the Next Generation Photovoltaics 3 program [DE-FOA-0000990]; DOE Office of Basic Energy Sciences, Office of Science - DOE Office of Energy Efficiency and Renewable Energy, Solar Energy Technologies Office; Center for Hybrid Organic Inorganic Semiconductors for Energy (CHOISE), an Energy Frontier Research Center - DOE Office of Basic Energy Sciences, Office of Science; National Center for Photovoltaics - DOE Office of Energy Efficiency and Renewable Energy, Solar Energy Technologies Office	U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); Alliance for Sustainable Energy LLC; Air Force Research Laboratory under Space Vehicles Directorate; DOE SunShot Initiative under the Next Generation Photovoltaics 3 program(United States Department of Energy (DOE)); DOE Office of Basic Energy Sciences, Office of Science - DOE Office of Energy Efficiency and Renewable Energy, Solar Energy Technologies Office(United States Department of Energy (DOE)); Center for Hybrid Organic Inorganic Semiconductors for Energy (CHOISE), an Energy Frontier Research Center - DOE Office of Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); National Center for Photovoltaics - DOE Office of Energy Efficiency and Renewable Energy, Solar Energy Technologies Office(United States Department of Energy (DOE))	The work at the National Renewable Energy Laboratory was supported by the U.S. Department of Energy (DOE) under contract DE-AC36-08GO28308 with Alliance for Sustainable Energy LLC, the manager and operator of the National Renewable Energy Laboratory. The work at the University of Toledo was partially supported by the Air Force Research Laboratory under Space Vehicles Directorate (FA9453-11-C-0253). We acknowledge support on perovskite synthesis and device fabrication and characterization from the DOE SunShot Initiative under the Next Generation Photovoltaics 3 program (DE-FOA-0000990); support on the transient reflection spectroscopy studies from the Center for Hybrid Organic Inorganic Semiconductors for Energy (CHOISE), an Energy Frontier Research Center funded by the DOE Office of Basic Energy Sciences, Office of Science; and support on various structural and optoelectronic characterizations of perovskite thin films from the De-risking Halide Perovskite Solar Cells programof the National Center for Photovoltaics, funded by the DOE Office of Energy Efficiency and Renewable Energy, Solar Energy Technologies Office.	Avila J, 2017, JOULE, V1, P431, DOI 10.1016/j.joule.2017.07.014; Berry JJ, 2017, ACS ENERGY LETT, V2, P2540, DOI 10.1021/acsenergylett.7b00964; Bush KA, 2017, NAT ENERGY, V2, DOI 10.1038/nenergy.2017.9; Cohen R, 1998, APPL PHYS LETT, V73, P1400, DOI 10.1063/1.122169; Eperon GE, 2017, NAT REV CHEM, V1, DOI 10.1038/s41570-017-0095; Eperon GE, 2016, SCIENCE, V354, P861, DOI 10.1126/science.aaf9717; Forgacs D, 2017, ADV ENERGY MATER, V7, DOI 10.1002/aenm.201602121; Hao F, 2014, J AM CHEM SOC, V136, P8094, DOI 10.1021/ja5033259; Harvey SP, 2018, ACS APPL MATER INTER, V10, P28541, DOI 10.1021/acsami.8b07937; Horantner MT, 2017, ACS ENERGY LETT, V2, P2506, DOI 10.1021/acsenergylett.7b00647; Kapil G, 2018, NANO LETT, V18, P3600, DOI 10.1021/acs.nanolett.8b00701; Ke WJ, 2016, ADV MATER, V28, P5214, DOI 10.1002/adma.201600594; Kojima A, 2009, J AM CHEM SOC, V131, P6050, DOI 10.1021/ja809598r; Kumar MH, 2014, ADV MATER, V26, P7122, DOI 10.1002/adma.201401991; Lee MM, 2012, SCIENCE, V338, P643, DOI 10.1126/science.1228604; Lee SJ, 2016, J AM CHEM SOC, V138, P3974, DOI 10.1021/jacs.6b00142; Leijtens T, 2018, NAT ENERGY, V3, P828, DOI 10.1038/s41560-018-0190-4; Liao WQ, 2016, ADV MATER, V28, P9333, DOI 10.1002/adma.201602992; Lin YZ, 2017, ADV MATER, V29, DOI 10.1002/adma.201700607; Ma L, 2016, J AM CHEM SOC, V138, P14750, DOI 10.1021/jacs.6b09257; McMeekin DP, 2016, SCIENCE, V351, P151, DOI 10.1126/science.aad5845; Park NG, 2016, NAT ENERGY, V1, DOI 10.1038/NENERGY.2016.152; Perkins CL, 2006, J VAC SCI TECHNOL A, V24, P497, DOI 10.1116/1.2194929; Prasanna R, 2017, J AM CHEM SOC, V139, P11117, DOI 10.1021/jacs.7b04981; Rajagopal A, 2017, ACS ENERGY LETT, V2, P2531, DOI 10.1021/acsenergylett.7b00847; Rajagopal A, 2017, ADV MATER, V29, DOI 10.1002/adma.201702140; Reid OG, 2017, J PHYS D APPL PHYS, V50, DOI 10.1088/1361-6463/aa9559; Repins IL, 2015, REV SCI INSTRUM, V86, DOI 10.1063/1.4905535; Royea WJ, 2000, APPL PHYS LETT, V77, P1988, DOI 10.1063/1.1312203; Saliba M, 2016, SCIENCE, V354, P206, DOI 10.1126/science.aah5557; Shao SY, 2018, ADV MATER, V30, DOI 10.1002/adma.201803703; Shi D, 2015, SCIENCE, V347, P519, DOI 10.1126/science.aaa2725; Tan HR, 2017, SCIENCE, V355, P722, DOI 10.1126/science.aai9081; Yang WS, 2017, SCIENCE, V356, P1376, DOI 10.1126/science.aan2301; Yang Y, 2017, NAT ENERGY, V2, DOI 10.1038/nenergy.2016.207; Yang Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8961; Yang ZB, 2017, ADV MATER, V29, DOI 10.1002/adma.201704418; Yokoyama T, 2016, J PHYS CHEM LETT, V7, P776, DOI 10.1021/acs.jpclett.6b00118; Zhao DW, 2018, NAT ENERGY, V3, P1093, DOI 10.1038/s41560-018-0278-x; Zhao DW, 2018, ACS ENERGY LETT, V3, P305, DOI 10.1021/acsenergylett.7b01287; Zhao DW, 2017, NAT ENERGY, V2, DOI 10.1038/nenergy.2017.18; Zhao XH, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4904993; Zheng XP, 2017, NAT ENERGY, V2, DOI 10.1038/nenergy.2017.102; 2018, ACS APPL MATER INTER, V10, P2854, DOI DOI 10.1021/JA809598R	44	534	539	84	778	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 3	2019	364	6439					475	+		10.1126/science.aav7911	http://dx.doi.org/10.1126/science.aav7911			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HW6ON	31000592				2022-12-28	WOS:000466809600032
J	Behan, FM; Iorio, F; Picco, G; Goncalves, E; Beaver, CM; Migliardi, G; Santos, R; Rao, YH; Sassi, F; Pinnelli, M; Ansari, R; Harper, S; Jackson, DA; Mcrae, R; Pooley, R; Wilkinson, P; van der Meer, D; Dow, D; Buser-Doepner, C; Bertotti, A; Trusolino, L; Stronach, EA; Saez-Rodriguez, J; Yusa, K; Garnett, MJ				Behan, Fiona M.; Iorio, Francesco; Picco, Gabriele; Goncalves, Emanuel; Beaver, Charlotte M.; Migliardi, Giorgia; Santos, Rita; Rao, Yanhua; Sassi, Francesco; Pinnelli, Marika; Ansari, Rizwan; Harper, Sarah; Jackson, David Adam; Mcrae, Rebecca; Pooley, Rachel; Wilkinson, Piers; van der Meer, Dieudonne; Dow, David; Buser-Doepner, Carolyn; Bertotti, Andrea; Trusolino, Livio; Stronach, Euan A.; Saez-Rodriguez, Julio; Yusa, Kosuke; Garnett, Mathew J.			Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens	NATURE			English	Article							WERNER-SYNDROME HELICASE; INSTABILITY; DEPENDENCY; LANDSCAPE; HOMOLOG; PROTEIN; CELLS; WRN	Functional genomics approaches can overcome limitations-such as the lack of identification of robust targets and poor clinical efficacy-that hamper cancer drug development. Here we performed genome-scale CRISPR-Cas9 screens in 324 human cancer cell lines from 30 cancer types and developed a data-driven framework to prioritize candidates for cancer therapeutics. We integrated cell fitness effects with genomic biomarkers and target tractability for drug development to systematically prioritize new targets in defined tissues and genotypes. We verified one of our most promising dependencies, the Werner syndrome ATP-dependent helicase, as a synthetic lethal target in tumours from multiple cancer types with microsatellite instability. Our analysis provides a resource of cancer dependencies, generates a framework to prioritize cancer drug targets and suggests specific new targets. The principles described in this study can inform the initial stages of drug development by contributing to a new, diverse and more effective portfolio of cancer drug targets.	[Behan, Fiona M.; Iorio, Francesco; Picco, Gabriele; Goncalves, Emanuel; Beaver, Charlotte M.; Ansari, Rizwan; Harper, Sarah; Jackson, David Adam; Mcrae, Rebecca; Pooley, Rachel; Wilkinson, Piers; van der Meer, Dieudonne; Yusa, Kosuke; Garnett, Mathew J.] Wellcome Sanger Inst, Cambridge, England; [Behan, Fiona M.; Iorio, Francesco; Dow, David; Buser-Doepner, Carolyn; Stronach, Euan A.; Saez-Rodriguez, Julio; Yusa, Kosuke; Garnett, Mathew J.] Open Targets, Cambridge, England; [Iorio, Francesco; Saez-Rodriguez, Julio] European Mol Biol Lab, European Bioinformat Inst, Cambridge, England; [Migliardi, Giorgia; Sassi, Francesco; Pinnelli, Marika; Bertotti, Andrea; Trusolino, Livio] IRCCS, Candiolo Canc Inst FPO, Turin, Italy; [Migliardi, Giorgia; Pinnelli, Marika; Bertotti, Andrea; Trusolino, Livio] Univ Torino, Dept Oncol, Turin, Italy; [Santos, Rita; Dow, David; Stronach, Euan A.] GlaxoSmithKline Res & Dev Ltd, Stevenage, Herts, England; [Rao, Yanhua; Buser-Doepner, Carolyn] GlaxoSmithKline Res & Dev Ltd, Collegeville, PA USA; [Saez-Rodriguez, Julio] Rhein Westfal TH Aachen, Joint Res Ctr Computat Biomed, Fac Med, Aachen, Germany; [Saez-Rodriguez, Julio] Heidelberg Univ, Inst Computat Biomed, Fac Med, Bioquant, Heidelberg, Germany; [Saez-Rodriguez, Julio] Heidelberg Univ Hosp, Heidelberg, Germany; [Yusa, Kosuke] Kyoto Univ, Inst Frontier Life & Med Sci, Stem Cell Genet, Kyoto, Japan	Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin; GlaxoSmithKline; GlaxoSmithKline; RWTH Aachen University; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Kyoto University	Yusa, K; Garnett, MJ (corresponding author), Wellcome Sanger Inst, Cambridge, England.; Yusa, K; Garnett, MJ (corresponding author), Open Targets, Cambridge, England.; Yusa, K (corresponding author), Kyoto Univ, Inst Frontier Life & Med Sci, Stem Cell Genet, Kyoto, Japan.	k.yusa@infront.kyoto-u.ac.jp; mathew.garnett@sanger.ac.uk	Iorio, Francesco/H-3284-2019; sassi, francesco/AAB-6844-2020; Saez-Rodriguez, Julio/H-7114-2019; Migliardi, Giorgia/AAB-6619-2020	Iorio, Francesco/0000-0001-7063-8913; sassi, francesco/0000-0002-4741-0408; Saez-Rodriguez, Julio/0000-0002-8552-8976; Wilkinson, Piers/0000-0001-9360-1486; picco, gabriele/0000-0001-8568-2781; Pinnelli, Marika/0000-0002-3565-2493; Goncalves, Emanuel/0000-0002-9967-5205; Trusolino, Livio/0000-0002-6379-3365; van der Meer, Dieudonne/0000-0001-9913-7872; Migliardi, Giorgia/0000-0001-5770-8120	Wellcome Trust [206194, 102696]; Open Targets [OTAR015]; SU2C [SU2C-AACR-DT1213]; AIRC [20697, 18532]; 5x1000 grant [21091]; ERC [724748 - BEAT]; FPRC-ONLUS, 5x1000 Ministero della Salute 2011 and 2014; Transcan, TACTIC	Wellcome Trust(Wellcome TrustEuropean Commission); Open Targets; SU2C; AIRC(Fondazione AIRC per la ricerca sul cancro); 5x1000 grant; ERC(European Research Council (ERC)European Commission); FPRC-ONLUS, 5x1000 Ministero della Salute 2011 and 2014; Transcan, TACTIC	We thank D. Adams, G. Vassiliou and L. Parts for comments on the manuscript, members of the M.J.G. laboratory and Sanger Institute facilities (Wellcome Trust grant 206194). Work was funded by Open Targets (OTAR015) to M.J.G., K.Y. and J.S.-R. The K.Y. laboratory is supported by Wellcome Trust (206194). The M.J.G. laboratory is supported by SU2C (SU2C-AACR-DT1213) and Wellcome Trust (102696 and 206194). Support was also received from AIRC 20697 (A.B.) and 18532 (L.T.); 5x1000 grant 21091 (A.B. and L.T.); ERC Consolidator Grant 724748 - BEAT (A.B.); FPRC-ONLUS, 5x1000 Ministero della Salute 2011 and 2014 (L.T.); and Transcan, TACTIC (L.T.).	Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ballouz S, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004868; Baralis E, 2012, J MED SYST, V36, pS81, DOI 10.1007/s10916-012-9891-6; Brown KK, 2018, MEDCHEMCOMM, V9, P606, DOI 10.1039/c7md00633k; Cerami EG, 2011, NUCLEIC ACIDS RES, V39, pD685, DOI 10.1093/nar/gkq1039; Chan EM, 2019, NATURE, V568, P551, DOI 10.1038/s41586-019-1102-x; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Cokelaer T, 2018, BIOINFORMATICS, V34, P1226, DOI 10.1093/bioinformatics/btx744; Cortes-Ciriano I, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15180; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Garcia-Alonso L, 2018, CANCER RES, V78, P769, DOI 10.1158/0008-5472.CAN-17-1679; Garraway LA, 2013, J CLIN ONCOL, V31, P1806, DOI 10.1200/JCO.2012.46.8934; Hart T, 2017, G3-GENES GENOM GENET, V7, P2719, DOI 10.1534/g3.117.041277; Hart T, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1015-8; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Haugen AC, 2008, CANCER RES, V68, P8465, DOI 10.1158/0008-5472.CAN-08-0002; Hay M, 2014, NAT BIOTECHNOL, V32, P40, DOI 10.1038/nbt.2786; Iorio F, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4989-y; Iorio F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25076-6; Iorio F, 2016, CELL, V166, P740, DOI 10.1016/j.cell.2016.06.017; Kamath-Loeb AS, 2004, J BIOL CHEM, V279, P55499, DOI 10.1074/jbc.M407128200; Ketkar A, 2017, J BIOL CHEM, V292, P3154, DOI 10.1074/jbc.M116.767699; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Massacesi C, 2016, ONCOTARGETS THER, V9, P203, DOI 10.2147/OTT.S89967; McDonald ER, 2017, CELL, V170, P577, DOI 10.1016/j.cell.2017.07.005; Meyers RM, 2017, NAT GENET, V49, P1779, DOI 10.1038/ng.3984; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Myung K, 2001, NAT GENET, V27, P113, DOI 10.1038/83673; Opresko PL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004825; Perry JJP, 2006, NAT STRUCT MOL BIOL, V13, P414, DOI 10.1038/nsmb1088; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Saydam N, 2007, NUCLEIC ACIDS RES, V35, P5706, DOI 10.1093/nar/gkm500; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tsherniak A, 2017, CELL, V170, P564, DOI 10.1016/j.cell.2017.06.010; Tzelepis K, 2016, CELL REP, V17, P1193, DOI 10.1016/j.celrep.2016.09.079; van der Meer D, 2019, NUCLEIC ACIDS RES, V47, pD923, DOI 10.1093/nar/gky872; Viswanathan VS, 2017, NATURE, V547, P453, DOI 10.1038/nature23007; Wang T, 2017, CELL, V168, P890, DOI 10.1016/j.cell.2017.01.013; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Yoshihama M, 2002, GENOME RES, V12, P379, DOI 10.1101/gr.214202; Zehir A, 2017, NAT MED, V23, P703, DOI 10.1038/nm.4333	47	484	491	29	311	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 25	2019	568	7753					511	+		10.1038/s41586-019-1103-9	http://dx.doi.org/10.1038/s41586-019-1103-9			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HU9DR	30971826	Green Submitted			2022-12-28	WOS:000465594200043
J	Huk, AC; Hart, E				Huk, Alexander C.; Hart, Eric			Parsing signal and noise in the brain	SCIENCE			English	Editorial Material									[Huk, Alexander C.] Univ Texas Austin, Dept Neurosci, Ctr Perceptual Syst, Austin, TX 78712 USA; Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Huk, AC (corresponding author), Univ Texas Austin, Dept Neurosci, Ctr Perceptual Syst, Austin, TX 78712 USA.	huk@utexas.edu						Allen WE, 2019, SCIENCE, V364, P253, DOI 10.1126/science.aav3932; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Critchley HD, 1996, J NEUROPHYSIOL, V75, P1673, DOI 10.1152/jn.1996.75.4.1673; Grundemann J, 2019, SCIENCE, V364, P254, DOI 10.1126/science.aav8736; Janak PH, 2015, NATURE, V517, P284, DOI 10.1038/nature14188; Meister MLR, 2013, J NEUROSCI, V33, P2254, DOI 10.1523/JNEUROSCI.2984-12.2013; Najafi F, 2018, NEURON, V100, P453, DOI 10.1016/j.neuron.2018.10.017; Shadlen M N, 1995, Curr Opin Neurobiol, V5, P248, DOI 10.1016/0959-4388(95)80033-6; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; Softky W R, 1995, Curr Opin Neurobiol, V5, P239, DOI 10.1016/0959-4388(95)80032-8; Stringer C, 2019, SCIENCE, V364, P255, DOI 10.1126/science.aav7893	11	8	8	2	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2019	364	6437					236	237		10.1126/science.aax1512	http://dx.doi.org/10.1126/science.aax1512			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HU0JG	31000652				2022-12-28	WOS:000464956600028
J	Wurm, G				Wurm, Gerhard			Traveling to the origins of the Solar System	SCIENCE			English	Editorial Material									[Wurm, Gerhard] Univ Duisburg Essen, D-47057 Duisburg, Germany	University of Duisburg Essen	Wurm, G (corresponding author), Univ Duisburg Essen, D-47057 Duisburg, Germany.	gerhard.wurm@uni-due.de		Wurm, Gerhard/0000-0002-7962-4961				Biele J, 2015, SCIENCE, V349, DOI 10.1126/science.aaa9816; Dermott SF, 2018, NAT ASTRON, V2, P549, DOI 10.1038/s41550-018-0482-4; Ho T. M., 2018, AM GEOPH UN FALL M; Keppler M., 2019, ARXIV190207639ASTROP; Kitazato K, 2019, SCIENCE, V364, P272, DOI 10.1126/science.aav7432; McCord TB, 2018, METEORIT PLANET SCI, V53, P1778, DOI 10.1111/maps.13135; Sugita S, 2019, SCIENCE, V364, P252, DOI 10.1126/science.aaw0422; Watanabe S, 2019, SCIENCE, V364, P268, DOI 10.1126/science.aav8032	9	0	0	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2019	364	6437					230	231		10.1126/science.aax3089	http://dx.doi.org/10.1126/science.aax3089			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HU0JG	31000648				2022-12-28	WOS:000464956600024
J	Gotian, R				Gotian, Ruth			Why you need a support team	NATURE			English	Editorial Material									[Gotian, Ruth] Weill Cornell Med, Mentoring, New York, NY 10065 USA; [Gotian, Ruth] Weill Cornell Med, Anaesthesiol, New York, NY 10065 USA	Cornell University; Cornell University	Gotian, R (corresponding author), Weill Cornell Med, Mentoring, New York, NY 10065 USA.; Gotian, R (corresponding author), Weill Cornell Med, Anaesthesiol, New York, NY 10065 USA.		Gotian, Ruth/A-1656-2019	Gotian, Ruth/0000-0003-2484-2205					0	1	1	0	3	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 18	2019	568	7752					425	426		10.1038/d41586-019-00992-3	http://dx.doi.org/10.1038/d41586-019-00992-3			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HU0GZ	30976108				2022-12-28	WOS:000464950700063
J	Guglielmi, G				Guglielmi, Giorgia			Facing up to genome injustice	NATURE			English	News Item							DIVERSITY							Guglielmi, Giorgia/0000-0003-0649-3232				Bardill J, 2018, SCIENCE, V360, P384, DOI 10.1126/science.aaq1131; Claw KG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05188-3; Raff JA, 2015, AM J PHYS ANTHROPOL, V157, P603, DOI 10.1002/ajpa.22750; Sirugo G, 2019, CELL, V177, P26, DOI 10.1016/j.cell.2019.02.048; Uren C, 2017, MOL GENET GENOMICS, V292, P499, DOI 10.1007/s00438-017-1296-2; Yakubu Aminu, 2018, AAS Open Res, V1, P13, DOI 10.12688/aasopenres.12844.2	6	19	20	0	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 18	2019	568	7752					290	293		10.1038/d41586-019-01166-x	http://dx.doi.org/10.1038/d41586-019-01166-x			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HU0GZ	30992587	Bronze			2022-12-28	WOS:000464950700020
J	Khera, AV; Chaffin, M; Wade, KH; Zahid, S; Brancale, J; Xia, R; Distefano, M; Senol-Cosar, O; Haas, ME; Bick, A; Aragam, KG; Lander, ES; Smith, GD; Mason-Suares, H; Fornage, M; Lebo, M; Timpson, NJ; Kaplan, LM; Kathiresan, S				Khera, Amit, V; Chaffin, Mark; Wade, Kaitlin H.; Zahid, Sohail; Brancale, Joseph; Xia, Rui; Distefano, Marina; Senol-Cosar, Ozlem; Haas, Mary E.; Bick, Alexander; Aragam, Krishna G.; Lander, Eric S.; Smith, George Davey; Mason-Suares, Heather; Fornage, Myriam; Lebo, Matthew; Timpson, Nicholas J.; Kaplan, Lee M.; Kathiresan, Sekar			Polygenic Prediction of Weight and Obesity Trajectories from Birth to Adulthood	CELL			English	Article							MISSING HERITABILITY; RISK PREDICTION; FRAMESHIFT MUTATION; GENETIC-VARIATION; BODY-WEIGHT; VARIANTS; PREVALENCE; DEFICIENCY; PREVENTION; CHILDHOOD	Severe obesity is a rapidly growing global health threat. Although often attributed to unhealthy lifestyle choices or environmental factors, obesity is known to be heritable and highly polygenic; the majority of inherited susceptibility is related to the cumulative effect of many common DNA variants. Here we derive and validate a new polygenic predictor comprised of 2.1 million common variants to quantify this susceptibility and test this predictor in more than 300,000 individuals ranging from middle age to birth. Among middle-aged adults, we observe a 13-kg gradient in weight and a 25-fold gradient in risk of severe obesity across polygenic score deciles. In a longitudinal birth cohort, we note minimal differences in birth weight across score deciles, but a significant gradient emerged in early childhood and reached 12 kg by 18 years of age. This new approach to quantify inherited susceptibility to obesity affords new opportunities for clinical prevention and mechanistic assessment.	[Khera, Amit, V; Bick, Alexander; Aragam, Krishna G.; Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA; [Khera, Amit, V; Aragam, Krishna G.; Kathiresan, Sekar] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Khera, Amit, V; Chaffin, Mark; Zahid, Sohail; Haas, Mary E.; Bick, Alexander; Aragam, Krishna G.; Lander, Eric S.; Kathiresan, Sekar] Broad Inst MIT & Harvard, Cardiovasc Dis Initiat, Cambridge, MA 02142 USA; [Khera, Amit, V; Zahid, Sohail; Brancale, Joseph; Bick, Alexander; Aragam, Krishna G.; Kaplan, Lee M.; Kathiresan, Sekar] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Wade, Kaitlin H.; Smith, George Davey; Timpson, Nicholas J.] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol BS8 1TH, Avon, England; [Wade, Kaitlin H.; Smith, George Davey; Timpson, Nicholas J.] Univ Bristol Sch Med, Populat Hlth Sci, Bristol BS8 1TH, Avon, England; [Wade, Kaitlin H.; Timpson, Nicholas J.] Avon Longitudinal Study Parents & Children, Bristol BS8 1TH, Avon, England; [Brancale, Joseph; Kaplan, Lee M.] Massachusetts Gen Hosp, Obes Metab & Nutr Inst, Boston, MA 02114 USA; [Xia, Rui; Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Houston, TX 77030 USA; [Distefano, Marina; Senol-Cosar, Ozlem; Mason-Suares, Heather; Lebo, Matthew] Partners HealthCare Personalized Med, Lab Mol Med, Cambridge, MA 02139 USA; [Distefano, Marina; Senol-Cosar, Ozlem; Mason-Suares, Heather; Lebo, Matthew] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Distefano, Marina; Senol-Cosar, Ozlem; Mason-Suares, Heather; Lebo, Matthew] Harvard Med Sch, Dept Pathol, Cambridge, MA 02115 USA; [Lander, Eric S.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Lander, Eric S.] Harvard Med Sch, Program Hlth Sci & Technol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; University of Bristol; University of Bristol; University of Bristol; Harvard University; Massachusetts General Hospital; University of Texas System; University of Texas Health Science Center Houston; Partners Healthcare System; Harvard University; Brigham & Women's Hospital; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Khera, AV; Kathiresan, S (corresponding author), Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA.; Khera, AV; Kathiresan, S (corresponding author), Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA.; Khera, AV; Kathiresan, S (corresponding author), Broad Inst MIT & Harvard, Cardiovasc Dis Initiat, Cambridge, MA 02142 USA.; Khera, AV; Kathiresan, S (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.	avkhera@mgh.harvard.edu; skathiresan1@mgh.harvard.edu	Timpson, Nicholas John/O-7548-2015; Davey Smith, George/A-7407-2013; Mason-Suares, Heather/AAW-6668-2020	Timpson, Nicholas John/0000-0002-7141-9189; Davey Smith, George/0000-0002-1407-8314; Mason-Suares, Heather/0000-0002-0146-4881; Haas, Mary Elizabeth/0000-0002-2816-9268; Brancale, Joseph/0000-0002-1948-5103; Bick, Alexander/0000-0001-5824-9595; Chaffin, Mark/0000-0002-1234-5562; Lebo, Matthew/0000-0002-9733-5207	National Human Genome Research Institute [1K08HG010155]; National Lipid Association; Broad Institute of MIT and Harvard; Wellcome Trust [202802/Z/16/Z, 102215/2/13/2]; University of Bristol NIHR Biomedical Research Centre [S-BRC-1215-20011]; MRC Integrative Epidemiology Unit [MC_UU_12013/3]; National Heart, Lung, and Blood Institute [HL127564]; Ofer and Shelly Nemirovsky Research Scholar Award from Massachusetts General Hospital; UM1 award from the National Human Genome Research Institute [HG008895]; NIH [DK088661, DK090956, DK040561]; Merck Research Laboratories; Ethicon Endo-Surgery; National Heart, Lung, and Blood Institute (NHLBI) [HHSN268201300025C, HHSN268201300026C, HHSN268201300027C, HHSN268201300028C, HHSN268201300029C, HHSN268200900041C]; National Institute on Aging (NIA); NIA [AG0005]; NHLBI [AG0005]; Gene Environment Association Studies (GENEVA) through National Human Genome Research Institute [U01-HG004729, U01-HG04424, U01-HG004446]; UK Medical Research Council; University of Bristol; MRC [MC_UU_12013/3, MC_UU_00011/1] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL127564] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K08HG010155, UM1HG008895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Lipid Association; Broad Institute of MIT and Harvard; Wellcome Trust(Wellcome TrustEuropean Commission); University of Bristol NIHR Biomedical Research Centre; MRC Integrative Epidemiology Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Ofer and Shelly Nemirovsky Research Scholar Award from Massachusetts General Hospital; UM1 award from the National Human Genome Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck Research Laboratories(Merck & Company); Ethicon Endo-Surgery; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Gene Environment Association Studies (GENEVA) through National Human Genome Research Institute; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Bristol; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a K08 award from the National Human Genome Research Institute (1K08HG010155), a junior faculty research award from the National Lipid Association, a BroadIgnite grant from the Broad Institute of MIT and Harvard (each to A.V.K.), the Wellcome Trust (202802/Z/16/Z), the University of Bristol NIHR Biomedical Research Centre (S-BRC-1215-20011), the MRC Integrative Epidemiology Unit (MC_UU_12013/3 to N.J.T.), an RO1 award from the National Heart, Lung, and Blood Institute (HL127564 to S.K.), and the Ofer and Shelly Nemirovsky Research Scholar Award from Massachusetts General Hospital (to S.K.). Exome sequencing of UK Biobank participants was supported by a UM1 award from the National Human Genome Research Institute (HG008895 to E.S.L. and S.K.). The Partners HealthCare System bariatric surgery cohort analysis was supported by grants from the NIH (DK088661, DK090956, and DK040561), Merck Research Laboratories, and Ethicon Endo-Surgery (all to L.M.K.). The CARDIA study is supported by contracts HHSN268201300025C, HHSN268201300026C, HHSN268201300027C, HHSN268201300028C, HHSN268201300029C, and HHSN268200900041C from the National Heart, Lung, and Blood Institute (NHLBI); the intramural research program of the National Institute on Aging (NIA); and an intra-agency agreement between NIA and NHLBI (AG0005). Genotyping and imputation were funded as part of the Gene Environment Association Studies (GENEVA) through grants U01-HG004729, U01-HG04424, and U01-HG004446 from the National Human Genome Research Institute. This manuscript has been reviewed and approved by CARDIA for scientific content. We are extremely grateful to all families who took part in this study, the midwives for their help with recruiting them, and the whole ALSPAC team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists, and nurses. The UK Medical Research Council and Wellcome Trust (grant ref. 102215/2/13/2) and the University of Bristol provide core support for ALSPAC. The ALSPAC analysis is the work of the authors, and Dr. Kaitlin Wade and Prof. Nicholas Timpson serve as guarantors for the contents of this paper.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Barsh GS, 2000, NATURE, V404, P644, DOI 10.1038/35007519; Belsky DW, 2013, BIODEMOGR SOC BIOL, V59, P85, DOI 10.1080/19485565.2013.774628; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Charlton C., 2019, MLWIN VERSION 303; Chatterjee N, 2016, NAT REV GENET, V17, P392, DOI 10.1038/nrg.2016.27; Chatterjee N, 2013, NAT GENET, V45, P400, DOI 10.1038/ng.2579; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; Elks Cathy E, 2012, Front Endocrinol (Lausanne), V3, P29, DOI 10.3389/fendo.2012.00029; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Fisher S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r1; Flannick J, 2013, NAT GENET, V45, P1380, DOI 10.1038/ng.2794; Flegal KM, 2016, JAMA-J AM MED ASSOC, V315, P2284, DOI 10.1001/jama.2016.6458; Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Golan D, 2014, P NATL ACAD SCI USA, V111, pE5272, DOI 10.1073/pnas.1419064111; Hatoum IJ, 2013, AM J HUM GENET, V92, P827, DOI 10.1016/j.ajhg.2013.04.009; Howe LD, 2016, STAT METHODS MED RES, V25, P1854, DOI 10.1177/0962280213503925; Hung CF, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0334-3; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Karlson EW, 2016, J PERS MED, V6, DOI 10.3390/jpm6010002; Khera AV, 2019, CIRCULATION, V139, P1593, DOI 10.1161/CIRCULATIONAHA.118.035658; Khera AV, 2018, NAT GENET, V50, P1219, DOI 10.1038/s41588-018-0183-z; Khera AV, 2017, CIRCULATION, V135, P1005, DOI 10.1161/CIRCULATIONAHA.116.026479; Khera AV, 2016, J AM COLL CARDIOL, V67, P2578, DOI 10.1016/j.jacc.2016.03.520; Kuhnen P, 2016, NEW ENGL J MED, V375, P240, DOI 10.1056/NEJMoa1512693; Larsen LH, 2005, J CLIN ENDOCR METAB, V90, P219, DOI 10.1210/jc.2004-0497; Leckie G, 2013, J STAT SOFTW, V52, P1; Lee JJ, 2018, NAT GENET, V50, P1112, DOI 10.1038/s41588-018-0147-3; Li SX, 2010, AM J CLIN NUTR, V91, P184, DOI 10.3945/ajcn.2009.28403; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Loos RJF, 2017, CELL METAB, V25, P535, DOI 10.1016/j.cmet.2017.02.013; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Manickam K, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.2140; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Natarajan P, 2017, CIRCULATION, V135, P2091, DOI 10.1161/CIRCULATIONAHA.116.024436; Pharoah PDP, 2008, NEW ENGL J MED, V358, P2796, DOI 10.1056/NEJMsa0708739; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Qi QB, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1610; Qi QB, 2012, NEW ENGL J MED, V367, P1387, DOI 10.1056/NEJMoa1203039; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Sandholt CH, 2010, DIABETES, V59, P1667, DOI 10.2337/db09-1042; Smith GD, 2016, LANCET, V387, P1349, DOI 10.1016/S0140-6736(16)00588-2; Stutzmann F, 2008, DIABETES, V57, P2511, DOI 10.2337/db08-0153; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Tilling K, 2014, ANN NUTR METAB, V65, P129, DOI 10.1159/000362695; Tomiyama AJ, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1116-5; Torkamani A, 2018, NAT REV GENET, V19, P581, DOI 10.1038/s41576-018-0018-x; Turcot V, 2018, NAT GENET, V50, P26, DOI 10.1038/s41588-017-0011-x; Tyrrell J, 2017, INT J EPIDEMIOL, V46, P559, DOI 10.1093/ije/dyw337; Vaisse C, 2000, J CLIN INVEST, V106, P253, DOI 10.1172/JCI9238; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]; Vilhjalmsson BJ, 2015, AM J HUM GENET, V97, P576, DOI 10.1016/j.ajhg.2015.09.001; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Xiang ZM, 2006, BIOCHEMISTRY-US, V45, P7277, DOI 10.1021/bi0600300; Yampolsky LY, 2005, HUM MOL GENET, V14, P3191, DOI 10.1093/hmg/ddi350; Yang J, 2015, NAT GENET, V47, P1114, DOI 10.1038/ng.3390; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yanovski SZ, 2018, JAMA-J AM MED ASSOC, V319, P223, DOI 10.1001/jama.2017.20051; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404; Zhang MF, 2018, GUT, V67, P521, DOI 10.1136/gutjnl-2016-313146; Zhu ZH, 2015, AM J HUM GENET, V96, P377, DOI 10.1016/j.ajhg.2015.01.001	73	262	270	6	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2019	177	3					587	+		10.1016/j.cell.2019.03.028	http://dx.doi.org/10.1016/j.cell.2019.03.028			19	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HU0FV	31002795	Green Accepted, Bronze, Green Submitted, Green Published			2022-12-28	WOS:000464947700014
J	Pallok, K; De Maio, F; Ansell, DA				Pallok, Kristen; De Maio, Fernando; Ansell, David A.			Structural Racism - A 60-Year-Old Black Woman with Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEALTH	A woman on Chicago's primarily black South Side is seen for a breast lump at a community hospital that lacks the resources for high-quality cancer care. A navigator from the Metropolitan Chicago Breast Cancer Task Force reroutes her to a qualified medical center.	[Pallok, Kristen; Ansell, David A.] Rush Med Coll, Chicago, IL 60612 USA; [De Maio, Fernando] Depaul Univ, Chicago, IL 60604 USA; [Ansell, David A.] Metropolitan Chicago Breast Canc Taskforce, Chicago, IL USA	Rush University; DePaul University	Pallok, K (corresponding author), Rush Med Coll, Chicago, IL 60612 USA.							Ansell D, 2009, CANCER CAUSE CONTROL, V20, P1681, DOI 10.1007/s10552-009-9419-7; Bailey ZD, 2017, LANCET, V389, P1453, DOI 10.1016/S0140-6736(17)30569-X; Geronimus AT, 2000, AM J PUBLIC HEALTH, V90, P867, DOI 10.2105/AJPH.90.6.867; Rauscher GH, 2013, ANN EPIDEMIOL, V23, P210, DOI 10.1016/j.annepidem.2013.01.006; Sighoko D, 2017, CANCER CAUSE CONTROL, V28, P563, DOI 10.1007/s10552-017-0878-y	5	37	37	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 18	2019	380	16					1489	1493		10.1056/NEJMp1811499	http://dx.doi.org/10.1056/NEJMp1811499			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU3AO	30995369	Bronze, Green Published			2022-12-28	WOS:000465144100008
J	Wang, CY; Wong, WW; Tsai, HC; Chen, YH; Kuo, BS; Lynn, S; Blazkova, J; Clarridge, KE; Su, HW; Lin, CY; Tseng, FC; Lai, A; Yang, FH; Lin, CH; Tseng, W; Lin, HY; Finstad, CL; Wong-Staal, F; Hanson, CV; Chun, TW; Liao, MJ				Wang, Chang-Yi; Wong, Wing-Wai; Tsai, Hung-Chin; Chen, Yen-Hsu; Kuo, Be-Sheng; Lynn, Shugene; Blazkova, Jana; Clarridge, Katherine E.; Su, Hsiao-Wen; Lin, Chia-Ying; Tseng, Fan-Chen; Lai, Annie; Yang, Fu-Hung; Lin, Chen-Han; Tseng, William; Lin, Hsiao-Yi; Finstad, Connie L.; Wong-Staal, Flossie; Hanson, Carl V.; Chun, Tae-Wook; Liao, Mei-June			Effect of Anti-CD4 Antibody UB-421 on HIV-1 Rebound after Treatment Interruption	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IBALIZUMAB; RESISTANCE; INFECTION; RESERVOIR; VIREMIA	Background Administration of a single broadly neutralizing human immunodeficiency virus (HIV)-specific antibody to HIV-infected persons leads to the development of antibody-resistant virus in the absence of antiretroviral therapy (ART). It is possible that monotherapy with UB-421, an antibody that blocks the virus-binding site on human CD4+ T cells, could induce sustained virologic suppression without induction of resistance in HIV-infected persons after analytic treatment interruption. Methods We conducted a nonrandomized, open-label, phase 2 clinical study evaluating the safety, pharmacokinetics, and antiviral activity of UB-421 monotherapy in HIV-infected persons undergoing analytic treatment interruption. All the participants had undetectable plasma viremia (<20 copies of HIV RNA per milliliter) at the screening visit. After discontinuation of ART, participants received eight intravenous infusions of UB-421, at a dose of either 10 mg per kilogram of body weight every week (Cohort 1) or 25 mg per kilogram every 2 weeks (Cohort 2). The primary outcome was the time to viral rebound (>= 400 copies per milliliter). Results A total of 29 participants were enrolled, 14 in Cohort 1 and 15 in Cohort 2. Administration of UB-421 maintained virologic suppression (<20 copies per milliliter) in all the participants (94.5% of measurements at study visits 2 through 9) during analytic treatment interruption, with intermittent viral blips (range, 21 to 142 copies per milliliter) observed in 8 participants (28%). No study participants had plasma viral rebound to more than 400 copies per milliliter. CD4+ T-cell counts remained stable throughout the duration of the study. Rash, mostly of grade 1, was a common and transient adverse event; one participant discontinued the study drug owing to a rash. A decrease in the population of CD4+ regulatory T cells was observed during UB-421 monotherapy. Conclusions UB-421 maintained virologic suppression (during the 8 to 16 weeks of study) in participants in the absence of ART. One participant discontinued therapy owing to a rash. (Funded by United Biomedical and others; ClinicalTrials.gov number, NCT02369146.)	[Wang, Chang-Yi; Kuo, Be-Sheng; Finstad, Connie L.; Wong-Staal, Flossie] United Biomed, 25 Davids Dr, Hauppauge, NY 11788 USA; [Wang, Chang-Yi; Lynn, Shugene] United Biomed Asia, Hsinchu, Taiwan; [Wang, Chang-Yi; Kuo, Be-Sheng; Su, Hsiao-Wen; Lin, Chia-Ying; Tseng, Fan-Chen; Lai, Annie; Yang, Fu-Hung; Lin, Chen-Han; Tseng, William; Liao, Mei-June] United BioPharma, Hsinchu, Taiwan; [Wong, Wing-Wai; Lin, Hsiao-Yi] Taipei Vet Gen Hosp, Taipei, Taiwan; [Tsai, Hung-Chin] Kaohsiung Vet Gen Hosp, Kaohsiung, Taiwan; [Chen, Yen-Hsu] Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan; [Blazkova, Jana; Clarridge, Katherine E.; Chun, Tae-Wook] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Hanson, Carl V.] Calif Dept Publ Hlth, Richmond, VA USA	Taipei Veterans General Hospital; Kaohsiung Veterans General Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Wang, CY (corresponding author), United Biomed, 25 Davids Dr, Hauppauge, NY 11788 USA.	cywang@unitedbiomedical.com	Chun, Tae-Wook/W-9187-2019; Chun, Tae-Wook/AAC-3101-2020	Chun, Tae-Wook/0000-0001-5153-7340; Chen, Yen-hsu/0000-0002-8667-4844	United Biomedical; United Biomedical Asia; United BioPharma; Ministry of Economic Administration, Taiwan [104-EC-17-A-20-I5-0007]; National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000851] Funding Source: NIH RePORTER	United Biomedical; United Biomedical Asia; United BioPharma; Ministry of Economic Administration, Taiwan; National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported mostly by private funding from United Biomedical, United Biomedical Asia, and United BioPharma, and in part by a grant (104-EC-17-A-20-I5-0007) from the Ministry of Economic Administration, Taiwan, and by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.	Bar KJ, 2016, NEW ENGL J MED, V375, P2037, DOI 10.1056/NEJMoa1608243; Caskey M, 2017, NAT MED, V23, P185, DOI 10.1038/nm.4268; Chevalier MF, 2013, BLOOD, V121, P29, DOI 10.1182/blood-2012-07-409755; Chun TW, 2012, AIDS, V26, P1261, DOI 10.1097/QAD.0b013e328353f3f1; Chun TW, 2010, AIDS, V24, P2803, DOI 10.1097/QAD.0b013e328340a239; Cihlar T, 2016, CURR OPIN VIROL, V18, P50, DOI 10.1016/j.coviro.2016.03.004; Crawley AM, 2012, SEMIN IMMUNOL, V24, P231, DOI 10.1016/j.smim.2012.02.006; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Dhody K, 2018, HIV CLIN TRIALS, V19, P85, DOI 10.1080/15284336.2018.1452842; Emu B, 2018, NEW ENGL J MED, V379, P645, DOI 10.1056/NEJMoa1711460; Jacobson JM, 2010, J INFECT DIS, V201, P1481, DOI 10.1086/652190; Jacobson JM, 2009, ANTIMICROB AGENTS CH, V53, P450, DOI 10.1128/AAC.00942-08; Knox DC, 2017, NEW ENGL J MED, V376, P501, DOI 10.1056/NEJMc1611639; Lin H-H, 2017, C RETR OPP INF CROI, P438; Magnus C, 2016, VIRUS RES, V218, P57, DOI 10.1016/j.virusres.2015.10.009; Murray AJ, 2016, J IMMUNOL, V197, P407, DOI 10.4049/jimmunol.1600343; Mzingwane ML, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0628-x; Patel SS, 2013, WORLD J GASTROENTERO, V19, P5174, DOI 10.3748/wjg.v19.i31.5174; Pattacini L, 2016, JAIDS-J ACQ IMM DEF, V72, P119, DOI 10.1097/QAI.0000000000000919; Scheid JF, 2016, NATURE, V535, P556, DOI 10.1038/nature18929; Toma J, 2011, J VIROL, V85, P3872, DOI 10.1128/JVI.02237-10; Tran TA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003305; Wang C-Y, 2017, 24 C RETR OPP INF 20, p450LB; Wang CY, 1999, P NATL ACAD SCI USA, V96, P10367, DOI 10.1073/pnas.96.18.10367; Wensing AM, 2017, TOP ANTIVIR MED, V24, P132	25	26	26	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 18	2019	380	16					1535	1545		10.1056/NEJMoa1802264	http://dx.doi.org/10.1056/NEJMoa1802264			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU3AO	30995373	Bronze			2022-12-28	WOS:000465144100014
J	Hawkes, N				Hawkes, Nigel			Patient choice in elective care increased emergency readmissions	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Moscelli G, 139 CHE U YORK	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 15	2019	365								l1793	10.1136/bmj.l1793	http://dx.doi.org/10.1136/bmj.l1793			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU8OI	30988013				2022-12-28	WOS:000465548300008
J	Farmer, JD; Hepburn, C; Ives, MC; Hale, T; Wetzer, T; Mealy, P; Rafaty, R; Srivastav, S; Way, R				Farmer, J. D.; Hepburn, C.; Ives, M. C.; Hale, T.; Wetzer, T.; Mealy, P.; Rafaty, R.; Srivastav, S.; Way, R.			Sensitive intervention points in the post-carbon transition	SCIENCE			English	Editorial Material									[Farmer, J. D.; Hepburn, C.; Ives, M. C.; Wetzer, T.; Mealy, P.; Rafaty, R.; Srivastav, S.; Way, R.] Univ Oxford, Inst New Econ Thinking, Oxford Martin Sch, Oxford, England; [Farmer, J. D.] Univ Oxford, Math Inst, Oxford, England; [Farmer, J. D.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Hepburn, C.; Ives, M. C.; Mealy, P.; Srivastav, S.; Way, R.] Univ Oxford, Smith Sch Enterprise & Environm, Oxford, England; [Hale, T.] Univ Oxford, Blavatnik Sch Govt, Oxford, England; [Wetzer, T.] Univ Oxford, Fac Law, Oxford, England; [Wetzer, T.] Univ Oxford, Oxford Man Inst Quantitat Finance, Oxford, England; [Mealy, P.] Univ Cambridge, Bennett Inst Publ Policy, Cambridge, England	University of Oxford; University of Oxford; The Santa Fe Institute; University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of Cambridge	Farmer, JD (corresponding author), Univ Oxford, Inst New Econ Thinking, Oxford Martin Sch, Oxford, England.; Farmer, JD (corresponding author), Univ Oxford, Math Inst, Oxford, England.; Farmer, JD (corresponding author), Santa Fe Inst, Santa Fe, NM 87501 USA.	doyne.farmer@inet.ox.ac.uk; matthew.ives@smithschool.ox.ac.uk	Ives, Matthew/H-7647-2019; Srivastav, Sugandha/AAO-2109-2021	Hepburn, Cameron/0000-0003-0467-7441; Ives, Matthew/0000-0002-3536-2787; Way, Rupert/0000-0002-0684-4955				Centola D, 2018, SCIENCE, V360, P1116, DOI 10.1126/science.aas8827; Geels FW, 2017, SCIENCE, V357, P1242, DOI 10.1126/science.aao3760; Hale T, 2018, CATALYTIC COOPERATIO; KURAN T, 1989, PUBLIC CHOICE, V61, P41, DOI 10.1007/BF00116762; Lafond F, 2018, TECHNOL FORECAST SOC, V128, P104, DOI 10.1016/j.techfore.2017.11.001; Landell-Mills Natasha, 2018, ARE OIL GAS CO OVERS; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Maedows D, 1999, LEVERAGE POINTS PLAC; Nachmany M., 2018, GLOBAL TRENDS CLIMAT, DOI 10.1163/9789004322714_cclc_2017-0148-001; Pacala S, 2004, SCIENCE, V305, P968, DOI 10.1126/science.1100103; Paluck EL, 2016, P NATL ACAD SCI USA, V113, P566, DOI 10.1073/pnas.1514483113; Pfeiffer A, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aabc5f; Sovacool BK, 2017, SOC STUD SCI, V47, P703, DOI 10.1177/0306312717709363; Torn MS, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025540; Way R, 2019, J ECON DYN CONTROL, V101, P211, DOI 10.1016/j.jedc.2018.10.006	15	69	69	3	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2019	364	6436					132	134		10.1126/science.aaw7287	http://dx.doi.org/10.1126/science.aaw7287			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HT5RC	30975879	Green Submitted			2022-12-28	WOS:000464620000025
J	van Kuilenburg, ABP; Tarailo-Graovac, M; Richmond, PA; Drogemoller, BI; Pouladi, MA; Leen, R; Brand-Arzamendi, K; Dobritzsch, D; Dolzhenko, E; Eberle, MA; Hayward, B; Jones, MJ; Karbassi, F; Kobor, MS; Koster, J; Kumari, D; Li, M; MacIsaac, J; McDonald, C; Meijer, J; Nguyen, C; Rajan-Babu, IS; Scherer, SW; Sim, B; Trost, B; Tseng, LA; Turkenburg, M; van Vugt, JJFA; Veldink, JH; Walia, JS; Wang, YD; van Weeghel, M; Wright, GEB; Xu, XD; Yuen, RKC; Zhang, JQ; Ross, CJ; Wasserman, WW; Geraghty, MT; Santra, S; Wanders, RJA; Wen, XY; Waterham, HR; Usdin, K; van Karnebeek, CDM				van Kuilenburg, Andre B. P.; Tarailo-Graovac, Maja; Richmond, Phillip A.; Drogemoller, Britt I.; Pouladi, Mahmoud A.; Leen, Rene; Brand-Arzamendi, Koroboshka; Dobritzsch, Doreen; Dolzhenko, Egor; Eberle, Michael A.; Hayward, Bruce; Jones, Meaghan J.; Karbassi, Farhad; Kobor, Michael S.; Koster, Janet; Kumari, Daman; Li, Meng; MacIsaac, Julia; McDonald, Cassandra; Meijer, Judith; Nguyen, Charlotte; Rajan-Babu, Indhu-Shree; Scherer, Stephen W.; Sim, Bernice; Trost, Brett; Tseng, Laura A.; Turkenburg, Marjolein; van Vugt, Joke J. F. A.; Veldink, Jan H.; Walia, Jagdeep S.; Wang, Youdong; van Weeghel, Michel; Wright, Galen E. B.; Xu, Xiaohong; Yuen, Ryan K. C.; Zhang, Jinqiu; Ross, Colin J.; Wasserman, Wyeth W.; Geraghty, Michael T.; Santra, Saikat; Wanders, Ronald J. A.; Wen, Xiao-Yan; Waterham, Hans R.; Usdin, Karen; van Karnebeek, Clara D. M.			Glutaminase Deficiency Caused by Short Tandem Repeat Expansion in GLS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IDENTIFICATION; GLUTAMATE; ATAXIA	We report an inborn error of metabolism caused by an expansion of a GCA-repeat tract in the 5 ' untranslated region of the gene encoding glutaminase (GLS) that was identified through detailed clinical and biochemical phenotyping, combined with whole-genome sequencing. The expansion was observed in three unrelated patients who presented with an early-onset delay in overall development, progressive ataxia, and elevated levels of glutamine. In addition to ataxia, one patient also showed cerebellar atrophy. The expansion was associated with a relative deficiency of GLS messenger RNA transcribed from the expanded allele, which probably resulted from repeat-mediated chromatin changes upstream of the GLS repeat. Our discovery underscores the importance of careful examination of regions of the genome that are typically excluded from or poorly captured by exome sequencing. Three probands with early-onset developmental delay had elevated levels of plasma glutamines, which implicated the candidate gene GLS, encoding the enzyme glutaminase. However, exome-sequencing analysis yielded little to confirm the association. The investigators then used genome sequencing and triplet repeat expansion upstream of the GLS coding sequence.	[van Kuilenburg, Andre B. P.; Leen, Rene; Koster, Janet; Meijer, Judith; Tseng, Laura A.; Turkenburg, Marjolein; van Weeghel, Michel; Wanders, Ronald J. A.; Waterham, Hans R.; van Karnebeek, Clara D. M.] Univ Amsterdam, Amsterdam Univ Med Ctr, Emma Childrens Hosp, Dept Clin Chem,Amsterdam Gastroenterol & Metab, Amsterdam, Netherlands; [van Kuilenburg, Andre B. P.; Leen, Rene; Koster, Janet; Meijer, Judith; Tseng, Laura A.; Turkenburg, Marjolein; van Weeghel, Michel; Wanders, Ronald J. A.; Waterham, Hans R.; van Karnebeek, Clara D. M.] Univ Amsterdam, Amsterdam Univ Med Ctr, Emma Childrens Hosp, Dept Pediat,Amsterdam Gastroenterol & Metab, Amsterdam, Netherlands; [van Kuilenburg, Andre B. P.; Leen, Rene; Koster, Janet; Meijer, Judith; Tseng, Laura A.; Turkenburg, Marjolein; van Weeghel, Michel; Wanders, Ronald J. A.; Waterham, Hans R.; van Karnebeek, Clara D. M.] Univ Amsterdam, Amsterdam Univ Med Ctr, Emma Childrens Hosp, Dept Clin Genet,Amsterdam Gastroenterol & Metab, Amsterdam, Netherlands; [van Kuilenburg, Andre B. P.; Wanders, Ronald J. A.; Waterham, Hans R.; van Karnebeek, Clara D. M.] Univ Amsterdam, Amsterdam Univ Med Ctr, Emma Childrens Hosp, Dept Clin Chem,United Metab Dis, Amsterdam, Netherlands; [van Kuilenburg, Andre B. P.; Wanders, Ronald J. A.; Waterham, Hans R.; van Karnebeek, Clara D. M.] Univ Amsterdam, Amsterdam Univ Med Ctr, Emma Childrens Hosp, Dept Pediat,United Metab Dis, Amsterdam, Netherlands; [van Kuilenburg, Andre B. P.; Wanders, Ronald J. A.; Waterham, Hans R.; van Karnebeek, Clara D. M.] Univ Amsterdam, Amsterdam Univ Med Ctr, Emma Childrens Hosp, Dept Clin Genet,United Metab Dis, Amsterdam, Netherlands; [van Vugt, Joke J. F. A.; Veldink, Jan H.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurol, Utrecht, Netherlands; [van Vugt, Joke J. F. A.; Veldink, Jan H.] Project MinE ALS Sequencing Consortium, Utrecht, Netherlands; [Tarailo-Graovac, Maja] Univ Calgary, Cumming Sch Med, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Tarailo-Graovac, Maja] Univ Calgary, Cumming Sch Med, Dept Med Genet, Calgary, AB, Canada; [Tarailo-Graovac, Maja] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Richmond, Phillip A.; Jones, Meaghan J.; Kobor, Michael S.; MacIsaac, Julia; Wasserman, Wyeth W.; van Karnebeek, Clara D. M.] Univ British Columbia, BC Childrens Hosp, Res Inst, Ctr Mol Med & Therapeut, Vancouver, BC, Canada; [Drogemoller, Britt I.; Wright, Galen E. B.; Ross, Colin J.] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada; [McDonald, Cassandra; Rajan-Babu, Indhu-Shree; Wasserman, Wyeth W.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [van Karnebeek, Clara D. M.] Univ British Columbia, Dept Pediat, Vancouver, BC, Canada; [Brand-Arzamendi, Koroboshka; Karbassi, Farhad; Li, Meng; Wang, Youdong; Wen, Xiao-Yan] St Michaels Hosp, Zebrafish Ctr Adv Drug Discovery, Toronto, ON, Canada; [Brand-Arzamendi, Koroboshka; Karbassi, Farhad; Li, Meng; Wang, Youdong; Wen, Xiao-Yan] Univ Toronto, Toronto, ON, Canada; [Nguyen, Charlotte; Scherer, Stephen W.; Trost, Brett; Yuen, Ryan K. C.] Univ Toronto, Hosp Sick Children, Ctr Appl Genom Genet & Genome Biol, Toronto, ON, Canada; [Nguyen, Charlotte; Scherer, Stephen W.; Yuen, Ryan K. C.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Scherer, Stephen W.] Univ Toronto, McLaughlin Ctr, Toronto, ON, Canada; [Wen, Xiao-Yan] Univ Toronto, Inst Med Sci, Dept Med, Toronto, ON, Canada; [Wen, Xiao-Yan] Univ Toronto, Inst Med Sci, Dept Physiol, Toronto, ON, Canada; [Wen, Xiao-Yan] Univ Toronto, Inst Med Sci, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Walia, Jagdeep S.; Geraghty, Michael T.] Univ Ottawa, Childrens Hosp Eastern Ontario, Dept Pediat, Div Med Genet, Ottawa, ON, Canada; [Pouladi, Mahmoud A.] Natl Univ Singapore, Dept Med, Singapore, Singapore; [Pouladi, Mahmoud A.] Natl Univ Singapore, Dept Physiol, Singapore, Singapore; [Pouladi, Mahmoud A.; Sim, Bernice; Xu, Xiaohong; Zhang, Jinqiu] Agcy Sci Technol & Res, Translat Lab Genet Med, Singapore, Singapore; [Dobritzsch, Doreen] Uppsala Univ, Dept Chem, Biomed Ctr, Uppsala, Sweden; [Dolzhenko, Egor; Eberle, Michael A.] Illumina, San Diego, CA USA; [Hayward, Bruce; Kumari, Daman; Usdin, Karen] NIDDK, Gene Struct & Dis Sect, Lab Cell & Mol Biol, NIH, Bethesda, MD 20892 USA; [Santra, Saikat] Birmingham Childrens Hosp, Dept Clin Inherited Metab Disorders, Birmingham, W Midlands, England	Emma Children's Hospital; University of Amsterdam; Emma Children's Hospital; University of Amsterdam; Emma Children's Hospital; University of Amsterdam; Emma Children's Hospital; University of Amsterdam; Emma Children's Hospital; University of Amsterdam; Emma Children's Hospital; University of Amsterdam; Utrecht University; Utrecht University Medical Center; University of Calgary; University of Calgary; Alberta Childrens Hospital; University of Calgary; BC Childrens Hospital; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Ottawa; Children's Hospital of Eastern Ontario; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); Uppsala University; Illumina; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Birmingham	van Karnebeek, CDM (corresponding author), Amsterdam Univ Med Ctr, Emma Childrens Hosp, Dept Pediat Metab Dis, Rm H8-268,Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	c.d.vankarnebeek@amsterdamumc.nl	Yuen, Ryan K. C./J-4876-2012; Kumari, Daman/AAN-6704-2020; Jones, Meaghan J/J-7672-2017; Scherer, Stephen W./B-3785-2013; Pouladi, Mahmoud/B-8743-2016; Trost, Brett/K-4127-2016	Yuen, Ryan K. C./0000-0001-7273-4968; Jones, Meaghan J/0000-0003-1593-997X; Scherer, Stephen W./0000-0002-8326-1999; Walia, Jagdeep/0000-0001-7055-2239; Pouladi, Mahmoud/0000-0002-9030-0976; Ross, Colin/0000-0003-1476-7037; van Vugt, Joke/0000-0002-4161-4004; Wen, Xiao-Yan/0000-0001-6728-0025; Wasserman, Wyeth/0000-0001-6098-6412; Tseng, Laura/0000-0001-9904-7025; Drogemoller, Britt/0000-0002-3348-5855; Veldink, Jan/0000-0001-5572-9657; Kobor, Michael/0000-0003-4140-1743; Trost, Brett/0000-0003-4863-7273; Eberle, Michael/0000-0001-8965-1253; Tarailo-Graovac, Maja/0000-0002-4472-8584; Rajan Babu, Indhu Shree/0000-0002-5614-5212; van Kuilenburg, Andre/0000-0002-7989-4910	BC Children's Hospital Foundation (First Collaborative Area of Innovation); Alberta Children's Hospital Research Institute Foundation; Canadian Institutes of Health Research [301221]; Rare Diseases Foundation; Canadian Rare Disease Models and Mechanisms Network; Health Canada Platform Support Grant from the Brain Canada Foundation [PSG14-3505]; Natural Sciences and Engineering Research Council of Canada [GPIN 05389-14]; Michael Smith Foundation for Health Research; National Ataxia Foundation; National Institutes of Health [DK057808]; Autism Speaks; Foundation Metakids; Genome BC; Genome Canada; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK057602, ZIADK057808] Funding Source: NIH RePORTER	BC Children's Hospital Foundation (First Collaborative Area of Innovation); Alberta Children's Hospital Research Institute Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Rare Diseases Foundation; Canadian Rare Disease Models and Mechanisms Network; Health Canada Platform Support Grant from the Brain Canada Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); National Ataxia Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Autism Speaks; Foundation Metakids; Genome BC; Genome Canada(Genome Canada); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by the BC Children's Hospital Foundation (First Collaborative Area of Innovation), Alberta Children's Hospital Research Institute Foundation, a grant (301221) from the Canadian Institutes of Health Research, the Rare Diseases Foundation, the Canadian Rare Disease Models and Mechanisms Network, a Health Canada Platform Support Grant (PSG14-3505, to Dr. Wen) from the Brain Canada Foundation, a grant (GPIN 05389-14, to Dr. Wen) from the Natural Sciences and Engineering Research Council of Canada, the Michael Smith Foundation for Health Research, the National Ataxia Foundation, a grant (DK057808, to Dr. Usdin) from the National Institutes of Health, a grant (to Dr. Scherer) from Autism Speaks, and a grant (to Dr. van Karnebeek) from Foundation Metakids. The informatics infrastructure was supported by Genome BC and Genome Canada (ABC4DE Project).	Alfares A, 2018, GENET MED, V20, P1328, DOI 10.1038/gim.2018.41; Altman BJ, 2016, NAT REV CANCER, V16, P749, DOI 10.1038/nrc.2016.114; Cheung WA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-249; Dolzhenko E, 2017, GENOME RES, V27, P1895, DOI 10.1101/gr.225672.117; Elgadi KM, 1999, PHYSIOL GENOMICS, V1, P51, DOI 10.1152/physiolgenomics.1999.1.2.51; Gaisler-Salomon I, 2009, NEUROPSYCHOPHARMACOL, V34, P2305, DOI 10.1038/npp.2009.58; Gilissen C, 2014, NATURE, V511, P344, DOI [10.1038/nature13394, 10.3389/fnhum.2013.00444]; Gueant JL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02306-5; Guergueltcheva V, 2012, AM J HUM GENET, V91, P553, DOI 10.1016/j.ajhg.2012.07.019; Hannan AJ, 2018, NAT REV GENET, V19, P286, DOI 10.1038/nrg.2017.115; Kohler S, 2017, NUCLEIC ACIDS RES, V45, pD865, DOI 10.1093/nar/gkw1039; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lionel AC, 2018, GENET MED, V20, P435, DOI 10.1038/gim.2017.119; Lynch DS, 2018, ANN CLIN TRANSL NEUR, V5, P216, DOI 10.1002/acn3.522; Masson J, 2006, J NEUROSCI, V26, P4660, DOI 10.1523/JNEUROSCI.4241-05.2006; Mozzetta C, 2015, NAT REV MOL CELL BIO, V16, P499, DOI 10.1038/nrm4029; Subramanian S, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r13; Takeda K, 2012, J NEUROCHEM, V121, P184, DOI 10.1111/j.1471-4159.2012.07684.x; Tarailo-Graovac M, 2016, NEW ENGL J MED, V374, P2246, DOI 10.1056/NEJMoa1515792; Tarailo-Graovac M, 2009, CURR PROTOC BIOINFOR, V25; Tarailo-Graovac M, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0584-6; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; van Blitterswijk M, 2013, LANCET NEUROL, V12, P978, DOI 10.1016/S1474-4422(13)70210-2; van Karnebeek CDM, 2014, MOL GENET METAB, V111, P428, DOI 10.1016/j.ymgme.2014.01.011; van Kuilenburg ABP, 2018, HUM MUTAT, V39, P947, DOI 10.1002/humu.23538; Wang Y, 2014, STEM CELLS DEV, V23, P2782, DOI 10.1089/scd.2014.0022; Wright CF, 2018, NAT REV GENET, V19, P253, DOI 10.1038/nrg.2017.116	27	36	36	2	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 11	2019	380	15					1433	1441		10.1056/NEJMoa1806627	http://dx.doi.org/10.1056/NEJMoa1806627			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HT5NG	30970188	Bronze, Green Accepted			2022-12-28	WOS:000464610000010
J	Laurenza, D				Laurenza, Domenico			Leonardo's contributions to human anatomy	LANCET			English	Editorial Material									[Laurenza, Domenico] Museo Galileo Inst, I-50122 Florence, Italy; [Laurenza, Domenico] Museum Hist Sci, I-50122 Florence, Italy; [Laurenza, Domenico] Schroeder Arts, New York, NY USA		Laurenza, D (corresponding author), Museo Galileo Inst, I-50122 Florence, Italy.; Laurenza, D (corresponding author), Museum Hist Sci, I-50122 Florence, Italy.	domlar@libero.it						Canezza A., 1933, ARCISPEDALI ROMA NEL, P57; Cazort M., 1996, INGENIOUS MACHINE NA; Clark K, 1968, CATALOGUE DRAWINGS L, V2nd; Clayton M, 2012, L DAVINCI ANATOMIST, P32; de Toni GB., 1895, ATTI REALE I VENETO, V7, P190; Keele K, 1979, L DAVINCI DISEGNI AN, P134; Keele KD, 1980, CORPUS STUDI ANATOMI, p36r; Keele KD, 1952, L DAVINCI MOVEMENT H; Kemp M, 1971, J Warburg Courtauld Inst, V34, P115, DOI 10.2307/751018; Laurenza D., 2009, LEONARDO LANATOMIA, P24; Laurenza D., 2001, FIGURA UMANA FISIOGN, P61; Laurenza Domenico., 2011, L DAVINCIS ANATOMICA; Nova A., 2005, ZEITSPRUNGE, P136; Sacino G., 1984, PUGLIA NELLEVOLUZION, P119; Solmi E., 1909, MEMORIE ACCAD SCI TO, V59, P33	15	2	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 6	2019	393	10179					1473	1476		10.1016/S0140-6736(19)30716-0	http://dx.doi.org/10.1016/S0140-6736(19)30716-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HS0OU	30967218				2022-12-28	WOS:000463561000032
J	Torjesen, I				Torjesen, Ingrid			Universities' data systems can be hacked in under two hours, cybersecurity testing shows	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		BSI, 2018, BRIT STAND CYB RISK; Chapman J, 2019, SAFE IS YOUR DATA CY	2	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 5	2019	365								l1633	10.1136/bmj.l1633	http://dx.doi.org/10.1136/bmj.l1633			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HS6UC	30952676				2022-12-28	WOS:000464005800003
J	Brasch, J; Goodman, KM; Noble, AJ; Rapp, M; Mannepalli, S; Bahna, F; Dandey, VP; Bepler, T; Berger, B; Maniatis, T; Potter, CS; Carragher, B; Honig, B; Shapiro, L				Brasch, Julia; Goodman, Kerry M.; Noble, Alex J.; Rapp, Micah; Mannepalli, Seetha; Bahna, Fabiana; Dandey, Venkata P.; Bepler, Tristan; Berger, Bonnie; Maniatis, Tom; Potter, Clinton S.; Carragher, Bridget; Honig, Barry; Shapiro, Lawrence			Visualization of clustered protocadherin neuronal self-recognition complexes	NATURE			English	Article							TILT-SERIES; ALPHA; PHOSPHORYLATION; RECONSTRUCTION; ARCHITECTURE; DIVERSITY; ALIGNMENT; SPOTITON; FEATURES; SYSTEM	Neurite self-recognition and avoidance are fundamental properties of all nervous systems(1). These processes facilitate dendritic arborization(2,3), prevent formation of autapses(4) and allow free interaction among non-self neurons(1,2,3,4,5). Avoidance among self neurites is mediated by stochastic cell-surface expression of combinations of about 60 isoforms of alpha-, beta- and gamma-clustered protocadherin that provide mammalian neurons with single-cell identities(1,2,4-13). Avoidance is observed between neurons that express identical protocadherin repertoires(2,5), and single-isoform differences are sufficient to prevent self-recognition(10). Protocadherins form isoform-promiscuous cis dimers and isoform-specific homophilic trans dimersi (10,14-20) Although these interactions have previously been characterized in isolation(15,17-20), structures of full-length protocadherin ectodomains have not been determined, and how these two interfaces engage in self-recognition between neuronal surfaces remains unknown. Here we determine the molecular arrangement of full-length clustered protocadherin ectodomains in single-isoform self-recognition complexes, using X-ray crystallography and cryo-electron tomography. We determine the crystal structure of the clustered protocadherin , gamma B4 ectodomain, which reveals a zipper-like lattice that is formed by alternating cis and trans interactions. Using cryo-electron tomography, we show that clustered protocadherin gamma B6 ectodomains tethered to liposomes spontaneously assemble into linear arrays at membrane contact sites, in a configuration that is consistent with the assembly observed in the crystal structure. These linear assemblies pack against each other as parallel arrays to form larger two-dimensional structures between membranes. Our results suggest that the formation of ordered linear assemblies by clustered protocadherins represents the initial self-recognition step in neuronal avoidance, and thus provide support for the isoform-mismatch chain-termination model of protocadherin-mediated self-recognition, which depends on these linear chains(11).	[Brasch, Julia; Goodman, Kerry M.; Rapp, Micah; Mannepalli, Seetha; Bahna, Fabiana; Maniatis, Tom; Honig, Barry; Shapiro, Lawrence] Columbia Univ, Zuckerman Mind Brain & Behav Inst, New York, NY 10027 USA; [Brasch, Julia; Noble, Alex J.; Rapp, Micah; Dandey, Venkata P.; Potter, Clinton S.; Carragher, Bridget] Natl Resource Automated Mol Microscopy, Simons Electron Microscopy Ctr, New York Struct Biol Ctr, New York, NY USA; [Brasch, Julia; Goodman, Kerry M.; Rapp, Micah; Mannepalli, Seetha; Maniatis, Tom; Potter, Clinton S.; Carragher, Bridget; Honig, Barry; Shapiro, Lawrence] Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10027 USA; [Bahna, Fabiana; Honig, Barry] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; [Bahna, Fabiana; Honig, Barry; Shapiro, Lawrence] Columbia Univ, Dept Syst Biol, New York, NY 10027 USA; [Bepler, Tristan] MIT, Computat & Syst Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Bepler, Tristan; Berger, Bonnie] MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Berger, Bonnie] MIT, Dept Math, Cambridge, MA 02139 USA; [Honig, Barry] Columbia Univ, Dept Med, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Columbia University	Honig, B; Shapiro, L (corresponding author), Columbia Univ, Zuckerman Mind Brain & Behav Inst, New York, NY 10027 USA.; Honig, B; Shapiro, L (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10027 USA.; Honig, B (corresponding author), Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA.; Honig, B; Shapiro, L (corresponding author), Columbia Univ, Dept Syst Biol, New York, NY 10027 USA.; Honig, B (corresponding author), Columbia Univ, Dept Med, New York, NY 10027 USA.	bh6@cumc.columbia.edu; lss8@columbia.edu	Shapiro, Lawrence/AAE-7172-2019	Noble, Alex/0000-0001-8634-2279; Bepler, Tristan/0000-0001-5595-9954	National Institutes of Health (NIH) [P41GM103403]; National Science Foundation [MCB-1412472]; NIH [R01MH114817, F32GM128303, R01GM081871, GM103310, OD019994]; Simons Foundation [SF349247]; NYSTAR; Agouron Institute [F00316]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103310, F32GM128303, T32GM087237, R01GM081871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH114817] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; NYSTAR; Agouron Institute(Pfizer); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank D. Neau, S. Banerjee and S. Narayanasami for help with synchrotron data collection, conducted at the APS NE-CAT 24-ID-C beamline (supported by National Institutes of Health (NIH) P41GM103403). We acknowledge support from a National Science Foundation grant (MCB-1412472) to B.H., NIH grants R01MH114817 to T.M. and L.S., F32GM128303 to A.J.N. and R01GM081871 to B.B. Electron microscopy was performed at the Simons Electron Microscopy Center (SEMC) and National Resource for Automated Molecular Microscopy located at the New York Structural Biology Center, which is supported by grants from the Simons Foundation (SF349247), NYSTAR and NIH (GM103310 and OD019994) and from the Agouron Institute (F00316). We thank E. Eng and L.Y. Yen for technical support at SEMC.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agulleiro JI, 2011, BIOINFORMATICS, V27, P582, DOI 10.1093/bioinformatics/btq692; Agulleiro JI, 2015, J STRUCT BIOL, V189, P147, DOI 10.1016/j.jsb.2014.11.009; Bepler T., 2018, POSITIVE UNLABELED C; Castano-Diez D, 2017, J STRUCT BIOL, V197, P135, DOI 10.1016/j.jsb.2016.06.005; Castano-Diez D, 2012, J STRUCT BIOL, V178, P139, DOI 10.1016/j.jsb.2011.12.017; Chen M, 2017, NAT METHODS, V14, P983, DOI [10.1038/NMETH.4405, 10.1038/nmeth.4405]; Dandey VP, 2018, J STRUCT BIOL, V202, P161, DOI 10.1016/j.jsb.2018.01.002; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fan L, 2018, ELIFE, V7, DOI 10.7554/eLife.35242; Goodman KM, 2017, P NATL ACAD SCI USA, V114, pE9829, DOI 10.1073/pnas.1713449114; Goodman KM, 2016, ELIFE, V5, DOI 10.7554/eLife.20930; Goodman KM, 2016, NEURON, V90, P709, DOI 10.1016/j.neuron.2016.04.004; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; Haas IG, 2005, J BIOL CHEM, V280, P9313, DOI 10.1074/jbc.M412909200; Harrison OJ, 2011, STRUCTURE, V19, P244, DOI 10.1016/j.str.2010.11.016; Ing-Esteves S, 2018, J NEUROSCI, V38, P2713, DOI 10.1523/JNEUROSCI.3035-17.2018; Jain T, 2012, J STRUCT BIOL, V179, P68, DOI 10.1016/j.jsb.2012.04.020; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keeler AB, 2015, J BIOL CHEM, V290, P20674, DOI 10.1074/jbc.M115.642306; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Kostadinov D, 2015, ELIFE, V4, DOI 10.7554/eLife.08964; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Lefebvre JL, 2012, NATURE, V488, P517, DOI 10.1038/nature11305; Mah KM, 2017, SEMIN CELL DEV BIOL, V69, P158, DOI 10.1016/j.semcdb.2017.07.043; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Molumby MJ, 2016, CELL REP, V15, P1037, DOI 10.1016/j.celrep.2016.03.093; Mountoufaris G, 2017, SCIENCE, V356, P411, DOI 10.1126/science.aai8801; Nicoludis JM, 2016, ELIFE, V5, DOI 10.7554/eLife.18449; Nicoludis JM, 2015, STRUCTURE, V23, P2087, DOI 10.1016/j.str.2015.09.005; Noble AJ, 2018, ELIFE, V7, DOI 10.7554/eLife.34257; Noble AJ, 2015, J STRUCT BIOL, V192, P270, DOI 10.1016/j.jsb.2015.10.003; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Razinkov I, 2016, J STRUCT BIOL, V195, P190, DOI 10.1016/j.jsb.2016.06.001; Rubinstein R, 2017, SEMIN CELL DEV BIOL, V69, P140, DOI 10.1016/j.semcdb.2017.07.023; Rubinstein R, 2015, CELL, V163, P629, DOI 10.1016/j.cell.2015.09.026; Schalm SS, 2010, P NATL ACAD SCI USA, V107, P13894, DOI 10.1073/pnas.1007182107; Schreiner D, 2010, P NATL ACAD SCI USA, V107, P14893, DOI 10.1073/pnas.1004526107; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Suloway C, 2009, J STRUCT BIOL, V167, P11, DOI 10.1016/j.jsb.2009.03.019; Suo L, 2012, J MOL CELL BIOL, V4, P362, DOI 10.1093/jmcb/mjs034; Thu CA, 2014, CELL, V158, P1045, DOI 10.1016/j.cell.2014.07.012; Toyoda S, 2014, NEURON, V82, P94, DOI 10.1016/j.neuron.2014.02.005; Wei H, 2018, J STRUCT BIOL, V202, P170, DOI 10.1016/j.jsb.2018.01.001; Winkler H, 2006, ULTRAMICROSCOPY, V106, P240, DOI 10.1016/j.ultramic.2005.07.007; Wu Q, 2001, GENOME RES, V11, P389, DOI 10.1101/gr.167301; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Yagi T, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00045; Zipursky SL, 2013, ANNU REV NEUROSCI, V36, P547, DOI 10.1146/annurev-neuro-062111-150414; Zipursky SL, 2010, CELL, V143, P343, DOI 10.1016/j.cell.2010.10.009; 2017, NAT METHODS, V14, P331, DOI DOI 10.1038/NMETH.4193	55	43	43	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 9	2019	569	7755					280	+		10.1038/s41586-019-1089-3	http://dx.doi.org/10.1038/s41586-019-1089-3			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HX5VX	30971825	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000467473600053
J	Grabenhorst, F; Baez-Mendoza, R; Genest, W; Deco, G; Schultz, W				Grabenhorst, Fabian; Baez-Mendoza, Raymundo; Genest, Wilfried; Deco, Gustavo; Schultz, Wolfram			Primate Amygdala Neurons Simulate Decision Processes of Social Partners	CELL			English	Article							PREFRONTAL CORTEX; FRONTAL-CORTEX; REWARD VALUE; MECHANISMS; PREDICTION; BEHAVIOR; MONKEY; EXPRESSION; RESPONSES; SYSTEMS	By observing their social partners, primates learn about reward values of objects. Here, we show that monkeys' amygdala neurons derive object values from observation and use these values to simulate a partner monkey's decision process. While monkeys alternated making reward-based choices, amygdala neurons encoded object-specific values learned from observation. Dynamic activities converted these values to representations of the recorded monkey's own choices. Surprisingly, the same activity patterns unfolded spontaneously before partner's choices in separate neurons, as if these neurons simulated the partner's decision-making. These "simulation neurons" encoded signatures of mutual-inhibitory decision computation, including value comparisons and value-to-choice conversions, resulting in accurate predictions of partner's choices. Population decoding identified differential contributions of amygdala subnuclei. Biophysical modeling of amygdala circuits showed that simulation neurons emerge naturally from convergence between object-value neurons and self-other neurons. By simulating decision computations during observation, these neurons could allow primates to reconstruct their social partners' mental states.	[Grabenhorst, Fabian; Baez-Mendoza, Raymundo; Genest, Wilfried; Schultz, Wolfram] Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3DY, England; [Deco, Gustavo] Univ Pompeu Fabra, Dept Technol & Informat, Ctr Brain & Cognit, Carrer Tanger 122-140, Barcelona 08018, Spain; [Deco, Gustavo] Univ Barcelona, Inst Catalana Recerca & Estudis Avancats, Passeig Lluis Co 23, Barcelona 08010, Spain; [Baez-Mendoza, Raymundo] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurosurg, 55 Fruit St, Boston, MA 02114 USA	University of Cambridge; Pompeu Fabra University; University of Barcelona; ICREA; University of Barcelona; Harvard University; Harvard Medical School; Massachusetts General Hospital	Grabenhorst, F (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3DY, England.	fg292@cam.ac.uk	Báez-Mendoza, Raymundo/AAS-8768-2020; Deco, Gustavo/A-6341-2008	Deco, Gustavo/0000-0002-8995-7583; Baez-Mendoza, Raymundo/0000-0002-5989-7647	Wellcome Trust [095495, 206207/Z/17/Z]; European Research Council (ERC) [293549]; NIH Caltech Conte Center [P50MH094258]; MGH ECOR Fund for Medical Discovery; Brain & Behavior Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094258] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council (ERC)(European Research Council (ERC)European Commission); NIH Caltech Conte Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MGH ECOR Fund for Medical Discovery; Brain & Behavior Research Foundation(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank A. David and C. Thompson for animal care, P. Taylor for anesthesia, and H. Cousins and A. Stasiak for computer programming. This work was supported by the Wellcome Trust (Principal Research Fellowship and Programme Grant 095495 to W.S.; Sir Henry Dale Fellowship 206207/Z/17/Z to F.G.), the European Research Council (ERC Advanced Grant 293549 to W.S.), the NIH Caltech Conte Center (P50MH094258 to W.S.), and the MGH ECOR Fund for Medical Discovery and NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation (to R.B.-M.).	Adolphs R, 2006, BRAIN RES, V1079, P25, DOI 10.1016/j.brainres.2005.12.127; Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; Amaral DG, 2002, BIOL PSYCHIAT, V51, P11, DOI 10.1016/S0006-3223(01)01307-5; [Anonymous], 1998, NEURAL NETWORKS BRAI; Baez-Mendoza R, 2016, SCI REP-UK, V6, DOI 10.1038/srep37199; Baez-Mendoza R, 2013, P NATL ACAD SCI USA, V110, P16634, DOI 10.1073/pnas.1211342110; BARLOW H, 1990, ANNU REV NEUROSCI, V13, P15, DOI 10.1146/annurev.neuro.13.1.15; Baron-Cohen S, 2000, NEUROSCI BIOBEHAV R, V24, P355, DOI 10.1016/S0149-7634(00)00011-7; Behrens TEJ, 2008, NATURE, V456, P245, DOI 10.1038/nature07538; Belova MA, 2008, J NEUROSCI, V28, P10023, DOI 10.1523/JNEUROSCI.1400-08.2008; Chang S. W. C., 2017, EMERGING FIELD PRIMA, DOI [10.1523/ENEURO.0295-17.2017, DOI 10.1523/ENEURO.0295-17.2017]; Chang SWC, 2015, P NATL ACAD SCI USA, V112, P16012, DOI 10.1073/pnas.1514761112; Chang SWC, 2013, P NATL ACAD SCI USA, V110, P10387, DOI 10.1073/pnas.1301213110; Chang SWC, 2013, NAT NEUROSCI, V16, P243, DOI 10.1038/nn.3287; Chau BKH, 2014, NAT NEUROSCI, V17, P463, DOI 10.1038/nn.3649; Deco G, 2013, PROG NEUROBIOL, V103, P194, DOI 10.1016/j.pneurobio.2012.01.010; Fabbri-Destro M, 2008, PHYSIOLOGY, V23, P171, DOI 10.1152/physiol.00004.2008; Gordon R. M., 1996, THEORIES THEORIES MI, P11, DOI DOI 10.1017/CB09780511597985.003; Gothard KM, 2007, J NEUROPHYSIOL, V97, P1671, DOI 10.1152/jn.00714.2006; Grabenhorst F, 2016, ELIFE, V5, DOI 10.7554/eLife.18731; Grabenhorst F, 2012, P NATL ACAD SCI USA, V109, P18950, DOI 10.1073/pnas.1212706109; Haroush K, 2015, CELL, V160, P1233, DOI 10.1016/j.cell.2015.01.045; Heyes C, 2012, J COMP PSYCHOL, V126, P193, DOI 10.1037/a0025180; Hosokawa T, 2012, J NEUROSCI, V32, P7662, DOI 10.1523/JNEUROSCI.6479-11.2012; Hunt LT, 2017, NAT REV NEUROSCI, V18, P172, DOI 10.1038/nrn.2017.7; Hunt LT, 2012, NAT NEUROSCI, V15, P470, DOI 10.1038/nn.3017; Isoda M, 2018, P JPN ACAD B-PHYS, V94, P305, DOI 10.2183/pjab.94.020; Janak PH, 2015, NATURE, V517, P284, DOI 10.1038/nature14188; Johansen JP, 2011, CELL, V147, P509, DOI 10.1016/j.cell.2011.10.009; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Klavir O, 2013, NEURON, V80, P1290, DOI 10.1016/j.neuron.2013.09.035; Kluver H, 1939, ARCH NEURO PSYCHIATR, V42, P979; Lai MC, 2014, LANCET, V383, P896, DOI 10.1016/S0140-6736(13)61539-1; Lee D, 2016, TRENDS NEUROSCI, V39, P40, DOI 10.1016/j.tins.2015.11.002; LEONARD CM, 1985, BEHAV BRAIN RES, V15, P159, DOI 10.1016/0166-4328(85)90062-2; Munuera J, 2018, NAT NEUROSCI, V21, P415, DOI 10.1038/s41593-018-0082-8; Noonan MP, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001940; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Paxinos G., 2000, THE RHESUS MONKEY BR; Rabinowitz N. C., 2018, P MACHINE LEARN RES, V80, P4218; Rudebeck PH, 2017, J NEUROSCI, V37, P2186, DOI 10.1523/JNEUROSCI.0933-16.2017; Rutishauser U, 2015, TRENDS NEUROSCI, V38, P295, DOI 10.1016/j.tins.2015.03.001; Rutishauser U, 2013, NEURON, V80, P887, DOI 10.1016/j.neuron.2013.08.029; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Seo H, 2014, SCIENCE, V346, P340, DOI 10.1126/science.1256254; Shanton K, 2010, WIRES COGN SCI, V1, P527, DOI 10.1002/wcs.33; Strait CE, 2014, NEURON, V82, P1357, DOI 10.1016/j.neuron.2014.04.032; Subiaul F, 2004, SCIENCE, V305, P407, DOI 10.1126/science.1099136; Tsutsui KI, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12554; Wang XJ, 2008, NEURON, V60, P215, DOI 10.1016/j.neuron.2008.09.034; Wittmann MK, 2018, ANNU REV NEUROSCI, V41, P99, DOI 10.1146/annurev-neuro-080317-061450; Wittmann MK, 2016, NEURON, V91, P482, DOI 10.1016/j.neuron.2016.06.022; Wong KF, 2006, J NEUROSCI, V26, P1314, DOI 10.1523/JNEUROSCI.3733-05.2006; Yoshida K, 2012, NAT NEUROSCI, V15, P1307, DOI 10.1038/nn.3180; Yoshida K, 2011, CURR BIOL, V21, P249, DOI 10.1016/j.cub.2011.01.004; 2013, SCIENCE, V340, P483	60	43	43	2	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 2	2019	177	4					986	+		10.1016/j.cell.2019.02.042	http://dx.doi.org/10.1016/j.cell.2019.02.042			28	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HW7AU	30982599	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000466843000017
J	Dyer, O				Dyer, Owen			US medical school abandons affirmative action after pressure from Trump administration	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 23	2019	365								l1789	10.1136/bmj.l1789	http://dx.doi.org/10.1136/bmj.l1789			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HW1MM	31015187				2022-12-28	WOS:000466447000002
J	Grundemann, J; Bitterman, Y; Lu, TJ; Krabbe, S; Grewe, BF; Schnitzer, MJ; Luthi, A				Grundemann, Jan; Bitterman, Yael; Lu, Tingjia; Krabbe, Sabine; Grewe, Benjamin F.; Schnitzer, Mark J.; Luthi, Andreas			Amygdala ensembles encode behavioral states	SCIENCE			English	Article							INDUCED FREEZING BEHAVIOR; LATERAL AMYGDALA; CORTICAL STATE; INHIBITORY CIRCUIT; OPEN-FIELD; PLUS-MAZE; FEAR; ANXIETY; NEURONS; HYPOTHALAMUS	Internal states, including affective or homeostatic states, are important behavioral motivators. The amygdala regulates motivated behaviors, yet how distinct states are represented in amygdala circuits is unknown. By longitudinally imaging neural calcium dynamics in freely moving mice across different environments, we identified opponent changes in activity levels of two major, nonoverlapping populations of basal amygdala principal neurons. This population signature does not report global anxiety but predicts switches between exploratory and nonexploratory, defensive states. Moreover, the amygdala separately processes external stimuli and internal states and broadcasts state information via several output pathways to larger brain networks. Our findings extend the concept of thalamocortical "brain-state" coding to include affective and exploratory states and provide an entry point into the state dependency of brain function and behavior in defined circuits.	[Grundemann, Jan; Bitterman, Yael; Lu, Tingjia; Krabbe, Sabine; Luthi, Andreas] Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, Basel, Switzerland; [Grundemann, Jan] Univ Basel, Dept Biomed, Klingelbergstr 50-70, Basel, Switzerland; [Grewe, Benjamin F.] Univ & ETH Zurich, Inst Neuroinformat, Winterthurerstr 190, Zurich, Switzerland; [Grewe, Benjamin F.] Swiss Fed Inst Technol, Dept Elect Engn & Informat Technol, Zurich, Switzerland; [Schnitzer, Mark J.] Stanford Univ, Howard Hughes Med Inst, CNC Program, James H Clark Ctr Biomed Engn & Sci, Stanford, CA 94305 USA; [Luthi, Andreas] Univ Basel, CH-4000 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; University of Basel; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Howard Hughes Medical Institute; Stanford University; University of Basel	Grundemann, J; Luthi, A (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, Basel, Switzerland.; Grundemann, J (corresponding author), Univ Basel, Dept Biomed, Klingelbergstr 50-70, Basel, Switzerland.; Luthi, A (corresponding author), Univ Basel, CH-4000 Basel, Switzerland.	jan.grundemann@unibas.ch; andreas.luthi@fmi.ch	bitterman, yael/GRS-6144-2022; Grewe, Benjamin/E-7044-2017; Luthi, Andreas/D-7940-2016	bitterman, yael/0000-0002-4153-3888; Grundemann, Jan/0000-0002-3149-0001; Grewe, Benjamin/0000-0001-8560-2120; Krabbe, Sabine/0000-0002-5735-469X; Luthi, Andreas/0000-0002-1859-4252	Swiss National Science Foundation; EMBO; Marie Curie Actions; Brain & Behavior Research Foundation (NARSAD Young Investigator awards); Swiss Data Science Center; DARPA; NIH; ERC; Novartis Research Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EMBO(European Molecular Biology Organization (EMBO)); Marie Curie Actions(European Commission); Brain & Behavior Research Foundation (NARSAD Young Investigator awards); Swiss Data Science Center; DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERC(European Research Council (ERC)European Commission); Novartis Research Foundation	Research was supported by the Swiss National Science Foundation (core grant to A.L., Ambizione Fellowship to J.G., SNF professorship to J.G., and Sinergia to B.F.G.), EMBO and Marie Curie Actions (J.G.), Brain & Behavior Research Foundation (NARSAD Young Investigator awards to S.K. and B.F.G.), Swiss Data Science Center (B.F.G.), DARPA (M.J.S.), NIH (M.J.S.), ERC (advanced grant to A.L.), and Novartis Research Foundation.	ADAMEC RE, 1993, PHYSIOL BEHAV, V54, P101, DOI 10.1016/0031-9384(93)90050-P; Adamec R, 2010, INT J NEUROPSYCHOPH, V13, P747, DOI 10.1017/S1461145709990496; Allikmets L. K., 1967, NEUROSCI TRANSLATION, V1, P119; Amano T, 2011, J NEUROSCI, V31, P15481, DOI 10.1523/JNEUROSCI.3410-11.2011; Amir A, 2018, NEURON, V97, P656, DOI 10.1016/j.neuron.2017.12.035; Amir A, 2015, J NEUROSCI, V35, P12994, DOI 10.1523/JNEUROSCI.0407-15.2015; Anderson DJ, 2014, CELL, V157, P187, DOI 10.1016/j.cell.2014.03.003; ANDERSON DC, 1976, PHYSIOL BEHAV, V17, P391, DOI 10.1016/0031-9384(76)90096-2; Bakshi VP, 2012, NEUROPHARMACOLOGY, V62, P737, DOI 10.1016/j.neuropharm.2011.01.040; Belova MA, 2007, NEURON, V55, P970, DOI 10.1016/j.neuron.2007.08.004; Betley JN, 2015, NATURE, V521, P180, DOI 10.1038/nature14416; Beyeler A, 2016, NEURON, V90, P348, DOI 10.1016/j.neuron.2016.03.004; Blanchard R.J., 1971, LEARN MOTIV, V2, P351, DOI DOI 10.1016/0023-9690(71)90016-6; Blanchard RJ, 1998, PHYSIOL BEHAV, V63, P561, DOI 10.1016/S0031-9384(97)00508-8; Botta P, 2015, NAT NEUROSCI, V18, P1493, DOI 10.1038/nn.4102; CONTI LH, 1990, PSYCHOPHARMACOLOGY, V102, P492, DOI 10.1007/BF02247130; Dalvi A, 1999, PHARMACOL BIOCHEM BE, V62, P727, DOI 10.1016/S0091-3057(98)00220-2; Douglass AM, 2017, NAT NEUROSCI, V20, P1384, DOI 10.1038/nn.4623; Druckmann S, 2012, CURR BIOL, V22, P2095, DOI 10.1016/j.cub.2012.08.058; Engel TA, 2016, SCIENCE, V354, P1140, DOI 10.1126/science.aag1420; Everitt BJ, 2003, ANN NY ACAD SCI, V985, P233; Fadok JP, 2017, NATURE, V542, P96, DOI 10.1038/nature21047; Felix-Ortiz AC, 2014, J NEUROSCI, V34, P586, DOI 10.1523/JNEUROSCI.4257-13.2014; Felix-Ortiz AC, 2013, NEURON, V79, P658, DOI 10.1016/j.neuron.2013.06.016; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Goosens KA, 2003, NEURON, V40, P1013, DOI 10.1016/S0896-6273(03)00728-1; Grewe BF, 2017, NATURE, V543, P670, DOI 10.1038/nature21682; Grundemann J, 2015, CURR OPIN NEUROBIOL, V35, P200, DOI 10.1016/j.conb.2015.10.005; Harris KD, 2011, NAT REV NEUROSCI, V12, P509, DOI 10.1038/nrn3084; HELMSTETTER FJ, 1993, PHARMACOL BIOCHEM BE, V44, P433, DOI 10.1016/0091-3057(93)90487-E; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Inoue T, 1996, PHARMACOL BIOCHEM BE, V53, P825, DOI 10.1016/0091-3057(95)02084-5; Jennings JH, 2013, SCIENCE, V341, P1517, DOI 10.1126/science.1241812; Kennedy A, 2014, COLD SH Q B, V79, P199, DOI 10.1101/sqb.2014.79.024984; Kim EJ, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar7328; Kim J, 2016, NAT NEUROSCI, V19, P1636, DOI 10.1038/nn.4414; KRETTEK JE, 1977, J COMP NEUROL, V172, P687, DOI 10.1002/cne.901720408; Kyriazi P., NEURON, V99; LEE EHY, 1986, PHYSIOL BEHAV, V37, P659, DOI 10.1016/0031-9384(86)90301-X; Lee SC, 2017, NEURON, V96, P81, DOI 10.1016/j.neuron.2017.09.002; Lee SH, 2012, NEURON, V76, P209, DOI 10.1016/j.neuron.2012.09.012; LESTER LS, 1985, BEHAV NEUROSCI, V99, P756, DOI 10.1037/0735-7044.99.4.756; Li Y, 2017, CELL, V171, P1176, DOI 10.1016/j.cell.2017.10.015; Likhtik E, 2014, NAT NEUROSCI, V17, P106, DOI 10.1038/nn.3582; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Lovett-Barron M, 2017, CELL, V171, P1411, DOI 10.1016/j.cell.2017.10.021; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; Maki Y, 2000, EUR J PHARMACOL, V406, P411, DOI 10.1016/S0014-2999(00)00706-8; McGinley MJ, 2015, NEURON, V87, P1143, DOI 10.1016/j.neuron.2015.09.012; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; Musall S, 2018, BIORXIV, DOI [10.1101/308288, DOI 10.1101/308288]; Namburi P, 2015, NATURE, V520, P675, DOI 10.1038/nature14366; Nieh EH, 2016, NEURON, V90, P1286, DOI 10.1016/j.neuron.2016.04.035; Nieh EH, 2013, BRAIN RES, V1511, P73, DOI 10.1016/j.brainres.2012.11.001; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; PANKSEPP J, 1971, PHYSIOL BEHAV, V6, P321, DOI 10.1016/0031-9384(71)90163-6; Pare D, 2000, J NEUROSCI, V20, P2701; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Paxinos G, 2012, PAXINOS FRANKLINS MO; Paz R, 2006, NAT NEUROSCI, V9, P1321, DOI 10.1038/nn1771; Polack PO, 2013, NAT NEUROSCI, V16, P1331, DOI 10.1038/nn.3464; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Rajbhandari AK, 2015, J NEUROSCI, V35, P14270, DOI 10.1523/JNEUROSCI.5080-14.2015; Reimer J, 2014, NEURON, V84, P355, DOI 10.1016/j.neuron.2014.09.033; Remedios R, 2017, NATURE, V550, P388, DOI 10.1038/nature23885; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Salzman CD, 2010, ANNU REV NEUROSCI, V33, P173, DOI 10.1146/annurev.neuro.051508.135256; Scholvinck ML, 2015, J NEUROSCI, V35, P170, DOI 10.1523/JNEUROSCI.4994-13.2015; Senn V, 2014, NEURON, V81, P428, DOI 10.1016/j.neuron.2013.11.006; SIMON P, 1994, BEHAV BRAIN RES, V61, P59, DOI 10.1016/0166-4328(94)90008-6; STITH RD, 1976, J NEUROSCI RES, V2, P317, DOI 10.1002/jnr.490020409; Stringer C, 2018, BIORXIV, DOI [10.1101/306019, DOI 10.1101/306019]; Stujenske JM, 2014, NEURON, V83, P919, DOI 10.1016/j.neuron.2014.07.026; Tervo DGR, 2016, NEURON, V92, P372, DOI 10.1016/j.neuron.2016.09.021; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Tovote P, 2016, NATURE, V534, P206, DOI 10.1038/nature17996; Tye KM, 2007, J NEUROSCI, V27, P3937, DOI 10.1523/JNEUROSCI.5281-06.2007; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Vogel E, 2016, NEURON, V91, P644, DOI 10.1016/j.neuron.2016.06.036; Yang Y, 2016, NAT NEUROSCI, V19, P1348, DOI 10.1038/nn.4370	83	72	73	3	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2019	364	6437					254	+	eaav8736	10.1126/science.aav8736	http://dx.doi.org/10.1126/science.aav8736			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HU0JG	31000636	Green Submitted			2022-12-28	WOS:000464956600041
J	Parasidis, E; Pike, E; McGraw, D				Parasidis, Efthimios; Pike, Elizabeth; McGraw, Deven			A Belmont Report for Health Data	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Just as indignities common in human-subjects research led to the articulation of ethical principles in the Belmont Report 40 years ago, contemporary concerns about data use call for stakeholders to promulgate ethical guidance for health data.	[Parasidis, Efthimios] Ohio State Univ, Moritz Coll Law, Columbus, OH 43210 USA; [Parasidis, Efthimios] Ohio State Univ, Coll Publ Hlth, Columbus, OH 43210 USA; [Pike, Elizabeth] Dept Hlth & Human Serv, Off Chief Informat Officer, Washington, DC USA; [McGraw, Deven] Ciitizen, Palo Alto, CA USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Parasidis, E (corresponding author), Ohio State Univ, Moritz Coll Law, Columbus, OH 43210 USA.; Parasidis, E (corresponding author), Ohio State Univ, Coll Publ Hlth, Columbus, OH 43210 USA.							Cohen IG, 2018, JAMA-J AM MED ASSOC, V320, P231, DOI 10.1001/jama.2018.5630; Grady C, 2015, CHEST, V148, P1148, DOI 10.1378/chest.15-0706; Grande D, 2013, JAMA INTERN MED, V173, P1798, DOI 10.1001/jamainternmed.2013.9166; Malin BA, 2013, J AM MED INFORM ASSN, V20, P2, DOI 10.1136/amiajnl-2012-001509; Mayer-Schonberger V, 2018, FOREIGN AFFAIRS	5	20	21	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 18	2019	380	16					1493	1495		10.1056/NEJMp1816373	http://dx.doi.org/10.1056/NEJMp1816373			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU3AO	30995370				2022-12-28	WOS:000465144100009
J	Davidson, MB				Davidson, Mayer B.			Review: Rapid-acting analogues do not differ from regular human insulin for mortality or HbA(1c) in type 2 diabetes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Davidson, Mayer B.] Charles R Drew Univ, Los Angeles, CA 90059 USA	Charles R. Drew University of Medicine & Science	Davidson, MB (corresponding author), Charles R Drew Univ, Los Angeles, CA 90059 USA.							Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS73, DOI 10.2337/dc18-S008; Davidson MB, 2014, DIABETES CARE, V37, P1771, DOI 10.2337/dc13-2915; Gordon S., 2018, HIGH COST HAS 1 4 DI; 2013, DIABETES CARE, V36, P1865, DOI DOI 10.2337/DC12-1694	4	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2019	170	8					JC39	JC39		10.7326/ACPJ201904160-039	http://dx.doi.org/10.7326/ACPJ201904160-039			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU7YQ	30986829				2022-12-28	WOS:000465499900005
J	Obeyesekere, MN				Obeyesekere, Manoj N.			Review: In adults with AF and HF, AF catheter ablation vs drug therapy reduces mortality and HF hospitalizations	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Obeyesekere, Manoj N.] Northern Hosp, Melbourne, Vic, Australia		Obeyesekere, MN (corresponding author), Northern Hosp, Melbourne, Vic, Australia.		O, Manoj/AAM-8692-2020					Calkins H, 2018, EUROPACE, V20, P157, DOI [10.1093/europace/eux274, 10.1093/europace/eux275, 10.1016/j.hrthm.2017.05.012]; Marrouche NF, 2018, NEW ENGL J MED, V378, P417, DOI 10.1056/NEJMoa1707855	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2019	170	8					JC43	JC43		10.7326/ACPJ201904160-043	http://dx.doi.org/10.7326/ACPJ201904160-043			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU7YQ	30986833				2022-12-28	WOS:000465499900009
J	Sio, TT; Le-Rademacher, JG; Leenstra, JL; Loprinzi, CL; Rine, G; Curtis, A; Singh, AK; Martenson, JA; Novotny, PJ; Tan, AD; Qin, R; Ko, SJ; Reiter, PL; Miller, RC				Sio, Terence T.; Le-Rademacher, Jennifer G.; Leenstra, James L.; Loprinzi, Charles L.; Rine, Grant; Curtis, Amarinthia; Singh, Anurag K.; Martenson, James A., Jr.; Novotny, Paul J.; Tan, Angelina D.; Qin, Rui; Ko, Stephen J.; Reiter, Paul L.; Miller, Robert C.			Effect of Doxepin Mouthwash or Diphenhydramine-Lidocaine-Antacid Mouthwash vs Placebo on Radiotherapy-Related Oral Mucositis Pain The Alliance A221304 Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRACTICE GUIDELINES; FOLLOW-UP; CANCER; RINSE; CHEMOTHERAPY; PREVENTION; MANAGEMENT; RADIATION; THERAPY; HEAD	IMPORTANCE Oral mucositis causes substantial morbidity during head and neck radiotherapy. In a randomized study, doxepin mouthwash was shown to reduce oral mucositis-related pain. A common mouthwash comprising diphenhydramine-lidocaine-antacid is also widely used. OBJECTIVE To evaluate the effect of doxepin mouthwash or diphenhydramine-lidocaine-antacid mouthwash for the treatment of oral mucositis-related pain. DESIGN, SETTING, AND PARTICIPANTS A phase 3 randomized trialwas conducted from November 1, 2014, to May 16, 2016, at 30 US institutions and included 275 patients who underwent definitive head and neck radiotherapy, had an oral mucositis pain score of 4 points or greater (scale, 0-10), and were followed up for a maximum of 28 days. INTERVENTIONS Ninety-two patients were randomized to doxepin mouthwash (25 mg/5 mL water); 91 patients to diphenhydramine-lidocaine-antacid; and 92 patients to placebo. MAIN OUTCOME AND MEASURES The primary end point was total oral mucositis pain reduction (defined by the area under the curve and adjusted for baseline pain score) during the 4 hours after a single dose of doxepin mouthwash or diphenhydramine-lidocaine-antacid mouthwash compared with a single dose of placebo. The minimal clinically important difference was a 3.5-point change. The secondary end points included drowsiness, unpleasant taste, and stinging or burning. All scales ranged from 0 (best) to 10 (worst). RESULTS Among the 275 patients randomized (median age, 61 years; 58 [21%] women), 227 (83%) completed treatment per protocol. Mucositis pain during the first 4 hours decreased by 11.6 points in the doxepin mouthwash group, by 11.7 points in the diphenhydramine-lidocaine-antacid mouthwash group, and by 8.7 points in the placebo group. The between-group difference was 2.9 points (95% CI, 0.2-6.0; P=.02) for doxepin mouthwash vs placebo and 3.0 points (95% CI, 0.1-5.9; P=.004) for diphenhydramine-lidocaine-antacid mouthwash vs placebo. More drowsiness was reported with doxepin mouthwash vs placebo (by 1.5 points [95% CI, 0-4.0]; P=.03), unpleasant taste (by 1.5 points [95% CI, 0-3.0]; P=.002), and stinging or burning (by 4.0 points [95% CI, 2.5-5.0]; P<.001). Maximum grade 3 adverse events for the doxepin mouthwash occurred in 3 patients (4%); diphenhydramine-lidocaine-antacid mouthwash, 3 (4%); and placebo, 2 (2%). Fatigue was reported by 5 patients (6%) in the doxepin mouthwash group and no patients in the diphenhydramine-lidocaine-antacid mouthwash group. CONCLUSIONS AND RELEVANCE Among patients undergoing head and neck radiotherapy, the use of doxepin mouthwash or diphenhydramine-lidocaine-antacid mouthwash vs placebo significantly reduced oral mucositis pain during the first 4 hours after administration; however, the effect size was less than the minimal clinically important difference. Further research is needed to assess longer-term efficacy and safety for both mouthwashes.	[Sio, Terence T.] Mayo Clin Hosp, Dept Radiat Oncol, Phoenix, AZ USA; [Le-Rademacher, Jennifer G.; Novotny, Paul J.; Tan, Angelina D.; Qin, Rui] Mayo Clin, Alliance Stat & Data Ctr, Rochester, MN USA; [Leenstra, James L.; Martenson, James A., Jr.] Mayo Clin, Dept Radiat Oncol, Rochester, MN USA; [Loprinzi, Charles L.] Mayo Clin, Div Med Oncol, Rochester, MN USA; [Rine, Grant] Wichita Natl Canc Inst, Community Oncol Res Program, Wichita, KS USA; [Curtis, Amarinthia] NCI, Southeast Clin Oncol, Res Consortium, Community Oncol Res Program, Spartanburg, SC USA; [Singh, Anurag K.] Roswell Pk Canc Inst, Buffalo, NY 14263 USA; [Ko, Stephen J.; Miller, Robert C.] Mayo Clin, Dept Radiat Oncol, Jacksonville, FL USA; [Reiter, Paul L.] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA; [Miller, Robert C.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA	Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic; Mayo Clinic; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Roswell Park Cancer Institute; Mayo Clinic; University System of Ohio; Ohio State University; University System of Maryland; University of Maryland Baltimore	Miller, RC (corresponding author), Univ Maryland, Dept Radiat Oncol, Sch Med, 22 S Greene St, Baltimore, MD 21201 USA.	robertmiller@umm.edu	SINGH, ANIL KUMAR/M-4786-2017; Singh, Ashok/HGF-2506-2022	SINGH, ANIL KUMAR/0000-0003-2933-4058; Miller, Robert/0000-0001-8932-2732	National Cancer Institute, National Institutes of Health [UG1CA189823, U10CA180790, U10CA180850, U10CA180866, UG1CA189858, UG1CA189808]; Mayo Clinic Symptom Intervention Program; NATIONAL CANCER INSTITUTE [UG1CA233191, UG1CA189823, UG1CA189808, P30CA016056, UG1CA189858, P30CA016058, UG1CA232760, UG1CA233331, U10CA180790, U10CA180866, U10CA180850] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Mayo Clinic Symptom Intervention Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grants UG1CA189823 (Alliance for Clinical Trials in Oncology National Cancer Institute Community Oncology Research Program), U10CA180790, U10CA180850, U10CA180866, UG1CA189858, and UG1CA189808 from the National Cancer Institute, National Institutes of Health, and by funding from the Mayo Clinic Symptom Intervention Program.	Bellm LA, 2002, CANCER INVEST, V20, P793, DOI 10.1081/CNV-120002497; Chan Alexandre, 2005, J Oncol Pharm Pract, V11, P139, DOI 10.1191/1078155205jp166oa; Clarkson JE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001973.pub4; Dodd MJ, 2000, ORAL SURG ORAL MED O, V90, P39, DOI 10.1067/moe.2000.105713; Epstein JB, 2001, ORAL ONCOL, V37, P632, DOI 10.1016/S1368-8375(01)00005-7; Epstein JB, 2007, J PAIN SYMPTOM MANAG, V33, P111, DOI 10.1016/j.jpainsymman.2006.11.002; Epstein JB, 2006, ANESTH ANALG, V103, P465, DOI 10.1213/01.ane.0000223661.60471.78; Epstein JB, 2008, SPEC CARE DENT, V28, P73, DOI 10.1111/j.1754-4505.2008.00015.x; Keefe DM, 2007, CANCER-AM CANCER SOC, V109, P820, DOI 10.1002/cncr.22484; Kuk JS, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.5521; Leenstra JL, 2014, J CLIN ONCOL, V32, P1571, DOI 10.1200/JCO.2013.53.2630; Lehmann E. L., 2006, NONPARAMETRICS STAT; Norman Geoffrey R, 2004, Expert Rev Pharmacoecon Outcomes Res, V4, P581, DOI 10.1586/14737167.4.5.581; Qian W, 2000, STAT MED, V19, P2657; Rose-Ped AM, 2002, CANCER NURS, V25, P461, DOI 10.1097/00002820-200212000-00010; Rubenstein EB, 2004, CANCER-AM CANCER SOC, V100, P2026, DOI 10.1002/cncr.20163; Schriger DL, 2018, ANN EMERG MED, V71, P239, DOI 10.1016/j.annemergmed.2017.05.033; Sonis ST, 1999, CANCER-AM CANCER SOC, V85, P2103, DOI 10.1002/(SICI)1097-0142(19990515)85:10<2103::AID-CNCR2>3.0.CO;2-0; Sudoh Y, 2003, PAIN, V103, P49, DOI 10.1016/S0304-3959(02)00375-5; Worthington HV, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000978.pub3	20	27	27	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 16	2019	321	15					1481	1490		10.1001/jama.2019.3504	http://dx.doi.org/10.1001/jama.2019.3504			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HT7SY	30990550	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000464765900015
J	Kidia, K				Kidia, Khameer			Physicians as Border Guards - The Troubling Exam for Immigrants	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEALTH	Rules proposed by the Trump administration depend on physicians performing "exams" to spot immigrants who are sick enough to become reliant on the government for living costs. The impact would be devastating for immigrants who are denied visas.	[Kidia, Khameer] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Kidia, Khameer] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kidia, K (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.; Kidia, K (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.							Abubakar I, 2018, LANCET, V392, P2606, DOI 10.1016/S0140-6736(18)32114-7; [Anonymous], 2018, FED REGISTER, V83, P51; Department of Homeland Security Office of the Inspector General, 2018, USCIS MED ADM SCREEN; Derose KP, 2007, HEALTH AFFAIR, V26, P1258, DOI 10.1377/hlthaff.26.5.1258; United Nations Office of the High Commissioner for Human Rights, 2014, REC PRINC GUID HUM R	5	1	1	1	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 11	2019	380	15					1394	1395		10.1056/NEJMp1901727	http://dx.doi.org/10.1056/NEJMp1901727			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HT5NG	30973216				2022-12-28	WOS:000464610000006
J	Villanueva, A				Villanueva, Augusto			Hepatocellular Carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIAL; CHRONIC HEPATITIS-B; DOUBLE-BLIND; PHASE-III; TRANSARTERIAL CHEMOEMBOLIZATION; COST-EFFECTIVENESS; LIVER-TRANSPLANTATION; 2ND-LINE TREATMENT; CLINICAL-PRACTICE; ADJUVANT THERAPY		[Villanueva, Augusto] Icahn Sch Med Mt Sinai, Liver Canc Program, Div Liver Dis, Dept Med,Tisch Canc Inst,Grad Sch Biomed Sci, New York, NY 10029 USA; [Villanueva, Augusto] Icahn Sch Med Mt Sinai, Div Hematol & Med Oncol, Dept Med, Tisch Canc Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Villanueva, A (corresponding author), Div Liver Dis, 1425 Madison Ave,Box 1123,Rm 11-70E, New York, NY 10029 USA.	augusto.villanueva@mssm.edu		Villanueva, Augusto/0000-0003-3585-3727				Abou-Alfa G, 2016, P AM SOC CLIN ONC S4, V34, P192, DOI DOI 10.1200/jco.2016.34.4_suppl.192; Abou-Alfa GK, 2018, NEW ENGL J MED, V379, P54, DOI 10.1056/NEJMoa1717002; Abou-Alfa GK, 2018, ANN ONCOL, V29, P1402, DOI 10.1093/annonc/mdy101; [Anonymous], OPDIVO NIV PRESCR IN; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Bruix J, 2017, LANCET, V389, P56, DOI 10.1016/S0140-6736(16)32453-9; Bruix J, 2015, LANCET ONCOL, V16, P1344, DOI 10.1016/S1470-2045(15)00198-9; Burrel M, 2012, J HEPATOL, V56, P1330, DOI 10.1016/j.jhep.2012.01.008; Cainap C, 2015, J CLIN ONCOL, V33, P172, DOI 10.1200/JCO.2013.54.3298; Centers for Disease Control and Prevention, 2018, TRENDS LIV CANC MORT; Chang MH, 2009, JNCI-J NATL CANCER I, V101, P1348, DOI 10.1093/jnci/djp288; Cheng AL, 2013, J CLIN ONCOL, V31, P4067, DOI 10.1200/JCO.2012.45.8372; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Chernyak V, 2018, RADIOLOGY, V289, P816, DOI 10.1148/radiol.2018181494; Child C G, 1964, Major Probl Clin Surg, V1, P1; Chow PKH, 2018, J CLIN ONCOL, V36, P1913, DOI 10.1200/JCO.2017.76.0892; Cucchetti A, 2013, J HEPATOL, V59, P300, DOI 10.1016/j.jhep.2013.04.009; D'Amico G, 2018, J HEPATOL, V68, P563, DOI 10.1016/j.jhep.2017.10.020; El-Khoueiry AB, 2017, LANCET, V389, P2492, DOI 10.1016/S0140-6736(17)31046-2; ELKHOUEIRY AB, 2018, J CLIN ONCOL S, V36; Estes C, 2018, J HEPATOL, V69, P896, DOI 10.1016/j.jhep.2018.05.036; European Assoc Study Liver, 2018, J HEPATOL, V69, P182, DOI 10.1016/j.jhep.2018.03.019; Forner A, 2018, LANCET, V391, P1301, DOI 10.1016/S0140-6736(18)30010-2; Hsu C-H, 2019, AS PAC ASS STUD LIV; Ishizawa T, 2008, GASTROENTEROLOGY, V134, P1908, DOI 10.1053/j.gastro.2008.02.091; Jemal A., 2017, J NATL CANC I, V109; Johnson PJ, 2015, J CLIN ONCOL, V33, P550, DOI 10.1200/JCO.2014.57.9151; Johnson PJ, 2013, J CLIN ONCOL, V31, P3517, DOI 10.1200/JCO.2012.48.4410; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Kanwal F, 2017, GASTROENTEROLOGY, V153, P996, DOI 10.1053/j.gastro.2017.06.012; Kudo M, 2018, LANCET GASTROENTEROL, V3, P424, DOI 10.1016/S2468-1253(18)30078-5; Kudo M, 2018, LANCET, V391, P1163, DOI 10.1016/S0140-6736(18)30207-1; Kudo M, 2014, HEPATOLOGY, V60, P1697, DOI 10.1002/hep.27290; Labgaa I, 2018, ONCOGENE, V37, P3740, DOI 10.1038/s41388-018-0206-3; Lencioni R, 2016, HEPATOLOGY, V64, P106, DOI 10.1002/hep.28453; Levrero M, 2016, J HEPATOL, V64, pS84, DOI 10.1016/j.jhep.2016.02.021; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Llovet JM, 2002, GUT, V50, P123, DOI 10.1136/gut.50.1.123; Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2018, NAT REV CLIN ONCOL, V15, P599, DOI 10.1038/s41571-018-0073-4; Llovet JM, 2013, J CLIN ONCOL, V31, P3509, DOI 10.1200/JCO.2012.47.3009; Lok AS, 2009, GASTROENTEROLOGY, V136, P138, DOI 10.1053/j.gastro.2008.09.014; Manghisi G, 1998, HEPATOLOGY, V28, P751; Marrero JA, 2018, HEPATOLOGY, V68, P723, DOI 10.1002/hep.29913; Matsui O, 2011, ABDOM IMAGING, V36, P264, DOI 10.1007/s00261-011-9685-1; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Mazzaferro V, 2018, GASTROENTEROLOGY, V154, P128, DOI 10.1053/j.gastro.2017.09.025; Meyer T, 2017, LANCET GASTROENTEROL, V2, P565, DOI 10.1016/S2468-1253(17)30156-5; Moon AM, 2018, GASTROENTEROLOGY, V155, P1128, DOI 10.1053/j.gastro.2018.06.079; Morgan RL, 2013, ANN INTERN MED, V158, P329, DOI 10.7326/0003-4819-158-5-201303050-00005; Nahon P, 2018, GASTROENTEROLOGY, V155, P1436, DOI 10.1053/j.gastro.2018.07.015; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Omata M, 2017, HEPATOL INT, V11, P317, DOI 10.1007/s12072-017-9799-9; Papatheodoridis GV, 2015, J HEPATOL, V62, P956, DOI 10.1016/j.jhep.2015.01.002; Poustchi H, 2011, HEPATOLOGY, V54, P1998, DOI 10.1002/hep.24581; Qin SK, 2013, J CLIN ONCOL, V31, P3501, DOI 10.1200/JCO.2012.44.5643; Reig M, 2016, J HEPATOL, V65, P719, DOI 10.1016/j.jhep.2016.04.008; Rich NE, 2019, CLIN GASTROENTEROL H, V17, P551, DOI 10.1016/j.cgh.2018.05.039; Ricke J, 2018, ANN ONCOL, V29; Rimassa L, 2018, LANCET ONCOL, V19, P682, DOI 10.1016/S1470-2045(18)30146-3; Roayaie S, 2015, HEPATOLOGY, V62, P440, DOI 10.1002/hep.27745; Roberts LR, 2018, HEPATOLOGY, V67, P401, DOI 10.1002/hep.29487; Salem R, 2016, GASTROENTEROLOGY, V151, P1155, DOI 10.1053/j.gastro.2016.08.029; Sangro B, 2013, J HEPATOL, V59, P81, DOI 10.1016/j.jhep.2013.02.022; Sarasin FP, 1996, AM J MED, V101, P422, DOI 10.1016/S0002-9343(96)00197-0; Schulze K, 2016, J HEPATOL, V65, P1031, DOI 10.1016/j.jhep.2016.05.035; Sia D, 2017, GASTROENTEROLOGY, V153, P812, DOI 10.1053/j.gastro.2017.06.007; Singal AG, 2019, GASTROENTEROLOGY; Singal AG, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001624; Takahashi S, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.4107; Taylor EJ, 2017, HEPATOLOGY, V66, P1546, DOI 10.1002/hep.29315; Torrecilla S, 2017, J HEPATOL, V67, P1222, DOI 10.1016/j.jhep.2017.08.013; Tremosini S, 2012, GUT, V61, P1481, DOI 10.1136/gutjnl-2011-301862; Tzartzeva K, 2018, GASTROENTEROLOGY, V154, P1706, DOI 10.1053/j.gastro.2018.01.064; Vilgrain V, 2017, LANCET ONCOL, V18, P1624, DOI 10.1016/S1470-2045(17)30683-6; Villanueva A, 2011, GASTROENTEROLOGY, V140, P1501, DOI 10.1053/j.gastro.2011.02.006; Waziry R, 2017, J HEPATOL, V67, P1204, DOI 10.1016/j.jhep.2017.07.025; WHO, PROJ MORT CAUS DEATH; WHO, CANC TOD; Yang HI, 2011, LANCET ONCOL, V12, P568, DOI 10.1016/S1470-2045(11)70077-8; Yang JD, 2018, HEPATOLOGY, V68, P78, DOI 10.1002/hep.29594; Yau T, 2014, GASTROENTEROLOGY, V146, P1691, DOI 10.1053/j.gastro.2014.02.032; Younossi Z, 2019, CLIN GASTROENTEROL H, V17, P748, DOI 10.1016/j.cgh.2018.05.057; Yuen MF, 2018, NAT REV DIS PRIMERS, V4, DOI [10.1038/nrdp.2018.35, 10.1038/nrdp.2018.36]; Zehir A, 2017, NAT MED, V23, P703, DOI 10.1038/nm.4333; Zhang BH, 2004, J CANCER RES CLIN, V130, P417, DOI 10.1007/s00432-004-0552-0; Zhu AX, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.4003; Zhu AX, 2018, LANCET ONCOL, V19, P940, DOI 10.1016/S1470-2045(18)30351-6; Zhu AX, 2015, LANCET ONCOL, V16, P859, DOI 10.1016/S1470-2045(15)00050-9; Zhu AX, 2015, J CLIN ONCOL, V33, P559, DOI 10.1200/JCO.2013.53.7746; Zhu AX, 2014, JAMA-J AM MED ASSOC, V312, P57, DOI 10.1001/jama.2014.7189; Zucman-Rossi J, 2015, GASTROENTEROLOGY, V149, P1226, DOI 10.1053/j.gastro.2015.05.061	94	1834	1938	49	428	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 11	2019	380	15					1450	1462		10.1056/NEJMra1713263	http://dx.doi.org/10.1056/NEJMra1713263			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HT5NG	30970190				2022-12-28	WOS:000464610000012
J	Silbergleit, R; Elm, JJ				Silbergleit, Robert; Elm, Jordan J.			Levetiracetam no better than phenytoin in children with convulsive status epilepticus	LANCET			English	Editorial Material							LORAZEPAM; DIAZEPAM		[Silbergleit, Robert] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48103 USA; [Elm, Jordan J.] Med Univ South Carolina, Dept Publ Hlth Sci, Data Coordinat Unit, Charleston, SC 29425 USA	University of Michigan System; University of Michigan; Medical University of South Carolina	Silbergleit, R (corresponding author), Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48103 USA.	robert.silbergleit@umich.edu			US National Institutes of Health	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are both Principal Investigators of the ESETT clinical trial, which is funded by the US National Institutes of Health, with overlapping goals to the reported trials. ESETT has completed enrolment but has not yet been published. We declare no other competing interests.	Alldredge BK, 2001, NEW ENGL J MED, V345, P631, DOI 10.1056/NEJMoa002141; Bleck T, 2013, EPILEPSIA, V54, P89, DOI 10.1111/epi.12288; Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; Chamberlain JM, 2014, JAMA-J AM MED ASSOC, V311, P1652, DOI 10.1001/jama.2014.2625; Connor JT, 2013, J CLIN EPIDEMIOL, V66, pS130, DOI 10.1016/j.jclinepi.2013.02.015; Dalziel SR, 2019, LANCET, V393, P2135, DOI 10.1016/S0140-6736(19)30722-6; Glauser T, 2016, EPILEPSY CURR, V16, P48, DOI 10.5698/1535-7597-16.1.48; Guterman EL, 2019, NEUROHOSPITALIST, V9, P133, DOI 10.1177/1941874418819349; Lyttle MD, 2019, LANCET, V393, P2125, DOI 10.1016/S0140-6736(19)30724-X; Silbergleit R, 2012, NEW ENGL J MED, V366, P591, DOI 10.1056/NEJMoa1107494	10	4	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 25	2019	393	10186					2101	2102		10.1016/S0140-6736(19)30896-7	http://dx.doi.org/10.1016/S0140-6736(19)30896-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HZ5KS	31005387	hybrid			2022-12-28	WOS:000468891400005
J	Feld, L; Glick, LR; Cifu, AS				Feld, Lauren; Glick, Laura R.; Cifu, Adam S.			Diagnosis and Management of Crohn Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Feld, Lauren; Cifu, Adam S.] Univ Chicago, 5841 S Maryland Ave,Ste MC 3051, Chicago, IL 60637 USA; [Glick, Laura R.] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Cifu, AS (corresponding author), Univ Chicago, 5841 S Maryland Ave,Ste MC 3051, Chicago, IL 60637 USA.	adamcifu@uchicago.edu						Behm BW, 2008, COCHRANE DB SYST REV, V23, DOI DOI 10.1002/14651858.CD006893; Sandborn WJ, 2013, NEW ENGL J MED, V369, P711, DOI 10.1056/NEJMoa1215739; van Rheenen PF, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3369; 2018, AM J GASTROENTEROL, V113, P481, DOI DOI 10.1038/AJG.2018.27; 2007, GUT, V56, P1226, DOI DOI 10.1136/GUT.2006.099978; 2016, INFLAMM BOWEL DIS, V22, P2182, DOI DOI 10.1097/MIB.0000000000000893; 2011, AM J GASTROENTEROL, V106, P617, DOI DOI 10.1038/AJG.2011.71	7	2	2	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2019	321	18					1822	1823		10.1001/jama.2019.3684	http://dx.doi.org/10.1001/jama.2019.3684			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HY7ME	30969326				2022-12-28	WOS:000468319100019
J	Afshin, A; Sur, PJ; Fay, KA; Cornaby, L; Ferrara, G; Salama, JS; Mullany, EC; Abate, KH; Abbafati, C; Abebe, Z; Afarideh, M; Aggarwal, A; Agrawal, S; Akinyemiju, T; Alahdab, F; Bacha, U; Bachman, VF; Badali, H; Badawi, A; Bensenor, IM; Bernabe, E; Biryukov, SH; Biadgilign, SKK; Cahill, LE; Carrero, JJ; Cercy, KM; Dandona, L; Dandona, R; Dang, AK; Degefa, MG; Zaki, ME; Esteghamati, A; Esteghamati, S; Fanzo, J; Farinha, CSES; Farvid, MS; Farzadfar, F; Feigin, VL; Fernandes, JC; Flor, LS; Foigt, NA; Forouzanfar, MH; Ganji, M; Geleijnse, JM; Gillum, RF; Goulart, AC; Grosso, G; Guessous, I; Hamidi, S; Hankey, GJ; Harikrishnan, S; Hassen, HY; Hay, SI; Hoang, CL; Horino, M; Islami, F; Jackson, MD; James, SL; Johansson, L; Jonas, JB; Kasaeian, A; Khader, YS; Khalil, IA; Khang, YH; Kimokoti, RW; Kokubo, Y; Kumar, GA; Lallukka, T; Lopez, AD; Lorkowski, S; Lotufo, PA; Lozano, R; Malekzadeh, R; Marz, W; Meier, T; Melaku, YA; Mendoza, W; Mensink, GBM; Micha, R; Miller, TR; Mirarefin, M; Mohan, V; Mokdad, AH; Mozaffarian, D; Nagel, G; Naghavi, M; Nguyen, CT; Nixon, MR; Ong, KL; Pereira, DM; Poustchi, H; Qorbani, M; Rai, RK; Razo-Garcia, C; Rehm, CD; Rivera, JA; Rodriguez-Ramirez, S; Roshandel, G; Roth, GA; Sanabria, J; Sanchez-Pimienta, TG; Sartorius, B; Schmidhuber, J; Schutte, AE; Sepanlou, SG; Shin, MJ; Sorensen, RJD; Springmann, M; Szponar, L; Thorne-Lyman, AL; Thrift, AG; Touvier, M; Tran, BX; Tyrovolas, S; Ukwaja, KN; Ullah, I; Uthman, OA; Vaezghasemi, M; Vasankari, TJ; Vollset, SE; Vos, T; Vu, GT; Vu, LG; Weiderpass, E; Werdecker, A; Wijeratne, T; Willett, WC; Wu, JH; Xu, GL; Yonemoto, N; Yu, CH; Murray, CJL				Afshin, Ashkan; Sur, Patrick John; Fay, Kairsten A.; Cornaby, Leslie; Ferrara, Giannina; Salama, Joseph S.; Mullany, Erin C.; Abate, Kalkidan Hassen; Abbafati, Cristiana; Abebe, Zegeye; Afarideh, Mohsen; Aggarwal, Anju; Agrawal, Sutapa; Akinyemiju, Tomi; Alahdab, Fares; Bacha, Umar; Bachman, Victoria F.; Badali, Hamid; Badawi, Alaa; Bensenor, Isabela M.; Bernabe, Eduardo; Biryukov, Stan H.; Biadgilign, Sibhatu Kassa K.; Cahill, Leah E.; Carrero, Juan J.; Cercy, Kelly M.; Dandona, Lalit; Dandona, Rakhi; Anh Kim Dang; Degefa, Meaza Girma; Zaki, Maysaa El Sayed; Esteghamati, Alireza; Esteghamati, Sadaf; Fanzo, Jessica; Farinha, Carla Sofia E. Sa; Farvid, Maryam S.; Farzadfar, Farshad; Feigin, Valery L.; Fernandes, Joao C.; Flor, Luisa Sorio; Foigt, Nataliya A.; Forouzanfar, Mohammad H.; Ganji, Morsaleh; Geleijnse, Johanna M.; Gillum, Richard F.; Goulart, Alessandra C.; Grosso, Giuseppe; Guessous, Idris; Hamidi, Samer; Hankey, Graeme J.; Harikrishnan, Sivadasanpillai; Hassen, Hamid Yimam; Hay, Simon I.; Chi Linh Hoang; Horino, Masako; Islami, Farhad; Jackson, Maria D.; James, Spencer L.; Johansson, Lars; Jonas, Jost B.; Kasaeian, Amir; Khader, Yousef Saleh; Khalil, Ibrahim A.; Khang, Young-Ho; Kimokoti, Ruth W.; Kokubo, Yoshihiro; Kumar, G. Anil; Lallukka, Tea; Lopez, Alan D.; Lorkowski, Stefan; Lotufo, Paulo A.; Lozano, Rafael; Malekzadeh, Reza; Marz, Winfried; Meier, Toni; Melaku, Yohannes A.; Mendoza, Walter; Mensink, Gert B. M.; Micha, Renata; Miller, Ted R.; Mirarefin, Mojde; Mohan, Viswanathan; Mokdad, Ali H.; Mozaffarian, Dariush; Nagel, Gabriele; Naghavi, Mohsen; Cuong Tat Nguyen; Nixon, Molly R.; Ong, Kanyin L.; Pereira, David M.; Poustchi, Hossein; Qorbani, Mostafa; Rai, Rajesh Kumar; Razo-Garcia, Christian; Rehm, Colin D.; Rivera, Juan A.; Rodriguez-Ramirez, Sonia; Roshandel, Gholamreza; Roth, Gregory A.; Sanabria, Juan; Sanchez-Pimienta, Tania G.; Sartorius, Benn; Schmidhuber, Josef; Schutte, Aletta Elisabeth; Sepanlou, Sadaf G.; Shin, Min-Jeong; Sorensen, Reed J. D.; Springmann, Marco; Szponar, Lucjan; Thorne-Lyman, Andrew L.; Thrift, Amanda G.; Touvier, Mathilde; Bach Xuan Tran; Tyrovolas, Stefanos; Ukwaja, Kingsley Nnanna; Ullah, Irfan; Uthman, Olalekan A.; Vaezghasemi, Masoud; Vasankari, Tommi Juhani; Vollset, Stein Emil; Theo Vos; Giang Thu Vu; Linh Gia Vu; Weiderpass, Elisabete; Werdecker, Andrea; Wijeratne, Tissa; Willett, Walter C.; Wu, Jason H.; Xu, Gelin; Yonemoto, Naohiro; Yu, Chuanhua; Murray, Christopher J. L.		GBD 2017 Diet Collaborators	Health effects of dietary risks in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017	LANCET			English	Article							COST-EFFECTIVENESS; ENVIRONMENTAL SUSTAINABILITY; CARDIOVASCULAR-DISEASE; SODIUM-INTAKE; CONSUMPTION; IMPACT; ASSOCIATIONS; NUTRITION; REGIONS; US	Background Suboptimal diet is an important preventable risk factor for non-communicable diseases (NCDs); however, its impact on the burden of NCDs has not been systematically evaluated. This study aimed to evaluate the consumption of major foods and nutrients across 195 countries and to quantify the impact of their suboptimal intake on NCD mortality and morbidity. Methods By use of a comparative risk assessment approach, we estimated the proportion of disease-specific burden attributable to each dietary risk factor (also referred to as population attributable fraction) among adults aged 25 years or older. The main inputs to this analysis included the intake of each dietary factor, the effect size of the dietary factor on disease endpoint, and the level of intake associated with the lowest risk of mortality. Then, by use of diseasespecific population attributable fractions, mortality, and disability-adjusted life-years (DALYs), we calculated the number of deaths and DALYs attributable to diet for each disease outcome. Findings In 2017, 11 million (95% uncertainty interval [UI] 10-12) deaths and 255 million (234-274) DALYs were attributable to dietary risk factors. High intake of sodium (3 million [1-5] deaths and 70 million [34-118] DALYs), low intake of whole grains (3 million [2-4] deaths and 82 million [59-109] DALYs), and low intake of fruits (2 million [1-4] deaths and 65 million [41-92] DALYs) were the leading dietary risk factors for deaths and DALYs globally and in many countries. Dietary data were from mixed sources and were not available for all countries, increasing the statistical uncertainty of our estimates. Interpretation This study provides a comprehensive picture of the potential impact of suboptimal diet on NCD mortality and morbidity, highlighting the need for improving diet across nations. Our findings will inform implementation of evidence-based dietary interventions and provide a platform for evaluation of their impact on human health annually.	[Afshin, Ashkan; Hay, Simon I.; Khalil, Ibrahim A.; Mokdad, Ali H.; Naghavi, Mohsen; Vollset, Stein Emil; Theo Vos; Murray, Christopher J. L.] Univ Washington, Dept Hlth Metr Sci, Seattle, WA 98195 USA; [Afshin, Ashkan; Sur, Patrick John; Fay, Kairsten A.; Cornaby, Leslie; Ferrara, Giannina; Salama, Joseph S.; Mullany, Erin C.; Biryukov, Stan H.; Cercy, Kelly M.; Dandona, Lalit; Dandona, Rakhi; Feigin, Valery L.; Forouzanfar, Mohammad H.; Hay, Simon I.; James, Spencer L.; Khalil, Ibrahim A.; Lopez, Alan D.; Lozano, Rafael; Mokdad, Ali H.; Naghavi, Mohsen; Nixon, Molly R.; Ong, Kanyin L.; Roth, Gregory A.; Sorensen, Reed J. D.; Vollset, Stein Emil; Theo Vos; Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr Evaluat, Seattle, WA 98195 USA; [Aggarwal, Anju] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Bachman, Victoria F.] Univ Washington, Sch Med, Seattle, WA 98195 USA; [Roth, Gregory A.] Univ Washington, Div Cardiol, Seattle, WA 98195 USA; [Sorensen, Reed J. D.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Sur, Patrick John] Univ Calif Riverside, Sch Med, Riverside, CA 92521 USA; [Abate, Kalkidan Hassen] Jimma Univ, Dept Populat & Family Hlth, Jimma, Ethiopia; [Abbafati, Cristiana] Univ Roma La Sapienza, Dept Law Philosophy & Econ Studies, Rome, Italy; [Abebe, Zegeye] Univ Gondar, Dept Human Nutr, Gondar, Ethiopia; [Melaku, Yohannes A.] Univ Gondar, Inst Publ Hlth, Gondar, Ethiopia; [Afarideh, Mohsen; Esteghamati, Alireza; Ganji, Morsaleh] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Tehran, Iran; [Esteghamati, Sadaf] Univ Tehran Med Sci, Endocrine Res Ctr, Tehran, Iran; [Farzadfar, Farshad] Univ Tehran Med Sci, Noncommunicable Dis Res Ctr, Tehran, Iran; [Kasaeian, Amir] Univ Tehran Med Sci, Hematol Malignancies Res Ctr, Tehran, Iran; [Malekzadeh, Reza; Poustchi, Hossein; Roshandel, Gholamreza; Sepanlou, Sadaf G.] Univ Tehran Med Sci, Digest Dis Res Inst, Tehran, Iran; [Kasaeian, Amir] Univ Tehran Med Sci, Hematol Oncol & Stem Cell Transplantat Res Ctr, Tehran, Iran; [Agrawal, Sutapa] Vital Strategies, Gurugram, India; [Akinyemiju, Tomi] Univ Kentucky, Dept Epidemiol, Lexington, KY USA; [Alahdab, Fares] Mayo Clin, Fdn Med Educ & Res, Evidence Based Practice Ctr, Rochester, MN USA; [Bacha, Umar] Univ Management & Technol, Sch Hlth Sci, Lahore, Pakistan; [Badali, Hamid] Mazandaran Univ Med Sci, Dept Med Mycol, Sari, Iran; [Badawi, Alaa] Publ Hlth Agcy Canada, Publ Hlth Risk Sci Div, Toronto, ON, Canada; [Badawi, Alaa] Univ Toronto, Dept Nutr Sci, Toronto, ON, Canada; [Bensenor, Isabela M.; Goulart, Alessandra C.] Univ Sao Paulo, Dept Internal Med, Sao Paulo, Brazil; [Lotufo, Paulo A.] Univ Sao Paulo, Dept Med, Sao Paulo, Brazil; [Goulart, Alessandra C.] Univ Sao Paulo, Ctr Clin & Epidemiol Res, Sao Paulo, Brazil; [Bernabe, Eduardo] Kings Coll London, Inst Dent, London, England; [Cahill, Leah E.] Dalhousie Univ, Dept Med, Halifax, NS, Canada; [Cahill, Leah E.; Farvid, Maryam S.; Willett, Walter C.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Thorne-Lyman, Andrew L.] Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Carrero, Juan J.; Weiderpass, Elisabete] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Agrawal, Sutapa; Dandona, Lalit; Dandona, Rakhi; Kumar, G. Anil] Publ Hlth Fdn India, Gurugram, India; [Anh Kim Dang; Cuong Tat Nguyen] Duy Tan Univ, Inst Global Hlth Innovat, Hanoi, Vietnam; [Degefa, Meaza Girma] Mekelle Univ, Dept Nutr & Dietet, Mekelle, Ethiopia; [Zaki, Maysaa El Sayed] Mansoura Univ, Dept Clin Pathol, Mansoura, Egypt; [Fanzo, Jessica] Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD USA; [Thorne-Lyman, Andrew L.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Farinha, Carla Sofia E. Sa] Natl Stat Off, Lisbon, Portugal; [Fanzo, Jessica] Food & Agr Org United Nations, Nutr & Food Syst Div, Rome, Italy; [Schmidhuber, Josef] Food & Agr Org United Nations, Trade & Markets Div, Rome, Italy; [Feigin, Valery L.] Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Fernandes, Joao C.] Catholic Univ Portugal, Ctr Biotechnol & Fine Chem, Porto, Portugal; [Flor, Luisa Sorio] Sergio Arouca Natl Sch Publ Hlth, Rio De Janeiro, Brazil; [Flor, Luisa Sorio] Univ Fed Espirito Santo, Vitoria, Brazil; [Foigt, Nataliya A.] Natl Acad Med Sci Ukraine, Inst Gerontol, Kiev, Ukraine; [Geleijnse, Johanna M.] Wageningen Univ & Res, Div Human Nutr & Hlth, Wageningen, Netherlands; [Gillum, Richard F.] Howard Univ, Dept Community & Family Med, Div Gen Internal Med, Washington, DC 20059 USA; [Grosso, Giuseppe] Vittorio Emanuele Univ Hosp Polyclin, Registro Tumori Integrato, Catania, Italy; [Guessous, Idris] Geneva Univ Hosp, Dept Community Med Primary Care & Emergency Med, Unit Populat Epidemiol, Geneva, Switzerland; [Guessous, Idris] Univ Lausanne, Dept Ambulatory Care & Community Med, Lausanne, Switzerland; [Hamidi, Samer] Hamdan Bin Mohammed Smart Univ, Sch Hlth & Environm Studies, Dubai, U Arab Emirates; [Hankey, Graeme J.] Univ Western Australia, Sch Med, Perth, WA, Australia; [Hankey, Graeme J.] Sir Charles Gairdner Hosp, Dept Neurol, Perth, WA, Australia; [Harikrishnan, Sivadasanpillai] Sree Chitra Tirunal Inst Med Sci & Technol, Dept Cardiol, Trivandrum, Kerala, India; [Hassen, Hamid Yimam] Mizan Tepi Univ, Dept Publ Hlth, Teppi, Ethiopia; [Hassen, Hamid Yimam] Univ Hosp Antwerp, Unit Epidemiol & Social Med, Antwerp, Belgium; [Chi Linh Hoang; Giang Thu Vu; Linh Gia Vu] Nguyen Tat Thanh Univ, Ctr Excellence Behav Med, Ho Chi Minh, Vietnam; [Horino, Masako; Mirarefin, Mojde] Nevada Div Publ & Behav Hlth, Carson City, NV USA; [Islami, Farhad] Amer Canc Soc, Surveillance & Hlth Serv Res, Atlanta, GA 30329 USA; [Jackson, Maria D.] Univ West Indies, Dept Community Hlth & Psychiat, Mona, Jamaica; [Jonas, Jost B.] Heidelberg Univ, Dept Ophthalmol, Mannheim, Germany; [Marz, Winfried] Heidelberg Univ, Med Clin V, Mannheim, Germany; [Jonas, Jost B.] Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China; [Khader, Yousef Saleh] Jordan Univ Sci & Technol, Dept Publ Hlth & Community Med, Ramtha, Jordan; [Khang, Young-Ho] Seoul Natl Univ, Dept Hlth Policy & Management, Inst Hlth Policy & Management, Seoul, South Korea; [Kimokoti, Ruth W.] Simmons Coll, Dept Nutr, Boston, MA 02115 USA; [Kokubo, Yoshihiro] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Cardiol, Suita, Osaka, Japan; [Lallukka, Tea] Finnish Inst Occupat Hlth, Populat & Work Abil Program, Helsinki, Finland; [Lallukka, Tea] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Wijeratne, Tissa] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Lopez, Alan D.] Univ Melbourne, Melbourne, Vic, Australia; [Lorkowski, Stefan] Friedrich Schiller Univ Jena, Inst Nutr, Jena, Germany; [Meier, Toni] Innovat Off, Jena, Germany; [Lorkowski, Stefan] Competence Cluster Nutr & Cardiovasc Hlth NUTRICA, Jena, Germany; [Malekzadeh, Reza; Sepanlou, Sadaf G.] Shiraz Univ Med Sci, Noncommunicable Dis Res Ctr, Shiraz, Iran; [Marz, Winfried] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Meier, Toni] Martin Luther Univ Halle Wittenberg, Inst Agr & Nutr Sci, Halle, Germany; [Melaku, Yohannes A.] Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia; [Mendoza, Walter] United Nations Populat Fund UNFPA, Peru Country Off, Lima, Peru; [Mensink, Gert B. M.] Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Berlin, Germany; [Micha, Renata; Mozaffarian, Dariush] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA USA; [Miller, Ted R.] Pacific Inst Res & Evaluat, Calverton, MD USA; [Miller, Ted R.] Curtin Univ, Sch Publ Hlth, Perth, WA, Australia; [Mohan, Viswanathan] Madras Diabet Res Fdn, Dept Diabetol, Chennai, Tamil Nadu, India; [Nagel, Gabriele] Univ Ulm, Inst Epidemiol & Med Biometry, Ulm, Germany; [Pereira, David M.] Univ Porto, REQUIMTE, LAQV, Porto, Portugal; [Pereira, David M.] Cartagena Univ, Cartagena, Colombia; [Qorbani, Mostafa] Alborz Univ Med Sci, Noncommunicable Dis Res Ctr, Karaj, Iran; [Rai, Rajesh Kumar] Soc Hlth & Demog Surveillance, Suri, India; [Rai, Rajesh Kumar] Univ Goettingen, Dept Econ, Gottingen, Germany; [Razo-Garcia, Christian] Ctr Populat Hlth Res, Cuernavaca, Morelos, Mexico; [Rivera, Juan A.; Rodriguez-Ramirez, Sonia] Ctr Nutr & Hlth Res, Cuernavaca, Morelos, Mexico; [Sanchez-Pimienta, Tania G.] Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico; [Rehm, Colin D.] Montefiore Med Ctr, Dept Epidemiol & Populat Hlth, Bronx, NY USA; [Roshandel, Gholamreza] Golestan Univ Med Sci, Golestan Res Ctr Gastroenterol & Hepatol, Gorgan, Golestan, Iran; [Sanabria, Juan] Marshall Univ, Dept Surg, Huntington, WV USA; [Sanabria, Juan] Case Western Reserve Univ, Dept Nutr & Prevent Med, Cleveland, OH 44106 USA; [Sartorius, Benn] Univ Kwazulu Natal, Dept Publ Hlth Med, Durban, South Africa; [Schutte, Aletta Elisabeth] North West Univ, HART, Potchefstroom, South Africa; [Schutte, Aletta Elisabeth] South African Med Res Council, Unit Hypertens & Cardiovasc Dis, Cape Town, South Africa; [Shin, Min-Jeong] Korea Univ, Seoul, South Korea; [Springmann, Marco] Univ Oxford, Nuffield Dept Populat Hlth, Oxford Martin Programme Future Food, Oxford, England; [Springmann, Marco] Univ Oxford, Nuffield Dept Populat Hlth, Ctr Populat Approaches Noncommunicable Dis Preven, Oxford, England; [Szponar, Lucjan] Natl Food & Nutr Inst, Warsaw, Poland; [Thrift, Amanda G.] Monash Univ, Melbourne, Vic, Australia; [Touvier, Mathilde] Natl Inst Hlth & Med Res, Nutr Epidemiol Res Team, Paris, France; [Bach Xuan Tran] Hanoi Med Univ, Dept Hlth Econ, Hanoi, Vietnam; [Tyrovolas, Stefanos] San Juan de Dios Sanitary Pk, Res & Dev Unit, Sant Boi De Llobregat, Spain; [Tyrovolas, Stefanos] Carlos III Hlth Inst, Biomed Res Networking Ctr, Mental Hlth Network CIBERSAM, Madrid, Spain; [Ukwaja, Kingsley Nnanna] Fed Teaching Hosp, Dept Internal Med, Abakaliki, Nigeria; [Ullah, Irfan] Gomal Univ, Gomal Ctr Biochem & Biotechnol, Dera Ismail Khan, Pakistan; [Ullah, Irfan] Mufti Mehmood Mem Teaching Hosp, TB Culture Lab, Dera Ismail Khan, Pakistan; [Uthman, Olalekan A.] Univ Warwick, Div Hlth Sci, Coventry, W Midlands, England; [Vaezghasemi, Masoud] Umea Univ, Dept Publ Hlth & Clin Med, Dept Social Work, Umea, Sweden; [Vasankari, Tommi Juhani] UKK Inst, Tampere, Finland; [Weiderpass, Elisabete] Canc Registry Norway, Dept Res, Oslo, Norway; [Werdecker, Andrea] Fed Inst Populat Res, Demog Change & Ageing Res Area, Wiesbaden, Germany; [Wijeratne, Tissa] La Trobe Univ, Dept Psychol, Melbourne, Vic, Australia; [Willett, Walter C.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Wu, Jason H.] Univ New South Wales, George Inst Global Hlth, Newtown, NSW, Australia; [Xu, Gelin] Nanjing Univ, Sch Med, Nanjing, Jiangsu, Peoples R China; [Yonemoto, Naohiro] Natl Ctr Neurol & Psychiat, Dept Psychopharmacol, Tokyo, Japan; [Yu, Chuanhua] Wuhan Univ, Dept Epidemiol & Biostat, Global Hlth Inst, Wuhan, Hubei, Peoples R China	University of Washington; University of Washington Seattle; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California Riverside; Jimma University; Sapienza University Rome; University of Gondar; University of Gondar; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; University of Kentucky; Mayo Clinic; University of Management & Technology (UMT); Mazandaran University Medical Sciences; Public Health Agency of Canada; University of Toronto; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; University of London; King's College London; Dalhousie University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Karolinska Institutet; Public Health Foundation of India; Duy Tan University; Mekelle University; Egyptian Knowledge Bank (EKB); Mansoura University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Food & Agriculture Organization of the United Nations (FAO); Food & Agriculture Organization of the United Nations (FAO); Auckland University of Technology; Universidade Catolica Portuguesa; Universidade Federal do Espirito Santo; National Academy of Medical Sciences of Ukraine; D. F. Chebotarev Institute of Gerontology of the National Academy of Medical Sciences of Ukraine; Wageningen University & Research; Howard University; Azienda Ospedaliera Universitaria Policlinico Vittorio Emanuele Presidio Ferraotto; University of Geneva; University of Lausanne; University of Western Australia; University of Western Australia; Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST); University of Antwerp; Nguyen Tat Thanh University (NTTU); American Cancer Society; University West Indies Mona Jamaica; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Capital Medical University; Jordan University of Science & Technology; Seoul National University (SNU); Simmons University; National Cerebral & Cardiovascular Center - Japan; Finnish Institute of Occupational Health; University of Helsinki; University of Melbourne; University of Melbourne; Friedrich Schiller University of Jena; Shiraz University of Medical Science; Medical University of Graz; Martin Luther University Halle Wittenberg; University of Adelaide; Robert Koch Institute; Tufts University; Pacific Institute for Research & Evaluation (PIRE); Curtin University; Madras Diabetes Research Foundation; Ulm University; Universidade do Porto; Universidad de Cartagena; University of Gottingen; Instituto Nacional de Salud Publica; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Golestan University of Medical Sciences; Marshall University; Case Western Reserve University; University of Kwazulu Natal; North West University - South Africa; South African Medical Research Council; Korea University; University of Oxford; University of Oxford; Monash University; Institut National de la Sante et de la Recherche Medicale (Inserm); Hanoi Medical University; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Gomal University; University of Warwick; Umea University; UKK Institute; University of Oslo; La Trobe University; Harvard University; Brigham & Women's Hospital; George Institute for Global Health; University of New South Wales Sydney; University of Sydney; Nanjing University; National Center for Neurology & Psychiatry - Japan; Wuhan University	Murray, CJL (corresponding author), Univ Washington, Inst Hlth Metr Evaluat, Seattle, WA 98195 USA.	cjlm@uw.edu	f, m/AAM-2063-2021; Lopez, Alan D/F-1487-2010; Tyrovolas, Stefanos/M-2758-2014; Fernandes, Joao C/AAF-2091-2019; Nagel, Gabriele/C-3635-2012; Badawi, Alaa/ABC-1300-2021; Hankey, Graeme J/H-4968-2014; Lopez, Alan/AAA-2734-2022; Mozaffarian, Dariush/ABC-2822-2020; Aggarwal, Anju/I-7512-2019; Naohiro, Yonemoto/Y-3761-2019; Kasaeian, Amir/C-8290-2017; Lorkowski, Stefan/B-9689-2008; Weiderpass, Elisabete/AAP-2747-2021; abbafati, cristiana/AAD-7511-2022; Pereira, David/M-9286-2013; Hay, Simon Iain/F-8967-2015; Zaki, Maysaa El Sayed/C-1522-2013; Goulart, Alessandra C/J-2845-2014; Feigin, Valery/AAF-2313-2019; Afarideh, Mohsen/H-8945-2019; Foigt, Nataliya/AAU-5229-2020; Meier, Toni/AAB-1704-2021; Khader, Yousef/AAE-9620-2019; Joukar, Farahnaz/GMW-7238-2022; Badali, Hamid/J-8036-2016; FRACP, Tissa Wijeratne MD PhD/I-2086-2019; FARINHA, carla Sofia/W-9306-2019; Bacha, Umar/M-2055-2015; Fanzo, Jessica/HCH-3533-2022; Geleijnse, Johanna Marianna M/B-5749-2012; Abate, Kalkidan Hassen/ABA-9014-2020; Grosso, Giuseppe/K-6730-2016; Rodríguez-Ramírez, Sonia/AAB-8988-2022; Abebe, Zegeye/AAJ-6459-2020; Zaki, Maysaa El Sayed/H-3049-2019; Cahill, Leah/AAS-2704-2021; Roshandel, Gholamreza/AAJ-9562-2021; Alahdab, Fares/N-6680-2013; Bernabe, Eduardo/R-3441-2017; Qorbani, Mostafa/M-8171-2017; Mokdad, Ali H./AAD-1232-2022; Wu, Jason/J-2936-2019; S, Harikrishnan/AAT-8083-2021; Sposato, Luciano A/D-7782-2012; Schutte, Aletta E/E-5126-2018; Ullah, Irfan/L-5150-2017; Grosso, Giuseppe/ABA-1587-2020; Lozano, Rafael/T-5352-2018; Sepanlou, Sadaf/H-9343-2016; Uthman, Olalekan/P-7916-2014; Thrift, Amanda/I-6251-2012; Touvier, Mathilde/GLT-6939-2022; Mensink, Gert/B-2447-2009; Hassen, Hamid/A-1105-2019	Lopez, Alan D/0000-0001-5818-6512; Fernandes, Joao C/0000-0003-1556-1698; Nagel, Gabriele/0000-0001-6185-8535; Hankey, Graeme J/0000-0002-6044-7328; Kasaeian, Amir/0000-0003-2018-9368; Lorkowski, Stefan/0000-0002-9649-840X; Weiderpass, Elisabete/0000-0003-2237-0128; Pereira, David/0000-0003-0384-7592; Hay, Simon Iain/0000-0002-0611-7272; Zaki, Maysaa El Sayed/0000-0001-5431-0248; Goulart, Alessandra C/0000-0003-1076-5210; Afarideh, Mohsen/0000-0002-3578-5640; Foigt, Nataliya/0000-0002-3613-5965; Meier, Toni/0000-0001-6056-0665; Khader, Yousef/0000-0002-7830-6857; Joukar, Farahnaz/0000-0003-0102-0575; Badali, Hamid/0000-0002-6010-8414; FRACP, Tissa Wijeratne MD PhD/0000-0002-1701-7111; FARINHA, carla Sofia/0000-0002-4110-2156; Bacha, Umar/0000-0002-4156-1125; Geleijnse, Johanna Marianna M/0000-0001-7638-0589; Abate, Kalkidan Hassen/0000-0001-9752-5417; Grosso, Giuseppe/0000-0003-3930-5285; Rodríguez-Ramírez, Sonia/0000-0002-5439-4389; Abebe, Zegeye/0000-0001-6922-0376; Zaki, Maysaa El Sayed/0000-0001-5431-0248; Roshandel, Gholamreza/0000-0002-5494-0722; Alahdab, Fares/0000-0001-5481-696X; Bernabe, Eduardo/0000-0002-1858-3713; Mokdad, Ali H./0000-0002-4994-3339; Wu, Jason/0000-0003-2073-3562; Sposato, Luciano A/0000-0001-6425-9343; Schutte, Aletta E/0000-0001-9217-4937; Grosso, Giuseppe/0000-0003-3930-5285; Lozano, Rafael/0000-0002-7356-8823; Feigin, Valery L./0000-0002-6372-1740; Esteghamati, Alireza/0000-0001-5114-3982; Biadgilign, Sibhatu/0000-0002-7582-5977; Farvid, Maryam/0000-0003-1783-4186; Fanzo, Jessica/0000-0002-6760-1359; Sepanlou, Sadaf/0000-0002-3669-5129; Lucjan, szponar/0000-0003-4225-8299; Hamidi, Samer/0000-0002-6766-3728; Melaku, Yohannes Adama/0000-0002-3051-7313; Lallukka, Tea/0000-0003-3841-3129; S, Harikrishnan/0000-0002-7509-0712; Uthman, Olalekan/0000-0002-8567-3081; Thrift, Amanda/0000-0001-8533-4170; Miller, Ted/0000-0002-0958-2639; Farzadfar, Farshad/0000-0001-8288-4046; Touvier, Mathilde/0000-0002-8322-8857; Kimokoti, Ruth/0000-0002-4980-3256; Mensink, Gert/0000-0001-6268-5998; Ullah, Irfan/0000-0001-6992-6723; Hassen, Hamid/0000-0001-6485-4193; Sanchez Pimienta, Tania Georgina/0000-0002-7743-0047; Islami, Farhad/0000-0002-7357-5994; Rai, Rajesh Kumar/0000-0002-5249-9937; Degefa, Meaza/0000-0003-0175-6937	Bill AMP; Melinda Gates Foundation	Bill AMP; Melinda Gates Foundation	Bill & Melinda Gates Foundation.	Afshin A, 2015, CURR CARDIOL REP, V17, DOI 10.1007/s11886-015-0658-9; Anand SS, 2015, J AM COLL CARDIOL, V66, P1590, DOI 10.1016/j.jacc.2015.07.050; Auestad N, 2015, ADV NUTR, V6, P19, DOI 10.3945/an.114.005694; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Brown GW., 2014, HDB GLOBAL HLTH POLI; Cobiac LJ, 2013, ANNU REV NUTR, V33, P373, DOI 10.1146/annurev-nutr-071812-161133; Colditz GA, 2010, CRIT REV FOOD SCI, V50, P10, DOI 10.1080/10408398.2010.526838; Djalalinia S, 2017, ARCH IRAN MED, V20, P392; Downs SM, 2013, B WORLD HEALTH ORGAN, V91, P262, DOI 10.2471/BLT.12.111468; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8; Heller MC, 2013, ENVIRON SCI TECHNOL, V47, P12632, DOI 10.1021/es4025113; Hill RJ, 2001, BRIT J NUTR, V85, P415, DOI 10.1079/BJN2000281; Illner AK, 2012, INT J EPIDEMIOL, V41, P1187, DOI 10.1093/ije/dys105; Lachat C, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001465; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; McGuire S, 2011, ADV NUTR, V2, P293, DOI 10.3945/an.111.000430; McLean RM, 2014, NUTRIENTS, V6, P4651, DOI 10.3390/nu6114651; Mente A, 2016, LANCET, V388, P465, DOI 10.1016/S0140-6736(16)30467-6; Micha R, 2012, EUR J CLIN NUTR, V66, P119, DOI 10.1038/ejcn.2011.147; Micha R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175149; Micha R, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008705; Micha R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2272; Mozaffarian D, 2014, NEW ENGL J MED, V371, P624, DOI 10.1056/NEJMoa1304127; Mozaffarian D, 2012, CIRCULATION, V126, P1514, DOI 10.1161/CIR.0b013e318260a20b; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; Newton JN, 2015, LANCET, V386, P2257, DOI 10.1016/S0140-6736(15)00195-6; Norat T, 2010, ASS FOOD NUTR PHYS A; Organization W. H, 2009, 2008 2013 ACT PLAN G; Owen L, 2012, J PUBLIC HEALTH-UK, V34, P37, DOI 10.1093/pubmed/fdr075; Sabate J, 2014, AM J CLIN NUTR, V100, p476S, DOI 10.3945/ajcn.113.071522; Schmidhuber J, 2018, LANCET PLANET HEALTH, V2, pE353, DOI 10.1016/S2542-5196(18)30170-0; Singh GM, 2015, CIRCULATION, V132, P639, DOI 10.1161/CIRCULATIONAHA.114.010636; Singh GM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124845; Singh GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065174; Smith-Spangler CM, 2010, ANN INTERN MED, V152, P481, DOI 10.7326/0003-4819-152-8-201004200-00212; Tilman D, 2014, NATURE, V515, P518, DOI 10.1038/nature13959; Trinquart L, 2016, INT J EPIDEMIOL, V45, P251, DOI 10.1093/ije/dyv184; Wang Q, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002891; Willett WC, 2013, ANNU REV PUBL HEALTH, V34, P77, DOI 10.1146/annurev-publhealth-031811-124646; World Cancer Research Fund / American Institute for Cancer Research, 2018, DIET NUTR PHYS ACT C; World Health Organization, 2009, INT DIET PHYS ACT WH; World Health Organization, 2013, GLOB ACT PLAN PREV C; 2004, PUBLIC HEALTH NUTR, V7, P245, DOI DOI 10.1079/PHN2003592	45	1689	1750	62	364	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 11	2019	393	10184					1958	1972		10.1016/S0140-6736(19)30041-8	http://dx.doi.org/10.1016/S0140-6736(19)30041-8			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HX9AE	30954305	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000467698100031
J	Weisenburger, S; Tejera, F; Demas, J; Chen, B; Manley, J; Sparks, FT; Traub, FM; Daigle, T; Zeng, HK; Losonczy, A; Vaziri, A				Weisenburger, Siegfried; Tejera, Frank; Demas, Jeffrey; Chen, Brandon; Manley, Jason; Sparks, Fraser T.; Traub, Francisca Martinez; Daigle, Tanya; Zeng, Hongkui; Losonczy, Attila; Vaziri, Alipasha			Volumetric Ca2+ Imaging in the Mouse Brain Using Hybrid Multiplexed Sculpted Light Microscopy	CELL			English	Article							TEMPORAL FOCUSING CHARACTERISTICS; NEURONAL-ACTIVITY; FLUORESCENT PROTEINS; 2-PHOTON EXCITATION; PARIETAL CORTEX; HIPPOCAMPUS; DYNAMICS; DEPTH; TECHNOLOGIES; ORGANIZATION	Calcium imaging using two-photon scanning microscopy has become an essential tool in neuroscience. However, in its typical implementation the tradeoffs between fields of view, acquisition speeds, and depth restrictions in scattering brain tissue pose severe limitations. Here, using an integrated systems-wide optimization approach combined with multiple technical innovations, we introduce a new design paradigm for optical microscopy based on maximizing biological information while maintaining the fidelity of obtained neuron signals. Our modular design utilizes hybrid multi-photon acquisition and allows volumetric recording of neuroactivity at single-cell resolution within up to 1 x 1 x 1.22 mm volumes at up to 17 Hz in awake behaving mice. We establish the capabilities and potential of the different configurations of our imaging system at depth and across brain regions by applying it to in vivo recording of up to 12,000 neurons in mouse auditory cortex, posterior parietal cortex, and hippocampus.	[Weisenburger, Siegfried; Tejera, Frank; Demas, Jeffrey; Chen, Brandon; Manley, Jason; Traub, Francisca Martinez; Vaziri, Alipasha] Rockefeller Univ, Lab Neurotechnol & Biophys, 1230 York Ave, New York, NY 10021 USA; [Sparks, Fraser T.; Losonczy, Attila] Columbia Univ, Dept Neurosci, New York, NY USA; [Losonczy, Attila] Columbia Univ, Kavli Inst Brain Sci, New York, NY USA; [Sparks, Fraser T.; Losonczy, Attila] Columbia Univ, Mortimer B Zuckerman Mind Brain Behav Inst, New York, NY USA; [Daigle, Tanya; Zeng, Hongkui] Allen Inst Brain Sci, Seattle, WA USA; [Vaziri, Alipasha] Res Inst Mol Pathol, Vienna, Austria; [Vaziri, Alipasha] Rockefeller Univ, Kavli Neural Syst Inst, 1230 York Ave, New York, NY 10021 USA	Rockefeller University; Columbia University; Columbia University; Columbia University; Allen Institute for Brain Science; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Rockefeller University	Vaziri, A (corresponding author), Rockefeller Univ, Lab Neurotechnol & Biophys, 1230 York Ave, New York, NY 10021 USA.; Vaziri, A (corresponding author), Res Inst Mol Pathol, Vienna, Austria.; Vaziri, A (corresponding author), Rockefeller Univ, Kavli Neural Syst Inst, 1230 York Ave, New York, NY 10021 USA.	vaziri@rockefeller.edu	Weisenburger, Siegfried/O-7944-2019	Weisenburger, Siegfried/0000-0003-2044-0372; Sparks, Fraser/0000-0002-4716-5246; Chen, Brandon/0000-0002-7912-3470; Demas, Jeff/0000-0001-6132-0188	Leon Levy Fellowship at The Rockefeller University; National Institutes of Health [U01NS094263, U01NS103488, U19NS104590, R01MH100631, R01NS094668]; Intelligence Advanced Research Projects Activity (IARPA) via Department of Interior/Interior Business Center (DoI/IBC) [D16PC00002]; Kavli Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS094263, U19NS104590, U01NS103488, R01NS094668] Funding Source: NIH RePORTER	Leon Levy Fellowship at The Rockefeller University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intelligence Advanced Research Projects Activity (IARPA) via Department of Interior/Interior Business Center (DoI/IBC); Kavli Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank P. Strogies and J.M. Petrillo at the Instrument Design and Fabrication Facility (IDFF) of the Rockefeller University for manufacturing mechanical components; T. Nobauer for help with characterization recordings; Q. Lin, M.H. Davenport, and T. Noba uer for discussions on data analysis; and R. Prevedel for discussions and estimations at the early stage of this project. S.W. has been supported by a Leon Levy Fellowship at The Rockefeller University. This work was supported through funding from the National Institutes of Health awards U01NS094263 (A.V.), U01NS103488 (A.V.), U19NS104590 (A.L.), R01MH100631 (A.L.), and R01NS094668 (A.L.); the Intelligence Advanced Research Projects Activity (IARPA) via Department of Interior/Interior Business Center (DoI/IBC) contract number D16PC00002 (A.V.); and the Kavli Foundation (A.V.).	Ahmed OJ, 2009, TRENDS NEUROSCI, V32, P329, DOI 10.1016/j.tins.2009.01.009; Allen Institute for Brain Science, 2018, ALL BRAIN ATL MOUS B; Amir W, 2007, OPT LETT, V32, P1731, DOI 10.1364/OL.32.001731; Andrasfalvy BK, 2010, P NATL ACAD SCI USA, V107, P11981, DOI 10.1073/pnas.1006620107; Barrett AB, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001052; Bewersdorf J, 1998, OPT LETT, V23, P655, DOI 10.1364/OL.23.000655; Blackwell JM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01755-2; Botcherby EJ, 2012, P NATL ACAD SCI USA, V109, P2919, DOI 10.1073/pnas.1111662109; Bouchard MB, 2015, NAT PHOTONICS, V9, P113, DOI [10.1038/NPHOTON.2014.323, 10.1038/nphoton.2014.323]; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Buonomano DV, 2009, NAT REV NEUROSCI, V10, P113, DOI 10.1038/nrn2558; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cheng A, 2011, NAT METHODS, V8, P139, DOI 10.1038/NMETH.1552; Choi H, 2012, OPT EXPRESS, V20, P26219, DOI 10.1364/OE.20.026219; Cover TM., 2001, ELEMENTS INFORM THEO; Daigle TL, 2018, CELL, V174, P465, DOI 10.1016/j.cell.2018.06.035; Dana H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4997; Dana H, 2013, OPT EXPRESS, V21, P5677, DOI 10.1364/OE.21.005677; Dana H, 2012, OPT LETT, V37, P2913, DOI 10.1364/OL.37.002913; Dana H, 2011, OPT EXPRESS, V19, P4937, DOI 10.1364/OE.19.004937; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Duocastella M, 2017, ACS PHOTONICS, V4, P1797, DOI 10.1021/acsphotonics.7b00382; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Emiliani V, 2015, J NEUROSCI, V35, P13917, DOI 10.1523/JNEUROSCI.2916-15.2015; Escobet-Montalban A, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau1338; Giovannucci A, 2019, ELIFE, V8, DOI 10.7554/eLife.38173; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; HERCULANOHOUZEL S, 2013, FRONT NEUROANAT, V7; Hernandez O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11928; Hopt A, 2001, BIOPHYS J, V80, P2029, DOI 10.1016/S0006-3495(01)76173-5; Horton NG, 2013, NAT PHOTONICS, V7, P205, DOI [10.1038/NPHOTON.2012.336, 10.1038/nphoton.2012.336]; Hosmer D. W., 2005, APPLIED LOGISTIC REG; Kandel E., 2000, PRINCIPLES NEURAL SC; Kato S, 2015, CELL, V163, P656, DOI 10.1016/j.cell.2015.09.034; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kong LJ, 2015, NAT METHODS, V12, P759, DOI [10.1038/nmeth.3476, 10.1038/NMETH.3476]; Kuchibhotla K, 2018, CURR OPIN NEUROBIOL, V52, P65, DOI 10.1016/j.conb.2018.04.002; Lu RW, 2018, BIOMED OPT EXPRESS, V9, P1964, DOI 10.1364/BOE.9.001964; Lu RW, 2017, NAT NEUROSCI, V20, P620, DOI 10.1038/nn.4516; Makino H, 2017, NEURON, V94, P880, DOI 10.1016/j.neuron.2017.04.015; Mao TY, 2011, NEURON, V72, P111, DOI 10.1016/j.neuron.2011.07.029; McClelland JL, 1996, HIPPOCAMPUS, V6, P654; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Mohan H, 2018, NEUROSCIENCE, V368, P240, DOI 10.1016/j.neuroscience.2017.06.020; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Oron D, 2005, OPT EXPRESS, V13, P1468, DOI 10.1364/OPEX.13.001468; Ouzounov DG, 2017, NAT METHODS, V14, P388, DOI 10.1038/nmeth.4183; Papagiakoumou E, 2010, NAT METHODS, V7, P848, DOI [10.1038/NMETH.1505, 10.1038/nmeth.1505]; Pnevmatikakis E. A., 2013, ADV NEURAL INF PROCE; Pnevmatikakis EA, 2017, J NEUROSCI METH, V291, P83, DOI 10.1016/j.jneumeth.2017.07.031; Pnevmatikakis EA, 2016, NEURON, V89, P285, DOI 10.1016/j.neuron.2015.11.037; Podgorski K, 2016, J NEUROPHYSIOL, V116, P1012, DOI 10.1152/jn.00275.2016; Prevedel R, 2016, NAT METHODS, V13, P1021, DOI [10.1038/NMETH.4040, 10.1038/nmeth.4040]; Reddy GD, 2008, NAT NEUROSCI, V11, P713, DOI 10.1038/nn.2116; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Shain WJ, 2017, OPT LETT, V42, P995, DOI 10.1364/OL.42.000995; Shannon C. E., 1949, MATH THEORY COMMUNIC; So PTC, 2000, ANNU REV BIOMED ENG, V2, P399, DOI 10.1146/annurev.bioeng.2.1.399; Sofroniew NJ, 2016, ELIFE, V5, DOI 10.7554/eLife.14472; Soltesz I, 2018, NAT NEUROSCI, V21, P484, DOI 10.1038/s41593-018-0118-0; Sompolinsky H, 2014, CURR OPIN NEUROBIOL, V25, pXIII, DOI 10.1016/j.conb.2014.02.002; Song A, 2017, NAT METHODS, V14, P420, DOI 10.1038/nmeth.4226; Sparks FT, 2011, EUR J NEUROSCI, V34, P780, DOI 10.1111/j.1460-9568.2011.07796.x; Squire L.R., 1984, MEMORY CONSOLIDATION; Stiebler I, 1997, J COMP PHYSIOL A, V181, P559, DOI 10.1007/s003590050140; Stirman JN, 2016, NAT BIOTECHNOL, V34, P857, DOI 10.1038/nbt.3594; Tao XD, 2017, PROC SPIE, V10051, DOI 10.1117/12.2253922; Tsai PS, 2009, FRONT NEUROSCI, P59; Vasquez-Lopez SA, 2017, ELIFE, V6, DOI 10.7554/eLife.25141; Vaziri A, 2012, CURR OPIN NEUROBIOL, V22, P128, DOI 10.1016/j.conb.2011.11.011; Wang MR, 2018, BIOMED OPT EXPRESS, V9, DOI 10.1364/BOE.9.003534; Weisenburger S, 2018, ANNU REV NEUROSCI, V41, P431, DOI 10.1146/annurev-neuro-072116-031458; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Yang WJ, 2017, NAT METHODS, V14, P349, DOI 10.1038/nmeth.4230; Yang WJ, 2016, NEURON, V89, P269, DOI 10.1016/j.neuron.2015.12.012; Zaremba JD, 2017, NAT NEUROSCI, V20, P1612, DOI 10.1038/nn.4634; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhu GH, 2005, OPT EXPRESS, V13, P2153, DOI 10.1364/OPEX.13.002153; 2016, NAT NEUROSCI, V19, P1154; 2013, NAT NEUROSCI, V16, P130; 2017, NAT METHODS, V14, P811; 2013, NAT METHODS, V10, P1013; 1997, OPT LETT, V22, P135; 2012, J NEUROSCI, V32, P9159; 2014, NAT NEUROSCI, V17, P1500; 2016, NAT METHODS, V13, P1001	91	91	91	11	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 2	2019	177	4					1050	+		10.1016/j.cell.2019.03.011	http://dx.doi.org/10.1016/j.cell.2019.03.011			31	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HW7AU	30982596	Bronze, Green Accepted			2022-12-28	WOS:000466843000022
J	Slomski, A				Slomski, Anita			Caring Text Messages for Preventing Suicides	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2019	321	16					1558	1558		10.1001/jama.2019.4592	http://dx.doi.org/10.1001/jama.2019.4592			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HV7BZ	31012930				2022-12-28	WOS:000466137800038
J	Brydges, T; Elben, A; Jurcevic, P; Vermersch, B; Maier, C; Lanyon, BP; Zoller, P; Blatt, R; Roos, CF				Brydges, Tiff; Elben, Andreas; Jurcevic, Petar; Vermersch, Benoit; Maier, Christine; Lanyon, Ben P.; Zoller, Peter; Blatt, Rainer; Roos, Christian F.			Probing Renyi entanglement entropy via randomized measurements	SCIENCE			English	Article							MANY-BODY LOCALIZATION; QUANTUM; TRANSITION	Entanglement is a key feature of many-body quantum systems. Measuring the entropy of different partitions of a quantum system provides a way to probe its entanglement structure. Here, we present and experimentally demonstrate a protocol for measuring the second-order Renyi entropy based on statistical correlations between randomized measurements. Our experiments, carried out with a trapped-ion quantum simulator with partition sizes of up to 10 qubits, prove the overall coherent character of the system dynamics and reveal the growth of entanglement between its parts, in both the absence and presence of disorder. Our protocol represents a universal tool for probing and characterizing engineered quantum systems in the laboratory, which is applicable to arbitrary quantum states of up to several tens of qubits.	[Brydges, Tiff; Elben, Andreas; Jurcevic, Petar; Vermersch, Benoit; Maier, Christine; Lanyon, Ben P.; Zoller, Peter; Blatt, Rainer; Roos, Christian F.] Univ Innsbruck, Ctr Quantum Phys, Innsbruck, Austria; [Brydges, Tiff; Elben, Andreas; Jurcevic, Petar; Vermersch, Benoit; Maier, Christine; Lanyon, Ben P.; Zoller, Peter; Blatt, Rainer; Roos, Christian F.] Univ Innsbruck, Inst Expt Phys, Innsbruck, Austria; [Brydges, Tiff; Elben, Andreas; Jurcevic, Petar; Vermersch, Benoit; Maier, Christine; Lanyon, Ben P.; Zoller, Peter; Blatt, Rainer; Roos, Christian F.] Austrian Acad Sci, Inst Quantum Opt & Quantum Informat, Innsbruck, Austria	University of Innsbruck; University of Innsbruck; Austrian Academy of Sciences	Roos, CF (corresponding author), Univ Innsbruck, Ctr Quantum Phys, Innsbruck, Austria.; Roos, CF (corresponding author), Univ Innsbruck, Inst Expt Phys, Innsbruck, Austria.; Roos, CF (corresponding author), Austrian Acad Sci, Inst Quantum Opt & Quantum Informat, Innsbruck, Austria.	christian.roos@uibk.ac.at	Roos, Christian F/D-8475-2011; Brydges, Tiff/AAD-9552-2019; Zoller, Peter/O-1639-2014; Jurcevic, Petar/O-4268-2014	Roos, Christian F/0000-0001-7121-8259; Brydges, Tiff/0000-0001-5239-9752; Zoller, Peter/0000-0003-4014-1505; Blatt, Rainer/0000-0002-3122-2461; Vermersch, Benoit/0000-0001-6781-2079; Jurcevic, Petar/0000-0003-1234-6386; Elben, Andreas/0000-0003-1444-6356	ERC Synergy Grant UQUAM; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program [741541]; SFB FoQuS (FWF project) [F4016-N23]; QTFLAG-QuantERA; Quantum Flagship project PASQuanS	ERC Synergy Grant UQUAM; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program(European Research Council (ERC)); SFB FoQuS (FWF project); QTFLAG-QuantERA; Quantum Flagship project PASQuanS	We acknowledge funding from the ERC Synergy Grant UQUAM, the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program under grant agreement no. 741541, the SFB FoQuS (FWF project no. F4016-N23), QTFLAG-QuantERA, and the Quantum Flagship project PASQuanS.	Abanin D. A., 2018, ARXIV180411065V1COND; Bardarson JH, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.017202; Basko DM, 2006, ANN PHYS-NEW YORK, V321, P1126, DOI 10.1016/j.aop.2005.11.014; Bloch I, 2012, NAT PHYS, V8, P267, DOI [10.1038/nphys2259, 10.1038/NPHYS2259]; Browaeys A, 2016, J PHYS B-AT MOL OPT, V49, DOI 10.1088/0953-4075/49/15/152001; Burin AL, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.104428; Daley AJ, 2014, ADV PHYS, V63, P77, DOI 10.1080/00018732.2014.933502; Eisert J, 2010, REV MOD PHYS, V82, P277, DOI 10.1103/RevModPhys.82.277; Ekert AK, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.217901; Elben A, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.050406; Elben A., 2018, ARXIV181202624QUANTP; Fitzpatrick M, 2017, PHYS REV X, V7, DOI 10.1103/PhysRevX.7.011016; Friis N, 2018, PHYS REV X, V8, DOI 10.1103/PhysRevX.8.021012; Gambetta JM, 2017, NPJ QUANTUM INFORM, V3, DOI 10.1038/s41534-016-0004-0; Gross D, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.150401; Horodecki R, 2009, REV MOD PHYS, V81, P865, DOI 10.1103/RevModPhys.81.865; Islam R, 2015, NATURE, V528, P77, DOI 10.1038/nature15750; Johansson JR, 2013, COMPUT PHYS COMMUN, V184, P1234, DOI 10.1016/j.cpc.2012.11.019; Jurcevic P, 2014, NATURE, V511, P202, DOI 10.1038/nature13461; Kaufman AM, 2016, SCIENCE, V353, P794, DOI 10.1126/science.aaf6725; Lanyon BP, 2017, NAT PHYS, V13, P1158, DOI 10.1038/NPHYS4244; Linke NM, 2018, PHYS REV A, V98, DOI 10.1103/PhysRevA.98.052334; Lukin A., 2018, ARXIV180509819CONDMA; Maier C, 2019, PHYS REV LETT, V122, DOI 10.1103/PhysRevLett.122.050501; Mezzadri F., 2007, NOT AM MATH SOC, V54, P592; Neill C, 2018, SCIENCE, V360, P195, DOI 10.1126/science.aao4309; Pirvu B, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/2/025012; Porras D, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.207901; Safavi-Naini A, 2019, PHYS REV A, V99, DOI 10.1103/PhysRevA.99.033610; Saffman M, 2016, J PHYS B-AT MOL OPT, V49, DOI 10.1088/0953-4075/49/20/202001; Schreiber M, 2015, SCIENCE, V349, P842, DOI 10.1126/science.aaa7432; Serbyn M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.260601; Smith J, 2016, NAT PHYS, V12, P907, DOI [10.1038/nphys3783, 10.1038/NPHYS3783]; Torlai G, 2018, NAT PHYS, V14, P447, DOI 10.1038/s41567-018-0048-5; van Enk SJ, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.110503; Vermersch B, 2018, PHYS REV A, V97, DOI 10.1103/PhysRevA.97.023604; Vidal G, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.147902; Wolf MM, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.070502; Xu K, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.050507; Zaletel MP, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.165112	43	249	249	3	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2019	364	6437					260	+		10.1126/science.aau4963	http://dx.doi.org/10.1126/science.aau4963			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HU0JG	31000658	Green Submitted			2022-12-28	WOS:000464956600044
J	Lehrbach, NJ; Breen, PC; Ruvkun, G				Lehrbach, Nicolas J.; Breen, Peter C.; Ruvkun, Gary			Protein Sequence Editing of SKN-1A/Nrf1 by Peptide:N-Glycanase Controls Proteasome Gene Expression	CELL			English	Article							TRANSCRIPTION FACTOR NRF1; CAENORHABDITIS-ELEGANS; ENDOPLASMIC-RETICULUM; OXIDATIVE STRESS; DROSOPHILA MODEL; N-GLYCANASE; SKN-1; DEGRADATION; INHIBITION; LONGEVITY	The proteasome mediates selective protein degradation and is dynamically regulated in response to proteotoxic challenges. SKN-1A/Nrf1, an endoplasmic reticulum (ER)-associated transcription factor that undergoes N-linked glycosylation, serves as a sensor of proteasome dysfunction and triggers compensatory upregulation of proteasome subunit genes. Here, we show that the PNG-1/NGLY1 peptide:N-glycanase edits the sequence of SKN-1A protein by converting particular N-glycosylated asparagine residues to aspartic acid. Genetically introducing aspartates at these N-glycosylation sites bypasses the requirement for PNG-1/NGLY1, showing that protein sequence editing rather than deglycosylation is key to SKN-1A function. This pathway is required to maintain sufficient proteasome expression and activity, and SKN-1A hyperactivation confers resistance to the proteotoxicity of human amyloid beta peptide. Deglycosylation-dependent protein sequence editing explains how ER-associated and cytosolic isoforms of SKN-1 perform distinct cytoprotective functions corresponding to those of mammalian Nrf1 and Nrf2. Thus, we uncover an unexpected mechanism by which N-linked glycosylation regulates protein function and proteostasis.	[Lehrbach, Nicolas J.; Breen, Peter C.; Ruvkun, Gary] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Lehrbach, Nicolas J.; Ruvkun, Gary] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Ruvkun, G (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.; Ruvkun, G (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.	ruvkun@molbio.mgh.harvard.edu		Lehrbach, Nicolas/0000-0001-7342-4136	NIH Office of Research Infrastructure Programs [P40 OD010440]; NIH [R01 AG016636]; Grace Science Foundation; Human Frontier Science Program (Long Term Fellowship); NATIONAL INSTITUTE ON AGING [R01AG016636] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	NIH Office of Research Infrastructure Programs; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grace Science Foundation; Human Frontier Science Program (Long Term Fellowship)(Human Frontier Science Program); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Fred Goldberg, Keith Blackwell, and members of their labs for useful discussions. Some strains used were provided by the CGC, which is funded by the NIH Office of Research Infrastructure Programs (P40 OD010440). This work was supported by the NIH (R01 AG016636 to G.R.), the Grace Science Foundation, and the Human Frontier Science Program (Long Term Fellowship to N.J.L.).	An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Arribere JA, 2014, GENETICS, V198, P837, DOI 10.1534/genetics.114.169730; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Biswas M, 2010, TOXICOL APPL PHARM, V244, P16, DOI 10.1016/j.taap.2009.07.034; Blackwell TK, 2015, FREE RADICAL BIO MED, V88, P290, DOI 10.1016/j.freeradbiomed.2015.06.008; BLACKWELL TK, 1994, SCIENCE, V266, P621, DOI 10.1126/science.7939715; Bott LC, 2016, HUM MOL GENET, V25, P1979, DOI 10.1093/hmg/ddw073; BOWERMAN B, 1992, CELL, V68, P1061, DOI 10.1016/0092-8674(92)90078-Q; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; Choe KP, 2009, MOL CELL BIOL, V29, P2704, DOI 10.1128/MCB.01811-08; Collins GA, 2017, CELL, V169, P792, DOI 10.1016/j.cell.2017.04.023; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; Enns GM, 2014, GENET MED, V16, P751, DOI 10.1038/gim.2014.22; Freeze HH, 2015, ANNU REV NEUROSCI, V38, P105, DOI 10.1146/annurev-neuro-071714-034019; Frokjaer-Jensen C, 2014, NAT METHODS, V11, P529, DOI [10.1038/NMETH.2889, 10.1038/nmeth.2889]; Fukushige T, 2017, GENETICS, V206, P939, DOI 10.1534/genetics.117.202515; Fuse Y, 2017, MOLECULES, V22, DOI 10.3390/molecules22030436; Glover-Cutter KM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003701; Grimberg KB, 2011, MOL CELL BIOL, V31, P897, DOI 10.1128/MCB.00799-10; Grotzke JE, 2013, P NATL ACAD SCI USA, V110, P3393, DOI 10.1073/pnas.1300328110; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Koizumi S, 2016, ELIFE, V5, DOI 10.7554/eLife.18357; Lam C, 2017, GENET MED, V19, P160, DOI 10.1038/gim.2016.75; Lee CS, 2013, FEBS J, V280, P3609, DOI 10.1111/febs.12350; Lee CS, 2011, P NATL ACAD SCI USA, V108, P8408, DOI 10.1073/pnas.1019209108; Lehrbach NJ, 2016, ELIFE, V5, DOI 10.7554/eLife.17721; Leung L, 2003, J BIOL CHEM, V278, P48021, DOI 10.1074/jbc.M308439200; Li X, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002119; Link CD, 2006, EXP GERONTOL, V41, P1007, DOI 10.1016/j.exger.2006.06.059; Lo JY, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006762; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Motohashi H, 2002, GENE, V294, P1, DOI 10.1016/S0378-1119(02)00788-6; Ohtsuji M, 2008, J BIOL CHEM, V283, P33554, DOI 10.1074/jbc.M804597200; Owings KG, 2018, HUM MOL GENET, V27, P1055, DOI 10.1093/hmg/ddy026; Paek J, 2012, CELL METAB, V16, P526, DOI 10.1016/j.cmet.2012.09.007; Pang SS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6048; Pilla E, 2017, ANNU REV CELL DEV BI, V33, P439, DOI 10.1146/annurev-cellbio-111315-125334; Radhakrishnan SK, 2014, ELIFE, V3, DOI [10.7554/elife.01856, 10.7554/eLife.01856]; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Rodriguez TP, 2018, G3-GENES GENOM GENET, V8, P2193, DOI 10.1534/g3.118.300578; Rousseau A, 2018, NAT REV MOL CELL BIO, V19, P697, DOI 10.1038/s41580-018-0040-z; Saez I, 2014, CURR GENOMICS, V15, P38, DOI 10.2174/138920291501140306113344; Segref A, 2014, CELL METAB, V19, P642, DOI 10.1016/j.cmet.2014.01.016; Segref A, 2011, GENETICS, V187, P1235, DOI 10.1534/genetics.111.126797; Sha Z, 2014, CURR BIOL, V24, P1573, DOI 10.1016/j.cub.2014.06.004; Sirkis R, 2006, J MOL BIOL, V364, P376, DOI 10.1016/j.jmb.2006.08.086; Staab TA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003354; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Steinbaugh MJ, 2015, ELIFE, V4, DOI 10.7554/eLife.07836; SUZUKI T, 1994, J BIOL CHEM, V269, P17611; SUZUKI T, 1993, BIOCHEM BIOPH RES CO, V194, P1124, DOI 10.1006/bbrc.1993.1938; Suzuki T, 2016, MOL ASPECTS MED, V51, P89, DOI 10.1016/j.mam.2016.05.004; Tang LL, 2015, MECH AGEING DEV, V149, P88, DOI 10.1016/j.mad.2015.06.001; Tomlin FM, 2017, ACS CENTRAL SCI, V3, P1143, DOI 10.1021/acscentsci.7b00224; Tozser J, 2010, VIRUSES-BASEL, V2, P147, DOI 10.3390/v2010147; TRIEZENBERG SJ, 1995, CURR OPIN GENET DEV, V5, P190, DOI 10.1016/0959-437X(95)80007-7; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Wang WP, 2006, J BIOL CHEM, V281, P19676, DOI 10.1074/jbc.M602802200; Wu CW, 2017, GENETICS, V206, P859, DOI 10.1534/genetics.117.200592; Zhang Y, 2007, BIOCHEM J, V408, P161, DOI 10.1042/BJ20070761	62	54	55	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2019	177	3					737	+		10.1016/j.cell.2019.03.035	http://dx.doi.org/10.1016/j.cell.2019.03.035			29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HU0FV	31002798	Green Accepted, Bronze			2022-12-28	WOS:000464947700025
J	Schiattarella, GG; Altamirano, F; Tong, D; French, KM; Villalobos, E; Kim, SY; Luo, X; Jiang, N; May, HI; Wang, ZV; Hill, TM; Mammen, PPA; Huang, J; Lee, DI; Hahn, VS; Sharma, K; Kass, DA; Lavandero, S; Gillette, TG; Hill, JA				Schiattarella, Gabriele G.; Altamirano, Francisco; Tong, Dan; French, Kristin M.; Villalobos, Elisa; Kim, Soo Young; Luo, Xiang; Jiang, Nan; May, Herman I.; Wang, Zhao V.; Hill, Theodore M.; Mammen, Pradeep P. A.; Huang, Jian; Lee, Dong I.; Hahn, Virginia S.; Sharma, Kavita; Kass, David A.; Lavandero, Sergio; Gillette, Thomas G.; Hill, Joseph A.			Nitrosative stress drives heart failure with preserved ejection fraction	NATURE			English	Article							NITRIC-OXIDE SYNTHASE; S-NITROSYLATION; DYSFUNCTION; INHIBITION; MODEL	Heart failure with preserved ejection fraction (HFpEF) is a common syndrome with high morbidity and mortality for which there are no evidence-based therapies. Here we report that concomitant metabolic and hypertensive stress in mice-elicited by a combination of high-fat diet and inhibition of constitutive nitric oxide synthase using N-omega-nitro-larginine methyl ester (L-NAME)-recapitulates the numerous systemic and cardiovascular features of HFpEF in humans. Expression of one of the unfolded protein response effectors, the spliced form of X-box-binding protein 1 (XBP1s), was reduced in the myocardium of our rodent model and in humans with HFpEF. Mechanistically, the decrease in XBP1s resulted from increased activity of inducible nitric oxide synthase (iNOS) and S-nitrosylation of the endonuclease inositol-requiring protein 1 alpha (IRE1 alpha), culminating in defective XBP1 splicing. Pharmacological or genetic suppression of iNOS, or cardiomyocyte-restricted overexpression of XBP1s, each ameliorated the HFpEF phenotype. We report that iNOS-driven dysregulation of the IRE1 alpha-XBP1 pathway is a crucial mechanism of cardiomyocyte dysfunction in HFpEF.	[Schiattarella, Gabriele G.; Altamirano, Francisco; Tong, Dan; French, Kristin M.; Villalobos, Elisa; Kim, Soo Young; Luo, Xiang; Jiang, Nan; May, Herman I.; Wang, Zhao V.; Hill, Theodore M.; Mammen, Pradeep P. A.; Huang, Jian; Lavandero, Sergio; Gillette, Thomas G.; Hill, Joseph A.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Div Cardiol, Dallas, TX 75390 USA; [Schiattarella, Gabriele G.] Univ Naples Federico II, Div Cardiol, Dept Adv Biomed Sci, Naples, Italy; [Lee, Dong I.; Hahn, Virginia S.; Sharma, Kavita; Kass, David A.] Johns Hopkins Sch Med, Div Cardiol, Dept Med, Baltimore, MD USA; [Lavandero, Sergio] Univ Chile, Fac Chem & Pharmaceut Sci, Adv Ctr Chron Dis ACCDiS, Santiago, Chile; [Lavandero, Sergio] Univ Chile, Fac Med, Santiago, Chile; [Lavandero, Sergio] Univ Chile, Fac Med, Inst Biomed Sci ICBM, Ctr Mol Studies Cell CEMC, Santiago, Chile; [Hill, Joseph A.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Naples Federico II; Johns Hopkins University; Johns Hopkins Medicine; Universidad de Chile; Universidad de Chile; Universidad de Chile; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hill, JA (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Div Cardiol, Dallas, TX 75390 USA.; Hill, JA (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	joseph.hill@utsouthwestern.edu	Schiattarella, Gabriele/Z-2624-2019; May, Herman I/S-6782-2018; Villalobos, Elisa/AAD-1357-2019; French, Kristin/X-2727-2019; Lavandero, Sergio/B-6001-2013; Tong, Dan/H-7140-2013; Altamirano, Francisco/I-1928-2013	Schiattarella, Gabriele/0000-0002-7582-7171; May, Herman I/0000-0002-9264-2320; Villalobos, Elisa/0000-0002-5542-2521; Lavandero, Sergio/0000-0003-4258-1483; Tong, Dan/0000-0002-3551-2861; Hahn, Virginia/0000-0002-0578-2668; Kim, Soo Young/0000-0002-4793-2193; Altamirano, Francisco/0000-0002-1612-2729	NIH [HL-120732, HL-128215, HL-126012, F32HL136151, F32HL142244, 2T32HL007227-41, HL-135827, HL-119012, R01-HL102478]; American Heart Association (AHA) [16POST30680016, 16PRE29660003, 14SFRN20510023, 14SFRN20670003, 16SFRN28620000]; AHA; Theodore and Beulah Beasley Foundation [18POST34060230]; University Federico II of Naples; Fondation Leducq TransAtlantic Network of Excellence [11CVD04]; Cancer Prevention and Research Institute of Texas [RP110486P3]; Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center [U54-HD087351]; Fondo Nacional de Desarrollo Cientifico y Tecnologico [FONDAP 15130011]; BioTechne Grant Foundation; Compagnia di San Paolo STAR program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007227, R01HL120732, R35HL135827] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); AHA(American Heart Association); Theodore and Beulah Beasley Foundation; University Federico II of Naples; Fondation Leducq TransAtlantic Network of Excellence(Leducq Foundation); Cancer Prevention and Research Institute of Texas; Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center(Ohio State University); Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); BioTechne Grant Foundation; Compagnia di San Paolo STAR program(Compagnia di San Paolo); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from NIH: HL-120732 (J.A.H.), HL-128215 (J.A.H.), HL-126012 (J.A.H.), F32HL136151 (K.M.F.), F32HL142244 (D.T.), 2T32HL007227-41 (V.S.H.), HL-135827 (D.A.K.), HL-119012 (D.A.K.), R01-HL102478 (P.P.A.M.), the American Heart Association (AHA): 16POST30680016 (F.A.), 16PRE29660003 (S.Y.K.), 14SFRN20510023 (J.A.H.), 14SFRN20670003 (J.A.H.) and 16SFRN28620000 (K.S. and D.A.K.), AHA and the Theodore and Beulah Beasley Foundation 18POST34060230 (G.G.S.), University Federico II of Naples and Compagnia di San Paolo STAR program (G.G.S.), Fondation Leducq TransAtlantic Network of Excellence11CVD04 (J.A.H.), Cancer Prevention and Research Institute of Texas RP110486P3 (J.A.H.), Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center U54-HD087351 (P.P.A.M.) and by Fondo Nacional de Desarrollo Cientifico y Tecnologico, FONDAP 15130011 (S.L.). We thank G. S. Hotamisligil and L. Yang for providing ERN1 wild-type and ERN1 M1+M2-expressing adenoviruses. We thank A. Rosenberg for his help with the ProteinSimple capillary immunoassay analysis (partly supported by The BioTechne Grant Foundation).	Borlaug BA, 2015, J AM COLL CARDIOL, V66, P1672, DOI 10.1016/j.jacc.2015.07.067; Butler J, 2014, JAMA-J AM MED ASSOC, V312, P789, DOI 10.1001/jama.2014.6643; Chirinos Julio A, 2016, Curr Heart Fail Rep, V13, P47, DOI 10.1007/s11897-016-0277-9; Dunlay SM, 2017, NAT REV CARDIOL, V14, DOI 10.1038/nrcardio.2017.65; FURFINE ES, 1993, BIOCHEMISTRY-US, V32, P8512, DOI 10.1021/bi00084a017; Gonzalez-Lopez E, 2015, EUR HEART J, V36, P2585, DOI 10.1093/eurheartj/ehv338; Gould N, 2013, J BIOL CHEM, V288, P26473, DOI 10.1074/jbc.R113.460261; Jia J, 2014, CELL, V159, P623, DOI 10.1016/j.cell.2014.09.032; Kong YL, 2006, CIRCULATION, V113, P2579, DOI 10.1161/CIRCULATIONAHA.106.625467; Kopincova J, 2012, PHARMACOL REP, V64, P511, DOI 10.1016/S1734-1140(12)70846-0; Methawasin M, 2016, CIRCULATION, V134, P1085, DOI 10.1161/CIRCULATIONAHA.116.023003; MOORE WM, 1994, J MED CHEM, V37, P3886, DOI 10.1021/jm00049a007; Oeser Clarissa, 2016, Nat Rev Cardiol, V13, P2, DOI 10.1038/nrcardio.2015.176; Oh M, 2005, MOL CELL BIOL, V25, P6629, DOI 10.1128/MCB.25.15.6629-6638.2005; Paulus WJ, 2013, J AM COLL CARDIOL, V62, P263, DOI 10.1016/j.jacc.2013.02.092; Primessnig U, 2016, EUR J HEART FAIL, V18, P987, DOI 10.1002/ejhf.524; Redfield MM, 2015, NEW ENGL J MED, V373, P2314, DOI 10.1056/NEJMoa1510774; Roh J, 2017, CIRC RES, V120, P1243, DOI 10.1161/CIRCRESAHA.116.310119; Rothermel BA, 2005, PHYSIOL GENOMICS, V23, P18, DOI 10.1152/physiolgenomics.00061.2005; Shah SJ, 2016, CIRCULATION, V134, P73, DOI 10.1161/CIRCULATIONAHA.116.021884; Sharma K, 2014, CIRC RES, V115, P79, DOI 10.1161/CIRCRESAHA.115.302922; Wang JM, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao4617; Wang ZV, 2015, CELL METAB, V21, P215, DOI 10.1016/j.cmet.2015.01.016; Wang ZV, 2014, CELL, V156, P1179, DOI 10.1016/j.cell.2014.01.014; Yang L, 2015, SCIENCE, V349, P500, DOI 10.1126/science.aaa0079; Zamani P, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004262; Zhi G, 2005, P NATL ACAD SCI USA, V102, P17519, DOI 10.1073/pnas.0506846102; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523	28	291	298	22	101	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 18	2019	568	7752					351	+		10.1038/s41586-019-1100-z	http://dx.doi.org/10.1038/s41586-019-1100-z			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HU0GZ	30971818	Green Accepted			2022-12-28	WOS:000464950700047
J	Abe, N; Fujieda, Y; Amengual, O; Atsumi, T				Abe, Nobuya; Fujieda, Yuichiro; Amengual, Olga; Atsumi, Tatsuya			Disseminated subcutaneous nodules and destructive polyarthritis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GOUT		[Fujieda, Yuichiro] Hokkaido Univ, Fac Med, Dept Rheumatol Endocrinol & Nephrol, Sapporo, Hokkaido, Japan; Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Fujieda, Y (corresponding author), Hokkaido Univ, Fac Med, Dept Rheumatol Endocrinol & Nephrol, Sapporo, Hokkaido, Japan.	edaichi@med.hokudai.ac.jp	藤枝, 雄一郎/AAG-1610-2020; Amengual, Olga/G-1692-2012	藤枝, 雄一郎/0000-0003-4705-341X; Amengual, Olga/0000-0002-1193-4832; Abe, Nobuya/0000-0001-8644-1007				Baraf HSB, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4318; Kasper IR, 2016, SEMIN ARTHRITIS RHEU, V45, P669, DOI 10.1016/j.semarthrit.2016.01.005; Kumar Sunil, 2002, N Z Med J, V115, pU109; Richette P, 2017, ANN RHEUM DIS, V76, P29, DOI [10.1136/annrheumdis-2016-209707, 10.1136/annrheumdis-2016-210356]; Sundy JS, 2011, JAMA-J AM MED ASSOC, V306, P711, DOI [10.1001/jama.2011.1169, 10.1001/jama.2011.116]	5	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2019	365								l1344	10.1136/bmj.l1344	http://dx.doi.org/10.1136/bmj.l1344			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU8OY	30996027				2022-12-28	WOS:000465550000002
J	Wise, J				Wise, Jacqui			BMJ Awards 2019: Primary Care Team of the Year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2019	365								l1665	10.1136/bmj.l1665	http://dx.doi.org/10.1136/bmj.l1665			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU8OP	30992264				2022-12-28	WOS:000465549000004
J	Paterlini, M				Paterlini, Marta			Italy calls on retired doctors to fill health worker gap	LANCET			English	Editorial Material																			0	9	9	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 13	2019	393	10180					1492	1492		10.1016/S0140-6736(19)30849-9	http://dx.doi.org/10.1016/S0140-6736(19)30849-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU0DA	30983578				2022-12-28	WOS:000464940400012
J	Bewley, S; Blennerhassett, M; Payne, M				Bewley, Susan; Blennerhassett, Mitzi; Payne, Mandy			Cost of extending the NHS breast screening age range in England	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CANCER; BENEFITS; OVERDIAGNOSIS; SURVIVAL; IMPACT; HARMS; WOMEN; VIEW		[Bewley, Susan] Kings Coll London, London, England	University of London; King's College London		mpayne@healthwatch-uk.org	Payne, Mandy/GVU-1814-2022; Payne, Mandy/AAF-8233-2020	Payne, Mandy/0000-0003-3555-8023				[Anonymous], 2017, NHS BREAST SCREENING; [Anonymous], 2017, AGEX PARTICIPANT INF; [Anonymous], 2016, PRESCRIRE; Ariyarathenam AV, 2013, INT J SURG, V11, P535, DOI 10.1016/j.ijsu.2013.05.003; Baum M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f385; Beral V., 2016, AGE EXTENSION TRIAL; Biller-Andorno N, 2014, NEW ENGL J MED, V370, P1965, DOI 10.1056/NEJMp1401875; Burton RC, 2012, BREAST CANCER RES TR, V131, P949, DOI 10.1007/s10549-011-1794-6; de Glas NA, 2013, BREAST CANCER RES TR, V138, P561, DOI 10.1007/s10549-013-2462-9; de Glas NA, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5410; Department of Health, 2007, CANC REF STRAT; Domenighetti G, 2003, INT J EPIDEMIOL, V32, P816, DOI 10.1093/ije/dyg257; Gigerenzer G, 2009, JNCI-J NATL CANCER I, V101, P1216, DOI 10.1093/jnci/djp237; Gotzsche PC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub5; Harding Center for Risk Literacy, 2018, EARL DET BREAST CANC; Hersch J, 2015, LANCET, V385, P1642, DOI 10.1016/S0140-6736(15)60123-4; Hoffmann TC, 2015, JAMA INTERN MED, V175, P274, DOI 10.1001/jamainternmed.2014.6016; Jorgensen KJ, 2017, ANN INTERN MED, V166, P313, DOI 10.7326/M16-0270; Jorgensen KJ, 2017, BREAST, V31, P261, DOI 10.1016/j.breast.2016.08.002; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Richards M, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6843; Royal College of Radiologists, 2017, NEW REP REV WORKF CR; Wegwarth O, 2013, JAMA INTERN MED, V173, P2086, DOI 10.1001/jamainternmed.2013.10363; Wegwarth O, 2011, PATIENT EDUC COUNS, V84, P251, DOI 10.1016/j.pec.2010.07.025; Wegwarth O, 2011, MED DECIS MAKING, V31, P386, DOI 10.1177/0272989X10391469; Weijer C, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001346; Welch HG, 2016, NEW ENGL J MED, V375, P1438, DOI 10.1056/NEJMoa1600249	27	5	5	3	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 10	2019	365								l1293	10.1136/bmj.l1293	http://dx.doi.org/10.1136/bmj.l1293			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU0EL	30971394				2022-12-28	WOS:000464944100003
J	Maskell, G				Maskell, Giles			A really stupid mistake: it does feel like a cop out to blame my error on human frailty, but I'm afraid that's exactly what it was	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												gilesmaskell@nhs.net							0	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 8	2019	365								l1617	10.1136/bmj.l1617	http://dx.doi.org/10.1136/bmj.l1617			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU0EE	30962221				2022-12-28	WOS:000464943400008
J	Armstrong, PW; Naylor, CD				Armstrong, Paul W.; Naylor, C. David			Counteracting Health Misinformation A Role for Medical Journals?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Armstrong, Paul W.] Univ Alberta, Canadian VIGOUR Ctr, Edmonton, AB, Canada; [Armstrong, Paul W.] Univ Alberta, Div Cardiol, Edmonton, AB, Canada; [Naylor, C. David] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Alberta; University of Alberta; University of Toronto	Armstrong, PW (corresponding author), 2 132 Ki Ka Shing Ctr Hlth Res Innovat, Edmonton, AB T6G 2E1, Canada.	paul.armstrong@ualberta.ca						[Anonymous], 2018, FINANCIAL TIMES; Chou WYS, 2018, JAMA-J AM MED ASSOC, V320, P2417, DOI 10.1001/jama.2018.16865; Hellmuth J, 2019, JAMA-J AM MED ASSOC, V321, P543, DOI 10.1001/jama.2018.21560; Hill JA, 2019, CIRCULATION, V139, P571, DOI 10.1161/CIRCULATIONAHA.118.039193; Kumar S, 2019, SCIENCE, V363, P679, DOI 10.1126/science.363.6428.679; Merchant RM, 2018, JAMA-J AM MED ASSOC, V320, P2415, DOI 10.1001/jama.2018.18416; Stead S, 2019, GLOBE MAIL; Vosoughi S, 2018, SCIENCE, V359, P1146, DOI 10.1126/science.aap9559; Wenzel RP, 2017, NEW ENGL J MED, V377, P607, DOI 10.1056/NEJMp1706528	9	35	37	2	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 21	2019	321	19					1863	1864		10.1001/jama.2019.5168	http://dx.doi.org/10.1001/jama.2019.5168			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HZ1FC	31009036				2022-12-28	WOS:000468591200009
J	Palma, DA; Olson, R; Harrow, S; Gaede, S; Louie, AV; Haasbeek, C; Mulroy, L; Lock, M; Rodrigues, GB; Yaremko, BP; Schellenberg, D; Ahmad, B; Griffioen, G; Senthi, S; Swaminath, A; Kopek, N; Liu, M; Moore, K; Currie, S; Bauman, GS; Warner, A; Senan, S				Palma, David A.; Olson, Robert; Harrow, Stephen; Gaede, Stewart; Louie, Alexander V.; Haasbeek, Cornelis; Mulroy, Liam; Lock, Michael; Rodrigues, George B.; Yaremko, Brian P.; Schellenberg, Devin; Ahmad, Belal; Griffioen, Gwendolyn; Senthi, Sashendra; Swaminath, Anand; Kopek, Neil; Liu, Mitchell; Moore, Karen; Currie, Suzanne; Bauman, Glenn S.; Warner, Andrew; Senan, Suresh			Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial	LANCET			English	Article							CELL LUNG-CANCER; CLINICAL-PRACTICE GUIDELINES; METASTASIS-DIRECTED THERAPY; PROSTATE-CANCER; BREAST-CANCER; II TRIALS; MULTICENTER; STATE	Background The oligometastatic paradigm suggests that some patients with a limited number of metastases might be cured if all lesions are eradicated. Evidence from randomised controlled trials to support this paradigm is scarce. We aimed to assess the effect of stereotactic ablative radiotherapy (SABR) on survival, oncological outcomes, toxicity, and quality of life in patients with a controlled primary tumour and one to five oligometastatic lesions. Methods This randomised, open-label phase 2 study was done at 10 hospitals in Canada, the Netherlands, Scotland, and Australia. Patients aged 18 or older with a controlled primary tumour and one to five metastatic lesions, Eastern Cooperative Oncology Group score of 0-1, and a life expectancy of at least 6 months were eligible. After stratifying by the number of metastases (1-3 vs 4-5), we randomly assigned patients (1:2) to receive either palliative standard of care treatments alone (control group), or standard of care plus SABR to all metastatic lesions (SABR group), using a computer-generated randomisation list with permuted blocks of nine. Neither patients nor physicians were masked to treatment allocation. The primary endpoint was overall survival. We used a randomised phase 2 screening design with a two-sided a of 0.20 (wherein p<0.20 designates a positive trial). All analyses were intention to treat. This study is registered with ClinicalTrials. gov, number NCT01446744. Findings 99 patients were randomised between Feb 10, 2012, and Aug 30, 2016. Of 99 patients, 33 (33%) were assigned to the control group and 66 (67%) to the SABR group. Two (3%) patients in the SABR group did not receive allocated treatment and withdrew from the trial; two (6%) patients in the control group also withdrew from the trial. Median follow-up was 25 months (IQR 19-54) in the control group versus 26 months (23-37) in the SABR group. Median overall survival was 28 months (95% CI 19-33) in the control group versus 41 months (26-not reached) in the SABR group (hazard ratio 0.57, 95% CI 0.30-1.10; p=0.090). Adverse events of grade 2 or worse occurred in three (9%) of 33 controls and 19 (29%) of 66 patients in the SABR group (p=0.026), an absolute increase of 20% (95% CI 5-34). Treatment-related deaths occurred in three (4.5%) of 66 patients after SABR, compared with none in the control group. Interpretation SABR was associated with an improvement in overall survival, meeting the primary endpoint of this trial, but three (4.5%) of 66 patients in the SABR group had treatment-related death. Phase 3 trials are needed to conclusively show an overall survival benefit, and to determine the maximum number of metastatic lesions wherein SABR provides a benefit. Copyright (C) 2019 Elsevier Ltd. All rights reserved.	[Palma, David A.; Gaede, Stewart; Louie, Alexander V.; Lock, Michael; Rodrigues, George B.; Yaremko, Brian P.; Ahmad, Belal; Bauman, Glenn S.; Warner, Andrew] London Hlth Sci Ctr, London, ON N6A 5W9, Canada; [Olson, Robert] British Columbia Canc Ctr North, Prince George, BC, Canada; [Harrow, Stephen; Moore, Karen; Currie, Suzanne] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland; [Haasbeek, Cornelis; Griffioen, Gwendolyn; Senan, Suresh] Vrije Univ Amsterdam, Amsterdam UMC, Amsterdam, Netherlands; [Mulroy, Liam] Nova Scotia Canc Ctr, Halifax, NS, Canada; [Schellenberg, Devin] British Columbia Canc Surrey Ctr, Surrey, BC, Canada; [Senthi, Sashendra] Alfred Hlth Radiat Oncol, Melbourne, Vic, Australia; [Swaminath, Anand] Juravinski Canc Ctr, Hamilton, ON, Canada; [Kopek, Neil] McGill Univ, Ctr Hlth, Montreal, PQ, Canada; [Liu, Mitchell] British Columbia Canc, Vancouver, BC, Canada	London Health Sciences Centre; Beatson Oncology Centre; University of Amsterdam; Vrije Universiteit Amsterdam; McMaster University; McGill University	Palma, DA (corresponding author), London Hlth Sci Ctr, London, ON N6A 5W9, Canada.	david.palma@lhsc.on.ca	Senan, Suresh/P-5790-2019; Olson, Robert Anton/S-5982-2019	Senan, Suresh/0000-0003-3995-2204; Olson, Robert Anton/0000-0003-4532-6197	Ontario Institute for Cancer Research and London Regional Cancer Program Catalyst Grant	Ontario Institute for Cancer Research and London Regional Cancer Program Catalyst Grant	Ontario Institute for Cancer Research and London Regional Cancer Program Catalyst Grant.	Andrews DW, 2004, LANCET, V363, P1665, DOI 10.1016/S0140-6736(04)16250-8; Ashworth A, 2013, LUNG CANCER, V82, P197, DOI 10.1016/j.lungcan.2013.07.026; Barney JD, 1939, J UROLOGY, V42, P269, DOI 10.1016/S0022-5347(17)71516-9; Bartlett EK, 2015, CANCER-AM CANCER SOC, V121, P747, DOI 10.1002/cncr.29134; Bernstein MB, 2016, NAT REV CLIN ONCOL, V13, P516, DOI 10.1038/nrclinonc.2016.30; Cardoso F, 2012, ANN ONCOL, V23, P11, DOI 10.1093/annonc/mds232; Collen C, 2014, ANN ONCOL, V25, P1954, DOI 10.1093/annonc/mdu370; Ettinger DS, 2017, J NATL COMPR CANC NE, V15, P504, DOI 10.6004/jnccn.2017.0050; Fiorentino F, 2010, J ROY SOC MED, V103, P60, DOI 10.1258/jrsm.2009.090299; Gomez DR, 2016, LANCET ONCOL, V17, P1672, DOI 10.1016/S1470-2045(16)30532-0; HELLMAN S, 1995, J CLIN ONCOL, V13, P8, DOI 10.1200/JCO.1995.13.1.8; Hong JC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195149; Iyengar P, 2018, JAMA ONCOL, V4, DOI 10.1001/jamaoncol.2017.3501; Kucharczyk MJ, 2017, BREAST CANCER RES TR, V164, P13, DOI 10.1007/s10549-017-4228-2; Lewis SL, 2017, AM J CLIN ONCOL-CANC, V40, P418, DOI 10.1097/COC.0000000000000169; Macbeth F, 2017, INT J RADIAT ONCOL, V99, P768, DOI 10.1016/j.ijrobp.2017.02.035; Marquart J, 2018, JAMA ONCOL, V4, P1093, DOI 10.1001/jamaoncol.2018.1660; Ost P, 2018, J CLIN ONCOL, V36, P446, DOI 10.1200/JCO.2017.75.4853; Ost P, 2015, EUR UROL, V67, P852, DOI 10.1016/j.eururo.2014.09.004; Palma DA, 2014, NAT REV CLIN ONCOL, V11, P549, DOI 10.1038/nrclinonc.2014.96; Palma DA, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-305; PATCHELL RA, 1990, NEW ENGL J MED, V322, P494, DOI 10.1056/NEJM199002223220802; Rubinstein LV, 2005, J CLIN ONCOL, V23, P7199, DOI 10.1200/JCO.2005.01.149; Ruers T, 2012, ANN ONCOL, V23, P2619, DOI 10.1093/annonc/mds053; Ruers T, 2017, J NATL CANC I, V109; Sharma MR, 2011, JNCI-J NATL CANCER I, V103, P1093, DOI 10.1093/jnci/djr218; Timmerman RD, 2014, J CLIN ONCOL, V32, P2847, DOI 10.1200/JCO.2014.55.4675; Treasure T, 2009, EJSO-EUR J SURG ONC, V35, P686, DOI 10.1016/j.ejso.2008.12.005; Utley M, 2007, 33 INT C OP RES APPL, P493; Vilela RA, 2018, J MED IMAG RADIAT ON, V62, P692, DOI 10.1111/1754-9485.12747	30	918	936	8	81	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 18	2019	393	10185					2051	2058		10.1016/S0140-6736(18)32487-5	http://dx.doi.org/10.1016/S0140-6736(18)32487-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HY4QC	30982687				2022-12-28	WOS:000468112000028
J	Gurwitz, JH; Pearson, SD				Gurwitz, Jerry H.; Pearson, Steven D.			Novel Therapies for an Aging Population Grappling With Price, Value, and Affordability	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gurwitz, Jerry H.] Meyers Primary Care Inst, 385 Grove St, Worcester, MA 01605 USA; [Gurwitz, Jerry H.] Univ Massachusetts, Med Sch, Div Geriatr Med, Worcester, MA 01605 USA; [Gurwitz, Jerry H.; Pearson, Steven D.] Inst Clin & Econ Review, Boston, MA USA	University of Massachusetts System; University of Massachusetts Worcester	Gurwitz, JH (corresponding author), Meyers Primary Care Inst, 385 Grove St, Worcester, MA 01605 USA.	jerry.gurwitz@umassmed.edu			Laura and John Arnold Foundation [R33AG057806]; National Institute on Aging; NATIONAL INSTITUTE ON AGING [R33AG057806] Funding Source: NIH RePORTER	Laura and John Arnold Foundation; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Laura and John Arnold Foundation (Drs Pearson and Gurwitz) and by grant R33AG057806 from the National Institute on Aging (Dr Gurwitz).	Bernard MA, 2018, JAMA-J AM MED ASSOC, V320, P1535, DOI 10.1001/jama.2018.12368; Harris R., 2018, SEARCH NEW WAYS PAY; Kamal R, 2019, WHAT ARE RECENT FORE; Maurer MS, 2018, NEW ENGL J MED, V379, P1007, DOI 10.1056/NEJMoa1805689; Newman T., 2018, FACTS MEDICARE SPEND; Tilburt JC, 2013, JAMA-J AM MED ASSOC, V309, P773, DOI 10.1001/jama.2013.368; 2015, EUR HEART J, V36, P2585, DOI DOI 10.1093/EURHEARTJ/EHV338	7	16	16	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2019	321	16					1567	1568		10.1001/jama.2019.2633	http://dx.doi.org/10.1001/jama.2019.2633			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HV7BZ	31012942	Green Accepted			2022-12-28	WOS:000466137800009
J	Rimmer, A				Rimmer, Abi			Doctors still see own mental health problems as sign of weakness, research finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		British Medical Association, 2019, CAR MENT HLTH MED WO	1	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 23	2019	365								l1861	10.1136/bmj.l1861	http://dx.doi.org/10.1136/bmj.l1861			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HW1MM	31015197				2022-12-28	WOS:000466447000005
J	[Anonymous]				[Anonymous]			HHS Funds Development of Vaccine Against Marburg Virus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2019	321	16					1557	1557		10.1001/jama.2019.4035	http://dx.doi.org/10.1001/jama.2019.4035			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HV7BZ	31012915				2022-12-28	WOS:000466137800003
J	Barnett, R				Barnett, Richard			Case histories Alzheimer's disease	LANCET			English	Editorial Material												richard@richardbarnettwriter.com							0	28	30	2	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 20	2019	393	10181					1589	1589		10.1016/S0140-6736(19)30851-7	http://dx.doi.org/10.1016/S0140-6736(19)30851-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU0DL	31007191				2022-12-28	WOS:000464941500015
J	Bleriot, C; Ng, LG; Ginhoux, F				Bleriot, Camille; Ng, Lai Guan; Ginhoux, Florent			"Cloaking'' on Time: A Cover-Up Act by Resident Tissue Macrophages	CELL			English	Editorial Material							INJURY	In this issue of Cell, Uderhardt et al. employed intravital two-photon microscopy to examine tissue-resident macrophage responses to sterile cellular injuries of variable size. They observed that while multi-cell "macrolesions'' are characteristically pro-inflammatory, resident macrophages can "cloak'' single-cell microlesions to prevent excessive neutrophil recruitment and limit subsequent tissue damage.	[Bleriot, Camille; Ng, Lai Guan; Ginhoux, Florent] ASTAR, Singapore Immunol Network SIgN, 8A Biomed Grove,Immunos Bldg 3-4, Singapore 138648, Singapore; [Ng, Lai Guan] Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, 288 Nanjing Rd, Tianjin 300020, Peoples R China; [Ng, Lai Guan] Chinese Acad Med Sci, Blood Dis Hosp, 288 Nanjing Rd, Tianjin 300020, Peoples R China; [Ginhoux, Florent] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, 280 South Chongqing Rd, Shanghai 200025, Peoples R China	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Sciences; Shanghai Jiao Tong University	Ginhoux, F (corresponding author), ASTAR, Singapore Immunol Network SIgN, 8A Biomed Grove,Immunos Bldg 3-4, Singapore 138648, Singapore.; Ginhoux, F (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, 280 South Chongqing Rd, Shanghai 200025, Peoples R China.	florent_ginhoux@immunol.a-star.edu.sg	Ng, Lai Guan/N-6980-2019; Ng, Lai Guan/E-5673-2011	Ng, Lai Guan/0000-0003-1905-3586; Ng, Lai Guan/0000-0003-1905-3586; BLERIOT, Camille/0000-0002-4298-2888				Amit I, 2016, NAT IMMUNOL, V17, P18, DOI 10.1038/ni.3325; Chakarov S, 2019, SCIENCE, V363, P1190, DOI 10.1126/science.aau0964; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Guilliams M, 2017, NAT REV IMMUNOL, V17, P451, DOI 10.1038/nri.2017.42; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Ng LG, 2011, J INVEST DERMATOL, V131, P2058, DOI 10.1038/jid.2011.179; Pirzgalska RM, 2017, NAT MED, V23, P1309, DOI 10.1038/nm.4422; Roberts AW, 2017, IMMUNITY, V47, P913, DOI 10.1016/j.immuni.2017.10.006; Uderhardt S, 2019, CELL, V177, P541, DOI 10.1016/j.cell.2019.02.028	10	1	1	2	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2019	177	3					514	516		10.1016/j.cell.2019.03.042	http://dx.doi.org/10.1016/j.cell.2019.03.042			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HU0FV	31002790	Bronze			2022-12-28	WOS:000464947700006
J	Yang, YS; Kato, M; Wu, X; Litsios, A; Sutter, BM; Wang, Y; Hsu, CH; Wood, NE; Lemoff, A; Mirzaei, H; Heinemann, M; Tu, BP				Yang, Yu-San; Kato, Masato; Wu, Xi; Litsios, Athanasios; Sutter, Benjamin M.; Wang, Yun; Hsu, Chien-Hsiang; Wood, N. Ezgi; Lemoff, Andrew; Mirzaei, Hamid; Heinemann, Matthias; Tu, Benjamin P.			Yeast Ataxin-2 Forms an Intracellular Condensate Required for the Inhibition of TORC1 Signaling during Respiratory Growth	CELL			English	Article							CELL-FREE FORMATION; POLYGLUTAMINE EXPANSIONS; LIFE-SPAN; P-BODIES; AUTOPHAGY; DOMAINS; GRANULES; PROTEIN; COMPLEX	Yeast ataxin-2, also known as Pbp1 (polyA binding protein-binding protein 1), is an intrinsically disordered protein implicated in stress granule formation, RNA biology, and neurodegenerative disease. To understand the endogenous function of this protein, we identify Pbp1 as a dedicated regulator of TORC1 signaling and autophagy under conditions that require mitochondrial respiration. Pbp1 binds to TORC1 specifically during respiratory growth, but utilizes an additional methionine-rich, low complexity (LC) region to inhibit TORC1. This LC region causes phase separation, forms reversible fibrils, and enables self-association into assemblies required for TORC1 inhibition. Mutants that weaken phase separation in vitro exhibit reduced capacity to inhibit TORC1 and induce autophagy. Loss of Pbp1 leads to mitochondrial dysfunction and reduced fitness during nutritional stress. Thus, Pbp1 forms a condensate in response to respiratory status to regulate TORC1 signaling.	[Yang, Yu-San; Kato, Masato; Wu, Xi; Sutter, Benjamin M.; Wang, Yun; Lemoff, Andrew; Mirzaei, Hamid; Tu, Benjamin P.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Litsios, Athanasios; Heinemann, Matthias] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Mol Syst Biol, NL-9747 AG Groningen, Netherlands; [Hsu, Chien-Hsiang] Univ Texas Southwestern Med Ctr Dallas, Simmons Canc Ctr, Dallas, TX 75390 USA; [Hsu, Chien-Hsiang] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Wood, N. Ezgi] Univ Texas Southwestern Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Groningen; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Francisco; University of Texas System; University of Texas Southwestern Medical Center Dallas	Tu, BP (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	benjamin.tu@utsouthwestern.edu	Heinemann, Matthias/B-9421-2008	Heinemann, Matthias/0000-0002-5512-9077; Lemoff, Andrew/0000-0002-4943-0170; Litsios, Athanasios/0000-0003-3588-4988	NIH [R01GM094314]; Welch Foundation [I-1797, I-1919]; David and Lucile Packard Foundation; Cancer Prevention and Research Institute of Texas [RR150058]; HHMI-Simons Faculty Scholars Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094314] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021684] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Cancer Prevention and Research Institute of Texas; HHMI-Simons Faculty Scholars Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank K. Luby-Phelps and the UTSW Live Cell Imaging Core Facility for assistance with microscopy experiments. We thank S. McKnight, S. Fu, Y. Kuo, and the Tu Lab for valuable advice and suggestions. B.P.T. is supported by grants from the NIH (R01GM094314), the Welch Foundation (I-1797), the David and Lucile Packard Foundation, and a HHMI-Simons Faculty Scholars Award. M.K. is funded by the support of an anonymous donor to the laboratory of S. McKnight. N.E.W. is supported by Cancer Prevention and Research Institute of Texas (RR150058) and Welch Foundation (I-1919), which were obtained by A. Doncic.	ASTBURY WILLIAM THOMAS, 1935, BIOCHEM JOUR, V29, P2351; Bakthavachalu B, 2018, NEURON, V98, P754, DOI 10.1016/j.neuron.2018.04.032; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Bar DZ, 2016, P NATL ACAD SCI USA, V113, pE4620, DOI 10.1073/pnas.1512156113; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Carmo-Silva S, 2017, TRENDS ENDOCRIN MET, V28, P309, DOI 10.1016/j.tem.2016.12.006; Chen J, 2017, NAT CHEM BIOL, V13, P1179, DOI [10.1038/NCHEMBIO.2478, 10.1038/nchembio.2478]; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Alves-Cruzeiro JMD, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00572; Drost J, 2013, J MOL NEUROSCI, V51, P68, DOI 10.1007/s12031-012-9949-4; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Ferrezuelo F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2015; Filer D, 2017, NATURE, V552, P263, DOI 10.1038/nature25007; Fittschen M, 2015, NEUROGENETICS, V16, P181, DOI 10.1007/s10048-015-0441-5; GEDDES AJ, 1968, J MOL BIOL, V32, P343, DOI 10.1016/0022-2836(68)90014-4; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Huberts DHEW, 2014, P NATL ACAD SCI USA, V111, P11727, DOI 10.1073/pnas.1410024111; Huberts DHEW, 2013, NAT PROTOC, V8, P1019, DOI 10.1038/nprot.2013.060; Janssens GE, 2015, ELIFE, V4, DOI 10.7554/eLife.08527; Kanki T, 2009, AUTOPHAGY, V5, P1186, DOI 10.4161/auto.5.8.9854; Kato M, 2019, CELL, V177, P711, DOI 10.1016/j.cell.2019.02.044; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kroschwald S, 2015, ELIFE, V4, DOI 10.7554/eLife.06807; Lastres-Becker I, 2008, CEREBELLUM, V7, P115, DOI 10.1007/s12311-008-0019-y; Laxman S, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005948; Laxman S, 2013, CELL, V154, P416, DOI 10.1016/j.cell.2013.06.043; Lee SS, 2012, P NATL ACAD SCI USA, V109, P4916, DOI 10.1073/pnas.1113505109; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lin Y, 2016, CELL, V167, P789, DOI 10.1016/j.cell.2016.10.003; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mangus DA, 1998, MOL CELL BIOL, V18, P7383, DOI 10.1128/MCB.18.12.7383; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Nonhoff U, 2007, MOL BIOL CELL, V18, P1385, DOI 10.1091/mbc.E06-12-1120; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Panchaud N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004112; Prouteau M, 2017, NATURE, V550, P265, DOI 10.1038/nature24021; Ralser M, 2005, J MOL BIOL, V346, P203, DOI 10.1016/j.jmb.2004.11.024; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664; Romero CM, 2007, FLUID PHASE EQUILIBR, V258, P67, DOI 10.1016/j.fluid.2007.05.029; Sellier C, 2016, EMBO J, V35, P1276, DOI 10.15252/embj.201593350; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Shi KY, 2017, P NATL ACAD SCI USA, V114, pE1111, DOI 10.1073/pnas.1620293114; Sunde M, 1997, ADV PROTEIN CHEM, V50, P123, DOI 10.1016/S0065-3233(08)60320-4; Sutter BM, 2013, CELL, V154, P403, DOI 10.1016/j.cell.2013.06.041; Swisher KD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010006; Takahara T, 2012, MOL CELL, V47, P242, DOI 10.1016/j.molcel.2012.05.019; Tatton WG, 1999, BBA-BIOENERGETICS, V1410, P195, DOI 10.1016/S0005-2728(98)00167-4; van Dijken JP, 2000, ENZYME MICROB TECH, V26, P706, DOI 10.1016/S0141-0229(00)00162-9; WOOTTON JC, 1994, COMPUT CHEM, V18, P269, DOI 10.1016/0097-8485(94)85023-2; Wu X, 2011, MOL BIOL CELL, V22, P4124, DOI 10.1091/mbc.E11-06-0525; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zopf CJ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003161	58	45	46	2	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2019	177	3					697	+		10.1016/j.cell.2019.02.043	http://dx.doi.org/10.1016/j.cell.2019.02.043			31	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HU0FV	30982600	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000464947700022
J	Dunn, AS				Dunn, Andrew S.			Inhaled tranexamic acid improved recovery from hemoptysis compared with placebo	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							EFFICACY		[Dunn, Andrew S.] Mt Sinai Hlth Syst, New York, NY 10019 USA	Icahn School of Medicine at Mount Sinai	Dunn, AS (corresponding author), Mt Sinai Hlth Syst, New York, NY 10019 USA.							Bellam BL, 2016, PULM PHARMACOL THER, V40, P80, DOI 10.1016/j.pupt.2016.07.006; Prutsky G, 2016, COCHRANE DB SYST REV, V11; Wang JW, 2017, J ARTHROPLASTY, V32, P801, DOI 10.1016/j.arth.2016.08.020	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2019	170	8					JC45	JC45		10.7326/ACPJ201904160-045	http://dx.doi.org/10.7326/ACPJ201904160-045			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU7YQ	30986835				2022-12-28	WOS:000465499900011
J	Friedrich, MJ				Friedrich, M. J.			Monster 2015-2016 El Nino Event Triggered Infectious Diseases	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 16	2019	321	15					1448	1448		10.1001/jama.2019.3155	http://dx.doi.org/10.1001/jama.2019.3155			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HT7SY	30990557				2022-12-28	WOS:000464765900005
J	Gupta, A; Graber, ML				Gupta, Ashwin; Graber, Mark L.			Inpatient Notes: Just What the Doctor Ordered-Checklists to Improve Diagnosis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Gupta, Ashwin] Vet Affairs Ann Arbor Healthcare Syst, 2215 Fuller Rd,Mail Code 111, Ann Arbor, MI 48105 USA; [Gupta, Ashwin] Univ Michigan, Med Sch, Ann Arbor, MI 48109 USA; [Graber, Mark L.] Soc Improve Diag Med, Evanston, IL USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan	Gupta, A (corresponding author), Vet Affairs Ann Arbor Healthcare Syst, 2215 Fuller Rd,Mail Code 111, Ann Arbor, MI 48105 USA.	ashwing@med.umich.edu						Ely JW, 2011, ACAD MED, V86, P307, DOI 10.1097/ACM.0b013e31820824cd; Gawande A., 2009, CHECKLIST MANIFESTO; Gupta A, 2018, BMJ QUAL SAF, V27, P53, DOI 10.1136/bmjqs-2017-006774; Weiser TG, 2018, BRIT J SURG, V105, P927, DOI 10.1002/bjs.10907	4	4	4	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2019	170	8					HO2	HO3		10.7326/M19-0829	http://dx.doi.org/10.7326/M19-0829			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU7YQ	30986851				2022-12-28	WOS:000465499900001
J	Sancar, F				Sancar, Feyza			Robotically Assisted Surgical Devices Raise Caution	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 16	2019	321	15					1449	1449		10.1001/jama.2019.3834	http://dx.doi.org/10.1001/jama.2019.3834			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HT7SY	30990539				2022-12-28	WOS:000464765900006
J	Kar, P				Kar, Partha			Partha Kar: Rebalancing society's perceptions	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kar, Partha] Portsmouth Hosp NHS Trust, Portsmouth, Hants, England	Portsmouth Hospitals NHS Trust	Kar, P (corresponding author), Portsmouth Hosp NHS Trust, Portsmouth, Hants, England.	drparthakar@gmail.com	Kar, Partha/AAT-4839-2020						0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 15	2019	365								l1776	10.1136/bmj.l1776	http://dx.doi.org/10.1136/bmj.l1776			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU8OI	30987967	Bronze			2022-12-28	WOS:000465548300004
J	Rimmer, A				Rimmer, Abi			Private hospitals must publish outcome data to prevent another Ian Paterson, warn surgeons	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Dyer C, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3757	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 10	2019	365								l1722	10.1136/bmj.l1722	http://dx.doi.org/10.1136/bmj.l1722			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU0EL	30971396				2022-12-28	WOS:000464944100011
J	Salisbury, H				Salisbury, Helen			Helen Salisbury: Who let the drug companies in?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												helen.salisbury@phc.ox.ac.uk						MOBERLY T, 2019, BMJ-BRIT MED J, V364, P12640, DOI DOI 10.1136/BMJ.L1353	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 10	2019	365								l1581	10.1136/bmj.l1581	http://dx.doi.org/10.1136/bmj.l1581			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU0EL	30971401	Bronze			2022-12-28	WOS:000464944100005
J	Kuehn, B				Kuehn, Bridget			Vaping and Pregnancy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	2	2	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 9	2019	321	14					1344	1344		10.1001/jama.2019.3424	http://dx.doi.org/10.1001/jama.2019.3424			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HT5PG	30964535				2022-12-28	WOS:000464615200034
J	Dutel, H; Galland, M; Tafforeau, P; Long, JA; Fagan, MJ; Janvier, P; Herrel, A; Santin, MD; Clement, G; Herbin, M				Dutel, Hugo; Galland, Manon; Tafforeau, Paul; Long, John A.; Fagan, Michael J.; Janvier, Philippe; Herrel, Anthony; Santin, Mathieu D.; Clement, Gael; Herbin, Marc			Neurocranial development of the coelacanth and the evolution of the sarcopterygian head	NATURE			English	Article							NEOCERATODUS-FORSTERI OSTEICHTHYES; LATIMERIA-CHALUMNAE SMITH; FISH; ANATOMY; ORIGIN; BRAIN; ONTOGENY; SKULL	The neurocranium of sarcopterygian fishes was originally divided into an anterior (ethmosphenoid) and posterior (otoccipital) portion by an intracranial joint, and underwent major changes in its overall geometry before fusing into a single unit in lungfishes and early tetrapods(1). Although the pattern of these changes is well-documented, the developmental mechanisms that underpin variation in the form of the neurocranium and its associated soft tissues during the evolution of sarcopterygian fishes remain poorly understood. The coelacanth Latimeria is the only known living vertebrate that retains an intracranial joint(2,3). Despite its importance for understanding neurocranial evolution, the development of the neurocranium of this ovoviviparous fish remains unknown. Here we investigate the ontogeny of the neurocranium and brain in Latimeria chalumnae using conventional and synchrotron X-ray micro-computed tomography as well as magnetic resonance imaging, performed on an extensive growth series for this species. We describe the neurocranium at the earliest developmental stage known for Latimeria, as well as the major changes that the neurocranium undergoes during ontogeny. Changes in the neurocranium are associated with an extreme reduction in the relative size of the brain along with an enlargement of the notochord. The development of the notochord appears to have a major effect on the surrounding cranial components, and might underpin the formation of the intracranial joint. Our results shed light on the interplay between the neurocranium and its adjacent soft tissues during development in Latimeria, and provide insights into the developmental mechanisms that are likely to have underpinned the evolution of neurocranial diversity in sarcopterygian fishes.	[Dutel, Hugo; Fagan, Michael J.] Univ Hull, Sch Engn & Comp Sci, Med & Biol Engn Res Grp, Kingston Upon Hull, N Humberside, England; [Dutel, Hugo] Univ Bristol, Sch Earth Sci, Bristol, Avon, England; [Galland, Manon] Univ Paris Diderot, UMR 7206, MNHN, CNRS,Ecoanthropol & Ethnobiol,Dept Homme & Enviro, Paris, France; [Tafforeau, Paul] European Synchrotron Radiat Facil, Grenoble, France; [Long, John A.] Flinders Univ S Australia, Coll Sci & Engn, Adelaide, SA, Australia; [Janvier, Philippe; Clement, Gael] Sorbonne Univ, UMR 7207, MNHN, CNRS,CR2P,Dept Origines & Evolut, Paris, France; [Herrel, Anthony; Herbin, Marc] MNHN, UMR 7179, CNRS, MECADEV,Dept Adaptat Vivant, Paris, France; [Santin, Mathieu D.] Sorbonne Univ, INSERM, U1127, CNRS,UMR 7225,Ctr NeuroImaging Res,ICM Brain & Sp, Paris, France	University of Hull; University of Bristol; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite; European Synchrotron Radiation Facility (ESRF); Flinders University South Australia; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Dutel, H (corresponding author), Univ Hull, Sch Engn & Comp Sci, Med & Biol Engn Res Grp, Kingston Upon Hull, N Humberside, England.; Dutel, H (corresponding author), Univ Bristol, Sch Earth Sci, Bristol, Avon, England.	h.dutel@bristol.ac.uk	Santin, Mathieu/AAJ-2213-2020; Herrel, Anthony/C-3712-2013	Herrel, Anthony/0000-0003-0991-4434; Dutel, Hugo/0000-0002-1908-5150; Long, John/0000-0001-8012-0114; Tafforeau, Paul/0000-0002-5962-1683	Agence Nationale de la Recherche [LabEx ANR-10-LABX-0003-BCDiv, n\u0001 ANR-11I-DEX-0004-02]; BBSRC [BB/M008525/1]; BBSRC [BB/M008061/1] Funding Source: UKRI	Agence Nationale de la Recherche(French National Research Agency (ANR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank R. Bills and A. Paterson (South African Institute for Aquatic Biodiversity (SAIAB)) for the loan of the fetus; and D. Neumann (Zoologische Staatssammlung Munchen (ZSM)) for the loan of P2; M. Garcia Sanz for micro-computed tomography scanning of the adult specimen at 'AST-RX, plate-forme d'acces scientifique a la tomographie a rayons X' in the 'UMS 2700 Outils et Methodes de Systematique integrative CNRS-MNHN'; the European Synchrotron Radiation Facility (ESRF) for granting beam time to H.D. on ID19 for performing the PPC-SR mu CT acquisitions (Proposal EC-1023); C. Bens and A. Verguin of the Collections de Pieces anatomiques en Fluides at the Museum National d'Histoire Naturelle (MNHN) for their help; and E. Heude (MNHN) and P. Gueriau (University of Lausanne) for their comments and input on an earlier version of the draft. This work was supported by a grant from Agence Nationale de la Recherche under the LabEx ANR-10-LABX-0003-BCDiv, in the program 'Investissements d'avenir' n\u0001 ANR-11I-DEX-0004-02. H. D. was supported by a BBSRC grant (BB/M008525/1).	Ahlberg PE, 1996, NATURE, V381, P61, DOI 10.1038/381061a0; Ahlberg PE, 2008, NATURE, V453, P1199, DOI 10.1038/nature06991; Andrews S. M., 2006, T ROY SOC EDINBURGH, V96, P197, DOI DOI 10.1017/S0263593300001309; ANTHONY J, 1976, CR ACAD SCI D NAT, V283, P1739; Benno B, 2006, S AFR J SCI, V102, P486; Clack JA, 2001, SYST ASSOC SPEC VOL, V61, P392; Clement AM, 2018, ELIFE, V7, DOI 10.7554/eLife.34349; Clement AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141277; Clement AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113898; de Beer G. R., 1938, DEV VERTEBRATE SKULL; Dupret V, 2014, NATURE, V507, P500, DOI 10.1038/nature12980; Dutel H, 2015, CURR BIOL, V25, P1228, DOI 10.1016/j.cub.2015.02.076; Dutel H, 2015, ANAT REC, V298, P579, DOI 10.1002/ar.23103; Dutel H, 2013, NATURWISSENSCHAFTEN, V100, P1007, DOI 10.1007/s00114-013-1104-8; Giles S, 2014, J PALEONTOL, V88, P636, DOI 10.1666/13-094; Goodrich E. S., 1930, STUDIES STRUCTURE DE, V1; Herbin M., 2011, SMITHIANA SPECIAL PU, V3; Hureau J.-C., 1977, CYBIUM, V2, P129; Janvier P., 1996, EARLY VERTEBRATES; Kemp A, 1999, J ZOOL, V248, P97, DOI 10.1017/S0952836999005117; Kemp A, 2000, J ZOOL, V250, P347, DOI 10.1017/S0952836900003095; KRUSKA DCT, 1988, BRAIN BEHAV EVOLUT, V32, P353, DOI 10.1159/000116562; Kuratani S, 1999, ZOOL SCI, V16, P803, DOI 10.2108/zsj.16.803; Kuratani S, 2018, GENESIS, V56, DOI 10.1002/dvg.23213; Kuratani S, 2013, J ANAT, V222, P41, DOI 10.1111/j.1469-7580.2012.01505.x; Lu J, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600154; Lu J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2170; Maisey JG, 2001, SYST ASSOC SPEC VOL, V61, P263; Mee-Mann C., 1982, THESIS; Millot J., 1965, ANATOMIE LATIMERIA C, VII; Nieuwenhuys R., 1998, CENTRAL NERVOUS SYST, V1-3; NORTHCUTT RG, 1978, J MORPHOL, V155, P181, DOI 10.1002/jmor.1051550205; Pradel A, 2009, P NATL ACAD SCI USA, V106, P5224, DOI 10.1073/pnas.0807047106; Smith JLB, 1939, NATURE, V143, P455, DOI 10.1038/143455a0; Yu XB, 1998, J VERTEBR PALEONTOL, V18, P261, DOI 10.1080/02724634.1998.10011055	35	24	24	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 23	2019	569	7757					556	+		10.1038/s41586-019-1117-3	http://dx.doi.org/10.1038/s41586-019-1117-3			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ4TN	30996349	Green Accepted			2022-12-28	WOS:000468844100051
J	Flory, J; Lipska, K				Flory, James; Lipska, Kasia			Metformin in 2019	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DISEASE		[Flory, James] Mem Sloan Kettering Canc Ctr, Div Subspecialty Med, Serv Endocrinol, 1275 York Ave, New York, NY 10021 USA; [Lipska, Kasia] Yale Sch Med, Dept Internal Med, Endocrinol Sect, New Haven, CT USA	Memorial Sloan Kettering Cancer Center; Yale University	Flory, J (corresponding author), 885 Second Ave,Room 1012, New York, NY 10017 USA.	floryj@mskcc.org			AHRQ HHS [K08 HS023898] Funding Source: Medline; NCI NIH HHS [P30 CA008748] Funding Source: Medline	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bonnet F, 2017, DIABETES OBES METAB, V19, P473, DOI 10.1111/dom.12854; Cefalu WT, 2019, DIABETES CARE, V42, pS90, DOI 10.2337/dc19-S009; Crowley MJ, 2017, ANN INTERN MED, V166, P191, DOI 10.7326/M16-1901; FDA, LAB INF GLUC TABL GL; Griffin SJ, 2017, DIABETOLOGIA, V60, P1620, DOI 10.1007/s00125-017-4337-9; Inzucchi SE, 2017, DIABETES CARE, V40, P1128, DOI 10.2337/dc16-2372; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Rena G, 2017, DIABETOLOGIA, V60, P1577, DOI 10.1007/s00125-017-4342-z; Talaulikar VS, 2016, OBSTET GYNECOL SURV, V71, P307, DOI 10.1097/OGX.0000000000000312; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8	10	126	132	9	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 21	2019	321	19					1926	1927		10.1001/jama.2019.3805	http://dx.doi.org/10.1001/jama.2019.3805			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HZ1FC	31009043	Green Accepted			2022-12-28	WOS:000468591200021
J	Raber, I; McCarthy, CP; Yeh, RW				Raber, Inbar; McCarthy, Cian P.; Yeh, Robert W.			Health Insurance and Mobile Health Devices Opportunities and Concerns	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Raber, Inbar] Harvard Med Sch, Dept Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [McCarthy, Cian P.] Harvard Med Sch, Dept Med, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Yeh, Robert W.] Beth Israel Deaconess Med Ctr, Dept Med, Smith Ctr Outcomes Res Cardiol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center	Yeh, RW (corresponding author), Beth Israel Deaconess Med Ctr, Smith Ctr Outcomes Res Cardiol, 375 Longwood Ave,Fourth Floor, Boston, MA 02215 USA.	ryeh@bidmc.harvard.edu	Yeh, Robert/AAJ-3463-2020					Case MA, 2015, JAMA-J AM MED ASSOC, V313, P625, DOI 10.1001/jama.2014.17841; Chokshi NP, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009173; Hafner M, 2018, INCENTIVES PHYS ACTI; Jakicic JM, 2016, JAMA-J AM MED ASSOC, V316, P1161, DOI 10.1001/jama.2016.12858; Kontos Emily, 2014, J Med Internet Res, V16, pe172, DOI 10.2196/jmir.3117; 2016, ANN INTERN MED, V164, P385, DOI DOI 10.7326/M15-1635	6	12	12	3	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2019	321	18					1767	1768		10.1001/jama.2019.3353	http://dx.doi.org/10.1001/jama.2019.3353			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HY7ME	30973573				2022-12-28	WOS:000468319100009
J	Polite, BN; Gluck, AR; Brawley, OW				Polite, Blase N.; Gluck, Abbe R.; Brawley, Otis W.			Ensuring Equity and Justice in the Care and Outcomes of Patients With Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Polite, Blase N.] Univ Chicago, Pritzker Sch Med, Canc Ctr, Chicago, IL 60637 USA; [Gluck, Abbe R.] Yale Law Sch, New Haven, CT USA; [Brawley, Otis W.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, 1550 Orleans St,Ste 1M16, Baltimore, MD 21231 USA	University of Chicago; Yale University; Johns Hopkins University; Johns Hopkins Medicine	Brawley, OW (corresponding author), Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, 1550 Orleans St,Ste 1M16, Baltimore, MD 21231 USA.	otis.brawley@jhu.edu						Bauchner H, 2019, JAMA-J AM MED ASSOC, V321, P751, DOI 10.1001/jama.2019.1081; Delaware Department of Health and Social Services, 2010, DISP CANC INC MORT D; Itzkowitz SH, 2016, CANCER-AM CANCER SOC, V122, P269, DOI 10.1002/cncr.29595; New York State Department of Health, 1976, COL CANC INC MORT YE; Siegel RL, 2018, CA-CANCER J CLIN, V68, P329, DOI 10.3322/caac.21460; 2014, CANCER EPIDEMIOL, V38, P118, DOI DOI 10.1016/J.CANEP.2013.09.009; 2013, J CLIN ONCOL, V31, P1928, DOI DOI 10.1200/JCO.2012.47.8412; 2017, J ENV PUBLIC HLTH, P1; 2017, CANCER CAUSE CONTROL, V28, P563, DOI DOI 10.1007/S10552-017-0878-Y	9	22	22	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2019	321	17					1663	1664		10.1001/jama.2019.4266	http://dx.doi.org/10.1001/jama.2019.4266			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HX3TE	30958509				2022-12-28	WOS:000467314800009
J	Charenton, C; Wilkinson, ME; Nagai, K				Charenton, Clement; Wilkinson, Max E.; Nagai, Kiyoshi			Mechanism of 5 ' splice site transfer for human spliceosome activation	SCIENCE			English	Article							U4/U6.U5 TRI-SNRNP; CRYO-EM STRUCTURE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; REQUIRES ATP; RNA; PROTEIN; ARCHITECTURE; RESOLUTION; NUCLEAR	The prespliceosome, comprising U1 and U2 small nuclear ribonucleoproteins (snRNPs) bound to the precursor messenger RNA 5'splice site (5'SS) and branch point sequence, associates with the U4/U6. U5 tri-snRNP to form the fully assembled precatalytic pre-B spliceosome. Here, we report cryo-electron microscopy structures of the human pre-B complex captured before U1 snRNP dissociation at 3.3-angstrom core resolution and the human tri-snRNP at 2.9-angstrom resolution. U1 snRNP inserts the 5'SS-U1 snRNA helix between the two RecA domains of the Prp28 DEAD-box helicase. Adenosine 5'-triphosphate-dependent closure of the Prp28 RecA domains releases the 5'SS to pair with the nearby U6 ACAGAGA-box sequence presented as a mobile loop. The structures suggest that formation of the 5'SS-ACAGAGA helix triggers remodeling of an intricate protein-RNA network to induce Brr2 helicase relocation to its loading sequence in U4 snRNA, enabling Brr2 to unwind the U4/U6 snRNA duplex to allow U6 snRNA to form the catalytic center of the spliceosome.	[Charenton, Clement; Wilkinson, Max E.; Nagai, Kiyoshi] MRC Lab Mol Biol, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Charenton, C; Wilkinson, ME; Nagai, K (corresponding author), MRC Lab Mol Biol, Cambridge CB2 0QH, England.	ccharent@mrc-lmb.cam.ac.uk; mwilkin@mrc-lmb.cam.ac.uk; kn@mrc-lmb.cam.ac.uk	Charenton, Clement/ABF-8608-2021	Charenton, Clement/0000-0002-8959-7012; Wilkinson, Max/0000-0003-4738-9503	Medical Research Council [MC_U105184330]; European Research Council Advanced Grant [AdG-693087-SPLICE3D]; EMBO; Marie Sklodowska-Curie fellowships; Cambridge-Rutherford Memorial PhD Scholarship; MRC [MC_U105184330] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council Advanced Grant(European Research Council (ERC)); EMBO(European Molecular Biology Organization (EMBO)); Marie Sklodowska-Curie fellowships; Cambridge-Rutherford Memorial PhD Scholarship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The project was supported by the Medical Research Council (MC_U105184330) and a European Research Council Advanced Grant (AdG-693087-SPLICE3D). C.C. was supported by EMBO and Marie Sklodowska-Curie fellowships. M.E.W. was supported by a Cambridge-Rutherford Memorial PhD Scholarship;	Absmeier E, 2015, GENE DEV, V29, P2576, DOI 10.1101/gad.271528.115; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agafonov DE, 2016, SCIENCE, V351, P1416, DOI 10.1126/science.aad2085; Bai R, 2018, SCIENCE, V360, P1423, DOI 10.1126/science.aau0325; Bertram K, 2017, CELL, V170, P701, DOI 10.1016/j.cell.2017.07.011; Boesler C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11997; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fica SM, 2019, SCIENCE, V363, P710, DOI 10.1126/science.aaw5569; Fica SM, 2013, NATURE, V503, P229, DOI 10.1038/nature12734; Galej WP, 2013, NATURE, V493, P638, DOI 10.1038/nature11843; Jacewicz A, 2014, NUCLEIC ACIDS RES, V42, P12885, DOI 10.1093/nar/gku930; Jakab G, 1997, BIOCHIMIE, V79, P387, DOI 10.1016/S0300-9084(97)86148-2; Kastner B, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a032417; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kondo Y, 2015, ELIFE, V4, DOI 10.7554/eLife.04986; Korneta I, 2012, NUCLEIC ACIDS RES, V40, P7046, DOI 10.1093/nar/gks347; Laggerbauer B, 1998, P NATL ACAD SCI USA, V95, P4188, DOI 10.1073/pnas.95.8.4188; Lebedev AA, 2012, ACTA CRYSTALLOGR D, V68, P431, DOI 10.1107/S090744491200251X; Leung AKW, 2011, NATURE, V473, P536, DOI 10.1038/nature09956; Mallam AL, 2012, NATURE, V490, P121, DOI 10.1038/nature11402; Mayeda A, 1999, METH MOL B, V118, P309; Nakane T, 2018, ELIFE, V7, DOI [10.7554/elife.36861, 10.7554/eLife.36861]; OUBRIDGE C, 1994, NATURE, V372, P432, DOI 10.1038/372432a0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plaschka C., 2019, COLD SPRING HARB PER; Plaschka C, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a032391; Plaschka C, 2018, NATURE, V559, P420, DOI 10.1038/s41586-018-0323-8; Plaschka C, 2017, NATURE, V546, P617, DOI 10.1038/nature22799; Pomeranz Krummel Daniel A, 2009, Nature, V458, P475, DOI 10.1038/nature07851; Raghunathan PL, 1998, CURR BIOL, V8, P847, DOI 10.1016/S0960-9822(07)00345-4; Schneider M, 2010, NAT STRUCT MOL BIOL, V17, P216, DOI 10.1038/nsmb.1718; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Sharma S, 2014, GENE DEV, V28, P2518, DOI 10.1101/gad.248625.114; Staley JP, 1999, MOL CELL, V3, P55, DOI 10.1016/S1097-2765(00)80174-4; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Nguyen THD, 2016, NATURE, V530, P298, DOI 10.1038/nature16940; Nguyen THD, 2015, NATURE, V523, P47, DOI 10.1038/nature14548; Wagner T, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0437-z; Wan RX, 2016, SCIENCE, V351, P466, DOI 10.1126/science.aad6466; Wu TP, 1996, NUCLEIC ACIDS RES, V24, P3472, DOI 10.1093/nar/24.17.3472; Yan CY, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a032409; Zahler AM, 2018, RNA, V24, P1314, DOI 10.1261/rna.066878.118; Zhan XC, 2018, CELL RES, V28, P1129, DOI 10.1038/s41422-018-0094-7; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166; 2016, SCIENCE, V351, P466, DOI DOI 10.1126/SCIENCE.AAD6466; 1997, BIOCHIMIE, V79, P387, DOI DOI 10.1016/S0300-9084(97)86148-2; 1998, P NATL ACAD SCI USA, V95, P4188, DOI DOI 10.1073/PNAS.95.8.4188	49	64	64	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 26	2019	364	6438					362	+		10.1126/science.aax3289	http://dx.doi.org/10.1126/science.aax3289			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HU9VW	30975767	Green Accepted			2022-12-28	WOS:000465643400041
J	Fenves, AZ; Mojtahed, A; Nisavic, M; Massoth, LR				Fenves, Andrew Z.; Mojtahed, Amirkasra; Nisavic, Mladen; Massoth, Lucas R.			Case 13-2019: A 54-Year-Old Man with Alcohol Withdrawal and Altered Mental Status	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HOSPITALIZED PATIENT; METABOLIC-ACIDOSIS; ETHYLENE-GLYCOL; INTERFERENCE; INTOXICATION		[Fenves, Andrew Z.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Boston, MA 02115 USA; [Mojtahed, Amirkasra] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02115 USA; [Massoth, Lucas R.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02115 USA; [Fenves, Andrew Z.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Mojtahed, Amirkasra] Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA; [Nisavic, Mladen] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Massoth, Lucas R.] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Fenves, AZ (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Boston, MA 02115 USA.			Massoth, Lucas/0000-0002-0479-5950				Abramson S, 2000, CURR OPIN NEPHROL HY, V9, P695, DOI 10.1097/00041552-200011000-00017; [Anonymous], 2016, COB CREJ2 CREAT JAFF; Emadi A, 2007, NEW ENGL J MED, V356, P530, DOI 10.1056/NEJMc063237; EMMETT M, 1977, MEDICINE, V56, P38, DOI 10.1097/00005792-197756010-00002; Feldman M, 2005, J LAB CLIN MED, V146, P317, DOI 10.1016/j.lab.2005.07.008; Fenves AZ, 2006, CLIN J AM SOC NEPHRO, V1, P441, DOI 10.2215/CJN.01411005; Greenberg N, 2012, CLIN CHEM, V58, P391, DOI 10.1373/clinchem.2011.172288; Jones AW, 2000, J ANAL TOXICOL, V24, P8, DOI 10.1093/jat/24.1.8; Judge BS, 2005, MED CLIN N AM, V89, P1107, DOI 10.1016/j.mcna.2005.06.011; Killeen C, 2011, AM J THER, V18, pE113, DOI 10.1097/MJT.0b013e3181c960cb; Kosten TR, 2003, NEW ENGL J MED, V348, P1786, DOI 10.1056/NEJMra020617; Kraut JA, 2018, NEW ENGL J MED, V378, P270, DOI 10.1056/NEJMra1615295; KROLL MH, 1987, CLIN CHEM, V33, P1129; Ng PCY, 2018, INTERN EMERG MED, V13, P375, DOI 10.1007/s11739-018-1799-9; Tintu A, 2013, ANN CLIN BIOCHEM, V50, P70, DOI 10.1258/acb.2012.012052; Uribarri J, 1998, MEDICINE, V77, P73, DOI 10.1097/00005792-199803000-00001; Wood E, 2018, JAMA-J AM MED ASSOC, V320, P825, DOI 10.1001/jama.2018.10574; Zaman F, 2002, AM J KIDNEY DIS, V40, DOI 10.1053/ajkd.2002.34938	18	1	1	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 25	2019	380	17					1657	1665		10.1056/NEJMcpc1900591	http://dx.doi.org/10.1056/NEJMcpc1900591			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU9FC	31018073				2022-12-28	WOS:000465598600013
J	Henretig, FM; Kirk, MA; McKay, CA				Henretig, Fred M.; Kirk, Mark A.; McKay, Charles A., Jr.			Hazardous Chemical Emergencies and Poisonings	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SODIUM THIOSULFATE; INDUSTRIAL-CHEMICALS; MEDICAL TOXICOLOGY; HYDROXOCOBALAMIN; MANAGEMENT; EXPOSURE; WEAPONS; DECONTAMINATION; PREPAREDNESS; INHALATION		[Henretig, Fred M.] Univ Penn, Div Emergency Med, Philadelphia, PA 19104 USA; [Henretig, Fred M.] Univ Penn, Poison Control Ctr, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Henretig, Fred M.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Kirk, Mark A.] Dept Homeland Secur, Washington, DC USA; [McKay, Charles A., Jr.] Univ Connecticut, Hlth Ctr, Div Med Toxicol, Dept Emergency Med, Hartford, CT 06112 USA; [McKay, Charles A., Jr.] Hartford Hosp, Hartford, CT 06115 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Connecticut; Hartford Hospital	Henretig, FM (corresponding author), Childrens Hosp Philadelphia, Poison Control Ctr, 3401 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	henretig@email.chop.edu						Abedin MJ, 2012, J MED TOXICOL, V8, P108, DOI 10.1007/s13181-012-0214-6; Ahmad S, 2016, ANN NY ACAD SCI, V1374, P123, DOI 10.1111/nyas.13095; Alberts WM, 1996, CHEST, V109, P1618, DOI 10.1378/chest.109.6.1618; [Anonymous], 2012, REP TOX CHEM SYNDR D; [Anonymous], 2017, CHEM HAZ EM MED MAN; [Anonymous], 1991, MMWR-MORBID MORTAL W, V40, P619; [Anonymous], 2014, NAT TOX SUBST INC PR; Auf der Heide E, 2006, ANN EMERG MED, V47, P34, DOI 10.1016/j.annemergmed.2005.05.009; Baradaran-Rafii A, 2017, OCUL SURF, V15, P48, DOI 10.1016/j.jtos.2016.09.002; Barry E, 2018, NY TIMES; BAUD FJ, 1991, NEW ENGL J MED, V325, P1761, DOI 10.1056/NEJM199112193252502; Bebarta VS, 2017, ACAD EMERG MED, V24, P1088, DOI 10.1111/acem.13213; Bebarta VS, 2017, ANN EMERG MED, V69, P718, DOI 10.1016/j.annemergmed.2016.09.034; Bebarta VS, 2012, ANN EMERG MED, V59, P532, DOI 10.1016/j.annemergmed.2012.01.022; Borron SW, 2007, ANN EMERG MED, V49, P794, DOI 10.1016/j.annemergmed.2007.01.026; Borron SW, 2015, EMERG MED CLIN N AM, V33, P89, DOI 10.1016/j.emc.2014.09.014; Borron SW, 2012, CURR PHARM BIOTECHNO, V13, P1940; Brenner M, 2017, J CLIN TOXICOL, V7, P355; Burklow TR, 2003, PEDIATR ANN, V32, P230, DOI 10.3928/0090-4481-20030401-06; Centers for Disease Control and Prevention, 2017, EM PREP RESP CHEM; Chen J, 2009, RADIAT PROT DOSIM, V134, P132, DOI 10.1093/rpd/ncp083; Chilcott RP, 2015, PRIMARY RESPONSE INC, V1; Chilcott RP, 2018, ANN EMERG MED; Cibulsky SM, 2014, PATIENT DECONTAMINAT; Ciottone GR, 2018, NEW ENGL J MED, V378, P1611, DOI 10.1056/NEJMra1705224; CURRY SC, 1994, ANN EMERG MED, V24, P65, DOI 10.1016/S0196-0644(94)70164-4; Curry SC, 2005, CRITICAL CARE TOXICO, P987; Dart RC, 2018, ANN EMERG MED, V71, P314, DOI 10.1016/j.annemergmed.2017.05.021; Disaster Preparedness Advisory Council, 2016, PEDIATRICS, V137; Duncan MA, 2010, J MED TOXICOL, V6, P461, DOI 10.1007/s13181-010-0114-6; Eaton D. L., 2013, CASARETT DOULLS TOXI, P13, DOI DOI 10.1036/0071470514; Eddleston M., 2015, GOLDFRANKS TOXICOLOG, V10th, P1409; Eddleston M, 2016, BRIT J CLIN PHARMACO, V81, P462, DOI 10.1111/bcp.12784; Eddleston M, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000104; Eisenkraft A, 2016, TOXICOL REP, V3, P202, DOI 10.1016/j.toxrep.2015.12.007; Gabbay DS, 2001, J EMERG MED, V20, P141, DOI 10.1016/S0736-4679(00)00301-2; Garlich FM, 2012, CLIN TOXICOL, V50, P136, DOI 10.3109/15563650.2011.650173; Geller RJ, 2006, PEDIATRICS, V118, P2146, DOI 10.1542/peds.2006-1251; Grainge C, 2010, CLIN TOXICOL, V48, P497, DOI 10.3109/15563650.2010.506877; Greenberg MI, 2016, CLIN TOXICOL, V54, P79, DOI 10.3109/15563650.2015.1121272; HALL A H, 1987, Journal of Emergency Medicine, V5, P115, DOI 10.1016/0736-4679(87)90074-6; Hampson NB, 2016, ANN AM THORAC SOC, V13, P1768, DOI 10.1513/AnnalsATS.201604-318OC; Hampson NB, 2012, AM J RESP CRIT CARE, V186, P1095, DOI 10.1164/rccm.201207-1284CI; Hardison LS, 2014, J MED TOXICOL, V10, P51, DOI 10.1007/s13181-013-0319-6; Henretig FM, 2002, ANN EMERG MED, V40, P405, DOI 10.1007/mem.2002.126779; Henretig FM, 2002, J PEDIATR-US, V141, P311, DOI 10.1067/mpd.2002.127408; Hick JL, 2003, ANN EMERG MED, V42, P381, DOI 10.1016/S0196-0644(03)00442-6; Holland MG, 2015, EMERG MED CLIN N AM, V33, P51, DOI 10.1016/j.emc.2014.09.006; Holstege CP, 2012, CRIT CARE CLIN, V28, P479, DOI 10.1016/j.ccc.2012.07.008; Holstege CP, 2015, GOLDFRANKS TOXICOLOG, P1602; Hurst C.G., 2008, TXB MILITARY MED, P259; Jett DA, 2016, ANN NY ACAD SCI, V1374, P5, DOI 10.1111/nyas.13179; John H, 2018, FORENSIC TOXICOL, V36, P61, DOI 10.1007/s11419-017-0376-7; Kales SN, 2004, NEW ENGL J MED, V350, P800, DOI 10.1056/NEJMra030370; King AM, 2015, EMERG MED CLIN N AM, V33, P133, DOI 10.1016/j.emc.2014.09.010; Kirk M, 2015, EMERG MED CLIN N AM, V33, P69, DOI 10.1016/j.emc.2014.09.007; Kirk MA, 2007, EMERG MED CLIN N AM, V25, P527, DOI 10.1016/j.emc.2007.02.005; Kleinschmidt KC, 2015, GOLDFRANKS TOXICOLOG, P155; KLEINSCHWARTZ W, 1989, MED TOXICOL ADV DRUG, V4, P219, DOI 10.1007/BF03259998; Larson TC, 2016, DISASTER MED PUBLIC, V10, P199, DOI 10.1017/dmp.2015.127; Leary AD, 2014, DISASTER MED PUBLIC, V8, P260, DOI 10.1017/dmp.2014.41; Mackie E, 2014, DISASTER MED PUBLIC, V8, P411, DOI 10.1017/dmp.2014.81; Madsen James M, 2010, Am J Disaster Med, V5, P333; MCCormick LC, 2015, EMERG MED CLIN N AM, V33, P197, DOI 10.1016/j.emc.2014.09.012; McKay CA, 2015, GOLDFRANKS TOXICOLOG, P1665; Mckay CA, 2014, EMERG MED CLIN N AM, V32, P127, DOI 10.1016/j.emc.2013.09.003; Mintegi S, 2013, PEDIATR EMERG CARE, V29, P1234, DOI 10.1097/PEC.0b013e3182aa4ee1; Mishra PK, 2009, INT J OCCUP MED ENV, V22, P193, DOI 10.2478/v10001-009-0028-1; MOFENSON HC, 1974, PEDIATRICS, V54, P336; Moore BL, 2015, EMERG MED CLIN N AM, V33, P37, DOI 10.1016/j.emc.2014.09.005; Mukaida K, 2017, OCCUP ENVIRON MED, V74, P321, DOI 10.1136/oemed-2015-103437; Myhrer T, 2014, NEUROTOXICOLOGY, V44, P27, DOI 10.1016/j.neuro.2014.04.011; Naraghi ZS, 2005, EUR J DERMATOL, V15, P140; Nelson LS, 2015, GOLDFRANKS TOXICOLOG, P1567; Office of the Assistant Secretary for Preparedness and Response, 2018, CONT MED COUNT TREAT; Okumura T, 1998, ACAD EMERG MED, V5, P618, DOI 10.1111/j.1553-2712.1998.tb02471.x; Okumura T, 1996, ANN EMERG MED, V28, P129, DOI 10.1016/S0196-0644(96)70052-5; Pace R, 2014, CLIN TOXICOL, V52, P647, DOI 10.3109/15563650.2014.939659; Paddock Richard, 2017, NY TIMES; Parker-Cote JL, 2018, CLIN TOXICOL, V56, P609, DOI 10.1080/15563650.2018.1435886; Rajavi Zhale, 2017, J Ophthalmic Vis Res, V12, P65, DOI 10.4103/jovr.jovr_253_16; Ruder JB, 2015, J BURN CARE RES, V36, pE23, DOI 10.1097/BCR.0000000000000065; Russell D, 2010, CLIN TOXICOL, V48, P171, DOI 10.3109/15563651003698042; Sahloul MZ, 2016, ANN AM THORAC SOC, V13, P147, DOI 10.1513/AnnalsATS.201510-661PS; Sang-A-Gad P, 2011, CLIN TOXICOL, V49, P834, DOI 10.3109/15563650.2011.618456; Schwartz MD, 2018, DISASTER MED PUBLIC; Schwartz M, 2007, J MED TOXICOL, V3, P139, DOI 10.1007/BF03160924; SHARMA A, 2015, GOLDFRANKS TOXICOLOG, V10, P324; Suchard J.R., 2015, GOLDFRANKS TOXICOLOG, P1678; Summerhill EM, 2017, ANN AM THORAC SOC, V14, P1060, DOI 10.1513/AnnalsATS.201704-297WS; Sutter ME, 2012, CLIN TOXICOL, V50, P892, DOI 10.3109/15563650.2012.744031; Teran-MacIver M, 2008, MCN-AM J MATERN-CHIL, V33, P224, DOI 10.1097/01.NMC.0000326076.03999.ca; Tewari-Singh N, 2016, ANN NY ACAD SCI, V1374, P184, DOI 10.1111/nyas.13099; Tomassoni AJ, 2015, EMERG MED CLIN N AM, V33, P13, DOI 10.1016/j.emc.2014.09.004; Tourinsky, 2008, TXB MILITARY MED MED, P155; US Army Medical Research Institute of Chemical Defense, 2014, MED MAN CHEM CAS HDB, V5th; Vajner JE, 2013, J MED TOXICOL, V9, P259, DOI 10.1007/s13181-013-0309-8; Vandenplas O, 2014, ALLERGY, V69, P1141, DOI 10.1111/all.12448; Weaver LK, 2009, NEW ENGL J MED, V360, P1217, DOI 10.1056/NEJMcp0808891; Weaver LK, 2002, NEW ENGL J MED, V347, P1057, DOI 10.1056/NEJMoa013121; Weibrecht K, 2012, ANN EMERG MED, V59, P70, DOI 10.1016/j.annemergmed.2011.07.023; White CW, 2016, ANN NY ACAD SCI, V1378, P87, DOI 10.1111/nyas.13130; Wiener Sage W, 2004, J Intensive Care Med, V19, P22, DOI 10.1177/0885066603258659; Worek F, 2016, ARCH TOXICOL, V90, P2131, DOI 10.1007/s00204-016-1772-1; World Health Organization, 2009, MAN PUBL HLTH MAN CH; Zakharov S, 2015, BASIC CLIN PHARMACOL, V117, P209, DOI 10.1111/bcpt.12387	106	28	28	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 25	2019	380	17					1638	1655		10.1056/NEJMra1504690	http://dx.doi.org/10.1056/NEJMra1504690			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU9FC	31018070				2022-12-28	WOS:000465598600011
J	Horvath, JC; Anderson, GF				Horvath, Jane C.; Anderson, Gerard F.			The States as Important Laboratories for Federal Prescription Drug Cost-Containment Efforts	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Horvath, Jane C.] Horvath Hlth Policy, POB 196, College Pk, MD 20741 USA; [Anderson, Gerard F.] Johns Hopkins Ctr Hosp Finance & Management, Johns Hopkins Sch Med, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins Medicine	Horvath, JC (corresponding author), Horvath Hlth Policy, POB 196, College Pk, MD 20741 USA.	horvathhealthpolicy@gmail.com						[Anonymous], 2018, CULTIVATING VIBRANT; Crisp E, 2019, LOUISIANA MAKES ANOT; Department of Health and Human Services CfMaMS, 2018, FED REGISTER, P54546; Greene JA, 2016, JAMA-J AM MED ASSOC, V315, P461, DOI 10.1001/jama.2015.18720; Kaiser Family Foundation, 2018, PUBL OP PRESCR DRUGS; McClellan M, 2017, FORMER FDA COMMISSIO; Trusheim MR, 2018, JAMA-J AM MED ASSOC, V320, P1977, DOI 10.1001/jama.2018.15782; Willingham E, WHY DID MYLAN HIKE E	8	5	5	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2019	321	16					1561	1562		10.1001/jama.2019.2189	http://dx.doi.org/10.1001/jama.2019.2189			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HV7BZ	31012941				2022-12-28	WOS:000466137800006
J	Di Carlo, D; Arai, F; Goda, K; Huang, TJ; Lo, YH; Nitta, N; Ozeki, Y; Tsia, K; Uemura, S; Wong, KKY				Di Carlo, Dino; Arai, Fumihito; Goda, Keisuke; Huang, Tony Jun; Lo, Yu-Hwa; Nitta, Nao; Ozeki, Yasuyuki; Tsia, Kevin; Uemura, Sotaro; Wong, Kenneth K. Y.			Comment on "Ghost cytometry"	SCIENCE			English	Editorial Material								Ota et al. (Reports, 15 June 2018, p. 1246) report using pseudo-random optical masks and a spatial-temporal transformation to perform blur-free, high-frame rate imaging of cells in flow with a high signal-to-noise ratio. They also claim sorting at rates of 3000 cells per second, based on imaging data. The experiments conducted and results reported in their study are insufficient to support these conclusions.	[Di Carlo, Dino] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA; [Arai, Fumihito] Nagoya Univ, Dept Micronano Syst Engn, Nagoya, Aichi, Japan; [Goda, Keisuke; Nitta, Nao] Univ Tokyo, Dept Chem, Tokyo, Japan; [Huang, Tony Jun] Duke Univ, Dept Mech Engn & Mat Sci, Durham, NC 27706 USA; [Lo, Yu-Hwa] Univ Calif San Diego, Dept Elect & Comp Engn, San Diego, CA 92103 USA; [Nitta, Nao] Japan Sci & Technol Agcy, Saitama, Japan; [Ozeki, Yasuyuki] Univ Tokyo, Dept Elect Engn & Informat Syst, Tokyo, Japan; [Tsia, Kevin; Wong, Kenneth K. Y.] Univ Hong Kong, Dept Elect & Elect Engn, Hong Kong, Peoples R China; [Uemura, Sotaro] Univ Tokyo, Dept Biol Sci, Tokyo, Japan	University of California System; University of California Los Angeles; Nagoya University; University of Tokyo; Duke University; University of California System; University of California San Diego; Japan Science & Technology Agency (JST); University of Tokyo; University of Hong Kong; University of Tokyo	Di Carlo, D (corresponding author), Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA.	dicarlo@ucla.edu	GODA, KEISUKE/G-4997-2014; Tsia, Kevin Kin Man/E-9896-2010; Huang, Tony Jun/A-1546-2009; /C-1865-2009	Tsia, Kevin Kin Man/0000-0002-6394-9657; Huang, Tony Jun/0000-0003-1205-3313; /0000-0003-3668-3539; Uemura, Sotaro/0000-0001-9701-1803; Arai, Fumihito/0000-0002-2508-1615; Ozeki, Yasuyuki/0000-0002-9004-0799; Nitta, Nao/0000-0002-9093-9016; Di Carlo, Dino/0000-0003-3942-4284; Goda, Keisuke/0000-0001-6302-6038				Baret JC, 2009, LAB CHIP, V9, P1850, DOI 10.1039/b902504a; Brasko C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02628-4; Candes EJ, 2006, COMMUN PUR APPL MATH, V59, P1207, DOI 10.1002/cpa.20124; Collins DJ, 2015, LAB CHIP, V15, P3439, DOI 10.1039/c5lc00614g; Di Carlo D, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.094503; Hur SC, 2011, LAB CHIP, V11, P912, DOI [10.1039/c0lc00595a, 10.1039/c01c00595a]; Lindmo T., 1990, FLOW CYTOMETRY SORTI, P145; MONROE JG, 1983, J IMMUNOL METHODS, V63, P45, DOI 10.1016/0022-1759(83)90208-9; Nyberg KD, 2018, INTEGR BIOL-UK, V10, P218, DOI 10.1039/c7ib00222j; Ota S, 2018, SCIENCE, V360, P1246, DOI 10.1126/science.aan0096; Piruska A, 2005, LAB CHIP, V5, P1348, DOI 10.1039/b508288a; Vinson V., 2018, SCIENCE, V360, P1198	12	4	4	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2019	364	6437							eaav1429	10.1126/science.aav1429	http://dx.doi.org/10.1126/science.aav1429			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HU0JG	31000635				2022-12-28	WOS:000464956600001
J	Kempton, HR; Qi, LS				Kempton, Hannah R.; Qi, Lei S.			When genome editing goes off-target	SCIENCE			English	Editorial Material							UNBIASED DETECTION; CRISPR-CAS9; SEQ; SPECIFICITIES; CLEAVAGE		[Kempton, Hannah R.; Qi, Lei S.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Qi, Lei S.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Qi, Lei S.] Stanford Univ, Stanford ChEM H Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Qi, LS (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.; Qi, LS (corresponding author), Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA.; Qi, LS (corresponding author), Stanford Univ, Stanford ChEM H Inst, Stanford, CA 94305 USA.	stanley.qi@stanford.edu	Qi, Lei S/AAC-5088-2019	Qi, Lei S/0000-0002-3965-3223	National Science Foundation Graduate Research Fellowship Program; Stanford Bio-X Fellowship Program	National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); Stanford Bio-X Fellowship Program	H.R.K. acknowledges the National Science Foundation Graduate Research Fellowship Program and Stanford Bio-X Fellowship Program. L.S.Q. acknowledges the Pew Scholar Foundation, Alfred P. Sloan Foundation, and Li Ka Shing Foundation.	Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gaudelli NM, 2017, NATURE, V551, P464, DOI 10.1038/nature24644; Jin S, 2019, SCIENCE, V364, P292, DOI 10.1126/science.aaw7166; Kim D, 2019, NAT BIOTECHNOL, V37, P430, DOI 10.1038/s41587-019-0050-1; Kim D, 2017, NAT BIOTECHNOL, V35, P475, DOI 10.1038/nbt.3852; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/nmeth.3284, 10.1038/NMETH.3284]; Knott GJ, 2018, SCIENCE, V361, P866, DOI 10.1126/science.aat5011; Rees HA, 2018, NAT REV GENET, V19, P770, DOI 10.1038/s41576-018-0059-1; Tsai SQ, 2017, NAT METHODS, V14, P607, DOI [10.1038/NMETH.4278, 10.1038/nmeth.4278]; Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Wang XL, 2015, NAT BIOTECHNOL, V33, P175, DOI 10.1038/nbt.3127; Wienert B, 2019, SCIENCE, V364, P286, DOI 10.1126/science.aav9023; Zuo EW, 2019, SCIENCE, V364, P289, DOI 10.1126/science.aav9973	14	12	12	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2019	364	6437					234	236		10.1126/science.aax1827	http://dx.doi.org/10.1126/science.aax1827			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HU0JG	31000651				2022-12-28	WOS:000464956600027
J	Chan, DC; Huynh, J; Studdert, DM				Chan, David C.; Huynh, Johnny; Studdert, David M.			Accuracy of Valuations of Surgical Procedures in the Medicare Fee Schedule	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY; NSQIP; WORK	A 2005-2015 analysis of the accuracy of valuations of 293 common surgical procedures showed substantial absolute discrepancies in operative times estimated by the Relative Value Scale Update Committee (RUC) and times recorded in a surgical registry, but the RUC did not systematically over- or underestimate times. Background The Relative Value Scale Update Committee (RUC) of the American Medical Association plays a central role in determining physician reimbursement. The RUC's role and performance have been criticized but subjected to little empirical evaluation. Methods We analyzed the accuracy of valuations of 293 common surgical procedures from 2005 through 2015. We compared the RUC's estimates of procedure time with "benchmark" times for the same procedures derived from the clinical registry maintained by the American College of Surgeons National Surgical Quality Improvement Program (NSQIP). We characterized inaccuracies, quantified their effect on physician revenue, and examined whether re-review corrected them. Results At the time of 108 RUC reviews, the mean absolute discrepancy between RUC time estimates and benchmark times was 18.5 minutes, or 19.8% of the RUC time. However, RUC time estimates were neither systematically shorter nor longer than benchmark times overall (beta, 0.97; 95% confidence interval, 0.94 to 1.01; P=0.10). Our analyses suggest that whereas orthopedic surgeons and urologists received higher payments than they would have if benchmark times had been used ($160 million and $40 million more, respectively, in Medicare reimbursement in 2011 through 2015), cardiothoracic surgeons, neurosurgeons, and vascular surgeons received lower payments ($130 million, $60 million, and $30 million less, respectively). The accuracy of RUC time estimates improved in 47% of RUC revaluations, worsened in 27%, and was unchanged in 25%. (Percentages do not sum to 100 because of rounding.) Conclusions In this analysis of frequently conducted operations, we found substantial absolute discrepancies between intraoperative times as estimated by the RUC and the times recorded for the same procedures in a surgical registry, but the RUC did not systematically overestimate or underestimate times. (Funded by the National Institutes of Health.)	[Chan, David C.; Studdert, David M.] Stanford Univ, Ctr Hlth Policy, Ctr Primary Care & Outcomes Res, Sch Med, Stanford, CA 94305 USA; [Studdert, David M.] Stanford Law Sch, Stanford, CA USA; [Chan, David C.] Vet Affairs Palo Alto Hlth Care Syst, Dept Med, Palo Alto, CA USA; [Huynh, Johnny] Univ Calif Los Angeles, Dept Econ, Los Angeles, CA 90024 USA	Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of California System; University of California Los Angeles	Chan, DC (corresponding author), Ctr Hlth Policy PCOR, 117 Encina Commons, Stanford, CA 94305 USA.	david.c.chan@stanford.edu	Studdert, David/AAF-3116-2021	Studdert, David/0000-0003-0585-5537; Huynh, Johnny/0000-0002-2738-1398	National Institutes of Health [1DP5OD019903-01]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD019903] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by a Director's Early Independence Award (1DP5OD019903-01, to Dr. Chan) from the National Institutes of Health.	American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP), ACS NSQIP IT WORKS; American Medical Association, 2018, RVS UPD PROC; [Anonymous], 2018, MED RBRVS 2018 PHYS; Bodenheimer T, 2007, ANN INTERN MED, V146, P301, DOI 10.7326/0003-4819-146-4-200702200-00011; Braun P, 2011, METHODOLOGICAL MED R; Burgette LF, 2017, HEALTH SERV RES, V52, P74, DOI 10.1111/1475-6773.12474; Burwell SM, 2015, NEW ENGL J MED, V372, P897, DOI 10.1056/NEJMp1500445; Centers for Medicare and Medicaid Services, PHYS SUPPL PROC SUMM; Centers for Medicare & Medicaid Services (CMS) HHS, 2016, Fed Regist, V81, P77008; Cohen ME, 2013, J AM COLL SURGEONS, V217, P336, DOI 10.1016/j.jamcollsurg.2013.02.027; Congressional Budget Office, 2017, BAS PROJ MED; Cromwell J, 2010, MED CARE RES REV, V67, P676, DOI 10.1177/1077558710371115; Eaton J, 2010, KAISER HLTH NEWS; Ginsburg PB, 2007, NEW ENGL J MED, V356, P1201, DOI 10.1056/NEJMp068272; Goodson JD, 2007, JAMA-J AM MED ASSOC, V298, P2308, DOI 10.1001/jama.298.19.2308; Khuri SF, 1998, ANN SURG, V228, P491, DOI 10.1097/00000658-199810000-00006; Klepper B., 2013, HLTH AFFAIRS BLOG; Laugesen MJ, 2012, HEALTH AFFAIR, V31, P965, DOI 10.1377/hlthaff.2011.0557; Laugesen Miriam J, 2016, FIXING MED PRICES PH; Mabry CD, 2005, ANN SURG, V241, P929, DOI 10.1097/01.sla.0000165201.06970.0e; Matthews AW, 2010, WALL STREET J; McCall N, 2006, MED CARE RES REV, V63, P764, DOI 10.1177/1077558706293635; Medicare Payment Advisory Commission, 2006, MED PAYM POL REP C; Medicare Payment Advisory Commission, 2008, MED PAYM POL REP C; Reinhardt UE, 2010, NY TIMES; Sheils CR, 2016, SURGERY, V160, P1182, DOI 10.1016/j.surg.2016.04.034; The Society of Thoracic Surgeons, STS NAT DAT; Whoriskey P, 2013, WASHINGTON POST; Wynn BO, 2015, DEV MODEL VALIDATION; Zuckerman S., 2016, COLLECTING EMPIRICAL	30	42	42	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 18	2019	380	16					1546	1554		10.1056/NEJMsa1807379	http://dx.doi.org/10.1056/NEJMsa1807379			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU3AO	30995374	Bronze, Green Accepted			2022-12-28	WOS:000465144100015
J	Iacobucci, G				Iacobucci, Gareth			NHS trusts pay pension contributions in cash to ease consultants' tax burden	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		ARMSTRONG S, 2019, BMJ-BRIT MED J, V364, P50357, DOI DOI 10.1136/BMJ.L206; ARMSTRONG S, 2019, BMJ-BRIT MED J, V364, P37244, DOI DOI 10.1136/BMJ.L998; Cumbo J, 2019, FINANCIAL TIMES; IACOBUCCI G, 2019, BMJ-BRIT MED J, V364, P24411, DOI DOI 10.1136/BMJ.L977; Pension Scheme NHS, 2019, TAP ANN ALL; Thiruchelvam S, 2019, TIMES	6	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 18	2019	365								l1846	10.1136/bmj.l1846	http://dx.doi.org/10.1136/bmj.l1846			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU8PD	31000632				2022-12-28	WOS:000465550700013
J	Zemp, M; Huss, M; Thibert, E; Eckert, N; McNabb, R; Huber, J; Barandun, M; Machguth, H; Nussbaumer, SU; Gartner-Roer, I; Thomson, L; Paul, F; Maussion, F; Kutuzov, S; Cogley, JG				Zemp, M.; Huss, M.; Thibert, E.; Eckert, N.; McNabb, R.; Huber, J.; Barandun, M.; Machguth, H.; Nussbaumer, S. U.; Gartner-Roer, I.; Thomson, L.; Paul, F.; Maussion, F.; Kutuzov, S.; Cogley, J. G.			Global glacier mass changes and their contributions to sea-level rise from 1961 to 2016	NATURE			English	Article							BALANCE MEASUREMENTS; COMPLETE INVENTORY; SURFACE ELEVATION; VOLUME CHANGE; SARENNES; SERIES; AREA	Glaciers distinct from the Greenland and Antarctic ice sheets cover an area of approximately 706,000 square kilometres globally(1), with an estimated total volume of 170,000 cubic kilometres, or 0.4 metres of potential sea-level-rise equivalent(2). Retreating and thinning glaciers are icons of climate change(3) and affect regional runoff(4) as well as global sea level(5,6). In past reports from the Intergovernmental Panel on Climate Change, estimates of changes in glacier mass were based on the multiplication of averaged or interpolated results from available observations of a few hundred glaciers by defined regional glacier areas(7-10). For data-scarce regions, these results had to be complemented with estimates based on satellite altimetry and gravimetry(11). These past approaches were challenged by the small number and heterogeneous spatiotemporal distribution of in situ measurement series and their often unknown ability to represent their respective mountain ranges, as well as by the spatial limitations of satellite altimetry (for which only point data are available) and gravimetry (with its coarse resolution). Here we use an extrapolation of glaciological and geodetic observations to show that glaciers contributed 27 +/- 22 millimetres to global mean sea-level rise from 1961 to 2016. Regional specific-mass-change rates for 2006-2016 range from -0.1 metres to -1.2 metres of water equivalent per year, resulting in a global sea-level contribution of 335 +/- 144 gigatonnes, or 0.92 +/- 0.39 millimetres, per year. Although statistical uncertainty ranges overlap, our conclusions suggest that glacier mass loss may be larger than previously reported(11.) The present glacier mass loss is equivalent to the sea-level contribution of the Greenland Ice Sheet(12), clearly exceeds the loss from the Antarctic Ice Sheet(13), and accounts for 25 to 30 per cent of the total observed sea-level rise(14). Present mass-loss rates indicate that glaciers could almost disappear in some mountain ranges in this century, while heavily glacierized regions will continue to contribute to sea-level rise beyond 2100.	[Zemp, M.; Huber, J.; Machguth, H.; Nussbaumer, S. U.; Gartner-Roer, I.; Paul, F.] Univ Zurich, Dept Geog, Zurich, Switzerland; [Huss, M.] Swiss Fed Inst Technol, Lab Hydraul Hydrol & Glaciol VAW, Zurich, Switzerland; [Huss, M.; Barandun, M.; Machguth, H.; Nussbaumer, S. U.] Univ Fribourg, Dept Geosci, Fribourg, Switzerland; [Thibert, E.; Eckert, N.] Univ Grenoble Alpes, Irstea, UR ETGR, Grenoble, France; [McNabb, R.] Univ Oslo, Dept Geosci, Oslo, Norway; [Thomson, L.] Queens Univ, Dept Geog & Planning, Kingston, ON, Canada; [Maussion, F.] Univ Innsbruck, Dept Atmospher & Cryospher Sci, Innsbruck, Austria; [Kutuzov, S.] Russian Acad Sci, Inst Geog, Dept Glaciol, Moscow, Russia; [Cogley, J. G.] Trent Univ, Dept Geog, Peterborough, ON, Canada	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Fribourg; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); INRAE; University of Oslo; Queens University - Canada; University of Innsbruck; Institute of Geography, Russian Academy of Sciences; Russian Academy of Sciences; Trent University	Zemp, M (corresponding author), Univ Zurich, Dept Geog, Zurich, Switzerland.	michael.zemp@geo.uzh.ch	Kutuzov, Stanislav/A-2775-2013; Maussion, Fabien/B-9814-2013	Kutuzov, Stanislav/0000-0003-2007-0922; Maussion, Fabien/0000-0002-3211-506X; THIBERT, Emmanuel/0000-0003-2843-5367; McNabb, Robert/0000-0003-0016-493X; Huss, Matthias/0000-0002-2377-6923; Machguth, Horst/0000-0001-5924-0998; Barandun, Martina/0000-0003-1820-7600	Polar Geospatial Center under National Science Foundation (NSF) Office of Polar Programs (OPP) [1043681, 1559691, 1542736]; Federal Office of Meteorology and Climatology MeteoSwiss of the Global Climate Observing System (GCOS) Switzerland; Cryospheric Commission of the Swiss Academy of Science; Copernicus Climate Change Service (C3S); European Space Agency (ESA) project Glaciers_cci [4000109873/14/I-NB]; European Space Agency (ESA) project Sea-Level Budget Closure CCI [4000119910/17/I-NB]; Irstea Grenoble as part of LabEx OSUG@2020	Polar Geospatial Center under National Science Foundation (NSF) Office of Polar Programs (OPP)(National Science Foundation (NSF)); Federal Office of Meteorology and Climatology MeteoSwiss of the Global Climate Observing System (GCOS) Switzerland; Cryospheric Commission of the Swiss Academy of Science; Copernicus Climate Change Service (C3S); European Space Agency (ESA) project Glaciers_cci; European Space Agency (ESA) project Sea-Level Budget Closure CCI; Irstea Grenoble as part of LabEx OSUG@2020	We thank the national correspondents and principal investigators of the WGMS network as well as the Global Land Ice Measurements from Space (GLIMS) and RGI communities for free and open access to their data sets. We thank B. Armstrong for polishing the language. Arctic digital elevation model (DEM) strips were provided by the Polar Geospatial Center under National Science Foundation (NSF) Office of Polar Programs (OPP) awards 1043681, 1559691 and 1542736. This study was enabled by support from the Federal Office of Meteorology and Climatology MeteoSwiss within the framework of the Global Climate Observing System (GCOS) Switzerland, the Cryospheric Commission of the Swiss Academy of Science, the Copernicus Climate Change Service (C3S) implemented by the European Centre for Medium-range Weather Forecasts (ECMWF) on behalf of the European Commission, the European Space Agency (ESA) projects Glaciers_cci (4000109873/14/I-NB) and Sea-Level Budget Closure CCI (4000119910/17/I-NB), and Irstea Grenoble as part of LabEx OSUG@2020.	Andreassen LM, 2016, CRYOSPHERE, V10, P535, DOI 10.5194/tc-10-535-2016; [Anonymous], 2011, WORKING GROUP MASS B; Basantes-Serrano R, 2016, J GLACIOL, V62, P124, DOI 10.1017/jog.2016.17; Bojinski S, 2014, B AM METEOROL SOC, V95, P1431, DOI 10.1175/BAMS-D-13-00047.1; Brun F, 2018, NAT GEOSCI, V11, P543, DOI 10.1038/s41561-018-0171-z; Cogley JG, 2016, ANN GLACIOL, V57, P41, DOI 10.3189/2016AoG71A040; Cogley JG, 2012, MAR GEOD, V35, P379, DOI 10.1080/01490419.2012.709476; Cogley JG, 2009, ANN GLACIOL, V50, P96, DOI 10.3189/172756409787769744; Cogley JG, 1998, J GLACIOL, V44, P315, DOI 10.3189/S0022143000002641; Cox LH, 2004, J GLACIOL, V50, P363, DOI 10.3189/172756504781829855; Dyurgerov M. B., 2005, INSTAAROP58; Dyurgerov M.B., 2002, 55 U COL I ARCT ALP; Eckert N, 2011, J GLACIOL, V57, P134, DOI 10.3189/002214311795306673; Falaschi D, 2013, ARCT ANTARCT ALP RES, V45, P19, DOI 10.1657/1938-4246-45.1.19; Falk MJ, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007666; Fischer M, 2015, CRYOSPHERE, V9, P525, DOI 10.5194/tc-9-525-2015; Fountain AG, 1999, GEOGR ANN A, V81A, P563; Fountain AG, 2016, J GLACIOL, V62, P976, DOI 10.1017/jog.2016.86; Gardner AS, 2013, SCIENCE, V340, P852, DOI 10.1126/science.1234532; GCOS, 2016, GCOS200; Girod L, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9070704; GTN-G, 2017, GTN G GLAC REG, DOI [10.5904/gtng-glacreg-2017-07, DOI 10.5904/GTNG-GLACREG-2017-07]; Hannesdottir H, 2015, CRYOSPHERE, V9, P565, DOI 10.5194/tc-9-565-2015; Huber J, 2017, EARTH SYST SCI DATA, V9, P115, DOI 10.5194/essd-9-115-2017; Huss M, 2013, CRYOSPHERE, V7, P877, DOI 10.5194/tc-7-877-2013; Huss M, 2018, NAT CLIM CHANGE, V8, P135, DOI 10.1038/s41558-017-0049-x; Huss M, 2015, FRONT EARTH SC-SWITZ, V3, DOI 10.3389/feart.2075.00054; Huss M, 2012, J GEOPHYS RES-EARTH, V117, DOI 10.1029/2012JF002523; Huss M, 2012, J GLACIOL, V58, P278, DOI 10.3189/2012JoG11J216; Huss M, 2009, ANN GLACIOL, V50, P198, DOI 10.3189/172756409787769627; Kaab A, 2015, CRYOSPHERE, V9, P557, DOI 10.5194/tc-9-557-2015; Kaser G, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027511; Khan SA, 2015, REP PROG PHYS, V78, DOI 10.1088/0034-4885/78/4/046801; Khromova T., 2019, REG ENVIRON CHANGE, V18, P1; Korsgaard NJ, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.32; Krzywinski M, 2014, NAT METHODS, V11, P699, DOI 10.1038/nmeth.3005; Le Bris R, 2015, ANN GLACIOL, V56, P184, DOI 10.3189/2015AoG70A227; LETREGUILLY A, 1990, ARCTIC ALPINE RES, V22, P43, DOI 10.2307/1551719; Lliboutry L., 1974, J GLACIOL, V13, P371, DOI [10.1017/S0022143000023169, 10.3189/S0022143000023169, DOI 10.1017/S0022143000023169]; Marzeion B, 2015, CRYOSPHERE, V9, P2399, DOI 10.5194/tc-9-2399-2015; Marzeion B, 2018, NAT CLIM CHANGE, V8, P305, DOI 10.1038/s41558-018-0093-1; Marzeion B, 2014, SCIENCE, V345, P919, DOI 10.1126/science.1254702; McNabb R, 2019, CRYOSPHERE, V13, P895, DOI 10.5194/tc-13-895-2019; Mernild SH, 2013, CRYOSPHERE, V7, P1565, DOI 10.5194/tc-7-1565-2013; Mernild SH, 2015, GEOGR TIDSSKR-DEN, V115, P39, DOI 10.1080/00167223.2015.1026917; Nuth C, 2011, CRYOSPHERE, V5, P271, DOI 10.5194/tc-5-271-2011; Ohmura A, 2004, GEOPHYS MONOGR SER, V150, P239, DOI 10.1029/150GM19; Paul F, 2010, CRYOSPHERE, V4, P569, DOI 10.5194/tc-4-569-2010; Pfeffer WT, 2014, J GLACIOL, V60, P537, DOI 10.3189/2014JoG13J176; Puga JL, 2015, NAT METHODS, V12, P1098, DOI 10.1038/nmeth1115-1098b; Radic V, 2014, CLIM DYNAM, V42, P37, DOI 10.1007/s00382-013-1719-7; Radic V, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001373; Rastner P, 2012, CRYOSPHERE, V6, P1483, DOI 10.5194/tc-6-1483-2012; RGI Consortium Randolph Glacier Inventory, 2017, DAT GLOB GLAC OUTL G, DOI [10.7265/N5-RGI-60, DOI 10.7265/N5-RGI-60]; Shean D., 2017, **DATA OBJECT**, DOI [10.5067/GSACB044M4PK, DOI 10.5067/GSACB044M4PK]; Shepherd A, 2018, NATURE, V558, P219, DOI 10.1038/s41586-018-0179-y; Thibert E, 2008, J GLACIOL, V54, P522, DOI 10.3189/002214308785837093; Thomson LI, 2017, J GLACIOL, V63, P55, DOI 10.1017/jog.2016.112; Vaughan DG, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P317; Vijay S, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8121038; Wang PY, 2014, GLOBAL PLANET CHANGE, V114, P14, DOI 10.1016/j.gloplacha.2014.01.001; Watson CS, 2015, NAT CLIM CHANGE, V5, P565, DOI 10.1038/nclimate2635; Zemp M, 2013, CRYOSPHERE, V7, P1227, DOI 10.5194/tc-7-1227-2013; Zemp M., 2017, ICSU WDS IUGG IACS U, P244, DOI [10.5904/wgms-fog-2017-10, DOI 10.5904/WGMS-FOG-2017-10]	64	409	424	35	231	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 18	2019	568	7752					382	+		10.1038/s41586-019-1071-0	http://dx.doi.org/10.1038/s41586-019-1071-0			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HU0GZ	30962533	Green Submitted			2022-12-28	WOS:000464950700054
J	Colaianni, CA				Colaianni, C. Alessandra			Casting	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Colaianni, C. Alessandra] Massachusetts Eye & Ear, Dept Otolaryngol, 243 Charles St, Boston, MA 02141 USA	Harvard University; Massachusetts Eye & Ear Infirmary	Colaianni, CA (corresponding author), Massachusetts Eye & Ear, Dept Otolaryngol, 243 Charles St, Boston, MA 02141 USA.	alessa_colaianni@meei.harvard.edu							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 16	2019	321	15					1455	1456		10.1001/jama.2019.3954	http://dx.doi.org/10.1001/jama.2019.3954			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HT7SY	30990553				2022-12-28	WOS:000464765900009
J	[Anonymous]				[Anonymous]			Breast Cancer Screening in Average-Risk Women	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																			0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2019	170	8					I18	I18		10.7326/P19-0007	http://dx.doi.org/10.7326/P19-0007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU7YQ	30959524				2022-12-28	WOS:000465499900003
J	Benea-Chelmus, IC; Settembrini, FF; Scalari, G; Faist, J				Benea-Chelmus, Ileana-Cristina; Settembrini, Francesca Fabiana; Scalari, Giacomo; Faist, Jerome			Electric field correlation measurements on the electromagnetic vacuum state	NATURE			English	Article							TERAHERTZ	Quantum mechanics ascribes to the ground state of the electromagnetic radiation(1) zero-point electric field fluctuations that permeate empty space at all frequencies. No energy can be extracted from the ground state of a system, and therefore these fluctuations cannot be measured directly with an intensity detector. The experimental proof of their existence therefore came from more indirect evidence, such as the Lamb shift(2,3,4), the Casimir force between close conductors(5,6,7) or spontaneous emission(1,8). A direct method of determining the spectral characteristics of vacuum field fluctuations has so far been missing. Here we perform a direct measurement of the field correlation on these fluctuations in the terahertz frequency range by using electro-optic detection(9) in a nonlinear crystal placed in a cryogenic environment. We investigate their temporal and spatial coherence, which, at zero time delay and spatial distance, has a peak value of 6.2 x 10(-2) volts squared per square metre, corresponding to a fluctuating vacuum field(10,11) of 0.25 volts per metre. With this measurement, we determine the spectral components of the ground state of electromagnetic radiation within the bandwidth of our electro-optic detection.	[Benea-Chelmus, Ileana-Cristina; Settembrini, Francesca Fabiana; Scalari, Giacomo; Faist, Jerome] Swiss Fed Inst Technol, Inst Quantum Elect, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Benea-Chelmus, IC; Faist, J (corresponding author), Swiss Fed Inst Technol, Inst Quantum Elect, Zurich, Switzerland.	ileanab@ethz.ch; jerome.faist@phys.ethz.ch	Scalari, Giacomo/Q-1048-2017	Scalari, Giacomo/0000-0003-4028-803X; Benea-Chelmus, Ileana-Cristina/0000-0002-4814-4498; Settembrini, Francesca Fabiana/0000-0002-2017-4695	European Research Council (Advanced Grant, Quantum Metamaterials in the Ultra Strong Coupling Regime); Swiss National Science Foundation [165639]	European Research Council (Advanced Grant, Quantum Metamaterials in the Ultra Strong Coupling Regime); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded by the European Research Council (Advanced Grant, Quantum Metamaterials in the Ultra Strong Coupling Regime) and the Swiss National Science Foundation (grant 165639). We acknowledge the mechanical workshop at ETHZ. We acknowledge the contribution of M. Ernzer to the noise analysis tools, E. Mavrona to the design of opto-mechanical components and the extraction of the refractive index of ZnTe, and A. Imamoglu for discussions.	Aspelmeyer M, 2014, REV MOD PHYS, V86, P1391, DOI 10.1103/RevModPhys.86.1391; Bayer A, 2017, NANO LETT, V17, P6340, DOI 10.1021/acs.nanolett.7b03103; Benea-Chelmus IC, 2018, ACS PHOTONICS, V5, P1398, DOI 10.1021/acsphotonics.7b01407; Benea-Chelmus IC, 2017, PHYS REV A, V96, DOI 10.1103/PhysRevA.96.033821; Benea-Chelmus IC, 2016, PHYS REV A, V93, DOI 10.1103/PhysRevA.93.043812; BETHE HA, 1947, PHYS REV, V72, P339, DOI 10.1103/PhysRev.72.339; Bozyigit D, 2011, NAT PHYS, V7, P154, DOI [10.1038/nphys1845, 10.1038/NPHYS1845]; Casimir H. B. G., 1948, INDAG MATH, V10, P261; Ciuti C, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.115303; Cong K., 2016, J OPT SOC AM B, V33, pC80; da Silva MP, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.043804; Fragner A, 2008, SCIENCE, V322, P1357, DOI 10.1126/science.1164482; Gunter G, 2009, NATURE, V458, P178, DOI 10.1038/nature07838; Hagenmuller D, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.223601; Keller J, 2017, NANO LETT, V17, P7410, DOI 10.1021/acs.nanolett.7b03228; Khalili FY, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.033840; Kizmann M., 2018, PREPRINT; KWIAT PG, 1995, PHYS REV LETT, V75, P4337, DOI 10.1103/PhysRevLett.75.4337; Lahteenmaki P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12548; LAMB WE, 1947, PHYS REV, V72, P241, DOI 10.1103/PhysRev.72.241; Loudon R., 2000, QUANTUM THEORY LIGHT; MOORE GT, 1970, J MATH PHYS, V11, P2679, DOI 10.1063/1.1665432; Moskalenko AS, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.263601; Orgiu E, 2015, NAT MATER, V14, P1123, DOI [10.1038/nmat4392, 10.1038/NMAT4392]; PURCELL EM, 1946, PHYS REV, V69, P681; Riek C, 2017, NATURE, V541, P376, DOI 10.1038/nature21024; Riek C, 2015, SCIENCE, V350, P420, DOI 10.1126/science.aac9788; Rungsawang R, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3027474; Scalari G, 2012, SCIENCE, V335, P1323, DOI 10.1126/science.1216022; van Kolck A, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3528456; Walls D., 1994, QUANTUM OPT; Wilson CM, 2011, NATURE, V479, P376, DOI 10.1038/nature10561; WU Q, 1995, APPL PHYS LETT, V67, P3523, DOI 10.1063/1.114909	33	50	50	5	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2019	568	7751					202	+		10.1038/s41586-019-1083-9	http://dx.doi.org/10.1038/s41586-019-1083-9			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HT2SH	30971847	Green Submitted			2022-12-28	WOS:000464412700042
J	Hawkes, N				Hawkes, Nigel			Asthma: traffic pollution is blamed for one in eight new cases in children	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Achakulwisut P, 2019, LANCET PLANET HEALTH, V3, pE166, DOI 10.1016/S2542-5196(19)30046-4	1	0	0	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 11	2019	365								l1767	10.1136/bmj.l1767	http://dx.doi.org/10.1136/bmj.l1767			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU0ER	30975703				2022-12-28	WOS:000464944700014
J	Richmond, A; Cranfield, T; Cooper, N				Richmond, Anna; Cranfield, Thomas; Cooper, Nicola			LIFE Study tips for medical students	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PERFECT		[Richmond, Anna; Cranfield, Thomas] Univ Nottingham, Nottingham, England; [Cooper, Nicola] Derby Teaching Hosp NHS Fdn Trust, Derby, England	University of Nottingham	Richmond, A (corresponding author), Univ Nottingham, Nottingham, England.	anna.richmond@nottingham.ac.uk						Benjamin AS, 2010, COGNITIVE PSYCHOL, V61, P228, DOI 10.1016/j.cogpsych.2010.05.004; Bickerdike A, 2016, INT J MED EDUC, V7, P230, DOI 10.5116/ijme.576f.d074; Brown PC., 2014, J EDUC RES; Daley BJ, 2010, MED EDUC, V44, P440, DOI 10.1111/j.1365-2923.2010.03628.x; Deng F, 2015, PERSPECT MED EDUC, V4, P308, DOI 10.1007/s40037-015-0220-x; Didau D, 2016, WHAT EVERYTHING YOU; Dunlosky J, 2013, PSYCHOL SCI PUBL INT, V14, P4, DOI 10.1177/1529100612453266; Hatala RM, 2003, ADV HEALTH SCI EDUC, V8, P17, DOI 10.1023/A:1022687404380; Larsen DP, 2009, MED EDUC, V43, P1174, DOI 10.1111/j.1365-2923.2009.03518.x; MAYER RE, 1992, J EDUC PSYCHOL, V84, P444, DOI 10.1037/0022-0663.84.4.444; Moulton CAE, 2006, ANN SURG, V244, P400, DOI 10.1097/01.sla.0000234808.85789.6a; Pashler Harold, 2008, Psychol Sci Public Interest, V9, P105, DOI 10.1111/j.1539-6053.2009.01038.x; Rawson KA, 2015, EDUC PSYCHOL REV, V27, P483, DOI 10.1007/s10648-014-9273-3; Riener C., 2010, CHANGE MAGAZINE HIGH, V42, P32, DOI [10.1080/00091383.2010.503139, DOI 10.1080/00091383.2010.503139]; Rohrer D, 2012, EDUC PSYCHOL REV, V24, P355, DOI 10.1007/s10648-012-9201-3; Shin Hong-Im, 2010, Korean J Med Educ, V22, P197, DOI 10.3946/kjme.2010.22.3.197	16	8	8	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 11	2019	365								k663	10.1136/bmj.k663	http://dx.doi.org/10.1136/bmj.k663			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU0ER	30975707				2022-12-28	WOS:000464944700001
J	Bery, S; Ciancaglini, L; Garces, PS; Brim, B; Wharton, G; Mossialos, E				Bery, Sherwan; Ciancaglini, Lorenzo; Garces, Pedro San Jose; Brim, Bangin; Wharton, George; Mossialos, Elias			Time to address the plight of the people of northeastern Syria	LANCET			English	Editorial Material									[Bery, Sherwan] Kurdish Red Crescent, Qamishli, Syria; [Ciancaglini, Lorenzo; Garces, Pedro San Jose] Ponte Per, Amuda, Syria; [Brim, Bangin] Charite Univ Med Berlin, Berlin, Germany; [Brim, Bangin] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London, England; [Brim, Bangin; Wharton, George; Mossialos, Elias] London Sch Econ & Polit Sci, Dept Hlth Policy, London WC2A 2AE, England	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of London; London School of Hygiene & Tropical Medicine; University of London; London School Economics & Political Science	Mossialos, E (corresponding author), London Sch Econ & Polit Sci, Dept Hlth Policy, London WC2A 2AE, England.	e.a.mossialos@lse.ac.uk	Mossialos, Elias/ABE-1301-2021					Democratic Federation of Northeast Syria Al Cezire Committee of Health, 2018, PRIM HLTH CAR MOD; Global Polio Eradication Initiative, 2017, CIRC VACC DER POL CO; Self Administration of North East Syria, 2018, REP SELF ADM PRES HL; UN Office for the Coordination of Humanitarian Affairs, 2019, HUM NEEDS OV SYR AR; Un Ponte Per. Kurdish Red Crescent, 2018, QAMISHLI N E SYRIA D; United Nations Office for the Coordination of Humanitarian Affairs, 2019, HUM NEEDS OV 2019 SY; United Nations Office for the Coordination of Humanitarian Affairs, 2018, 30 US OFF COORD HUM; WHO, 2018, WHOL SYR HLTH CLUST; WHO, 2018, HLTH RES AV MON SYST; WHO Regional Office for the Eastern Mediterranean, 2019, EWARS WEEKLY B W 020, V6, P3; WHO Regional Office for the Eastern Mediterranean, 2014, MENT HLTH CAR SYR AN; WHO UNICEF, 2018, SYR AR REP EST IMM C	12	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 6	2019	393	10179					1394	1396		10.1016/S0140-6736(19)30491-X	http://dx.doi.org/10.1016/S0140-6736(19)30491-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HS0OU	30967201				2022-12-28	WOS:000463561000009
J	Newman, M				Newman, Melanie			Expenses disclosure at BMA sparks review	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Campbell D., 2015, GUARDIAN; Pickersgill TP, 2004, BMJ	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2019	364								l1407	10.1136/bmj.l1407	http://dx.doi.org/10.1136/bmj.l1407			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HR5VS	30957767	Bronze			2022-12-28	WOS:000463215700015
J	Jaffe, S				Jaffe, Susan			Scott Gottlieb steps down from US FDA leadership	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 16	2019	393	10176					1086	1087		10.1016/S0140-6736(19)30575-6	http://dx.doi.org/10.1016/S0140-6736(19)30575-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HP1HF	30957743				2022-12-28	WOS:000461416600012
J	Rowhani-Rahbar, A; Zatzick, DF; Rivara, FP				Rowhani-Rahbar, Ali; Zatzick, Douglas F.; Rivara, Frederick P.			Long-lasting Consequences of Gun Violence and Mass Shootings	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Rowhani-Rahbar, Ali] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Rowhani-Rahbar, Ali; Zatzick, Douglas F.; Rivara, Frederick P.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Zatzick, Douglas F.] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Rivara, Frederick P.] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Rowhani-Rahbar, A (corresponding author), Univ Washington, Dept Epidemiol, POB 357236, Seattle, WA 98195 USA.	rowhani@uw.edu		Rowhani-Rahbar, Ali/0000-0002-2705-4485	National Institutes of Health, Department of Justice, City of Seattle	National Institutes of Health, Department of Justice, City of Seattle	The University of Washington has received funding from the National Institutes of Health, Department of Justice, City of Seattle, and Arnold Ventures to support firearm injury research conducted by Drs Rowhani-Rahbar and Rivara. No other disclosures were reported.	[Anonymous], 2007, PSYCHIATRY, V70, P283, DOI 10.1521/psyc.2007.70.4.283; Engel C, 2003, TERRORISM DISASTER I; King R, MASS SHOOTINGS HAVE; Leiner M, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00099; Naghavi M, 2018, JAMA-J AM MED ASSOC, V320, P792, DOI 10.1001/jama.2018.10060; Travers A, 2018, CURR PSYCHIAT REP, V20, DOI 10.1007/s11920-018-0903-1; 2017, TRAUMA VIOLENCE ABUS, V18, P62, DOI DOI 10.1177/1524838015591572; 2017, JAMA PSYCHIAT, V74, P1251, DOI DOI 10.1001/JAMAPSYCHIATRY.2017.3037	8	18	18	1	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2019	321	18					1765	1766		10.1001/jama.2019.5063	http://dx.doi.org/10.1001/jama.2019.5063			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HY7ME	30977768				2022-12-28	WOS:000468319100008
J	Crocker, JT; Hale, CP; Vanka, A; Ricotta, DN; McSparron, JI; Huang, GC				Crocker, Jonathan T.; Hale, Caleb P.; Vanka, Anita; Ricotta, Daniel N.; McSparron, Jakob I.; Huang, Grace C.			Raising the Bar for Procedural Competency Among Hospitalists	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Crocker, Jonathan T.; Hale, Caleb P.; Vanka, Anita; Ricotta, Daniel N.; Huang, Grace C.] Harvard Med Sch, Boston, MA 02115 USA; [Crocker, Jonathan T.; Hale, Caleb P.; Vanka, Anita; Ricotta, Daniel N.; Huang, Grace C.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [McSparron, Jakob I.] Univ Michigan, Ann Arbor, MI 48109 USA; [Crocker, Jonathan T.; Hale, Caleb P.; Vanka, Anita; Ricotta, Daniel N.; Huang, Grace C.] 330 Brookline Ave,PBS-2, Boston, MA 02215 USA; [McSparron, Jakob I.] 1500 East Med Ctr Dr,SPC 5361, Ann Arbor, MI 48109 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; University of Michigan System; University of Michigan	Huang, GC (corresponding author), 330 Brookline Ave,E-ES-202A, Boston, MA 02215 USA.; Huang, GC (corresponding author), 330 Brookline Ave,PBS-2, Boston, MA 02215 USA.	ghuang@bidmc.harvard.edu	Huang, Grace/ABD-6878-2021					American Board of Internal Medicine, 2014, INT MED POL PROC REQ; [Anonymous], 2011, TODAYS HOSPITALIST; Ault MJ, 2007, NEW ENGL J MED, V356, P1789, DOI 10.1056/NEJMc063239; Barsuk Jeffrey H, 2012, J Grad Med Educ, V4, P23, DOI 10.4300/JGME-D-11-00161.1; De Gottardi A, 2009, CLIN GASTROENTEROL H, V7, P906, DOI 10.1016/j.cgh.2009.05.004; Nichani S, 2017, J HOSP MED, V12, P283, DOI [10.12788/jhm.2715, 10.12788/jhm.2728]; 2012, NEUROLOGY, V79, P132, DOI DOI 10.1212/WNL.0B013E31825DD39D; 2018, J HOSP MED, V13, P117, DOI DOI 10.12788/JHM; 2015, THORAX, V70, P127, DOI DOI 10.1136/THORAXJNL-2014-206114	9	5	5	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 7	2019	170	9					654	+		10.7326/M18-3007	http://dx.doi.org/10.7326/M18-3007			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HW9KX	31009942				2022-12-28	WOS:000467010800011
J	Ruddy, KJ; Ganz, PA				Ruddy, Kathryn J.; Ganz, Patricia A.			Treatment of Nonmetastatic Breast Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Ruddy, Kathryn J.] Mayo Clin, Coll Med, Dept Oncol, Rochester, MN USA; [Ganz, Patricia A.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Hlth Policy & Management, Los Angeles, CA USA; [Ganz, Patricia A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Ganz, Patricia A.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA	Mayo Clinic; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Ganz, PA (corresponding author), Jonsson Comprehens Canc Ctr, 650 Charles Young Dr S,Room A2-125 CHS, Los Angeles, CA 90095 USA.	pganz@mednet.ucla.edu		Ganz, Patricia/0000-0002-1841-4143				Bland K., 2018, BREAST COMPREHENSIVE; Jacobsen Paul B, 2017, Am Soc Clin Oncol Educ Book, V37, P674, DOI 10.14694/EDBK_175673; Waks AG, 2019, JAMA-J AM MED ASSOC, V321, P288, DOI 10.1001/jama.2018.19323; 2017, J CLIN ONCOL, V35, P2838, DOI DOI 10.1200/JCO.2017.74.0472; 2018, J NATL COMPR CANC NE, V16, P310, DOI DOI 10.6004/JNCCN.2018.0012; 2016, J CLIN ONCOL, V34, P611, DOI DOI 10.1200/JCO.2015.64.3809; 2019, J CLIN ONCOL, V37, P423, DOI DOI 10.1200/JCO.18.01160	7	22	22	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2019	321	17					1716	1717		10.1001/jama.2019.3927	http://dx.doi.org/10.1001/jama.2019.3927			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HX3TE	30977769				2022-12-28	WOS:000467314800021
J	Leemans, C; van der Zwalm, MCH; Brueckner, L; Comoglio, F; van Schaik, T; Pagie, L; van Arensbergen, J; van Steensel, B				Leemans, Christ; van der Zwalm, Marloes C. H.; Brueckner, Laura; Comoglio, Federico; van Schaik, Tom; Pagie, Ludo; van Arensbergen, Joris; van Steensel, Bas			Promoter-Intrinsic and Local Chromatin Features Determine Gene Repression in LADs	CELL			English	Article							NUCLEAR LAMINA INTERACTIONS; TRANSCRIPTIONAL REPRESSION; LENTIVIRAL VECTORS; READ ALIGNMENT; CHIP-SEQ; HETEROCHROMATIN; EXPRESSION; ELEMENTS; MAPS; ORGANIZATION	It is largely unclear whether genes that are naturally embedded in lamina-associated domains (LADs) are inactive due to their chromatin environment or whether LADs are merely secondary to the lack of transcription. We show that hundreds of human promoters become active when moved from their native LAD position to a neutral context in the same cells, indicating that LADs form a repressive environment. Another set of promoters inside LADs is able to "escape" repression, although their transcription elongation is attenuated. By inserting reporters into thousands of genomic locations, we demonstrate that escaper promoters are intrinsically less sensitive to LAD repression. This is not simply explained by promoter strength but by the interplay between promoter sequence and local chromatin features that vary strongly across LADs. Enhancers also differ in their sensitivity to LAD chromatin. This work provides a general framework for the systematic understanding of gene regulation by repressive chromatin.	[Leemans, Christ; van der Zwalm, Marloes C. H.; Brueckner, Laura; Comoglio, Federico; van Schaik, Tom; Pagie, Ludo; van Arensbergen, Joris; van Steensel, Bas] Netherlands Canc Inst, Div Gene Regulat, Amsterdam, Netherlands; [Leemans, Christ; van der Zwalm, Marloes C. H.; Brueckner, Laura; Comoglio, Federico; van Schaik, Tom; Pagie, Ludo; van Arensbergen, Joris; van Steensel, Bas] Netherlands Canc Inst, Oncode Inst, Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	van Steensel, B (corresponding author), Netherlands Canc Inst, Div Gene Regulat, Amsterdam, Netherlands.; van Steensel, B (corresponding author), Netherlands Canc Inst, Oncode Inst, Amsterdam, Netherlands.	b.v.steensel@nki.nl	Schaik, Tom/ABD-5197-2020	Schaik, Tom/0000-0001-7850-5074; Leemans, Christ/0000-0002-3271-840X	NIH Common Fund 4D Nucleome Program [U54DK107965]; ERC [293662, 694466]; ZonMW TOP; Swiss National Science Foundation; KWF Dutch Cancer Society; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK107965] Funding Source: NIH RePORTER	NIH Common Fund 4D Nucleome Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERC(European Research Council (ERC)European Commission); ZonMW TOP; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); KWF Dutch Cancer Society(KWF Kankerbestrijding); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the NKI Genomics Core Facility for technical support. We thank Harmen Bussemaker, Vincent FitzPatrick, members of our laboratory, the Division of Gene Regulation, and the 4DN Center for Nuclear Cytomics for helpful discussions. This work was supported by NIH Common Fund 4D Nucleome Program (grant U54DK107965), ERC advanced grants 293662 and 694466, and ZonMW TOP to B.v.S. and an early postdoc mobility fellowship from the Swiss National Science Foundation to F.C. The Oncode Institute is supported by KWF Dutch Cancer Society.	Akhtar W, 2014, NAT PROTOC, V9, P1255, DOI 10.1038/nprot.2014.072; Akhtar W, 2013, CELL, V154, P914, DOI 10.1016/j.cell.2013.07.018; Allshire RC, 2018, NAT REV MOL CELL BIO, V19, P229, DOI 10.1038/nrm.2017.119; Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Bian Q, 2013, J CELL BIOL, V203, P767, DOI 10.1083/jcb.201305027; Brown G., 2018, GREYLISTCHIP GREY LI; Catarino RR, 2018, GENE DEV, V32, P202, DOI 10.1101/gad.310367.117; Chuang CH, 2006, CURR BIOL, V16, P825, DOI 10.1016/j.cub.2006.03.059; Comoglio F, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003419; Core LJ, 2014, NAT GENET, V46, P1311, DOI 10.1038/ng.3142; Corrales M, 2017, GENOME RES, V27, P1153, DOI 10.1101/gr.211433.116; de Jong J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004250; de Sio FRS, 2012, FASEB J, V26, P4561, DOI 10.1096/fj.12-206177; Dialynas G, 2010, DEVELOPMENT, V137, P3067, DOI 10.1242/dev.048231; Dirks RAM, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0284-4; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ehsani R, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1349-2; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Fishilevich S, 2017, DATABASE-OXFORD, DOI 10.1093/database/bax028; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Gonzalez-Sandoval A, 2016, TRENDS GENET, V32, P485, DOI 10.1016/j.tig.2016.05.004; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Harr JC, 2015, J CELL BIOL, V208, P33, DOI 10.1083/jcb.201405110; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hu GQ, 2013, CELL STEM CELL, V12, P180, DOI 10.1016/j.stem.2012.11.003; Kelsey G, 2017, SCIENCE, V358, P69, DOI 10.1126/science.aan6826; Kind J, 2015, CELL, V163, P134, DOI 10.1016/j.cell.2015.08.040; Kind J, 2013, CELL, V153, P178, DOI 10.1016/j.cell.2013.02.028; King HW, 2018, GENOME RES, V28, P1494, DOI 10.1101/gr.237180.118; Ku MC, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R85, 10.1186/gb-2012-13-10-r85]; Kumaran RI, 2008, J CELL BIOL, V180, P51, DOI 10.1083/jcb.200706060; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee DC, 2009, EXP CELL RES, V315, P996, DOI 10.1016/j.yexcr.2009.01.003; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lizio M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0560-6; Luperchio T.R., 2017, CHROMOSOME CONFORMAT, DOI [10.1101/122226, DOI 10.1101/122226]; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Pengelly AR, 2015, GENE DEV, V29, P1487, DOI 10.1101/gad.265439.115; Penke TJR, 2016, GENE DEV, V30, P1866, DOI 10.1101/gad.286278.116; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Pradeepa MM, 2016, NAT GENET, V48, P681, DOI 10.1038/ng.3550; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rahl PB, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a020990; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Rivera CM, 2013, CELL, V155, P39, DOI 10.1016/j.cell.2013.09.011; Roven C, 2003, NUCLEIC ACIDS RES, V31, P3487, DOI 10.1093/nar/gkg630; Salzberg AC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173723; Schmidt C, 2015, NAT METHODS, V12, P963, DOI [10.1038/nmeth.3542, 10.1038/NMETH.3542]; Schwalb B, 2016, SCIENCE, V352, P1225, DOI 10.1126/science.aad9841; Starmer J, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0991-z; Stricker SH, 2017, NAT REV GENET, V18, P51, DOI 10.1038/nrg.2016.138; Tarasov A, 2015, BIOINFORMATICS, V31, P2032, DOI 10.1093/bioinformatics/btv098; Therizols P, 2014, SCIENCE, V346, P1238, DOI 10.1126/science.1259587; Towbin BD, 2012, CELL, V150, P934, DOI 10.1016/j.cell.2012.06.051; Tyler DS, 2017, SCIENCE, V356, P1397, DOI 10.1126/science.aal2066; van Arensbergen J, 2017, NAT BIOTECHNOL, V35, P145, DOI 10.1038/nbt.3754; van Steensel B, 2017, CELL, V169, P780, DOI 10.1016/j.cell.2017.04.022; Vogel MJ, 2007, NAT PROTOC, V2, P1467, DOI 10.1038/nprot.2007.148; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274; Winter GE, 2017, MOL CELL, V67, P5, DOI 10.1016/j.molcel.2017.06.004; Wu FN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00176-x; Yokochi T, 2009, P NATL ACAD SCI USA, V106, P19363, DOI 10.1073/pnas.0906142106; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zentner GE, 2014, NAT REV GENET, V15, P814, DOI 10.1038/nrg3798; Zheng XB, 2015, MOL BIOL CELL, V26, P2685, DOI 10.1091/mbc.E15-04-0210; Zorita E, 2015, BIOINFORMATICS, V31, P1913, DOI 10.1093/bioinformatics/btv053; 2012, CELL, V151, P1608; 2017, SCI DATA, V4, P70107; 2014, MOL CELL, V55, P277	72	62	63	2	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 2	2019	177	4					852	+		10.1016/j.cell.2019.03.009	http://dx.doi.org/10.1016/j.cell.2019.03.009			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HW7AU	30982597	hybrid, Green Published			2022-12-28	WOS:000466843000008
J	Devi, S				Devi, Sharmila			Cyclone Idai: 1 month later, devastation persists	LANCET			English	Editorial Material																			0	24	25	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 20	2019	393	10181					1585	1585		10.1016/S0140-6736(19)30892-X	http://dx.doi.org/10.1016/S0140-6736(19)30892-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU0DL	31007189				2022-12-28	WOS:000464941500013
J	Hare, BM; Scholten, O; Dwyer, J; Trinh, TNG; Buitink, S; ter Veen, S; Bonardi, A; Corstanje, A; Falcke, H; Horandel, JR; Huege, T; Mitra, P; Mulrey, K; Nelles, A; Rachen, JP; Rossetto, L; Schellart, P; Winchen, T; Anderson, J; Avruch, IM; Bentum, MJ; Blaauw, R; Broderick, JW; Brouw, WN; Bruggen, M; Butcher, HR; Ciardi, B; Fallows, RA; de Geus, E; Duscha, S; Eisloffel, J; Garrett, MA; Griessmeier, JM; Gunst, AW; van Haarlem, MP; Hessels, JWT; Hoeft, M; van der Horst, AJ; Iacobelli, M; Koopmans, LVE; Krankowski, A; Maat, P; Norden, MJ; Paas, H; Pandey-Pommier, M; Pandey, VN; Pekal, R; Pizzo, R; Reich, W; Rothkaehl, H; Rottgering, HJA; Rowlinson, A; Schwarz, DJ; Shulevski, A; Sluman, J; Smirnov, O; Soida, M; Tagger, M; Toribio, MC; van Ardenne, A; Wijers, RAMJ; van Weeren, RJ; Wucknitz, O; Zarka, P; Zucca, P				Hare, B. M.; Scholten, O.; Dwyer, J.; Trinh, T. N. G.; Buitink, S.; ter Veen, S.; Bonardi, A.; Corstanje, A.; Falcke, H.; Horandel, J. R.; Huege, T.; Mitra, P.; Mulrey, K.; Nelles, A.; Rachen, J. P.; Rossetto, L.; Schellart, P.; Winchen, T.; Anderson, J.; Avruch, I. M.; Bentum, M. J.; Blaauw, R.; Broderick, J. W.; Brouw, W. N.; Brueggen, M.; Butcher, H. R.; Ciardi, B.; Fallows, R. A.; de Geus, E.; Duscha, S.; Eisloeffel, J.; Garrett, M. A.; Griessmeier, J. M.; Gunst, A. W.; van Haarlem, M. P.; Hessels, J. W. T.; Hoeft, M.; van der Horst, A. J.; Iacobelli, M.; Koopmans, L. V. E.; Krankowski, A.; Maat, P.; Norden, M. J.; Paas, H.; Pandey-Pommier, M.; Pandey, V. N.; Pekal, R.; Pizzo, R.; Reich, W.; Rothkaehl, H.; Rottgering, H. J. A.; Rowlinson, A.; Schwarz, D. J.; Shulevski, A.; Sluman, J.; Smirnov, O.; Soida, M.; Tagger, M.; Toribio, M. C.; van Ardenne, A.; Wijers, R. A. M. J.; van Weeren, R. J.; Wucknitz, O.; Zarka, P.; Zucca, P.			Needle-like structures discovered on positively charged lightning branches	NATURE			English	Article							LEADER; STROKES	Lightning is a dangerous yet poorly understood natural phenomenon. Lightning forms a network of plasma channels propagating away from the initiation point with both positively and negatively charged ends-called positive and negative leaders1. Negative leaders propagate in discrete steps, emitting copious radio pulses in the 30-300-megahertz frequency band(2-8) that can be remotely sensed and imaged with high spatial and temporal resolution(9-11). Positive leaders propagate more continuously and thus emit very little high-frequency radiation(12). Radio emission from positive leaders has nevertheless been mapped(13-15), and exhibits a pattern that is different from that of negative leaders(11-13,16,17). Furthermore, it has been inferred that positive leaders can become transiently disconnected from negative leaders(9,12,16,18-20), which may lead to current pulses that both reconnect positive leaders to negative leaders(11,16,17,20-22) and cause multiple cloud-to-ground lightning events1. The disconnection process is thought to be due to negative differential resistance(18), but this does not explain why the disconnections form primarily on positive leaders(22), or why the current in cloud-to-ground lightning never goes to zero(23). Indeed, it is still not understood how positive leaders emit radiofrequency radiation or why they behave differently from negative leaders. Here we report three-dimensional radio interferometric observations of lightning over the Netherlands with unprecedented spatiotemporal resolution. We find small plasma structures-which we call ` needles'-that are the dominant source of radio emission from the positive leaders. These structures appear to drain charge from the leader, and are probably the reason why positive leaders disconnect from negative ones, and why cloud-to-ground lightning connects to the ground multiple times.	[Hare, B. M.; Scholten, O.; Trinh, T. N. G.] Univ Groningen, KVI Ctr Adv Radiat Technol, Groningen, Netherlands; [Scholten, O.; Falcke, H.] Vrije Univ Brussels, Inter Univ Inst High Energies, Brussels, Belgium; [Dwyer, J.] Univ New Hampshire, Dept Phys, Durham, NH 03824 USA; [Dwyer, J.] Univ New Hampshire, Space Sci Ctr EOS, Durham, NH 03824 USA; [Buitink, S.; Huege, T.; Mitra, P.; Mulrey, K.; Winchen, T.] Vrije Univ Brussel, Inst Astrophys, Brussels, Belgium; [Buitink, S.; Bonardi, A.; Corstanje, A.; Horandel, J. R.; Rachen, J. P.; Rossetto, L.; Schellart, P.] Radboud Univ Nijmegen, Dept Astrophys, IMAPP, Nijmegen, Netherlands; [ter Veen, S.; Falcke, H.; Avruch, I. M.; Bentum, M. J.; Blaauw, R.; Broderick, J. W.; Brouw, W. N.; Fallows, R. A.; de Geus, E.; Duscha, S.; Gunst, A. W.; van Haarlem, M. P.; Hessels, J. W. T.; Iacobelli, M.; Maat, P.; Norden, M. J.; Pandey, V. N.; Pizzo, R.; Rowlinson, A.; Sluman, J.; van Ardenne, A.; Zucca, P.] Netherlands Inst Radio Astron, ASTRON, Dwingeloo, Netherlands; [Falcke, H.; Horandel, J. R.] NIKHEF, Sci Pk Amsterdam, Amsterdam, Netherlands; [Huege, T.] KIT, Inst Nucl Phys, Karlsruhe, Germany; [Nelles, A.] Humboldt Univ, Inst Phys, Berlin, Germany; [Nelles, A.] DESY, Zeuthen, Germany; [Schellart, P.] Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA; [Anderson, J.] Tech Univ Berlin, Inst Geodesy & Geoinformat Sci, Berlin, Germany; [Anderson, J.] Geodesy GFZ German Res Ctr Geosci, Dept 1, Potsdam, Germany; [Avruch, I. M.] Sci & Technol, Delft, Netherlands; [Bentum, M. J.] Eindhoven Univ Technol, Eindhoven, Netherlands; [Brouw, W. N.; Koopmans, L. V. E.; Pandey, V. N.] Univ Groningen, Kapteyn Astron Inst, Groningen, Netherlands; [Brueggen, M.] Univ Hamburg, Hamburg, Germany; [Butcher, H. R.] Australian Natl Univ, Res Sch Astron & Astrophys, Canberra, ACT, Australia; [Ciardi, B.] Max Planck Inst Astrophys, Garching, Germany; [de Geus, E.] SmarterVision BV, Assen, Netherlands; [Eisloeffel, J.; Hoeft, M.] Thuringer Landessternwarte, Tautenburg, Germany; [Garrett, M. A.] Univ Manchester, Sch Phys & Astron, Jodrell Bank Ctr Astrophys, Manchester, Lancs, England; [Garrett, M. A.; Rottgering, H. J. A.; Toribio, M. C.; van Weeren, R. J.] Leiden Univ, Leiden Observ, Leiden, Netherlands; [Griessmeier, J. M.; Tagger, M.] Univ Orleans, CNRS, LPC2E, Orleans, France; [Griessmeier, J. M.; Pandey-Pommier, M.] Univ Orleans, Stn Radioastron Nancay, Observ Paris, CNRS,INSU,OSUC, Nancay, France; [Hessels, J. W. T.; Rowlinson, A.; Shulevski, A.; Wijers, R. A. M. J.] Univ Amsterdam, Anton Pannekoek Inst Astron, Amsterdam, Netherlands; [van der Horst, A. J.] George Washington Univ, Dept Phys, Washington, DC 20052 USA; [Krankowski, A.] Univ Warmia & Mazury, Space Radiodiagnost Res Ctr, Olsztyn, Poland; [Paas, H.] Univ Groningen, CIT, Groningen, Netherlands; [Pandey-Pommier, M.] Univ Lyon, Observ Lyon, CRAL, UMR5574, St Genis Laval, France; [Pekal, R.] Poznan Supercomp & Networking Ctr PCSS, Poznan, Poland; [Reich, W.; Wucknitz, O.] Max Planck Inst Radioastron, Bonn, Germany; [Rothkaehl, H.] Space Res Ctr PAS, Warsaw, Poland; [Schwarz, D. J.] Univ Bielefeld, Fak Phys, Bielefeld, Germany; [Smirnov, O.] Rhodes Univ, Dept Phys & Elect, Grahamstown, South Africa; [Smirnov, O.] SKA South Africa, Pinelands, South Africa; [Soida, M.] Jagiellonian Univ, Astron Observ, Krakow, Poland; [Zarka, P.] PSL SU UPMC UPD SPC, CNRS, Observ Paris, LESIA & USN, Meudon, France	University of Groningen; Vrije Universiteit Brussel; University System Of New Hampshire; University of New Hampshire; University System Of New Hampshire; University of New Hampshire; Vrije Universiteit Brussel; Radboud University Nijmegen; FOM National Institute for Subatomic Physics; Helmholtz Association; Karlsruhe Institute of Technology; Humboldt University of Berlin; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Princeton University; Technical University of Berlin; Eindhoven University of Technology; University of Groningen; University of Hamburg; Australian National University; Max Planck Society; University of Manchester; Jodrell Bank Centre for Astrophysics; Leiden University; Leiden University - Excl LUMC; Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Universite de Orleans; University of Amsterdam; George Washington University; University of Warmia & Mazury; University of Groningen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Max Planck Society; Centrum Badan Kosmicznych, Polish Academy of Sciences; Polish Academy of Sciences; Space Research Centre of the Polish Academy of Sciences; University of Bielefeld; Rhodes University; SKA South Africa; Jagiellonian University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite	Hare, BM; Scholten, O (corresponding author), Univ Groningen, KVI Ctr Adv Radiat Technol, Groningen, Netherlands.; Scholten, O (corresponding author), Vrije Univ Brussels, Inter Univ Inst High Energies, Brussels, Belgium.	b.h.hare@rug.nl; scholten@kvi.nl	Hessels, Jason/GTO-3261-2022; Smirnov, Oleg/AEO-9012-2022; Hare, B./AAB-6274-2022; Nelles, Anna/AAU-1193-2020; Hare, Brian/AAD-6143-2021; Broderick, Jess/AAD-2450-2019; Buitink, Stijn/F-2113-2016; Rachen, Jörg Paul/AAR-4369-2020; Shulevski, Aleksandar/E-5591-2015; Rowlinson, Antonia/M-7054-2018	Hessels, Jason/0000-0003-2317-1446; Nelles, Anna/0000-0002-1720-6350; Hare, Brian/0000-0001-5138-1235; Broderick, Jess/0000-0002-2239-6099; Buitink, Stijn/0000-0002-6177-497X; Rachen, Jörg Paul/0000-0002-6310-3889; Shulevski, Aleksandar/0000-0002-1827-0469; Huege, Tim/0000-0002-2783-4772; Krankowski, Andrzej/0000-0003-2812-6222; Rowlinson, Antonia/0000-0002-1195-7022; Schwarz, Dominik/0000-0003-2413-0881; Mulrey, Katharine/0000-0001-8026-8020; Toribio, M. Carmen/0000-0001-8063-2881; van der Horst, Alexander/0000-0001-9149-6707; Wijers, Ralph/0000-0002-3101-1808; van Weeren, Reinout/0000-0002-0587-1660; Fallows, Richard/0000-0002-5186-8040; Corstanje, Arthur/0000-0001-5992-6228	Advanced Grant of the European Research Council (FP/2007-2013)/ERC Grant [227610]; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme [640130]; FOM [12PR304]; DFG [NE 2031/2-1, NE WI 4946/1-1]; International LOFAR Telescope (ILT) [LC6_003]; CNRS-INSU, France; Observatoire de Paris, France; Universite d'Orleans, France; BMBF, Germany; MIWF-NRW, Germany; MPG, Germany; Science Foundation Ireland (SFI), Ireland; Department of Business, Enterprise and Innovation (DBEI), Ireland; NWO, The Netherlands; Science and Technology Facilities Council, UK; Ministry of Science and Higher Education, Poland	Advanced Grant of the European Research Council (FP/2007-2013)/ERC Grant(European Research Council (ERC)); European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme(European Research Council (ERC)); FOM(FOM (The Netherlands)); DFG(German Research Foundation (DFG)); International LOFAR Telescope (ILT); CNRS-INSU, France(Centre National de la Recherche Scientifique (CNRS)); Observatoire de Paris, France; Universite d'Orleans, France; BMBF, Germany(Federal Ministry of Education & Research (BMBF)); MIWF-NRW, Germany; MPG, Germany(Max Planck Society); Science Foundation Ireland (SFI), Ireland(Science Foundation Ireland); Department of Business, Enterprise and Innovation (DBEI), Ireland; NWO, The Netherlands(Netherlands Organization for Scientific Research (NWO)Netherlands Government); Science and Technology Facilities Council, UK(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland)	The LOFAR cosmic ray key science project acknowledges funding from an Advanced Grant of the European Research Council (FP/2007-2013)/ERC Grant Agreement number 227610. The project has also received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement number 640130). We furthermore acknowledge financial support from FOM (FOM-project 12PR304). A.N. is supported by the DFG (research fellowship NE 2031/2-1). T.W. is supported by the DFG (research fellowship NE WI 4946/1-1). This paper is based (in part) on data obtained with the International LOFAR Telescope (ILT) under project code LC6_003. LOFAR25 is the Low Frequency Array designed and constructed by ASTRON. It has observing, data processing and data storage facilities in several countries, that are owned by various parties (each with their own funding sources), and that are collectively operated by the ILT foundation under a joint scientific policy. The ILT resources have benefited from the following recent major funding sources: CNRS-INSU, Observatoire de Paris and Universite d'Orleans, France; BMBF, MIWF-NRW, MPG, Germany; Science Foundation Ireland (SFI), Department of Business, Enterprise and Innovation (DBEI), Ireland; NWO, The Netherlands; The Science and Technology Facilities Council, UK; Ministry of Science and Higher Education, Poland.	Akita M, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012016; Becerra M, 2006, J PHYS D APPL PHYS, V39, P3708, DOI 10.1088/0022-3727/39/16/028; Behnke SA, 2014, J GEOPHYS RES-ATMOS, V119, P833, DOI 10.1002/2013JD020781; Biagi CJ, 2014, J GEOPHYS RES-ATMOS, V119, DOI 10.1002/2013JD020281; Chen ML, 1999, J GEOPHYS RES-ATMOS, V104, P27573, DOI 10.1029/1999JD900846; COORAY V, 2017, ATMOSPHERE-BASEL, V8, DOI DOI 10.3390/atmos8120245; Dong WS, 2001, CHINESE SCI BULL, V46, P1561, DOI 10.1007/BF02900582; Dwyer JR, 2014, PHYS REP, V534, P147, DOI 10.1016/j.physrep.2013.09.004; Edens HE, 2014, GEOPHYS RES LETT, V41, P1336, DOI 10.1002/2013GL059180; Edens HE, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053666; Heckman S., 1992, THESIS; Hill JD, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD015818; Jiang RB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03686-w; Lyu FC, 2016, GEOPHYS RES LETT, V43, P5516, DOI 10.1002/2016GL069267; MALAN DJ, 1951, PROC R SOC LON SER-A, V206, P145, DOI 10.1098/rspa.1951.0061; MAZUR V, 1989, J GEOPHYS RES-ATMOS, V94, P3311, DOI 10.1029/JD094iD03p03311; Mazur V, 2002, CR PHYS, V3, P1393, DOI 10.1016/S1631-0705(02)01412-3; Mazur V, 2016, J ELECTROSTAT, V82, P79, DOI 10.1016/j.elstat.2016.05.005; Ngin T, 2014, GEOPHYS RES LETT, V41, P3266, DOI 10.1002/2014GL059601; Norden M., 2010, 9 INT S EL COMP JOIN, P569; Qi Q, 2016, ATMOS RES, V178, P260, DOI 10.1016/j.atmosres.2016.03.027; Rison W, 1999, GEOPHYS RES LETT, V26, P3573, DOI 10.1029/1999GL010856; Shao XM, 1999, J GEOPHYS RES-ATMOS, V104, P9601, DOI 10.1029/1999JD900036; Shao XM, 1996, J GEOPHYS RES-ATMOS, V101, P26641, DOI 10.1029/96JD01803; SHAO XM, 1995, J GEOPHYS RES-ATMOS, V100, P2749, DOI 10.1029/94JD01943; Stock MG, 2014, J GEOPHYS RES-ATMOS, V119, P3134, DOI 10.1002/2013JD020217; Thomas RJ, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004549; van Haarlem MP, 2013, ASTRON ASTROPHYS, V556, DOI 10.1051/0004-6361/201220873; Wang Z., 2016, J GEOPHYS RES D, V121; Yoshida S, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL042065	30	42	42	4	66	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 18	2019	568	7752					360	363		10.1038/s41586-019-1086-6	http://dx.doi.org/10.1038/s41586-019-1086-6			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HU0GZ	30996312	Green Submitted			2022-12-28	WOS:000464950700049
J	O'Connell, RW; Bashor, CJ				O'Connell, Ronan W.; Bashor, Caleb J.			The Least Mating Pathway: Synthetically Refactoring a Familiar Signaling System for New Applications	CELL			English	Editorial Material							BIOLOGY	Synthetic refactoring makes naturally occurring regulatory systems more amenable to manipulation by removing or recoding their natural genetic complexity. Shaw et al. apply this technique to the yeast mating response pathway, creating a simplified, highly engineerable signaling module that can be used to construct precisely optimized, application-specific GPCR biosensors.	[O'Connell, Ronan W.; Bashor, Caleb J.] Rice Univ, Dept Bioengn, Houston, TX 77030 USA; [Bashor, Caleb J.] Rice Univ, Dept Biosci, Houston, TX 77030 USA	Rice University; Rice University	Bashor, CJ (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77030 USA.; Bashor, CJ (corresponding author), Rice Univ, Dept Biosci, Houston, TX 77030 USA.	caleb.bashor@rice.edu						Atay O, 2017, J CELL BIOL, V216, P317, DOI 10.1083/jcb.201609124; Bardwell L, 2005, PEPTIDES, V26, P337, DOI 10.1016/j.peptides.2004.10.001; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Bashor CJ, 2018, ANNU REV BIOPHYS, V47, P399, DOI 10.1146/annurev-biophys-070816-033903; Galloway KE, 2013, SCIENCE, V341, P1358, DOI 10.1126/science.1235005; Gordley RM, 2016, P NATL ACAD SCI USA, V113, P13528, DOI 10.1073/pnas.1610973113; Mukherji S, 2009, NAT REV GENET, V10, P859, DOI 10.1038/nrg2697; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; Shaw WM, 2019, CELL, V177, P782, DOI 10.1016/j.cell.2019.02.023; Smanski MJ, 2016, NAT REV MICROBIOL, V14, P135, DOI 10.1038/nrmicro.2015.24	10	0	0	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2019	177	3					521	523		10.1016/j.cell.2019.04.003	http://dx.doi.org/10.1016/j.cell.2019.04.003			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HU0FV	31002793	Bronze			2022-12-28	WOS:000464947700009
J	Bero, LA; Norris, SL; Lawrence, MA				Bero, Lisa A.; Norris, Susan L.; Lawrence, Mark A.			Making nutrition guidelines fit for purpose	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIALS; ENVIRONMENTAL-HEALTH SCIENCE; RESEARCH AGENDA ANALYSIS; POLICY; RISK; INTERVENTIONS; REDUCTIONIST; SPONSORSHIP; INTEGRATION; NUTRIENTS		[Bero, Lisa A.] Univ Sydney, Sch Pharm, Fac Med & Hlth, Charles Perkins Ctr, Sydney, NSW, Australia; [Norris, Susan L.] WHO, Dept Informat Evidence & Res, CH-1211 Geneva, Switzerland; [Lawrence, Mark A.] Deakin Univ, Sch Exercise & Nutr Sci, Inst Phys Act & Nutr, Geelong, Vic, Australia	University of Sydney; World Health Organization; Deakin University	Bero, LA (corresponding author), Univ Sydney, Sch Pharm, Fac Med & Hlth, Charles Perkins Ctr, Sydney, NSW, Australia.	lisa.bero@sydney.edu.au		Lawrence, Mark/0000-0001-6899-3983				Afshin A, 2019, LANCET, V393, P1958, DOI 10.1016/S0140-6736(19)30041-8; Anderson LM, 2011, RES SYNTH METHODS, V2, P33, DOI 10.1002/jrsm.32; Australian Government, 2017, F2017C01048 AUSTR GO; Bero L, 2018, SYST REV-LONDON, V7, DOI 10.1186/s13643-018-0915-2; Bero L, 2017, AM J PUBLIC HEALTH, V107, P93, DOI 10.2105/AJPH.2016.303518; Blake P, 2018, NUTR REV, V76, P290, DOI 10.1093/nutrit/nux074; Blumberg J, 2010, NUTR REV, V68, P478, DOI 10.1111/j.1753-4887.2010.00307.x; Booth A, BMJ GLOBAL HLTH; Braveman PA, 2011, AM J PREV MED, V40, pS58, DOI 10.1016/j.amepre.2010.09.026; Burlingame Barbara, 2014, Front Nutr, V1, P3, DOI 10.3389/fnut.2014.00003; Cannon G, 2005, PUBLIC HEALTH NUTR, V8, P673, DOI 10.1079/PHN2005819; Cartwright N, 2011, LANCET, V377, P1400, DOI 10.1016/S0140-6736(11)60563-1; Dobrow MJ, 2004, SOC SCI MED, V58, P207, DOI 10.1016/S0277-9536(03)00166-7; Fabbri A, 2018, AM J PUBLIC HEALTH, V108, pE9, DOI 10.2105/AJPH.2018.304677; Fabbri A, 2018, PUBLIC HEALTH NUTR, V21, P3422, DOI 10.1017/S1368980018002100; Fabbri A, 2017, PUBLIC HEALTH NUTR, V20, P3193, DOI 10.1017/S1368980017002178; Fabbri A, 2017, PUBLIC HEALTH NUTR, V20, P1306, DOI 10.1017/S1368980016003128; Fardet A, 2014, ADV NUTR, V5, P430, DOI 10.3945/an.114.006122; Food and Agriculture Organization, 2012, SUST DIETS BIOD DIR; Forsyth SR, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-122; Fox DM, 2017, AM J PUBLIC HEALTH, V107, P88, DOI 10.2105/AJPH.2016.303485; Gough D., 2002, SOC POLICY SOC, V1, P225, DOI [10.1017/S147474640200307X, DOI 10.1017/S147474640200307X]; Green LW, 2014, HEALTH PROMOT J AUST, V25, P25, DOI 10.1071/HE13101; Heaney RP, 2008, J NUTR, V138, P1591, DOI 10.1093/jn/138.9.1591; Heaney RP, 2006, AM J CLIN NUTR, V84, P471, DOI 10.1093/ajcn/84.3.471; Heaney RP, 2014, NUTR REV, V72, P354, DOI 10.1111/nure.12118; Lam J, 2014, ENVIRON HEALTH PERSP, V122, P1040, DOI 10.1289/ehp.1307923; Lappe JM, 2012, DERM-ENDOCRINOL, V4, P95, DOI 10.4161/derm.19833; Lawrence M, 2016, COCHRANE DB SYST REV, V11; Lawrence M, 2016, NUTRIENTS, V8, DOI 10.3390/nu8090555; Lawrence M, 2015, PUBLIC HEALTH NUTR, V18, P2287, DOI 10.1017/S1368980015002402; Luke DA, 2012, ANNU REV PUBL HEALTH, V33, P357, DOI 10.1146/annurev-publhealth-031210-101222; Morgan RL, 2018, ENVIRON INT, V120, P382, DOI 10.1016/j.envint.2018.08.018; Morgan RL, 2016, ENVIRON INT, V92-93, P611, DOI 10.1016/j.envint.2016.01.004; National Research Council (U. S.), 2014, BOARD ENV STUD TOX C; Naude CE, 2017, NUTR J, V16, DOI 10.1186/s12937-017-0244-7; Norris SL, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-000963; Pawson R, 2012, J EPIDEMIOL COMMUN H, V66, P386, DOI 10.1136/jech-2012-201061; Pelletier DL, 2013, ADV NUTR, V4, P92, DOI 10.3945/an.112.003160; Penders B, 2017, EUR J NUTR, V56, DOI 10.1007/s00394-017-1507-y; Petticrew M, 2003, J EPIDEMIOL COMMUN H, V57, P527, DOI 10.1136/jech.57.7.527; Petticrew M, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-000899; Raubenheimer D, 2016, ANNU REV NUTR, V36, P603, DOI 10.1146/annurev-nutr-071715-051118; Raubenheimer D, 2012, PHILOS T R SOC B, V367, P1628, DOI 10.1098/rstb.2012.0007; Rehfuess EA, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-000844; Rey-Lopez JP, 2018, EUR J PUBLIC HEALTH, DOI [10.1093/eurpub/cky17530169613, DOI 10.1093/EURPUB/CKY17530169613]; Rooney AA, 2016, ENVIRON INT, V92-93, P617, DOI 10.1016/j.envint.2016.01.005; Rooney AA, 2014, ENVIRON HEALTH PERSP, V122, P711, DOI 10.1289/ehp.1307972; Schulze MB, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2396; Stanton RA, 2013, MED J AUSTRALIA, V198, P350, DOI 10.5694/mja13.10297; Temple NJ, 2016, BRIT J NUTR, V116, P381, DOI 10.1017/S0007114516002129; Vandenberg LN, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0156-6; Wang Z, SYSTEMATIC REV TOOLS; Whaley P, 2016, ENVIRON INT, V92-93, P556, DOI 10.1016/j.envint.2015.11.002; Woodruff TJ, 2014, ENVIRON HEALTH PERSP, V122, P1007, DOI 10.1289/ehp.1307175	55	12	12	2	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2019	365								l1579	10.1136/bmj.l1579	http://dx.doi.org/10.1136/bmj.l1579			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU8OP	30992263	Green Published, Bronze			2022-12-28	WOS:000465549000001
J	Friedrich, MJ				Friedrich, M. J.			Antimicrobial Resistance on the Rise in Zoonotic Bacteria in Europe	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 16	2019	321	15					1448	1448		10.1001/jama.2019.3829	http://dx.doi.org/10.1001/jama.2019.3829			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HT7SY	30990559				2022-12-28	WOS:000464765900030
J	Fischer, WA; Crozier, I; Bausch, DG; Muyembe, JJ; Mulangu, S; Diaz, JV; Kojan, R; Wohl, DA; Jacob, ST				Fischer, William A., II; Crozier, Ian; Bausch, Daniel G.; Muyembe, Jean-Jacques; Mulangu, Sabue; Diaz, Janet V.; Kojan, Richard; Wohl, David A.; Jacob, Shevin T.			Shifting the Paradigm - Applying Universal Standards of Care to Ebola Virus Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								As the treatment paradigm for patients with Ebola virus disease shifts from isolation to aggressive supportive care and antiviral therapy, the global health community can work toward establishing universal standards of care with a goal of eliminating disparities.	[Fischer, William A., II] Univ N Carolina, Div Pulm & Crit Care Med, Chapel Hill, NC 27515 USA; [Wohl, David A.] Univ N Carolina, Div Infect Dis, Chapel Hill, NC 27515 USA; [Crozier, Ian] Frederick Natl Lab Canc Res, Integrated Res Facil, Clin Monitoring Res Program Directorate, Frederick, MD USA; [Bausch, Daniel G.] Publ Hlth England, UK Publ Hlth Rapid Support Team, London, England; [Bausch, Daniel G.] London Sch Hyg & Trop Med, London, England; [Jacob, Shevin T.] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, Merseyside, England; [Muyembe, Jean-Jacques; Mulangu, Sabue] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Muyembe, Jean-Jacques; Mulangu, Sabue] Univ Kinshasa, Fac Med, Dept Microbiol, Kinshasa, DEM REP CONGO; [Diaz, Janet V.] WHO, Hlth Emergencies Program, Clin Management Team, Geneva, Switzerland; [Kojan, Richard] Alliance Int Med Act ALIMA, Dakar, Senegal	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Public Health England; University of London; London School of Hygiene & Tropical Medicine; Liverpool School of Tropical Medicine; Institute Nacional de Recherche Biomedical; Universite de Kinshasa; World Health Organization	Fischer, WA (corresponding author), Univ N Carolina, Div Pulm & Crit Care Med, Chapel Hill, NC 27515 USA.		Jacob, Shevin/CAF-0449-2022	Jacob, Shevin/0000-0003-2425-9394	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Bah EI, 2015, NEW ENGL J MED, V372, P40, DOI 10.1056/NEJMoa1411249; Davey RT, 2016, NEW ENGL J MED, V375, P1448, DOI 10.1056/NEJMoa1604330; Garske T, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0308; Uyeki TM, 2016, NEW ENGL J MED, V374, P636, DOI 10.1056/NEJMoa1504874; World Health Organization, 2018, NOT REC CONS MON EM	5	11	11	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 11	2019	380	15					1389	1391		10.1056/NEJMp1817070	http://dx.doi.org/10.1056/NEJMp1817070			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HT5NG	30970184	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000464610000004
J	Weston, G				Weston, Gabriel			Gabriel Weston: Fresh thinking on bacteria	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												gabriel.weston@nhs.net						[Anonymous], 2015, BBC 2	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 8	2019	365								l1621	10.1136/bmj.l1621	http://dx.doi.org/10.1136/bmj.l1621			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU0EE	30962248	Bronze			2022-12-28	WOS:000464943400009
J	Goga, A; Singh, Y; Jackson, D; Mukungunugwa, S; Wafula, R; Eliya, M; Ng'ambi, WF; Nabitaka, L; Chirinda, W; Bhardwaj, S; Essajee, S; Hayashi, C; Pillay, Y				Goga, Ameena; Singh, Yagespari; Jackson, Debra; Mukungunugwa, Solomon; Wafula, Rose; Eliya, Michael; Ng'ambi, Wingston Felix; Nabitaka, Linda; Chirinda, Witness; Bhardwaj, Sanjana; Essajee, Shaffiq; Hayashi, Chika; Pillay, Yogan			How are countries in sub-Saharan African monitoring the impact of programmes to prevent vertical transmission of HIV?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MOTHER-TO-CHILD; PREVALENCE		[Goga, Ameena; Singh, Yagespari; Chirinda, Witness] South African Med Res Council, Hlth Syst Res Unit, Cape Town, South Africa; [Goga, Ameena] Univ Pretoria, Dept Paediat, Pretoria, South Africa; [Jackson, Debra] Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa; [Jackson, Debra] Unicef, Hlth Sect, New York, NY USA; [Mukungunugwa, Solomon] Minist Hlth, PMTCT, AIDS & TB Unit, Paediat HIV Care Treatment, Harare, Zimbabwe; [Wafula, Rose] Natl Aids & STI Control Program, Nairobi, Kenya; [Eliya, Michael] Minist Hlth, HIV & AIDS Dept, Lilongwe, Malawi; [Ng'ambi, Wingston Felix] Univ Malawi, Coll Med, Dept Hlth Syst & Policy, Hlth Econ & Policy Unit, Lilongwe Campus, Lilongwe, Malawi; [Nabitaka, Linda] Minist Hlth, Kampala, Uganda; [Bhardwaj, Sanjana] Unicef Pretoria, Unicef Nigeria, Pretoria, South Africa; [Essajee, Shaffiq; Hayashi, Chika] Unicef, Data & Analyt Sect, New York, NY USA; [Pillay, Yogan] Natl Dept Hlth, MCWHN, HIV AIDS, TB, Pretoria, South Africa	South African Medical Research Council; University of Pretoria; University of the Western Cape; UNICEF; University of Malawi; UNICEF	Goga, A (corresponding author), South African Med Res Council, Hlth Syst Res Unit, Cape Town, South Africa.; Goga, A (corresponding author), Univ Pretoria, Dept Paediat, Pretoria, South Africa.	Ameena.Goga@mrc.ac.za	Pillay, Yogan/AAW-4966-2021	Pillay, Yogan/0000-0003-2700-6181; Jackson, Debra/0000-0003-3307-632X	South African Medical Research Council (SAMRC)	South African Medical Research Council (SAMRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We have read and understood BMJ policy on declaration of interests and have no relevant interests to declare. This paper was funded by the South African Medical Research Council (SAMRC). The views expressed in this paper are not the views of either organisation, but of the authors.	[Anonymous], 2012, SHORT GUID METH MEAS; Dorrington R., 2018, THEMBISA VERSION 4 1; Goga A, 2017, S AFRICAN HLTH REV; Goga AE, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.020405; Goga AE, 2015, J EPIDEMIOL COMMUN H, V69, P240, DOI 10.1136/jech-2014-204535; Larsson EC, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.26308; Malawi Ministry of Health, 2016, MAL POP BAS HIV IMP; Massyn N, 2016, TUBERCULOSIS; Ministry of Health Uganda, 2017, UG POP BAS HIV IMP A; Moyo F, 2018, PEDIATR INFECT DIS J, V37, P559, DOI [10.1097/INF.0000000000001840, 10.1097/inf.0000000000001840]; Sherman GG, 2014, SAMJ S AFR MED J, V104, P235, DOI [10.7196/SAMJ.7598, 10.7196/samj.7598]; Sherman GG, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.010701; Sinunu MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100741; Stover J, 2017, AIDS, V31, pS5, DOI 10.1097/QAD.0000000000001322; Dinh TH, 2018, CLIN INFECT DIS, V66, P576, DOI 10.1093/cid/cix820; UNAIDS, 2016, FAST TRACK AIDS FREE; UNICEF, 2016, TOG WE CAN IMPR CAS; Wang HD, 2016, LANCET HIV, V3, pE361, DOI 10.1016/S2352-3018(16)30087-X; WHO, 2012, US ANT DRUGS TREAT P; World Health Organization, 2014, GLOB GUID CRIT PROC; ZIMPHIA, 2020, ZIMB POP BAS HIV IMP	22	2	2	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2019	364								l660	10.1136/bmj.l660	http://dx.doi.org/10.1136/bmj.l660			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HR5VS	30957768	hybrid, Green Published			2022-12-28	WOS:000463215700001
J	Cadena, C; Ahmad, S; Xavier, A; Willemsen, J; Park, S; Park, JW; Oh, SW; Fujita, T; Hou, FJ; Binder, M; Hur, S				Cadena, Cristhian; Ahmad, Sadeem; Xavier, Audrey; Willemsen, Joschka; Park, Sehoon; Park, Ji Woo; Oh, Seong-Wook; Fujita, Takashi; Hou, Fajian; Binder, Marco; Hur, Sun			Ubiquitin-Dependent and -Independent Roles of E3 Ligase RIPLET in Innate Immunity	CELL			English	Article							ANTIVIRAL SIGNAL ACTIVATION; PARAMYXOVIRUS V PROTEINS; RIG-I; STRUCTURAL BASIS; RNA RECOGNITION; MDA5; MECHANISM; TRIM25; FILAMENTS; DNA	The conventional view posits that E3 ligases function primarily through conjugating ubiquitin (Ub) to their substrate molecules. We report here that RIPLET, an essential E3 ligase in antiviral immunity, promotes the antiviral signaling activity of the viral RNA receptor RIG-I through both Ub-dependent and -independent manners. RIPLET uses its dimeric structure and a bivalent binding mode to preferentially recognize and ubiquitinate RIG-I pre-oligomerized on dsRNA. In addition, RIPLET can cross-bridge RIG-I filaments on longer dsRNAs, inducing aggregate-like RIG-I assemblies. The consequent receptor clustering synergizes with the Ub-dependent mechanism to amplify RIG-I-mediated antiviral signaling in an RNA-length dependent manner. These observations show the unexpected role of an E3 ligase as a co-receptor that directly participates in receptor oligomerization and ligand discrimination. It also highlights a previously unrecognized mechanism by which the innate immune system measures foreign nucleic acid length, a common criterion for self versus non-self nucleic acid discrimination.	[Cadena, Cristhian; Hur, Sun] Harvard Med Sch, Div Med Sci, Program Virol, Boston, MA 02115 USA; [Cadena, Cristhian; Ahmad, Sadeem; Hur, Sun] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Cadena, Cristhian; Ahmad, Sadeem; Xavier, Audrey; Park, Sehoon; Park, Ji Woo; Hur, Sun] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Xavier, Audrey] Free Univ Berlin, Inst Chem & Biochem, Berlin, Germany; [Willemsen, Joschka; Binder, Marco] German Canc Res Ctr, Res Grp Dynam Early Viral Infect & Innate Antivir, Div F170, D-69120 Heidelberg, Germany; [Park, Ji Woo] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA; [Oh, Seong-Wook; Fujita, Takashi] Kyoto Univ, Lab Mol Genet, Inst Frontier Life & Med Sci, Kyoto, Japan; [Hou, Fajian] Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai, Peoples R China; [Willemsen, Joschka] Novartis Inst Biomed Res, Autoimmun Transplantat & Inflammat, Novartis Campus Forum 1, CH-4056 Basel, Switzerland	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Free University of Berlin; Helmholtz Association; German Cancer Research Center (DKFZ); Boston College; Kyoto University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Novartis	Hur, S (corresponding author), Harvard Med Sch, Div Med Sci, Program Virol, Boston, MA 02115 USA.; Hur, S (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.; Hur, S (corresponding author), Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA.	Sun.Hur@childrens.harvard.edu	Binder, Marco/E-9717-2011; Park, Ji Woo/T-8021-2019; Willemsen, Joschka/O-6261-2017	Binder, Marco/0000-0002-5805-6109; Xavier, Audrey/0000-0002-8801-1307; Park, Ji Woo/0000-0003-0233-0890; Willemsen, Joschka/0000-0003-3106-6697	NSF fellowship; Cancer Research Institute fellowship; German Academic Exchange Service PROMOS program; German Research Foundation [DFG TRR179]; German Federal Ministry of Education and Research (ERASysApp) [031A602C]; Burroughs Wellcome Fund; NIH [R01AI106912, R01AI111784, R21AI130791]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI130791, R01AI106912, R21AI119880, R01AI111784] Funding Source: NIH RePORTER	NSF fellowship(National Science Foundation (NSF)); Cancer Research Institute fellowship; German Academic Exchange Service PROMOS program; German Research Foundation(German Research Foundation (DFG)); German Federal Ministry of Education and Research (ERASysApp); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Sandra Wust for her assistance, Drs. Gack and Oshiumi for sharing TRIM25<SUP>-/-</SUP>and RIPLET<SUP>-/-</SUP> MEFs, respectively, and Dr. O.Pornillos for sharing the TRIM25 construct and protein purification protocol. This work was supported by NSF fellowship (C.C.), Cancer Research Institute fellowship (S.A.), German Academic Exchange Service PROMOS program (A.X.), the German Research Foundation (DFG TRR179, TP11) (M.B.), German Federal Ministry of Education and Research (ERASysApp, 031A602C) (M.B.), Burroughs Wellcome Fund and NIH grants (R01AI106912, R01AI111784 and R21AI130791) (S.H.).	Ahmad S, 2018, CELL, V172, P797, DOI 10.1016/j.cell.2017.12.016; Alexandrov A, 2001, BIOTECHNIQUES, V30, P1194, DOI 10.2144/01306bm01; Andreeva L, 2017, NATURE, V549, P394, DOI 10.1038/nature23890; Antos JM, 2009, J AM CHEM SOC, V131, P10800, DOI 10.1021/ja902681k; Binder M, 2011, J BIOL CHEM, V286, P27278, DOI 10.1074/jbc.M111.256974; Chen Y, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006727; Choudhury NR, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0444-9; Devarkar SC, 2018, MOL CELL, V72, P355, DOI 10.1016/j.molcel.2018.08.021; Dong KC, 2011, STRUCTURE, V19, P1053, DOI 10.1016/j.str.2011.06.010; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005760; Hartman NC, 2011, CURR OPIN CELL BIOL, V23, P370, DOI 10.1016/j.ceb.2011.05.003; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537; Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Kuri T, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-50; Luo DH, 2012, STRUCTURE, V20, P1983, DOI 10.1016/j.str.2012.08.029; Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369; MARMORSTEIN R, 1992, NATURE, V356, P408, DOI 10.1038/356408a0; Meyerson NR, 2017, CELL HOST MICROBE, V22, P627, DOI 10.1016/j.chom.2017.10.003; Morrone SR, 2014, P NATL ACAD SCI USA, V111, pE62, DOI 10.1073/pnas.1313577111; Motz C, 2013, SCIENCE, V339, P690, DOI 10.1126/science.1230949; Nishimura T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002484; Oh SW, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005444; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Onomoto K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043031; Oshiumi H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003533; Oshiumi H, 2010, CELL HOST MICROBE, V8, P496, DOI 10.1016/j.chom.2010.11.008; Oshiumi H, 2009, J BIOL CHEM, V284, P807, DOI 10.1074/jbc.M804259200; Patel JR, 2013, EMBO REP, V14, P780, DOI 10.1038/embor.2013.102; Peisley A, 2014, NATURE, V509, P110, DOI 10.1038/nature13140; Peisley A, 2013, MOL CELL, V51, P573, DOI 10.1016/j.molcel.2013.07.024; Peisley A, 2012, P NATL ACAD SCI USA, V109, pE3340, DOI 10.1073/pnas.1208618109; Peisley A, 2011, P NATL ACAD SCI USA, V108, P21010, DOI 10.1073/pnas.1113651108; Rawling DC, 2015, ELIFE, V4, DOI 10.7554/eLife.09391; Rawling DC, 2014, CURR OPIN STRUC BIOL, V25, P25, DOI 10.1016/j.sbi.2013.11.011; Reuther P, 2015, SCI REP-UK, V5, DOI 10.1038/srep11346; Rodriguez KR, 2013, J VIROL, V87, P2974, DOI 10.1128/JVI.02843-12; Sanchez JG, 2016, CELL REP, V16, P1315, DOI 10.1016/j.celrep.2016.06.070; Sanchez JG, 2014, P NATL ACAD SCI USA, V111, P2494, DOI 10.1073/pnas.1318962111; Shi YH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15138; Sohn J, 2016, CURR OPIN STRUC BIOL, V37, P134, DOI 10.1016/j.sbi.2016.01.011; Weinert C, 2015, SCI REP-UK, V5, DOI 10.1038/srep10819; Wu B, 2016, METHODS MOL BIOL, V1390, P131, DOI [10.1007/978-1-4939-3335-8_9, 10.1007/978-1-4939-3335-8]; Wu B, 2015, CURR OPIN VIROL, V12, P91, DOI 10.1016/j.coviro.2015.04.004; Wu B, 2014, MOL CELL, V55, P511, DOI 10.1016/j.molcel.2014.06.010; Wu B, 2013, CELL, V152, P276, DOI 10.1016/j.cell.2012.11.048; Wu XF, 2015, IMMUNOL REV, V266, P161, DOI 10.1111/imr.12310; Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zheng X., 2017, J VIROL, V91, P91; Zhou W, 2018, CELL, V174, P300, DOI 10.1016/j.cell.2018.06.026; 2014, NATURE, V514, P372, DOI DOI 10.1038/NATURE13590; 2009, IMMUNITY, V31, P25, DOI DOI 10.1016/J.IMMUNI.2009.05.008; 2009, SCIENCE, V323, P1070, DOI DOI 10.1126/SCIENCE.1168352; 2014, CELL REP, V9, P1265, DOI DOI 10.1016/J.CELREP.2014.10.017	57	101	105	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 16	2019	177	5					1187	+		10.1016/j.cell.2019.03.017	http://dx.doi.org/10.1016/j.cell.2019.03.017			30	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HY4NB	31006531	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000468103800012
J	Al-Batran, SE; Homann, N; Pauligk, C; Goetze, TO; Meiler, J; Kasper, S; Kopp, HG; Mayer, F; Haag, GM; Luley, K; Lindig, U; Schmiegel, W; Pohl, M; Stoehlmacher, J; Folprecht, G; Probst, S; Prasnikar, N; Fischbach, W; Mahlberg, R; Trojan, J; Koenigsmann, M; Martens, UM; Thuss-Patience, P; Egger, M; Block, A; Heinemann, V; Illerhaus, G; Moehler, M; Schenk, M; Kullmann, F; Behringer, DM; Heike, M; Pink, D; Teschendorf, C; Lohr, C; Bernhard, H; Schuch, G; Rethwisch, V; von Weikersthal, LF; Hartmann, JT; Kneba, M; Daum, S; Schulmann, K; Weniger, J; Belle, S; Gaiser, T; Oduncu, FS; Guntner, M; Hozaeel, W; Reichart, A; Jager, E; Kraus, T; Monig, S; Bechstein, WO; Schuler, M; Schmalenberg, H; Hofheinz, RD				Al-Batran, Salah-Eddin; Homann, Nils; Pauligk, Claudia; Goetze, Thorsten O.; Meiler, Johannes; Kasper, Stefan; Kopp, Hans-Georg; Mayer, Frank; Haag, Georg Martin; Luley, Kim; Lindig, Udo; Schmiegel, Wolff; Pohl, Michael; Stoehlmacher, Jan; Folprecht, Gunnar; Probst, Stephan; Prasnikar, Nicole; Fischbach, Wolfgang; Mahlberg, Rolf; Trojan, Joerg; Koenigsmann, Michael; Martens, Uwe M.; Thuss-Patience, Peter; Egger, Matthias; Block, Andreas; Heinemann, Volker; Illerhaus, Gerald; Moehler, Markus; Schenk, Michael; Kullmann, Frank; Behringer, Dirk M.; Heike, Michael; Pink, Daniel; Teschendorf, Christian; Loehr, Carmen; Bernhard, Helga; Schuch, Gunter; Rethwisch, Volker; von Weikersthal, Ludwig Fischer; Hartmann, Joerg T.; Kneba, Michael; Daum, Severin; Schulmann, Karsten; Weniger, Joerg; Belle, Sebastian; Gaiser, Timo; Oduncu, Fuat S.; Guentner, Martina; Hozaeel, Wael; Reichart, Alexander; Jaeger, Elke; Kraus, Thomas; Moenig, Stefan; Bechstein, Wolf O.; Schuler, Martin; Schmalenberg, Harald; Hofheinz, Ralf D.		FLOT4-AIO Investigators	Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial	LANCET			English	Article							OPEN-LABEL; CANCER; MULTICENTER; CHEMORADIOTHERAPY; RESECTION; SURGERY; ESOPHAGEAL; REGRESSION; STOMACH	Background Docetaxel-based chemotherapy is effective in metastatic gastric and gastro-oesophageal junction adenocarcinoma. This study reports on the safety and efficacy of the docetaxel-based triplet FLOT (fluorouracil plus leucovorin, oxaliplatin and docetaxel) as a perioperative therapy for patients with locally advanced, resectable tumours. Methods In this controlled, open-label, phase 2/3 trial, we randomly assigned 716 patients with histologically-confirmed advanced clinical stage cT2 or higher or nodal positive stage (cN+), or both, resectable tumours, with no evidence of distant metastases, via central interactive web-based-response system, to receive either three pre-operative and three postoperative 3-week cycles of 50 mg/m(2) epirubicin and 60 mg/m(2) cisplatin on day 1 plus either 200 mg/m(2) fluorouracil as continuous intravenous infusion or 1250 mg/m(2) capecitabine orally on days 1 to 21 (ECF/ECX; control group) or four preoperative and four postoperative 2-week cycles of 50 mg/m(2) docetaxel, 85 mg/m(2) oxaliplatin, 200 mg/m(2) leucovorin and 2600 mg/m(2) fluorouracil as 24-h infusion on day 1 (FLOT; experimental group). The primary outcome of the trial was overall survival (superiority) analysed in the intention-to-treat population. This trial is registered with ClinicalTrials. gov, number NCT01216644. Findings Between Aug 8, 2010, and Feb 10, 2015, 716 patients were randomly assigned to treatment in 38 German hospitals or with practice-based oncologists. 360 patients were assigned to ECF/ECX and 356 patients to FLOT. Overall survival was increased in the FLOT group compared with the ECF/ECX group (hazard ratio [HR] 0.77; 95% confidence interval [CI; 0.63 to 0.94]; median overall survival, 50 months [38.33 to not reached] vs 35 months [27.35 to 46.26]). The number of patients with related serious adverse events (including those occurring during hospital stay for surgery) was similar in the two groups (96 [27%] in the ECF/ECX group vs 97 [27%] in the FLOT group), as was the number of toxic deaths (two [<1%] in both groups). Hospitalisation for toxicity occurred in 94 patients (26%) in the ECF/ECX group and 89 patients (25%) in the FLOT group. Interpretation In locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma, perioperative FLOT improved overall survival compared with perioperative ECF/ECX. Copyright (C) 2019 Elsevier Ltd. All rights reserved.	[Al-Batran, Salah-Eddin; Pauligk, Claudia; Goetze, Thorsten O.] Krankenhaus NW Frankfurt, UCT Univ Canc Ctr, Inst Clin Canc Res, D-60488 Frankfurt, Germany; [Al-Batran, Salah-Eddin; Pauligk, Claudia; Goetze, Thorsten O.] Krankenhaus NW Frankfurt, IKF Klin Krebsforsch GmbH, Frankfurt, Germany; [Homann, Nils] Klinikum Wolfsburg, Wolfsburg, Germany; [Meiler, Johannes; Kasper, Stefan; Schuler, Martin] Univ Duisburg Essen, Dept Med Oncol, West German Canc Ctr, Essen, Germany; [Schuler, Martin] Partner Site Univ Hosp Essen, German Canc Consortium DKTK, Essen, Germany; [Kopp, Hans-Georg] RBCT, Stuttgart, Germany; [Mayer, Frank] Univ Klinikum Eberhard Karls Univ, Med Klin 2, Abt Onkol Hamatol Immunol Rheumatol Pneumol, Tubingen, Germany; [Haag, Georg Martin] Univ Klinikum Heidelberg, Natl Ctr Tumorerkrankungen, Abt Med Onkol, Heidelberg, Germany; [Luley, Kim] Univ Klinikum Schleswig Holstein, Klin Hamatol & Onkol, Lubeck, Germany; [Lindig, Udo] Univ Klinikum Jena, Klin Innere Med 2, Abt Hamatol & Onkol, Jena, Germany; [Schmiegel, Wolff; Pohl, Michael] Ruhr Univ Bochum, Dept Med, Univ Klinikum Knappschaftskrankenhaus Bochum GmbH, Bochum, Germany; [Schmiegel, Wolff] Ruhr Univ Bochum, Berufsgenossenschaftliches Univ Klinikum Bergmann, Dept Gastroenterol & Hepatol, Bochum, Germany; [Stoehlmacher, Jan; Folprecht, Gunnar] Univ Klinikum Carl Gustav Carus, Med Klin & Poliklin 1, Dresden, Germany; [Probst, Stephan] Klinikum Bielefeld, Klin Hamatol & Onkol, Bielefeld, Germany; [Prasnikar, Nicole] Asklepios Klin Barmbek, Hamatol Onkol & Palliat Med, Hamburg, Germany; [Fischbach, Wolfgang] Klinikum Aschaffenburg, Med Klin 2, Gastroenterol & Onkol, Aschaffenburg, Germany; [Mahlberg, Rolf] Klinikum Mutterhaus Borromaerinnen, Med Klin 1, Trier, Germany; [Trojan, Joerg] Goethe Univ, Univ Klinikum Frankfurt, Med Klin 1, Frankfurt, Germany; [Koenigsmann, Michael] Gesell Med Stat & Projektentwicklung, MediProjekt, Hannover, Germany; [Martens, Uwe M.] SLK Kliniken GmbH, Canc Ctr Heilbronn Franken, Klin Innere Med 3, Heilbronn, Germany; [Thuss-Patience, Peter] Charite Univ Med Berlin, Med Klin S Hamatol Onkol & Tumorimmunol, Berlin, Germany; [Daum, Severin] Charite Univ Med Berlin, Klin Gastroenterol Infektiol & Rheumatol, Berlin, Germany; [Egger, Matthias] Ortenau Klinikum Lahr, Med Klin, Gastroenterol & Onkol, Sekt Hamatol & Onkol, Lahr, Germany; [Block, Andreas] Univ Klinikum Hamburg Eppendorf, Med Klin & Poliklin Onkol Hamatol 2, UCCH, KMT,Sekt Pneumol, Hamburg, Germany; [Heinemann, Volker] Klinikum Univ Munchen, Med Klin & Poliklin 3, Campus Grosshadern, Munich, Germany; [Illerhaus, Gerald] Klinikum Stuttgart, Klin Hamatol Onkol & Palliat Med, Stuttgart, Germany; [Moehler, Markus] Johannes Gutenberg Univ Mainz, Med Klin & Poliklin 1, Mainz, Germany; [Schenk, Michael] Krankenhaus Barmherzige Bruder Regensburg, Klin Onkol & Hamatol, Regensburg, Germany; [Kullmann, Frank] Klinikum Weiden, Med Klin 1, Weiden, Germany; [Behringer, Dirk M.] Augusta Krankenanstalt Bochum, Klin Hamatol & Onkol, Bochum, Germany; [Heike, Michael] Klinikum Dortmund gGmbH, Med Klin, Gastroenterol Hamatol Onkol Endokrinol, Dortmund, Germany; [Pink, Daniel] Helios Klinikum Bad Saarow, Klin Hamatol Onkol & Palliat Med, Bad Saarow Pieskow, Germany; [Pink, Daniel] Univ Med Greifswald, Klin & Poliklin Innere Med C, Hamatol & Onkol & Transplantat Zentrum, Greifswald, Germany; [Teschendorf, Christian] St Josefs Hosp, Innere Med Klin, Dortmund, Germany; [Loehr, Carmen] Horst Schmidt Kliniken, Innere Med 2, Wiesbaden, Germany; [Bernhard, Helga] Klinikum Darmstadt, Med Klin 5, Hamatol & Onkol, Darmstadt, Germany; [Schuch, Gunter] HOPA, Hamburg, Germany; [Rethwisch, Volker] Klinikum Dortmund gGmbH, Med Klin, Gastroenterol Hamatol Onkol Endokrinol, Dortmund, Germany; [von Weikersthal, Ludwig Fischer] MVZ Gesundheitszentrum St Marien GmbH, Hamatol Internist Onkol, Amberg, Germany; [Hartmann, Joerg T.] Franziskus Hosp Bielefeld, Catholic Hosp Consortium Eastern Westphalia, Klin Innere Med Hamatol Internist Onkol Immunol 2, Bielefeld, Germany; [Kneba, Michael] Univ Clin Schleswig Holstein, Klin Innere Med Hamatol & Onkol 2, Campus Kiel, Kiel, Germany; [Schulmann, Karsten] MVZ Arnsberg, Praxis Hamatol & Onkol, Arnsberg, Germany; [Belle, Sebastian] Univ Med Mannheim, Med Klin 2, Mannheim, Germany; [Gaiser, Timo] Univ Med Mannheim, Inst Pathol, Mannheim, Germany; [Oduncu, Fuat S.] Klinikum Univ Munchen, Med Klin & Poliklin 3, Munich, Germany; [Guentner, Martina] Trium Anal Online, Munich, Germany; [Hozaeel, Wael] Marienhospital, MVZ Onkol GmbH, Hagen, Germany; [Reichart, Alexander; Jaeger, Elke] Krankenhaus NW Frankfurt, UCT Univ Canc Ctr, Klin Onkol & Hamatol, Frankfurt, Germany; [Kraus, Thomas] Krankenhaus NW Frankfurt, UCT Univ Canc Ctr, Klin Allgemein Viszeral & Minimal Invas Chirurg, Frankfurt, Germany; [Moenig, Stefan] Hop Univ Geneve, Serv Chirurg Viscerale, Geneva, Switzerland; [Bechstein, Wolf O.] Frankfurt Univ Hosp & Clin, Dept Gen & Visceral Surg, Frankfurt, Germany; [Schmalenberg, Harald] Univ Klinikum Jena, Klin Innere Med 2, Abt Hamatol & Internist Onkol, Jena, Germany; [Hofheinz, Ralf D.] Univ Med Mannheim, Tagestherapiezentrum ITM, Med Klin 3, Mannheim, Germany	Krankenhaus Nordwest; Krankenhaus Nordwest; University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ); Eberhard Karls University of Tubingen; University of Hamburg; University Medical Center Hamburg-Eppendorf; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Kiel; Schleswig Holstein University Hospital; Friedrich Schiller University of Jena; Ruhr University Bochum; Ruhr University Bochum; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; Klinikum Stuttgart; Johannes Gutenberg University of Mainz; Klinikum Dortmund; Helios Kliniken; Greifswald Medical School; Klinikum Darmstadt; Klinikum Dortmund; University of Kiel; Schleswig Holstein University Hospital; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruprecht Karls University Heidelberg; University of Munich; St. Marien Hospital; Krankenhaus Nordwest; Krankenhaus Nordwest; University of Geneva; Friedrich Schiller University of Jena; Ruprecht Karls University Heidelberg	Al-Batran, SE (corresponding author), Krankenhaus NW Frankfurt, UCT Univ Canc Ctr, Inst Clin Canc Res, D-60488 Frankfurt, Germany.	albatran@ikf-khnw.de	Kasper, Stefan/I-4521-2015; Haag, Georg Martin/AAB-6323-2022; Schulmann, Karsten/N-2230-2016; Pink, Daniel/A-1084-2014; Folprecht, Gunnar/F-8638-2011	Kasper, Stefan/0000-0002-5947-8733; Pink, Daniel/0000-0001-7243-7373; Folprecht, Gunnar/0000-0002-9321-9911; Daum, Severin/0000-0003-0060-6013; Kopp, Hans-Georg/0000-0002-0825-8888	German Cancer Aid (Deutsche Krebshilfe); Chugai; Stiftung Leben mit Krebs Foundation; Sanofi-Aventis	German Cancer Aid (Deutsche Krebshilfe)(Deutsche Krebshilfe); Chugai; Stiftung Leben mit Krebs Foundation; Sanofi-Aventis(Sanofi-Aventis)	The German Cancer Aid (Deutsche Krebshilfe), Sanofi-Aventis, Chugai, and Stiftung Leben mit Krebs Foundation.	Al-Batran SE, 2008, ANN ONCOL, V19, P1882, DOI 10.1093/annonc/mdn403; Al-Batran SE, 2017, JAMA ONCOL, V3, P1237, DOI 10.1001/jamaoncol.2017.0515; Al-Batran SE, 2016, LANCET ONCOL, V17, P1697, DOI 10.1016/S1470-2045(16)30531-9; Alderson D, 2017, LANCET ONCOL, V18, P1249, DOI 10.1016/S1470-2045(17)30447-3; Becker K, 2003, CANCER-AM CANCER SOC, V98, P1521, DOI 10.1002/cncr.11660; Cats A, 2018, LANCET ONCOL, V19, P616, DOI 10.1016/S1470-2045(18)30132-3; Cunningham D, 2017, LANCET ONCOL, V18, P357, DOI 10.1016/S1470-2045(17)30043-8; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Ford HER, 2014, LANCET ONCOL, V15, P78, DOI 10.1016/S1470-2045(13)70549-7; Freidlin B, 2007, J CLIN ONCOL, V25, P5019, DOI 10.1200/JCO.2007.11.8711; Fuchs CS, 2017, J CLIN ONCOL, V35, P3671, DOI 10.1200/JCO.2017.74.2130; Homann N, 2012, INT J CANCER, V130, P1706, DOI 10.1002/ijc.26180; Low DE, 2019, ANN SURG, V269, P291, DOI 10.1097/SLA.0000000000002611; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Moehler M, 2011, Z GASTROENTEROL, V49, P461, DOI 10.1055/s-0031-1273201; Schulz C, 2015, INT J CANCER, V137, P678, DOI 10.1002/ijc.29403; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Siewert JR, 1998, BRIT J SURG, V85, P1457; Van Cutsem E, 2006, J CLIN ONCOL, V24, P4991, DOI 10.1200/JCO.2006.06.8429; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; Ychou M, 2011, J CLIN ONCOL, V29, P1715, DOI 10.1200/JCO.2010.33.0597; 2013, EUR J CANCER, V49, P835, DOI DOI 10.1016/J.EJCA.2012.09.025	22	869	908	4	98	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 11	2019	393	10184					1948	1957		10.1016/S0140-6736(18)32557-1	http://dx.doi.org/10.1016/S0140-6736(18)32557-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HX9AE	30982686				2022-12-28	WOS:000467698100030
J	Tuttle, KR				Tuttle, Katherine R.			A turning point for chronic kidney disease in diabetes	LANCET			English	Editorial Material									[Tuttle, Katherine R.] Providence Hlth Care, Providence Med Res Ctr, Spokane, WA 99204 USA; [Tuttle, Katherine R.] Univ Washington, Kidney Res Inst, Nephrol Div, Seattle, WA 98195 USA; [Tuttle, Katherine R.] Univ Washington, Inst Translat Hlth Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Tuttle, KR (corresponding author), Providence Hlth Care, Providence Med Res Ctr, Spokane, WA 99204 USA.; Tuttle, KR (corresponding author), Univ Washington, Kidney Res Inst, Nephrol Div, Seattle, WA 98195 USA.; Tuttle, KR (corresponding author), Univ Washington, Inst Translat Hlth Sci, Seattle, WA 98195 USA.	katherine.tuttle@providence.org		Tuttle, Katherine/0000-0002-2235-0103				Bello AK, 2017, JAMA-J AM MED ASSOC, V317, P1864, DOI 10.1001/jama.2017.4046; Bowe B, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.4412; de Zeeuw D, 2015, LANCET DIABETES ENDO, V3, P687, DOI 10.1016/S2213-8587(15)00261-2; de Zeeuw D, 2013, NEW ENGL J MED, V369, P2492, DOI 10.1056/NEJMoa1306033; Heerspink HJL, 2019, LANCET, V393, P1937, DOI 10.1016/S0140-6736(19)30772-X; Himmelfarb J, 2013, NEW ENGL J MED, V369, P2549, DOI 10.1056/NEJMe1313104; IDF International Diabetes Federation, 2017, DIABETES ATLAS, V8th; Mann JFE, 2017, NEW ENGL J MED, V377, P839, DOI 10.1056/NEJMoa1616011; Packham DK, 2012, J AM SOC NEPHROL, V23, P123, DOI 10.1681/ASN.2011040378; Perkovic V, 2018, LANCET DIABETES ENDO, V6, P691, DOI 10.1016/S2213-8587(18)30141-4; Thomas MC, 2016, NAT REV NEPHROL, V12, P73, DOI 10.1038/nrneph.2015.173; Tuttle KR, 2018, LANCET DIABETES ENDO, V6, P605, DOI 10.1016/S2213-8587(18)30104-9; United States Renal Data System, 2018, USRDS ANN DAT REP EP, V1; Voelker J, 2017, J AM SOC NEPHROL, V28, P953, DOI 10.1681/ASN.2015111230; Wanner C, 2016, NEW ENGL J MED, V375, P323, DOI [10.1056/NEJMoa1515920, 10.1056/NEJMc1611290]; Xie Y, 2018, KIDNEY INT, V94, P567, DOI 10.1016/j.kint.2018.04.011	16	2	2	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 11	2019	393	10184					1913	1914		10.1016/S0140-6736(19)30855-4	http://dx.doi.org/10.1016/S0140-6736(19)30855-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HX9AE	30995973				2022-12-28	WOS:000467698100004
J	Smit, EF; de Langen, AJ				Smit, Egbert F.; de langen, Adrianus J.			Pembrolizumab for all PD-L1-positive NSCLC	LANCET			English	Editorial Material							NIVOLUMAB		[Smit, Egbert F.; de langen, Adrianus J.] Netherlands Canc Inst, Dept Thorac Oncol, NL-1007 MB Amsterdam, Netherlands	Netherlands Cancer Institute	Smit, EF (corresponding author), Netherlands Canc Inst, Dept Thorac Oncol, NL-1007 MB Amsterdam, Netherlands.	e.smit@nki.nl		Smit, Egbert/0000-0002-7329-6995				Carbone DP, 2017, NEW ENGL J MED, V376, P2415, DOI 10.1056/NEJMoa1613493; Felip E, 2018, P AM SOC CLIN ONCO S, V36; Ferrara R, 2018, JAMA ONCOL, V4, P1543, DOI 10.1001/jamaoncol.2018.3676; Gandhi L, 2018, NEW ENGL J MED, V378, P2078, DOI 10.1056/NEJMoa1801005; Gettinger SN, 2015, J CLIN ONCOL, V33, P2004, DOI 10.1200/JCO.2014.58.3708; Mok TSK, 2019, LANCET, V393, P1819, DOI 10.1016/S0140-6736(18)32409-7; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Socinski M, 2018, ASCO ANN M S, V36, P9002, DOI DOI 10.1200/JCO.2018.36.15_suppl.9002	8	12	14	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 4	2019	393	10183					1776	1778		10.1016/S0140-6736(18)32559-5	http://dx.doi.org/10.1016/S0140-6736(18)32559-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HW7GR	30955976				2022-12-28	WOS:000466858700005
J	Flasch, DA; Macia, A; Sanchez, L; Ljungman, M; Heras, SR; Garcia-Perez, JL; Wilson, TE; Moran, JV				Flasch, Diane A.; Macia, Angela; Sanchez, Laura; Ljungman, Mats; Heras, Sara R.; Garcia-Perez, Jose L.; Wilson, Thomas E.; Moran, John V.			Genome-wide de novo L1 Retrotransposition Connects Endonuclease Activity with Replication	CELL			English	Article							LINE-1 REVERSE-TRANSCRIPTASE; INTEGRATION SITE SELECTION; TRANSPOSABLE ELEMENTS; READ ALIGNMENT; FANCONI-ANEMIA; NUCLEAR LAMINA; GENE; IDENTIFICATION; REVEALS; RNA	L1 retrotransposon-derived sequences comprise approximately 17% of the human genome. Darwinian selective pressures alter L1 genomic distributions during evolution, confounding the ability to determine initial L1 integration preferences. Here, we generated high-confidence datasets of greater than 88,000 engineered L1 insertions in human cell lines that act as proxies for cells that accommodate retrotransposition in vivo. Comparing these insertions to a null model, in which L1 endonuclease activity is the sole determinant dictating L1 integration preferences, demonstrated that L1 insertions are not significantly enriched in genes, transcribed regions, or open chromatin. By comparison, we provide compelling evidence that the L1 endonuclease disproportionately cleaves predominant lagging strand DNA replication templates, while lagging strand 3'-hydroxyl groups may prime endonuclease-independent L1 retrotransposition in a Fanconi anemia cell line. Thus, acquisition of an endonuclease domain, in conjunction with the ability to integrate into replicating DNA, allowed L1 to become an autonomous, interspersed retrotransposon.	[Flasch, Diane A.; Wilson, Thomas E.; Moran, John V.] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; [Macia, Angela; Sanchez, Laura; Heras, Sara R.; Garcia-Perez, Jose L.] Pfizer Univ Granada, GENYO Ctr Genom & Oncol, Dept Genom Med, Pts Granada 18016, Spain; [Macia, Angela; Sanchez, Laura; Heras, Sara R.; Garcia-Perez, Jose L.] Andalusian Reg Govt, Pts Granada 18016, Spain; [Ljungman, Mats] Univ Michigan, Ctr Comprehens Canc, Translat Oncol Program, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Ljungman, Mats] Univ Michigan, Ctr RNA Biomed, Ann Arbor, MI 48109 USA; [Ljungman, Mats] Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA; [Garcia-Perez, Jose L.] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Med Res Council,Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Wilson, Thomas E.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Moran, John V.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Pfizer; University of Granada; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Edinburgh; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Flasch, DA; Wilson, TE; Moran, JV (corresponding author), Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA.; Wilson, TE (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.; Moran, JV (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA.	daflasch@umich.edu; wilsonte@umich.edu; moranj@umich.edu	Heras, Sara/C-3964-2017	Heras, Sara/0000-0003-1677-7685; Macia Ortega, Angela/0000-0001-8735-0916; SANCHEZ CONTRERAS, LAURA/0000-0003-2243-6166	NIH [UM1 HG009382, T32 HG000040, CA200731, GM120767, GM060518, U01MH106892]; MINECO-FEDER [SAF2017-89745-R]; European Research Council (ERC) [ERC-STG-2012-309433]; Howard Hughes Medical Institute (HHMI) [IECS-55007420]; HHMI; NATIONAL CANCER INSTITUTE [R01CA200731] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG009382, T32HG000040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH106892] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MINECO-FEDER; European Research Council (ERC)(European Research Council (ERC)); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); HHMI(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank members of the Moran laboratory and Brain Somatic Mosaicism Network, Shanda Birkeland, Arushi Varshney, Jeff Kidd, Patrick O'Brien, Saurabh Agarwal, and Stephen Parker for suggestions and comments; John Moldovan and Owen Funk for RNA isolations; Suyapa Amador-Cubero and Cesar Lopez-Ruiz (Genyo) for preparing PD20F samples; Purificacion Catalina (Biobanco SAS) for SKY-FISH and karyotype analyses; Santiago Morell and Martin Munoz-Lopez for sharing unpublished L1 retrotransposition data in FA mutant cells; Manhong Dai for administering the University of Michigan (UM) Molecular and Behavioral Neurosciences Institute computing cluster; Michelle Paulsen, Karan Bedi, and Brian Magnuson for performing Bru-seq experiments; and Robert Lyons and the UM DNA Sequencing Core for generating sequencing data. We are grateful to Henrietta Lacks, now deceased, and to her surviving family members for their contributions to biomedical research. The HeLa cell line that was established from her tumor cells without her knowledge or consent in 1951, have made significant contributions to scientific progress and advances in human health. Funding support: D.A.F, NIH training grant T32 HG000040; M.L., NIH grant UM1 HG009382; J.L.G.P., grants MINECO-FEDER (SAF2017-89745-R), the European Research Council (ERC-Consolidator ERC-STG-2012-309433), and the Howard Hughes Medical Institute (HHMI; IECS-55007420); T.E.W., NIH grants CA200731 and GM120767; and J.V.M., NIH grants GM060518 and U01MH106892 and previous funding from HHMI.	Alisch RS, 2006, GENE DEV, V20, P210, DOI 10.1101/gad.1380406; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Beck CR, 2011, ANNU REV GENOM HUM G, V12, P187, DOI 10.1146/annurev-genom-082509-141802; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bembom O., 2009, R PACKAGE VERSION, V1360; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Ceccaldi R, 2016, NAT REV MOL CELL BIO, V17, P337, DOI 10.1038/nrm.2016.48; Chen CK, 2016, SCIENCE, V354, P468, DOI 10.1126/science.aae0047; Churakov G, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-376; Cost GJ, 1998, BIOCHEMISTRY-US, V37, P18081, DOI 10.1021/bi981858s; Coufal NG, 2011, P NATL ACAD SCI USA, V108, P20382, DOI 10.1073/pnas.1100273108; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Dimitrieva S, 2013, NUCLEIC ACIDS RES, V41, pD101, DOI 10.1093/nar/gks1092; Doucet AJ, 2015, MOL CELL, V60, P728, DOI 10.1016/j.molcel.2015.10.012; Faulkner GJ, 2017, TRENDS GENET, V33, P802, DOI 10.1016/j.tig.2017.07.004; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Garcia-Perez JL, 2007, HUM MOL GENET, V16, P1569, DOI 10.1093/hmg/ddm105; Garcia-Perez JL, 2010, NATURE, V466, P769, DOI 10.1038/nature09209; Gilbert N, 2005, MOL CELL BIOL, V25, P7780, DOI 10.1128/MCB.25.17.7780-7795.2005; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Hancks DC, 2016, MOBILE DNA-UK, V7, DOI 10.1186/s13100-016-0065-9; Hausser J, 2009, J MACH LEARN RES, V10, P1469; HEIDMANN T, 1988, P NATL ACAD SCI USA, V85, P2219, DOI 10.1073/pnas.85.7.2219; Huvet M, 2007, GENOME RES, V17, P1278, DOI 10.1101/gr.6533407; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Jacob-Hirsch J, 2018, CELL RES, V28, P187, DOI 10.1038/cr.2018.8; Jurka J, 1997, P NATL ACAD SCI USA, V94, P1872, DOI 10.1073/pnas.94.5.1872; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kopera HC, 2011, P NATL ACAD SCI USA, V108, P20345, DOI 10.1073/pnas.1100275108; Kulpa DA, 2006, NAT STRUCT MOL BIOL, V13, P655, DOI 10.1038/nsmb1107; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; LaFave MC, 2014, NUCLEIC ACIDS RES, V42, P4257, DOI 10.1093/nar/gkt1399; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langley AR, 2016, NUCLEIC ACIDS RES, V44, P10230, DOI 10.1093/nar/gkw760; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Levin HL, 2011, NAT REV GENET, V12, P615, DOI 10.1038/nrg3030; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Liu NA, 2018, NATURE, V553, P228, DOI 10.1038/nature25179; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; Macia A, 2017, GENOME RES, V27, P335, DOI 10.1101/gr.206805.116; Malik HS, 1999, MOL BIOL EVOL, V16, P793, DOI 10.1093/oxfordjournals.molbev.a026164; McCole RB, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004646; Mita P, 2018, ELIFE, V7, DOI 10.7554/eLife.30058; Monot C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003499; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Morrish TA, 2002, NAT GENET, V31, P159, DOI 10.1038/ng898; Morrish TA, 2007, NATURE, V446, P208, DOI 10.1038/nature05560; Paulsen MT, 2014, METHODS, V67, P45, DOI 10.1016/j.ymeth.2013.08.015; Petryk N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10208; Pulsipher M, 1998, MOL MED, V4, P468, DOI 10.1007/BF03401752; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Repanas K, 2007, NUCLEIC ACIDS RES, V35, P4914, DOI 10.1093/nar/gkm516; Richardson SR, 2018, BIOESSAYS, V40, DOI 10.1002/bies.201700189; Richardson SR, 2015, MICROBIOL SPECTR, V3, P1, DOI DOI 10.1128/MICR0BI0LSPEC.MDNA3-0061-2014; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Sandmeyer S., 2015, MDNA3 0057 2014; Sassaman DM, 1997, NAT GENET, V16, P37, DOI 10.1038/ng0597-37; Scott EC, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060131; Sekhon JS, 2011, J STAT SOFTW, V42, P1; Simons C, 2006, GENOME RES, V16, P164, DOI 10.1101/gr4624306; Simons C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-470; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Spradling AC, 2011, P NATL ACAD SCI USA, V108, P15948, DOI 10.1073/pnas.1112960108; Sultana T, 2019, MOL CELL, V74, P555, DOI 10.1016/j.molcel.2019.02.036; Sultana T, 2017, NAT REV GENET, V18, P292, DOI 10.1038/nrg.2017.7; Symer DE, 2002, CELL, V110, P327, DOI 10.1016/S0092-8674(02)00839-5; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Touchon M, 2005, P NATL ACAD SCI USA, V102, P9836, DOI 10.1073/pnas.0500577102; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Upton KR, 2015, CELL, V161, P228, DOI 10.1016/j.cell.2015.03.026; van Steensel B, 2017, CELL, V169, P780, DOI 10.1016/j.cell.2017.04.022; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Weddington N, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-530; Wei W, 2000, ANAL BIOCHEM, V284, P435, DOI 10.1006/abio.2000.4675; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001; Weichenrieder O, 2004, STRUCTURE, V12, P975, DOI 10.1016/j.str.2004.04.011; Wissing S, 2012, HUM MOL GENET, V21, P208, DOI 10.1093/hmg/ddr455; Wolfe D, 2013, BIODATA MIN, V6, DOI 10.1186/1756-0381-6-18; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; ZEUTHEN J, 1980, INT J CANCER, V25, P19, DOI 10.1002/ijc.2910250104; Zhang A, 2014, NUCLEIC ACIDS RES, V42, P3803, DOI 10.1093/nar/gkt1308; Zhong J, 2003, EMBO J, V22, P4555, DOI 10.1093/emboj/cdg433; 2016, EBIOMEDICINE, V8, P184; 2013, GENOME RES, V23, P270	91	49	50	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 2	2019	177	4					837	+		10.1016/j.cell.2019.02.050	http://dx.doi.org/10.1016/j.cell.2019.02.050			43	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HW7AU	30955886	Green Accepted, Bronze			2022-12-28	WOS:000466843000007
J	Collins, GS; Moons, KGM				Collins, Gary S.; Moons, Karel G. M.			Reporting of artificial intelligence prediction models	LANCET			English	Editorial Material							INDIVIDUAL PROGNOSIS; DIAGNOSIS TRIPOD; RISK; DISEASE		[Collins, Gary S.] Univ Oxford, Ctr Stat Med, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7LD, England; [Moons, Karel G. M.] Univ Utrecht, Julius Ctr Hlth Sci & Primary Care, Univ Med Ctr Utrecht, Utrecht, Netherlands; [Moons, Karel G. M.] Univ Utrecht, Cochrane Netherlands, Univ Med Ctr Utrecht, Utrecht, Netherlands	University of Oxford; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Collins, GS (corresponding author), Univ Oxford, Ctr Stat Med, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7LD, England.	gary.collins@csm.ox.ac.uk	Collins, Gary Stephen/A-2258-2014	Collins, Gary Stephen/0000-0002-2772-2316				Bouwmeester W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001221; Chen JH, 2017, NEW ENGL J MED, V376, P2507, DOI 10.1056/NEJMp1702071; Collins GS, 2015, J CLIN EPIDEMIOL, V68, P112, DOI [10.1016/j.jclinepi.2014.11.010, 10.7326/M14-0697, 10.1136/bmj.g7594, 10.1186/s12916-014-0241-z, 10.1016/j.eururo.2014.11.025, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Collins GS, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-40; Damen JAAG, 2016, BMJ-BRIT MED J, V353, P12416; Hippisley-Cox J, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2099; Johnston SC, 2007, LANCET, V369, P283, DOI 10.1016/S0140-6736(07)60150-0; Malinchoc M, 2000, HEPATOLOGY, V31, P864, DOI 10.1053/he.2000.5852; Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698; Ratner M, 2018, NAT BIOTECHNOL, V36, P673, DOI 10.1038/nbt0818-673a; Tangri N, 2013, ANN INTERN MED, V158, P596, DOI 10.7326/0003-4819-158-8-201304160-00004; van Gorp MJ, 2004, CIRCULATION, V109, P2092, DOI 10.1161/01.CIR.0000125853.51637.C8; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	13	286	288	4	34	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 20	2019	393	10181					1577	1579		10.1016/S0140-6736(19)30037-6	http://dx.doi.org/10.1016/S0140-6736(19)30037-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU0DL	31007185				2022-12-28	WOS:000464941500009
J	Doughty, CT; Guidon, AC; Paganoni, S; Hedley-Whyte, ET				Doughty, Christopher T.; Guidon, Amanda C.; Paganoni, Sabrina; Hedley-Whyte, E. Tessa			Case 12-2019: A 60-Year-Old Man with Weakness and Difficulty Chewing	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; BULBAR MUSCULAR-ATROPHY; MULTIDISCIPLINARY CARE; CLINICAL-FEATURES; NATURAL-HISTORY; EL-ESCORIAL; FLAIL ARM; ALS; DISEASE; ASSOCIATION	A 60-year-old man was evaluated in the neurology clinic of this hospital because of difficulty chewing and progressive, generalized weakness. Physical examination revealed atrophy and fasciculations in multiple muscle groups; a video shows examination of a similar patient.	[Doughty, Christopher T.] Brigham & Womens Hosp, Dept Neurol, 75 Francis St, Boston, MA 02115 USA; [Guidon, Amanda C.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Paganoni, Sabrina] Massachusetts Gen Hosp, Dept Phys Med & Rehabil, Boston, MA 02114 USA; [Hedley-Whyte, E. Tessa] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Paganoni, Sabrina] Spaulding Rehabil Hosp, Boston, MA USA; [Doughty, Christopher T.; Guidon, Amanda C.] Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA; [Paganoni, Sabrina] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Hedley-Whyte, E. Tessa] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Spaulding Rehabilitation Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Doughty, CT (corresponding author), Brigham & Womens Hosp, Dept Neurol, 75 Francis St, Boston, MA 02115 USA.; Doughty, CT (corresponding author), Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA.		Hedley-Whyte, E Tessa/AAJ-9975-2021	Hedley-Whyte, E Tessa/0000-0002-1687-8905				AHIMA e-HIM Personal Health Record Work Group, 2005, J NEUROL NEUROSUR PS, V76, p64A; AMATO AA, 1993, NEUROLOGY, V43, P791, DOI 10.1212/WNL.43.4.791; Andrews JA, 2018, JAMA NEUROL, V75, P58, DOI 10.1001/jamaneurol.2017.3339; Atsuta N, 2006, BRAIN, V129, P1446, DOI 10.1093/brain/awl096; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Brown RH, 2017, NEW ENGL J MED, V377, P1602, DOI [10.1056/NEJMra1603471, 10.1038/nrdp.2017.71, 10.1016/S0140-6736(10)61156-7, 10.1056/NEJMc1710379, 10.1038/nrdp.2017.85, 10.1016/S0140-6736(17)31287-4]; Calvo A, 2017, J NEUROL, V264, P54, DOI 10.1007/s00415-016-8313-y; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Daube JR, 2009, MUSCLE NERVE, V39, P244, DOI 10.1002/mus.21180; Daube JR, 2000, MUSCLE NERVE, V23, P1488, DOI 10.1002/1097-4598(200010)23:10<1488::AID-MUS4>3.0.CO;2-E; Felice KJ, 1998, J NEUROL SCI, V160, pS30, DOI 10.1016/S0022-510X(98)00195-6; Gilhus NE, 2015, LANCET NEUROL, V14, P1023, DOI 10.1016/S1474-4422(15)00145-3; Hu MTM, 1998, J NEUROL NEUROSUR PS, V65, P950, DOI 10.1136/jnnp.65.6.950; KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671; KILLIAN JM, 1994, MUSCLE NERVE, V17, P747, DOI 10.1002/mus.880170708; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Lee JH, 2005, ACTA NEUROL SCAND, V112, P57, DOI 10.1111/j.1600-0404.2005.00428.x; Martin S, 2017, AMYOTROPH LAT SCL FR, V18, P569, DOI 10.1080/21678421.2017.1349151; Meriggioli MN, 2009, LANCET NEUROL, V8, P475, DOI 10.1016/S1474-4422(09)70063-8; Miller RG, 2009, NEUROLOGY, V73, P1227, DOI 10.1212/WNL.0b013e3181bc01a4; Miller RG, 2014, AMYOTROPH LAT SCL FR, V15, P165, DOI 10.3109/21678421.2013.875706; Miller RG, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001447.pub3; MULDER DW, 1959, NEUROLOGY, V9, P627, DOI 10.1212/WNL.9.10.627; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Oskarsson B, 2018, MUSCLE NERVE; Paganoni S, 2017, MUSCLE NERVE, V56, P848, DOI 10.1002/mus.25725; Paganoni S, 2015, NEUROREHABILITATION, V37, P53, DOI 10.3233/NRE-151240; Traynor BJ, 2000, ARCH NEUROL-CHICAGO, V57, P1171, DOI 10.1001/archneur.57.8.1171; Van De Rijn M, 2018, AMYOTROPH LAT SCL FR, V19, P143, DOI 10.1080/21678421.2017.1392577; Van den Berg-Vos RM, 2002, J NEUROL, V249, P330, DOI 10.1007/s004150200013; Wijesekera LC, 2009, NEUROLOGY, V72, P1087, DOI 10.1212/01.wnl.0000345041.83406.a2	31	0	0	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 18	2019	380	16					1566	1574		10.1056/NEJMcpc1900141	http://dx.doi.org/10.1056/NEJMcpc1900141			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU3AO	30995378				2022-12-28	WOS:000465144100018
J	Mahase, E				Mahase, Elisabeth			Measles cases rise 300% globally in first few months of 2019	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Centers for Disease Control and Prevention, 2019, MEASL CAS 2019; DYER O, 2019, BMJ-BRIT MED J, V364, P59351, DOI DOI 10.1136/BMJ.L739; Tanne JH, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1724; THORNTON J, 2019, BMJ-BRIT MED J, V364, P28117, DOI DOI 10.1136/BMJ.L634; World Health Organization, 2019, NEW MEASL SURV DAT; World Health Organization, 2019, DISTR MEASL CAS COUN	6	17	17	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2019	365								l1810	10.1136/bmj.l1810	http://dx.doi.org/10.1136/bmj.l1810			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU8OP	30992273				2022-12-28	WOS:000465549000011
J	Devi, S				Devi, Sharmila			International outrage over Brunei's discriminatory laws	LANCET			English	Editorial Material																			0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 13	2019	393	10180					1489	1489		10.1016/S0140-6736(19)30847-5	http://dx.doi.org/10.1016/S0140-6736(19)30847-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU0DA	30983576				2022-12-28	WOS:000464940400010
J	Dyer, C				Dyer, Clare			Dermatologist wins 6000 pound and injunction to remove defamatory blog	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 11	2019	365								l1766	10.1136/bmj.l1766	http://dx.doi.org/10.1136/bmj.l1766			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU0ER	30975719				2022-12-28	WOS:000464944700013
J	Traeger, MW; Cornelisse, VJ; Asselin, J; Price, B; Roth, NJ; Willcox, J; Tee, BK; Fairley, CK; Chang, CC; Armishaw, J; Vujovic, O; Penn, M; Cundill, P; Forgan-Smith, G; Gall, J; Pickett, C; Mak, A; Spelman, TD; Nguyen, L; Murphy, DA; Ryan, KE; El-Hayek, C; West, M; Ruth, S; Batrouney, C; Lockwood, JT; Hoy, JF; Hellard, ME; Stoove, MA; Wright, EJ; de Wit, J; Lal, L; Audsley, J; Duncan, A; Sasadeusz, J; Allan, B; Whelan, M; McPhail, D; Wilson, D; Holt, M; Williams, C; Wesselingh, S; Ward, J; Gallant, D; Ward, A; Chong, A; McKinnon, K; Aguirre, I; Read, T; Moore, R; Lau, H; Collins, D; Edwards, S; Boyd, S; Paige, E; Wade, A; Bell, C; Donohue, W; Elliot, S; Calabretto, H; Owen, L; Kelsall, J				Traeger, Michael W.; Cornelisse, Vincent J.; Asselin, Jason; Price, Brian; Roth, Norman J.; Willcox, Jeff; Tee, Ban Kiem; Fairley, Christopher K.; Chang, Christina C.; Armishaw, Jude; Vujovic, Olga; Penn, Matthew; Cundill, Pauline; Forgan-Smith, George; Gall, John; Pickett, Claire; Mak, Anne; Spelman, Tim D.; Long Nguyen; Murphy, Dean A.; Ryan, Kathleen E.; El-Hayek, Carol; West, Michael; Ruth, Simon; Batrouney, Colin; Lockwood, John T.; Hoy, Jennifer F.; Hellard, Margaret E.; Stoove, Mark A.; Wright, Edwina J.; de Wit, John; Lal, Luxi; Audsley, Jennifer; Duncan, Alison; Sasadeusz, Joe; Allan, Brent; Whelan, Michael; McPhail, Daniel; Wilson, David; Holt, Martin; Williams, Chris; Wesselingh, Steve; Ward, James; Gallant, Danny; Ward, Alison; Chong, Alistair; McKinnon, Katharine; Aguirre, Ivette; Read, Timothy; Moore, Richard; Lau, Helan; Collins, Danielle; Edwards, Sian; Boyd, Susan; Paige, Emma; Wade, Amanda; Bell, Charlotte; Donohue, William; Elliot, Samuel; Calabretto, Helen; Owen, Louise; Kelsall, Jenny		PrEPX Study Team	Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MEN; SEX; CHLAMYDIA	IMPORTANCE Emerging evidence suggests that risk of bacterial sexually transmitted infections (STIs) increases among gay and bisexual men following initiation of HIV preexposure prophylaxis (PrEP). OBJECTIVE To describe STI incidence and behavioral risk factors among a cohort of predominantly gay and bisexual men who use PrEP, and to explore changes in STI incidence following PrEP commencement. DESIGN, SETTING, AND PARTICIPANTS The Pre-exposure Prophylaxis Expanded (PrEPX) Study, a multisite, open-label intervention study, was nested within the Australian Collaboration for Coordinated Enhanced Sentinel Surveillance (ACCESS) clinic network. A total of 4275 participants were enrolled (July 26, 2016-April 1, 2018) in Victoria, Australia. Of these, 2981 enrolled at 5 ACCESS clinics (3 primary care, 1 sexual health, and 1 community-based HIV rapid testing service), had at least 1 follow-up visit, and were monitored until April 30, 2018. EXPOSURES Upon enrollment, participants received daily oral tenofovir disoproxil fumurate and emtricitabine for HIV PrEP, quarterly HIV and STI testing, and clinical monitoring. MAIN OUTCOMES AND MEASURES The primary outcome was incidence of chlamydia, gonorrhea, or syphilis. Incidence rates and hazard ratios describing behavioral risk factors of STI diagnosis were calculated. Incidence rate ratios (IRRs), adjusted for change in testing frequency, described changes in STI incidence from 1-year preenrollment to study follow-up among participants with preenrollment testing data (n = 1378). RESULTS Among the 2981 individuals (median age, 34 years [interquartile range, 28-42]), 98.5% identified as gay or bisexual males, 29% used PrEP prior to enrollment, 89 (3%) withdrew and were censored at date of withdrawal, leaving 2892 (97.0%) enrolled at final follow-up. During a mean follow-up of 1.1 years (3185.0 person-years), 2928 STIs were diagnosed among 1427 (48%) participants (1434 chlamydia, 1242 gonorrhea, 252 syphilis). STI incidence was 91.9 per 100 person-years, with 736 participants (25%) accounting for 2237 (76%) of all STIs. Among 2058 participants with complete data for multivariable analysis, younger age, greater partner number, and group sex were associated with greater STI risk, but condom use was not. Among 1378 participants with preenrollment testing data, STI incidence increased from 69.5 per 100 person-years prior to enrollment to 98.4 per 100 person-years during follow-up (IRR, 1.41 [95% CI, 1.29-1.56]). After adjusting for testing frequency, the increase in incidence from 1 year preenrollment to follow-up was significant for any STI (adjusted IRR, 1.12 [95% CI, 1.02-1.23]) and for chlamydia (adjusted IRR, 1.17 [95% CI, 1.04-1.33]). CONCLUSIONS AND RELEVANCE Among gay and bisexual men using PrEP, STIs were highly concentrated among a subset, and receipt of PrEP after study enrollment was associated with an increased incidence of STIs compared with preenrollment. These findings highlight the importance of frequent STI testing among gay and bisexual men using PrEP.	[Wilson, David] Burnet Inst, 85 Commercial Rd, Melbourne, Vic 3004, Australia; [Traeger, Michael W.; Asselin, Jason; Spelman, Tim D.; Long Nguyen; Ryan, Kathleen E.; El-Hayek, Carol; Hellard, Margaret E.; Stoove, Mark A.; Wright, Edwina J.; Lal, Luxi] Burnet Inst, Dis Eliminat Program, Melbourne, Vic, Australia; [Cornelisse, Vincent J.; Price, Brian; Chang, Christina C.; Armishaw, Jude; Vujovic, Olga; Mak, Anne; Ryan, Kathleen E.; Lockwood, John T.; Hoy, Jennifer F.; Hellard, Margaret E.; Wright, Edwina J.; Audsley, Jennifer] Alfred Hlth, Dept Infect Dis, Melbourne, Vic, Australia; [Cornelisse, Vincent J.; Price, Brian; Chang, Christina C.; Armishaw, Jude; Vujovic, Olga; Mak, Anne; Ryan, Kathleen E.; Lockwood, John T.; Hoy, Jennifer F.; Hellard, Margaret E.; Wright, Edwina J.; Audsley, Jennifer] Monash Univ, Melbourne, Vic, Australia; [Cornelisse, Vincent J.; Fairley, Christopher K.; Read, Timothy] Alfred Hlth, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia; [Cornelisse, Vincent J.; Roth, Norman J.] Prahran Market Clin, Melbourne, Vic, Australia; [Cornelisse, Vincent J.; Fairley, Christopher K.; Chang, Christina C.] Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia; [Willcox, Jeff; Moore, Richard; Edwards, Sian; Boyd, Susan] Northside Clin, Melbourne, Vic, Australia; [Tee, Ban Kiem; Lau, Helan] Thorne Harbour Hlth, Ctr Clin, Melbourne, Vic, Australia; [Penn, Matthew; Cundill, Pauline] Thorne Harbour Hlth, PRONTO Clin, Melbourne, Vic, Australia; [Forgan-Smith, George; Gall, John] ERA Hlth, Melbourne, Vic, Australia; [Pickett, Claire] Ballarat Community Hlth Ctr, Ballarat, Vic, Australia; [Spelman, Tim D.; Hellard, Margaret E.; Stoove, Mark A.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Spelman, Tim D.; Wright, Edwina J.; Audsley, Jennifer] Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Murphy, Dean A.] Univ Sydney, Dept Gender & Cultural Studies, Sydney, NSW, Australia; [Murphy, Dean A.; Holt, Martin] Univ New South Wales, Kirby Inst, Sydney, NSW, Australia; [West, Michael] Govt Victoria, Dept Hlth & Human Serv, Sexual Hlth & Viral Hepatitis Serv, Melbourne, Vic, Australia; [Ruth, Simon; Batrouney, Colin] Thorne Harbour Hlth, Melbourne, Vic, Australia; [de Wit, John] Univ New South West, Ctr Social Res Hlth, Sydney, NSW, Australia; [Audsley, Jennifer; Sasadeusz, Joe] Royal Melbourne Hosp, Melbourne, Vic, Australia; [Duncan, Alison; Sasadeusz, Joe; Chong, Alistair; Aguirre, Ivette; Collins, Danielle; Paige, Emma] The Alfred, Alfred Hlth, Melbourne, Vic, Australia; [Sasadeusz, Joe] Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Allan, Brent] Living Posit Victoria, Melbourne, Vic, Australia; [Whelan, Michael] PAN PrEP Access Now, Melbourne, Vic, Australia; [McPhail, Daniel; Williams, Chris] PrEPd Change, Melbourne, Vic, Australia; [Wesselingh, Steve; Ward, James; Gallant, Danny] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia; [Ward, Alison; Bell, Charlotte] Adelaide Sexual Hlth Ctr, Adelaide, SA, Australia; [Ward, Alison; Bell, Charlotte] Royal Adelaide Hosp, Adelaide, SA, Australia; [Chong, Alistair] Univ Melbourne, Melbourne, Vic, Australia; [McKinnon, Katharine] La Trobe Univ, Melbourne, Vic, Australia; [Cornelisse, Vincent J.; Roth, Norman J.; Lau, Helan] Prahran Market Clin, Melbourne, Vic, Australia; [Wade, Amanda] Geelong Hosp, Geelong, Vic, Australia; [Wade, Amanda] Barwon Hlth, Geelong, Vic, Australia; [Donohue, William] OBrien St Practice, Adelaide, SA, Australia; [Elliot, Samuel] Riverside Family Med Practice, St Marys, SA, Australia; [Calabretto, Helen] SHINE SA, Woodville, SA, Australia; [Owen, Louise] Sexual Hlth Serv Tasmania, Hobart, Tas, Australia; [Owen, Louise] Clin 60, Hobart, Tas, Australia; [Owen, Louise] Clin 34, Launceston, Tas, Australia; [Kelsall, Jenny] Harm Reduct Victoria, North Melbourn, Vic, Australia	Burnet Institute; Burnet Institute; Monash University; Monash University; Monash University; University of Melbourne; University of Sydney; University of New South Wales Sydney; Kirby Institute; Royal Melbourne Hospital; South Australian Health & Medical Research Institute (SAHMRI); Royal Adelaide Hospital; University of Melbourne; La Trobe University; Geelong Hospital	Traeger, MW (corresponding author), Burnet Inst, 85 Commercial Rd, Melbourne, Vic 3004, Australia.	michael.traeger@burnet.edu.au	Ward, James/ABD-1439-2020; El-Hayek, Carol/AAA-8666-2019; Traeger, Michael/O-3267-2019; Hoy, Jennifer/AAK-7968-2020; bell, charlotte/AAF-7720-2020; Wright, Edwina J/I-2950-2014; Cornelisse, Vincent/P-1346-2015	Ward, James/0000-0002-2892-4542; El-Hayek, Carol/0000-0001-5743-5994; Wright, Edwina J/0000-0001-8626-782X; Traeger, Michael/0000-0002-3452-350X; Cornelisse, Vincent/0000-0003-0657-9677; Stoove, Mark/0000-0003-2887-1409; Ryan, Kathleen/0000-0001-5892-4482; Chang, Christina Catherine/0000-0003-0109-0725; Murphy, Dean/0000-0003-2752-7091	Victorian Department of Health and Human Services; Thorne Harbour Health; Alfred Health; National Health and Medical Research Council (NHMRC); NHMRC [APP1092160]; Victorian Operational Infrastructure Support Program	Victorian Department of Health and Human Services; Thorne Harbour Health; Alfred Health; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Victorian Operational Infrastructure Support Program	The Pre-exposure Prophylaxis Expanded (PrEPX) Study was supported by funding from the Victorian Department of Health and Human Services, Thorne Harbour Health, and Alfred Health. Dr Cornelisse receives a stipend from the research training program of the Australian government's Department of Education and Training. Dr Stoove is supported by a National Health and Medical Research Council (NHMRC) senior research fellowship. Dr Chang is supported by an NHMRC early career fellowship (APP1092160). The Burnet Institute gratefully acknowledges support received from the Victorian Operational Infrastructure Support Program. Gilead Sciences donated study drug to the VicPrEP study (precursor to this study).	Australian Government Dept of Health, 2018, 8 NAT HIV STRAT; Australian Government Dept of Health, PRESCR MED BIOL TGA; Beymer MR, 2018, SEX TRANSM INFECT, V94, P457, DOI 10.1136/sextrans-2017-053377; Blumenthal Jill, 2014, Virtual Mentor, V16, P909, DOI 10.1001/virtualmentor.2014.16.11.stas1-1411; Callander D, 2018, JMIR RES PROTOC, V7, DOI 10.2196/11028; Centers for Disease Control and Prevention, 2016, DED GUID GON CHLAM L; Cornelisse VJ, 2018, SEX TRANSM DIS, V45, P506, DOI [10.1097/olq.0000000000000800, 10.1097/OLQ.0000000000000800]; Daoud JI, 2018, J PHYS CONF SER, V949, DOI 10.1088/1742-6596/949/1/012009; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Grant RM, 2015, C RETR OPP INF FEBR; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Grulich AE, 2018, LANCET HIV, V5, pE629, DOI 10.1016/S2352-3018(18)30215-7; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Holt M, 2017, SEX HEALTH, V14, P72, DOI 10.1071/SH16072; Jenness SM, 2017, CLIN INFECT DIS, V65, P712, DOI 10.1093/cid/cix439; Kelly CA, 2013, INT PERSPECT SEX R H, V39, P14, DOI 10.1363/3901413; Lal L, 2017, AIDS, V31, P1709, DOI [10.1097/QAD.0000000000001519, 10.1097/qad.0000000000001519]; Liu AY, 2016, JAMA INTERN MED, V176, P75, DOI 10.1001/jamainternmed.2015.4683; Lockwood J, 2017, J INT AIDS SOC, V20, P57; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; PRENTICE RL, 1981, BIOMETRIKA, V68, P373, DOI 10.1093/biomet/68.2.373; RYAN KE, 2018, FRONT PUBLIC HEALTH, V6, DOI DOI 10.3389/FPUBB.2018.00151; Templeton DJ, 2014, SEX HEALTH, V11, P217, DOI 10.1071/SH14003; Traeger MW, 2018, CLIN INFECT DIS, V67, P676, DOI 10.1093/cid/ciy182; Nguyen VK, 2018, AIDS, V32, P523, DOI 10.1097/QAD.0000000000001718	26	182	184	4	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 9	2019	321	14					1380	1390		10.1001/jama.2019.2947	http://dx.doi.org/10.1001/jama.2019.2947			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HT5PG	30964528	Green Published, Bronze			2022-12-28	WOS:000464615200017
J	Gaston, DC; Peaper, DR; Advani, SD				Gaston, David C.; Peaper, David R.; Advani, Sonali D.			Fever, Rash, and Migratory Polyarthralgias	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RAT BITE FEVER		[Gaston, David C.; Advani, Sonali D.] Yale Sch Med, Dept Med, Infect Dis Sect, New Haven, CT USA; [Peaper, David R.] Yale Sch Med, Dept Lab Med, New Haven, CT USA	Yale University; Yale University	Advani, SD (corresponding author), Yale Sch Med, Yale New Haven Hosp, Dept Med, Infect Dis Sect, 20 York St,Hunter 527, New Haven, CT 06510 USA.	sonali.advani@yale.edu		Advani, Sonali/0000-0001-5162-6482				Centers for Disease Control and Prevention (CDC), 1998, MMWR-MORBID MORTAL W, V47, P89; Centers for Disease Control and Prevention (CDC), RAB DOM AN; Crews JD, 2014, JAMA PEDIATR, V168, P1165, DOI 10.1001/jamapediatrics.2014.1604; Elliott SP, 2007, CLIN MICROBIOL REV, V20, P13, DOI 10.1128/CMR.00016-06; FRANK L, 1948, ARCH DERMATOL SYPH, V57, P261, DOI 10.1001/archderm.1948.01520140123015; Hammer A, 2017, J NEUROSURG-SPINE, V27, P92, DOI 10.3171/2016.12.SPINE161042; Kwon CW, 2016, JAMA DERMATOL, V152, P723, DOI 10.1001/jamadermatol.2015.6034; Nathan M, 2017, J THORAC CARDIOV SUR, V153, DOI 10.1016/j.jtcvs.2016.11.012; Surana NK., 2018, HARRISONS PRINCIPLES, V20; Suzuki K, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx038	10	2	2	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 21	2019	321	19					1930	1931		10.1001/jama.2019.4799	http://dx.doi.org/10.1001/jama.2019.4799			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HZ1FC	31002308				2022-12-28	WOS:000468591200023
J	Pullan, RL; Halliday, KE; Oswald, WE; Mcharo, C; Beaumont, E; Kepha, S; Witek-McManus, S; Gichuki, PM; Allen, E; Drake, T; Pitt, C; Matendechero, SH; Gwayi-Chore, MC; Anderson, RM; Njenga, SM; Brooker, SJ; Mwandawiro, CS				Pullan, Rachel L.; Halliday, Katherine E.; Oswald, William E.; Mcharo, Carlos; Beaumont, Emma; Kepha, Stella; Witek-McManus, Stefan; Gichuki, Paul M.; Allen, Elizabeth; Drake, Tom; Pitt, Catherine; Matendechero, Sultani H.; Gwayi-Chore, Marie-Claire; Anderson, Roy M.; Njenga, Sammy M.; Brooker, Simon J.; Mwandawiro, Charles S.			Effects, equity, and cost of school-based and community-wide treatment strategies for soil-transmitted helminths in Kenya: a cluster-randomised controlled trial	LANCET			English	Article							INFECTIONS	Background School-based deworming programmes can reduce morbidity attributable to soil-transmitted helminths in children but do not interrupt transmission in the wider community. We assessed the effects of alternative mass treatment strategies on community soil-transmitted helminth infection. Methods In this cluster-randomised controlled trial, 120 community units (clusters) serving 150 000 households in Kenya were randomly assigned (1:1:1) to receive albendazole through annual school-based treatment targeting 2-14 year olds or annual or biannual community-wide treatment targeting all ages. The primary outcome was community hookworm prevalence, assessed at 12 and 24 months through repeat cross-sectional surveys. Secondary outcomes were Ascaris lumbricoides and Trichuris trichiura prevalence, infection intensity of each soil-transmitted helminth species, and treatment coverage and costs. Analysis was by intention to treat. This trial is registered with ClinicalTrials. gov, number NCT02397772. Findings After 24 months, prevalence of hookworm changed from 18.6% (95% CI 13.9-23.2) to 13. 8% (10.5-17.0) in the annual school-based treatment group, 17.9% (13.7-22.1) to 8.0% (6.0-10.1) in the annual community-wide treatment group, and 20.6% (15.8-25.5) to 6.2% (4. 9-7.5) in the biannual community-wide treatment group. Relative to annual school-based treatment, the risk ratio for annual community-wide treatment was 0. 59 (95% CI 0. 42-0.83; p<0.001) and for biannual community-wide treatment was 0. 46 (0.33-0.63; p<0.001). More modest reductions in risk were observed after 12 months. Risk ratios were similar across demographic and socioeconomic subgroups after 24 months. No adverse events related to albendazole were reported. Interpretation Community-wide treatment was more effective in reducing hookworm prevalence and intensity than school-based treatment, with little additional benefit of treating every 6 months, and was shown to be remarkably equitable in coverage and effects. Copyright (C) 2019 The Author(s). Published by Elsevier Ltd.	[Pullan, Rachel L.; Halliday, Katherine E.; Oswald, William E.; Kepha, Stella; Witek-McManus, Stefan; Brooker, Simon J.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1E 7HT, England; [Beaumont, Emma; Allen, Elizabeth] London Sch Hyg & Trop Med, Fac Epidemiol & Publ Hlth, London, England; [Drake, Tom; Pitt, Catherine] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London, England; [Mcharo, Carlos; Kepha, Stella; Gichuki, Paul M.; Njenga, Sammy M.; Mwandawiro, Charles S.] Kenya Govt Med Res Ctr, Eastern & Southern Africa Ctr Int Parasite Contro, Nairobi, Kenya; [Kepha, Stella] Pwani Univ, Biosci Res Ctr, Kilifi, Kenya; [Matendechero, Sultani H.] Minist Hlth, Div Communicable Dis Prevent & Control, Neglected Trop Dis Unit, Nairobi, Kenya; [Gwayi-Chore, Marie-Claire] Evidence Act, Deworm World Initiat, Nairobi, Kenya; [Anderson, Roy M.] Imperial Coll London, London Ctr Neglected Trop Dis Res, Dept Infect Dis Epidemiol, Fac Med,Sch Publ Hlth, St Marys Campus, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Kenya Medical Research Institute; Pwani University; Imperial College London	Pullan, RL (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1E 7HT, England.	rachel.pullan@lshtm.ac.uk	; Pitt, Catherine/K-3001-2012	Njenga, Sammy/0000-0001-6309-476X; Pitt, Catherine/0000-0003-4967-8966; Anderson, Roy/0000-0002-9528-3175; Halliday, Katherine/0000-0001-5307-2823; Pullan, Rachel/0000-0001-9844-1362; Oswald, William/0000-0002-5287-2834	Bill & Melinda Gates Foundation; Joint Global Health Trials Scheme of the Medical Research Council; UK Department for International Development; Wellcome Trust; Children's Investment Fund Foundation; MRC [MR/N00597X/1, MR/R015600/1] Funding Source: UKRI	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Joint Global Health Trials Scheme of the Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development; Wellcome Trust(Wellcome TrustEuropean Commission); Children's Investment Fund Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Bill & Melinda Gates Foundation, the Joint Global Health Trials Scheme of the Medical Research Council, the UK Department for International Development, the Wellcome Trust, and the Children's Investment Fund Foundation.	ANDERSON RM, 1985, ADV PARASIT, V24, P1, DOI 10.1016/S0065-308X(08)60561-8; Anderson R, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0435; [Anonymous], 2017, Wkly Epidemiol Rec, V92, P749; Asbjornsdottir KH, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006166; Bangert M, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0288-0; Brooker SJ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008950; Clarke NE, 2017, LANCET, V389, P287, DOI 10.1016/S0140-6736(16)32123-7; Clasen T, 2014, LANCET GLOB HEALTH, V2, pE645, DOI 10.1016/S2214-109X(14)70307-9; Farrell SH, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2206-5; Fitzpatrick C, 2016, INT HEALTH, V8, pi15, DOI 10.1093/inthealth/ihw002; McCollum R, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3043-8; Meurs L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005310; Nikolay B, 2014, INT J PARASITOL, V44, P765, DOI 10.1016/j.ijpara.2014.05.009; Njomo DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048395; Okoyo C, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1679-y; Palmeirim MS, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006458; Pion SDS, 2017, LANCET INFECT DIS, V17, P763, DOI 10.1016/S1473-3099(17)30175-5; Silumbwe A, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4414-5; Strunz EC, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001620; Truscott JE, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-266; Turner HC, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0885-3; Uniting to Combat Neglected Tropical Diseases, 2018, 5 UN COMB NEGL TROP; Vercruysse J, 2011, INT J PARASITOL-DRUG, V1, P14, DOI 10.1016/j.ijpddr.2011.09.002; Victora CG, 2003, LANCET, V362, P233, DOI 10.1016/S0140-6736(03)13917-7; Walker A, 2016, WHAT IS COST DEWORMI; Werkman M, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006114; WHO, 2012, ACC WORK OV GLOB IMP, P13; WHO, 2017, REP WHO ADV GROUP DE, P28; Wilkinson T, 2016, VALUE HEALTH, V19, P921, DOI 10.1016/j.jval.2016.04.015; World Bank, 2018, OFF EXCH RAT LCU PER; World Health Organization, 2017, SEL US ESS MED REP W; World Health Organization, 2017, GUID PREV CHEM CONTR; 2013, AM J TROP MED HYG, V89, P875, DOI DOI 10.4269/AJTMH.13-0237	33	40	40	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 18	2019	393	10185					2039	2050		10.1016/S0140-6736(18)32591-1	http://dx.doi.org/10.1016/S0140-6736(18)32591-1			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HY4QC	31006575	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000468112000027
J	Parada, GA; Goldsmith, ZK; Kolmar, S; Rimgard, BP; Mercado, BQ; Hammarstrom, L; Hammes-Schiffer, S; Mayer, JM				Parada, Giovanny A.; Goldsmith, Zachary K.; Kolmar, Scott; Rimgard, Belinda Pettersson; Mercado, Brandon Q.; Hammarstrom, Leif; Hammes-Schiffer, Sharon; Mayer, James M.			PHYSICAL CHEMISTRY Concerted proton-electron transfer reactions in the Marcus inverted region	SCIENCE			English	Article							HYDROGEN-BONDED PHENOLS; COUPLED ELECTRON; TYROSINE OXIDATION; BASIS-SETS; DISTANCE; QUANTUM; THERMOCHEMISTRY; DESIGN; SERIES; STATES	Electron transfer reactions slow down when they become very thermodynamically favorable, a counterintuitive interplay of kinetics and thermodynamics termed the inverted region in Marcus theory. Here we report inverted region behavior for proton-coupled electron transfer (PCET). Photochemical studies of anthracene-phenol-pyridine triads give rate constants for PCET charge recombination that are slower for the more thermodynamically favorable reactions. Photoexcitation forms an anthracene excited state that undergoes PCET to create a charge-separated state. The rate constants for return charge recombination show an inverted dependence on the driving force upon changing pyridine substituents and the solvent. Calculations using vibronically nonadiabatic PCET theory yield rate constants for simultaneous tunneling of the electron and proton that account for the results.	[Parada, Giovanny A.; Goldsmith, Zachary K.; Kolmar, Scott; Mercado, Brandon Q.; Hammes-Schiffer, Sharon; Mayer, James M.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Rimgard, Belinda Pettersson; Hammarstrom, Leif] Uppsala Univ, Dept Chem, Angstrom Lab, Uppsala, Sweden	Yale University; Uppsala University	Hammes-Schiffer, S; Mayer, JM (corresponding author), Yale Univ, Dept Chem, New Haven, CT 06520 USA.; Hammarstrom, L (corresponding author), Uppsala Univ, Dept Chem, Angstrom Lab, Uppsala, Sweden.	leif.hammarstrom@kemi.uu.se; sharon.hammes-schiffer@yale.edu; james.mayer@yale.edu	Hammes-Schiffer, Sharon/B-7325-2013; Rimgard, Belinda/GRE-9142-2022	Kolmar, Scott/0000-0002-7797-700X; Goldsmith, Zachary/0000-0002-5556-4079; Mayer, James/0000-0002-3943-5250; Parada, Giovanny/0000-0002-1669-8832	U.S. National Institutes of Health [R01GM050422, R37GM056207]; Swedish Research Council [2016-04271]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM056207, R01GM050422] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support was provided by the U.S. National Institutes of Health (R01GM050422 to J.M.M. and R37GM056207 to S.H.-S.) and by the Swedish Research Council (2016-04271 to L.H.).	Andrieux CP, 2003, J AM CHEM SOC, V125, P10119, DOI 10.1021/ja035268f; [Anonymous], 1993, ANGEW CHEM INT ED EN, V32, P1111; Armarego W.L.F., 2013, PURIFICATION LAB CHE, VSeventh, P103; ASAHI T, 1993, J AM CHEM SOC, V115, P5665, DOI 10.1021/ja00066a036; Auer B, 2011, J AM CHEM SOC, V133, P8282, DOI 10.1021/ja201560v; BARBARA PF, 1992, SCIENCE, V256, P975, DOI 10.1126/science.256.5059.975; Barbara PF, 1996, J PHYS CHEM-US, V100, P13148, DOI 10.1021/jp9605663; Barone V, 1998, J PHYS CHEM A, V102, P1995, DOI 10.1021/jp9716997; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Biczok L, 1997, J AM CHEM SOC, V119, P12601, DOI 10.1021/ja9727528; Blowers P, 1999, J PHYS CHEM A, V103, P7047, DOI 10.1021/jp990039u; Bowring MA, 2018, J AM CHEM SOC, V140, P7449, DOI 10.1021/jacs.8b04455; Chai JD, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2834918; CLARK T, 1983, J COMPUT CHEM, V4, P294, DOI 10.1002/jcc.540040303; CLOSS GL, 1988, SCIENCE, V240, P440, DOI 10.1126/science.240.4851.440; Costentin C, 2007, J AM CHEM SOC, V129, P9953, DOI 10.1021/ja071150d; Costentin C, 2009, P NATL ACAD SCI USA, V106, P18143, DOI 10.1073/pnas.0910065106; Davis AP, 2010, J PHYS CHEM A, V114, P12299, DOI 10.1021/jp106088n; Edwards SJ, 2009, J PHYS CHEM B, V113, P14545, DOI 10.1021/jp907808t; Frisch M. J., 2010, GAUSSIAN 09; Gadosy TA, 1999, J PHYS CHEM A, V103, P8834, DOI 10.1021/jp992216x; Glover SD, 2017, J AM CHEM SOC, V139, P2090, DOI 10.1021/jacs.6b12531; Glover SD, 2014, J AM CHEM SOC, V136, P14039, DOI 10.1021/ja503348d; Goldsmith RH, 2008, J AM CHEM SOC, V130, P7659, DOI 10.1021/ja8004623; Hammes-Schiffer S, 2010, CHEM REV, V110, P6939, DOI 10.1021/cr1001436; HARIHARA.PC, 1973, THEOR CHIM ACTA, V28, P213, DOI 10.1007/BF00533485; HEHRE WJ, 1972, J CHEM PHYS, V56, P2257, DOI 10.1063/1.1677527; Ho JM, 2015, PHYS CHEM CHEM PHYS, V17, P2859, DOI 10.1039/c4cp04538f; Horvath S, 2012, P NATL ACAD SCI USA, V109, P15663, DOI 10.1073/pnas.1118333109; Irebo T, 2008, J AM CHEM SOC, V130, P9194, DOI 10.1021/ja802076v; Kaljurand I, 2000, J ORG CHEM, V65, P6202, DOI 10.1021/jo005521j; KLIGER DS, 1970, J CHEM PHYS, V53, P4059, DOI 10.1063/1.1673879; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Lennox JC, 2017, ACS ENERGY LETT, V2, P1246, DOI 10.1021/acsenergylett.7b00063; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; MARCUS RA, 1993, ANGEW CHEM INT EDIT, V32, P1111, DOI 10.1002/anie.199311113; Markle TF, 2012, J PHYS CHEM A, V116, P12249, DOI 10.1021/jp311388n; Markle TF, 2012, J PHYS CHEM B, V116, P571, DOI 10.1021/jp2091736; Markle TF, 2011, J AM CHEM SOC, V133, P17341, DOI 10.1021/ja2056853; Miller DC, 2016, TOPICS CURR CHEM, V374, DOI 10.1007/s41061-016-0030-6; Morris WD, 2017, J AM CHEM SOC, V139, P10312, DOI 10.1021/jacs.7b03562; Mullen K.M., 2007, J STAT SOFTW, V18, P1, DOI DOI 10.18637/JSS.V018.I03; Namazian M, 2010, J CHEM THEORY COMPUT, V6, P2721, DOI 10.1021/ct1003252; NELSEN SF, 1987, J AM CHEM SOC, V109, P677, DOI 10.1021/ja00237a007; Peters KS, 2009, ACCOUNTS CHEM RES, V42, P89, DOI 10.1021/ar8001156; Reece SY, 2009, ANNU REV BIOCHEM, V78, P673, DOI 10.1146/annurev.biochem.78.080207.092132; Rhile IJ, 2006, J AM CHEM SOC, V128, P6075, DOI 10.1021/ja054167+; Rhile IJ, 2004, J AM CHEM SOC, V126, P12718, DOI 10.1021/ja031583q; Schrauben JN, 2012, J AM CHEM SOC, V134, P16635, DOI 10.1021/ja305668h; Seh ZW, 2017, SCIENCE, V355, DOI 10.1126/science.aad4998; Snellenburg JJ, 2012, J STAT SOFTW, V49, P1, DOI 10.18637/jss.v049.i03; Solis BH, 2014, INORG CHEM, V53, P6427, DOI 10.1021/ic5002896; Soudackov A, 2000, J CHEM PHYS, V113, P2385, DOI 10.1063/1.482053; Torrado A, 1996, J ORG CHEM, V61, P8940, DOI 10.1021/jo961466w; ULSTRUP J, 1975, J CHEM PHYS, V63, P4358, DOI 10.1063/1.431152; van Stokkum IHM, 2004, BBA-BIOENERGETICS, V1657, P82, DOI 10.1016/j.bbabio.2004.04.011; Warren JJ, 2010, CHEM REV, V110, P6961, DOI 10.1021/cr100085k; Weinberg DR, 2012, CHEM REV, V112, P4016, DOI 10.1021/cr200177j; Weller A., 1968, PURE APPL CHEM, V16, P115, DOI [10.1351/pac196816010115, DOI 10.1351/PAC196816010115]; Yanai T, 2004, CHEM PHYS LETT, V393, P51, DOI 10.1016/j.cplett.2004.06.011	60	69	69	11	147	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 3	2019	364	6439					471	+		10.1126/science.aaw4675	http://dx.doi.org/10.1126/science.aaw4675			90	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HW6ON	30975771	Green Accepted			2022-12-28	WOS:000466809600031
J	Lukin, A; Rispoli, M; Schittko, R; Tai, ME; Kaufman, AM; Choi, S; Khemani, V; Leonard, J; Greiner, M				Lukin, Alexander; Rispoli, Matthew; Schittko, Robert; Tai, M. Eric; Kaufman, Adam M.; Choi, Soonwon; Khemani, Vedika; Leonard, Julian; Greiner, Markus			Probing entanglement in a many-body-localized system	SCIENCE			English	Article							ANDERSON LOCALIZATION; QUANTUM; THERMALIZATION; DYNAMICS; ATOMS	An interacting quantum system that is subject to disorder may cease to thermalize owing to localization of its constituents, thereby marking the breakdown of thermodynamics. The key to understanding this phenomenon lies in the system's entanglement, which is experimentally challenging to measure. We realize such a many-body-localized system in a disordered Bose-Hubbard chain and characterize its entanglement properties through particle fluctuations and correlations. We observe that the particles become localized, suppressing transport and preventing the thermalization of subsystems. Notably, we measure the development of nonlocal correlations, whose evolution is consistent with a logarithmic growth of entanglement entropy, the hallmark of many-body localization. Our work experimentally establishes many-body localization as a qualitatively distinct phenomenon from localization in noninteracting, disordered systems.	[Lukin, Alexander; Rispoli, Matthew; Schittko, Robert; Tai, M. Eric; Kaufman, Adam M.; Choi, Soonwon; Khemani, Vedika; Leonard, Julian; Greiner, Markus] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Tai, M. Eric] NIST, JILA, Boulder, CO USA; [Tai, M. Eric] Univ Colorado, Boulder, CO 80309 USA; [Tai, M. Eric] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Choi, Soonwon] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA	Harvard University; National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of California System; University of California Berkeley	Greiner, M (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	greiner@physics.harvard.edu		Choi, Soonwon/0000-0002-1247-062X; Lukin, Alexander/0000-0002-4930-8722	National Science Foundation; Gordon and Betty Moore Foundations EPiQS Initiative; Air Force Office of Scientific Research MURI program; Army Research Office MURI program; NSF Graduate Research Fellowship Program; Swiss National Science Foundation; Harvard Society of Fellows; William F. Milton Fund	National Science Foundation(National Science Foundation (NSF)); Gordon and Betty Moore Foundations EPiQS Initiative; Air Force Office of Scientific Research MURI program(MURI); Army Research Office MURI program; NSF Graduate Research Fellowship Program(National Science Foundation (NSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Harvard Society of Fellows; William F. Milton Fund	We are supported by grants from the National Science Foundation, the Gordon and Betty Moore Foundations EPiQS Initiative, an Air Force Office of Scientific Research MURI program, an Army Research Office MURI program, and the NSF Graduate Research Fellowship Program. J.L. acknowledges support from the Swiss National Science Foundation. V.K. acknowledges support from the Harvard Society of Fellows and the William F. Milton Fund.	Abanin D. A., 2018, ARXIV180411065CONDMA; Agarwal K, 2017, ANN PHYS-BERLIN, V529, DOI 10.1002/andp.201600326; Altman E, 2015, ANNU REV CONDEN MA P, V6, P383, DOI 10.1146/annurev-conmatphys-031214-014701; ANDERSON PW, 1958, PHYS REV, V109, P1492, DOI 10.1103/PhysRev.109.1492; Aubry S., 1980, Annals of the Israel Physical Society, V3, P133; Bakr WS, 2009, NATURE, V462, P74, DOI 10.1038/nature08482; Bardarson JH, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.017202; Basko DM, 2006, ANN PHYS-NEW YORK, V321, P1126, DOI 10.1016/j.aop.2005.11.014; Billy J, 2008, NATURE, V453, P891, DOI 10.1038/nature07000; Bordia P, 2017, NAT PHYS, V13, P460, DOI [10.1038/NPHYS4020, 10.1038/nphys4020]; Bordia P, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.140401; Choi JY, 2016, SCIENCE, V352, P1547, DOI 10.1126/science.aaf8834; D'Errico C, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.095301; De Roeck W, 2017, PHYS REV B, V95, DOI 10.1103/PhysRevB.95.155129; Deissler B, 2010, NAT PHYS, V6, P354, DOI 10.1038/NPHYS1635; DEUTSCH JM, 1991, PHYS REV A, V43, P2046, DOI 10.1103/PhysRevA.43.2046; Elben A, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.050406; Gadway B, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.145306; Gornyi IV, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.206603; Hartmann T, 2004, NEW J PHYS, V6, DOI 10.1088/1367-2630/6/1/002; Huse DA, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.174202; Islam R, 2015, NATURE, V528, P77, DOI 10.1038/nature15750; Iyer S, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.134202; Jendrzejewski F, 2012, NAT PHYS, V8, P398, DOI [10.1038/NPHYS2256, 10.1038/nphys2256]; Kaufman AM, 2016, SCIENCE, V353, P794, DOI 10.1126/science.aaf6725; Khemani V, 2017, PHYS REV X, V7, DOI 10.1103/PhysRevX.7.021013; Kondov SS, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.083002; Kondov SS, 2011, SCIENCE, V334, P66, DOI 10.1126/science.1209019; Lahini Y, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.013906; Luschen HP, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.260401; Luschen HP, 2017, PHYS REV X, V7, DOI 10.1103/PhysRevX.7.011034; Ma RC, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.095301; Melko RG, 2016, PHYS REV A, V93, DOI 10.1103/PhysRevA.93.042336; Nandkishore R, 2017, ANN PHYS-BERLIN, V529, DOI 10.1002/andp.201600181; Nandkishore R, 2015, ANNU REV CONDEN MA P, V6, P15, DOI 10.1146/annurev-conmatphys-031214-014726; Neill C, 2016, NAT PHYS, V12, P1037, DOI [10.1038/NPHYS3830, 10.1038/nphys3830]; Oganesyan V, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.155111; Potter AC, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.031033; Preiss PM, 2015, SCIENCE, V347, P1229, DOI 10.1126/science.1260364; Rigol M, 2008, NATURE, V452, P854, DOI 10.1038/nature06838; Roati G, 2008, NATURE, V453, P895, DOI 10.1038/nature07071; Schreiber M, 2015, SCIENCE, V349, P842, DOI 10.1126/science.aaa7432; Schwartz T, 2007, NATURE, V446, P52, DOI 10.1038/nature05623; Semeghini G, 2015, NAT PHYS, V11, P554, DOI 10.1038/NPHYS3339; Serbyn M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.127201; Serbyn M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.260601; Smith J, 2016, NAT PHYS, V12, P907, DOI [10.1038/nphys3783, 10.1038/NPHYS3783]; SREDNICKI M, 1994, PHYS REV E, V50, P888, DOI 10.1103/PhysRevE.50.888; Vosk R, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.031032; Wolf MM, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.070502; Znidaric M, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.064426; Zupancic P, 2016, OPT EXPRESS, V24, P13881, DOI 10.1364/OE.24.013881	53	237	237	4	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2019	364	6437					256	+		10.1126/science.aau0818	http://dx.doi.org/10.1126/science.aau0818			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HU0JG	31000657	Green Submitted			2022-12-28	WOS:000464956600043
J	Mayor, S				Mayor, Susan			Contaminated blood scandal: solicitors for victims call for hepatitis C screening programme in England and Wales	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		DYER C, 2018, BMJ-BRIT MED J, V362, DOI DOI 10.1136/BMJ.K4108	1	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 19	2019	365								l1845	10.1136/bmj.l1845	http://dx.doi.org/10.1136/bmj.l1845			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU8PH	31003967				2022-12-28	WOS:000465551100001
J	Ponsford, R; Thompson, C; Paparini, S				Ponsford, Ruth; Thompson, Claire; Paparini, Sara			We need a renewed focus on primary prevention to tackle youth knife violence	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INTERVENTIONS; PROGRAMS; COMMON		[Ponsford, Ruth] London Sch Hyg & Trop Med, Sch Hlth Intervent, London, England; [Thompson, Claire; Paparini, Sara] London Sch Hyg & Trop Med, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Ponsford, R (corresponding author), London Sch Hyg & Trop Med, Sch Hlth Intervent, London, England.	Ruth.Ponsford@lshtm.ac.uk	Thompson, Claire/ABE-7242-2021	Thompson, Claire/0000-0002-0864-9811; Ponsford, Ruth/0000-0003-2612-0249				Bonell C, 2013, J EPIDEMIOL COMMUN H, V67, P677, DOI 10.1136/jech-2012-202247; Farrington DP, 2017, AGGRESS VIOLENT BEH, V33, P91, DOI 10.1016/j.avb.2016.11.003; Matjasko JL, 2012, AGGRESS VIOLENT BEH, V17, P540, DOI 10.1016/j.avb.2012.06.006; Melendez-Torres GJ, 2016, J EPIDEMIOL COMMUN H, V70, P1171, DOI 10.1136/jech-2015-206132; Popay J, 2018, INT J PUBLIC HEALTH, V63, P1013, DOI 10.1007/s00038-018-1145-z; Wilkinson R, 2004, ANN NY ACAD SCI, V1036, P1, DOI 10.1196/annals.1330.001; World Health Organization, 2015, WHO LIB, P100	7	1	1	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2019	365								l1769	10.1136/bmj.l1769	http://dx.doi.org/10.1136/bmj.l1769			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU8OP	30992272	Green Submitted, Green Published			2022-12-28	WOS:000465549000006
J	Hartmann, J				Hartmann, Jens			Plate tectonics, carbon, and climate	SCIENCE			English	Editorial Material							CYCLE		[Hartmann, Jens] Univ Hamburg, Ctr Earth Syst Res & Sustainabil CEN, Dept Geosci, Hamburg, Germany	University of Hamburg	Hartmann, J (corresponding author), Univ Hamburg, Ctr Earth Syst Res & Sustainabil CEN, Dept Geosci, Hamburg, Germany.	geo@hattes.de	Hartmann, Jens/A-6306-2008; Hartmann, Jens/AAB-3313-2020	Hartmann, Jens/0000-0003-1878-9321; Hartmann, Jens/0000-0003-1878-9321				Burton MR, 2013, REV MINERAL GEOCHEM, V75, P323, DOI 10.2138/rmg.2013.75.11; Gernon TM, 2016, NAT GEOSCI, V9, P242, DOI 10.1038/NGEO2632; Hartmann J, 2017, GEOCHEM PERSPECT LET, V4, P41, DOI 10.7185/geochemlet.1734; Hartmann J, 2009, GLOBAL PLANET CHANGE, V69, P185, DOI 10.1016/j.gloplacha.2009.07.007; Hayes JM, 2006, PHILOS T R SOC B, V361, P931, DOI 10.1098/rstb.2006.1840; Kelemen PB, 2015, P NATL ACAD SCI USA, V112, pE3997, DOI 10.1073/pnas.1507889112; Lee CTA, 2015, ELEMENTS, V11, P125, DOI 10.2113/gselements.11.2.125; Lenton TM, 2018, EARTH-SCI REV, V178, P1, DOI 10.1016/j.earscirev.2017.12.004; Li GJ, 2013, GEOCHIM COSMOCHIM AC, V103, P11, DOI 10.1016/j.gca.2012.10.014; Mcdonald F. A., 2019, SCIENCE, V364, P181; Merdith AS, 2017, GONDWANA RES, V50, P84, DOI 10.1016/j.gr.2017.04.001; Morner NA, 2002, GLOBAL PLANET CHANGE, V33, P185, DOI 10.1016/S0921-8181(02)00070-X; West AJ, 2012, GEOLOGY, V40, P811, DOI 10.1130/G33041.1	13	3	3	6	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2019	364	6436					126	127		10.1126/science.aax1657	http://dx.doi.org/10.1126/science.aax1657			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HT5RC	30975875				2022-12-28	WOS:000464620000021
J	Rada, AG				Garcia Rada, Aser			Assisted dying: case of man who helped his wife to die reignites Spain's euthanasia debate	BMJ-BRITISH MEDICAL JOURNAL			English	News Item														Garcia Rada, Aser/0000-0003-1026-2453				Casino G., 2004, BMJ-BRIT MED J, V329, P864, DOI [10.1136/bmj.329.7470.864-a, DOI 10.1136/BMJ.329.7470.864-A]; De Benito E, 2019, PAIS; Rada AG, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5868; Rada AG, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3155	4	2	2	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 11	2019	365								l1764	10.1136/bmj.l1764	http://dx.doi.org/10.1136/bmj.l1764			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU0ER	30975905				2022-12-28	WOS:000464944700012
J	Rimmer, A				Rimmer, Abi			Sixty seconds on ... housework	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Fahlen S, 2016, DEMOGR RES, V35, P1411, DOI 10.4054/DemRes.2016.35.48; Freischlag JA, 2019, JAMA SURG, DOI [10.1001/jamasurg.2019.0535.30969329, DOI 10.1001/JAMASURG.2019.0535.30969329]; Lyu HG, 2019, JAMA SURG, DOI [10.1001/jamasurg.2019.0529.30969336, DOI 10.1001/JAMASURG.2019.0529.30969336]	3	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 11	2019	365								l1775	10.1136/bmj.l1775	http://dx.doi.org/10.1136/bmj.l1775			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU0ER	30975696				2022-12-28	WOS:000464944700015
J	Fink, HA; MacDonald, R; Forte, ML; Rosebush, CE; Ensrud, KE; Schousboe, JT; Nelson, VA; Ullman, K; Butler, M; Olson, CM; Taylor, BC; Brasure, M; Wilt, TJ				Fink, Howard A.; MacDonald, Roderick; Forte, Mary L.; Rosebush, Christina E.; Ensrud, Kristine E.; Schousboe, John T.; Nelson, Victoria A.; Ullman, Kristen; Butler, Mary; Olson, Carin M.; Taylor, Brent C.; Brasure, Michelle; Wilt, Timothy J.			Long-Term Drug Therapy and Drug Discontinuations and Holidays for Osteoporosis Fracture Prevention A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							ESTROGEN PLUS PROGESTIN; CONTINUING OUTCOMES RELEVANT; MILD COGNITIVE IMPAIRMENT; ZOLEDRONIC ACID TREATMENT; BONE-MINERAL DENSITY; POSTMENOPAUSAL WOMEN; VERTEBRAL FRACTURES; MULTIPLE OUTCOMES; BISPHOSPHONATE USE; BREAST-CANCER	Background: Optimal long-term osteoporosis drug treatment (ODT) is uncertain. Purpose: To summarize the effects of long-term ODT and ODT discontinuation and holidays. Data Sources: Electronic bibliographic databases (January 1995 to October 2018) and systematic review bibliographies. Study Selection: 48 studies that enrolled men or postmenopausal women aged 50 years or older who were being investigated or treated for fracture prevention, compared long-term ODT (> 3 years) versus control or ODT continuation versus discontinuation, reported incident fractures (for trials) or harms (for trials and observational studies), and had low or medium risk of bias (ROB). Data Extraction: Two reviewers independently rated ROB and strength of evidence (SOE). One extracted data; another verified accuracy. Data Synthesis: Thirty-five trials (9 unique studies) and 13 observational studies (11 unique studies) had low or medium ROB. In women with osteoporosis, 4 years of alendronate reduced clinical fractures (hazard ratio [HR], 0.64 [95% CI, 0.50 to 0.82]) and radiographic vertebral fractures (both moderate SOE), whereas 4 years of raloxifene reduced vertebral but not nonvertebral fractures. In women with osteopenia or osteoporosis, 6 years of zoledronic acid reduced clinical fractures (HR, 0.73 [CI, 0.60 to 0.90]), including nonvertebral fractures (high SOE) and clinical vertebral fractures (moderate SOE). Long-term bisphosphonates increased risk for 2 rare harms: atypical femoral fractures (low SOE) and osteonecrosis of the jaw (mostly low SOE). In women with unspecified osteoporosis status, 5 to 7 years of hormone therapy reduced clinical fractures (high SOE), including hip fractures (moderate SOE), but increased serious harms. After 3 to 5 years of treatment, bisphosphonate continuation versus discontinuation reduced radiographic vertebral fractures (zoledronic acid; low SOE) and clinical vertebral fractures (alendronate; moderate SOE) but not nonvertebral fractures (low SOE). Limitation: No trials studied men, clinical fracture data were sparse, methods for estimating harms were heterogeneous, and no trials compared sequential treatments or different durations of drug holidays. Conclusion: Long-term alendronate and zoledronic acid therapies reduce fracture risk in women with osteoporosis. Long-term bisphosphonate treatment may increase risk for rare adverse events, and continuing treatment beyond 3 to 5 years may reduce risk for vertebral fractures. Long-term hormone therapy reduces hip fracture risks but has serious harms. Primary Funding Source: National Institutes of Health and Agency for Healthcare Research and Quality. (PROSPERO: CRD42018087006)	[Fink, Howard A.; MacDonald, Roderick; Forte, Mary L.; Rosebush, Christina E.; Ensrud, Kristine E.; Schousboe, John T.; Nelson, Victoria A.; Ullman, Kristen; Butler, Mary; Olson, Carin M.; Taylor, Brent C.; Brasure, Michelle; Wilt, Timothy J.] Univ Minnesota, 1260 Mayo Bldg,MMC 807,420 Delaware St SE, Minneapolis, MN 55455 USA; [Fink, Howard A.; MacDonald, Roderick; Ensrud, Kristine E.; Ullman, Kristen; Taylor, Brent C.; Wilt, Timothy J.] Minneapolis VA Hlth Care Syst, Minneapolis, MN USA; [Schousboe, John T.] HealthPartners, Bloomington, MN USA; [Fink, Howard A.] Minneapolis VA Hlth Care Syst, Geriatr Res Educ & Clin Ctr, 11-G,One Vet Dr, Minneapolis, MN 55417 USA; [MacDonald, Roderick; Ensrud, Kristine E.; Wilt, Timothy J.] Minneapolis VA Hlth Care Syst, Ctr Care Delivery & Outcomes Res, 1110,One Vet Dr, Minneapolis, MN 55417 USA; [Forte, Mary L.] Univ Minnesota, Div Hlth Policy & Management, Sch Publ Hlth, MMC 729 8729A,D330-4 Mayo Mem Bldg, Minneapolis, MN 55455 USA; [Schousboe, John T.] HealthPartners Inst, 3311 Old Shakopee Rd, Bloomington, MN 55425 USA; [Nelson, Victoria A.; Brasure, Michelle] Univ Minnesota, Div Hlth Policy & Management, Sch Publ Hlth, MMC 197,D330-6 Mayo Mem Bldg,420 Delaware St SE, Minneapolis, MN 55455 USA; [Ullman, Kristen; Olson, Carin M.; Taylor, Brent C.] Minneapolis VA Hlth Care Syst, Ctr Care Delivery & Outcomes Res, 152,One Vet Dr, Minneapolis, MN 55417 USA; [Butler, Mary] Univ Minnesota, Div Hlth Policy & Management, Sch Publ Hlth, MMC 729,D381 Mayo Mem Bldg,420 Delaware St SE, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; HealthPartners Institute for Education & Research; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; HealthPartners Institute for Education & Research; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities	Fink, HA (corresponding author), Minneapolis VA Hlth Care Ctr, Geriatr Res Educ & Clin Ctr, 11-G,One Vet Dr, Minneapolis, MN 55417 USA.	Howard.fink@va.gov	Forte, Mary L./S-3435-2019; Taylor, Brent C/A-8069-2009	Forte, Mary L./0000-0003-4566-2529; Taylor, Brent C/0000-0002-2140-8377; Ensrud, Kristine/0000-0002-9069-3036	Minnesota Evidence-based Practice Center [290-2015-00008-I]	Minnesota Evidence-based Practice Center	This manuscript is based on research conducted by the Minnesota Evidence-based Practice Center under contract 290-2015-00008-I to the AHRQ, through an interagency agreement with the NIH Office of Disease Prevention.	Abrahamsen B, 2009, J BONE MINER RES, V24, P1095, DOI [10.1359/JBMR.081247, 10.1359/jbmr.081247]; Adams AL, 2018, AM SOC BON MIN RES A; Adams AL, 2018, J BONE MINER RES, V33, P1252, DOI 10.1002/jbmr.3420; Adler RA, 2016, J BONE MINER RES, V31, P16, DOI 10.1002/jbmr.2708; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Barrett-Connor E, 2002, JAMA-J AM MED ASSOC, V287, P847, DOI 10.1001/jama.287.7.847; Barrett-Connor E, 2004, J BONE MINER RES, V19, P1270, DOI 10.1359/JBMR.040406; Barrett-Connor E, 2009, AM J MED, V122, P754, DOI 10.1016/j.amjmed.2009.01.033; Bauer D, 2018, AM SOC BON MIN RES A; Bauer DC, 2006, J BONE MINER RES, V21, P292, DOI 10.1359/JBMR.051018; Bauer DC, 2018, J BONE MINER RES, V33, P634, DOI 10.1002/jbmr.3355; Black D, 2018, AM SOC BON MIN RES A; Black DM, 2019, ENDOCR REV, V40, P333, DOI 10.1210/er.2018-00001; Black DM, 2015, J BONE MINER RES, V30, P934, DOI 10.1002/jbmr.2442; Black DM, 2012, J BONE MINER RES, V27, P243, DOI 10.1002/jbmr.1494; Black DM, 2010, NEW ENGL J MED, V362, P1761, DOI 10.1056/NEJMoa1001086; Black DM, 2006, JAMA-J AM MED ASSOC, V296, P2927, DOI 10.1001/jama.296.24.2927; Bone HG, 2004, NEW ENGL J MED, V350, P1189, DOI 10.1056/NEJMoa030897; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Cauley JA, 2003, JAMA-J AM MED ASSOC, V290, P1729, DOI 10.1001/jama.290.13.1729; Cauley JA, 2001, BREAST CANCER RES TR, V65, P125, DOI 10.1023/A:1006478317173; Chiu WY, 2014, J CLIN ENDOCR METAB, V99, P2729, DOI 10.1210/jc.2013-4119; Compston J, 2013, MATURITAS, V75, P392, DOI 10.1016/j.maturitas.2013.05.013; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; Cummings SR, 2018, J BONE MINER RES, V33, P190, DOI 10.1002/jbmr.3337; Curtis J, 2018, AM SOC BON MIN RES A; Delmas PD, 2002, J CLIN ENDOCR METAB, V87, P3609, DOI 10.1210/jc.87.8.3609; Donaldson MG, 2012, J BONE MINER RES, V27, P1804, DOI 10.1002/jbmr.1625; Duvernoy CS, 2005, MENOPAUSE, V12, P444, DOI 10.1097/01.GME.0000151653.02620.89; Ensrud K, 2006, AM J CARDIOL, V97, P520, DOI 10.1016/j.amjcard.2005.09.083; Erviti J, 2013, BMJ OPEN, V3, DOI [10.1136/bmjopen-2012-002084, 10.1136/bmjopen-2012-002091]; Grady D, 2004, OBSTET GYNECOL, V104, P837, DOI 10.1097/01.AOG.0000137349.79204.b8; Grady D, 2010, AM J MED, V123, DOI 10.1016/j.amjmed.2009.12.018; Jackson RD, 2006, J BONE MINER RES, V21, P817, DOI 10.1359/JBMR.060312; Johnell O, 2004, J FAM PRACTICE, V53, P789; Katsoulis M, 2017, J INTERN MED, V281, P300, DOI 10.1111/joim.12586; Khan AA, 2015, J BONE MINER RES, V30, P3, DOI 10.1002/jbmr.2405; Kim SY, 2011, J BONE MINER RES, V26, P993, DOI 10.1002/jbmr.288; Koh JH, 2017, OSTEOPOROSIS INT, V28, P3251, DOI 10.1007/s00198-017-4169-y; Lim SJ, 2018, OSTEOPOROSIS INT, V29, P2427, DOI 10.1007/s00198-018-4640-4; Lin TC, 2014, OSTEOPOROSIS INT, V25, P1503, DOI 10.1007/s00198-014-2624-6; Martino S, 2005, CURR MED RES OPIN, V21, P1441, DOI 10.1185/030079905X61839; Martino S, 2004, J NATL CANCER I, V96, P1751, DOI 10.1093/jnci/djh319; McClung M, 2009, OBSTET GYNECOL, V114, P999, DOI 10.1097/AOG.0b013e3181bdce0a; Miller PD, 2008, BONE, V43, P222, DOI 10.1016/j.bone.2008.04.007; Miller PD, 2016, JAMA-J AM MED ASSOC, V316, P722, DOI 10.1001/jama.2016.11136; Park-Wyllie LY, 2011, JAMA-J AM MED ASSOC, V305, P783, DOI 10.1001/jama.2011.190; PECK WA, 1993, AM J MED, V94, P646; Qaseem A, 2017, ANN INTERN MED, V166, P818, DOI 10.7326/M15-1361; Quandt SA, 2005, MAYO CLIN PROC, V80, P343, DOI 10.4065/80.3.343; Reid IR, 2018, NEW ENGL J MED, V379, P2407, DOI 10.1056/NEJMoa1808082; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Ryder KM, 2008, J GEN INTERN MED, V23, P1177, DOI 10.1007/s11606-008-0622-0; Schilcher J, 2015, ACTA ORTHOP, V86, P100, DOI 10.3109/17453674.2015.1004149; Schousboe JT, 2016, J CLIN DENSITOM, V19, P8, DOI 10.1016/j.jocd.2015.08.004; Schwartz AV, 2010, J BONE MINER RES, V25, P976, DOI 10.1002/jbmr.11; Sellmeyer DE, 2010, JAMA-J AM MED ASSOC, V304, P1480, DOI 10.1001/jama.2010.1360; Shane E, 2014, J BONE MINER RES, V29, P1, DOI 10.1002/jbmr.1998; Shumaker SA, 2004, JAMA-J AM MED ASSOC, V291, P2947, DOI 10.1001/jama.291.24.2947; Shumaker SA, 2003, JAMA-J AM MED ASSOC, V289, P2651, DOI 10.1001/jama.289.20.2651; Siris ES, 2005, J BONE MINER RES, V20, P1514, DOI 10.1359/JBMR.050509; Sontag A, 2010, CURR MED RES OPIN, V26, P71, DOI 10.1185/03007990903427082; Tonino RP, 2000, J CLIN ENDOCR METAB, V85, P3109, DOI 10.1210/jc.85.9.3109; Vestergaard P, 2011, OSTEOPOROSIS INT, V22, P993, DOI 10.1007/s00198-010-1512-y; Vestergaard P, 2012, J ORAL MAXIL SURG, V70, P821, DOI 10.1016/j.joms.2011.02.093; Vestergaard P, 2010, CALCIFIED TISSUE INT, V86, P335, DOI 10.1007/s00223-010-9349-0; Watts Nelson B, 2010, Endocr Pract, V16, P1016; Wimalawansa SJ, 1998, AM J MED, V104, P219, DOI 10.1016/S0002-9343(98)00029-1; Wright NC, 2014, J BONE MINER RES, V29, P2520, DOI 10.1002/jbmr.2269	69	52	61	1	21	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 2	2019	171	1					37	+		10.7326/M19-0533	http://dx.doi.org/10.7326/M19-0533			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IF7KB	31009947				2022-12-28	WOS:000473261600006
J	Crowley, RA; Bornstein, SS; Carney, JK; Cooney, TG; Engel, LS; Gantzer, HE; Henry, TL; Lenchus, JD; McCandless, BM; Southworth, MB; Syed, F; Valdrighi, A; Quinton, J; Wallace, MA				Crowley, Ryan A.; Bornstein, Sue S.; Carney, Jan K.; Cooney, Thomas G.; Engel, Lee S.; Gantzer, Heather E.; Henry, Tracey L.; Lenchus, Joshua D.; McCandless, Bridget M.; Southworth, Molly B.; Syed, Fatima; Valdrighi, Alexandria; Quinton, Jacob; Wallace, Mary Anderson		Amer Coll Phys	Improving the Patient Protection and Affordable Care Act's Insurance Coverage Provisions: A Position Paper From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Review							HEALTH	The coverage reforms of the Patient Protection and Affordable Care Act have fundamentally changed the U.S. health care system. The law's health insurance regulations, which include protections for persons with preexisting conditions, have made health insurance more accessible. The premium tax credit and cost-sharing subsidies have made nongroup coverage more affordable. The essential health benefit package and coverage for preventive services without cost sharing have made insurance more comprehensive. Perhaps most important, the Medicaid expansion extended coverage to millions of low-income adults. Despite these gains, more needs to be done to bring the United States closer to achieving universal coverage. In this position paper, the American College of Physicians recommends action to enhance and expand eligibility for health insurance financial subsidies; stabilize health insurance marketplaces; provide sustained funding for outreach, education, and enrollment assistance activities; test and implement a mechanism to encourage enrollment; expand Medicaid in all states; and establish a public insurance option to increase competition.	[Crowley, Ryan A.] Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA; [Bornstein, Sue S.] Texas Med Home Initiat, Dallas, TX USA; [Bornstein, Sue S.] 3111 Beverly Dr, Dallas, TX 75205 USA	American College of Physicians	Crowley, RA (corresponding author), Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA.	rcrowley@acponline.org			ACP operating budget	ACP operating budget	Financial support for the development of this guideline comes exclusively from the ACP operating budget.	American College of Physicians, 2007, ACH HIGH PERF HLTH C; American College of Physicians, 2016, ADDR INCR BURD HLTH; American College of Physicians, 2005, DEV MED BUY IN PROGR; American College of Physicians, 2009, PUBL PLAN OPT HLTH I; American College of Physicians, 2016, MED EXP PREM ASS OTH; [Anonymous], 2017, 3Q MED MBES ENR; Artiga, 2018, EFFECTS MEDICAID EXP; Baicker K, 2013, NEW ENGL J MED, V368, P1713, DOI 10.1056/NEJMsa1212321; Berchick ER, 2018, CURRENT POPULATION R; Bharmal N, 2018, RAND HLTH Q; Bleiberg J, 2015, LOOK BACK TECHNICAL; BLUMBERG LINDA J., 2018, CHARACTERISTICS REMA, P9; Blumberg LJ, 2018, CHARACTERISTICS REMA; Brantley E, 2018, HLTH AFFAIRS BLOG, DOI [10.1377/hblog20180812.221535/full/, DOI 10.1377/HBLOG20180812.221535/FULL/]; Burton Rachel A., 2018, WHAT EXPLAINS 2018 S; Centers for Medicare & Medicaid Services, 2017, HLTH INS EXCH TRENDS; Centers for Medicare & Medicaid Services, 2018, CMS FIN REP SHOWS 11; Centers for Medicare & Medicaid Services, 2018, EARL 2018 EFF ENR SN; Claxton G, 2017, WOULD STATES ELIMINA; Cohen R.A., 2018, HLTH INSURANCE COVER; Collins Sara R., 2017, WELL DOES INSURANCE; Collins SR, 2018, POINT BLOG      0501; Congressional Budget Office, 2013, BUDG OP ADD PUBL PLA; Congressional Budget Office, 2018, FED SUBS HLTH INS CO; Congressional Budget Office, 2017, REP IND HLTH INS MAN; Corlette S, 2016, STRATEGIES STABILIZE; Corlette S., 2018, SHORT TERM LTD DURAT; Corlette S, 2018, POINT BLOG      0628; Cox C, 2017, PREMIUM CHANGES INSU; Cox C., 2016, EXPLAINING HLTH CARE; Curran E, 2018, POINT BLOG      0105; Dorn S, 2018, HLTH AFFAIRS BLOG, DOI [10.1377/hblog20180501.141197/full/, DOI 10.1377/HBLOG20180501.141197/FULL/]; Eibner C, 2018, EFFECT ELIMINATING I; Eibner C, 2017, OPTIONS EXPAND HLTH; Elligers JJ, 2018, RAND HLTH Q; Fang J, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004313; Fehr R., 2018, Individual Insurance market performance in mid-2018; Fehr R., 2018, MAPPING PREEXISTING; Fiedler M., 2018, DID ACAS INDIVIDUAL; Frean M, 2016, 22213 NBER; Frean M, 2016, NEW ENGL J MED, V375, P1605, DOI 10.1056/NEJMp1609016; Gambino L., 2017, GUARDIAN; Garfield R, 2018, IMPLICATIONS MEDICAI; Garfield R, 2014, UNINSURED STARTING L; Garfield R, 2018, ESTIMATES ELIGIBILIT; Goldstein A, 2017, WASHINGTON POST; Government Accountability Office, 2016, PAT PROT AFF CAR ACT; Gruber J., 2011, HLTH CARE REFORM IND; Hall M., 2018, STABILIZING STRENGTH; Hayes SL, 2017, COMMONWEALTH FUND; Holahan J, 2018, IMPLICATIONS MEDICAI; Hu L, 2017, WP201610 NBER; Jost T., 2017, HLTH AFFAIRS BLOG, DOI [10.1377/hblog20170712.061031/full/, DOI 10.1377/HBLOG20170712.061031/FULL/]; Jurdi R, 2019, IEEE ICC; Kaiser Family Foundation, 2017, KEY FACTS UN POP; Kaiser Family Foundation, 2017, INS PART 2018 IND MA; Kamal R, 2017, LOSS COST SHARING SU; Kamal R., 2018, KAISER FAMILY FDN BL; Kamal R, 2018, REPEAL INDIVIDUAL MA; Kirzinger A, 2016, FINAL LOOK CA PREVIO; Kliff S., 2017, VOX             1020; Kominski GF, 2017, ANNU REV PUBL HEALTH, V38, P489, DOI 10.1146/annurev-publhealth-031816-044555; Leonard K., 2018, WASHINGTON EXAM 0322; Liu J, 2017, EXTENDING MARKETPLAC; Maylone Bethany, 2017, EVIDENCE PRIVATE OPT; Miller TP, 2017, EXAMINING EFFECTIVEN; Ohio Department of Medicaid, 2018, OH MED GROUP 8 ASS F; Pollitz K., 2017, DATA NOTE CHANGES 20; Pollitz K., 2018, DATA NOTE FURTHER RE; Semanskee A., 2017, INSURER PARTICIPATIO; Sloan, 2017, PLANS MORE RESTRICTI; Sommers BD, 2017, NEW ENGL J MED, V377, P586, DOI 10.1056/NEJMsb1706645; Sommers BD, 2015, NEW ENGL J MED, V373, P2395, DOI 10.1056/NEJMp1509462; Stein J, 2017, VOX             0823; U. S. Census Bureau, 2017, P60260 US CENS BUR; U. S. Department of Health and Human Services Assistant Secretary for Planning and Evaluation, 2017, HLTH COV AM PREEX CO; U. S. Government Accountability Office, 2017, FED HLTH INS MARK AN; Van Parys J, 2018, HEALTH AFFAIR, V37, P1243, DOI 10.1377/hlthaff.2018.0054; 2017, HLTH AFF, V36, P297, DOI DOI 10.1377/HLTHAFF.2016.1165; 2018, HLTH AFF, V37, P951, DOI DOI 10.1377/HLTHAFF.2017.1638; 2017, HLTH AFF, V36, P1656, DOI DOI 10.1377/HLTHAFF.2017.0798; 2018, HLTH AFF MILLWOOD, V37, P1099, DOI DOI 10.1377/HLTHAFF.2018.033190; 2016, HLTH AFF, V35, P8, DOI DOI 10.1377/HLTHAFF.2015.1458; 2018, HLTH AFF, V37, P607, DOI DOI 10.1377/HLTHAFF.2017.1205; 2016, JAMA INTERN MED, V176, P1501, DOI DOI 10.1001/JAMAINTERNMED.2016.4419; 2016, HLTH AFF, V35, P1842, DOI DOI 10.1377/HLTHAFF.2016.0693; 2018, HLTH AFF MILLWOOD, V37, P956, DOI DOI 10.1377/HLTHAFF.2017.1507; 2018, HLTH AFF, V37, P591, DOI DOI 10.1377/HLTHAFF.2017.1390; 2017, HLTH AFF MILLWOOD, V36, P755, DOI DOI 10.1377/HLTHAFF.2016.1456; 2017, HLTH AFF MILLWOOD, V36, P1606, DOI DOI 10.1377/HLTHAFF.2016.166935; 2015, HLTH AFF MILLWOOD, V34, P1010, DOI DOI 10.1377/HLTHAFF.2015.0215; 2017, ANN EMERG MED, V70, P215, DOI DOI 10.1016/J.ANNEMERGMED.2017.03.023	92	5	5	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 7	2019	170	9					651	+		10.7326/M18-3401	http://dx.doi.org/10.7326/M18-3401			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HW9KX	30986852				2022-12-28	WOS:000467010800010
J	Juszczak, E; Altman, DG; Hopewell, S; Schulz, K				Juszczak, Edmund; Altman, Douglas G.; Hopewell, Sally; Schulz, Kenneth			Reporting of Multi-Arm Parallel-Group Randomized Trials Extension of the CONSORT 2010 Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CLINICAL-TRIALS; OPEN-LABEL; MULTIPLICITY; EFFICACY; PLACEBO; ADJUSTMENT; REDUCTION; THERAPY; DESIGN	IMPORTANCE The quality of reporting of randomized clinical trials is suboptimal. In an era in which the need for greater research transparency is paramount, inadequate reporting hinders assessment of the reliability and validity of trial findings. The Consolidated Standards of Reporting Trials (CONSORT) 2010 Statement was developed to improve the reporting of randomized clinical trials, but the primary focus was on parallel-group trials with 2 groups. Multi-arm trials that use a parallel-group design (comparing treatments by concurrently randomizing participants to one of the treatment groups, usually with equal probability) but have 3 or more groups are relatively common. The quality of reporting of multi-arm trials varies substantially, making judgments and interpretation difficult. While the majority of the elements of the CONSORT 2010 Statement apply equally to multi-arm trials, some elements need adaptation, and, in some cases, additional issues need to be clarified. OBJECTIVE To present an extension to the CONSORT 2010 Statement for reporting multi-arm trials to facilitate the reporting of such trials. DESIGN A guideline writing group, which included all authors, formed following the CONSORT group meeting in 2014. The authors met in person and by teleconference bimonthly between 2014 and 2018 to develop and revise the checklist and the accompanying text, with additional discussions by email. A draft manuscript was circulated to the wider CONSORT group of 36 individuals, plus 5 other selected individuals known for their specialist knowledge in clinical trials, for review. Extensive feedback was received from 14 individuals and, after detailed consideration of their comments, a final revised version of the extension was prepared. FINDINGS This CONSORT extension for multi-arm trials expands on 10 items of the CONSORT 2010 checklist and provides examples of good reporting and a rationale for the importance of each extension item. Key recommendations are that multi-arm trials should be identified as such and require clear objectives and hypotheses referring to all of the treatment groups. Primary treatment comparisons should be identified and authors should report the planned and unplanned comparisons resulting from multiple groups completely and transparently. If statistical adjustments for multiplicity are applied, the rationale and method used should be described. CONCLUSIONS AND RELEVANCE This extension of the CONSORT 2010 Statement provides specific guidance for the reporting of multi-arm parallel-group randomized clinical trials and should help provide greater transparency and accuracy in the reporting of such trials.	[Juszczak, Edmund] Univ Oxford, NPEU Clin Trials Unit, Natl Perinatal Epidemiol Unit, Nuffield Dept Populat Hlth, Old Rd Campus, Oxford OX3 7LF, England; [Altman, Douglas G.; Hopewell, Sally] Univ Oxford, Ctr Stat Med, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England; [Schulz, Kenneth] FHI 360, Durham, NC USA; [Schulz, Kenneth] Univ N Carolina, Sch Med, Chapel Hill, NC 27515 USA	University of Oxford; University of Oxford; FHI 360; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Juszczak, E (corresponding author), Univ Oxford, NPEU Clin Trials Unit, Natl Perinatal Epidemiol Unit, Nuffield Dept Populat Hlth, Old Rd Campus, Oxford OX3 7LF, England.	ed.juszczak@npeu.ox.ac.uk		Hopewell, Sally/0000-0002-6881-6984				Agar MR, 2017, JAMA INTERN MED, V177, P34, DOI 10.1001/jamainternmed.2016.7491; Agnelli G, 2013, NEW ENGL J MED, V368, P699, DOI 10.1056/NEJMoa1207541; Ahren B, 2014, DIABETES CARE, V37, P2141, DOI 10.2337/dc14-0024; Altman DG, 2018, J ROY SOC MED, V111, P143, DOI 10.1177/0141076818764320; Bauer Peter, 2003, J Biopharm Stat, V13, P691, DOI 10.1081/BIP-120024203; Brittenden J, 2014, NEW ENGL J MED, V371, P1218, DOI 10.1056/NEJMoa1400781; Catto JWF, 2013, EUR UROL, V64, P523, DOI 10.1016/j.eururo.2013.07.037; Cohen DR, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0697-y; Connick P, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-021944; Cook RJ, 1996, J ROY STAT SOC A STA, V159, P93, DOI 10.2307/2983471; Dickersin K, 2002, EVAL HEALTH PROF, V25, P38, DOI 10.1177/0163278702025001004; Dimario M, 2016, ADAPTIVE DESIGNS CON; DUNCAN DB, 1955, BIOMETRICS, V11, P1, DOI 10.2307/3001478; European Medicines Agency, 2001, ICH TOP E 10 CHOIC C; Foa EB, 2018, JAMA-J AM MED ASSOC, V319, P354, DOI 10.1001/jama.2017.21242; Fong DTP, 2012, CLIN BIOMECH, V27, P1072, DOI 10.1016/j.clinbiomech.2012.08.003; Freidlin B, 2008, CLIN CANCER RES, V14, P4368, DOI 10.1158/1078-0432.CCR-08-0325; Geddes JR, 2010, LANCET, V375, P385, DOI 10.1016/S0140-6736(09)61828-6; Gray R, 2014, LANCET, V384, P1196, DOI 10.1016/S0140-6736(14)60683-8; Hopewell S, 2008, PLOS MED, V5, P48, DOI 10.1371/journal.pmed.0050020; Howard DR, 2018, STAT METHODS MED RES, V27, P1513, DOI 10.1177/0962280216664759; Howard RJ, 2007, NEW ENGL J MED, V357, P1382, DOI 10.1056/NEJMoa066583; Hsu J., 1996, MULTIPLE COMP THEORY; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; MOHER D, 1994, JAMA-J AM MED ASSOC, V272, P122, DOI 10.1001/jama.272.2.122; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Moss AJ, 2012, NEW ENGL J MED, V367, P2275, DOI 10.1056/NEJMoa1211107; Ndibazza J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050325; Odutayo A, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j917; Parmar MKB, 2014, LANCET, V384, P283, DOI 10.1016/S0140-6736(14)61122-3; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Pickard R, 2012, LANCET, V380, P1927, DOI 10.1016/S0140-6736(12)61380-4; Pocock SJ., 2013, CLIN TRIALS PRACTICA; Proschan MA, 2000, CONTROL CLIN TRIALS, V21, P527, DOI 10.1016/S0197-2456(00)00106-9; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Sankoh AJ, 2003, STAT MED, V22, P3133, DOI 10.1002/sim.1557; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1016/j.ijsu.2011.09.004, 10.1186/1741-7015-8-18]; Schulz KF, 2005, LANCET, V365, P1591, DOI 10.1016/S0140-6736(05)66461-6; Senn S., 2021, THE BLIND DAT; The European Medicines Evaluation Agency, 2017, GUID MULT ISS CLIN T; Turner L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000030.pub2; Wason JMS, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-364	43	83	82	2	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2019	321	16					1610	1620		10.1001/jama.2019.3087	http://dx.doi.org/10.1001/jama.2019.3087			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HV7BZ	31012939	Green Published, Bronze			2022-12-28	WOS:000466137800018
J	Stringer, C; Pachitariu, M; Steinmetz, N; Reddy, CB; Carandini, M; Harris, KD				Stringer, Carsen; Pachitariu, Marius; Steinmetz, Nicholas; Reddy, Charu Bai; Carandini, Matteo; Harris, Kenneth D.			Spontaneous behaviors drive multidimensional, brainwide activity	SCIENCE			English	Article							LOCOMOTION; MODULATION; STATE; ORGANIZATION; INFORMATION; VARIABILITY; PROJECTIONS; MECHANISMS; RESPONSES; DYNAMICS	Neuronal populations in sensory cortex produce variable responses to sensory stimuli and exhibit intricate spontaneous activity even without external sensory input. Cortical variability and spontaneous activity have been variously proposed to represent random noise, recall of prior experience, or encoding of ongoing behavioral and cognitive variables. Recording more than 10,000 neurons in mouse visual cortex, we observed that spontaneous activity reliably encoded a high-dimensional latent state, which was partially related to the mouse's ongoing behavior and was represented not just in visual cortex but also across the forebrain. Sensory inputs did not interrupt this ongoing signal but added onto it a representation of external stimuli in orthogonal dimensions. Thus, visual cortical population activity, despite its apparently noisy structure, reliably encodes an orthogonal fusion of sensory and multidimensional behavioral information.	[Stringer, Carsen; Pachitariu, Marius] HHMI Janelia Res Campus, Ashburn, VA 20147 USA; [Stringer, Carsen] UCL, Gatsby Computat Neurosci Unit, London W1T 4JG, England; [Pachitariu, Marius; Harris, Kenneth D.] UCL Inst Neurol, London WC1E 6DE, England; [Steinmetz, Nicholas; Reddy, Charu Bai; Carandini, Matteo] UCL Inst Ophthalmol, London EC1V 9EL, England; [Steinmetz, Nicholas] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA	University of London; University College London; University of London; University College London; University of London; University College London; University of Washington; University of Washington Seattle	Stringer, C; Pachitariu, M (corresponding author), HHMI Janelia Res Campus, Ashburn, VA 20147 USA.; Stringer, C (corresponding author), UCL, Gatsby Computat Neurosci Unit, London W1T 4JG, England.; Pachitariu, M; Harris, KD (corresponding author), UCL Inst Neurol, London WC1E 6DE, England.	stringerc@janelia.hhmi.org; pachitarium@janelia.hhmi.org; kenneth.harris@ucl.ac.uk	Carandini, Matteo/ABD-8296-2021; Steinmetz, Nick/B-8555-2018	Carandini, Matteo/0000-0003-4880-7682; Steinmetz, Nick/0000-0001-7029-2908; Stringer, Carsen/0000-0002-9229-4100; Pachitariu, Marius/0000-0001-7106-814X; Bai Reddy, Charu/0000-0002-8195-3326; Harris, Kenneth/0000-0002-5930-6456	Wellcome Trust [095668, 095669, 108726, 205093, 204915]; European Research Council [694401]; Simons Foundation [SCGB 325512]; 4-year Gatsby Foundation Ph.D. studentship; HHMI Janelia; Human Frontier Sciences Program; Marie Curie Action of the EU [656528]	Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Simons Foundation; 4-year Gatsby Foundation Ph.D. studentship; HHMI Janelia; Human Frontier Sciences Program(Human Frontier Science Program); Marie Curie Action of the EU	This research was funded by the Wellcome Trust (095668, 095669, 108726, 205093, and 204915), the European Research Council (694401), and the Simons Foundation (SCGB 325512). C.S. was funded by a 4-year Gatsby Foundation Ph.D. studentship. M.C. holds the GlaxoSmithKline/Fight for Sight Chair in Visual Neuroscience. C.S. and M.P. are now funded by HHMI Janelia. N.S. was supported by postdoctoral fellowships from the Human Frontier Sciences Program and the Marie Curie Action of the EU (656528).	Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Berkes P, 2011, SCIENCE, V331, P83, DOI 10.1126/science.1195870; Brown AEX, 2013, P NATL ACAD SCI USA, V110, P791, DOI 10.1073/pnas.1211447110; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Christensen A. J., 2017, BIORXIV, DOI DOI 10.1101/214007; Cohen MR, 2011, NAT NEUROSCI, V14, P811, DOI 10.1038/nn.2842; Constantinople CM, 2011, NEURON, V69, P1061, DOI 10.1016/j.neuron.2011.02.040; Dadarlat MC, 2017, J NEUROSCI, V37, P3764, DOI 10.1523/JNEUROSCI.2728-16.2017; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Dipoppa M, 2018, NEURON, V98, P602, DOI 10.1016/j.neuron.2018.03.037; Economon MN, 2016, ELIFE, V5, DOI 10.7554/eLife.10566; Engel TA, 2016, SCIENCE, V354, P1140, DOI 10.1126/science.aag1420; Erisken S, 2014, CURR BIOL, V24, DOI 10.1016/j.cub.2014.10.045; Fernandez LMJ, 2017, CEREB CORTEX, V27, P5444, DOI 10.1093/cercor/bhw311; Friedrich J, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005423; Gamanut R, 2018, NEURON, V97, P698, DOI 10.1016/j.neuron.2017.12.037; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Goris RLT, 2014, NAT NEUROSCI, V17, P858, DOI 10.1038/nn.3711; Han F, 2008, NEURON, V60, P321, DOI 10.1016/j.neuron.2008.08.026; Han YY, 2018, NATURE, V556, P51, DOI 10.1038/nature26159; Harris J. A, 2018, BIORXIV, DOI [10.1101/292961, DOI 10.1101/292961]; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Hoffman KL, 2002, SCIENCE, V297, P2070, DOI 10.1126/science.1073538; Izenman A. J., 1975, Journal of Multivariate Analysis, V5, P248, DOI 10.1016/0047-259X(75)90042-1; Jun JJ, 2017, NATURE, V551, P232, DOI 10.1038/nature24636; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Kumikova A, 2017, CURR BIOL, V27, P688, DOI 10.1016/j.cub.2017.01.013; Lin IC, 2015, NEURON, V87, P644, DOI 10.1016/j.neuron.2015.06.035; London M, 2010, NATURE, V466, P123, DOI 10.1038/nature09086; Luczak A, 2009, NEURON, V62, P413, DOI 10.1016/j.neuron.2009.03.014; Ludwig KA, 2009, J NEUROPHYSIOL, V101, P1679, DOI 10.1152/jn.90989.2008; Machado AS, 2015, ELIFE, V4, DOI 10.7554/eLife.07892; Mathis A, 2018, NAT NEUROSCI, V21, P1281, DOI 10.1038/s41593-018-0209-y; McGinley MJ, 2015, NEURON, V87, P179, DOI 10.1016/j.neuron.2015.05.038; Montijn JS, 2016, CELL REP, V16, P2486, DOI 10.1016/j.celrep.2016.07.065; Moreno-Bote R, 2014, NAT NEUROSCI, V17, P1410, DOI 10.1038/nn.3807; Musall S, 2018, BIORXIV, DOI [10.1101/308288, DOI 10.1101/308288]; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; O'Neill J, 2010, TRENDS NEUROSCI, V33, P220, DOI 10.1016/j.tins.2010.01.006; Okun M, 2019, CEREB CORTEX, V29, P2196, DOI 10.1093/cercor/bhz023; Okun M, 2015, NATURE, V521, P511, DOI 10.1038/nature14273; Okun M, 2012, J NEUROSCI, V32, P17108, DOI 10.1523/JNEUROSCI.1831-12.2012; Pachitariu M., 2017, BIORXIV, DOI DOI 10.1101/061507; Pachitariu M., 2018, RECORDINGS 10000 NEU, DOI [10.25378/janelia.6163622.v6, DOI 10.25378/JANELIA.6163622.V6, 10.25378/janelia.6163622.v4, DOI 10.25378/JANELIA.6163622.V4]; Pachitariu M., 2016, NIPS P; Pachitariu M, 2018, J NEUROSCI, V38, P7976, DOI 10.1523/JNEUROSCI.3339-17.2018; Paken JMP, 2016, ELIFE, V5, DOI 10.7554/eLife.14985; Peron SP, 2015, NEURON, V86, P783, DOI 10.1016/j.neuron.2015.03.027; Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Polack PO, 2013, NAT NEUROSCI, V16, P1331, DOI 10.1038/nn.3464; Powell K, 2015, ELIFE, V4, DOI 10.7554/eLife.07290; Reimer J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13289; Ringach DL, 2009, CURR OPIN NEUROBIOL, V19, P439, DOI 10.1016/j.conb.2009.07.005; Robie AA, 2017, CELL, V170, P393, DOI 10.1016/j.cell.2017.06.032; Roth MM, 2016, NAT NEUROSCI, V19, P299, DOI 10.1038/nn.4197; Ruff DA, 2014, NAT NEUROSCI, V17, P1591, DOI 10.1038/nn.3835; Saleem AB, 2013, NAT NEUROSCI, V16, P1864, DOI 10.1038/nn.3567; Schneider DM, 2014, NATURE, V513, P189, DOI 10.1038/nature13724; Steinmetz N., 2019, 8 PROBE NEUROPIXELS; Steinmetz N., 2019, 8 PROBE NEUROPIXELS, DOI [10.25378/janelia.7739750.v4, DOI 10.25378/JANELIA.7739750.V4]; Steinmetz N., 2019, ZENODO, DOI [10.5281/zenodo.2575669, DOI 10.5281/ZENODO.2575669]; Steinmetz N., 2019, MOUSELAND STRINGER P; Steinmetz NA, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0207-17.2017; Stringer C, 2018, RECORDINGS 10000 NEU; Stringer C, 2018, BIORXIV, DOI [10.1101/374090, DOI 10.1101/374090]; Stringer C, 2016, ELIFE, V5, DOI 10.7554/eLife.19695; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Vinck M, 2015, NEURON, V86, P740, DOI 10.1016/j.neuron.2015.03.028; Williamson RS, 2015, CURR BIOL, V25, P1885, DOI 10.1016/j.cub.2015.05.045; Wiltschko AB, 2015, NEURON, V88, P1121, DOI 10.1016/j.neuron.2015.11.031	71	373	376	7	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2019	364	6437					255	+	eaav7893	10.1126/science.aav7893	http://dx.doi.org/10.1126/science.aav7893			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HU0JG	31000656	Green Accepted, Green Submitted			2022-12-28	WOS:000464956600042
J	Rimmer, A				Rimmer, Abi			When doctors and parents disagree: royal college issues advice on dealing with conflict	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		DYER C, 2019, BMJ-BRIT MED J, V365, DOI DOI 10.1136/BMJ.L1625; DYER C, 2018, BMJ-BRIT MED J, V361, DOI DOI 10.1136/BMJ.K1895; Forbat L, 2018, ARCH DIS CHILD; Linney M, 2019, ARCH DIS CHILD, V104, P413, DOI 10.1136/archdischild-2018-316485	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 18	2019	365								l1835	10.1136/bmj.l1835	http://dx.doi.org/10.1136/bmj.l1835			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU8PD	31000519				2022-12-28	WOS:000465550700008
J	Hawkes, N				Hawkes, Nigel			Could giving statins to over 75s really save 8000 lives a year?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						Ferket BS, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001361; Fulcher J, 2019, LANCET, V393, P407, DOI 10.1016/S0140-6736(18)31942-1; Kristensen ML, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007118	3	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2019	365								l1779	10.1136/bmj.l1779	http://dx.doi.org/10.1136/bmj.l1779			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU8OY	30996024				2022-12-28	WOS:000465550000008
J	Chatterjee, P				Chatterjee, Patralekha			Health debate rising around the upcoming Indian election	LANCET			English	Editorial Material																			0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 13	2019	393	10180					1490	1491		10.1016/S0140-6736(19)30848-7	http://dx.doi.org/10.1016/S0140-6736(19)30848-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU0DA	30983577				2022-12-28	WOS:000464940400011
J	Watts, G				Watts, Geoff			Ramani Moonesinghe: anaesthetist with a perioperative vision	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 13	2019	393	10180					1495	1495		10.1016/S0140-6736(19)30802-5	http://dx.doi.org/10.1016/S0140-6736(19)30802-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU0DA	30983580				2022-12-28	WOS:000464940400014
J	Gilani, A				Gilani, Artaza			The way I am	SCIENCE			English	Editorial Material									[Gilani, Artaza] UCL, Natl Inst Hlth Res, Sch Primary Care Res, London, England	University of London; University College London	Gilani, A (corresponding author), UCL, Natl Inst Hlth Res, Sch Primary Care Res, London, England.	SciCareerEditor@aaas.org		Gilani, Artaza/0000-0002-5385-8524					0	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2019	364	6436					202	202		10.1126/science.364.6436.202	http://dx.doi.org/10.1126/science.364.6436.202			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HT5RC	30975890				2022-12-28	WOS:000464620000047
J	Song, H; Fang, F; Arnberg, FK; Mataix-Cols, D; Fernandez de la Cruz, L; Almqvist, C; Fall, K; Lichtenstein, P; Thorgeirsson, G; Valdimarsdottir, UA				Song, Huan; Fang, Fang; Arnberg, Filip K.; Mataix-Cols, David; Fernandez de la Cruz, Lorena; Almqvist, Catarina; Fall, Katja; Lichtenstein, Paul; Thorgeirsson, Gudmundur; Valdimarsdottir, Unnur A.			Stress related disorders and risk of cardiovascular disease: population based, sibling controlled cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; MORTALITY; SYMPTOMS; VETERANS; EVENTS; ASSOCIATION; PREVALENCE; DISASTER; TRAUMA	OBJECTIVE To assess the association between stress related disorders and subsequent risk of cardiovascular disease. DESIGN Population based, sibling controlled cohort study. SETTING Population of Sweden. PARTICIPANTS 136 637 patients in the Swedish National Patient Register with stress related disorders, including post-traumatic stress disorder (PTSD), acute stress reaction, adjustment disorder, and other stress reactions, from 1987 to 2013; 171 314 unaffected full siblings of these patients; and 1 366 370 matched unexposed people from the general population. MAIN OUTCOME MEASURES Primary diagnosis of incident cardiovascular disease-any or specific subtypes (ischaemic heart disease, cerebrovascular disease, emboli/thrombosis, hypertensive diseases, heart failure, arrhythmia/conduction disorder, and fatal cardiovascular disease)-and 16 individual diagnoses of cardiovascular disease. Hazard ratios for cardiovascular disease were derived from Cox models, after controlling for multiple confounders. RESULTS During up to 27 years of follow-up, the crude incidence rate of any cardiovascular disease was 10.5, 8.4, and 6.9 per 1000 person years among exposed patients, their unaffected full siblings, and the matched unexposed individuals, respectively. In sibling based comparisons, the hazard ratio for any cardiovascular disease was 1.64 (95% confidence interval 1.45 to 1.84), with the highest subtype specific hazard ratio observed for heart failure (6.95, 1.88 to 25.68), during the first year after the diagnosis of any stress related disorder. Beyond one year, the hazard ratios became lower (overall 1.29, 1.24 to 1.34), ranging from 1.12 (1.04 to 1.21) for arrhythmia to 2.02 (1.45 to 2.82) for artery thrombosis/embolus. Stress related disorders were more strongly associated with early onset cardiovascular diseases (hazard ratio 1.40 (1.32 to 1.49) for attained age < 50) than later onset ones (1.24 (1.18 to 1.30) for attained age >= 50; P for difference=0.002). Except for fatal cardiovascular diseases, these associations were not modified by the presence of psychiatric comorbidity. Analyses within the population matched cohort yielded similar results (hazard ratio 1.71 (1.59 to 1.83) for any cardiovascular disease during the first year of follow-up and 1.36 (1.33 to 1.39) thereafter). CONCLUSION Stress related disorders are robustly associated with multiple types of cardiovascular disease, independently of familial background, history of somatic/psychiatric diseases, and psychiatric comorbidity.	[Song, Huan; Thorgeirsson, Gudmundur; Valdimarsdottir, Unnur A.] Univ Iceland, Fac Med, Ctr Publ Hlth Sci, Reykjavik, Iceland; [Song, Huan; Fang, Fang; Almqvist, Catarina; Fall, Katja; Lichtenstein, Paul; Valdimarsdottir, Unnur A.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Arnberg, Filip K.] Uppsala Univ, Dept Neurosci, Natl Ctr Disaster Psychiat, Psychiat, Uppsala, Sweden; [Arnberg, Filip K.] Stockholm Univ, Stress Res Inst, Stockholm, Sweden; [Mataix-Cols, David; Fernandez de la Cruz, Lorena] Karolinska Inst, Dept Clin Neurosci, Ctr Psychiat Res, Stockholm, Sweden; [Mataix-Cols, David; Fernandez de la Cruz, Lorena] Stockholm Cty Council, Stockholm Hlth Care Serv, Stockholm, Sweden; [Almqvist, Catarina] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Stockholm, Sweden; [Fall, Katja] Orebro Univ, Sch Med Sci, Clin Epidemiol & Biostat, Orebro, Sweden; [Valdimarsdottir, Unnur A.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	University of Iceland; Karolinska Institutet; Uppsala University; Stockholm University; Karolinska Institutet; Stockholm County Council; Karolinska Institutet; Karolinska University Hospital; Orebro University; Harvard University; Harvard T.H. Chan School of Public Health	Song, H (corresponding author), Univ Iceland, Fac Med, Ctr Publ Hlth Sci, Reykjavik, Iceland.	huan@hi.is	Arnberg, Filip/I-5756-2019; de la Cruz, Lorena Fernández/M-9923-2019; Mataix-Cols, David/AAF-3347-2021; Fall, Katja/AAE-1876-2021	Arnberg, Filip/0000-0002-1317-2093; de la Cruz, Lorena Fernández/0000-0002-1571-5485; Mataix-Cols, David/0000-0002-4545-0924; Fall, Katja/0000-0002-3649-2639; Fang, Fang/0000-0002-3310-6456	Grant of Excellence, Icelandic Research Fund [163362-051]; ERC Consolidator Grant (StressGene) [726413]; Karolinska Institutet; Swedish Research Council through the Swedish Initiative for Research on Microdata in the Social And Medical Sciences (SIMSAM) framework [340-2013-5867]	Grant of Excellence, Icelandic Research Fund; ERC Consolidator Grant (StressGene); Karolinska Institutet(Karolinska Institutet); Swedish Research Council through the Swedish Initiative for Research on Microdata in the Social And Medical Sciences (SIMSAM) framework	The study was supported by Grant of Excellence, Icelandic Research Fund (grant No 163362-051 to UAV), and ERC Consolidator Grant (StressGene, grant No 726413 to UAV); by the Karolinska Institutet (Senior Researcher Award and Strategic Research Area in Epidemiology to FF); and by the Swedish Research Council through the Swedish Initiative for Research on Microdata in the Social And Medical Sciences (SIMSAM) framework (grant No 340-2013-5867 to CA).	American Psychiatric Association, 1994, DIAGN START MAN MED; [Anonymous], 2015, CARD DIS CVDS; Auer PL, 2017, TRENDS CARDIOVAS MED, V27, P397, DOI 10.1016/j.tcm.2017.03.005; Bergelt C, 2006, BRIT J CANCER, V95, P1579, DOI 10.1038/sj.bjc.6603471; Boscarino JA, 2008, PSYCHOSOM MED, V70, P668, DOI 10.1097/PSY.0b013e31817bccaf; Burg MM, 2017, PSYCHOSOM MED, V79, P181, DOI 10.1097/PSY.0000000000000376; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; COHEN S, 1991, NEW ENGL J MED, V325, P606, DOI 10.1056/NEJM199108293250903; Cohen S, 2012, P NATL ACAD SCI USA, V109, P5995, DOI 10.1073/pnas.1118355109; Connelly KA, 2004, BRIT HEART J, V90, P52; D'Onofrio BM, 2013, AM J PUBLIC HEALTH, V103, P46, DOI 10.2105/AJPH.2013.301252; de Vries GJ, 2009, J TRAUMA STRESS, V22, P259, DOI 10.1002/jts.20429; Engdahl J, 2002, RESUSCITATION, V52, P235, DOI 10.1016/S0300-9572(01)00464-6; Fall K, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000197; Fullerton CS, 2004, AM J PSYCHIAT, V161, P1370, DOI 10.1176/appi.ajp.161.8.1370; Gradus JL, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009334; Gradus JL, 2015, AM J EPIDEMIOL, V182, P451, DOI 10.1093/aje/kwv066; Gradus JL, 2015, EUR J EPIDEMIOL, V30, P563, DOI 10.1007/s10654-015-0032-7; Gros DF, 2012, PSYCHIAT RES, V196, P267, DOI 10.1016/j.psychres.2011.10.022; Harvey AG, 1999, J CONSULT CLIN PSYCH, V67, P985, DOI 10.1037/0022-006X.67.6.985; Jordan HT, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000431; Jordan HT, 2011, PREV MED, V53, P370, DOI 10.1016/j.ypmed.2011.10.014; Kessler RC, 2017, EUR J PSYCHOTRAUMATO, V8, DOI 10.1080/20008198.2017.1353383; Khera AV, 2016, NEW ENGL J MED, V375, P2349, DOI 10.1056/NEJMoa1605086; Koenen KC, 2017, PSYCHOL MED, V47, P209, DOI [10.1017/s0033291716002294, 10.1017/S0033291716002294]; Kubzansky LD, 2007, ARCH GEN PSYCHIAT, V64, P109, DOI 10.1001/archpsyc.64.1.109; Kubzansky LD, 2009, HEALTH PSYCHOL, V28, P125, DOI 10.1037/0278-6133.28.1.125; Lambert PC, 2009, STATA J, V9, P265, DOI 10.1177/1536867X0900900206; Li J, 2003, LANCET, V361, P363, DOI 10.1016/S0140-6736(03)12387-2; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; National Collaborating Centre for Mental Health (UK), 2005, POST STRESS DIS MAN; Norhammar A, 2017, EUR J PREV CARDIOL, V24, P52, DOI 10.1177/2047487317709554; O'Donovan A, 2015, BIOL PSYCHIAT, V77, P365, DOI 10.1016/j.biopsych.2014.06.015; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; Roy SS, 2015, AM J PUBLIC HEALTH, V105, P757, DOI 10.2105/AJPH.2014.302342; Scherrer JF, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.011133; Sharkey SW, 2005, CIRCULATION, V111, P472, DOI 10.1161/01.CIR.0000153801.51470.EB; Shen Q, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4218; Song H, 2018, JAMA-J AM MED ASSOC, V319, P2388, DOI 10.1001/jama.2018.7028; Steptoe A, 2012, NAT REV CARDIOL, V9, P360, DOI 10.1038/nrcardio.2012.45; Sumner JA, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003197; Sumner JA, 2015, CIRCULATION, V132, P251, DOI 10.1161/CIRCULATIONAHA.114.014492; Vaccarino V, 2013, J AM COLL CARDIOL, V62, P970, DOI 10.1016/j.jacc.2013.04.085; Wentworth BA, 2013, CARDIOL REV, V21, P16, DOI 10.1097/CRD.0b013e318265343b; World Health Organisation, 1993, ICD 10 CLASSIFICATIO; Ziegelstein RC, 2007, JAMA-J AM MED ASSOC, V298, P324, DOI 10.1001/jama.298.3.324	46	68	68	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 10	2019	365								l1255	10.1136/bmj.l1255	http://dx.doi.org/10.1136/bmj.l1255			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU0EL	30971390	Green Published, hybrid			2022-12-28	WOS:000464944100002
J	Dyer, C				Dyer, Clare			Hadiza Bawa-Garba can return to practice under close supervision	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		DYER C, 2018, BMJ-BRIT MED J, V362, P30228, DOI DOI 10.1136/BMJ.K3510; Dyer C, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5969	2	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2019	365								l1702	10.1136/bmj.l1702	http://dx.doi.org/10.1136/bmj.l1702			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU0EH	30967383				2022-12-28	WOS:000464943700015
J	Wise, J				Wise, Jacqui			BMJ Awards 2019: Education Team of the Year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2019	365								l1651	10.1136/bmj.l1651	http://dx.doi.org/10.1136/bmj.l1651			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU0EH	30967438				2022-12-28	WOS:000464943700007
J	Mayor, S				Mayor, Susan			Sixty seconds on . . . bad diets	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		GBD 2017 Diet Collaborators, 2019, LANCET	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 8	2019	365								l1649	10.1136/bmj.l1649	http://dx.doi.org/10.1136/bmj.l1649			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU0EE	30962185				2022-12-28	WOS:000464943400011
J	Apolzan, JW; Venditti, EM; Edelstein, SL; Knowler, WC; Dabelea, D; Boyko, EJ; Pi-Sunyer, X; Kalyani, RR; Franks, PW; Srikanthan, P; Gadde, KM				Apolzan, John W.; Venditti, Elizabeth M.; Edelstein, Sharon L.; Knowler, William C.; Dabelea, Dana; Boyko, Edward J.; Pi-Sunyer, Xavier; Kalyani, Rita R.; Franks, Paul W.; Srikanthan, Preethi; Gadde, Kishore M.		Diabet Prevention Program Res Grp	Long-Term Weight Loss With Metformin or Lifestyle Intervention in the Diabetes Prevention Program Outcomes Study	ANNALS OF INTERNAL MEDICINE			English	Article							FOLLOW-UP; REDUCTION	Background: Identifying reliable predictors of long-term weight loss (LTWL) could lead to improved weight management. Objective: To identify some predictors of LTWL. Design: The DPP (Diabetes Prevention Program) was a randomized controlled trial that compared weight loss with metformin, intensive lifestyle intervention (ILS), or placebo. Its Outcomes Study (DPPOS) observed patients after the masked treatment phase ended. (ClinicalTrials.gov: NCT00004992 and NCT00038727) Setting: 27 DPP and DPPOS clinics. Participants: Of the 3234 randomly assigned participants, 1066 lost at least 5% of baseline weight in the first year and were followed for 15 years. Measurements: Treatment assignment, personal characteristics, and weight. Results: After 1 year, 289 (28.5%) participants in the metformin group, 640 (62.6%) in the ILS group, and 137 (13.4%) in the placebo group had lost at least 5% of their weight. After the masked treatment phase ended, the mean weight loss relative to baseline that was maintained between years 6 and 15 was 6.2% (95% CI, 5.2% to 7.2%) in the metformin group, 3.7% (CI, 3.1% to 4.4%) in the ILS group, and 2.8% (CI, 1.3% to 4.4%) in the placebo group. Independent predictors of LTWL included greater weight loss in the first year in all groups, older age and continued metformin use in the metformin group, older age and absence of either diabetes or a family history of diabetes in the ILS group, and higher fasting plasma glucose levels at baseline in the placebo group. Limitation: Post hoc analysis; examination of nonrandomized subsets of randomized groups after year 1. Conclusion: Among persons with weight loss of at least 5% after 1 year, those originally randomly assigned to metformin had the greatest loss during years 6 to 15. Older age and the amount of weight initially lost were the most consistent predictors of LTWL maintenance. Primary Funding Source: National Institutes of Health.	[Apolzan, John W.; Gadde, Kishore M.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70810 USA; [Venditti, Elizabeth M.] Univ Pittsburgh, Western Psychiat Inst & Clin, Med Ctr, 3811 OHara St, Pittsburgh, PA 15213 USA; [Edelstein, Sharon L.] George Washington Univ, Biostat Ctr, 6110 Execut Blvd,Suite 750, Rockville, MD 20852 USA; [Knowler, William C.] NIDDK, 1550 East Indian Sch Rd, Phoenix, AZ 85014 USA; [Dabelea, Dana] Colorado Sch Publ Hlth, Dept Epidemiol, 13001 East 17th Ave, Aurora, CO 80045 USA; [Boyko, Edward J.] VA Puget Sound Hlth Care Syst, Seattle Epidemiol Res & Informat Ctr, 1660 South Columbian Way, Seattle, WA 98108 USA; [Pi-Sunyer, Xavier] Columbia Univ Coll Phys & Surg, Dept Med, 1150 St Nicholas Ave,Suite 121, New York, NY 10032 USA; [Kalyani, Rita R.] Johns Hopkins Univ, Sch Med, 1830 East Monument St,Suite 333, Baltimore, MD 21287 USA; [Franks, Paul W.] Lund Univ, Diabet Ctr, Skane Univ Hosp, Bldg 91,Jan Waldenstroms Gata 35, SE-20502 Malmo, Sweden; [Srikanthan, Preethi] Univ Calif Los Angeles, Dept Med, 330 South Garfield Ave,Suite 308, Los Angeles, CA 91801 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC; George Washington University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Colorado School of Public Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; Columbia University; Johns Hopkins University; Lund University; Skane University Hospital; University of California System; University of California Los Angeles	Gadde, KM (corresponding author), George Washington Univ, DPPOS Coordinating Ctr, Biostat Ctr, 6110 Execut Blvd,Suite 750, Rockville, MD 20852 USA.	Kishore.gadde@pbrc.edu	Gadde, Kishore/N-1963-2017; Franks, Paul/AAA-3300-2020; Boyko, Edward J/G-2484-2017; Uwaifo, Gabriel I/M-2361-2016; Clark, Jeanne/AGG-8199-2022; Apolzan, John William/N-1949-2017	Gadde, Kishore/0000-0002-1856-5574; Boyko, Edward J/0000-0002-3695-192X; Uwaifo, Gabriel I/0000-0002-6962-9304; Clark, Jeanne/0000-0003-1194-0092; Apolzan, John William/0000-0001-8492-7820; Gregg, Edward/0000-0003-2381-6822; Ryan, Donna/0000-0001-8374-2277	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health [U01 DK048489]; DPPOS; NIDDK [U01 DK048489]; Intramural Research Program; Indian Health Service; National Institute of Child Health and Human Development; National Institute on Aging; National Eye Institute; National Heart, Lung, and Blood Institute; National Cancer Institute; Office of Research on Women's Health; National Institute on Minority Health and Health Disparities; Centers for Disease Control and Prevention; American Diabetes Association; Bristol-Myers Squibb; ParkeDavis; NIDDK; LifeScan; Health o meter; Hoechst Marion Roussel; Merck-Medco Managed Care; Merck and Company; Nike Sports Marketing; SlimFast Foods; McKesson BioServices; Matthews Media Group; Henry M. Jackson Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK048397, U01DK048514, U01DK048375, P30DK017047, U01DK048349, U01DK048443, U01DK048413, U01DK048377, U01DK048404, U01DK048406, U01DK048407, ZIADK075078, U01DK048339, U01DK048434, U01DK048437, U01DK048412, U01DK048489, U01DK048400, U01DK048381, U01DK048468, U01DK048485] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); DPPOS; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural Research Program; Indian Health Service(United States Department of Health & Human Services); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); American Diabetes Association(American Diabetes Association); Bristol-Myers Squibb(Bristol-Myers Squibb); ParkeDavis; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); LifeScan; Health o meter; Hoechst Marion Roussel; Merck-Medco Managed Care; Merck and Company(Merck & Company); Nike Sports Marketing; SlimFast Foods; McKesson BioServices; Matthews Media Group; Henry M. Jackson Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research reported in this article was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health under award number U01 DK048489. During the DPP and the DPPOS, the NIDDK provided funding to the clinical centers and the Coordinating Center for the design and conduct of the study and the collection, management, analysis, and interpretation of the data (U01 DK048489). The Southwestern American Indian Centers were supported directly by the NIDDK, including its Intramural Research Program, and the Indian Health Service. The General Clinical Research Center Program, the National Center for Research Resources, and the Department of Veterans Affairs supported data collection at many of the clinical centers. Funding was also provided by the National Institute of Child Health and Human Development; the National Institute on Aging; the National Eye Institute; the National Heart, Lung, and Blood Institute; the National Cancer Institute; the Office of Research on Women's Health; the National Institute on Minority Health and Health Disparities; the Centers for Disease Control and Prevention; and the American Diabetes Association. Bristol-Myers Squibb and ParkeDavis provided additional funding and material support during the DPP. Lipha (Merck-Sante ') provided medication, and LifeScan donated materials during the DPP and the DPPOS. This research was also supported in part by the intramural research program of the NIDDK. LifeScan, Health o meter, Hoechst Marion Roussel, Merck-Medco Managed Care, Merck and Company, Nike Sports Marketing, SlimFast Foods, and Quaker Oats donated materials, equipment, or medicines for concomitant conditions. McKesson BioServices, Matthews Media Group, and the Henry M. Jackson Foundation provided support services under subcontract with the Coordinating Center.	Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS73, DOI 10.2337/dc18-S008; [Anonymous], 2000, Diabetes Care, V23, P1619; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Bray GA, 1999, DIABETES CARE, V22, P623; Bray GA, 2012, DIABETES CARE, V35, P731, DOI 10.2337/dc11-1299; Delahanty L, 2002, DIABETES CARE, V25, P1992, DOI 10.2337/diacare.25.11.1992; Diggle PJ, 1994, ANAL LONGITUDINAL DA; DPP Res Grp, 2002, DIABETES CARE, V25, P2165; Elfhag K, 2005, OBES REV, V6, P67, DOI 10.1111/j.1467-789X.2005.00170.x; Funk LM, 2018, EAT WEIGHT DISORD-ST, V23, P587, DOI 10.1007/s40519-017-0425-6; Gavin JR, 1997, DIABETES CARE, V20, P1183; Jensen MK, 2013, CIRCULATION, V127, DOI 10.1161/01.cir.0000437739.71477.ee; Knowler WC, 2003, DIABETES CARE, V26, P977; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lalonde T. L., 2013, J DATA SCI, V11, P715; le Roux CW, 2017, LANCET, V389, P1399, DOI 10.1016/S0140-6736(17)30069-7; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; MORIGUTI JC, J GERONTOL A, V55, pB58; Nathan DM, 2015, LANCET DIABETES ENDO, V3, P866, DOI 10.1016/S2213-8587(15)00291-0; ROBERTS SB, 1994, JAMA-J AM MED ASSOC, V272, P1601, DOI 10.1001/jama.272.20.1601; STUMVOLL M, 1995, NEW ENGL J MED, V333, P550, DOI 10.1056/NEJM199508313330903; Sumithran P, 2011, NEW ENGL J MED, V365, P1597, DOI 10.1056/NEJMoa1105816; Torgerson JS, 2004, DIABETES CARE, V27, P155, DOI 10.2337/diacare.27.1.155; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Unick JL, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0904-1; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; AM J CLIN NUTR, V71, P1421; 2008, INT J OBESITY, V32, P1537, DOI DOI 10.1038/IJO.2008.134; 2012, ANN INTERN MED, V156, P218, DOI DOI 10.7326/0003-4819-156-3-201202070-00011; 2014, OBESITY, V22, P39, DOI DOI 10.1002/OBY.20506; 2007, DIABETES, V56, P1153, DOI DOI 10.2337/DB06-0918; 2006, DIABETES CARE, V29, P2102, DOI DOI 10.2337/DC06-0560; 2018, CLIN CHEM, V64, P118, DOI DOI 10.1373/CLINCHEM.2017.272815; 1987, CLIN SCI, V73, P41; 2003, J CLIN ENDOCR METAB, V88, P1133, DOI DOI 10.1210/JC.2002-021450; 2017, DIABETES CARE, V40, P1331, DOI DOI 10.2337/DC16-2099; 2017, AM J CLIN NUTR, V106, P1337, DOI DOI 10.3945/AJCN.117.157446; 2018, DIABETES OBES METAB, V20, P219, DOI DOI 10.1111/DOM.13054; 2017, DIABETOLOGIA, V60, P1577, DOI DOI 10.1007/S00125-017-4342-Z; 2001, J NUTR, V131, P1833; 2013, EXP CLIN ENDOCRINOL, V121, P27, DOI DOI 10.1055/S-0032-1327734; 2017, DIABETOLOGIA, V60, P1662, DOI DOI 10.1007/S00125-017-4352-X; 2017, OBESITY, V25, P2088, DOI DOI 10.1002/OBY.21978; 1999, P SOC EXP BIOL MED, V221, P153; 1988, BIOMETRICS, V44, P1049; 2015, J CLIN ENDOCR METAB, V100, P363, DOI DOI 10.1210/JC.2014-3421; 2017, OBESITY, V25, P1867, DOI DOI 10.1002/OBY.21914; 2004, OBES RES, V12, P1426; 2012, TRANSL BEHAV MED, V2, P381, DOI DOI 10.1007/S13142-012-0168-X; 2001, J NEUROENDOCRINOL, V13, P1066; 2007, INT J OBESITY, DOI DOI 10.1038/SJ.IJO.0803631; 1997, AM J CLIN NUTR, V66, P760; 1998, EUR J CLIN INVEST, V28, P441	53	58	59	1	26	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 21	2019	170	10					682	+		10.7326/M18-1605	http://dx.doi.org/10.7326/M18-1605			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HY7RL	31009939	Green Accepted			2022-12-28	WOS:000468333600016
J	Ludvigsson, JF; Neovius, M; Soderling, J; Gudbjornsdottir, S; Svensson, AM; Franzen, S; Stephansson, O; Pasternak, B				Ludvigsson, Jonas F.; Neovius, Martin; Soderling, Jonas; Gudbjornsdottir, Soffia; Svensson, Ann-Marie; Franzen, Stefan; Stephansson, Olof; Pasternak, Bjorn			Maternal Glycemic Control in Type 1 Diabetes and the Risk for Preterm Birth A Population-Based Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							PREGNANCY	Background: Maternal type 1 diabetes (T1D) has been linked to preterm birth and other adverse pregnancy outcomes. How these risks vary with glycated hemoglobin (or hemoglobin A(1c) [HbA(1c)]) levels is unclear. Objective: To examine preterm birth risk according to periconceptional HbA(1c) levels in women with T1D. Design: Population-based cohort study. Setting: Sweden, 2003 to 2014. Patients: 2474 singletons born to women with T1D and 1 165 216 reference infants born to women without diabetes. Measurements: Risk for preterm birth (< 37 gestational weeks). Secondary outcomes were neonatal death, large for gestational age, macrosomia, infant birth injury, hypoglycemia, respiratory distress, 5-minute Apgar score less than 7, and stillbirth. Results: Preterm birth occurred in 552 (22.3%) of 2474 infants born to mothers with T1D versus 54 287 (4.7%) in 1 165 216 infants born to mothers without diabetes. The incidence of preterm birth was 13.2% in women with a periconceptional HbA(1c) level below 6.5% (adjusted risk ratio [aRR] vs. women without T1D, 2.83 [95% CI, 2.28 to 3.52]), 20.6% in those with a level from 6.5% to less than 7.8% (aRR, 4.22 [CI, 3.74 to 4.75]), 28.3% in those with a level from 7.8% to less than 9.1% (aRR, 5.56 [CI, 4.84 to 6.38]), and 37.5% in those with a level of 9.1% or higher (aRR, 6.91 [CI, 5.85 to 8.17]). The corresponding aRRs for medically indicated preterm birth (n = 320) were 5.26 (CI, 3.83 to 7.22), 7.42 (CI, 6.21 to 8.86), 11.75 (CI, 9.72 to 14.20), and 17.51 (CI, 14.14 to 21.69), respectively. The corresponding aRRs for spontaneous preterm birth (n = 223) were 1.81 (CI, 1.31 to 2.52), 2.86 (CI, 2.38 to 3.44), 2.88 (CI, 2.23 to 3.71), and 2.80 (CI, 1.94 to 4.03), respectively. Increasing HbA(1c) levels were associated with the study's secondary outcomes: large for gestational age, hypoglycemia, respiratory distress, low Apgar score, neonatal death, and stillbirth. Limitation: Because HbA(1c) levels were registered annually at routine visits, they were not available for all pregnant women with T1D. Conclusion: The risk for preterm birth was strongly linked to periconceptional HbA(1c) levels. Women with HbA(1c) levels consistent with recommended target levels also were at increased risk. Primary Funding Source: Swedish Diabetes Foundation.	[Ludvigsson, Jonas F.] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Neovius, Martin; Soderling, Jonas; Stephansson, Olof; Pasternak, Bjorn] Karolinska Inst, Clin Epidemiol Div T2, Dept Med Solna, S-17176 Stockholm, Sweden; [Gudbjornsdottir, Soffia; Franzen, Stefan] Karolinska Inst, Stockholm, Sweden; [Ludvigsson, Jonas F.] Orebro Univ Hosp, Orebro, Sweden; [Ludvigsson, Jonas F.] Univ Nottingham, Nottingham, England; [Ludvigsson, Jonas F.] Columbia Univ Coll Phys & Surg, 630 W 168th St, New York, NY 10032 USA; [Gudbjornsdottir, Soffia; Svensson, Ann-Marie; Franzen, Stefan] Ctr Registers Vastra Gotaland, Gothenburg, Sweden; [Gudbjornsdottir, Soffia; Franzen, Stefan] Univ Gothenburg, Gothenburg, Sweden; [Pasternak, Bjorn] Statens Serum Inst, Copenhagen, Denmark; [Gudbjornsdottir, Soffia; Svensson, Ann-Marie; Franzen, Stefan] Vastra Gotalandsregionen, Swedish Natl Diabet Register, Medicinaregatan 18G, S-41345 Gothenburg, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Orebro University; University of Nottingham; Columbia University; University of Gothenburg; Statens Serum Institut	Ludvigsson, JF (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden.	jonasludvigsson@yahoo.com	Ludvigsson, Jonas F/A-8560-2012; Pasternak, Bjorn/H-5739-2012	Ludvigsson, Jonas F/0000-0003-1024-5602; Pasternak, Bjorn/0000-0002-2097-8466; Neovius, Martin/0000-0003-2300-3055; Stephansson, Olof/0000-0003-1528-4563	Swedish Diabetes Foundation; Strategic Research Area Epidemiology Program at Karolinska Institutet; Swedish Research Council [2016-01974, 2013-2429]; Stockholm County Council (ALF project) [20130156]; strategic Research Program in Epidemiology at Karolinska Institutet	Swedish Diabetes Foundation; Strategic Research Area Epidemiology Program at Karolinska Institutet; Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council (ALF project)(Stockholm County Council); strategic Research Program in Epidemiology at Karolinska Institutet	By grants from the Swedish Diabetes Foundation. Dr. Pasternak was supported by an investigator grant from the Strategic Research Area Epidemiology Program at Karolinska Institutet and the Swedish Research Council (2016-01974). Dr. Stephansson was supported by grants from the Swedish Research Council (2013-2429) and the Stockholm County Council (ALF project 20130156) and received financial support from the strategic Research Program in Epidemiology at Karolinska Institutet.	American Diabetes Association, 2017, Diabetes Care, V40, pS114; Centre for Epidemiology Swedish National Board of Health and Welfare, SWED MED BIRTH REG S; Correa A, 2015, MATERN CHILD HLTH J, V19, P635, DOI 10.1007/s10995-014-1553-5; Eliasson B, 2014, DIABETES RES CLIN PR, V106, pS291, DOI 10.1016/S0168-8227(14)70732-6; Evers IN, 2004, BMJ-BRIT MED J, V328, P915, DOI 10.1136/bmj.38043.583160.EE; FARRAG OAM, 1987, AUST NZ J OBSTET GYN, V27, P6, DOI 10.1111/j.1479-828X.1987.tb00921.x; Inkster Melanie E, 2006, BMC Pregnancy Childbirth, V6, P30, DOI 10.1186/1471-2393-6-30; Liu Yang, 2015, Int J Stat Med Res, V4, P287; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Middleton P, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008540.pub4; Murphy HR, 2011, DIABETIC MED, V28, P1060, DOI 10.1111/j.1464-5491.2011.03333.x; National Institute for Health Care and Excellence, DIAB PREGN MAN PREC; Owens LA, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0499-y; Starikov R, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0580-y; Thomson AJ, 1997, BRIT J OBSTET GYNAEC, V104, P1054, DOI 10.1111/j.1471-0528.1997.tb12066.x; VRAY M, 1991, DIABETES CARE, V14, P994; 2013, J CLIN ENDOCR METAB, V98, P4227, DOI DOI 10.1210/JC.2013-2465; 2006, DIABETES CARE, V29, P2612, DOI DOI 10.2337/DC06-0914; 2009, EUR J EPIDEMIOL, V24, P659, DOI DOI 10.1007/S10654-009-9350-Y; 2011, AM J EPIDEMIOL, V174, P984, DOI DOI 10.1093/AJE/KWR183; 2004, CLIN CHEM, V50, P166, DOI DOI 10.1373/CLINCHEM.2003.024802; 2014, J DIABETES COMPLICAT, V28, P203, DOI DOI 10.1016/J.JDIAC0MP.2013.10; 1996, ACTA PAEDIAT, V85, P843; 2014, DIABETOLOGIA, V57, P285, DOI DOI 10.1007/S00125-013-3108-5; 2015, INT J EPIDEMIOL, V44, P1660, DOI DOI 10.1093/IJE/DYV137; 2004, DIABETES CARE, V27, P2824; 1986, AM J EPIDEMIOL, V123, P174; 2008, J DIABETES COMPLICAT, V22, P297, DOI DOI 10.1016/J.JDIACOMP.2007.03.008; 1997, ACTA OBSTET GYNECOL, V76, P907; 2017, EUR J EPIDEMIOL, V32, P765, DOI DOI 10.1007/S10654-017-0316-1; 2015, DIABETES CARE, V38, P34, DOI DOI 10.2337/DC14-1755; 2015, J INTERN MED, V277, P94, DOI DOI 10.1111/J0IM.12303; 1994, OBSTET GYNECOL, V83, P918; 2012, LANCET, V379, P2162, DOI DOI 10.1016/S0140-6736(12)60820-4; 2011, DIABETOLOGIA, V54, P2771, DOI DOI 10.1007/S00125-011-2281-7; 2017, DIABETOLOGIA, V60, P1668, DOI DOI 10.1007/S00125-017-4314-3; 2012, DIABETOLOGIA, V55, P3193, DOI DOI 10.1007/S00125-012-2721-Z; 2003, AM J EPIDEMIOL, V157, P940, DOI DOI 10.1093/AJE/KWG074; 1998, HUM REPROD, V13, P245; 2015, CLIN EPIDEMIOL, V7, P491, DOI DOI 10.2147/CLEP.S90589; 2017, ANN INTERN MED, V167, P268, DOI DOI 10.7326/M16-2607; DIABETOLOGIA, V43, P79; 2009, DIABETES CARE, V32, P1046, DOI DOI 10.2337/DC08-2061; 2006, J PERINATOL, V26, P458, DOI DOI 10.1038/SJ.JP.7211546	44	15	17	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 21	2019	170	10					691	+		10.7326/M18-1974	http://dx.doi.org/10.7326/M18-1974			27	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HY7RL	31009941				2022-12-28	WOS:000468333600017
J	Akiyama, MJ; Norton, BL; Arnsten, JH; Agyemang, L; Heo, M; Litwin, AH				Akiyama, Matthew J.; Norton, Brianna L.; Arnsten, Julia H.; Agyemang, Linda; Heo, Moonseong; Litwin, Alain H.			Intensive Models of Hepatitis C Care for People Who Inject Drugs Receiving Opioid Agonist Therapy A Randomized Controlled Trial	ANNALS OF INTERNAL MEDICINE			English	Article							GENOTYPE 1; SOFOSBUVIR	Background: Many people who inject drugs (PWID) are denied treatment for hepatitis C virus (HCV) infection, even if they are receiving opioid agonist therapy (OAT). Research suggests that HCV in PWID may be treated effectively, but optimal models of care for promoting adherence and sustained virologic response (SVR) have not been evaluated in the direct-acting antiviral (DM) era. Objective: To determine whether directly observed therapy (DOT) and group treatment (GT) are more effective than self-administered individual treatment (SIT) in promoting adherence and achieving SVR among PWID receiving OAT. Design: Three-group, randomized controlled trial conducted from October 2013 to April 2017. (ClinicalTrials.gov: NCT01857245) Setting: Three OAT programs in Bronx, New York. Participants: Persons aged 18 years and older with genotype 1 HCV infection who were willing to receive HCV therapy on site in the OAT program. Of 190 persons screened, 158 were randomly assigned to a study group and 150 initiated treatment DOT (n = 51), GT (n = 48), and SIT (n = 51). Intervention: 2 intensive interventions (DOT and GT) and 1 control condition (SIT). Measurements: Primary: adherence, measured by using electronic blister packs. Secondary: HCV treatment completion and SVR 12 weeks after treatment completion. Results: Mean age was 51 years; 65% of participants had positive results on urine drug testing during the 6 months before treatment, and 75% reported ever injecting drugs. Overall adherence, estimated from mixed-effects models using the daily timeframe, was 78% (95% CI, 75% to 81%) and was greater among participants randomly assigned to DOT (86% [CI, 80% to 92%]) than those assigned to SIT (75% [CI, 70% to 81%]; difference, 11% [CI, 5% to 18%]; Bonferroni-corrected P = 0.001). No significant difference in adherence was observed between participants randomly assigned to GT (80% [CI, 74% to 86%]) and those assigned to SIT (difference, 4.7% [CI, -2% to 11%]; Bonferroni-corrected P = 0.29). The HCV treatment completion rate was 97%, with no differences among groups (P = 0.53). Overall SVR was 94% (CI, 89% to 97%); the SVR rate was 98% in the DOT group, 94% in the GT group, and 90% in the SIT group (P = 0.152). Limitation: These findings may not be generalizable to PWID not enrolled in OAT programs. Conclusion: All models of onsite HCV care delivered to PWID in OAT programs resulted in high SVR, despite ongoing drug use. Directly observed therapy was associated with greater adherence than SIT.	[Akiyama, Matthew J.; Norton, Brianna L.; Arnsten, Julia H.; Agyemang, Linda] Montefiore Med Ctr, Albert Einstein Coll Med, Bronx, NY 10467 USA; [Heo, Moonseong] Clemson Univ, Clemson, SC USA; [Litwin, Alain H.] Univ South Carolina, Sch Med Greenville, Columbia, SC 29208 USA; [Litwin, Alain H.] Prisma Hlth Upstate, Greenville, SC USA; [Litwin, Alain H.] Clemson Univ, Sch Hlth Res, Clemson, SC USA; [Litwin, Alain H.] Dept Med, 701 Grove Rd,5th Floor Support Tower, Greenville, SC 29605 USA; [Akiyama, Matthew J.; Norton, Brianna L.; Arnsten, Julia H.; Agyemang, Linda] 3300 Kossuth Ave, Bronx, NY 10467 USA; [Heo, Moonseong] 605 Grove Rd,Suite 205, Greenville, SC 29605 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Clemson University; University of South Carolina System; University of South Carolina Columbia; Greenville Health System; Clemson University	Litwin, AH (corresponding author), Dept Med, 701 Grove Rd,5th Floor Support Tower, Greenville, SC 29605 USA.	alain.litwin@prismahealth.org	Akiyama, Matthew Jiro/AAE-7230-2021	Heo, Moonseong/0000-0001-7711-1209; Akiyama, Matthew/0000-0003-4290-3083	National Institute on Drug Abuse [R01DA034086, K99DA043011];  [IN-337-1779]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA034086, K99DA043011] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	By grants R01DA034086 and K99DA043011 from the National Institute on Drug Abuse. Gilead Sciences also provided support (grant IN-337-1779) for the research and supplied study medication, SOF/LDV.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Aghemo Alessio, 2017, Gastroenterology, V152, P1238, DOI 10.1053/j.gastro.2017.02.022; Akiyama MJ, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2964-5; Alderks C.E., 2017, TRENDS USE METHADONE; American Association for the Study of Liver Disease; Infectious Dis- eases Society of America, 2017, HCV GUID REC TEST MA; Boyd J, 2017, HARM REDUCT J, V14, DOI 10.1186/s12954-017-0159-9; Centers for Disease Control, HCV SURV REP 2015; Degenhardt L, 2017, LANCET GLOB HEALTH, V5, pE1192, DOI 10.1016/S2214-109X(17)30375-3; Information Mediary Corp, MED IC SMART LAB; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Litwin AH, 2011, INT C VIR HEP 2011 B; Osinusi A, 2013, JAMA-J AM MED ASSOC, V310, P804, DOI 10.1001/jama.2013.109309; Patel M, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx062; Strathdee SA, 2005, CLIN INFECT DIS, V40, pS304, DOI 10.1086/427445; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Verna Elizabeth C, 2006, Clin Liver Dis, V10, P919; Zeuzem S, 2018, NEW ENGL J MED, V378, P354, DOI 10.1056/NEJMoa1702417; 2018, EXP THER MED, V15, P970, DOI DOI 10.3892/ETM.2017.5488; 2002, J GEN INTERN MED, V17, P377; 2017, INT J DRUG POLICY, V47, P202, DOI DOI 10.1016/J.DRUGPO.2017.05.025; 2017, J SUBST ABUSE TREAT, V75, P49, DOI DOI 10.1016/J.JSAT.2016.12.014; 2007, INT J DRUG POLICY, V18, P406, DOI DOI 10.1016/J.DRUGPO.2007.01.010; 1992, J SUBST ABUSE TREAT, V9, P199; 2005, J SUBST ABUSE TREAT, V28, P181, DOI DOI 10.1016/J.JSAT.2004.12.004; 2016, CLIN INFECT DIS, V63, P1405, DOI DOI 10.1093/CID/CIW580; 2014, JAMA INTERN MED, V174, P1974, DOI DOI 10.1001/JAMAINTERNMED.2014.5416; 2014, J ADDICT MED, V8, P249, DOI DOI 10.1097/ADM.0000000000000041; 2003, AM J MED, V114, P573, DOI DOI 10.1016/S0002-9343(03)00093-7; 2009, J VIRAL HEPATITUS, V16, P352, DOI DOI 10.1111/J.1365-2893.2009.01080.X; 2012, ANN INTERN MED, V156, P271, DOI DOI 10.7326/0003-4819-156-4-201202210-00004; 2004, ADDICTION, V99, P885, DOI DOI 10.1111/J.1360-0443.2004.00740.X; 2011, J HEPATOL, V55, P69, DOI DOI 10.1016/J.JHEP.2010.10.032; 2018, LIVER INT, V38, P1179, DOI DOI 10.1111/LIV.13650; 2018, HEPATOLOGY, V68, P827, DOI DOI 10.1002/HEP.29811; 2008, J COMMUNITY HLTH, V33, P126, DOI DOI 10.1007/S10900-007-9083-3; 2016, ANN INTERN MED, V165, P625, DOI DOI 10.7326/M16-0816; 2017, CLIN GASTROENTEROL H, V15, P421, DOI DOI 10.1016/J.CGH.2016.10.037; 2017, ANN INTERN MED, V167, P812, DOI DOI 10.7326/M17-1876; 2017, DRUG ALCOHOL DEPEN, V178, P106, DOI DOI 10.1016/J.DRUGALCDEP.2017.04.032; 2001, DRUG ALCOHOL DEPEND, V61, P211; 2010, J ADDICT MED, V4, P20, DOI DOI 10.1097/ADM.0B013E3181ADD3DE; 2003, J GEN INTERN MED, V18, P104; 2015, INT J DRUG POLICY, V26, P1014, DOI DOI 10.1016/J.DRUGPO.2015.08.008; 2012, J SUBST ABUSE TREAT, V43, P424, DOI DOI 10.1016/J.JSAT.2012.08.007; 2011, CLIN INFECT DIS, V53, P150, DOI DOI 10.1093/CID/CIR306; 2014, ADDICTION, V109, P2053, DOI DOI 10.1111/ADD.12682; 2018, LANCET GASTROENTEROL, V3, P153, DOI DOI 10.1016/S2468-1253(17)30404-1; 2008, ADDICTION, V103, P905, DOI DOI 10.1111/J.1360-0443.2008	50	74	74	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 7	2019	170	9					594	+		10.7326/M18-1715	http://dx.doi.org/10.7326/M18-1715			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HW9KX	30959528	Green Accepted			2022-12-28	WOS:000467010800004
J	Kuehn, B				Kuehn, Bridget			Trends in Blood Infection Rates	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2019	321	16					1559	1559		10.1001/jama.2019.3818	http://dx.doi.org/10.1001/jama.2019.3818			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HV7BZ	31012943				2022-12-28	WOS:000466137800005
J	Florez-Pollack, S; Mauskar, MM				Florez-Pollack, Stephanie; Mauskar, Melissa M.			Disseminated Gonococcal Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 20-year-old woman presented with erythematous pustules on her arms and legs and joint pain in both ankles. Blood cultures were positive for Neisseria gonorrhoeae.	[Florez-Pollack, Stephanie; Mauskar, Melissa M.] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Mauskar, MM (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA.	melissa.mauskar@utsouthwestern.edu		Florez-Pollack, Stephanie/0000-0002-5959-0856					0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 18	2019	380	16					1565	1565		10.1056/NEJMicm1811120	http://dx.doi.org/10.1056/NEJMicm1811120			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU3AO	30995376				2022-12-28	WOS:000465144100017
J	Gusten, R; Wiesemeyer, H; Neufeld, D; Menten, KM; Graf, UU; Jacobs, K; Klein, B; Ricken, O; Risacher, C; Stutzki, J				Guesten, Rolf; Wiesemeyer, Helmut; Neufeld, David; Menten, Karl M.; Graf, Urs U.; Jacobs, Karl; Klein, Bernd; Ricken, Oliver; Risacher, Christophe; Stutzki, Juergen			Astrophysical detection of the helium hydride ion HeH+	NATURE			English	Article							EMISSION; CH; DESTRUCTION; DISTANCE; NGC-7027; SEARCH	During the dawn of chemistry(1,2), when the temperature of the young Universe had fallen below some 4,000 kelvin, the ions of the light elements produced in Big Bang nucleosynthesis recombined in reverse order of their ionization potential. With their higher ionization potentials, the helium ions He2+ and He+ were the first to combine with free electrons, forming the first neutral atoms; the recombination of hydrogen followed. In this metal-free and low-density environment, neutral helium atoms formed the Universe's first molecular bond in the helium hydride ion HeH+ through radiative association with protons. As recombination progressed, the destruction of HeH+ created a path to the formation of molecular hydrogen. Despite its unquestioned importance in the evolution of the early Universe, the HeH+ ion has so far eluded unequivocal detection in interstellar space. In the laboratory the ion was discovered3 as long ago as 1925, but only in the late 1970s was the possibility that HeH+ might exist in local astrophysical plasmas discussed4-7. In particular, the conditions in planetary nebulae were shown to be suitable for producing potentially detectable column densities of HeH+. Here we report observations, based on advances in terahertz spectroscopy8,9 and a high-altitude observatory10, of the rotational ground-state transition of HeH+ at a wavelength of 149.1 micrometres in the planetary nebula NGC 7027. This confirmation of the existence of HeH+ in nearby interstellar space constrains our understanding of the chemical networks that control the formation of this molecular ion, in particular the rates of radiative association and dissociative recombination.	[Guesten, Rolf; Wiesemeyer, Helmut; Menten, Karl M.; Klein, Bernd; Ricken, Oliver; Risacher, Christophe] Max Planck Inst Radioastron, Bonn, Germany; [Neufeld, David] Johns Hopkins Univ, Baltimore, MD USA; [Graf, Urs U.; Jacobs, Karl; Stutzki, Juergen] Univ Cologne, Phys Inst 1, Cologne, Germany; [Klein, Bernd] Univ Appl Sci Bonn Rhein Sieg, St Augustin, Germany; [Risacher, Christophe] Inst Radioastron Millimetr, St Martin Dheres, France	Max Planck Society; Johns Hopkins University; University of Cologne; Hochschule Bonn Rhein Sieg	Gusten, R (corresponding author), Max Planck Inst Radioastron, Bonn, Germany.	rguesten@mpifr-bonn.mpg.de	risacher, christophe/AAC-3463-2021	risacher, christophe/0000-0001-7162-4185; Graf, Urs/0000-0003-4439-6716	German Aerospace Center (DLR) [50 OK 1102, 1103, 1104]; Deutsche Forschungsgemeinschaft (DFG); NASA's Astrophysical Data Analysis Program (ADAP) [120364]; NASA [NAS2-97001]; Deutsches SOFIA Institut (DSI), under DLR [50 OK 0901, 50 OK 1301]	German Aerospace Center (DLR)(Helmholtz AssociationGerman Aerospace Centre (DLR)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NASA's Astrophysical Data Analysis Program (ADAP); NASA(National Aeronautics & Space Administration (NASA)); Deutsches SOFIA Institut (DSI), under DLR	upGREAT is a development by the Max-Planck Institut (MPI) fur Radioastronomie and the Kolner Observatorium fur SubMillimeter Astronomie (KOSMA)/Universitat zu Koln, in cooperation with the Deutsches Zentrum fur Luft-und Raumfahrt (DLR; German Aerospace Center) Institut fur Optische Sensorsysteme. The development of upGREAT is financed by the participating institutes, by the German Aerospace Center (DLR) under grants 50 OK 1102, 1103 and 1104, and within the Collaborative Research Centre 956, funded by the Deutsche Forschungsgemeinschaft (DFG). The work of D.N. was supported by grant 120364 from NASA's Astrophysical Data Analysis Program (ADAP). SOFIA is jointly operated by the Universities Space Research Association (USRA), under NASA contract NAS2-97001, and the Deutsches SOFIA Institut (DSI), under DLR contracts 50 OK 0901 and 50 OK 1301 to the University of Stuttgart. We thank the SOFIA operations and engineering teams for their dedication and supportive responses to our requests, and E. Young and G. Sandell for making these observations possible. We are grateful to O. Novotny for recomputing the thermal rate coefficient for the dissociative recombination of HeH<SUP>+</SUP>, using published experimental merged-beam cross-section measurements in the literature<SUP>27</SUP>. We thank J. Loreau for providing published cross-section calculations for the radiative association reaction (reaction (1)) in tabular form, and for clarifying that these cross-sections apply specifically to collisions of H (1s) and He<SUP>+</SUP> (1s) in the singlet state.	[Anonymous], 1977, ANN NY ACAD SCI, DOI DOI 10.1111/J.2164-0947.1977.TB02944.X; BASART JP, 1987, ASTROPHYS J, V317, P412, DOI 10.1086/165286; BLACK JH, 1978, ASTROPHYS J, V222, P125, DOI 10.1086/156128; Bovino S, 2011, ASTRON ASTROPHYS, V529, DOI 10.1051/0004-6361/201116740; CECCHIPESTELLINI C, 1993, ASTROPHYS J, V413, P611, DOI 10.1086/173030; Curik R, 2017, J CHEM PHYS, V147, DOI 10.1063/1.4994921; Davidson SA, 2001, ASTROPHYS J, V546, P330, DOI 10.1086/318255; Dinerstein HL, 2001, ASTROPHYS J, V562, P515, DOI 10.1086/323469; Ferland GJ, 2013, REV MEX ASTRON ASTR, V49, P137; FLOWER DR, 1979, ASTRON ASTROPHYS, V72, P361; Galli D, 2013, ANNU REV ASTRON ASTR, V51, P163, DOI 10.1146/annurev-astro-082812-141029; Guan X, 2012, ASTRON ASTROPHYS, V542, DOI 10.1051/0004-6361/201218925; Heyminck S, 2012, ASTRON ASTROPHYS, V542, DOI 10.1051/0004-6361/201218811; Hogness TR, 1925, PHYS REV, V26, P0044, DOI 10.1103/PhysRev.26.44; Klein B, 2012, ASTRON ASTROPHYS, V542, DOI 10.1051/0004-6361/201218864; Lepp S, 2002, J PHYS B-AT MOL OPT, V35, pR57, DOI 10.1088/0953-4075/35/10/201; Liu XW, 1997, MON NOT R ASTRON SOC, V290, pL71, DOI 10.1093/mnras/290.4.L71; Loreau J, 2013, J PHYS CHEM A, V117, P9486, DOI 10.1021/jp312007q; MASSON CR, 1989, ASTROPHYS J, V336, P294, DOI 10.1086/167011; Matsushima F, 1997, PHYS REV LETT, V78, P1664, DOI 10.1103/PhysRevLett.78.1664; MILLER S, 1992, NATURE, V355, P420, DOI 10.1038/355420a0; MOORHEAD JM, 1988, ASTROPHYS J, V326, P899, DOI 10.1086/166147; Muller HSP, 2005, J MOL STRUCT, V742, P215, DOI 10.1016/j.molstruc.2005.01.027; Novotny O, 2013, ASTROPHYS J, V777, DOI 10.1088/0004-637X/777/1/54; Perry AJ, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4895505; Putz P, 2015, P 26 INT S SPAC THZ; Risacher C, 2016, ASTRON ASTROPHYS, V595, DOI 10.1051/0004-6361/201629045; Risacher C, 2016, IEEE T THZ SCI TECHN, V6, P199, DOI 10.1109/TTHZ.2015.2508005; ROBERGE W, 1982, ASTROPHYS J, V255, P489, DOI 10.1086/159849; Stancil PC, 1998, ASTROPHYS J, V509, P1, DOI 10.1086/306473; Stromholm C, 1996, PHYS REV A, V54, P3086, DOI 10.1103/PhysRevA.54.3086; Vranckx S, 2013, J PHYS B-AT MOL OPT, V46, DOI 10.1088/0953-4075/46/15/155201; Young ET, 2012, ASTROPHYS J LETT, V749, DOI 10.1088/2041-8205/749/2/L17; Zicler E, 2017, ASTRON ASTROPHYS, V607, DOI 10.1051/0004-6361/201731441; Zijlstra AA, 2008, ASTROPHYS J, V681, P1296, DOI 10.1086/588778; Zinchenko I, 2011, MON NOT R ASTRON SOC, V415, pL78, DOI 10.1111/j.1745-3933.2011.01083.x; ZYGELMAN B, 1990, ASTROPHYS J, V365, P239, DOI 10.1086/169475	37	91	91	8	55	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 18	2019	568	7752					357	+		10.1038/s41586-019-1090-x	http://dx.doi.org/10.1038/s41586-019-1090-x			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HU0GZ	30996316	Green Submitted			2022-12-28	WOS:000464950700048
J	Ahuja, A; Ahuja, NK				Ahuja, Amisha; Ahuja, Nitin Kumar			Clinical Role-Play in Autonomous Sensory Meridian Response (ASMR) Videos Performance and Placebo in the Digital Era	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Ahuja, Amisha] Thomas Jefferson Univ, Dept Internal Med, Philadelphia, PA 19107 USA; [Ahuja, Nitin Kumar] Univ Penn, Div Gastroenterol, 3400 Civ Ctr Blvd,7 S Pavilion, Philadelphia, PA 19104 USA	Jefferson University; University of Pennsylvania	Ahuja, NK (corresponding author), Univ Penn, Div Gastroenterol, 3400 Civ Ctr Blvd,7 S Pavilion, Philadelphia, PA 19104 USA.	nitin.ahuja@uphs.upenn.edu						Barratt EL, 2017, PEERJ, V5, DOI 10.7717/peerj.3846; Beck J, ATLANTIC; Cash DK, 2018, PEERJ, V6, DOI 10.7717/peerj.5229; Kaptchuk TJ, 2015, NEW ENGL J MED, V373, P8, DOI 10.1056/NEJMp1504023; Kaptchuk TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015591; Lochte BC, 2018, BIOIMPACTS, V8, P295, DOI 10.15171/bi.2018.32; Poerio GL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196645; Richard C., COMMUNICATION; Smith SD, 2017, SOC NEUROSCI-UK, V12, P361, DOI 10.1080/17470919.2016.1188851	9	4	4	1	35	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 9	2019	321	14					1336	1337		10.1001/jama.2019.2302	http://dx.doi.org/10.1001/jama.2019.2302			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HT5PG	30964507				2022-12-28	WOS:000464615200001
J	Appleby, J				Appleby, John			What does the UK spend on health and social care?	BMJ-BRITISH MEDICAL JOURNAL			English	Letter									[Appleby, John] Nuffield Trust, London, England		Appleby, J (corresponding author), Nuffield Trust, London, England.	john.appleby@nuffieldtrust.org.uk						Organisation for Economic Co-operation and Development, 2011, SYST HLTH ACC	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2019	365								l1619	10.1136/bmj.l1619	http://dx.doi.org/10.1136/bmj.l1619			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU0EH	30967387				2022-12-28	WOS:000464943700004
J	Lally, K				Lally, Kate			Having the Conversation I Encourage Others to Have	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Lally, Kate] Dana Farber Canc Inst, Dept Psychosocial Oncol & Palliat Care, 450 Brookline Ave,DA 2015, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute	Lally, K (corresponding author), Dana Farber Canc Inst, Dept Psychosocial Oncol & Palliat Care, 450 Brookline Ave,DA 2015, Boston, MA 02215 USA.	kate_lally@DFCI.harvard.edu							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 9	2019	321	14					1353	1353		10.1001/jama.2019.3166	http://dx.doi.org/10.1001/jama.2019.3166			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HT5PG	30964532				2022-12-28	WOS:000464615200011
J	Horton, R				Horton, Richard			Offline: Global health has forgotten the Arab World	LANCET			English	Editorial Material												richard.horton@lancet.com							0	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 6	2019	393	10179					1398	1398		10.1016/S0140-6736(19)30805-0	http://dx.doi.org/10.1016/S0140-6736(19)30805-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HS0OU	30967203	Bronze			2022-12-28	WOS:000463561000011
J	Christie, B				Christie, Bryan			First women to study medicine in the UK are honoured	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 5	2019	365								l1635	10.1136/bmj.l1635	http://dx.doi.org/10.1136/bmj.l1635			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HS6UC	30952651				2022-12-28	WOS:000464005800004
J	Dyer, O				Dyer, Owen			Postpartum depression: new drug will be monitored at approved sites	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Meltzer-Brody S, 2018, LANCET, V392, P1058, DOI 10.1016/S0140-6736(18)31551-4; US Food and Drug Administration, FDA APPR 1 TREATM PO; US Food and Drug Administration, 2018, JOINT M PSYCH DRUG A	3	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2019	364								l1400	10.1136/bmj.l1400	http://dx.doi.org/10.1136/bmj.l1400			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HR5VS	30957774				2022-12-28	WOS:000463215700014
J	Sun, YQ; Burgess, S; Staley, JR; Wood, AM; Bell, S; Kaptoge, SK; Guo, Q; Bolton, TR; Mason, AM; Butterworth, AS; Di Angelantonio, E; Vie, GA; Bjorngaard, JH; Kinge, JM; Chen, Y; Mai, XM				Sun, Yi-Qian; Burgess, Stephen; Staley, James R.; Wood, Angela M.; Bell, Steven; Kaptoge, Stephen K.; Guo, Qi; Bolton, Thomas R.; Mason, Amy M.; Butterworth, Adam S.; Di Angelantonio, Emanuele; Vie, Gunnhild A.; Bjorngaard, Johan H.; Kinge, Jonas Minet; Chen, Yue; Mai, Xiao-Mei			Body mass index and all cause mortality in HUNT and UK Biobank studies: linear and non-linear mendelian randomisation analyses	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BMI; OBESITY; COHORT; RISK; FAT	OBJECTIVE To investigate the shape of the causal relation between body mass index (BMI) and mortality. DESIGN Linear and non-linear mendelian randomisation analyses. SETTING Nord-Trondelag Health (HUNT) Study (Norway) and UK Biobank (United Kingdom). PARTICIPANTS Middle to early late aged participants of European descent: 56 150 from the HUNT Study and 366 385 from UK Biobank. MAIN OUTCOME MEASURES All cause and cause specific (cardiovascular, cancer, and non-cardiovascular non-cancer) mortality. RESULTS 12 015 and 10 344 participants died during a median of 18.5 and 7.0 years of follow-up in the HUNT Study and UK Biobank, respectively. Linear mendelian randomisation analyses indicated an overall positive association between genetically predicted BMI and the risk of all cause mortality. An increase of 1 unit in genetically predicted BMI led to a 5% (95% confidence interval 1% to 8%) higher risk of mortality in overweight participants (BMI 25.0-29.9) and a 9% (4% to 14%) higher risk of mortality in obese participants (BMI = 30.0) but a 34% (16% to 48%) lower risk in underweight (BMI < 18.5) and a 14% (-1% to 27%) lower risk in low normal weight participants (BMI 18.5-19.9). Non-linear mendelian randomisation indicated a J shaped relation between genetically-predicted BMI and the risk of all cause mortality, with the lowest risk at a BMI of around 22-25 for the overall sample. Subgroup analyses by smoking status, however, suggested an always-increasing relation of BMI with mortality in never smokers and a J shaped relation in ever smokers. CONCLUSIONS The previously observed J shaped relation between BMI and risk of all cause mortality appears to have a causal basis, but subgroup analyses by smoking status revealed that the BMI-mortality relation is likely comprised of at least two distinct curves, rather than one J shaped relation. An increased risk of mortality for being underweight was only evident in ever smokers.	[Sun, Yi-Qian] Norwegian Univ Sci & Technol, Dept Clin & Mol Med IKOM, NTNU, Trondheim, Norway; [Burgess, Stephen] Cambridge Inst Publ Hlth, MRC Biostat Unit, Cambridge CB2 0SR, England; [Burgess, Stephen; Staley, James R.; Wood, Angela M.; Bell, Steven; Kaptoge, Stephen K.; Guo, Qi; Bolton, Thomas R.; Mason, Amy M.; Butterworth, Adam S.; Di Angelantonio, Emanuele] Univ Cambridge, Dept Publ Hlth & Primary Care, Cardiovasc Epidemiol Unit, Cambridge, England; [Staley, James R.] Univ Bristol, Bristol Med Sch, Populat Hlth Sci, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Wood, Angela M.; Bell, Steven; Kaptoge, Stephen K.; Guo, Qi; Bolton, Thomas R.; Butterworth, Adam S.; Di Angelantonio, Emanuele] Univ Cambridge, Dept Publ Hlth & Primary Care, NIHR Blood & Transplant Res Unit Donor Hlth & Gen, Cambridge, England; [Vie, Gunnhild A.; Bjorngaard, Johan H.; Mai, Xiao-Mei] Norwegian Univ Sci & Technol, Dept Publ Hlth & Nursing, NTNU, Trondheim, Norway; [Kinge, Jonas Minet] Norwegian Inst Publ Hlth, Oslo, Norway; [Kinge, Jonas Minet] Univ Oslo, Oslo, Norway; [Chen, Yue] Univ Ottawa, Sch Epidemiol & Publ Hlth, Fac Med, Ottawa, ON, Canada	Norwegian University of Science & Technology (NTNU); MRC Biostatistics Unit; University of Cambridge; University of Cambridge; University of Bristol; University of Cambridge; Norwegian University of Science & Technology (NTNU); Norwegian Institute of Public Health (NIPH); University of Oslo; University of Ottawa	Burgess, S (corresponding author), Cambridge Inst Publ Hlth, MRC Biostat Unit, Cambridge CB2 0SR, England.; Burgess, S (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Cardiovasc Epidemiol Unit, Cambridge, England.	sb452@medschl.cam.ac.uk	DiAngelantonio, Emanuele/ABE-6852-2020; Wood, Angela/GZA-5762-2022	Wood, Angela/0000-0002-7937-304X; Burgess, Stephen/0000-0001-5365-8760; Bell, Steven/0000-0001-6774-3149; Sun, Yi-Qian/0000-0002-9634-9236; Di Angelantonio, Emanuele/0000-0001-8776-6719	Norwegian Cancer Society [5769155-2015]; Research Council of Norway "Gaveforsterkning"; Research Council of Norway [250335]; Sir Henry Dale Fellowship - Wellcome Trust [204623/Z/16/Z]; Sir Henry Dale Fellowship - Royal Society [204623/Z/16/Z]; UK Medical Research Council [MR/L003120/1]; British Heart Foundation [RG/13/13/30194]; National Institute for Health Research (Cambridge Biomedical Research Centre at the Cambridge University Hospitals NHS Foundation Trust); MRC [MC_UU_00002/7] Funding Source: UKRI	Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway "Gaveforsterkning"(Research Council of Norway); Research Council of Norway(Research Council of Norway); Sir Henry Dale Fellowship - Wellcome Trust(Wellcome Trust); Sir Henry Dale Fellowship - Royal Society; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); National Institute for Health Research (Cambridge Biomedical Research Centre at the Cambridge University Hospitals NHS Foundation Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	YQS and this work were supported by the Norwegian Cancer Society (project ID 5769155-2015) and Research Council of Norway "Gaveforsterkning". GAV and JMK were supported by the Research Council of Norway (grant No 250335). SBu is supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (grant No 204623/Z/16/Z). This work was supported by core funding from the UK Medical Research Council (MR/L003120/1), British Heart Foundation (RG/13/13/30194), and National Institute for Health Research (Cambridge Biomedical Research Centre at the Cambridge University Hospitals NHS Foundation Trust). The funders had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.	Aune D, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2156; Banack HR, 2016, AM J EPIDEMIOL, V183, P122, DOI 10.1093/aje/kwv168; Bhaskaran K, 2018, LANCET DIABETES ENDO, V6, P944, DOI [10.1016/s2213-8587(18)30288-2, 10.1016/S2213-8587(18)30288-2]; Bigaard J, 2004, OBES RES, V12, P1042, DOI 10.1038/oby.2004.131; Bowden J, 2016, GENET EPIDEMIOL, V40, P304, DOI 10.1002/gepi.21965; Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080; Burgess S, 2014, EPIDEMIOLOGY, V25, P877, DOI 10.1097/EDE.0000000000000161; Burgess S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7325; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Camhi SM, 2011, OBESITY, V19, P402, DOI 10.1038/oby.2010.248; Carreras-Torres R, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1767; Cheng FW, 2016, OBESITY, V24, P2232, DOI 10.1002/oby.21612; DAVIES NM, 2018, BMJ-BRIT MED J, V362, DOI DOI 10.1136/BMJ.K601; Di Angelantonio E, 2016, LANCET, V388, P776, DOI 10.1016/S0140-6736(16)30175-1; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Didelez V, 2007, STAT METHODS MED RES, V16, P309, DOI 10.1177/0962280206077743; Dobner J, 2018, CLIN MICROBIOL INFEC, V24, P24, DOI 10.1016/j.cmi.2017.02.013; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Galyfos G, 2017, J VASC SURG, V65, P1193, DOI 10.1016/j.jvs.2016.09.032; Gkatzionis A, 2019, INT J EPIDEMIOL, V48, P691, DOI 10.1093/ije/dyy202; Krokstad S, 2013, INT J EPIDEMIOL, V42, P968, DOI 10.1093/ije/dys095; Lee DH, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k2575; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Palmer TM, 2011, AM J EPIDEMIOL, V173, P1392, DOI 10.1093/aje/kwr026; Perera S, 2016, SUICIDE LIFE-THREAT, V46, P697, DOI 10.1111/sltb.12244; Peter RS, 2015, INT J OBESITY, V39, P530, DOI 10.1038/ijo.2014.168; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Staley JR, 2017, GENET EPIDEMIOL, V41, P341, DOI 10.1002/gepi.22041; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Swanson SA, 2018, EUR J EPIDEMIOL, V33, P723, DOI 10.1007/s10654-018-0396-6; Wade KH, 2018, OBESITY, V26, P1796, DOI 10.1002/oby.22313; Wang HD, 2017, LANCET, V390, P1084, DOI 10.1016/S0140-6736(17)31833-0; Winslow UC, 2015, INT J EPIDEMIOL, V44, P540, DOI 10.1093/ije/dyu276; Winter JE, 2014, AM J CLIN NUTR, V99, P875, DOI 10.3945/ajcn.113.068122	35	79	79	1	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2019	364								l1042	10.1136/bmj.l1042	http://dx.doi.org/10.1136/bmj.l1042			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HR5VS	30957776	Green Published, hybrid			2022-12-28	WOS:000463215700004
J	Pieterse, AH; Stiggelbout, AM; Montori, VM				Pieterse, Arwen H.; Stiggelbout, Anne M.; Montori, Victor M.			Shared Decision Making and the Importance of Time	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FACILITATORS; BARRIERS		[Pieterse, Arwen H.; Stiggelbout, Anne M.] Leiden Univ, Med Ctr, Med Decis Making, Dept Biomed Data Sci, Leiden, Netherlands; [Montori, Victor M.] Mayo Clin, Knowledge & Evaluat Res Unit, Rochester, MN USA; [Montori, Victor M.] Patient Revolut, Rochester, MN USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Mayo Clinic	Pieterse, AH (corresponding author), POB 9600, NL-2300 RC Leiden, Netherlands.	a.h.pieterse@lumc.nl	Pieterse, Arwen/C-2367-2018					Joseph-Williams N, 2014, PATIENT EDUC COUNS, V94, P291, DOI 10.1016/j.pec.2013.10.031; Legare F, 2008, PATIENT EDUC COUNS, V73, P526, DOI 10.1016/j.pec.2008.07.018; Ospina NS, 2019, J GEN INTERN MED, V34, P36, DOI 10.1007/s11606-018-4540-5; Rotenstein LS, 2017, NEW ENGL J MED, V377, P1309, DOI 10.1056/NEJMp1707537; Thorne S, 2013, PATIENT EDUC COUNS, V90, P291, DOI 10.1016/j.pec.2012.02.018	5	83	84	2	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 2	2019	322	1					25	26		10.1001/jama.2019.3785	http://dx.doi.org/10.1001/jama.2019.3785			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IH7AA	31002337				2022-12-28	WOS:000474655200011
J	Mok, TSK; Wu, YL; Kudaba, I; Kowalski, DM; Cho, BC; Turna, HZ; Castro, G; Srimuninnimit, V; Laktionov, KK; Bondarenko, I; Kubota, K; Lubiniecki, GM; Zhang, J; Kush, D; Lopes, G				Mok, Tony S. K.; Wu, Yi-Long; Kudaba, Iveta; Kowalski, Dariusz M.; Cho, Byoung Chul; Turna, Hande Z.; Castro, Gilberto, Jr.; Srimuninnimit, Vichien; Laktionov, Konstantin K.; Bondarenko, Igor; Kubota, Kaoru; Lubiniecki, Gregory M.; Zhang, Jin; Kush, Debra; Lopes, Gilberto		KEYNOTE-042 Investigators	Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial	LANCET			English	Article							NIVOLUMAB; CARBOPLATIN; PACLITAXEL; BEVACIZUMAB; CRIZOTINIB; GEFITINIB	Background First-line pembrolizumab monotherapy improves overall and progression-free survival in patients with untreated metastatic non-small-cell lung cancer with a programmed death ligand 1 (PD-L1) tumour proportion score (TPS) of 50% or greater. We investigated overall survival after treatment with pembrolizumab monotherapy in patients with a PD-L1 TPS of 1% or greater. Methods This randomised, open-label, phase 3 study was done in 213 medical centres in 32 countries. Eligible patients were adults (>= 18 years) with previously untreated locally advanced or metastatic non-small-cell lung cancer without a sensitising EGFR mutation or ALK translocation and with an Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1, life expectancy 3 months or longer, and a PD-L1 TPS of 1% or greater. Randomisation was computer generated, accessed via an interactive voice-response and integrated web-response system, and stratified by region of enrolment (east Asia vs rest of world), ECOG performance status score (0 vs 1), histology (squamous vs non-squamous), and PD-L1 TPS (>= 50% vs 1-49%). Enrolled patients were randomly assigned 1:1 in blocks of four per stratum to receive pembrolizumab 200 mg every 3 weeks for up to 35 cycles or the investigator's choice of platinum-based chemotherapy for four to six cycles. Primary endpoints were overall survival in patients with a TPS of 50% or greater, 20% or greater, and 1% or greater (one-sided significance thresholds, p=0.0122, p=0.0120, and p=0.0124, respectively) in the intention-to-treat population, assessed sequentially if the previous findings were significant. This study is registered at ClinicalTrials. gov, number NCT02220894. Findings From Dec 19, 2014, to March 6, 2017, 1274 patients (902 men, 372 women, median age 63 years [IQR 57-69]) with a PD-L1 TPS of 1% or greater were allocated to pembrolizumab (n=637) or chemotherapy (n=637) and included in the intention-to-treat population. 599 (47%) had a TPS of 50% or greater and 818 patients (64%) had a TPS of 20% or greater. As of Feb 26, 2018, median follow-up was 12.8 months. Overall survival was significantly longer in the pembrolizumab group than in the chemotherapy group in all three TPS populations (>= 50% hazard ratio 0.69, 95% CI 0.56-0.85, p=0.0003; >= 20% 0.77, 0.64-0.92, p=0.0020, and >= 1% 0.81, 0.71-0.93, p=0.0018). The median surival values by TPS population were 20.0 months (95% CI 15. 4-24.9) for pembrolizumab versus 12.2 months (10.4-14.2) for chemotherapy, 17.7 months (15.3-22.1) versus 13.0 months (11.6-15.3), and 16.7 months (13.7) versus 12.1 months (11.3-13.3), respectively. Treatment-related adverse events of grade 3 or worse occurred in 113 (18%) of 636 treated patients in the pembrolizumab group and in 252 (41%) of 615 in the chemotherapy group and led to death in 13 (2%) and 14 (2%) patients, respectively. Interpretation The benefit-to-risk profile suggests that pembrolizumab monotherapy can be extended as first-line therapy to patients with locally advanced or metastatic non-small-cell lung cancer without sensitising EGFR or ALK alterations and with low PD-L1 TPS. Copyright (C) 2019 Elsevier Ltd. All rights reserved.	[Mok, Tony S. K.] Chinese Univ Hong Kong, Dept Clin Oncol, State Key Lab South China, Shatin, Hong Kong, Peoples R China; [Wu, Yi-Long] Guangdong Gen Hosp, Dept Pulm Oncol, Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China; [Wu, Yi-Long] Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China; [Kudaba, Iveta] Riga East Clin Univ, Dept Internal Dis, Latvian Oncol Ctr, Riga, Latvia; [Kowalski, Dariusz M.] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Lung Canc & Chest Tumours, Warsaw, Poland; [Cho, Byoung Chul] Yonsei Canc Ctr, Div Med Oncol, Seoul, South Korea; [Turna, Hande Z.] Istanbul Univ, Dept Internal Med, Div Med Oncol, Cerrahpasa Med Fac, Istanbul, Turkey; [Castro, Gilberto, Jr.] Inst Canc Estado Sao Paulo, Dept Med Oncol, Sao Paulo, Brazil; [Srimuninnimit, Vichien] Siriraj Hosp, Div Med Oncol, Dept Med, Bangkok, Thailand; [Laktionov, Konstantin K.] NN Blokhin Russian Canc Res Ctr, Dept Thorac & Abdominal Oncol, Moscow, Russia; [Bondarenko, Igor] Dnipropetrovsk Med Acad, Oncol & Med Radiol Dept, Dnipro, Ukraine; [Kubota, Kaoru] Nippon Med Coll Hosp, Dept Pulm Med & Oncol, Tokyo, Japan; [Lubiniecki, Gregory M.; Kush, Debra] Merck & Co Inc, Clin Dev, Kenilworth, NJ USA; [Zhang, Jin] Merck & Co Inc, Biostat & Res Design Stat, Kenilworth, NJ USA; [Lopes, Gilberto] Univ Miami, Dept Med Oncol, Sylvester Comprehens Canc Ctr, Miami, FL USA	Chinese University of Hong Kong; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Maria Sklodowska-Curie National Research Institute of Oncology; Yonsei University; Yonsei University Health System; Istanbul University; Istanbul University - Cerrahpasa; Mahidol University; N.N. Blokhin Russian Cancer Research Center; Dnipro State Medical University; Nippon Medical School; Merck & Company; Merck & Company; University of Miami	Mok, TSK (corresponding author), Chinese Univ Hong Kong, Dept Clin Oncol, State Key Lab South China, Shatin, Hong Kong, Peoples R China.	tony@clo.cuhk.edu.hk	Turna, Hande/AAA-2972-2020; Tho, Lye Mun/X-1745-2019; Bondarenko, Igor N/GQP-1497-2022; Yumuk, Perran Fulden/A-6189-2018; Wu, Yi-Long/AAW-9832-2020; Ferreira, Carlos Gil/AAD-4104-2020; Ozyilkan, Ozgur/AAD-2817-2021; de Castro, Gilberto/C-1627-2013; Mok, Tony Shu Kam/B-2310-2019; Freitas, Helano C/F-5139-2017; Altundag, Ozden/W-9219-2019; Bondarenko, Igor/W-9412-2019; Wu, Yi-Long/AAB-9137-2022; GIROTTO, GUSTAVO COLAGIOVANNI/AAF-4533-2021; Wu, Yi-Long/C-3396-2008; Wu, Yi-Long/GRJ-9238-2022	Turna, Hande/0000-0003-0558-9371; Bondarenko, Igor N/0000-0002-7071-2471; Yumuk, Perran Fulden/0000-0001-8650-299X; Ferreira, Carlos Gil/0000-0002-7228-7018; Ozyilkan, Ozgur/0000-0001-8825-4918; de Castro, Gilberto/0000-0001-8765-3044; Mok, Tony Shu Kam/0000-0002-8251-0551; Freitas, Helano C/0000-0002-8415-073X; Altundag, Ozden/0000-0003-0197-6622; Bondarenko, Igor/0000-0002-7071-2471; GIROTTO, GUSTAVO COLAGIOVANNI/0000-0002-4098-1320; Wu, Yi-Long/0000-0002-3611-0258; Wu, Yi-Long/0000-0002-3611-0258; Jassem, Jacek/0000-0002-8875-6747; Zhou, Caicun/0000-0002-2246-5541; Kalinka, Ewa/0000-0003-4791-8372; Laktionov, Konstantin/0000-0003-4469-502X; Galindo, Hector/0000-0001-5741-2266; Ksienski, Doran/0000-0001-6300-8294; Juergens, Rosalyn/0000-0001-8627-4704; Danchaivijitr, Pongwut/0000-0002-8230-5232; Kowalski, Dariusz/0000-0002-9452-3229; Ochsenbein, Adrian/0000-0003-1773-5436; Liam, Chong-Kin/0000-0002-3639-9231; Oleksandr, Ivashchuk/0000-0003-1747-2648; CAY SENLER, FILIZ/0000-0002-7156-4650; Mas, Luis/0000-0002-2323-9271; Arrieta, Oscar/0000-0002-1164-3779; Cho, Byoung Chul/0000-0002-5562-270X; Hespanhol, Venceslau/0000-0001-6577-0063	Merck Sharp & Dohme - Merck Sharp Dohme	Merck Sharp & Dohme - Merck Sharp Dohme	Merck Sharp & Dohme.; This study was funded by Merck Sharp & Dohme. We thank the patients and their families and caregivers for participating in this trial and all the investigators and site personnel. At Merck Sharp & Dohme, we thank Roger Dansey for critical review of the manuscript, Lu Xu for assistance with statistical analyses, Jim Betzel and Sara Sadowski for study support, and Melanie A Leiby for medical writing and editorial assistance.	Bellmunt J, 2017, NEW ENGL J MED, V376, P1015, DOI 10.1056/NEJMoa1613683; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Carbone DP, 2017, NEW ENGL J MED, V376, P2415, DOI 10.1056/NEJMoa1613493; Davies J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175679; EFRON B, 1977, J AM STAT ASSOC, V72, P557, DOI 10.2307/2286217; Ferris RL, 2016, NEW ENGL J MED, V375, P1856, DOI 10.1056/NEJMoa1602252; Gandhi L, 2018, NEW ENGL J MED, V378, P2078, DOI 10.1056/NEJMoa1801005; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Goffin J, 2010, J THORAC ONCOL, V5, P260, DOI 10.1097/JTO.0b013e3181c6f035; Herbst RS, 2016, LANCET, V387, P1540, DOI 10.1016/S0140-6736(15)01281-7; HWANG IK, 1990, STAT MED, V9, P1439, DOI 10.1002/sim.4780091207; Lazzari C, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00004; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; MIETTINEN O, 1985, STAT MED, V4, P213, DOI 10.1002/sim.4780040211; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; Paz-Ares L, 2018, NEW ENGL J MED, V379, P2040, DOI 10.1056/NEJMoa1810865; Peters S, 2017, NEW ENGL J MED, V377, P829, DOI 10.1056/NEJMoa1704795; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Solomon BJ, 2014, NEW ENGL J MED, V371, P2167, DOI [10.1056/NEJMoa1408440, 10.1056/NEJMx150034]; Soria JC, 2017, LANCET, V389, P917, DOI 10.1016/S0140-6736(17)30123-X; Zinner RG, 2015, J THORAC ONCOL, V10, P134, DOI 10.1097/JTO.0000000000000366; 2019, J CLIN ONCOL, V37, P537, DOI DOI 10.1200/JCO.18.00149; 2016, APPL IMMUNOHISTO M M, V24, P392, DOI DOI 10.1097/PAI.0000000000000408	27	1481	1556	25	228	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 4	2019	393	10183					1819	1830		10.1016/S0140-6736(18)32409-7	http://dx.doi.org/10.1016/S0140-6736(18)32409-7			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HW7GR	30955977				2022-12-28	WOS:000466858700032
J	Jacome-Galarza, CE; Percin, GI; Muller, JT; Mass, E; Lazarov, T; Eitler, J; Rauner, M; Yadav, VK; Crozet, L; Bohm, M; Loyher, PL; Karsenty, G; Waskow, C; Geissmann, F				Jacome-Galarza, Christian E.; Percin, Gulce I.; Muller, James T.; Mass, Elvira; Lazarov, Tomi; Eitler, Jiri; Rauner, Martina; Yadav, Vijay K.; Crozet, Lucile; Bohm, Mathieu; Loyher, Pierre-Louis; Karsenty, Gerard; Waskow, Claudia; Geissmann, Frederic			Developmental origin, functional maintenance and genetic rescue of osteoclasts	NATURE			English	Article							BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; OSTEOPETROSIS; LINEAGE; DIFFERENTIATION; PRECURSORS; LIGAND; DEFICIENCY; ACTIVATION; INDUCTION	Osteoclasts are multinucleated giant cells that resorb bone, ensuring development and continuous remodelling of the skeleton and the bone marrow haematopoietic niche. Defective osteoclast activity leads to osteopetrosis and bone marrow failure(1-9), whereas excess activity can contribute to bone loss and osteoporosis(10). Osteopetrosis can be partially treated by bone marrow transplantation in humans and mice(11-18), consistent with a haematopoietic origin of osteoclasts(13,16,19) and studies that suggest that they develop by fusion of monocytic precursors derived from haematopoietic stem cells in the presence of CSF1 and RANK ligand(1,20). However, the developmental origin and lifespan of osteoclasts, and the mechanisms that ensure maintenance of osteoclast function throughout life in vivo remain largely unexplored. Here we report that osteoclasts that colonize fetal ossification centres originate from embryonic erythro-myeloid progenitors(21,22). These erythro-myeloid progenitor-derived osteoclasts are required for normal bone development and tooth eruption. Yet, timely transfusion of haematopoietic-stem-cell-derived monocytic cells in newborn mice is sufficient to rescue bone development in early-onset autosomal recessive osteopetrosis. We also found that the postnatal maintenance of osteoclasts, bone mass and the bone marrow cavity involve iterative fusion of circulating blood monocytic cells with long-lived osteoclast syncytia. As a consequence, parabiosis or transfusion of monocytic cells results in long-term gene transfer in osteoclasts in the absence of haematopoietic-stem-cell chimerism, and can rescue an adult-onset osteopetrotic phenotype caused by cathepsin K deficiency(23,24). In sum, our results identify the developmental origin of osteoclasts and a mechanism that controls their maintenance in bones after birth. These data suggest strategies to rescue osteoclast deficiency in osteopetrosis and to modulate osteoclast activity in vivo.	[Jacome-Galarza, Christian E.; Muller, James T.; Mass, Elvira; Lazarov, Tomi; Crozet, Lucile; Bohm, Mathieu; Loyher, Pierre-Louis; Geissmann, Frederic] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Immunol Program, 1275 York Ave, New York, NY 10021 USA; [Percin, Gulce I.; Eitler, Jiri; Waskow, Claudia] Inst Immunol, Regenerat Hematopoiesis & Anim Models Hematopoies, Dresden, Germany; [Percin, Gulce I.; Waskow, Claudia] Friedrich Schiller Univ, Regenerat Hematopoiesis, Leibniz Inst Aging, Fritz Lipmann Inst,Fac Biol Sci, Jena, Germany; [Rauner, Martina; Waskow, Claudia] Fac Med, Dept Med 3, Dresden, Germany; [Yadav, Vijay K.; Karsenty, Gerard] Columbia Univ, Med Ctr, Dept Genet & Dev, New York, NY USA; [Mass, Elvira] Univ Bonn, LIMES Inst, Dev Biol, Innate Immune Syst, Bonn, Germany	Memorial Sloan Kettering Cancer Center; Friedrich Schiller University of Jena; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Technische Universitat Dresden; Columbia University; University of Bonn	Geissmann, F (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Immunol Program, 1275 York Ave, New York, NY 10021 USA.; Waskow, C (corresponding author), Inst Immunol, Regenerat Hematopoiesis & Anim Models Hematopoies, Dresden, Germany.; Waskow, C (corresponding author), Friedrich Schiller Univ, Regenerat Hematopoiesis, Leibniz Inst Aging, Fritz Lipmann Inst,Fac Biol Sci, Jena, Germany.; Waskow, C (corresponding author), Fac Med, Dept Med 3, Dresden, Germany.	claudia.waskow@leibniz-fli.de; geissmaf@mskcc.org	Mass, Elvira/AAH-3805-2019; Waskow, Claudia/F-8146-2010	Mass, Elvira/0000-0003-2318-2356; Waskow, Claudia/0000-0003-3261-0922; LOYHER, Pierre-Louis/0000-0003-2315-9711; Yadav, Vijay Kumar/0000-0003-2345-2846; Percin, Gulce/0000-0002-3515-0434	NIH/NCI [P30CA008748]; NIH/NIAID [1R01AI130345]; NIH/NHLBI [R01HL138090]; German Research Foundation (DFG) [FOR2033-A03, TRR127-A5, WA2837/6-1, WA2837/7-1]; NATIONAL CANCER INSTITUTE [T32CA009149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI130345] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); German Research Foundation (DFG)(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a NIH/NCI P30CA008748 MSKCC core grant, NIH/NIAID 1R01AI130345 and NIH/NHLBI R01HL138090 to F.G. and by the German Research Foundation (DFG) through FOR2033-A03, TRR127-A5, WA2837/6-1 and WA2837/7-1 to C.W. The authors thank Y. Kobayashi, J. Pollard, T. Graf, R. Stanley, J. Frampton, T. Boehm and J. Penninger for providing mouse strains, and the MSKCC molecular cytology core for preparation of histological samples. The authors are indebted to R. O'Reilly and F. Boulad for helpful suggestions. F.G. is grateful to G. Ruth for support. This study is dedicated to the memory of Lucile Crozet.	Arndt K, 2018, BLOOD, V131, P1311, DOI 10.1182/blood-2017-09-806844; ASH P, 1980, NATURE, V283, P669, DOI 10.1038/283669a0; BALLET JJ, 1977, LANCET, V2, P1137; Benz C, 2008, J EXP MED, V205, P1187, DOI 10.1084/jem.20072168; COCCIA PF, 1980, NEW ENGL J MED, V302, P701, DOI 10.1056/NEJM198003273021301; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Deng L, 2010, AM J PATHOL, V176, P952, DOI 10.2353/ajpath.2010.090622; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Filgueira L, 2004, J HISTOCHEM CYTOCHEM, V52, P411, DOI 10.1177/002215540405200312; Frattini A, 2005, P NATL ACAD SCI USA, V102, P14629, DOI 10.1073/pnas.0507637102; Gelb BD, 1996, SCIENCE, V273, P1236, DOI 10.1126/science.273.5279.1236; Grinenko T, 2014, J EXP MED, V211, P209, DOI 10.1084/jem.20131115; Hameyer D, 2007, PHYSIOL GENOMICS, V31, P32, DOI 10.1152/physiolgenomics.00019.2007; Hanada R, 2009, NATURE, V462, P505, DOI 10.1038/nature08596; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Jiang X, 2005, J HISTOCHEM CYTOCHEM, V53, P593, DOI 10.1369/jhc.4A6401.2005; JOTEREAU FV, 1978, DEV BIOL, V63, P253, DOI 10.1016/0012-1606(78)90132-X; Kamran P, 2013, JOVE-J VIS EXP, DOI 10.3791/50556; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lau RYC, 2011, J OSTEOPOROS, V2011, DOI 10.4061/2011/293808; Li J, 2006, GENESIS, V44, P328, DOI 10.1002/dvg.20219; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maeda K, 2012, NAT MED, V18, P405, DOI 10.1038/nm.2653; MAROTEAUX P, 1962, PRESSE MED, V70, P999; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; McGrath KE, 2015, CELL REP, V11, P1892, DOI 10.1016/j.celrep.2015.05.036; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; NISBET NW, 1977, LANCET, V2, P1236; Orchard PJ, 2015, BLOOD, V126, P270, DOI 10.1182/blood-2015-01-625541; Percin GI, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07685-x; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Shalhoub V, 2000, BRIT J HAEMATOL, V111, P501, DOI 10.1046/j.1365-2141.2000.02379.x; SORELL M, 1981, AM J MED, V70, P1280, DOI 10.1016/0002-9343(81)90839-1; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stadtfeld M, 2005, DEVELOPMENT, V132, P203, DOI 10.1242/dev.01558; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Taniguchi N, 2007, MOL CELL BIOL, V27, P5650, DOI 10.1128/MCB.00130-07; Tondravi MM, 1997, NATURE, V386, P81, DOI 10.1038/386081a0; WALKER DG, 1973, SCIENCE, V180, P875, DOI 10.1126/science.180.4088.875; WALKER DG, 1975, SCIENCE, V190, P784, DOI 10.1126/science.1105786; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0	46	192	198	12	144	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 25	2019	568	7753					541	+		10.1038/s41586-019-1105-7	http://dx.doi.org/10.1038/s41586-019-1105-7			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HU9DR	30971820	Green Accepted			2022-12-28	WOS:000465594200049
J	Korablev, O; Vandaele, AC; Montmessin, F; Fedorova, AA; Trokhimovskiy, A; Forget, F; Lefevre, F; Daerden, F; Thomas, IR; Trompet, L; Erwin, JT; Aoki, S; Robert, S; Neary, L; Viscardy, S; Grigoriev, AV; Ignatiev, NI; Shakun, A; Patrakeev, A; Belyaev, DA; Bertaux, JL; Olsen, KS; Baggio, L; Alday, J; Ivanov, YS; Ristic, B; Mason, J; Willame, Y; Depiesse, C; Hetey, L; Berkenbosch, S; Clairquin, R; Queirolo, C; Beeckman, B; Neefs, E; Patel, MR; Bellucci, G; Lopez-Moreno, JJ; Wilson, CF; Etiope, G; Zelenyi, L; Svedhem, H; Vago, JL; Alonso-Rodrigo, G; Altieri, F; Anufreychik, K; Arnold, G; Bauduin, S; Bolsee, D; Carrozzo, G; Clancy, RT; Cloutis, E; Crismani, M; Da Pieve, F; D'Aversa, E; Duxbury, N; Encrenaz, T; Fouchet, T; Funke, B; Fussen, D; Garcia-Comas, M; Gerard, JC; Giuranna, M; Gkouvelis, L; Gonzalez-Galindo, F; Grassi, D; Guerlet, S; Hartogh, P; Holmes, J; Hubert, B; Kaminski, J; Karatekin, O; Kasaba, Y; Kass, D; Khatuntsev, I; Kleinbohl, A; Kokonkov, N; Krasnopolsky, V; Kuzmin, R; Lacombe, G; Lanciano, O; Lellouch, E; Lewis, S; Luginin, M; Liuzzi, G; Lopez-Puertas, M; Lopez-Valverde, M; Maattanen, A; Mahieux, A; Marcq, E; Martin-Torres, J; Maslov, I; Medvedev, A; Millour, E; Moshkin, B; Mumma, MJ; Nakagawa, H; Novak, RE; Oliva, F; Patsaev, D; Piccialli, A; Quantin-Nataf, C; Renotte, E; Ritter, B; Rodin, A; Schmidt, F; Schneider, N; Shematovich, V; Smith, MD; Teanby, NA; Thiemann, E; Thomas, N; Auwera, JV; Vazquez, L; Villanueva, G; Vincendon, M; Whiteway, J; Wilquet, V; Wolff, MJ; Wolkenberg, P; Yelle, R; Young, R; Zasova, L; Zorzano, MP				Korablev, Oleg; Vandaele, Ann Carine; Montmessin, Franck; Fedorova, Anna A.; Trokhimovskiy, Alexander; Forget, Francois; Lefevre, Franck; Daerden, Frank; Thomas, Ian R.; Trompet, Loic; Erwin, Justin T.; Aoki, Shohei; Robert, Severine; Neary, Lori; Viscardy, Sebastien; Grigoriev, Alexey V.; Ignatiev, Nikolay I.; Shakun, Alexey; Patrakeev, Andrey; Belyaev, Denis A.; Bertaux, Jean-Loup; Olsen, Kevin S.; Baggio, Lucio; Alday, Juan; Ivanov, Yuriy S.; Ristic, Bojan; Mason, Jon; Willame, Yannick; Depiesse, Cedric; Hetey, Laszlo; Berkenbosch, Sophie; Clairquin, Roland; Queirolo, Claudio; Beeckman, Bram; Neefs, Eddy; Patel, Manish R.; Bellucci, Giancarlo; Lopez-Moreno, Jose-Juan; Wilson, Colin F.; Etiope, Giuseppe; Zelenyi, Lev; Svedhem, Hakan; Vago, Jorge L.; Alonso-Rodrigo, Gustavo; Altieri, Francesca; Anufreychik, Konstantin; Arnold, Gabriele; Bauduin, Sophie; Bolsee, David; Carrozzo, Giacomo; Clancy, R. Todd; Cloutis, Edward; Crismani, Matteo; Da Pieve, Fabiana; D'Aversa, Emiliano; Duxbury, Natalia; Encrenaz, Therese; Fouchet, Thierry; Funke, Bernd; Fussen, Didier; Garcia-Comas, Maia; Gerard, Jean-Claude; Giuranna, Marco; Gkouvelis, Leo; Gonzalez-Galindo, Francisco; Grassi, Davide; Guerlet, Sandrine; Hartogh, Paul; Holmes, James; Hubert, Benoit; Kaminski, Jacek; Karatekin, Ozgur; Kasaba, Yasumasa; Kass, David; Khatuntsev, Igor; Kleinbohl, Armin; Kokonkov, Nikita; Krasnopolsky, Vladimir; Kuzmin, Ruslan; Lacombe, Gaetan; Lanciano, Orietta; Lellouch, Emmanuel; Lewis, Stephen; Luginin, Mikhail; Liuzzi, Giuliano; Lopez-Puertas, Manuel; Lopez-Valverde, Miguel; Maattanen, Anni; Mahieux, Arnaud; Marcq, Emmanuel; Martin-Torres, Javier; Maslov, Igor; Medvedev, Alexander; Millour, Ehouarn; Moshkin, Boris; Mumma, Michael J.; Nakagawa, Hiromu; Novak, Robert E.; Oliva, Fabrizio; Patsaev, Dmitry; Piccialli, Arianna; Quantin-Nataf, Cathy; Renotte, Etienne; Ritter, Birgit; Rodin, Alexander; Schmidt, Frederic; Schneider, Nick; Shematovich, Valery; Smith, Michael D.; Teanby, Nicholas A.; Thiemann, Ed; Thomas, Nicolas; Auwera, Jean Vander; Vazquez, Luis; Villanueva, Geronimo; Vincendon, Matthieu; Whiteway, James; Wilquet, Valerie; Wolff, Michael J.; Wolkenberg, Paulina; Yelle, Roger; Young, Roland; Zasova, Ludmila; Paz Zorzano, Maria		ACS NOMAD Team	No detection of methane on Mars from early ExoMars Trace Gas Orbiter observations	NATURE			English	Article							WATER-VAPOR; MARTIAN ATMOSPHERE; CRATER; CYCLE	The detection of methane on Mars has been interpreted as indicating that geochemical or biotic activities could persist on Mars today(1). A number of different measurements of methane show evidence of transient, locally elevated methane concentrations and seasonal variations in background methane concentrations(2-5). These measurements, however, are difficult to reconcile with our current understanding of the chemistry and physics of the Martian atmosphere(6,7), which-given methane's lifetime of several centuries-predicts an even, well mixed distribution of methane(1,6,8). Here we report highly sensitive measurements of the atmosphere of Mars in an attempt to detect methane, using the ACS and NOMAD instruments onboard the ESA-Roscosmos ExoMars Trace Gas Orbiter from April to August 2018. We did not detect any methane over a range of latitudes in both hemispheres, obtaining an upper limit for methane of about 0.05 parts per billion by volume, which is 10 to 100 times lower than previously reported positive detections(2,4). We suggest that reconciliation between the present findings and the background methane concentrations found in the Gale crater(4) would require an unknown process that can rapidly remove or sequester methane from the lower atmosphere before it spreads globally.	[Korablev, Oleg; Fedorova, Anna A.; Trokhimovskiy, Alexander; Grigoriev, Alexey V.; Ignatiev, Nikolay I.; Shakun, Alexey; Patrakeev, Andrey; Belyaev, Denis A.; Bertaux, Jean-Loup; Zelenyi, Lev; Anufreychik, Konstantin; Khatuntsev, Igor; Kokonkov, Nikita; Kuzmin, Ruslan; Luginin, Mikhail; Maslov, Igor; Moshkin, Boris; Patsaev, Dmitry; Zasova, Ludmila] Russian Acad Sci, Space Res Inst IKI, Moscow, Russia; [Vandaele, Ann Carine; Daerden, Frank; Thomas, Ian R.; Trompet, Loic; Erwin, Justin T.; Aoki, Shohei; Robert, Severine; Neary, Lori; Viscardy, Sebastien; Ristic, Bojan; Willame, Yannick; Depiesse, Cedric; Hetey, Laszlo; Berkenbosch, Sophie; Clairquin, Roland; Queirolo, Claudio; Beeckman, Bram; Neefs, Eddy; Bolsee, David; Da Pieve, Fabiana; Fussen, Didier; Mahieux, Arnaud; Piccialli, Arianna; Wilquet, Valerie] Royal Belgian Inst Space Aeron BIRA IASB, Brussels, Belgium; [Montmessin, Franck; Lefevre, Franck; Bertaux, Jean-Loup; Olsen, Kevin S.; Baggio, Lucio; Lacombe, Gaetan; Maattanen, Anni; Marcq, Emmanuel] Univ Paris Saclay, Sorbonne Univ, UVSQ,CNRS, Lab Atmospheres Milieux,Observat Spatiales LATMOS, Paris, France; [Forget, Francois; Guerlet, Sandrine; Millour, Ehouarn; Young, Roland] CNRS Jussieu, LMD, Paris, France; [Alday, Juan; Wilson, Colin F.] Univ Oxford, Dept Phys, Oxford, England; [Ivanov, Yuriy S.] Natl Acad Sci Ukraine, Main Astron Observ, Kiev, Ukraine; [Mason, Jon; Patel, Manish R.; Holmes, James; Lewis, Stephen] Open Univ, Sch Phys Sci, Milton Keynes, Bucks, England; [Bellucci, Giancarlo; Etiope, Giuseppe; Altieri, Francesca; Carrozzo, Giacomo; D'Aversa, Emiliano; Giuranna, Marco; Grassi, Davide; Oliva, Fabrizio; Wolkenberg, Paulina] INAF, Inst Astrofis & Planetol Spaziali, Rome, Italy; [Lopez-Moreno, Jose-Juan; Funke, Bernd; Garcia-Comas, Maia; Gonzalez-Galindo, Francisco; Lopez-Puertas, Manuel; Lopez-Valverde, Miguel] CSIC, Inst Astrofis Andalucia, Granada, Spain; [Etiope, Giuseppe] Ist Nazl Geofis & Vulcanol, Rome, Italy; [Etiope, Giuseppe] Babes Bolyai Univ, Fac Environm Sci & Engn, Cluj Napoca, Romania; [Svedhem, Hakan; Vago, Jorge L.] ESA, European Space Res & Technol Ctr ESTEC, Noordwijk, Netherlands; [Alonso-Rodrigo, Gustavo] Univ Politecn Madrid IDR UPM, Inst Univ Microgravedad, Madrid, Spain; [Arnold, Gabriele] Deutsch Zentrum Luft & Raumfahrt DLR, Inst Planetary Res, Berlin, Germany; [Bauduin, Sophie; Auwera, Jean Vander] Univ Libre Bruxelles, Brussels, Belgium; [Clancy, R. Todd; Wolff, Michael J.] Space Sci Inst, Boulder, CO USA; [Cloutis, Edward] Univ Winnipeg, Dept Geog, Winnipeg, MB, Canada; [Crismani, Matteo; Liuzzi, Giuliano; Mumma, Michael J.; Novak, Robert E.; Smith, Michael D.; Villanueva, Geronimo] NASA, Goddard Space Flight Ctr, Greenbelt, MD USA; [Duxbury, Natalia] Moscow MV Lomonosov State Univ, Moscow, Russia; [Encrenaz, Therese; Fouchet, Thierry; Lellouch, Emmanuel] Observ Paris, LESIA, Paris, France; [Gerard, Jean-Claude; Gkouvelis, Leo; Hubert, Benoit; Ritter, Birgit] Univ Liege, Lab Planetary & Atmospher Phys, Liege, Belgium; [Hartogh, Paul; Medvedev, Alexander] Max Planck Inst, Gottingen, Germany; [Kaminski, Jacek] Polish Acad Sci, Inst Geophys, Warsaw, Poland; [Karatekin, Ozgur] Royal Observ Belgium, Brussels, Belgium; [Kasaba, Yasumasa; Nakagawa, Hiromu] Tohoku Univ, Sendai, Miyagi, Japan; [Kass, David; Kleinbohl, Armin] CALTECH, Jet Prop Lab, Pasadena, CA USA; [Krasnopolsky, Vladimir] Catholic Univ Amer, Washington, DC 20064 USA; [Krasnopolsky, Vladimir; Rodin, Alexander] Moscow Inst Phys & Technol, Sch Fundamental & Appl Phys, Moscow, Russia; [Kuzmin, Ruslan] Russian Acad Sci, Vernadsky Inst, Moscow, Russia; [Lanciano, Orietta] ASI, Rome, Italy; [Martin-Torres, Javier; Paz Zorzano, Maria] Lulea Univ Technol, Lulea, Sweden; [Martin-Torres, Javier] Univ Granada, Inst Andaluz Ciencias Tierra, Granada, Spain; [Quantin-Nataf, Cathy] Univ Claude Bernard, Lab Geol Lyon, Lyon, France; [Renotte, Etienne] AMOS, Liege, Belgium; [Schmidt, Frederic] Univ Paris Sud, Geosci Paris Sud GEOPS, Orsay, France; [Schneider, Nick; Thiemann, Ed] LASP, Boulder, CO USA; [Shematovich, Valery] Russian Acad Sci, Inst Astron, Moscow, Russia; [Teanby, Nicholas A.] Univ Bristol, Sch Earth Sci, Bristol, Avon, England; [Thomas, Nicolas] Univ Bern, Bern, Switzerland; [Vazquez, Luis] Univ Complutense Madrid, Madrid, Spain; [Vincendon, Matthieu] Univ Paris Sud, IAS, Orsay, France; [Whiteway, James] York Univ, Ctr Res Earth & Space Sci, Toronto, ON, Canada; [Yelle, Roger] Univ Arizona, LPL, Tucson, AZ USA; [Paz Zorzano, Maria] CSIC, INTA, Ctr Astrobiol, Madrid, Spain	Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Ecole des Ponts ParisTech; UDICE-French Research Universities; Sorbonne Universite; University of Oxford; National Academy of Sciences Ukraine; Main Astronomical Observatory of NASU; Open University - UK; Istituto Nazionale Astrofisica (INAF); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); Istituto Nazionale Geofisica e Vulcanologia (INGV); Babes Bolyai University from Cluj; European Space Agency; Universidad Politecnica de Madrid; Helmholtz Association; German Aerospace Centre (DLR); Universite Libre de Bruxelles; University of Winnipeg; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Lomonosov Moscow State University; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; University of Liege; Max Planck Society; Polish Academy of Sciences; Institute of Geophysics of the Polish Academy of Sciences; Tohoku University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Catholic University of America; Moscow Institute of Physics & Technology; Russian Academy of Sciences; Vernadsky Institute of Geochemistry & Analytical Chemistry; Agenzia Spaziale Italiana (ASI); Lulea University of Technology; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Andaluz de Ciencias de la Tierra (IACT); University of Granada; Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Universite Paris Saclay; Institute of Astronomy of the Russian Academy of Sciences; Russian Academy of Sciences; University of Bristol; University of Bern; Complutense University of Madrid; UDICE-French Research Universities; Universite Paris Saclay; York University - Canada; University of Arizona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA)	Korablev, O (corresponding author), Russian Acad Sci, Space Res Inst IKI, Moscow, Russia.	korab@iki.rssi.ru	Määttänen, Anni E/F-2943-2012; Etiope, Giuseppe/H-3343-2011; karatekin, ozgur/AAS-8419-2020; Fouchet, Thierry/C-6374-2017; Martin-Torres, Javier/M-3779-2019; Krasnopolsky, Vladimir/L-5085-2013; Malova, Helmi/ABE-6236-2021; Wilson, Colin/AAI-3307-2020; Mahieux, Arnaud/R-2991-2017; Shematovich, Valery/AAA-8925-2021; Belyaev, Denis/A-5404-2015; Alday, Juan/AAK-8984-2020; Khatuntsev, Igor V./B-4248-2015; Medvedev, Alexander S./AAC-3242-2019; Martin-Torres, Javier/G-6329-2015; Moreno, Jose Juan Lopez/M-5537-2019; Guerlet, Sandrine/ABE-1516-2020; Garcia-Comas, Maya/E-4050-2014; GIURANNA, Marco/S-9378-2017; Kasaba, Yasumasa/ABB-4167-2020; Robert, Séverine/AAF-7296-2021; Trokhimovskiy, Alexander/GQY-6914-2022; Liuzzi, Giuliano/GQO-7495-2022; Fedorova, Anna A/L-5116-2013; Funke, Bernd/C-2162-2008; Rodin, Alexander V./L-1904-2013; Neary, Lori L/S-9299-2017; Korablev, Oleg/L-5083-2013; Grassi, Davide/B-7916-2018; Rodrigo, Gustavo Alonso/G-2986-2015; Patsaev, Dmitry/AAS-5776-2021; Liuzzi, Giuliano/P-5238-2019; Bellucci, Giancarlo/ABA-9201-2020; Zorzano, María-Paz/F-2184-2015; Aoki, Shohei/AAU-8029-2020; Daerden, Frank/S-8759-2017; Lopez-Puertas, Manuel/M-8219-2013; Vandaele, Ann Carine/D-7167-2016; Crismani, Matteo/H-3791-2016; Thomas, Nicolas/G-4693-2015	Määttänen, Anni E/0000-0002-7326-8492; Etiope, Giuseppe/0000-0001-8614-4221; Fouchet, Thierry/0000-0001-9040-8285; Malova, Helmi/0000-0001-6511-2335; Wilson, Colin/0000-0001-5355-1533; Mahieux, Arnaud/0000-0001-5359-7179; Shematovich, Valery/0000-0002-1062-1287; Belyaev, Denis/0000-0003-1123-5983; Alday, Juan/0000-0003-1459-3444; Khatuntsev, Igor V./0000-0002-3256-122X; Medvedev, Alexander S./0000-0003-2713-8977; Martin-Torres, Javier/0000-0001-6479-2236; Moreno, Jose Juan Lopez/0000-0002-7946-2624; Guerlet, Sandrine/0000-0001-5019-899X; Garcia-Comas, Maya/0000-0003-2323-4486; GIURANNA, Marco/0000-0001-8967-9184; Kasaba, Yasumasa/0000-0002-8160-3553; Robert, Séverine/0000-0001-7445-3027; Trokhimovskiy, Alexander/0000-0003-4041-4972; Liuzzi, Giuliano/0000-0003-3638-5750; Funke, Bernd/0000-0003-0462-4702; Rodin, Alexander V./0000-0002-3601-7790; Neary, Lori L/0000-0001-6773-324X; Korablev, Oleg/0000-0003-1115-0656; Grassi, Davide/0000-0003-1653-3066; Rodrigo, Gustavo Alonso/0000-0002-1220-5586; Bellucci, Giancarlo/0000-0003-0867-8679; Zorzano, María-Paz/0000-0002-4492-9650; Aoki, Shohei/0000-0001-6727-125X; Kaminski, Jacek/0000-0002-9702-5356; Carrozzo, Filippo Giacomo/0000-0002-0391-6407; Wolkenberg, Paulina/0000-0001-6769-3719; Montmessin, Franck/0000-0002-4187-1457; Daerden, Frank/0000-0001-7433-1839; Altieri, Francesca/0000-0002-6338-8300; Teanby, Nicholas/0000-0003-3108-5775; Luginin, Mikhail/0000-0002-4434-0213; GERARD, Jean-Claude/0000-0002-8565-8746; Vago, Jorge Luis/0000-0003-1938-6639; Lopez-Puertas, Manuel/0000-0003-2941-7734; Marcq, Emmanuel/0000-0002-1924-641X; D'Aversa, Emiliano/0000-0002-5842-5867; Vandaele, Ann Carine/0000-0001-8940-9301; Fedorova, Anna/0000-0002-4176-2955; Olsen, Kevin/0000-0002-2173-9889; Willame, Yannick/0000-0001-7813-4605; Da Pieve, Fabiana/0000-0001-6985-9145; Thomas, Ian/0000-0003-3887-6668; Crismani, Matteo/0000-0003-3127-2466; Nakagawa, Hiromu/0000-0001-8166-0171; Viscardy, Sebastien/0000-0002-5608-7438; Oliva, Fabrizio/0000-0002-6271-3722; Young, Roland/0000-0002-7241-8954; Mason, Jonathon/0000-0002-4603-4009; Piccialli, Arianna/0000-0002-5098-2925; Thomas, Nicolas/0000-0002-0146-0071	Roscosmos; CNES; ESA; Russian government [14.W03.31.0017, 0120.0 602993 (0028-2014-0004)]; Belgian Science Policy Office (BELSPO); ESA Prodex Office [PEA 4000103401, PEA 4000121493]; Spanish MICINN through its Plan Nacional and by European funds [ESP2015-65064-C2-1-P, ESP2017-87143-R]; UK Space Agency [ST/R005761/1, ST/P001262/1, ST/R001405/1, ST/S00145X/1, ST/R001367/1, ST/P001572/1, ST/R001502/1]; Italian Space Agency [2018-2-HH.0]; Belgian Fonds de la Recherche Scientifique-FNRS [30442502]; STFC [1935849] Funding Source: UKRI	Roscosmos; CNES(Centre National D'etudes Spatiales); ESA(European Space Agency); Russian government; Belgian Science Policy Office (BELSPO)(Belgian Federal Science Policy Office); ESA Prodex Office; Spanish MICINN through its Plan Nacional and by European funds; UK Space Agency; Italian Space Agency(Agenzia Spaziale Italiana (ASI)); Belgian Fonds de la Recherche Scientifique-FNRS(Fonds de la Recherche Scientifique - FNRS); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	ExoMars is the space mission of ESA and Roscosmos. The ACS experiment is led by IKI, the Space Research Institute in Moscow, assisted by LATMOS in France. The project acknowledges funding by Roscosmos and CNES. The science operations of ACS are funded by Roscosmos and ESA. IKI affiliates acknowledge funding under grant number 14.W03.31.0017 and contract number 0120.0 602993 (0028-2014-0004) of the Russian government. The NOMAD experiment is led by the Royal Belgian Institute for Space Aeronomy (BIRA-IASB), assisted by co-PI teams from Spain (IAA-CSIC), Italy (INAF-IAPS), and the UK (Open University). This project acknowledges funding by the Belgian Science Policy Office (BELSPO), with the financial and contractual coordination of the ESA Prodex Office (PEA 4000103401 and PEA 4000121493), by Spanish MICINN through its Plan Nacional and by European funds under grants ESP2015-65064-C2-1-P and ESP2017-87143-R (MINECO/FEDER), as well as by the UK Space Agency through grants ST/R005761/1, ST/P001262/1, ST/R001405/1, ST/S00145X/1, ST/R001367/1, ST/P001572/1 and ST/R001502/1, and the Italian Space Agency through grant 2018-2-HH.0. This work was supported by the Belgian Fonds de la Recherche Scientifique-FNRS under grant number 30442502 (ET_HOME). We are indebted to the large number of people responsible for designing, building, testing, launching, communicating to and operating the spacecraft and science instruments, whose efforts made the success of TGO possible.	[Anonymous], 2000, INVERSE METHODS ATMO; Clancy RT, 2016, ICARUS, V266, P112, DOI 10.1016/j.icarus.2015.11.016; Etiope G, 2013, REV GEOPHYS, V51, P276, DOI 10.1002/rog.20011; Fedorova A, 2018, ICARUS, V300, P440, DOI 10.1016/j.icarus.2017.09.025; Formisano V, 2004, SCIENCE, V306, P1758, DOI 10.1126/science.1101732; Giuranna M., 2019, NAT GEOSCI; Gordon IE, 2017, J QUANT SPECTROSC RA, V203, P3, DOI 10.1016/j.jqsrt.2017.06.038; Korablev O, 2018, SPACE SCI REV, V214, DOI 10.1007/s11214-017-0437-6; Krashnopolsky VA, 2004, ICARUS, V172, P537, DOI 10.1016/j.icarus.2004.07.004; Krasnopolsky VA, 2012, ICARUS, V217, P144, DOI 10.1016/j.icarus.2011.10.019; Lefevre F, 2017, CAMB PLANET, P405; Lefevre F, 2009, NATURE, V460, P720, DOI 10.1038/nature08228; Liuzzi G, 2019, ICARUS, V321, P671, DOI 10.1016/j.icarus.2018.09.021; Maltagliati L, 2013, ICARUS, V223, P942, DOI 10.1016/j.icarus.2012.12.012; Millour E., 2015, EUR PLAN SCI C, V10, pEPSC2015; Mischna MA, 2011, PLANET SPACE SCI, V59, P227, DOI 10.1016/j.pss.2010.07.005; More J. J., 1980, ANL8074, VIII; Mumma MJ, 2009, SCIENCE, V323, P1041, DOI 10.1126/science.1165243; Oehler DZ, 2017, ASTROBIOLOGY, V17, P1233, DOI 10.1089/ast.2017.1657; Smith MD, 2018, ICARUS, V301, P117, DOI 10.1016/j.icarus.2017.09.027; Steele LJ, 2017, ICARUS, V289, P56, DOI 10.1016/j.icarus.2017.02.010; Svedhem H., SPACE SCI REV; Trompet L, 2016, APPL OPTICS, V55, P9275, DOI 10.1364/AO.55.009275; Tyler D, 2015, GEOPHYS RES LETT, V42, P7343, DOI 10.1002/2015GL064957; Vago J, 2015, SOLAR SYST RES+, V49, P518, DOI 10.1134/S0038094615070199; Vandaele AC, 2018, SPACE SCI REV, V214, DOI 10.1007/s11214-018-0517-2; Vandaele A. C., 2019, NATURE; Vasavada AR, 2012, SPACE SCI REV, V170, P793, DOI 10.1007/s11214-012-9911-3; Viscardy S, 2016, GEOPHYS RES LETT, V43, P1868, DOI 10.1002/2015GL067443; Waugh DW, 2019, ICARUS, V317, P148, DOI 10.1016/j.icarus.2018.08.002; Webster CR, 2018, SCIENCE, V360, P1093, DOI 10.1126/science.aaq0131; Webster CR, 2015, SCIENCE, V347, P415, DOI 10.1126/science.1261713; Webster CR, 2013, SCIENCE, V342, P355, DOI 10.1126/science.1242902; Yung YL, 2018, ASTROBIOLOGY, V18, P1221, DOI 10.1089/ast.2018.1917; Zahnle K, 2015, SCIENCE, V347, P370, DOI 10.1126/science.aaa3687; Zahnle K, 2011, ICARUS, V212, P493, DOI 10.1016/j.icarus.2010.11.027; 2004, ICARUS, V168, P116, DOI DOI 10.1016/J.ICARUS.2003.12.003; 2013, ICARUS, V223, P11, DOI DOI 10.1016/J.ICARUS.2012.11.013	38	79	80	9	64	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 25	2019	568	7753					517	+		10.1038/s41586-019-1096-4	http://dx.doi.org/10.1038/s41586-019-1096-4			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HU9DR	30971829	Green Submitted, Green Accepted			2022-12-28	WOS:000465594200044
J	Pemmaraju, N; Lane, AA; Sweet, KL; Stein, AS; Vasu, S; Blum, W; Rizzieri, DA; Wang, ES; Duvic, M; Sloan, JM; Spence, S; Shemesh, S; Brooks, CL; Balser, J; Bergstein, I; Lancet, JE; Kantarjian, HM; Konopleva, M				Pemmaraju, Naveen; Lane, Andrew A.; Sweet, Kendra L.; Stein, Anthony S.; Vasu, Sumithira; Blum, William; Rizzieri, David A.; Wang, Eunice S.; Duvic, Madeleine; Sloan, J. Mark; Spence, Sharon; Shemesh, Shay; Brooks, Christopher L.; Balser, John; Bergstein, Ivan; Lancet, Jeffrey E.; Kantarjian, Hagop M.; Konopleva, Marina			Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WORLD-HEALTH-ORGANIZATION; INTERLEUKIN-3 RECEPTOR; MYELOID NEOPLASMS; RESPONSE CRITERIA; TRANSPLANTATION; CLASSIFICATION; LEUKEMIA; RECOMMENDATIONS; DIAGNOSIS; LYMPHOMA	Background Blastic plasmacytoid dendritic-cell neoplasm (BPDCN) is an aggressive hematologic cancer that is caused by transformed plasmacytoid dendritic cells that overexpress interleukin-3 receptor subunit alpha (IL3RA or CD123). Tagraxofusp (SL-401) is a CD123-directed cytotoxin consisting of human interleukin-3 fused to truncated diphtheria toxin. Methods In this open-label, multicohort study, we assigned 47 patients with untreated or relapsed BPDCN to receive an intravenous infusion of tagraxofusp at a dose of 7 mu g or 12 mu g per kilogram of body weight on days 1 to 5 of each 21-day cycle. Treatment continued until disease progression or unacceptable toxic effects. The primary outcome was the combined rate of complete response and clinical complete response among patients who had not received previous treatment for BPDCN. A secondary outcome was the duration of response. Results Of the 47 patients, 32 were receiving tagraxofusp as first-line treatment and 15 had received previous treatment. The median age of the patients was 70 years (range, 22 to 84). Among the 29 previously untreated patients who received tagraxofusp at a dose of 12 mu g per kilogram, the primary outcome occurred in 21 (72%), and the overall response rate was 90%; of these patients, 45% went on to undergo stem-cell transplantation. Survival rates at 18 and 24 months were 59% and 52%, respectively. Among the 15 previously treated patients, the response rate was 67%, and the median overall survival was 8.5 months. The most common adverse events were increased levels of alanine aminotransferase (64%) and aspartate aminotransferase (60%), hypoalbuminemia (55%), peripheral edema (51%), and thrombocytopenia (49%). Capillary leak syndrome was reported in 19% of the patients and was associated with one death in each of the dose subgroups. Conclusions In adult patients with untreated or relapsed BPDCN, the use of tagraxofusp led to clinical responses. Serious adverse events included capillary leak syndrome; hepatic dysfunction and thrombocytopenia were common. (Funded by Stemline Therapeutics and the Leukemia and Lymphoma Society Therapy Acceleration Program; ClinicalTrials.gov number, .) Patients with blastic plasmacytoid dendritic-cell neoplasm, an aggressive hematologic cancer, were treated with the cytotoxin tagraxofusp in a dose-escalation case series. Previously untreated patients had a 72% complete response rate, and 45% underwent stem-cell transplantation. Toxic effects included hepatic dysfunction, thrombocytopenia, and capillary leak syndrome.	[Pemmaraju, Naveen; Duvic, Madeleine; Kantarjian, Hagop M.; Konopleva, Marina] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Lane, Andrew A.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Sloan, J. Mark] Boston Univ, Sch Med, Boston, MA 02118 USA; [Balser, John] Veristat, Southborough, MA USA; [Sweet, Kendra L.; Lancet, Jeffrey E.] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA; [Stein, Anthony S.] City Hope Natl Med Ctr, Natl Med Ctr, Duarte, CA USA; [Vasu, Sumithira] Ohio State Univ, Columbus, OH 43210 USA; [Blum, William] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Rizzieri, David A.] Duke Univ, Med Ctr, Durham, NC USA; [Wang, Eunice S.] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA; [Spence, Sharon; Shemesh, Shay; Brooks, Christopher L.; Bergstein, Ivan] Stemline Therapeut, New York, NY USA	University of Texas System; UTMD Anderson Cancer Center; Harvard University; Dana-Farber Cancer Institute; Boston University; H Lee Moffitt Cancer Center & Research Institute; City of Hope; University System of Ohio; Ohio State University; Emory University; Duke University	Pemmaraju, N (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, 1400 Holcombe Blvd.,Unit 428, Houston, TX 77030 USA.	npemmaraju@mdanderson.org		Sloan, John/0000-0001-7069-4528; Brooks, Christopher/0000-0003-3487-6644; Wang, Eunice/0000-0002-8644-0968; Lane, Andrew/0000-0001-7380-0226	Stemline Therapeutics; Leukemia and Lymphoma Society Therapy Acceleration Program	Stemline Therapeutics; Leukemia and Lymphoma Society Therapy Acceleration Program	Funded by Stemline Therapeutics and the Leukemia and Lymphoma Society Therapy Acceleration Program; ClinicalTrials.gov number, NCT02113982.	Agha ME, 2018, NEW ENGL J MED, V379, P1479, DOI 10.1056/NEJMc1808354; Aoki T, 2015, BLOOD, V125, P3559, DOI 10.1182/blood-2015-01-621268; Arber DA, 2016, BLOOD, V127, P2391, DOI 10.1182/blood-2016-03-643544; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; Cheson BD, 2014, J CLIN ONCOL, V32, P3059, DOI 10.1200/JCO.2013.54.8800; Dalle S, 2010, BRIT J DERMATOL, V162, P74, DOI 10.1111/j.1365-2133.2009.09373.x; Dietrich S, 2011, BIOL BLOOD MARROW TR, V17, P1250, DOI 10.1016/j.bbmt.2010.12.706; Facchetti F, 2017, WHO CLASSIFICATION T, P353; Frankel AE, 2013, BLOOD, V122, P3942; Frankel A, 2008, LEUKEMIA LYMPHOMA, V49, P543, DOI 10.1080/10428190701799035; Frankel AE, 2014, BLOOD, V124, P385, DOI 10.1182/blood-2014-04-566737; Han LN, 2015, CYTOM PART A, V87A, P346, DOI 10.1002/cyto.a.22628; Jordan CT, 2000, LEUKEMIA, V14, P1777, DOI 10.1038/sj.leu.2401903; Lucioni M, 2011, BLOOD, V118, P4591, DOI 10.1182/blood-2011-03-337501; Martin-Martin L, 2016, ONCOTARGET, V7, P10174, DOI 10.18632/oncotarget.7101; Martin-Martin L, 2015, ONCOTARGET, V6, P19204, DOI 10.18632/oncotarget.4146; Montero J, 2017, CANCER DISCOV, V7, P156, DOI 10.1158/2159-8290.CD-16-0999; Olsen EA, 2011, J CLIN ONCOL, V29, P2598, DOI 10.1200/JCO.2010.32.0630; Pagano L, 2013, HAEMATOLOGICA, V98, P239, DOI 10.3324/haematol.2012.072645; Testa U, 2014, BIOMARK RES, V2, DOI 10.1186/2050-7771-2-4; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262	21	172	177	2	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 25	2019	380	17					1628	1637		10.1056/NEJMoa1815105	http://dx.doi.org/10.1056/NEJMoa1815105			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU9FC	31018069	Bronze			2022-12-28	WOS:000465598600010
J	Yang, L; Cao, C; Kantor, ED; Nguyen, LH; Zheng, XB; Park, Y; Giovannucci, EL; Matthews, CE; Colditz, GA; Cao, Y				Yang, Lin; Cao, Chao; Kantor, Elizabeth D.; Nguyen, Long H.; Zheng, Xiaobin; Park, Yikyung; Giovannucci, Edward L.; Matthews, Charles E.; Colditz, Graham A.; Cao, Yin			Trends in Sedentary Behavior Among the US Population, 2001-2016	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NUTRITION EXAMINATION SURVEY; PHYSICAL-ACTIVITY; NATIONAL-HEALTH; UNITED-STATES; SITTING TIME; ADULTS; CHILDREN; ASSOCIATION; MORTALITY; EPIDEMIOLOGY	IMPORTANCE Prolonged sitting, particularly watching television or videos, has been associated with increased risk of multiple diseases and mortality. However, changes in sedentary behaviors over time have not been well described in the United States. OBJECTIVE To evaluate patterns and temporal trends in sedentary behaviors and sociodemographic and lifestyle correlates in the US population. DESIGN, SETTING, AND PARTICIPANTS A serial, cross-sectional analysis of the US nationally representative data from the National Health and Nutrition Examination Survey (NHANES) among children aged 5 through 11 years (2001-2016); adolescents, 12 through 19 years (2003-2016); and adults, 20 years or older (2003-2016). EXPOSURES Survey cycle. MAIN OUTCOMES AND MEASURES Prevalence of sitting watching television or videos for 2 h/d or more, computer use outside work or school for 1 h/d or more, and total sitting time (h/d in those aged >= 12 years). RESULTS Data on 51 896 individuals (mean, 37.2 years [SE, 0.19]; 25 968 [50%] female) were analyzed from 2001-2016 NHANES data, including 10 359 children, 9639 adolescents, and 31 898 adults. The estimated prevalence of sitting watching television or videos for 2 h/d or more was high among all ages (children, 62%[95% CI, 57% to 67%]; adolescents, 59%[95% CI, 54% to 65%]; adults, 65%[95% CI, 61% to 69%]; adults aged 20-64 years, 62%[95% CI, 58% to 66%]; and >= 65 years, 84%[95% CI, 81% to 88%] in the 2015-2016 cycle). From 2001 through 2016, the trends decreased among children over time (difference, -3.4%[95% CI, -11% to 4.5%]; P for trend = .004), driven by non-Hispanic white children; were stable among adolescents (-4.8%[95% CI, -12% to 2.3%]; P for trend = .60) and among adults aged 20 through 64 years (-0.7%[95% CI, -5.6% to 4.1%]; P for trend = .82); but increased among adults aged 65 years or older (difference, 3.5%[95% CI, -1.2% to 8.1%]; P for trend =. 03). The estimated prevalence of computer use outside school or work for 1 h/d or more increased in all ages (children, 43%[95% CI, 40% to 46%] to 56%[95% CI, 49% to 63%] from 2001 to 2016; difference, 13%[95% CI, 5.6% to 21%]; P for trend < .001; adolescents, 53%[95% CI, 47% to 58%] to 57%[95% CI, 53% to 62%] from 2003 to 2016, difference, 4.8%[95% CI, -1.8% to 11%]; P for trend = .002; adults, 29% [27% to 32%] to 50% [48% to 53%] from 2003 to 2016, difference, 21% [95% CI, 18% to 25%]; P for trend <. 001). From 2007 to 2016, total hours per day of sitting time increased among adolescents (7.0 [95% CI, 6.7 to 7.4] to 8.2 [95% CI, 7.9 to 8.4], difference, 1.1 [95% CI, 0.7 to 1.5]) and adults (5.5 [95% CI, 5.2 to 5.7] to 6.4 [95% CI, 6.2 to 6.6]; difference, 1.0 [95% CI, 0.7 to 1.3]; P for trend <. 001 for both). CONCLUSIONS AND RELEVANCE In this nationally representative survey of the US population from 2001 through 2016, the estimated prevalence of sitting watching television or videos for at least 2 hours per day generally remained high and stable. The estimated prevalence of computer use during leisure-time increased among all age groups, and the estimated total sitting time increased among adolescents and adults.	[Yang, Lin] Alberta Hlth Serv, Canc Epidemiol & Prevent Res, CancerControl Alberta, Calgary, AB, Canada; [Yang, Lin] Univ Calgary, Dept Community Hlth Sci, Cumming Sch Med, Calgary, AB, Canada; [Yang, Lin] Univ Calgary, Dept Oncol, Cumming Sch Med, Calgary, AB, Canada; [Yang, Lin] Med Univ Vienna, Dept Epidemiol, Ctr Publ Hlth, Vienna, Austria; [Cao, Chao; Zheng, Xiaobin; Park, Yikyung; Colditz, Graham A.; Cao, Yin] Washington Univ, Sch Med, Dept Surg, Div Publ Hlth Sci, 660 S Euclid Ave,Campus Box 8100, St Louis, MO 63110 USA; [Kantor, Elizabeth D.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Nguyen, Long H.] Massachusetts Gen Hosp, Dept Med, Div Gastroenterol, Boston, MA 02114 USA; [Nguyen, Long H.] Massachusetts Gen Hosp, Clin & Translat Epidemiol Unit, Boston, MA 02114 USA; [Nguyen, Long H.] Harvard Med Sch, Boston, MA 02115 USA; [Zheng, Xiaobin] Sun Yat Sen Univ, Dept Colorectal Surg, Affiliated Hosp 6, Guangzhou, Guangdong, Peoples R China; [Zheng, Xiaobin] Sun Yat Sen Univ, Guangdong Prov Key Lab Colorectal & Pelv Floor Di, Affiliated Hosp 6, Guangzhou, Guangdong, Peoples R China; [Giovannucci, Edward L.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Giovannucci, Edward L.] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Matthews, Charles E.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Colditz, Graham A.; Cao, Yin] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63110 USA	Alberta Health Services (AHS); University of Calgary; University of Calgary; University of Calgary; Medical University of Vienna; Washington University (WUSTL); Memorial Sloan Kettering Cancer Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Sun Yat Sen University; Sun Yat Sen University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Siteman Cancer Center; Washington University (WUSTL)	Cao, Y (corresponding author), Washington Univ, Sch Med, Dept Surg, Div Publ Hlth Sci, 660 S Euclid Ave,Campus Box 8100, St Louis, MO 63110 USA.	yin.cao@wustl.edu	Cao, Yin/ABE-2332-2021; Cao, Chao/AAJ-8013-2020; Yang, Lin/AAE-4979-2020; Colditz, Graham/A-3963-2009	Cao, Yin/0000-0001-9835-7662; Cao, Chao/0000-0002-0455-1171; Yang, Lin/0000-0002-1698-6666; Colditz, Graham/0000-0002-7307-0291; Nguyen, Long/0000-0002-5436-4219; Park, Yikyung/0000-0002-6281-489X	National Cancer Institute [P30CA008748, P30CA091842]; Biostatistics Shared Resource, of the Cancer Center Support grant; NATIONAL CANCER INSTITUTE [P30CA008748, K07CA218377, P30CA091842, ZIACP010197] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Biostatistics Shared Resource, of the Cancer Center Support grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr Kantor's effort on this project is supported by grant P30CA008748 from the National Cancer Institute. Dr Colditz is supported by grant P30CA091842 from the National Cancer Institute and Biostatistics Shared Resource, a component of the Cancer Center Support grant.	Aadahl M, 2013, SCAND J PUBLIC HEALT, V41, P706, DOI 10.1177/1403494813493151; Andersen RE, 1998, JAMA-J AM MED ASSOC, V279, P938, DOI 10.1001/jama.279.12.938; [Anonymous], 2017, ESS FACTS COMP VID G; Atkin AJ, 2012, INT J EPIDEMIOL, V41, P1460, DOI 10.1093/ije/dys118; Bassett DR, 2015, J PHYS ACT HEALTH, V12, P1102, DOI 10.1123/jpah.2014-0050; Biswas A, 2015, ANN INTERN MED, V162, P123, DOI 10.7326/M14-1651; Bureau of Labor Statistics, 2018, AM TIM US SURV QUEST; Bureau of Labor Statistics, 2018, AM TIM US SURV 2017; Chau JY, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-76; Cohen SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059975; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Crespo CJ, 2001, ARCH PEDIAT ADOL MED, V155, P360, DOI 10.1001/archpedi.155.3.360; Curtin Lester R, 2012, Vital Health Stat 2, P1; Ekelund U, 2016, LANCET, V388, P1302, DOI 10.1016/S0140-6736(16)30370-1; Gortmaker SL, 1996, ARCH PEDIAT ADOL MED, V150, P356, DOI 10.1001/archpedi.1996.02170290022003; Hales CM, 2018, JAMA-J AM MED ASSOC, V319, P1723, DOI 10.1001/jama.2018.3060; Harrington DM, 2014, J SCI MED SPORT, V17, P371, DOI 10.1016/j.jsams.2013.07.017; Healy GN, 2011, AM J PREV MED, V41, P216, DOI 10.1016/j.amepre.2011.05.005; Iannotti RJ, 2013, PEDIATRICS, V132, P606, DOI 10.1542/peds.2013-1488; Kuczmarski RJ, 2002, VITAL HLTH STAT, V11, P246, DOI DOI 10.1097/00008486-200203000-00006; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Matthews CE, 2012, AM J CLIN NUTR, V95, P437, DOI 10.3945/ajcn.111.019620; Nelson MC, 2006, PEDIATRICS, V118, pE1627, DOI 10.1542/peds.2006-0926; Patterson R, 2018, EUR J EPIDEMIOL, V33, P811, DOI 10.1007/s10654-018-0380-1; Piercy KL, 2018, JAMA-J AM MED ASSOC, V320, P2020, DOI 10.1001/jama.2018.14854; Robinson TN, 1995, J HLTH ED, V26, pS91, DOI [DOI 10.1080/10556699.1995.10603155, 10.1080/10556699.1995.10603155]; Schmid D, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju098; Siegel RL, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw322; Sisson SB, 2009, INT J PEDIATR OBES, V4, P353, DOI 10.3109/17477160902934777; Tremblay MS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-98; U.S. Department of Health and Human Services, 2018, PHYS ACT GUID AM; Ussery EN, 2018, JAMA-J AM MED ASSOC, V320, P2036, DOI 10.1001/jama.2018.17797; van der Ploeg HP, 2013, AM J PREV MED, V44, P382, DOI 10.1016/j.amepre.2012.11.034; Walsh JJ, 2018, LANCET CHILD ADOLESC, V2, P783, DOI 10.1016/S2352-4642(18)30278-5; Whitt-Glover MC, 2009, J PUBLIC HEALTH POL, V30, pS309, DOI 10.1057/jphp.2008.46; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z; Wilmot E, 2014, THER ADV CHRONIC DIS, V5, P234, DOI 10.1177/2040622314548679; Wong MD, 2002, NEW ENGL J MED, V347, P1585, DOI 10.1056/NEJMsa012979; World Health Organization (WHO), 2018, MOR ACT PEOPL HEALTH	39	197	198	7	48	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2019	321	16					1587	1597		10.1001/jama.2019.3636	http://dx.doi.org/10.1001/jama.2019.3636			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HV7BZ	31012934	Green Published, Bronze			2022-12-28	WOS:000466137800015
J	Berggren, M; Malliaras, GG				Berggren, Magnus; Malliaras, George G.			How conducting polymer electrodes operate	SCIENCE			English	Editorial Material							ELECTROCHEMISTRY; DEVICES		[Berggren, Magnus] Linkoping Univ, Lab Organ Elect, ITN, Linkoping, Sweden; [Malliaras, George G.] Univ Cambridge, Dept Engn, Cambridge, England	Linkoping University; University of Cambridge	Berggren, M (corresponding author), Linkoping Univ, Lab Organ Elect, ITN, Linkoping, Sweden.	magnus.berggren@liu.se; gm603@cam.ac.uk	Berggren, Magnus/J-6401-2015; Malliaras, George/HDM-2006-2022	Berggren, Magnus/0000-0001-5154-0291; Malliaras, George/0000-0002-4582-8501	KAW; SSF; VINNOVA; VR; EPSRC; EU Horizon 2020; KAUST	KAW; SSF(Swedish Foundation for Strategic Research); VINNOVA(Vinnova); VR(Swedish Research Council); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EU Horizon 2020; KAUST(King Abdullah University of Science & Technology)	The authors acknowledge financial support from KAW, SSF, VINNOVA, and VR (M.B.) and from EPSRC, EU Horizon 2020, and KAUST (G.G.M.).	Arkhipov VI, 1998, J APPL PHYS, V84, P848, DOI 10.1063/1.368146; Choi W, 2011, J AM CHEM SOC, V133, P19839, DOI 10.1021/ja206961t; FELDBERG SW, 1984, J AM CHEM SOC, V106, P4671, DOI 10.1021/ja00329a004; Friend RH, 1999, NATURE, V397, P121, DOI 10.1038/16393; Heinze J, 2010, CHEM REV, V110, P4724, DOI 10.1021/cr900226k; Koch N, 2007, CHEMPHYSCHEM, V8, P1438, DOI 10.1002/cphc.200700177; Miglbauer E, 2018, CHEM COMMUN, V54, P11873, DOI 10.1039/c8cc06802j; Proctor CM, 2016, J POLYM SCI POL PHYS, V54, P1433, DOI 10.1002/polb.24038; Rivnay J, 2018, NAT REV MATER, V3, DOI 10.1038/natrevmats.2017.86; Sirringhaus H, 1998, SCIENCE, V280, P1741, DOI 10.1126/science.280.5370.1741; Song ZP, 2013, ENERG ENVIRON SCI, V6, P2280, DOI 10.1039/c3ee40709h; Tybrandt K, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao3659	12	86	86	11	167	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2019	364	6437					233	234		10.1126/science.aaw9295	http://dx.doi.org/10.1126/science.aaw9295			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HU0JG	31000650	Green Submitted			2022-12-28	WOS:000464956600026
J	He, M; Chaurushiya, MS; Webster, JD; Kummerfeld, S; Reja, R; Chaudhuri, S; Chen, YJ; Modrusan, Z; Haley, B; Dugger, DL; Eastham-Anderson, J; Lau, S; Dey, A; Caothien, R; Roose-Girma, M; Newton, K; Dixit, VM				He, Meng; Chaurushiya, Mira S.; Webster, Joshua D.; Kummerfeld, Sarah; Reja, Rohit; Chaudhuri, Subhra; Chen, Ying-Jiun; Modrusan, Zora; Haley, Benjamin; Dugger, Debra L.; Eastham-Anderson, Jeffrey; Lau, Shari; Dey, Anwesha; Caothien, Roger; Roose-Girma, Merone; Newton, Kim; Dixit, Vishva M.			Intrinsic apoptosis shapes the tumor spectrum linked to inactivation of the deubiquitinase BAP1	SCIENCE			English	Article							MUTATIONS PREDISPOSE; GERMLINE MUTATION; UVEAL MELANOMA; MUTANTS; RING1B; GENE	Malignancies arising from mutation of tumor suppressors have unexplained tissue proclivity. For example, BAP1 encodes a widely expressed deubiquitinase for histone H2A, but germline mutations are predominantly associated with uveal melanomas and mesotheliomas. We show that BAP1 inactivation causes apoptosis in mouse embryonic stem cells, fibroblasts, liver, and pancreatic tissue but not in melanocytes and mesothelial cells. Ubiquitin ligase RNF2, which silences genes by monoubiquitinating H2A, promoted apoptosis in BAP1-deficient cells by suppressing expression of the prosurvival genes Bcl2 and Mcl1. In contrast, BAP1 loss in melanocytes had little impact on expression of prosurvival genes, instead inducing Mitf. Thus, BAP1 appears to modulate gene expression by countering H2A ubiquitination, but its loss only promotes tumorigenesis in cells that do not engage an RNF2-dependent apoptotic program.	[He, Meng; Chaurushiya, Mira S.; Dugger, Debra L.; Newton, Kim; Dixit, Vishva M.] Genentech Inc, Dept Physiol Chem, 1 DNA Way, San Francisco, CA 94080 USA; [Webster, Joshua D.; Eastham-Anderson, Jeffrey; Lau, Shari] Genentech Inc, Dept Pathol, 1 DNA Way, San Francisco, CA 94080 USA; [Kummerfeld, Sarah; Reja, Rohit] Genentech Inc, Dept Bioinformat, 1 DNA Way, San Francisco, CA 94080 USA; [Chaudhuri, Subhra; Chen, Ying-Jiun; Modrusan, Zora; Haley, Benjamin; Caothien, Roger; Roose-Girma, Merone] Genentech Inc, Dept Mol Biol, 1 DNA Way, San Francisco, CA 94080 USA; [Dey, Anwesha] Genentech Inc, Dept Discovery Oncol, 1 DNA Way, San Francisco, CA 94080 USA; [Chaurushiya, Mira S.] 5AM Ventures, 501 2nd St 350, San Francisco, CA 94107 USA; [Kummerfeld, Sarah] Garvan Inst Med Res, Kinghorn Ctr Clin Genom, 384 Victoria St, Darlinghurst, NSW 2010, Australia	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Garvan Institute of Medical Research	Newton, K; Dixit, VM (corresponding author), Genentech Inc, Dept Physiol Chem, 1 DNA Way, San Francisco, CA 94080 USA.	knewton@gene.com; dixit@gene.com	dixit, vishva m/A-4496-2012	dixit, vishva m/0000-0001-6983-0326; Kummerfeld, Sarah/0000-0002-0089-2358; Reja, Rohit/0000-0002-2254-3968	Genentech	Genentech(Roche HoldingGenentech)	Work was funded by Genentech.	Abdel-Rahman MH, 2011, J MED GENET, V48, P856, DOI 10.1136/jmedgenet-2011-100156; Badhai J., 2018, ESMO OPEN, V3, DOI [10.1136/esmoopen-2018-EACR25.741, DOI 10.1136/ESMOOPEN-2018-EACR25.741]; Baughman JM, 2016, CELL REP, V16, P583, DOI 10.1016/j.celrep.2016.05.096; Ben-Saadon R, 2006, MOL CELL, V24, P701, DOI 10.1016/j.molcel.2006.10.022; Bott M, 2011, NAT GENET, V43, P668, DOI 10.1038/ng.855; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Callow MG, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0301-y; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; de Dieuleveult M, 2016, NATURE, V530, P113, DOI 10.1038/nature16505; Dey A, 2012, SCIENCE, V337, P1541, DOI 10.1126/science.1221711; Farley MN, 2013, MOL CANCER RES, V11, P1061, DOI 10.1158/1541-7786.MCR-13-0111; Gil J, 2014, TRENDS CELL BIOL, V24, P632, DOI 10.1016/j.tcb.2014.06.005; Gowen LC, 1996, NAT GENET, V12, P191, DOI 10.1038/ng0296-191; Harbour JW, 2012, PIGM CELL MELANOMA R, V25, DOI 10.1111/j.1755-148X.2012.00979.x; Illingworth RS, 2015, GENE DEV, V29, P1897, DOI 10.1101/gad.268151.115; Kadariya Y, 2016, CANCER RES, V76, P2836, DOI 10.1158/0008-5472.CAN-15-3371; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Loeb DM, 2006, CELL CYCLE, V5, P1249, DOI 10.4161/cc.5.12.2807; Lua I, 2016, J HEPATOL, V64, P1137, DOI 10.1016/j.jhep.2016.01.010; Napolitano A, 2016, ONCOGENE, V35, P1996, DOI 10.1038/onc.2015.243; Neri F, 2017, NATURE, V543, P72, DOI 10.1038/nature21373; Popova T, 2013, AM J HUM GENET, V92, P974, DOI 10.1016/j.ajhg.2013.04.012; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Samuelson AV, 1997, P NATL ACAD SCI USA, V94, P12094, DOI 10.1073/pnas.94.22.12094; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Shain AH, 2016, NAT REV CANCER, V16, P345, DOI 10.1038/nrc.2016.37; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Takeuchi O, 2005, P NATL ACAD SCI USA, V102, P11272, DOI 10.1073/pnas.0504783102; Testa JR, 2011, NAT GENET, V43, P1022, DOI 10.1038/ng.912; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Wang SS, 2014, P NATL ACAD SCI USA, V111, P16538, DOI 10.1073/pnas.1414789111; Webster JD, 2019, PIGM CELL MELANOMA R, V32, P269, DOI 10.1111/pcmr.12735; Wiesner T, 2012, AM J SURG PATHOL, V36, P818, DOI 10.1097/PAS.0b013e3182498be5; Wiesner T, 2011, NAT GENET, V43, P1018, DOI 10.1038/ng.910; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Xu JF, 2014, CANCER RES, V74, P4388, DOI 10.1158/0008-5472.CAN-14-1328; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	39	48	48	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2019	364	6437					283	+		10.1126/science.aav4902	http://dx.doi.org/10.1126/science.aav4902			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HU0JG	31000662				2022-12-28	WOS:000464956600050
J	deBronkart, D				deBronkart, Dave			Open access: remember the patients	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[deBronkart, Dave] Soc Participatory Med, Newburyport, MA 01950 USA		deBronkart, D (corresponding author), Soc Participatory Med, Newburyport, MA 01950 USA.	dave@epatientdave.com							0	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 18	2019	365								l1545	10.1136/bmj.l1545	http://dx.doi.org/10.1136/bmj.l1545			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU8PD	31000502	Bronze			2022-12-28	WOS:000465550700003
J	Rimmer, A				Rimmer, Abi			Exclusive: Trainees can face fees of 65 pound a night to stay in hospital during 24 hour non-resident on-call shifts	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		BMA, 2019, FAT FAC CHART; British Association of Urological Surgeons, CURR BSOT CAMP; RIMMER A, 2019, BMJ-BRIT MED J, V364, P92177, DOI DOI 10.1136/BMJ.L848	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 18	2019	365								l1836	10.1136/bmj.l1836	http://dx.doi.org/10.1136/bmj.l1836			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU8PD	31000504				2022-12-28	WOS:000465550700009
J	Jones, N				Jones, Nicola			THE QUEST FOR QUIETER SEAS	NATURE			English	News Item							NOISE											D'Amico Angela, 2009, Aquatic Mammals, V35, P452, DOI 10.1578/AM.35.4.2009.452; Lusseau David, 2009, Endangered Species Research, V6, P211, DOI 10.3354/esr00154; McCauley RD, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0195; Morisaka T, 2005, J MAMMAL, V86, P541, DOI 10.1644/1545-1542(2005)86[541:EOANOT]2.0.CO;2; Rolland R. M., 2012, P BIOL SCI, V22, P2363; Simpson SD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10544; Veirs S., 2018, PEERJ PREPRINTS, V6; Weilgart, 2018, IMPACT OCEAN NOISE P; Williams R, 2018, OCEANOGRAPHY, V31, P16, DOI 10.5670/oceanog.2018.207; Williams R, 2006, BIOL CONSERV, V133, P301, DOI 10.1016/j.biocon.2006.06.010	10	21	22	6	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2019	568	7751					158	161		10.1038/d41586-019-01098-6	http://dx.doi.org/10.1038/d41586-019-01098-6			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HT2SH	30971842	Bronze			2022-12-28	WOS:000464412700023
J	Jha, AK				Jha, Ashish K.			Deprescribing Policies: Time for a Fresh Approach	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Jha, Ashish K.] Harvard TH Chan Sch Publ Hlth, Global Hlth & Hlth Policy, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Jha, AK (corresponding author), Harvard TH Chan Sch Publ Hlth, Global Hlth & Hlth Policy, Boston, MA 02115 USA.								0	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 9	2019	321	14					1341	1342		10.1001/jama.2019.2939	http://dx.doi.org/10.1001/jama.2019.2939			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HT5PG	30964517	Bronze			2022-12-28	WOS:000464615200004
J	Burki, T				Burki, Talha			2019 Gairdner awards recognise global mental health	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 6	2019	393	10179					1401	1401		10.1016/S0140-6736(19)30807-4	http://dx.doi.org/10.1016/S0140-6736(19)30807-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HS0OU	30967205				2022-12-28	WOS:000463561000013
J	Iacobucci, G				Iacobucci, Gareth			Health secretary is called in to settle row over cancer scanning services	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Campbell D., 2019, GUARDIAN; Oxfordshire County Council, 2019, AGENDA; SALISBURY H, 2019, BMJ-BRIT MED J, V364, DOI DOI 10.1136/BMJ.L1220	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 5	2019	365								l1632	10.1136/bmj.l1632	http://dx.doi.org/10.1136/bmj.l1632			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HS6UC	30952694				2022-12-28	WOS:000464005800002
J	Dyer, C				Dyer, Clare			Spinal surgeon loses appeal in case of woman left disabled after heparin injection	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		DYER C, 2018, BMJ-BRIT MED J, V361, DOI DOI 10.1136/BMJ.K2565	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2019	364								l1394	10.1136/bmj.l1394	http://dx.doi.org/10.1136/bmj.l1394			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HR5VS	30957765				2022-12-28	WOS:000463215700012
J	Siu, A; Allore, H; Brown, D; Charles, ST; Lohman, M				Siu, Albert; Allore, Heather; Brown, Darryl; Charles, Susan T.; Lohman, Matthew			National Institutes of Health Pathways to Prevention Workshop: Research Gaps for Long-Term Drug Therapies for Osteoporotic Fracture Prevention	ANNALS OF INTERNAL MEDICINE			English	Review							POST HOC ANALYSIS; POSTMENOPAUSAL WOMEN; ZOLEDRONIC ACID; HIP FRACTURE; BONE-DENSITY; CARE; BISPHOSPHONATES; DISCONTINUATION; DENOSUMAB; TRIAL	On 30 and 31 October 2018, the National Institutes of Health convened the Pathways to Prevention (P2P) Workshop: Appropriate Use of Drug Therapies for Osteoporotic Fracture Prevention to assess the available evidence on long-term (> 3 years) use of drug therapies to prevent osteoporotic fractures and identify research gaps and needs for advancing the field. The workshop was cosponsored by the NIH Office of Disease Prevention (ODP), National Institute of Arthritis and Musculoskeletal and Skin Diseases, and National Institute on Aging. A multidisciplinary working group developed the agenda, and an Evidence-based Practice Center prepared an evidence report through a contract with the Agency for Healthcare Research and Quality to facilitate the discussion. During the 1.5-day workshop, invited experts discussed the body of evidence and attendees had the opportunity to comment during open discussions. After data from the evidence report, expert presentations, and public comments were weighed, an unbiased independent panel prepared a draft report that was posted on the ODP Web site for 5 weeks for public comment. This final report summarizes the panel's findings and recommendations. Current gaps in knowledge are highlighted, and a set of recommendations for new, strengthened research to better inform the long-term use of osteoporotic drug therapies is delineated.	[Siu, Albert] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Allore, Heather] Yale Sch Publ Hlth, Yale Sch Med, New Haven, CT USA; [Brown, Darryl] Drexel Univ, Dornsife Sch Publ Hlth, Philadelphia, PA 19104 USA; [Charles, Susan T.] Univ Calif Irvine, Irvine, CA USA; [Lohman, Matthew] Univ South Carolina, Arnold Sch Publ Hlth, 915 Greene St,Discovery Bldg,Room 440, Columbia, SC 29208 USA; [Siu, Albert] Icahn Sch Med Mt Sinai, Brookdale Dept Geriatr & Palliat Med, One Gustave Levy Pl,Box 1070, New York, NY 10029 USA; [Allore, Heather] Yale Sch Med, Sect Geriatr, Dept Internal Med, 300 George St, New Haven, CT 06520 USA; [Brown, Darryl] Drexel Univ, Dept Hlth Management & Policy, Dornsife Sch Publ Hlth, Nesbitt Hall,3215 Market St,Third Floor, Philadelphia, PA 19104 USA; [Charles, Susan T.] Univ Calif Irvine, Dept Psychol Sci, 4326 Social & Behav Sci Gateway, Irvine, CA 92697 USA	Icahn School of Medicine at Mount Sinai; Yale University; Drexel University; University of California System; University of California Irvine; University of South Carolina System; University of South Carolina Columbia; Icahn School of Medicine at Mount Sinai; Yale University; Drexel University; University of California System; University of California Irvine	Siu, A (corresponding author), Icahn Sch Med Mt Sinai, Brookdale Dept Geriatr & Palliat Med, One Gustave Levy Pl,Box 1070, New York, NY 10029 USA.	albert.siu@mssm.edu	Lohman, Matthew/U-9821-2017	Lohman, Matthew/0000-0002-2273-2160				Adams AL, 2018, 2018 AM SOC BON MIN, DOI DOI 10.1002/jbmr.2708; Adler RA, 2018, EUR J ENDOCRINOL, V178, pR81, DOI 10.1530/EJE-17-1002; Agency for Healthcare Research and Quality, 2019, WORKSH DRAFT SYST EV; Black DM, 2015, J BONE MINER RES, V30, P934, DOI 10.1002/jbmr.2442; Black DM, 2006, JAMA-J AM MED ASSOC, V296, P2927, DOI 10.1001/jama.296.24.2927; Black DM, 2018, 2018 AM SOC BON MIN, DOI DOI 10.4158/EP161435.ESGL; Bone HG, 2017, LANCET DIABETES ENDO, V5, P513, DOI 10.1016/S2213-8587(17)30138-9; Cipriani C, 2018, J ENDOCRINOL INVEST, V41, P1359, DOI 10.1007/s40618-018-0898-9; Cohen A, 2015, J CLIN ENDOCR METAB, V100, P4208, DOI 10.1210/jc.2015-2829; Committee on Practice Bulletins-Gynecology The American College of Obstetricians and Gynecologists, 2012, Obstet Gynecol, V120, P718, DOI 10.1097/AOG.0b013e31826dc446; Crandall CJ, 2014, ANN INTERN MED, V161, P711, DOI 10.7326/M14-0317; Cummings SR, 2018, J BONE MINER RES, V33, P190, DOI 10.1002/jbmr.3337; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Edwards BJ, 2013, J BONE JOINT SURG AM, V95A, P297, DOI 10.2106/JBJS.K.01181; Feldstein AC, 2012, J BONE MINER RES, V27, P977, DOI 10.1002/jbmr.1550; Fink HA, 2019, ANN INTERN MED, V171, P37, DOI 10.7326/M19-0533; Guggina P, 2012, BONE, V51, P975, DOI 10.1016/j.bone.2012.08.130; Hiligsmann M, 2015, CURR RHEUMATOL REP, V17, DOI 10.1007/s11926-015-0533-0; Jaleel A, 2018, THER ADV MUSCULOSKEL, V10, P141, DOI 10.1177/1759720X18785539; Jha S, 2015, J BONE MINER RES, V30, P2179, DOI 10.1002/jbmr.2565; Kim SC, 2015, AM J MED, V128, P519, DOI 10.1016/j.amjmed.2015.01.014; Lee S, 2011, OSTEOPOROSIS INT, V22, P741, DOI 10.1007/s00198-010-1335-x; Lewiecki EM, 2018, OSTEOPOROSIS INT, V29, P717, DOI 10.1007/s00198-017-4345-0; Majumdar SR, 2011, OSTEOPOROSIS INT, V22, P223, DOI 10.1007/s00198-010-1212-7; McClung MR, 2017, OSTEOPOROSIS INT, V28, P1723, DOI 10.1007/s00198-017-3919-1; McClung M, 2009, OBSTET GYNECOL, V114, P999, DOI 10.1097/AOG.0b013e3181bdce0a; National Institutes of Health, 2000, OST PREV DIAGN THER; Nuti R, 2019, INTERN EMERG MED, V14, P85, DOI 10.1007/s11739-018-1874-2; Ortman JM, 2013, FFC GW BROWN BAG SEM; Qaseem A, 2017, ANN INTERN MED, V166, P818, DOI 10.7326/M15-1361; Reynolds K, 2013, OSTEOPOROSIS INT, V24, P2509, DOI 10.1007/s00198-013-2326-5; Shu ADH, 2009, AM J MANAG CARE, V15, P417; Silverman S, 2018, CURR OSTEOPOROS REP, V16, P772, DOI 10.1007/s11914-018-0494-0; Solomon DH, 2014, J BONE MINER RES, V29, P1667, DOI 10.1002/jbmr.2180; Solomon DH, 2019, NAT I HLTH PATHW PRE; Swart E, 2016, CLIN ORTHOP RELAT R, V474, P222, DOI 10.1007/s11999-015-4494-4; Tsourdi E, 2017, BONE, V105, P11, DOI 10.1016/j.bone.2017.08.003; Viswanathan M, 2018, JAMA-J AM MED ASSOC, V319, P2532, DOI 10.1001/jama.2018.6537; Wright NC, 2014, J BONE MINER RES, V29, P2520, DOI 10.1002/jbmr.2269; Wysowski DK, 2013, BONE, V57, P423, DOI 10.1016/j.bone.2013.09.008; Yarnall KSH, 2003, AM J PUBLIC HEALTH, V93, P635, DOI 10.2105/AJPH.93.4.635	41	17	20	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 2	2019	171	1					51	+		10.7326/M19-0961	http://dx.doi.org/10.7326/M19-0961			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IF7KB	31009943				2022-12-28	WOS:000473261600007
J	Rodriguez-Gutierrez, R; McCoy, RG				Rodriguez-Gutierrez, Rene; McCoy, Rozalina G.			Measuring What Matters in Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Rodriguez-Gutierrez, Rene] Mayo Clin, Knowledge & Evaluat Res Unit Endocrinol, Div Endocrinol Diabet Metab & Nutr, Dept Med, Rochester, MN USA; [Rodriguez-Gutierrez, Rene] Dr Jose E Gonzalez Univ Hosp, Mayo Clin, Plataforma INVEST Med UANL KER Unit, Knowledge & Evaluat Res Unit Mexico, Monterrey, Mexico; [McCoy, Rozalina G.] Mayo Clin, Dept Med, Div Community Internal Med, 200 First St SW, Rochester, MN 55905 USA; [McCoy, Rozalina G.] Mayo Clin, Dept Hlth Sci Res, Div Hlth Care Policy & Res, Rochester, MN USA	Mayo Clinic; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Mayo Clinic; Mayo Clinic	McCoy, RG (corresponding author), Mayo Clin, Dept Med, Div Community Internal Med, 200 First St SW, Rochester, MN 55905 USA.	mccoy.rozalina@mayo.edu			National Institute of Diabetes and Digestive and Kidney Diseases [K23DK114497]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK114497] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr McCoy is supported by grant K23DK114497 from the National Institute of Diabetes and Digestive and Kidney Diseases. No other disclosureswere reported.	Cefalu WT, 2018, DIABETES CARE, V41, P14, DOI 10.2337/dci17-0057; Davies MJ, 2018, DIABETOLOGIA, V61, P2461, DOI 10.1007/s00125-018-4729-5; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Lipska KJ, 2017, JAMA-J AM MED ASSOC, V317, P1017, DOI 10.1001/jama.2017.0029; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Rodriguez-Gutierrez R, 2016, JAMA INTERN MED, V176, P1714, DOI 10.1001/jamainternmed.2016.5046; Rodriguez-Gutierrez R, 2016, CIRC-CARDIOVASC QUAL, V9, P504, DOI 10.1161/CIRCOUTCOMES.116.002901; Spencer-Bonilla G, 2017, J GEN INTERN MED, V32, P1141, DOI 10.1007/s11606-017-4117-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6	9	21	21	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 21	2019	321	19					1865	1866		10.1001/jama.2019.4310	http://dx.doi.org/10.1001/jama.2019.4310			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HZ1FC	30985865	Green Accepted			2022-12-28	WOS:000468591200010
J	Cohen, J				Cohen, Jon			WANING IMMUNITY	SCIENCE			English	Editorial Material																			0	9	9	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2019	364	6437					224	227		10.1126/science.364.6437.224	http://dx.doi.org/10.1126/science.364.6437.224			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HU0JG	31000646				2022-12-28	WOS:000464956600022
J	Yang, N; Duong, CH; Kelleher, PJ; McCoy, AB; Johnson, MA				Yang, Nan; Duong, Chinh H.; Kelleher, Patrick J.; McCoy, Anne B.; Johnson, Mark A.			Deconstructing water's diffuse OH stretching vibrational spectrum with cold clusters	SCIENCE			English	Article							ALKALI-METAL IONS; SPECTROSCOPIC EVIDENCE; INFRARED-SPECTROSCOPY; DYNAMICS; LIQUID; SIGNATURES; MOLECULES; HEXAMER; COMPLEX; CAGE	The diffuse vibrational envelope displayed by water precludes direct observation of how different hydrogen-bond topologies dictate the spectral response of individual hydroxy group (OH) oscillators. Using cold, isotopically labeled cluster ions, we report the spectral signatures of a single, intact water (H2O) molecule embedded at various sites in the clathrate-like cage structure adopted by the Cs+center dot(D2O)(20) ion. These patterns reveal the site-dependent correlation between the frequencies of the two OH groups on the same water molecule and establish that the bound OH companion of the free OH group exclusively accounts for bands in the lower-energy region of the spectrum. The observed multiplet structures reveal the homogeneous linewidths of the fundamentals and quantify the anharmonic contributions arising from coupling to both the intramolecular bending and intermolecular soft modes.	[Yang, Nan; Duong, Chinh H.; Kelleher, Patrick J.; Johnson, Mark A.] Yale Univ, Sterling Chem Lab, New Haven, CT 06520 USA; [McCoy, Anne B.] Univ Washington, Dept Chem, Seattle, WA 98195 USA	Yale University; University of Washington; University of Washington Seattle	Johnson, MA (corresponding author), Yale Univ, Sterling Chem Lab, New Haven, CT 06520 USA.; McCoy, AB (corresponding author), Univ Washington, Dept Chem, Seattle, WA 98195 USA.	abmccoy@uw.edu; mark.johnson@yale.edu	Yang, Nan/ABD-1792-2020	Yang, Nan/0000-0003-1253-2154; Duong, Chinh/0000-0001-8026-1371; Kelleher, Patrick/0000-0003-2790-4942	National Science Foundation [CHE-1465100, CHE-1619660]; Air Force Office of Scientific Research under DURIP grant [FA9550-17-1-0267]; National Science Foundation Graduate Research Fellowship [DGE-1122492]; MRI grant from the National Science Foundation [CHE-1624430]	National Science Foundation(National Science Foundation (NSF)); Air Force Office of Scientific Research under DURIP grant(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); MRI grant from the National Science Foundation	M.A.J. thanks the National Science Foundation under grant CHE-1465100 for funding the research on the Cs<SUP>+</SUP> water clusters and the Air Force Office of Scientific Research under DURIP grant FA9550-17-1-0267 for funding the two-color, IR-IR tandem time-of-flight mass spectrometry instrument. C.H.D. thanks the National Science Foundation Graduate Research Fellowship for funding under grant DGE-1122492. A.B.M. thanks the National Science Foundation under grant CHE-1619660. Parts of this work were performed using the Ilahie cluster, which was purchased with funds from an MRI grant from the National Science Foundation (CHE-1624430).	Abel B, 2012, PHYS CHEM CHEM PHYS, V14, P22, DOI 10.1039/c1cp21803d; Anick DJ, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3397812; Auer BM, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2925258; Bakker HJ, 2010, CHEM REV, V110, P1498, DOI 10.1021/cr9001879; Bankura A, 2014, J PHYS CHEM C, V118, P29401, DOI 10.1021/jp506120t; Clarkson JR, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2713109; Clarkson JR, 2005, SCIENCE, V307, P1443, DOI 10.1126/science.1106977; Cole WTS, 2018, J CHEM PHYS, V148, DOI 10.1063/1.5006195; Cole WTS, 2017, J CHEM PHYS, V147, DOI 10.1063/1.4997046; Cooper RJ, 2013, J PHYS CHEM A, V117, P6571, DOI 10.1021/jp405147h; Corcelli SA, 2004, J CHEM PHYS, V120, P8107, DOI 10.1063/1.1683072; Craig SM, 2017, P NATL ACAD SCI USA, V114, pE4706, DOI 10.1073/pnas.1705089114; De Marco L, 2016, J CHEM PHYS, V145, DOI 10.1063/1.4961752; Dzugan LC, 2018, FARADAY DISCUSS, V212, P443, DOI 10.1039/c8fd00120k; Fournier JA, 2014, P NATL ACAD SCI USA, V111, P18132, DOI 10.1073/pnas.1420734111; Fournier JA, 2014, SCIENCE, V344, P1009, DOI 10.1126/science.1253788; Frisch M.J., 2016, GAUSSIAN 16; Gruenbaum SM, 2013, J CHEM THEORY COMPUT, V9, P3109, DOI 10.1021/ct400292q; Hammer NI, 2004, SCIENCE, V306, P675, DOI 10.1126/science.1102792; Hayashi T, 2005, J PHYS CHEM A, V109, P64, DOI 10.1021/jp046685x; HORNIG DF, 1958, SPECTROCHIM ACTA, V12, P338, DOI 10.1016/0371-1951(58)80060-0; Keutsch FN, 2001, P NATL ACAD SCI USA, V98, P10533, DOI 10.1073/pnas.191266498; Miyazaki M, 2004, SCIENCE, V304, P1134, DOI 10.1126/science.1096037; Nagata Y, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.226101; Ohno K, 2005, PHYS CHEM CHEM PHYS, V7, P3005, DOI 10.1039/b506641g; Paarmann A, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3139003; Perakis F, 2016, CHEM REV, V116, P7590, DOI 10.1021/acs.chemrev.5b00640; Perez C, 2014, ANGEW CHEM INT EDIT, V53, P14368, DOI 10.1002/anie.201407447; Perez C, 2012, SCIENCE, V336, P897, DOI 10.1126/science.1220574; Robertson WH, 2002, J PHYS CHEM A, V106, P1205, DOI 10.1021/jp0137468; Schaefer J, 2016, J PHYS CHEM LETT, V7, P4591, DOI 10.1021/acs.jpclett.6b02513; Schulz F, 2003, PHYS CHEM CHEM PHYS, V5, P5021, DOI 10.1039/b310657h; Schulz F, 2002, CHEMPHYSCHEM, V3, P98, DOI 10.1002/1439-7641(20020118)3:1<98::AID-CPHC98>3.0.CO;2-1; SELINGER A, 1991, J PHYS CHEM-US, V95, P8442, DOI 10.1021/j100175a008; Smit WJ, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.133003; Smith JD, 2004, SCIENCE, V306, P851, DOI 10.1126/science.1102560; Steinel T, 2004, CHEM PHYS LETT, V386, P295, DOI 10.1016/j.cplett.2004.01.042; Tabor DP, 2015, J PHYS CHEM A, V119, P9917, DOI 10.1021/acs.jpca.5b06954; Tainter CJ, 2013, J PHYS CHEM LETT, V4, P12, DOI 10.1021/jz301780k; Wei X, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.085401; Wolk AB, 2014, ACCOUNTS CHEM RES, V47, P202, DOI 10.1021/ar400125a; Wolke CT, 2016, SCIENCE, V354, P1131, DOI 10.1126/science.aaf8425; Wolke CT, 2016, J CHEM PHYS, V144, DOI 10.1063/1.4941285; Yang N, 2017, CHEM PHYS LETT, V690, P159, DOI 10.1016/j.cplett.2017.09.042; Young RM, 2012, CHEM REV, V112, P5553, DOI 10.1021/cr300042h; Zatula AS, 2012, INT J MASS SPECTROM, V330, P191, DOI 10.1016/j.ijms.2012.07.017	46	40	40	8	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2019	364	6437					275	+		10.1126/science.aaw4086	http://dx.doi.org/10.1126/science.aaw4086			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HU0JG	31000660				2022-12-28	WOS:000464956600048
J	Vrselja, Z; Daniele, SG; Silbereis, J; Talpo, F; Morozov, YM; Sousa, AMM; Tanaka, BS; Skarica, M; Pletikos, M; Kaur, N; Zhuang, ZW; Liu, Z; Alkawadri, R; Sinusas, AJ; Latham, SR; Waxman, SG; Sestan, N				Vrselja, Zvonimir; Daniele, Stefano G.; Silbereis, John; Talpo, Francesca; Morozov, Yury M.; Sousa, Andre M. M.; Tanaka, Brian S.; Skarica, Mario; Pletikos, Mihovil; Kaur, Navjot; Zhuang, Zhen W.; Liu, Zhao; Alkawadri, Rafeed; Sinusas, Albert J.; Latham, Stephen R.; Waxman, Stephen G.; Sestan, Nenad			Restoration of brain circulation and cellular functions hours post-mortem	NATURE			English	Article							COMPLETE ISCHEMIA; NEURONAL DEATH; MONKEY BRAIN; CARDIAC-ARREST; DOMESTIC PIG; RECOVERY; RESUSCITATION; METABOLISM; HIPPOCAMPUS; PERFUSION	The brains of humans and other mammals are highly vulnerable to interruptions in blood flow and decreases in oxygen levels. Here we describe the restoration and maintenance of microcirculation and molecular and cellular functions of the intact pig brain under ex vivo normothermic conditions up to four hours post-mortem. We have developed an extracorporeal pulsatile-perfusion system and a haemoglobin-based, acellular, non-coagulative, echogenic, and cytoprotective perfusate that promotes recovery from anoxia, reduces reperfusion injury, prevents oedema, and metabolically supports the energy requirements of the brain. With this system, we observed preservation of cytoarchitecture; attenuation of cell death; and restoration of vascular dilatory and glial inflammatory responses, spontaneous synaptic activity, and active cerebral metabolism in the absence of global electrocorticographic activity. These findings demonstrate that under appropriate conditions the isolated, intact large mammalian brain possesses an underappreciated capacity for restoration of microcirculation and molecular and cellular activity after a prolonged post-mortem interval.	[Vrselja, Zvonimir; Daniele, Stefano G.; Silbereis, John; Talpo, Francesca; Morozov, Yury M.; Sousa, Andre M. M.; Skarica, Mario; Pletikos, Mihovil; Kaur, Navjot; Sestan, Nenad] Yale Sch Med, Dept Neurosci, New Haven, CT 06510 USA; [Vrselja, Zvonimir; Daniele, Stefano G.; Silbereis, John; Talpo, Francesca; Morozov, Yury M.; Sousa, Andre M. M.; Skarica, Mario; Pletikos, Mihovil; Kaur, Navjot; Sestan, Nenad] Yale Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA; [Daniele, Stefano G.] Yale Sch Med, Med Scientist Training Program, New Haven, CT USA; [Talpo, Francesca] Univ Pavia, Dept Biol & Biotechnol L Spallanzani, Pavia, Italy; [Tanaka, Brian S.; Waxman, Stephen G.] Yale Sch Med, Ctr Neurosci & Regenerat Res, New Haven, CT USA; [Tanaka, Brian S.; Alkawadri, Rafeed; Waxman, Stephen G.] Yale Sch Med, Dept Neurol, New Haven, CT USA; [Tanaka, Brian S.; Waxman, Stephen G.] VA Connecticut Healthcare Syst, Rehabil Res Ctr, West Haven, CT USA; [Pletikos, Mihovil] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Zhuang, Zhen W.; Liu, Zhao; Sinusas, Albert J.] Yale Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT USA; [Liu, Zhao; Sinusas, Albert J.] Yale Sch Med, Dept Radiol & Biomed Imaging, New Haven, CT USA; [Alkawadri, Rafeed] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA; [Latham, Stephen R.] Yale Univ, Interdisciplinary Ctr Bioeth, New Haven, CT USA; [Sestan, Nenad] Yale Sch Med, Dept Genet, New Haven, CT 06510 USA; [Sestan, Nenad] Yale Sch Med, Dept Psychiat, New Haven, CT 06510 USA; [Sestan, Nenad] Yale Sch Med, Dept Comparat Med, New Haven, CT 06510 USA; [Sestan, Nenad] Yale Sch Med, Yale Child Study Ctr, New Haven, CT 06510 USA; [Sestan, Nenad] Yale Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; University of Pavia; Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Boston University; Yale University; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University	Sestan, N (corresponding author), Yale Sch Med, Dept Neurosci, New Haven, CT 06510 USA.; Sestan, N (corresponding author), Yale Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA.; Sestan, N (corresponding author), Yale Sch Med, Dept Genet, New Haven, CT 06510 USA.; Sestan, N (corresponding author), Yale Sch Med, Dept Psychiat, New Haven, CT 06510 USA.; Sestan, N (corresponding author), Yale Sch Med, Dept Comparat Med, New Haven, CT 06510 USA.; Sestan, N (corresponding author), Yale Sch Med, Yale Child Study Ctr, New Haven, CT 06510 USA.; Sestan, N (corresponding author), Yale Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06510 USA.	nenad.sestan@yale.edu	Talpo, Francesca/AAN-8720-2020; Waxman, Stephen/Z-2507-2019; Liu, Zhao/S-3351-2019; Sinusas, Albert J/A-7235-2009; Kaur, Navjot/V-9270-2019; Sousa, Andre M. M./C-1203-2015	Talpo, Francesca/0000-0003-3393-4451; Waxman, Stephen/0000-0001-5718-7177; Liu, Zhao/0000-0002-9847-7098; Kaur, Navjot/0000-0001-8514-203X; Daniele, Stefano/0000-0002-3987-1415; Morozov, Yury/0000-0002-3679-6819; Tanaka, Brian/0000-0002-6678-6478; Sousa, Andre M. M./0000-0003-1740-5066	NIH [MH113257]; NIH BRAIN Initiative [MH117064]; NIH shared instrument grant [OD021845]; NIH/NIGMS Medical Scientist Training Grant [T32GM007205]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH113257, RF1MH117064] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021845] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH BRAIN Initiative; NIH shared instrument grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIGMS Medical Scientist Training Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank HbO<INF>2</INF> Therapeutics, specifically J. Baqai, G. Dube, and R. Buskar, for providing the Hemopure product and their input in optimizing oxygen delivery methods; C. Aardema, D. Faulkner and R. Robertson for technical assistance and discussions on the perfusion system; T. Constable and M. Qiu for help with MRI imaging; A. Liu and T. Wing for assisting in ECoG discussions and data acquisition; and various members of our laboratory community for their comments on the manuscript. We thank A. Duque for assistance in using the equipment from the Yale Macaque Brain Resource, supported by NIH MH113257. This work was supported by the NIH BRAIN Initiative MH117064, NIH shared instrument grant OD021845, which funded purchase of the microSPECT/CT scanner, and NIH/NIGMS Medical Scientist Training Grant T32GM007205.	Albers GW, 2018, NEW ENGL J MED, V378, P708, DOI 10.1056/NEJMoa1713973; Barksdale KA, 2010, FASEB J, V24, P3590, DOI 10.1096/fj.09-152108; Borjigin J, 2013, P NATL ACAD SCI USA, V110, P14432, DOI 10.1073/pnas.1308285110; Budde MD, 2010, P NATL ACAD SCI USA, V107, P14472, DOI 10.1073/pnas.1004841107; Charpak S, 1998, P NATL ACAD SCI USA, V95, P4748, DOI 10.1073/pnas.95.8.4748; COLE SL, 1956, JAMA-J AM MED ASSOC, V161, P1454, DOI 10.1001/jama.1956.02970150022005; Conrad MS, 2012, DEV NEUROSCI-BASEL, V34, P291, DOI 10.1159/000339311; CRAIN BJ, 1988, NEUROSCIENCE, V27, P387; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Farahany NA, 2018, NATURE, V556, P429, DOI 10.1038/d41586-018-04813-x; Felix B, 1999, BRAIN RES BULL, V49, P1, DOI 10.1016/S0361-9230(99)00012-X; Greer DM, 2006, SEMIN NEUROL, V26, P373, DOI 10.1055/s-2006-948317; GRENELL RG, 1946, J NEUROPATH EXP NEUR, V5, P131, DOI 10.1097/00005072-194604000-00004; HAWS CW, 1983, J PHARMACOL EXP THER, V225, P24; HINZEN DH, 1972, AM J PHYSIOL, V223, P1158, DOI 10.1152/ajplegacy.1972.223.5.1158; HIRSCH H, 1957, PFLUG ARCH GES PHYS, V265, P281, DOI 10.1007/BF00364180; HIRSCH H, 1975, ARCH PSYCHIAT NERVEN, V221, P171, DOI 10.1007/BF00431053; HOLM IE, 1994, HIPPOCAMPUS, V4, P115, DOI 10.1002/hipo.450040112; HORN M, 1992, ACTA NEUROPATHOL, V85, P79, DOI 10.1007/BF00304636; HOSSMANN KA, 1970, SCIENCE, V168, P375, DOI 10.1126/science.168.3929.375; HOSSMANN KA, 1974, BRAIN RES, V81, P59, DOI 10.1016/0006-8993(74)90478-8; HOSSMANN KA, 1971, ELECTROEN CLIN NEURO, V30, P535, DOI 10.1016/0013-4694(71)90151-9; Hoxworth JM, 1999, BRAIN RES, V821, P467, DOI 10.1016/S0006-8993(98)01332-8; Hughes A, 2007, EMERG MED J, V24, P511, DOI 10.1136/emj.2006.040261; Keep RF, 2012, TRANSL STROKE RES, V3, P263, DOI 10.1007/s12975-012-0152-2; Kety SS, 1999, BRAIN RES BULL, V50, P415, DOI 10.1016/S0361-9230(99)00171-9; Kisler K, 2017, NAT REV NEUROSCI, V18, P419, DOI 10.1038/nrn.2017.48; KLEIHUES P, 1975, BRAIN RES, V95, P61, DOI 10.1016/0006-8993(75)90207-3; Kowalski J, 2016, HIPPOCAMPUS, V26, P668, DOI 10.1002/hipo.22550; Lam TI, 2013, P NATL ACAD SCI USA, V110, pE4362, DOI 10.1073/pnas.1313029110; Offiah CE, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20150851; Olmos-Serrano JL, 2016, NEURON, V89, P1208, DOI 10.1016/j.neuron.2016.01.042; Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038; Park KW, 2007, EXP MOL MED, V39, P812, DOI 10.1038/emm.2007.88; SARWAR M, 1978, RADIOLOGY, V127, P409, DOI 10.1148/127.2.409; Schmidt V., 2015, COMP ANATOMY PIG BRA; SCHMIDTKASTNER R, 1991, NEUROSCIENCE, V40, P599, DOI 10.1016/0306-4522(91)90001-5; Shin WH, 2004, GLIA, V46, P142, DOI 10.1002/glia.10357; SIESJO BK, 1981, J CEREBR BLOOD F MET, V1, P155, DOI 10.1038/jcbfm.1981.18; Simkin D, 2015, J NEUROSCI, V35, P13206, DOI 10.1523/JNEUROSCI.0193-15.2015; Stacy MR, 2014, CIRC-CARDIOVASC IMAG, V7, P92, DOI 10.1161/CIRCIMAGING.113.000884; STYS PK, 1991, ANN NEUROL, V30, P375, DOI 10.1002/ana.410300309; Verwer RWH, 2002, FASEB J, V16, P54, DOI 10.1096/fj.01-0504com; Viel JJ, 2001, J NEUROSCI RES, V64, P311, DOI 10.1002/jnr.1081; WAGNER SR, 1994, ANESTHESIOLOGY, V81, P1516, DOI 10.1097/00000542-199412000-00028; Watanabe H, 2001, NEUROIMAGE, V14, P1089, DOI 10.1006/nimg.2001.0910; ZIMMERMANN V, 1975, BRAIN RES, V85, P1, DOI 10.1016/0006-8993(75)90997-X	47	103	106	23	124	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 18	2019	568	7752					336	+		10.1038/s41586-019-1099-1	http://dx.doi.org/10.1038/s41586-019-1099-1			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HU0GZ	30996318	Green Submitted, Green Accepted			2022-12-28	WOS:000464950700045
J	Christie, B				Christie, Bryan			Safety checklist cuts risk of death after surgery in Scotland	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Ramsay G, 2019, BRIT J SURG, V106, P1005, DOI 10.1002/bjs.11151; World Health Organization, WHO SURG SAF CHECKL	2	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2019	365								l1826	10.1136/bmj.l1826	http://dx.doi.org/10.1136/bmj.l1826			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU8OY	30995978				2022-12-28	WOS:000465550000010
J	Iacobucci, G				Iacobucci, Gareth			UK hospital uses AI to predict which patients are most likely to miss appointments	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Nelson A, 2019, NPJ DIGIT MED, V2, DOI 10.1038/s41746-019-0103-3	1	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 15	2019	365								l1792	10.1136/bmj.l1792	http://dx.doi.org/10.1136/bmj.l1792			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU8OI	30988009				2022-12-28	WOS:000465548300007
J	Li, Y; Peng, YG; Han, L; Miri, MA; Li, W; Xiao, M; Zhu, XF; Zhao, JL; Alu, A; Fan, SH; Qiu, CW				Li, Ying; Peng, Yu-Gui; Han, Lei; Miri, Mohammad-Ali; Li, Wei; Xiao, Meng; Zhu, Xue-Feng; Zhao, Jianlin; Alu, Andrea; Fan, Shanhui; Qiu, Cheng-Wei			Anti-parity-time symmetry in diffusive systems	SCIENCE			English	Article								Various concepts related to parity-time symmetry, including anti-parity-time symmetry, have found broad applications in wave physics. Wave systems are fundamentally described by Hermitian operators, whereas their unusual properties are introduced by incorporation of gain and loss. We propose that the related physics need not be restricted to wave dynamics, and we consider systems described by diffusive dynamics. We study the heat transfer in two countermoving media and show that this system exhibits anti-parity-time symmetry. The spontaneous symmetry breaking results in a phase transition from motionless temperature profiles, despite the mechanical motion of the background, to moving temperature profiles. Our results extend the concepts of parity-time symmetry beyond wave physics and may offer opportunities to manipulate heat and mass transport.	[Li, Ying; Peng, Yu-Gui; Han, Lei; Qiu, Cheng-Wei] Natl Univ Singapore, Dept Elect & Comp Engn, Singapore 117583, Singapore; [Peng, Yu-Gui; Zhu, Xue-Feng] Huazhong Univ Sci & Technol, Sch Phys, Wuhan 430074, Hubei, Peoples R China; [Peng, Yu-Gui; Zhu, Xue-Feng] Huazhong Univ Sci & Technol, Innovat Inst, Wuhan 430074, Hubei, Peoples R China; [Han, Lei] Northwestern Polytech Univ, MOE Key Lab Mat Phys & Chem Extraordinary Condit, Sch Nat & Appl Sci, Xian 710072, Shaanxi, Peoples R China; [Han, Lei; Zhao, Jianlin] Northwestern Polytech Univ, Shaanxi Key Lab Opt Informat Technol, Sch Nat & Appl Sci, Xian 710072, Shaanxi, Peoples R China; [Miri, Mohammad-Ali; Alu, Andrea] Univ Texas Austin, Dept Elect & Comp Engn, Austin, TX 78712 USA; [Miri, Mohammad-Ali] CUNY Queens Coll, Dept Phys, Flushing, NY 11367 USA; [Li, Wei; Xiao, Meng; Fan, Shanhui] Stanford Univ, Ginzton Lab, Dept Elect Engn, Stanford, CA 94305 USA; [Xiao, Meng] Wuhan Univ, Sch Phys & Technol, Wuhan 430072, Hubei, Peoples R China; [Alu, Andrea] CUNY, Photon Initiat, Adv Sci Res Ctr, New York, NY 10031 USA; [Alu, Andrea] CUNY, Phys Program, Grad Ctr, New York, NY 10026 USA; [Alu, Andrea] CUNY City Coll, Dept Elect Engn, New York, NY 10031 USA	National University of Singapore; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Northwestern Polytechnical University; Northwestern Polytechnical University; University of Texas System; University of Texas Austin; City University of New York (CUNY) System; Queens College NY (CUNY); Stanford University; Wuhan University; City University of New York (CUNY) System; City University of New York (CUNY) System; City University of New York (CUNY) System; City College of New York (CUNY)	Qiu, CW (corresponding author), Natl Univ Singapore, Dept Elect & Comp Engn, Singapore 117583, Singapore.; Zhu, XF (corresponding author), Huazhong Univ Sci & Technol, Sch Phys, Wuhan 430074, Hubei, Peoples R China.; Zhu, XF (corresponding author), Huazhong Univ Sci & Technol, Innovat Inst, Wuhan 430074, Hubei, Peoples R China.; Fan, SH (corresponding author), Stanford Univ, Ginzton Lab, Dept Elect Engn, Stanford, CA 94305 USA.	xfzhu@hust.edu.cn; shanhui@stanford.edu; chengwei.qiu@nus.edu.sg	Li, Wei/C-5904-2017; Fan, Shanhui/B-4659-2012; Alu, Andrea/A-1328-2007; Li, Ying/AAG-7404-2019; Qiu, Cheng-Wei/AAI-6274-2021	Li, Wei/0000-0002-2227-9431; Alu, Andrea/0000-0002-4297-5274; Li, Ying/0000-0002-2730-7171; , meng/0000-0002-2087-3007; Han, Lei/0000-0002-2726-8125; Peng, Yu-Gui/0000-0001-6637-7108; zhu, xuefeng/0000-0002-1308-0834; Zhao, Jianlin/0000-0002-4619-1215	Ministry of Education, Singapore [R-263-000-C05-112]; National Natural Science Foundation of China [11674119, 11690030, 11690032]; Bird Nest Plan of HUST; U.S. Department of Energy [DE-FG-07ER46426]	Ministry of Education, Singapore(Ministry of Education, Singapore); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Bird Nest Plan of HUST; U.S. Department of Energy(United States Department of Energy (DOE))	C.-W.Q. acknowledges financial support from the Ministry of Education, Singapore (project R-263-000-C05-112). X.-F.Z. and Y.-G.P. acknowledge the financial support of the National Natural Science Foundation of China (grants 11674119, 11690030, and 11690032) and the Bird Nest Plan of HUST. W.L. and S.F. acknowledge the support of U.S. Department of Energy grant DE-FG-07ER46426.	Assawaworrarit S, 2017, NATURE, V546, P387, DOI 10.1038/nature22404; Bejan A., 2013, CONVECTION HEAT TRAN, DOI [10.1002/9781118671627, DOI 10.100219781118671627]; Bender CM, 2007, REP PROG PHYS, V70, P947, DOI 10.1088/0034-4885/70/6/R03; Bender CM, 1998, PHYS REV LETT, V80, P5243, DOI 10.1103/PhysRevLett.80.5243; Chang L, 2014, NAT PHOTONICS, V8, P524, DOI [10.1038/nphoton.2014.133, 10.1038/NPHOTON.2014.133]; Choi Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04690-y; Doppler J, 2016, NATURE, V537, P76, DOI 10.1038/nature18605; El-Ganainy R, 2018, NAT PHYS, V14, P11, DOI 10.1038/NPHYS4323; Feng L, 2014, SCIENCE, V346, P972, DOI 10.1126/science.1258479; Feng L, 2013, NAT MATER, V12, P108, DOI [10.1038/NMAT3495, 10.1038/nmat3495]; FEYNMAN RP, 1949, PHYS REV, V76, P749, DOI 10.1103/PhysRev.76.749; Fleury R, 2014, SCIENCE, V343, P516, DOI 10.1126/science.1246957; Franke-Arnold S, 2011, SCIENCE, V333, P65, DOI 10.1126/science.1203984; Guo A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.093902; Hassan AU, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.093002; Heiss WD, 2012, J PHYS A-MATH THEOR, V45, DOI 10.1088/1751-8113/45/44/444016; Hodaei H, 2014, SCIENCE, V346, P975, DOI 10.1126/science.1258480; Huang R, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.153601; Konotop VV, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.123902; Li Y, 2019, NAT MATER, V18, P48, DOI 10.1038/s41563-018-0239-6; Lin Z, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.213901; Makris KG, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.103904; Miri MA, 2019, SCIENCE, V363, P42, DOI 10.1126/science.aar7709; Morgado TA, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.133901; Peng B, 2014, SCIENCE, V346, P328, DOI 10.1126/science.1258004; Peng B, 2014, NAT PHYS, V10, P394, DOI [10.1038/nphys2927, 10.1038/NPHYS2927]; Peng P, 2016, NAT PHYS, V12, P1139, DOI [10.1038/NPHYS3842, 10.1038/nphys3842]; Regensburger A, 2012, NATURE, V488, P167, DOI 10.1038/nature11298; Ruter CE, 2010, NAT PHYS, V6, P192, DOI 10.1038/NPHYS1515; Silveirinha MG, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.013842; Silveirinha MG, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.031013; Torrent D, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.125501; Wong ZJ, 2016, NAT PHOTONICS, V10, P796, DOI [10.1038/NPHOTON.2016.216, 10.1038/nphoton.2016.216]; Wu JH, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.033811; Wu JH, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.123004; Xu H, 2016, NATURE, V537, P80, DOI 10.1038/nature18604; Yang F, 2017, PHYS REV A, V96, DOI 10.1103/PhysRevA.96.053845; Yoon JW, 2018, NATURE, V562, P86, DOI 10.1038/s41586-018-0523-2; Zhang XL, 2018, PHYS REV X, V8, DOI 10.1103/PhysRevX.8.021066; Zhu XF, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.031042	40	126	127	19	207	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2019	364	6436					170	+		10.1126/science.aaw6259	http://dx.doi.org/10.1126/science.aaw6259			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HT5RC	30975886				2022-12-28	WOS:000464620000040
J	Mayor, S				Mayor, Susan			GPs should lead process of defining diseases to cut overdiagnosis, panel recommends	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Moynihan R, 2019, BMJ EVID-BASED MED, V24, P170, DOI 10.1136/bmjebm-2018-111148	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2019	365								l1660	10.1136/bmj.l1660	http://dx.doi.org/10.1136/bmj.l1660			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU0EH	30967388				2022-12-28	WOS:000464943700009
J	Spetz, J; Toretsky, C; Chapman, S; Phoenix, B; Tierney, M				Spetz, Joanne; Toretsky, Christopher; Chapman, Susan; Phoenix, Bethany; Tierney, Matthew			Nurse Practitioner and Physician Assistant Waivers to Prescribe Buprenorphine and State Scope of Practice Restrictions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Spetz, Joanne; Toretsky, Christopher] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, 3333 Calif St,Ste 265, San Francisco, CA 94118 USA; [Chapman, Susan] Univ Calif San Francisco, Dept Social & Behav Sci, San Francisco, CA 94143 USA; [Phoenix, Bethany; Tierney, Matthew] Univ Calif San Francisco, Dept Community Hlth Syst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Spetz, J (corresponding author), Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, 3333 Calif St,Ste 265, San Francisco, CA 94118 USA.	Joanne.Spetz@ucsf.edu		Spetz, Joanne/0000-0003-3112-5511	National Council of State Boards of Nursing's Center for Regulatory Excellence [R101026]	National Council of State Boards of Nursing's Center for Regulatory Excellence	This research was supported by the National Council of State Boards of Nursing's Center for Regulatory Excellence (grant R101026).	American Association of Physician Assistants, 6 KEY EL MOD PA PRAC; Andrilla CHA, 2020, MED CARE RES REV, V77, P208, DOI 10.1177/1077558718793070; Andrilla CHA, 2019, J RURAL HEALTH, V35, P108, DOI 10.1111/jrh.12307; Jones CM, 2015, AM J PUBLIC HEALTH, V105, pE55, DOI 10.2105/AJPH.2015.302664; Phillips SJ, 2018, NURSE PRACT, V43, P27, DOI 10.1097/01.NPR.0000527569.36428.ed	5	44	44	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 9	2019	321	14					1407	1408		10.1001/jama.2019.0834	http://dx.doi.org/10.1001/jama.2019.0834			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HT5PG	30964519	Green Published, Bronze			2022-12-28	WOS:000464615200022
J	Goga, A; Singh, Y; Jackson, D; Pillay, Y; Bhardwaj, S; Chirinda, W; Hayashi, C; Essajee, S; Idele, P				Goga, Ameena; Singh, Yagespari; Jackson, Debra; Pillay, Yogan; Bhardwaj, Sanjana; Chirinda, Witness; Hayashi, Chika; Essajee, Shaffiq; Idele, Priscilla			Is elimination of vertical transmission of HIV in high prevalence settings achievable?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TO-CHILD TRANSMISSION		[Goga, Ameena; Singh, Yagespari; Chirinda, Witness] South African Med Res Council, Hlth Syst Res Unit, Cape Town, South Africa; [Goga, Ameena] Univ Pretoria, Dept Paediat, Pretoria, South Africa; [Jackson, Debra] Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa; [Jackson, Debra; Essajee, Shaffiq] Unicef, Hlth Sect, New York, NY USA; [Pillay, Yogan] Natl Dept Hlth, Pretoria, South Africa; [Bhardwaj, Sanjana] Unicef South Africa, Hlth Sect, Pretoria, South Africa; [Hayashi, Chika] Unicef, Data & Analyt Sect, New York, NY USA; [Idele, Priscilla] Innocenti, Unicef Off Res, Florence, Italy	South African Medical Research Council; University of Pretoria; University of the Western Cape; UNICEF; UNICEF	Goga, A (corresponding author), South African Med Res Council, Hlth Syst Res Unit, Cape Town, South Africa.; Goga, A (corresponding author), Univ Pretoria, Dept Paediat, Pretoria, South Africa.	AGogaAmeena.Goga@mrc.ac.za	Pillay, Yogan/AAW-4966-2021	Pillay, Yogan/0000-0003-2700-6181; Jackson, Debra/0000-0003-3307-632X	South African Medical Research Council (SAMRC)	South African Medical Research Council (SAMRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)South African Medical Research Council)	We have read and understood BMJ policy on declaration of interests and have no relevant interests to declare. The article was funded by the South African Medical Research Council (SAMRC). The views expressed in this paper are those of the authors not of the funders.	[Anonymous], 2020, HIGH POSS COST COVID; Barigye H, EVALUATION NAMIBIAS; Bhardwaj S, 2014, SAMJ S AFR MED J, V104, P239, DOI [10.7196/samj.7605, 10.7196/SAMJ.7605]; Dowdle W R, 1998, Bull World Health Organ, V76 Suppl 2, P22; Dowdle WR, 2011, VACCINE, V29, pD70, DOI 10.1016/j.vaccine.2011.04.006; Goga A, 2018, SAMJ S AFR MED J, V108, pS17, DOI [10.7196/SAMJ.2018.v108i3.12817, 10.7196/samj.2017.v108i3b.12817]; Goga A, BMC INFECT DIS; National Department of Health, 2015, 2013 NAT ANT HIV SEN; UNAIDS, 2016, FAST TRACK AIDS FREE; Unicef South African Medical Research Council Ministry of Health, 2016, TOG WE CAN IMPR CAS; Unicef UNFPA World Health Organization, 2011, ACH SUST MAT NEON TE; World Health Organization, 2017, GLOB GUID PROC CRIT; World Health Organization, 2002, PREV HIV INF YOUNG C; World Health Organization, 2002, STRAT APPR PREV HIV; World Health Organization, 2014, GLOB GUID CRIT PROC; World Health Organization, 2016, THAIL BEL ARM EL MOT; World Health Organization SEARO, 2016, THAIL IS 1 COUNTR AS; World Health Organization Unicef, 2016, 2016 GUID UPD HIV IN	18	7	7	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2019	364								l687	10.1136/bmj.l687	http://dx.doi.org/10.1136/bmj.l687			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HR5VS	30957782	Green Published, hybrid			2022-12-28	WOS:000463215700002
J	Scurt, FG; Ewert, L; Mertens, PR; Haller, H; Schmidt, BMW; Chatzikyrkou, C				Scurt, Florian G.; Ewert, Lara; Mertens, Peter R.; Haller, Hermann; Schmidt, Bernhard M. W.; Chatzikyrkou, Christos			Clinical outcomes after ABO-incompatible renal transplantation: a systematic review and meta-analysis	LANCET			English	Review							DONOR KIDNEY-TRANSPLANTATION; ANTIGEN-SPECIFIC IMMUNOADSORPTION; ANTIBODY-MEDIATED REJECTION; RITUXIMAB THERAPY; TRIALS; SPLENECTOMY; SURVIVAL; QUALITY; RISK; DESENSITIZATION	Background ABO-incompatible renal transplantation (ABOi-rTx) is increasingly used to overcome organ shortage. Evidence about its non-inferiority in comparison with ABO-compatible renal transplantation (ABOc-rTx) needs to be analysed at early and late timepoints. We aimed to investigate differences in outcome after ABOi-rTX and ABOc-rTX. Methods We did a systematic review and meta-analysis of observational studies published up until Dec 31, 2017, that reported outcome data (>= 1 year of follow-up) after ABOi-rTx and included an ABO-compatible control group, by searching the Cochrane Central Register of Controlled Trials (CENTRAL), Embase Ovid, MEDLINE Ovid, and PubMed. Trials on recipients of ABOi-rTx were assessed, if an ABO-compatible control group was included and if outcome data on at least graft or recipient survival with 1 year or more of follow-up were available. Exclusion criteria included case reports, editorials, reviews and letters, animal studies, meeting papers, studies unable to extract data, non-renal solid organ and bone-marrow transplant studies, and deceased donor ABOc-rTx. Data were extracted from published reports. Primary endpoints were all-cause mortality and graft survival at 1, 3, 5, and more than 8 years after transplantation. In the meta-analysis, we used a fixed-effects model if the I (2) value was 0, and both a fixed-effects and random-effects model if I-2 was more than 0. This study is registered with PROSPERO, number CRD42018094550. Findings 1264 studies were screened and 40 studies including 49 patient groups were identified. 65 063 patients were eligible for analysis, 7098 of whom had undergone ABOi-rTx. Compared with ABOc-rTx, ABOi-rTx was associated with significantly higher 1-year mortality (odds ratio [OR] 2.17 [95% CI 1.63-2.90], p<0.0001; I-2=37%), 3 years (OR 1.89 [1.46-2.45], p<0.0001; I-2=29%), and 5 years (OR 1.47 [1.08-2.00], p=0.010; I-2=68%) following transplantation. Death-censored graft survival was lower with ABOi-rTx than with ABOc-rTx at 1 year (OR 2.52 [1.80-3.54], p<0.0001; I-2=61%) and 3 years (OR 1.59 [1.15-2.18], p=0.0040; I-2=58%) only. Graft losses were equivalent to that of ABOc-rTx after 5 years and patient survival after 8 years. No publication bias was detected and the results were robust to trial sequential analysis until 5 years after transplantation; thereafter, data became futile or inconclusive. Interpretation Despite progress in desensitisation protocols and optimisation of ABOi-rTx procedures, excess mortality and loss of kidney grafts was found compared with ABOc-rTx within the first 3 years after transplantation. Only long-term outcomes after 5 years yielded equivalent survival rates and organ function. Awareness of the increased risks of infection, organ rejection, and bleeding could improve care of patients and promote efforts towards paired kidney exchange programmes. Copyright (C) 2019 Elsevier Ltd. All rights reserved.	[Scurt, Florian G.; Ewert, Lara; Mertens, Peter R.; Chatzikyrkou, Christos] Otto von Guericke Univ, Clin Nephrol & Hypertens Diabetol & Endocrinol, Hlth Campus Immunol Infectiol & Inflammat, Magdeburg, Germany; [Haller, Hermann; Schmidt, Bernhard M. W.] Hannover Med Sch, Dept Hypertens & Nephrol, Hannover, Germany	Otto von Guericke University; Hannover Medical School	Scurt, FG; Chatzikyrkou, C (corresponding author), Otto von Guericke Univ, Clin Nephrol Hypertens Endocrinol & Diabetol, D-39120 Magdeburg, Germany.	florian.scurt@med.ovgu.de	Chatzikyrkou, Christos/AAX-9470-2020; Mertens, Peter/AAI-7310-2020; Chatzikyrkou, Christos/AAJ-8934-2020		Deutsche Forschungsgemeinschaft [SFB 854];  [ME-1365/7-2];  [ME-1365/9-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ; 	PRM, FGS, and CC are supported by the Deutsche Forschungsgemeinschaft SFB 854 (project A01), and grants ME-1365/7-2, ME-1365/9-2.	Ashimine S, 2014, KIDNEY INT, V85, P425, DOI 10.1038/ki.2013.291; Axelrod D, 2016, AM J TRANSPLANT, V16, P1465, DOI 10.1111/ajt.13616; Baek CH, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0201-7; Barbosa D, 2014, TRANSPLANTATION, V97, P755, DOI 10.1097/01.TP.0000437671.78716.f3; Barnett ANR, 2014, TRANSPL INT, V27, P187, DOI 10.1111/tri.12234; Becker LE, 2015, TRANSPLANTATION, V99, P2364, DOI 10.1097/TP.0000000000000753; Bentall A, 2016, TRANSFUSION, V56, P2668, DOI 10.1111/trf.13770; Bentall A, 2015, TRANSPLANTATION, V99, pE8, DOI 10.1097/TP.0000000000000483; Chow KV, 2017, TRANSPLANTATION, V101, P1433, DOI 10.1097/TP.0000000000001415; Copenhagen Trial Unit, 2017, TRIAL SEQ AN TSA; Cuffy MC, 2015, AM J TRANSPLANT, V15, P1484, DOI 10.1111/ajt.13218; de Weerd AE, 2015, TRANSPL INT, V28, P25, DOI 10.1111/tri.12412; Deeks J.J., 2010, STAT ALGORITHMS REV; Delamothe T, 2004, BMJ-BRIT MED J, V328, P1, DOI 10.1136/bmj.328.7430.1; DEMETS DL, 1987, STAT MED, V6, P341, DOI 10.1002/sim.4780060325; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dorje C, 2015, CLIN TRANSPLANT, V29, P268, DOI 10.1111/ctr.12515; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; EVANS RW, 1985, NEW ENGL J MED, V312, P553, DOI 10.1056/NEJM198502283120905; Flint SM, 2011, AM J TRANSPLANT, V11, P1016, DOI 10.1111/j.1600-6143.2011.03464.x; Fuchinoue S, 2011, TRANSPLANTATION, V91, P853, DOI 10.1097/TP.0b013e31820f08e8; Galliford J, 2008, TRANSPLANTATION, V86, P901, DOI 10.1097/TP.0b013e3181880c0f; Genberg H, 2008, TRANSPLANTATION, V85, P1745, DOI 10.1097/TP.0b013e3181726849; Genberg H, 2011, NEPHROL DIAL TRANSPL, V26, P2394, DOI 10.1093/ndt/gfr237; GJORSTRUP P, 1990, TRANSFUS SCI, V11, P281, DOI 10.1016/0955-3886(90)90028-H; Gloor JM, 2003, TRANSPLANTATION, V75, P971, DOI 10.1097/01.TP.0000058226.397.32; Glorie K, 2014, TRANSPL INT, V27, P333, DOI 10.1111/tri.12202; Gulleroglu K, 2016, EXP CLIN TRANSPLANT, V14, P172, DOI 10.6002/ect.2014.0156; Habicht A, 2011, NEPHROL DIAL TRANSPL, V26, P4124, DOI 10.1093/ndt/gfr215; Hatakeyama S, 2014, TRANSPL P, V46, P445, DOI 10.1016/j.transproceed.2013.09.036; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Higgins JPT, 2011, STAT MED, V30, P903, DOI 10.1002/sim.4088; Hosokawa S, 1990, J Clin Apher, V5, P197, DOI 10.1002/jca.2920050406; HUME DM, 1955, J CLIN INVEST, V34, P327, DOI 10.1172/JCI103085; Hwang JK, 2013, TRANSPL P, V45, P2931, DOI 10.1016/j.transproceed.2013.08.038; Jakobsen JC, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000111; Jakobsen JC, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-120; Jeon BJ, 2010, KOREAN J UROL, V51, P863, DOI 10.4111/kju.2010.51.12.863; Kaihara S, 2005, TRANSPLANT P, V37, P1804, DOI 10.1016/j.transproceed.2005.02.107; Kamar N, 2010, AM J TRANSPLANT, V10, P89, DOI 10.1111/j.1600-6143.2009.02785.x; Ko EJ, 2017, TRANSPL INT, V30, P1215, DOI 10.1111/tri.12979; Kohei N, 2012, AM J TRANSPLANT, V12, P469, DOI 10.1111/j.1600-6143.2011.03830.x; Kwon H, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004249; Lentine KL, 2014, TRANSPLANTATION, V98, P54, DOI 10.1097/TP.0000000000000029; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mascha EJ, 2015, ANESTH ANALG, V121, P1430, DOI 10.1213/ANE.0000000000000993; Masterson R, 2014, AM J TRANSPLANT, V14, P2807, DOI 10.1111/ajt.12920; Melexopoulou Christina, 2015, World J Transplant, V5, P329, DOI 10.5500/wjt.v5.i4.329; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Montgomery JR, 2012, TRANSPLANTATION, V93, P603, DOI 10.1097/TP.0b013e318245b2af; Morath C, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00234; Okumi M, 2016, AM J TRANSPLANT, V16, P886, DOI 10.1111/ajt.13502; Opelz G, 2015, TRANSPLANTATION, V99, P1197, DOI 10.1097/TP.0000000000000522; Orandi BJ, 2016, NEW ENGL J MED, V374, P940, DOI 10.1056/NEJMoa1508380; Pogue JM, 1997, CONTROL CLIN TRIALS, V18, P580, DOI 10.1016/S0197-2456(97)00051-2; PORT FK, 1993, JAMA-J AM MED ASSOC, V270, P1339, DOI 10.1001/jama.270.11.1339; RUSSELL JD, 1992, TRANSPLANTATION, V54, P656, DOI 10.1097/00007890-199210000-00018; Sautenet B, 2017, TRANSPLANTATION, V101, P1875, DOI 10.1097/TP.0000000000001776; Sharif A, 2012, CLIN J AM SOC NEPHRO, V7, P1320, DOI 10.2215/CJN.00770112; Takahashi K, 2006, XENOTRANSPLANTATION, V13, P118, DOI 10.1111/j.1399-3089.2006.00278.x; Takahashi K, 2004, AM J TRANSPLANT, V4, P1089, DOI 10.1111/j.1600-6143.2004.00464.x; Takahashi K, 2013, TRANSPLANT REV-ORLAN, V27, P1, DOI 10.1016/j.trre.2012.07.003; Tanabe K, 1998, TRANSPLANTATION, V65, P224; Terasaki P, 2006, CLIN J AM SOC NEPHRO, V1, P400, DOI 10.2215/CJN.02311205; Thorlund K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039471; Tong A, 2017, TRANSPLANTATION, V101, P1887, DOI 10.1097/TP.0000000000001774; Turner RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059202; Tyden G, 2005, AM J TRANSPLANT, V5, P145, DOI 10.1111/j.1600-6143.2004.00653.x; Tyden G, 2007, TRANSPLANTATION, V83, P1153, DOI 10.1097/01.tp.0000262570.18117.55; van den Hoogen MWF, 2015, AM J TRANSPLANT, V15, P407, DOI 10.1111/ajt.13052; Wells G., NEWCASTLE OTTAWA SCA; Wetterslev J, 2008, J CLIN EPIDEMIOL, V61, P64, DOI 10.1016/j.jclinepi.2007.03.013; Wetterslev J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008884.pub2; Wetterslev J, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-86; Yu JH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173878; 2009, TRANSPLANTATION, V87, P1889, DOI DOI 10.1097/TP.0B013E3181A76AE1; 2015, TRANSPLANTATION, V99, P400, DOI DOI 10.1097/TP.0000000000000312; 2016, NEPHROL DIAL TRANSPL, V31, P663, DOI DOI 10.1093/NDT/GFV388; 2010, NEPHROL DIAL TRANSPL, V25, P3778, DOI DOI 10.1093/NDT/GFQ229; 2015, TRANSPL P, V47, P1720, DOI DOI 10.1016/J.TRANSPROCEED.2015.05.026; 2016, NEPHROL DIAL TRANSPL, V31, P1013, DOI DOI 10.1093/NDT/GFW017; 2012, TRANSPL P, V44, P214, DOI DOI 10.1016/J.TRANSPROCEED.2011.12.017; 2008, AM J TRANSPLANT, V8, P86, DOI DOI 10.1111/J.1600-6143.2007.02036.X; 2006, TRANSPLANTATION, V82, P155, DOI DOI 10.1097/01.TP.0000226152.13584.AE; 2017, CLIN NEPHROL, V88, P117, DOI DOI 10.5414/CN109114; 2009, AM J TRANSPLANT, V9, P1279, DOI DOI 10.1111/J.1600-6143.2009.02606.X; 2009, CONTRIB NEPHROL, V162, P61; 2016, KIDNEY RES CLIN PRAC, V35, P50, DOI DOI 10.1016/J.KRCP.2015.11.001; 2009, PROTEOM CLIN APPL, V3, P797, DOI DOI 10.1002/PRCA.200800232; 2016, CLIN TRANSPLANT, V30, P872, DOI DOI 10.1111/CTR.12759	90	54	55	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 18	2019	393	10185					2059	2072		10.1016/S0140-6736(18)32091-9	http://dx.doi.org/10.1016/S0140-6736(18)32091-9			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HY4QC	31006573				2022-12-28	WOS:000468112000029
J	Saito, Y; Li, L; Coyaud, E; Luna, A; Sander, C; Raught, B; Asara, JM; Brown, M; Muthuswamy, SK				Saito, Yasuhiro; Li, Lewyn; Coyaud, Etienne; Luna, Augustin; Sander, Chris; Raught, Brian; Asara, John M.; Brown, Myles; Muthuswamy, Senthil K.			LLGL2 rescues nutrient stress by promoting leucine uptake in ER+ breast cancer	NATURE			English	Article							ESTROGEN-RECEPTOR BINDING; AMINO-ACID TRANSPORTER-1; PROGESTERONE-RECEPTOR; MECHANISMS; EXPRESSION; INHIBITOR; POLARITY; DOMAIN; CELLS; LAT1	Drosophila Lgl and its mammalian homologues, LLGL1 and LLGL2, are scaffolding proteins that regulate the establishment of apical-basal polarity in epithelial cells(1,2). Whereas Lgl functions as a tumour suppressor in Drosophila(1), the roles of mammalian LLGL1 and LLGL2 in cancer are unclear. The majority (about 75%) of breast cancers express oestrogen receptors (ERs)(3), and patients with these tumours receive endocrine treatment(4). However, the development of resistance to endocrine therapy and metastatic progression are leading causes of death for patients with ER+ disease(4). Here we report that, unlike LLGL1, LLGL2 is overexpressed in ER+ breast cancer and promotes cell proliferation under nutrient stress. LLGL2 regulates cell surface levels of a leucine transporter, SLC7A5, by forming a trimeric complex with SLC7A5 and a regulator of membrane fusion, YKT6, to promote leucine uptake and cell proliferation. The oestrogen receptor targets LLGL2 expression. Resistance to endocrine treatment in breast cancer cells was associated with SLC7A5- and LLGL2-dependent adaption to nutrient stress. SLC7A5 was necessary and sufficient to confer resistance to tamoxifen treatment, identifying SLC7A5 as a potential therapeutic target for overcoming resistance to endocrine treatments in breast cancer. Thus, LLGL2 functions as a promoter of tumour growth and not as a tumour suppressor in ER+ breast cancer. Beyond breast cancer, adaptation to nutrient stress is critically important(5), and our findings identify an unexpected role for LLGL2 in this process.	[Saito, Yasuhiro; Muthuswamy, Senthil K.] Harvard Med Sch, Dept Med, Canc Res Inst, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Saito, Yasuhiro; Muthuswamy, Senthil K.] Harvard Med Sch, Dept Pathol, Canc Res Inst, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Saito, Yasuhiro] Keio Univ, Inst Adv Biosci, Yamagata, Japan; [Li, Lewyn; Brown, Myles] Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02115 USA; [Li, Lewyn; Brown, Myles] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Coyaud, Etienne; Raught, Brian] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Coyaud, Etienne; Raught, Brian] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Luna, Augustin; Sander, Chris] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Asara, John M.] Harvard Med Sch, Div Signal Transduct, Dept Med, Canc Res Inst,Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Keio University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Harvard University; Dana-Farber Cancer Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Muthuswamy, SK (corresponding author), Harvard Med Sch, Dept Med, Canc Res Inst, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.; Muthuswamy, SK (corresponding author), Harvard Med Sch, Dept Pathol, Canc Res Inst, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.	smuthusw@bidmc.harvard.edu	Muthuswamy, Senthil K/AGY-2834-2022; COYAUD, Etienne/ABD-9726-2020; Brown, Myles/B-6906-2008; Brown, Myles/AAX-5332-2021	Muthuswamy, Senthil K/0000-0001-6564-9634; COYAUD, Etienne/0000-0002-5893-4557; Brown, Myles/0000-0002-8213-1658	National Institutes of Health (NIH) [5P01CA120964]; Human Frontier Science Program [LT000091/2014]; Yamagata prefectural government; City of Tsuruoka; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE [P01CA120964] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); Yamagata prefectural government; City of Tsuruoka; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the Muthuswamy laboratory for discussions, R. Schiff for TamR cells, T. Xiao for advice on CRISPR-Cas9, J. Zoeller for advice on mouse experiments, F. Au-Yeung for assistance with BioID experiments, and M. Yuan for assistance with mass spectrometry. The work was supported by funding from the National Institutes of Health (NIH) (grant 5P01CA120964; J.M.A.), a long term postdoctoral fellowship (LT000091/2014) from the Human Frontier Science Program and research funds from the Yamagata prefectural government and the City of Tsuruoka (Y.S.), and the Breast Cancer Research Foundation (S.K.M.).	Betsunoh H, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-509; Bhutia YD, 2015, CANCER RES, V75, P1782, DOI 10.1158/0008-5472.CAN-14-3745; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Cantor JR, 2017, CELL, V169, P258, DOI 10.1016/j.cell.2017.03.023; Choi H, 2011, NAT METHODS, V8, P70, DOI 10.1038/NMETH.1541; CLARK GM, 1984, J CLIN ONCOL, V2, P1102, DOI 10.1200/JCO.1984.2.10.1102; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Dingar D, 2015, J PROTEOMICS, V118, P95, DOI 10.1016/j.jprot.2014.09.029; Dong W, 2015, J CELL BIOL, V211, P273, DOI 10.1083/jcb.201503067; Efeyan A, 2015, NATURE, V517, P302, DOI 10.1038/nature14190; Eng JK, 2013, PROTEOMICS, V13, P22, DOI 10.1002/pmic.201200439; Franco HL, 2015, MOL CELL, V58, P21, DOI 10.1016/j.molcel.2015.02.001; Fukasawa M, 2004, P NATL ACAD SCI USA, V101, P4815, DOI 10.1073/pnas.0401183101; Kessner D, 2008, BIOINFORMATICS, V24, P2534, DOI 10.1093/bioinformatics/btn323; Kim CS, 2008, BIOL PHARM BULL, V31, P1096, DOI 10.1248/bpb.31.1096; Kobayashi H, 2005, J SURG ONCOL, V90, P233, DOI 10.1002/jso.20257; Kongpracha P, 2017, J PHARMACOL SCI, V133, P96, DOI 10.1016/j.jphs.2017.01.006; Lu J, 2017, ONCOGENE, V36, P231, DOI 10.1038/onc.2016.194; Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; Mohammed H, 2015, NATURE, V523, P313, DOI 10.1038/nature14583; Nakanishi K, 2006, VIRCHOWS ARCH, V448, P142, DOI 10.1007/s00428-005-0063-7; Nawashiro H, 2006, INT J CANCER, V119, P484, DOI 10.1002/ijc.21866; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Qin Q, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1274-4; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Roux KJ, 2013, CURR PROTOC PROTEIN, V19, P1; Sabbah M, 1999, P NATL ACAD SCI USA, V96, P11217, DOI 10.1073/pnas.96.20.11217; Saito Y, 2010, J EXP MED, V207, P2157, DOI 10.1084/jem.20100602; Shaw FL, 2012, J MAMMARY GLAND BIOL, V17, P111, DOI 10.1007/s10911-012-9255-3; Szasz AM, 2016, ONCOTARGET, V7, P49322, DOI 10.18632/oncotarget.10337; Tavera-Mendoza LE, 2017, LAB ANIM-UK, V51, P85, DOI 10.1177/0023677216640706; Timmerman LA, 2013, CANCER CELL, V24, P450, DOI 10.1016/j.ccr.2013.08.020; Wang Q, 2015, AM J CANCER RES, V5, P1281; Wang Q, 2011, CANCER RES, V71, P7525, DOI 10.1158/0008-5472.CAN-11-1821; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024; 1989, CANC RES, V49, P6670	37	74	74	2	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 9	2019	569	7755					275	+		10.1038/s41586-019-1126-2	http://dx.doi.org/10.1038/s41586-019-1126-2			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HX5VX	30996345				2022-12-28	WOS:000467473600052
J	Shi, Y; Gao, WN; Lytle, NK; Huang, PW; Yuan, X; Dann, AM; Ridinger-Saison, M; DelGiorno, KE; Antal, CE; Liang, GY; Atkins, AR; Erikson, G; Sun, HY; Meisenhelder, J; Terenziani, E; Woo, G; Fang, LJ; Santisakultarm, TP; Manor, U; Xu, RL; Becerra, CR; Borazanci, E; Von Hoff, DD; Grandgenett, PM; Hollingsworth, MA; Leblanc, M; Umetsu, SE; Collisson, EA; Scadeng, M; Lowy, AM; Donahue, TR; Reya, T; Downes, M; Evans, RM; Wahl, GM; Pawson, T; Tian, R; Hunter, T				Shi, Yu; Gao, Weina; Lytle, Nikki K.; Huang, Peiwu; Yuan, Xiao; Dann, Amanda M.; Ridinger-Saison, Maya; DelGiorno, Kathleen E.; Antal, Corina E.; Liang, Gaoyang; Atkins, Annette R.; Erikson, Galina; Sun, Huaiyu; Meisenhelder, Jill; Terenziani, Elena; Woo, Gyunghwi; Fang, Linjing; Santisakultarm, Thom P.; Manor, Uri; Xu, Ruilian; Becerra, Carlos R.; Borazanci, Erkut; Von Hoff, Daniel D.; Grandgenett, Paul M.; Hollingsworth, Michael A.; Leblanc, Mathias; Umetsu, Sarah E.; Collisson, Eric A.; Scadeng, Miriam; Lowy, Andrew M.; Donahue, Timothy R.; Reya, Tannishtha; Downes, Michael; Evans, Ronald M.; Wahl, Geoffrey M.; Pawson, Tony; Tian, Ruijun; Hunter, Tony			Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring	NATURE			English	Article							LEUKEMIA INHIBITORY FACTOR; DUCTAL ADENOCARCINOMA INITIATION; STEM-CELLS; DISTINCT POPULATIONS; STELLATE CELL; PROMOTES; STAT3; IDENTIFICATION; PROGRESSION; FIBROBLASTS	Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis largely owing to inefficient diagnosis and tenacious drug resistance. Activation of pancreatic stellate cells (PSCs) and consequent development of dense stroma are prominent features accounting for this aggressive biology(1,2). The reciprocal interplay between PSCs and pancreatic cancer cells (PCCs) not only enhances tumour progression and metastasis but also sustains their own activation, facilitating a vicious cycle to exacerbate tumorigenesis and drug resistance(3-7). Furthermore, PSC activation occurs very early during PDAC tumorigenesis(8-10), and activated PSCs comprise a substantial fraction of the tumour mass, providing a rich source of readily detectable factors. Therefore, we hypothesized that the communication between PSCs and PCCs could be an exploitable target to develop effective strategies for PDAC therapy and diagnosis. Here, starting with a systematic proteomic investigation of secreted disease mediators and underlying molecular mechanisms, we reveal that leukaemia inhibitory factor (LIF) is a key paracrine factor from activated PSCs acting on cancer cells. Both pharmacologic LIF blockade and genetic Lifr deletion markedly slow tumour progression and augment the efficacy of chemotherapy to prolong survival of PDAC mouse models, mainly by modulating cancer cell differentiation and epithelial-mesenchymal transition status. Moreover, in both mouse models and human PDAC, aberrant production of LIF in the pancreas is restricted to pathological conditions and correlates with PDAC pathogenesis, and changes in the levels of circulating LIF correlate well with tumour response to therapy. Collectively, these findings reveal a function of LIF in PDAC tumorigenesis, and suggest its translational potential as an attractive therapeutic target and circulating marker. Our studies underscore how a better understanding of cell-cell communication within the tumour microenvironment can suggest novel strategies for cancer therapy.	[Shi, Yu; Sun, Huaiyu; Meisenhelder, Jill; Terenziani, Elena; Woo, Gyunghwi; Hunter, Tony] Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Gao, Weina; Huang, Peiwu; Yuan, Xiao; Tian, Ruijun] Southern Univ Sci & Technol, Dept Chem, Shenzhen, Peoples R China; [Gao, Weina; Huang, Peiwu; Yuan, Xiao; Tian, Ruijun] Southern Univ Sci & Technol, Shenzhen Key Lab Cell Microenvironm, Shenzhen, Peoples R China; [Lytle, Nikki K.; Reya, Tannishtha] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Lytle, Nikki K.; Reya, Tannishtha] Sanford Consortium Regenerat Med, La Jolla, CA USA; [Huang, Peiwu] Hong Kong Baptist Univ, Dept Chem, State Key Lab Environm & Biol Anal, Hong Kong, Peoples R China; [Dann, Amanda M.; Donahue, Timothy R.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Ridinger-Saison, Maya; DelGiorno, Kathleen E.; Antal, Corina E.; Liang, Gaoyang; Atkins, Annette R.; Leblanc, Mathias; Downes, Michael; Evans, Ronald M.; Wahl, Geoffrey M.] Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Erikson, Galina] Salk Inst Biol Studies, Integrat Genom & Bioinformat Core, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Fang, Linjing; Santisakultarm, Thom P.; Manor, Uri] Salk Inst Biol Studies, Waitt Adv Biophoton Ctr, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Xu, Ruilian] Shenzhen Peoples Hosp, Inst Oncol, Shenzhen, Peoples R China; [Becerra, Carlos R.] Baylor Univ, Med Ctr, Texas Oncol, Dallas, TX USA; [Borazanci, Erkut; Von Hoff, Daniel D.] Translat Genom Res Inst, Scottsdale, AZ USA; [Borazanci, Erkut; Von Hoff, Daniel D.] HonorHealth, Scottsdale, AZ USA; [Grandgenett, Paul M.; Hollingsworth, Michael A.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Fred & Pamela Buffett Canc Ctr, Omaha, NE USA; [Umetsu, Sarah E.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Collisson, Eric A.] Univ Calif San Francisco, Dept Med, Hematol Oncol, San Francisco, CA USA; [Scadeng, Miriam] Univ Calif San Diego, Dept Radiol, Ctr Funct MRI, La Jolla, CA 92093 USA; [Lowy, Andrew M.] Univ Calif San Diego, Sch Med, Dept Surg, Div Surg Oncol, La Jolla, CA 92093 USA; [Reya, Tannishtha] Univ Calif San Diego, Sch Med, Moores Canc Ctr, La Jolla, CA 92093 USA; [Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Pawson, Tony; Tian, Ruijun] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Pawson, Tony] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Ridinger-Saison, Maya] Trovagene, San Diego, CA USA; [Terenziani, Elena] Crown Biosci San Diego, San Diego, CA USA	Salk Institute; Southern University of Science & Technology; Southern University of Science & Technology; University of California System; University of California San Diego; Hong Kong Baptist University; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Salk Institute; Salk Institute; Salk Institute; Jinan University; Baylor University; Baylor University Medical Center; Texas Oncology; Translational Genomics Research Institute; University of Nebraska System; University of Nebraska Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; Salk Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Shi, Y; Hunter, T (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.; Tian, R (corresponding author), Southern Univ Sci & Technol, Dept Chem, Shenzhen, Peoples R China.; Tian, R (corresponding author), Southern Univ Sci & Technol, Shenzhen Key Lab Cell Microenvironm, Shenzhen, Peoples R China.; Tian, R (corresponding author), Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada.	yshi@salk.edu; tianrj@sustech.edu.cn; hunter@salk.edu	DelGiorno, Kathy/AAJ-9911-2021; Tian, Ruijun/J-3019-2014; Shi, Yu/N-4319-2019	DelGiorno, Kathy/0000-0002-5749-8394; Shi, Yu/0000-0001-6742-9598; Borazanci, Erkut/0000-0001-5136-5462; Evans, Ronald/0000-0002-9986-5965; Atkins, Annette/0000-0003-2558-7058; Scadeng, Miriam/0000-0002-9593-2956; Tian, Ruijun/0000-0001-9521-5124	Ministry of Science and Technology of China [2016YFA0501403]; National Natural Science Foundation of China [21575057]; NIH [CA014195, CA082683, CA080100, P50CA127297, U01CA210240, P30CA36727, 5R50CA211462, CA178015, CA227807, CA222862, CA197699, CA186043, CA155620]; Lustgarten Foundation [388246, 552873]; Helmsley Charitable Trust [2012-PG-MED002]; William Isacoff Research Foundation; SU2C Pancreatic Cancer Dream Team [SU2C-AACR-DT-05-09, SU2C-AACR-DT-20-16]; NRSA [F31CA206416, T32GM007752, F32CA217033]; Flinn Foundation; Lustgarten; Ipsen/Biomeasure; Freeberg; NCI [CCSG CA014195]; Helmsley Charitable Trust; NATIONAL CANCER INSTITUTE [R01CA080100, R01CA155620, P50CA127297, R01CA082683, R01CA186043, F32CA217033, R01CA178015, R50CA211462, R01CA222862, R35CA197699, P30CA014195, R01CA227807, U01CA210240, F31CA206416] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lustgarten Foundation; Helmsley Charitable Trust; William Isacoff Research Foundation; SU2C Pancreatic Cancer Dream Team; NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flinn Foundation; Lustgarten; Ipsen/Biomeasure(Ipsen); Freeberg; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Helmsley Charitable Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank .F McCormick and M. Wang (UCSF) for sharing reagents and results, R. Shaw (Salk) for KP<SUP>f/f</SUP>L mice, M. Karin (UCSD) for mouse cancer samples and comments on the manuscript, H. Han and E. Menashi (Tgen) for experimental suggestions and reagents, J. Zimmerman and S. Simon for laboratory support, N. Cernac and J. Chang for laboratory assistance, J. Chambers and K. Suter-Brady for animal work, T. Zhang and K. Mcintyre for histology services. This work was supported by the following grants: Ministry of Science and Technology of China (2016YFA0501403) and National Natural Science Foundation of China (21575057) to R.T; NIH CA014195, CA082683, CA080100, Lustgarten Foundation (awards 388246 and 552873), Helmsley Charitable Trust (2012-PG-MED002), and William Isacoff Research Foundation to T.H.; SU2C Pancreatic Cancer Dream Team (SU2C-AACR-DT-05-09, SU2C-AACR-DT-20-16) to D.D.V.H., R.M.E., G.W., T.H., A.M.L., T.R. and M.D.; NRSA F31CA206416 and T32GM007752 to N.K.L.; F32CA217033 to G.L.; Flinn Foundation to E.B.; NIH CA178015, CA227807 and CA222862 to E.A.C.; NIH CA197699 and CA186043 to T.R.; NIH CA155620 to A.M.L.; NIH P50CA127297, U01CA210240, P30CA36727 and 5R50CA211462 to P.M.G. and M.A.H. R.M.E. is a Howard Hughes Medical Institute Investigator and March of Dimes Chair in Molecular and Developmental Biology, and supported by Lustgarten, Ipsen/Biomeasure, Freeberg and William Isacoff Research Foundation. We thank Salk core facilities and staff, financially supported by NCI CCSG CA014195, including Advanced Biophotonics, Flow Cytometry, Functional Genomics, Integrative Genomics and Bioinformatics, Next Generation Sequencing and Transgenic Cores. Y.S. received a fellowship from the Helmsley Charitable Trust. T.H. is a Frank and Else Schilling American Cancer Society Professor and the Renato Dulbecco Chair in Cancer Research.	Albrengues J, 2014, CELL REP, V7, P1664, DOI 10.1016/j.celrep.2014.04.036; Andrews S., 2010, FASTQC QUALITY CONTR; Apte MV, 2013, GASTROENTEROLOGY, V144, P1210, DOI 10.1053/j.gastro.2012.11.037; Bayne LJ, 2012, CANCER CELL, V21, P822, DOI 10.1016/j.ccr.2012.04.025; Biffi G, 2019, CANCER DISCOV, V9, P282, DOI 10.1158/2159-8290.CD-18-0710; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Bressy C, 2018, CANCER RES, V78, P909, DOI 10.1158/0008-5472.CAN-15-2790; Chen WD, 2017, J CHROMATOGR A, V1498, P207, DOI 10.1016/j.chroma.2017.01.033; Chu GC, 2007, J CELL BIOCHEM, V101, P887, DOI 10.1002/jcb.21209; Corcoran RB, 2011, CANCER RES, V71, P5020, DOI 10.1158/0008-5472.CAN-11-0908; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Erkan M, 2012, GUT, V61, P172, DOI 10.1136/gutjnl-2011-301220; Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114; Fox RG, 2016, NATURE, V534, P407, DOI 10.1038/nature17988; Fukuda A, 2011, CANCER CELL, V19, P441, DOI 10.1016/j.ccr.2011.03.002; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hong OY, 2000, AM J PATHOL, V157, P1623, DOI 10.1016/S0002-9440(10)64800-6; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Jameson GS, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.4_suppl.341; KIM KJ, 1992, J IMMUNOL METHODS, V156, P9, DOI 10.1016/0022-1759(92)90005-E; Kim MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020636; Laklai H, 2016, NAT MED, V22, P497, DOI 10.1038/nm.4082; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li CW, 2011, GASTROENTEROLOGY, V141, P2218, DOI 10.1053/j.gastro.2011.08.009; Linkert M, 2010, J CELL BIOL, V189, P777, DOI 10.1083/jcb.201004104; Liu SC, 2013, J CLIN INVEST, V123, P5269, DOI 10.1172/JCI63428; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Mahadevan D, 2007, MOL CANCER THER, V6, P1186, DOI 10.1158/1535-7163.MCT-06-0686; Nicola NA, 2015, CYTOKINE GROWTH F R, V26, P533, DOI 10.1016/j.cytogfr.2015.07.001; Ohlund D, 2017, J EXP MED, V214, P579, DOI 10.1084/jem.20162024; Omary MB, 2007, J CLIN INVEST, V117, P50, DOI 10.1172/JCI30082; Penuelas S, 2009, CANCER CELL, V15, P315, DOI 10.1016/j.ccr.2009.02.011; Peterson AC, 2012, MOL CELL PROTEOMICS, V11, P1475, DOI 10.1074/mcp.O112.020131; Pylayeva-Gupta Y, 2012, CANCER CELL, V21, P836, DOI 10.1016/j.ccr.2012.04.024; Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roy N, 2016, GENE DEV, V30, P2669, DOI 10.1101/gad.291021.116; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shackelford DB, 2013, CANCER CELL, V23, P143, DOI 10.1016/j.ccr.2012.12.008; Sherman MH, 2014, CELL, V159, P80, DOI 10.1016/j.cell.2014.08.007; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tape CJ, 2016, CELL, V165, P910, DOI 10.1016/j.cell.2016.03.029; Tian RJ, 2015, P NATL ACAD SCI USA, V112, pE1594, DOI 10.1073/pnas.1503286112; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; Zhang H, 2003, NAT BIOTECHNOL, V21, P660, DOI 10.1038/nbt827; Zheng Y, 2013, NATURE, V499, P166, DOI 10.1038/nature12308	50	183	189	17	192	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 2	2019	569	7754					131	+		10.1038/s41586-019-1130-6	http://dx.doi.org/10.1038/s41586-019-1130-6			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HW2NX	30996350	Green Accepted, Green Submitted			2022-12-28	WOS:000466523700047
J	Visconti, P; Butchart, SHM; Brooks, TM; Langhammer, PF; Marnewick, D; Vergara, S; Yanosky, A; Watson, JEM				Visconti, Piero; Butchart, Stuart H. M.; Brooks, Thomas M.; Langhammer, Penny F.; Marnewick, Daniel; Vergara, Sheila; Yanosky, Alberto; Watson, James E. M.			Protected area targets post-2020	SCIENCE			English	Editorial Material									[Visconti, Piero] Zool Soc London, Inst Zool, London NW1 4RY, England; [Visconti, Piero] UCL, Ctr Biodivers & Environm Res, London C1E6BT, England; [Visconti, Piero] IIASA, Schlosspl 1, A-2361 Laxenburg, Austria; [Butchart, Stuart H. M.] BirdLife Int, Cambridge CB2 3QZ, England; [Butchart, Stuart H. M.] Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England; [Brooks, Thomas M.] Int Union Conservat Nat, CH-1196 Gland, Switzerland; [Langhammer, Penny F.] Global Wildlife Conservat, Austin, TX 78767 USA; [Langhammer, Penny F.] Amphibian Survival Alliance, London SW7 2HQ, England; [Langhammer, Penny F.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Marnewick, Daniel] BirdLife South Africa, ZA-2196 Dunkeld West, South Africa; [Vergara, Sheila] ASEAN Ctr Biodivers, Laguna, Philippines; [Yanosky, Alberto] Guyra Paraguay CONACYT, CC 1132, Asuncion, Paraguay; [Watson, James E. M.] Univ Queensland, Sch Earth & Environm Sci, St Lucia, Qld 4072, Australia; [Watson, James E. M.] Wildlife Conservat Soc, Global Conservat Program, Bronx, NY 10460 USA	Zoological Society of London; University of London; University College London; International Institute for Applied Systems Analysis (IIASA); BirdLife International; University of Cambridge; Arizona State University; Arizona State University-Tempe; University of Queensland; Wildlife Conservation Society	Visconti, P (corresponding author), Zool Soc London, Inst Zool, London NW1 4RY, England.; Visconti, P (corresponding author), UCL, Ctr Biodivers & Environm Res, London C1E6BT, England.; Visconti, P (corresponding author), IIASA, Schlosspl 1, A-2361 Laxenburg, Austria.	visconti@iiasa.ac.at; stuart.butchart@birdlife.org; jwatson@wcs.org	Watson, James Edward Maxwell/D-8779-2013; Marnewick, Daniel/Y-7188-2019; Butchart, Stuart/AAJ-1852-2021; Visconti, Piero/A-3253-2009	Watson, James Edward Maxwell/0000-0003-4942-1984; Marnewick, Daniel/0000-0002-5101-589X; Butchart, Stuart/0000-0002-1140-4049; Visconti, Piero/0000-0001-6823-2826; Brooks, Thomas/0000-0001-8159-3116				Barnes MD, 2018, NAT ECOL EVOL, V2, P759, DOI 10.1038/s41559-018-0501-y; Butchart SHM, 2015, CONSERV LETT, V8, P329, DOI 10.1111/conl.12158; Devillers R, 2015, AQUAT CONSERV, V25, P480, DOI 10.1002/aqc.2445; Geldmann J, 2018, CONSERV LETT, V11, DOI 10.1111/conl.12434; Geldmann J, 2015, BIOL CONSERV, V191, P692, DOI 10.1016/j.biocon.2015.08.029; Green EJ, 2019, CONSERV BIOL, V33, P1360, DOI 10.1111/cobi.13322; IUCN, 2016, GUID US GLOB STAND I, VFirst; Jones KR, 2018, SCIENCE, V360, P788, DOI 10.1126/science.aap9565; Kuempel CD, 2016, CONSERV LETT, V9, P422, DOI 10.1111/conl.12298; Pressey RL, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0280; Symes WS, 2016, GLOBAL CHANGE BIOL, V22, P656, DOI 10.1111/gcb.13089; UNEP, 2022, PROT PLAN WORLD DAT, V2022; Venter O, 2018, CONSERV BIOL, V32, P127, DOI 10.1111/cobi.12970; Venter O, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001891; Watson JEM, 2014, NATURE, V515, P67, DOI 10.1038/nature13947	15	167	168	11	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2019	364	6437					239	241		10.1126/science.aav6886	http://dx.doi.org/10.1126/science.aav6886			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HU0JG	30975769	Green Accepted			2022-12-28	WOS:000464956600030
J	Farahany, NA; Greely, HT; Giattino, CM				Farahany, Nita A.; Greely, Henry T.; Giattino, Charles M.			Part-revived pig brains raise ethical quandaries	NATURE			English	Editorial Material							MECHANISMS		[Farahany, Nita A.] Duke Univ, Law & Philosophy, Durham, NC 27708 USA; [Farahany, Nita A.] Duke Univ, Duke Initiat Sci & Soc, Durham, NC 27708 USA; [Greely, Henry T.] Stanford Univ, Law, Stanford, CA 94305 USA; [Greely, Henry T.] Stanford Univ, Ctr Law & Biosci, Stanford, CA 94305 USA; [Greely, Henry T.] Stanford Univ, Stanford Program Neurosci & Soc, Stanford, CA 94305 USA; [Giattino, Charles M.] Duke Univ, Dept Psychol & Neurosci, Durham, NC USA; [Giattino, Charles M.] Duke Univ, Ctr Cognit Neurosci, Durham, NC USA	Duke University; Duke University; Stanford University; Stanford University; Stanford University; Duke University; Duke University	Farahany, NA (corresponding author), Duke Univ, Law & Philosophy, Durham, NC 27708 USA.; Farahany, NA (corresponding author), Duke Univ, Duke Initiat Sci & Soc, Durham, NC 27708 USA.	farahany@duke.edu	Farahany, Nita/AGH-5500-2022	Farahany, Nita/0000-0003-4808-6256				Azoulay A., 2018, UN CHRONICLE; Brown EN, 2010, NEW ENGL J MED, V363, P2638, DOI 10.1056/NEJMra0808281; Casali AG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006294; Demertzi A, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aat7603; Farahany NA, 2018, NATURE, V556, P429, DOI 10.1038/d41586-018-04813-x; Greely HT, 2018, J NEUROSCI, V38, P10586, DOI 10.1523/JNEUROSCI.2077-18.2018; Horikawa T, 2013, SCIENCE, V340, P639, DOI 10.1126/science.1234330; Huth AG, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00081; Karnatovskaia LV, 2014, NEUROHOSPITALIST, V4, P153, DOI 10.1177/1941874413519802; Koch C, 2016, NAT REV NEUROSCI, V17, P307, DOI 10.1038/nrn.2016.22; Mashour GA, 2018, TRENDS NEUROSCI, V41, P150, DOI 10.1016/j.tins.2018.01.003; Nuffield Council on Bioethics, 2005, ETH RES INV AN; Ogden BE, 2016, ILAR J, V57, P301, DOI 10.1093/ilar/ilw018; Shemie SD, 2014, INTENS CARE MED, V40, P788, DOI 10.1007/s00134-014-3242-7; Vrselja Z, 2019, NATURE, V568, P336, DOI 10.1038/s41586-019-1099-1	15	17	17	0	7	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 18	2019	568	7752					299	302						4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HU0GZ	30996311	Bronze			2022-12-28	WOS:000464950700022
J	Uderhardt, S; Martins, AJ; Tsang, JS; Lammermann, T; Germain, RN				Uderhardt, Stefan; Martins, Andrew J.; Tsang, John S.; Lammermann, Tim; Germain, Ronald N.			Resident Macrophages Cloak Tissue Microlesions to Prevent Neutrophil-Driven Inflammatory Damage	CELL			English	Article							PHYSIOLOGICAL ROLES; MUSCULAR-DYSTROPHY; MUSCLE INJURY; MONOCYTES; MOUSE; POLARIZATION; ENVIRONMENT; RESOLUTION; RECEPTOR; BIOLOGY	Neutrophils are attracted to and generate dense swarms at sites of cell damage in diverse tissues, often extending the local disruption of organ architecture produced by the initial insult. Whether the inflammatory damage resulting from such neutrophil accumulation is an inescapable consequence of parenchymal cell death has not been explored. Using a combination of dynamic intravital imaging and confocal multiplex microscopy, we report here that tissue-resident macrophages rapidly sense the death of individual cells and extend membrane processes that sequester the damage, a process that prevents initiation of the feedforward chemoattractant signaling cascade that results in neutrophil swarms. Through this "cloaking" mechanism, the resident macrophages prevent neutrophil-mediated inflammatory damage, maintaining tissue homeostasis in the face of local cell injury that occurs on a regular basis in many organs because of mechanical and other stresses.	[Uderhardt, Stefan; Germain, Ronald N.] NIAID, Lymphocyte Biol Sect, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Martins, Andrew J.; Tsang, John S.] NIAID, Syst Genom & Bioinformat Unit, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Lammermann, Tim] Max Planck Inst Immunobiol & Epigenet, Grp Immune Cell Dynam, D-79108 Freibcurg, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Max Planck Society	Uderhardt, S; Germain, RN (corresponding author), NIAID, Lymphocyte Biol Sect, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	uderhardts@nih.gov; rgermain@nih.gov	Germain, Ronald/ABE-7090-2020; Uderhardt, Stefan/AAA-5224-2022; Lämmermann, Tim/AAD-7453-2022; Martins, Andrew/AAU-7039-2021; Germain, Ronald N./Z-1945-2019	Uderhardt, Stefan/0000-0002-2489-2109; Martins, Andrew/0000-0002-1832-1924; 	intramural research program of the National Institute of Allergy and Infectious Diseases, NIH; Deutsche Forschungsgemeinschaft (DFG) [UD 84/1-1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001143, ZIAAI000545] Funding Source: NIH RePORTER	intramural research program of the National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to M. Tanaka and T. McGaha for providing CD169-DTR mice and A.M. Schmidt for providing RAGE mice. We thank the members of the R.N.G. laboratory and the Laboratory of Immune System Biology (LISB) for comments and discussions and A. Rumenapf for proofreading. This work was supported by the intramural research program of the National Institute of Allergy and Infectious Diseases, NIH. S.U. received a stipend from the Deutsche Forschungsgemeinschaft (DFG) (UD 84/1-1).	Afonso PV, 2012, DEV CELL, V22, P1079, DOI 10.1016/j.devcel.2012.02.003; Amit I, 2016, NAT IMMUNOL, V17, P18, DOI 10.1038/ni.3325; Nicolas-Avila JA, 2017, IMMUNITY, V46, P15, DOI 10.1016/j.immuni.2016.12.012; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Brandes M, 2013, CELL, V154, P197, DOI 10.1016/j.cell.2013.06.013; Cekic C, 2016, NAT REV IMMUNOL, V16, P177, DOI 10.1038/nri.2016.4; Constien R, 2001, GENESIS, V30, P36, DOI 10.1002/gene.1030; Dal-Secco D, 2015, J EXP MED, V212, P447, DOI 10.1084/jem.20141539; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Degryse B, 2001, J CELL BIOL, V152, P1197, DOI 10.1083/jcb.152.6.1197; Ensan S, 2016, NAT IMMUNOL, V17, P159, DOI 10.1038/ni.3343; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Fullerton JN, 2016, NAT REV DRUG DISCOV, V15, P551, DOI 10.1038/nrd.2016.39; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Gordon S, 2017, PFLUG ARCH EUR J PHY, V469, P365, DOI 10.1007/s00424-017-1945-7; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Hodgetts S, 2006, NEUROMUSCULAR DISORD, V16, P591, DOI 10.1016/j.nmd.2006.06.011; Huebener P, 2015, J CLIN INVEST, V125, P539, DOI 10.1172/JCI76887; Jakubzick C, 2013, IMMUNITY, V39, P599, DOI 10.1016/j.immuni.2013.08.007; Jung CKE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119768; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Li WZ, 2017, P NATL ACAD SCI USA, V114, pE7321, DOI 10.1073/pnas.1708981114; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Miyake Y, 2007, J CLIN INVEST, V117, P2268, DOI 10.1172/JCI31990; Mojumdar K, 2014, EMBO MOL MED, V6, P1476, DOI 10.15252/emmm.201403967; Molawi K, 2014, J EXP MED, V211, P2151, DOI 10.1084/jem.20140639; Murray PJ, 2018, SEMIN IMMUNOL, V35, P12, DOI 10.1016/j.smim.2017.12.005; Murray PJ, 2017, ANNU REV PHYSIOL, V79, P541, DOI 10.1146/annurev-physiol-022516-034339; Ng LG, 2011, J INVEST DERMATOL, V131, P2058, DOI 10.1038/jid.2011.179; Okabe Y, 2016, NAT IMMUNOL, V17, P9, DOI 10.1038/ni.3320; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; Schreiber HA, 2013, J EXP MED, V210, P2025, DOI 10.1084/jem.20130903; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; Uderhardt S, 2012, IMMUNITY, V36, P834, DOI 10.1016/j.immuni.2012.03.010; Venereau E, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00422; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034	44	157	160	1	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2019	177	3					541	+		10.1016/j.cell.2019.02.028	http://dx.doi.org/10.1016/j.cell.2019.02.028			32	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HU0FV	30955887	Green Accepted, Bronze			2022-12-28	WOS:000464947700011
J	Hurley, R				Hurley, Richard			Evidence to contradict "substantial" forced organ harvesting from prisoners in China is lacking, tribunal hears	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		House of Commons, 2019, EARL DAY MOT FORC LI; HURLEY R, 2018, BMJ-BRIT MED J, V363, DOI DOI 10.1136/BMJ.K5250; Kilgour D, 2016, BLOODY HARVEST SLAUG; Rogers W, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024473; Shannon J, 2019, CHINA ORGANS WRITTEN; WISE J, 2019, BMJ-BRIT MED J, V364, DOI DOI 10.1136/BMJ.L596	6	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2019	365								l1805	10.1136/bmj.l1805	http://dx.doi.org/10.1136/bmj.l1805			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU8OP	30992257				2022-12-28	WOS:000465549000010
J	Salisbury, H				Salisbury, Helen			Helen Salisbury: Evidence and experience	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												helen.salisbury@phc.ox.ac.uk						NICE (National Institute for Health and Care Excellence), 2014, CARD DIS RISK ASS RE	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2019	365								l1772	10.1136/bmj.l1772	http://dx.doi.org/10.1136/bmj.l1772			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU8OP	30992278	Bronze			2022-12-28	WOS:000465549000007
J	Horton, R				Horton, Richard			Offline: Facing down the violence of liberal communists	LANCET			English	Editorial Material												richard.horton@lancet.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 13	2019	393	10180					1488	1488		10.1016/S0140-6736(19)30853-0	http://dx.doi.org/10.1016/S0140-6736(19)30853-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU0DA	30983575	Bronze			2022-12-28	WOS:000464940400009
J	Beyeler, A				Beyeler, Anna			Do antidepressants restore lost synapses?	SCIENCE			English	Editorial Material							PREFRONTAL CORTEX; DEPRESSION; KETAMINE		[Beyeler, Anna] Univ Bordeaux, INSERM 1215, Neuroctr Magendie, 146 Rue Leo Saignat, F-33000 Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux	Beyeler, A (corresponding author), Univ Bordeaux, INSERM 1215, Neuroctr Magendie, 146 Rue Leo Saignat, F-33000 Bordeaux, France.	anna.beyeler@inserm.fr	Beyeler, Anna/V-9934-2019	/0000-0003-2371-5706	Region Nouvelle-Aquitaine; French NIH (INSERM); Brain and Behavior Research Foundation	Region Nouvelle-Aquitaine(Region Auvergne-Rhone-AlpesRegion Bourgogne-Franche-ComteRegion Hauts-de-FranceRegion Nouvelle-Aquitaine); French NIH (INSERM); Brain and Behavior Research Foundation	I thank A. Braine for help with this Perspective, and the Region Nouvelle-Aquitaine, the French NIH (INSERM), and the Brain and Behavior Research Foundation for financial support.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Daly EJ, 2018, JAMA PSYCHIAT, V75, P139, DOI 10.1001/jamapsychiatry.2017.3739; Hayashi-Takagi A, 2015, NATURE, V525, P333, DOI 10.1038/nature15257; He H, 2017, BRAIN STRUCT FUNCT, V222, P4051, DOI 10.1007/s00429-017-1451-x; Kessler RC, 2013, ANNU REV PUBL HEALTH, V34, P119, DOI 10.1146/annurev-publhealth-031912-114409; Liu W, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/6871089; Moda-Sava RN, 2019, SCIENCE, V364, P147, DOI 10.1126/science.aat8078; Otis JM, 2017, NATURE, V543, P103, DOI 10.1038/nature21376; Shansky RM, 2009, CEREB CORTEX, V19, P2479, DOI 10.1093/cercor/bhp003; Vander Weele CM, 2018, NATURE, V563, P397, DOI 10.1038/s41586-018-0682-1; Warden MR, 2012, NATURE, V492, P428, DOI 10.1038/nature11617; Yang Y, 2018, NATURE, V554, P317, DOI 10.1038/nature25509; Young KD, 2018, PSYCHIAT CLIN NEUROS, V72, P466, DOI 10.1111/pcn.12665	14	2	2	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2019	364	6436					129	130		10.1126/science.aax0719	http://dx.doi.org/10.1126/science.aax0719			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HT5RC	30975877				2022-12-28	WOS:000464620000023
J	Shepherd, A				Shepherd, Alison			London mayor tackles air pollution	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 10	2019	365								l1701	10.1136/bmj.l1701	http://dx.doi.org/10.1136/bmj.l1701			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU0EL	30971407				2022-12-28	WOS:000464944100010
J	Wei, L; Lai, ECC; Kao-Yang, YH; Walker, BR; MacDonald, TM; Andrew, R				Wei, Li; Lai, Edward Chia-Cheng; Kao-Yang, Yea-Huei; Walker, Brian R.; MacDonald, Thomas M.; Andrew, Ruth			Incidence of type 2 diabetes mellitus in men receiving steroid 5 alpha-reductase inhibitors: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEPATIC STEATOSIS; RESEARCH DATABASE; RISK-FACTORS; DUTASTERIDE; THERAPY; PREVALENCE; DIHYDROTESTOSTERONE; GLUCOCORTICOIDS; VALIDATION	OBJECTIVE To investigate the incidence of new onset type 2 diabetes mellitus in men receiving steroid 5 alpha-reductase inhibitors (dutasteride or finasteride) for long term treatment of benign prostatic hyperplasia. DESIGN Population based cohort study. SETTING UK Clinical Practice Research Datalink (CPRD; 2003-14) and Taiwanese National Health Insurance Research Database (NHIRD; 2002-12). PARTICIPANTS Men in the CPRD who received dutasteride (n=8231), finasteride (n=30 774), or tamsulosin (n=16 270) were evaluated. Propensity score matching (2: 1; dutasteride to finasteride or tamsulosin) produced cohorts of 2090, 3445, and 4018, respectively. In the NHIRD, initial numbers were 1251 (dutasteride), 4194 (finasteride), and 86 263 (tamsulosin), reducing to 1251, 2445, and 2502, respectively, after propensity score matching. MAIN OUTCOMES MEASURE Incident type 2 diabetes using a Cox proportional hazard model. RESULTS In the CPRD, 2081 new onset type 2 diabetes events (368 dutasteride, 1207 finasteride, and 506 tamsulosin) were recorded during a mean follow-up time of 5.2 years (SD 3.1 years). The event rate per 10 000 person years was 76.2 (95% confidence interval 68.4 to 84.0) for dutasteride, 76.6 (72.3 to 80.9) for finasteride, and 60.3 (55.1 to 65.5) for tamsulosin. There was a modest increased risk of type 2 diabetes for dutasteride (adjusted hazard ratio 1.32, 95% confidence interval 1.08 to 1.61) and finasteride (1.26, 1.10 to 1.45) compared with tamsulosin. Results for the NHIRD were consistent with the findings for the CPRD (adjusted hazard ratio 1.34, 95% confidence interval 1.17 to 1.54 for dutasteride, and 1.49, 1.38 to 1.61 for finasteride compared with tamsulosin). Propensity score matched analyses showed similar results. CONCLUSIONS The risk of developing new onset type 2 diabetes appears to be higher in men with benign prostatic hyperplasia exposed to 5 alpha-reductase inhibitors than in men receiving tamsulosin, but did not differ between men receiving dutasteride and those receiving finasteride. Additional monitoring might be required for men starting these drugs, particularly in those with other risk factors for type 2 diabetes.	[Wei, Li] UCL, Sch Pharm, Res Dept Practice & Policy, London, England; [Lai, Edward Chia-Cheng; Kao-Yang, Yea-Huei] Natl Cheng Kung Univ, Coll Med, Inst Clin Pharm & Pharmaceut Sci, Sch Pharm, Tainan, Taiwan; [Walker, Brian R.; Andrew, Ruth] Univ Edinburgh, Queens Med Res Inst, Univ BHF Ctr Cardiovasc Sci, Edinburgh EH16 4TJ, Midlothian, Scotland; [Walker, Brian R.] Newcastle Univ, Int Ctr Life, Inst Genet Med, Newcastle Upon Tyne, Tyne & Wear, England; [MacDonald, Thomas M.] Ninewells Hosp & Med Sch, Med Monitoring Unit, Dundee, Scotland	University of London; University College London; University of London School of Pharmacy; National Cheng Kung University; University of Edinburgh; Newcastle University - UK; University of Dundee	Andrew, R (corresponding author), Univ Edinburgh, Queens Med Res Inst, Univ BHF Ctr Cardiovasc Sci, Edinburgh EH16 4TJ, Midlothian, Scotland.	ruth.andrew@ed.ac.uk	Andrew, Ruth/C-2727-2008; Li, Wei/Z-1091-2019	Andrew, Ruth/0000-0002-6916-2994; Li, Wei/0000-0002-2015-7262; MacDonald, Thomas/0000-0001-5189-6669	Edinburgh and Lothians Health Foundation; MRC [G106/1249] Funding Source: UKRI	Edinburgh and Lothians Health Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by Edinburgh and Lothians Health Foundation. The funder had no role in the design, conduct, or data interpretation of the study. The researchers were independent from the funders, and all authors, external and internal, had full access to all of the data (including statistical reports and tables).	Andriole GL, 2010, NEW ENGL J MED, V362, P1192, DOI 10.1056/NEJMoa0908127; Andriole GL, 2003, EUR UROL, V44, P82, DOI 10.1016/S0302-2838(03)00198-2; Bank TW, 2018, DIAB PREV POP AG 20; Bechis SK, 2014, J UROLOGY, V192, P16, DOI 10.1016/j.juro.2014.01.114; Brown TT, 2005, ARCH INTERN MED, V165, P1179, DOI 10.1001/archinte.165.10.1179; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Chen CC, 2012, EPILEPSIA, V53, P283, DOI 10.1111/j.1528-1167.2011.03332.x; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Clark RV, 2004, J CLIN ENDOCR METAB, V89, P2179, DOI 10.1210/jc.2003-030330; Dowman JK, 2013, ENDOCRINOLOGY, V154, P4536, DOI 10.1210/en.2013-1592; Gisleskog PO, 1998, CLIN PHARMACOL THER, V64, P636, DOI 10.1016/S0009-9236(98)90054-6; Gress TW, 2000, NEW ENGL J MED, V342, P905, DOI 10.1056/NEJM200003303421301; GURWITZ JH, 1994, ARCH INTERN MED, V154, P97, DOI 10.1001/archinte.154.1.97; Hackett G, 2019, WORLD J MENS HEALTH, V37, P31, DOI 10.5534/wjmh.180027; Hazlehurst JM, 2016, J CLIN ENDOCR METAB, V101, P102, DOI 10.1210/jc.2015-2928; Heisel O, 2004, AM J TRANSPLANT, V4, P583, DOI 10.1046/j.1600-6143.2003.00372.x; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Holt RIG, 2006, DIABETES OBES METAB, V8, P125, DOI 10.1111/j.1463-1326.2005.00495.x; Jhan JH, 2018, J DIABETES COMPLICAT, V32, P688, DOI 10.1016/j.jdiacomp.2018.03.007; Lai ECC, 2016, PHARMACOEPIDEM DR S, V25, P123, DOI 10.1002/pds.3903; Lee SS, 2016, PROSTATE, V76, P41, DOI 10.1002/pros.23097; Livingstone DEW, 2017, J ENDOCRINOL, V232, P29, DOI [10.1530/JOE-16-0125, 10.1530/joe-16-0125]; Livingstone DEW, 2015, DIABETES, V64, P447, DOI 10.2337/db14-0249; Loke YK, 2013, J CLIN PHARM THER, V38, P405, DOI 10.1111/jcpt.12080; Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Schulman C, 2006, BJU INT, V97, P73, DOI 10.1111/j.1464-410X.2005.05909.x; Services UDoHaH, 2010, NGC8255 SERV UDOHAH; Traish A, 2017, HORM MOL BIOL CLIN I, V30, DOI 10.1515/hmbci-2017-0015; Upreti R, 2014, J CLIN ENDOCR METAB, V99, pE1397, DOI 10.1210/jc.2014-1395; Wei L, 2004, ANN INTERN MED, V141, P764, DOI 10.7326/0003-4819-141-10-200411160-00007; WHO, 2016, GLOB REP PSOR; Wu CY, 2010, GASTROENTEROLOGY, V139, P1165, DOI 10.1053/j.gastro.2010.06.067; Zghebi SS, 2017, DIABETES OBES METAB, V19, P1537, DOI 10.1111/dom.12964	34	20	22	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 10	2019	365								l1204	10.1136/bmj.l1204	http://dx.doi.org/10.1136/bmj.l1204			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU0EL	30971393	Green Published			2022-12-28	WOS:000464944100001
J	Fraser, B				Fraser, Barbara			Providing care for trans women with HIV/AIDS in Peru	LANCET			English	Editorial Material																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 6	2019	393	10179					1399	1400		10.1016/S0140-6736(19)30806-2	http://dx.doi.org/10.1016/S0140-6736(19)30806-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HS0OU	30967204				2022-12-28	WOS:000463561000012
J	Pevsner, J				Pevsner, Jonathan			Leonardo da Vinci's studies of the brain	LANCET			English	Review								Leonardo da Vinci (1452-1519) contributed to the study of the nervous system. His earliest surviving anatomical drawings (circa 1485-93) included studies of the skull, brain, and cerebral ventricles. These works reflected his efforts to understand medieval psychology, including the localisation of sensory and motor functions to the brain. He was also the first to pith a frog, concluding that piercing the spinal medulla causes immediate death. After a 10-year interval in the early 1500s Leonardo resumed his anatomical studies and developed a method to inject hot wax into the ventricular system, creating a cast that showed the shape and extent of the ventricles. During this period he also progressed in his understanding of the anatomy of the cranial nerves. Besides being the first to identify the olfactory nerve as a cranial nerve, his dissections showed him that contrary to previous theories, the nerves do not converge on the lateral or third ventricles. Leonardo also performed detailed studies of the peripheral nervous system. Although his discoveries had little influence on the development of the field of anatomy, they represent an astonishingly sharp break from the field that had seen little if any progress in the previous 13 centuries. His work reflects the emergence of the modern scientific era and forms a key part of his integrative approach to art and science.	[Pevsner, Jonathan] Kennedy Krieger Inst, Dept Neurol, Baltimore, MD 21205 USA	Kennedy Krieger Institute	Pevsner, J (corresponding author), Kennedy Krieger Inst, Dept Neurol, Baltimore, MD 21205 USA.	pevsner@kennedykrieger.org						Bullough V., 1974, DICT SCI BIOGRAPHY, P468; Carpi JBD, 1959, SHORT INTRO ANATOMY; Clark K., 1988, L DAVINCI, P119; Clark K, 1968, CATALOGUE DRAWINGS L, V2nd; CLARKE EDWIN, 1962, TRANS AND STUD COLL PHYSICIANS PHILADELPHIA, V30, P85; da Vinci Leonardo, 1960, MANUSCRIT B I FRANCE, p9r; da Vinci Leonardo, 1911, QUADERNI ANATOMIA FO, P1911; da Vinci Leonardo, 1901, MANOSCRITTI L DAVINC; da Vinci Leonardo, 1898, MANOSCRITTI L DAVINC; Dewhurst K., 1996, ILLUSTRATED HIST BRA; Galen Wilson L., 1974, DICT SCI BIOGRAPHY, P227; Gruner OC, 1930, TREATISE CANON MED A; Keele KD, 1983, L DAVINCIS ELEMENTS, P60; Keele KD, 1978, CORPUS ANATOMICAL ST, p1r; Keele KD, 1963, ESSAY HIST ITALIAN N, P15; Keele KD, 1983, L DAVINCIS ELEMENTS, P229; Keele KD, 1978, CORPUS ANATOMICAL ST, p113r; Keele KD, 1978, CORPUS ANATOMICAL ST, p4r; Keele KD, 1978, CORPUS ANATOMICAL ST, p39r; Keele KD, 1978, CORPUS ANATOMICAL ST, p40r; Keele KD, 1978, CORPUS ANATOMICAL ST; Keele KD, 1978, CORTPUS ANATOMICAL S, p32r; Keele Kenneth D., 1969, LEONARDOS LEGACY INT, P35; Kemp M, 1971, J Warburg Courtauld Inst, V34, P115, DOI 10.2307/751018; Kemp M, 1972, J Warburg Courtauld Inst, V35, P200; Lindberg David G., 1976, THEORIES VISION AL K; MacCurdy E., 1938, NOTEBOOKS L DAVINCI; Magoun HW, 1958, CIBA FDN S NEUROLOGI; McMahon AP, 1956, L DAVINCI TREATISE P; O'Malley CD, 1963, STORIA NEUROLOGIA IT, P31; O'Malley CD, 1952, L DAVINCI HUMAN BODY, P147; Pedretti Carlo., 1977, LIT WORKS L DAVINCI; Pevsner J, 2002, TRENDS NEUROSCI, V25, P217, DOI 10.1016/S0166-2236(00)02121-4; Richter J.P., 1883, LIT WORKS L DAVINCI; Richter JeanPaul., 1970, LIT WORKS L DAVINCI; Siegel R.E., 1970, GALEN SENSE PERCEPTI; Strong DS, 1979, LEONARDO ON THE EYE, P53; Sudhoff W, 1913, STUDIEN GESCH MED, V7, P149; Venerella J, 2002, MANUSCRIPTS L DAVINC; Verboon Annemieke R, 2014, Sudhoffs Arch, V98, P212	40	6	6	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 6	2019	393	10179					1465	1472		10.1016/S0140-6736(19)30302-2	http://dx.doi.org/10.1016/S0140-6736(19)30302-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HS0OU	30967217				2022-12-28	WOS:000463561000031
J	Zarocostas, J				Zarocostas, John			WHO structural overhaul draws mixed initial response	LANCET			English	Editorial Material																			0	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 16	2019	393	10176					1085	1085		10.1016/S0140-6736(19)30574-4	http://dx.doi.org/10.1016/S0140-6736(19)30574-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HP1HF	30957742				2022-12-28	WOS:000461416600011
